Citrus Sinensis ID: 013404

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440---
Protein Sequence
MKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSEDLHEGR
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccccccHHHHHHHHHHHccccccccccccEEccccccEEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHcccccccccccccccHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccHHEEEEHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEccccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEcccccccEEEEEEEEccccccHHHHHccccEEccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHcccc
Coil and Loop (DISEMBL)
mkapthraspssssstsnkgkhsnLILIFGIGTGLLITAIISVLIICScafrgrkskaspketakprtadavtlggslphptstRFLAYEELKEatnnfepasilgeggfgrVFKGVLSDGTAVAIKRltcggqqgdkEFLVEVEMLSRLHHRNLVKLVGYYssrdssqhllcyelvpngsleswlhgplgvnchlDWETRMKIALDAARGLaylhedsqpcvihrdfkasnillennfhakvadfglakqapegrtnylSTRVmgtfgyvapeyamtghLLVKSDVYSYGVVLLELltgrkpvdmsqpsgqenlvtwarpilrdkdrleeladprlggkypkedfIRVCTIAAacvapeanqrptmGEVVQSLKMVQRVIecqdptltssnnranlrqssttfdsdgtssmfssgpysglsafdnenvsrtavfsedlhegr
Flexible Loop (DISEMBL)
mkapthraspssssstsnkgkhSNLILIFGIGTGLLITAIISVLIICSCAFRgrkskaspketakprtadavtlggslphpTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTgrkpvdmsqpsgqenlvtwarpilrdkdrleeladprlggkypkedfIRVCTIAAACvapeanqrPTMGEVVQSLKMVQRVIECQdptltssnnranlrqssttfdsdgtssMFSSGPYSGlsafdnenvsrTAVFSEDLHEGR
Low Complexity Region (SEG)
MKapthraspssssstsnkgkhsnlilifgigtgllitaiiSVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQssttfdsdgtssmfssgPYSGLSAFDNENVSRTAVFSEDLHEGR
Disordered region (IsUnstruct)
***********************NLILIFGIGTGLLITAIISVLIICSCAFR********************************RFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR*************LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEAN****MGEVVQSLKMVQRVIEC************************************************************
Disordered Region (DISOPRED)
***************************IFGIGTGLLITAIISVLIIC**************************************FLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM*******************************************************************
Disordered Region (DISEMBL)
********************KHSNLILIFGIGTGLLITAIISVLIICSCAFRG***************ADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSEDLHEGR
Disordered Region (DISPRO)
**********************SNLILIFGIGTGLLITAIISVLIICSCAFRG****************************TSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV***************************************************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSEDLHEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	443	2.2.26 [Sep-21-2011]
Q8RWW0	744	Receptor-like serine/thre	no	no	0.647	0.385	0.633	1e-103
Q9C660	762	Proline-rich receptor-lik	no	no	0.758	0.440	0.488	2e-89
Q9SX31	708	Proline-rich receptor-lik	no	no	0.826	0.516	0.452	3e-89
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.862	0.560	0.441	5e-88
Q9FE20	456	Serine/threonine-protein	no	no	0.724	0.703	0.513	6e-88
Q9LV48	652	Proline-rich receptor-lik	no	no	0.641	0.435	0.530	3e-82
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.756	0.471	0.464	1e-81
Q9SFT7	414	Serine/threonine-protein	no	no	0.645	0.690	0.519	4e-81
P43293	389	Probable serine/threonine	no	no	0.747	0.850	0.457	4e-81
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.717	0.441	0.501	5e-81

>sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1

 Score =  374 bits (961), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 187/295 (63%), Positives = 226/295 (76%), Gaps = 8/295 (2%)

Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 142
           S +     EL++AT+ F    +LGEGGFGRV++G + DGT VA+K LT   Q  D+EF+ 
Sbjct: 333 SVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIA 392

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EVEMLSRLHHRNLVKL+G     +     L YELV NGS+ES LH        LDW+ R+
Sbjct: 393 EVEMLSRLHHRNLVKLIGI--CIEGRTRCLIYELVHNGSVESHLH-----EGTLDWDARL 445

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           KIAL AARGLAYLHEDS P VIHRDFKASN+LLE++F  KV+DFGLA++A EG + ++ST
Sbjct: 446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHIST 504

Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 322
           RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR+PVDMSQPSG+ENLVTWARP+
Sbjct: 505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564

Query: 323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
           L +++ LE+L DP L G Y  +D  +V  IA+ CV  E + RP MGEVVQ+LK++
Sbjct: 565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLI 619

Required during the differentiation of the protoderm into shoots epidermis and cuticle.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  330 bits (845), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 184/377 (48%), Positives = 236/377 (62%), Gaps = 41/377 (10%)

Query: 31  IGTGLLITAIISVLIICSCAFRGRKSKAS----------PKETAKPRTADAVT------- 73
           IG  L++  +I V++   C  + RK + S          P E++ PR+  A+        
Sbjct: 335 IGVALVLLTLIGVVV---CCLKKRKKRLSTIGGGYVMPTPMESSSPRSDSALLKTQSSAP 391

Query: 74  -----------LGGSLP--HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD 120
                      L  S P     S    +YEEL  ATN F   ++LGEGGFGRV+KGVL D
Sbjct: 392 LVGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPD 451

Query: 121 GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 180
              VA+K+L  GG QGD+EF  EV+ +SR+HHRNL+ +VGY  S +  + LL Y+ VPN 
Sbjct: 452 ERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISEN--RRLLIYDYVPNN 509

Query: 181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 240
           +L   LH        LDW TR+KIA  AARGLAYLHED  P +IHRD K+SNILLENNFH
Sbjct: 510 NLYFHLHA--AGTPGLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFH 567

Query: 241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
           A V+DFGLAK A +  T +++TRVMGTFGY+APEYA +G L  KSDV+S+GVVLLEL+TG
Sbjct: 568 ALVSDFGLAKLALDCNT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITG 626

Query: 301 RKPVDMSQPSGQENLVTWARPILRDKDRLEE---LADPRLGGKYPKEDFIRVCTIAAACV 357
           RKPVD SQP G E+LV WARP+L +    EE   LADP+LG  Y   +  R+   AAAC+
Sbjct: 627 RKPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACI 686

Query: 358 APEANQRPTMGEVVQSL 374
              A +RP M ++V++ 
Sbjct: 687 RHSATKRPRMSQIVRAF 703

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1

 Score =  329 bits (843), Expect = 3e-89,   Method: Compositional matrix adjust.
 Identities = 180/398 (45%), Positives = 243/398 (61%), Gaps = 32/398 (8%)

Query: 4   PTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICS-------CAFRGRKS 56
           PT R    + +ST+N G  +  ++   +   L++  +  + + C         A  G   
Sbjct: 259 PTLRPPLDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDV 318

Query: 57  KASPKETAKPRTADAVTLGGSLPHPTSTR----------------FLAYEELKEATNNFE 100
             SP  +     +    +  S P   S R                  +YEEL +ATN F 
Sbjct: 319 TPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFS 378

Query: 101 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
             ++LGEGGFG V+KG+L DG  VA+K+L  GG QGD+EF  EVE LSR+HHR+LV +VG
Sbjct: 379 QENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVG 438

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
           +  S D  + LL Y+ V N  L   LHG   V   LDW TR+KIA  AARGLAYLHED  
Sbjct: 439 HCISGD--RRLLIYDYVSNNDLYFHLHGEKSV---LDWATRVKIAAGAARGLAYLHEDCH 493

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
           P +IHRD K+SNILLE+NF A+V+DFGLA+ A +  T +++TRV+GTFGY+APEYA +G 
Sbjct: 494 PRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSGK 552

Query: 281 LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---DKDRLEELADPRL 337
           L  KSDV+S+GVVLLEL+TGRKPVD SQP G E+LV WARP++    + +  + LADP+L
Sbjct: 553 LTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKL 612

Query: 338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           GG Y + +  R+   A ACV   A +RP MG++V++ +
Sbjct: 613 GGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFE 650

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  325 bits (832), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 189/428 (44%), Positives = 252/428 (58%), Gaps = 46/428 (10%)

Query: 10  PSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSK---------ASP 60
           PSSS   S  G  +  I+  G+  GL+    +S+ ++     R RK K           P
Sbjct: 224 PSSSPGKSEVG--TGGIVAIGVIVGLVF---LSLFVMGVWFTRKRKRKDPGTFVGYTMPP 278

Query: 61  KETAKPRTADAVTLGGSLPHPTSTR----------------------FLAYEELKEATNN 98
              + P+ +D V        P   R                      + +Y+EL + T+ 
Sbjct: 279 SAYSSPQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSYDELSQVTSG 338

Query: 99  FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           F   ++LGEGGFG V+KGVLSDG  VA+K+L  GG QG++EF  EVE++SR+HHR+LV L
Sbjct: 339 FSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTL 398

Query: 159 VGYYSSRDSSQH-LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           VGY  S    QH LL Y+ VPN +L   LH P      + WETR+++A  AARG+AYLHE
Sbjct: 399 VGYCISE---QHRLLVYDYVPNNTLHYHLHAP--GRPVMTWETRVRVAAGAARGIAYLHE 453

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYA 276
           D  P +IHRD K+SNILL+N+F A VADFGLAK A E   N ++STRVMGTFGY+APEYA
Sbjct: 454 DCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYA 513

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR---DKDRLEELA 333
            +G L  K+DVYSYGV+LLEL+TGRKPVD SQP G E+LV WARP+L    + +  +EL 
Sbjct: 514 TSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELV 573

Query: 334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN 393
           DPRLG  +   +  R+   AAACV   A +RP M +VV++L  ++   +  +      + 
Sbjct: 574 DPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDITNGMRPGQSQ 633

Query: 394 RANLRQSS 401
             + RQ S
Sbjct: 634 VFDSRQQS 641

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  325 bits (832), Expect = 6e-88,   Method: Compositional matrix adjust.
 Identities = 168/327 (51%), Positives = 214/327 (65%), Gaps = 6/327 (1%)

Query: 87  LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVE 145
            A+ EL  AT NF P + LGEGGFGRV+KG L S G  VA+K+L   G QG++EFLVEV 
Sbjct: 74  FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVL 133

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           MLS LHH NLV L+GY +  D  Q LL YE +P GSLE  LH        LDW  RMKIA
Sbjct: 134 MLSLLHHPNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIA 191

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
             AA+GL +LH+ + P VI+RDFK+SNILL+  FH K++DFGLAK  P G  +++STRVM
Sbjct: 192 AGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVM 251

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
           GT+GY APEYAMTG L VKSDVYS+GVV LEL+TGRK +D   P G++NLV WARP+  D
Sbjct: 252 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFND 311

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 385
           + +  +LADPRL G++P     +   +A+ C+  +A  RP + +VV +L  +    +  D
Sbjct: 312 RRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLAN--QAYD 369

Query: 386 PTLTSS-NNRANLRQSSTTFDSDGTSS 411
           P+   S  NR        T + DG  S
Sbjct: 370 PSKDDSRRNRDERGARLITRNDDGGGS 396

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  306 bits (783), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 155/292 (53%), Positives = 206/292 (70%), Gaps = 8/292 (2%)

Query: 87  LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM 146
             YEEL  ATN F  A++LG+GGFG V KG+L  G  VA+K+L  G  QG++EF  EVE+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           +SR+HHR+LV L+GY  +    Q LL YE VPN +LE  LHG       ++W TR+KIAL
Sbjct: 328 ISRVHHRHLVSLIGYCMA--GVQRLLVYEFVPNNNLEFHLHGK--GRPTMEWSTRLKIAL 383

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
            +A+GL+YLHED  P +IHRD KASNIL++  F AKVADFGLAK A +  T ++STRVMG
Sbjct: 384 GSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRVMG 442

Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR-- 324
           TFGY+APEYA +G L  KSDV+S+GVVLLEL+TGR+PVD +     ++LV WARP+L   
Sbjct: 443 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRA 502

Query: 325 -DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
            ++   E LAD ++G +Y +E+  R+   AAACV   A +RP M ++V++L+
Sbjct: 503 SEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  304 bits (778), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 170/366 (46%), Positives = 227/366 (62%), Gaps = 31/366 (8%)

Query: 70  DAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRL 129
           D+  +G    H        YEEL + T  F   +ILGEGGFG V+KG L+DG  VA+K+L
Sbjct: 330 DSAVMGSGQTH------FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQL 383

Query: 130 TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG- 188
             G  QGD+EF  EVE++SR+HHR+LV LVGY  +   S+ LL YE VPN +LE  LHG 
Sbjct: 384 KVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIA--DSERLLIYEYVPNQTLEHHLHGK 441

Query: 189 --PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 246
             P+     L+W  R++IA+ +A+GLAYLHED  P +IHRD K++NILL++ F A+VADF
Sbjct: 442 GRPV-----LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADF 496

Query: 247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 306
           GLAK     +T ++STRVMGTFGY+APEYA +G L  +SDV+S+GVVLLEL+TGRKPVD 
Sbjct: 497 GLAKLNDSTQT-HVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQ 555

Query: 307 SQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ 363
            QP G+E+LV WARP+L    +     EL D RL   Y + +  R+   AAACV     +
Sbjct: 556 YQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK 615

Query: 364 RPTMGEVVQSLKMVQRVIECQDPTLTS----------SNNRANLRQSSTTFDSDGTSSMF 413
           RP M +VV++L     + +  +               +N+    R+ +  FD    S M+
Sbjct: 616 RPRMVQVVRALDSEGDMGDISNGNKVGQSSAYDSGQYNNDTMKFRKMAFGFDDSSDSGMY 675

Query: 414 SSGPYS 419
            SG YS
Sbjct: 676 -SGDYS 680

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1

 Score =  302 bits (773), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 150/289 (51%), Positives = 199/289 (68%), Gaps = 3/289 (1%)

Query: 87  LAYEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVE 145
            ++ EL  AT NF    ++GEGGFGRV+KG L   G  VA+K+L   G QG+KEF+VEV 
Sbjct: 67  FSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVL 126

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           MLS LHH++LV L+GY +  D  Q LL YE +  GSLE  L         LDW+TR++IA
Sbjct: 127 MLSLLHHKHLVNLIGYCA--DGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIA 184

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
           L AA GL YLH+ + P VI+RD KA+NILL+  F+AK++DFGLAK  P G   ++S+RVM
Sbjct: 185 LGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVM 244

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
           GT+GY APEY  TG L  KSDVYS+GVVLLEL+TGR+ +D ++P  ++NLVTWA+P+ ++
Sbjct: 245 GTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKE 304

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
             R  ELADP L G +P++   +   +AA C+  EA  RP M +VV +L
Sbjct: 305 PSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  302 bits (773), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 162/354 (45%), Positives = 226/354 (63%), Gaps = 23/354 (6%)

Query: 53  GRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGR 112
           G K  ++   +  PRT   +    +L +       +  ELK AT NF P S++GEGGFG 
Sbjct: 28  GSKGSSTASFSYMPRTEGEILQNANLKN------FSLSELKSATRNFRPDSVVGEGGFGC 81

Query: 113 VFKGVLSD----------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           VFKG + +          G  +A+KRL   G QG +E+L E+  L +L H NLVKL+GY 
Sbjct: 82  VFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGY- 140

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              +    LL YE +  GSLE+ L         L W TR+++AL AARGLA+LH ++QP 
Sbjct: 141 -CLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLH-NAQPQ 198

Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 282
           VI+RDFKASNILL++N++AK++DFGLA+  P G  +++STRVMGT GY APEY  TGHL 
Sbjct: 199 VIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLS 258

Query: 283 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 342
           VKSDVYS+GVVLLELL+GR+ +D +QP G+ NLV WARP L +K RL  + DPRL G+Y 
Sbjct: 259 VKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYS 318

Query: 343 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK--MVQRVI--ECQDPTLTSSN 392
               +++  +A  C++ +A  RPTM E+V++++   +Q+    E Q+P ++  N
Sbjct: 319 LTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASKEQQNPQISIDN 372

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  301 bits (772), Expect = 5e-81,   Method: Compositional matrix adjust.
 Identities = 172/343 (50%), Positives = 224/343 (65%), Gaps = 25/343 (7%)

Query: 68  TADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIK 127
           T D+  LG    H       +YEEL E T  F   +ILGEGGFG V+KG L DG  VA+K
Sbjct: 346 TPDSAILGSGQTH------FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVK 399

Query: 128 RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH-LLCYELVPNGSLESWL 186
           +L  G  QGD+EF  EVE++SR+HHR+LV LVGY  S    QH LL YE V N +LE  L
Sbjct: 400 QLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIS---DQHRLLIYEYVSNQTLEHHL 456

Query: 187 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 246
           HG  G+   L+W  R++IA+ +A+GLAYLHED  P +IHRD K++NILL++ + A+VADF
Sbjct: 457 HG-KGLPV-LEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADF 514

Query: 247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 306
           GLA+     +T ++STRVMGTFGY+APEYA +G L  +SDV+S+GVVLLEL+TGRKPVD 
Sbjct: 515 GLARLNDTTQT-HVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQ 573

Query: 307 SQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ 363
           +QP G+E+LV WARP+L    +   L EL D RL  +Y + +  R+   AAACV     +
Sbjct: 574 TQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPK 633

Query: 364 RPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDS 406
           RP M +VV       R ++C   +   SN    + Q STT+DS
Sbjct: 634 RPRMVQVV-------RALDCDGDSGDISNG-IKIGQ-STTYDS 667

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	443
147821305	707	hypothetical protein VITISV_041991 [Viti	1.0	0.626	0.862	0.0
225437589	707	PREDICTED: receptor-like serine/threonin	1.0	0.626	0.860	0.0
356501859	695	PREDICTED: receptor-like serine/threonin	0.997	0.635	0.846	0.0
351727989	568	NAK-like ser/thr protein kinase [Glycine	0.995	0.776	0.846	0.0
297814127	725	kinase family protein [Arabidopsis lyrat	0.997	0.609	0.821	0.0
357442219	630	Protein kinase 2B [Medicago truncatula]	0.995	0.7	0.819	0.0
449484209	723	PREDICTED: receptor-like serine/threonin	0.977	0.598	0.859	0.0
449469022	723	PREDICTED: receptor-like serine/threonin	0.977	0.598	0.859	0.0
30679031	725	protein kinase family protein [Arabidops	0.997	0.609	0.810	0.0
3912917	707	putative NAK-like ser/thr protein kinase	0.997	0.625	0.810	0.0

>gi|147821305|emb|CAN74588.1| hypothetical protein VITISV_041991 [Vitis vinifera]

 Score =  795 bits (2053), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 382/443 (86%), Positives = 408/443 (92%)

Query: 1   MKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASP 60
           M+AP ++ S S+S   SNK KH NL+LI GI  G+L  AIISV+++  CA   +K+K SP
Sbjct: 265 MEAPANQYSASTSHVDSNKRKHPNLVLILGIIAGILTVAIISVIMVSLCASCRKKTKPSP 324

Query: 61  KETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD 120
           +E  KP TAD V + GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD
Sbjct: 325 EENVKPSTADPVPVVGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD 384

Query: 121 GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 180
           GTAVAIKRLT GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELVPNG
Sbjct: 385 GTAVAIKRLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVPNG 444

Query: 181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 240
           SLE+WLHGPLGVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH
Sbjct: 445 SLEAWLHGPLGVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 504

Query: 241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
           AKVADFGLAK+APEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG
Sbjct: 505 AKVADFGLAKKAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 564

Query: 301 RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPE 360
           R+PV+MSQPSGQENLVTWARPILRDKDRLEELAD RL GKYPKEDF+RVCTIAAACVAPE
Sbjct: 565 RRPVEMSQPSGQENLVTWARPILRDKDRLEELADERLAGKYPKEDFVRVCTIAAACVAPE 624

Query: 361 ANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSG 420
           ANQRPTMGEVVQSLKMVQRV+E QD  LTSSN R NLRQSSTTF+SDGTSS+FSSGPYSG
Sbjct: 625 ANQRPTMGEVVQSLKMVQRVMEYQDSMLTSSNARPNLRQSSTTFESDGTSSIFSSGPYSG 684

Query: 421 LSAFDNENVSRTAVFSEDLHEGR 443
           LSAFDN+N+SRTAVFSEDLHEGR
Sbjct: 685 LSAFDNDNISRTAVFSEDLHEGR 707

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225437589|ref|XP_002270928.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2 [Vitis vinifera] gi|297743991|emb|CBI36961.3| unnamed protein product [Vitis vinifera]

 Score =  792 bits (2046), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 381/443 (86%), Positives = 407/443 (91%)

Query: 1   MKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASP 60
           M+AP ++ S S+S   SNK KH NL+LI GI  G+L  AII V+++  CA   +K+K SP
Sbjct: 265 MEAPANQYSASTSHVDSNKRKHPNLVLILGIIAGILTVAIICVIMVSLCASCRKKTKPSP 324

Query: 61  KETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD 120
           +E  KP TAD V + GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD
Sbjct: 325 EENVKPSTADPVPVVGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD 384

Query: 121 GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 180
           GTAVAIKRLT GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELVPNG
Sbjct: 385 GTAVAIKRLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVPNG 444

Query: 181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 240
           SLE+WLHGPLGVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH
Sbjct: 445 SLEAWLHGPLGVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 504

Query: 241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
           AKVADFGLAK+APEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG
Sbjct: 505 AKVADFGLAKKAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 564

Query: 301 RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPE 360
           R+PV+MSQPSGQENLVTWARPILRDKDRLEELAD RL GKYPKEDF+RVCTIAAACVAPE
Sbjct: 565 RRPVEMSQPSGQENLVTWARPILRDKDRLEELADERLAGKYPKEDFVRVCTIAAACVAPE 624

Query: 361 ANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSG 420
           ANQRPTMGEVVQSLKMVQRV+E QD  LTSSN R NLRQSSTTF+SDGTSS+FSSGPYSG
Sbjct: 625 ANQRPTMGEVVQSLKMVQRVMEYQDSMLTSSNARPNLRQSSTTFESDGTSSIFSSGPYSG 684

Query: 421 LSAFDNENVSRTAVFSEDLHEGR 443
           LSAFDN+N+SRTAVFSEDLHEGR
Sbjct: 685 LSAFDNDNISRTAVFSEDLHEGR 707

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356501859|ref|XP_003519741.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max]

 Score =  786 bits (2029), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 375/443 (84%), Positives = 402/443 (90%), Gaps = 1/443 (0%)

Query: 1   MKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASP 60
           MKAP  RA  ++ SSTS++G+ SNL+LI GI TG+L  +I+ VLI+C C  R  K+K  P
Sbjct: 254 MKAPQRRAPTATLSSTSDRGRRSNLLLILGIVTGILFISIVCVLILCLCTMRP-KTKTPP 312

Query: 61  KETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD 120
            ET KPR   AV+  GSLPHPTSTRF+AYEELKEATNNFEPAS+LGEGGFGRV+KGVL+D
Sbjct: 313 TETEKPRIESAVSAVGSLPHPTSTRFIAYEELKEATNNFEPASVLGEGGFGRVYKGVLND 372

Query: 121 GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 180
           GTAVAIKRLT GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELVPNG
Sbjct: 373 GTAVAIKRLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVPNG 432

Query: 181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 240
           SLE+WLHGPLG+NC LDW+TRMKIALDAARGLAY+HEDSQPCVIHRDFKASNILLENNFH
Sbjct: 433 SLEAWLHGPLGINCPLDWDTRMKIALDAARGLAYMHEDSQPCVIHRDFKASNILLENNFH 492

Query: 241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
           AKVADFGLAKQAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL G
Sbjct: 493 AKVADFGLAKQAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLIG 552

Query: 301 RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPE 360
           RKPVDMSQPSGQENLVTWARPILRDKD LEELADPRLGG+YPKEDF+RVCTIAAACVAPE
Sbjct: 553 RKPVDMSQPSGQENLVTWARPILRDKDSLEELADPRLGGRYPKEDFVRVCTIAAACVAPE 612

Query: 361 ANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSG 420
           A+QRP MGEVVQSLKMVQRV E  DP L SSN R NLRQSSTT+DSDGTSSMFSSGPYSG
Sbjct: 613 ASQRPAMGEVVQSLKMVQRVTESHDPVLASSNTRPNLRQSSTTYDSDGTSSMFSSGPYSG 672

Query: 421 LSAFDNENVSRTAVFSEDLHEGR 443
           LS FD  N+SRTAVFSEDLHEGR
Sbjct: 673 LSTFDYHNISRTAVFSEDLHEGR 695

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351727989|ref|NP_001235388.1| NAK-like ser/thr protein kinase [Glycine max] gi|223452482|gb|ACM89568.1| NAK-like ser/thr protein kinase [Glycine max]

 Score =  782 bits (2020), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/442 (84%), Positives = 401/442 (90%), Gaps = 1/442 (0%)

Query: 2   KAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPK 61
           KAP  RA  ++ SSTS+ G+HSNL++I GI TG+L  +I+ VLI+C C  R  K+K  P 
Sbjct: 128 KAPKRRAPTTTLSSTSDGGRHSNLLIILGIVTGVLFISIVCVLILCLCTMRP-KTKTPPT 186

Query: 62  ETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG 121
           ET   R   AV   GSLPHPTSTRF+AYEELKEATNNFEPAS+LGEGGFGRVFKGVL+DG
Sbjct: 187 ETENSRIESAVPAVGSLPHPTSTRFIAYEELKEATNNFEPASVLGEGGFGRVFKGVLNDG 246

Query: 122 TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 181
           TAVAIKRLT GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELV NGS
Sbjct: 247 TAVAIKRLTSGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVANGS 306

Query: 182 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 241
           LE+WLHGPLG+NC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA
Sbjct: 307 LEAWLHGPLGINCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 366

Query: 242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
           KVADFGLAKQAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR
Sbjct: 367 KVADFGLAKQAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 426

Query: 302 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA 361
           KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG+YPKEDF+RVCTIAAACVAPEA
Sbjct: 427 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGRYPKEDFVRVCTIAAACVAPEA 486

Query: 362 NQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGL 421
           +QRPTMGEVVQSLKMVQR+ E  DP L SSN R NLRQSSTT++SDGTSSMFSSGPYSGL
Sbjct: 487 SQRPTMGEVVQSLKMVQRITESHDPVLASSNTRPNLRQSSTTYESDGTSSMFSSGPYSGL 546

Query: 422 SAFDNENVSRTAVFSEDLHEGR 443
           S FD +N+SRTAVFSEDLHEGR
Sbjct: 547 STFDYDNISRTAVFSEDLHEGR 568

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297814127|ref|XP_002874947.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297320784|gb|EFH51206.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  760 bits (1962), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 364/443 (82%), Positives = 397/443 (89%), Gaps = 1/443 (0%)

Query: 2   KAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPK 61
           KAP+  +S S+S  +  K KH NLILIF I  G+LI AII+VL+ICSCA R  K+    K
Sbjct: 283 KAPSQGSSASTSVRSPGKKKHPNLILIFAIAAGVLILAIITVLVICSCALREEKAPDPHK 342

Query: 62  ETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG 121
           ET KPR  DA ++GGSLPHP STRFL+YEELKEAT+NFE ASILGEGGFG+V++G+L+DG
Sbjct: 343 ETVKPRNLDAGSVGGSLPHPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADG 402

Query: 122 TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 181
           TAVAIK+LT GG QGDKEF VE++MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS
Sbjct: 403 TAVAIKKLTSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 462

Query: 182 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 241
           LE+WLHGPLG+NC LDW+TRMKIALDAARGLAYLHEDSQP VIHRDFKASNILLENNF+A
Sbjct: 463 LEAWLHGPLGLNCPLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNA 522

Query: 242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
           KVADFGLAKQAPEGR N+LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR
Sbjct: 523 KVADFGLAKQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 582

Query: 302 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA 361
           KPVDMSQPSGQENLVTW RPILRDKDRLEEL D RL GKYPKEDFIRVCTIAAACVAPEA
Sbjct: 583 KPVDMSQPSGQENLVTWTRPILRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEA 642

Query: 362 NQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN-RANLRQSSTTFDSDGTSSMFSSGPYSG 420
           +QRPTMGEVVQSLKMVQRV+E QDP L +SN  R N RQSS TF+S+ TSSMFSSGPYSG
Sbjct: 643 SQRPTMGEVVQSLKMVQRVVEYQDPVLNTSNKARPNRRQSSATFESEVTSSMFSSGPYSG 702

Query: 421 LSAFDNENVSRTAVFSEDLHEGR 443
           LSAFD+EN++RT VFSEDLHEGR
Sbjct: 703 LSAFDHENITRTTVFSEDLHEGR 725

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357442219|ref|XP_003591387.1| Protein kinase 2B [Medicago truncatula] gi|355480435|gb|AES61638.1| Protein kinase 2B [Medicago truncatula]

 Score =  759 bits (1961), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/443 (81%), Positives = 397/443 (89%), Gaps = 2/443 (0%)

Query: 1   MKAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASP 60
           +K P  R   ++SSSTS++G+HSNL++I GI TG+LI +II VLI+C C  R +  +  P
Sbjct: 190 VKTPERRVPTATSSSTSDRGRHSNLLVILGIVTGILIMSIICVLILCLCTLRPKTKR--P 247

Query: 61  KETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD 120
            ET KPR    V+   S  HPTSTRF++YE+L+EATNNFEPAS+LGEGGFGRVFKGVL+D
Sbjct: 248 TETEKPRIEHVVSSVASHRHPTSTRFISYEDLREATNNFEPASVLGEGGFGRVFKGVLND 307

Query: 121 GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG 180
           GTAVAIKRLT GGQQGDKE LVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELVPNG
Sbjct: 308 GTAVAIKRLTNGGQQGDKELLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVPNG 367

Query: 181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 240
           SLE+WLHGPLG+NC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH
Sbjct: 368 SLEAWLHGPLGINCSLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 427

Query: 241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
           AKVADFGLAK APEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG
Sbjct: 428 AKVADFGLAKLAPEGRVNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG 487

Query: 301 RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPE 360
           RKPV+MSQP+GQENLVTWARPILR K++LEELADPRLGG+YPKEDF RVCTIAAACVAPE
Sbjct: 488 RKPVEMSQPTGQENLVTWARPILRVKEQLEELADPRLGGRYPKEDFFRVCTIAAACVAPE 547

Query: 361 ANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSG 420
           ANQRPTMGEVVQSLKMVQR+ E  DP L SSN R NLRQSS T+DSDG SSMFSSGPYSG
Sbjct: 548 ANQRPTMGEVVQSLKMVQRITENYDPALPSSNTRPNLRQSSATYDSDGASSMFSSGPYSG 607

Query: 421 LSAFDNENVSRTAVFSEDLHEGR 443
           LSAFD +N+SRTAVFSEDLHEGR
Sbjct: 608 LSAFDYDNISRTAVFSEDLHEGR 630

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449484209|ref|XP_004156817.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus]

 Score =  754 bits (1947), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/433 (85%), Positives = 393/433 (90%)

Query: 11  SSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTAD 70
           S+S ++ +KG HSNL L+ GIG G L  AI+ VLIIC C     K++A P  T KPR  D
Sbjct: 291 STSPNSPSKGHHSNLTLLLGIGAGFLFIAILFVLIICLCTSHFGKTEAPPLVTEKPRVED 350

Query: 71  AVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT 130
            V + GS PHP+S RFL YEELKEATNNFE ASILGEGGFGRVFKGVLSDGTAVAIKRLT
Sbjct: 351 KVPVAGSFPHPSSMRFLTYEELKEATNNFEAASILGEGGFGRVFKGVLSDGTAVAIKRLT 410

Query: 131 CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL 190
            GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELV NGSLE+WLHGPL
Sbjct: 411 SGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVANGSLEAWLHGPL 470

Query: 191 GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 250
           GVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK
Sbjct: 471 GVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 530

Query: 251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 310
           QAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS
Sbjct: 531 QAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 590

Query: 311 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
           GQENLVTWARPILRDKDRLEELADP+LGGKYPKEDF+RVCTIAAACVAPEA QRPTMGEV
Sbjct: 591 GQENLVTWARPILRDKDRLEELADPQLGGKYPKEDFVRVCTIAAACVAPEAGQRPTMGEV 650

Query: 371 VQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVS 430
           VQSLKMVQRV E QD  + SSNNR NLRQSSTTF+SDG+SSMFSSGPYSGLSAFDN+NVS
Sbjct: 651 VQSLKMVQRVTEYQDSIVPSSNNRTNLRQSSTTFESDGSSSMFSSGPYSGLSAFDNDNVS 710

Query: 431 RTAVFSEDLHEGR 443
           RTA+FSEDLHEGR
Sbjct: 711 RTAIFSEDLHEGR 723

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449469022|ref|XP_004152220.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus]

 Score =  754 bits (1946), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/433 (85%), Positives = 393/433 (90%)

Query: 11  SSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPKETAKPRTAD 70
           S+S ++ +KG HSNL L+ GIG G L  AI+ VLIIC C     K++A P  T KPR  D
Sbjct: 291 STSPNSPSKGHHSNLTLLLGIGAGFLFIAILFVLIICLCTSHCGKTEAPPLVTEKPRVED 350

Query: 71  AVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT 130
            V + GS PHP+S RFL YEELKEATNNFE ASILGEGGFGRVFKGVLSDGTAVAIKRLT
Sbjct: 351 KVPVAGSFPHPSSMRFLTYEELKEATNNFEAASILGEGGFGRVFKGVLSDGTAVAIKRLT 410

Query: 131 CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL 190
            GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS+RDSSQ+LLCYELV NGSLE+WLHGPL
Sbjct: 411 SGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSNRDSSQNLLCYELVANGSLEAWLHGPL 470

Query: 191 GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 250
           GVNC LDW+TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK
Sbjct: 471 GVNCPLDWDTRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 530

Query: 251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 310
           QAPEGR NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS
Sbjct: 531 QAPEGRANYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS 590

Query: 311 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
           GQENLVTWARPILRDKDRLEELADP+LGGKYPKEDF+RVCTIAAACVAPEA QRPTMGEV
Sbjct: 591 GQENLVTWARPILRDKDRLEELADPQLGGKYPKEDFVRVCTIAAACVAPEAGQRPTMGEV 650

Query: 371 VQSLKMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVS 430
           VQSLKMVQRV E QD  + SSNNR NLRQSSTTF+SDG+SSMFSSGPYSGLSAFDN+NVS
Sbjct: 651 VQSLKMVQRVTEYQDSIVPSSNNRTNLRQSSTTFESDGSSSMFSSGPYSGLSAFDNDNVS 710

Query: 431 RTAVFSEDLHEGR 443
           RTA+FSEDLHEGR
Sbjct: 711 RTAIFSEDLHEGR 723

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|30679031|ref|NP_192110.2| protein kinase family protein [Arabidopsis thaliana] gi|21928159|gb|AAM78107.1| AT4g02010/T10M13_2 [Arabidopsis thaliana] gi|32815839|gb|AAP88328.1| At4g02010/T10M13_2 [Arabidopsis thaliana] gi|332656711|gb|AEE82111.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  750 bits (1936), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/443 (81%), Positives = 394/443 (88%), Gaps = 1/443 (0%)

Query: 2   KAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPK 61
           KAP+  +S ++S  +  K +H NLILIF I  G+LI AII+VL+ICS A R  K+    K
Sbjct: 283 KAPSQGSSATTSVRSPGKKRHPNLILIFSIAAGVLILAIITVLVICSRALREEKAPDPHK 342

Query: 62  ETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG 121
           E  KPR  DA + GGSLPHP STRFL+YEELKEAT+NFE ASILGEGGFG+V++G+L+DG
Sbjct: 343 EAVKPRNLDAGSFGGSLPHPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADG 402

Query: 122 TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 181
           TAVAIK+LT GG QGDKEF VE++MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS
Sbjct: 403 TAVAIKKLTSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 462

Query: 182 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 241
           LE+WLHGPLG+NC LDW+TRMKIALDAARGLAYLHEDSQP VIHRDFKASNILLENNF+A
Sbjct: 463 LEAWLHGPLGLNCPLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNA 522

Query: 242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
           KVADFGLAKQAPEGR N+LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR
Sbjct: 523 KVADFGLAKQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 582

Query: 302 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA 361
           KPVDMSQPSGQENLVTW RP+LRDKDRLEEL D RL GKYPKEDFIRVCTIAAACVAPEA
Sbjct: 583 KPVDMSQPSGQENLVTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEA 642

Query: 362 NQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN-RANLRQSSTTFDSDGTSSMFSSGPYSG 420
           +QRPTMGEVVQSLKMVQRV+E QDP L +SN  R N RQSS TF+S+ TSSMFSSGPYSG
Sbjct: 643 SQRPTMGEVVQSLKMVQRVVEYQDPVLNTSNKARPNRRQSSATFESEVTSSMFSSGPYSG 702

Query: 421 LSAFDNENVSRTAVFSEDLHEGR 443
           LSAFD+EN++RT VFSEDLHEGR
Sbjct: 703 LSAFDHENITRTTVFSEDLHEGR 725

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|3912917|gb|AAC78693.1| putative NAK-like ser/thr protein kinase [Arabidopsis thaliana] gi|7268585|emb|CAB80694.1| putative NAK-like ser/thr protein kinase [Arabidopsis thaliana]

 Score =  749 bits (1935), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/443 (81%), Positives = 394/443 (88%), Gaps = 1/443 (0%)

Query: 2   KAPTHRASPSSSSSTSNKGKHSNLILIFGIGTGLLITAIISVLIICSCAFRGRKSKASPK 61
           KAP+  +S ++S  +  K +H NLILIF I  G+LI AII+VL+ICS A R  K+    K
Sbjct: 265 KAPSQGSSATTSVRSPGKKRHPNLILIFSIAAGVLILAIITVLVICSRALREEKAPDPHK 324

Query: 62  ETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG 121
           E  KPR  DA + GGSLPHP STRFL+YEELKEAT+NFE ASILGEGGFG+V++G+L+DG
Sbjct: 325 EAVKPRNLDAGSFGGSLPHPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADG 384

Query: 122 TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 181
           TAVAIK+LT GG QGDKEF VE++MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS
Sbjct: 385 TAVAIKKLTSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 444

Query: 182 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 241
           LE+WLHGPLG+NC LDW+TRMKIALDAARGLAYLHEDSQP VIHRDFKASNILLENNF+A
Sbjct: 445 LEAWLHGPLGLNCPLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNA 504

Query: 242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
           KVADFGLAKQAPEGR N+LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR
Sbjct: 505 KVADFGLAKQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 564

Query: 302 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA 361
           KPVDMSQPSGQENLVTW RP+LRDKDRLEEL D RL GKYPKEDFIRVCTIAAACVAPEA
Sbjct: 565 KPVDMSQPSGQENLVTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEA 624

Query: 362 NQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN-RANLRQSSTTFDSDGTSSMFSSGPYSG 420
           +QRPTMGEVVQSLKMVQRV+E QDP L +SN  R N RQSS TF+S+ TSSMFSSGPYSG
Sbjct: 625 SQRPTMGEVVQSLKMVQRVVEYQDPVLNTSNKARPNRRQSSATFESEVTSSMFSSGPYSG 684

Query: 421 LSAFDNENVSRTAVFSEDLHEGR 443
           LSAFD+EN++RT VFSEDLHEGR
Sbjct: 685 LSAFDHENITRTTVFSEDLHEGR 707

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	443
TAIR|locus:2132168	725	AT4G02010 [Arabidopsis thalian	0.907	0.554	0.808	8.6e-175
TAIR|locus:504954886	1113	AT5G56890 [Arabidopsis thalian	0.683	0.272	0.616	1.8e-94
TAIR|locus:2038992	744	ALE2 "Abnormal Leaf Shape 2" [	0.647	0.385	0.637	3e-94
TAIR|locus:2026925	708	PERK9 "proline-rich extensin-l	0.706	0.442	0.523	9.4e-82
TAIR|locus:2028756	762	PERK10 "proline-rich extensin-	0.645	0.375	0.571	2e-81
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.659	0.428	0.549	8.5e-81
TAIR|locus:2179857	456	PBS1 "avrPphB susceptible 1" [	0.683	0.664	0.530	2.9e-80
TAIR|locus:2183018	513	AT5G18610 [Arabidopsis thalian	0.744	0.643	0.497	5.4e-79
TAIR|locus:2099009	400	AT3G58690 [Arabidopsis thalian	0.650	0.72	0.542	8.7e-79
TAIR|locus:2151191	378	CDL1 "CDG1-like 1" [Arabidopsi	0.702	0.822	0.507	1.1e-78

TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)]

 Score = 1698 (602.8 bits), Expect = 8.6e-175, P = 8.6e-175
 Identities = 326/403 (80%), Positives = 352/403 (87%)

Query:    42 SVLIICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEP 101
             +VL+ICS A R  K+    KE  KPR  DA + GGSLPHP STRFL+YEELKEAT+NFE 
Sbjct:   323 TVLVICSRALREEKAPDPHKEAVKPRNLDAGSFGGSLPHPASTRFLSYEELKEATSNFES 382

Query:   102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
             ASILGEGGFG+V++G+L+DGTAVAIK+LT GG QGDKEF VE++MLSRLHHRNLVKLVGY
Sbjct:   383 ASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGY 442

Query:   162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
             YSSRDSSQHLLCYELVPNGSLE+WLHGPLG+NC LDW+TRMKIALDAARGLAYLHEDSQP
Sbjct:   443 YSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNCPLDWDTRMKIALDAARGLAYLHEDSQP 502

Query:   222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
              VIHRDFKASNILLENNF+AKVADFGLAKQAPEGR N+LSTRVMGTFGYVAPEYAMTGHL
Sbjct:   503 SVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHL 562

Query:   282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW RP+LRDKDRLEEL D RL GKY
Sbjct:   563 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRDKDRLEELVDSRLEGKY 622

Query:   342 PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN-RANLRQX 400
             PKEDFIRVCTIAAACVAPEA+QRPTMGEVVQSLKMVQRV+E QDP L +SN  R N RQ 
Sbjct:   623 PKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLKMVQRVVEYQDPVLNTSNKARPNRRQS 682

Query:   401 XXXXXXXXXXXXXXXXPYSGLSAFDNENVSRTAVFSEDLHEGR 443
                             PYSGLSAFD+EN++RT VFSEDLHEGR
Sbjct:   683 SATFESEVTSSMFSSGPYSGLSAFDHENITRTTVFSEDLHEGR 725

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)]

 Score = 940 (336.0 bits), Expect = 1.8e-94, P = 1.8e-94
 Identities = 190/308 (61%), Positives = 227/308 (73%)

Query:    79 PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK 138
             P   S +     E+ +ATNNF+ + +LGEGGFGRV++GV  DGT VA+K L    QQG +
Sbjct:   703 PFTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSR 762

Query:   139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW 198
             EFL EVEMLSRLHHRNLV L+G     D ++ L+ YEL+PNGS+ES LHG    +  LDW
Sbjct:   763 EFLAEVEMLSRLHHRNLVNLIGI-CIEDRNRSLV-YELIPNGSVESHLHGIDKASSPLDW 820

Query:   199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
             + R+KIAL AARGLAYLHEDS P VIHRDFK+SNILLEN+F  KV+DFGLA+ A +   N
Sbjct:   821 DARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDN 880

Query:   259 -YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 317
              ++STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP GQENLV+
Sbjct:   881 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVS 940

Query:   318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
             W RP L   + L  + D  LG +   +   +V  IA+ CV PE + RP MGEVVQ+LK+V
Sbjct:   941 WTRPFLTSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQALKLV 1000

Query:   378 QRVIECQD 385
                 EC +
Sbjct:  1001 SN--ECDE 1006

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
 Identities = 188/295 (63%), Positives = 227/295 (76%)

Query:    83 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 142
             S +     EL++AT+ F    +LGEGGFGRV++G + DGT VA+K LT   Q  D+EF+ 
Sbjct:   333 SVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIA 392

Query:   143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
             EVEMLSRLHHRNLVKL+G     +     L YELV NGS+ES LH   G    LDW+ R+
Sbjct:   393 EVEMLSRLHHRNLVKLIGICI--EGRTRCLIYELVHNGSVESHLHE--GT---LDWDARL 445

Query:   203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             KIAL AARGLAYLHEDS P VIHRDFKASN+LLE++F  KV+DFGLA++A EG + ++ST
Sbjct:   446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEG-SQHIST 504

Query:   263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 322
             RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR+PVDMSQPSG+ENLVTWARP+
Sbjct:   505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564

Query:   323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
             L +++ LE+L DP L G Y  +D  +V  IA+ CV  E + RP MGEVVQ+LK++
Sbjct:   565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLI 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010068 "protoderm histogenesis" evidence=IMP

GO:0042335 "cuticle development" evidence=IMP

GO:0048367 "shoot system development" evidence=IGI

GO:0048645 "organ formation" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 820 (293.7 bits), Expect = 9.4e-82, P = 9.4e-82
 Identities = 170/325 (52%), Positives = 224/325 (68%)

Query:    54 RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 113
             R   ++P   +K R+    +  G L +  S    +YEEL +ATN F   ++LGEGGFG V
Sbjct:   335 RMQSSAPVGASK-RSGSYQSQSGGLGN--SKALFSYEELVKATNGFSQENLLGEGGFGCV 391

Query:   114 FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 173
             +KG+L DG  VA+K+L  GG QGD+EF  EVE LSR+HHR+LV +VG+  S D  + LL 
Sbjct:   392 YKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGD--RRLLI 449

Query:   174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 233
             Y+ V N  L   LHG   V   LDW TR+KIA  AARGLAYLHED  P +IHRD K+SNI
Sbjct:   450 YDYVSNNDLYFHLHGEKSV---LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNI 506

Query:   234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 293
             LLE+NF A+V+DFGLA+ A +  T +++TRV+GTFGY+APEYA +G L  KSDV+S+GVV
Sbjct:   507 LLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVV 565

Query:   294 LLELLTGRKPVDMSQPSGQENLVTWARPILR---DKDRLEELADPRLGGKYPKEDFIRVC 350
             LLEL+TGRKPVD SQP G E+LV WARP++    + +  + LADP+LGG Y + +  R+ 
Sbjct:   566 LLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMI 625

Query:   351 TIAAACVAPEANQRPTMGEVVQSLK 375
               A ACV   A +RP MG++V++ +
Sbjct:   626 EAAGACVRHLATKRPRMGQIVRAFE 650

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
 Identities = 168/294 (57%), Positives = 209/294 (71%)

Query:    83 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 142
             S    +YEEL  ATN F   ++LGEGGFGRV+KGVL D   VA+K+L  GG QGD+EF  
Sbjct:   414 SRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKA 473

Query:   143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
             EV+ +SR+HHRNL+ +VGY  S +  + LL Y+ VPN +L   LH   G    LDW TR+
Sbjct:   474 EVDTISRVHHRNLLSMVGYCISEN--RRLLIYDYVPNNNLYFHLHAA-GTP-GLDWATRV 529

Query:   203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             KIA  AARGLAYLHED  P +IHRD K+SNILLENNFHA V+DFGLAK A +  T +++T
Sbjct:   530 KIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNT-HITT 588

Query:   263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 322
             RVMGTFGY+APEYA +G L  KSDV+S+GVVLLEL+TGRKPVD SQP G E+LV WARP+
Sbjct:   589 RVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPL 648

Query:   323 LRDKDRLEE---LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS 373
             L +    EE   LADP+LG  Y   +  R+   AAAC+   A +RP M ++V++
Sbjct:   649 LSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRA 702

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 811 (290.5 bits), Expect = 8.5e-81, P = 8.5e-81
 Identities = 166/302 (54%), Positives = 215/302 (71%)

Query:    86 FLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVE 145
             + +Y+EL + T+ F   ++LGEGGFG V+KGVLSDG  VA+K+L  GG QG++EF  EVE
Sbjct:   326 WFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVE 385

Query:   146 MLSRLHHRNLVKLVGYYSSRDSSQH-LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
             ++SR+HHR+LV LVGY  S    QH LL Y+ VPN +L   LH P G    + WETR+++
Sbjct:   386 IISRVHHRHLVTLVGYCISE---QHRLLVYDYVPNNTLHYHLHAP-GRPV-MTWETRVRV 440

Query:   205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 263
             A  AARG+AYLHED  P +IHRD K+SNILL+N+F A VADFGLAK A E   N ++STR
Sbjct:   441 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTR 500

Query:   264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 323
             VMGTFGY+APEYA +G L  K+DVYSYGV+LLEL+TGRKPVD SQP G E+LV WARP+L
Sbjct:   501 VMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLL 560

Query:   324 R---DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 380
                 + +  +EL DPRLG  +   +  R+   AAACV   A +RP M +VV++L  ++  
Sbjct:   561 GQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEA 620

Query:   381 IE 382
              +
Sbjct:   621 TD 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 806 (288.8 bits), Expect = 2.9e-80, P = 2.9e-80
 Identities = 164/309 (53%), Positives = 209/309 (67%)

Query:    88 AYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEM 146
             A+ EL  AT NF P + LGEGGFGRV+KG L S G  VA+K+L   G QG++EFLVEV M
Sbjct:    75 AFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLM 134

Query:   147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
             LS LHH NLV L+GY +  D  Q LL YE +P GSLE  LH        LDW  RMKIA 
Sbjct:   135 LSLLHHPNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAA 192

Query:   207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
              AA+GL +LH+ + P VI+RDFK+SNILL+  FH K++DFGLAK  P G  +++STRVMG
Sbjct:   193 GAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMG 252

Query:   267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 326
             T+GY APEYAMTG L VKSDVYS+GVV LEL+TGRK +D   P G++NLV WARP+  D+
Sbjct:   253 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDR 312

Query:   327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDP 386
              +  +LADPRL G++P     +   +A+ C+  +A  RP + +VV +L  +    +  DP
Sbjct:   313 RKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLAN--QAYDP 370

Query:   387 TLTSSN-NR 394
             +   S  NR
Sbjct:   371 SKDDSRRNR 379

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0006952 "defense response" evidence=TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)]

 Score = 794 (284.6 bits), Expect = 5.4e-79, P = 5.4e-79
 Identities = 169/340 (49%), Positives = 217/340 (63%)

Query:    55 KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 114
             KS+  P E  K  TA      G   H  +  F  + EL  AT NF P  +LGEGGFGRV+
Sbjct:    44 KSRRGP-EQKKELTAPKE---GPTAHIAAQTF-TFRELAAATKNFRPECLLGEGGFGRVY 98

Query:   115 KGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 173
             KG L + G  VA+K+L   G QG++EFLVEV MLS LHH NLV L+GY +  D  Q LL 
Sbjct:    99 KGRLETTGQIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLV 156

Query:   174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI 233
             YE +P GSLE  LH        LDW TRM IA  AA+GL YLH+ + P VI+RD K+SNI
Sbjct:   157 YEYMPLGSLEDHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNI 216

Query:   234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 293
             LL + +H K++DFGLAK  P G   ++STRVMGT+GY APEYAMTG L +KSDVYS+GVV
Sbjct:   217 LLGDGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 276

Query:   294 LLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIA 353
              LEL+TGRK +D ++  G+ NLV WARP+ +D+ +  ++ADP L G+YP     +   +A
Sbjct:   277 FLELITGRKAIDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVA 336

Query:   354 AACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNN 393
             A C+  +A  RP +G+VV +L  +    +  DP   S  N
Sbjct:   337 AMCLQEQAATRPLIGDVVTALTYLAS--QTFDPNAPSGQN 374

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)]

 Score = 792 (283.9 bits), Expect = 8.7e-79, P = 8.7e-79
 Identities = 159/293 (54%), Positives = 211/293 (72%)

Query:    85 RFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEV 144
             +   +++L  AT  F  ++++G GGFG V++GVL+DG  VAIK +   G+QG++EF +EV
Sbjct:    73 QIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHAGKQGEEEFKMEV 132

Query:   145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL---GVNCHLDWETR 201
             E+LSRL    L+ L+GY S  D+S  LL YE + NG L+  L+ P     V   LDWETR
Sbjct:   133 ELLSRLRSPYLLALLGYCS--DNSHKLLVYEFMANGGLQEHLYLPNRSGSVPPRLDWETR 190

Query:   202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
             M+IA++AA+GL YLHE   P VIHRDFK+SNILL+ NF+AKV+DFGLAK   +    ++S
Sbjct:   191 MRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKVGSDKAGGHVS 250

Query:   262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 321
             TRV+GT GYVAPEYA+TGHL  KSDVYSYGVVLLELLTGR PVDM + +G+  LV+WA P
Sbjct:   251 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATGEGVLVSWALP 310

Query:   322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
              L D+D++ ++ DP L G+Y  ++ ++V  IAA CV  EA+ RP M +VVQSL
Sbjct:   311 QLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVVQSL 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
 Identities = 161/317 (50%), Positives = 212/317 (66%)

Query:    59 SPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVL 118
             S K  AK   +++ + G    H  +  F  + EL  AT NF    ++GEGGFGRV+KG L
Sbjct:    36 SEKSRAKSSLSESKSKGSD--HIVAQTF-TFSELATATRNFRKECLIGEGGFGRVYKGYL 92

Query:   119 -SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 177
              S     AIK+L   G QG++EFLVEV MLS LHH NLV L+GY +  D  Q LL YE +
Sbjct:    93 ASTSQTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRLLVYEYM 150

Query:   178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 237
             P GSLE  LH        LDW TRMKIA  AA+GL YLH+ + P VI+RD K SNILL++
Sbjct:   151 PLGSLEDHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDD 210

Query:   238 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLEL 297
             ++  K++DFGLAK  P G  +++STRVMGT+GY APEYAMTG L +KSDVYS+GVVLLE+
Sbjct:   211 DYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEI 270

Query:   298 LTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACV 357
             +TGRK +D S+ +G++NLV WARP+ +D+ +  ++ADP L G+YP     +   +AA CV
Sbjct:   271 ITGRKAIDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCV 330

Query:   358 APEANQRPTMGEVVQSL 374
               + N RP + +VV +L
Sbjct:   331 QEQPNLRPLIADVVTAL 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	443
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-53
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-50
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-45
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-33
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-32
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-32
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-31
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-30
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-29
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-28
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-26
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-25
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-25
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-21
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-21
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-18
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-17
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	8e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-17
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-14
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-12
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-11
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  178 bits (454), Expect = 4e-53
 Identities = 85/279 (30%), Positives = 122/279 (43%), Gaps = 33/279 (11%)

Query: 103 SILGEGGFGRVFKGVLSD-----GTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLV 156
             LGEG FG V+KG L          VA+K L     +Q  +EFL E  ++ +L H N+V
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           KL+G     +     +  E +  G L S+L         L     +  AL  ARG+ YL 
Sbjct: 65  KLLGV--CTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLE 119

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
             S+   IHRD  A N L+  N   K++DFGL++   +    Y          ++APE  
Sbjct: 120 --SKNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAPESL 175

Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 335
             G    KSDV+S+GV+L E+ T G +P       G  N        L++  RL     P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--LKNGYRL-----P 223

Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           +     P      +  +   C A +   RPT  E+V+ L
Sbjct: 224 Q-----PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  177 bits (452), Expect = 7e-53
 Identities = 85/279 (30%), Positives = 123/279 (44%), Gaps = 32/279 (11%)

Query: 103 SILGEGGFGRVFKGVLSDG-----TAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLV 156
             LGEG FG V+KG L          VA+K L     +Q  +EFL E  ++ +L H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           KL+G     +    ++  E +P G L  +L         L     +  AL  ARG+ YL 
Sbjct: 65  KLLGV--CTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLE 120

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
             S+   IHRD  A N L+  N   K++DFGL++   +    Y          ++APE  
Sbjct: 121 --SKNF-IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESL 176

Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 335
             G    KSDV+S+GV+L E+ T G +P       G  N        L+   RL +  + 
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--LKKGYRLPKPPNC 229

Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                 P E +     +   C A +   RPT  E+V+ L
Sbjct: 230 ------PPELY----KLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  170 bits (432), Expect = 1e-50
 Identities = 73/197 (37%), Positives = 97/197 (49%), Gaps = 14/197 (7%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLVKLVGYY 162
           LGEGGFG V+       G  VAIK +         E  L E+E+L +L+H N+VKL G +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              +     L  E    GSL+  L         L  +  ++I L    GL YLH  S   
Sbjct: 61  EDENH--LYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLH--SNG- 112

Query: 223 VIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           +IHRD K  NILL  +N   K+ADFGL+K         L   ++GT  Y+APE  +    
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKGY 170

Query: 282 L-VKSDVYSYGVVLLEL 297
              KSD++S GV+L EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  171 bits (435), Expect = 2e-50
 Identities = 89/282 (31%), Positives = 131/282 (46%), Gaps = 42/282 (14%)

Query: 105 LGEGGFGRVFKGVL-----SDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG V+KG L        T VA+K L  G  ++  +EFL E  ++ +L H N+V+L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G  +        +  E +P G L  +L         L  +  +++AL  A+G+ YL   
Sbjct: 67  LGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLE-- 119

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYA 276
           S+   +HRD  A N L+  N   K++DFGL++   E   +Y   R  G     ++APE  
Sbjct: 120 SKNF-VHRDLAARNCLVTENLVVKISDFGLSRDIYE--DDYYRKRGGGKLPIKWMAPESL 176

Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLE--EL 332
             G    KSDV+S+GV+L E+ T G +P   MS     E ++      L D  RL   E 
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----NEEVLEL----LEDGYRLPRPEN 228

Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
               L   Y          +   C A +   RPT  E+V+ L
Sbjct: 229 CPDEL---Y---------ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  162 bits (412), Expect = 4e-47
 Identities = 84/278 (30%), Positives = 120/278 (43%), Gaps = 32/278 (11%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLV 156
           +E    LGEG FG+V+       G  VAIK +     + D+E  L E+++L +L H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           +L   +   D  +  L  E    G L   L         L  +            L YLH
Sbjct: 61  RLYDVF--EDEDKLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALEYLH 114

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
                 ++HRD K  NILL+ + H K+ADFGLA+Q        L+T V GT  Y+APE  
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVL 168

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
           +        D++S GV+L ELLTG+ P       G + L+   + I + K        P 
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFP-----GDDQLLELFKKIGKPK-----PPFPP 218

Query: 337 LGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
                  E  D IR        +  +  +R T  E +Q
Sbjct: 219 PEWDISPEAKDLIR------KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  161 bits (411), Expect = 8e-47
 Identities = 82/286 (28%), Positives = 123/286 (43%), Gaps = 39/286 (13%)

Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
            LGEG FG V+KG L       T VA+K L     + + K+FL E  ++ +L H N+V+L
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-----LDWETRMKIALDAARGLA 213
           +G  +  +     L  E +  G L  +L     V        L  +  +  A+  A+G+ 
Sbjct: 62  LGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           YL   S+  V HRD  A N L+  +   K++DFGL++   +       T       ++AP
Sbjct: 120 YLA--SKKFV-HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLE- 330
           E    G    KSDV+S+GV+L E+ T G  P   +S               LR   RL  
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLRKGYRLPK 228

Query: 331 -ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
            E     L   Y          +  +C   +   RPT  E+V+ L+
Sbjct: 229 PEYCPDEL---Y---------ELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (398), Expect = 5e-45
 Identities = 92/287 (32%), Positives = 128/287 (44%), Gaps = 42/287 (14%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNL 155
           +E    LG G FG V+K      G  VA+K L    +  + D+    E+ +L RL H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           V+L+  +   D     L  E    G L  +L         L  +   KIAL   RGL YL
Sbjct: 61  VRLIDAF--EDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYL 114

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE- 274
           H +    +IHRD K  NILL+ N   K+ADFGLAK+  +  ++  +T V GT  Y+APE 
Sbjct: 115 HSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-TTFV-GTPWYMAPEV 169

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 334
                    K DV+S GV+L ELLTG+ P                  IL     +  +  
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPF-------------SGENILDQLQLIRRILG 216

Query: 335 PRLGGKYPKE--------DFIRVCTIAAACVAPEANQRPTMGEVVQS 373
           P L    PK         D I+       C+  + ++RPT  E++Q 
Sbjct: 217 PPLEFDEPKWSSGSEEAKDLIKK------CLNKDPSKRPTAEEILQH 257

Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  137 bits (348), Expect = 2e-37
 Identities = 85/286 (29%), Positives = 120/286 (41%), Gaps = 27/286 (9%)

Query: 105 LGEGGFGRVFKG---VLSDGTA--VAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+V       L D T   VA+K L   G +Q   +F  E+E+L  L H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLH 216
            G           L  E +P+GSL  +L  H        ++ +  +  +    +G+ YL 
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLG 126

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYVAPE 274
                  IHRD  A NIL+E+    K++DFGLAK  PE +  Y          F Y APE
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
              T      SDV+S+GV L EL T G        P  +   +           RL EL 
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPPAEFLRMIGIAQGQMIVTRLLELL 239

Query: 334 DPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
               G + P+       V  +   C   E   RP+  +++  +  +
Sbjct: 240 KE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  136 bits (345), Expect = 3e-37
 Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 16/206 (7%)

Query: 104 ILGEGGFGRVFKGVLSD-GTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           +LG G FG V+  +  D G  +A+K   L+   ++  +    E+ +LS L H N+V+  G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKI-ALDAARGLAYLHE 217
                + +   +  E V  GSL S L   G L        E  ++        GLAYLH 
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP-------EPVIRKYTRQILEGLAYLHS 119

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
           +    ++HRD K +NIL++++   K+ADFG AK+  +  T   +  V GT  ++APE   
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKP 303
                  +D++S G  ++E+ TG+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (323), Expect = 3e-33
 Identities = 88/351 (25%), Positives = 138/351 (39%), Gaps = 29/351 (8%)

Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSRL-HHR 153
           ++     LGEG FG V+     D   VA+K L    +   KE   FL E+++L+ L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           N+VKL  ++  +D     L  E V  GSLE  L          + E    I       L 
Sbjct: 59  NIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-FILAQILSALE 115

Query: 214 YLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRT----NYLSTRVMGTF 268
           YLH      +IHRD K  NILL  +    K+ DFGLAK  P+  +      L +  +GT 
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 269 GYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
           GY+APE  +     +    SD++S G+ L ELLTG  P +  + +      T    +   
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE-GEKNSSATSQTLKIILELP 231

Query: 326 KDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 383
              L     P       K   D ++        +A +   R +    +    +    ++ 
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLK------KLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285

Query: 384 QDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAV 434
            D +     + +   + S     +   S  +S   SG     +++     +
Sbjct: 286 SDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  125 bits (315), Expect = 5e-33
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 14/207 (6%)

Query: 99  FEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           FE    +G+GGFG V+K      G  VAIK +    ++  ++ + E+++L +  H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM-KIALDAARGLAYLH 216
             G Y  +D     +  E    GSL+  L            E+++  +  +  +GL YLH
Sbjct: 62  YYGSYLKKDELW--IVMEFCSGGSLKDLLKS----TNQTLTESQIAYVCKELLKGLEYLH 115

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
            +    +IHRD KA+NILL ++   K+ DFGL+ Q  + +       ++GT  ++APE  
Sbjct: 116 SNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEVI 169

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKP 303
                  K+D++S G+  +EL  G+ P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  124 bits (313), Expect = 9e-33
 Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 14/202 (6%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V++G+ ++ T VA+K L  G     K+FL E +++ +L H  L++L  Y   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQL--YAVC 70

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  EL+  GSL  +L G  G    L     + +A   A G+AYL   +    I
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN---YI 125

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD  A N+L+  N   KVADFGLA+   E   +    R    F   + APE A+     
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKE---DIYEAREGAKFPIKWTAPEAALYNRFS 182

Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L E++T GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 2e-32
 Identities = 74/213 (34%), Positives = 112/213 (52%), Gaps = 22/213 (10%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRN 154
           N++   ++G G FG V+KG+ L  G  VAIK+++    + +  K  + E+++L  L H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 155 LVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL-DAAR 210
           +VK   Y  S ++S  L    E   NGSL   +   GP         E+ + + +    +
Sbjct: 61  IVK---YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-------ESLVAVYVYQVLQ 110

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GLAYLHE     VIHRD KA+NIL   +   K+ADFG+A +  +   +  S  V+GT  +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +APE          SD++S G  ++ELLTG  P
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 6e-32
 Identities = 95/313 (30%), Positives = 142/313 (45%), Gaps = 58/313 (18%)

Query: 91  ELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEV 144
            LKE     E   +LG G FG V+KGV + +G      VAIK L      + +KE L E 
Sbjct: 3   ILKET--ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60

Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETR 201
            +++ + H ++V+L+G   S   SQ  L  +L+P G L  ++      +G    L+W  +
Sbjct: 61  YVMASVDHPHVVRLLGICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ 117

Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
           +      A+G++YL E     ++HRD  A N+L++   H K+ DFGLAK        Y +
Sbjct: 118 I------AKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA 168

Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 320
                   ++A E  +      KSDV+SYGV + EL+T G KP +   P         A 
Sbjct: 169 EGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP---------AV 218

Query: 321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTI-----AAACVAPEANQRPTMGEVVQSL- 374
            I    D LE+      G + P+     +CTI        C   +A  RPT  E++    
Sbjct: 219 EI---PDLLEK------GERLPQPP---ICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266

Query: 375 KMVQRVIECQDPT 387
           KM       +DP 
Sbjct: 267 KM------ARDPQ 273

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  119 bits (300), Expect = 6e-31
 Identities = 72/195 (36%), Positives = 102/195 (52%), Gaps = 9/195 (4%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V++G+  +   VAIK L        ++F  EV+ L RL H++L+ L    S 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  EL+  GSL ++L  P G    L   + + +A   A G+AYL E +    I
Sbjct: 74  --GEPVYIITELMEKGSLLAFLRSPEGQV--LPVASLIDMACQVAEGMAYLEEQN---SI 126

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 284
           HRD  A NIL+  +   KVADFGLA+   E    YLS+     + + APE A  G    K
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDKKIPYKWTAPEAASHGTFSTK 184

Query: 285 SDVYSYGVVLLELLT 299
           SDV+S+G++L E+ T
Sbjct: 185 SDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 1e-30
 Identities = 83/277 (29%), Positives = 123/277 (44%), Gaps = 35/277 (12%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKE-FLVEVEMLSRLHHRNLVKLVGY 161
           +G+G FG V+KGVL   T VA+K  TC        K  FL E E+L +  H N+VKL+G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVK--TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
                     +  ELVP GSL ++L         L  +  ++++LDAA G+ YL      
Sbjct: 61  --CVQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLE---SK 112

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
             IHRD  A N L+  N   K++DFG++++   G              + APE    G  
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 282 LVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
             +SDV+SYG++L E  + G  P       G  N  T        ++R+E       G +
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPY-----PGMSNQQT--------RERIES------GYR 213

Query: 341 YPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLK 375
            P        +  +   C A +   RP+  E+   L+
Sbjct: 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 71/205 (34%), Positives = 101/205 (49%), Gaps = 20/205 (9%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L   G    + FL E +++ +L H  LV+L    S 
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 165 RDSSQHLLCY---ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
            +       Y   E +  GSL  +L    G    L     + +A   A G+AYL   +  
Sbjct: 73  EEP-----IYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESRN-- 123

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTG 279
             IHRD  A NIL+  N   K+ADFGLA+   +   +  + R    F   + APE A  G
Sbjct: 124 -YIHRDLAARNILVGENLVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPEAANYG 179

Query: 280 HLLVKSDVYSYGVVLLELLT-GRKP 303
              +KSDV+S+G++L E++T GR P
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  114 bits (288), Expect = 5e-29
 Identities = 74/241 (30%), Positives = 101/241 (41%), Gaps = 54/241 (22%)

Query: 97  NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLV----------EVE 145
           ++F+   I+GEG F  V            AIK L       DK  L+          E E
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKIEKE 53

Query: 146 MLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRM 202
           +L+RL  H  ++KL  YY+ +D        E  PNG L  ++   G L   C     TR 
Sbjct: 54  VLTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-----TRF 106

Query: 203 KIA--LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------Q 251
             A  L A   L YLH      +IHRD K  NILL+ + H K+ DFG AK          
Sbjct: 107 YAAEILLA---LEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160

Query: 252 APEGRTNYLSTR---------VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK 302
                TN  S            +GT  YV+PE          SD+++ G ++ ++LTG+ 
Sbjct: 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Query: 303 P 303
           P
Sbjct: 221 P 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 7e-29
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           + +G+G FG V  G    G  VA+K L          FL E  +++ L H NLV+L+G  
Sbjct: 12  ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGV- 68

Query: 163 SSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
                +   +  E +  GSL  +L   G       +    ++  ALD   G+ YL E + 
Sbjct: 69  -VLQGNPLYIVTEYMAKGSLVDYLRSRG----RAVITLAQQLGFALDVCEGMEYLEEKN- 122

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 278
              +HRD  A N+L+  +  AKV+DFGLAK+A +G+ +       G     + APE    
Sbjct: 123 --FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-------GKLPVKWTAPEALRE 173

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                KSDV+S+G++L E+ + GR P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  113 bits (285), Expect = 1e-28
 Identities = 96/282 (34%), Positives = 125/282 (44%), Gaps = 21/282 (7%)

Query: 105 LGEGGFGRVF---KGVLSDGTA--VAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+V        +DGT   VA+K L    GQQ    +  E+ +L  L+H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  S +      L  E VP GSL  +L         L+    +  A     G+AYLH  
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ 126

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 275
                IHRD  A N+LL+N+   K+ DFGLAK  PEG   Y   R  G    F Y A E 
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWY-AVEC 181

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 335
                    SDV+S+GV L ELLT       S P   E ++   +  +    RL EL + 
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFEEMIGPKQGQM-TVVRLIELLER 239

Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
            +    PK     V  +   C   EA  RPT   ++  LK +
Sbjct: 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  111 bits (281), Expect = 4e-28
 Identities = 92/304 (30%), Positives = 131/304 (43%), Gaps = 56/304 (18%)

Query: 92  LKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 150
           L + T  FE   ++GEG +G+V+K      G  VAIK +     + ++E   E  +L + 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59

Query: 151 -HHRNLVKLVGYYSSRDSS----QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
            +H N+    G +  ++      Q  L  EL   GS+   + G       L  E    I 
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTR 263
            +  RGLAYLHE+    VIHRD K  NILL  N   K+ DFG++ Q  +  GR N     
Sbjct: 120 RETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN----T 172

Query: 264 VMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVT 317
            +GT  ++APE              +SDV+S G+  +EL  G+ P+ DM  P        
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPM------- 224

Query: 318 WARP---ILRDKDRLEELADPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMG 368
             R    I R+         P L  K P+       DFI  C I          QRP M 
Sbjct: 225 --RALFKIPRNP-------PPTL--KSPENWSKKFNDFISECLIK------NYEQRPFME 267

Query: 369 EVVQ 372
           E+++
Sbjct: 268 ELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  107 bits (269), Expect = 1e-26
 Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)

Query: 98  NFEPASILGEGGFGRVFKGVL-SDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRN 154
           +FE  + +G+G FG VFK V  +D    A+K+  L+   ++  +E + E  +L++L    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLD--WETRMKIALDAARG 211
           +++   YY S      L +  E   NG L   L    G     D  W   ++I L    G
Sbjct: 61  IIR---YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----G 113

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+LH      ++HRD K+ N+ L+   + K+ D G+AK          +  ++GT  Y+
Sbjct: 114 LAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYL 168

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
           +PE         KSDV++ GVVL E  TG+ P D        N       I+R       
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKIIRGV----- 217

Query: 332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 365
              P +   Y ++    +  +   C+  +  QRP
Sbjct: 218 --FPPVSQMYSQQ----LAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (269), Expect = 1e-26
 Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 55/286 (19%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G+G FG+V+     SDG    +K   L+   ++  ++ L EV++L +L+H N++K    
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 162 YSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           +  +      LC   E    G L   +            E  +   +     L YLH   
Sbjct: 68  FEEKGK----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE----- 274
              ++HRD K  NI L +N   K+ DFG++K       +   T V GT  Y++PE     
Sbjct: 124 ---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVV-GTPYYLSPELCQNK 178

Query: 275 -YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
            Y        KSD++S G VL EL T + P                     + + L ELA
Sbjct: 179 PYN------YKSDIWSLGCVLYELCTLKHPF--------------------EGENLLELA 212

Query: 334 DPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 373
              L G+YP        +   + +   + +  +  +RP++ +++QS
Sbjct: 213 LKILKGQYPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  106 bits (265), Expect = 3e-26
 Identities = 75/199 (37%), Positives = 108/199 (54%), Gaps = 14/199 (7%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           +LG+G FG VFKG L D T VA+K  TC     Q+   +FL E  +L +  H N+VKL+G
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
             + R      +  ELVP G   S+L         L  +  +K ALDAA G+AYL  +S+
Sbjct: 60  VCTQRQPI--YIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYL--ESK 112

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
            C IHRD  A N L+  N   K++DFG+++Q  +G  +    + +    + APE    G 
Sbjct: 113 NC-IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGR 170

Query: 281 LLVKSDVYSYGVVLLELLT 299
              +SDV+SYG++L E  +
Sbjct: 171 YSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 6e-26
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 46/224 (20%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHR 153
           +E  + +GEG +G+V+K      G  VA+K++    +   + F +    E+++L +L H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR--- 210
           N+V+L    +S+      + +E + +  L   L  P            +K      +   
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE-----------VKFTESQIKCYM 106

Query: 211 -----GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEGRTNYLSTRV 264
                GL YLH +    ++HRD K SNIL+ N+   K+ADFGLA         +Y + RV
Sbjct: 107 KQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TNRV 162

Query: 265 MGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGR 301
           + T  Y  PE      LL+       + D++S G +L EL  G+
Sbjct: 163 I-TLWYRPPE------LLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  105 bits (264), Expect = 6e-26
 Identities = 86/280 (30%), Positives = 130/280 (46%), Gaps = 45/280 (16%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LG G FG V++G+ L DG   A+K ++       GQ+  K+   E+ +LS+L H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR---GLA 213
           +G  + R+     +  ELVP GSL   L  +G               I L   +   GL 
Sbjct: 68  LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSF---------PEPVIRLYTRQILLGLE 116

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           YLH+ +    +HRD K +NIL++ N   K+ADFG+AKQ  E      +    G+  ++AP
Sbjct: 117 YLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAP 170

Query: 274 EYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
           E     G   + +D++S G  +LE+ TG KP     P  Q   V     I R K+     
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATG-KP-----PWSQLEGVAAVFKIGRSKELPPIP 224

Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
                  K    DFI        C+  + + RPT  E+++
Sbjct: 225 DHLSDEAK----DFILK------CLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  105 bits (263), Expect = 7e-26
 Identities = 74/215 (34%), Positives = 108/215 (50%), Gaps = 16/215 (7%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VAIK L  G    +  FL E  ++ +L H  LV+L   Y+ 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRL---YAV 69

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   L     + +A   A G+A++   +    I
Sbjct: 70  VTQEPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIERKNY---I 124

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+      K+ADFGLA+       N  + R    F   + APE    G   
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 181

Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  105 bits (263), Expect = 1e-25
 Identities = 89/294 (30%), Positives = 128/294 (43%), Gaps = 37/294 (12%)

Query: 103 SILGEGGFGRVFK---GVLSDGTA--VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
             LG+G FG V       L D T   VA+K+L     +  ++F  E+E+L  L H N+VK
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLAYLH 216
             G   S       L  E +P GSL  +L      +   LD    +  A    +G+ YL 
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQICKGMEYL- 124

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAP 273
             S+  V HRD    NIL+E+    K+ DFGL K  P+ +  Y   R  G    F Y AP
Sbjct: 125 -GSKRYV-HRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-AP 180

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLT----GRKP----VDMSQPSGQENLVTWAR-PILR 324
           E        V SDV+S+GVVL EL T       P    + M     Q  ++ +    +L+
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240

Query: 325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 378
           +  RL     P   G  P E    +  I   C   + +QRP+  E+   ++ ++
Sbjct: 241 NNGRL-----PAPPG-CPAE----IYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 81/262 (30%), Positives = 114/262 (43%), Gaps = 21/262 (8%)

Query: 97  NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRN 154
                 S LGEG  G V K  L + G   A+K +T        K+ L E+E+        
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VK  G +    SS   +  E    GSL+S           +  +   KIA    +GL+Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
           LH      +IHRD K SNILL      K+ DFG++ +      N L+    GT  Y+APE
Sbjct: 121 LHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL----VNSLAGTFTGTSFYMAPE 173

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPV--DMSQPSGQENLVTW--ARPILRDKDRLE 330
                   + SDV+S G+ LLE+   R P   +   P G   L+++    P    KD   
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKD--- 230

Query: 331 ELADPRLGGKYPKE--DFIRVC 350
              +P  G K+ +E  DFI+ C
Sbjct: 231 ---EPGNGIKWSEEFKDFIKQC 249

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (258), Expect = 4e-25
 Identities = 73/202 (36%), Positives = 107/202 (52%), Gaps = 15/202 (7%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 69

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G +G   +L     + +A   A G+AY+   +    +
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 124

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 4e-25
 Identities = 87/285 (30%), Positives = 122/285 (42%), Gaps = 48/285 (16%)

Query: 105 LGEGGFGRVFKGV--LSDGT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KGV  +  G    VA+K L       G KEFL E  ++++L H  +V+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH--LDWETRMKIALDAARGLAYLHE 217
           G          +L  EL P G L  +L     +      +       A   A G+AYL  
Sbjct: 63  GVCKG---EPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES 113

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-----YVA 272
                 +HRD  A N+LL N   AK++DFG+++    G   Y +T    T G     + A
Sbjct: 114 KH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENLVTWARPILRDKDRLE 330
           PE    G    KSDV+SYGV L E  + G KP  +M    G E        +L   +RL 
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---KGAE-----VIAMLESGERLP 218

Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                      P+E    + +I  +C       RPT  E+  + +
Sbjct: 219 R----------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  102 bits (256), Expect = 6e-25
 Identities = 70/202 (34%), Positives = 102/202 (50%), Gaps = 15/202 (7%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L   G    + FL E +++ +L H  LV+L    S 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L    G    L     M  A   A G+AY+   +    I
Sbjct: 73  EPI---YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM--AAQVAAGMAYIERMN---YI 124

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +++NIL+ +    K+ADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL+T GR P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (256), Expect = 1e-24
 Identities = 70/221 (31%), Positives = 103/221 (46%), Gaps = 31/221 (14%)

Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVK 157
           LGEG FG+VF G         D   VA+K L         K+F  E E+L+   H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGP-------LGVNC-HLDWETRMKIALD 207
             G  +  +    ++ +E + +G L  +L  HGP              L     ++IA+ 
Sbjct: 73  FYGVCT--EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
            A G+ YL   SQ  V HRD    N L+  +   K+ DFG+++      T+Y   RV G 
Sbjct: 131 IASGMVYL--ASQHFV-HRDLATRNCLVGYDLVVKIGDFGMSRDVYT--TDYY--RVGGH 183

Query: 268 ----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 ++ PE  M      +SDV+S+GVVL E+ T G++P
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  102 bits (254), Expect = 1e-24
 Identities = 86/273 (31%), Positives = 132/273 (48%), Gaps = 33/273 (12%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV L   Y+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPL---YAV 69

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L    G   +L     + +A   A G+AY+   +    I
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERMN---YI 124

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +N   K+ADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 283 VKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
           +KSDV+S+G++L EL+T GR P       G  N     R +L   +R   +  P+ G   
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPY-----PGMVN-----REVLEQVERGYRMPCPQ-GCPE 230

Query: 342 PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
              + +++C         + ++RPT  E +QS 
Sbjct: 231 SLHELMKLCW------KKDPDERPTF-EYIQSF 256

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  101 bits (254), Expect = 1e-24
 Identities = 82/283 (28%), Positives = 122/283 (43%), Gaps = 43/283 (15%)

Query: 105 LGEGGFGRVFKGVLSDGTA----VAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V +G  S        VA+K L          +FL E  ++  L H NL++L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLH----GPLGVNCHLDWETRMKIALDAARGLAYL 215
           G          ++  EL P GSL   L     G   ++   D+      A+  A G+ YL
Sbjct: 63  GVV--LTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYL 113

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST---RVMGTFGYVA 272
              S+   IHRD  A NILL ++   K+ DFGL +  P+   +Y+     +V   F + A
Sbjct: 114 E--SKRF-IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
           PE   T      SDV+ +GV L E+ T G +P   +  SG + L    + I ++ +RLE 
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEP--WAGLSGSQIL----KKIDKEGERLER 222

Query: 332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                     P+     +  +   C A     RPT   + + L
Sbjct: 223 ----------PEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  100 bits (252), Expect = 3e-24
 Identities = 81/265 (30%), Positives = 126/265 (47%), Gaps = 32/265 (12%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRN 154
           ++ E    LG G  G V K +    G  +A+K +     +   K+ L E+++L + +   
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 155 LVKLVG-YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           +V   G +Y++ D S   +C E +  GSL+  L    G    +      KIA+   +GL 
Sbjct: 61  IVGFYGAFYNNGDIS---ICMEYMDGGSLDKILKEVQGR---IPERILGKIAVAVLKGLT 114

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           YLHE  +  +IHRD K SNIL+ +    K+ DFG++ Q      N L+   +GT  Y+AP
Sbjct: 115 YLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKTFVGTSSYMAP 168

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
           E        VKSD++S G+ L+EL TGR P                 P     + L+ + 
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYP-----------PENDPPDGIFELLQYIV 217

Query: 334 D---PRL-GGKYPKE--DFIRVCTI 352
           +   PRL  GK+  +  DF+ +C I
Sbjct: 218 NEPPPRLPSGKFSPDFQDFVNLCLI 242

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 4e-24
 Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 58/296 (19%)

Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G+          T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHL----DWETRMKIALDAARG 211
           L+G  S       L+  EL+  G L+S+L    P   N         +  +++A + A G
Sbjct: 74  LLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY--------LSTR 263
           +AYL        +HRD  A N ++  +   K+ DFG+ +   E  T+Y        L  R
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 186

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTWARPI 322
            M      APE    G    KSDV+S+GVVL E+ T        QP  G  N        
Sbjct: 187 WM------APESLKDGVFTTKSDVWSFGVVLWEMATL-----AEQPYQGLSN-------- 227

Query: 323 LRDKDRLEELADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                  EE+    + G +   P+    ++  +   C       RPT  E+V SLK
Sbjct: 228 -------EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  100 bits (251), Expect = 4e-24
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 37/285 (12%)

Query: 97  NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRN 154
           ++ E   +LG+G  G V+K      G   A+K++   G  +  K+ L E++ L       
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 155 LVKLVG-YYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           +VK  G +Y   + S   +  E +  GSL   L   G +             IA    +G
Sbjct: 61  VVKCYGAFYKEGEIS---IVLEYMDGGSLADLLKKVGKIPEPV------LAYIARQILKG 111

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           L YLH      +IHRD K SN+L+ +    K+ADFG++K          +   +GT  Y+
Sbjct: 112 LDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYM 167

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
           +PE          +D++S G+ LLE   G+ P     P GQ +     + I         
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFELMQAICDG------ 218

Query: 332 LADPRL-GGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS 373
              P L   ++  E  DFI      +AC+  +  +RP+  E++Q 
Sbjct: 219 -PPPSLPAEEFSPEFRDFI------SACLQKDPKKRPSAAELLQH 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 99.7 bits (249), Expect = 8e-24
 Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 49/285 (17%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G FG+V+  V L  G  +A+K  R+     +  KE   E+++L  L H NLVK  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
              R+  +  +  E    G+LE  L    G    LD        L    GLAYLH     
Sbjct: 68  EVHRE--KVYIFMEYCSGGTLEELLEH--GRI--LDEHVIRVYTLQLLEGLAYLHSHG-- 119

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYVAPE---YA 276
            ++HRD K +NI L++N   K+ DFG A +     T        + GT  Y+APE     
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA---------RPILRDKD 327
                   +D++S G V+LE+ TG++P      S  +N   +          +P + D  
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW-----SELDN--EFQIMFHVGAGHKPPIPDSL 231

Query: 328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
           +L              +DF+  C  +      +  +RPT  E++Q
Sbjct: 232 QLSPEG----------KDFLDRCLES------DPKKRPTASELLQ 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 8e-24
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 15/211 (7%)

Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V +G L         VAIK L  G     + +FL E  ++ +  H N+++L
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +   S   ++  E + NGSL+ +L    G          + +    A G+ YL   
Sbjct: 71  EGVVTK--SRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYL--- 122

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
           S+   +HRD  A NIL+ +N   KV+DFGL+++  +    Y +        + APE    
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 307
                 SDV+S+G+V+ E+++ G +P  DMS
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 18/211 (8%)

Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIK---RLTCGGQQGDKEFLVEVEMLSRLHHR 153
           +FE   ++G+G FG+V      D     A+K   +  C  +   +  L E  +L  L+H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDAARGL 212
            LV L  +YS +D     L  +L+  G L    H  L        E ++K    +    L
Sbjct: 61  FLVNL--WYSFQDEENMYLVVDLLLGGDLR--YH--LSQKVKFS-EEQVKFWICEIVLAL 113

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            YLH      +IHRD K  NILL+   H  + DF +A +        L+T   GT GY+A
Sbjct: 114 EYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMA 167

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           PE        V  D +S GV   E L G++P
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 78/279 (27%), Positives = 121/279 (43%), Gaps = 36/279 (12%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           F+    LGEG +G V+K +    G  VAIK +        +E + E+ +L +     +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 158 LVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
              YY S   +  L +  E    GS+   +      N  L  E    I     +GL YLH
Sbjct: 63  ---YYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
            +     IHRD KA NILL     AK+ADFG++ Q  +  T      V+GT  ++APE  
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVI 171

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRLEELADP 335
                  K+D++S G+  +E+  G+ P     P     ++     P L          DP
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLS---------DP 222

Query: 336 RLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
               K+  E  DF++ C +       +  +RP+  +++Q
Sbjct: 223 ---EKWSPEFNDFVKKCLVK------DPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 70/204 (34%), Positives = 110/204 (53%), Gaps = 21/204 (10%)

Query: 103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
            I+GEG FG V +G  + G  VA+K + C      + FL E  ++++LHH+NLV+L+G  
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVI 68

Query: 163 SSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
               +  +++  EL+  G+L ++L   G   V+        ++ +LD A G+ YL     
Sbjct: 69  --LHNGLYIV-MELMSKGNLVNFLRTRGRALVSV----IQLLQFSLDVAEGMEYLESKK- 120

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
             ++HRD  A NIL+  +  AKV+DFGLA+    G  N   +++     + APE      
Sbjct: 121 --LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN---SKL--PVKWTAPEALKHKK 173

Query: 281 LLVKSDVYSYGVVLLELLT-GRKP 303
              KSDV+SYGV+L E+ + GR P
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+ G   +   VAIK +   G   +++F+ E +++ +L H  LV+L G  + 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           R  S   L +E + +G L  +L    G       ET + + LD   G+AYL       VI
Sbjct: 71  R--SPICLVFEFMEHGCLSDYLRAQRGK---FSQETLLGMCLDVCEGMAYLESS---NVI 122

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 284
           HRD  A N L+  N   KV+DFG+ +   + +    ST       + +PE         K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSK 181

Query: 285 SDVYSYGVVLLELLT-GRKPVD 305
           SDV+S+GV++ E+ + G+ P +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 84/315 (26%), Positives = 128/315 (40%), Gaps = 70/315 (22%)

Query: 97  NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLH 151
           N +E   ++GEG +G V K    + G  VAIK+      + D++     L EV++L +L 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFK--ESEDDEDVKKTALREVKVLRQLR 58

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+V L   +  +   +  L +E V    LE     P G    L  +          + 
Sbjct: 59  HENIVNLKEAFRRKG--RLYLVFEYVERTLLELLEASPGG----LPPDAVRSYIWQLLQA 112

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR----TNYLSTRVMGT 267
           +AY H  +   +IHRD K  NIL+  +   K+ DFG A+          T+Y++TR    
Sbjct: 113 IAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR---- 165

Query: 268 FGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKPV-----DMSQ------- 308
             Y APE      LLV         DV++ G ++ ELL G  P+     D+ Q       
Sbjct: 166 -WYRAPE------LLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKC 217

Query: 309 -----PSGQENLVTWAR------PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACV 357
                PS QE   +  R      P     + LE         +YP +          AC+
Sbjct: 218 LGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER--------RYPGKVSSPALDFLKACL 269

Query: 358 APEANQRPTMGEVVQ 372
             +  +R T  E++Q
Sbjct: 270 RMDPKERLTCDELLQ 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 35/218 (16%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRN 154
            N E    +GEG  G V+K    + G  VAIK++    Q   KE ++ E+ ++    H N
Sbjct: 22  KNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPN 76

Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL-HGPLGVNCHLDWETRMK-IALDAARG 211
           +V     Y   D    L +  E +  GSL   +    + +N     E ++  +  +  +G
Sbjct: 77  IVDYYDSYLVGD---ELWVVMEYMDGGSLTDIITQNFVRMN-----EPQIAYVCREVLQG 128

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           L YLH  SQ   IHRD K+ NILL  +   K+ADFG A Q  + ++   S  V+GT  ++
Sbjct: 129 LEYLH--SQNV-IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWM 183

Query: 272 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE      Y        K D++S G++ +E+  G  P
Sbjct: 184 APEVIKRKDYGP------KVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 81/298 (27%), Positives = 128/298 (42%), Gaps = 67/298 (22%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           +E    +G G +G V+K   ++ G  VAIK +        +    E+ ML    H N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRMKIAL---DAARG 211
             G Y  RD  +  +  E    GSL+       GPL         + ++IA    +  +G
Sbjct: 65  YFGSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPL---------SELQIAYVCRETLKG 113

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFG 269
           LAYLHE      IHRD K +NILL  +   K+ADFG++ Q     T  ++ R   +GT  
Sbjct: 114 LAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPY 166

Query: 270 YVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVD----------MSQPSGQENLV 316
           ++APE A     G    K D+++ G+  +EL   + P+           +S+ +      
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP--- 223

Query: 317 TWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
               P L+DK+            K+     DFI+ C         +  +RPT  +++Q
Sbjct: 224 ----PKLKDKE------------KWSPVFHDFIKKCLTK------DPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.4 bits (235), Expect = 5e-22
 Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 43/286 (15%)

Query: 98  NFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHRN 154
           +F+    LG+G +G V+K   LSD    A+K +  G   Q ++E  V E+ +L+ ++H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 155 LVKLVGYY-SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           ++    Y  +  D ++  +  E  P G L   +         +  +   +I +   RGL 
Sbjct: 61  II---SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
            LHE     ++HRD K++NILL  N   K+ D G++K         ++   +GT  Y+AP
Sbjct: 118 ALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAP 170

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
           E         KSD++S G +L E+ T   P +             AR        +++L 
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE-------------ARS-------MQDLR 210

Query: 334 DPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMGEVVQS 373
                GKYP       +D         + +  +   RP   +++ S
Sbjct: 211 YKVQRGKYPPIPPIYSQDLQNFIR---SMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 6e-22
 Identities = 75/221 (33%), Positives = 104/221 (47%), Gaps = 51/221 (23%)

Query: 105 LGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDKEFLV---EVEM-------LSRLHH 152
           LG+G FG+V   V     G   A+K L        K+ ++   EVE        LSR++H
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINH 52

Query: 153 RNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMK-----I 204
             +VKL  +Y+ +     L L  E  P G L S L   G          E R +     I
Sbjct: 53  PFIVKL--HYAFQTEE-KLYLVLEYAPGGELFSHLSKEGRFS-------EERARFYAAEI 102

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
            L     L YLH      +I+RD K  NILL+ + H K+ DFGLAK+      +  +T  
Sbjct: 103 VL----ALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFC 154

Query: 265 MGTFGYVAPEYAM-TGHLLVKS-DVYSYGVVLLELLTGRKP 303
            GT  Y+APE  +  G+   K+ D +S GV+L E+LTG+ P
Sbjct: 155 -GTPEYLAPEVLLGKGY--GKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 94.5 bits (235), Expect = 7e-22
 Identities = 61/217 (28%), Positives = 114/217 (52%), Gaps = 30/217 (13%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRL----TCGGQQGDKEFLV------EVEMLSRLHH 152
           ++G+G +GRV+  + ++ G  +A+K++    T  G+   ++  +      E+E L  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL--DA 208
            N+V+ +G+ ++ +     L  E VP GS+ S L  +G         +E ++        
Sbjct: 68  LNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGR--------FEEQLVRFFTEQV 117

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
             GLAYLH      ++HRD KA N+L++ +   K++DFG++K++ +   N  +  + G+ 
Sbjct: 118 LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174

Query: 269 GYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKP 303
            ++APE   +       K D++S G V+LE+  GR+P
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 94.4 bits (235), Expect = 9e-22
 Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 44/289 (15%)

Query: 105 LGEGGFGRVFKGVLS--DGTA----VAIKRLT-CGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           LG G FG V++G+    DG A    VA+K L     +Q + +FL+E  ++S+ +H+N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-CHLDWETRMKIALDAARGLAY 214
           L+G   S +     +  EL+  G L+S+L    P       L  +  +  A D A+G  Y
Sbjct: 74  LIGV--SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 215 LHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLST--RVMGTFG 269
           L E+     IHRD  A N LL        AK+ADFG+A+     R +Y     R M    
Sbjct: 132 LEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPIK 186

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 328
           ++ PE  + G    K+DV+S+GV+L E+ + G  P                 P   +++ 
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY----------------PGRTNQEV 230

Query: 329 LEELADPRLGGK--YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           +E +     GG+   PK     V  I   C       RP    +++ ++
Sbjct: 231 MEFVT---GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 27/220 (12%)

Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LGEG FG+V+KG L         T+VAIK L      +    EF  E E++S L H N+V
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-EFRQEAELMSDLQHPNIV 71

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPL-GVNCHLDWETRMK---------I 204
            L+G  +    +  L  +E + +G L  +L  + P   V      ET            I
Sbjct: 72  CLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A+  A G+ YL   S    +HRD  A N L+      K++DFGL++         + ++ 
Sbjct: 130 AIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           +    ++ PE  + G    +SD++S+GVVL E+ + G +P
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 27/280 (9%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYY 162
           LG G  G V K   +  GT +A K +  G +    K+ L E++++   H      +V +Y
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM---HECRSPYIVSFY 69

Query: 163 SSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
            +  +  ++ +C E +  GSL+      GP+ V      E   KIA+    GL YL+   
Sbjct: 70  GAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV------EILGKIAVAVVEGLTYLYNVH 123

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           +  ++HRD K SNIL+ +    K+ DFG++ +      N ++   +GT  Y++PE    G
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGEL----INSIADTFVGTSTYMSPERIQGG 177

Query: 280 HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 339
              VKSDV+S G+ ++EL  G+ P   S              IL    ++ +   PRL  
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG--ILDLLQQIVQEPPPRL-- 233

Query: 340 KYPKEDFIRVCT-IAAACVAPEANQRPTMGEVVQSLKMVQ 378
             P  DF         AC+  +  +RPT  ++      +Q
Sbjct: 234 --PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 69/213 (32%), Positives = 95/213 (44%), Gaps = 33/213 (15%)

Query: 108 GGFGRVF---KGVLSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGY 161
           G +GRVF   K   S G   AIK +            + L E ++LS+     +VKL  Y
Sbjct: 4   GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--Y 59

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           YS +      L  E +P G L S L     V   LD +       +    L YLH +   
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLEN---VGS-LDEDVARIYIAEIVLALEYLHSNG-- 113

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS------TRVMGTFGYVAPEY 275
            +IHRD K  NIL+++N H K+ DFGL+K     R   L+       R++GT  Y+APE 
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 276 AMTGHLLVKS-----DVYSYGVVLLELLTGRKP 303
                +L +      D +S G +L E L G  P
Sbjct: 173 -----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 23/218 (10%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT-CGGQQGDKEFLV-----EVEMLSRL 150
            +     LG G F   ++   +  GT +A+K++T       ++E +V     E+ +++RL
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
           +H ++++++G  ++ + S   L  E +  GS+   L   G             +      
Sbjct: 61  NHPHIIRMLG--ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA------VIINYTEQL 112

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQ--APEGRTNYLSTRVM 265
            RGL+YLHE+    +IHRD K +N+L+++     ++ADFG A +  A          +++
Sbjct: 113 LRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           GT  ++APE           DV+S G V++E+ T + P
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 92.3 bits (229), Expect = 4e-21
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 17/204 (8%)

Query: 105 LGEGGFGRVF------KGVLSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVK 157
           LGEG FG+V       +G  + G  VA+K L    G     +   E+E+L  L+H N+VK
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
             G  +    +   L  E +P+GSL+ +L  P   N  ++ + ++K A+   +G+ YL  
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKN-KINLKQQLKYAVQICKGMDYLGS 127

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTFGYVAPEY 275
                 +HRD  A N+L+E+    K+ DFGL K  +  +             F Y APE 
Sbjct: 128 RQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APEC 183

Query: 276 AMTGHLLVKSDVYSYGVVLLELLT 299
            +     + SDV+S+GV L ELLT
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 92.8 bits (230), Expect = 4e-21
 Identities = 79/289 (27%), Positives = 117/289 (40%), Gaps = 41/289 (14%)

Query: 105 LGEGGFGRVFKG------VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF           D   VA+K L        K+F  E E+L+ L H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGP----------LGVNCHLDWETRMKIAL 206
            G     D    ++ +E + +G L  +L  HGP                L     + IA 
Sbjct: 73  YGV--CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
             A G+ YL        +HRD    N L+  N   K+ DFG+++         +    M 
Sbjct: 131 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 325
              ++ PE  M      +SDV+S+GV+L E+ T G++P      +     +T  R + R 
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER- 246

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                    PR+    PKE    V  I   C   E  QR  + E+ + L
Sbjct: 247 ---------PRV---CPKE----VYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 91.7 bits (228), Expect = 4e-21
 Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 16/201 (7%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    D +F+ E +++ +L H NLV+L G  + 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L    G    L  E  + +  D    + YL  +     I
Sbjct: 71  Q--RPIFIVTEYMANGCLLNYLRERKGK---LGTEWLLDMCSDVCEAMEYLESN---GFI 122

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGHL 281
           HRD  A N L+  +   KV+DFGLA+   + +  Y S+   GT     +  PE       
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--YTSS--QGTKFPVKWAPPEVFDYSRF 178

Query: 282 LVKSDVYSYGVVLLELLTGRK 302
             KSDV+S+GV++ E+ +  K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 86/306 (28%), Positives = 137/306 (44%), Gaps = 52/306 (16%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHR 153
             +E   ++GEG +G V K    + G  VAIK+           K  + E+ ML +L H 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           NLV L+  +  R   +  L +E V +  L+     P G    LD     K      RG+ 
Sbjct: 61  NLVNLIEVF--RRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIE 114

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAP-EGRTNYLSTRVMGTFGY 270
           + H  +   +IHRD K  NIL+  +   K+ DFG A+   AP E  T+Y++TR      Y
Sbjct: 115 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WY 166

Query: 271 VAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKPV-----DMSQ----PSGQEN 314
            APE      LLV         D+++ G ++ E+LTG +P+     D+ Q         N
Sbjct: 167 RAPE------LLVGDTKYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGN 219

Query: 315 LVTWARPILRDKD------RLEELADPR-LGGKYPKEDFIRVCTIAAACVAPEANQRPTM 367
           L+   + I   K+      RL E+ +   L  ++PK   + V  +A  C+  + + RP+ 
Sbjct: 220 LIPRHQEIF-QKNPLFAGMRLPEVKEIEPLEKRFPKLSGL-VLDLAKQCLRIDPDDRPSS 277

Query: 368 GEVVQS 373
            +++  
Sbjct: 278 SQLLHH 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 74/222 (33%), Positives = 113/222 (50%), Gaps = 29/222 (13%)

Query: 97  NNFEPASILGEGGFGRVFKG-VLSDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRL-H 151
           N+ +   ++GEG FG+V K  +  DG  +  AIKR+     + D ++F  E+E+L +L H
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-------GPLGVNCH-----LDWE 199
           H N++ L+G    R      L  E  P+G+L  +L         P     +     L  +
Sbjct: 67  HPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124

Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
             +  A D ARG+ YL   SQ   IHRD  A NIL+  N+ AK+ADFGL++    G+  Y
Sbjct: 125 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 177

Query: 260 LSTRVMGTFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           +  + MG     ++A E          SDV+SYGV+L E+++
Sbjct: 178 VK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 91.8 bits (228), Expect = 6e-21
 Identities = 76/224 (33%), Positives = 112/224 (50%), Gaps = 36/224 (16%)

Query: 104 ILGEGGFGRVFKG----VLSDGTA---VAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNL 155
            LG G FG V++G    +L  G+    VA+K L  G   Q  KEFL E  ++S  +H N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--------PLGVNCHLDWETRMKIALD 207
           VKL+G     +    ++  EL+  G L S+L          PL     L  +  + I LD
Sbjct: 62  VKLLGVCLLNEPQYIIM--ELMEGGDLLSYLRDARVERFGPPL-----LTLKELLDICLD 114

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHA----KVADFGLAKQAPEGRTNYLST 262
            A+G  YL E      IHRD  A N L+ E  + A    K+ DFGLA+     +++Y   
Sbjct: 115 VAKGCVYL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRK 169

Query: 263 RVMGTFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
              G     ++APE  + G    +SDV+S+GV++ E+LT G++P
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.2 bits (227), Expect = 9e-21
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 17/220 (7%)

Query: 89  YEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG-QQGDKEFLV-EVE 145
           YE L+           +G+G FG V K    SDG  +  K +  G   + +K+ LV EV 
Sbjct: 2   YEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           +L  L H N+V+       R +    +  E    G L   +        +++ E   +I 
Sbjct: 52  ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111

Query: 206 LDAARGLAYLH--EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
                 L   H   D    V+HRD K +NI L+ N + K+ DFGLAK    G  +  +  
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKT 169

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            +GT  Y++PE         KSD++S G ++ EL     P
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 43/225 (19%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 151
            +E    LGEG +  V+K      G  VAIK++  G ++  K+      L E+++L  L 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLE------SWLHGPLGVNCHLDWETRMKIA 205
           H N++ L+  +  + +    L +E +    LE      S +  P  +  +      M + 
Sbjct: 61  HPNIIGLLDVFGHKSNIN--LVFEFME-TDLEKVIKDKSIVLTPADIKSY------MLMT 111

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
           L   RGL YLH +    ++HRD K +N+L+ ++   K+ADFGLA+          + +V+
Sbjct: 112 L---RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-THQVV 164

Query: 266 GTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKP 303
            T  Y APE      LL  +       D++S G +  ELL  R P
Sbjct: 165 -TRWYRAPE------LLFGARHYGVGVDMWSVGCIFAELLL-RVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 91.3 bits (226), Expect = 1e-20
 Identities = 94/332 (28%), Positives = 145/332 (43%), Gaps = 52/332 (15%)

Query: 85  RFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAV----AIKRLT-CGGQQGDK 138
           R L   ELK          +LG G FG V+KG+ + +G  V    AIK L    G + + 
Sbjct: 2   RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54

Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH 195
           EF+ E  +++ + H +LV+L+G   S       L  +L+P+G L  ++H     +G    
Sbjct: 55  EFMDEALIMASMDHPHLVRLLGVCLSPTIQ---LVTQLMPHGCLLDYVHEHKDNIGSQLL 111

Query: 196 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 255
           L+W       +  A+G+ YL E     ++HRD  A N+L+++  H K+ DFGLA+     
Sbjct: 112 LNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162

Query: 256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 314
              Y +        ++A E         +SDV+SYGV + EL+T G KP D         
Sbjct: 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------G 214

Query: 315 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           + T   P L +K   E L  P +         I V  +   C   +A+ RP   E+    
Sbjct: 215 IPTREIPDLLEKG--ERLPQPPICT-------IDVYMVMVKCWMIDADSRPKFKELAAEF 265

Query: 375 KMVQR------VIECQDPTLTSSNNRANLRQS 400
             + R      VI+  D     S N +   Q+
Sbjct: 266 SRMARDPQRYLVIQGDDRMKLPSPNDSKFFQN 297

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  ++ T VA+K L   G    + FL E  ++  L H  LV+L    + 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            +     +  E +  GSL  +L    G    L     +  +   A G+AY+   +    I
Sbjct: 73  EEPI--YIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKN---YI 125

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+N+L+  +   K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L E++T G+ P
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 48/237 (20%)

Query: 95  ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-F----LVEVEMLS 148
              ++E    LGEG FG V+K   +  G  VA+K++       +K+ F    L E+++L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILK 62

Query: 149 RLHHRNLVKLVGY---YSSRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHL---DWET 200
           +L H N+V L+        +   +    Y + P  +  L   L  P   +  L     + 
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKC 119

Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------- 250
            M   L+   G+ YLHE+    ++HRD KA+NIL++N    K+ADFGLA+          
Sbjct: 120 YMLQLLE---GINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173

Query: 251 -QAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGR 301
                G   Y  T ++ T  Y  PE  +     T  +    D++  G V  E+ T R
Sbjct: 174 GGGGGGTRKY--TNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 65/199 (32%), Positives = 98/199 (49%), Gaps = 20/199 (10%)

Query: 105 LGEGGFGRVFKGVL-SDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G FG VF G L +D T VA+K  R T       K FL E  +L +  H N+V+L+G 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
            + +      +  ELV  G   ++L   GP      L  +  +++  +AA G+ YL    
Sbjct: 62  CTQKQPI--YIVMELVQGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK- 113

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               IHRD  A N L+      K++DFG++++  +G   Y ST  M      + APE   
Sbjct: 114 --HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTAPEALN 169

Query: 278 TGHLLVKSDVYSYGVVLLE 296
            G    +SDV+S+G++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 68/214 (31%), Positives = 109/214 (50%), Gaps = 27/214 (12%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRL---TCGGQQGDKEFLV---EVEMLSRLHHRNLVK 157
           +LG+G +G V+ G+ + G  +A+K++   T      +KE+     EV++L  L H N+V+
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLG--VNCHLDWETRMKIALDAARGLA 213
            +G  +  D +   +  E VP GS+ S L+  GPL   V C        K       G+A
Sbjct: 67  YLG--TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC--------KYTKQILDGVA 116

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ----APEGRTNYLSTRVMGTFG 269
           YLH +   CV+HRD K +N++L  N   K+ DFG A++       G  + +   + GT  
Sbjct: 117 YLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           ++APE         KSD++S G  + E+ TG+ P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 80/305 (26%), Positives = 133/305 (43%), Gaps = 46/305 (15%)

Query: 85  RFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTA----VAIKRLT-CGGQQGDK 138
           R L   EL++         +LG G FG V KG+ + +G +    VAIK +    G+Q  +
Sbjct: 2   RILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54

Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH 195
           E    +  +  L H  +V+L+G       +   L  +L P GSL   +      L     
Sbjct: 55  EITDHMLAMGSLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRL 111

Query: 196 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 255
           L+W       +  A+G+ YL E     ++HR+  A NILL+++   ++ADFG+A      
Sbjct: 112 LNW------CVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Query: 256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 314
              Y  +       ++A E  + G    +SDV+SYGV + E+++ G +P    +P    +
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222

Query: 315 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           L+          ++ E LA P++         I V  +   C   + N RPT  E+    
Sbjct: 223 LL----------EKGERLAQPQICT-------IDVYMVMVKCWMIDENVRPTFKELANEF 265

Query: 375 KMVQR 379
             + R
Sbjct: 266 TRMAR 270

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 73/236 (30%), Positives = 109/236 (46%), Gaps = 32/236 (13%)

Query: 105 LGEGGFGRVFK-GVLSDGTAVAIKRL-----TCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LG GGFGRV    V S     A+K +        GQQ  +    E E+L   +H  +VKL
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58

Query: 159 VGYYSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYL 215
              +  +D  +++ +  E    G L + L   G        ++  R  IA        YL
Sbjct: 59  YRTF--KDK-KYIYMLMEYCLGGELWTILRDRGLFD-----EYTARFYIAC-VVLAFEYL 109

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H      +I+RD K  N+LL++N + K+ DFG AK+   G+  +  T   GT  YVAPE 
Sbjct: 110 HNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEI 163

Query: 276 AMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 330
            +  G+     D +S G++L ELLTGR P        ++ +  +   IL+   +LE
Sbjct: 164 ILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDD---EDPMEIYND-ILKGNGKLE 214

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 37/212 (17%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 161
           +GEG +G V+K      G  VAIK++    +     K  L E+++L  L+H N++KL+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 162 YSSRDSSQHLLC-------YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +  +    +L+        Y+L+ +         P  +     ++          +GLA+
Sbjct: 67  FRHKGDL-YLVFEFMDTDLYKLIKDRQR----GLPESLIKSYLYQL--------LQGLAF 113

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGR--TNYLSTRVMGTFGYV 271
            H      ++HRD K  N+L+      K+ADFGLA+      R  T+Y+ TR      Y 
Sbjct: 114 CHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYR 165

Query: 272 APE--YAMTGHLLVKSDVYSYGVVLLELLTGR 301
           APE      G+     D++S G +  ELL+ R
Sbjct: 166 APELLLGDKGY-STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 75/252 (29%), Positives = 110/252 (43%), Gaps = 25/252 (9%)

Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF           D   VA+K L        K+F  E E+L+ L H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGV-------NCHLDWETRMKIALDAA 209
            G     D    ++ +E + +G L  +L  HGP  V          L     + IA   A
Sbjct: 73  YGVCVEGDPL--IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+ YL        +HRD    N L+  N   K+ DFG+++         +    M    
Sbjct: 131 AGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENL--VTWARPILRDK 326
           ++ PE  M      +SDV+S GVVL E+ T G++P    Q S  E +  +T  R + R +
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--WYQLSNNEVIECITQGRVLQRPR 245

Query: 327 DRLEELADPRLG 338
              +E+ D  LG
Sbjct: 246 TCPKEVYDLMLG 257

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 18/214 (8%)

Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V +G L         VAIK L  G  ++  ++FL E  ++ +  H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +   S   ++  E + NG+L+S+L    G    +     ++     A G+ YL E 
Sbjct: 71  EGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM 125

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 275
           +    +HRD  A NIL+ +N   KV+DFGL++   +  ++   T  +G      + APE 
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 276 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 307
                    SDV+SYG+V+ E+++ G +P  DMS
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 38/228 (16%)

Query: 103 SILGEGGFGRVFKGV-LSDGTAVAIKR--LTCGGQQGDKE-------FLVEVEMLSRLHH 152
           +++G G FG V+ G+  S G  +A+K+  L                    E+ +L  L H
Sbjct: 6   ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 153 RNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWL--HGPLGVNCHLDWETRMK-IALDA 208
            N+V+   Y  S   + HL  + E VP GS+ + L  +G          ET ++      
Sbjct: 66  ENIVQ---YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE-------ETLVRNFVRQI 115

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR----- 263
            +GL YLH      +IHRD K +NIL++N    K++DFG++K+      N LST+     
Sbjct: 116 LKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGAR 169

Query: 264 --VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV-DMSQ 308
             + G+  ++APE         K+D++S G +++E+LTG+ P  D +Q
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 17/202 (8%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
            +G+G FG V  G    G  VA+K +        + FL E  ++++L H NLV+L+G   
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                 +++  E +  GSL  +L    G +  L  +  +K +LD    + YL  ++    
Sbjct: 70  EEKGGLYIVT-EYMAKGSLVDYLRSR-GRSV-LGGDCLLKFSLDVCEAMEYLEANN---F 123

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGR-TNYLSTRVMGTFGYVAPEYAMTGHLL 282
           +HRD  A N+L+  +  AKV+DFGL K+A   + T  L  +      + APE        
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 177

Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
            KSDV+S+G++L E+ + GR P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 84/285 (29%), Positives = 130/285 (45%), Gaps = 35/285 (12%)

Query: 104 ILGEGGFGRVFKGVLS--DGTA--VAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           ILGEG FG V +G LS  DG+   VA+K  +L        +EFL E   +    H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 158 LVGY-YSSRDSSQ---HLLCYELVPNGSLESWL-HGPLGVNC-HLDWETRMKIALDAARG 211
           L+G  + +    +    ++    + +G L S+L +  LG     L  +T +K  +D A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGY 270
           + YL   S    IHRD  A N +L  +    VADFGL+K+   G   Y   R+      +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVKW 181

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           +A E         KSDV+++GV + E+ T G+ P       G EN   +    LR  +RL
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY-----PGVENHEIYD--YLRHGNRL 234

Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                     K P++    +  +  +C   +   RPT  ++ + L
Sbjct: 235 ----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 65/216 (30%), Positives = 112/216 (51%), Gaps = 24/216 (11%)

Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG VF+G+L        AVAIK L  G  ++  ++FL E  ++ +  H N+++L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL--DAARGLAYLH 216
            G  +    +  ++  E + NG+L+ +L    G     ++ +   + +    A G+ YL 
Sbjct: 72  EGVVTKFKPA--MIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLS 124

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAP 273
           + +    +HRD  A NIL+ +N   KV+DFGL++     PEG   Y ++       + AP
Sbjct: 125 DMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAP 179

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 307
           E          SDV+S+G+V+ E+++ G +P  DMS
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 78/312 (25%), Positives = 130/312 (41%), Gaps = 52/312 (16%)

Query: 98  NFEPASILGEGGFGRVFKGV------LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRL 150
           N      LGEG FG+V K         +  T VA+K L       + ++ L E  +L ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-----GPLGVNCHLDWETR---- 201
           +H +++KL G  S       LL  E    GSL S+L      GP  +    +  +     
Sbjct: 61  NHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 202 -----------MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 250
                      +  A   +RG+ YL E     ++HRD  A N+L+      K++DFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 309
              E  +    ++      ++A E         +SDV+S+GV+L E++T G  P     P
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235

Query: 310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 369
              E L      +L+   R+E           P+     +  +   C   E ++RPT  +
Sbjct: 236 ---ERLFN----LLKTGYRMER----------PENCSEEMYNLMLTCWKQEPDKRPTFAD 278

Query: 370 VVQSLK--MVQR 379
           + + L+  MV+ 
Sbjct: 279 ISKELEKMMVKS 290

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 72/234 (30%), Positives = 113/234 (48%), Gaps = 16/234 (6%)

Query: 91  ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 150
           ELK+  ++FE  S LG G  G V K        +  ++L     +      + +  L  L
Sbjct: 1   ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-IRELQVL 57

Query: 151 HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           H  N   +VG+Y +  S   + +C E +  GSL+  L         +  E   K+++   
Sbjct: 58  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK----RIPEEILGKVSIAVL 113

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
           RGLAYL E  Q  ++HRD K SNIL+ +    K+ DFG++ Q  +   N      +GT  
Sbjct: 114 RGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRS 167

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 323
           Y++PE     H  V+SD++S G+ L+EL  GR P+    P  +E    + RP++
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI--PPPDAKELEAIFGRPVV 219

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 86.3 bits (214), Expect = 4e-19
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 23/227 (10%)

Query: 98  NFEPASILGEGGFGRVFKGVL----SDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLH 151
           ++ P  +LG+G FG   +  L     D + V  K   LT   ++  ++ L E+ +LS L 
Sbjct: 1   HYIPIRVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57

Query: 152 HRNLVKLVGYYSSRDSSQHLLC-YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           H N++    YY+       LL   E    G+L   +    G     + E  +        
Sbjct: 58  HPNII---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ--LFEEEMVLWYLFQIVS 112

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            ++Y+H+     ++HRD K  NI L      K+ DFG++K    G    ++  V+GT  Y
Sbjct: 113 AVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYY 167

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 317
           ++PE         KSD+++ G VL ELLT ++  D + P    NLV 
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 6e-19
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 45/222 (20%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-------FLVEVEMLSRL 150
           +E    LGEG +G V+K      G  VA+K++     + D E        L E+ +L  L
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKEL 55

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM--KIALDA 208
            H N+VKL+    + +   +L+  E      L+ +L               +   I    
Sbjct: 56  KHPNIVKLLDVIHT-ERKLYLVF-EYCDM-DLKKYLD-----KRPGPLSPNLIKSIMYQL 107

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMG 266
            RGLAY H      ++HRD K  NIL+  +   K+ADFGLA+    P       +  V+ 
Sbjct: 108 LRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP---LRTYTHEVV- 160

Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
           T  Y APE      +L+ S  YS  V       +  E++TG+
Sbjct: 161 TLWYRAPE------ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 26/219 (11%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            N+    +LG+G FGRV+     D G  +A+K++       + +  V     E+++L  L
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWL--HGPLGVNCHLDWETRMKIALD 207
            H  +V+   YY      + L  + E +P GS++  L  +G L         TR K    
Sbjct: 62  QHERIVQ---YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV-----TR-KYTRQ 112

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVM 265
              G+ YLH +    ++HRD K +NIL ++  + K+ DFG +K  Q        + + V 
Sbjct: 113 ILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VT 168

Query: 266 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKP 303
           GT  +++PE  ++G     K+DV+S G  ++E+LT + P
Sbjct: 169 GTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 88/333 (26%), Positives = 143/333 (42%), Gaps = 47/333 (14%)

Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 4   LKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 62  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 114

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL E     ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 115 --CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169

Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D    S   +       
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------- 222

Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR-- 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R  
Sbjct: 223 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272

Query: 380 ----VIECQDPTLTSSNNRANLRQSSTTFDSDG 408
               VI+  +     S   +N  ++    +   
Sbjct: 273 QRYLVIQGDERMHLPSPTDSNFYRALMDEEDMD 305

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.8 bits (220), Expect = 1e-18
 Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 20/239 (8%)

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E+  + +L H N+VKL+G    R      L +E +   +L   L         L WE R 
Sbjct: 733 EIADMGKLQHPNIVKLIG--LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           KIA+  A+ L +LH    P V+  +     I+++      +    L          ++S+
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842

Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 322
                  YVAPE   T  +  KSD+Y +G++L+ELLTG+ P D ++     ++V WAR  
Sbjct: 843 ------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYC 895

Query: 323 LRDKDRLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
             D   L+   DP + G     + + + V  +A  C A +   RP   +V+++L+   R
Sbjct: 896 YSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 34/274 (12%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    D EF+ E +++ +L H  LV+L G  + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L               +++  D   G+AYL E  Q   I
Sbjct: 71  QRPI--YIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYL-ESKQ--FI 122

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGHL 281
           HRD  A N L+++    KV+DFGL++   +    Y S+  +G+     +  PE  +    
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSS--VGSKFPVRWSPPEVLLYSKF 178

Query: 282 LVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
             KSDV+++GV++ E+ + G+ P +    S     V+    + R          P L  +
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR----------PHLASE 228

Query: 341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                  +V  I  +C   +A +RPT  +++ S+
Sbjct: 229 -------KVYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 24/208 (11%)

Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           LG+GGFG V    +   G   A K+L       ++G++  L E ++L ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 161 YYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLDWETRMKI-ALDAARGLAYL 215
            + ++D     LC    L+  G L+  +   G  G       E R    A     GL +L
Sbjct: 61  AFETKDD----LCLVMTLMNGGDLKYHIYNVGEPGFP-----EARAIFYAAQIICGLEHL 111

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H+     +++RD K  N+LL+++ + +++D GLA +   G+         GT GY+APE 
Sbjct: 112 HQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEV 165

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                     D ++ G  L E++ GR P
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 79/294 (26%), Positives = 128/294 (43%), Gaps = 39/294 (13%)

Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 150
           L++    FE   ++G G +G+V+KG  +  G   AIK +   G + ++E   E+ ML + 
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKY 59

Query: 151 -HHRNLVKLVGYYSSRD----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
            HHRN+    G +  ++      Q  L  E    GS+   +    G     +W     I 
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--IC 117

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTR 263
            +  RGL++LH+     VIHRD K  N+LL  N   K+ DFG++ Q     GR N     
Sbjct: 118 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--- 171

Query: 264 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 318
            +GT  ++APE              KSD++S G+  +E+  G  P+    P         
Sbjct: 172 -IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------- 221

Query: 319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
               +R    +     PRL  K   + F    +   +C+    +QRPT  ++++
Sbjct: 222 ----MRALFLIPRNPAPRLKSKKWSKKFQ---SFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 17/207 (8%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G G    V+  + L +   VAIKR+     Q   + L  EV+ +S+ +H N+VK   YY
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK---YY 65

Query: 163 SSRDSSQHL-LCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           +S      L L    +  GSL   +    P G        T +K  L   +GL YLH + 
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHSNG 122

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFGYVAPEYAM 277
           Q   IHRD KA NILL  +   K+ADFG++    +G       R   +GT  ++APE   
Sbjct: 123 Q---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 278 TGH-LLVKSDVYSYGVVLLELLTGRKP 303
             H    K+D++S+G+  +EL TG  P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 86.0 bits (214), Expect = 1e-18
 Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 42/224 (18%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF---------LVEVEMLS 148
           +E    +G G +G V   V    G  VAIK+++         F         L E+++L 
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLR 54

Query: 149 RLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMK-I 204
            L H N++ L  +    S +    + +  EL     +E+ LH  +     L  +  ++  
Sbjct: 55  HLRHENIIGLLDILRPPSPEDFNDVYIVTEL-----METDLHKVIKSPQPLT-DDHIQYF 108

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA------PEGRTN 258
                RGL YLH  +   VIHRD K SNIL+ +N   K+ DFGLA+            T 
Sbjct: 109 LYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
           Y+ TR      Y APE  ++     K+ D++S G +  ELLT +
Sbjct: 166 YVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)

Query: 105 LGEGGFGRVFKGVL-----SDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGE  FG+++KG L          VAIK L      Q   EF  E  +++ LHH N+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLG--------VNCHLDWETRMKIA 205
           +G  +       L  +E +  G L  +L     H  +G        V   LD    + IA
Sbjct: 73  LGVVTQEQPVCML--FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
           +  A G+ YL   S    +H+D  A NIL+    H K++D GL+++        +  + +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
               ++ PE  M G     SD++S+GVVL E+ + G +P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 20/204 (9%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG V+K +       VAIK +     + + E +  E++ LS+     + K   YY
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK---YY 65

Query: 163 SS--RDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
            S  + S   ++  E    GS    L  G L      D      I  +   GL YLHE+ 
Sbjct: 66  GSFLKGSKLWII-MEYCGGGSCLDLLKPGKL------DETYIAFILREVLLGLEYLHEEG 118

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
               IHRD KA+NILL      K+ADFG++ Q     +   +T V GT  ++APE     
Sbjct: 119 ---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNTFV-GTPFWMAPEVIKQS 173

Query: 280 HLLVKSDVYSYGVVLLELLTGRKP 303
               K+D++S G+  +EL  G  P
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 66/235 (28%), Positives = 96/235 (40%), Gaps = 35/235 (14%)

Query: 97  NNFEPASILGEGGFGRVFK----GVLS--DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSR 149
           NN E    +G+G FGRVF+    G+L     T VA+K L          +F  E  +++ 
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 150 LHHRNLVKLVGYYSS--------------------RDSSQHLLCYELVPNGSLESWLHGP 189
             H N+VKL+G  +                     R  S    C       S       P
Sbjct: 65  FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
           L ++C      ++ IA   A G+AYL E      +HRD    N L+  N   K+ADFGL+
Sbjct: 125 LPLSC----TEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 177

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           +          S        ++ PE         +SDV++YGVVL E+ + G +P
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF           D   VA+K L    +   ++F  E E+L+ L H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGP--------LGVNC-HLDWETRMKIALD 207
            G  +  +    L+ +E + +G L  +L  HGP          V    L     + IA  
Sbjct: 73  YGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
            A G+ YL   +    +HRD    N L+      K+ DFG+++         +  R M  
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187

Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
             ++ PE  +      +SD++S+GVVL E+ T G++P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 27/218 (12%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +LG+G +G V+    LS    +AIK +     +  +    E+ + S L HRN+V+ +G  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 163 SSRDSSQHLLCY-ELVPNGSLESWLH---GPLGVNCHLDWETRMKI-ALDAARGLAYLHE 217
           S          + E VP GSL + L    GPL  N     E  +         GL YLH+
Sbjct: 75  SENG---FFKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIIFYTKQILEGLKYLHD 126

Query: 218 DSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE- 274
           +    ++HRD K  N+L+ N +    K++DFG +K+      N  +    GT  Y+APE 
Sbjct: 127 NQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPEV 180

Query: 275 --YAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQP 309
                 G+    +D++S G  ++E+ TG+ P +++ +P
Sbjct: 181 IDKGPRGYG-APADIWSLGCTIVEMATGKPPFIELGEP 217

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 105 LGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVG 160
           LG G FG V KGV         VAIK L    ++  + E + E E++ +L +  +V+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
                ++   +L  E+   G L  +L G       +     +++    + G+ YL   + 
Sbjct: 63  VC---EAEALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN- 115

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 278
              +HRD  A N+LL N  +AK++DFGL+K A     +Y   R  G +   + APE    
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINF 172

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                +SDV+SYG+ + E  + G+KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 71/289 (24%), Positives = 116/289 (40%), Gaps = 33/289 (11%)

Query: 98  NFEPASILGEGGFGRVFKGVLS------DGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRL 150
           N +  + LG G FG VF             T V +K L     +    EF  E++M  +L
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLGVNCHLDWETRMKIA 205
            H+N+V+L+G    R++  H +  E    G L+ +L              L  + ++ + 
Sbjct: 66  SHKNVVRLLGL--CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              A G+ +L   S    +HRD  A N L+ +    KV+   L+K        Y     +
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNAL 179

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
               ++APE         KSDV+S+GV++ E+ T  +      P             L D
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-----LPFYG----------LSD 224

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           ++ L  L   +L    P+    R+  +   C A     RP+  E+V +L
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.7 bits (208), Expect = 5e-18
 Identities = 71/235 (30%), Positives = 101/235 (42%), Gaps = 54/235 (22%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTA--VAIKRLTCGGQQGDKEFLV----------EV 144
           ++FE    LG G FGRV   V   G+    A+K L        K  +V          E 
Sbjct: 1   DDFEFIKTLGTGSFGRVML-VRHKGSGKYYALKIL-------SKAKIVKLKQVEHVLNEK 52

Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
            +L  + H  LV L  Y S +D S   L  E VP G L S L                + 
Sbjct: 53  RILQSIRHPFLVNL--YGSFQDDSNLYLVMEYVPGGELFSHL-----RKSG-------RF 98

Query: 205 ALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 256
               AR         L YLH      +++RD K  N+LL+++ + K+ DFG AK+  +GR
Sbjct: 99  PEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGR 154

Query: 257 TNYLSTRVMGTFGYVAPEYAM-TGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQP 309
           T  L     GT  Y+APE  +  G+   K+ D ++ G+++ E+L G  P     P
Sbjct: 155 TYTLC----GTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPPFFDDNP 203

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 86/305 (28%), Positives = 134/305 (43%), Gaps = 46/305 (15%)

Query: 85  RFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDK 138
           R L   ELK+         +LG G FG V+KG+ + DG      VAIK L      + +K
Sbjct: 2   RILKETELKKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK 54

Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH 195
           E L E  +++ +    + +L+G   +   S   L  +L+P G L  ++      +G    
Sbjct: 55  EILDEAYVMAGVGSPYVCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111

Query: 196 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 255
           L+W       +  A+G++YL E     ++HRD  A N+L+++  H K+ DFGLA+     
Sbjct: 112 LNW------CVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162

Query: 256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN 314
            T Y +        ++A E  +      +SDV+SYGV + EL+T G KP D         
Sbjct: 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP------ 216

Query: 315 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
               AR I    ++ E L  P +         I V  I   C   ++  RP   E+V   
Sbjct: 217 ----AREIPDLLEKGERLPQPPICT-------IDVYMIMVKCWMIDSECRPRFRELVDEF 265

Query: 375 KMVQR 379
             + R
Sbjct: 266 SRMAR 270

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 42/215 (19%)

Query: 105 LGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 161
           +GEG  G VFK      G  VA+K++     +G    + L E++ L    H  +VKL   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL--- 64

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD-----WETR--MKIALDAARGLAY 214
               D   H   + LV    +E        V    +      + +  M++ L    G+AY
Sbjct: 65  ---LDVFPHGSGFVLV----MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK---GVAY 114

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGTFGYVAP 273
           +H +    ++HRD K +N+L+  +   K+ADFGLA+  + E    Y S +V  T  Y AP
Sbjct: 115 MHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQV-ATRWYRAP 169

Query: 274 EYAMTGHLLVKS-------DVYSYGVVLLELLTGR 301
           E      LL  +       D+++ G +  ELL G 
Sbjct: 170 E------LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)

Query: 104 ILGEGGFGRVFKGVLS-DGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLVKL 158
           ++GEG FG+V + ++  DG  +  AIK L     + D ++F  E+E+L +L HH N++ L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIAL 206
           +G   +R      +  E  P G+L  +L                G    L  +  ++ A 
Sbjct: 69  LGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
           D A G+ YL E      IHRD  A N+L+  N  +K+ADFGL++    G   Y+  + MG
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMG 178

Query: 267 TFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++A E         KSDV+S+GV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 38/262 (14%)

Query: 91  ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM---- 146
           ELK+  ++FE  S LG G  G VFK V    + + + R            L+ +E+    
Sbjct: 1   ELKD--DDFEKISELGAGNGGVVFK-VSHKPSGLIMARK-----------LIHLEIKPAI 46

Query: 147 -------LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDW 198
                  L  LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  
Sbjct: 47  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPE 102

Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
           +   K+++   +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q  +   N
Sbjct: 103 QILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 160

Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 318
                 +GT  Y++PE     H  V+SD++S G+ L+E+  GR P+    P  +E  + +
Sbjct: 161 SF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI--PPPDAKELELMF 214

Query: 319 ARPILRDKDRLEELADPRLGGK 340
             P+  D    E    PR  G+
Sbjct: 215 GCPVEGDPAESETSPRPRPPGR 236

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 83.3 bits (206), Expect = 9e-18
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 21/214 (9%)

Query: 97  NNFEPASILGEGGFGRVFKGV---LSDGTA---VAIKRLTCGGQQGDKEFLV-EVEMLSR 149
           NN      LG G FG+V +     LS   A   VA+K L       ++E L+ E++++S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 150 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           L +H N+V L+G  +       L+  E    G L ++L         L  E  +  +   
Sbjct: 95  LGNHENIVNLLG--ACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQV 150

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL---STRVM 265
           A+G+A+L   S+ C IHRD  A N+LL +    K+ DFGLA+      +NY+   + R+ 
Sbjct: 151 AKGMAFL--ASKNC-IHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARL- 205

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
               ++APE         +SDV+SYG++L E+ +
Sbjct: 206 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 74/217 (34%), Positives = 98/217 (45%), Gaps = 37/217 (17%)

Query: 99  FEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGD----KEFLVEVEMLSRLHHR 153
           +E  S +GEG +G VFK    + G  VAIK+      + D    K  L E+ ML +L H 
Sbjct: 3   YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV--ESEDDPVIKKIALREIRMLKQLKHP 60

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           NLV L+  +  R    HL+ +E   +  L      P GV  HL      KI     + + 
Sbjct: 61  NLVNLIEVFR-RKRKLHLV-FEYCDHTVLNELEKNPRGVPEHL----IKKIIWQTLQAVN 114

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGR-TNYLSTRVMGTFGY 270
           + H     C IHRD K  NIL+      K+ DFG A+    P    T+Y++TR      Y
Sbjct: 115 FCH--KHNC-IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WY 166

Query: 271 VAPEYAMTGHLLVKS-------DVYSYGVVLLELLTG 300
            APE      LLV         DV++ G V  ELLTG
Sbjct: 167 RAPE------LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 24/229 (10%)

Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 150
           L++    FE   ++G G +G+V+KG  +  G   AIK +     + ++E  +E+ ML + 
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKY 69

Query: 151 -HHRNLVKLVGYYSSRDSSQH----LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
            HHRN+    G +  +    H     L  E    GS+   +    G     DW     I 
Sbjct: 70  SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--IC 127

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTR 263
            +  RGLA+LH      VIHRD K  N+LL  N   K+ DFG++ Q     GR N     
Sbjct: 128 REILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--- 181

Query: 264 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKPV-DM 306
            +GT  ++APE              +SD++S G+  +E+  G  P+ DM
Sbjct: 182 -IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 82.2 bits (203), Expect = 1e-17
 Identities = 81/283 (28%), Positives = 126/283 (44%), Gaps = 39/283 (13%)

Query: 105 LGEGGFGRVFKGVLSDGTAVA---IKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVG 160
           +G G FG+V  G    G + A   +K L           FL EV+    L+H N+++ +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDS 219
                +S  +LL  E  P G L+++L    G V      +   ++A + A GL +LH+  
Sbjct: 63  --QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEGRTNYLSTRVMGTFG--YVAPEYA 276
               IH D    N  L  +   K+ D+GLA +Q PE   +Y  T+        ++APE  
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE---DYYITKDCHAVPLRWLAPELV 174

Query: 277 MTGH--LLV-----KSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR 328
                 LL      KS+++S GV + EL T   +P      S ++ L    + ++R++D 
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP--YPDLSDEQVL----KQVVREQDI 228

Query: 329 LEELADPRLGGKYPKEDFIRVCTIAAAC-VAPEANQRPTMGEV 370
             +L  P+L  KY      R   +   C + PE   RPT  EV
Sbjct: 229 --KLPKPQLDLKYSD----RWYEVMQFCWLDPE--TRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 78/286 (27%), Positives = 129/286 (45%), Gaps = 55/286 (19%)

Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTC-GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G G FG V K +    GT +A+KR+     ++  K  L++++++ R    +   +V +Y
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR--SSDCPYIVKFY 69

Query: 163 ----SSRDSSQHLLCYELVPNGSLESW---LHGPLGVNCHLDWETRMKIALDAARGLAYL 215
                  D     +C EL+ + SL+ +   ++  L     +  E   KIA+   + L YL
Sbjct: 70  GALFREGDC---WICMELM-DISLDKFYKYVYEVL--KSVIPEEILGKIAVATVKALNYL 123

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
            E+ +  +IHRD K SNILL+ N + K+ DFG++ Q  +   +   TR  G   Y+APE 
Sbjct: 124 KEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPER 178

Query: 276 AMTGHLL---VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
                     V+SDV+S G+ L E+ TG+ P              W        D+L ++
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWNSVF----DQLTQV 223

Query: 333 AD---PRLGGKYPKE------DFIRVCTIAAACVAPEANQRPTMGE 369
                P L     +E      +FI +C I       + ++RP   E
Sbjct: 224 VKGDPPILSNSEEREFSPSFVNFINLCLIK------DESKRPKYKE 263

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 34/223 (15%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 154
            + +E    LG+G FG+V+K      G   A K +    ++  ++F+VE+++LS   H N
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESW---LHGPLGVNCHLDWETRMKIAL---DA 208
           +V L   Y   +    L+  E    G+L+S    L   L         T  +I       
Sbjct: 64  IVGLYEAYFYENKLWILI--EFCDGGALDSIMLELERGL---------TEPQIRYVCRQM 112

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---KQAPEGRTNYLSTRVM 265
              L +LH      VIHRD KA NILL  +   K+ADFG++   K   + R  ++     
Sbjct: 113 LEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI----- 164

Query: 266 GTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKP 303
           GT  ++APE              K+D++S G+ L+EL     P
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)

Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG VFKG+ +     VAIK +     + + E +  E+ +LS+     + K  G Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQP 221
             +D+   ++   L    +L+    GPL        ET++   L +  +GL YLH + + 
Sbjct: 72  L-KDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHSEKK- 122

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
             IHRD KA+N+LL  +   K+ADFG+A Q  +  T       +GT  ++APE       
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             K+D++S G+  +EL  G  P     P     L+    P             P L G Y
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 225

Query: 342 --PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             P ++F+       AC+  E + RPT  E+++
Sbjct: 226 SKPLKEFVE------ACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 16/209 (7%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+    +  T VA+K +   G    + FL E  ++  L H  LVKL    + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L    G    L     +  +   A G+A++ + +    I
Sbjct: 73  EPI---YIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YI 124

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  +   K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQP 309
           +KSDV+S+G++L+E++T GR P   MS P
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNP 210

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 29/218 (13%)

Query: 104 ILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNL 155
            LGEG FG+V K            + VA+K L     + D  + + E+EM+  +  H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----------MK 203
           + L+G   +++   +++  E   +G+L  +L    P G     D              + 
Sbjct: 79  INLLGV-CTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
            A   ARG+ +L   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y    
Sbjct: 137 FAYQVARGMEFL--ASKKC-IHRDLAARNVLVTEDHVMKIADFGLARDIHH--IDYYRKT 191

Query: 264 VMGTFGY--VAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             G      +APE         +SDV+S+GV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 77/305 (25%), Positives = 121/305 (39%), Gaps = 56/305 (18%)

Query: 105 LGEGGFGRV----------------FKGVLSDGTA-VAIKRLTCGG-QQGDKEFLVEVEM 146
           LGEG FG V                 +   +D    VA+K L         ++FL EV++
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 147 LSRLHHRNLVKLVG-------------YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           LSRL   N+ +L+G             Y  + D +Q L  +    +G   +         
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS------ 126

Query: 194 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 253
             L + T + +A   A G+ YL        +HRD    N L+  N+  K+ADFG+++   
Sbjct: 127 --LSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVD-MSQPS 310
                 +  R      ++A E  + G    KSDV+++GV L E+LT    +P + ++   
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241

Query: 311 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
             EN    A    RD  R   L  P      PK+ +  +      C   +   RPT  E+
Sbjct: 242 VIEN----AGHFFRDDGRQIYLPRPPN---CPKDIYELMLE----CWRRDEEDRPTFREI 290

Query: 371 VQSLK 375
              L+
Sbjct: 291 HLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 20/212 (9%)

Query: 99  FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 154
           F    +LG+GGFG V    V + G   A K+L       ++G+   L E ++L +++ R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKI-ALDAARG 211
           +V L   Y ++D+    L   L+  G L+  ++  G  G       E R    A +   G
Sbjct: 62  VVSLAYAYETKDAL--CLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEICCG 114

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           L  LH++    +++RD K  NILL+++ H +++D GLA   PEG+T  +  RV GT GY+
Sbjct: 115 LEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYM 168

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE           D ++ G +L E++ G+ P
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 71/227 (31%), Positives = 100/227 (44%), Gaps = 35/227 (15%)

Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           +G+GG+G+VF     D G  VA+KR+           +  L E ++L+      LVKL  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-- 66

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            Y+ +D     L  E VP G   + L+  G L  +    +   M  A+DA   L Y    
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY---- 122

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---- 274
                IHRD K  N L++ + H K+ DFGL+K          +  V+G+  Y+APE    
Sbjct: 123 -----IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRG 172

Query: 275 --YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTW 318
             Y  T       D +S G +L E L G  P   S P+   ENL  W
Sbjct: 173 KGYDFT------VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 70/215 (32%), Positives = 107/215 (49%), Gaps = 29/215 (13%)

Query: 104 ILGEGGFGRVFKGVLS-DGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLVKL 158
           ++GEG FG+V K  +  DG  +  AIKR+     + D ++F  E+E+L +L HH N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIAL 206
           +G    R      L  E  P+G+L  +L                     L  +  +  A 
Sbjct: 62  LGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
           D ARG+ YL +      IHRD  A NIL+  N+ AK+ADFGL++    G+  Y+  + MG
Sbjct: 120 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMG 171

Query: 267 TFG--YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++A E          SDV+SYGV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 18/211 (8%)

Query: 100 EPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRN 154
                +GEG FG V++GV     ++  AVA+K          +E FL E  ++ +  H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLA 213
           +VKL+G  +        +  EL P G L S+L     VN + LD  + +  +   +  LA
Sbjct: 69  IVKLIGVITENPV---WIVMELAPLGELRSYLQ----VNKYSLDLASLILYSYQLSTALA 121

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           YL   S+  V HRD  A N+L+ +    K+ DFGL++   E  + Y +++      ++AP
Sbjct: 122 YLE--SKRFV-HRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAP 177

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           E          SDV+ +GV + E+L  G KP
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 51/257 (19%)

Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGP-------LGVNCHLDW 198
           L  LH  N   +VG+Y +  S   + +C E +  GSL+  L          LG       
Sbjct: 50  LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG------- 102

Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
               KI++   RGL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q      +
Sbjct: 103 ----KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 152

Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 318
            ++   +GT  Y++PE     H  V+SD++S G+ L+E+  GR P+        E +   
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212

Query: 319 ARPILRDKDRLE----------------ELAD-------PRLGGKYPKEDFIRVCTIAAA 355
                  K+                   EL D       P+L      ++F         
Sbjct: 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEF---QDFVDK 269

Query: 356 CVAPEANQRPTMGEVVQ 372
           C+     +R  + E+ +
Sbjct: 270 CLKKNPKERADLKELTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 80.0 bits (197), Expect = 7e-17
 Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 33/292 (11%)

Query: 99  FEPASILGEGGFGRVFKGVL--SDGT--AVAIKRLTCG--GQQGDKEFLVEVEMLSRLHH 152
           F    +LG+G FG V +  L   DG+   VA+K L          +EFL E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 153 RNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWL-HGPLGVN-CHLDWETRMKIAL 206
            N++KL+G      +   L    +    + +G L ++L    +G     L  +T ++  +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
           D A G+ YL   S    IHRD  A N +L  N    VADFGL+K+   G           
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 325
              ++A E          SDV+++GV + E++T G+ P      +G EN   +   I   
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLI--- 229

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
                     RL  K P +    V  +   C +PE   RP+   +   L+++
Sbjct: 230 -------KGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 72/240 (30%), Positives = 108/240 (45%), Gaps = 16/240 (6%)

Query: 80  HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK 138
            P ++  L  E L + T+ +E    +G+G +G+V+K     DG+  A+K L       D+
Sbjct: 5   FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDE 63

Query: 139 EFLVEVEMLSRL-HHRNLVKLVGYYSSRD---SSQHLLCYELVPNGSLESWLHGPLGVNC 194
           E   E  +L  L +H N+VK  G +   D     Q  L  EL   GS+   + G L    
Sbjct: 64  EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123

Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
            LD      I   A  GL +LH +    +IHRD K +NILL      K+ DFG++ Q   
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKPVDMSQP 309
            R    ++  +GT  ++APE              + DV+S G+  +EL  G  P+    P
Sbjct: 181 TRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.9 bits (197), Expect = 8e-17
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 20/212 (9%)

Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV       VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 71

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 72  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 124

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 125 --FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQ 308
             +KSDV+++GV+L E+ T G  P   +D+SQ
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.2 bits (198), Expect = 9e-17
 Identities = 73/231 (31%), Positives = 114/231 (49%), Gaps = 35/231 (15%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE-FLV----EVEM 146
           K   + F+    +GEG +G+V+K    D G  VA+K++       +KE F +    E+++
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL---DNEKEGFPITAIREIKI 59

Query: 147 LSRLHHRNLVKLVGYYSS--------RDSSQHLLCYELVPN---GSLESWLHGPLGVNCH 195
           L +L+HRN+V L    +         +D     L +E + +   G LES L     V+  
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFS 114

Query: 196 LDW-ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
            D  ++ MK  L+   GL Y H+ +    +HRD K SNILL N    K+ADFGLA+    
Sbjct: 115 EDHIKSFMKQLLE---GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
             +   + +V+ T  Y  PE  +       + DV+S G +L EL T +KP+
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 27/222 (12%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVE--MLSR 149
           +   +++E    +G G +G V+K   L  G   A+K +    + GD   L++ E  M+  
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKE 62

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALD 207
             H N+V   G Y SR+  +  +C E    GSL+   H  GPL     + +  R     +
Sbjct: 63  CKHCNIVAYFGSYLSRE--KLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCR-----E 114

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VM 265
             +GLAYLH   +   +HRD K +NILL +N   K+ADFG+A +     T  ++ R   +
Sbjct: 115 TLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI----TATIAKRKSFI 167

Query: 266 GTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPV 304
           GT  ++APE A     G      D+++ G+  +EL   + P+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 18/211 (8%)

Query: 99  FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 154
           F    +LG+GGFG V    V + G   A KRL       ++G+   L E ++L +++ + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 155 LVKLVGYYSSRDSSQHLLCYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           +V L   Y ++D+    LC  L  +  G L+  ++  +G N   + E  +  A +   GL
Sbjct: 62  VVNLAYAYETKDA----LCLVLTIMNGGDLKFHIYN-MG-NPGFEEERALFYAAEILCGL 115

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
             LH ++    ++RD K  NILL++  H +++D GLA + PEG +  +  RV GT GY+A
Sbjct: 116 EDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMA 169

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           PE        +  D +  G ++ E++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 80/292 (27%), Positives = 127/292 (43%), Gaps = 48/292 (16%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRN 154
           ++ E    LG G +G V K   +  GT +A+KR+      Q  K  L+++++  R     
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVD-- 58

Query: 155 LVKLVGYYSS--RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
               V +Y +  R+     +C E++ + SL+ +          +  +   KIA+   + L
Sbjct: 59  CPYTVTFYGALFREGDV-WICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS-TRVMGTFGYV 271
            YLH   +  VIHRD K SN+L+  N   K+ DFG++        + ++ T   G   Y+
Sbjct: 117 EYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL----VDSVAKTIDAGCKPYM 170

Query: 272 APEY----AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 327
           APE            VKSDV+S G+ ++EL TGR P D           +W  P  + K 
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWKTPFQQLKQ 219

Query: 328 RLEELADPRLGGKYPKE-------DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
            +EE   P+L    P E       DF+  C            +RP   E++Q
Sbjct: 220 VVEE-PSPQL----PAEKFSPEFQDFVNKCLKK------NYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 28/211 (13%)

Query: 108 GGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKEFL-VEVE---MLSRLHHRNLVKLVGY 161
           G FG V+  K   + G   AIK L         +   V+ E   M+ +     + KL   
Sbjct: 7   GAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL--- 62

Query: 162 YSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           Y S  S  +L L  E +  G   S +   G L      DW  +  IA +   G+  LH+ 
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP----EDW-AKQYIA-EVVLGVEDLHQR 116

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
               +IHRD K  N+L++   H K+ DFGL+      R    + + +GT  Y+APE  + 
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILG 167

Query: 279 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
                 SD +S G V+ E L G  P     P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 32/212 (15%)

Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G+G FG V+ G L D        A+K L       + ++FL E  ++    H N++ L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-------MKIALDAARG 211
           +G     + S  ++         L    HG L     +  ET        +   L  A+G
Sbjct: 62  LGICLPSEGSPLVV---------LPYMKHGDL--RNFIRSETHNPTVKDLIGFGLQVAKG 110

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS----TRVMGT 267
           + YL        +HRD  A N +L+ +F  KVADFGLA+   +    Y S    T     
Sbjct: 111 MEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYD--KEYYSVHNHTGAKLP 165

Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             ++A E   T     KSDV+S+GV+L EL+T
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 84/304 (27%), Positives = 136/304 (44%), Gaps = 35/304 (11%)

Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGGQQGDK 138
           P S + + ++   + ++ +E    +G+G +G+VFK VL+  +G+  A+K L       D+
Sbjct: 2   PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILD-PIHDIDE 59

Query: 139 EFLVEVEMLSRLH-HRNLVKLVGYYSSRD---SSQHLLCYELVPNGSLESWLHGPLGVNC 194
           E   E  +L  L  H N+VK  G Y  +D     Q  L  EL   GS+   + G L    
Sbjct: 60  EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119

Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
            ++      I  +A  GL +LH +     IHRD K +NILL      K+ DFG++ Q   
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKPVDMSQP 309
            R    ++  +GT  ++APE       L      + DV+S G+  +EL  G  P+    P
Sbjct: 177 TRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Query: 310 SGQENLVTWARPILR-DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 368
                     R + +  ++    L  P L       DFIR       C+  +  +RPT+ 
Sbjct: 235 ---------MRALFKIPRNPPPTLHQPELWSN-EFNDFIR------KCLTKDYEKRPTVS 278

Query: 369 EVVQ 372
           +++Q
Sbjct: 279 DLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 18/211 (8%)

Query: 99  FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 154
           F    +LG+GGFG V    V + G   A K+L       ++G+   L E  +L +++ R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 155 LVKLVGYYSSRDSSQHLLCYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           +V L   Y ++D+    LC  L  +  G L+  ++  +G N   D +  +  A +   GL
Sbjct: 62  VVSLAYAYETKDA----LCLVLTIMNGGDLKFHIYN-MG-NPGFDEQRAIFYAAELCCGL 115

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
             L  +    +++RD K  NILL++  H +++D GLA Q PEG T  +  RV GT GY+A
Sbjct: 116 EDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMA 169

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           PE           D +  G ++ E++ G+ P
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 62/234 (26%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT-------CGGQQGDKEFLVEVEMLSR 149
            ++  S +GEG +G V        G  VAIK+++       C      +  L E+++L R
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC------QRTLREIKILRR 59

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM------- 202
             H N++ +                +++   S ES  +    V   +  ET +       
Sbjct: 60  FKHENIIGI---------------LDIIRPPSFES-FNDVYIVQELM--ETDLYKLIKTQ 101

Query: 203 KIALDAA--------RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-P 253
            ++ D          RGL Y+H  +   V+HRD K SN+LL  N   K+ DFGLA+ A P
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158

Query: 254 EGR-----TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
           E       T Y++TR      Y APE  +      K+ D++S G +L E+L+ R
Sbjct: 159 EHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 32/282 (11%)

Query: 104 ILGEGGFGRVFKGVLSDGT-----AVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLVK 157
           +L EG FGR+F G+L D        V +K +     +      L E  +L  L H+N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLA 213
           ++      D     + Y  +  G+L+ +L     G       L  +  + +A+  A G++
Sbjct: 73  ILH-VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           YLH+     VIH+D  A N +++     K+ D  L++       + L         ++A 
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
           E  +       SDV+S+GV+L EL+T G+ P     P     +  +    L+D  RL + 
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY----LKDGYRLAQP 241

Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
            +       P E F     + A C A +  +RP+  ++VQ L
Sbjct: 242 IN------CPDELF----AVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 74/244 (30%), Positives = 119/244 (48%), Gaps = 34/244 (13%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV---EVEMLSRLHHR 153
           +FE    +G G +G V+K   ++ G   AIK +     +  ++F V   E+ M+    H 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL---EPGEDFAVVQQEIIMMKDCKHS 66

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMK-IALDAAR 210
           N+V   G Y  RD  +  +C E    GSL+   H  GPL        E+++  ++ +  +
Sbjct: 67  NIVAYFGSYLRRD--KLWICMEFCGGGSLQDIYHVTGPLS-------ESQIAYVSRETLQ 117

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTF 268
           GL YLH   +   +HRD K +NILL +N H K+ADFG++ Q     T  ++ R   +GT 
Sbjct: 118 GLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI----TATIAKRKSFIGTP 170

Query: 269 GYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT---WARPI 322
            ++APE A     G      D+++ G+  +EL   + P+    P     L+T   +  P 
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK 230

Query: 323 LRDK 326
           L+DK
Sbjct: 231 LKDK 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 77.8 bits (191), Expect = 6e-16
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 25/219 (11%)

Query: 105 LGEGGFGRVFKGVLSDGT------AVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVK 157
           LGE  FG+V+KG L          AVAIK L    +    +EF  E  M SRL H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLG-------VNCHLDWETRMKIA 205
           L+G  +       +  Y    +  L  +L     H  +G       V   L+    + I 
Sbjct: 73  LLGVVTKEQPLSMIFSY--CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              A G+ +L   S   V+H+D    N+L+ +  + K++D GL ++        L    +
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
               +++PE  M G   + SD++SYGVVL E+ + G +P
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 44/281 (15%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVGY 161
           ++G G +G V++G  +  G  VA+K +       D  +   EV +LS+L       +  Y
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 162 YSSRDSSQHL-LCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL---DAARGLAYLH 216
           Y S      L +  E    GS+ + +  GP+             I++   +    L Y+H
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY---------ISVIIREVLVALKYIH 118

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
           +     VIHRD KA+NIL+ N  + K+ DFG+A    +  +   ST V GT  ++APE  
Sbjct: 119 KVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV-GTPYWMAPEVI 173

Query: 277 MTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 335
             G     K+D++S G+ + E+ TG  P           L+  ++P             P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-------------P 220

Query: 336 RL-GGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS 373
           RL    Y K   +F+      AAC+  E  +R +  E+++S
Sbjct: 221 RLEDNGYSKLLREFV------AACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.4 bits (191), Expect = 8e-16
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 47/225 (20%)

Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE-------FLVEVEMLSR 149
            FE  + +GEG +G V++   +  G  VA+K++     + D E        L E+ +L  
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLREITLLLN 62

Query: 150 LHHRNLVKL----VGYYSSRDSSQHLLCYELVPN------GSLESWLHGPLGVNCHLDWE 199
           L H N+V+L    VG        +HL    LV         SL   +  P         E
Sbjct: 63  LRHPNIVELKEVVVG--------KHLDSIFLVMEYCEQDLASLLDNMPTPFS-------E 107

Query: 200 TRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
           +++K + L   RGL YLHE+    +IHRD K SN+LL +    K+ADFGLA+    G   
Sbjct: 108 SQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPA 162

Query: 259 YLSTRVMGTFGYVAPE--YAMTGHLLVKSDVYSYGVVLLELLTGR 301
              T  + T  Y APE     T +     D+++ G +L ELL  +
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTT-AIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 77/274 (28%), Positives = 123/274 (44%), Gaps = 39/274 (14%)

Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG V+KG+ +     VAIK +     + + E +  E+ +LS+     + +  G Y
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 163 SSRDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQ 220
                ++  +  E +  GS    L  GPL        ET +   L +  +GL YLH + +
Sbjct: 72  LK--GTKLWIIMEYLGGGSALDLLKPGPLE-------ETYIATILREILKGLDYLHSERK 122

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD KA+N+LL      K+ADFG+A Q  +  T       +GT  ++APE      
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 281 LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
              K+D++S G+  +EL  G  P     P     L+    P             P L G+
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQ 224

Query: 341 Y--PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
           Y  P ++F+       AC+  +   RPT  E+++
Sbjct: 225 YSKPFKEFVE------ACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 67/224 (29%), Positives = 100/224 (44%), Gaps = 61/224 (27%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF--------LVEVEMLSRL-HHRN 154
           LG+G FG V+       G  VAIK++        K+F        L EV+ L +L  H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSL----ESWLHGPLGVNCHLDWETRMK-IALDAA 209
           +VKL      R++ +    +E +  G+L    +     P         E+ ++ I     
Sbjct: 60  IVKL--KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-------ESVIRSIIYQIL 109

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR-----TNYLSTRV 264
           +GLA++H+       HRD K  N+L+      K+ADFGLA+   E R     T+Y+STR 
Sbjct: 110 QGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTR- 162

Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYS-------YGVVLLELLTGR 301
                Y APE      +L++S  YS        G ++ EL T R
Sbjct: 163 ----WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)

Query: 99  FEPASILGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN 154
           F    +LG+GGFG V    V + G   A K+L       ++G+   L E ++L +++ R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 155 LVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAAR 210
           +V L   Y ++D+    LC    L+  G L+  ++  G  G     D E  +  A +   
Sbjct: 62  VVSLAYAYETKDA----LCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAAEITC 113

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GL  LH +    +++RD K  NILL++  H +++D GLA + PEG T  +  RV GT GY
Sbjct: 114 GLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGY 167

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +APE           D +  G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 74/269 (27%), Positives = 113/269 (42%), Gaps = 49/269 (18%)

Query: 105 LGEGGFGRV---------------FKGVLSDGTA--VAIKRLTCGGQQGDK-EFLVEVEM 146
           LGEG FG V               F   +  G    VA+K L     +  + +FL EV++
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH---------------GP 189
           LSRL   N+++L+G     D     LC   E + NG L  +L                 P
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
                 + + + + +AL  A G+ YL   S    +HRD    N L+  N   K+ADFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           +    G    +  R +    ++A E  + G     SDV+++GV L E+L     +   QP
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQP 241

Query: 310 SGQ---ENLVTWARPILRDKDRLEELADP 335
            G+   E ++  A    RD+ R   L  P
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRP 270

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)

Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V  G L         VAIK L  G  ++  ++FL E  ++ +  H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +   S   ++  E + NGSL+++L    G          + +    A G+ YL + 
Sbjct: 71  EGVVTK--SKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM 125

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEY 275
                +HRD  A NIL+ +N   KV+DFGL++     PE    Y +        + APE 
Sbjct: 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIPIRWTAPEA 180

Query: 276 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 307
                    SDV+SYG+V+ E+++ G +P  +MS
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)

Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGVNCHLDWETRMKIALDAARG 211
           L+G  S    +  L+  EL+  G L+S+L           V      +  +++A + A G
Sbjct: 74  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-- 269
           +AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G     
Sbjct: 132 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 186

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           +++PE    G     SDV+S+GVVL E+ T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 81/285 (28%), Positives = 126/285 (44%), Gaps = 36/285 (12%)

Query: 105 LGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LGEG FG V +G L+        AV   ++    +   ++FL E   +    H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 160 GYYSSRDSSQH----LLCYELVPNGSLESWL-HGPLGVNCHLDWETRM--KIALDAARGL 212
           G       S+     ++    + +G L S+L +  LG +C     T+M  K   D A G+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGM 125

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYV 271
            YL   S    IHRD  A N +L  N +  VADFGL+K+   G   Y   R+      ++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG-DYYRQGRIAKMPVKWI 181

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 330
           A E         KSDV+S+GV + E+ T G+ P       G EN   +    LR  +RL+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVENSEIY--DYLRQGNRLK 234

Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           +  D  L G Y         ++ ++C       RP+   +   L+
Sbjct: 235 QPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 25/207 (12%)

Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEF---LVEVEMLSRLHHRNLVKLVG 160
           +G G FG V F   +     VAIK+++  G+Q ++++   + EV  L +L H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDS 219
            Y    ++  ++ Y L     +      PL        E  +  I   A +GLAYLH   
Sbjct: 83  CYLREHTAWLVMEYCLGSASDILEVHKKPLQ-------EVEIAAICHGALQGLAYLHSH- 134

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE--YAM 277
               IHRD KA NILL      K+ADFG A       +       +GT  ++APE   AM
Sbjct: 135 --ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVILAM 186

Query: 278 -TGHLLVKSDVYSYGVVLLELLTGRKP 303
             G    K DV+S G+  +E L  RKP
Sbjct: 187 DEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 67/234 (28%), Positives = 113/234 (48%), Gaps = 24/234 (10%)

Query: 105 LGEGGFGRVFK-GVLSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           LG+GGFG V    V + G   A K+L       + G+K  L+E E+L +++   +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 161 YYSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAYLHE 217
            +   +S  HL L   L+  G L+  ++  G  G    L+ E  +  +     G+ +LH 
Sbjct: 61  AF---ESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHS 113

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                +++RD K  N+LL++  + +++D GLA +  +G+T    T+  GT GY+APE   
Sbjct: 114 MD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILK 167

Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVTWARPILRDKDRLE 330
                   D ++ G  + E++ GR P  D  +   +E L    R  L D+ + E
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK---RRTLEDEVKFE 218

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 66/228 (28%), Positives = 108/228 (47%), Gaps = 48/228 (21%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---F----LVEVEMLSR 149
            +E  + + EG +G V++      G  VA+K+L     + +KE   F    L E+ +L +
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREINILLK 60

Query: 150 LHHRNLVKL----VGYYSSRDSSQHLLCYELVPNG--SLESWLHGPLGVNCHLDWETRMK 203
           L H N+V +    VG     +  +  +  E V +   SL   +  P   +   + +  M 
Sbjct: 61  LQHPNIVTVKEVVVG----SNLDKIYMVMEYVEHDLKSLMETMKQPFLQS---EVKCLML 113

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
             L    G+A+LH++    ++HRD K SN+LL N    K+ DFGLA++       Y  T+
Sbjct: 114 QLL---SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQ 165

Query: 264 VMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPV 304
           ++ T  Y APE      LL+         D++S G +  ELLT +KP+
Sbjct: 166 LVVTLWYRAPE------LLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 35/210 (16%)

Query: 104 ILGEGGFGRVFKG-VLSDGTAVAIK----RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ILG G  G V+K   L     +A+K     +T   Q   K+ + E+E+L +     ++  
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ---KQIMSELEILYKCDSPYIIGF 64

Query: 159 VG--YYSSRDSSQHLLCYELVPNGSLESWLHGP---LGVNCHLDWETRMKIALDAARGLA 213
            G  +  +R S    +C E +  GSL+ +   P   LG           +IA+   +GL 
Sbjct: 65  YGAFFVENRIS----ICTEFMDGGSLDVYRKIPEHVLG-----------RIAVAVVKGLT 109

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           YL       ++HRD K SN+L+      K+ DFG++ Q      N ++   +GT  Y+AP
Sbjct: 110 YLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAP 162

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           E        + SDV+S G+  +EL  GR P
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 37/273 (13%)

Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG VFKG+ +     VAIK +     + + E +  E+ +LS+     + K  G Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 163 SSRDSSQHLLCYELVPNGS-LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
                ++  +  E +  GS L+    GP          T +K  L   +GL YLH + + 
Sbjct: 72  LK--GTKLWIIMEYLGGGSALDLLRAGPFD---EFQIATMLKEIL---KGLDYLHSEKK- 122

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
             IHRD KA+N+LL      K+ADFG+A Q  +  T       +GT  ++APE       
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             K+D++S G+  +EL  G  P     P             +R    + +   P L G++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHP-------------MRVLFLIPKNNPPTLTGEF 225

Query: 342 PK--EDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
            K  ++FI       AC+  + + RPT  E+++
Sbjct: 226 SKPFKEFID------ACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 75.2 bits (185), Expect = 6e-15
 Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 36/223 (16%)

Query: 94  EATNNFEPASILGEGGFGRV--FKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSR 149
           E TN +     +G G FG V   +  L+ G  VAIK++          K    E+++L  
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-------M 202
           L H N++ L   + S     + +  EL             LG + H    +R        
Sbjct: 66  LRHENIISLSDIFISPLEDIYFVT-EL-------------LGTDLHRLLTSRPLEKQFIQ 111

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                  RGL Y+H      V+HRD K SNIL+  N   K+ DFGLA+      T Y+ST
Sbjct: 112 YFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVST 168

Query: 263 RVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPV 304
           R      Y APE  +T     V+ D++S G +  E+L G KP+
Sbjct: 169 RY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 77/301 (25%), Positives = 115/301 (38%), Gaps = 84/301 (27%)

Query: 97  NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKE----------FLV 142
           ++FE   ++G G FG V+   L      G   A+K L        K              
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRA 50

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETR 201
           E ++L+      +VKL  YYS +D  +HL L  E +P G L + L   +  +   +   R
Sbjct: 51  ERDILADADSPWIVKL--YYSFQDE-EHLYLVMEYMPGGDLMNLL---IRKDVFPEETAR 104

Query: 202 -----MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 256
                + +ALD+   L +         IHRD K  NIL++ + H K+ADFGL K+  + +
Sbjct: 105 FYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155

Query: 257 TNYL----------------------STRVM-----GTFGYVAPEYAMTGHLLVKSDVYS 289
                                       RV      GT  Y+APE        ++ D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215

Query: 290 YGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFI 347
            GV+L E+L G  P             T+ + I+  K+ L    DP        E  D I
Sbjct: 216 LGVILYEMLYGFPPF-----YSDTLQETYNK-IINWKESLRFPPDP----PVSPEAIDLI 265

Query: 348 R 348
            
Sbjct: 266 C 266

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 25/207 (12%)

Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVG 160
           +G G FG V+    S     VA+K+++  G+Q +   ++ + EV+ L +L H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDS 219
            Y    ++  ++ Y L     L      PL        E  +  I   A +GLAYLH   
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQ-------EVEIAAITHGALQGLAYLHSH- 140

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT- 278
              +IHRD KA NILL      K+ADFG A ++    +       +GT  ++APE  +  
Sbjct: 141 --NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAM 192

Query: 279 --GHLLVKSDVYSYGVVLLELLTGRKP 303
             G    K DV+S G+  +E L  RKP
Sbjct: 193 DEGQYDGKVDVWSLGITCIE-LAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.7 bits (183), Expect = 7e-15
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 16/199 (8%)

Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG+G FG+V+K    + G   A K +    ++  ++++VE+E+L+  +H  +VKL+G + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                +  +  E  P G++++ +   L ++  L       I       L YLH      +
Sbjct: 80  W--DGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHSMK---I 131

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL- 282
           IHRD KA N+LL  +   K+ADFG++  A   +T       +GT  ++APE  M   +  
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 283 ----VKSDVYSYGVVLLEL 297
                K+D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 74.0 bits (182), Expect = 8e-15
 Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 51/300 (17%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC---GGQQGDKEFLVEVEMLSRLH 151
             NF+    +G+G F  V+K + L DG  VA+K++        +  ++ L E+++L +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 152 HRNLVKLVGYYSSR-DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           H N++K   Y +S  ++++  +  EL   G L   +         +   T  K  +    
Sbjct: 61  HPNVIK---YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L ++H      ++HRD K +N+ +      K+ D GL      GR  + S++       
Sbjct: 118 ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGL------GR--FFSSKTTAAHSL 166

Query: 271 VAPEYAMTGHLL------VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 324
           V   Y M+   +       KSD++S G +L E+   + P                     
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG------------------ 208

Query: 325 DKDRLEELADPRLGGKY---PKEDF---IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 378
           DK  L  L        Y   P + +   +R   + + C+ P+  +RP +  V+Q  K + 
Sbjct: 209 DKMNLYSLCKKIEKCDYPPLPADHYSEELR--DLVSRCINPDPEKRPDISYVLQVAKEMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 69/232 (29%), Positives = 108/232 (46%), Gaps = 31/232 (13%)

Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVG 160
           +G G FG V F   + +   VAIK+++  G+Q +   ++ + EV  L +L H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAARGLAYLHE 217
            Y    ++  ++ Y L     L      PL           ++IA     A +GLAYLH 
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPL---------QEVEIAAVTHGALQGLAYLHS 133

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGTFGYVAPEYA 276
            +   +IHRD KA NILL      K+ DFG A   AP       +   +GT  ++APE  
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVI 183

Query: 277 MT---GHLLVKSDVYSYGVVLLELLTGRKPV-DMSQPSGQENLVTWARPILR 324
           +    G    K DV+S G+  +EL   + P+ +M+  S   ++     P L+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 30/206 (14%)

Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG+G FG+V+K    + G   A K +    ++  ++++VE+++L+   H N+VKL+  + 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 164 SRDSSQHLLCYELVPNGSLESW---LHGPLGVNCHLDWETRMKI----ALDAARGLAYLH 216
             ++   L+  E    G++++    L  PL        E ++++     L+A   L YLH
Sbjct: 73  YENNLWILI--EFCAGGAVDAVMLELERPLT-------EPQIRVVCKQTLEA---LNYLH 120

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
           E+    +IHRD KA NIL   +   K+ADFG++  A   RT       +GT  ++APE  
Sbjct: 121 ENK---IIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVV 175

Query: 277 MTGH-----LLVKSDVYSYGVVLLEL 297
           M           K+DV+S G+ L+E+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 25/217 (11%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRL-TCGGQQGDKEFLV-EVEMLSRL---HH 152
           +E  + +GEG +G V+K   L+ G  VA+K++     ++G     + E+ +L +L    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 153 RNLVKL----VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL 206
            N+V+L     G  + R+    L+ +E V +  L ++L      G    L  ET   +  
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLV-FEHV-DQDLATYLSKCPKPG----LPPETIKDLMR 114

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
              RG+ +LH      ++HRD K  NIL+ ++   K+ADFGLA+           T V+ 
Sbjct: 115 QLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMALTSVVV 168

Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           T  Y APE  +        D++S G +  EL   R+P
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 75/262 (28%), Positives = 117/262 (44%), Gaps = 28/262 (10%)

Query: 75  GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGG 133
            GSL  P        E+ ++    F     +G G FG V F   +     VAIK+++  G
Sbjct: 6   AGSLKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG 62

Query: 134 QQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL 190
           +Q +   ++ + EV+ L R+ H N ++  G Y    ++  ++ Y L     L      PL
Sbjct: 63  KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPL 122

Query: 191 GVNCHLDWETRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
                   E  +  I   A +GLAYLH  +   +IHRD KA NILL      K+ADFG A
Sbjct: 123 Q-------EVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA 172

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPV-D 305
             A    +       +GT  ++APE  +    G    K DV+S G+  +EL   + P+ +
Sbjct: 173 SIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226

Query: 306 MSQPSGQENLVTWARPILRDKD 327
           M+  S   ++     P L+  +
Sbjct: 227 MNAMSALYHIAQNESPTLQSNE 248

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 40/277 (14%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    + +F+ E +++ +L H  LV+L G  + 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L    G    L  +  + +  D   G+ YL  +S    I
Sbjct: 71  QKPL--YIVTEFMENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNS---FI 122

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG------YVAPEYAMT 278
           HRD  A N L+ +    KV+DFG+ +         L      + G      +  PE    
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYV-------LDDEYTSSSGAKFPVKWSPPEVFNF 175

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 337
                KSDV+S+GV++ E+ T G+ P +        N       ++    R   L  P+L
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NY-----EVVEMISRGFRLYRPKL 225

Query: 338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                      V  +  +C   +   RPT  E+++++
Sbjct: 226 ASMT-------VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 51/250 (20%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-F----LVEVEM 146
            +  + +E  + +G+G FG VFK         VA+K++    +   KE F    L E+++
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKI 64

Query: 147 LSRLHHRNLVKLV------GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW-- 198
           L  L H N+V L+          +R      L +E       E  L G L  N ++ +  
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLS-NKNVKFTL 118

Query: 199 ---ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QA 252
              +  MK+ L+   GL Y+H +    ++HRD KA+NIL+  +   K+ADFGLA+    +
Sbjct: 119 SEIKKVMKMLLN---GLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Query: 253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPVD 305
              + N  + RV+ T  Y  PE      LL+         D++  G ++ E+ T R P+ 
Sbjct: 173 KNSKPNRYTNRVV-TLWYRPPE------LLLGERDYGPPIDMWGAGCIMAEMWT-RSPI- 223

Query: 306 MSQPSGQENL 315
           M   + Q  L
Sbjct: 224 MQGNTEQHQL 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 105 LGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG+          AV I +          E L E  ++ +L +  +V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  EL   G L  +L      N H+  +   ++    + G+ YL E +
Sbjct: 63  GIC---EAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMN 171

Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 71/219 (32%), Positives = 104/219 (47%), Gaps = 31/219 (14%)

Query: 105 LGEGGFGRVFK----GVLSDGTA----VAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V      G+  D       VA+K L       D   LV E+EM+  +  H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-----CHLDWETR-----M 202
           ++ L+G   ++D   ++L  E    G+L  +L    P G++     C L  E       +
Sbjct: 80  IINLLGA-CTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   SQ C IHRD  A N+L+  +   K+ADFGLA+       +Y   
Sbjct: 138 SCAYQVARGMEYLA--SQKC-IHRDLAARNVLVTEDNVMKIADFGLARDVHN--IDYYKK 192

Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 23/217 (10%)

Query: 98  NFEPASILGEGGFGRVF--KGVLSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHR 153
            +E    +GEG FG+++  K   SD     IK   LT    +  +    EV +L+++ H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAA 209
           N+V    + S +++ +  +  E    G L   ++   GV    +  L W   ++I+L   
Sbjct: 60  NIVTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL--- 112

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            GL ++H+     ++HRD K+ NI L +N   AK+ DFG+A+Q  +  +  L+   +GT 
Sbjct: 113 -GLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTP 166

Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
            Y++PE         K+D++S G VL EL T + P +
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 70/280 (25%), Positives = 123/280 (43%), Gaps = 38/280 (13%)

Query: 105 LGEGGFGRVFKGVLSDGTA--VAIKRLTC-------GGQQGDKEF---LVEVEML-SRLH 151
           LG G FG V+K    +     +A+K +           ++ DK     + EV ++  +L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 152 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           H N+V+   YY +   +  L +  +L+    L    +           E    I +    
Sbjct: 68  HPNIVR---YYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L YLH++ +  ++HRD   +NI+L  +    + DFGLAKQ  +   + L T V+GT  Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL-TSVVGTILY 179

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 330
             PE         K+DV+++G +L ++ T      +  P    N+++ A  I      +E
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKI------VE 227

Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
            + +P   G Y +     V  +  +C+ P+A  RP + +V
Sbjct: 228 AVYEPLPEGMYSE----DVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 32/221 (14%)

Query: 97  NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHH-R 153
           N+ E    +G G  G+V+K      G  +A+K++   G ++ +K  L++++++ + H   
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPN--GSLESWLHGP-----LGVNCHLDWETRMKIAL 206
            +VK  GY+ +   S   +C EL+      L   + GP     LG           K+ +
Sbjct: 75  YIVKCYGYFIT--DSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----------KMTV 121

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
              + L YL E     VIHRD K SNILL+ + + K+ DFG++ +  + +     TR  G
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAG 176

Query: 267 TFGYVAPEY----AMTGHLLVKSDVYSYGVVLLELLTGRKP 303
              Y+APE            +++DV+S G+ L+EL TG+ P
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 35/281 (12%)

Query: 105 LGEGGFGRVFKGVLSDG---TAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           +G G FG+V  G ++ G     V +K L      Q   +FL E +    L H NL++ +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHG-PLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
             +  + + +LL  E  P G L+ +L           D  T  ++A + A GL +LH+++
Sbjct: 63  QCT--EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYVAPEYA- 276
               IH D    N LL  +   K+ D+GL+    + + +Y  T  ++     ++APE   
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 277 -MTGHLLV-----KSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL 329
            + G+LLV     +S+V+S GV + EL   G +P      S ++ L    R      ++ 
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP--YRHLSDEQVLTYTVR------EQQ 227

Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
            +L  PRL  K P  D  R   +   C      QRP+  EV
Sbjct: 228 LKLPKPRL--KLPLSD--RWYEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 18/214 (8%)

Query: 98  NFEPASILGEGGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRLHHR 153
            +E   ++G G FG V   +   +D   V IK++       D+      E ++L  L H 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 154 NLVKLVGYYSS-RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           N++    YY +  +    ++  E  P G+L  ++      N  LD +T +   +     L
Sbjct: 60  NII---EYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLAL 114

Query: 213 AYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
            ++H      ++HRD K  NILL+ +    K+ DFG++K        Y    V+GT  Y+
Sbjct: 115 HHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY---TVVGTPCYI 168

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           +PE         KSD+++ G VL EL + ++  +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 70/245 (28%), Positives = 115/245 (46%), Gaps = 27/245 (11%)

Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL---VG 160
           LG G  G VF  V SD    VA+K++     Q  K  L E++++ RL H N+VK+   +G
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 161 YYSSRDSSQHLLCYEL----VPNGSLESWL-----HGPLGVNCHLDWETRMKIALDAARG 211
              S  +       EL    +    +E+ L      GPL          R+       RG
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEE-----HARL-FMYQLLRG 126

Query: 212 LAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAK-QAPE-GRTNYLSTRVMGTF 268
           L Y+H  +   V+HRD K +N+ +   +   K+ DFGLA+   P      YLS  ++  +
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183

Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 327
            Y +P   ++ +   K+ D+++ G +  E+LTG+     +    Q  L+  + P++R++D
Sbjct: 184 -YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242

Query: 328 RLEEL 332
           R E L
Sbjct: 243 RNELL 247

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 26/212 (12%)

Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G   D       T VA+K +       ++ EFL E  ++      ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+ +G L+S+L        + P      L  +  +++A + A
Sbjct: 74  LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIA 129

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF- 268
            G+AYL+       +HRD  A N ++ ++F  K+ DFG+ +   E  T+Y      G   
Sbjct: 130 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 184

Query: 269 -GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             ++APE    G     SD++S+GVVL E+ +
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 57/274 (20%), Positives = 116/274 (42%), Gaps = 39/274 (14%)

Query: 112 RVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVKLVGYYSSRDS 167
            ++KG+  +   V I+       +G K  +     E++ L R+   N++K+ G+    D 
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKF-HKGHKVLIDITENEIKNLRRIDSNNILKIYGFII--DI 90

Query: 168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHR 226
              L    L+       +L   L     L ++T++ +A+D  +GL  L++  ++P   ++
Sbjct: 91  VDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147

Query: 227 DFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV 283
           +  + + L+  N+  K+   GL K     P    N++          +  EY       +
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY------TI 201

Query: 284 KSDVYSYGVVLLELLTGRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 342
           K D+YS GVVL E+ TG+ P + ++     + ++                   +L    P
Sbjct: 202 KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII---------NKNNSL----KLPLDCP 248

Query: 343 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 376
            E    +  I  AC + ++ +RP + E++ +L +
Sbjct: 249 LE----IKCIVEACTSHDSIKRPNIKEILYNLSL 278

Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)

Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 83  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 141 SCTYQVARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDV--NNIDYYKK 195

Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.5 bits (175), Expect = 7e-14
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 18/229 (7%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G  G V+  + ++ G  VAIK++    QQ  KE ++ E+ ++    H N+V  +  Y
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              D  +  +  E +  GSL   +         +D      +  +  + L +LH +    
Sbjct: 86  LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 135

Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           VIHRD K+ NILL  +   K+ DFG   Q  PE       + ++GT  ++APE       
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 192

Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRL 329
             K D++S G++ +E++ G  P     P     L+ T   P L++ ++L
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 24/218 (11%)

Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTC--GGQQGDKE---FLVEVEMLSRLH 151
           N+    +LG G FG V+    +D G  +A+K++      Q+  KE      E+++L  L 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAA 209
           H  +V+  G     +  +  +  E +P GS++  L  +G L  N      TR +      
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV-----TR-RYTRQIL 116

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS----TRVM 265
           +G++YLH +    ++HRD K +NIL ++  + K+ DFG +K+    +T  +S      V 
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVT 170

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           GT  +++PE         K+DV+S    ++E+LT + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 40/228 (17%)

Query: 98  NFEPASILGEGGFGRV----FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLS 148
            +E    LG+G +G V         S+   VAIK++T       K+ L      E+++L 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKIT---NVFSKKILAKRALRELKLLR 56

Query: 149 RLH-HRNLVKLVGYYSSRDSS-QHLLCYELVPNGSLESWLHG--PLGVNCHLDWETRMKI 204
               H+N+  L         +   L  YE +    L   +    PL  + H        +
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHFQSFIYQIL 115

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-------KQAPEGRT 257
                 GL Y+H  +   V+HRD K  N+L+  +   K+ DFGLA        +     T
Sbjct: 116 -----CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 258 NYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
            Y++TR      Y APE  ++     K+ DV+S G +L ELL GRKPV
Sbjct: 168 EYVATR-----WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 28/220 (12%)

Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRLH 151
           N+    +LG+G FGRV+    +D G  +A+K++    +  +    V     E+++L  L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 152 HRNLVKLVGYYSSRDSSQHLLC--YELVPNGSLESWL--HGPLGVNCHLDWETRMKIALD 207
           H  +V+  G    RD  +  L    E +P GS++  L  +G L  N      TR K    
Sbjct: 63  HERIVQYYGCL--RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV-----TR-KYTRQ 114

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS----TR 263
              G++YLH +    ++HRD K +NIL ++  + K+ DFG +K+    +T  LS      
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKS 168

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           V GT  +++PE         K+D++S G  ++E+LT + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 11/203 (5%)

Query: 105 LGEGGFGRVFKGVL-SDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           LG+GGFG V    + + G   A K+L       ++G +  +VE  +L+++H R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA- 59

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
            Y+ +  +   L   ++  G L   ++     N                 GL +LH   Q
Sbjct: 60  -YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---Q 115

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
             +I+RD K  N+LL+N+ + +++D GLA +  +G++   +    GT G++APE      
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173

Query: 281 LLVKSDVYSYGVVLLELLTGRKP 303
                D ++ GV L E++  R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)

Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 1   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 60

Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 61  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 120

Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 121 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 173 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 23/217 (10%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC-GGQQGDKEFLV-EVEMLSRLH---H 152
           +EP + +G G +G V+K      G  VA+K +     + G     V EV +L RL    H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 153 RNLVKLVGYYSSRDSSQHL---LCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIALD 207
            N+V+L+   ++  + +     L +E V +  L ++L    P G    L  ET   +   
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG----LPAETIKDLMRQ 116

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
             RGL +LH +   C++HRD K  NIL+ +    K+ADFGLA+           T V+ T
Sbjct: 117 FLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVT 170

Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
             Y APE  +        D++S G +  E+   RKP+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 43/218 (19%)

Query: 105 LGEGGFGRVFKGVLSD---GTAVAIKRL--TCGGQQGDKEFLVEVEMLSRL-HHRNLVKL 158
           LG+G +G V+K +  D      VA+K++          +    E+  L  L  H N+VKL
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +    + +     L +E      +E+ LH  +  N   D   R  I     + L Y+H  
Sbjct: 73  LNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRY-IMYQLLKALKYIHSG 126

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR--------TNYLSTRVMGTFGY 270
           +   VIHRD K SNILL ++   K+ADFGLA+   E          T+Y++TR      Y
Sbjct: 127 N---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR-----WY 178

Query: 271 VAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
            APE      +L+ S  Y+ GV       +L E+L G+
Sbjct: 179 RAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 42/297 (14%)

Query: 105 LGEGGFGRV-----------------FKGVLSDGTAVAIKRLTCGGQQGDK-EFLVEVEM 146
           LGEG FG V                      +    VA+K L     +  + +FL E+++
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLD----- 197
           +SRL   N+++L+    + D     LC   E + NG L  +L  H P       D     
Sbjct: 73  MSRLKDPNIIRLLAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 198 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 257
           + T + +A   A G+ YL   S    +HRD    N L+  N+  K+ADFG+++    G  
Sbjct: 129 YSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 317
             +  R +    +++ E  + G     SDV+++GV L E+LT  K    SQ S  E ++ 
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-DEQVIE 244

Query: 318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                 RD+ R   L  P      P      +  +  +C    A +RP+  E+  +L
Sbjct: 245 NTGEFFRDQGRQVYLPKP---ALCPDS----LYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 66/238 (27%), Positives = 97/238 (40%), Gaps = 65/238 (27%)

Query: 99  FEPASILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGDKEFLV--------EVEML 147
           +E    +G G +GRV+K       DG   AIK+      +GDKE           E+ +L
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALL 56

Query: 148 SRLHHRNLVKLVG-YYSSRDSSQHLLC----YEL--------------VPNGSLESWLHG 188
             L H N+V LV  +    D S +LL     ++L              +P   ++S L  
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 189 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL--ENNFHA--KVA 244
            L                    G+ YLH +    V+HRD K +NIL+  E       K+ 
Sbjct: 117 IL-------------------NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIG 154

Query: 245 DFGLAK--QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLT 299
           D GLA+   AP  +       V+ T  Y APE  +      K+ D+++ G +  ELLT
Sbjct: 155 DLGLARLFNAPL-KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 36/273 (13%)

Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V        G  VA+K++    QQ  +    EV ++   HH N+V +   Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  G+L       +  +  ++ E    + L   R L+YLH      V
Sbjct: 90  VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLSVLRALSYLHNQG---V 139

Query: 224 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           IHRD K+ +ILL ++   K++DFG    ++K+ P+ ++      ++GT  ++APE     
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS------LVGTPYWMAPEVISRL 193

Query: 280 HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 339
               + D++S G++++E++ G  P              +  P L+   R+ +   PR+  
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRVKD 240

Query: 340 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
            +     +R        +  E +QR T  E++Q
Sbjct: 241 SHKVSSVLR--GFLDLMLVREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 104 ILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEF---LVEVEMLS-RLHHRNLVKL 158
           +LG+G FG+VF   L       AIK L       D +    +VE  +LS    H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 159 VGYYSSRDSSQHLL-CYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLAYLH 216
              Y +  + ++L    E +  G L   +      +CH  D       A +   GL +LH
Sbjct: 62  ---YCTFQTKENLFFVMEYLNGGDLMFHIQ-----SCHKFDLPRATFYAAEIICGLQFLH 113

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMGTFGYVAPE 274
                 +++RD K  NILL+ + H K+ADFG+ K+    + +T        GT  Y+APE
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC----GTPDYIAPE 166

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             +        D +S+GV+L E+L G+ P
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNL 155
           NF+    LGEG +  V+KG   + G  VA+K +    ++G     + E+ ++  L H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           V+L  +      ++ +L +E + +  L+ ++    GV   LD  T         +G+A+ 
Sbjct: 61  VRL--HDVIHTENKLMLVFEYM-DKDLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTRVMGTFGYVAP 273
           HE+    V+HRD K  N+L+      K+ADFGLA+    P    N  S  V+ T  Y AP
Sbjct: 117 HENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP---VNTFSNEVV-TLWYRAP 169

Query: 274 EYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
           +  +       S D++S G ++ E++TGR
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 35/222 (15%)

Query: 105 LGEGGFGRV----------FKGVLSDG-----TAVAIKRLTCGGQQGDK-EFLVEVEMLS 148
           LGEG FG V          F G  +         VA+K L     +  + +FL E++++S
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSL---------ESWLHGPLGVNCHLD 197
           RL + N+++L+G   S D     LC   E + NG L         ES       +   + 
Sbjct: 73  RLKNPNIIRLLGVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPS-VS 127

Query: 198 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 257
               + +A+  A G+ YL   +    +HRD    N L+ N++  K+ADFG+++    G  
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             +  R +    ++A E  + G     SDV+++GV L E+ T
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 38/224 (16%)

Query: 94  EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGD--KEFLVEVEMLSRL 150
           E  + ++  S +G G +G+V     +  G  VAIK+L+   Q     K    E+ +L  +
Sbjct: 12  EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM 71

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLES----WLHGPL-GVNCH-------LDW 198
            H N++ L+  ++              P  SLE     +L   L G + +       L  
Sbjct: 72  DHENVIGLLDVFT--------------PASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD 117

Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
           +    +     RGL Y+H      +IHRD K SNI +  +   K+ DFGLA+   +  T 
Sbjct: 118 DHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG 174

Query: 259 YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGR 301
           Y++TR      Y APE  +   H     D++S G ++ ELLTG+
Sbjct: 175 YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 9/103 (8%)

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A +   GL +LHE     +I+RD K  N+LL++  H K+ADFG+ K   EG    ++T  
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTST 155

Query: 265 M-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVD 305
             GT  Y+APE  ++      + D ++ GV+L E+L G+ P +
Sbjct: 156 FCGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 28/223 (12%)

Query: 98  NFEPASILGEGGFGRVFKGVLSDGTA------VAIKRLTCGGQQGDKEFLVEVEMLSRLH 151
           + E    +G G FGRV                +AI  +    Q+  +    E  +L  + 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE--QHVHNEKRVLKEVS 59

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAA 209
           H  +++L  +++  D     +  E VP G L S+L   G    +  L + + +  AL+  
Sbjct: 60  HPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE-- 115

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
               YLH      +++RD K  NILL+   H K+ DFG AK+  + RT  L     GT  
Sbjct: 116 ----YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWTLC----GTPE 163

Query: 270 YVAPE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 311
           Y+APE     GH     D ++ G+++ E+L G  P     P G
Sbjct: 164 YLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.9 bits (168), Expect = 7e-13
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 37/222 (16%)

Query: 105 LGEGGFGRVFKGVLSDG-----------TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-H 151
           LGEG FG+V   V+++            T VA+K L     + D  + + E+EM+  +  
Sbjct: 26  LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-CH---------LDWE 199
           H+N++ L+G   ++D   +++  E    G+L  +L    P G+  C+         L ++
Sbjct: 83  HKNIINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
             +  A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y
Sbjct: 141 DLVSCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHH--IDY 195

Query: 260 LSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                 G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 45/229 (19%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-----KEFLVEVEMLSRLH 151
            ++P   +G G +G V   +    G  VAIK++       D     K  L E+++L    
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI---PHAFDVPTLAKRTLRELKILRHFK 62

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSL-----------ESWLHGPLGVNCHLDWET 200
           H N++ +      RD         L P G+            ES LH  +  +  L  E 
Sbjct: 63  HDNIIAI------RDI--------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEH 108

Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRT 257
                    RGL Y+H      VIHRD K SN+L+  +   ++ DFG+A+    +P    
Sbjct: 109 IRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165

Query: 258 NYLSTRVMGTFGYVAPE--YAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            ++ T  + T  Y APE   ++  +     D++S G +  E+L GR+ +
Sbjct: 166 YFM-TEYVATRWYRAPELLLSLPEYTT-AIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 36/227 (15%)

Query: 94  EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCG--GQQGDKEFLVEVEMLSRL 150
           E    + P   +G G +G V     S+    VAIK++      +   K  L E+++L  L
Sbjct: 2   EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL 61

Query: 151 HHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
            H N++ +  +     R++   + + YEL     +++ LH  +  +  L  +        
Sbjct: 62  DHENVIAIKDIMPPPHREAFNDVYIVYEL-----MDTDLHQIIRSSQTLSDDHCQYFLYQ 116

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR---TNYLSTRV 264
             RGL Y+H  +   V+HRD K SN+LL  N   K+ DFGLA+   E     T Y+ TR 
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR- 172

Query: 265 MGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKPV 304
                Y APE      LL+         DV+S G +  ELL GRKP+
Sbjct: 173 ----WYRAPE------LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 21/210 (10%)

Query: 103 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKLV 159
            ++G+G +G V   +    G  VAIK++    +        L E+++L  L H ++V++ 
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 160 GYY---SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
                 S R+     + +EL     +ES LH  +  N  L  E          R L Y+H
Sbjct: 66  HIMLPPSRREFKDIYVVFEL-----MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEY 275
             +   V HRD K  NIL   +   K+ DFGLA+ A  +  T    T  + T  Y APE 
Sbjct: 121 TAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 176

Query: 276 AMTGHLLVKS----DVYSYGVVLLELLTGR 301
            + G    K     D++S G +  E+LTG+
Sbjct: 177 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 77/252 (30%), Positives = 106/252 (42%), Gaps = 49/252 (19%)

Query: 121 GTAVAIKRLTCGGQQGDKE---FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL--CYE 175
           G  VAIK L     + + +   F  E  + +RL+H N+V L+    S ++   LL   +E
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFE 59

Query: 176 LVPNGSLESWL--HGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS 231
            VP  +L   L   G L  G    L     M   LDA   LA  H      ++HRD K  
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRL-----MLQVLDA---LACAHNQG---IVHRDLKPQ 108

Query: 232 NILL---ENNFHAKVADFGLAKQAPEGR-----TNYLSTRVMGTFGYVAPEYAMTGHLLV 283
           NI++       HAKV DFG+    P  R     T   +T V+GT  Y APE      +  
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 284 KSDVYSYGVVLLELLTGRK----------------PVDMSQPSGQEN--LVTWARPILRD 325
            SD+Y++G++ LE LTG++                PVD+S P       L    R  L  
Sbjct: 169 NSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNK 228

Query: 326 KDRLEELADPRL 337
             R    + P L
Sbjct: 229 DPRQRAASAPAL 240

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 28/220 (12%)

Query: 99  FEPASILGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDKEF--LVEVEMLSRLH--- 151
           +E  + +GEG +G+VFK   + + G  VA+KR+     +       + EV +L  L    
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62

Query: 152 HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           H N+V+L  V   S  D    L L +E V +  L ++L         +  ET   +    
Sbjct: 63  HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDK--VPEPGVPTETIKDMMFQL 119

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK----QAPEGRTNYLSTRV 264
            RGL +LH      V+HRD K  NIL+ ++   K+ADFGLA+    Q          T V
Sbjct: 120 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-------ALTSV 169

Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
           + T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 20/228 (8%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNL 155
            EP   +G G FG V+      DG  VA+K++    Q     K    E++ML    H N+
Sbjct: 2   VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 156 VKLVGYYSSRDSSQ--HLLCYE--LVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAAR 210
           +  +      D  Q  H+  +E   V    ++S LH  +     L  +  +K+ L    R
Sbjct: 62  LSAL------DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD-HVKVFLYQILR 114

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GL YLH      ++HRD K  N+L+ +N   K+ DFGLA+      + +++  V+  + Y
Sbjct: 115 GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170

Query: 271 VAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 317
            APE  M + H     D++S G +  ELL  R       P  Q +L+T
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 35/215 (16%)

Query: 104 ILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFL---------VEVEMLSRL 150
           +LG+G FG+VF   K    D G   A+K L        K  L         +E ++L+ +
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEV 55

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAA 209
           +H  +VKL  +Y+ +   +  L  + +  G L + L   +     +  E  +K  L + A
Sbjct: 56  NHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELA 108

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
             L +LH      +I+RD K  NILL+   H K+ DFGL+K++ +      S    GT  
Sbjct: 109 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 163

Query: 270 YVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRKP 303
           Y+APE     GH    +D +S+GV++ E+LTG  P
Sbjct: 164 YMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 151
            +E    +GEG +G VFK         VA+KR+       D E      L E+ +L  L 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKELK 57

Query: 152 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           H+N+V+L   Y    S + L L +E   +  L+ +       N  +D E          +
Sbjct: 58  HKNIVRL---YDVLHSDKKLTLVFEYC-DQDLKKYFDS---CNGDIDPEIVKSFMFQLLK 110

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GLA+ H  +   V+HRD K  N+L+  N   K+ADFGLA+        Y S  V+ T  Y
Sbjct: 111 GLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWY 165

Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
             P+      L   S D++S G +  EL    +P+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 23/210 (10%)

Query: 105 LGEGGFGRVFKGVLSDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVGY 161
           LG+G +G V+K VL   T V  A+K +     +    + ++E+++L +     +V   G 
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           +    +    +C E +  GSL+  L+        +  +   +I     +GL +L E+   
Sbjct: 68  FFIEGAV--YMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTRVMGTFGYVAPEY---- 275
            +IHRD K +N+L+  N   K+ DFG++    A   +TN      +G   Y+APE     
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN------IGCQSYMAPERIKSG 176

Query: 276 AMTGHLL--VKSDVYSYGVVLLELLTGRKP 303
               +    V+SDV+S G+ +LE+  GR P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 13/200 (6%)

Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V    V S G  VA+K++    QQ  +    EV ++    H N+V++   Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  G+L       +  +  ++ E    + L   + L+ LH      V
Sbjct: 88  VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLKALSVLHAQG---V 137

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV 283
           IHRD K+ +ILL ++   K++DFG   Q  +      S  ++GT  ++APE         
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGP 195

Query: 284 KSDVYSYGVVLLELLTGRKP 303
           + D++S G++++E++ G  P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)

Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRLH 151
           N+    +LG+G FGRV+     D G  +A K++    +  +    V     E+++L  L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAA 209
           H  +V+  G    R      +  E +P GS++  L  +G L  +      TR K      
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV-----TR-KYTRQIL 116

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR-VMGTF 268
            G++YLH +    ++HRD K +NIL ++  + K+ DFG +K+      +    R V GT 
Sbjct: 117 EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173

Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            +++PE         K+DV+S G  ++E+LT + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)

Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           ILG G FG + +G L         VAI   R  C  +Q  + FL E   L +  H N+V+
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ-RRGFLAEALTLGQFDHSNIVR 70

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G  +    +  ++  E + NG+L+S+L    G    L     M +    A G+ YL E
Sbjct: 71  LEGVITR--GNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSE 125

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG--TFGYVAPEY 275
                 +H+   A  +L+ ++   K++ F    +  E ++  + T + G     + APE 
Sbjct: 126 MG---YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 276 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 307
               H    SDV+S+G+V+ E+++ G +P  DMS
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 17/202 (8%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G +G V   +    G  VAIK+L+   Q     K    E+ +L  + H N++ L+  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 162 YSSRDSSQHLLCYELV-PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
           ++S  S      + LV P   +++ L   +G    L  +    +      GL Y+H    
Sbjct: 83  FTSAVSGDEFQDFYLVMP--YMQTDLQKIMGH--PLSEDKVQYLVYQMLCGLKYIHSAG- 137

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG- 279
             +IHRD K  N+ +  +   K+ DFGLA+ A    T Y+ TR      Y APE  +   
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWM 190

Query: 280 HLLVKSDVYSYGVVLLELLTGR 301
           H     D++S G ++ E+LTG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 25/285 (8%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC---GGQQGDKEFLVEVEMLSRLHHR 153
           NF+    +G G F  V++   L D   VA+K++        +  ++ + E+++L +L+H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           N++K +  +   +    +L  EL   G L   +         +   T  K  +     + 
Sbjct: 63  NVIKYLDSFIEDNELNIVL--ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           ++H      V+HRD K +N+ +      K+ D GL +      T   S  ++GT  Y++P
Sbjct: 121 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
           E         KSD++S G +L E+   + P        + NL +  +       ++E+  
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLFSLCQ-------KIEQCD 224

Query: 334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 378
            P L  ++  E    + ++   C+ P+ +QRP +G V Q  K + 
Sbjct: 225 YPPLPTEHYSEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 7/102 (6%)

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A + + GL +LH      +I+RD K  N++L++  H K+ADFG+ K   E   + ++TR 
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT 160

Query: 265 M-GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
             GT  Y+APE           D ++YGV+L E+L G+ P D
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 20/209 (9%)

Query: 104 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKE-FLVEVEMLSRLH-HRNLVKL 158
           +LG+G FG+V    L   G   A+K L      Q  D E  + E  +LS    H  L +L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDAARGLAYLHE 217
             Y   +   +     E V  G L   +            E R +  A +    L +LH+
Sbjct: 62  --YCCFQTPDRLFFVMEFVNGGDLMFHIQ-----KSRRFDEARARFYAAEITSALMFLHD 114

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFGYVAPEYA 276
                +I+RD K  N+LL++  H K+ADFG+ K   EG  N  +T    GT  Y+APE  
Sbjct: 115 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPEIL 168

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
                    D ++ GV+L E+L G  P +
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 8e-12
 Identities = 66/259 (25%), Positives = 100/259 (38%), Gaps = 73/259 (28%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVE---------- 145
           ++FE   ++G G FG V      D G   A+K+L        K  ++E E          
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERD 53

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI- 204
           +L+   +  +VKL  YYS +D +   L  E +P G + + L   +  +   + ETR  I 
Sbjct: 54  ILAEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIA 108

Query: 205 ----ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------- 250
               A+D+   L Y         IHRD K  N+LL+   H K++DFGL            
Sbjct: 109 ETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159

Query: 251 -----------QAPEGRTNYLSTR---------------VMGTFGYVAPEYAMTGHLLVK 284
                                S R                +GT  Y+APE  +      +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219

Query: 285 SDVYSYGVVLLELLTGRKP 303
            D +S GV++ E+L G  P
Sbjct: 220 CDWWSLGVIMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 15/209 (7%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTA-VAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N FE   ++GEG +G V K    +    VAIK+   +   ++  +  L E++ML  L   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           N+V+L   +  R   +  L +E V    LE     P GV      + R  I     + + 
Sbjct: 61  NIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGV---PPEKVRSYI-YQLIKAIH 114

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR-TNYLSTRVMGTFGYVA 272
           + H++    ++HRD K  N+L+ +N   K+ DFG A+   EG   NY  T  + T  Y +
Sbjct: 115 WCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY--TEYVATRWYRS 169

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
           PE  +        D++S G +L EL  G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 41/106 (38%), Positives = 58/106 (54%), Gaps = 15/106 (14%)

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A + A GL +LH      +I+RD K  N++L+   H K+ADFG+ K   E      +TR 
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRT 160

Query: 265 M-GTFGYVAPE---YAMTGHLLVKS-DVYSYGVVLLELLTGRKPVD 305
             GT  Y+APE   Y   G    KS D +++GV+L E+L G+ P D
Sbjct: 161 FCGTPDYIAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 58/231 (25%), Positives = 106/231 (45%), Gaps = 16/231 (6%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +G+G  G VF  + ++ G  VAIK++    Q   +  + E+ ++  L + N+V  +  + 
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  GSL   +         +D      +  +  + L +LH +    V
Sbjct: 87  VGD--ELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLHANQ---V 136

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 282
           IHRD K+ N+LL  +   K+ DFG   Q  PE       + ++GT  ++APE        
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYG 193

Query: 283 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRLEEL 332
            K D++S G++ +E++ G  P     P     L+ T   P L++ ++L  +
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 47/138 (34%), Positives = 71/138 (51%), Gaps = 15/138 (10%)

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GL +LH      +I+RD K  N++L+ + H K+ADFG+ K+   G     ++   GT  Y
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV-----DMSQPSGQENLVTWARPILRD 325
           +APE           D +S+GV+L E+L G+ P      D    S + +   + R I ++
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKE 222

Query: 326 -KDRLEEL--ADP--RLG 338
            KD LE+L   DP  RLG
Sbjct: 223 SKDILEKLFERDPTRRLG 240

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 31/222 (13%)

Query: 91  ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEML 147
           E+ +   + +    +G G +G V   +    G  VAIK+L    Q     K    E+ +L
Sbjct: 12  EVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68

Query: 148 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN------GSLESWLHGPLGVNCHLDWETR 201
             + H N++ L+  ++   S      + LV        G L    H  L        E R
Sbjct: 69  KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLS-------EDR 119

Query: 202 MK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 260
           ++ +     +GL Y+H      +IHRD K  N+ +  +   K+ DFGLA+Q     T Y+
Sbjct: 120 IQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYV 176

Query: 261 STRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
            TR      Y APE  +   H     D++S G ++ E+LTG+
Sbjct: 177 VTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 54/210 (25%), Positives = 100/210 (47%), Gaps = 21/210 (10%)

Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V      S G  VA+K++    QQ  +    EV ++    H N+V++   Y 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D    ++  E +  G+L   +      +  ++ E    + L   + L++LH      V
Sbjct: 87  VGDELWVVM--EFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQG---V 136

Query: 224 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           IHRD K+ +ILL ++   K++DFG    ++K+ P  ++      ++GT  ++APE     
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS------LVGTPYWMAPEVISRL 190

Query: 280 HLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
               + D++S G++++E++ G  P     P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 28/206 (13%)

Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKL 158
           +GEG FG   K +L     DG    IK +        +  E   EV +LS + H N+V+ 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63

Query: 159 VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLA 213
             Y  S + + +L +  +    G L   ++   GV    +  LDW  ++ +AL       
Sbjct: 64  --YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------ 115

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           ++H+     ++HRD K+ NI L  +   K+ DFG+A+      T  L+   +GT  Y++P
Sbjct: 116 HVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYLSP 170

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLT 299
           E         KSD+++ G VL E+ T
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 23/218 (10%)

Query: 91  ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEML 147
           E+ E   N  P   +G G +G V           VA+K+L+   Q     +    E+ +L
Sbjct: 12  EVPERYQNLTP---VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68

Query: 148 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG--VNCH-LDWETRMKI 204
             + H N++ L+  ++   S ++     LV N      +   L   V C  L  E    +
Sbjct: 69  KHMKHENVIGLLDVFTPATSIENFNEVYLVTN-----LMGADLNNIVKCQKLSDEHVQFL 123

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                RGL Y+H      +IHRD K SN+ +  +   ++ DFGLA+QA +  T Y++TR 
Sbjct: 124 IYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR- 179

Query: 265 MGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
                Y APE  +   H     D++S G ++ ELL G+
Sbjct: 180 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 7/94 (7%)

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GL +LH+     +I+RD K  N+LL+ + H K+ADFG+ K+   G     ++   GT  Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162

Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
           +APE  + G    +S D +S+GV+L E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 72/239 (30%), Positives = 98/239 (41%), Gaps = 43/239 (17%)

Query: 98  NFEPASILGEGGFGRVF----KGVLSDGTAVAIKRL---TCGGQQGDKEF-LVEVEMLSR 149
           NFE   +LG G +G+VF     G    G   A+K L   T   +    E    E ++L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           +     +  + Y    D+  HL+  + V  G L + L+             R        
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLI-LDYVNGGELFTHLY------------QREHFTESEV 107

Query: 210 R--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNY 259
           R         L +LH   Q  +I+RD K  NILL++  H  + DFGL+K+  A E    Y
Sbjct: 108 RVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164

Query: 260 LSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKP--VDMSQPSGQE 313
                 GT  Y+APE       GH     D +S GV+  ELLTG  P  VD  Q S  E
Sbjct: 165 ---SFCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSE 219

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 61/242 (25%), Positives = 94/242 (38%), Gaps = 27/242 (11%)

Query: 90  EELKEATN--NFEPASILGEGGFGRVFKGVLSDGTA--VAIKRLTCGGQQGDKEFLVEVE 145
           ++ +E      +     L  G  GRVF      G    V +K     GQ+G    L+E  
Sbjct: 57  QKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKI----GQKGTT--LIEAM 109

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHLDWETRMK 203
           +L  ++H +++++     S      + C  L P  +  L ++L         L  +  + 
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGA----ITCMVL-PHYSSDLYTYLTKRSR---PLPIDQALI 161

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           I      GL YLH      +IHRD K  NI + +     + D G A Q P     +L   
Sbjct: 162 IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLG-- 215

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 323
           + GT    APE         K+D++S G+VL E+L     +    PS  E  V      L
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Query: 324 RD 325
             
Sbjct: 276 LK 277

Length = 357

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 64.0 bits (155), Expect = 3e-11
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 18/229 (7%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G  G V+  + ++ G  VAIK++    QQ  KE ++ E+ ++    + N+V  +  Y
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              D  +  +  E +  GSL   +         +D      +  +  + L +LH +    
Sbjct: 86  LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSNQ--- 135

Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           VIHRD K+ NILL  +   K+ DFG   Q  PE       + ++GT  ++APE       
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 192

Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRL 329
             K D++S G++ +E++ G  P     P     L+ T   P L++ +RL
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 31/219 (14%)

Query: 105 LGEGGFGRVFK----GVLSD----GTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V +    G+          VA+K L       D   L+ E+E++  +  H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   +++   +++  E    G+L  +L    P G +   D          ++  +
Sbjct: 80  IINLLGV-CTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL  +S+ C IHRD  A N+L+  +   K+ADFGLA+   +   +Y   
Sbjct: 138 SCAYQVARGMEYL--ESRRC-IHRDLAARNVLVTEDNVMKIADFGLARGVHD--IDYYKK 192

Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+G+++ E+ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 35/193 (18%)

Query: 196 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 255
           LD +  ++ +   A+G+ +L   S+ C IHRD  A N+LL +   AK+ DFGLA+     
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL--ASKNC-IHRDVAARNVLLTDGRVAKICDFGLARDI-MN 264

Query: 256 RTNYLSTRVMGT----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPS 310
            +NY+   V G       ++APE        V+SDV+SYG++L E+ + G+ P     P 
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY----PG 317

Query: 311 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMG 368
                      IL +    + +     G +  + DF    + +I   C   E  +RPT  
Sbjct: 318 -----------ILVNSKFYKMVKR---GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFS 363

Query: 369 EVVQSLKMVQRVI 381
           ++ Q   ++QR +
Sbjct: 364 QISQ---LIQRQL 373

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 24/205 (11%)

Query: 105 LGEGGFGRV---FKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           +G G  G V   F  VL  G  VA+K+L+     Q   K    E+ +L  ++H+N++ L+
Sbjct: 29  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86

Query: 160 GYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
             ++ + S +      L  EL+ + +L   +H        LD E    +      G+ +L
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELM-DANLCQVIH------MELDHERMSYLLYQMLCGIKHL 139

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H      +IHRD K SNI+++++   K+ DFGLA+ A    TN++ T  + T  Y APE 
Sbjct: 140 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEV 193

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTG 300
            +        D++S G ++ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 24/163 (14%)

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA  H  S+  +IHRD K++NILL +N   K+ DFG +K      ++ +     GT  YV
Sbjct: 154 LAVHHVHSKH-MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
           APE         K+D++S GV+L ELLT ++P                     D + +EE
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPF--------------------DGENMEE 252

Query: 332 LADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
           +    L G+Y   P      +  I  A ++ +  +RP+  +++
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 55/219 (25%)

Query: 105 LGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEF--------LVEVEMLSRL-HHRN 154
           +GEG F  V K      G   AIK +        K F        L E++ L RL  H N
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMK-------KHFKSLEQVNNLREIQALRRLSPHPN 59

Query: 155 LVKLVGY-YSSRDSSQHLLC-------YELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           +++L+   +  +     L+        YEL+           PL        E R+K  +
Sbjct: 60  ILRLIEVLFDRKTGRLALVFELMDMNLYELIKG------RKRPLP-------EKRVKSYM 106

Query: 207 -DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK----QAPEGRTNYLS 261
               + L ++H +    + HRD K  NIL++++   K+ADFG  +    + P   T Y+S
Sbjct: 107 YQLLKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYIS 160

Query: 262 TRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLT 299
           TR      Y APE  +T G+   K D+++ G V  E+L+
Sbjct: 161 TR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 40/226 (17%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTC----GGQQGDKEF----------LVEVEMLSR 149
           LGEG +G+V K      G  VAIK++           D++           L E+++++ 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           + H N++ LV  Y   D    ++         + S L   +     L       I L   
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDI-------MASDLKKVVDRKIRLTESQVKCILLQIL 129

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-------------KQAPEGR 256
            GL  LH+      +HRD   +NI + +    K+ADFGLA             K     R
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
              ++++V+ T  Y APE  M       + D++S G +  ELLTG+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 18/232 (7%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G  G V+  + ++ G  VAI+++    QQ  KE ++ E+ ++    + N+V  +  Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              D  +  +  E +  GSL   +         +D      +  +  + L +LH +    
Sbjct: 87  LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136

Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           VIHRD K+ NILL  +   K+ DFG   Q  PE       + ++GT  ++APE       
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 193

Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDKDRLEEL 332
             K D++S G++ +E++ G  P     P     L+ T   P L++ ++L  +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 56/291 (19%)

Query: 105 LGEGGFGRVFKGVL---SDG--------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR 153
           LG+G F  ++KGVL   SD          +V +K L     +    F     ++S+L H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIALDAARGL 212
           +LVKL G    RD  ++++  E V  G L+ +LH     V+ H  W  ++ +A   A  L
Sbjct: 62  HLVKLYG-VCVRD--ENIMVEEYVKFGPLDVFLHREKNNVSLH--W--KLDVAKQLASAL 114

Query: 213 AYLHEDSQPCVIHRDFKASNILL-------ENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            YL ED +  ++H +    NIL+             K++D G+              R+ 
Sbjct: 115 HYL-EDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI- 168

Query: 266 GTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 323
               ++APE    G   L + +D +S+G  LLE+ +      +S  S  E    +     
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICS-NGEEPLSTLSSSEKERFY----- 219

Query: 324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           +D+ RL       L       + I        C   +  +RP+   +++ L
Sbjct: 220 QDQHRLPMPDCAELA------NLIN------QCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 41/280 (14%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC---GGQQGDKEFLVEVEMLSRLHHR 153
           NF     +G G F  V++   L DG  VA+K++        +   + + E+++L +L+H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 154 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM-------KIA 205
           N++K   YY+S      L +  EL   G L   +        H   + R+       K  
Sbjct: 63  NVIK---YYASFIEDNELNIVLELADAGDLSRMIK-------HFKKQKRLIPEKTVWKYF 112

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
           +     L ++H      V+HRD K +N+ +      K+ D GL +      T   S  ++
Sbjct: 113 VQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LV 167

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
           GT  Y++PE         KSD++S G +L E+   + P        + NL +  +     
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCK----- 218

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP 365
             ++E+   P L   +  E+  ++  +   C+ P+  +RP
Sbjct: 219 --KIEQCDYPPLPSDHYSEELRQLVNM---CINPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 34/173 (19%)

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E+E+L  ++H N+VK    +      Q LL  E +  GSLE           H+  E  +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLL--EFMDGGSLE---------GTHIADEQFL 170

Query: 203 KIALDAAR----GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
               D AR    G+AYLH      ++HRD K SN+L+ +  + K+ADFG+++   +    
Sbjct: 171 A---DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224

Query: 259 YLSTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLELLTGRKP 303
             S+  +GT  Y++PE   T        G+     D++S GV +LE   GR P
Sbjct: 225 CNSS--VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 68/232 (29%), Positives = 96/232 (41%), Gaps = 59/232 (25%)

Query: 99  FEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKEFLV---EVEML---- 147
           F   ++LG G FG+V   +L++    G   AIK L        K  ++   EVE L    
Sbjct: 1   FRCLAVLGRGHFGKV---LLAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEK 50

Query: 148 ------SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
                 +   H  LV L   + + D        E    G L   +H       H D  + 
Sbjct: 51  RIFETANSERHPFLVNLFACFQTEDHV--CFVMEYAAGGDL--MMH------IHTDVFSE 100

Query: 202 MKIALDAAR---GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGR 256
            +    AA    GL YLHE+    +++RD K  N+LL+     K+ADFGL K+      R
Sbjct: 101 PRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157

Query: 257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVLLELLTGRKP 303
           T   ST   GT  ++APE      L   S     D +  GV++ E+L G  P
Sbjct: 158 T---ST-FCGTPEFLAPEV-----LTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 46/230 (20%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLH 151
           +    +++  +I+G G FG V++ +  D +  VAIK++    Q  ++E L+    +  L+
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLN 117

Query: 152 HRNLVKLVGYY---SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-- 206
           H N++ L  YY     + + +++       N  +E     P  V+ ++    R   AL  
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFL-----NVVME---FIPQTVHKYMKHYARNNHALPL 169

Query: 207 --------DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGR- 256
                      R LAY+H      + HRD K  N+L++ N H  K+ DFG AK    G+ 
Sbjct: 170 FLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226

Query: 257 -TNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTG 300
             +Y+ +R      Y APE  +     T H+    D++S G ++ E++ G
Sbjct: 227 SVSYICSRF-----YRAPELMLGATNYTTHI----DLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 39/217 (17%)

Query: 104 ILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN---LV 156
           I+G GGFG V+    +D G   A+K L       +QG+   L E  MLS +   +   +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 157 KLVGYYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLDWETRMKI-ALDAARG 211
            +   + + D     L +  +L+  G L   L  HG          E  M+  A +   G
Sbjct: 61  CMSYAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFS-------EAEMRFYAAEIILG 109

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----KQAPEGRTNYLSTRVMGT 267
           L ++H      V++RD K +NILL+ + H +++D GLA    K+ P           +GT
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGT 158

Query: 268 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
            GY+APE    G     S D +S G +L +LL G  P
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 23/215 (10%)

Query: 104 ILGEGGFGRVFKGVL-SDGTAVAIKRL---TCGGQQGDKEFLVEVE-MLSRLHHRNLVKL 158
           ++G+G FG+V      SDG+  A+K L   T   ++     + E   +L  L H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
             +YS + + +     + V  G L   L       C L+   R   A + A  + YLH  
Sbjct: 62  --HYSFQTAEKLYFVLDYVNGGELFFHLQRE---RCFLEPRARF-YAAEVASAIGYLHSL 115

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMGTFGYVAPEYA 276
           +   +I+RD K  NILL++  H  + DFGL K+   PE  T+       GT  Y+APE  
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC----GTPEYLAPEVL 168

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPV---DMSQ 308
                    D +  G VL E+L G  P    D+SQ
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 67/217 (30%), Positives = 100/217 (46%), Gaps = 39/217 (17%)

Query: 104 ILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRN---LV 156
           I+G GGFG V+    +D G   A+K L       +QG+   L E  MLS +   +   +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 157 KLVGYYSSRDSSQHLLCY--ELVPNGSLESWL--HGPLGVNCHLDWETRMKI-ALDAARG 211
            +   + + D     LC+  +L+  G L   L  HG          E  M+  A +   G
Sbjct: 61  CMTYAFHTPDK----LCFILDLMNGGDLHYHLSQHGVFS-------EKEMRFYATEIILG 109

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----KQAPEGRTNYLSTRVMGT 267
           L ++H      V++RD K +NILL+ + H +++D GLA    K+ P           +GT
Sbjct: 110 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGT 158

Query: 268 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
            GY+APE    G     S D +S G +L +LL G  P
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIAL-DAARG 211
           +VKL+    + +     L +E + +  L+ ++      G+   L     +K  L    +G
Sbjct: 61  IVKLLDVIHTENKL--YLVFEFL-HQDLKKFMDASPLSGIPLPL-----IKSYLFQLLQG 112

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y 
Sbjct: 113 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 167

Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 30/229 (13%)

Query: 98  NFEPASILGEGGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRN 154
            +    ++GEG FGR    + V SD    A+K +         E    E  +L+++ H N
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN 59

Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAA 209
           +V    +  S ++  HL +  E    G L   +    G     +  L W  +M +     
Sbjct: 60  IV---AFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL----- 111

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGT 267
            G+ ++HE     V+HRD K+ NI L  N   K+ DFG A+   +P     Y  T V GT
Sbjct: 112 -GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYV-GT 163

Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
             YV PE         KSD++S G +L EL T + P    Q +  +NL+
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF---QANSWKNLI 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 71/224 (31%), Positives = 95/224 (42%), Gaps = 46/224 (20%)

Query: 98  NFEPASILGEGGFGRV----FKGVLSDGTAVAIKRL----TCGGQQGDKEFLVEVEMLSR 149
           +FE    LG G FGRV     KG    G   AIK L        +Q       E  +L  
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQ-HVAQEKSILME 74

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L H  +V ++  +   +    LL  E V  G L +          HL      +   D A
Sbjct: 75  LSHPFIVNMMCSFQDENRVYFLL--EFVVGGELFT----------HL--RKAGRFPNDVA 120

Query: 210 R--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
           +           YLH      +I+RD K  N+LL+N  H KV DFG AK+ P+ RT  L 
Sbjct: 121 KFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-RTFTLC 176

Query: 262 TRVMGTFGYVAPEYAMT-GHLLVKS-DVYSYGVVLLELLTGRKP 303
               GT  Y+APE   + GH   K+ D ++ GV+L E + G  P
Sbjct: 177 ----GTPEYLAPEVIQSKGH--GKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 31/231 (13%)

Query: 90  EELKEATNNFEPASILGEGGFGRVFKGVLSDGT--AVAIKRL----TCGGQQGDKEFLVE 143
            + K    +F     LG G FGRV      +     VAIKR         +Q D  F  E
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SE 81

Query: 144 VEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG----PLGVNCHLDWE 199
            ++L+ ++H   V L G  S +D S   L  E V  G   ++L      P  V C   + 
Sbjct: 82  RKILNYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF--YA 137

Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
            ++ +  +  + L          +++RD K  N+LL+ +   K+ DFG AK   + RT  
Sbjct: 138 AQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVV-DTRTYT 187

Query: 260 LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           L     GT  Y+APE  +  GH    +D ++ G+ + E+L G  P   ++P
Sbjct: 188 LC----GTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 7/100 (7%)

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 263
           A +    L +LH      VI+RD K  NILL+   H K+ADFG+ K   EG  N   +T 
Sbjct: 102 AAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT 155

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             GT  Y+APE           D ++ GV++ E++ G+ P
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.5 bits (146), Expect = 5e-10
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 5/96 (5%)

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L YLHE     +I+RD K  N+LL++  H K+ D+G+ K+    R    ++   GT  Y
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNY 162

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 306
           +APE           D ++ GV++ E++ GR P D+
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 16/201 (7%)

Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGYY 162
           LGEG +  V+KG+   +G  VA+K ++   ++G     + E  +L  L H N+V L    
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
            ++++   +   E +     +  +  P G++ +              RGLAY+H      
Sbjct: 73  HTKETLTFVF--EYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRGLAYIHGQH--- 123

Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 282
           ++HRD K  N+L+      K+ADFGLA+        Y S  V  T  Y  P+  + G   
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGATD 180

Query: 283 VKS--DVYSYGVVLLELLTGR 301
             S  D++  G + +E+L G+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 22/231 (9%)

Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V        G  VA+K +    QQ  +    EV ++    H+N+V++  Y S
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--YKS 86

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                +  +  E +  G+L   +         L+ E    +     + L YLH      V
Sbjct: 87  YLVGEELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---V 138

Query: 224 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           IHRD K+ +ILL  +   K++DFG    ++K  P+ ++      ++GT  ++APE     
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS------LVGTPYWMAPEVISRT 192

Query: 280 HLLVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTWARPILRDKDRL 329
               + D++S G++++E++ G  P     P    + L     P L++  ++
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 9/106 (8%)

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFGY 270
           L +LHE     +I+RD K  N+LL+   H K+ D+G+ K   EG R    ++   GT  Y
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNY 162

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM--SQPSGQEN 314
           +APE           D ++ GV++ E++ GR P D+     +  +N
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL--V 159
           +GEG +G V+KG     G  VA+K  RL    +      + E+ +L  L H N+V L  V
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
               SR      L +E + +  L+ +L   L    ++D E          +G+ + H   
Sbjct: 68  LMQESR----LYLIFEFL-SMDLKKYLDS-LPKGQYMDAELVKSYLYQILQGILFCHSRR 121

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
              V+HRD K  N+L++N    K+ADFGLA+    G    + T  + T  Y APE  +  
Sbjct: 122 ---VLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 280 HLL-VKSDVYSYGVVLLELLTGRKPV 304
                  D++S G +  E+ T +KP+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 35/102 (34%), Positives = 57/102 (55%), Gaps = 7/102 (6%)

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A + A GL +LH      +I+RD K  N++L++  H K+ADFG+ K   E   + ++T+ 
Sbjct: 107 AAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKT 160

Query: 265 M-GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
             GT  Y+APE           D +++GV+L E+L G+ P +
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 25/162 (15%)

Query: 158 LVGYYSSRDSSQHL-LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAY 214
           +V  + S ++ +HL +  E V  G   + L   G L V+       RM  A +    L Y
Sbjct: 63  VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-----ARMYFA-ETVLALEY 116

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-------------YLS 261
           LH      ++HRD K  N+L+ +  H K+ DFGL+K      T              +L 
Sbjct: 117 LHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            +V GT  Y+APE  +        D ++ G++L E L G  P
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 18/202 (8%)

Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGYY 162
           LGEG +  VFKG        VA+K +    ++G     + EV +L  L H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNC-HLDWETRMKIAL-DAARGLAYLHEDSQ 220
            +       L +E + +  L+ +L      NC +L     +KI +    RGL+Y H+   
Sbjct: 73  HTERCLT--LVFEYLDS-DLKQYLD-----NCGNLMSMHNVKIFMFQLLRGLSYCHKRK- 123

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TG 279
             ++HRD K  N+L+      K+ADFGLA+ A    T   S  V+ T  Y  P+  + + 
Sbjct: 124 --ILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGST 179

Query: 280 HLLVKSDVYSYGVVLLELLTGR 301
                 D++  G +L E+ TGR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFGY 270
           L YLH      V++RD K  N++L+ + H K+ DFGL K   EG ++  + +   GT  Y
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +APE           D +  GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 38/235 (16%)

Query: 98  NFEPASILGEGGFGRVF---------------KGVLSDGTAVAIKRLTCGGQQGDKEFLV 142
           NFE   +LG G +G+VF                 VL   T V   + T       +    
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTT-------EHTRT 53

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E ++L  +     +  + Y    D+  HL+  + +  G L + L            E ++
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLI-LDYINGGELFTHLSQRERFKEQ---EVQI 109

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
               +    L +LH+     +I+RD K  NILL++N H  + DFGL+K+  E      + 
Sbjct: 110 YSG-EIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AY 164

Query: 263 RVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 314
              GT  Y+AP+       GH     D +S GV++ ELLTG  P  +    G++N
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTV---DGEKN 215

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 5/96 (5%)

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L +LHE     +I+RD K  N+LL+ + H K+ D+G+ K+         ++   GT  Y
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNY 162

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 306
           +APE           D ++ GV++ E++ GR P D+
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 53/173 (30%), Positives = 75/173 (43%), Gaps = 24/173 (13%)

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   ARG+ +L   S+ C IHRD  A NILL  N   K+ DFGLA+   +          
Sbjct: 180 SFQVARGMEFLA--SRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL 323
                ++APE         +SDV+S+GV+L E+ + G  P     P  Q N     R  L
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY----PGVQINEEFCQR--L 290

Query: 324 RDKDRLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           +D  R+   E A P +              I  AC   +  +RPT   +V+ L
Sbjct: 291 KDGTRMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 66/255 (25%), Positives = 103/255 (40%), Gaps = 58/255 (22%)

Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRL---------TCGGQQGDKEFLVEVEML 147
           +FE   ++G G FG V      D G   A+K L           G  + +++ LVE + L
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 148 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
                  +VK+  +YS +D     L  E +P G + + L   +  +   + ET+  IA +
Sbjct: 62  W------VVKM--FYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIA-E 109

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNY------- 259
               +  +H   Q   IHRD K  N+LL++  H K++DFGL     +  RT +       
Sbjct: 110 TVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 260 -------------------------LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVL 294
                                    L+   +GT  Y+APE  M        D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 295 LELLTGRKPVDMSQP 309
            E+L G  P     P
Sbjct: 227 YEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 2/99 (2%)

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
           L E     ++HRD K++NI L      K+ DFG +KQ  +  +  +++   GT  Y+APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE 313
                    K+D++S GV+L ELLT  +P     PS +E
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP--FKGPSQRE 278

Length = 478

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)

Query: 97  NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRN 154
           +++E    LGEG +  V+KG    +G  VA+K +    ++G     + E  +L  L H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLA 213
           +V L     ++++    L +E V     +     P G+  H +    +K+ L    RGL+
Sbjct: 65  IVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGL--HPE---NVKLFLFQLLRGLS 117

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           Y+H   Q  ++HRD K  N+L+ +    K+ADFGLA+        Y +  V  T  Y  P
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPP 172

Query: 274 EYAM-TGHLLVKSDVYSYGVVLLELLTG 300
           +  + +       D++  G + +E++ G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 26/205 (12%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTC-----GGQQGDKEFL---VEVEMLSRLHHRNLV 156
           LG+G FG V+  ++ D  AVA +RL        G+    E +    E ++LS+L H  +V
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 157 KLVGYYSSRDSSQHL--LCYELVPNGSLESWLHG--PLGVNCHLDWETRMKIALDAARGL 212
           K    +  RD+   +   C     +  LE   H    L  N   +W  ++ +      G+
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            Y+H+     ++HRD KA NI L+NN   K+ DFG+++    G  + L+T   GT  Y++
Sbjct: 120 HYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCD-LATTFTGTPYYMS 173

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLEL 297
           PE         KSD++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 16/205 (7%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKL 158
           ++G+G FG+V      ++    A+K L       ++ +K  + E   +L  + H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
             ++S + + +     + +  G L   L       C L+   R   A + A  L YLH  
Sbjct: 62  --HFSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARF-YAAEIASALGYLHSL 115

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
           +   +++RD K  NILL++  H  + DFGL K+  E   N  ++   GT  Y+APE    
Sbjct: 116 N---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCGTPEYLAPEVLHK 170

Query: 279 GHLLVKSDVYSYGVVLLELLTGRKP 303
                  D +  G VL E+L G  P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 16/214 (7%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 153
           + +E    +GEG +G+V+K    + G  VA+K  RL    +      L E+ +L  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 154 N-LVKLVGYYSSRDSSQHLLCYELV---PNGSLESWLHGPLGVNCH-LDWETRMKIALDA 208
             +V+L+      + +     Y LV    +  L+ ++          L  +T        
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLY-LVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGT 267
            +G+A+ H+     V+HRD K  N+L++      K+AD GL +       +Y  T  + T
Sbjct: 120 LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVT 174

Query: 268 FGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTG 300
             Y APE  +   H     D++S G +  E+   
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 24/211 (11%)

Query: 99  FEPASILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           +   S L  G  G VF            V +K +T G   G      E+++L  + HR +
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR-----EIDILKTISHRAI 148

Query: 156 VKLVGYYSSRDSSQHLLCYEL-VPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGL 212
           + L+  Y  +      +C  +      L +++   GPL +   +  + R+   L+A   L
Sbjct: 149 INLIHAYRWKS----TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRL---LEA---L 198

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
           AYLH      +IHRD K  NI L+   +A + DFG A +              GT    +
Sbjct: 199 AYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNS 255

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           PE         K+D++S G+VL E+      
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 41/220 (18%)

Query: 103 SILGEGGFGRVFKGVLSDGTAV-------AIKRLTCGGQQGDKEFL-VEVEMLSRLHHRN 154
            +LG+GG+G+VF+     G           +K+ T    Q D      E  +L  + H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAAR--- 210
           +V L+  Y+ +   +  L  E +  G L            HL+   R  I + D A    
Sbjct: 62  IVDLI--YAFQTGGKLYLILEYLSGGELFM----------HLE---REGIFMEDTACFYL 106

Query: 211 -----GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
                 L +LH   Q  +I+RD K  NILL+   H K+ DFGL K++       ++    
Sbjct: 107 SEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTVTHTFC 161

Query: 266 GTFGYVAPEYAM-TGHLLVKS-DVYSYGVVLLELLTGRKP 303
           GT  Y+APE  M +GH   K+ D +S G ++ ++LTG  P
Sbjct: 162 GTIEYMAPEILMRSGH--GKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 26/174 (14%)

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   ARG+ +L   S+ C IHRD  A NILL  N   K+ DFGLA+   +          
Sbjct: 179 SFQVARGMEFL--ASRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235

Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWAR 320
                ++APE         +SDV+S+GV+L E+ + G  P   V + +   +        
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR------- 288

Query: 321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
             L++  R+          + P+     + +I   C       RPT  E+V+ L
Sbjct: 289 --LKEGTRM----------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 6e-09
 Identities = 70/257 (27%), Positives = 101/257 (39%), Gaps = 80/257 (31%)

Query: 99  FEPASILGEGGFGRVFKGVLSDGTAV--AIKRLTCGGQQGDKE----------FLVEVEM 146
           F+   +LG+G  GRVF  V   GT    A+K L       DK+           L E E+
Sbjct: 3   FKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVL-------DKKEMIKRNKVKRVLTEQEI 54

Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMK-I 204
           L+ L H  L  L   Y+S  +  +L L  +  P G L   L                K +
Sbjct: 55  LATLDHPFLPTL---YASFQTETYLCLVMDYCPGGELFRLLQ-----------RQPGKCL 100

Query: 205 ALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEG 255
           + + AR         L YLH      +++RD K  NILL  + H  ++DF L+KQ   E 
Sbjct: 101 SEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157

Query: 256 R--------------------------TNYLSTRVMGTFGYVAPEY-AMTGHLLVKSDV- 287
                                       ++ S   +GT  Y+APE  +  GH    S V 
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVD 214

Query: 288 -YSYGVVLLELLTGRKP 303
            ++ G++L E+L G  P
Sbjct: 215 WWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 12/113 (10%)

Query: 196 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 255
           LD E  +  +   A+G+++L   S+ C IHRD  A NILL +    K+ DFGLA+     
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL--ASKNC-IHRDLAARNILLTHGRITKICDFGLARDI-RN 266

Query: 256 RTNYLSTRVMGT----FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            +NY+   V G       ++APE         +SDV+SYG++L E+ + G  P
Sbjct: 267 DSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFGY 270
           L YLH      V++RD K  N++L+ + H K+ DFGL K   EG ++  + +   GT  Y
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +APE           D +  GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 22/204 (10%)

Query: 105 LGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGY 161
           LGEG +  V+KG   L+D   VA+K +    ++G     + EV +L  L H N+V L   
Sbjct: 14  LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL-DAARGLAYLHED 218
             +  S    L +E + +  L+ +L   G   +N H      +K+ L    RGL Y H  
Sbjct: 73  IHTEKSLT--LVFEYL-DKDLKQYLDDCGNS-INMH-----NVKLFLFQLLRGLNYCHRR 123

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM- 277
               V+HRD K  N+L+      K+ADFGLA+ A    T   S  V+ T  Y  P+  + 
Sbjct: 124 K---VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV-TLWYRPPDILLG 178

Query: 278 TGHLLVKSDVYSYGVVLLELLTGR 301
           +     + D++  G +  E+ TGR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 62/218 (28%), Positives = 87/218 (39%), Gaps = 50/218 (22%)

Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL---- 158
           LGEG +  V+KG     G  VA+K +    ++G     + E  +L  L H N+V L    
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 159 --------VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
                   V  Y   D  Q++   +    G     L     V   L             R
Sbjct: 73  HTKKTLTLVFEYLDTDLKQYM---DDCGGG-----LS-MHNVRLFL---------FQLLR 114

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL--AKQAPEGRTNYLSTRVMGTF 268
           GLAY H   Q  V+HRD K  N+L+      K+ADFGL  AK  P   +   S  V+ T 
Sbjct: 115 GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVV-TL 167

Query: 269 GYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGR 301
            Y  P+  +     +  L    D++  G +  E+ TGR
Sbjct: 168 WYRPPDVLLGSTEYSTSL----DMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 47/160 (29%), Positives = 65/160 (40%), Gaps = 19/160 (11%)

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV--NCHLDWETRMKIALDAARG 211
           N+V L  Y  S DS    L  +    G L S +   L +   C   W   M +ALDA   
Sbjct: 46  NMVCLHKYIVSEDSV--FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA--- 100

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
              LH +   C   RD   +NILL++  H ++  F    +  +         +     Y 
Sbjct: 101 ---LHREGIVC---RDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 311
           APE           D +S G +L ELLTG+  V+   PSG
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSG 188

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 35/104 (33%), Positives = 50/104 (48%), Gaps = 14/104 (13%)

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           +ALDA   + +         IHRD K  N+LL+ + H K+ADFG   +          T 
Sbjct: 153 LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203

Query: 264 VMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 303
           V GT  Y++PE   +    G+   + D +S GV L E+L G  P
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 19/217 (8%)

Query: 97  NNFEPASILGEGGFGRV---FKGVLSDGTAV-AIKRLTCGGQQGDKEFLVEVEMLSRLHH 152
            +F+  S++G G FG V    +    D  A+  +K+     Q+    F  E ++LS  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             + +L   Y+ +D     L  E  P G L S L      N + D           A  +
Sbjct: 61  PWIPQLQ--YAFQDKDNLYLVMEYQPGGDLLSLL------NRYEDQFDEDMAQFYLAELV 112

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
             +H   Q   +HRD K  N+L++   H K+ADFG A +    +    S   +GT  Y+A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIA 171

Query: 273 PEY--AMTGHLL----VKSDVYSYGVVLLELLTGRKP 303
           PE    M G       V+ D +S GV+  E++ GR P
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 52/256 (20%)

Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAV----------AIKRLTCGGQQGDKEFLV--EVE 145
           +FE   ++G G FG V    L +   V           +KR      + +++ LV  + +
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 146 MLSRLHH-----RNLVKLVGYYSSRDSSQHLLCYE-LVPNGSLESWLHGPLGVNCHLDWE 199
            ++ LH+      NL  ++ YY   D    L  +E  +P      +L             
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL------------- 108

Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
             M IA+D+   L Y         +HRD K  NIL++ N H ++ADFG   +  E  T  
Sbjct: 109 AEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V 158

Query: 260 LSTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 314
            S+  +GT  Y++PE   AM    G    + D +S GV + E+L G  P         E+
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF------YAES 212

Query: 315 LVTWARPILRDKDRLE 330
           LV     I+  K+R +
Sbjct: 213 LVETYGKIMNHKERFQ 228

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 41/218 (18%)

Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK------ 157
           +G+G FG+V++    D     A+K L+       KE + + E+   +  RN++       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLS------KKEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 158 ---LVGY-YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-------IAL 206
              +VG  +S +  S   L  + +  G L  W         HL  E R         IA 
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGEL-FW---------HLQKEGRFSEDRAKFYIA- 103

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
           +    L +LH+     +++RD K  NILL+   H  + DFGL+K       N  +    G
Sbjct: 104 ELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCG 158

Query: 267 TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
           T  Y+APE  +      K  D +S GV++ E+  G  P
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 42/214 (19%)

Query: 105 LGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL--- 158
           LGEG +  VFKG   L++   VA+K +    ++G     + EV +L  L H N+V L   
Sbjct: 14  LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 159 ---------VGYYSSRDSSQHLL-CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
                    V  Y  +D  Q++  C  ++   +++ +L+  L                  
Sbjct: 73  VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL------------------ 114

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            RGLAY H      V+HRD K  N+L+      K+ADFGLA+ A    T   S  V+ T 
Sbjct: 115 -RGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TL 168

Query: 269 GYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
            Y  P+  + +     + D++  G +  E+ +GR
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)

Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 155
           N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N+
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 156 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           + L+  ++ + S +      L  EL+     +        +   LD E    +      G
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLCG 131

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y 
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 185

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
           APE  +        D++S G ++ E      L  GR  +D
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)

Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 155
           N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N+
Sbjct: 28  NLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 156 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           + L+  ++ + S +      +  EL+     +        +   LD E    +      G
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLCG 138

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +        D++S G ++ E++ G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 7/90 (7%)

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
           YYS + ++   L  E +  G ++S LH    +  + D E  +K   + A  L YLH    
Sbjct: 70  YYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRHG- 124

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAK 250
             +IHRD K  N+L+ N  H K+ DFGL+K
Sbjct: 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 19/203 (9%)

Query: 104 ILGEGGFGRV-FKGVLSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           ++G+G +G V      +DG    IK+L      ++  K    E ++LS+L H N+V    
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLAYLH 216
            +   D   +++       G L   L    G     N  ++W  ++ +AL       YLH
Sbjct: 67  SWEGEDGLLYIV-MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ------YLH 119

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
           E     ++HRD K  N+ L      KV D G+A+   E + +  ST ++GT  Y++PE  
Sbjct: 120 EKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMAST-LIGTPYYMSPELF 174

Query: 277 MTGHLLVKSDVYSYGVVLLELLT 299
                  KSDV++ G  + E+ T
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 42/247 (17%)

Query: 98  NFEPASILGEGGFGRVF----KGVLSDGTAVAIKRL-TCGGQQGDK---EFLVEVEMLSR 149
           NFE   +LG G +G+VF          G   A+K L      Q  K       E  +L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           +     +  + Y    ++  HL+  + V  G + + L+             R   + D  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLI-LDYVSGGEMFTHLY------------QRDNFSEDEV 107

Query: 210 R--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNY 259
           R         L +LH+     +++RD K  NILL++  H  + DFGL+K+  + E    Y
Sbjct: 108 RFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY 164

Query: 260 LSTRVMGTFGYVAPEY--AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 317
                 GT  Y+APE      GH     D +S G+++ ELLTG  P  +      ++ V+
Sbjct: 165 ---SFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220

Query: 318 WARPILR 324
             R IL+
Sbjct: 221 --RRILK 225

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 11/95 (11%)

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTFG 269
           L  LH+ +   VI+RD K  NILL+   H  + DFGL K     + +TN       GT  
Sbjct: 106 LENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC----GTPE 158

Query: 270 YVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
           Y+APE  + GH   K+ D ++ GV+L E+LTG  P
Sbjct: 159 YLAPEL-LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 55/223 (24%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKE-----FLVEVEMLSRLHHRNLV 156
           +GEG +G V+K      G  VA+K  RL     + + E      + E+ +L  L+H N+V
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRL-----ETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 157 KLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM----KIALDAA-- 209
           +L        S   L L +E +                  LD +  M       LD    
Sbjct: 62  RL---LDVVHSENKLYLVFEFL-----------------DLDLKKYMDSSPLTGLDPPLI 101

Query: 210 --------RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
                   +G+AY H      V+HRD K  N+L++     K+ADFGLA+        Y  
Sbjct: 102 KSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-- 156

Query: 262 TRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKP 303
           T  + T  Y APE  +         D++S G +  E++  R+P
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 7/94 (7%)

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFG 269
            L YLH      +++RD K  N++L+ + H K+ DFGL K   EG T+  + +   GT  
Sbjct: 107 ALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPE 160

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           Y+APE           D +  GVV+ E++ GR P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFG 269
            L YLH +    V++RD K  N++L+ + H K+ DFGL K   EG  +  + +   GT  
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPE 161

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           Y+APE           D +  GVV+ E++ GR P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 18/206 (8%)

Query: 104 ILGEGGFGRVFKGVLS-DGTAVAIKRL---TCGGQQGDKEFLVEVE-MLSRLHHRNLVKL 158
           ++G+G FG+V       DG   A+K L       ++  K  + E   +L  + H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDAARGLAYLHE 217
             +YS + + +     + V  G L   L            E R +  A + A  L YLH 
Sbjct: 62  --HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-----EPRARFYAAEIASALGYLHS 114

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
            +   +++RD K  NILL++  H  + DFGL K+         +T   GT  Y+APE   
Sbjct: 115 IN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIR 169

Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKP 303
                   D +  G VL E+L G  P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 66/260 (25%), Positives = 100/260 (38%), Gaps = 66/260 (25%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLS--RLHHR 153
           ++FE   ++G G FG V      D G   A+K L        K  ++E E ++  R    
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53

Query: 154 NLVKLVG------YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI--- 204
            LV+  G      +YS +D     L  E +P G + + L   +  +   +  T+  I   
Sbjct: 54  ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAET 110

Query: 205 --ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNY-- 259
             A+DA   L +         IHRD K  N+LL+   H K++DFGL     +  RT +  
Sbjct: 111 VLAIDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161

Query: 260 ------------------------------LSTRVMGTFGYVAPEYAMTGHLLVKSDVYS 289
                                         L+   +GT  Y+APE  M        D +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221

Query: 290 YGVVLLELLTGRKPVDMSQP 309
            GV++ E+L G  P     P
Sbjct: 222 LGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 17/110 (15%)

Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG-LAKQAPEGRTN 258
             M +A+D+   L Y         +HRD K  N+LL+ N H ++ADFG   +   +G   
Sbjct: 109 AEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159

Query: 259 YLSTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLTGRKP 303
             S   +GT  Y++PE   AM    G    + D +S GV + E+L G  P
Sbjct: 160 --SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 62/210 (29%), Positives = 90/210 (42%), Gaps = 26/210 (12%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---FLVEVE-MLSRLHHRNLVKL 158
           ++G+G FG+V      +DG   A+K L        KE    + E   +L  + H  LV L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKI-ALDAARGLA 213
             +YS + + +     + V  G L   L      P         E R +  A + A  L 
Sbjct: 62  --HYSFQTADKLYFVLDYVNGGELFFHLQRERSFP---------EPRARFYAAEIASALG 110

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           YLH  +   +I+RD K  NILL++  H  + DFGL K+  E      ++   GT  Y+AP
Sbjct: 111 YLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAP 165

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           E           D +  G VL E+L G  P
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 54/290 (18%)

Query: 105 LGEGGFGRVFKGVLSDGTAVA---IKRLTC-GGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           +G G FG+V    +   T VA   +K L      +   EFL + +    L H N+++ +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-------MKIALDAARGLA 213
                ++  +LL +E    G L+S+L           W  R        ++A + A G+ 
Sbjct: 63  --QCVEAIPYLLVFEYCELGDLKSYL-------SQEQWHRRNSQLLLLQRMACEIAAGVT 113

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--RVMGTFGYV 271
           ++H+ +    +H D    N  L ++   KV D+G+       + +Y+ T         ++
Sbjct: 114 HMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS--RYKEDYIETEDDKCVPLRWL 168

Query: 272 APEY--AMTGHLLVK-----SDVYSYGVVLLELLTGRKPVDMSQP----SGQENLVTWAR 320
           APE      G L+       S+V++ GV L EL       + +QP    S +E L     
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLSDREVL----N 219

Query: 321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
            +++D+    +L  P+L   Y +    R   +   C      +R T  EV
Sbjct: 220 HVIKDQQ--VKLFKPQLELPYSE----RWYEVLQFCWLS-PEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 61/283 (21%), Positives = 118/283 (41%), Gaps = 41/283 (14%)

Query: 105 LGEGGFGRVFKGV---LSDG-----TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG+G F ++FKG+   + D      T V +K L    +   + F     M+S+L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC-HLDWETRMKIALDAARGLAYL 215
              G     D  + ++  E V  GSL+++L      N  ++ W  ++++A   A  L +L
Sbjct: 63  LNYGVCVCGD--ESIMVQEYVKFGSLDTYLKK--NKNLINISW--KLEVAKQLAWALHFL 116

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT--FGYVAP 273
            +     + H +  A N+LL      K  +    K +  G +  +  + +      +V P
Sbjct: 117 EDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPP 173

Query: 274 E-YAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
           E      +L + +D +S+G  L E+ +G  KP+               + +   +DR + 
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---------QKKLQFYEDRHQ- 223

Query: 332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                     P   +  +  +   C+  E + RP+   +++ L
Sbjct: 224 ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 41/232 (17%)

Query: 91  ELKEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGG--QQGDKEFL-VEVEM 146
           +L+    ++E   ++G G FG V      S     A+K L+     ++ D  F   E ++
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK--- 203
           ++  +   +V+L  +Y+ +D     +  E +P G L         VN   +++   K   
Sbjct: 97  MAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDL---------VNLMSNYDVPEKWAR 145

Query: 204 -------IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEG 255
                  +ALDA   + +         IHRD K  N+LL+ + H K+ADFG   K   EG
Sbjct: 146 FYTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196

Query: 256 RTNYLSTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 303
                    +GT  Y++PE   +    G+   + D +S GV L E+L G  P
Sbjct: 197 MVR--CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 53/227 (23%)

Query: 99  FEPASILGEGGFGRVFKG---VLSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLH 151
           +E    +GEG +G V+K    V ++  A+   RL    +Q D+      + E+ +L  + 
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL----EQEDEGVPSTAIREISLLKEMQ 59

Query: 152 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA- 209
           H N+V+L        S + L L +E +                  LD +  M  + D A 
Sbjct: 60  HGNIVRL---QDVVHSEKRLYLVFEYL-----------------DLDLKKHMDSSPDFAK 99

Query: 210 -------------RGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEG 255
                        RG+AY H      V+HRD K  N+L++   +A K+ADFGLA+    G
Sbjct: 100 NPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF--G 154

Query: 256 RTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
                 T  + T  Y APE  + + H     D++S G +  E++  +
Sbjct: 155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 4/100 (4%)

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL  N   K+ DFGLA+   +          
Sbjct: 185 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                ++APE        ++SDV+S+GV+L E+ + G  P
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 5/85 (5%)

Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT---- 278
           +IHRD K  N+LL+ + H K+ADFG   +  E       T V GT  Y++PE   +    
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221

Query: 279 GHLLVKSDVYSYGVVLLELLTGRKP 303
           G+   + D +S GV L E+L G  P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 10/93 (10%)

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG--RTNYLSTRVMGTF 268
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A      T Y+ TR     
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182

Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
            Y APE  +        D++S G ++ E++ G 
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 37/245 (15%)

Query: 89  YEELKEATNNFEPASILGEGGFGRVFKGVLSDGT-------AVAIKRLTCGGQQGDKEFL 141
           Y++ +   N +E    +G G FG VF  V    T       A++ + L    ++   + +
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFL-VKHKRTQEFFCWKAISYRGLK---EREKSQLV 60

Query: 142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
           +EV ++  L H+N+V+ +  + ++ + +  +  E    G L   +     +   ++    
Sbjct: 61  IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120

Query: 202 MKIALDAARGLAYLHE----DSQPCVIHRDFKASNILLE-------------NNFH---- 240
           + I       LAY H      +   V+HRD K  NI L              NN +    
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELL 298
           AK+ DFGL+K         ++   +GT  Y +PE  +  T     KSD+++ G ++ EL 
Sbjct: 181 AKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 299 TGRKP 303
           +G+ P
Sbjct: 238 SGKTP 242

Length = 1021

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 9/94 (9%)

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
           ARG+ +L   S+ CV HRD  A N+LL      K+ DFGLA+      +NY+S     TF
Sbjct: 247 ARGMEFLA--SKNCV-HRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKG--STF 300

Query: 269 ---GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
               ++APE          SDV+SYG++L E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 64/280 (22%), Positives = 104/280 (37%), Gaps = 106/280 (37%)

Query: 97  NNFEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHH 152
            +F    ++G+G FG V + V     G   A+K L            ++ EM  +  L H
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTL------------LKSEMFKKDQLAH 47

Query: 153 ----RNL---------VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWE 199
               R++         V L  YYS +D+    L  E +P G L + L         + ++
Sbjct: 48  VKAERDVLAESDSPWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTML---------IKYD 96

Query: 200 ------TRMKIA-----LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 248
                 TR  +A     ++A   L +         IHRD K  NIL++   H K++DFGL
Sbjct: 97  TFSEDVTRFYMAECVLAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGL 147

Query: 249 A------------KQAPEGRTNYL----------------------------STRVM--- 265
           +            ++  +G++N                              + R+M   
Sbjct: 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYS 207

Query: 266 --GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             GT  Y+APE  +      + D +S G ++ E L G  P
Sbjct: 208 TVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 8/95 (8%)

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFG-LAKQAPEGRTNYLSTRVMGTFGYVAP 273
           +H   Q   +HRD K  N+LL+ N H ++ADFG   K   +G     S+  +GT  Y++P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SSVAVGTPDYISP 172

Query: 274 EY--AM---TGHLLVKSDVYSYGVVLLELLTGRKP 303
           E   AM    G    + D +S GV + E+L G  P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 44/233 (18%)

Query: 104 ILGEGGFGRVFKGVLSD---GTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           ++G+GG G V+     D      VA+K++           K FL E ++ + L H  +V 
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 158 LVGYYSSRDSSQHLLCY-------ELVPN----GSLESWLHGPLGVNCHLDWETRMKIAL 206
           +    S  D   + + Y        L+ +     SL   L     V         + I  
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV------GAFLSIFH 120

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPE--------GR 256
                + Y+H      V+HRD K  NILL       + D+G A  K+  E          
Sbjct: 121 KICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 257 TNYLST------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            N   +      +++GT  Y+APE  +       +D+Y+ GV+L ++LT   P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
           A G+ +L   S+ CV HRD  A N+L+      K+ DFGLA+      +NY+S     TF
Sbjct: 249 ANGMEFLA--SKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKG--STF 302

Query: 269 ---GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
               ++APE          SDV+S+G++L E+ T
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 16/153 (10%)

Query: 103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
            +L  G   RV+   L       + ++    ++   +   EV +L  L  + L       
Sbjct: 4   KLLKGGLTNRVYL--LGTKDEDYVLKIN-PSREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHG-PLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           S        L         L  W+ G  L      + E    IA   A  LA LH+    
Sbjct: 61  SGESDGWSYL---------LMEWIEGETLDEVSEEEKE---DIAEQLAELLAKLHQLPLL 108

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
            + H D    NIL+++     + D+  A   P 
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 62/278 (22%), Positives = 101/278 (36%), Gaps = 75/278 (26%)

Query: 99  FEPASILGEGGFGRVFKGVLSDGTAV-AIKRLTCGGQQGDKEFLV---------EVEMLS 148
           F     LG G FG V      D  A+ A+K L        K+ L+         E ++L+
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR------KKDVLLRNQVAHVKAERDILA 56

Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL 206
              +  +V+L  YYS +D        + +P G + S L   G    +    +   +  A+
Sbjct: 57  EADNEWVVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAV 114

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----------------- 249
           ++   + +         IHRD K  NIL++ + H K+ DFGL                  
Sbjct: 115 ESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDH 165

Query: 250 ----------------------------KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
                                       ++A       L+  ++GT  Y+APE  +    
Sbjct: 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY 225

Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQP-SGQENLVTW 318
               D +S GV+L E+L G+ P     P   Q  ++ W
Sbjct: 226 TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 65/282 (23%), Positives = 101/282 (35%), Gaps = 87/282 (30%)

Query: 99  FEPASILGEGGFGRVFKGVLSDGTAV----------AIKRLTCGGQQGDKEFLVEVEMLS 148
           F     +G G FG V      D  A+           + R      + +++ L E +   
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--- 59

Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALD 207
              +  +VKL  YYS +D        + +P G + S L              R+ I   D
Sbjct: 60  ---NEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRLGIFEED 101

Query: 208 AAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL----------- 248
            AR         +  +H+      IHRD K  NIL++ + H K+ DFGL           
Sbjct: 102 LARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158

Query: 249 ------------------------AKQAPEGRTNY------LSTRVMGTFGYVAPE-YAM 277
                                    +  P  R         L+  ++GT  Y+APE    
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218

Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG-QENLVTW 318
           TG+  +  D +S GV+L E+L G+ P     P+  Q  ++ W
Sbjct: 219 TGYTQL-CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.4 bits (111), Expect = 1e-05
 Identities = 50/170 (29%), Positives = 71/170 (41%), Gaps = 27/170 (15%)

Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHL 196
           E +V   M     + N +KL  YYS      H+L  + + +G L   L   G L      
Sbjct: 58  EPMVHQLMK---DNPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEA--- 109

Query: 197 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEG 255
             E + KI       L  LH+ +   +IH D K  N+L         + D+GL K    G
Sbjct: 110 --EVK-KIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG 161

Query: 256 RTNYLSTRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
                +     GT  Y +PE  + GH    S D ++ GV+  ELLTG+ P
Sbjct: 162 -----TPSCYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 70/273 (25%), Positives = 115/273 (42%), Gaps = 43/273 (15%)

Query: 105 LGEGGFGRVFKGVLSDGT---AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G +G V+K    DG      A+K++   G         E+ +L  L H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIE--GTGISMSACREIALLRELKHPNVIALQKV 66

Query: 162 YSSRDSSQHLLCYELVPNGSLESW----LHGPLGVN---CHLDWETRMKIALDAARGLAY 214
           + S    +  L ++   +   + W     H     N     L       +      G+ Y
Sbjct: 67  FLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 215 LHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTF 268
           LH +    V+HRD K +NIL+          K+AD G A+   +P      L   V+ TF
Sbjct: 124 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK- 326
            Y APE  +      K+ D+++ G +  ELLT  +P+   +   QE++ T + P   D+ 
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCR---QEDIKT-SNPFHHDQL 234

Query: 327 DRL---------EELADPRLGGKYP--KEDFIR 348
           DR+         ++  D R   +YP  ++DF R
Sbjct: 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRR 267

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 59/224 (26%)

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD--WET 200
           E ++L+   +  +VKL  YYS +D        + +P G + S L         L   +  
Sbjct: 51  ERDILAEADNEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA 108

Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA----------- 249
            + +A+++   + +         IHRD K  NIL++ + H K+ DFGL            
Sbjct: 109 ELTLAIESVHKMGF---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159

Query: 250 ----------------------------------KQAPEGRTNYLSTRVMGTFGYVAPEY 275
                                             ++A +     L+  ++GT  Y+APE 
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS-GQENLVTW 318
            +        D +S GV+L E+L G+ P     P+  Q  ++ W
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 58/228 (25%)

Query: 105 LGEGGFGRVFKGVLSDGTA---VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G +G V+K    DG      A+K++   G         E+ +L  L H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 66

Query: 162 YSSR---------DSSQHLLCYEL--------------VPNGSLESWLHGPLGVNCHLDW 198
           + S          D ++H L + +              +P G ++S L+  L        
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD------- 119

Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK--QA 252
                       G+ YLH +    V+HRD K +NIL+          K+AD G A+   +
Sbjct: 120 ------------GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLT 299
           P      L   V+ TF Y APE  +      K+ D+++ G +  ELLT
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 53/276 (19%)

Query: 58  ASPKETAKPRTADAVTLGGSLPHPTSTRFLAY----EELKEATNNFEPASILGEGGFGRV 113
            +  E A P     VT   +LP+ +      Y    E++  +T  F+  S+LGEG FG+V
Sbjct: 88  TTNVEVAPPPKKKKVTY--ALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKV 145

Query: 114 FKG---VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSS 164
            +       +  AV I R      +  K   +E++ + ++   +      L+K+  Y+  
Sbjct: 146 VEAWDRKRKEYCAVKIVRNVPKYTRDAK---IEIQFMEKVRQADPADRFPLMKIQRYF-- 200

Query: 165 RDSSQHLLCYELVPNGS-LESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           ++ + H +C  +   G  L  W+  HGP   + HL      +I       L Y H  ++ 
Sbjct: 201 QNETGH-MCIVMPKYGPCLLDWIMKHGPFS-HRHL-----AQIIFQTGVALDYFH--TEL 251

Query: 222 CVIHRDFKASNILLEN---------NFH-------AKVADFGLAKQAPEGRTNYLSTRVM 265
            ++H D K  NIL+E          N          ++ D G        RT  +STR  
Sbjct: 252 HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTR-- 309

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
               Y +PE  +    +  +D++S G ++ EL TG+
Sbjct: 310 ---HYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 30/92 (32%), Positives = 40/92 (43%), Gaps = 4/92 (4%)

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
           R + YLHE+    +IHRD KA NI + +     + DFG A   P            GT  
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIA 248

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
             APE           D++S G+VL E+ T  
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 44.3 bits (104), Expect = 9e-05
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 34/171 (19%)

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLL------CYELVPNGSLESWLHGPLGVNCHL 196
           E+  L RL+H N++K+     S  ++  +        Y  + + + + W   PL      
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-WKDRPL------ 265

Query: 197 DWETR--MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
             +TR  MK  L A   + Y+H+     +IHRD K  NI L  +    + DFG A     
Sbjct: 266 LKQTRAIMKQLLCA---VEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTA----- 314

Query: 255 GRTNYLSTRVMGTFGYV------APEYAMTGHLLVKSDVYSYGVVLLELLT 299
               +   R    +G+V      +PE          +D++S G++LL++L+
Sbjct: 315 --MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 39/115 (33%), Positives = 59/115 (51%), Gaps = 19/115 (16%)

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD----FGLAKQAPEGRTNY 259
           I   A RGL YLH++     IHR+ KAS+IL+  +    ++     + L +   + +  Y
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162

Query: 260 ----LSTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKP-VDM 306
                ST V+    +++PE     + G+  VKSD+YS G+   EL TGR P  DM
Sbjct: 163 DFPQFSTSVLP---WLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 35/219 (15%)

Query: 103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVKL 158
               +     + K      T VA+K++        KE L     E+    +L H N++  
Sbjct: 8   KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILP- 63

Query: 159 VGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL---DAARGL 212
             Y +S      L +   L+  GS E  L  H P G+      E    IA    D    L
Sbjct: 64  --YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----EL--AIAFILKDVLNAL 114

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADF----GLAKQAPEGRTNYLSTR-VMGT 267
            Y+H  S+   IHR  KAS+ILL  +    ++       + K     R  +   +  +  
Sbjct: 115 DYIH--SKGF-IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171

Query: 268 FGYVAPEY---AMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             +++PE     + G+   KSD+YS G+   EL  G  P
Sbjct: 172 LPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 46/246 (18%)

Query: 140 FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWE 199
           F     ++S++ H +L  + G       S++++  E V +G L+  L    G    +   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKG---RVPVA 117

Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA-------KVADFGLAKQA 252
            ++ +A   A  L+YL + +   ++H +  A NILL     A       K++D G++  A
Sbjct: 118 WKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA 174

Query: 253 --PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLEL-LTGRKPVDMSQ 308
              E R   +         ++APE    G  L   +D +S+G  LLE+   G  P+    
Sbjct: 175 LSREERVERIP--------WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226

Query: 309 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 368
           PS +E            K RL E +   L             T+ + C+  E  QRP+  
Sbjct: 227 PSEKERF-------YEKKHRLPEPSCKELA------------TLISQCLTYEPTQRPSFR 267

Query: 369 EVVQSL 374
            +++ L
Sbjct: 268 TILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	443
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
smart00090	237	RIO RIO-like kinase.	99.78
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.41
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.33
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.14
KOG3087	229	consensus Serine/threonine protein kinase [General	99.12
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.03
COG4248	637	Uncharacterized protein with protein kinase and he	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
PRK09902	216	hypothetical protein; Provisional	98.79
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.79
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.58
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.57
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.47
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.47
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.37
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.33
PLN02876	822	acyl-CoA dehydrogenase	98.26
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.22
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.17
PRK10593	297	hypothetical protein; Provisional	98.12
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.1
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.09
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.06
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.04
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.02
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.9
PRK05231	319	homoserine kinase; Provisional	97.77
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.76
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.66
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.64
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.4
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.37
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.32
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.31
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.19
PLN02236	344	choline kinase	97.13
KOG2270	520	consensus Serine/threonine protein kinase involved	97.01
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.95
PLN02756	418	S-methyl-5-thioribose kinase	96.94
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.9
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.8
COG2334	331	Putative homoserine kinase type II (protein kinase	96.71
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.65
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.56
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.55
PRK06148	1013	hypothetical protein; Provisional	96.4
PRK12396	409	5-methylribose kinase; Reviewed	96.22
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.18
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	96.17
PRK11768	325	serine/threonine protein kinase; Provisional	96.15
PTZ00384	383	choline kinase; Provisional	95.88
PF04478	154	Mid2: Mid2 like cell wall stress sensor; InterPro:	95.86
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.68

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-60  Score=459.81  Aligned_cols=290  Identities=57%  Similarity=0.989  Sum_probs=256.8

Q ss_pred             CccccCHHHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEee
Q 013404           83 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY  162 (443)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  162 (443)
                      ..+.|+++++..+|++|...+.||+|+||.||+|.+++|..||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56779999999999999999999999999999999999999999988765443145699999999999999999999999


Q ss_pred             ecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceE
Q 013404          163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK  242 (443)
Q Consensus       163 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  242 (443)
                      ...+. +.+||||||++|+|.++|+.....  +++|.+|++||.++|+||+|||+...|+|+|||||++|||||+++++|
T Consensus       141 ~e~~~-~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  141 LEGGE-HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             ecCCc-eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            84332 589999999999999999975443  799999999999999999999999998999999999999999999999


Q ss_pred             EccccccccCCC-CCcccccccc-ccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 013404          243 VADFGLAKQAPE-GRTNYLSTRV-MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       243 l~Dfgla~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~  320 (443)
                      |+|||+|+..+. ...   .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+...+.....+..|++
T Consensus       218 lsDFGLa~~~~~~~~~---~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~  294 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTS---VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK  294 (361)
T ss_pred             ccCccCcccCCccccc---eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence            999999976654 221   1112 89999999999999999999999999999999999999998766666777999998


Q ss_pred             HHhhccccccccccCccC-CCCCH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          321 PILRDKDRLEELADPRLG-GKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      +.+.+. .+.+++|+.+. +.++. ++..++..++.+|++.+|.+||+|.||++.|+.+..
T Consensus       295 ~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  295 PLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            888876 89999999987 66665 688889999999999999999999999998865543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-51  Score=397.65  Aligned_cols=263  Identities=35%  Similarity=0.545  Sum_probs=213.3

Q ss_pred             CCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           99 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      +...+.||+|+||+||+|.+.+...||||++.......  .+.|.+|+.+|.+++|||||+|+|+|..... ..++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEEEEe
Confidence            34456699999999999999755559999998654333  4589999999999999999999999974322 68999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-ceEEccccccccCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAPEG  255 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~  255 (443)
                      +++|+|.++++..  ....+++..++.++.|||+||.|||++++  ||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999864  24579999999999999999999999875  99999999999999997 9999999999876543


Q ss_pred             CccccccccccCcccccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      .  ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||....+      ...+..+....       
T Consensus       198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~-------  262 (362)
T KOG0192|consen  198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGG-------  262 (362)
T ss_pred             c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcC-------
Confidence            2  2234468999999999999  56999999999999999999999999975443      11111111111       


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhcC
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ  384 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~  384 (443)
                         .....+..+...+..++.+||+.||++||++.+++..|+.+.......
T Consensus       263 ---~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~  310 (362)
T KOG0192|consen  263 ---LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA  310 (362)
T ss_pred             ---CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence               112223334456889999999999999999999999999988755543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.5e-51  Score=412.99  Aligned_cols=265  Identities=26%  Similarity=0.435  Sum_probs=223.8

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      .+.+.+..+.||+|.||+||+|...      +...||||.++..... ..++|++|++++..|+|||||+|+|+|.  ++
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~--~~  561 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR--EG  561 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc--cC
Confidence            4566777899999999999999853      3467999999977665 5789999999999999999999999998  45


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCC------C----CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLG------V----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN  237 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  237 (443)
                      ..+++|+|||..|||.+||.....      .    ..+|+..+.+.||.|||.||+||-++.   +|||||..+|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence            589999999999999999963211      1    234889999999999999999999999   999999999999999


Q ss_pred             CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 013404          238 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV  316 (443)
Q Consensus       238 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~  316 (443)
                      +..+||+||||++.....+++.......-+.+||+||.+..++|+++||||||||+|||+++ |+.||......+.    
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV----  714 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV----  714 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH----
Confidence            99999999999999988777655556677889999999999999999999999999999999 9999975443221    


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                                  ++.+.+.++ -.+|..++..++.|+..||+.+|.+||+++||-..|+...+..
T Consensus       715 ------------Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  715 ------------IECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             ------------HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence                        111222222 3567777778999999999999999999999999998876543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-51  Score=391.38  Aligned_cols=255  Identities=31%  Similarity=0.462  Sum_probs=213.5

Q ss_pred             CCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404           99 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +...+.||+|.||.||.|.+++...||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++  .++||||||+
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--piyIVtE~m~  284 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--PIYIVTEYMP  284 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC--ceEEEEEecc
Confidence            3456889999999999999988889999999865 345678999999999999999999999998433  7899999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcc
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN  258 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  258 (443)
                      .|+|.+||+..  ....+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+...++ .+
T Consensus       285 ~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y  358 (468)
T KOG0197|consen  285 KGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EY  358 (468)
T ss_pred             cCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC-ce
Confidence            99999999862  2456888999999999999999999999   999999999999999999999999999954433 33


Q ss_pred             ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       259 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                      .......-+..|.|||.+..+.++.|||||||||+||||+| |+.||.....      .+.+. .+..+.++        
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~ev~~-~le~GyRl--------  423 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EEVLE-LLERGYRL--------  423 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------HHHHH-HHhccCcC--------
Confidence            34445567889999999999999999999999999999999 8888864321      22222 23334433        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                        ..|..++..+.+++..||+.+|++|||++.+...|+.+..
T Consensus       424 --p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  424 --PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             --CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence              3455566679999999999999999999999888887753

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-50  Score=369.77  Aligned_cols=257  Identities=29%  Similarity=0.440  Sum_probs=209.5

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      +++..+.||+|..|+||++.++ +++.+|+|.+..... ...+++.+|++++++.+|||||.++|.|..+.. ...++||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mE  158 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICME  158 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehh
Confidence            4455788999999999999965 788999999965433 335789999999999999999999999985443 6999999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||++|+|++++...    +.+++...-+++.+|++||.|||+ .+   |+||||||+|||++..|++||||||.++.+..
T Consensus       159 YMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            99999999999753    458999999999999999999996 66   99999999999999999999999999998765


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      .    .....+||..|||||.+.+..|+.++||||||++++|+++|+.||....+. .....+....+..+.       -
T Consensus       232 S----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll~~Iv~~p-------p  299 (364)
T KOG0581|consen  232 S----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELLCAIVDEP-------P  299 (364)
T ss_pred             h----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHHHHHhcCC-------C
Confidence            4    456789999999999999999999999999999999999999999654111 112222222222211       0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      |.+...   ....+++.++..||+.||.+||++.|+++|-+..
T Consensus       300 P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~  339 (364)
T KOG0581|consen  300 PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK  339 (364)
T ss_pred             CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence            222221   1344589999999999999999999999986543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-49  Score=382.89  Aligned_cols=251  Identities=27%  Similarity=0.437  Sum_probs=213.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ..|...+.||+|||+.||.++. .+|+.||+|++.+.   .....+...+||++.++|+|||||+++++|+  +..++||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE--Ds~nVYi   95 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE--DSNNVYI   95 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee--cCCceEE
Confidence            5689999999999999999996 88999999999764   2334567899999999999999999999998  6668999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |.|+|.+++|..+++.    .+++++.++..++.||+.||.|||+++   |+|||||..|+||++++++||+|||||..+
T Consensus        96 vLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l  168 (592)
T KOG0575|consen   96 VLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL  168 (592)
T ss_pred             EEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence            9999999999999974    457999999999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  .....+||+.|+|||++....++..+||||+||+||-|+.|++||+...      +.+-...+......    
T Consensus       169 e~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~~Y~----  236 (592)
T KOG0575|consen  169 EYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLNEYS----  236 (592)
T ss_pred             cCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhcCcc----
Confidence            65433  3456899999999999999999999999999999999999999997432      22222222222211    


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                              .|........+||.++|+.||.+|||+++|+.+-..
T Consensus       237 --------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  237 --------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             --------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence                    222333446789999999999999999999987544

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=367.30  Aligned_cols=201  Identities=32%  Similarity=0.516  Sum_probs=178.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC--CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ..+|...+.||+|+||+||+|++ .++..||||.+...  .....+.+..|+.+|+.++|||||.+++++..  .+.++|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~l   86 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIYL   86 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEEE
Confidence            35788889999999999999995 46899999999766  33345667899999999999999999999884  448999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC------CceEEccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN------FHAKVADF  246 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Df  246 (443)
                      |||||+||+|.+||+..    ..+++..+..++.|+|.||++||+++   ||||||||+||||+..      -.+||+||
T Consensus        87 VMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             EEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            99999999999999853    36899999999999999999999999   9999999999999764      56899999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ  308 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~  308 (443)
                      |+|+.+....   .....+|++.|||||+++.++|+.|+|+||+|++||++++|+.||+...
T Consensus       160 GfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  160 GFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             chhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9999887533   3566899999999999999999999999999999999999999998544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-51  Score=360.70  Aligned_cols=257  Identities=27%  Similarity=0.393  Sum_probs=211.3

Q ss_pred             cCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .+|+++++||+|+||.||++. +.+|..||.|.+....-  ...+++..|+.+|++|+|||||+++++....+...++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468889999999999999999 67899999999985533  335678999999999999999999985544455458899


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcC-CCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS-QPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||..|+|...++..+...+.+++..+++++.|++.||.++|+.- +..|.||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999999876666778999999999999999999999831 123999999999999999999999999999988


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  .....+|||.||+||.+.+.+|+.||||||+||++|||+.-..||.+.      ++.+.-..+-+. + .   
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg-d-~---  245 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG-D-Y---  245 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC-C-C---
Confidence            76543  456789999999999999999999999999999999999999999754      344333332211 1 1   


Q ss_pred             ccCccCCCCC-HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 013404          333 ADPRLGGKYP-KEDFIRVCTIAAACVAPEANQRPTMGEVVQ  372 (443)
Q Consensus       333 ~d~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~  372 (443)
                            ..+| .-....+..||..|+..||+.||+.-.++.
T Consensus       246 ------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  246 ------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             ------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence                  1123 334556889999999999999998644443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-49  Score=364.52  Aligned_cols=258  Identities=27%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCC-------CHHHHHHHHHHHhhcCCCceeeEEEeeecCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ-------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD  166 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  166 (443)
                      ..+.|.+.+.||+|+||.|-+|. ..+|+.||||+++.....       ......+|+++|++|+|||||++.++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34667788999999999999999 568999999999754221       1223579999999999999999999998544


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC---CceEE
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKV  243 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl  243 (443)
                        ..|+||||+.||+|.+++-.    ++.+.+.....+++|++.|+.|||++|   |+||||||+|||+..+   ..+||
T Consensus       250 --s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI  320 (475)
T KOG0615|consen  250 --SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI  320 (475)
T ss_pred             --ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence              67999999999999999965    345777888999999999999999999   9999999999999765   78999


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccccCCC---CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL---LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~  320 (443)
                      +|||+|+......   .+...+||+.|.|||++.+..+   ..+.|+||+||+||-+++|.+||.......  .+   ..
T Consensus       321 tDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl---~e  392 (475)
T KOG0615|consen  321 TDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SL---KE  392 (475)
T ss_pred             cccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cH---HH
Confidence            9999999876432   4567899999999999987643   348899999999999999999996432211  11   11


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ++........        .....+..++..++|.+||..||++|||+.|+++|-|.-
T Consensus       393 QI~~G~y~f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  393 QILKGRYAFG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             HHhcCccccc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            2222211111        112234455688999999999999999999999987643

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=347.14  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=205.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|+++++||+|+||.||+++ .++++.+|+|.+++...   ...+...+|..+|.+++||.||+++-.|+  +...+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ--t~~kLy  101 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ--TEEKLY  101 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc--cCCeEE
Confidence            4689999999999999999999 45789999999976532   33566889999999999999999987766  566899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ||+||+.||.|..+|++    ...+++..+.-++.+|+.||.|||+.+   |+||||||+|||||++|+++|+||||++.
T Consensus       102 lVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence            99999999999999975    456899999999999999999999999   99999999999999999999999999996


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .-....  .....+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+      ...+...+...+-.   
T Consensus       175 ~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k~~---  243 (357)
T KOG0598|consen  175 DLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGKLP---  243 (357)
T ss_pred             cccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCcCC---
Confidence            544322  2345799999999999999999999999999999999999999997433      34444444444300   


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC----CHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP----TMGEVVQS  373 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~evl~~  373 (443)
                              ..+.-......+++...|+.||++|-    .+.+|-+|
T Consensus       244 --------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  244 --------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             --------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                    11111223467899999999999995    56665543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=378.94  Aligned_cols=257  Identities=27%  Similarity=0.438  Sum_probs=213.7

Q ss_pred             CCCCCceeeecCcEEEEEEEECC----CcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ...+.++||.|.||.||+|+++-    ...||||.++.... ....+|+.|+.||.+++||||++|.|+..  .....+|
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVT--ks~PvMI  707 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVT--KSKPVMI  707 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEe--cCceeEE
Confidence            34567899999999999999652    34799999997654 34568999999999999999999999987  4557899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |+|||++|+|+.||+.+.   ..+++.+...++.+||.||+||-+.+   +|||||.++|||++.+..+|++||||+|.+
T Consensus       708 iTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             EhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence            999999999999998654   45999999999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCcccc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          253 PEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       253 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .++..... .....-+.+|.|||.+...+++.+|||||||++|||.++ |.+||-.....+       +...++++.++ 
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe~gyRL-  853 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIEQGYRL-  853 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHHhccCC-
Confidence            66553222 222344679999999999999999999999999999887 999985332211       11122233333 


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                               .-|.+++..|.+|+.+||+.|-++||.+.+|+..|.++.+
T Consensus       854 ---------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  854 ---------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             ---------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                     3456677789999999999999999999999999998864

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.6e-46  Score=335.79  Aligned_cols=265  Identities=25%  Similarity=0.353  Sum_probs=205.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      +.|+.+.++|+|+||.||+++. ++|+.||||++.....+.  .+-.++|+++|++|+|+|+|.++.+|.  ....++||
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr--rkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR--RKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH--hcceeEEE
Confidence            4588889999999999999995 579999999997654322  345789999999999999999999987  45589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      +|||+. ++.+-|...   ...++...+.++++|+++|+.|+|+++   ++||||||+|||++.++.+||||||+|+.+.
T Consensus        80 FE~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             eeecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc
Confidence            999987 544444432   234788999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH--------HHHHHhh
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT--------WARPILR  324 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~  324 (443)
                      .....  -+..+.|..|.|||.+.+ .+|....|||++||++.||++|.+-|......++...+.        .-..++.
T Consensus       153 ~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  153 APGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             CCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            43333  256688999999999987 689999999999999999999999987655443332221        1122222


Q ss_pred             ccccccccccCccC------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 DKDRLEELADPRLG------GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 ~~~~~~~~~d~~~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .......+.-|...      ..+| ....-+.+++..||+.||++|++-++++.|
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            22222222222221      1122 122357899999999999999999999865

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=354.87  Aligned_cols=265  Identities=27%  Similarity=0.405  Sum_probs=218.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC-HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +....+.++||+|-||.|.++....+..||||+++...... ..+|..|+++|.+|+|||||.++|+|..++  .+++++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--PicmI~  614 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCMIT  614 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHHHH
Confidence            44556789999999999999999888999999999776554 478999999999999999999999998544  789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      |||++|+|.+||......  .+.-....+|+.||+.||+||.+.+   +|||||.++|+|++.++++||+|||+++.+..
T Consensus       615 EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence            999999999999754322  2455677889999999999999999   99999999999999999999999999999888


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ...+....+.+-+.+|||+|.+..+++++++|||+||+++||+++  ...||....   .++.++-...++.......- 
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~~~~-  765 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGRQVV-  765 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCccee-
Confidence            877777777888999999999999999999999999999999754  788986322   22223322333333222211 


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                            ..-|.-+...+++++..||..|.++||+++++...|...
T Consensus       766 ------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 ------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                  123444555688999999999999999999999887653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-45  Score=359.06  Aligned_cols=264  Identities=28%  Similarity=0.464  Sum_probs=205.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+|..      .++..||||+++.... .....+.+|+.++.++ +||||++++++|.. ..
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK-PN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC-CC
Confidence            46799999999999999999974      2356899999975432 2245789999999999 89999999998864 33


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCC-------------------------------------------------------
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGV-------------------------------------------------------  192 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  192 (443)
                      ...+++|||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4678999999999999999643210                                                       


Q ss_pred             ---CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCcc
Q 013404          193 ---NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG  269 (443)
Q Consensus       193 ---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  269 (443)
                         ..++++.++..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134788899999999999999999998   99999999999999999999999999986543322222233456788


Q ss_pred             cccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHH
Q 013404          270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIR  348 (443)
Q Consensus       270 y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  348 (443)
                      |+|||++.+..++.++|||||||++|||++ |..||......  ..   ... .+.....      ..    .+......
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~---~~~-~~~~~~~------~~----~~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EE---FCQ-RLKDGTR------MR----APENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HH---HHH-HHhcCCC------CC----CCCCCCHH
Confidence            999999999999999999999999999997 99999653321  11   111 1111111      11    11222335


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          349 VCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       349 l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      +.+++.+||+.||++||++.||++.|+.+.+
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-46  Score=346.82  Aligned_cols=261  Identities=30%  Similarity=0.434  Sum_probs=205.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|.....+...+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677899999999999999954 58999999987653333567899999999999999999999744333236889999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEccccccccCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPE  254 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~  254 (443)
                      |+++|+|.+++.+..+   .+++..+..++.||++||+|||+++   |+||||||+|||++. ++.+||+|||+++....
T Consensus        97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            9999999999986532   5999999999999999999999999   999999999999999 79999999999987653


Q ss_pred             C-CccccccccccCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          255 G-RTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       255 ~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      . ..........||+.|||||++..+. ...++|||||||++.||+||+.||...     .....+...+.... .    
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-~----  240 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-S----  240 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-C----
Confidence            1 1111233578999999999999643 335999999999999999999999642     11122222222111 1    


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                       .|    .+|........+++..|++.||++|||+++++++....+
T Consensus       241 -~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  241 -LP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             -CC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence             12    333344445789999999999999999999999865443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=357.48  Aligned_cols=269  Identities=26%  Similarity=0.409  Sum_probs=211.4

Q ss_pred             HHHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCC
Q 013404           89 YEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD  166 (443)
Q Consensus        89 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  166 (443)
                      .++.....+.+.+...||+|+||+||+|.|.+  .||||+++.....  ..+.|.+|+.+|++-+|.||+=|+|||... 
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-  460 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-  460 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-
Confidence            35555566677888999999999999999852  4999999876543  357899999999999999999999999732 


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                        ...+|+.+|+|-+|+.+||...   ..++..+.+.|+.||++||.|||.++   |||||||..||||.++++|||+||
T Consensus       461 --~~AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  461 --PLAIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             --ceeeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence              4599999999999999999643   45889999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      ||+.....-..........|...|||||+++.   .+|+..+||||||+++|||+||..||. .+..++.-   |   ++
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi---f---mV  605 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII---F---MV  605 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE---E---Ee
Confidence            99865433222222234468889999999974   478999999999999999999999997 33222210   0   01


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ..+....+...      ....+...+.+|+..||..++++||.+.+|+..|+.+...+
T Consensus       606 GrG~l~pd~s~------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  606 GRGYLMPDLSK------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             cccccCccchh------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence            11111111111      11233345889999999999999999999999888887643

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-46  Score=385.68  Aligned_cols=265  Identities=29%  Similarity=0.463  Sum_probs=217.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC--Cc----EEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD--GT----AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      ..+.+..+.||+|.||.||.|...+  |.    .||||.++... .+...+|++|..+|++++|||||+++|+|..  ..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SG  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CC
Confidence            4456678899999999999999643  33    49999997654 3446789999999999999999999999984  55


Q ss_pred             eeEEEEeecCCCChhHhhcCCCC---CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD  245 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  245 (443)
                      ..++++|||++|+|..||++.+.   ....++..+.+.++.|||+|+.||++++   +|||||.++|+||++...+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence            78999999999999999986522   2446889999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      ||+|+.....+.+.......-+..|||||.+..+.++.|+|||||||+|||++| |..||......+.      ....+ 
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~-  918 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVL-  918 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHH-
Confidence            999997766655444444456789999999999999999999999999999999 8899975432211      11111 


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      .+.++          ..|..+...+++++..||+.+|++||++..|++.+..+.+...
T Consensus       919 ~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  919 EGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             hCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            22232          3355566678999999999999999999999998888776554

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=356.44  Aligned_cols=251  Identities=26%  Similarity=0.415  Sum_probs=212.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ...|....+||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...  .+++.||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLWVVM  349 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELWVVM  349 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeEEEE
Confidence            4567777899999999999998 667899999999988777778899999999999999999999988744  5899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      |||+||+|.|.+..     ..+++.++..|+.++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+..
T Consensus       350 Eym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             eecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            99999999999874     34899999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  .....+||+.|||||+.....|.+|.||||||++++||+-|.+||-...+.....+      +... +      -
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL------Ia~n-g------~  486 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN-G------T  486 (550)
T ss_pred             ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH------Hhhc-C------C
Confidence            554  35667999999999999999999999999999999999999999975443211111      1111 1      1


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      |.  -..+......+.+++.+||+.|+++||++.|+|+|
T Consensus       487 P~--lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 PK--LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CC--cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            11  12233444568899999999999999999999987

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=338.41  Aligned_cols=273  Identities=28%  Similarity=0.444  Sum_probs=207.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhh--cCCCceeeEEEeeecCC--CCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSSRD--SSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~--~~~~~l  172 (443)
                      ...+..++||+|+||.||+|++. ++.||||++.   .+..+.|++|-++++-  ++|+||++++++-...+  ..+++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34566788999999999999985 4999999997   3456789999998876  48999999998754222  447899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc------CCCceEecCCCcccEEecCCCceEEccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED------SQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      |++|.+.|+|.+||..     ..++|....+|+..+++||+|||+.      .+|+|+|||||++||||.+|+++.|+||
T Consensus       286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            9999999999999984     3589999999999999999999965      3678999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCC-CC-----chhhHHHHHHHHHHHHhCCCCCC-CCCCCCcch-----
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH-LL-----VKSDVYSYGVVLLELLTGRKPVD-MSQPSGQEN-----  314 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDv~S~G~il~elltg~~p~~-~~~~~~~~~-----  314 (443)
                      |||..+..+.........+||.+|||||++.+.- +.     .+.||||+|.+||||++.-.-++ ...+..+..     
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            9999887655444444578999999999997642 22     46899999999999998654332 111111111     


Q ss_pred             ----HHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          315 ----LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       315 ----~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                          -.+.++..+-.++....+.+.....    ..+..+++.+..||..||+-|.|+.=|.+.+..+....+
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence                1122222222222223333322221    334568999999999999999999999999888765443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-45  Score=351.32  Aligned_cols=268  Identities=26%  Similarity=0.351  Sum_probs=208.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .+.|+..++||+|.||.||+|+ ..+|+.||+|++.....  .......+||.+|++|+||||++|.+.........+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3567788999999999999999 67899999999987653  33456789999999999999999999988766778999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |+|||+. ||.-++...   ...+++.++..++.|++.||+|||+++   |+|||||.+|||||++|.+||+|||||+.+
T Consensus       196 VFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            9999987 999998743   346999999999999999999999999   999999999999999999999999999977


Q ss_pred             CCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc------
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD------  325 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  325 (443)
                      ....... .+..+-|+.|.|||++.+. .|+.+.|+||.||||.||++|++.|......++...+  +.-.=..      
T Consensus       269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI--fklcGSP~e~~W~  345 (560)
T KOG0600|consen  269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI--FKLCGSPTEDYWP  345 (560)
T ss_pred             cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH--HHHhCCCChhccc
Confidence            6544332 4566789999999999875 7999999999999999999999999765533322111  1100000      


Q ss_pred             cccccccccCccCCCCCHH-------HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKE-------DFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~-------~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...+...........+...       .....++|+..+|..||.+|.|+.+++++
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            0011100000001111111       11246789999999999999999999865

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-46  Score=351.85  Aligned_cols=267  Identities=25%  Similarity=0.351  Sum_probs=207.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHH--HHHHHHHHhhcC-CCceeeEEEeeecCCCCee
Q 013404           95 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE--FLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~  170 (443)
                      ..++|...++||.|.||.||+|+ ..+|..||||+++..-.. .++  -++|++.|++|+ |||||++.+++.+.+. .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-IL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eE
Confidence            34678889999999999999999 667999999999865333 333  367999999998 9999999999875544 89


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++|||||+. +|+++++..   +..+++..+..|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+||
T Consensus        86 ~fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccc
Confidence            999999965 999999864   567999999999999999999999999   9999999999999988899999999999


Q ss_pred             cCCCCCccccccccccCcccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH----------HHH
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV----------TWA  319 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~----------~~~  319 (443)
                      .......   -+..+.|..|.|||++. .+.|+.+.|+|++|||++|+.+-++-|.+....++..-+          .|.
T Consensus       159 ev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  159 EVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             ccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence            8766543   25678899999999875 668899999999999999999999999755433222110          111


Q ss_pred             HH--Hhh-ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          320 RP--ILR-DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       320 ~~--~~~-~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ..  +.. ..-++....-..+..-.+ ....+..+++.+|+++||++|||+.|.+++-
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            10  000 000011111111111112 2456688999999999999999999999873

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.4e-44  Score=342.23  Aligned_cols=250  Identities=21%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC---HHHHHHHHHHHhhcCCCceeeEEEeeec--CCCCeeEEEEee
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSS--RDSSQHLLCYEL  176 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~~~lv~e~  176 (443)
                      ...||+|++|.||+|.+ +|+.||||.++......   .+.|.+|+.+|.+++||||++++|++..  .+....+++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 58899999997654333   3668899999999999999999999875  334578899999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      +++|+|.+++...    ..+++.....++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||+++.....
T Consensus       104 ~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~  176 (283)
T PHA02988        104 CTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP  176 (283)
T ss_pred             CCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence            9999999999752    3588999999999999999999984 6   789999999999999999999999999865432


Q ss_pred             CccccccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      .     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....      ......+......     
T Consensus       177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~~-----  240 (283)
T PHA02988        177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNNS-----  240 (283)
T ss_pred             c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC-----
Confidence            2     23468899999999976  6889999999999999999999999974321      1122222211111     


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                       +    ..+......+.+++.+||+.||++|||++||++.|+.++..
T Consensus       241 -~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~~  282 (283)
T PHA02988        241 -L----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKFY  282 (283)
T ss_pred             -C----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHhc
Confidence             1    11222334588999999999999999999999999988753

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=6.5e-45  Score=348.97  Aligned_cols=247  Identities=30%  Similarity=0.434  Sum_probs=212.9

Q ss_pred             cCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|.+.+.||+|+||.||+|+ ..+.+.||+|.+.+.....  .+.+.+|++++++|+|||||.++++|+  ...++++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE--t~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE--TSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc--ccceEEEE
Confidence            578888999999999999999 4578899999998765433  457899999999999999999999987  45589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      +||+.| +|..+|..    +..++++.+..++.|++.||.|||+++   |.|||+||+|||++.++.+|++|||+|+...
T Consensus        80 te~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~  151 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS  151 (808)
T ss_pred             ehhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc
Confidence            999976 99999975    456999999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ..  ....+.+.||+.|||||+..+..|+..+|+||+||++||+++|++||..      ..+...++.+..+.-      
T Consensus       152 ~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~v------  217 (808)
T KOG0597|consen  152 TN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDPV------  217 (808)
T ss_pred             cC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCCC------
Confidence            53  2345778999999999999999999999999999999999999999963      334455555544421      


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                            ..|......+..++...|..||.+|.+..+++.|
T Consensus       218 ------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 ------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                  2234555568899999999999999999999977

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=354.30  Aligned_cols=241  Identities=26%  Similarity=0.392  Sum_probs=204.3

Q ss_pred             CCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          101 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       101 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      .++-||.|+.|.||+|++. ++.||||+++.-       -..+|+-|++|+||||+.|.|+|.  ....+|||||||..|
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCt--qsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCT--QSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeec--CCceeEEeeeccccc
Confidence            4578999999999999985 588999998621       235788999999999999999998  556899999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      -|...|+.    ..+++......|..+||.||.|||.++   |||||||.-||||..+..+||+|||-++...+..   .
T Consensus       198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---T  267 (904)
T KOG4721|consen  198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---T  267 (904)
T ss_pred             cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---h
Confidence            99999975    456888999999999999999999999   9999999999999999999999999998776542   2


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      +..+.||..|||||++++.+.++|.|||||||+||||+||..||...+....                +..+-...+.-.
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----------------IwGVGsNsL~Lp  331 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----------------IWGVGSNSLHLP  331 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----------------EEeccCCccccc
Confidence            4567999999999999999999999999999999999999999964332211                111222233345


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      .|..+...+.-|++.||+-.|..||++.+|+.||+..
T Consensus       332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            5667777889999999999999999999999998644

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-45  Score=348.10  Aligned_cols=255  Identities=27%  Similarity=0.374  Sum_probs=209.5

Q ss_pred             HHHhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           93 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        93 ~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      +...++|..++.||+|+|++|++|+ ..+++.||||++.+.-   ....+....|-.+|.+| .||.|++|+--|.  |.
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ--D~  146 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ--DE  146 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee--cc
Confidence            4556899999999999999999999 5679999999986542   22335677899999999 8999999977666  66


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ..+|+|+||+++|+|.++|++.    ..+++.....++.+|+.||+|||++|   ||||||||+|||||+||++||+|||
T Consensus       147 ~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  147 ESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             cceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecc
Confidence            6899999999999999999863    45899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCcc-----------ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 013404          248 LAKQAPEGRTN-----------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV  316 (443)
Q Consensus       248 la~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~  316 (443)
                      -|+.+......           .....++||..|.+||++.....+..+|+|+|||+||+|+.|.+||...++      .
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------y  293 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------Y  293 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------H
Confidence            99977543221           112458999999999999999999999999999999999999999974432      1


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      -.++.++.-        +-.+...++    +.+.+|+.+.|..||++|++.++|.+|.
T Consensus       294 liFqkI~~l--------~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  294 LIFQKIQAL--------DYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HHHHHHHHh--------cccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCc
Confidence            122222221        112223334    3478999999999999999999998874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-44  Score=347.49  Aligned_cols=256  Identities=27%  Similarity=0.402  Sum_probs=208.4

Q ss_pred             HhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccC----CC-CCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG----GQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDS  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  167 (443)
                      ...+|.+.+.||+|+||.|++|. ..+|..||+|.+...    .. ...+.+.+|+.+++.++ ||||++++.++.... 
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-   93 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-   93 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-
Confidence            45689999999999999999998 457899999977653    11 23456678999999998 999999999998544 


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-CceEEccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADF  246 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  246 (443)
                       ..++||||+.+|+|.+++..    ..++.+..+..++.|++.|++|||+.+   |+||||||+|||++.+ +++||+||
T Consensus        94 -~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   94 -KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             -eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence             69999999999999999975    345888999999999999999999999   9999999999999999 99999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH-LL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      |++.....  ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..      +.....+.+..
T Consensus       166 G~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~ki~~  237 (370)
T KOG0583|consen  166 GLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRKIRK  237 (370)
T ss_pred             ccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHHHhc
Confidence            99997741  112345679999999999999877 86 7899999999999999999999752      22222232333


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ....+...++           ...+..++.+||..||.+|+++.+|+++-|...
T Consensus       238 ~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  238 GEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            2222222110           345789999999999999999999997766543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=352.82  Aligned_cols=261  Identities=30%  Similarity=0.501  Sum_probs=207.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC--CC--cE-EEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS--DG--TA-VAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~--~~--~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      -++..+.++||+|+||.||+|++.  ++  .. ||||..+...   .....+|++|+++|++++|||||+++|++.  ..
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~--~~  233 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV--LE  233 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--CC
Confidence            345566799999999999999954  22  23 8999998533   344578999999999999999999999988  44


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ..+++|||+|+||+|.++|+...+   .++..+++.++.+.|.||+|||+++   ++||||.++|+|++.++.+||+|||
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence            478999999999999999986543   5899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCcccccc-ccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          248 LAKQAPEGRTNYLST-RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       248 la~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      +++.....   .... ...-+..|+|||.+....|+.++|||||||++||+++ |..||......      +....+...
T Consensus       308 Ls~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~  378 (474)
T KOG0194|consen  308 LSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKN  378 (474)
T ss_pred             cccCCcce---eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhc
Confidence            98865411   1111 2246789999999999999999999999999999999 88898643321      212222122


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                      ..++          ..+......+..++.+||..+|++||+|.++.+.|+.+......
T Consensus       379 ~~r~----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  379 GYRM----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             CccC----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            2211          12223334577888899999999999999999999988765443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=335.34  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=206.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCC-HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ...|++.+.||.|..++||+|+ ...++.||||++....... .+.+.+|+..|+.++||||++++..|..  ...+++|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LWvV  102 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELWVV  102 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeEEe
Confidence            4679999999999999999999 6678999999998765443 4789999999999999999999988874  4489999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |.||.+|++.+.+....  ...+++..+..|+.++++||.|||.+|   .||||||+.||||+++|.+||+|||.+..+.
T Consensus       103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999997543  334899999999999999999999999   9999999999999999999999999987554


Q ss_pred             CCCcc-ccc-cccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          254 EGRTN-YLS-TRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       254 ~~~~~-~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      +.... ... ...+||+.|||||+++.  ..|+.|+||||||++..||.+|..||....+..     .....+-.....+
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-----vLl~tLqn~pp~~  252 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-----VLLLTLQNDPPTL  252 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-----HHHHHhcCCCCCc
Confidence            43221 112 55789999999999754  479999999999999999999999997443321     1111111111111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .   -..+..+-.......+.+++..||+.||.+|||+++++++
T Consensus       253 ~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  253 L---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             c---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1   0000001111112358899999999999999999999975

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.8e-44  Score=316.24  Aligned_cols=262  Identities=25%  Similarity=0.385  Sum_probs=205.5

Q ss_pred             cCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .+|...+.||+|.||.||+|+ ..+|+.||||+++.....+  .....+|++.|+.++|+||+.++++|.  ....+.||
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceEEE
Confidence            367778999999999999999 6789999999998764332  356789999999999999999999987  44578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      +|||+. +|+..++..   ...++..++..++.++++||+|||.+.   |+||||||.|+|++++|.+||+|||+++...
T Consensus        80 fEfm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~  152 (318)
T KOG0659|consen   80 FEFMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFG  152 (318)
T ss_pred             EEeccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccC
Confidence            999976 999999753   556899999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-----c
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-----D  327 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~  327 (443)
                      ......  +..+-|..|.|||.+.+. .|+...||||.||++.||+-|.+-|.+...-  +++...++.+ .-+     .
T Consensus       153 ~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi--dQL~~If~~L-GTP~~~~WP  227 (318)
T KOG0659|consen  153 SPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI--DQLSKIFRAL-GTPTPDQWP  227 (318)
T ss_pred             CCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH--HHHHHHHHHc-CCCCcccCc
Confidence            655432  334789999999999875 7899999999999999999988777544322  2222211111 000     0


Q ss_pred             ccccc---------ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          328 RLEEL---------ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       328 ~~~~~---------~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .+..+         -.+.+.. .-..+.....+++..++..||.+|+++.|++++
T Consensus       228 ~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  228 EMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            01111         1111111 112233456899999999999999999999986

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.6e-43  Score=337.61  Aligned_cols=264  Identities=26%  Similarity=0.424  Sum_probs=201.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEECC-----------------CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSD-----------------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKL  158 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l  158 (443)
                      ++|.+.+.||+|+||.||++.+++                 +..||+|.+...... ...+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                 346999998754322 24579999999999999999999


Q ss_pred             EEeeecCCCCeeEEEEeecCCCChhHhhcCCC---------------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCce
Q 013404          159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPL---------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCV  223 (443)
Q Consensus       159 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  223 (443)
                      ++++..  ....+++|||+++|+|.+++....               .....+++.+++.++.|++.||.|||+.+   |
T Consensus        85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i  159 (304)
T cd05096          85 LGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---F  159 (304)
T ss_pred             EEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence            999874  347899999999999999985321               11234788899999999999999999999   9


Q ss_pred             EecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh--CC
Q 013404          224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GR  301 (443)
Q Consensus       224 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt--g~  301 (443)
                      +||||||+|||+++++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999986644333222334456889999999998899999999999999999987  55


Q ss_pred             CCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          302 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       302 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .||.....   ....................       ..+..+...+.+++.+||+.||++|||+.+|.+.|+
T Consensus       240 ~p~~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         240 QPYGELTD---EQVIENAGEFFRDQGRQVYL-------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCcCCH---HHHHHHHHHHhhhccccccc-------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            67753321   12222222222111110000       011122335889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-43  Score=350.86  Aligned_cols=260  Identities=26%  Similarity=0.427  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+|++      .++..||||+++.... ...+.+.+|++++..+ +||||++++++|.  +.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~--~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT--VG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec--cC
Confidence            45789999999999999999973      2456899999975432 2345788999999999 8999999999987  44


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCC--------------------------------------------------------
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLG--------------------------------------------------------  191 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  191 (443)
                      ...++||||+++|+|.++++....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            578999999999999999964321                                                        


Q ss_pred             ---------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          192 ---------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       192 ---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                                     ....+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                           0124788999999999999999999998   9999999999999999999999999998665433


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .........++..|+|||.+.+..++.++|||||||++|||++ |..||......  .....+    +......      
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~----~~~~~~~------  336 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM----IKEGYRM------  336 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH----HHhCccC------
Confidence            2222223345678999999999999999999999999999998 88888643211  111111    1111110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          ..+......+.+++.+||+.||++||++.||++.|+.
T Consensus       337 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         337 ----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                0011112357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.6e-42  Score=378.70  Aligned_cols=262  Identities=27%  Similarity=0.496  Sum_probs=211.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ...|...+.||+|+||.||+|.. .++..||||++.....    ....|++.+++++|||||+++++|..  ....++||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~  762 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH  762 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence            34677888999999999999996 5789999999864332    22356889999999999999999974  44789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.++++.       ++|.++.+++.|+++||+|||..+.++|+||||||+||+++.++..++. ||.......
T Consensus       763 Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~  834 (968)
T PLN00113        763 EYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT  834 (968)
T ss_pred             eCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence            99999999999962       7899999999999999999996655559999999999999998888775 665543221


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      .      ....+|..|+|||++.+..++.++|||||||++|||+||+.||+... ........|++..... .......|
T Consensus       835 ~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~  906 (968)
T PLN00113        835 D------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSD-CHLDMWID  906 (968)
T ss_pred             C------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCc-cchhheeC
Confidence            1      22367899999999999999999999999999999999999996432 2344567777654433 23455566


Q ss_pred             CccCC--CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          335 PRLGG--KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       335 ~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      +.+..  ..+.++...+.+++.+||+.||++||+|+||++.|+.+.+
T Consensus       907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            66543  3445667788999999999999999999999999987754

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.4e-43  Score=349.90  Aligned_cols=262  Identities=26%  Similarity=0.424  Sum_probs=202.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||++...      ++..||+|.++..... ....+.+|+++++.+ +|+||++++++|.  +.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT--HG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec--CC
Confidence            457899999999999999998742      2357999999754332 245688999999999 8999999999987  44


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCC--------------------------------------------------------
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLG--------------------------------------------------------  191 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  191 (443)
                      ...++||||+++|+|.++++....                                                        
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            578999999999999999853210                                                        


Q ss_pred             ----------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccccc
Q 013404          192 ----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS  261 (443)
Q Consensus       192 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  261 (443)
                                ...++++.++++++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...........
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                      1124788899999999999999999998   999999999999999999999999999865443222222


Q ss_pred             cccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       262 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......  ...    .......      .+.....
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~~------~~~~~~~  339 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY----KMVKRGY------QMSRPDF  339 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH----HHHHccc------CccCCCC
Confidence            23345678999999999999999999999999999997 999996432211  111    1111110      0000111


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      .+    ..+.+++.+||+.||++||++.+|++.|+.+.
T Consensus       340 ~~----~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         340 AP----PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            22    35889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-43  Score=326.19  Aligned_cols=279  Identities=24%  Similarity=0.381  Sum_probs=212.0

Q ss_pred             cCHHHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhh--cCCCceeeEEEeeec
Q 013404           87 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSS  164 (443)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~  164 (443)
                      +.+--.++...+..+.+.||+|.||.||+|.|+ |+.||||++..   .+...|.+|.++++.  |+|+||+.|++.-..
T Consensus       201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             chhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            334445567788899999999999999999996 78899999973   345678899999987  499999999976322


Q ss_pred             --CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-----cCCCceEecCCCcccEEecC
Q 013404          165 --RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-----DSQPCVIHRDFKASNILLEN  237 (443)
Q Consensus       165 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~Dlkp~NIll~~  237 (443)
                        ....+++||++|.+.|+|+|||..     ..++....++++..+|.||++||.     +|+|.|.|||||++|||+++
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk  351 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  351 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence              223478999999999999999984     458899999999999999999994     58999999999999999999


Q ss_pred             CCceEEccccccccCCCCCc--cccccccccCcccccccccccCC----C--CchhhHHHHHHHHHHHHhC---------
Q 013404          238 NFHAKVADFGLAKQAPEGRT--NYLSTRVMGTFGYVAPEYAMTGH----L--LVKSDVYSYGVVLLELLTG---------  300 (443)
Q Consensus       238 ~~~~kl~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDv~S~G~il~elltg---------  300 (443)
                      ++.+.|+|+|||........  ....+..+||-+|||||++...-    +  -..+||||||+++||++..         
T Consensus       352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee  431 (513)
T KOG2052|consen  352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE  431 (513)
T ss_pred             CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence            99999999999987654421  12234568999999999986531    2  2468999999999999752         


Q ss_pred             -CCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          301 -RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       301 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                       +.||....+.+. ++.+ .+..+-. .++....+   ......+.+..+.++++.||..||.-|-|+=.|.+.|.++.+
T Consensus       432 y~~Pyyd~Vp~DP-s~ee-MrkVVCv-~~~RP~ip---nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  432 YQLPYYDVVPSDP-SFEE-MRKVVCV-QKLRPNIP---NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             hcCCcccCCCCCC-CHHH-Hhcceee-cccCCCCC---cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence             357754433322 1111 1111100 11111111   122345777889999999999999999999999999888865


Q ss_pred             h
Q 013404          380 V  380 (443)
Q Consensus       380 ~  380 (443)
                      .
T Consensus       506 ~  506 (513)
T KOG2052|consen  506 S  506 (513)
T ss_pred             C
Confidence            3

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-43  Score=338.54  Aligned_cols=255  Identities=22%  Similarity=0.335  Sum_probs=205.4

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           94 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ...++|++++.||+|+||.||+++ ..+|..+|+|++++..   ....+..+.|-.+|....+|.||+|+-.|+  +...
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ--D~~~  215 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ--DKEY  215 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec--CCCe
Confidence            356899999999999999999999 5679999999998764   234567888999999999999999987776  6669


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      +||||||++||++..+|..    ...|++..+..++.+++.|+..+|+.|   ++||||||+|+|||..|++||+||||+
T Consensus       216 LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             eEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccccc
Confidence            9999999999999999974    346999999999999999999999999   999999999999999999999999998


Q ss_pred             ccCCC-----------------------CCc-----c-----------------ccccccccCcccccccccccCCCCch
Q 013404          250 KQAPE-----------------------GRT-----N-----------------YLSTRVMGTFGYVAPEYAMTGHLLVK  284 (443)
Q Consensus       250 ~~~~~-----------------------~~~-----~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~  284 (443)
                      .-...                       ...     .                 ......+|||.|||||++.+..|+..
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence            53211                       000     0                 00124689999999999999999999


Q ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCC
Q 013404          285 SDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ  363 (443)
Q Consensus       285 sDv~S~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~  363 (443)
                      +|.||||||+||||.|.+||....+...- .++.|...+ ..+.      +        .....+..+||.+|+. ||++
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-~fP~------~--------~~~s~eA~DLI~rll~-d~~~  432 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-KFPE------E--------VDLSDEAKDLITRLLC-DPEN  432 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-cCCC------c--------CcccHHHHHHHHHHhc-CHHH
Confidence            99999999999999999999876654332 333343221 1110      0        0111357889999999 9999


Q ss_pred             CC---CHHHHHHH
Q 013404          364 RP---TMGEVVQS  373 (443)
Q Consensus       364 RP---s~~evl~~  373 (443)
                      |-   .++||.+|
T Consensus       433 RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  433 RLGSKGAEEIKKH  445 (550)
T ss_pred             hcCcccHHHHhcC
Confidence            96   57777765

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.5e-43  Score=332.76  Aligned_cols=253  Identities=25%  Similarity=0.386  Sum_probs=200.1

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .|+..+.||+|+||.||++.. .+|+.||+|.+.....   .....+.+|+.++++++|+||+++++++.  +....+++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~--~~~~~~lv   78 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE--TKDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc--cCCeEEEE
Confidence            377889999999999999995 5789999999864322   22346788999999999999999999887  44478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++|+|.+++....  ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++....
T Consensus        79 ~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05631          79 LTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIP  153 (285)
T ss_pred             EEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence            99999999998885422  335889999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....   .....||..|+|||++.+..++.++|||||||++|||++|+.||.........  ...... ....       
T Consensus       154 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~-~~~~-------  220 (285)
T cd05631         154 EGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRR-VKED-------  220 (285)
T ss_pred             CCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHH-hhcc-------
Confidence            3221   23457899999999999999999999999999999999999999754322111  111111 1000       


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL  374 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L  374 (443)
                          ...++......+.+|+.+||+.||++||+     +++++++-
T Consensus       221 ----~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~  262 (285)
T cd05631         221 ----QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP  262 (285)
T ss_pred             ----cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence                00112222335789999999999999997     89998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6e-44  Score=311.21  Aligned_cols=269  Identities=24%  Similarity=0.303  Sum_probs=215.2

Q ss_pred             HhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC---CCee
Q 013404           95 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQH  170 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~  170 (443)
                      ..++|.+.+.||+|||+.||+++ ..++..||+|++.....++.+..++|++..++++|||++++++++....   ....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34689999999999999999999 7789999999999888777888999999999999999999998865322   3468


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ||+++|+..|+|.+.+.........+++.++++|+.+|++||++||+... +++||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999998766666689999999999999999999999864 59999999999999999999999999987


Q ss_pred             cCCCCCcccc-------ccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 013404          251 QAPEGRTNYL-------STRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       251 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~  320 (443)
                      ...-.-....       .....-|..|.|||.+.   +...++++|||||||+||+|+.|..||+..-..+         
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G---------  248 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG---------  248 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence            6532111100       11234688899999885   4467899999999999999999999997322111         


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                           ....-.+.++.+.-.-.....+.+.+++.+|++.||.+||++.+++..++.+.
T Consensus       249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                 11111222223222222224556899999999999999999999999887653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7e-43  Score=338.51  Aligned_cols=243  Identities=24%  Similarity=0.316  Sum_probs=195.3

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +.||+|+||.||+++. .+|+.||+|.++...   ......+.+|+.++++++||||+++++++.  +....++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~   78 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ--THDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--cCCEEEEEEeCCC
Confidence            4699999999999995 578999999987532   222356788999999999999999999887  4458899999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcc
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN  258 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  258 (443)
                      +|+|.+++..    ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-  150 (323)
T cd05571          79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-  150 (323)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence            9999999864    345889999999999999999999999   99999999999999999999999999875432211 


Q ss_pred             ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccC
Q 013404          259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG  338 (443)
Q Consensus       259 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  338 (443)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.      ......+....        .   
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~~~--------~---  212 (323)
T cd05571         151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEE--------I---  212 (323)
T ss_pred             -cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC--------C---
Confidence             12345799999999999999999999999999999999999999964321      11111111111        1   


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          339 GKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       339 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                       .++......+.+++.+||+.||++||     ++.+++++-
T Consensus       213 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~  252 (323)
T cd05571         213 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR  252 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence             11222233578999999999999999     899998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=334.29  Aligned_cols=265  Identities=26%  Similarity=0.345  Sum_probs=212.1

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--------------CCHHHHHHHHHHHhhcCCCce
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--------------QGDKEFLVEVEMLSRLHHRNL  155 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni  155 (443)
                      +-....++|++.+.||+|.||.|-+|+. .+++.||||++.+...              ...+...+||.+|++++||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            3445678999999999999999999994 5789999999864321              113578899999999999999


Q ss_pred             eeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCC-CChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEE
Q 013404          156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       156 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  234 (443)
                      |+|+.+..+.....+|||+|||..|.+...=     ..++ +++.++++++.+++.||+|||.++   |+||||||+|+|
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLL  242 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLL  242 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheE
Confidence            9999999888888999999999988876432     2344 899999999999999999999999   999999999999


Q ss_pred             ecCCCceEEccccccccCCCCCc---cccccccccCcccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          235 LENNFHAKVADFGLAKQAPEGRT---NYLSTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      |+++|.+||+|||.+.....+..   .......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||...
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            99999999999999986633211   11223478999999999887632    256789999999999999999999632


Q ss_pred             CCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          308 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                            ........+..+          .+.-...++..+.+.+||.++|+.||++|.+..+|..|.|....
T Consensus       323 ------~~~~l~~KIvn~----------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  323 ------FELELFDKIVND----------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ------hHHHHHHHHhcC----------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                  233333333333          22222223456678899999999999999999999999887653

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.3e-43  Score=331.01  Aligned_cols=258  Identities=28%  Similarity=0.499  Sum_probs=204.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEECC-C-----cEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSD-G-----TAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~-~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ++|++.+.||+|+||.||+|.... +     ..||+|.++..... ....|.+|++++.+++||||+++++++.  +...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT--KEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc--CCCc
Confidence            468889999999999999998532 2     57999998754322 2456899999999999999999999987  3447


Q ss_pred             eEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC
Q 013404          170 HLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN  237 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  237 (443)
                      .+++|||+++|+|.+++.....            ....+++.+++.++.|++.||.|||+.+   ++|+||||+||++++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcC
Confidence            8899999999999999964321            1145888999999999999999999998   999999999999999


Q ss_pred             CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 013404          238 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV  316 (443)
Q Consensus       238 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~  316 (443)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......   .+.
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~  236 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVI  236 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH
Confidence            99999999999986544332222334467889999999998899999999999999999998 99999643321   111


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ..    +.... .         ...+......+.+|+.+||+.||++||++.||+++|+.
T Consensus       237 ~~----i~~~~-~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EM----IRSRQ-L---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----HHcCC-c---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11    11110 0         11122333458899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.6e-42  Score=338.63  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=193.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .+|+..+.||+|+||.||++... +++.||||.+...... ....+.+|+++++.++|+||+++++++.  +....++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD--HNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec--cCCeEEEEE
Confidence            45667789999999999999954 6899999998654322 2457899999999999999999999986  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.+..        ...+..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       152 e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        152 EFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             ecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999999997543        2456788899999999999999999   99999999999999999999999999986643


Q ss_pred             CCccccccccccCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...  ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+   ...+... .  
T Consensus       221 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~-~--  292 (353)
T PLN00034        221 TMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCAICMS-Q--  292 (353)
T ss_pred             ccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHHHhcc-C--
Confidence            221  1234579999999998743     2345689999999999999999999973332211111   1111000 0  


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                          .+    ..+......+.+++.+||+.||++||++.|++++-+..
T Consensus       293 ----~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~  332 (353)
T PLN00034        293 ----PP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL  332 (353)
T ss_pred             ----CC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence                01    11122233588999999999999999999999875433

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-42  Score=335.36  Aligned_cols=243  Identities=25%  Similarity=0.318  Sum_probs=194.6

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +.||+|+||.||++.. .+|..||+|.++...   ......+.+|+++++.++||||+++++++.  .....++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~E~~~   78 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCFVMEYAN   78 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCEEEEEEeCCC
Confidence            4699999999999995 478999999987532   223456778999999999999999999887  4458899999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcc
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN  258 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  258 (443)
                      +|+|.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||+++++.+||+|||+++....... 
T Consensus        79 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-  150 (323)
T cd05595          79 GGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-  150 (323)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence            9999998864    235889999999999999999999999   99999999999999999999999999875432211 


Q ss_pred             ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccC
Q 013404          259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG  338 (443)
Q Consensus       259 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  338 (443)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..      .....+.....        .  
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~~~~--------~--  213 (323)
T cd05595         151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEEI--------R--  213 (323)
T ss_pred             -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhcCCC--------C--
Confidence             123357999999999999999999999999999999999999999643221      11111111111        1  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          339 GKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       339 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                        ++......+.+++.+||+.||++||     ++.+++++-
T Consensus       214 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~  252 (323)
T cd05595         214 --FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  252 (323)
T ss_pred             --CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence              1112223478999999999999998     899998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-43  Score=334.22  Aligned_cols=248  Identities=24%  Similarity=0.337  Sum_probs=201.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++... +|+.||+|.+....   ....+.+.+|++++++++||||+++++++.  +....++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l   78 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYM   78 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEE
Confidence            47889999999999999999964 68999999986432   123456889999999999999999998876  4558899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~  151 (291)
T cd05612          79 LMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL  151 (291)
T ss_pred             EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence            9999999999999964    235889999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ....     ....|++.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....     
T Consensus       152 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~-----  215 (291)
T cd05612         152 RDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAGKL-----  215 (291)
T ss_pred             cCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCc-----
Confidence            4321     234689999999999999999999999999999999999999964321      111222221111     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLKM  376 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L~~  376 (443)
                             .++......+.+++.+||+.||.+||+     +++++++-+.
T Consensus       216 -------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         216 -------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             -------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence                   111122334789999999999999995     9999987543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=313.15  Aligned_cols=236  Identities=29%  Similarity=0.395  Sum_probs=199.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|+..+.||.|+||+|.+++. .+|..+|+|+++...-.   ..+...+|..+|+.+.||+++++.+.|.  +...++|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~--d~~~lym  121 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK--DNSNLYM  121 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec--cCCeEEE
Confidence            5788899999999999999995 46889999999765322   2345778999999999999999998876  6669999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||++||.|..+|++    ..++++..+.-++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+..
T Consensus       122 vmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            9999999999999985    346899999999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ...     .-..+||+.|+|||++....|..++|-|+|||++|||+.|.+||...++      ......++...-.    
T Consensus       195 ~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~v~----  259 (355)
T KOG0616|consen  195 SGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGKVK----  259 (355)
T ss_pred             cCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCccc----
Confidence            543     3457999999999999999999999999999999999999999986654      2223333333222    


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCC
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQR  364 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  364 (443)
                              +|.--...+.+|+...|+.|-.+|
T Consensus       260 --------fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 --------FPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --------CCcccCHHHHHHHHHHHhhhhHhh
Confidence                    233333347789999999999999

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-42  Score=335.84  Aligned_cols=257  Identities=30%  Similarity=0.492  Sum_probs=203.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCc----EEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|++.+.||+|+||.||+|++. ++.    .||+|.++.... ...+++.+|+.+++.++||||++++|+|...   ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---Cc
Confidence            46899999999999999999853 343    489999875432 3356789999999999999999999998632   56


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++++||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence            79999999999999997532   34888999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...............++..|+|||++.+..++.++|||||||++|||++ |+.||+....   ..+    ..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~~----~~~~~~~~~~  230 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEI----SSILEKGERL  230 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHhCCCCC
Confidence            7654333222223345678999999999999999999999999999998 9999964321   111    1112211111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                                ..+..+...+.+++.+||+.+|++||++.+++..|..+.+
T Consensus       231 ----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         231 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                      0111222357899999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.5e-43  Score=339.30  Aligned_cols=264  Identities=27%  Similarity=0.435  Sum_probs=205.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++..... ..+.+..|+.++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence            357899999999999999999632      3478999998754322 235678899999999 899999999988643 3


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCC-------------------------------------------------------
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGV-------------------------------------------------------  192 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  192 (443)
                      ...+++|||+++++|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            4678999999999999998532210                                                       


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCccc
Q 013404          193 --NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY  270 (443)
Q Consensus       193 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y  270 (443)
                        ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              126889999999999999999999998   999999999999999999999999999876443322222334567789


Q ss_pred             ccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHH
Q 013404          271 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRV  349 (443)
Q Consensus       271 ~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  349 (443)
                      +|||++.+..++.++|||||||++|||++ |..||.......  .+.    ..+......          ..+......+
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~~----------~~~~~~~~~~  305 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGTRM----------RAPEYATPEI  305 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccCCC----------CCCccCCHHH
Confidence            99999999999999999999999999998 999996432211  111    111111110          1111223458


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          350 CTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       350 ~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      .+++.+||+.+|++||++.||+++|+.+.+
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1e-42  Score=338.56  Aligned_cols=266  Identities=25%  Similarity=0.356  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+++.. +|..||+|.+..... .....+.+|++++++++||||+++++++..  ....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEE
Confidence            368999999999999999999964 688999999875432 224578999999999999999999999874  4478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |||+++|+|.+++...    ..+++..+..++.|++.||.|||+. +   |+||||||+|||+++++.+||+|||++...
T Consensus        82 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          82 MEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             eecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            9999999999999642    3588899999999999999999985 5   999999999999999999999999999765


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH-Hhhcccc---
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP-ILRDKDR---  328 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~---  328 (443)
                      ....    .....|+..|+|||++.+..++.++|||||||++|||++|+.||......   .+...... .......   
T Consensus       155 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  227 (331)
T cd06649         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEGEPH  227 (331)
T ss_pred             cccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccCCcc
Confidence            4322    23457899999999999999999999999999999999999999643221   11110000 0000000   


Q ss_pred             -----------------------------ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          329 -----------------------------LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       329 -----------------------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                                                   ...+................+.+++.+||+.||++|||++|++++.+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~  305 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK  305 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence                                         0000000000000011223588999999999999999999999986543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-43  Score=342.45  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=207.4

Q ss_pred             CCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      -|++++.||.|+-|.|-+|+ ..+|+.+|||++....   ......+.+|+-+|+-+.|||++.++++++  +..++|||
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe--~~~~lylv   90 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE--NKQHLYLV   90 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec--cCceEEEE
Confidence            46778999999999999999 5689999999997652   222456889999999999999999999988  55689999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      .||+++|.|+++|-.    .+++.+.++.+++.||+.|+.|||..+   |+||||||+|+|||..+++||+|||+|....
T Consensus        91 lEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            999999999999964    456899999999999999999999999   9999999999999999999999999998655


Q ss_pred             CCCccccccccccCcccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .+.   ....-+|++.|.|||++++.+|. .++||||.|||||.|++|+.||+.      +++......+-+....+   
T Consensus       164 ~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------dNir~LLlKV~~G~f~M---  231 (786)
T KOG0588|consen  164 PGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------DNIRVLLLKVQRGVFEM---  231 (786)
T ss_pred             CCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------ccHHHHHHHHHcCcccC---
Confidence            433   23456999999999999999885 789999999999999999999973      33333333222221111   


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                               |.....+..+|+.+|+..||++|.|++||++|-+-.
T Consensus       232 ---------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  232 ---------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             ---------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence                     222233477899999999999999999999986543

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-44  Score=333.86  Aligned_cols=249  Identities=28%  Similarity=0.415  Sum_probs=208.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ..|...+.||+|+||.||+|.. .+++.||+|++..... ...++.++|+.+|.+++++||.++++.+.  .+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl--~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL--KGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee--ecccHHHHH
Confidence            3566778999999999999994 5789999999987654 34578999999999999999999999887  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      |||.||++.+.|..    ...+.+..+.-++.+++.||.|||.++   .+|||||+.|||+..+|.+||+|||++.....
T Consensus        91 ey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeec
Confidence            99999999999973    233578888889999999999999999   99999999999999999999999999988765


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ....++||+.|||||++....|+.|+||||||++.+||++|.+|+....+.....             .+..-.-
T Consensus       164 ~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------------lIpk~~P  228 (467)
T KOG0201|consen  164 TVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------------LIPKSAP  228 (467)
T ss_pred             hhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------------eccCCCC
Confidence            443  2366899999999999998899999999999999999999999997555432211             1222223


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      |.+.+.+..    .+.+++..||+.||+.||++.+++++
T Consensus       229 P~L~~~~S~----~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  229 PRLDGDFSP----PFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CccccccCH----HHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            444444444    38899999999999999999999976

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-42  Score=336.80  Aligned_cols=247  Identities=26%  Similarity=0.366  Sum_probs=200.5

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.++++++||||+++++++.  +....++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l   95 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ--DENRVYF   95 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--cCCEEEE
Confidence            57889999999999999999964 68899999986432   223456889999999999999999999987  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+++|+|.+++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus        96 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         96 LLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             EEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            9999999999999974    235788999999999999999999999   999999999999999999999999999866


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ....     ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+      ......+......    
T Consensus       169 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~----  233 (329)
T PTZ00263        169 PDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAGRLK----  233 (329)
T ss_pred             CCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHhcCCcC----
Confidence            4322     234789999999999999999999999999999999999999964321      1111222211100    


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLK  375 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L~  375 (443)
                          +...++    ..+.+++.+||+.||++||+     ++++++|-+
T Consensus       234 ----~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~  273 (329)
T PTZ00263        234 ----FPNWFD----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY  273 (329)
T ss_pred             ----CCCCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence                111122    34789999999999999997     788887743

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=350.91  Aligned_cols=264  Identities=23%  Similarity=0.324  Sum_probs=212.3

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEECCC-cEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEe-eec---CC-
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLSDG-TAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGY-YSS---RD-  166 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~---~~-  166 (443)
                      ....++++.+.|.+|||+.||+++...+ ..||+|++-..+....+.+.+||++|+.|+ |+|||.+++. ...   .. 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3456778889999999999999997655 999999998777777788999999999996 9999999993 221   12 


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ..+++|+||||+||.|-|++.....  ..|++.++++|+.|+++|+++||... |+|||||||-+||||..++..|||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence            3578899999999999999986543  34999999999999999999999985 55999999999999999999999999


Q ss_pred             cccccCCCCCcc-----cccc--ccccCccccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 013404          247 GLAKQAPEGRTN-----YLST--RVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV  316 (443)
Q Consensus       247 gla~~~~~~~~~-----~~~~--~~~gt~~y~aPE~~---~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~  316 (443)
                      |.+.........     +...  ...-|+-|.|||.+   .+...++|+|||+|||+||-|+....||+....       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            998643222110     0011  12458899999977   477889999999999999999999999974322       


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                                   ..|++....-.-.+.....+.+||+.||+.||++||++-+|++.+..++..
T Consensus       264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                         123333332222345667799999999999999999999999998877643

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-43  Score=325.65  Aligned_cols=251  Identities=24%  Similarity=0.405  Sum_probs=210.4

Q ss_pred             HhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHH---HHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           95 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK---EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ...+|++.+.||+|.||.|-++. ...|+.||||.++++...+.+   .+.+|+++|..|+||||+.++.+|.  +....
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE--NkdKI  128 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE--NKDKI  128 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc--CCceE
Confidence            45678999999999999999998 468999999999876554443   5788999999999999999999998  44588


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +|||||..+|.|+||+.+    ...|++.++..++.||..|+.|+|.++   ++|||||.+|||||.++++||+||||+.
T Consensus       129 vivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             EEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhh
Confidence            999999999999999975    446999999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      .+....   ....++|++-|.+||+..+.+|. +..|-|||||+||-|+.|..||++.+   .   ...++++-+...+ 
T Consensus       202 ly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---h---k~lvrQIs~GaYr-  271 (668)
T KOG0611|consen  202 LYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---H---KRLVRQISRGAYR-  271 (668)
T ss_pred             hhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---H---HHHHHHhhccccc-
Confidence            776533   34668999999999999999885 78999999999999999999998543   2   2223333222111 


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          .|    ..|.    ..+-||+|||..||++|.|+.+|..|.|.
T Consensus       272 ----EP----~~PS----dA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  272 ----EP----ETPS----DASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             ----CC----CCCc----hHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence                11    1122    25679999999999999999999998774

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-42  Score=344.00  Aligned_cols=263  Identities=24%  Similarity=0.391  Sum_probs=204.4

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcC-CCceeeEEEeeecCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRD  166 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  166 (443)
                      ..++|.+.+.||+|+||.||+|+..      .+..||||+++..... ..+.|.+|+++++++. ||||++++++|.  +
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--K  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--c
Confidence            3568899999999999999999852      2347999999754332 2457899999999996 999999999987  4


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCC-------------------------------------------------------
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLG-------------------------------------------------------  191 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  191 (443)
                      ....+|||||+++|+|.++|+....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            4578999999999999999864211                                                       


Q ss_pred             -------------------------------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEE
Q 013404          192 -------------------------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       192 -------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  234 (443)
                                                           ....+++..+..++.|+++||+|||+.+   |+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence                                                 0124788889999999999999999998   999999999999


Q ss_pred             ecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 013404          235 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE  313 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~  313 (443)
                      +++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......  .
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~  347 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--S  347 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--H
Confidence            99999999999999986544332222233457788999999999999999999999999999997 99998643211  0


Q ss_pred             hHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          314 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ..    ..........          ..+......+.+++.+||+.||++||++.+|.+.|+.+.
T Consensus       348 ~~----~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 TF----YNKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HH----HHHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            11    1111111110          111222345889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-42  Score=352.23  Aligned_cols=254  Identities=22%  Similarity=0.277  Sum_probs=203.5

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-C-CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-D-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .|.+.+.||+|+||.||++... + +..||+|.+..........+.+|+.+++.++||||++++++|..  ....+||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~E  145 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIME  145 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEEE
Confidence            4888999999999999999843 3 67889998765544444568889999999999999999999874  458999999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++........++++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999999988654333456889999999999999999999998   999999999999999999999999999876543


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+....  .    + 
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~--~----~-  289 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGK--Y----D-  289 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC--C----C-
Confidence            322223456799999999999999999999999999999999999999964321      11222221110  0    0 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                          ..+......+.+++.+||+.||++||++++++.+
T Consensus       290 ----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 ----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                0111222357899999999999999999999864

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=337.36  Aligned_cols=255  Identities=25%  Similarity=0.333  Sum_probs=202.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...   ......+.+|++++..++||||+++++++.  +....++
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~l   78 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYL   78 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEE
Confidence            36889999999999999999965 58899999987532   223456889999999999999999999987  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        79 v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~  151 (333)
T cd05600          79 AMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI  151 (333)
T ss_pred             EEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence            9999999999999964    235889999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ..     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ....+......+.  
T Consensus       152 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~~~--  218 (333)
T cd05600         152 VT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE------TWENLKYWKETLQ--  218 (333)
T ss_pred             cc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH------HHHHHHhcccccc--
Confidence            43     1234579999999999999999999999999999999999999997543211      1111111111110  


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                       .+.... ........+.+++.+||+.+|++||++++++++-+
T Consensus       219 -~~~~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         219 -RPVYDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             -CCCCCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence             111100 00112335789999999999999999999998743

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.3e-42  Score=325.58  Aligned_cols=256  Identities=24%  Similarity=0.403  Sum_probs=201.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC----CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++..... ....|.+|+.++++++||||+++++++.  .....
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe--cCCCc
Confidence            356889999999999999999853    3568999999765332 2357899999999999999999999987  44578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++...   ...+++.+++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence            9999999999999999743   235899999999999999999999998   9999999999999999999999999876


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ....... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......      ..... ..+... 
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~-~~~~~~-  226 (266)
T cd05064         156 EDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKA-VEDGFR-  226 (266)
T ss_pred             cccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHH-HHCCCC-
Confidence            5432211 11122345678999999999999999999999999999775 99999643221      11111 111111 


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                           .    ..+......+.+++..||+.+|++||++++|++.|..+
T Consensus       227 -----~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 -----L----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----C----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 0    11222334588999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-42  Score=315.19  Aligned_cols=269  Identities=24%  Similarity=0.286  Sum_probs=209.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .++|+.++.|++|+||.||+|+. ++++.||+|+++......  .-.-++||.+|.+++|||||.+..+....+-...|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            35688899999999999999994 578999999998654322  235689999999999999999999888777778999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |||||+. +|..++....   .++...++..+..|+++|++|||++.   |+|||||++|+|+.+.|.+||+|||+|+.+
T Consensus       155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence            9999987 9999998543   56889999999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-----
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-----  326 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  326 (443)
                      .....  ..+..+-|..|.|||.+.+. .|++..|+||+|||+.||+++++-|.+....++  +...+. ++.-+     
T Consensus       228 gsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~-llGtPte~iw  302 (419)
T KOG0663|consen  228 GSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFK-LLGTPSEAIW  302 (419)
T ss_pred             cCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHH-HhCCCccccC
Confidence            76533  24667889999999999875 689999999999999999999999875443222  111111 11110     


Q ss_pred             ---cccc--------ccccCccCCCCCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          327 ---DRLE--------ELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       327 ---~~~~--------~~~d~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                         ..+.        ......+...++.. ..+.-.+|+..+|..||.+|.|++|.+++=+.
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F  364 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF  364 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence               0000        00000111111111 22345789999999999999999999987543

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-42  Score=352.96  Aligned_cols=261  Identities=25%  Similarity=0.332  Sum_probs=207.5

Q ss_pred             HHHhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC--
Q 013404           93 KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--  167 (443)
Q Consensus        93 ~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  167 (443)
                      ....++|++.+.||+|+||.||++. ..+|+.||||.+.....  .....+.+|+.++..++|+|++++.+.+...+.  
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3445789999999999999999998 45789999999875432  234568889999999999999999877653221  


Q ss_pred             ----CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEE
Q 013404          168 ----SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV  243 (443)
Q Consensus       168 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  243 (443)
                          ...++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence                1367999999999999999754444567899999999999999999999998   999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      +|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....      .........
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~  258 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTL  258 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHh
Confidence            99999987654322222345679999999999999999999999999999999999999996432      222222222


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...  .    +     ..+......+.+++.+||+.||++||++.+++++
T Consensus       259 ~~~--~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 AGR--Y----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             cCC--C----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111  0    1     1122223458899999999999999999999876

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3e-42  Score=328.59  Aligned_cols=263  Identities=26%  Similarity=0.423  Sum_probs=207.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++.  ....
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~   81 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDP   81 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCc
Confidence            357889999999999999999842      34568999987655444567999999999999999999999987  4457


Q ss_pred             eEEEEeecCCCChhHhhcCCC---------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc
Q 013404          170 HLLCYELVPNGSLESWLHGPL---------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH  240 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  240 (443)
                      .+++|||+++++|.+++....         .....+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            899999999999999996432         11235899999999999999999999998   999999999999999999


Q ss_pred             eEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHH
Q 013404          241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       241 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  319 (443)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......      ...
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~  232 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVI  232 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHH
Confidence            99999999986644332222233456788999999999999999999999999999998 89998643321      111


Q ss_pred             HHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      ..+... . .     ......++    ..+.+++.+||+.||.+||++.+|++.|+.+.+.
T Consensus       233 ~~i~~~-~-~-----~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         233 ECITQG-R-V-----LQRPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHHcC-C-c-----CCCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            111111 1 0     01111223    3488999999999999999999999999888753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-42  Score=327.68  Aligned_cols=257  Identities=28%  Similarity=0.468  Sum_probs=203.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ++|.+.+.||+|+||.||+|...      ++..||+|.++..... ..+.|.+|+++++.++||||+++++++..  ...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE--GDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CCC
Confidence            46888899999999999999853      2478999999765443 34689999999999999999999999874  457


Q ss_pred             eEEEEeecCCCChhHhhcCCC----------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          170 HLLCYELVPNGSLESWLHGPL----------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                      .+++|||+++++|.+++....          .....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence            899999999999999996432          12345789999999999999999999998   99999999999999999


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~  318 (443)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....   ......
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~  236 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIEC  236 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH
Confidence            999999999976543322222233456788999999999999999999999999999998 9999864322   111111


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                         +..  ....         ..+......+.+++.+||+.||++||+++||++.|+
T Consensus       237 ---~~~--~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ---ITQ--GRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HHc--CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               111  1110         011122235889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.9e-43  Score=327.92  Aligned_cols=250  Identities=32%  Similarity=0.554  Sum_probs=192.4

Q ss_pred             CCceeeecCcEEEEEEEEC-----CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404          101 PASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus       101 ~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +.+.||.|.||.||+|.+.     .+..|+||.++..... ..+.|.+|++.+++++||||++++|+|.  +....++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~--~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI--ENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE--SSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc--ccccccccc
Confidence            3578999999999999976     3568999999654322 3578999999999999999999999998  444689999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.++|....  ...+++.+++.|+.|+++||.|||+.+   ++|+||+++|||+++++.+||+|||++.....
T Consensus        81 e~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             E--TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             cccccccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            9999999999998641  346899999999999999999999998   99999999999999999999999999987743


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ...............|+|||.+....++.++||||||+++|||++ |+.||....      ...+...+ .+.....   
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~~-~~~~~~~---  225 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEKL-KQGQRLP---  225 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHHH-HTTEETT---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccc-cccccce---
Confidence            332223334567789999999999999999999999999999999 678875321      12222222 2211111   


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                             .+......+.+++..||..||++||++.++++.|
T Consensus       226 -------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 -------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                   1112233488999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4e-42  Score=328.24  Aligned_cols=262  Identities=26%  Similarity=0.436  Sum_probs=207.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|.+.+.||+|+||.||++...      ++..+++|.+........+.+.+|++++++++||||+++++++.  +....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~   82 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG--DGDPL   82 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc--cCCce
Confidence            45788899999999999999842      34568999987555444567999999999999999999999987  44478


Q ss_pred             EEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC
Q 013404          171 LLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN  238 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  238 (443)
                      ++||||+++++|.+++.....            ....+++..++.++.|++.||+|||+++   |+||||||+|||++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~  159 (291)
T cd05094          83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN  159 (291)
T ss_pred             EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence            999999999999999964321            1234889999999999999999999999   9999999999999999


Q ss_pred             CceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 013404          239 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT  317 (443)
Q Consensus       239 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~  317 (443)
                      +.++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.||......   ....
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~  236 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE  236 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH
Confidence            9999999999986654332222334557889999999999999999999999999999999 99998643221   1111


Q ss_pred             HHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       318 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      .    ..... ..     ..    +......+.+++.+||+.+|++||++.+|++.|+.+.+.
T Consensus       237 ~----~~~~~-~~-----~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         237 C----ITQGR-VL-----ER----PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             H----HhCCC-CC-----CC----CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            1    11111 10     01    111233588999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.7e-42  Score=324.34  Aligned_cols=257  Identities=29%  Similarity=0.469  Sum_probs=200.5

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCc----EEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|++.+.||+|+||.||+|.+. +++    .+++|.+..... ....++..|+..+++++||||+++++++.   ....
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---~~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP---GASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---CCcc
Confidence            46788899999999999999953 444    477888754322 22356778888999999999999999874   2356


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++++||+++|+|.+++...   ...+++..+..++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++
T Consensus        84 ~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence            7899999999999999743   235899999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....+.   ...+    .+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~  230 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPD----LLEKGERL  230 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCcC
Confidence            7644333222334567789999999998899999999999999999998 99999643221   1111    11111111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                         ..+       ..+...+.+++.+||..||++||++.|+++.|..+.+
T Consensus       231 ---~~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 ---AQP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ---CCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence               011       1122346789999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.7e-42  Score=325.26  Aligned_cols=270  Identities=31%  Similarity=0.428  Sum_probs=204.5

Q ss_pred             CCCCceeeecCcEEEEEEEE-----CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           99 FEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      |+..+.||+|+||.||++..     .++..||+|.++.... .....|.+|++++++++||||+++++++...+....++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37889999999999988653     3577899999875432 23567889999999999999999999987655556889


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+++++|.+++..     ..+++.+++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence            9999999999999963     24899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++|..||........ ....+.... .....+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~~  235 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVRLIE  235 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhhhhh
Confidence            5432211 11223456779999999988899999999999999999999999864322110 000000000 00001111


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ..+.......+......+.+++..||+.+|++||++++|++.|+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111111222233346889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.3e-42  Score=329.11  Aligned_cols=266  Identities=23%  Similarity=0.294  Sum_probs=199.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.....  ...+.+.+|+++++.++||||+++++++.  +....++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR--RRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe--cCCEEEEE
Confidence            47899999999999999999965 678999999875432  23457889999999999999999999887  44588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||++++.|..+...    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~  151 (287)
T cd07848          79 FEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS  151 (287)
T ss_pred             EecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999998777655432    235889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH---------HHHHHhh
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT---------WARPILR  324 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~  324 (443)
                      ..... ......|++.|+|||++.+..++.++|||||||++|||++|+.||.............         +......
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            32211 1234568999999999999899999999999999999999999997533211100000         0000000


Q ss_pred             ccccccccccCccCC------CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 DKDRLEELADPRLGG------KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      . ........+....      .+.......+.+++.+||+.||++|||++|+++|
T Consensus       231 ~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         231 N-PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             c-chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0 0000000010000      0011123358899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-42  Score=320.76  Aligned_cols=255  Identities=30%  Similarity=0.468  Sum_probs=204.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++..  ....+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   81 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIVTE   81 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec--CCCeeeeee
Confidence            45688999999999999999998778889999987543 345679999999999999999999998873  447899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++....  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++.....
T Consensus        82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            999999999997533  346899999999999999999999998   999999999999999999999999999876532


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ... .......+..|+|||++.+..++.++||||||+++|||++ |+.||.....   ....   ..+ .....      
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~---~~~-~~~~~------  222 (261)
T cd05068         157 IYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVL---QQV-DQGYR------  222 (261)
T ss_pred             ccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHH---HHH-HcCCC------
Confidence            211 1111233468999999999999999999999999999999 9999864321   1111   111 11100      


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          ...+......+.+++.+||+.+|++||++.++++.|+.
T Consensus       223 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 ----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                01122233458899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-42  Score=321.56  Aligned_cols=257  Identities=27%  Similarity=0.468  Sum_probs=203.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC----CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|.+..    ...||||.++..... ....|.+|+.++++++||||+++++++.  +....
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT--KSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe--cCCce
Confidence            3578999999999999999999642    357999998754332 3457899999999999999999999887  44578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +++|||+++++|.+++....   ..+++.+++.++.|++.||+|||+.+   |+|+||||+|||+++++.++|+|||+++
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          81 MIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhh
Confidence            99999999999999997532   36899999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....   .......    ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~----~~~~~~  227 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAV----EDGYRL  227 (266)
T ss_pred             cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCC
Confidence            7753222222223345678999999999999999999999999999998 9999853221   1111111    111100


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                                ..+......+.+++.+||+.+|++||+++||+++|+.+
T Consensus       228 ----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      01112234588999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.5e-42  Score=325.43  Aligned_cols=259  Identities=26%  Similarity=0.429  Sum_probs=201.5

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      .+++|++.+.||+|+||.||+|...      ++..||+|.+..... ....+|.+|+.+++.++||||+++++++.  +.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence            4578999999999999999998753      346799999864322 23456889999999999999999999986  44


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCC------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCce
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGV------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA  241 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  241 (443)
                      ...++||||+++|+|.+++......      ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCE
Confidence            5789999999999999998643211      234678899999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 013404          242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  320 (443)
                      +|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....      .....
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~  232 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLR  232 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Confidence            9999999986544332222222345788999999999899999999999999999999 7888864321      11111


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..... . ..         ..+......+.+++.+||+.+|++||++.|+++.|+
T Consensus       233 ~~~~~-~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 FVMEG-G-LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHcC-C-cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11111 0 00         111222335889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-41  Score=317.42  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=200.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.+.||+|+||.||++.+.++..+|+|.+... ......|.+|++++++++||||+++++++..  ....+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEEEEc
Confidence            457888999999999999999888888999988643 2345678999999999999999999999873  4478999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++|+|.++++...   ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          81 MENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            99999999997532   34889999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+... ..   ... 
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~-~~---~~~-  222 (256)
T cd05114         155 YT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRG-FR---LYR-  222 (256)
T ss_pred             ee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCC-CC---CCC-
Confidence            11 1122345678999999998899999999999999999999 8999864321      1111111111 11   001 


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                            +......+.+++.+||+.+|++||+++++++.|
T Consensus       223 ------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         223 ------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                  111223578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.5e-42  Score=324.67  Aligned_cols=265  Identities=28%  Similarity=0.415  Sum_probs=203.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-----CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|++.+.||+|+||.||++..     .++..||+|.+........+.|.+|++++++++||||+++++++...+....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5788899999999999999974     25789999998765544556889999999999999999999987655556789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            999999999999999643   235899999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCcccc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc---------chHHHHHHH
Q 013404          252 APEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ---------ENLVTWARP  321 (443)
Q Consensus       252 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~---------~~~~~~~~~  321 (443)
                      ......... .....++..|+|||++.+..++.++|||||||++|||++|..++........         .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            654332211 1122345569999999988999999999999999999998876542211000         000000001


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      .+....          ....+......+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       238 ~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            111100          0011112233588999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-41  Score=320.26  Aligned_cols=261  Identities=23%  Similarity=0.372  Sum_probs=206.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|+. .+++.||||.+.....   .....+.+|+++++.++||||+++++++..  ....++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~   79 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI   79 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence            5789999999999999999995 4789999998764322   223568899999999999999999999874  447899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ++||+++|+|.+++.........+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~  156 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceec
Confidence            99999999999988643333445888999999999999999999998   999999999999999999999999998876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.....    ....+...+ ....     
T Consensus       157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-~~~~-----  224 (267)
T cd08228         157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-EQCD-----  224 (267)
T ss_pred             cchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-hcCC-----
Confidence            44321  12234688899999999988899999999999999999999999854321    112222111 1100     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                       .+.   ..+......+.+++.+||+.+|++||++++|++.|+.++
T Consensus       225 -~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         225 -YPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -CCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence             111   111223345889999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.1e-42  Score=321.49  Aligned_cols=255  Identities=27%  Similarity=0.454  Sum_probs=204.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.  +....+++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   81 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYIITE   81 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEEEe
Confidence            35788999999999999999998888899999986432 23578999999999999999999999876  4457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.++++...  ...+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++.....
T Consensus        82 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          82 YMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             cCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999999997532  345888999999999999999999998   999999999999999999999999999876543


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ... ......++..|+|||++....++.++|||||||++|||++ |+.||.....   .......    ......     
T Consensus       157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~----~~~~~~-----  223 (261)
T cd05072         157 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSAL----QRGYRM-----  223 (261)
T ss_pred             cee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHH----HcCCCC-----
Confidence            221 1223346778999999998889999999999999999998 9999964321   1111111    111110     


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      + ....++    ..+.+++.+||+.+|++||+++++.+.|+.
T Consensus       224 ~-~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 P-RMENCP----DELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             C-CCCCCC----HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1 111223    347899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.5e-42  Score=324.08  Aligned_cols=256  Identities=32%  Similarity=0.484  Sum_probs=208.4

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ...+|++.+.||.|+||.||+|...++..+|+|.+..........+..|+.+++.++||||+++++++.  +....+++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~   81 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS--VGEPVYIIT   81 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe--cCCCeEEEE
Confidence            345788999999999999999998888999999998665555678999999999999999999999987  444789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++....  ...+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          82 ELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             eecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            9999999999997543  345899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ...  ......++..|+|||.+....++.++||||||+++|+|++ |+.||.....   ......   +. ....     
T Consensus       157 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~---~~-~~~~-----  222 (261)
T cd05148         157 DVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQ---IT-AGYR-----  222 (261)
T ss_pred             ccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHH---HH-hCCc-----
Confidence            321  1223456778999999988899999999999999999998 8999964331   111111   11 1100     


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                           ...+......+.+++.+||+.||++|||++++++.|+.
T Consensus       223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 -----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                 01122233458899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.6e-42  Score=325.89  Aligned_cols=263  Identities=21%  Similarity=0.313  Sum_probs=197.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|... ++..||+|.++.... .....+.+|++++++++||||+++++++.  +....++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH--TERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc--CCCeEEEEE
Confidence            56899999999999999999954 688999999875432 23456789999999999999999999987  344789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++ +|.+++...   ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        83 e~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          83 EYLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             eCCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            99975 999988643   234788999999999999999999999   99999999999999999999999999976543


Q ss_pred             CCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc--------
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--------  325 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------  325 (443)
                      ...  ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||........   ..........        
T Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~  230 (288)
T cd07871         156 PTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPG  230 (288)
T ss_pred             CCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhc
Confidence            221  1233468999999998875 5689999999999999999999999965432211   1111111000        


Q ss_pred             ---cccccccccCccCCCC----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          326 ---KDRLEELADPRLGGKY----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       326 ---~~~~~~~~d~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         .........+......    .......+.+++.+||+.||.+|||++|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence               0000111111110000    00112346799999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.5e-42  Score=326.47  Aligned_cols=265  Identities=24%  Similarity=0.317  Sum_probs=196.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-C-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhc---CCCceeeEEEeeec---CC
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-S-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRL---HHRNLVKLVGYYSS---RD  166 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---~~  166 (443)
                      ++|++.+.||+|+||.||+|.. . +++.||+|.++....  .....+.+|+.+++.+   +||||++++++|..   ..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4689999999999999999985 3 468899999875432  2234567788777766   69999999998853   23


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ....+++|||++ ++|.+++....  ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence            346889999996 69999986432  335889999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      |+++......   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   ............
T Consensus       155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~  228 (290)
T cd07862         155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP  228 (290)
T ss_pred             cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCC
Confidence            9998654321   2334578999999999998899999999999999999999999997543211   111111000000


Q ss_pred             --ccc-------cccccCccCC---CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 --DRL-------EELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 --~~~-------~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                        ...       .....+....   .........+.+++.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence              000       0000000000   0001112346789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.2e-42  Score=324.33  Aligned_cols=258  Identities=27%  Similarity=0.472  Sum_probs=201.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-----CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|++.+.||+|+||.||+|..     .++..||+|.+..... .....+.+|++++++++||||+++++++..  ....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCce
Confidence            4678889999999999999984     2457899999975332 223578899999999999999999999874  4478


Q ss_pred             EEEEeecCCCChhHhhcCCCC-------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC
Q 013404          171 LLCYELVPNGSLESWLHGPLG-------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN  237 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  237 (443)
                      +++|||+++++|.+++.....             ....+++.+++.++.|++.||+|||+++   ++||||||+|||+++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcC
Confidence            999999999999999853211             1234788999999999999999999998   999999999999999


Q ss_pred             CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 013404          238 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV  316 (443)
Q Consensus       238 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~  316 (443)
                      ++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....   ....
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~  236 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVI  236 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHH
Confidence            99999999999987644332222333456778999999988889999999999999999998 9999864321   1111


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ..    .......      .....++    ..+.+++.+||+.||++||++.+|+++|..
T Consensus       237 ~~----~~~~~~~------~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EM----VRKRQLL------PCSEDCP----PRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----HHcCCcC------CCCCCCC----HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11    1111110      0111222    357899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.8e-43  Score=321.91  Aligned_cols=264  Identities=25%  Similarity=0.347  Sum_probs=200.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC---eeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS---QHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~~~l  172 (443)
                      -.|+..+++|.|+||.||+|.. .+++.||||++-.+..    .-.+|+++|+.+.|||||+++-+|......   ...|
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3466779999999999999995 4678999999864332    334699999999999999999888754443   4458


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-CceEEcccccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQ  251 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~  251 (443)
                      ||||||. +|.++++.....+..++...+.-+.+||.+||+|||+.+   |+||||||+|+|+|.+ |.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999987 999999854444566888889999999999999999998   9999999999999976 9999999999998


Q ss_pred             CCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh------
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR------  324 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  324 (443)
                      ...+..+   ....-|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+.  ..+++..++.+-.      
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence            8665443   334567789999999875 789999999999999999999999976443  2333332221100      


Q ss_pred             --ccccccccccCccCCC-----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 --DKDRLEELADPRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 --~~~~~~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                        ......+...+.+...     +......+.++++.++|+.+|++|.++.|++.+
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence              0001111111222111     222233457899999999999999999999976

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=317.56  Aligned_cols=268  Identities=25%  Similarity=0.372  Sum_probs=206.8

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEec--cCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeec---CCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS---RDSS  168 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~  168 (443)
                      ....|...+.||+|+||.|+.+.. .+|+.||||++.  .......++-.+|+++|+.++|+||+.+++++..   .+..
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            445666678999999999999994 578999999997  3444556788999999999999999999998865   3345


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..|+|+|+| .-+|...++.    +..++...+..+++|+++||+|+|+.+   |+||||||.|+|++.+..+||+|||+
T Consensus       100 DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence            789999999 4599999974    344899999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH---------
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW---------  318 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~---------  318 (443)
                      |+...........+..+.|..|.|||++. ...|+...||||.|||+.||++|++-|.+.+...+..++..         
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            99876432233456778899999999875 45899999999999999999999999976554333322211         


Q ss_pred             --------HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          319 --------ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       319 --------~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                              ++..+..-......   .+...++ .......+|+.+||..||.+|+|++|.++|-
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~---~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQ---PFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCC---CHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence                    11111110000000   0000111 1123467899999999999999999999873

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-41  Score=331.69  Aligned_cols=269  Identities=23%  Similarity=0.350  Sum_probs=197.1

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC---CeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~  171 (443)
                      +|++.+.||+|+||.||+|.. .+|..||||++....  ......+.+|++++++++||||+++++++...+.   ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999999995 478999999987432  2234568899999999999999999998754322   3579


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+. ++|.+++..    ...+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 699998864    335899999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCc-cccccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH---------HHH
Q 013404          252 APEGRT-NYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV---------TWA  319 (443)
Q Consensus       252 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~---------~~~  319 (443)
                      ...... ........||..|+|||++.+  ..++.++|||||||++|||++|+.||............         .+.
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            533221 111234579999999999875  67899999999999999999999999643321110000         000


Q ss_pred             HHHhhc--cccccccccCc---cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          320 RPILRD--KDRLEELADPR---LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       320 ~~~~~~--~~~~~~~~d~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..+...  ...+..+....   ....++ .....+.+++.+||+.||++||+++|++++-+
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence            000000  00000000000   000000 11234678999999999999999999998743

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-42  Score=330.47  Aligned_cols=240  Identities=23%  Similarity=0.312  Sum_probs=192.9

Q ss_pred             eeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       105 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      ||+|+||.||++... +++.||+|.++...   ......+.+|+.++++++||||+++++++.  +....++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g   78 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ--SPEKLYLVLAFINGG   78 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe--cCCeEEEEEcCCCCC
Confidence            799999999999954 68899999986432   233456888999999999999999999887  445889999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      +|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        79 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  149 (312)
T cd05585          79 ELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--K  149 (312)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--c
Confidence            99999964    235889999999999999999999999   99999999999999999999999999986433221  2


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....            .
T Consensus       150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~~------------~  211 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEPL------------R  211 (312)
T ss_pred             cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCCC------------C
Confidence            234579999999999999999999999999999999999999996432      2222232222211            1


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPT---MGEVVQS  373 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~  373 (443)
                      ++......+.+++.+||+.||++||+   +.|++++
T Consensus       212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            12222234789999999999999975   6777765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-41  Score=319.67  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=202.5

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .+|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|++++++++||||+++++++..  ....+++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   82 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITE   82 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEEEE
Confidence            45778899999999999999954 5889999998743 2335678999999999999999999999873  447899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++....  ...+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999999996532  345889999999999999999999998   999999999999999999999999999876443


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....      ......+.. ..      .
T Consensus       158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~-~~------~  223 (263)
T cd05052         158 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEK-GY------R  223 (263)
T ss_pred             eee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHC-CC------C
Confidence            211 1112234668999999999999999999999999999998 8999864321      122121111 10      0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      +.....++    ..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       224 ~~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCP----PKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCC----HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11112223    3588999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.6e-42  Score=331.48  Aligned_cols=243  Identities=23%  Similarity=0.326  Sum_probs=195.3

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +.||+|+||.||++.. .+|+.||+|.+....   ......+.+|+++++.++||||+++++++.  +....++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~   78 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN   78 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence            4699999999999995 468999999997532   223457888999999999999999999887  4458899999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcc
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN  258 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  258 (443)
                      +|+|.+++..    ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....... 
T Consensus        79 ~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-  150 (328)
T cd05593          79 GGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-  150 (328)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence            9999998864    235889999999999999999999999   99999999999999999999999999875432211 


Q ss_pred             ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccC
Q 013404          259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG  338 (443)
Q Consensus       259 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  338 (443)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+....        ..  
T Consensus       151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~~--------~~--  213 (328)
T cd05593         151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMED--------IK--  213 (328)
T ss_pred             -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccCC--------cc--
Confidence             12345799999999999999999999999999999999999999964321      11111111111        11  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          339 GKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       339 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                        ++......+.+++.+||+.||++||     ++.|++++-
T Consensus       214 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  252 (328)
T cd05593         214 --FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS  252 (328)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence              1222233478999999999999997     899999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-41  Score=322.71  Aligned_cols=264  Identities=25%  Similarity=0.388  Sum_probs=208.5

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEECC-----CcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      ..++|++.+.||+|+||.||+|...+     +..|++|++..... .....+.+|+.++++++||||+++++++... ..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~   82 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE   82 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence            35688899999999999999999654     68899999874432 2245688999999999999999999987643 45


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCC----CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA  244 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  244 (443)
                      ..+++++|+++|+|.+++......    ...+++.+++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            778999999999999999653221    146899999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHh
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      |||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||....+   ..+..+.    
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----  232 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYL----  232 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHH----
Confidence            9999986644332222233456778999999998899999999999999999999 9999964322   1122111    


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      ......      .....++    ..+.+++.+||+.||++||++.+|++.|+.+.+
T Consensus       233 ~~~~~~------~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         233 KDGYRL------AQPINCP----DELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HcCCCC------CCCCcCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            111111      0111122    357899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-41  Score=327.04  Aligned_cols=243  Identities=26%  Similarity=0.353  Sum_probs=194.2

Q ss_pred             ceeeecCcEEEEEEEE----CCCcEEEEEEeccCC----CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404          103 SILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +.||+|+||.||++..    .+++.||+|.++...    ......+.+|+.+++.++||||+++++++.  .....++||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ--TGGKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe--cCCeEEEEE
Confidence            6799999999999985    357899999987432    222356788999999999999999999987  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.+++..    ...+.+..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        80 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          80 EYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             eCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            99999999999864    235788889999999999999999999   99999999999999999999999999875432


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....       
T Consensus       153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~~-------  217 (323)
T cd05584         153 EGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGKL-------  217 (323)
T ss_pred             CCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC-------
Confidence            221  12345799999999999998899999999999999999999999964331      112222221110       


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                           ..+......+.+++.+||+.||++||     ++++++++-
T Consensus       218 -----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         218 -----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence                 11112223478999999999999999     899998764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.8e-41  Score=329.44  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=195.8

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||++.. .+++.||+|.++...   ......+..|..++..+ +||||+++++++.  +....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEeCC
Confidence            4699999999999995 468899999997532   22235678899999998 7999999999987  445889999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  151 (329)
T cd05588          79 SGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD  151 (329)
T ss_pred             CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence            99999998864    245899999999999999999999999   99999999999999999999999999875322111


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC--cchHHHHHHHHhhccccccccccC
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG--QENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||+......  ......+.........       .
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~  222 (329)
T cd05588         152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------I  222 (329)
T ss_pred             --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-------C
Confidence              1234579999999999999999999999999999999999999997432221  1122223222221110       0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCC------HHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPT------MGEVVQSL  374 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~~L  374 (443)
                      .    .+......+.+++.+||+.||.+||+      ++++++|-
T Consensus       223 ~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp  263 (329)
T cd05588         223 R----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP  263 (329)
T ss_pred             C----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCC
Confidence            1    11222234789999999999999997      67888763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=335.68  Aligned_cols=263  Identities=26%  Similarity=0.392  Sum_probs=215.6

Q ss_pred             HHHHHHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           90 EELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        90 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      ++++-.+.++....+||-|.||.||.|.|+ -...||||.++.+. ...++|+.|+.+|+.++|||+|+|+|+|.  ...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT--~Ep  336 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--HEP  336 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhc--cCC
Confidence            455555667777889999999999999976 35679999998543 45689999999999999999999999998  444


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..|||+|||..|+|.+||++..  ...++....++++.||+.||+||...+   +|||||..+|+|+.++..+||+||||
T Consensus       337 PFYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccch
Confidence            7899999999999999998654  334666778999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ++.+..+.+ .......-+..|.|||.+....++.|+|||+|||+||||.| |..||...+      + ..+-.+++.+.
T Consensus       412 sRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l-SqVY~LLEkgy  483 (1157)
T KOG4278|consen  412 SRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L-SQVYGLLEKGY  483 (1157)
T ss_pred             hhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H-HHHHHHHhccc
Confidence            998765432 22333456789999999999999999999999999999998 888885322      1 12223344433


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ++          +.|.-|...+++|++.||+++|.+||++.|+-+.++.+.
T Consensus       484 RM----------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  484 RM----------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             cc----------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            33          224445556999999999999999999999999988764

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-41  Score=323.31  Aligned_cols=259  Identities=28%  Similarity=0.429  Sum_probs=201.9

Q ss_pred             CCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           98 NFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... .....+.+|+.+++.++||||++++++|..  ....
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCCc
Confidence            4788899999999999999853      235788998875432 224578899999999999999999999874  4468


Q ss_pred             EEEEeecCCCChhHhhcCCCC--------------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCc
Q 013404          171 LLCYELVPNGSLESWLHGPLG--------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA  230 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  230 (443)
                      ++++||+++|+|.+++.....                    ....+++..++.++.|++.||+|||+.+   ++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence            999999999999999864211                    1235889999999999999999999998   99999999


Q ss_pred             ccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 013404          231 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP  309 (443)
Q Consensus       231 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~  309 (443)
                      +|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....+
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999986543332222233456778999999988889999999999999999998 9999864321


Q ss_pred             CCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      .   .+..    ......      ..    ..+......+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       236 ~---~~~~----~~~~~~------~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 E---RLFN----LLKTGY------RM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             H---HHHH----HHhCCC------CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            1   1111    111110      01    111222335889999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-41  Score=326.35  Aligned_cols=264  Identities=26%  Similarity=0.411  Sum_probs=205.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC--------CCcEEEEEEeccCC-CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD  166 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  166 (443)
                      ++|.+.+.||+|+||.||++...        ++..+|+|.++... ......+.+|+++++.+ +||||++++++|..  
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--
Confidence            57899999999999999999742        23579999997542 22345688899999999 79999999999874  


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEE
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  234 (443)
                      ....+++|||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.+   ++||||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence            4478999999999999999975321            1235889999999999999999999998   999999999999


Q ss_pred             ecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 013404          235 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE  313 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~  313 (443)
                      ++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....     
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----  247 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----  247 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----
Confidence            99999999999999976643222111222334578999999998899999999999999999998 888885332     


Q ss_pred             hHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          314 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                       .......+ ......          ..+......+.+++.+||+.+|++||++.+|++.|+.+.+...
T Consensus       248 -~~~~~~~~-~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         248 -VEELFKLL-KEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             -HHHHHHHH-HcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence             11111111 111100          1122223457899999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=319.54  Aligned_cols=259  Identities=28%  Similarity=0.438  Sum_probs=201.3

Q ss_pred             CCCCceeeecCcEEEEEEEEC-C---CcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCC----C
Q 013404           99 FEPASILGEGGFGRVFKGVLS-D---GTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S  168 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~-~---~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~  168 (443)
                      |.+.+.||+|+||.||+|... +   +..||+|+++.....  ....+.+|++.++.++||||+++++++...+.    .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567899999999999999853 2   367999998754332  23578999999999999999999998764332    2


Q ss_pred             eeEEEEeecCCCChhHhhcCCCC--CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLG--VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ..++++||+++|+|..++.....  ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence            47899999999999999854321  2346899999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      |+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....   .....+   +. .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~---~~-~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDY---LR-H  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH---HH-c
Confidence            99987654332222222345678999999988899999999999999999999 8888864321   111111   11 1


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ...      .    ..+......+.+++.+||+.||++||++.||++.|+.+
T Consensus       231 ~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNR------L----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC------C----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110      1    11222334588999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.6e-42  Score=333.17  Aligned_cols=247  Identities=25%  Similarity=0.331  Sum_probs=199.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-C-CcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-D-GTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|++.+.||+|+||.||+|... + +..||+|.+....   ....+.+.+|+.+++.++||||+++++++.  +....+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~  107 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK--DESYLY  107 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE--eCCEEE
Confidence            46889999999999999999854 3 3689999986432   233457889999999999999999999987  445889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       108 lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            99999999999999974    235889999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.      .....+.....    
T Consensus       181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~~~~----  245 (340)
T PTZ00426        181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILEGII----  245 (340)
T ss_pred             cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhcCCC----
Confidence            5432     12357999999999999988999999999999999999999999743321      11111111110    


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                              .++......+.+++.+||+.||++|+     ++++++++-+
T Consensus       246 --------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~  286 (340)
T PTZ00426        246 --------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW  286 (340)
T ss_pred             --------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence                    01111223467899999999999995     8999988743

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.6e-42  Score=326.50  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=205.2

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD  166 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  166 (443)
                      ..++|++.+.||+|+||.||++...      +...+|+|.+..... .....+.+|++++.++ +|+||+++++++.  .
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--Q   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--C
Confidence            4567889999999999999999853      236799999875422 2235688999999999 7999999999987  4


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCC------------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEE
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  234 (443)
                      ....+++|||+++|+|.++++...            .....+++..++.++.|++.||+|||+.+   |+||||||+|||
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            447899999999999999996421            22456899999999999999999999998   999999999999


Q ss_pred             ecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 013404          235 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE  313 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~  313 (443)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....    
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  240 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  240 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence            99999999999999987654332222223345678999999998999999999999999999998 9999863321    


Q ss_pred             hHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          314 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                        ...... ......          ...+......+.+++.+||..||++|||+.|+++.|+.+.
T Consensus       241 --~~~~~~-~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 --EELFKL-LKEGYR----------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --HHHHHH-HHcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              111111 111110          0112222345889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.3e-41  Score=318.43  Aligned_cols=259  Identities=27%  Similarity=0.414  Sum_probs=198.2

Q ss_pred             CCCCceeeecCcEEEEEEEECC-Cc--EEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----CCe
Q 013404           99 FEPASILGEGGFGRVFKGVLSD-GT--AVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQ  169 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  169 (443)
                      |.+.+.||+|+||.||+|.+.+ +.  .||+|.++...  ....+.+.+|+++++.++||||+++++++....    ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999999654 33  68999887542  223467889999999999999999999875321    224


Q ss_pred             eEEEEeecCCCChhHhhcCCC--CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          170 HLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      .+++|||+++|+|.+++....  .....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999874221  12345889999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      +++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.....   ..+..    .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~----~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYD----YLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHcC
Confidence            9987654332111222346778999999999999999999999999999999 7889864221   11111    11111


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ....          .+......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       231 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1110          1112223478999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.9e-42  Score=332.07  Aligned_cols=199  Identities=30%  Similarity=0.467  Sum_probs=172.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|++++++++||||++++++|..  ....++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEE
Confidence            468999999999999999999965 688899998875432 223568999999999999999999999874  4589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |||+++|+|.+++..    ...+++..+..++.|++.||.|||+. +   |+|+||||+|||+++++.+||+|||++...
T Consensus        82 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          82 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            999999999999964    23578899999999999999999974 5   999999999999999999999999998765


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      ....    .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            3321    23346899999999999989999999999999999999999999643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.8e-41  Score=322.13  Aligned_cols=267  Identities=21%  Similarity=0.307  Sum_probs=197.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++..  ....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEE
Confidence            468999999999999999999964 688999999875432 223467889999999999999999999874  4578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||++ ++|.+++...   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++...
T Consensus        82 ~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          82 FEYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            99995 6888888643   235888999999999999999999999   9999999999999999999999999987543


Q ss_pred             CCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc-----
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-----  327 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  327 (443)
                      ....  ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......  ..........+....     
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         155 VPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             CCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhcc
Confidence            3221  1233568999999998865 45789999999999999999999999743211  111111111110000     


Q ss_pred             ---cccccccCccCCCCCH---------HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          328 ---RLEELADPRLGGKYPK---------EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       328 ---~~~~~~d~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                         ..............+.         .....+.+++.+||+.||++|||++|+++|-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~  290 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY  290 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence               0000000000000000         01124678999999999999999999998643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=331.37  Aligned_cols=256  Identities=28%  Similarity=0.448  Sum_probs=214.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEECC---C--cEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSD---G--TAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      +.....++||.|-||.||+|.+.+   |  -.||||..+.+. ....+.|+.|..+|++++|||||+++|+|..   ...
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~  465 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPM  465 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cce
Confidence            344556889999999999999532   3  368999998754 3456789999999999999999999999973   268


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++|||.++-|.|..||+.++.   .++......+++||+.||+|||+..   +|||||..+|||+....-+||+|||+++
T Consensus       466 WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence            999999999999999986543   4888999999999999999999999   9999999999999999999999999999


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...+... +..+...-+..|||||.+.-..++.++|||.|||.+||+++ |..||..-...+...       .+++++  
T Consensus       540 ~~ed~~y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnGe--  609 (974)
T KOG4257|consen  540 YLEDDAY-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENGE--  609 (974)
T ss_pred             hccccch-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCCC--
Confidence            8876554 44556677889999999999999999999999999999987 999997544332211       011111  


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                              ...+|+.|+..++.|+.+||..||.+||.+.|+...|..+.+
T Consensus       610 --------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  610 --------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             --------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                    235667777789999999999999999999999999988865

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.5e-41  Score=326.79  Aligned_cols=246  Identities=25%  Similarity=0.369  Sum_probs=194.0

Q ss_pred             CCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHH---hhcCCCceeeEEEeeecCCCCeeE
Q 013404           99 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEML---SRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      |++.+.||+|+||.||++.. .+|+.||||.++...   ....+.+.+|++++   +.++||||+++++++.  +....+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~   78 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHVC   78 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEEE
Confidence            66789999999999999995 468999999997432   22334566776665   5668999999999987  445899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|..+++.     ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        79 lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05589          79 FVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE  150 (324)
T ss_pred             EEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence            99999999999998863     35899999999999999999999999   99999999999999999999999999875


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......  ......|++.|+|||.+.+..++.++|||||||++|||++|+.||.....      ......+.....    
T Consensus       151 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~~~~----  218 (324)
T cd05589         151 GMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVNDEV----  218 (324)
T ss_pred             CCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC----
Confidence            432211  12345799999999999999999999999999999999999999964332      111222221111    


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                          .    ++......+.+++.+||+.||++||     ++.+++++.
T Consensus       219 ----~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         219 ----R----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             ----C----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence                1    1112223478999999999999999     577777653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-42  Score=298.41  Aligned_cols=253  Identities=28%  Similarity=0.395  Sum_probs=209.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|-||.||+|+. +++-.||+|++.+..   .....++.+|+++-..|+||||+++++||.  +....|
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh--d~~riy   98 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH--DSKRIY   98 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee--ccceeE
Confidence            46899999999999999999994 567889999986542   233467899999999999999999999998  566899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      |++||.++|.|...|+...  ..++++.....+..|+|.||.|+|..+   ++||||||+|+|++.++.+||+|||.+..
T Consensus        99 LilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             EEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceee
Confidence            9999999999999998543  456889999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .+..    .....+||..|.+||...+..++...|+|++|++.||++.|.+||+....   ....   +.+..-     +
T Consensus       174 ~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etY---krI~k~-----~  238 (281)
T KOG0580|consen  174 APSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETY---KRIRKV-----D  238 (281)
T ss_pred             cCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHH---HHHHHc-----c
Confidence            6532    24567999999999999999999999999999999999999999974431   1111   111111     1


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      +       .+|........++|..|+..+|.+|.+..|++.+-+..
T Consensus       239 ~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  239 L-------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV  277 (281)
T ss_pred             c-------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence            1       12222233478999999999999999999999987654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-41  Score=329.98  Aligned_cols=244  Identities=24%  Similarity=0.314  Sum_probs=194.2

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +.||+|+||.||++.. .+|..||+|.++...   ......+..|++++..++||||+++.+++.  +....++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~--~~~~~~lv~E~~~   78 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ--THDRLCFVMEYAN   78 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE--cCCEEEEEEeCCC
Confidence            4699999999999985 478999999987532   223456788999999999999999999887  4458899999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      +|+|.+++..    ...+++..+..++.|++.||.|||+ .+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        79 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          79 GGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            9999998864    2358999999999999999999997 67   99999999999999999999999999875432211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....        . 
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i~~~~~--------~-  214 (325)
T cd05594         152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEI--------R-  214 (325)
T ss_pred             --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHHhcCCC--------C-
Confidence              12335699999999999999999999999999999999999999964321      111111111111        1 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                         ++......+.+++.+||+.||++|+     ++.+++++-+
T Consensus       215 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         215 ---FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             ---CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence               1111223478999999999999996     8999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-41  Score=320.82  Aligned_cols=258  Identities=28%  Similarity=0.444  Sum_probs=200.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|.+.+.||+|+||.||+|.+.      .+..||+|.+...... ....|.+|+.++++++|+||+++++++..  ..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence            467899999999999999999964      3568999988654332 23568999999999999999999998874  34


Q ss_pred             eeEEEEeecCCCChhHhhcCCCC---CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC---ceE
Q 013404          169 QHLLCYELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAK  242 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k  242 (443)
                      ..+++|||+++++|.+++.....   ....+++.+++.++.||+.||+|||+.+   ++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence            67899999999999999965421   1235899999999999999999999998   99999999999998654   599


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      |+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......   .+   ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~---~~~  233 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EV---MEF  233 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHH
Confidence            999999987643222111222334568999999999999999999999999999997 99999643321   11   111


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      +... ..          ...+......+.+++.+||+.+|++||++.+|+++|+
T Consensus       234 ~~~~-~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 VTGG-GR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHcC-Cc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111 10          0112222345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=321.87  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=200.9

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      +|++.+.||+|+||.||++.. .+++.||+|.+.....   .....+.+|+.+++.++||||+++++++..  ....+++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv   78 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV   78 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence            478889999999999999995 4689999999864322   223457889999999999999999998874  4478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++|+|.+++....  ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++...
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05605          79 LTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP  153 (285)
T ss_pred             EeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            99999999999886432  345899999999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....   .....|+..|+|||++.+..++.++|||||||++|||++|+.||.......  ........+...        
T Consensus       154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~~~~~--------  220 (285)
T cd05605         154 EGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERRVKED--------  220 (285)
T ss_pred             CCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHHhhhc--------
Confidence            3222   123478999999999998899999999999999999999999997433211  111111111000        


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                          ...++......+.+++.+||+.||++||     ++++++++-+
T Consensus       221 ----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05605         221 ----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF  263 (285)
T ss_pred             ----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence                0112222334578999999999999999     8889987743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.2e-41  Score=335.83  Aligned_cols=263  Identities=23%  Similarity=0.382  Sum_probs=203.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCCC-HHHHHHHHHHHhhcC-CCceeeEEEeeecCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLH-HRNLVKLVGYYSSRD  166 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  166 (443)
                      ..++|.+.+.||+|+||.||+|++.      .+..||+|+++...... .+.+.+|+++|.++. ||||++++++|..  
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence            4457888999999999999999853      34689999997543322 357889999999997 9999999999874  


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCC-------------------------------------------------------
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLG-------------------------------------------------------  191 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  191 (443)
                      ....++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            4478999999999999999964321                                                       


Q ss_pred             ---------------------------------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCccc
Q 013404          192 ---------------------------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN  232 (443)
Q Consensus       192 ---------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  232 (443)
                                                             ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence                                                   1124677888999999999999999988   9999999999


Q ss_pred             EEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 013404          233 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSG  311 (443)
Q Consensus       233 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~  311 (443)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-  348 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-  348 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-
Confidence            9999999999999999986533222111223457789999999998889999999999999999998 88998643211 


Q ss_pred             cchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          312 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                           ......+......          ..+......+.+++.+||+.+|++||++++|++.|+.+.
T Consensus       349 -----~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         349 -----EQFYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -----HHHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                 1111111111111          112222345889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.7e-41  Score=316.45  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=200.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .+|.+.+.||+|+||.||+|...++..+|+|.+.... .....|.+|+.++++++||||+++++++..  ....+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEEEc
Confidence            3577889999999999999998777789999987433 345679999999999999999999999874  4467999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++|+|.+++....   ..+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++......
T Consensus        81 ~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          81 MSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            99999999997532   25899999999999999999999998   9999999999999999999999999988654332


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....      ......+... ...     .
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~-~~~-----~  221 (256)
T cd05113         155 YT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQG-LRL-----Y  221 (256)
T ss_pred             ee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhcC-CCC-----C
Confidence            11 1122345678999999998889999999999999999998 9999864331      1111111111 100     0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                           .+......+.+++.+||+.+|++||++.+|++.|
T Consensus       222 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         222 -----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence                 0111234588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-42  Score=329.54  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=211.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|+.++++|+|+||.+++.+. .++..|++|.+......  ......+|+.++++++|||||.+.+.|... +...+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEEE
Confidence            5788999999999999999984 46789999999765433  344678899999999999999999998743 2238999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |+|++||+|.+.|.+.+  ...++++.++.|+.|++.|+.|||++.   |+|||||+.|||++.+..+||+|||+|+...
T Consensus        83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence            99999999999998655  456899999999999999999999888   9999999999999999999999999999887


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....  .....+||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+..      ..+..+.+.      ..
T Consensus       158 ~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~~~------~~  223 (426)
T KOG0589|consen  158 PEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKINRG------LY  223 (426)
T ss_pred             Cchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHhhc------cC
Confidence            6542  346679999999999999999999999999999999999999999754421      122222211      11


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                           ...+......+..++..|++.+|..||++.+++.+..
T Consensus       224 -----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~  260 (426)
T KOG0589|consen  224 -----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPH  260 (426)
T ss_pred             -----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence                 2234444456889999999999999999999998743

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.5e-41  Score=327.15  Aligned_cols=254  Identities=24%  Similarity=0.307  Sum_probs=198.0

Q ss_pred             CCCCCceeeecCcEEEEEEEE----CCCcEEEEEEeccCC----CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCC
Q 013404           98 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  168 (443)
                      +|++.+.||+|+||.||+++.    .+++.||+|.+....    ....+.+..|+.++..+ +||||+++++++.  +..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence            588899999999999999874    357899999986431    12235678899999999 5999999998886  445


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++||||+++|+|.+++..    ...+++.++..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~  151 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL  151 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcC
Confidence            78999999999999999864    235889999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.........  ......+...  
T Consensus       152 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~--  226 (332)
T cd05614         152 SKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILKC--  226 (332)
T ss_pred             CccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhcC--
Confidence            9865332221 12345799999999998865 4788999999999999999999999644322111  1111111111  


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                            ++.+...++    ..+.+++.+||+.||++||     ++++++++-+
T Consensus       227 ------~~~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         227 ------DPPFPSFIG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             ------CCCCCCCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence                  111111222    3478899999999999999     7889887743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.6e-41  Score=314.56  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=193.5

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      +.||+|+||.||+|.. .+++.||+|.+..... .....+.+|++++++++||||++++++|..  ....++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCC
Confidence            4699999999999995 4789999998764332 224578999999999999999999999874  44789999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      +|.+++...   ...+++.+++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...........
T Consensus        79 ~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          79 DFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            999999643   235889999999999999999999998   99999999999999999999999999876543211111


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG  339 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  339 (443)
                      ......+..|+|||.+.+..++.++||||||+++|||++ |..||......   ...    ......          ...
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~----~~~~~~----------~~~  215 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTR----EAIEQG----------VRL  215 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHH----HHHHcC----------CCC
Confidence            111223567999999999899999999999999999998 88888633211   111    111110          001


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          340 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       340 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            112222345889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-41  Score=323.32  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=200.4

Q ss_pred             CCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCCC-HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           98 NFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      +|++.+.||+|+||.||+|...      ++..||+|+++...... ...+.+|+.++..++||||+++++++..  ....
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CCce
Confidence            4677889999999999999853      24789999997543322 3568899999999999999999999874  3468


Q ss_pred             EEEEeecCCCChhHhhcCCC------------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC
Q 013404          171 LLCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN  238 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  238 (443)
                      ++++||+++++|.+++....            .....+++..++.++.|++.||.|||+.+   |+||||||.||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence            89999999999999985211            11235788899999999999999999998   9999999999999999


Q ss_pred             CceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 013404          239 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT  317 (443)
Q Consensus       239 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~  317 (443)
                      +.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....      ..
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~  234 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QD  234 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HH
Confidence            9999999999987644332222233456789999999998889999999999999999998 8888864321      12


Q ss_pred             HHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       318 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      +...+... . .         ..++......+.+++..||+.+|++||++++|+..|+.
T Consensus       235 ~~~~i~~~-~-~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIRNR-Q-V---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHcC-C-c---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            22221111 1 0         01122233458899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-41  Score=330.92  Aligned_cols=264  Identities=27%  Similarity=0.435  Sum_probs=203.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+|..      .+++.||||.++..... ....+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence            35789999999999999999973      34678999999754322 245688999999999 689999999988643 3


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCC-------------------------------------------------------
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGV-------------------------------------------------------  192 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  192 (443)
                      ...+++|||+++|+|.++++.....                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            4678999999999999998643210                                                       


Q ss_pred             --------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccccccc
Q 013404          193 --------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV  264 (443)
Q Consensus       193 --------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  264 (443)
                              ...+++.++..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++..............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    124688889999999999999999998   999999999999999999999999999865433222222233


Q ss_pred             ccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCH
Q 013404          265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK  343 (443)
Q Consensus       265 ~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  343 (443)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..||......  ...    ..........      ......  
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~----~~~~~~~~~~------~~~~~~--  307 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF----CRRLKEGTRM------RAPDYT--  307 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHH----HHHHhccCCC------CCCCCC--
Confidence            46678999999999999999999999999999997 89998643221  111    1111111110      000111  


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          344 EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       344 ~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                        ...+.+++..||+.||++||++.||+++|+.+.+
T Consensus       308 --~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 --TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             --CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              2347899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=332.85  Aligned_cols=255  Identities=25%  Similarity=0.317  Sum_probs=202.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++...   ......+.+|++++..++||||+++++++.  +....++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l   78 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYL   78 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEE
Confidence            47889999999999999999964 78999999987532   233467889999999999999999999887  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~  151 (350)
T cd05573          79 VMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKM  151 (350)
T ss_pred             EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence            99999999999999753    45889999999999999999999998   999999999999999999999999999866


Q ss_pred             CCCC---------------------------ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 013404          253 PEGR---------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD  305 (443)
Q Consensus       253 ~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~  305 (443)
                      ....                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~  231 (350)
T cd05573         152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY  231 (350)
T ss_pred             cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence            4432                           0011234579999999999999999999999999999999999999997


Q ss_pred             CCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-HHHHHHHHH
Q 013404          306 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQSLK  375 (443)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~L~  375 (443)
                      ....      ......+.......   .-+.. ..++    ..+.+++.+|+. ||.+||+ +++++++.+
T Consensus       232 ~~~~------~~~~~~i~~~~~~~---~~p~~-~~~~----~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         232 SDTL------QETYNKIINWKESL---RFPPD-PPVS----PEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             CCCH------HHHHHHHhccCCcc---cCCCC-CCCC----HHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            5431      11111122110100   00110 1122    347889999998 9999999 999998743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.6e-41  Score=341.58  Aligned_cols=267  Identities=22%  Similarity=0.345  Sum_probs=196.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecC------CC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR------DS  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  167 (443)
                      ...+|++.+.||+|+||.||+|.. .+++.||||++...    .....+|+.+++.++||||+++++++...      ..
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            346799999999999999999995 46889999988632    23345799999999999999999876431      12


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-CceEEccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADF  246 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  246 (443)
                      ..+++||||+++ +|.+++.........+++..+..++.|++.||+|||+.+   |+||||||+|||++.+ +.+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246689999975 787777533233456899999999999999999999999   9999999999999865 47999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      |+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|.+||......  ..+..... .+..
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~-~~~~  289 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQ-VLGT  289 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHH-HhCC
Confidence            99987643322   2235689999999988764 6899999999999999999999999754321  11111111 0000


Q ss_pred             c---------ccccccccC-----ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          326 K---------DRLEELADP-----RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       326 ~---------~~~~~~~d~-----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .         .....+.-+     .+...++......+.+|+.+||+.||.+|||+.|+++|-+
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence            0         000000000     0111112222345789999999999999999999998855

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.9e-41  Score=318.70  Aligned_cols=258  Identities=29%  Similarity=0.475  Sum_probs=202.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCc----EEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGT----AVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      .++|++.+.||+|+||.||+|.+ .+|.    .||+|.++..... ....+.+|+.++..++||||+++++++..   ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---ST   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CC
Confidence            35788899999999999999984 3444    4899998754332 34578899999999999999999999863   25


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++++||+++|+|.++++..   ...+++.+++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCce
Confidence            67999999999999999753   235899999999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      +...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ..+..+.    .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~  229 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLL----EKGER  229 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCCCc
Confidence            87654332222222345678999999998899999999999999999998 8999864321   1122221    11111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      .          ..+......+.+++.+||+.||++||++.++++.|+.+.+
T Consensus       230 ~----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         230 L----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             C----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1          0111223357899999999999999999999988876643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3e-41  Score=320.49  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             eeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          105 LGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       105 lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      ||+|+||.||++.. .+|+.||+|.+......   ..+.+..|+++++.++|+||+++.+++.  .....++||||+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~g   78 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ--TKTDLCLVMTIMNGG   78 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc--CCCeEEEEEeCCCCC
Confidence            69999999999985 47889999998643221   2346778999999999999999998886  445789999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      +|.+++.........+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........  .
T Consensus        79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~  153 (280)
T cd05608          79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--K  153 (280)
T ss_pred             CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--c
Confidence            999888643333456899999999999999999999999   99999999999999999999999999976544322  1


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...........          .  ..
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~----------~--~~  219 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILND----------S--VT  219 (280)
T ss_pred             ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhccc----------C--CC
Confidence            2345789999999999999999999999999999999999999964332111  11111111110          0  01


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                      ++......+.+++.+||+.||++||     ++++++++-+
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~  259 (280)
T cd05608         220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL  259 (280)
T ss_pred             CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence            1222334578999999999999999     7788887643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-40  Score=313.49  Aligned_cols=260  Identities=23%  Similarity=0.382  Sum_probs=208.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|+|++++++++..  ....++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l   79 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI   79 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence            57899999999999999999965 78999999886422   2235678999999999999999999999874  457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+++|+|.+++.........+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++..
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~  156 (267)
T cd08224          80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeec
Confidence            99999999999998654333456899999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ......  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||....    .............  .    
T Consensus       157 ~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~--~----  224 (267)
T cd08224         157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKC--D----  224 (267)
T ss_pred             cCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcC--C----
Confidence            432211  223468889999999998899999999999999999999999986432    1122221111110  0    


Q ss_pred             ccCccCCCCCH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          333 ADPRLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       333 ~d~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                           ....+. .....+.+++.+||..+|++||++.+|++.|+.++
T Consensus       225 -----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 -----YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 011111 23345889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.8e-41  Score=314.31  Aligned_cols=253  Identities=29%  Similarity=0.465  Sum_probs=202.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++.  + ...+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~-~~~~lv~e~   81 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS--E-EPIYIVTEY   81 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC--C-CCcEEEEEe
Confidence            46888999999999999999988888899999875433 4567999999999999999999999874  2 357899999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.++++...  ...+++.+++.++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          82 MSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999997532  335889999999999999999999998   9999999999999999999999999998654322


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......++..|+|||++.+..++.++||||||+++|||++ |..||.....      .+....+.. ...       
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~-~~~-------  221 (260)
T cd05070         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVER-GYR-------  221 (260)
T ss_pred             cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHc-CCC-------
Confidence            11 1122345678999999988889999999999999999999 8899864321      111111111 100       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                         ...+......+.+++.+||+.+|++|||++++.+.|++
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 ---MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               11122233458899999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.8e-41  Score=322.84  Aligned_cols=264  Identities=24%  Similarity=0.411  Sum_probs=206.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC--------CCcEEEEEEeccCC-CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR  165 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  165 (443)
                      .++|.+.+.||+|+||.||+++..        ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++.. 
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence            467888999999999999999741        24579999987432 23346789999999999 89999999999874 


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                       ....+++|||+++|+|.+++.....            ....+++.+++.++.|++.||.|||+++   ++||||||+||
T Consensus        93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          93 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence             4478999999999999999975321            1235788999999999999999999998   99999999999


Q ss_pred             EecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 013404          234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ  312 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~  312 (443)
                      ++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....    
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----  244 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----  244 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence            999999999999999987654332222233456778999999998899999999999999999998 788885332    


Q ss_pred             chHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                        ...+...+ ......          ..+......+.+++.+||+.+|++||++.||++.|+.+....
T Consensus       245 --~~~~~~~~-~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         245 --VEELFKLL-KEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             --HHHHHHHH-HcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence              22222222 111111          111222345888999999999999999999999998887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-41  Score=314.71  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=199.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++||||+++++++.  +....+++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~   80 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIVTEY   80 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEEEec
Confidence            3578889999999999999998777789999986432 23467889999999999999999999886  44478999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.+++....   ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......
T Consensus        81 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          81 MANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             CCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            99999999997432   25899999999999999999999999   9999999999999999999999999998654322


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......   ...   ..+. ...      ..
T Consensus       155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~---~~~~-~~~------~~  220 (256)
T cd05059         155 YT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVV---ESVS-AGY------RL  220 (256)
T ss_pred             cc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHH---HHHH-cCC------cC
Confidence            11 1112234567999999999999999999999999999999 89998643221   111   1111 110      00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                          ..+......+.+++.+||+.+|++||++.|+++.|
T Consensus       221 ----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 ----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                11112233588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.3e-41  Score=322.88  Aligned_cols=259  Identities=26%  Similarity=0.432  Sum_probs=202.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||++...      .+..||+|.++.... ...+.+.+|+++++++ +||||+++++++..  .
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--G  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--C
Confidence            457899999999999999999741      345799999875432 2245789999999999 79999999999874  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...+++|||+++|+|.++++...  ...+++.+++.++.|++.||+|||+++   |+|+||||+|||++.++.++|+|||
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            47899999999999999997532  234899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      +++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......  .....    .....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~----~~~~~  260 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYK----LIKEG  260 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHH----HHHcC
Confidence            9986654332222223356788999999999999999999999999999998 99998643221  11111    11111


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ..      .    ..+......+.+++.+||+.+|++||++.||++.|+.+
T Consensus       261 ~~------~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 YR------M----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             Cc------C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            00      0    01111123588999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.6e-41  Score=316.55  Aligned_cols=261  Identities=23%  Similarity=0.362  Sum_probs=206.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++.. .++..+|||.+.....   ....++.+|+.+++.++||||+++++++..  ....++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~   79 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI   79 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence            4688889999999999999994 5789999998764322   223578899999999999999999999874  447899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF  156 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence            99999999999998643333456899999999999999999999999   999999999999999999999999998766


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  ......++..|+|||++.+..++.++||||||+++|||++|..||......    ...+...+.       ..
T Consensus       157 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-------~~  223 (267)
T cd08229         157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-------QC  223 (267)
T ss_pred             ccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhh-------cC
Confidence            43322  122346889999999999889999999999999999999999999643211    111111111       11


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ..+..   .+......+.+++.+||+.||++|||+.+|++.++.+.
T Consensus       224 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         224 DYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            11111   11123345889999999999999999999999888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-41  Score=331.29  Aligned_cols=254  Identities=24%  Similarity=0.303  Sum_probs=199.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++.. .+|+.||+|.++....   ...+.+.+|+.+++.++||||+++++++.  +....++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~--~~~~~~l   78 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ--DKDNLYL   78 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeEEE
Confidence            4788999999999999999995 4789999999975422   23456888999999999999999999887  4457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~  152 (330)
T cd05601          79 VMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL  152 (330)
T ss_pred             EECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence            99999999999999753   235899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      ...... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||.....      ......+....
T Consensus       153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~  225 (330)
T cd05601         153 TANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQ  225 (330)
T ss_pred             CCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCC
Confidence            443221 223347899999999986      45678999999999999999999999964322      11222222211


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ..+ ..  +. ...++    ..+.+++..||+ +|.+||++++++++-
T Consensus       226 ~~~-~~--~~-~~~~~----~~~~~li~~ll~-~p~~R~t~~~l~~h~  264 (330)
T cd05601         226 RFL-KF--PE-DPKVS----SDFLDLIQSLLC-GQKERLGYEGLCCHP  264 (330)
T ss_pred             Ccc-CC--CC-CCCCC----HHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence            100 00  00 01122    347789999998 999999999999764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=340.38  Aligned_cols=254  Identities=30%  Similarity=0.468  Sum_probs=213.9

Q ss_pred             CCCceeeecCcEEEEEEEE-CCC----cEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404          100 EPASILGEGGFGRVFKGVL-SDG----TAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~-~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ...++||+|+||+||+|.+ ..|    -+||+|++.... .+...+++.|+-+|.+++|||+++|+|+|...   .+.||
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~qlv  775 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQLV  775 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHHHH
Confidence            3468899999999999994 444    378999886543 34567899999999999999999999999743   47899


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ++|++.|+|.||++..+   ..+..+..+.|..|||+||.|||++.   ++||||..+|||++.-..+||.|||+++...
T Consensus       776 tq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            99999999999998643   45788999999999999999999998   9999999999999999999999999999988


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....+......-.+.|||-|.+....|+.++|||||||++||++| |..|++.....       -+..+++.++++   
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------eI~dlle~geRL---  919 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------EIPDLLEKGERL---  919 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------HhhHHHhccccC---
Confidence            7776666666667889999999999999999999999999999999 99998754322       223344444433   


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                             ..|+.+...++.++.+||..|++.||+++++...+..+.+
T Consensus       920 -------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  920 -------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             -------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                   3466677779999999999999999999999988876643

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-41  Score=319.55  Aligned_cols=264  Identities=25%  Similarity=0.418  Sum_probs=199.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEECC---------------CcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSD---------------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVG  160 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~  160 (443)
                      ++|++.+.||+|+||.||++...+               ...||+|.++.... .....|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987532               23589999875432 22456899999999999999999999


Q ss_pred             eeecCCCCeeEEEEeecCCCChhHhhcCCCC--------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCccc
Q 013404          161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLG--------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN  232 (443)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  232 (443)
                      ++.  .....+++|||+++++|.+++.....        ....+++.+++.++.|++.||+|||+.+   ++|+||||+|
T Consensus        85 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N  159 (295)
T cd05097          85 VCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN  159 (295)
T ss_pred             EEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence            987  44578999999999999999864211        1124788999999999999999999998   9999999999


Q ss_pred             EEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 013404          233 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQPS  310 (443)
Q Consensus       233 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt--g~~p~~~~~~~  310 (443)
                      |++++++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++  |..||..... 
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-  238 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-  238 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence            9999999999999999986544332222233456778999999998899999999999999999998  5667754321 


Q ss_pred             CcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          311 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                        ......................   ...++    ..+.+++.+||+.||++||++++|++.|+
T Consensus       239 --~~~~~~~~~~~~~~~~~~~~~~---~~~~~----~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 --EQVIENTGEFFRNQGRQIYLSQ---TPLCP----SPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHHHHHHhhhhccccccCCC---CCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              1111111111111111000000   11122    35889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-41  Score=332.99  Aligned_cols=263  Identities=22%  Similarity=0.261  Sum_probs=196.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ..+|++.+.||+|+||.||++.. .+++.||+|...      ...+.+|++++++++||||+++++++..  ....++++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~  162 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLIL  162 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEEE
Confidence            36799999999999999999995 578899999753      3457889999999999999999999874  44789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      |++. ++|.+++..    ...+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       163 e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        163 PRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             ecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            9995 689988864    235889999999999999999999998   99999999999999999999999999975432


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHHhhccc------
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKD------  327 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~------  327 (443)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........+.....      
T Consensus       235 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        235 INAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            2111 123457999999999999999999999999999999999999887432211100 00000000000000      


Q ss_pred             ------ccccc---------ccCccCCCC--CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          328 ------RLEEL---------ADPRLGGKY--PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       328 ------~~~~~---------~d~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                            .+...         ..+......  .......+.+++.+||+.||++|||++|++++-+
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence                  00000         000000000  0112345788999999999999999999998754

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.6e-41  Score=314.16  Aligned_cols=255  Identities=31%  Similarity=0.447  Sum_probs=203.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||+|...++..||+|.++... ...+.|.+|++++++++||||+++++++.   ....+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e   80 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTE   80 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEEEEE
Confidence            35689999999999999999998776789999987533 34567999999999999999999999864   235789999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++....  ...+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            999999999997532  335789999999999999999999998   999999999999999999999999999866433


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ... ......++..|+|||+..+..++.++||||||+++|||++ |..||......      .....+.. ..       
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~-~~-------  220 (262)
T cd05071         156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVER-GY-------  220 (262)
T ss_pred             ccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhc-CC-------
Confidence            221 1223346778999999998899999999999999999999 88888643211      11111111 00       


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                         ....+......+.+++.+||+.+|++||+++++++.|+..
T Consensus       221 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 ---RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence               0011223344588999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7e-41  Score=320.23  Aligned_cols=265  Identities=27%  Similarity=0.415  Sum_probs=203.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC-----------------CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD-----------------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVK  157 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~  157 (443)
                      ..+|++.+.||+|+||.||++...+                 +..||+|.+...... ..+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578999999999999999988542                 245899998755332 3467889999999999999999


Q ss_pred             EEEeeecCCCCeeEEEEeecCCCChhHhhcCCCC-------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCc
Q 013404          158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG-------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA  230 (443)
Q Consensus       158 l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  230 (443)
                      ++++|..  ....+++|||+++++|.+++.....       ....+++..++.++.|++.||+|||+.+   ++|+||||
T Consensus        84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp  158 (296)
T cd05051          84 LLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT  158 (296)
T ss_pred             EEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence            9999874  3578999999999999999975431       1235899999999999999999999998   99999999


Q ss_pred             ccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 013404          231 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQ  308 (443)
Q Consensus       231 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt--g~~p~~~~~  308 (443)
                      +||++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999999986644333222334456789999999998889999999999999999998  677775322


Q ss_pred             CCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          309 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                         ....................       ...+......+.+++.+||+.||++||++.||++.|+
T Consensus       239 ---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 ---DQQVIENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---hHHHHHHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               11112222111111110000       0111122245899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-41  Score=319.62  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=202.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+..... .....+.+|+.+++.++||||+++++++..  ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST--GQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--CC
Confidence            457889999999999999999853      236899999865432 224578899999999999999999999874  45


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCC------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceE
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGV------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK  242 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  242 (443)
                      ..+++|||+++|+|.+++......      ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence            789999999999999999643221      234788999999999999999999998   99999999999999999999


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||.....   .....+.  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~--  234 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV--  234 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH--
Confidence            999999986644332222233456789999999998889999999999999999998 9999864322   1111111  


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                        .....      .    ..+......+.+++.+||+.+|++|||+.++++.|+
T Consensus       235 --~~~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 --IDGGH------L----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --hcCCC------C----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence              11110      0    111122345889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=334.18  Aligned_cols=255  Identities=25%  Similarity=0.342  Sum_probs=198.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+++. .+|+.||||++....   ......+.+|+.++..++||||+++++++.  +....++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~l   78 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ--DENYLYL   78 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCeEEE
Confidence            4789999999999999999995 468999999997432   223356788999999999999999999987  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        79 v~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          79 IMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             EECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence            9999999999999964    235899999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCcc------------------------------------ccccccccCcccccccccccCCCCchhhHHHHHHHHHH
Q 013404          253 PEGRTN------------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLE  296 (443)
Q Consensus       253 ~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~e  296 (443)
                      ......                                    .......||+.|+|||++....++.++|||||||++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence            321100                                    00112469999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHH
Q 013404          297 LLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT---MGEVVQS  373 (443)
Q Consensus       297 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~  373 (443)
                      |++|..||......      .....+......+   ..+. ...++    ..+.+++.+|+. +|.+|++   +++++++
T Consensus       232 l~~G~~Pf~~~~~~------~~~~~i~~~~~~~---~~~~-~~~~s----~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         232 MLVGYPPFCSDNPQ------ETYRKIINWKETL---QFPD-EVPLS----PEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             hhcCCCCCCCCCHH------HHHHHHHcCCCcc---CCCC-CCCCC----HHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99999999743321      1111111111111   0000 00122    246788889997 8999998   9999887


Q ss_pred             HH
Q 013404          374 LK  375 (443)
Q Consensus       374 L~  375 (443)
                      -+
T Consensus       297 ~~  298 (364)
T cd05599         297 PF  298 (364)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.4e-41  Score=320.00  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=201.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|...++||+|+||.||++...      ++..+|+|.+..........|.+|+++++.++|+||+++++++..  ....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   82 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRPL   82 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCce
Confidence            56788899999999999999732      356899999876555556789999999999999999999999874  4478


Q ss_pred             EEEEeecCCCChhHhhcCCCC-----------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          171 LLCYELVPNGSLESWLHGPLG-----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                      +++|||+++++|.+++.....           ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence            999999999999999964321           1135889999999999999999999999   99999999999999999


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~  318 (443)
                      .+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......      ..
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~  233 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------EA  233 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------HH
Confidence            999999999976543322212223345788999999999999999999999999999998 89998533221      11


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ....... ..      ......++    ..+.+++.+||+.||++||++++|++.|+
T Consensus       234 ~~~~~~~-~~------~~~~~~~~----~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 IECITQG-RE------LERPRTCP----PEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHcC-cc------CCCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            1111111 00      01111223    34789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.5e-41  Score=315.19  Aligned_cols=255  Identities=25%  Similarity=0.372  Sum_probs=200.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ..+|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..  ....++||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv~   85 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWICM   85 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEEE
Confidence            35799999999999999999995 5788999999976544455678899999999999999999999874  44789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.++++.    ...+++.++..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          86 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999999864    235889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ...  ......++..|+|||.+.   ...++.++|||||||++|||++|+.||....+.....  .     . ...   .
T Consensus       159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-----~-~~~---~  225 (267)
T cd06646         159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-----M-SKS---N  225 (267)
T ss_pred             ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-----e-ecC---C
Confidence            221  123346888999999874   3457889999999999999999999985332211100  0     0 000   0


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ...+....  .......+.+++.+||+.+|++||++++++++|
T Consensus       226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            01111110  111224588999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-40  Score=324.60  Aligned_cols=263  Identities=27%  Similarity=0.404  Sum_probs=204.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC--------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD  166 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  166 (443)
                      .+|.+.+.||+|+||.||++...        .+..||+|.++.... ...+.+.+|+++++++ +||||++++++|..  
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--
Confidence            46889999999999999999742        123689998875432 2346789999999999 79999999999873  


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEE
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  234 (443)
                      ....++++||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+++   ++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence            4478999999999999999964321            1235888999999999999999999998   999999999999


Q ss_pred             ecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 013404          235 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQE  313 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~  313 (443)
                      ++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....     
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----  241 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----  241 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----
Confidence            99999999999999986644322212222345678999999999999999999999999999998 888885332     


Q ss_pred             hHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          314 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                       ...+...+... ...          ..+......+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus       242 -~~~~~~~~~~~-~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         242 -VEELFKLLKEG-HRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             -HHHHHHHHHcC-CCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence             22222222111 100          111122335889999999999999999999999998886533

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.8e-41  Score=313.41  Aligned_cols=247  Identities=27%  Similarity=0.432  Sum_probs=194.6

Q ss_pred             eeeecCcEEEEEEEE---CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          104 ILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       104 ~lg~G~fg~V~~~~~---~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      .||+|+||.||+|.+   .++..+|+|+++.....  ..+.+.+|+.+++.+.||||+++++++.   ....+++|||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEecCC
Confidence            589999999999974   35788999998754322  2467899999999999999999999875   235789999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcc
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN  258 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  258 (443)
                      +|+|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||.||++++++.+||+|||+++........
T Consensus        79 ~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          79 LGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            9999999964    235889999999999999999999998   999999999999999999999999999876543321


Q ss_pred             cc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCc
Q 013404          259 YL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR  336 (443)
Q Consensus       259 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  336 (443)
                      .. .....++..|+|||.+....++.++|||||||++|||++ |..||.....   .   .+... ......      + 
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~---~~~~~-i~~~~~------~-  217 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---N---EVTQM-IESGER------M-  217 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H---HHHHH-HHCCCC------C-
Confidence            11 122344678999999988889999999999999999998 9999964321   1   11111 111110      1 


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                         ..+......+.+++.+||+.||++||++++|.+.|+..
T Consensus       218 ---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         218 ---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence               11222334588999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=331.78  Aligned_cols=243  Identities=26%  Similarity=0.395  Sum_probs=202.0

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCe
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  169 (443)
                      ..++|.+.++||+|+||+|+++... +++.+|||.+++..   ..+.+..+.|.+++.-. +||.+++++.+|+.  ..+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~  443 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEH  443 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--CCe
Confidence            4578999999999999999999954 68899999998764   34456788899998877 59999999998874  458


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      +++||||+.||++..+.+     ...+++..+.-++..|+.||.|||+++   ||+||||.+|||||.+|.+||+|||++
T Consensus       444 l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             EEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence            999999999999665554     345899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      +......  ..++.++||+.|||||++.+..|+...|-|||||+||||+.|..||.+++.+      +.+..++.+.   
T Consensus       516 Ke~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------e~FdsI~~d~---  584 (694)
T KOG0694|consen  516 KEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------EVFDSIVNDE---  584 (694)
T ss_pred             cccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCC---
Confidence            8654222  2456789999999999999999999999999999999999999999754432      2222333321   


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM  367 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  367 (443)
                               ..+|.-...+...++.++|..+|++|--+
T Consensus       585 ---------~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 ---------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                     13444445557889999999999999865

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.7e-40  Score=320.77  Aligned_cols=242  Identities=26%  Similarity=0.394  Sum_probs=189.5

Q ss_pred             ceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||+|... +++.||+|.++...   ....+.+..|..++..+ +||||+++++++.  .....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence            46999999999999964 67899999987532   22334566677777654 8999999999887  445889999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        79 ~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-  150 (316)
T cd05592          79 NGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-  150 (316)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence            99999999864    235889999999999999999999998   9999999999999999999999999997643322 


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+....        +. 
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~--------~~-  214 (316)
T cd05592         151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSILNDR--------PH-  214 (316)
T ss_pred             -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC--------CC-
Confidence             122345799999999999999999999999999999999999999974321      11111111111        11 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~~  373 (443)
                         ++......+.+++.+||+.||++||++. +++++
T Consensus       215 ---~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         215 ---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             ---CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence               1112223477899999999999999875 56554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.1e-41  Score=313.44  Aligned_cols=254  Identities=28%  Similarity=0.464  Sum_probs=203.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... .....|.+|+.++++++|+|++++++++.   ....+++||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e   80 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIITE   80 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEEE
Confidence            46788999999999999999998888999999987543 34568999999999999999999999864   236899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++....  ...+++.+++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            999999999986533  346889999999999999999999998   999999999999999999999999999766532


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ... ......++..|+|||++....++.++||||||+++||+++ |+.||.....   .....   .+ .....      
T Consensus       156 ~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~---~~-~~~~~------  221 (260)
T cd05067         156 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQ---NL-ERGYR------  221 (260)
T ss_pred             Ccc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHH---HH-HcCCC------
Confidence            211 1223346778999999998889999999999999999999 9999964321   11111   11 11100      


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      .    ..+......+.+++.+||+.+|++||+++++++.|+.
T Consensus       222 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 M----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            0    1111122358899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.7e-41  Score=325.23  Aligned_cols=243  Identities=26%  Similarity=0.362  Sum_probs=193.1

Q ss_pred             ceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||++... +++.||+|.+....   ......+..|..++..+ +||||+++++++.  +....++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence            46999999999999964 68899999987431   23345677888888877 6999999999987  445889999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          79 NGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             CCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence            99999999864    235889999999999999999999999   99999999999999999999999999875432211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....          
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~----------  213 (320)
T cd05590         152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEV----------  213 (320)
T ss_pred             --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCC----------
Confidence              22345799999999999999999999999999999999999999974331      122222222111          


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQSL  374 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~L  374 (443)
                        ..+......+.+++.+||+.||++||++      ++++++-
T Consensus       214 --~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~  254 (320)
T cd05590         214 --VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHP  254 (320)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence              0111122347899999999999999998      7777653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1e-40  Score=323.59  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=194.2

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCC-ceeeEEEeeecCCCCeeEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHR-NLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~l  172 (443)
                      +|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+..|++++..+.|+ +|+++++++.  +....++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEEEE
Confidence            5788999999999999999954 57899999987432   23345688899999999765 5778888876  3447899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05587          79 VMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN  151 (324)
T ss_pred             EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence            9999999999999864    235889999999999999999999998   999999999999999999999999998753


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+....      
T Consensus       152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~~------  217 (324)
T cd05587         152 IFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQSIMEHN------  217 (324)
T ss_pred             CCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC------
Confidence            22211  12345799999999999999999999999999999999999999964321      11111111111      


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS  373 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~  373 (443)
                        .    .++......+.+++.+||+.||.+|++.     ++++++
T Consensus       218 --~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         218 --V----SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             --C----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              1    1111222347889999999999999986     676655

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-40  Score=317.52  Aligned_cols=264  Identities=25%  Similarity=0.417  Sum_probs=199.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-----------------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-----------------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKL  158 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  158 (443)
                      ++|++.+.||+|+||.||++...                 ++..||+|.+..... .....|.+|+++++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998532                 234689999875432 234679999999999999999999


Q ss_pred             EEeeecCCCCeeEEEEeecCCCChhHhhcCCCCC-------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcc
Q 013404          159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV-------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS  231 (443)
Q Consensus       159 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~  231 (443)
                      ++++..  ....+++|||+++|+|.+++......       ...+++.++..++.|++.||+|||+.+   ++|+||||+
T Consensus        85 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~  159 (296)
T cd05095          85 LAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR  159 (296)
T ss_pred             EEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence            999874  44789999999999999999653211       234788899999999999999999999   999999999


Q ss_pred             cEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCC
Q 013404          232 NILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT--GRKPVDMSQP  309 (443)
Q Consensus       232 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt--g~~p~~~~~~  309 (443)
                      |||++.++.++|+|||+++...............++..|++||....+.++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            99999999999999999986544332222223345678999999888899999999999999999998  6788853322


Q ss_pred             CCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .   ...............  ....+     .+..+...+.+++.+||+.||++||++.+|++.|+
T Consensus       240 ~---~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 E---QVIENTGEFFRDQGR--QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H---HHHHHHHHHHhhccc--cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1   111111111111100  00001     11122245889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.3e-41  Score=326.08  Aligned_cols=249  Identities=22%  Similarity=0.361  Sum_probs=194.1

Q ss_pred             ceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||++... +++.||+|.++...   ......+..|+.++.++ +||||+++++++.  +....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE--eCCEEEEEEeCC
Confidence            46999999999999954 67899999997542   22334577899988877 7999999999987  445889999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~  151 (329)
T cd05618          79 NGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  151 (329)
T ss_pred             CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence            99999998864    245889999999999999999999999   99999999999999999999999999975432211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC--cchHHHHHHHHhhccccccccccC
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG--QENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.........        
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------  221 (329)
T cd05618         152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------  221 (329)
T ss_pred             --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------
Confidence              1234579999999999999999999999999999999999999996322111  1112222222211110        


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCC------HHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPT------MGEVVQS  373 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~~  373 (443)
                         ..++......+.+++.+||+.||++||+      +.++++|
T Consensus       222 ---~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         222 ---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               0122222345789999999999999998      5788766

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-41  Score=325.46  Aligned_cols=238  Identities=26%  Similarity=0.343  Sum_probs=190.1

Q ss_pred             ceeeecCcEEEEEEEE----CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404          103 SILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+..|++++++++||||+++++++.  +....++||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ--TEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCEEEEEEcC
Confidence            6799999999999874    3578999999875322  22345778999999999999999999987  44588999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        80 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          80 LRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            999999999964    335899999999999999999999999   9999999999999999999999999998654332


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCc
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR  336 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  336 (443)
                      .  ......|++.|+|||.+.+..++.++|||||||++|||++|+.||.....      ......+.....         
T Consensus       153 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~~---------  215 (318)
T cd05582         153 K--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAKL---------  215 (318)
T ss_pred             C--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCCC---------
Confidence            1  12345789999999999988899999999999999999999999964321      111111211111         


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 013404          337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE  369 (443)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  369 (443)
                         ..+......+.+++.+||+.||++||++.+
T Consensus       216 ---~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 ---GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence               111122234788999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-40  Score=319.11  Aligned_cols=252  Identities=22%  Similarity=0.362  Sum_probs=203.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++..  ....++|||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv~e   97 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVME   97 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEeec
Confidence            5788899999999999999985 5688999999986655556788999999999999999999999874  458899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++..     ..+++.++..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             ccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            9999999999863     34788999999999999999999998   999999999999999999999999998765432


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  ......+++.|+|||.+.+..++.++|||||||++|||++|+.||....+..     .+. .......       +
T Consensus       170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~-~~~~~~~-------~  234 (296)
T cd06654         170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALY-LIATNGT-------P  234 (296)
T ss_pred             cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHH-HHhcCCC-------C
Confidence            21  1223468899999999998889999999999999999999999996543211     111 1111100       0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .  ...+......+.+++.+||..+|++||++.+++++-+
T Consensus       235 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~  272 (296)
T cd06654         235 E--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (296)
T ss_pred             C--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence            0  0112222345789999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-40  Score=319.60  Aligned_cols=260  Identities=27%  Similarity=0.411  Sum_probs=200.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCc--EEEEEEeccCC-CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|++.+.||+|+||.||+|... ++.  .+++|.++... ....+.|.+|++++.++ +||||+++++++.  +....+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE--NRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc--cCCcce
Confidence            57889999999999999999864 333  47888887432 22345789999999999 7999999999986  344789


Q ss_pred             EEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          172 LCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                      +++||+++|+|.++++....            ....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCC
Confidence            99999999999999964321            1235889999999999999999999998   99999999999999999


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~  318 (443)
                      .+||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||.....      ...
T Consensus       157 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~  227 (297)
T cd05089         157 ASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AEL  227 (297)
T ss_pred             eEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence            99999999986432211   1111233567999999998899999999999999999997 9999964322      111


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      .......           .....+......+.+++.+||+.+|.+||+++++++.|+.+.+..
T Consensus       228 ~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         228 YEKLPQG-----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHHHhcC-----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1111111           000111122235789999999999999999999999998876544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-40  Score=312.11  Aligned_cols=248  Identities=26%  Similarity=0.439  Sum_probs=194.5

Q ss_pred             eeeecCcEEEEEEEEC---CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCC
Q 013404          104 ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN  179 (443)
Q Consensus       104 ~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~  179 (443)
                      .||+|+||.||+|.+.   ++..||+|.+...... ..+.|.+|+.++++++||||+++++++.   ....++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCCC
Confidence            3899999999999853   3557999998755332 2456899999999999999999999875   2367899999999


Q ss_pred             CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccc
Q 013404          180 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY  259 (443)
Q Consensus       180 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  259 (443)
                      ++|.+++...   ...+++.+++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+++.........
T Consensus        79 ~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          79 GPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            9999999643   235899999999999999999999998   9999999999999999999999999998654332211


Q ss_pred             c-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          260 L-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       260 ~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                      . .....++..|+|||.+....++.++|||||||++||+++ |..||.....      ..+.. .+.....         
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~~---------  216 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVMS-FIEQGKR---------  216 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHHH-HHHCCCC---------
Confidence            1 122234678999999988889999999999999999996 9999964321      11111 1111111         


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                       ...+......+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       217 -~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 -LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             112222334588999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9e-41  Score=328.94  Aligned_cols=202  Identities=27%  Similarity=0.388  Sum_probs=172.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++.. .+++.||+|++....   ......+.+|+.++.+++||||+++++++.  +....++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~--~~~~~~l   78 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ--DKLNLYL   78 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCeEEE
Confidence            4789999999999999999985 468899999996432   122356788999999999999999999987  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          79 IMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9999999999999974    345899999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCcc---------------------------------ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh
Q 013404          253 PEGRTN---------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT  299 (443)
Q Consensus       253 ~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt  299 (443)
                      ......                                 .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence            321100                                 00123579999999999999999999999999999999999


Q ss_pred             CCCCCCCC
Q 013404          300 GRKPVDMS  307 (443)
Q Consensus       300 g~~p~~~~  307 (443)
                      |+.||...
T Consensus       232 G~~Pf~~~  239 (363)
T cd05628         232 GYPPFCSE  239 (363)
T ss_pred             CCCCCCCC
Confidence            99999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.5e-41  Score=325.01  Aligned_cols=242  Identities=26%  Similarity=0.367  Sum_probs=188.0

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHH-HHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      ++||+|+||.||+|+. .+++.||+|.+....   ......+..|.. +++.++||||+++++++.  +....++||||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~   78 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDYV   78 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcCC
Confidence            4699999999999996 468899999986432   122334555554 578899999999999887  445889999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          79 NGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence            99999988864    235788899999999999999999998   99999999999999999999999999875322211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+      .......+.....          
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~----------  213 (321)
T cd05603         152 --TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHKPL----------  213 (321)
T ss_pred             --ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcCCC----------
Confidence              2234578999999999999899999999999999999999999996432      1122222221110          


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHH----HHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG----EVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~----evl~~  373 (443)
                        ..+......+.+++.+||+.||.+||+..    +++++
T Consensus       214 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         214 --QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence              11222233578999999999999999764    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.5e-41  Score=332.06  Aligned_cols=255  Identities=23%  Similarity=0.310  Sum_probs=195.1

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      +|+..+.||+|+||.||+|+. .+++.||+|++....   ......+.+|++++++++||||+++++++.  +....++|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lv   79 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFV   79 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe--cCCEEEEE
Confidence            588899999999999999985 568899999996532   223456889999999999999999999987  44589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~  152 (381)
T cd05626          80 MDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR  152 (381)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence            9999999999999642    35788999999999999999999999   9999999999999999999999999976431


Q ss_pred             CCCc---------------------------------------------cccccccccCcccccccccccCCCCchhhHH
Q 013404          254 EGRT---------------------------------------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVY  288 (443)
Q Consensus       254 ~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~  288 (443)
                      ....                                             ........||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (381)
T cd05626         153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW  232 (381)
T ss_pred             cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence            1000                                             0001235799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHH--ccCcCCCCCCC
Q 013404          289 SYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAA--CVAPEANQRPT  366 (443)
Q Consensus       289 S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~--cl~~dp~~RPs  366 (443)
                      ||||++|||++|+.||........      ...+......+.   -+. ...++.    .+.+++.+  |+..++..||+
T Consensus       233 SlG~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~---~~~-~~~~s~----~~~dli~~ll~~~~~~~~R~~  298 (381)
T cd05626         233 SVGVILFEMLVGQPPFLAPTPTET------QLKVINWENTLH---IPP-QVKLSP----EAVDLITKLCCSAEERLGRNG  298 (381)
T ss_pred             ehhhHHHHHHhCCCCCcCCCHHHH------HHHHHccccccC---CCC-CCCCCH----HHHHHHHHHccCcccccCCCC
Confidence            999999999999999975432111      111111111000   000 011223    35677776  55666667999


Q ss_pred             HHHHHHHHH
Q 013404          367 MGEVVQSLK  375 (443)
Q Consensus       367 ~~evl~~L~  375 (443)
                      ++++++|-+
T Consensus       299 ~~~~l~hp~  307 (381)
T cd05626         299 ADDIKAHPF  307 (381)
T ss_pred             HHHHhcCcc
Confidence            999998743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=313.26  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=200.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC-----CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ-----GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ++|++.+.||+|+||.||++.. .+++.||+|.+......     ....+.+|++++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   79 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL   79 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence            5789999999999999999985 46899999998644221     23468889999999999999999999874  4489


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++++||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++
T Consensus        80 ~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          80 SIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             EEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence            999999999999999864    235788999999999999999999999   9999999999999999999999999997


Q ss_pred             cCCCCCcccc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      .......... .....++..|+|||++.+..++.++||||||+++|||++|+.||...+..     ... .......   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~-~~~~~~~---  223 (263)
T cd06625         153 RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAI-FKIATQP---  223 (263)
T ss_pred             eccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHH-HHHhccC---
Confidence            6543221110 12345788999999999989999999999999999999999999643211     111 1111110   


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                             .....+......+.+++.+||..+|++||++.+++++.
T Consensus       224 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         224 -------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             -------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                   01112222333578999999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-40  Score=322.55  Aligned_cols=242  Identities=26%  Similarity=0.347  Sum_probs=189.3

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHH-HHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||+|.. .+|+.||+|.+....   ......+..|.. +++.++||||+++++++.  +....++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~--~~~~~~lv~e~~   78 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TADKLYFVLDYV   78 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE--eCCEEEEEEcCC
Confidence            4699999999999996 478999999986432   122344555555 467789999999999887  445889999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.......
T Consensus        79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence            99999999864    335888999999999999999999999   99999999999999999999999999875432211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+      .......+.....        .+
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~--------~~  215 (323)
T cd05575         152 --TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNKPL--------RL  215 (323)
T ss_pred             --ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcCCC--------CC
Confidence              2234579999999999999999999999999999999999999996432      1222222222111        11


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHH----HHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG----EVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~----evl~~  373 (443)
                      ....    ...+.+++.+||+.||.+||++.    +++++
T Consensus       216 ~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         216 KPNI----SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             CCCC----CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence            1122    23478999999999999999884    66554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-40  Score=321.90  Aligned_cols=264  Identities=25%  Similarity=0.419  Sum_probs=204.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC--------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR  165 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  165 (443)
                      .++|.+.+.||+|+||.||+++..        ....+|+|.++.... .....+..|+++++++ +||||++++++|.  
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence            357888999999999999999742        245799999875432 2345688999999999 6999999999987  


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                      +....+++|||+++|+|.+++.....            ....+++.++..++.|++.||.|||+++   ++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            34478999999999999999965321            1245889999999999999999999998   99999999999


Q ss_pred             EecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 013404          234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ  312 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~  312 (443)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....   
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---  242 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---  242 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999999999999999986643322211222334568999999999899999999999999999999 8888864321   


Q ss_pred             chHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                         ..... ........          ..+......+.+++.+||+.+|++||++.++++.|+.+....
T Consensus       243 ---~~~~~-~~~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         243 ---EELFK-LLREGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             ---HHHHH-HHHcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence               11111 11111110          111222335789999999999999999999999999886644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1e-40  Score=318.13  Aligned_cols=261  Identities=26%  Similarity=0.401  Sum_probs=201.5

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      .+++|++.+.||+|+||.||+|...      .+..||+|.+...... ....+.+|+.+++.++||||+++++++..  .
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--G   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence            4578999999999999999999743      2457999988644322 23468889999999999999999999873  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCC------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCce
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLG------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA  241 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  241 (443)
                      ...+++|||+++|+|.+++.....      ....+++..+..++.|++.||.|||+++   |+||||||+||++++++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence            478999999999999999964221      1234567888999999999999999998   9999999999999999999


Q ss_pred             EEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 013404          242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  320 (443)
                      +|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....      .+...
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~  232 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLK  232 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH
Confidence            9999999986544332222223345778999999999899999999999999999999 7888864321      11111


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      .+.. ....          ..+......+.+++.+||+.||++||++.++++.|+..
T Consensus       233 ~~~~-~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 FVMD-GGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHc-CCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1111 1100          01112234588999999999999999999999888765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.4e-40  Score=310.65  Aligned_cols=253  Identities=30%  Similarity=0.448  Sum_probs=201.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|||++++++++.   ....+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEEEEc
Confidence            4688889999999999999998777789999886433 34567899999999999999999999874   2357899999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.++++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          82 MGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            99999999997532  335789999999999999999999998   9999999999999999999999999997654322


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......++..|+|||...+..++.++||||||+++|||++ |+.||......   ....+   +... ..       
T Consensus       157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~---~~~~-~~-------  221 (260)
T cd05069         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ---VERG-YR-------  221 (260)
T ss_pred             cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHcC-CC-------
Confidence            11 1122346778999999998899999999999999999999 89998643211   11111   1111 00       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                         ...+......+.+++.+||+.||++||++++|++.|+.
T Consensus       222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               01122233458899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.5e-41  Score=331.01  Aligned_cols=256  Identities=23%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ..++|++.+.||+|+||.||+++. .+++.||+|.+...   .......+.+|+.+++.++||||+++++++.  +....
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~~  118 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKYL  118 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCEE
Confidence            346899999999999999999995 46889999998642   1223455788999999999999999999887  45589


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence            999999999999999863     24788889999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      ....... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....      ......+....
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~  263 (370)
T cd05596         191 KMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHK  263 (370)
T ss_pred             eccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC
Confidence            6543221 112345799999999998653    478899999999999999999999974332      11122222211


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHHH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK  375 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L~  375 (443)
                      ..+.   .+.     .......+.+++.+||+.+|.+  ||+++|++++-+
T Consensus       264 ~~~~---~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         264 NSLT---FPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             CcCC---CCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence            1110   000     0012234788999999999988  999999998854

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.8e-41  Score=324.84  Aligned_cols=243  Identities=26%  Similarity=0.347  Sum_probs=193.6

Q ss_pred             ceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||+|+.. +++.||+|.++...   ......+..|.+++..+ +||||+++++++.  +....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEeCC
Confidence            46999999999999964 57899999987532   22345677899998876 7999999999987  445789999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          79 NGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence            99999999864    235889999999999999999999999   99999999999999999999999999875432221


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....          
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~~~~~----------  213 (321)
T cd05591         152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESILHDDV----------  213 (321)
T ss_pred             --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC----------
Confidence              22345799999999999999999999999999999999999999974332      112222222110          


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCC-------CHHHHHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRP-------TMGEVVQSL  374 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-------s~~evl~~L  374 (443)
                        ..+......+.+++..||+.||++||       ++++++++-
T Consensus       214 --~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp  255 (321)
T cd05591         214 --LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP  255 (321)
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence              01111123478899999999999999       888888774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=310.24  Aligned_cols=250  Identities=29%  Similarity=0.496  Sum_probs=202.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||.|+||.||++... |+.||+|.++.... ..+.+.+|+.++++++|+||+++++++..  ....+++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e   80 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTE   80 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEE
Confidence            357888999999999999999875 78899999976543 45789999999999999999999999874  457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++....  ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          81 YMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            999999999997532  235899999999999999999999999   999999999999999999999999999876332


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ..     ....+..|+|||++....++.++||||||+++||+++ |..||.....   ..+..    .......      
T Consensus       156 ~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~------  217 (256)
T cd05039         156 QD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP----HVEKGYR------  217 (256)
T ss_pred             cc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHhcCCC------
Confidence            11     2345668999999998899999999999999999997 9999864321   11111    1111100      


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          ...+......+.+++.+||+.+|++||++.++++.|+.
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 ----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                01111223458899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-40  Score=333.40  Aligned_cols=263  Identities=19%  Similarity=0.209  Sum_probs=194.5

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .+|.+.+.||+|+||.||++... .++.||||...      ...+.+|+++|++++|+|||++++++..  ....+++||
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv~e  240 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLVLP  240 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEEE
Confidence            36889999999999999999964 57889999643      2346789999999999999999999874  447899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      ++. ++|.+++...   ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            994 7999988643   235899999999999999999999999   999999999999999999999999999865433


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CCCcchHHHHHHHHhhcccc----cc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ-PSGQENLVTWARPILRDKDR----LE  330 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~----~~  330 (443)
                      ..........||..|+|||++.+..++.++|||||||+||||++|..|+.... ..........+..++.....    ..
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            22222234579999999999999999999999999999999999887653221 11111111111111111000    00


Q ss_pred             cc----------------ccCccCCCCCH---HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          331 EL----------------ADPRLGGKYPK---EDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       331 ~~----------------~d~~~~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ..                ..+........   .....+.+|+.+||+.||.+|||+.|++++-
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp  456 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP  456 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence            00                00000000000   1112477899999999999999999999873

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-40  Score=317.80  Aligned_cols=258  Identities=27%  Similarity=0.410  Sum_probs=201.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||++...      ++..||+|.+..... .....|.+|+.++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV--GK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CC
Confidence            467999999999999999999853      467899999875432 224578999999999999999999999874  44


Q ss_pred             eeEEEEeecCCCChhHhhcCCC------------------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCc
Q 013404          169 QHLLCYELVPNGSLESWLHGPL------------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA  230 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  230 (443)
                      ..+++|||+++|+|.+++....                  .....+++.+++.++.|++.||+|||+.+   ++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence            7899999999999999996321                  11235788999999999999999999998   99999999


Q ss_pred             ccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 013404          231 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP  309 (443)
Q Consensus       231 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~  309 (443)
                      +||++++++.++|+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999876543322111222345678999999998899999999999999999998 8888853221


Q ss_pred             CCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                            ......+. .....          ..+......+.+++.+||+.+|++||++.|+++.|+
T Consensus       239 ------~~~~~~~~-~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         239 ------EEVIYYVR-DGNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ------HHHHHHHh-cCCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                  12221111 11100          111222345889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.2e-41  Score=318.13  Aligned_cols=268  Identities=28%  Similarity=0.419  Sum_probs=206.1

Q ss_pred             cCHHHHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeec
Q 013404           87 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS  164 (443)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  164 (443)
                      +.++.+....++|++.+.||+|+||.||++.. .+++.+|+|.+... ......+.+|+.+++++ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34455666788999999999999999999985 46789999987643 22345788899999999 69999999998753


Q ss_pred             ---CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCce
Q 013404          165 ---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA  241 (443)
Q Consensus       165 ---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  241 (443)
                         .+....+++|||+++++|.+++.........+++..+..++.|+++||.|||+.+   ++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence               2345689999999999999988643333456889999999999999999999998   9999999999999999999


Q ss_pred             EEccccccccCCCCCccccccccccCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 013404          242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV  316 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~  316 (443)
                      ||+|||+++.......  ......|+..|+|||++..     ..++.++|||||||++|||++|+.||....+..  .+.
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~  239 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF  239 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh
Confidence            9999999986543221  1233468999999998753     457889999999999999999999996433211  000


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                          ... . .......+       +......+.+++.+||+.||++||++.||++++.
T Consensus       240 ----~~~-~-~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         240 ----KIP-R-NPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             ----hcc-c-cCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence                000 0 00001111       1111234789999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-40  Score=319.52  Aligned_cols=257  Identities=23%  Similarity=0.298  Sum_probs=195.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+++. .+++.||+|.+...   .....+.+.+|+.++..++|+||+++++++.  +....++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l   78 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYL   78 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEE
Confidence            4789999999999999999995 46899999998642   1223456888999999999999999999987  4458999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        79 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  152 (331)
T cd05597          79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRL  152 (331)
T ss_pred             EEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence            99999999999999642   235889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCccccccccccCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ..... .......||+.|+|||++..     ..++.++|||||||++|||++|+.||....      .......+.....
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~~~~~i~~~~~  225 (331)
T cd05597         153 LADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKE  225 (331)
T ss_pred             CCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHHHHHHHHcCCC
Confidence            43322 11223469999999999863     457889999999999999999999996432      1222222222111


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCC--CCCCHHHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEAN--QRPTMGEVVQSLK  375 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~--~RPs~~evl~~L~  375 (443)
                      ... +  +.....++    ..+.+++.+|+..+++  .||++++++++-+
T Consensus       226 ~~~-~--~~~~~~~~----~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         226 HFQ-F--PPDVTDVS----EEAKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             ccc-C--CCccCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence            110 0  11111122    3467788887765443  3889999998844

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-40  Score=323.53  Aligned_cols=249  Identities=21%  Similarity=0.332  Sum_probs=194.8

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||++.. .+++.||+|.++....   ...+.+..|+.++.++ +||||+++++++.  +....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEeCC
Confidence            4699999999999995 4678999999975422   2235678899999888 6999999999887  445889999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          79 NGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence            99999998864    235899999999999999999999999   99999999999999999999999999875322211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+.........       .  
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~--  220 (327)
T cd05617         152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-------I--  220 (327)
T ss_pred             --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-------C--
Confidence              12345799999999999999999999999999999999999999965433222222223222221110       0  


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~  373 (443)
                        ..+......+.+++.+||+.||++||++      +++++|
T Consensus       221 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         221 --RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence              1121222347899999999999999984      577665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-40  Score=323.00  Aligned_cols=247  Identities=24%  Similarity=0.341  Sum_probs=194.9

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      +|++.+.||+|+||.||+|... +++.||+|.++...   ......+..|..++..+ +|++|+++++++.  +....++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ--TMDRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe--cCCEEEE
Confidence            5788999999999999999954 57899999987542   12234567788888877 5899999999887  4457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++.++..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        79 v~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~  151 (323)
T cd05616          79 VMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  151 (323)
T ss_pred             EEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence            9999999999999864    235889999999999999999999998   999999999999999999999999999754


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....     
T Consensus       152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~i~~~~~-----  218 (323)
T cd05616         152 MWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV-----  218 (323)
T ss_pred             CCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-----
Confidence            32211  12345799999999999999999999999999999999999999974332      111111211110     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS  373 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~  373 (443)
                             .++......+.+++.+||+.||++|++.     .++.++
T Consensus       219 -------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         219 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             -------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                   1122223457899999999999999985     666654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.3e-41  Score=308.45  Aligned_cols=269  Identities=23%  Similarity=0.326  Sum_probs=202.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCc-eeeEEEeeecCC----C
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRN-LVKLVGYYSSRD----S  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----~  167 (443)
                      ...|+..++||+|+||+||+|+ ..+|+.||+|++......  ......+|+.+|+.|+|+| ||.+.+++...+    .
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3456667889999999999999 557899999999866442  3456789999999999999 999999987533    1


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ..+++||||++. +|.+++.........++...+..++.|++.||+|||+++   |+||||||+|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence            367899999965 999999765432245777889999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      +|+...-....  .+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+...  ..++...++ .+..+
T Consensus       166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~-~lGtP  240 (323)
T KOG0594|consen  166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFR-LLGTP  240 (323)
T ss_pred             hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHH-HcCCC
Confidence            99976533322  2456789999999999887 789999999999999999999998875443  111221111 11111


Q ss_pred             c-----cccccccCc--cCCCC-CH-------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 D-----RLEELADPR--LGGKY-PK-------EDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 ~-----~~~~~~d~~--~~~~~-~~-------~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .     .+..+.+-.  ..... +.       .......+++.+||+.+|.+|.|++.++.|
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            0     000000100  00000 00       001256789999999999999999999986

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-40  Score=310.09  Aligned_cols=250  Identities=27%  Similarity=0.441  Sum_probs=199.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .+|++.+.||+|+||.||++... |..||+|.++..  ...+.|.+|+.++++++|+|++++++++.. +....++++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEEEEC
Confidence            47888999999999999999874 788999998643  235679999999999999999999997653 33467999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.+++....  ...+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999997532  234889999999999999999999998   9999999999999999999999999987654322


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                           ....++..|+|||++.+..++.++|||||||++|||++ |+.||....      .......+... .      .+
T Consensus       157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~-~------~~  218 (256)
T cd05082         157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKG-Y------KM  218 (256)
T ss_pred             -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcC-C------CC
Confidence                 22345668999999998899999999999999999998 999986322      12222211111 0      01


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      .    .+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus       219 ~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 D----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            1    1112233588999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.8e-41  Score=328.11  Aligned_cols=269  Identities=23%  Similarity=0.288  Sum_probs=200.3

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----  166 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  166 (443)
                      ...++|++.+.||+|+||.||++.. ..++.||||.+.....  .....+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999985 4688999999875432  23456888999999999999999999876432    


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ....+++|||+++ +|.+++..      .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence            2357899999965 77777642      3788999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch------------
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN------------  314 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~------------  314 (443)
                      |+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||..........            
T Consensus       164 g~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             cccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9998654321   1234578999999999999999999999999999999999999997543211100            


Q ss_pred             ----HHHHHHHHhhccccccccccCcc--------CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          315 ----LVTWARPILRDKDRLEELADPRL--------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       315 ----~~~~~~~~~~~~~~~~~~~d~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                          +................+..+..        ...........+.+++.+||+.||++|||+.|++++-+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~  313 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY  313 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence                00000011111000000000000        00011112345789999999999999999999998744

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.7e-40  Score=314.51  Aligned_cols=264  Identities=27%  Similarity=0.454  Sum_probs=203.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-----CCCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ..|++.+.||+|+||.||++.+     .++..||+|.++... ......+.+|++++++++|||++++.+++...+....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999974     357889999987543 2234678999999999999999999999876545578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +++|||+++++|.+++...   ...+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence            8999999999999999643   235899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---------CCcchHHHHHH
Q 013404          251 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLVTWAR  320 (443)
Q Consensus       251 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~---------~~~~~~~~~~~  320 (443)
                      ......... ......++..|+|||++.+..++.++||||||+++|||++++.|+.....         ........+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            765432211 12234567789999999888899999999999999999998776532110         00111111111


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                       ........          ..+......+.+++.+||+.+|++||+++++++.|+.+
T Consensus       238 -~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 -VLEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             -HHHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             11111100          11112234588999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1e-40  Score=314.99  Aligned_cols=256  Identities=29%  Similarity=0.466  Sum_probs=199.8

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC----C
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD----S  167 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----~  167 (443)
                      .++..|++.+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.++.++ +|+||+++++++...+    .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            3566788899999999999999995 468899999987543 3456788999999998 7999999999986432    2


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...+++|||+++++|.+++....  ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence            35789999999999999997532  345889999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI  322 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  322 (443)
                      ++........  ......|+..|+|||++.     ...++.++|||||||++|||++|+.||....+.     ..+.. .
T Consensus       157 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~-~  228 (272)
T cd06637         157 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL-I  228 (272)
T ss_pred             Cceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHH-H
Confidence            9986543221  123456899999999986     346788999999999999999999999633211     11110 0


Q ss_pred             hhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       323 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...  .....    ....++    ..+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~--~~~~~----~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 PRN--PAPRL----KSKKWS----KKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             hcC--CCCCC----CCCCcC----HHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            000  00000    111222    347899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-41  Score=332.11  Aligned_cols=255  Identities=22%  Similarity=0.294  Sum_probs=195.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++.. .+++.||||.+....   ....+.+.+|++++++++||||+++++++.  +....++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~l   78 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ--DAQYLYL   78 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCeeEE
Confidence            4788999999999999999985 578999999986432   222356888999999999999999999987  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        79 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~  151 (377)
T cd05629          79 IMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF  151 (377)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence            9999999999999964    235888999999999999999999999   999999999999999999999999999633


Q ss_pred             CCCCcc---------------------------------------------ccccccccCcccccccccccCCCCchhhH
Q 013404          253 PEGRTN---------------------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDV  287 (443)
Q Consensus       253 ~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv  287 (443)
                      ......                                             .......||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence            211000                                             00012469999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCC---
Q 013404          288 YSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR---  364 (443)
Q Consensus       288 ~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---  364 (443)
                      |||||++|||++|+.||......      .....+......+.   -+.. ..+    ...+.+++.+||+ +|.+|   
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~---~p~~-~~~----s~~~~dli~~lL~-~~~~r~~r  296 (377)
T cd05629         232 WSLGAIMFECLIGWPPFCSENSH------ETYRKIINWRETLY---FPDD-IHL----SVEAEDLIRRLIT-NAENRLGR  296 (377)
T ss_pred             EecchhhhhhhcCCCCCCCCCHH------HHHHHHHccCCccC---CCCC-CCC----CHHHHHHHHHHhc-CHhhcCCC
Confidence            99999999999999999643321      11111111111110   0100 011    2347789999998 66665   


Q ss_pred             CCHHHHHHHHH
Q 013404          365 PTMGEVVQSLK  375 (443)
Q Consensus       365 Ps~~evl~~L~  375 (443)
                      +++.|++++-+
T Consensus       297 ~~~~~~l~hp~  307 (377)
T cd05629         297 GGAHEIKSHPF  307 (377)
T ss_pred             CCHHHHhcCCC
Confidence            69999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-40  Score=321.27  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=190.4

Q ss_pred             ceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||+|... +|+.||+|.++...   ......+..|..++..+ +||||+++++++.  +....++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECCC
Confidence            46999999999999964 68899999987532   22345567788888765 8999999999987  445899999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05620          79 NGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN  151 (316)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence            99999999864    235889999999999999999999999   99999999999999999999999999875322211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   .   .....+...        .+..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~---~~~~~~~~~--------~~~~  215 (316)
T cd05620         152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---D---ELFESIRVD--------TPHY  215 (316)
T ss_pred             --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhC--------CCCC
Confidence              22345799999999999999999999999999999999999999964321   1   111111111        1111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~~  373 (443)
                      ...+    ...+.+++.+||+.||++||++. ++++|
T Consensus       216 ~~~~----~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         216 PRWI----TKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             CCCC----CHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            1112    23478899999999999999984 66654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-40  Score=321.32  Aligned_cols=242  Identities=26%  Similarity=0.380  Sum_probs=193.3

Q ss_pred             ceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||++... +++.||+|.++...   ......+..|++++..+ +||||+++++++.  +....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence            46999999999999964 57899999987532   22345677899999888 7999999999987  445899999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++...    ..+++.++..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        79 ~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          79 NGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence            999999998642    35899999999999999999999999   99999999999999999999999999875322211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||.....      ......+....        .  
T Consensus       152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~~--------~--  213 (318)
T cd05570         152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILEDE--------V--  213 (318)
T ss_pred             --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCC--------C--
Confidence              12335689999999999999999999999999999999999999964321      11112121111        0  


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~  373 (443)
                        .++......+.+++.+||+.||++||++     .+++++
T Consensus       214 --~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 --RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             --CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence              1111223357899999999999999999     888876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=309.89  Aligned_cols=255  Identities=29%  Similarity=0.452  Sum_probs=204.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||++..+++..||||.+.... ...+++.+|+.++++++|+||+++++++.  +....+++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e   81 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS--EEEPIYIVTE   81 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee--cCCceEEEEe
Confidence            46899999999999999999998888899999987543 34578999999999999999999999886  3447899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++....  ...+++.++..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||++......
T Consensus        82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccch
Confidence            999999999997533  345899999999999999999999998   999999999999999999999999999876532


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      .. .......++..|+|||.+.+..++.++||||||+++||+++ |+.||.....   ....   ...... ..      
T Consensus       157 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~---~~~~~~-~~------  222 (261)
T cd05034         157 EY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVL---EQVERG-YR------  222 (261)
T ss_pred             hh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH---HHHHcC-CC------
Confidence            11 11122335678999999998899999999999999999999 9999954321   1111   111110 00      


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          ...+......+.+++.+||+.+|++||+++++++.|+.
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 ----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                01111123358899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.6e-41  Score=329.74  Aligned_cols=256  Identities=23%  Similarity=0.300  Sum_probs=198.1

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ..++|++.+.||+|+||.||++... +++.||+|.+...   .......+.+|+.+++.++||||+++++++.  +....
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~~  118 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ--DDKYL  118 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEE
Confidence            3578999999999999999999964 6889999998642   1223456888999999999999999999987  44589


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++..     ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence            999999999999999963     24788999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      ....... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....      ......+....
T Consensus       191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~  263 (370)
T cd05621         191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHK  263 (370)
T ss_pred             ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC
Confidence            7643221 112345799999999998754    378899999999999999999999964321      11122222211


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHHH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK  375 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L~  375 (443)
                      ..+. +  +     ........+.+++..||+.++.+  ||++.|+++|-+
T Consensus       264 ~~~~-~--p-----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         264 NSLN-F--P-----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             cccC-C--C-----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence            1110 0  0     00111234678889999865544  899999998854

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-40  Score=320.03  Aligned_cols=242  Identities=28%  Similarity=0.415  Sum_probs=190.2

Q ss_pred             ceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||+|... +++.||+|.++...   ......+..|..++..+ +||||+++++++..  ....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence            46999999999999964 57899999987532   22345567788888764 89999999999874  45789999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          79 NGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence            99999999964    235889999999999999999999998   99999999999999999999999999875432211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||.....   ..+.   ..+...        .+..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~---~~i~~~--------~~~~  215 (316)
T cd05619         152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELF---QSIRMD--------NPCY  215 (316)
T ss_pred             --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHH---HHHHhC--------CCCC
Confidence              12345789999999999999999999999999999999999999964331   1111   111111        0111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~~  373 (443)
                          +......+.+++.+||+.||++||++. ++.++
T Consensus       216 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         216 ----PRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             ----CccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence                111223478899999999999999997 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.7e-40  Score=310.40  Aligned_cols=250  Identities=26%  Similarity=0.426  Sum_probs=201.6

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|+||.||++... +++.|++|.+....  ......+.+|++++++++|||++++++++.  +....+++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL--DKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec--cCCEEEEEE
Confidence            4778899999999999999964 68899999986432  234567889999999999999999999987  445889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.++++...  ...+++.+++.++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++....
T Consensus        79 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~  153 (256)
T cd08529          79 EYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD  153 (256)
T ss_pred             EeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence            9999999999997532  346889999999999999999999998   99999999999999999999999999886654


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ......|+..|+|||++.+..++.++||||||+++|||++|+.||.....   .   .........  ..     
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~~~--~~-----  218 (256)
T cd08529         154 NTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---G---ALILKIIRG--VF-----  218 (256)
T ss_pred             ccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHcC--CC-----
Confidence            322  12334688999999999999999999999999999999999999964331   1   111111111  00     


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +    ..+......+.+++.+||+.+|++||++.+++++
T Consensus       219 ~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 P----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             C----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1    1111223358899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5e-40  Score=310.08  Aligned_cols=255  Identities=27%  Similarity=0.408  Sum_probs=190.5

Q ss_pred             ceeeecCcEEEEEEEECC---CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          103 SILGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +.||+|+||.||+|...+   +..+|+|.++..... ....+.+|+.++++++||||+++++++.  +....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT--EVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCCCcEEEEECCC
Confidence            369999999999998643   457999998755432 2357889999999999999999999987  3447899999999


Q ss_pred             CCChhHhhcCCCC-CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          179 NGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       179 ~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      +|+|.++++.... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.......
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999964322 1234677888899999999999999998   99999999999999999999999999976543332


Q ss_pred             cccccccccCcccccccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........++..|+|||++.+.       .++.++||||||+++|||++ |+.||.......   ...+  . ..  ...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~--~-~~--~~~  227 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY--T-VR--EQQ  227 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH--H-hh--ccc
Confidence            2222334578899999988642       35789999999999999996 999996433211   1111  0 00  111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..+.++.+....+    ..+.+++..|| .+|++|||++||++.|+
T Consensus       228 ~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         228 LKLPKPRLKLPLS----DRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCCccCCCCC----hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1122222222222    24678999998 58999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=7.3e-41  Score=331.25  Aligned_cols=255  Identities=22%  Similarity=0.303  Sum_probs=195.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .+|++.+.||+|+||.||+++. .+++.||+|.+....   ......+.+|++++++++||||+++++.+.  +....++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~l   78 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYF   78 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCEEEE
Confidence            3689999999999999999995 468999999986432   223456889999999999999999999987  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        79 v~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          79 VMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            9999999999999964    235788899999999999999999999   999999999999999999999999997532


Q ss_pred             CCCC-----------------------------------------ccccccccccCcccccccccccCCCCchhhHHHHH
Q 013404          253 PEGR-----------------------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYG  291 (443)
Q Consensus       253 ~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G  291 (443)
                      ....                                         .........||+.|+|||++.+..++.++||||||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  231 (376)
T cd05598         152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence            1000                                         00011234799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC---CHH
Q 013404          292 VVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP---TMG  368 (443)
Q Consensus       292 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~  368 (443)
                      |++|||++|+.||....+..      ....+.......   ..+. ...++.    .+.+++.+|+ .+|.+|+   ++.
T Consensus       232 vilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~---~~~~-~~~~s~----~~~~li~~l~-~~p~~R~~~~t~~  296 (376)
T cd05598         232 VILYEMLVGQPPFLADTPAE------TQLKVINWETTL---HIPS-QAKLSR----EASDLILRLC-CGAEDRLGKNGAD  296 (376)
T ss_pred             ceeeehhhCCCCCCCCCHHH------HHHHHhccCccc---cCCC-CCCCCH----HHHHHHHHHh-cCHhhcCCCCCHH
Confidence            99999999999997543211      111111110000   0000 112222    3567777766 4999999   999


Q ss_pred             HHHHHHH
Q 013404          369 EVVQSLK  375 (443)
Q Consensus       369 evl~~L~  375 (443)
                      +++++-+
T Consensus       297 ell~h~~  303 (376)
T cd05598         297 EIKAHPF  303 (376)
T ss_pred             HHhCCCC
Confidence            9998743

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.7e-40  Score=311.54  Aligned_cols=257  Identities=27%  Similarity=0.478  Sum_probs=201.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CC---cEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|+..+.||+|+||.||+|... ++   ..+|+|.++.... ...+.+..|++++++++|||++++++++..  ....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCc
Confidence            357888899999999999999964 33   3799999875432 234678999999999999999999999874  4478


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +++|||+++++|.+++...   ...+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.
T Consensus        82 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          82 MIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence            9999999999999999643   245899999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCcccc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          251 QAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       251 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      .......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....      ..+...+. ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~-~~~~  228 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAIN-DGFR  228 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHh-cCCC
Confidence            6643322111 111233567999999998889999999999999999997 9999964321      12222221 1110


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      .     +     .+......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       229 ~-----~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 L-----P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C-----C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0     1     1112234578999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.7e-40  Score=312.79  Aligned_cols=252  Identities=24%  Similarity=0.412  Sum_probs=198.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++..  ....++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEE
Confidence            3678889999999999999984 5788999999865422 234578899999999999999999999874  34788999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|..+.        .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++.....
T Consensus        79 e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          79 EFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             ecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            999999997653        3678889999999999999999999   99999999999999999999999999976543


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHHhhccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ..    .....|+..|+|||++.+..++.++||||||+++|||++|+.||......... ....+........       
T Consensus       148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  216 (279)
T cd06619         148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------  216 (279)
T ss_pred             cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------
Confidence            21    23357899999999999999999999999999999999999999643221111 1111111111110       


Q ss_pred             cCcc-CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          334 DPRL-GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       334 d~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      .+.+ ....+    ..+.+++.+||+.+|++||+++|++++.+.
T Consensus       217 ~~~~~~~~~~----~~~~~li~~~l~~~P~~Rp~~~eil~~~~~  256 (279)
T cd06619         217 PPVLPVGQFS----EKFVHFITQCMRKQPKERPAPENLMDHPFI  256 (279)
T ss_pred             CCCCCCCcCC----HHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence            0111 11122    347899999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3e-40  Score=309.21  Aligned_cols=251  Identities=29%  Similarity=0.463  Sum_probs=201.8

Q ss_pred             ceeeecCcEEEEEEEECC----CcEEEEEEeccCCCCC-HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||++....    +..|++|.+....... .+.+.+|++++..++|+|++++++++..  ....+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence            469999999999999653    7889999998654433 5788999999999999999999999874  55789999999


Q ss_pred             CCCChhHhhcCCCCC-----CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          178 PNGSLESWLHGPLGV-----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ++++|.+++......     ...+++.+++.++.|++.||+|||+++   ++|+||||+||++++++.+||+|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccc
Confidence            999999999764211     356899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .............++..|+|||.+....++.++||||||+++|||++ |..||.....      ......+. ....   
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~-~~~~---  225 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLR-KGYR---  225 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHH-cCCC---
Confidence            65432222334567889999999998899999999999999999999 6999975421      11111111 1110   


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                             ...+......+.+++.+||+.+|++||++.+++++|+
T Consensus       226 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 -------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   0112222345889999999999999999999998863

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.5e-40  Score=318.48  Aligned_cols=264  Identities=25%  Similarity=0.380  Sum_probs=201.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||++.. .++..+|+|.+...... ....+.+|++++.+++||||++++++|.  +....+++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY--SDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCEEEEEe
Confidence            4689999999999999999995 46788999988754222 2356889999999999999999999987  445899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||+++++|.++++..    ..+++..+..++.|+++||.|||+ .+   ++|+||||+|||+++++.+||+|||++....
T Consensus        79 ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          79 EHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             eccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            999999999999742    458899999999999999999997 46   9999999999999999999999999987653


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc---c--
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD---R--  328 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~--  328 (443)
                      ...    .....++..|+|||.+.+..++.++||||||+++|||++|+.||.......   ...+.........   .  
T Consensus       152 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~  224 (308)
T cd06615         152 DSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHR  224 (308)
T ss_pred             ccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcc
Confidence            321    233568899999999988889999999999999999999999986433211   1111100000000   0  


Q ss_pred             ------------------ccccccCccCCCCCH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          329 ------------------LEELADPRLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       329 ------------------~~~~~d~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                                        ...+.... ....+. .....+.+++.+||+.+|++||++.+|+++.+..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  291 (308)
T cd06615         225 PVSGHPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK  291 (308)
T ss_pred             cccCCCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence                              00000000 000000 1223478999999999999999999999987654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.8e-40  Score=315.57  Aligned_cols=251  Identities=23%  Similarity=0.376  Sum_probs=203.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ..+|++.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++.  .....++||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~   95 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL--VGDELWVVM   95 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEee
Confidence            36789999999999999999995 578999999997665555677889999999999999999999987  445889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++..     ..+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.....
T Consensus        96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          96 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             cccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            99999999999863     34788999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ......+++.|+|||.+.+..++.++|||||||++|++++|+.||...++......      .....       .
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-------~  232 (297)
T cd06656         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-------T  232 (297)
T ss_pred             Ccc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-------C
Confidence            321  12334688899999999998899999999999999999999999965432211000      00000       0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +.  ...+......+.+++.+||+.+|++||++++|+++
T Consensus       233 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         233 PE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00  01122223447889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4e-40  Score=307.07  Aligned_cols=247  Identities=33%  Similarity=0.487  Sum_probs=195.1

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCC
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS  181 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  181 (443)
                      ++||+|+||.||+|...++..+|+|.++..... ....+.+|++++++++||||+++++++..  ....++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCCCc
Confidence            369999999999999888899999998754322 23468899999999999999999999874  447899999999999


Q ss_pred             hhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccccc
Q 013404          182 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS  261 (443)
Q Consensus       182 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  261 (443)
                      |.+++...   ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++......... ..
T Consensus        79 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~  151 (250)
T cd05085          79 FLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SS  151 (250)
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cC
Confidence            99998643   234789999999999999999999998   999999999999999999999999999754332211 11


Q ss_pred             cccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       262 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      ....++..|+|||++.+..++.++||||||+++||+++ |..||......   ....    ........          .
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~----~~~~~~~~----------~  214 (250)
T cd05085         152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QARE----QVEKGYRM----------S  214 (250)
T ss_pred             CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHHcCCCC----------C
Confidence            12244678999999998899999999999999999998 99999643211   1111    11111110          1


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .+......+.+++.+||+.+|++||++.|+++.|.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11222345889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.3e-40  Score=324.48  Aligned_cols=269  Identities=23%  Similarity=0.308  Sum_probs=199.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC----
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  167 (443)
                      ..++|++.+.||+|+||.||++.. .+|..||+|.+....  ......+.+|+.+++.++||||+++++++.....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999985 468999999986432  2234578899999999999999999998864321    


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++||||+++ +|.+.++.      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence            357899999965 67776642      3788899999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc------------hH
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE------------NL  315 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~------------~~  315 (443)
                      +++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...+.....            .+
T Consensus       169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            997643321   223457899999999999999999999999999999999999999754321100            00


Q ss_pred             H----HHHHHHhhcccccc-----ccccCccC---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          316 V----TWARPILRDKDRLE-----ELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       316 ~----~~~~~~~~~~~~~~-----~~~d~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      .    ..............     +.......   ..........+.+++.+||+.||++|||+.|++++-+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  318 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI  318 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence            0    00000111100000     00000000   00001112357899999999999999999999988654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.7e-40  Score=318.90  Aligned_cols=261  Identities=30%  Similarity=0.442  Sum_probs=200.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCc--EEEEEEeccCC-CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|.+. ++.  .+|+|.++... ......+.+|++++.++ +||||+++++++.  +....
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~--~~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC--CCCCc
Confidence            357888999999999999999964 454  46788776432 22345788999999999 8999999999987  44578


Q ss_pred             EEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC
Q 013404          171 LLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN  238 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  238 (443)
                      +++|||+++|+|.++++....            ....+++.+++.++.|++.||+|||+.+   ++||||||+|||++++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCC
Confidence            999999999999999964321            1235889999999999999999999998   9999999999999999


Q ss_pred             CceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 013404          239 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT  317 (443)
Q Consensus       239 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~  317 (443)
                      +.+||+|||+++......   ......++..|+|||++.+..++.++|||||||++|||+| |..||......      +
T Consensus       161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~  231 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E  231 (303)
T ss_pred             CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------H
Confidence            999999999986432111   1112234678999999988889999999999999999998 99999643221      1


Q ss_pred             HHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       318 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ..... ......          ..+......+.+++.+||+.+|++||+++++++.|+.+....
T Consensus       232 ~~~~~-~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         232 LYEKL-PQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HHHHH-hcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111 110000          011112234789999999999999999999999998775543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-40  Score=312.53  Aligned_cols=265  Identities=29%  Similarity=0.434  Sum_probs=206.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-----CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ..|++.+.||+|+||.||++.+.     ++..||||.+...... ..+.|.+|+++++.++||||+++++++........
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999853     3678999999765443 35689999999999999999999999876556678


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +++|||+++++|.+++....   ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            99999999999999997532   25899999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCcccc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc--------hHHHHHHH
Q 013404          251 QAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE--------NLVTWARP  321 (443)
Q Consensus       251 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~--------~~~~~~~~  321 (443)
                      .......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+.........        ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            7753322211 11234566799999999889999999999999999999999998543211100        00111111


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      .+....          ....+......+.+++.+||+.+|++||++.||++.|+.+
T Consensus       238 ~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111111          0111122234588999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.5e-40  Score=316.74  Aligned_cols=258  Identities=29%  Similarity=0.496  Sum_probs=201.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCc----EEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGT----AVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ++|+..+.||+|+||.||+|.+ .+|.    .||+|.+...... ....+.+|+.+++.++||||++++++|...   ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---Cc
Confidence            4678889999999999999985 3444    5788988654322 234688999999999999999999998632   46


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++++||+++|+|.+++...   ...+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence            7899999999999998743   235788999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...............++..|+|||++.+..++.++||||||+++|||++ |..||....   ......+    .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~----~~~~~~~  230 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDL----LEKGERL  230 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----HHCCCCC
Confidence            7654332222223346778999999999999999999999999999997 899986432   1111111    1111111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      .          .+......+.+++..||..+|++||+++++++.|+.+.+.
T Consensus       231 ~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 P----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0          0111223578999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=337.83  Aligned_cols=273  Identities=19%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC------CceeeEEEeee
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH------RNLVKLVGYYS  163 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~  163 (443)
                      ++....++|++.+.||+|+||.||+|.. .+++.||||+++... .....+..|+++++.++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3444568899999999999999999995 467899999996432 223456678888777754      45888998886


Q ss_pred             cCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCC---
Q 013404          164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNF---  239 (443)
Q Consensus       164 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~---  239 (443)
                      . +....++|||++ +++|.+++..    ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++   
T Consensus       202 ~-~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        202 N-ETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             c-CCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence            4 344788999988 7799998864    2358999999999999999999997 47   99999999999998765   


Q ss_pred             -------------ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 013404          240 -------------HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM  306 (443)
Q Consensus       240 -------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~  306 (443)
                                   .+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                         4999999988643221     2346799999999999999999999999999999999999999975


Q ss_pred             CCCCCcchHHH---------HHH--------HHhhccccccccccCc----cCCCCC---HHHHHHHHHHHHHccCcCCC
Q 013404          307 SQPSGQENLVT---------WAR--------PILRDKDRLEELADPR----LGGKYP---KEDFIRVCTIAAACVAPEAN  362 (443)
Q Consensus       307 ~~~~~~~~~~~---------~~~--------~~~~~~~~~~~~~d~~----~~~~~~---~~~~~~l~~li~~cl~~dp~  362 (443)
                      ...........         |..        .++.....+....++.    +....+   ......+++|+.+||+.||+
T Consensus       348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  427 (467)
T PTZ00284        348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ  427 (467)
T ss_pred             CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence            44321111110         100        0000000000000000    000000   01123578999999999999


Q ss_pred             CCCCHHHHHHHHHHhH
Q 013404          363 QRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       363 ~RPs~~evl~~L~~~~  378 (443)
                      +|||++|+++|-+...
T Consensus       428 ~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        428 KRLNARQMTTHPYVLK  443 (467)
T ss_pred             hCCCHHHHhcCccccc
Confidence            9999999999865543

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1e-40  Score=330.93  Aligned_cols=253  Identities=22%  Similarity=0.296  Sum_probs=192.8

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|++++++++||||+++++++.  +....++|
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~--~~~~~~lv   79 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYFV   79 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE--eCCEEEEE
Confidence            588899999999999999995 568899999986432   122356888999999999999999999987  44589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++|+|.+++...    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        80 ~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~  152 (382)
T cd05625          80 MDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (382)
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence            9999999999999642    35788899999999999999999999   9999999999999999999999999975321


Q ss_pred             CCC---------------------------------------------ccccccccccCcccccccccccCCCCchhhHH
Q 013404          254 EGR---------------------------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVY  288 (443)
Q Consensus       254 ~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~  288 (443)
                      ...                                             .........||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw  232 (382)
T cd05625         153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW  232 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence            100                                             00001234699999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC--
Q 013404          289 SYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT--  366 (443)
Q Consensus       289 S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs--  366 (443)
                      ||||++|||++|+.||....+.      .....+........   .+. ....+.    .+.+++.+|+ .+|++|++  
T Consensus       233 SlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~---~p~-~~~~s~----~~~~li~~l~-~~p~~R~~~~  297 (382)
T cd05625         233 SVGVILYEMLVGQPPFLAQTPL------ETQMKVINWQTSLH---IPP-QAKLSP----EASDLIIKLC-RGPEDRLGKN  297 (382)
T ss_pred             echHHHHHHHhCCCCCCCCCHH------HHHHHHHccCCCcC---CCC-cccCCH----HHHHHHHHHc-cCHhHcCCCC
Confidence            9999999999999999754321      11111111100000   000 011222    3566676665 49999997  


Q ss_pred             -HHHHHHHH
Q 013404          367 -MGEVVQSL  374 (443)
Q Consensus       367 -~~evl~~L  374 (443)
                       +.|+++|-
T Consensus       298 ~~~ei~~hp  306 (382)
T cd05625         298 GADEIKAHP  306 (382)
T ss_pred             CHHHHhcCC
Confidence             88888763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-40  Score=312.17  Aligned_cols=256  Identities=28%  Similarity=0.484  Sum_probs=198.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CC---cEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DG---TAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .+|++.+.||+|+||.||+|... ++   ..||+|.++... ......|..|+.++++++||||+++++++.  +....+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCceE
Confidence            35778899999999999999954 33   369999987542 223467999999999999999999999986  445789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|||+++++|.+++...   ...+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          82 IITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             EEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccc
Confidence            999999999999999753   235889999999999999999999998   99999999999999999999999999876


Q ss_pred             CCCCCccccccc-c--ccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          252 APEGRTNYLSTR-V--MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       252 ~~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ............ .  ..+..|+|||++.+..++.++|||||||++||+++ |..||.....   .....+.    ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i----~~~~  228 (269)
T cd05065         156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAI----EQDY  228 (269)
T ss_pred             cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHH----HcCC
Confidence            543322111111 1  12457999999999999999999999999999886 9999964321   1111111    1110


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ..          ..+.+....+.+++.+||+.+|++||++++|+..|+.+
T Consensus       229 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 RL----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00          11112233478999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.6e-40  Score=316.00  Aligned_cols=201  Identities=25%  Similarity=0.356  Sum_probs=164.1

Q ss_pred             CceeeecCcEEEEEEEEC---CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          102 ASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      .++||+|+||.||+|...   +++.||+|.+....  ....+.+|++++++++||||+++++++........+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999854   46789999986432  2356788999999999999999999987655667899999985


Q ss_pred             CCChhHhhcCCC-----CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe----cCCCceEEcccccc
Q 013404          179 NGSLESWLHGPL-----GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA  249 (443)
Q Consensus       179 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla  249 (443)
                       ++|.+++....     .....+++..+..++.|++.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888875321     11235888999999999999999999999   9999999999999    45678999999999


Q ss_pred             ccCCCCCcc-ccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 013404          250 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQ  308 (443)
Q Consensus       250 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~  308 (443)
                      +........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876433211 112345789999999998774 58899999999999999999999996443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.9e-40  Score=313.66  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=199.7

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .|+..+.||+|+||.||++.. .+++.||+|.+......   ....+.+|+.++++++|+|++++++.+..  ....+++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv   78 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV   78 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence            367789999999999999995 46889999998654322   22457789999999999999999998874  4588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++++|.+++....  ...+++.++..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++....
T Consensus        79 ~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          79 LTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             EEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            99999999999986432  235889999999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....   .....|+..|+|||++.+..++.++||||||+++|||++|+.||..........  . .......   ..   
T Consensus       154 ~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~--~-~~~~~~~---~~---  221 (285)
T cd05630         154 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--E-VERLVKE---VQ---  221 (285)
T ss_pred             CCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH--H-HHhhhhh---hh---
Confidence            3221   123478999999999999999999999999999999999999997533221111  0 0111100   00   


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLKM  376 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L~~  376 (443)
                       ......++    ..+.+++.+||+.||++||+     ++|++++-+.
T Consensus       222 -~~~~~~~~----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~  264 (285)
T cd05630         222 -EEYSEKFS----PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF  264 (285)
T ss_pred             -hhcCccCC----HHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence             00111222    34789999999999999999     8999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.2e-40  Score=311.44  Aligned_cols=246  Identities=25%  Similarity=0.361  Sum_probs=191.0

Q ss_pred             eeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          105 LGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       105 lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      ||+|+||.||++.. .+|+.||+|.+.....   .....+..|++++++++||||+++++++.  +....+++|||++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~   78 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG   78 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence            79999999999985 4689999999864321   12345667999999999999999999887  445789999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      +|.+++....  ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++........   
T Consensus        79 ~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---  150 (277)
T cd05607          79 DLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---  150 (277)
T ss_pred             CHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence            9999886432  335889999999999999999999998   99999999999999999999999999986644321   


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||.......  .............      ... ....
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~------~~~-~~~~  221 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDE------VKF-EHQN  221 (277)
T ss_pred             eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhccc------ccc-cccc
Confidence            233468999999999998889999999999999999999999996432211  1111111111110      000 0012


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ++    ..+.+++.+||+.||++||+++|+++.
T Consensus       222 ~~----~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         222 FT----EESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             CC----HHHHHHHHHHhccCHhhCCCCccchhh
Confidence            22    347899999999999999999766543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.3e-40  Score=309.39  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=196.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-----CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|+..+.||+|+||.||++.. .++..||+|.+.....     .....+.+|+.++++++||||+++++++........
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4789999999999999999985 4688999998864322     123468889999999999999999998875445678


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++++||+++++|.+++..    ...+++..++.++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            899999999999999964    234788999999999999999999998   9999999999999999999999999987


Q ss_pred             cCCCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........ .......++..|+|||++.+..++.++|||||||++|||++|+.||......     .. ........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~-~~~~~~~~---  225 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA-IFKIATQP---  225 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH-HHHHhcCC---
Confidence            65321111 1112345888999999999888999999999999999999999999643211     11 11111100   


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         ..+    ..+......+.+++ .||..+|++||+++||+++
T Consensus       226 ---~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 ---TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ---CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence               111    12222233455666 6888899999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-40  Score=327.28  Aligned_cols=267  Identities=26%  Similarity=0.367  Sum_probs=198.7

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC---CeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~  171 (443)
                      +|++.+.||+|+||.||++.. .+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++...+.   ...+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999995 5789999999864322  234578899999999999999999999864321   2678


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +|+||+. ++|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 588888753    345899999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH----------H--
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT----------W--  318 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~----------~--  318 (443)
                      ....... ......++..|+|||++.+. .++.++|||||||++|||++|+.||....+........          +  
T Consensus       153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            5433221 22334678999999998874 57899999999999999999999997544321111000          0  


Q ss_pred             ----HHH-HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          319 ----ARP-ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       319 ----~~~-~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          ... +...........  .+ ..........+.+++.+||+.||++|||+.|++++-+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  291 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLP--VL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL  291 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchH--Hh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence                000 000000000000  00 00111123457899999999999999999999987553

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.9e-40  Score=327.15  Aligned_cols=260  Identities=22%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD  166 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  166 (443)
                      ++....++|++.+.||+|+||.||++... +++.||+|.+....   ......+.+|+.+++.++||||+++++++.  +
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~  114 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--D  114 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--c
Confidence            34445689999999999999999999954 68899999986421   222345788999999999999999999987  4


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ....++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence            4589999999999999999963     24788889999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI  322 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  322 (443)
                      |+++....... .......||+.|+|||++...    .++.++|||||||++|||++|+.||.....      ......+
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i  259 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKI  259 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence            99986643221 112345799999999998754    378999999999999999999999974332      1222222


Q ss_pred             hhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHHH
Q 013404          323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK  375 (443)
Q Consensus       323 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L~  375 (443)
                      ......+. +.+       .......+.+++.+||..++.+  ||++++++++.+
T Consensus       260 ~~~~~~~~-~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         260 MNHKNSLT-FPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             HcCCCccc-CCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence            22211111 000       1112234678999999844443  789999998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5e-40  Score=309.82  Aligned_cols=256  Identities=24%  Similarity=0.388  Sum_probs=199.7

Q ss_pred             HHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           93 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        93 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      +.+++++.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++|+||+++++++..  ....+
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~   81 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFK   81 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEE
Confidence            34566777778999999999999995 4678899999876655556789999999999999999999999874  45789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCC--ChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHL--DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGL  248 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl  248 (443)
                      +++||+++++|.+++....   ..+  ++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.++|+|||+
T Consensus        82 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~  155 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT  155 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence            9999999999999997432   224  77888999999999999999998   999999999999976 67999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      +........  ......++..|+|||++....  ++.++||||||+++|+|++|+.||.......   ...+....... 
T Consensus       156 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-  229 (268)
T cd06624         156 SKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKI-  229 (268)
T ss_pred             heecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhcc-
Confidence            876543221  122345889999999986643  7889999999999999999999996432111   11111110000 


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                                 ....+......+.+++.+||+.+|++||++.|++++
T Consensus       230 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         230 -----------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -----------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                       111222333458899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-40  Score=309.67  Aligned_cols=251  Identities=30%  Similarity=0.460  Sum_probs=193.0

Q ss_pred             ceeeecCcEEEEEEEEC-CCc--EEEEEEeccCC-CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-DGT--AVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||+|... ++.  .+++|.++... ....+.+.+|++++.++ +||||+++++++..  ....+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence            36899999999999964 343  46888887433 23345788999999999 79999999999874  44689999999


Q ss_pred             CCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcc
Q 013404          178 PNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD  245 (443)
Q Consensus       178 ~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  245 (443)
                      ++|+|.+++.....            ....+++.+++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECC
Confidence            99999999964321            1235789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      ||++.......   .......+..|+|||++....++.++|||||||++|||++ |..||.....      ......+..
T Consensus       156 fgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~  226 (270)
T cd05047         156 FGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQ  226 (270)
T ss_pred             CCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhC
Confidence            99986432111   1112234667999999988899999999999999999997 9999954221      111111111


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                       ....          ..+......+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus       227 -~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 -GYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -CCCC----------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence             1010          011112234789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-40  Score=311.27  Aligned_cols=257  Identities=32%  Similarity=0.493  Sum_probs=203.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCc----EEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|++.+.||+|+||.||+|.+. +|.    .+|+|.+...... ....+.+|+.++++++||||++++++|..   ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cce
Confidence            46788899999999999999853 333    5899988755432 34678899999999999999999999874   478


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +++|||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             EEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence            99999999999999997532   34899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...............++..|+|||.+....++.++|+||||+++||+++ |+.||+....      .++...+ ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~-~~~~~~  230 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPDLL-EKGERL  230 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHH-hCCCCC
Confidence            7654332222222334678999999988899999999999999999998 9999964321      1111111 111100


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                                ..+..+...+.+++.+||..+|++||++.++++.|+.+.+
T Consensus       231 ----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 ----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                      1111122347889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.1e-40  Score=309.01  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=204.5

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||.|+||.||++.. .++..||+|.+.....  ...+.+..|++++++++||||+++++++........+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999984 5788999999875432  2245688899999999999999999988755566789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhh-----hcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH-----EDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      ||+++++|.+++.........+++..++.++.|++.||.|||     +.+   ++|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999754433557899999999999999999999     666   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....   ...+.   ..+...  . 
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~---~~~~~~--~-  226 (265)
T cd08217         158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLA---SKIKEG--K-  226 (265)
T ss_pred             ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHH---HHHhcC--C-
Confidence            87654332  1233468999999999998889999999999999999999999997533   11111   111110  0 


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                          .    ...+......+.+++.+||+.+|++||++.+|+++
T Consensus       227 ----~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 ----F----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----C----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                0    11222333458899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.6e-40  Score=309.98  Aligned_cols=256  Identities=27%  Similarity=0.468  Sum_probs=200.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-C---CcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-D---GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.++.... ...+.|.+|+.++++++||||+++++++.  +....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCccE
Confidence            57888999999999999999853 2   34799999875432 22457899999999999999999999987  344789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|||+++++|.+++...   ...+++.+++.++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||+++.
T Consensus        82 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          82 IVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            999999999999999753   235899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCcccc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          252 APEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       252 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ......... .....++..|+|||++.+..++.++||||||+++||+++ |..||......   .....   + .+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~---~-~~~~~~  228 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKA---I-EEGYRL  228 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHH---H-hCCCcC
Confidence            654322111 112234568999999998899999999999999999887 99998643221   11111   1 111110


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                           +     .+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus       229 -----~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 -----P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 1     1111223478999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.3e-41  Score=295.46  Aligned_cols=262  Identities=26%  Similarity=0.405  Sum_probs=209.2

Q ss_pred             HHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC----CH----HHHHHHHHHHhhc-CCCceeeEEEe
Q 013404           92 LKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ----GD----KEFLVEVEMLSRL-HHRNLVKLVGY  161 (443)
Q Consensus        92 ~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~----~~~~~E~~~l~~l-~h~niv~l~~~  161 (443)
                      -...-++|+..+.||+|..+.|-++.. .+|..+|+|++......    ..    +.-..|+.+|+++ .||||+++.++
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            344557788899999999999998874 57889999998654211    12    3456799999998 69999999999


Q ss_pred             eecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCce
Q 013404          162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA  241 (443)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  241 (443)
                      |.  ....+++|+|.|+.|.|.|+|..    ...++++...+|+.|+.+|++|||..+   ||||||||+|||++++.++
T Consensus        92 ye--s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i  162 (411)
T KOG0599|consen   92 YE--SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNI  162 (411)
T ss_pred             cc--CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccce
Confidence            87  44578999999999999999974    456999999999999999999999999   9999999999999999999


Q ss_pred             EEccccccccCCCCCccccccccccCccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchH
Q 013404          242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL  315 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~  315 (443)
                      ||+|||++..+..+..   ....+||++|+|||.+..      ..|+...|+|+.||+||.|+.|.+||....      .
T Consensus       163 ~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------Q  233 (411)
T KOG0599|consen  163 KISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------Q  233 (411)
T ss_pred             EEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------H
Confidence            9999999998876543   356799999999998854      367889999999999999999999996422      1


Q ss_pred             HHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          316 VTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      .-..+.+++.+.   ++.+|.+     .+......+||.+||+.||.+|.|++|+++|-+.++-
T Consensus       234 mlMLR~ImeGky---qF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  234 MLMLRMIMEGKY---QFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             HHHHHHHHhccc---ccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            112222222221   1112221     2333457899999999999999999999999776543

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-40  Score=323.14  Aligned_cols=193  Identities=24%  Similarity=0.332  Sum_probs=163.5

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ....+|++.+.||+|+||.||+|... ++..||+|....      .....|+.++++++||||+++++++..  ....++
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l  134 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS--GAITCM  134 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe--CCeeEE
Confidence            34568999999999999999999964 567899997542      233569999999999999999999874  447889


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |+||+. ++|.+++...   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       135 v~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             EEEccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            999994 6899988642   345899999999999999999999998   999999999999999999999999999754


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV  304 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~  304 (443)
                      ....   ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       208 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        208 VVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            3221   123456899999999999999999999999999999999966554

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.6e-40  Score=320.80  Aligned_cols=237  Identities=25%  Similarity=0.329  Sum_probs=185.8

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHH-HHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||++.. .+|+.||+|++....   ......+..|.. +++.++||||+++++++.  .....++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~--~~~~~~lv~e~~   78 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TTEKLYFVLDFV   78 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe--cCCEEEEEEcCC
Confidence            4699999999999995 478999999986432   122345556655 467789999999999887  445889999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|..++..    ...+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        79 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  151 (325)
T cd05604          79 NGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD  151 (325)
T ss_pred             CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence            99999998864    345889999999999999999999999   99999999999999999999999999875432211


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....        .+
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~~~~--------~~  215 (325)
T cd05604         152 --TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILHKPL--------VL  215 (325)
T ss_pred             --CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHcCCc--------cC
Confidence              12345799999999999999999999999999999999999999964321      111222221110        01


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG  368 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  368 (443)
                      ....    ...+.+++.+||+.+|++||++.
T Consensus       216 ~~~~----~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         216 RPGA----SLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             CCCC----CHHHHHHHHHHhccCHHhcCCCC
Confidence            1112    23477899999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-40  Score=326.04  Aligned_cols=266  Identities=22%  Similarity=0.259  Sum_probs=199.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC---CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ..+|++.+.||+|+||.||++...   .+..||+|.+...     ..+.+|++++++++||||+++++++..  ....++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l  163 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW--KSTVCM  163 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee--CCEEEE
Confidence            467999999999999999999753   3578999988632     345689999999999999999998873  447899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +||++. ++|.+++..    ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            999995 689998842    346899999999999999999999999   999999999999999999999999999866


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-ccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  331 (443)
                      .............||+.|+|||++.+..++.++|||||||++|||++|+.||.............-+...+... .....
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            54333222334679999999999999999999999999999999999999996544332111111111100000 00000


Q ss_pred             ---------c--ccCccCCCCC--H-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          332 ---------L--ADPRLGGKYP--K-----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       332 ---------~--~d~~~~~~~~--~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                               +  ........+.  .     .....+.+++.+||..||++||++.|++.+-+.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f  378 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF  378 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence                     0  0000000000  0     012346789999999999999999999987443

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-40  Score=347.67  Aligned_cols=259  Identities=22%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ..++|++.+.||+|+||.||++.. .++..||+|.+.....  .....|..|+.++++|+|||||+++++|.......++
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            456899999999999999999995 4677899999875432  2345788999999999999999999988765566789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCC----CceEecCCCcccEEecC----------
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ----PCVIHRDFKASNILLEN----------  237 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~Dlkp~NIll~~----------  237 (443)
                      |||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+.    ..|+||||||+||||+.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            9999999999999997543334569999999999999999999998542    23999999999999964          


Q ss_pred             -------CCceEEccccccccCCCCCccccccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 013404          238 -------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQ  308 (443)
Q Consensus       238 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~~~~~  308 (443)
                             .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++|||||||+||||++|+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   2348999999998654322   1234579999999999864  458899999999999999999999996322


Q ss_pred             CCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          309 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .     ....... +.....+      . ...++    ..+.+||..||+.+|.+||++.|++.+
T Consensus       248 ~-----~~qli~~-lk~~p~l------p-i~~~S----~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        248 N-----FSQLISE-LKRGPDL------P-IKGKS----KELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             c-----HHHHHHH-HhcCCCC------C-cCCCC----HHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            1     1121111 1111100      0 01122    347899999999999999999999965

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.4e-40  Score=308.79  Aligned_cols=249  Identities=31%  Similarity=0.474  Sum_probs=197.8

Q ss_pred             ceeeecCcEEEEEEEECC--C--cEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLSD--G--TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++++..   ...+++|||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence            468999999999998643  3  3699999986655 445689999999999999999999999874   5789999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++++|.+++.....  ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.......
T Consensus        78 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          78 PLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence            99999999975432  46899999999999999999999998   99999999999999999999999999987654322


Q ss_pred             cc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          258 NY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       258 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .+ ......++..|+|||++.+..++.++|||||||++|||++ |+.||.....      .+....+.......      
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~------  220 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEGERL------  220 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCcC------
Confidence            21 1123457789999999999999999999999999999999 9999963321      11111111111100      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                          ..+......+.+++.+||+.+|++||++.+|++.|.
T Consensus       221 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                011122345889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-40  Score=307.34  Aligned_cols=248  Identities=32%  Similarity=0.513  Sum_probs=195.6

Q ss_pred             ceeeecCcEEEEEEEEC-C---CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-D---GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      ++||+|+||.||+|.+. .   +..+|+|.+...... ..+.+.+|+++++.+.||||+++++++.   ....+++|||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEEEeC
Confidence            46999999999999843 2   268999998755432 3467899999999999999999999875   23578999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++...    ..+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++.......
T Consensus        78 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          78 PLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            999999999753    25899999999999999999999998   99999999999999999999999999986644332


Q ss_pred             ccc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          258 NYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       258 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....   ..+..+..    .....      
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~~~------  217 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGERL------  217 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCCcC------
Confidence            211 111234568999999998899999999999999999998 9999964321   11222211    11110      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                          ..+......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       218 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 ----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                11112223588999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.6e-40  Score=312.73  Aligned_cols=264  Identities=24%  Similarity=0.317  Sum_probs=194.8

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhc---CCCceeeEEEeeecC---CCC
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRL---HHRNLVKLVGYYSSR---DSS  168 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~---~~~  168 (443)
                      +|++.+.||+|+||.||+|.. .+++.||+|.++.....  ....+.+|+.+++.+   +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            478899999999999999995 46899999998754322  234566788777765   699999999987642   234


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..+++|||+++ +|.+++....  ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence            57899999974 8999886432  235899999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc-
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  327 (443)
                      ++.......   .....||..|+|||++.+..++.++|||||||++|||++|++||.......  .+..... ...... 
T Consensus       155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~-~~~~~~~  228 (288)
T cd07863         155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-LIGLPPE  228 (288)
T ss_pred             cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHH-HhCCCCh
Confidence            986543221   233568999999999999999999999999999999999999996433211  1111110 000000 


Q ss_pred             -cc-------cccccCccC---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          328 -RL-------EELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       328 -~~-------~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                       ..       .....+...   ..........+.+++.+||+.||++|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             00       000000000   00011123357899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.7e-40  Score=314.82  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=203.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .+|++.+.||.|+||.||+|.. .+|+.|++|.+........+.+.+|+.+++.++|||++++++++.  +....++|+|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e   96 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL--VGDELFVVME   96 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe--cCceEEEEEE
Confidence            4688899999999999999984 578999999997665555678899999999999999999999987  4458899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++..     ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          97 YLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             ecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            9999999999863     34899999999999999999999999   999999999999999999999999998865433


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...++..      .........  ...+   
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~~--~~~~---  235 (296)
T cd06655         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNG--TPEL---  235 (296)
T ss_pred             cc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC--Cccc---
Confidence            22  1233468889999999998889999999999999999999999996543211      111111110  0000   


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                          ..+......+.+++.+||..||++||++.+|+++=+
T Consensus       236 ----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~  271 (296)
T cd06655         236 ----QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (296)
T ss_pred             ----CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                011112234778999999999999999999998744

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.5e-40  Score=318.21  Aligned_cols=247  Identities=24%  Similarity=0.354  Sum_probs=193.7

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~l  172 (443)
                      +|+..+.||+|+||.||++.. .+|+.||+|.+....   ....+.+..|+.++..+. |++|+++.+++..  ....++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence            477889999999999999995 468899999987432   223456788999998885 5777888888763  447899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++.+++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        79 v~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~  151 (323)
T cd05615          79 VMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH  151 (323)
T ss_pred             EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence            9999999999999864    235899999999999999999999998   999999999999999999999999998754


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....     
T Consensus       152 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~~~~~-----  218 (323)
T cd05615         152 MVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSIMEHNV-----  218 (323)
T ss_pred             CCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-----
Confidence            32211  12345689999999999999999999999999999999999999974331      111122221111     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQS  373 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~  373 (443)
                             .++......+.+++.+||+.+|.+|++.     +++.++
T Consensus       219 -------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         219 -------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             -------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence                   1122223357889999999999999984     455544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-39  Score=317.30  Aligned_cols=256  Identities=21%  Similarity=0.267  Sum_probs=196.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+....   ......+.+|+.++..++|+||+++++++.  +....++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~--~~~~~~l   78 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ--DENYLYL   78 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence            47899999999999999999954 67899999986421   222345788999999999999999999987  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        79 v~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~  152 (331)
T cd05624          79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM  152 (331)
T ss_pred             EEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence            99999999999999742   235888999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCccccccccccCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ...... ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.....      ......+.....
T Consensus       153 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~  225 (331)
T cd05624         153 NQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEE  225 (331)
T ss_pred             cCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCC
Confidence            433221 1233569999999998875     4678899999999999999999999964321      112222222111


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSL  374 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L  374 (443)
                      ...  . +.....    ....+.+++.+|+..++.+  |+++++++++.
T Consensus       226 ~~~--~-p~~~~~----~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         226 RFQ--F-PSHITD----VSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             ccc--C-CCcccc----CCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence            110  0 110011    2235778999998866544  46899998874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.3e-40  Score=305.70  Aligned_cols=251  Identities=28%  Similarity=0.464  Sum_probs=199.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .+|++.+.||+|+||.||++.+.++..+|+|.+.... .....|.+|++++++++|||++++++++.  .....+++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT--ERSPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc--cCCceEEEEEc
Confidence            4677889999999999999998778899999887432 33567999999999999999999999986  44478999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.+++....   ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          81 MEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            99999999997432   34789999999999999999999998   9999999999999999999999999998654332


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......++.+|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+. ...   ....+
T Consensus       155 ~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~-~~~---~~~~~  223 (256)
T cd05112         155 YT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETIN-AGF---RLYKP  223 (256)
T ss_pred             cc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHh-CCC---CCCCC
Confidence            11 1122335678999999998899999999999999999998 9999864321      11111111 110   11111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      .       .....+.+++.+||+.+|++||++.++++.|
T Consensus       224 ~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 R-------LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             C-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            1       1124588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.7e-40  Score=312.50  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=196.8

Q ss_pred             CCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           99 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      |+..+.||+|+||.||++.. .+++.||+|.+.....   .....+.+|+++++.++|+|++++.+++..  ....+++|
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~   79 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL   79 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence            66778999999999999995 4688999999865422   223457889999999999999999988873  44789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++....  ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++.....
T Consensus        80 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05632          80 TIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE  154 (285)
T ss_pred             EeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence            9999999999886432  335899999999999999999999998   99999999999999999999999999976543


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...   .....|+..|+|||++.+..++.++|+||||+++|||++|..||........  ............        
T Consensus       155 ~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~~~~~--------  221 (285)
T cd05632         155 GES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRVLETE--------  221 (285)
T ss_pred             CCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhhhccc--------
Confidence            221   1234689999999999988999999999999999999999999964322111  111111111000        


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~  373 (443)
                      .    .++......+.+++..||+.||++||+     +.+++++
T Consensus       222 ~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         222 E----VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             c----ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            0    111122234788999999999999999     7777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1e-39  Score=314.37  Aligned_cols=268  Identities=22%  Similarity=0.316  Sum_probs=198.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++..  ....++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEEE
Confidence            56889999999999999999954 678899999875432 233567889999999999999999999874  44789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++ +|.+++...   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus        84 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          84 EYLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             eCCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            99975 888888643   234788999999999999999999998   99999999999999999999999999976433


Q ss_pred             CCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH---------HHHHHhh
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT---------WARPILR  324 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~  324 (443)
                      ...  ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............         +...+ .
T Consensus       157 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  233 (309)
T cd07872         157 PTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI-S  233 (309)
T ss_pred             Ccc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh-c
Confidence            221  1223467899999998865 468899999999999999999999997543321111100         00000 0


Q ss_pred             ccccccccccCccCCC----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          325 DKDRLEELADPRLGGK----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ..........+.....    ........+.+++.+||+.||.+|||+.|++++-+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  289 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF  289 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence            0000000000000000    001112346799999999999999999999987543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.3e-40  Score=307.90  Aligned_cols=239  Identities=22%  Similarity=0.376  Sum_probs=186.2

Q ss_pred             ceeeecCcEEEEEEEECC-------------CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404          103 SILGEGGFGRVFKGVLSD-------------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      +.||+|+||.||+|.+.+             ...|++|.+..........|.+|+.+++.++||||+++++++..  ...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR--DVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCC
Confidence            468999999999998532             23588998876544445678899999999999999999999874  446


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc-------eE
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-------AK  242 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~k  242 (443)
                      .+++|||+++|+|..++...   ...+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.       ++
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeE
Confidence            78999999999999998643   235899999999999999999999998   999999999999987654       89


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCCcchHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELL-TGRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~  320 (443)
                      ++|||++......      ....++..|+|||++. +..++.++|||||||++|||+ +|..||.........       
T Consensus       153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------  219 (262)
T cd05077         153 LSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------  219 (262)
T ss_pred             eCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------
Confidence            9999998755322      2235788899999886 467899999999999999998 588887543211100       


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      .......        .....    ....+.+++.+||+.||++||++.+|++.+
T Consensus       220 ~~~~~~~--------~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 RFYEGQC--------MLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHhcCc--------cCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0111100        00011    123578999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.7e-40  Score=313.89  Aligned_cols=266  Identities=30%  Similarity=0.433  Sum_probs=206.4

Q ss_pred             cCHHHHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeec
Q 013404           87 LAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS  164 (443)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  164 (443)
                      +.+.++..+.++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            44556666788999999999999999999995 568899999986432 2346678899999999 89999999999864


Q ss_pred             CC---CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCce
Q 013404          165 RD---SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA  241 (443)
Q Consensus       165 ~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  241 (443)
                      .+   ....++||||+++++|.++++........+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            33   24689999999999999998653333456899999999999999999999998   9999999999999999999


Q ss_pred             EEccccccccCCCCCccccccccccCcccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 013404          242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV  316 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~  316 (443)
                      ||+|||+++.......  ......|+..|+|||.+...     .++.++|||||||++|||++|+.||....+.  ..+.
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTLF  243 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHHH
Confidence            9999999986543221  12234688899999987643     3688999999999999999999999643211  1111


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .    ...  .....+.+       +......+.+++.+||+.+|++||++.|++++
T Consensus       244 ~----~~~--~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 K----IPR--NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             H----Hhc--CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1    110  00111111       11222358899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-40  Score=304.59  Aligned_cols=248  Identities=30%  Similarity=0.469  Sum_probs=196.1

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCC
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS  181 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  181 (443)
                      ++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++.  +....+++|||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV--QKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCCeEEEEEcCCCCc
Confidence            469999999999999766999999998765433 3467899999999999999999999987  4457899999999999


Q ss_pred             hhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccccc
Q 013404          182 LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS  261 (443)
Q Consensus       182 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  261 (443)
                      |.+++...   ...+++..++.++.+++.||.|||+++   ++||||||+||+++.++.+||+|||+++...........
T Consensus        79 l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          79 LLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            99999643   235788999999999999999999998   999999999999999999999999999865432211111


Q ss_pred             cccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       262 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      .....+..|+|||.+.+..++.++||||||+++|||++ |..||......   .....    .....          ...
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~----~~~~~----------~~~  215 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRER----IESGY----------RMP  215 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHH----HhcCC----------CCC
Confidence            12234667999999998899999999999999999999 88888643321   11111    11100          011


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .+......+.+++.+||+.+|++||++.||++.|+
T Consensus       216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            12222345889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-39  Score=306.95  Aligned_cols=252  Identities=26%  Similarity=0.415  Sum_probs=198.8

Q ss_pred             CCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC------CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      +|...+.||.|+||.||+|...+|+.+|+|.+......      ....+.+|++++++++|+||+++++++..  ....+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEE
Confidence            47788999999999999999888999999988644221      12458889999999999999999999874  45889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +++||+++++|.+++...    .++++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++..
T Consensus        79 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  151 (265)
T cd06631          79 IFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR  151 (265)
T ss_pred             EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence            999999999999999642    35788999999999999999999998   99999999999999999999999999876


Q ss_pred             CCCCCc----cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          252 APEGRT----NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       252 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ......    ........++..|+|||++.+..++.++||||||+++|||++|..||...+...     .. ........
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~  225 (265)
T cd06631         152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AM-FYIGAHRG  225 (265)
T ss_pred             hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HH-HHhhhccC
Confidence            532111    111223468899999999999889999999999999999999999996432111     10 00100000


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .     .+.+...+    ...+.+++.+||+.+|++||++.+++++
T Consensus       226 ~-----~~~~~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         226 L-----MPRLPDSF----SAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             C-----CCCCCCCC----CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0     11122222    3347899999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.8e-40  Score=307.01  Aligned_cols=250  Identities=21%  Similarity=0.308  Sum_probs=200.0

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      +|++.+.||+|+||.||++... ++..+|+|.++... ....+.+.+|+.+++.++|+||+++++++.  +....+++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE--ADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEEEEe
Confidence            4788899999999999999954 68899999986432 233467888999999999999999999987  4458899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++....  ...+++..++.++.|++.||.|||+++   |+|+||||+||++++++.++|+|||++......
T Consensus        79 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          79 YCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            999999999986432  345788999999999999999999999   999999999999999999999999999766432


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.....      ......+...  ...     
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~--~~~-----  218 (255)
T cd08219         154 GA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQG--SYK-----  218 (255)
T ss_pred             cc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcC--CCC-----
Confidence            21  12345688999999999988999999999999999999999999964321      1111111111  010     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                          ..+......+.+++.+||+.||++||++.+++..
T Consensus       219 ----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 ----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                1112223347899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.9e-40  Score=317.43  Aligned_cols=238  Identities=24%  Similarity=0.317  Sum_probs=185.1

Q ss_pred             ceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHH-HHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||++... +++.||+|.+....   ......+..|.. +++.++||||+++++++.  +....++||||+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~--~~~~~~lv~e~~   78 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKLYFVLDYI   78 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE--cCCeEEEEEeCC
Confidence            46999999999999964 67889999986432   122234444544 567789999999999887  445789999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+.+..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          79 NGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            99999999964    234778888999999999999999999   99999999999999999999999999975432221


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....        ..
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~--------~~  215 (325)
T cd05602         152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL--------QL  215 (325)
T ss_pred             --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhCCc--------CC
Confidence              12345799999999999999999999999999999999999999964321      112222221111        01


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGE  369 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  369 (443)
                      ...++    ..+.+++.+||+.||.+||++.+
T Consensus       216 ~~~~~----~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         216 KPNIT----NSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             CCCCC----HHHHHHHHHHcccCHHHCCCCCC
Confidence            11222    34788999999999999998774

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.1e-39  Score=315.03  Aligned_cols=200  Identities=25%  Similarity=0.361  Sum_probs=163.2

Q ss_pred             CceeeecCcEEEEEEEEC---CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          102 ASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      .++||+|+||.||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++........+++|||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999964   35789999986432  2356789999999999999999999987656667899999986


Q ss_pred             CCChhHhhcCCC-----CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe----cCCCceEEcccccc
Q 013404          179 NGSLESWLHGPL-----GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA  249 (443)
Q Consensus       179 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla  249 (443)
                      + +|.+++....     .....+++..+..++.|++.||.|||+.+   |+||||||+|||+    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            4 8888774221     11235888999999999999999999998   9999999999999    56678999999999


Q ss_pred             ccCCCCCccc-cccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          250 KQAPEGRTNY-LSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       250 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      +......... ......||..|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            8764432211 12345789999999998764 5789999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.9e-40  Score=309.89  Aligned_cols=251  Identities=31%  Similarity=0.511  Sum_probs=194.9

Q ss_pred             ceeeecCcEEEEEEEECC-------CcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404          103 SILGEGGFGRVFKGVLSD-------GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +.||+|+||.||+|+..+       +..+|+|.+..... .....+.+|+.+++.++||||++++++|.  +....+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL--LNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec--CCCCeEEEE
Confidence            369999999999998542       25799998865432 34567899999999999999999999987  344789999


Q ss_pred             eecCCCChhHhhcCCCC---CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-----ceEEccc
Q 013404          175 ELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-----HAKVADF  246 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Df  246 (443)
                      ||+++++|.+++.....   ....+++.+++.++.|++.||+|||+.+   ++|+||||+||+++.+.     .++|+||
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCc
Confidence            99999999999964321   1234789999999999999999999998   99999999999999877     8999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      |+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.....   ......   + ..
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~---~-~~  228 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH---V-TA  228 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH---H-hc
Confidence            99986543322222223346788999999999999999999999999999998 9999863321   111111   1 11


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ....          ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       229 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 GGRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CCcc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1100          111223345789999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1e-39  Score=306.53  Aligned_cols=252  Identities=26%  Similarity=0.424  Sum_probs=191.9

Q ss_pred             ceeeecCcEEEEEEEEC----CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||+|.+.    ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+ ...++++||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEecC
Confidence            46899999999999853    235799998854322 23467889999999999999999999875433 3578999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++....   ..+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.......
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          80 KHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            9999999997532   23677888999999999999999998   99999999999999999999999999976543211


Q ss_pred             cc--cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          258 NY--LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       258 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ..  ......++..|+|||.+.+..++.++|||||||++|||++| ..||....   .   .......... ..      
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~---~~~~~~~~~~-~~------  220 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---S---FDITVYLLQG-RR------  220 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---H---HHHHHHHhcC-CC------
Confidence            11  11233467789999999888999999999999999999995 55564321   1   1111111111 00      


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      +.....++    ..+.+++..||+.+|++||++.+|++.|+.+.
T Consensus       221 ~~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         221 LLQPEYCP----DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCCcCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            01111122    35789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-39  Score=306.29  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      ..+|++.+.||+|+||.||++...++..+|+|.+.... .....|.+|++++++++|+||+++.+++..   ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e   80 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITE   80 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEE
Confidence            45788999999999999999998778889999887432 234678999999999999999999998763   46789999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++....  ...+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            999999999997533  345788999999999999999999998   999999999999999999999999999765433


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ... ......++..|+|||++....++.++|+|||||++|++++ |+.||.....   .....+.    ......     
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~----~~~~~~-----  222 (260)
T cd05073         156 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRAL----ERGYRM-----  222 (260)
T ss_pred             Ccc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHH----hCCCCC-----
Confidence            211 1222345678999999998889999999999999999999 8999964321   1111111    111100     


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                           ..+......+.+++.+||+.+|++||++.++++.|+.
T Consensus       223 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 1111223358899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-39  Score=305.23  Aligned_cols=250  Identities=28%  Similarity=0.427  Sum_probs=202.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      ++|++.+.||+|+||.||+|... ++..+++|.+.....  .+.+.+|++++++++||||+++++++..  ....++++|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e   78 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIVME   78 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEEEe
Confidence            67899999999999999999965 478999999875432  6789999999999999999999999874  457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++...   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            99999999998642   345899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  ......++..|+|||++.+..++.++||||||+++|||++|+.||....+....      .....  .     ..+
T Consensus       153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~~~~--~-----~~~  217 (256)
T cd06612         153 MA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FMIPN--K-----PPP  217 (256)
T ss_pred             cc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hhhcc--C-----CCC
Confidence            21  123345888999999999889999999999999999999999999743321110      00000  0     000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .+  ..+......+.+++.+||+.||++||++.||+++
T Consensus       218 ~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         218 TL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            00  1122223458899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.3e-39  Score=305.53  Aligned_cols=254  Identities=22%  Similarity=0.341  Sum_probs=188.4

Q ss_pred             ceeeecCcEEEEEEEECCC---cEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          103 SILGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +.||+|+||.||+|...++   ..+++|.+..... ...+.|.+|+.+++.++||||++++++|.  +....++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV--EAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec--CCCccEEEEecCC
Confidence            3599999999999985433   3466777664432 33567999999999999999999999987  4457899999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcc
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN  258 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  258 (443)
                      +|+|.+++++.......+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||++.........
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            99999999754333345677788899999999999999998   999999999999999999999999998643322111


Q ss_pred             ccccccccCccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          259 YLSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       259 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .......++..|+|||++..       ..++.++||||||+++|||++ |..||.....      ..........  ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~--~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD--QQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh--ccc
Confidence            11234567889999998753       245789999999999999997 5677753221      1112222211  112


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      .+.++.+...+.    ..+.+++..|| .+|++||++++|++.|
T Consensus       228 ~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         228 KLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             ccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            223333333333    34677899999 5799999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.8e-40  Score=311.19  Aligned_cols=238  Identities=24%  Similarity=0.391  Sum_probs=184.7

Q ss_pred             eeeecCcEEEEEEEECC-------------------------CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeE
Q 013404          104 ILGEGGFGRVFKGVLSD-------------------------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL  158 (443)
Q Consensus       104 ~lg~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  158 (443)
                      .||+|+||.||+|.+..                         ...|++|.+..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13588998865443344678899999999999999999


Q ss_pred             EEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC
Q 013404          159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN  238 (443)
Q Consensus       159 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  238 (443)
                      +++|..  ....++||||+++|+|..++...   ...+++..++.++.|+++||+|||+.+   |+||||||+|||++..
T Consensus        82 ~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVR--GSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEe--CCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEecc
Confidence            999874  44789999999999999998643   335889999999999999999999998   9999999999999764


Q ss_pred             C-------ceEEccccccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCC
Q 013404          239 F-------HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELL-TGRKPVDMSQP  309 (443)
Q Consensus       239 ~-------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~ell-tg~~p~~~~~~  309 (443)
                      +       .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....+
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            3       3899999998654322      12357788999998875 56899999999999999985 69999864432


Q ss_pred             CCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ...   ..+    .......        ....    ...+.+++.+||+.+|++||++.+|++.|
T Consensus       228 ~~~---~~~----~~~~~~~--------~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         228 SEK---ERF----YEKKHRL--------PEPS----CKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHH---HHH----HHhccCC--------CCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            211   111    1111100        0111    12478999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.5e-40  Score=324.28  Aligned_cols=266  Identities=25%  Similarity=0.326  Sum_probs=202.5

Q ss_pred             CCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-C-----CceeeEEEeeecCCCCee
Q 013404           98 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-H-----RNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~~  170 (443)
                      +|++.+.||+|+||.|.+|. ..+++.||||+++.... -..+-..|+.+|..|+ |     -|+|++++||..  ..+.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~Hl  263 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHL  263 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--ccce
Confidence            78899999999999999999 45799999999985422 2345677999999996 4     389999999984  4589


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC--CceEEccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN--FHAKVADFGL  248 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgl  248 (443)
                      |||+|.+. -+|+++|+.+.  -..++...+..++.||+.||.+||+.+   |||+||||+||||.+-  ..+||+|||.
T Consensus       264 ciVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  264 CIVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence            99999995 59999998755  345899999999999999999999999   9999999999999753  4799999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH-----HHh
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR-----PIL  323 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~-----~~~  323 (443)
                      +........     ....+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..++...+..+.     .++
T Consensus       338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            987765433     3466778999999999999999999999999999999988887654433322211000     000


Q ss_pred             hcccccccccc------------------------------------C----ccCCCCCHHHHHHHHHHHHHccCcCCCC
Q 013404          324 RDKDRLEELAD------------------------------------P----RLGGKYPKEDFIRVCTIAAACVAPEANQ  363 (443)
Q Consensus       324 ~~~~~~~~~~d------------------------------------~----~~~~~~~~~~~~~l~~li~~cl~~dp~~  363 (443)
                      ....+.....+                                    |    .+....+...-..+.+++.+||.+||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence            00000000000                                    0    0001111133456889999999999999


Q ss_pred             CCCHHHHHHHHHHh
Q 013404          364 RPTMGEVVQSLKMV  377 (443)
Q Consensus       364 RPs~~evl~~L~~~  377 (443)
                      |+|..|+++|-+.-
T Consensus       493 R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  493 RITPAQALNHPFLT  506 (586)
T ss_pred             cCCHHHHhcCcccc
Confidence            99999999986543

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-39  Score=306.73  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=198.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-----CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ++|++.+.||+|+||.||+|.. .+|..||+|.+.....     ...+.+.+|+.++++++||||+++++++........
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5789999999999999999995 4689999998864321     123468889999999999999999998865445568


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +++|||+++++|.+++...    ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence            8999999999999998642    34788899999999999999999999   9999999999999999999999999987


Q ss_pred             cCCCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........ .......++..|+|||.+.+..++.++|||||||++|||++|+.||.....     .... ......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~-~~~~~~----  224 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAAI-FKIATQ----  224 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHHH-HHHhcC----
Confidence            65321111 011234688899999999888899999999999999999999999963211     1111 111111    


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                            ......+......+.+++.+|+. +|++||+++||+++
T Consensus       225 ------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         225 ------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                  01112344444567889999985 89999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-39  Score=307.98  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=201.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEECC----CcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|.+.+.||+|+||.||+|...+    ...||+|...... ....+.+.+|+.++++++||||+++++++..   ...+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence            467888999999999999998543    2468999887554 2334679999999999999999999998863   3568


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|||+++|+|.+++...   ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++.
T Consensus        83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence            999999999999999753   234899999999999999999999998   99999999999999999999999999986


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ...... ...+...++..|+|||.+....++.++||||||+++||+++ |..||......   ....+   + ...... 
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~---~-~~~~~~-  227 (270)
T cd05056         157 LEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR---I-ENGERL-  227 (270)
T ss_pred             cccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH---H-HcCCcC-
Confidence            644322 11223345678999999988889999999999999999986 99999643321   11111   1 111111 


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                           .    .+......+.+++.+|+..+|++||++.++++.|+.+..
T Consensus       228 -----~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 -----P----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             -----C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                 0    112223358899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-39  Score=341.11  Aligned_cols=263  Identities=22%  Similarity=0.304  Sum_probs=201.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.++||+|+||.||+|... +|+.||+|++......   ..+.|.+|++++++++||||+++++++.  +....++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~--d~~~lyL   79 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS--DGDPVYY   79 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe--eCCEEEE
Confidence            47899999999999999999954 6899999999754322   2357899999999999999999999987  4457899


Q ss_pred             EEeecCCCChhHhhcCCCC-------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcc
Q 013404          173 CYELVPNGSLESWLHGPLG-------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD  245 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  245 (443)
                      +|||+++|+|.+++.....       ....+++..++.++.|+++||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiD  156 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILD  156 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEe
Confidence            9999999999999863211       1234667888999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCc----------------cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 013404          246 FGLAKQAPEGRT----------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP  309 (443)
Q Consensus       246 fgla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~  309 (443)
                      ||+++.......                ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            999986521110                0011235699999999999999999999999999999999999999964321


Q ss_pred             CCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHhHh
Q 013404          310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQR  379 (443)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~~  379 (443)
                      ...    .+ ..........      ......+    ..+.+++.+||+.||++|| +++++++.|+...+
T Consensus       237 ~ki----~~-~~~i~~P~~~------~p~~~iP----~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        237 RKI----SY-RDVILSPIEV------APYREIP----PFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhh----hh-hhhccChhhc------cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            110    00 0000000000      0001222    3478899999999999995 67777777776654

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.8e-39  Score=304.36  Aligned_cols=250  Identities=26%  Similarity=0.436  Sum_probs=197.6

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC---------HHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      +|.+.+.||+|+||.||+|.. .+++.||+|.+.......         .+.+.+|+.++++++||||+++++++..  .
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence            467789999999999999985 467899999886543321         1457889999999999999999999874  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...+++|||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg  151 (267)
T cd06628          79 DHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFG  151 (267)
T ss_pred             CccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccC
Confidence            4788999999999999999642    35788999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCcc----ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          248 LAKQAPEGRTN----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       248 la~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      +++........    .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......     .. .....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~  225 (267)
T cd06628         152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QA-IFKIG  225 (267)
T ss_pred             CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HH-HHHHh
Confidence            99866532111    1112345888999999999888999999999999999999999999643211     00 11100


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                             ....+.+    +......+.+++.+||+.||++||++.+|+++
T Consensus       226 -------~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         226 -------ENASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -------ccCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                   0111111    22233457899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-39  Score=314.73  Aligned_cols=256  Identities=23%  Similarity=0.289  Sum_probs=195.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ......+.+|+.++..++|+||+++++++.  +....++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l   78 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ--DENNLYL   78 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCEEEE
Confidence            47889999999999999999964 57889999986321   222345888999999999999999999887  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        79 v~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~  152 (332)
T cd05623          79 VMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL  152 (332)
T ss_pred             EEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheec
Confidence            99999999999999742   235888999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ..... .......||+.|+|||++.     ...++.++|||||||++|||++|+.||....      .......+.....
T Consensus       153 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~  225 (332)
T cd05623         153 MEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKE  225 (332)
T ss_pred             ccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCc
Confidence            33221 1123357999999999986     3467899999999999999999999996432      2222222222211


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSL  374 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L  374 (443)
                      ...   -+......    ...+.+++.+|+..++++  |++++|++++-
T Consensus       226 ~~~---~p~~~~~~----s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~  267 (332)
T cd05623         226 RFQ---FPAQVTDV----SEDAKDLIRRLICSREHRLGQNGIEDFKQHP  267 (332)
T ss_pred             ccc---CCCccccC----CHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence            110   01101112    234678888888655444  68999999883

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.9e-39  Score=306.05  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=187.4

Q ss_pred             ceeeecCcEEEEEEEECC---CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          103 SILGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +.||+|+||.||+|...+   ...+|+|.+...... ....|.+|+.+++.++||||+++++++.  +....++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~--~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI--ESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCceEEEEEeCC
Confidence            359999999999997533   346888887644322 2356889999999999999999999987  4457899999999


Q ss_pred             CCChhHhhcCCCCC-CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          179 NGSLESWLHGPLGV-NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       179 ~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      +|+|.+++...... ....++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh
Confidence            99999999754322 233567888999999999999999998   99999999999999999999999999875433222


Q ss_pred             cccccccccCccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||....+.   ..   ........  .
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~---~~~~~~~~--~  227 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QV---LKQVVREQ--D  227 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HH---HHHHhhcc--C
Confidence            111223356778999998743       356889999999999999999 78888533211   11   11111111  1


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ..+..+.+...++    ..+.+++..|| .||++||++++|++.|
T Consensus       228 ~~~~~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         228 IKLPKPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ccCCCCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            1122222222233    34667888888 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-39  Score=308.70  Aligned_cols=265  Identities=28%  Similarity=0.347  Sum_probs=206.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|+..+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||++++++|...+....++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4678889999999999999996 4678999999875433 2346789999999999999999999998766666789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++.........+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999987643333456888999999999999999999998   99999999999999999999999999875533


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CCcchHHHHHHHHhhcccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP--SGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ..    .....++..|+|||.+.+..++.++||||||+++|||++|+.||.....  ........+..   ...  ...+
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~--~~~~  228 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV---NMP--NPEL  228 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh---cCC--chhh
Confidence            22    1234578899999999999999999999999999999999999975432  11112222211   100  0011


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      .+. ..  ........+.+++.+||+.+|++|||+.||+++-+.
T Consensus       229 ~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         229 KDE-PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             ccC-CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence            100 00  001123457899999999999999999999987553

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=317.34  Aligned_cols=254  Identities=27%  Similarity=0.300  Sum_probs=209.4

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCe
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  169 (443)
                      ....|++.+.||+|.||.||+++.. +|+.+|+|.+.+....   ....+.+|+++|+++. |||||.+.+.|..  ...
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~  110 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDS  110 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCe
Confidence            3467888899999999999999955 5999999999765443   3468999999999998 9999999999984  448


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC----CceEEcc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN----FHAKVAD  245 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D  245 (443)
                      .++|||++.||.|.+.+...     .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence            99999999999999999754     3899999999999999999999999   9999999999999543    5799999


Q ss_pred             ccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      ||++......   ......+||+.|+|||++....|+..+||||+||++|.|++|..||..........      .+...
T Consensus       183 FGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~  253 (382)
T KOG0032|consen  183 FGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRG  253 (382)
T ss_pred             CCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcC
Confidence            9999987662   23466799999999999999999999999999999999999999997554322111      12211


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..        ......-......+.+++..|+..||.+|+|+.++++|-|
T Consensus       254 ~~--------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  254 DF--------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             CC--------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence            11        1111222233455789999999999999999999999865

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-39  Score=321.26  Aligned_cols=266  Identities=22%  Similarity=0.277  Sum_probs=199.2

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----C
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  167 (443)
                      ..++|++.+.||+|+||.||++.. ..++.||||++....  ......+.+|+.+++.++||||+++++++...+    .
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999995 468899999987542  223457889999999999999999999875422    2


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++||||+++ +|.+++..      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence            357999999965 78777742      3788999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH-------
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR-------  320 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~-------  320 (443)
                      +++......   ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+....  +.....       
T Consensus       172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~  246 (364)
T cd07875         172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCP  246 (364)
T ss_pred             CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence            998654321   12345789999999999999999999999999999999999999965432111  000000       


Q ss_pred             -----------HHhhccccccc-----cccCcc---CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          321 -----------PILRDKDRLEE-----LADPRL---GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       321 -----------~~~~~~~~~~~-----~~d~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                                 ...........     +.....   ...........+.+++.+||+.||++|||+.|++++-+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~  320 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  320 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence                       00000000000     000000   00001112235789999999999999999999998744

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.1e-40  Score=310.84  Aligned_cols=259  Identities=27%  Similarity=0.433  Sum_probs=204.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||++.. .+|+.||+|.+..... ...+.+.+|+++++.++||||+++++++..  ....++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEEEE
Confidence            5688889999999999999995 4688999998865432 335678999999999999999999999874  45889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||+++++|.+++..    ...+++..+..++.+++.||.|||+ .+   ++|+||||+||++++++.++|+|||++....
T Consensus        83 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          83 EFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             ecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            99999999999864    2358899999999999999999997 46   9999999999999999999999999987543


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC-----cchHHHHHHHHhhcccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG-----QENLVTWARPILRDKDR  328 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~  328 (443)
                      ...    .....|+..|+|||++.+..++.++|||||||++|||++|+.||.......     ...+..+........  
T Consensus       156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  229 (284)
T cd06620         156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--  229 (284)
T ss_pred             hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--
Confidence            221    123468999999999988899999999999999999999999997543321     111222222222111  


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                           .+.+.   .......+.+++.+||+.||++||++.||+++...++
T Consensus       230 -----~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         230 -----PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             -----CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                 01110   1112345889999999999999999999998866554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.9e-40  Score=309.63  Aligned_cols=252  Identities=26%  Similarity=0.407  Sum_probs=198.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++.  +....+++|
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~--~~~~~~lv~   85 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL--RRDKLWICM   85 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE--eCCEEEEEE
Confidence            34788889999999999999985 468899999987655444566889999999999999999999987  445889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++..    ...+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        86 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          86 EFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             eccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            99999999999864    235889999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ...  ......|+..|+|||++.   ...++.++|||||||++|||++|+.||....+....  .    ..... .    
T Consensus       159 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~----~~~~~-~----  225 (267)
T cd06645         159 TIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F----LMTKS-N----  225 (267)
T ss_pred             ccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--H----hhhcc-C----
Confidence            211  123457899999999874   456889999999999999999999998543321110  0    00000 0    


Q ss_pred             cccCccC--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          332 LADPRLG--GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       332 ~~d~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...+...  ..++    ..+.+++.+||+.+|++||++++|+++
T Consensus       226 ~~~~~~~~~~~~~----~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 FQPPKLKDKMKWS----NSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCCcccccCCCC----HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0001110  0122    247889999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.8e-40  Score=311.31  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=197.6

Q ss_pred             CCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404           99 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      |++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++..  ....++++||+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e~~   84 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFC   84 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEEec
Confidence            567789999999999999965 577889999875544445678999999999999999999999874  45789999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++++|..++...   ..++++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        85 ~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          85 AGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            999999988642   345899999999999999999999998   99999999999999999999999999876543221


Q ss_pred             cccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          258 NYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                        ......++..|+|||++.     +..++.++|||||||++|||++|+.||....+.      ..........  ...+
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~--~~~~  228 (282)
T cd06643         159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE--PPTL  228 (282)
T ss_pred             --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcC--CCCC
Confidence              123356899999999884     345778999999999999999999998643211      1111111110  0001


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .       .+......+.+++.+||+.||++||++.+++++-+
T Consensus       229 ~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         229 A-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             C-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence            0       11112235789999999999999999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.2e-40  Score=309.13  Aligned_cols=253  Identities=31%  Similarity=0.515  Sum_probs=197.1

Q ss_pred             CCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHH--HHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           99 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      |++.+.||+|+||.||++... +++.||+|.+.........  ...+|+.++++++||||+++++++..  ....+++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence            567789999999999999965 5678999999865433222  34569999999999999999999874  558899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++..    ...+++..++.++.|+++||.+||+.+   ++|+||||+||++++++.++|+|||.+......
T Consensus        79 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~  151 (260)
T PF00069_consen   79 YCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN  151 (260)
T ss_dssp             EETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred             ccccccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            9999999999972    446899999999999999999999999   999999999999999999999999999764211


Q ss_pred             CccccccccccCcccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                        ........++..|+|||++. +..++.++||||||+++|+|++|..||....   ..+............  ...   
T Consensus       152 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~---~~~~~~~~~~~~~~~--~~~---  221 (260)
T PF00069_consen  152 --NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN---SDDQLEIIEKILKRP--LPS---  221 (260)
T ss_dssp             --TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS---HHHHHHHHHHHHHTH--HHH---
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccccccccccc---chhhhhhhhhccccc--ccc---
Confidence              11234567899999999998 8889999999999999999999999997441   111111111111100  000   


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...   ........+.+++.+||+.||++||++.+++++
T Consensus       222 ~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  222 SSQ---QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HTT---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccc---ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000   000001458899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-40  Score=327.36  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=195.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++.. .+++.||+|.++...   ......+.+|+.++..++||||+++++++.  +....++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~l   78 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYL   78 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence            4688999999999999999995 468999999986432   223456888999999999999999999887  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        79 v~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          79 IMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             EEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999999964    235889999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCcc---------------------------------ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh
Q 013404          253 PEGRTN---------------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT  299 (443)
Q Consensus       253 ~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt  299 (443)
                      ......                                 .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            321100                                 00123479999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHHH
Q 013404          300 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT---MGEVVQSL  374 (443)
Q Consensus       300 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~L  374 (443)
                      |+.||....+.      .....+......+   .-+. ....+    ..+.+++.+|+. ||.+|++   ++|+++|-
T Consensus       232 G~~Pf~~~~~~------~~~~~i~~~~~~~---~~p~-~~~~s----~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp  294 (360)
T cd05627         232 GYPPFCSETPQ------ETYRKVMNWKETL---VFPP-EVPIS----EKAKDLILRFCT-DSENRIGSNGVEEIKSHP  294 (360)
T ss_pred             CCCCCCCCCHH------HHHHHHHcCCCce---ecCC-CCCCC----HHHHHHHHHhcc-ChhhcCCCCCHHHHhcCC
Confidence            99999754321      1111121111111   0000 00122    246677777664 9999985   77887763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-39  Score=311.44  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=199.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      +.|++.+.||.|+||.||+|... ++..|++|.+........+.+.+|+.+++.++||||+++++++..  ....++|||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   89 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIMIE   89 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEEEe
Confidence            56889999999999999999964 588999999976655556778999999999999999999998873  447899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|..++...   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            99999999887543   235899999999999999999999998   999999999999999999999999998754332


Q ss_pred             CccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ..  ......++..|+|||++.     ...++.++|||||||++|||++|+.||.....      ...........    
T Consensus       164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~----  231 (292)
T cd06644         164 LQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE----  231 (292)
T ss_pred             cc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC----
Confidence            11  123346888999999885     34568899999999999999999999864321      11111111110    


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         .+..  ..+......+.+++.+||+.+|++||++++++++
T Consensus       232 ---~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         232 ---PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ---CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               0000  1111222357889999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2e-39  Score=308.37  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=196.1

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|+||.||+|+.. ++..||+|.++....  .....+.+|+.++++++||||+++++++.  +....++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM--QESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe--eCCeEEEEE
Confidence            4788899999999999999964 689999999875432  23467889999999999999999999987  445889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||++ ++|.+++..... ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        79 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  153 (285)
T cd07861          79 EFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI  153 (285)
T ss_pred             ecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence            9997 689998864332 346899999999999999999999998   99999999999999999999999999976543


Q ss_pred             CCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh-------hcc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL-------RDK  326 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~  326 (443)
                      ...  ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......  ...........       ...
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         154 PVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             Ccc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcc
Confidence            221  12234578899999988654 5789999999999999999999999743221  11111000000       000


Q ss_pred             cc---ccccccCccCC---CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 DR---LEELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 ~~---~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..   ...........   .........+.+++.+||+.||++|||+++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00   00000000000   0000112346799999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-39  Score=318.91  Aligned_cols=265  Identities=22%  Similarity=0.337  Sum_probs=198.3

Q ss_pred             HHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCC---
Q 013404           93 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---  166 (443)
Q Consensus        93 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  166 (443)
                      ....++|++.+.||+|+||.||+|.. .+++.||||.+.....  .....+.+|++++++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            34567899999999999999999985 5788999999875322  22356788999999999999999998875322   


Q ss_pred             -CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcc
Q 013404          167 -SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD  245 (443)
Q Consensus       167 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  245 (443)
                       ....+++++++ +++|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence             23568999988 7899988853     35899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      ||+++.....     .....||..|+|||++.+ ..++.++|||||||++|||++|+.||......  ..+..+.. ...
T Consensus       162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~-~~~  233 (343)
T cd07878         162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIME-VVG  233 (343)
T ss_pred             CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHH-HhC
Confidence            9999865432     233468999999999876 57889999999999999999999999643211  11111100 000


Q ss_pred             ccc----------cccccccCccCCCCCH--------HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          325 DKD----------RLEELADPRLGGKYPK--------EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       325 ~~~----------~~~~~~d~~~~~~~~~--------~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ...          ....... .+ ...+.        .....+.+++.+||+.||++|||+.|++++-+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~  301 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQ-SL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF  301 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhh-cc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence            000          0000000 00 00000        011236789999999999999999999987544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=308.32  Aligned_cols=251  Identities=27%  Similarity=0.381  Sum_probs=202.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+|++++++++..  ....++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEE
Confidence            36888899999999999999954 68899999987543 2334678899999999999999999999874  45889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++...     ++++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++....
T Consensus        79 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          79 EYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            999999999999742     6899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ......++..|+|||++.+..++.++||||||+++|||++|+.||...++..      ....+. ..      ..
T Consensus       151 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~-~~------~~  215 (274)
T cd06609         151 TMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIP-KN------NP  215 (274)
T ss_pred             ccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhh-hc------CC
Confidence            321  1234568889999999999889999999999999999999999997543211      111111 00      01


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      +.+...   .....+.+++.+||..+|++||++++++++-+
T Consensus       216 ~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~  253 (274)
T cd06609         216 PSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKHKF  253 (274)
T ss_pred             CCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence            111111   02234789999999999999999999998643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-39  Score=308.40  Aligned_cols=257  Identities=26%  Similarity=0.438  Sum_probs=200.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      .+|++.+.||+|+||.||+|+..      +...|++|.+...... ....+.+|++++++++|+||+++++++.  +...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR--EAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC--CCCc
Confidence            57888999999999999999853      2467999988654333 3467999999999999999999999986  4447


Q ss_pred             eEEEEeecCCCChhHhhcCCCCC-----CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGV-----NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA  244 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  244 (443)
                      .++||||+++|+|.+++......     ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.++|+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence            89999999999999999754321     125899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHh
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      |||+++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ....   ....
T Consensus       160 ~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~---~~~~  232 (275)
T cd05046         160 LLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVL---NRLQ  232 (275)
T ss_pred             ccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHH---HHHH
Confidence            9999875433221 12223456778999999988888999999999999999999 7888853221   1111   1111


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..  ....    .....++    ..+.+++.+||+.+|++||++.|+++.|+
T Consensus       233 ~~--~~~~----~~~~~~~----~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 AG--KLEL----PVPEGCP----SRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cC--CcCC----CCCCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            00  0000    0111223    35889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-39  Score=304.26  Aligned_cols=251  Identities=23%  Similarity=0.372  Sum_probs=200.6

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|++|.||++... +++.||+|.+.....  ...+.+.+|++++++++|+|++++++.+.. .....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence            4888999999999999999954 578999999865432  234568899999999999999999987653 234678999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++....  ...+++.+++.++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          80 GFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             cccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            9999999999997532  345899999999999999999999999   99999999999999999999999999986643


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ......+++.|+|||++.+..++.++||||||+++|||++|+.||...+      ...........  .+     
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~~~--~~-----  219 (257)
T cd08223         155 QCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRIIEG--KL-----  219 (257)
T ss_pred             cCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhc--CC-----
Confidence            221  2234568899999999999999999999999999999999999996432      11222222111  11     


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +    ..+......+.+++.+||+.+|++||++.+++++
T Consensus       220 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 P----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             C----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1    1122233458899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=324.33  Aligned_cols=245  Identities=28%  Similarity=0.447  Sum_probs=201.9

Q ss_pred             eeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCCh
Q 013404          104 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL  182 (443)
Q Consensus       104 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  182 (443)
                      +||+|.||+||.|+. ++...+|||.+........+-+.+|+.+-++|+|.|||+++|.|.  +++..-+.||.+|||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecCCCCcH
Confidence            699999999999995 456689999998777667778899999999999999999999976  55578899999999999


Q ss_pred             hHhhcCCCCCCCCC--ChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec-CCCceEEccccccccCCCCCccc
Q 013404          183 ESWLHGPLGVNCHL--DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNY  259 (443)
Q Consensus       183 ~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~  259 (443)
                      .++|+..-+   ++  ++.++--+..||++||.|||++.   |||||||-+|||++ -.|.+||+|||-++.+..-  +.
T Consensus       660 SsLLrskWG---PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP  731 (1226)
T KOG4279|consen  660 SSLLRSKWG---PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NP  731 (1226)
T ss_pred             HHHHHhccC---CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Cc
Confidence            999975332   34  67788889999999999999999   99999999999995 4789999999999877543  23


Q ss_pred             cccccccCcccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          260 LSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       260 ~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                      ....+.||..|||||++..+  .|..++|||||||++.||.||++||...... +.              .+..+---..
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qA--------------AMFkVGmyKv  796 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QA--------------AMFKVGMYKV  796 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hH--------------hhhhhcceec
Confidence            45668899999999999865  5889999999999999999999999532211 00              0111111223


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ....|.+...+...+|.+|+.+||.+||+++++++.
T Consensus       797 HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  797 HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            356678888889999999999999999999999863

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=303.04  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=203.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      ++|++.+.||.|+||.||++.. .+++.+++|.+........+.+.+|++++++++||||+++++++.  +....+++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~l~~e   80 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL--RRDKLWIVME   80 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE--eCCEEEEEEe
Confidence            5788999999999999999995 467889999998665556678999999999999999999999887  4457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++...   ...+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            99999999998643   245889999999999999999999998   999999999999999999999999998765432


Q ss_pred             CccccccccccCcccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ..  ......++..|+|||.+.+.   .++.++||||||+++|||++|+.||....+...  ...    ....     .+
T Consensus       155 ~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~----~~~~-----~~  221 (262)
T cd06613         155 IA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL----ISKS-----NF  221 (262)
T ss_pred             hh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHhc-----cC
Confidence            21  12334688899999998776   889999999999999999999999964332111  100    0000     00


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..+.+  .........+.+++.+||+.+|.+||++++|+.+
T Consensus       222 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 PPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             CCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00111  1122334468899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.3e-39  Score=303.03  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=202.3

Q ss_pred             CCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|+..+.||.|+||.||.++ ..+++.+++|.+....  ......+.+|++++++++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence            58889999999999999998 4568899999886543  3335678899999999999999999999874  45889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++....  ...+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~  153 (256)
T cd08221          79 EYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS  153 (256)
T ss_pred             EecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence            9999999999997542  345889999999999999999999998   99999999999999999999999999986644


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++|..||.....      ......+...  ....   
T Consensus       154 ~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~--~~~~---  220 (256)
T cd08221         154 EYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQG--NYTP---  220 (256)
T ss_pred             ccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcC--CCCC---
Confidence            332  22345689999999999888889999999999999999999999964322      1112111111  0100   


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                            .+......+.+++.+||+.+|++||+++++++++
T Consensus       221 ------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 ------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                  1112233478999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=326.33  Aligned_cols=251  Identities=29%  Similarity=0.451  Sum_probs=207.3

Q ss_pred             CCCCceeeecCcEEEEEEEEC--CCc--EEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           99 FEPASILGEGGFGRVFKGVLS--DGT--AVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ....++||+|.||.|++|.|.  +|+  .||||.++..... ...+|++|+.+|-+|+|||+++|+|+...   ....+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV  188 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMV  188 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHH
Confidence            345688999999999999975  343  6899999876544 56789999999999999999999999873   367899


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||.++.|+|.+.|++  .....|-......++.|||.||.||..++   +|||||..+|+||-....+||+||||.+.+.
T Consensus       189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence            999999999999987  23556888889999999999999999999   9999999999999998899999999999988


Q ss_pred             CCCcccccc-ccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          254 EGRTNYLST-RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       254 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .....|.+. ...-...|+|||.+....++.++|||+|||++|||+| |..||-....      .+... .+.++.++  
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------~qIL~-~iD~~erL--  334 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------IQILK-NIDAGERL--  334 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------HHHHH-hccccccC--
Confidence            776665443 3345778999999999999999999999999999999 7889864332      11111 11122222  


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                              .-++.|.+.+++++..||..+|.+||++..|.+.+
T Consensus       335 --------pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 --------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             --------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                    33566777899999999999999999999998543

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.7e-39  Score=305.55  Aligned_cols=252  Identities=27%  Similarity=0.370  Sum_probs=203.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ..|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++++.||||+++++++.  +....++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEEEEE
Confidence            35777889999999999999964 68899999987543 233467889999999999999999999987  445899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.+++..     .++++.++..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          82 EYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             ecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            99999999999863     34888999999999999999999998   99999999999999999999999999976644


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ......++..|+|||++.+..++.++|||||||++|||++|..||....+...      .... .          
T Consensus       154 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~-~----------  214 (277)
T cd06640         154 TQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LFLI-P----------  214 (277)
T ss_pred             Ccc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hhhh-h----------
Confidence            321  12334678899999999988899999999999999999999999964332110      0000 0          


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      .......+......+.+++.+||+.+|++||++.+++++-...
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06640         215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence            0001122334455688999999999999999999999885543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-39  Score=306.22  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=199.0

Q ss_pred             CCCCceeeecCcEEEEEEEEC----CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC----C
Q 013404           99 FEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S  168 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~  168 (443)
                      |.+.+.||+|+||.||+|.+.    +++.||||.+.....  ...+++.+|++++++++||||+++++++...+.    .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999853    367899999875432  234568899999999999999999998764322    1


Q ss_pred             eeEEEEeecCCCChhHhhcCCC--CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ..+++++|+++|+|.+++....  .....+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            3468899999999998875321  11234788999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      |+++...............++..|++||.+....++.++|||||||++|||++ |+.||.....   ..+..+..    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~----~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI----K  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH----c
Confidence            99987644332222223346678999999998889999999999999999999 8888864321   11111111    1


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ....      .    .+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus       231 ~~~~------~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRL------K----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcC------C----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111      0    0112233588999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.9e-40  Score=309.40  Aligned_cols=249  Identities=27%  Similarity=0.393  Sum_probs=199.0

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.  .....++|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL--KGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc--cCCceEEEEE
Confidence            3556788999999999999854 57889999987443 223457889999999999999999999987  4457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++..     ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          83 YLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            9999999999863     35889999999999999999999998   999999999999999999999999999765433


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  ......++..|+|||++.+..++.++|||||||++|||++|+.||....+...   .   .. ....      ..+
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~---~~-~~~~------~~~  219 (277)
T cd06642         155 QI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L---FL-IPKN------SPP  219 (277)
T ss_pred             ch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H---hh-hhcC------CCC
Confidence            21  12234678899999999998999999999999999999999999864322110   0   00 0000      011


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .+    +......+.+++.+||+.+|++||++.+|+++-+
T Consensus       220 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         220 TL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             CC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence            11    1222345789999999999999999999999755

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-39  Score=306.06  Aligned_cols=254  Identities=24%  Similarity=0.423  Sum_probs=198.6

Q ss_pred             CCCCCceeeecCcEEEEEEEECC--CcEEEEEEeccCCC----------CCHHHHHHHHHHHhh-cCCCceeeEEEeeec
Q 013404           98 NFEPASILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQ----------QGDKEFLVEVEMLSR-LHHRNLVKLVGYYSS  164 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  164 (443)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+.....          ....++..|+.++.+ ++||||+++++++. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            47888999999999999999654  68899998864321          123457788888875 69999999999987 


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEE
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKV  243 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl  243 (443)
                       +....+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||
T Consensus        80 -~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l  155 (269)
T cd08528          80 -ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTI  155 (269)
T ss_pred             -cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEE
Confidence             4458899999999999999885432234468899999999999999999996 56   999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      +|||++.......   ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....      ........
T Consensus       156 ~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------~~~~~~~~  226 (269)
T cd08528         156 TDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------LSLATKIV  226 (269)
T ss_pred             ecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------HHHHHHHh
Confidence            9999998755432   22345688999999999988899999999999999999999999963321      11111111


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..  ..    .+.....+    ...+.+++.+||+.||++||++.||.++++
T Consensus       227 ~~--~~----~~~~~~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 EA--VY----EPLPEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hc--cC----CcCCcccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11  00    01111112    234789999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.3e-39  Score=306.10  Aligned_cols=264  Identities=25%  Similarity=0.342  Sum_probs=199.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|+..+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|+.++++++|||++++++++.  .....+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR--RKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe--eCCEEEEE
Confidence            46888999999999999999965 689999999865432  23456889999999999999999999987  44578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++++|..++..    ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07847          79 FEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILT  151 (286)
T ss_pred             EeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecC
Confidence            999999888887753    235899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH----------
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI----------  322 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~----------  322 (443)
                      .....  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+  .+.......          
T Consensus       152 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07847         152 GPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQI  227 (286)
T ss_pred             CCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhh
Confidence            43321  223457889999999876 467899999999999999999999997443221  111111100          


Q ss_pred             hhccccccccccCccCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          323 LRDKDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       323 ~~~~~~~~~~~d~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +...........+......+.     .....+.+++.+||+.+|++||++.|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            000000001111111111111     112457899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.2e-39  Score=313.48  Aligned_cols=266  Identities=16%  Similarity=0.208  Sum_probs=192.6

Q ss_pred             CCceeeec--CcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404          101 PASILGEG--GFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus       101 ~~~~lg~G--~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      +.++||+|  +|++||++.. .+|+.||+|++......  ....+.+|+++++.++||||++++++|..  ....++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence            46789999  7899999985 57899999999754322  23467789999999999999999999874  447899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++....  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.++++||+........
T Consensus        80 ~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          80 FMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             ccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            999999999996432  234889999999999999999999999   999999999999999999999999875443211


Q ss_pred             Ccc-----ccccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc---
Q 013404          256 RTN-----YLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD---  325 (443)
Q Consensus       256 ~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  325 (443)
                      ...     .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  ............   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~  232 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccc
Confidence            110     00112356778999999876  468999999999999999999999996422110  000000000000   


Q ss_pred             -----cccc-----cccccCcc-----------------CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          326 -----KDRL-----EELADPRL-----------------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       326 -----~~~~-----~~~~d~~~-----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                           ...+     ....+...                 ...........+.+++.+||+.||++|||++|++++-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~  309 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  309 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence                 0000     00000000                 00011122345889999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-40  Score=309.96  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=201.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||.|+||.||++... ++..+|+|.+........+.|.+|++++++++||||+++++++.  +....++||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   81 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF--YENKLWILI   81 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe--cCCeEEEEe
Confidence            356889999999999999999964 68899999997655445567999999999999999999999987  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          82 EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999998643   235899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...  ......++..|+|||.+.     ...++.++||||||+++|||++|+.||......      .....+....  .
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--~  225 (280)
T cd06611         156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKILKSE--P  225 (280)
T ss_pred             ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHhcCC--C
Confidence            221  123356899999999875     345678999999999999999999999643221      1111111110  0


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                           +.+  ..+......+.+++..||+.+|.+||++.+|+++-+
T Consensus       226 -----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (280)
T cd06611         226 -----PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF  264 (280)
T ss_pred             -----CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence                 000  011112234788999999999999999999998744

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-39  Score=308.92  Aligned_cols=261  Identities=27%  Similarity=0.444  Sum_probs=202.2

Q ss_pred             CHHHHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecC
Q 013404           88 AYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR  165 (443)
Q Consensus        88 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  165 (443)
                      ++.++......|++.+.||.|+||.||+|.. .+++.+|+|.+.... .....+..|+.+++++ +|+||+++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4455566778899999999999999999995 568899999986432 2345688899999998 799999999988532


Q ss_pred             ----CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCce
Q 013404          166 ----DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA  241 (443)
Q Consensus       166 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  241 (443)
                          .....+++|||+++|+|.+++....  ...+++..++.++.|++.||.|||+.+   |+|+||+|+||++++++.+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence                2347899999999999999997533  235788889999999999999999998   9999999999999999999


Q ss_pred             EEccccccccCCCCCccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 013404          242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV  316 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~  316 (443)
                      +|+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||....+.....  
T Consensus       161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--  236 (282)
T cd06636         161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--  236 (282)
T ss_pred             EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence            9999999876532211  123356889999999875     3467889999999999999999999996432211100  


Q ss_pred             HHHHHHhhccccccccccCcc-CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          317 TWARPILRDKDRLEELADPRL-GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                          ... .      ...+.. ...++    ..+.+++.+||+.||.+||++.|++++
T Consensus       237 ----~~~-~------~~~~~~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         237 ----LIP-R------NPPPKLKSKKWS----KKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ----hHh-h------CCCCCCcccccC----HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                000 0      000111 11222    358899999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=295.79  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=203.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccC--CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      +++|++.+.||+|.|+.||++. ..+|+.+|+|.+...  ...+.+++.+|+++-+.|+|||||++.+.+.  +....+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~--~~~~~yl   87 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYL   87 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc--ccceeEE
Confidence            4578888999999999999987 567999999988643  2335678999999999999999999998765  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec---CCCceEEcccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLA  249 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla  249 (443)
                      |+|+|.|++|..-|-.    +..+++..+-..+.||+++|.|+|.++   |||||+||.|+||-   ..--+||+|||+|
T Consensus        88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA  160 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA  160 (355)
T ss_pred             EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence            9999999999766532    234677888899999999999999999   99999999999994   3456999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      .....+.   .....+||++|||||++...+|+..+|||+.||+||-|+.|.+||...+.      .+...++......+
T Consensus       161 i~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~------~rlye~I~~g~yd~  231 (355)
T KOG0033|consen  161 IEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYEQIKAGAYDY  231 (355)
T ss_pred             EEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH------HHHHHHHhccccCC
Confidence            9887433   34567899999999999999999999999999999999999999974321      12222232222111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                          +    +..-....+...+|+++||..||.+|.|+.|.++|-|..+
T Consensus       232 ----~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  232 ----P----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             ----C----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                1    1111122234678999999999999999999998766543

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-39  Score=302.67  Aligned_cols=246  Identities=30%  Similarity=0.519  Sum_probs=196.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.+.||+|+||.||++.. +++.||+|.++..  .....+.+|+.++++++|||++++++++..   ...+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEEC
Confidence            4688899999999999999875 5788999998643  234678999999999999999999998853   246899999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.+++....  ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        80 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          80 MSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             CCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            99999999997532  335789999999999999999999998   9999999999999999999999999987643321


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                           .....+..|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+ ......      
T Consensus       155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~-~~~~~~------  216 (254)
T cd05083         155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECV-EKGYRM------  216 (254)
T ss_pred             -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHH-hCCCCC------
Confidence                 12234568999999998899999999999999999998 9999864332      1111111 111100      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                          ..+......+.+++.+||+.+|++||+++++++.|+
T Consensus       217 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         217 ----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence                111122345789999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-40  Score=318.18  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=206.0

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCee
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  170 (443)
                      .....|+++++||+||.+.||++...+.+.||+|++....  .+....|.+|+..|.+| .|.+||+|++|-..  .+.+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence            3456789999999999999999998888889999876543  33356799999999999 59999999999653  4589


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      |+||||- ..+|..+|++...  ....| .+..+..|++.|+.+.|.++   |||.||||.|+|+.. |.+||+|||+|.
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIAN  507 (677)
T ss_pred             EEEeecc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhc
Confidence            9999987 4599999986432  22334 77888999999999999999   999999999999986 489999999999


Q ss_pred             cCCCCCccccccccccCcccccccccccCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGH-----------LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      ....+.+.......+||+.||+||.+....           .+.++||||+|||||+|+.|+.||....     +  .| 
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~-  579 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QI-  579 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HH-
Confidence            998888887788899999999999885432           4678999999999999999999995211     1  11 


Q ss_pred             HHHhhccccccccccCccCCCCCHHHH-HHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDF-IRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~-~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                             ..+..+.||...-+++.-.. ..+.++++.||++||++||+..|++++
T Consensus       580 -------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 -------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                   23455666654434432111 128899999999999999999999976

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-39  Score=303.11  Aligned_cols=237  Identities=26%  Similarity=0.477  Sum_probs=187.7

Q ss_pred             ceeeecCcEEEEEEEECC-C----------cEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404          103 SILGEGGFGRVFKGVLSD-G----------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      +.||+|+||.||+|...+ +          ..+++|.+...... ...|.+|+.++++++||||+++++++..   ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR---DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec---CCcE
Confidence            469999999999999653 3          25788877654333 6789999999999999999999999874   4678


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-------ceEEc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-------HAKVA  244 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~  244 (443)
                      ++|||+++|+|.+++....   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++       .+||+
T Consensus        77 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeC
Confidence            9999999999999997532   25889999999999999999999998   99999999999999887       79999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      |||++......      ....++..|+|||++...  .++.++||||||+++|||++ |..||.......   ...+.. 
T Consensus       151 Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~-  220 (259)
T cd05037         151 DPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ-  220 (259)
T ss_pred             CCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh-
Confidence            99999865431      223567789999999876  78999999999999999999 577775433211   111110 


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                         .....            +......+.+++.+||..+|++||++.+|++.|
T Consensus       221 ---~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 ---DQHRL------------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ---cCCCC------------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence               11100            000114588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.7e-39  Score=310.20  Aligned_cols=265  Identities=22%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++.  +....++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe--cCCeEEEEE
Confidence            57889999999999999999854 678999999875432 23456788999999999999999999987  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||++ ++|.+++...   ...+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||++.....
T Consensus        84 e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          84 EYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             eccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            9997 5999988643   235788999999999999999999998   99999999999999999999999999976533


Q ss_pred             CCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc--------
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD--------  325 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------  325 (443)
                      ...  ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.......   ........+..        
T Consensus       157 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (301)
T cd07873         157 PTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPG  231 (301)
T ss_pred             CCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchh
Confidence            221  12234578899999988654 57889999999999999999999997543211   11111111000        


Q ss_pred             ---cccccccccCccCCCC----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          326 ---KDRLEELADPRLGGKY----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       326 ---~~~~~~~~d~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                         .........+.....+    .......+.+++.+||+.||.+|||++|++++-+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~  288 (301)
T cd07873         232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY  288 (301)
T ss_pred             hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence               0000000001110000    0011234788999999999999999999998644

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-39  Score=305.25  Aligned_cols=255  Identities=26%  Similarity=0.434  Sum_probs=196.9

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC---C-------CHHHHHHHHHHHhhcCCCceeeEEEeeecCC
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---Q-------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD  166 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  166 (443)
                      +|...+.||+|+||.||+|.. .+|+.||+|.++....   .       ..+.+..|+.++++++|||++++++++..  
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence            467789999999999999984 4688999998864211   1       12357889999999999999999999874  


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ....++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~  152 (272)
T cd06629          80 EEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDF  152 (272)
T ss_pred             CCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeec
Confidence            45789999999999999999753    45889999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      |+++...............++..|+|||.+....  ++.++||||||+++||+++|..||...+.     ...... ...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~  226 (272)
T cd06629         153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMFK-LGN  226 (272)
T ss_pred             cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHHH-hhc
Confidence            9998654322222223456889999999987654  78999999999999999999999953221     111111 111


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .  ............    .....+.+++.+||+.+|++||++++|+++
T Consensus       227 ~--~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         227 K--RSAPPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             c--ccCCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            1  011111111111    223458889999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-39  Score=307.63  Aligned_cols=256  Identities=25%  Similarity=0.432  Sum_probs=199.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||++... ++..||+|.++.... .....+.+|++++++++||||+++++++..  ....++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEE
Confidence            36888999999999999999965 789999998875422 224578899999999999999999998874  45889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||+++++|..++.... ....+++..+..++.|++.||.|||+. +   |+|+||||+||+++.++.+||+|||++....
T Consensus        79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          79 EYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             eecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9999999999987532 123689999999999999999999974 6   9999999999999999999999999987653


Q ss_pred             CCCccccccccccCcccccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ...    .....++..|+|||.+.+.      .++.++|||||||++|||++|+.||......   ........+...  
T Consensus       155 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~--  225 (286)
T cd06622         155 ASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVDG--  225 (286)
T ss_pred             CCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhhc--
Confidence            321    2234678899999988554      3578999999999999999999999643221   111111111100  


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                              . ....+......+.+++.+||+.+|++||++++++++-+.
T Consensus       226 --------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~  265 (286)
T cd06622         226 --------D-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL  265 (286)
T ss_pred             --------C-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence                    0 011222334457899999999999999999999987553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=306.03  Aligned_cols=258  Identities=32%  Similarity=0.477  Sum_probs=201.8

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC----CC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD----SS  168 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----~~  168 (443)
                      .+++|++.+.||+|+||.||+|... +++.+++|.+..... ....+.+|+.+++++ .|+||+++++++....    ..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4678999999999999999999964 678999999875433 346789999999999 7999999999986433    34


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..+++|||+++++|.+++.........+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            578999999999999998754333456899999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      +........  ......++..|+|||++..     ..++.++||||||+++|||++|+.||......  ..+.    .+.
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~  231 (275)
T cd06608         160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALF----KIP  231 (275)
T ss_pred             ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHH----Hhh
Confidence            876543221  1233468899999998753     34678999999999999999999999632211  1111    111


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..  ..     +.+  ..+......+.+++.+||..||++|||+.+++++
T Consensus       232 ~~--~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         232 RN--PP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             cc--CC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            10  00     111  1112233458899999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.9e-39  Score=306.75  Aligned_cols=252  Identities=23%  Similarity=0.359  Sum_probs=202.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .+|.+.+.||+|+||.||++.. .++..||+|.+........+.+.+|+.++++++|||++++++++..  ....++|+|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e   96 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWVVME   96 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEEEEe
Confidence            5788999999999999999985 4688999999875555556778999999999999999999999874  447899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++..     ..+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             cCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            9999999999863     34788999999999999999999999   999999999999999999999999998765433


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  ......+++.|+|||.+....++.++||||||+++||+++|+.||...........      ....         +
T Consensus       169 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~---------~  231 (293)
T cd06647         169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN---------G  231 (293)
T ss_pred             cc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcC---------C
Confidence            22  12334688899999999888899999999999999999999999975432211100      0000         0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ......+......+.+++.+||+.+|++||++.+++.+-+
T Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~  271 (293)
T cd06647         232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (293)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            0000111122335788999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-39  Score=302.69  Aligned_cols=254  Identities=24%  Similarity=0.290  Sum_probs=204.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      +.|++++.||.|.-|+||++.+. ++..+|+|++.+..-.   ...+.+.|-+||+.++||.+..|++.|+.  ....||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~cl  154 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSCL  154 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeEE
Confidence            45677899999999999999975 4689999999865432   23467779999999999999999999984  448899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +||||+||+|+.+++.+.  ...+++..+.-++.+|+-||+|||-.|   ||.|||||+||||.++|++-|+||.|+...
T Consensus       155 ~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            999999999999998654  557999999999999999999999999   999999999999999999999999998543


Q ss_pred             CCC---------------------------------Cc---------------------cccccccccCccccccccccc
Q 013404          253 PEG---------------------------------RT---------------------NYLSTRVMGTFGYVAPEYAMT  278 (443)
Q Consensus       253 ~~~---------------------------------~~---------------------~~~~~~~~gt~~y~aPE~~~~  278 (443)
                      ...                                 ..                     ......++||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            110                                 00                     011234789999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccC
Q 013404          279 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVA  358 (443)
Q Consensus       279 ~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~  358 (443)
                      ...+.++|-|+|||++|||+.|..||.+.....      -+..++.+.....         . .......+.+||++.|.
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~------Tl~NIv~~~l~Fp---------~-~~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE------TLRNIVGQPLKFP---------E-EPEVSSAAKDLIRKLLV  373 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh------hHHHHhcCCCcCC---------C-CCcchhHHHHHHHHHhc
Confidence            999999999999999999999999997554322      1222232221111         1 11333457899999999


Q ss_pred             cCCCCCCC----HHHHHHH
Q 013404          359 PEANQRPT----MGEVVQS  373 (443)
Q Consensus       359 ~dp~~RPs----~~evl~~  373 (443)
                      .||.+|..    ++||-+|
T Consensus       374 KdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             cChhhhhccccchHHhhcC
Confidence            99999998    8888876

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.3e-39  Score=300.04  Aligned_cols=250  Identities=21%  Similarity=0.359  Sum_probs=200.8

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|+||.||++.. .+|+.||+|.+....  .....++.+|+.++++++||||+++++++.  +....++|+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE--ENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec--CCCeEEEEE
Confidence            478899999999999999995 468899999986532  223457899999999999999999999986  445889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++....  ...+++.+++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~  153 (256)
T cd08218          79 DYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS  153 (256)
T ss_pred             ecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence            9999999999986432  235788999999999999999999998   99999999999999999999999999986644


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ......|+..|+|||++.+..++.++|||||||++++|++|+.||....      .......+....  .     
T Consensus       154 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~--~-----  218 (256)
T cd08218         154 TVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGS--Y-----  218 (256)
T ss_pred             chh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCC--C-----
Confidence            321  1223468889999999998889999999999999999999999996432      112222221111  0     


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +    ..+......+.+++.+||+.+|++||++.+|+++
T Consensus       219 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 P----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             C----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            0    1122223358899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.4e-40  Score=307.45  Aligned_cols=239  Identities=23%  Similarity=0.432  Sum_probs=186.6

Q ss_pred             ceeeecCcEEEEEEEECC--------CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404          103 SILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.+++.++|||++++++++..  ....++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEEE
Confidence            469999999999998532        23488888865544445678999999999999999999999874  34688999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc--------eEEccc
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--------AKVADF  246 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Df  246 (443)
                      ||+++|+|.++++...   ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.        ++++||
T Consensus        79 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          79 EYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             ecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence            9999999999997532   25889999999999999999999998   999999999999987765        699999


Q ss_pred             cccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcchHHHHHHHHhh
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      |++......      ....++..|+|||++.+ ..++.++||||||+++|||++|. .||....+..      .. ....
T Consensus       153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~-~~~~  219 (258)
T cd05078         153 GISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KL-QFYE  219 (258)
T ss_pred             ccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HH-HHHH
Confidence            988654322      22467889999999986 45789999999999999999985 5554322111      00 0111


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ...            ..+......+.+++.+||+.||++|||++++++.|
T Consensus       220 ~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 DRH------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ccc------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            110            11222224588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=316.07  Aligned_cols=242  Identities=22%  Similarity=0.277  Sum_probs=185.9

Q ss_pred             eeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhc---CCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          105 LGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRL---HHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       105 lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      ||+|+||.||+|+. .+++.||||++.....   .....+..|..++..+   +||||+++++++.  +....++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcCC
Confidence            79999999999995 4689999999864321   1223455677777665   6999999999887  445789999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        79 ~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  151 (330)
T cd05586          79 SGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK  151 (330)
T ss_pred             CCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence            99999999864    345889999999999999999999999   99999999999999999999999999875433221


Q ss_pred             cccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR  336 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  336 (443)
                        ......||..|+|||++.+. .++.++|||||||++|||++|+.||.....      ......+......+     + 
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~-----~-  217 (330)
T cd05586         152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGKVRF-----P-  217 (330)
T ss_pred             --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCCCCC-----C-
Confidence              12345799999999998764 478999999999999999999999964321      11112111111100     0 


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCcCCCCCC----CHHHHHHHH
Q 013404          337 LGGKYPKEDFIRVCTIAAACVAPEANQRP----TMGEVVQSL  374 (443)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~evl~~L  374 (443)
                       ...++    ..+.+++.+||+.||++||    ++.+++++-
T Consensus       218 -~~~~~----~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~  254 (330)
T cd05586         218 -KNVLS----DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP  254 (330)
T ss_pred             -CccCC----HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence             01122    2467899999999999998    677777754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.8e-39  Score=306.12  Aligned_cols=256  Identities=28%  Similarity=0.433  Sum_probs=195.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHH-HhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEM-LSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||++... +|+.||+|+++.... .....+..|+.. ++.++||||+++++++.  .....+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~--~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF--REGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe--cCCcEEEE
Confidence            47889999999999999999964 689999999875432 233456667665 56678999999999987  44478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |||++ |+|.+++.........+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            99996 689888865433345789999999999999999999987 7   999999999999999999999999999865


Q ss_pred             CCCCccccccccccCccccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ....   ..+...++..|+|||.+.+    ..++.++|+|||||++|||++|+.||......    ... .......   
T Consensus       155 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~-~~~~~~~---  223 (283)
T cd06617         155 VDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQ-LKQVVEE---  223 (283)
T ss_pred             cccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHH-HHHHHhc---
Confidence            4321   1233468889999998865    45688999999999999999999999632211    111 1111110   


Q ss_pred             ccccccCcc-CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          329 LEELADPRL-GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       329 ~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                          ..+.. ...++    ..+.+++.+||+.+|++||++++++++-+..
T Consensus       224 ----~~~~~~~~~~~----~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  265 (283)
T cd06617         224 ----PSPQLPAEKFS----PEFQDFVNKCLKKNYKERPNYPELLQHPFFE  265 (283)
T ss_pred             ----CCCCCCccccC----HHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence                00111 01122    3478999999999999999999999864433

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.7e-39  Score=300.93  Aligned_cols=248  Identities=29%  Similarity=0.464  Sum_probs=198.1

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-----CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      +|+..+.||+|+||.||+|... ++..|++|.+.....     ...+.+.+|+.+++.++|+||+++++++.  +....+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~   78 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER--EEDNLY   78 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe--cCCeEE
Confidence            4677899999999999999965 789999999865432     23457889999999999999999999987  445789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +++||+++++|.+++...    ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++..
T Consensus        79 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~  151 (258)
T cd06632          79 IFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQ  151 (258)
T ss_pred             EEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcccee
Confidence            999999999999999642    35889999999999999999999998   99999999999999999999999999886


Q ss_pred             CCCCCccccccccccCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .....   ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.....      .......... ... 
T Consensus       152 ~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~-~~~-  220 (258)
T cd06632         152 VVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRS-KEL-  220 (258)
T ss_pred             ccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhc-ccC-
Confidence            54332   123456889999999987776 89999999999999999999999964331      1111111110 001 


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                          +    ..+......+.+++.+||+.+|++||++.+++.+
T Consensus       221 ----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         221 ----P----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ----C----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                1    1122223447889999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.3e-39  Score=301.61  Aligned_cols=254  Identities=24%  Similarity=0.403  Sum_probs=200.0

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC------CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      +|+..+.||+|+||.||++.. .+++.||+|.+......      ..+.+.+|++++++++|+||+++++++.  +....
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~   78 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHF   78 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeE
Confidence            578889999999999999984 57899999998643211      2357889999999999999999999987  45578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-ceEEcccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLA  249 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla  249 (443)
                      +++|||+++++|.+++..    ..++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++
T Consensus        79 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~  151 (268)
T cd06630          79 NLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAA  151 (268)
T ss_pred             EEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence            999999999999999964    235889999999999999999999999   99999999999998765 6999999998


Q ss_pred             ccCCCCCcc--ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          250 KQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       250 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      .........  .......++..|+|||.+.+..++.++||||||+++|+|++|..||.........   .........  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~--  226 (268)
T cd06630         152 ARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASA--  226 (268)
T ss_pred             cccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhcc--
Confidence            766433111  1122346889999999998888999999999999999999999999643322111   111111000  


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                              ......+......+.+++.+||+.+|++||++.+++++
T Consensus       227 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         227 --------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                    00112233334568899999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=307.67  Aligned_cols=264  Identities=27%  Similarity=0.382  Sum_probs=199.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+|... +++.||+|.++...  ....+.+.+|++++++++|+||+++++++..  ....+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence            36889999999999999999965 68899999887542  2234678999999999999999999999874  4578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||++++.|..++..    ...+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++....
T Consensus        79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~  151 (288)
T cd07833          79 FEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALR  151 (288)
T ss_pred             EecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence            999998777766543    234889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh---------
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL---------  323 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  323 (443)
                      ..... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+  .+.. .....         
T Consensus       152 ~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~  227 (288)
T cd07833         152 ARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYL-IQKCLGPLPPSHQE  227 (288)
T ss_pred             CCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHhh
Confidence            44321 12335678899999999888 88999999999999999999999996432211  1110 00000         


Q ss_pred             --hcccccc-----ccccCc-cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          324 --RDKDRLE-----ELADPR-LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       324 --~~~~~~~-----~~~d~~-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                        .......     ...++. ....++......+.+++.+||..+|++||++++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              0000000     000000 0001112224568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=318.99  Aligned_cols=245  Identities=30%  Similarity=0.431  Sum_probs=199.0

Q ss_pred             CCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCH---HHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .|.-++.||.|+||.||.++ ..+.+.||||++...+.+..   ++++.|++.|++++|||++.+.|||..  ....+||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWLV  104 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWLV  104 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHHH
Confidence            35567889999999999999 45788999999987766553   578899999999999999999999984  3478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||||- |+-.|++.-.   .+++.+.++..|..+.++||+|||+.+   .||||||+.||||++.|.|||+|||.|....
T Consensus       105 MEYCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  105 MEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC
Confidence            99994 5777777422   456889999999999999999999999   9999999999999999999999999997665


Q ss_pred             CCCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .      ...++|||.|||||++.   .+.|+-|+||||||++..||.-.++|+...+      ...-.-.+..+.    
T Consensus       178 P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN------AMSALYHIAQNe----  241 (948)
T KOG0577|consen  178 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNE----  241 (948)
T ss_pred             c------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch------HHHHHHHHHhcC----
Confidence            4      34569999999999884   5789999999999999999999999975322      222222222211    


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         .|.+.   ..+-...++.++..||+.-|.+|||.+++++|
T Consensus       242 ---sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 ---SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ---CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence               12222   22334468899999999999999999999865

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.2e-39  Score=299.42  Aligned_cols=249  Identities=22%  Similarity=0.388  Sum_probs=198.8

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|+..+.||+|+||.||++.. .+++.+|+|.+....  ......+.+|++++++++|||++++++.+.  .....++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEEEEE
Confidence            578899999999999999985 468899999987543  223467889999999999999999999876  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-CceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~  253 (443)
                      ||+++++|.+++....  ...+++..++.++.|++.||+|||+++   ++|+||+|+||+++++ +.+||+|||++....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (256)
T cd08220          79 EYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS  153 (256)
T ss_pred             ecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence            9999999999997532  335889999999999999999999998   9999999999999854 568999999998765


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..      ..........  ..   
T Consensus       154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~--~~---  219 (256)
T cd08220         154 SKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMSGT--FA---  219 (256)
T ss_pred             CCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHhcC--CC---
Confidence            4322   22346888999999999888999999999999999999999999643321      1111111110  00   


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                            ..+......+.+++.+||+.+|++|||+.|++++
T Consensus       220 ------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 ------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                  1111223347899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.3e-39  Score=308.05  Aligned_cols=266  Identities=24%  Similarity=0.367  Sum_probs=198.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+|... +++.||+|.+......  ..+.+.+|+++++.++||||+++++++.  +....+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEE
Confidence            46888999999999999999965 5899999988654322  2457889999999999999999999986  45588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++++|.++...    ...+++.+++.++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++....
T Consensus        79 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~  151 (286)
T cd07846          79 FEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA  151 (286)
T ss_pred             EecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence            999999999887753    234899999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHH-------HHhh
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWAR-------PILR  324 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~-~~~~~~~-------~~~~  324 (443)
                      ....  ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... .+..+..       ....
T Consensus       152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         152 APGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             CCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence            4322  1233467889999998875 45788999999999999999999998643321100 0000000       0000


Q ss_pred             ccccccccccCccCCC-----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 DKDRLEELADPRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..........+.....     ........+.+++.+||+.+|++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000000000100000     011123458899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.1e-38  Score=297.57  Aligned_cols=253  Identities=27%  Similarity=0.408  Sum_probs=205.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|++|.||+++.. +++.|++|++..... .....+.+|+..+.+++|+|++++++++..  ....+++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEE
Confidence            47889999999999999999965 589999999876544 345689999999999999999999999874  45889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||+++++|.+++...    ..+++..++.++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        79 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          79 EYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999999743    458999999999999999999999 88   9999999999999999999999999998764


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      .....  .....++..|+|||.+.+..++.++||||||+++|||++|+.||.............+   +...       .
T Consensus       152 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---~~~~-------~  219 (264)
T cd06623         152 NTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA---ICDG-------P  219 (264)
T ss_pred             cCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH---HhcC-------C
Confidence            43321  1244688899999999998999999999999999999999999975543122222211   1111       0


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .+.....   .....+.+++.+||+.+|++||++.+++++
T Consensus       220 ~~~~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         220 PPSLPAE---EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCCcc---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1111111   023458899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3e-39  Score=308.65  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=197.2

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .|.....||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++|+||+++++.+.  .....+++|||
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~--~~~~~~lv~e~  100 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL--VGDELWVVMEF  100 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee--cCCeEEEEEeC
Confidence            344456799999999999985 468899999987655445567899999999999999999999887  44588999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.+++..     ..+++.++..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus       101 ~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658         101 LEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            999999999853     34889999999999999999999998   9999999999999999999999999987654322


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCc
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR  336 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  336 (443)
                      .  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......   ...   ..+ ..      ...+.
T Consensus       173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~---~~~-~~------~~~~~  237 (292)
T cd06658         173 P--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAM---RRI-RD------NLPPR  237 (292)
T ss_pred             c--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHH-Hh------cCCCc
Confidence            1  123346889999999998888999999999999999999999999643221   111   110 00      01111


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...  .......+.+++.+||..||++|||+++++++
T Consensus       238 ~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         238 VKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111  01122347789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-38  Score=306.78  Aligned_cols=254  Identities=21%  Similarity=0.337  Sum_probs=195.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++... +++.|++|.+.....   .....+.+|+++++.++||||+++++.+.  .....++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l   78 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE--TKRHLCM   78 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe--cCCEEEE
Confidence            47889999999999999999954 578999999875432   22456889999999999999999999887  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        79 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~  151 (305)
T cd05609          79 VMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIG  151 (305)
T ss_pred             EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence            9999999999999964    235889999999999999999999998   999999999999999999999999998742


Q ss_pred             CCCC-------------ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          253 PEGR-------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       253 ~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      ....             .........++..|+|||.+.+..++.++|+||||+++|||++|..||.....      ..+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~  225 (305)
T cd05609         152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELF  225 (305)
T ss_pred             CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH
Confidence            1110             00011224578899999999988899999999999999999999999964321      1111


Q ss_pred             HHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ......     ....+.....++    ..+.+++.+||+.+|++||++.++.+.|
T Consensus       226 ~~~~~~-----~~~~~~~~~~~~----~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         226 GQVISD-----DIEWPEGDEALP----ADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             HHHHhc-----ccCCCCccccCC----HHHHHHHHHHhccChhhccCccCHHHHH
Confidence            111111     011111111223    3478999999999999999854444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-38  Score=299.56  Aligned_cols=258  Identities=27%  Similarity=0.414  Sum_probs=202.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||.|+||.||+|.. .++..+|+|++..... ...+.+.+|+++++.++|+|++++++.+.  +....++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV--VGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe--eCCEEEEEE
Confidence            4789999999999999999995 4678999999875432 24567899999999999999999999887  445889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++..... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        79 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          79 PYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             eccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999999999975321 245889999999999999999999999   99999999999999999999999999986654


Q ss_pred             CCccc--cccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          255 GRTNY--LSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       255 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .....  ......|+..|+|||++... .++.++|+|||||++|||++|+.||.......  .+...    ....     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~----~~~~-----  223 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT----LQND-----  223 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHH----hcCC-----
Confidence            33221  22334688999999998877 78999999999999999999999996443221  11111    1110     


Q ss_pred             cccCccCCCC-CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          332 LADPRLGGKY-PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       332 ~~d~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                        .+.+.... .......+.+++.+||+.||++||++++|+++
T Consensus       224 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 --PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              01111000 01223457899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.6e-40  Score=320.72  Aligned_cols=244  Identities=25%  Similarity=0.423  Sum_probs=195.5

Q ss_pred             CceeeecCcEEEEEEEEC-CCcEEEEEEeccC----CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404          102 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ..+||+|+|-+||+|.+. +|..||.-.++..    .....+.|..|+.+|+.|+||||++++.++.+.++....+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            467999999999999954 6888886444322    22334789999999999999999999999987777778899999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEccccccccCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~  255 (443)
                      +..|+|..|+.+.    +.++.+.+..|+.||++||.|||++. |+|+|||||.+||+|+. .|.+||+|+|||......
T Consensus       125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999763    34788899999999999999999986 55999999999999975 589999999999877544


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc--ccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--DRLEELA  333 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  333 (443)
                      ..    ....|||.|||||... ..|++..||||||+.|+||+|+..||..-.     +-.+..+.+....  ..+..+-
T Consensus       200 ~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  200 HA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             cc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCHHHhhccC
Confidence            32    3478999999999877 889999999999999999999999996322     2222222222211  1122222


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      |            ..+.++|.+||.. .++|||+.|++++
T Consensus       270 d------------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  270 D------------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             C------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            2            2378999999999 8999999999975

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-38  Score=298.23  Aligned_cols=251  Identities=31%  Similarity=0.491  Sum_probs=198.1

Q ss_pred             CCCCceeeecCcEEEEEEEECC-----CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           99 FEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      |++.+.||.|+||.||++...+     +..||+|.++..... ..+.+..|++++..++|+||+++++++..  ....++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEE
Confidence            4567899999999999999653     388999999765433 46689999999999999999999999874  357899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+++++|.+++....  ...+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||+++..
T Consensus        79 i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceec
Confidence            999999999999997532  112899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....... .....++..|+|||.+.+..++.++||||||++++||++ |..||.....      .......... ...  
T Consensus       154 ~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~~-~~~--  223 (258)
T smart00219      154 YDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEVLEYLKKG-YRL--  223 (258)
T ss_pred             ccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcC-CCC--
Confidence            5442221 112347789999999988889999999999999999998 7888864221      1111111111 110  


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                              ..+......+.+++.+||+.+|++|||+.++++.|
T Consensus       224 --------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 --------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                    01111233588899999999999999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=307.09  Aligned_cols=272  Identities=22%  Similarity=0.288  Sum_probs=199.6

Q ss_pred             CCCCCceeeecCcEEEEEEEEC---CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .|++.+.||+|+||.||+|...   ++..||+|.+....   ......+.+|+.++++++||||+++++++...+....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999964   47899999998633   33346788899999999999999999999866456899


Q ss_pred             EEEeecCCCChhHhhcCCCCC-CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC----CCceEEccc
Q 013404          172 LCYELVPNGSLESWLHGPLGV-NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADF  246 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df  246 (443)
                      +||||+++ +|.+++...... ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 777776533222 236889999999999999999999999   999999999999999    999999999


Q ss_pred             cccccCCCCCcc-ccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-------hHHH
Q 013404          247 GLAKQAPEGRTN-YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-------NLVT  317 (443)
Q Consensus       247 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~-------~~~~  317 (443)
                      |+++........ .......++..|+|||.+.+. .++.++|||||||++|||++|+.||.........       .+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            999876443221 112234678899999988764 5789999999999999999999999754433210       0111


Q ss_pred             HHHHHh----------hccccccccccCccCCCCC---------H--HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          318 WARPIL----------RDKDRLEELADPRLGGKYP---------K--EDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       318 ~~~~~~----------~~~~~~~~~~d~~~~~~~~---------~--~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .+..+-          ..........+......++         .  .....+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            100000          0000000000000000111         0  122357899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-39  Score=309.14  Aligned_cols=254  Identities=27%  Similarity=0.346  Sum_probs=200.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|+..+.||+|+||.||++... +++.||+|.+......   ..+.+..|+++++.++||||+++++++.  +....++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l   78 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ--TETYLCL   78 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee--cCCEEEE
Confidence            36888999999999999999965 5899999999754322   3456889999999999999999999987  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+.+++|.+++....  ...+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          79 VMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             EEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            999999999999987432  346899999999999999999999998   999999999999999999999999998755


Q ss_pred             CCCCcc---------------------------ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 013404          253 PEGRTN---------------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD  305 (443)
Q Consensus       253 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~  305 (443)
                      ......                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            322110                           01113468889999999998889999999999999999999999996


Q ss_pred             CCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC----HHHHHHH
Q 013404          306 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT----MGEVVQS  373 (443)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~evl~~  373 (443)
                      ..+..  .   .+ ..+......        .  .........+.+++.+||+.||++||+    ++|++++
T Consensus       234 ~~~~~--~---~~-~~~~~~~~~--------~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         234 GSNRD--E---TF-SNILKKEVT--------F--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCchH--H---HH-HHHhcCCcc--------C--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            43321  1   11 111111100        0  001112345889999999999999999    7777775

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.6e-39  Score=304.70  Aligned_cols=263  Identities=24%  Similarity=0.321  Sum_probs=194.2

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|+||.||+|... +|+.||+|.++....  .....+.+|++++++++||||+++++++.  +....++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH--SDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc--cCCceEEEE
Confidence            4788899999999999999964 689999999875422  22356788999999999999999999987  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||++ ++|.+++...   ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        79 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  151 (284)
T cd07839          79 EYCD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI  151 (284)
T ss_pred             ecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence            9996 5888887642   245899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc-----c
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-----R  328 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~  328 (443)
                      ....  .....++..|+|||++.+. .++.++|||||||++|||++|..|+...... ...+ ...........     .
T Consensus       152 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~  227 (284)
T cd07839         152 PVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQL-KRIFRLLGTPTEESWPG  227 (284)
T ss_pred             CCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHH-HHHHHHhCCCChHHhHH
Confidence            2211  1234578899999998765 4689999999999999999999986432211 1111 10000000000     0


Q ss_pred             ccccccC----ccCC-----CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          329 LEELADP----RLGG-----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       329 ~~~~~d~----~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +....+.    ....     .........+.+++.+||+.||.+|||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000000    0000     0011123457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.2e-39  Score=309.17  Aligned_cols=252  Identities=24%  Similarity=0.371  Sum_probs=199.6

Q ss_pred             CCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404           99 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      |.....||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++||||+++++++..  ....++++||+
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e~~  100 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLMEFL  100 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEecC
Confidence            33445799999999999985 4689999999876555556778899999999999999999998874  45789999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++++|.+++..     ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus       101 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         101 QGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            99999998753     34889999999999999999999999   99999999999999999999999999876543321


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.   ...   ..+ ....      .+..
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~---~~~-~~~~------~~~~  237 (297)
T cd06659         173 --KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAM---KRL-RDSP------PPKL  237 (297)
T ss_pred             --cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHH-hccC------CCCc
Confidence              123356899999999999888999999999999999999999999643221   111   111 1100      0000


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      .  ........+.+++.+||+.+|++||++++++++-...
T Consensus       238 ~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~  275 (297)
T cd06659         238 K--NAHKISPVLRDFLERMLTREPQERATAQELLDHPFLL  275 (297)
T ss_pred             c--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence            0  0111123478899999999999999999999875544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=307.93  Aligned_cols=248  Identities=23%  Similarity=0.370  Sum_probs=207.8

Q ss_pred             cCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .-|.+.+.||+|.|..|-+++ .-+|..||||++.+..-.  ....+.+|++.|+-++|||||+|+.+..  ....+|||
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD--TQTKlyLi   95 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID--TQTKLYLI   95 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc--ccceEEEE
Confidence            346778899999999999998 458999999999765332  3457889999999999999999999876  44589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe-cCCCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~  252 (443)
                      +|.-++|+|+|||-+.   ...+.+..+.+++.||+.|+.|+|..+   +|||||||+||.+ .+-|-+||.|||++..+
T Consensus        96 LELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999999999543   345899999999999999999999999   9999999999986 56789999999999877


Q ss_pred             CCCCccccccccccCcccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ..+..   .+..+|+..|-|||++.+..|+ ++.||||||||||-|++|+.||...+..                ..+..
T Consensus       170 ~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTm  230 (864)
T KOG4717|consen  170 QPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTM  230 (864)
T ss_pred             CCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhh
Confidence            66543   3567999999999999999886 6789999999999999999999744322                33444


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ++|-..  ..|.....++.+||..||..||.+|.+.+||+..
T Consensus       231 ImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  231 IMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            455433  3455566678999999999999999999999854

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-38  Score=302.55  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|+||.||+|.. .+|+.||+|++.....  .....+.+|+.++++++||||+++++++..  ....++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence            478889999999999999996 4689999999876542  234679999999999999999999999874  55789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+ +++|.+++...   ...+++.+++.++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        79 e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~  151 (286)
T cd07832          79 EYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSE  151 (286)
T ss_pred             ccc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence            999 99999998643   245899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-------
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-------  326 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  326 (443)
                      ... .......++..|+|||.+.+. .++.++||||||+++|||++|.+||......   ....+....+...       
T Consensus       152 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07832         152 EEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPG  227 (286)
T ss_pred             CCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhh
Confidence            321 112234688999999988654 4689999999999999999998887543221   1111111111000       


Q ss_pred             ----ccccccccCccCC----CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 ----DRLEELADPRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 ----~~~~~~~d~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                          .....+..+....    ....+....+++++.+||+.+|++||++++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                0000000000000    0001123568899999999999999999999976

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=298.94  Aligned_cols=271  Identities=26%  Similarity=0.373  Sum_probs=223.4

Q ss_pred             HHHHHHHhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEe
Q 013404           89 YEELKEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGY  161 (443)
Q Consensus        89 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~  161 (443)
                      ..++.....+++...++-+|.||.||.|.+.      +.+.|-||.++....+ ....++.|.-.+..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3455566778888999999999999999654      3456778888755433 24568889999999999999999999


Q ss_pred             eecCCCCeeEEEEeecCCCChhHhhcCCCC----CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC
Q 013404          162 YSSRDSSQHLLCYELVPNGSLESWLHGPLG----VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN  237 (443)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  237 (443)
                      +.. +....+.+|.++.-|+|..||...++    ....++..+...++.|++.|++|||+++   ++|.||..+|++||+
T Consensus       356 ~ie-~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  356 SIE-DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             Eee-ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            875 55578889999999999999983322    2345778889999999999999999999   999999999999999


Q ss_pred             CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 013404          238 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV  316 (443)
Q Consensus       238 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~  316 (443)
                      ..++||+|-.++|.+...+.+........+..||+||.+.+..|+.++|||||||+||||+| |+.||..-+|.+.    
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm----  507 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM----  507 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH----
Confidence            99999999999999988888877777788999999999999999999999999999999998 9999965444322    


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                         ...+.++.++.+          |.+++.++..++..||..+|++||++++++..|.++...
T Consensus       508 ---~~ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  508 ---EHYLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             ---HHHHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence               223444554433          334445688999999999999999999999999887643

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.6e-38  Score=299.68  Aligned_cols=250  Identities=29%  Similarity=0.437  Sum_probs=199.7

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      -|+..+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.++++++||||+++++++.  +....++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE--eCCeEEEEEE
Confidence            467789999999999999985 4688999998864432 23457889999999999999999999987  4457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++..     ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        83 ~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          83 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence            9999999999863     35889999999999999999999998   999999999999999999999999998765432


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  ......++..|+|||.+.+..++.++|||||||++|+|++|..||.....      ..+...+... .      .+
T Consensus       155 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~-~------~~  219 (277)
T cd06641         155 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLIPKN-N------PP  219 (277)
T ss_pred             hh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHHhcC-C------CC
Confidence            21  12234688899999999888899999999999999999999999964221      1111111110 0      11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      .+...++    ..+.+++.+||+.+|++||++.+++++-..
T Consensus       220 ~~~~~~~----~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  256 (277)
T cd06641         220 TLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHKFI  256 (277)
T ss_pred             CCCcccC----HHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence            1112222    347899999999999999999999997443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=301.80  Aligned_cols=264  Identities=23%  Similarity=0.328  Sum_probs=194.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++.  +....++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH--TKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe--cCCeEEEEE
Confidence            57889999999999999999964 6889999998754322 2345778999999999999999999987  445889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++ +|.+++....   ..+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||+++....
T Consensus        83 e~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          83 EYLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             ecCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            99975 9999886432   35889999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc--cc---
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--DR---  328 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---  328 (443)
                      ....  .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......  ..........+...  ..   
T Consensus       156 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07844         156 PSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPG  231 (291)
T ss_pred             CCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhh
Confidence            2111  122356889999998875 45789999999999999999999999643311  00000000000000  00   


Q ss_pred             ---c---ccc----c-cCccCCCCC-HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          329 ---L---EEL----A-DPRLGGKYP-KEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       329 ---~---~~~----~-d~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         .   ...    . ...+....+ ......+.+++.+||+.+|++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence               0   000    0 000000000 0001356789999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.2e-38  Score=303.32  Aligned_cols=263  Identities=25%  Similarity=0.323  Sum_probs=197.6

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-----CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-----GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      +|++.+.||+|+||.||+|... +|+.||+|.++.....     ....+..|++++++++|+||+++++++..  ....+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~   78 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN   78 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence            4778899999999999999954 6899999999765432     23457789999999999999999999874  45889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+ +|+|.+++....   ..+++..++.++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        79 lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~  151 (298)
T cd07841          79 LVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS  151 (298)
T ss_pred             EEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeee
Confidence            999999 899999997532   35899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh------
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR------  324 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  324 (443)
                      .......  .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.......  .+.........      
T Consensus       152 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  227 (298)
T cd07841         152 FGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENW  227 (298)
T ss_pred             ccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhh
Confidence            6543221  123356788999998865 467899999999999999999988776433211  11111100000      


Q ss_pred             -ccccccccccCccCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 -DKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 -~~~~~~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                       ....+............+     ......+.+++.+||+.||++||+++||+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             000000000000001111     1223468899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=299.61  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=199.1

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcC---CCceeeEEEeeecCCCCeeEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++   |||++++++++.  +....++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEEEE
Confidence            577889999999999999995 578999999987543 234567889999999996   999999999987  4457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+++++|.+++..     ..+++..++.++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||++...
T Consensus        80 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            9999999999999863     25889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .....  ......|+..|+|||.+.++ .++.++||||||+++|+|++|..||.......      +...       ...
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~-------~~~  216 (277)
T cd06917         152 NQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMML-------IPK  216 (277)
T ss_pred             CCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhc-------ccc
Confidence            54332  12334688999999988654 56889999999999999999999996433211      1100       000


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ...+.+...   .....+.+++.+||+.||++||++.+++++-+.
T Consensus       217 ~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         217 SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence            011111111   122357899999999999999999999986443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.4e-39  Score=300.33  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=202.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|++++++++||||+++++++..  ....++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEE
Confidence            36788899999999999999965 688999999876533 334678999999999999999999998874  45889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||+++++|.+++....   ..+++..+..++.|++.||+|||+ .+   ++|+||||+||++++++.++|+|||.+....
T Consensus        79 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          79 EYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999999997532   468889999999999999999999 88   9999999999999999999999999987653


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....    ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...............       
T Consensus       153 ~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~-------  220 (265)
T cd06605         153 NSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP-------  220 (265)
T ss_pred             HHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC-------
Confidence            3211    1256888999999999999999999999999999999999999643221 112222222222111       


Q ss_pred             cCccCCCCCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          334 DPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       334 d~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .+.    .+.. ....+.+++..||..||++||++.+++.+-+
T Consensus       221 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  259 (265)
T cd06605         221 PPR----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPF  259 (265)
T ss_pred             CCC----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence            011    1111 2334789999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.3e-38  Score=302.15  Aligned_cols=246  Identities=27%  Similarity=0.380  Sum_probs=199.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++... +++.||+|.+....   ......+.+|++++++++||||+++++++.  +....++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~   78 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ--DDSNLYL   78 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCeEEE
Confidence            47888999999999999999954 68999999986432   223456889999999999999999999987  4457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+++++|.+++...    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++..
T Consensus        79 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~  151 (290)
T cd05580          79 VMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV  151 (290)
T ss_pred             EEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence            99999999999999643    45889999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ...     .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ...........      
T Consensus       152 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~------  214 (290)
T cd05580         152 KGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEGK------  214 (290)
T ss_pred             CCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC------
Confidence            543     2334688999999999888889999999999999999999999964331      11111111110      


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                        .    ..+......+.+++.+||+.||++||     +++|++++-
T Consensus       215 --~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~  255 (290)
T cd05580         215 --V----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP  255 (290)
T ss_pred             --c----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCc
Confidence              0    11222234578999999999999999     888888663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-38  Score=303.00  Aligned_cols=266  Identities=23%  Similarity=0.309  Sum_probs=199.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+|... +++.+|+|.++.....  ....+.+|+.++.+++||||+++++++...+....+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            47888999999999999999965 6889999999754322  23457789999999999999999999876544689999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||++ ++|.+++....   ..+++.+++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||+++...
T Consensus        85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99997 49999886432   35899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH----------HH
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR----------PI  322 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~----------~~  322 (443)
                      .....  .....++..|+|||.+.+. .++.++|+||||+++|||++|..||.......  .+.....          ..
T Consensus       158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         158 SPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             CCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchHHHHH
Confidence            43221  1234578899999988764 46899999999999999999999997443211  1110000          00


Q ss_pred             hhc----c-ccccccccCccCCCCCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          323 LRD----K-DRLEELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       323 ~~~----~-~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...    . ..........+...++.. ....+.+++.+||+.+|++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000    0 000000111111112211 23457899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.3e-38  Score=297.40  Aligned_cols=253  Identities=28%  Similarity=0.415  Sum_probs=199.0

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|.+.+.||+|+||.||+|.. .+++.|++|.++.....  ..+.+..|+.++++++|+||+++++++.  +....++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence            478889999999999999995 47889999998765443  4567899999999999999999999876  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~  151 (264)
T cd06626          79 EYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN  151 (264)
T ss_pred             ecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence            999999999999742    34788999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcccc--ccccccCcccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          255 GRTNYL--STRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       255 ~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ......  .....++..|+|||++.+..   ++.++||||||+++||+++|+.||......     .........  .. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~--~~-  223 (264)
T cd06626         152 NTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA--GH-  223 (264)
T ss_pred             CCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc--CC-
Confidence            332211  11346788999999998766   889999999999999999999999643211     111111110  00 


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                          .+.+...  ......+.+++.+||+.+|++||++.+++.+
T Consensus       224 ----~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         224 ----KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             ----CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                0111000  1113347799999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.4e-38  Score=299.65  Aligned_cols=266  Identities=21%  Similarity=0.281  Sum_probs=195.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++.+|.+.+.||+|+||.||+|.. .+|..||+|.+...... ....+.+|+.+++.++|+||+++.+++.  +....++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH--TKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe--cCCeEEE
Confidence            357899999999999999999985 46889999998754332 2346788999999999999999999987  4457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+. ++|.+++...   ...+.+..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++..
T Consensus        81 v~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          81 VFEYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEeccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999995 6887777532   234778889999999999999999998   999999999999999999999999999764


Q ss_pred             CCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh-------
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR-------  324 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------  324 (443)
                      ......  .....++..|+|||.+.+. .++.++|||||||++|||++|+.||+...... ..+.. ....+.       
T Consensus       154 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~-~~~~~~~~~~~~~  229 (291)
T cd07870         154 SIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEK-IWTVLGVPTEDTW  229 (291)
T ss_pred             CCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH-HHHHcCCCChhhh
Confidence            332211  2234578899999998764 57889999999999999999999997433211 11110 000000       


Q ss_pred             -----ccccccccccCccCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 -----DKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 -----~~~~~~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                           ..................     ......+.+++.+|++.||++|||+.|++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                 000000000000000000     0012357789999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.9e-38  Score=299.16  Aligned_cols=248  Identities=24%  Similarity=0.384  Sum_probs=198.3

Q ss_pred             CCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404           99 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      |...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++..  ....++++||+
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e~~   98 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVMEFL   98 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEecc
Confidence            44457999999999999985 5788999999875544455678899999999999999999998873  45789999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++++|.+++..     ..+++.++..++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          99 EGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            99999999874     34889999999999999999999999   99999999999999999999999998875543221


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...++      ......+....       .+..
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~~-------~~~~  235 (285)
T cd06648         171 --RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDNL-------PPKL  235 (285)
T ss_pred             --ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhcC-------CCCC
Confidence              12234688999999999888899999999999999999999999964332      11111111110       0111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .  .+......+.+++.+||+.+|++||++.+++++
T Consensus       236 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         236 K--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             c--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            0  011122358899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.4e-38  Score=302.95  Aligned_cols=270  Identities=25%  Similarity=0.304  Sum_probs=200.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.++.....  ....+.+|+.++++++|+||+++++++........++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46799999999999999999996 46899999998754322  2335678999999999999999999987555457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+. ++|.+++...   ...+++.++..++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence            999996 4898888643   245899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-----
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-----  326 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  326 (443)
                      ......  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........   ...........     
T Consensus       159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~  233 (309)
T cd07845         159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIW  233 (309)
T ss_pred             CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhc
Confidence            543211  122345788999999875 4678999999999999999999999974432111   11111100000     


Q ss_pred             ------ccccccccCccC-CCC---CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          327 ------DRLEELADPRLG-GKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       327 ------~~~~~~~d~~~~-~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                            ........+... ...   .......+.+++.+||+.||++|||+++++++-+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~  294 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK  294 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                  000000000000 000   001133467899999999999999999999875543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.8e-38  Score=298.78  Aligned_cols=263  Identities=22%  Similarity=0.323  Sum_probs=195.5

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|+..+.||.|+||.||+|+.. +|+.||||.+.....  .....+.+|++++++++||||+++++++.  +....+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEe
Confidence            5888999999999999999964 688999999875432  22357889999999999999999999986  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+. ++|.+++....  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        79 e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~  152 (284)
T cd07860          79 EFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV  152 (284)
T ss_pred             eccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9995 68999886532  345899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCccccccccccCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-------
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-------  326 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  326 (443)
                      ....  .....++..|+|||++.+.. ++.++||||||+++|||+||+.||......  ..........-...       
T Consensus       153 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         153 PVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             Cccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhh
Confidence            2211  12335688999999887654 588999999999999999999999643211  11111111000000       


Q ss_pred             -------ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 -------DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 -------~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                             ..........+. .........+.+++.+||+.||++||++++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                   000000000000 0000112346789999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=296.84  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=198.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC-----CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|++.+.||+|+||.||+|.. .++..||+|.+....     ......+.+|++++++++|+||+++++++...+....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5789999999999999999995 468999999875321     1223578899999999999999999999876555678


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++++||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence            899999999999999864    234788999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCc-cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRT-NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ....... ........++..|+|||++.+..++.++|+|||||++|||++|+.||......     .. ........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~~~~---  225 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AA-IFKIATQP---  225 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HH-HHHHHcCC---
Confidence            6532111 01112346889999999999888999999999999999999999999632211     11 11111110   


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                             .....+......+.+++.+||+ +|..||+..+++.|
T Consensus       226 -------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         226 -------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                   1112233333458899999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.6e-38  Score=292.65  Aligned_cols=254  Identities=28%  Similarity=0.390  Sum_probs=204.3

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|...+.||+|++|.||+|... ++..|++|.+.....  ...+.+.+|+.++++++||||+++++++........++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999965 788999999875543  3356789999999999999999999998744225789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999999753    26899999999999999999999988   99999999999999999999999999987755


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...........++..|+|||.+.....+.++||||||+++++|++|..||....     ..........          .
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~----------~  218 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIG----------S  218 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhcc----------c
Confidence            432111234568889999999988889999999999999999999999997543     1111111111          0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .......+......+.+++.+|++.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            011112222334568899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.3e-38  Score=306.20  Aligned_cols=269  Identities=25%  Similarity=0.340  Sum_probs=199.4

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC--CCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCee
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  170 (443)
                      ..++|++.+.||+|+||.||+|... +|+.+|+|++...  .......+.+|+.+++++ +||||++++++|...+....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567899999999999999999964 6889999988643  222345677899999999 99999999999876556678


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||++ ++|.+++...     .+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||+|||+++
T Consensus        85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999997 5999998642     5788999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCcc---ccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH-HHH------
Q 013404          251 QAPEGRTN---YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWA------  319 (443)
Q Consensus       251 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~-~~~------  319 (443)
                      ........   .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||............ .+.      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            66443221   12234568999999998765 46788999999999999999999999643321110000 000      


Q ss_pred             --HHHh-hcc-ccccccccC---ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          320 --RPIL-RDK-DRLEELADP---RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       320 --~~~~-~~~-~~~~~~~d~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                        .... ... ..+..+...   ...... ......+.+++.+||+.||++||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              0000 000 000000000   000000 1123457899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.9e-38  Score=301.86  Aligned_cols=250  Identities=28%  Similarity=0.388  Sum_probs=195.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ..|+..+.||+|+||.||+|... +|+.||+|.+......   ..+.+.+|+++++.++||||+++.++|..  ....++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l   92 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL   92 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence            45888899999999999999954 6899999998644332   23568899999999999999999999874  447899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||++ |+|.+++...   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++...
T Consensus        93 v~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          93 VMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             EHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence            999996 5787777532   235899999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...      ....++..|+|||++.   ...++.++||||||+++|||++|+.||......      ..........   
T Consensus       166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------~~~~~~~~~~---  230 (307)
T cd06607         166 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQND---  230 (307)
T ss_pred             CCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------HHHHHHhcCC---
Confidence            432      2246788999999874   456889999999999999999999998643211      1111111000   


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                          .+.+   .+......+.+++.+||+.+|++||++.+|+.+.+..
T Consensus       231 ----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  271 (307)
T cd06607         231 ----SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL  271 (307)
T ss_pred             ----CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence                0111   1112334588999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.5e-38  Score=306.34  Aligned_cols=269  Identities=22%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----C
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----S  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  167 (443)
                      ..++|+..+.||+|+||.||++.. .+|+.||+|.+....  ......+.+|+.++++++||||+++++++....    .
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999995 478999999986432  223456788999999999999999999876432    2


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++||||+. ++|.+.+..      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence            35789999995 588888753      2788999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc------------hH
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE------------NL  315 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~------------~~  315 (443)
                      +++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.....            .+
T Consensus       164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9986543221   23346788999999999999999999999999999999999999644321100            00


Q ss_pred             HHH----HHHHhhccc-----ccccccc----CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          316 VTW----ARPILRDKD-----RLEELAD----PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       316 ~~~----~~~~~~~~~-----~~~~~~d----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ...    .........     ....+..    +......+......+.+++.+||+.||++||++.|++++-+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence            000    000000000     0000000    000001111234457899999999999999999999987543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.6e-38  Score=293.57  Aligned_cols=250  Identities=22%  Similarity=0.393  Sum_probs=198.8

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|+||.||++... +|..+|+|.+....  ....+.+.+|+++++.++|+||+++++++.  +....++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEE
Confidence            5788899999999999999964 58899999986542  123457889999999999999999999886  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-ceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  253 (443)
                      ||+++++|.+++....  ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++ .+||+|||.+....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~  153 (257)
T cd08225          79 EYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN  153 (257)
T ss_pred             ecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence            9999999999997532  235789999999999999999999998   99999999999998875 46999999998664


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....  ......|++.|+|||++.+..++.++||||||+++|||++|..||....      ...+........  .    
T Consensus       154 ~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~--~----  219 (257)
T cd08225         154 DSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGY--F----  219 (257)
T ss_pred             CCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhccc--C----
Confidence            3321  1223468899999999988889999999999999999999999996432      222222222110  1    


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      . .....+    ...+.+++.+||+.+|++||++.+|+++
T Consensus       220 ~-~~~~~~----~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         220 A-PISPNF----SRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             C-CCCCCC----CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0 011112    2358899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1e-37  Score=290.07  Aligned_cols=250  Identities=28%  Similarity=0.457  Sum_probs=201.9

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      +|+..+.||+|++|.||++... ++..+++|++..........+.+|++++++++|+|++++++++..  ....++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEec
Confidence            4778899999999999999965 688999999976654456789999999999999999999999874  3578999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.+++....   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        79 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          79 CSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             CCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            99999999987532   46899999999999999999999988   9999999999999999999999999998765443


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCc
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR  336 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  336 (443)
                      .   .....++..|++||.+.+..++.++||||||+++++|++|+.||......      ........  .....+.+  
T Consensus       153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~--~~~~~~~~--  219 (253)
T cd05122         153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT--NGPPGLRN--  219 (253)
T ss_pred             c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh--cCCCCcCc--
Confidence            2   23456888999999999888999999999999999999999999643211      11111000  00111110  


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                           +......+.+++..||+.||++|||+.+++++
T Consensus       220 -----~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 -----PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -----ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 11112358899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.2e-38  Score=292.86  Aligned_cols=252  Identities=26%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|+||.||++... ++..|++|++.....  .....+.+|+++++.++|||++++++.+..  ....++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence            5788899999999999999964 688999999976543  345678899999999999999999998874  35889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++.........+++.++..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            999999999999764333457899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ..  .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ..........  ..     
T Consensus       156 ~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~--~~-----  220 (258)
T cd08215         156 TV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILKG--QY-----  220 (258)
T ss_pred             Cc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhcC--CC-----
Confidence            32  122345688999999999988899999999999999999999999964331      1111111111  01     


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +    ..+......+.+++.+||+.+|++||++.+++++
T Consensus       221 ~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 P----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1    1111223357899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.4e-38  Score=298.39  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=204.0

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .+++|+..+.||+|+||.||+|... ++..|++|.+..... ....+.+|+++++.++|+|++++++++...  ...+++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv   93 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWVV   93 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEEE
Confidence            4567888899999999999999975 688999999975543 456789999999999999999999998743  588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      +||+++++|.+++....   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999997532   36899999999999999999999988   9999999999999999999999999987554


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....  ......++..|++||.+.+..++.++||||||+++|+|++|+.||....+.      .........  ......
T Consensus       168 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~--~~~~~~  237 (286)
T cd06614         168 KEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTK--GIPPLK  237 (286)
T ss_pred             cchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc--CCCCCc
Confidence            3221  122345788999999999888999999999999999999999998643221      111111110  010100


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                             .+......+.+++.+||+.+|.+||++.+|+++...
T Consensus       238 -------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  273 (286)
T cd06614         238 -------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL  273 (286)
T ss_pred             -------chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHh
Confidence                   011122357899999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-37  Score=298.15  Aligned_cols=269  Identities=20%  Similarity=0.273  Sum_probs=195.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCC---Ce
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDS---SQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~---~~  169 (443)
                      ++|++.+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.+++.+. ||||+++++++...+.   ..
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999954 689999998865432  23457888999999995 6999999998864332   23


Q ss_pred             eEEEEeecCCCChhHhhcCCCCC-CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEcccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGV-NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFG  247 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg  247 (443)
                      .+++|||+++ +|.+++...... ...+++..++.++.||++||.|||+.+   |+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7899999985 899888643322 346899999999999999999999998   999999999999998 8899999999


Q ss_pred             ccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      +++........  .....+++.|+|||++.+ ..++.++||||||+++|||++|..||......  ..+.......-...
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHhCCCC
Confidence            98765332211  122356888999998865 45789999999999999999999999643211  11111110000000


Q ss_pred             cc----cccccc----CccCC----CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 DR----LEELAD----PRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 ~~----~~~~~d----~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..    .....+    +....    .........+.+++.+||+.||.+||++.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00    000000    00000    0001123457899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-38  Score=306.95  Aligned_cols=266  Identities=25%  Similarity=0.357  Sum_probs=197.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC---CCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~  170 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++||||+++++++...+   ....
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999984 578999999986432 223456888999999999999999998865322   2357


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++++||+.+ +|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            899999964 88888753     35899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccc-cccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc--
Q 013404          251 QAPEGRTNY-LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--  326 (443)
Q Consensus       251 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  326 (443)
                      ......... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..   .........+...  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~  231 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQ  231 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCH
Confidence            654322111 1123468899999998754 56889999999999999999999999643211   1111111111100  


Q ss_pred             ccccccccCc---------cCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 DRLEELADPR---------LGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 ~~~~~~~d~~---------~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .....+.+..         .....+     ......+.+++.+||+.+|++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000000         000000     0113457899999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-38  Score=297.87  Aligned_cols=248  Identities=25%  Similarity=0.324  Sum_probs=200.4

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      +|++.+.||.|+||.||++... ++..||+|.+.....   ...+.+.+|++++++++||||+++++++.  +....++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv   78 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLV   78 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEE
Confidence            5788999999999999999965 689999999975432   23567899999999999999999998876  45589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      +||+++++|.+++...    ..+++.++..++.|+++||.|||+++   ++|+||+|+||++++++.++|+|||++....
T Consensus        79 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~  151 (258)
T cd05578          79 VDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT  151 (258)
T ss_pred             EeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence            9999999999999643    36889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....   .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......    ..+.......        
T Consensus       152 ~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~--------  216 (258)
T cd05578         152 PDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET--------  216 (258)
T ss_pred             CCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc--------
Confidence            4321   233468889999999998889999999999999999999999997544321    1111111110        


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH--HHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM--GEVVQ  372 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~evl~  372 (443)
                         .....+......+.+++.+||+.||.+||++  +|+++
T Consensus       217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence               0011222223568899999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=296.21  Aligned_cols=264  Identities=23%  Similarity=0.346  Sum_probs=197.7

Q ss_pred             CCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           99 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      |++.+.||+|+||.||+|... +++.+|+|.+....  ......+.+|++++++++|+|++++++++........++++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567899999999999999965 58899999998653  233457889999999999999999999987543368999999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++ +|.+++...   ...+++.+++.++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 899988643   246899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc--cc---c
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--DR---L  329 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---~  329 (443)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   ............  ..   .
T Consensus       154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhcccc
Confidence            321 1223456788999998765 467899999999999999999999997543211   111111100000  00   0


Q ss_pred             ccc-----------ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 EEL-----------ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ~~~-----------~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..+           ....+...+...+...+.+++.+||+.+|++||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000           00000000001113457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.2e-38  Score=300.67  Aligned_cols=257  Identities=28%  Similarity=0.419  Sum_probs=193.2

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|+..+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.++.++. |+||+++++++..  ....+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEE
Confidence            556678899999999999995 4689999999875432 23457889999999996 9999999998863  44778999


Q ss_pred             eecCCCChhHhhcCC-CCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          175 ELVPNGSLESWLHGP-LGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       175 e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||+.. +|.++.... ......+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99864 665543210 01134689999999999999999999975 7   999999999999999999999999999765


Q ss_pred             CCCCccccccccccCcccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      .....   .....|+..|+|||.+.+.   .++.++|||||||++|||++|+.||....     ............    
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~----  226 (288)
T cd06616         159 VDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG----  226 (288)
T ss_pred             ccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC----
Confidence            43221   2334688899999998766   68999999999999999999999996432     111111111110    


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                         ..+.+....+......+.+++.+||+.+|++||++++|+++-+
T Consensus       227 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~  269 (288)
T cd06616         227 ---DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF  269 (288)
T ss_pred             ---CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence               0111111111223345889999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9e-38  Score=300.52  Aligned_cols=271  Identities=23%  Similarity=0.329  Sum_probs=195.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCC------
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------  166 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  166 (443)
                      .++|++.+.||+|+||.||++... +++.||||.+.....  .....+.+|++++++++||||++++++|....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357899999999999999999954 688999998864432  22345678999999999999999999886432      


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ....++||||+. ++|.+++...   ...+++.+++.++.|++.||+|||+++   ++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence            235689999996 4888888642   235899999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCcc--ccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH--
Q 013404          247 GLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP--  321 (443)
Q Consensus       247 gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--  321 (443)
                      |++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.................  
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999865432211  111234578899999988764 468899999999999999999999975433211111111000  


Q ss_pred             ---Hhhcccccc---ccccCccC-CCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          322 ---ILRDKDRLE---ELADPRLG-GKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       322 ---~~~~~~~~~---~~~d~~~~-~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         .+.......   .+..+.-. ...     +......+.+++.+||+.||++||+++|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence               000000000   00000000 000     00012346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1e-37  Score=301.59  Aligned_cols=250  Identities=30%  Similarity=0.415  Sum_probs=195.8

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .|...+.||+|+||.||+++. .++..||+|.+......   ....+.+|++++++++|||++++++++..  ....++|
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  103 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLV  103 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEE
Confidence            477788999999999999995 46889999998754322   23468889999999999999999999874  4478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||++ |+|.+++...   ..++++.++..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++....
T Consensus       104 ~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         104 MEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             EeCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            99996 5888877532   345899999999999999999999998   9999999999999999999999999987543


Q ss_pred             CCCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ..      ....++..|+|||++.   .+.++.++|||||||++|||++|+.||......      .....+.....   
T Consensus       177 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~---  241 (317)
T cd06635         177 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES---  241 (317)
T ss_pred             Cc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhccC---
Confidence            32      2346888999999874   456889999999999999999999998643211      11111111100   


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                          +..   ........+.+++.+||+.+|.+||++.+|++++..+.
T Consensus       242 ----~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         242 ----PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ----CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                000   11122234789999999999999999999999876654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.1e-38  Score=295.04  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=201.7

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|+||.||++.. .+++.+|+|.+....  ......+.+|++++++++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence            478889999999999999985 467899999987543  2234568889999999999999999998873  45889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++.........+++..++.++.|++.||.|||+.+   ++|+||+|.||++++++.+||+|||+++....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            999999999998653333456899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ..    .....++..|++||.+.+..++.++|+||||+++|||++|+.||...+..   .+.   .....  ...     
T Consensus       156 ~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~---~~~~~--~~~-----  218 (256)
T cd08530         156 NM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLR---YKVQR--GKY-----  218 (256)
T ss_pred             CC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHhc--CCC-----
Confidence            31    22345788999999999989999999999999999999999999643311   111   11110  011     


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                          ...+......+.+++.+||+.+|++||++.+++++
T Consensus       219 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 ----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                11222334568999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-40  Score=294.77  Aligned_cols=249  Identities=28%  Similarity=0.394  Sum_probs=207.0

Q ss_pred             CCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404           99 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      |.++++||+|+||.||++.. ..|+.+|+|.+...  .+.+++..|+.++++...|++|+++|.|.  ....+++|||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF--K~sDLWIVMEYC  110 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF--KHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc--cCCceEeehhhc
Confidence            56789999999999999985 57999999998754  35788999999999999999999999876  445799999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      .-|+..|.++..   +++|++.++..++...++||+|||...   -+|||||+.||||+-+|.+||+|||.+-.+.+...
T Consensus       111 GAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  111 GAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             CCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            999999999743   567999999999999999999999998   89999999999999999999999999987765332


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                        ....+.||+.|||||++..-.|..++||||||++..||..|++||..-.+.....         .-+      ..|..
T Consensus       185 --KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------MIP------T~PPP  247 (502)
T KOG0574|consen  185 --KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------MIP------TKPPP  247 (502)
T ss_pred             --hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------ecc------CCCCC
Confidence              3456789999999999999999999999999999999999999997544322110         000      01111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      .-.-|.+-...+-++++.||-.+|++|-|+.++++|-
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            1122334445688999999999999999999998763

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.5e-38  Score=296.94  Aligned_cols=261  Identities=24%  Similarity=0.303  Sum_probs=194.2

Q ss_pred             CCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEEe
Q 013404           99 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      |++.+.||+|+||.||+|.. .+++.||+|.++.... .......+|+.++.++. |+|++++++++........++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56788999999999999995 4688999999875422 22334567999999985 999999999988654468899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |++ |+|.+++...   ...+++.+++.++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            996 5888888643   235899999999999999999999998   999999999999999 99999999999866433


Q ss_pred             CccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc-------
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-------  327 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------  327 (443)
                      ..   .....++..|+|||++.. ..++.++|||||||++|||++|..||...+..   ....+.........       
T Consensus       153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhh
Confidence            22   123457889999997654 56788999999999999999999999654321   11111111110000       


Q ss_pred             ---cccccccCccCC----CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          328 ---RLEELADPRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       328 ---~~~~~~d~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         .......+....    .........+.+++.+||+.+|++||++++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence               000000000000    0011224568999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-37  Score=295.93  Aligned_cols=264  Identities=23%  Similarity=0.356  Sum_probs=197.2

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      +|++.+.||.|++|.||+|+.. +|..||+|.++..... ....+.+|+.++++++||||+++++++..  ....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEe
Confidence            5888999999999999999964 6889999999765433 34567889999999999999999999874  447899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++ +|.+++..... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++.....
T Consensus        79 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          79 YMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             cCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            9985 89988864321 346899999999999999999999998   999999999999999999999999999765332


Q ss_pred             CccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc--cccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--DRLEEL  332 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  332 (443)
                      ..  ......++..|++||.+.+. .++.++|||||||++|||++|+.||........  ...... .....  .....+
T Consensus       154 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~  228 (284)
T cd07836         154 VN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFR-IMGTPTESTWPGI  228 (284)
T ss_pred             cc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHH-HhCCCChhhHHHH
Confidence            11  11234578899999988654 568899999999999999999999975432211  111000 00000  000000


Q ss_pred             cc-CccCCC-----------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          333 AD-PRLGGK-----------YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       333 ~d-~~~~~~-----------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .+ +.+...           ........+.+++.+||+.||++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00 000000           011123457899999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-37  Score=294.71  Aligned_cols=244  Identities=24%  Similarity=0.341  Sum_probs=186.4

Q ss_pred             eeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHHHhh---cCCCceeeEEEeeecCCCCeeEEEEee
Q 013404          104 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSR---LHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus       104 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .||+|+||.||++.. .+++.+|+|.+......   ....+.+|..++..   .+|||++.+++++..  ....++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence            489999999999995 46889999988654221   12334455544433   479999999998874  3478999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++.......
T Consensus        79 ~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          79 MNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            999999999864    345899999999999999999999999   9999999999999999999999999987553322


Q ss_pred             ccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                          .....|+..|+|||.+.+ ..++.++|||||||++|||++|..||..........+...   ...        ...
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~~--------~~~  216 (279)
T cd05633         152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT--------VNV  216 (279)
T ss_pred             ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hhc--------CCc
Confidence                123468999999998864 5688999999999999999999999975433221111110   000        011


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                          ..+......+.+++.+||+.||.+||     +++|++++..
T Consensus       217 ----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~  257 (279)
T cd05633         217 ----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF  257 (279)
T ss_pred             ----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence                12222334578999999999999999     6999998743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.9e-38  Score=303.91  Aligned_cols=271  Identities=23%  Similarity=0.364  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecC--CCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|.. .+|..||+|++.....  .....+.+|+.++++++||||+++++++...  .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            46899999999999999999995 4689999999875422  3346778899999999999999999877532  33467


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+. ++|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++
T Consensus        84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence            89999995 699999864    234899999999999999999999998   9999999999999999999999999997


Q ss_pred             cCCCCCcc--ccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-
Q 013404          251 QAPEGRTN--YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-  326 (443)
Q Consensus       251 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  326 (443)
                      ........  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........   ........... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~  232 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPS  232 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCCh
Confidence            65432211  11234578899999998865 4688999999999999999999999964332111   11100000000 


Q ss_pred             ---------ccccccccC-ccCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          327 ---------DRLEELADP-RLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       327 ---------~~~~~~~d~-~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                               .......+. ......+     ......+.+++.+||+.+|++||++++++.+.+.-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence                     000000000 0000011     11234588999999999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.9e-38  Score=293.41  Aligned_cols=243  Identities=26%  Similarity=0.337  Sum_probs=194.8

Q ss_pred             eeecCcEEEEEEEEC-CCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       105 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      ||.|+||.||+++.. +++.||+|.+.....   ...+.+.+|+++++.++||||+++++++.  +....++++||++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK--DKKYIYMLMEYCLGG   78 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE--cCCccEEEEecCCCC
Confidence            699999999999964 588999999865432   23467899999999999999999999887  445789999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      +|.+++...    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        79 ~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~  148 (262)
T cd05572          79 ELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---K  148 (262)
T ss_pred             cHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---c
Confidence            999999752    34888999999999999999999998   9999999999999999999999999998765432   1


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      .....++..|++||.+.+..++.++|+||||+++|||++|..||......    ...........          .....
T Consensus       149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~----------~~~~~  214 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKG----------NGKLE  214 (262)
T ss_pred             cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhcc----------CCCCC
Confidence            22346888999999998888999999999999999999999999754321    12222222110          01112


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQS  373 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~  373 (443)
                      ++......+.+++.+||+.+|++||+     ++|++++
T Consensus       215 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         215 FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            22222446899999999999999999     7787765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=293.48  Aligned_cols=262  Identities=23%  Similarity=0.321  Sum_probs=195.3

Q ss_pred             CCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           99 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      |++.+.||.|++|.||+|.. .+|..||+|++.....  .....+.+|+++++.++|||++++++++.  +....+++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~--~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH--SENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec--cCCeEEEEEe
Confidence            56789999999999999995 4789999999875432  23457889999999999999999999987  4458899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |++ ++|.+++....  ...+++..++.++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||+++.....
T Consensus        79 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~  152 (283)
T cd07835          79 FLD-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP  152 (283)
T ss_pred             ccC-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence            995 69999987533  235899999999999999999999998   999999999999999999999999999765432


Q ss_pred             CccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc--------
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--------  326 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  326 (443)
                      ...  .....++..|+|||++.+. .++.++||||||+++|||++|+.||......  ..+...........        
T Consensus       153 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         153 VRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             ccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhh
Confidence            211  1223568899999988654 5789999999999999999999999643321  11111111000000        


Q ss_pred             ---c---cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 ---D---RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 ---~---~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         +   .......... ..........+.+++.+||+.+|.+||+++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         229 SLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               0   0000000000 00011112357899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=312.17  Aligned_cols=273  Identities=25%  Similarity=0.376  Sum_probs=207.8

Q ss_pred             CCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----CCeeEE
Q 013404           99 FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQHLL  172 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~l  172 (443)
                      +...+.||+|+||.||+|+ ..+|+.||||.++.... ...+.+.+|+++|++|+|+|||+++++-....    ....++
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3456789999999999999 56899999999986543 34577899999999999999999998754333    446789


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec--CCC--ceEEccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE--NNF--HAKVADFGL  248 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfgl  248 (443)
                      +||||.+|||...|..+.+ ...|++.+.+.++.+++.||.|||+++   |+||||||.||++-  ++|  .-||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            9999999999999987654 456999999999999999999999999   99999999999983  333  479999999


Q ss_pred             cccCCCCCccccccccccCcccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      |+...++.   ......||..|++||... .+.|+..+|.|||||++|+++||..||..........-+.|.. +...+.
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~-~tkkp~  246 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI-ITKKPS  246 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh-hccCCC
Confidence            99887654   457789999999999998 4888999999999999999999999996443322111122221 122222


Q ss_pred             cccccccCccCC------------CCCHHHHHHHHHHHHHccCcCCCCCC--CHHHHHHHHHHhHh
Q 013404          328 RLEELADPRLGG------------KYPKEDFIRVCTIAAACVAPEANQRP--TMGEVVQSLKMVQR  379 (443)
Q Consensus       328 ~~~~~~d~~~~~------------~~~~~~~~~l~~li~~cl~~dp~~RP--s~~evl~~L~~~~~  379 (443)
                      ......++..++            .........+-..+..+|..+|.+|-  ...+....+..+.+
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            222222222221            11233345566777888899999998  66666666655543

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-38  Score=324.39  Aligned_cols=266  Identities=28%  Similarity=0.451  Sum_probs=210.7

Q ss_pred             HHHHhcCCCCCceeeecCcEEEEEEEEC----C----CcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEEEe
Q 013404           92 LKEATNNFEPASILGEGGFGRVFKGVLS----D----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGY  161 (443)
Q Consensus        92 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~  161 (443)
                      .+...++..+.+.||+|.||.|++|...    .    ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3344555667779999999999999843    1    357999999865443 457899999999999 69999999999


Q ss_pred             eecCCCCeeEEEEeecCCCChhHhhcCCC---CCC---------CCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCC
Q 013404          162 YSSRDSSQHLLCYELVPNGSLESWLHGPL---GVN---------CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK  229 (443)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  229 (443)
                      |..  ....++|+||+..|+|.++|+..+   ...         ..++....+.++.|||.|++||++..   ++||||.
T Consensus       371 ~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA  445 (609)
T KOG0200|consen  371 CTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA  445 (609)
T ss_pred             ecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence            985  557899999999999999998655   111         13888999999999999999999998   9999999


Q ss_pred             cccEEecCCCceEEccccccccCCCCCccccccc-cccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 013404          230 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR-VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMS  307 (443)
Q Consensus       230 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~  307 (443)
                      ++|||++++..+||+|||+++............. ..-+..|||||.+....|+.++||||||++||||+| |..||...
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            9999999999999999999997665443321211 114567999999999999999999999999999999 88998641


Q ss_pred             CCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          308 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ..  ...+.+    .+.++.+++          .|..+..+++++++.||+.+|++||++.++++.++...
T Consensus       526 ~~--~~~l~~----~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  526 PP--TEELLE----FLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             Cc--HHHHHH----HHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            10  111222    334443332          24444556889999999999999999999999998854

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-37  Score=302.61  Aligned_cols=259  Identities=23%  Similarity=0.358  Sum_probs=192.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----CC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  168 (443)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|++++++++||||+++++++....    ..
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999995 468999999986432  222456889999999999999999999876432    23


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++++||+.. +|..++.      ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence            56899999964 7877653      24788999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh----
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL----  323 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----  323 (443)
                      ++.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........   ........    
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~  235 (342)
T cd07879         164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPG  235 (342)
T ss_pred             CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCC
Confidence            8765322     123467889999999876 4688999999999999999999999975332110   00000000    


Q ss_pred             -------hccc------cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          324 -------RDKD------RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       324 -------~~~~------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                             ....      .........+...++ .....+.+++.+||+.||++||++++++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhc-CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   0000      000000000000000 112347899999999999999999999976

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5e-37  Score=289.43  Aligned_cols=249  Identities=23%  Similarity=0.289  Sum_probs=191.5

Q ss_pred             HHHHHhcCCCCCcee--eecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC
Q 013404           91 ELKEATNNFEPASIL--GEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD  166 (443)
Q Consensus        91 ~~~~~~~~~~~~~~l--g~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  166 (443)
                      +.....++|++.+.+  |+|+||.||++.. .++..+|+|.+.......     .|+.....+ +|||++++++++..  
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~--   80 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT--   80 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec--
Confidence            444456778887777  9999999999995 568889999986432211     123222222 69999999999874  


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-ceEEcc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVAD  245 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~D  245 (443)
                      ....++||||+++++|.+++...    ..+++.++..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence            34889999999999999999742    26899999999999999999999999   99999999999999988 999999


Q ss_pred             ccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      ||+++......      ...++..|+|||++.+..++.++||||||+++|||++|+.||...... ......+.... ..
T Consensus       154 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~  225 (267)
T PHA03390        154 YGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-QK  225 (267)
T ss_pred             CccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-cc
Confidence            99987654322      236889999999999989999999999999999999999999743222 11222222211 10


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-HHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQS  373 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~  373 (443)
                      .  .          .........+.+++.+||+.+|.+||+ +++++++
T Consensus       226 ~--~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 K--L----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             c--C----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            0  0          111123335889999999999999995 6999865

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-37  Score=300.98  Aligned_cols=273  Identities=22%  Similarity=0.316  Sum_probs=202.2

Q ss_pred             ccCHHHHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEee
Q 013404           86 FLAYEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYY  162 (443)
Q Consensus        86 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~  162 (443)
                      .....++...+++|++.+.||+|+||.||++.. .+++.||+|++.....  ...+.+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            344566777889999999999999999999984 5789999999875322  2245688899999999999999999987


Q ss_pred             ecCC----CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC
Q 013404          163 SSRD----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN  238 (443)
Q Consensus       163 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  238 (443)
                      ....    ....+++++++ +++|.+++..     ..+++..+..++.|+++||+|||+.+   |+||||||+||+++++
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~  156 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNED  156 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCC
Confidence            5322    23467788876 7899988863     34889999999999999999999999   9999999999999999


Q ss_pred             CceEEccccccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 013404          239 FHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT  317 (443)
Q Consensus       239 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~  317 (443)
                      +.+||+|||+++.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......  .+..
T Consensus       157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~  229 (345)
T cd07877         157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKL  229 (345)
T ss_pred             CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence            99999999998865332     123467889999998866 568889999999999999999999996433211  1110


Q ss_pred             HHHHHhhcccc----------------ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          318 WARPILRDKDR----------------LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       318 ~~~~~~~~~~~----------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ...........                +......... .........+.+++..||+.||++||++.+++.+-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  302 (345)
T cd07877         230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  302 (345)
T ss_pred             HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence            00000000000                0000000000 000011234789999999999999999999998854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-37  Score=303.29  Aligned_cols=265  Identities=23%  Similarity=0.339  Sum_probs=198.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC---Ce
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  169 (443)
                      .++|.+.+.||+|+||.||++.. .+++.||||.+....  ......+.+|+.+++.++|+||+++++++.....   ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999995 578999999987532  2234567889999999999999999998764321   35


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++++||+. ++|.+++..    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999995 689998864    345899999999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc--
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--  326 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  326 (443)
                      +.......  ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+...   ............  
T Consensus       156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  230 (337)
T cd07858         156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSE  230 (337)
T ss_pred             cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCh
Confidence            86644321  1233467889999998865 468899999999999999999999996432111   010000000000  


Q ss_pred             --------cc-------ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          327 --------DR-------LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       327 --------~~-------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                              ..       +....++... .........+.+++.+||+.+|++||++++++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~  292 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP  292 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence                    00       0000000000 00112234578999999999999999999999883

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.3e-37  Score=293.84  Aligned_cols=264  Identities=22%  Similarity=0.316  Sum_probs=193.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+.....  .....+.+|++++++++||||+++++++.  +....++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe--cCCeEEEE
Confidence            57889999999999999999964 688999999865432  22457889999999999999999999987  44588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~  252 (443)
                      |||++ ++|.+++....  ...+++..+..++.||+.||+|||+.+   ++|+||+|+||+++. ++.+||+|||++...
T Consensus        80 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             Eeccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            99996 58888875432  234678888999999999999999998   999999999999985 567999999999765


Q ss_pred             CCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-----
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-----  326 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  326 (443)
                      ......  .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.  +..... .....     
T Consensus       154 ~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~~-~~~~~~~~~~  228 (294)
T PLN00009        154 GIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIFR-ILGTPNEETW  228 (294)
T ss_pred             CCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HhCCCChhhc
Confidence            432211  1234578899999988764 578999999999999999999999975332111  110000 00000     


Q ss_pred             ---ccccccc--cCccCCC----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 ---DRLEELA--DPRLGGK----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 ---~~~~~~~--d~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         ..+....  -+.....    ........+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000000  0000000    001112347899999999999999999999976

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.5e-37  Score=292.99  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=191.3

Q ss_pred             eeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          105 LGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       105 lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      ||+|+||.||++.. .+|+.||+|.+....   ......+..|+++++.++||||+++++++..  ....++||||++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~   78 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG   78 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence            68999999999985 468899999986432   2224457789999999999999999998873  44789999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      +|.+++....  ...+++.++..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........   
T Consensus        79 ~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---  150 (277)
T cd05577          79 DLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---  150 (277)
T ss_pred             cHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence            9999997533  235899999999999999999999998   99999999999999999999999999876543211   


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..........  .........        .    ..
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~--------~----~~  216 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRRTLEM--------A----VE  216 (277)
T ss_pred             cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhccccc--------c----cc
Confidence            223467889999999988889999999999999999999999996543311110  000000000        0    01


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                      .+......+.+++.+||+.||++||     ++.+++++-
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~  255 (277)
T cd05577         217 YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP  255 (277)
T ss_pred             CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence            1222233578999999999999999     666677653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.6e-37  Score=293.82  Aligned_cols=257  Identities=15%  Similarity=0.179  Sum_probs=183.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEECC----CcEEEEEEeccCCCCCHH-----------HHHHHHHHHhhcCCCceeeEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDK-----------EFLVEVEMLSRLHHRNLVKLVGY  161 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~l~~~  161 (443)
                      ++|++.++||+|+||.||+|...+    +..+|+|...........           ....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999999654    345677754433221111           12223344566789999999987


Q ss_pred             eecCCCC--eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          162 YSSRDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       162 ~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                      +......  ..+++++++. .++.+.+...    ...++..+..++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            6543322  3457777764 3676666532    23567888999999999999999998   99999999999999999


Q ss_pred             ceEEccccccccCCCCCcc-----ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 013404          240 HAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN  314 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~  314 (443)
                      .++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999865432111     11123469999999999999999999999999999999999999997543221110


Q ss_pred             ---HHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          315 ---LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       315 ---~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                         ..++...+......         ....+    ..+.+++..|++.+|++||+++++++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIK---------IKNAN----KFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhhhhc---------cCCCC----HHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence               01111111111000         01122    3478999999999999999999999865

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=312.37  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .+++...||.|+||.||++..+ ++-..|.|.+........++|+-||++|....||+||+|++.|...  +.++++.||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e--nkLwiliEF  110 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE--NKLWILIEF  110 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc--CceEEEEee
Confidence            3566788999999999999965 4556678888776667778999999999999999999999876643  378999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      |.||-....+-..   ...|++.++..+++|++.||.|||+++   |+|||||+.|||++-+|.++|+|||.+.......
T Consensus       111 C~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  111 CGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             cCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            9999999887543   456999999999999999999999999   9999999999999999999999999987554322


Q ss_pred             ccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          257 TNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                        .....+.||++|||||+.+     ..+|+.++||||||++|.||..+.+|-...++      ......+..  .....
T Consensus       185 --qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaK--SePPT  254 (1187)
T KOG0579|consen  185 --QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK--SEPPT  254 (1187)
T ss_pred             --hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhh--cCCCc
Confidence              2345689999999999875     45789999999999999999999998653222      222111111  11111


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ++.       |..-...+.+++..||..||..||++.++++|-
T Consensus       255 Llq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  255 LLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             ccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence            111       222334578999999999999999999999764

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.2e-37  Score=296.67  Aligned_cols=266  Identities=20%  Similarity=0.264  Sum_probs=193.0

Q ss_pred             ceeeec--CcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEG--GFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G--~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      ..||+|  +||+||++.. .+|+.||+|.+......  ..+.+.+|+.+++.++||||++++++|..  ....++++||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence            456666  9999999995 47899999998754322  23568889999999999999999999974  44789999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++++|.+++....  ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++++||+.+........
T Consensus        82 ~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          82 AYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             cCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            9999999987543  235889999999999999999999998   99999999999999999999999986543321111


Q ss_pred             cc-----cccccccCcccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH---------
Q 013404          258 NY-----LSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP---------  321 (443)
Q Consensus       258 ~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~---------  321 (443)
                      ..     ......++..|+|||++.+.  .++.++|||||||++|||++|+.||.......  .+......         
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccc
Confidence            00     00112356679999998764  57899999999999999999999996432110  00000000         


Q ss_pred             -------Hhhc---------------cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          322 -------ILRD---------------KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       322 -------~~~~---------------~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                             ....               ......+.+..+....+......+.+++.+||+.||++|||++|++++-+.-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~  312 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK  312 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence                   0000               0000001111111222233456789999999999999999999999886643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.9e-37  Score=293.44  Aligned_cols=268  Identities=25%  Similarity=0.340  Sum_probs=197.9

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----  166 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  166 (443)
                      ...++|++.+.||+|+||.||+|... +|+.||+|.++....  .....+.+|++++++++||||+++++++...+    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999999964 688999999975432  23356788999999999999999999886433    


Q ss_pred             ----CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceE
Q 013404          167 ----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK  242 (443)
Q Consensus       167 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  242 (443)
                          ....++++||+++ +|.+++...   ...+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                2368899999976 787777643   235899999999999999999999998   99999999999999999999


Q ss_pred             EccccccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      |+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......  ..+.. +..
T Consensus       157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~-~~~  232 (302)
T cd07864         157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLEL-ISR  232 (302)
T ss_pred             eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHH-HHH
Confidence            9999999866443221 1122346778999998865 35788999999999999999999999743321  11111 111


Q ss_pred             Hhhccc--cccccc--------c------CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          322 ILRDKD--RLEELA--------D------PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       322 ~~~~~~--~~~~~~--------d------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ......  ....+.        +      ....... ......+.+++..||+.+|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            110000  000000        0      0000000 0112357899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-38  Score=306.66  Aligned_cols=253  Identities=25%  Similarity=0.333  Sum_probs=205.7

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ....|.+...||+|.|+.|.+++. .++..||+|.+++..-.  ..+.+.+|+++|+.|+|||||+++.+...  ...++
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~ly  131 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLY  131 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeE
Confidence            356789999999999999999994 57899999999865433  23558899999999999999999999874  44899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+.+|.+++++...    ..+.+..+..++.|+.+|++|||+++   |||||||++||||+.+.++||+|||++..
T Consensus       132 lV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence            999999999999999753    34666888999999999999999999   99999999999999999999999999988


Q ss_pred             CCCCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      +....   .....+|++.|.|||++.+..| .+++|+||+|++||-|++|..||+...-.+.      -...+..+.++ 
T Consensus       205 ~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------r~rvl~gk~rI-  274 (596)
T KOG0586|consen  205 FDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------RPRVLRGKYRI-  274 (596)
T ss_pred             ecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc------cchheeeeecc-
Confidence            76432   3456799999999999998877 5899999999999999999999984332111      11111111111 


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                                 +.-....+.++++++|-.+|.+|++++++.++-|..
T Consensus       275 -----------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n  310 (596)
T KOG0586|consen  275 -----------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN  310 (596)
T ss_pred             -----------cceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence                       111122467899999999999999999999876644

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.7e-37  Score=294.14  Aligned_cols=245  Identities=24%  Similarity=0.382  Sum_probs=194.7

Q ss_pred             CceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          102 ASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      ...||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|+|++++++++..  ....+++|||++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~  102 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGG  102 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecCCCC
Confidence            36799999999999986 5789999999865544455678999999999999999999999874  44889999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      +|.+++..     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++........  .
T Consensus       103 ~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~  172 (292)
T cd06657         103 ALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  172 (292)
T ss_pred             cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence            99998853     34789999999999999999999998   99999999999999999999999999876543221  1


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      .....++..|+|||.+.+..++.++|+||||+++|||++|..||......   ........   .   .    .+.+.. 
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~---~---~----~~~~~~-  238 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD---N---L----PPKLKN-  238 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---h---C----CcccCC-
Confidence            23346889999999998888899999999999999999999998643211   11111110   0   0    011100 


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                       .......+.+++.+||+.+|.+||++.+++++
T Consensus       239 -~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         239 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             -cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence             01112247789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-37  Score=316.65  Aligned_cols=274  Identities=20%  Similarity=0.241  Sum_probs=187.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEECC--CcEEEEEEec--------------c---CCCCCHHHHHHHHHHHhhcCCCce
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLSD--GTAVAIKRLT--------------C---GGQQGDKEFLVEVEMLSRLHHRNL  155 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~--------------~---~~~~~~~~~~~E~~~l~~l~h~ni  155 (443)
                      ..++|++.+.||+|+||.||++.++.  +...+.|.+.              .   ........+.+|+.+|++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            45789999999999999999987532  2222222110              0   111123468899999999999999


Q ss_pred             eeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCC-CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEE
Q 013404          156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       156 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  234 (443)
                      +++++++...  ...+++++++. ++|.+++.... .........++..++.|++.||.|||+++   |+||||||+|||
T Consensus       226 v~l~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        226 LKIEEILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcEeEEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            9999998743  47889999984 58888775321 11222345677889999999999999999   999999999999


Q ss_pred             ecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCCcc
Q 013404          235 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQE  313 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p-~~~~~~~~~~  313 (443)
                      ++.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..+ +.........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            999999999999999876543221 22345799999999999999999999999999999999998754 4322211112


Q ss_pred             hHHHHHHHHhhccc-------cccccccC-cc---CCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          314 NLVTWARPILRDKD-------RLEELADP-RL---GGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       314 ~~~~~~~~~~~~~~-------~~~~~~d~-~~---~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .+......+.....       .+...++. .+   ....+.     .....+.+++.+||+.||++|||+.|++++-+
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            22111111000000       00000000 00   000000     00123567899999999999999999998744

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=284.11  Aligned_cols=248  Identities=31%  Similarity=0.485  Sum_probs=200.2

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  .....+.+|++++.+++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence            4788899999999999999854 678999999976543  344678999999999999999999999873  45789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  151 (254)
T cd06627          79 EYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND  151 (254)
T ss_pred             ecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence            999999999998643    46899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ....  .....++..|+|||...+..++.++|||+||+++|+|++|+.||.....     ....... ..  ..     .
T Consensus       152 ~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~-~~--~~-----~  216 (254)
T cd06627         152 VSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRI-VQ--DD-----H  216 (254)
T ss_pred             Cccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHH-hc--cC-----C
Confidence            3321  2334688899999999888889999999999999999999999964321     1111111 00  00     0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +.    .+......+.+++.+||..+|++||++.+++.+
T Consensus       217 ~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         217 PP----LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CC----CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            11    111223357899999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=289.05  Aligned_cols=263  Identities=24%  Similarity=0.298  Sum_probs=194.4

Q ss_pred             CCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhc---CCCceeeEEEeeecCCC---Ce
Q 013404           99 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRL---HHRNLVKLVGYYSSRDS---SQ  169 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~---~~  169 (443)
                      |++.+.||+|+||.||+|... +++.||+|.++.....  ....+.+|+.+++++   +|||++++++++...+.   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999975 5899999999754322  234566788877666   59999999999875432   23


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .+++|||++ ++|.+++....  ...+++..++.++.|+++||.|||+.+   ++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence            889999997 48999886532  235899999999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........   .....++..|+|||.+.+..++.++|||||||++|||++|..||......  ..+..+..... .....
T Consensus       155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~  228 (287)
T cd07838         155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIG-LPSEE  228 (287)
T ss_pred             eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcC-CCChH
Confidence            77643321   12335788999999999999999999999999999999999998643321  11111111100 00000


Q ss_pred             ---------cccccCccC---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 ---------EELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ---------~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                               .........   ..........+.+++.+||+.||++||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                     000000000   00111223557889999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-37  Score=290.11  Aligned_cols=261  Identities=23%  Similarity=0.320  Sum_probs=197.6

Q ss_pred             CCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           99 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      |++.+.||+|++|.||++... +++.+++|.+......  ....+..|++++++++|+||+++++++.  +....++++|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR--HKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc--cCCCEEEEEe
Confidence            567789999999999999954 7889999998755332  3467888999999999999999999887  4458899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++ +|.+++...   ...+++.+++.++.|++.||.|||+.+   |+|+||+|+||++++++.++|+|||.+......
T Consensus        79 ~~~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~  151 (283)
T cd05118          79 FMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP  151 (283)
T ss_pred             ccCC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence            9975 888888642   246899999999999999999999999   999999999999999999999999999876544


Q ss_pred             CccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc--cccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--DRLEEL  332 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  332 (443)
                      ..  ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+.  +.. ....+...  .....+
T Consensus       152 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~  226 (283)
T cd05118         152 VR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFK-IFRTLGTPDPEVWPKF  226 (283)
T ss_pred             cc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHcCCCchHhcccc
Confidence            31  12234578899999998876 789999999999999999999999964432111  000 00000000  000000


Q ss_pred             cc---------Ccc----CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          333 AD---------PRL----GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       333 ~d---------~~~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .+         +..    ...........+.+++.+||+.||.+||++.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00         000    000112234568899999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.7e-37  Score=293.80  Aligned_cols=268  Identities=25%  Similarity=0.327  Sum_probs=195.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCC------
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------  166 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  166 (443)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+......  ....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999954 6889999998654322  2346788999999999999999998775322      


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ....++++||+.+ +|...+...   ...+++.++..++.|+++||+|||+.+   |+|+||||+||++++++.+||+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence            2357899999965 787777642   345899999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCccc---------cccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 013404          247 GLAKQAPEGRTNY---------LSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV  316 (443)
Q Consensus       247 gla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~  316 (443)
                      |+++.........         ..+...++..|+|||.+.+. .++.++|||||||++|||++|+.||.........  .
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~--~  237 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL--H  237 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH--H
Confidence            9998654322111         11234578889999987654 5789999999999999999999999643321111  1


Q ss_pred             HHHHHHhhc--------cccccccccCccCCCCCH-------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          317 TWARPILRD--------KDRLEELADPRLGGKYPK-------EDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       317 ~~~~~~~~~--------~~~~~~~~d~~~~~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ... .....        ...+....+.......+.       .....+.+++.+||+.||++|||+.|++.+
T Consensus       238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         238 LIF-KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHH-HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            100 00000        000000000000000110       111357899999999999999999999865

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.5e-37  Score=295.90  Aligned_cols=265  Identities=20%  Similarity=0.245  Sum_probs=191.4

Q ss_pred             CCceeeecCcEEEEEEEECCCcEEEEEEeccC--CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          101 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       101 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +.+.+|.|+++.||++.. +++.||||++...  .......+..|+++++.++|+||+++++++.  +....+++|||++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~--~~~~~~~~~e~~~   82 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI--VDSELYVVSPLMA   82 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee--cCCeEEEEEeccC
Confidence            344455556666665554 6899999998754  2334467999999999999999999999887  4457899999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcc
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN  258 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  258 (443)
                      +|+|.+++....  ...+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.+.........
T Consensus        83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          83 YGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            999999997532  235888999999999999999999999   999999999999999999999999998755322111


Q ss_pred             -----ccccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH----hh---
Q 013404          259 -----YLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI----LR---  324 (443)
Q Consensus       259 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~----~~---  324 (443)
                           .......++..|+|||++..  ..++.++|||||||++|||++|+.||......  ..+.......    +.   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  235 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKST  235 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCc
Confidence                 11123457788999999876  35889999999999999999999999743221  1111100000    00   


Q ss_pred             ---ccccccc----cccCcc----CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          325 ---DKDRLEE----LADPRL----GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       325 ---~~~~~~~----~~d~~~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                         ....+..    ..++..    ...........+.+++.+||+.||++|||+++++++-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence               0000000    000000    01112222346788999999999999999999998755

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.8e-37  Score=293.35  Aligned_cols=256  Identities=28%  Similarity=0.483  Sum_probs=194.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .++|++.+.||+|+||.||+|... +++.||||.++.... .....+..|+.++.+.. ||||++++++|.  +....++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI--TDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee--cCCeEEE
Confidence            357888999999999999999976 489999999975432 23456777887777774 999999999987  4457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +|||+. ++|.+++...   ...+++..+..++.|++.||+|||+ .+   |+||||+|+||++++++.+||+|||++..
T Consensus        92 v~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          92 CMELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             EeeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence            999985 4787776542   2368999999999999999999997 46   99999999999999999999999999876


Q ss_pred             CCCCCccccccccccCcccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      .......   ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......     .+......... 
T Consensus       165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-  235 (296)
T cd06618         165 LVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-  235 (296)
T ss_pred             ccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-
Confidence            5433221   2335788999999987553    788999999999999999999999642211     11111111111 


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                       .     +....  .......+.+++.+||+.||++||++++++++.+..
T Consensus       236 -~-----~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~  277 (296)
T cd06618         236 -P-----PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR  277 (296)
T ss_pred             -C-----CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence             0     00000  001223578999999999999999999999886543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-36  Score=295.71  Aligned_cols=266  Identities=25%  Similarity=0.311  Sum_probs=198.2

Q ss_pred             HHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           93 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        93 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ...+++|++.+.||.|+||.||++.. .+++.||+|++....  ....+.+.+|++++++++||||++++++|.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~   84 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS-PLED   84 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec-CCCc
Confidence            34678999999999999999999984 478999999886432  2234678899999999999999999998864 2346


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++++||+ +++|.+++..     ..+++..+..++.|+++||.|||+.+   |+||||+|+||++++++.++|+|||++
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence            78999998 5699998863     34778888999999999999999999   999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch-H--------HHHH
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN-L--------VTWA  319 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~-~--------~~~~  319 (443)
                      ......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... +        .++.
T Consensus       156 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         156 RIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             cccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            754322     123457889999998766 568999999999999999999999996433211000 0        0111


Q ss_pred             HHHhhccccccccccCccCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          320 RPILRDKDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ...... .....+..-......+.     .....+.+++.+||+.+|++||++++++.+-
T Consensus       231 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~  289 (328)
T cd07856         231 NTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP  289 (328)
T ss_pred             Hhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            110000 00000000000011111     1124588999999999999999999998763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.2e-37  Score=290.62  Aligned_cols=250  Identities=27%  Similarity=0.386  Sum_probs=200.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|.+.+.||+|+||.||++... +|+.||+|.+....   ......+.+|++++++++ ||||+++++++.  +....+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEE
Confidence            47889999999999999999964 78999999987532   122356888999999998 999999999876  445789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|||+++++|.+++...    ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        79 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~  151 (280)
T cd05581          79 FVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV  151 (280)
T ss_pred             EEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence            999999999999999743    36899999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCcc------------------ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 013404          252 APEGRTN------------------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE  313 (443)
Q Consensus       252 ~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~  313 (443)
                      .......                  .......++..|+|||......++.++||||||++++++++|+.||.....   .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~  228 (280)
T cd05581         152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---Y  228 (280)
T ss_pred             cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---H
Confidence            6443211                  112234678899999999888899999999999999999999999974431   1


Q ss_pred             hHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH----HHHHHH
Q 013404          314 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM----GEVVQS  373 (443)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~evl~~  373 (443)
                         ..........            ...+......+.+++.+||+.+|++||++    ++++++
T Consensus       229 ---~~~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 ---LTFQKILKLE------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ---HHHHHHHhcC------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence               1111111110            11122223457899999999999999999    888764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.6e-36  Score=289.38  Aligned_cols=252  Identities=27%  Similarity=0.372  Sum_probs=195.6

Q ss_pred             CCCCCceeeecCcEEEEEEEE----CCCcEEEEEEeccCCC----CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCC
Q 013404           98 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQ----QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  168 (443)
                      +|++.+.||.|+||.||++..    .+|..||+|++.....    ...+.+.+|++++.++ +|+||+++++++.  ...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCC
Confidence            478889999999999999985    3688999999875321    2245688899999999 5999999998876  344


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++||||+|+|||+++++.+||+|||+
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  151 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  151 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcc
Confidence            78899999999999999964    235788999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      ++........ ......|+..|+|||.+...  .++.++||||||+++|+|++|..||......  .....+........
T Consensus       152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~  228 (290)
T cd05613         152 SKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE  228 (290)
T ss_pred             ceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC
Confidence            9865433211 12235688999999998753  4678999999999999999999999643221  11222222221111


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS  373 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~  373 (443)
                              +    .++......+.+++.+||+.||++||     ++++++++
T Consensus       229 --------~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 --------P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             --------C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                    1    11222233578999999999999997     77888765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-36  Score=296.23  Aligned_cols=265  Identities=22%  Similarity=0.343  Sum_probs=196.6

Q ss_pred             HHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC--
Q 013404           93 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--  167 (443)
Q Consensus        93 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  167 (443)
                      ....++|++.+.||+|+||.||++.. .+|..||||++.....  .....+.+|++++++++||||+++++++.....  
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            34567899999999999999999984 5789999999864322  223568899999999999999999998864322  


Q ss_pred             --CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcc
Q 013404          168 --SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD  245 (443)
Q Consensus       168 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  245 (443)
                        ...++||||+ +++|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence              2458999999 7799988863     35889999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH-------
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT-------  317 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~-------  317 (443)
                      ||++.......     ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......  .+..       
T Consensus       162 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~  234 (343)
T cd07880         162 FGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGT  234 (343)
T ss_pred             cccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence            99998654321     23467889999998876 458899999999999999999999997432210  0000       


Q ss_pred             ----HHHHHhhcc-----ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          318 ----WARPILRDK-----DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       318 ----~~~~~~~~~-----~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                          +...+....     ..+.......+ ..........+.+++.+|++.||++|||+.+++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~  299 (343)
T cd07880         235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP  299 (343)
T ss_pred             CCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence                000000000     00000000000 000011123478999999999999999999999763

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.8e-36  Score=286.04  Aligned_cols=243  Identities=26%  Similarity=0.359  Sum_probs=185.8

Q ss_pred             eeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHH---HhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404          104 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEM---LSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus       104 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .||+|+||.||++.. .+++.||+|.+......   ....+..|..+   ++...||||+++++++..  ....++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence            489999999999985 46889999998654221   12234444443   444579999999998874  4478999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.......
T Consensus        79 ~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          79 MNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence            999999998864    345899999999999999999999998   9999999999999999999999999987654322


Q ss_pred             ccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                          .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||...........   .....        ....
T Consensus       152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~--------~~~~  216 (278)
T cd05606         152 ----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTL--------TMAV  216 (278)
T ss_pred             ----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhh--------ccCC
Confidence                1234689999999998754 688999999999999999999999975432211111   00000        0011


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                      .+    +......+.+++.+||..+|.+||     ++.+++++-
T Consensus       217 ~~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~  256 (278)
T cd05606         217 EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP  256 (278)
T ss_pred             CC----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence            11    112234588999999999999999     999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=284.33  Aligned_cols=242  Identities=23%  Similarity=0.289  Sum_probs=184.3

Q ss_pred             ceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHHH-hhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEML-SRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||+|.. .+|+.||+|.+......   ....+..|..++ ...+|+|++++++++.  +....++++||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEecc
Confidence            5699999999999985 46889999998654221   122344555544 4458999999999987  445889999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++++|.+++...    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||+++....   
T Consensus        80 ~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---  149 (260)
T cd05611          80 NGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---  149 (260)
T ss_pred             CCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence            999999999642    35889999999999999999999998   99999999999999999999999999876433   


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCcc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL  337 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  337 (443)
                         .....++..|+|||.+.+..++.++||||||+++|||++|..||.....      ......+.......    ....
T Consensus       150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~----~~~~  216 (260)
T cd05611         150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNILSRRINW----PEEV  216 (260)
T ss_pred             ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcccCC----CCcc
Confidence               1234678899999999888889999999999999999999999964322      11111111110000    0011


Q ss_pred             CCCCCHHHHHHHHHHHHHccCcCCCCCCCHH---HHHHH
Q 013404          338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMG---EVVQS  373 (443)
Q Consensus       338 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~---evl~~  373 (443)
                          .......+.+++.+||+.+|++||++.   |++.+
T Consensus       217 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         217 ----KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             ----cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence                111223478999999999999999665   55444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.2e-37  Score=299.22  Aligned_cols=266  Identities=22%  Similarity=0.291  Sum_probs=194.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC--------
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--------  167 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------  167 (443)
                      .+|++.+.||.|+||.||+|.. .+|..||+|.+........+.+.+|++++++++||||+++++++.....        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            6789999999999999999995 5689999999976665566778999999999999999999987653221        


Q ss_pred             ----CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec-CCCceE
Q 013404          168 ----SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAK  242 (443)
Q Consensus       168 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k  242 (443)
                          ...+++|||++ ++|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++ +++.+|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                25689999997 599988853     34889999999999999999999998   99999999999997 456789


Q ss_pred             EccccccccCCCCCcc-ccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 013404          243 VADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~  320 (443)
                      |+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+....  .....
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~~~~  233 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM--QLILE  233 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHH
Confidence            9999999765332111 11122357889999997654 56788999999999999999999999644321110  00000


Q ss_pred             HHhh----cccc----c-cccccCccCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          321 PILR----DKDR----L-EELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       321 ~~~~----~~~~----~-~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ....    +...    . ............+     ......+.+++.+||+.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            0000    0000    0 0000000000000     0112347789999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.4e-37  Score=287.33  Aligned_cols=243  Identities=28%  Similarity=0.401  Sum_probs=190.7

Q ss_pred             eeecCcEEEEEEEEC-CCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       105 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      ||.|+||.||++... +|+.+++|.+.....   .....+.+|++++++++||||+++++.+.  .....++++||++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~   78 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPGG   78 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCCC
Confidence            689999999999975 589999999875433   23457889999999999999999998876  455789999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc---
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT---  257 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~---  257 (443)
                      +|.+++...    ..+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++........   
T Consensus        79 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          79 DLASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            999999742    25899999999999999999999998   99999999999999999999999999876543321   


Q ss_pred             ---cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          258 ---NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       258 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                         ........++..|+|||......++.++||||||+++|||++|..||.....      .............      
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~~------  219 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILNGKIE------  219 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCCcC------
Confidence               1112335678899999999888899999999999999999999999964332      1112211111000      


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ  372 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  372 (443)
                        .....  .....+.+++.+||+.+|++||++.++.+
T Consensus       220 --~~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~  253 (265)
T cd05579         220 --WPEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEE  253 (265)
T ss_pred             --CCccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence              00000  01345789999999999999999944443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.3e-37  Score=295.34  Aligned_cols=251  Identities=27%  Similarity=0.379  Sum_probs=194.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      +.|...+.||+|+||.||+|.. .++..+|+|.+.....   ....++.+|+++++.++|+|++++++++..  ....++
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l   92 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL   92 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEE
Confidence            3466778899999999999995 4678899999864322   223568889999999999999999999874  457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+. |+|.+++...   ...+++.++..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++...
T Consensus        93 v~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          93 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceee
Confidence            999996 6888877532   235889999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...      ....++..|+|||.+.   ...++.++|||||||++|||++|..||......      .........  ..
T Consensus       166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~--~~  231 (308)
T cd06634         166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN--ES  231 (308)
T ss_pred             cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhc--CC
Confidence            432      2346788999999874   356788999999999999999999998532211      111111110  00


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                           +...   .......+.+++.+||+.+|++||++++++++.+...
T Consensus       232 -----~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         232 -----PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             -----CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence                 1110   1122234788999999999999999999998865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.8e-36  Score=292.39  Aligned_cols=244  Identities=28%  Similarity=0.417  Sum_probs=191.0

Q ss_pred             CCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           99 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      |...+.||+|+||.||+|+. .+|..|++|.+......   ....+.+|+++++.++|||++++++++..  ....+++|
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~  100 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLVM  100 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEE
Confidence            56678899999999999995 46889999998754332   23468889999999999999999999874  45789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+. |+|.+++...   ..++++.+++.++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus       101 e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633         101 EYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             ecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence            9996 5888877532   235899999999999999999999998   99999999999999999999999999864322


Q ss_pred             CCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                            .....|+..|+|||++.   ...++.++|||||||++|||++|..||...+..      .........  ....
T Consensus       174 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~--~~~~  239 (313)
T cd06633         174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN--DSPT  239 (313)
T ss_pred             ------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhc--CCCC
Confidence                  12346888999999984   456888999999999999999999998643221      111111111  0000


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .    ....++    ..+.+++.+||+.+|++||++.+++.+
T Consensus       240 ~----~~~~~~----~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 L----QSNEWT----DSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C----CccccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0    011122    347889999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-36  Score=293.46  Aligned_cols=264  Identities=25%  Similarity=0.308  Sum_probs=200.5

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC---CCeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~~  171 (443)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...+   ....+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788999999999999999964 58999999987543  334567899999999999999999999876432   23679


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|||++ ++|.+++...    ..+++..++.++.|++.||+|||+.+   |+|+||||.|||++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999997 5899988642    36899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCcc-ccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc--
Q 013404          252 APEGRTN-YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD--  327 (443)
Q Consensus       252 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  327 (443)
                      ....... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||.......      ....+.....  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~~~  226 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID------QLNLIVEVLGTP  226 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH------HHHHHHHhcCCC
Confidence            6543210 112334678899999999887 88999999999999999999999996543211      1111111000  


Q ss_pred             -----------ccccccc-CccCCC-----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          328 -----------RLEELAD-PRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       328 -----------~~~~~~d-~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                                 ....... ......     ........+.+++.+||+.+|++||++++++++-+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  291 (330)
T cd07834         227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY  291 (330)
T ss_pred             ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence                       0000000 000000     01112345789999999999999999999998743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.3e-37  Score=287.78  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=193.6

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---C--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---G--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      +|.+.+.||+|+||.||++... .+..+++|.++..   .  ......+..|+.++++++||||+++++++.  +....+
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   78 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL--ERDAFC   78 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh--cCCceE
Confidence            4788899999999999999854 3444555555432   1  122345778999999999999999999886  344789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|||+++++|.+++.........+++.+++.++.|++.||.|||+.+   ++|+||+|+||++++ +.++|+|||+++.
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~  154 (260)
T cd08222          79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRL  154 (260)
T ss_pred             EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceee
Confidence            999999999999998654333457899999999999999999999998   999999999999986 4699999999876


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....      ...........      
T Consensus       155 ~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~------  220 (260)
T cd08222         155 LMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG------  220 (260)
T ss_pred             cCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC------
Confidence            643322  1233467889999999988888999999999999999999999996322      11111111111      


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                       ..+    ..+......+.+++.+||+.+|++||++.|++++
T Consensus       221 -~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         221 -PTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -CCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence             011    1122333458899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-37  Score=289.67  Aligned_cols=263  Identities=24%  Similarity=0.301  Sum_probs=194.4

Q ss_pred             CCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEEe
Q 013404           99 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      |++.+.||+|+||.||+|... +++.|++|++...... ......+|+..+++++ |||++++++++..  ....++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence            567889999999999999965 5788999998754322 2234567999999998 9999999999874  558899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+ +|+|.+++....  ...+++.+++.++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++......
T Consensus        79 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          79 YM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             cC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            99 889999987533  245899999999999999999999998   999999999999999999999999999866432


Q ss_pred             CccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchH----------HHHHHHHhh
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL----------VTWARPILR  324 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~----------~~~~~~~~~  324 (443)
                      ..   .....++..|+|||.+.. ..++.++|+||||+++|||++|+.||...........          ..|......
T Consensus       153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         153 PP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             CC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence            21   123467889999998754 4578999999999999999999999964432111000          001000000


Q ss_pred             ccccccccccCccC---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 DKDRLEELADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 ~~~~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      . ............   ..........+.+++.+||+.+|++||+++|++.+
T Consensus       230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0 000000000000   00000113458899999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-36  Score=288.66  Aligned_cols=254  Identities=26%  Similarity=0.335  Sum_probs=195.7

Q ss_pred             CCCCCceeeecCcEEEEEEEE----CCCcEEEEEEeccCC----CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCC
Q 013404           98 NFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  168 (443)
                      +|++.+.||+|+||.||++..    .+++.||||.++...    ....+.+.+|++++.++ +||||+++++.+.  ...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence            477889999999999999884    256889999987432    12235688999999999 5999999998876  445


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++||||+++|+|.+++..    ...+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~  151 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGL  151 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcc
Confidence            78899999999999999864    235888999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      ++........ ......|+..|+|||.+.+..  .+.++||||||+++|||++|..||.......  .............
T Consensus       152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~  228 (288)
T cd05583         152 SKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK  228 (288)
T ss_pred             cccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC
Confidence            8765433221 122346889999999987654  7889999999999999999999996432211  1112222111110


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                              +    ..+......+.+++.+||+.||++|||+.++.+.|+
T Consensus       229 --------~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         229 --------P----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             --------C----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence                    1    111122234788999999999999999887766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=273.86  Aligned_cols=252  Identities=26%  Similarity=0.473  Sum_probs=194.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++.+.+..||.|+.|.||+.+. .+|..+|||.+...+. ...++++..+.++..- ..|+||+.+|||..+  ...++.
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~Ic  169 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVFIC  169 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHHHH
Confidence            3445667899999999999995 4689999999976543 3456788888877665 489999999999843  367888


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||.|. -.++.++...   ..++++..+-++...+++||.||.+++.  |+|||+||+|||+|+.|++||||||++-.+-
T Consensus       170 MelMs-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  170 MELMS-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHH-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceee
Confidence            99984 3666666543   3458888888999999999999997653  9999999999999999999999999998776


Q ss_pred             CCCccccccccccCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      +...   .+...|-+.|||||.+.-   ..|+.++||||||+.|+||.||+.||.....+     .+....++.+.   .
T Consensus       244 dSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe~ltkvln~e---P  312 (391)
T KOG0983|consen  244 DSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FEVLTKVLNEE---P  312 (391)
T ss_pred             cccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HHHHHHHHhcC---C
Confidence            5443   456689999999999864   47889999999999999999999999754322     11111222211   1


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..+++..  .+.+    .+++++..||+.|+.+||...+++++
T Consensus       313 P~L~~~~--gFSp----~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 PLLPGHM--GFSP----DFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCccc--CcCH----HHHHHHHHHhhcCcccCcchHHHhcC
Confidence            1111111  1333    48899999999999999999999986

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=281.33  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             HhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCC---HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           95 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .-++|..+++||+|.||.|-+++ ..+|+.+|+|++++.-.-.   ...-+.|-++|+..+||.+..+.-.|+  ....+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ--t~drl  243 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ--TQDRL  243 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc--cCceE
Confidence            45789999999999999999999 5579999999998653322   334567899999999999988865665  44589


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      |+||||..||.|.-+|..    ...+++....-+...|+.||.|||+++   ||.||||.+|.|||.+|++||+|||+++
T Consensus       244 CFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  244 CFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             EEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccch
Confidence            999999999999998875    345788888889999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .--...  .....++||+.|+|||++....|..+.|-|.+||++|||++|+.||...+....   .   .-++.+     
T Consensus       317 E~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---F---eLIl~e-----  383 (516)
T KOG0690|consen  317 EEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---F---ELILME-----  383 (516)
T ss_pred             hccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---H---HHHHhh-----
Confidence            543221  234568999999999999999999999999999999999999999975443221   1   111111     


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS  373 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~  373 (443)
                      ++       .+|.....+...|+.-.|..||.+|.     .+.||.++
T Consensus       384 d~-------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 DL-------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             hc-------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            11       22333333466788899999999995     46676654

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-36  Score=295.62  Aligned_cols=266  Identities=22%  Similarity=0.269  Sum_probs=194.5

Q ss_pred             cCCC-CCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC--------------HHHHHHHHHHHhhcCCCceeeEEE
Q 013404           97 NNFE-PASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--------------DKEFLVEVEMLSRLHHRNLVKLVG  160 (443)
Q Consensus        97 ~~~~-~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  160 (443)
                      ++|. +.+.||.|+||.||+|... +++.||||.++......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 3577999999999999954 68999999986542221              124778999999999999999999


Q ss_pred             eeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc
Q 013404          161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH  240 (443)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  240 (443)
                      ++..  ....+++|||++ |+|.+++..    ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.
T Consensus        88 ~~~~--~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         88 VYVE--GDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI  157 (335)
T ss_pred             EEec--CCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence            9873  447899999996 699999864    335889999999999999999999998   999999999999999999


Q ss_pred             eEEccccccccCCCCCc------------cccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          241 AKVADFGLAKQAPEGRT------------NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       241 ~kl~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      ++|+|||+++.......            ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999976541100            0111223568889999998764 4689999999999999999999999754


Q ss_pred             CCCCcchHHHHHHHHhhcccc--ccc------------cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          308 QPSGQENLVTWARPILRDKDR--LEE------------LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~--~~~------------~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +...   ....+.........  ...            ...+... .........+.+++.+||+.+|++||+++|++.+
T Consensus       238 ~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        238 NEID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CHHH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            3211   11111111110000  000            0000000 0001113457899999999999999999999987


Q ss_pred             HHH
Q 013404          374 LKM  376 (443)
Q Consensus       374 L~~  376 (443)
                      .+.
T Consensus       314 ~~~  316 (335)
T PTZ00024        314 EYF  316 (335)
T ss_pred             ccc
Confidence            544

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.8e-36  Score=292.54  Aligned_cols=269  Identities=23%  Similarity=0.263  Sum_probs=193.5

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-C--CcEEEEEEeccCCC--CCHHHHHHHHHHHhhc-CCCceeeEEEeeecC--CCCe
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-D--GTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR--DSSQ  169 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~  169 (443)
                      +|++.+.||+|+||.||++... .  +..||+|.+.....  ...+.+.+|+++++++ +||||+++++++...  ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999954 4  77999999874322  2245788899999999 599999999875422  2235


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .+++++|+. ++|.+++..    ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            678888885 699998864    345899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCcc--ccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchH---------HH
Q 013404          250 KQAPEGRTN--YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENL---------VT  317 (443)
Q Consensus       250 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~---------~~  317 (443)
                      +........  .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......         ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            865432211  11233568999999998765 4689999999999999999999999975432110000         00


Q ss_pred             HHHHHhhccc-----cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          318 WARPILRDKD-----RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       318 ~~~~~~~~~~-----~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      +...+.....     .........+.. ........+.+++.+||+.||++||++.+++++-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~  294 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY  294 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            0000000000     000000000000 00011235789999999999999999999997744

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=286.16  Aligned_cols=260  Identities=26%  Similarity=0.350  Sum_probs=196.3

Q ss_pred             CCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           99 FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      |+..+.||+|+||.||+|+.. +++.||+|.+....  ....+.+..|+.++++++|+|++++++++..  ....++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence            566788999999999999964 58999999998653  2334678889999999999999999999873  457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |++ ++|.+++....   ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+++.....
T Consensus        79 ~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~  151 (282)
T cd07829          79 YCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP  151 (282)
T ss_pred             CcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence            997 59999997532   35899999999999999999999998   999999999999999999999999999876443


Q ss_pred             CccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc---------
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD---------  325 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------  325 (443)
                      ...  .....++..|+|||.+.+. .++.++||||||+++|||++|+.||........   ..........         
T Consensus       152 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07829         152 LRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGV  226 (282)
T ss_pred             ccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhh
Confidence            221  1233567789999998776 789999999999999999999999965332111   0000000000         


Q ss_pred             ------cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          326 ------KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       326 ------~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                            ................+ .....+.+++.+||+.+|++||++++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         227 TKLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence                  00000000000000000 113458899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-36  Score=295.89  Aligned_cols=262  Identities=23%  Similarity=0.348  Sum_probs=195.7

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC----
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  167 (443)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999964 67899999986432  2233567889999999999999999887653221    


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++|+||+ +++|.+++..     ..+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence            2478999998 6799999863     35899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      ++......     .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......   ............
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~  235 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTP  235 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCC
Confidence            99865432     123467889999998865 367899999999999999999999996433211   011000000000


Q ss_pred             c----------ccccccc---CccCCCC---CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          327 D----------RLEELAD---PRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       327 ~----------~~~~~~d---~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .          .......   ......+   .......+.+++.+||+.+|++|||+.+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0          0000000   0000000   00113458899999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.9e-37  Score=318.38  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=189.3

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeec-------
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS-------  164 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  164 (443)
                      ...++|+.++.||+||||.||+++.+ ||+.||||++.... ........+|+..|++|+|||||+++..+..       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45678999999999999999999954 89999999997654 2223568899999999999999998632100       


Q ss_pred             ----------------------------------------------------------C---------------------
Q 013404          165 ----------------------------------------------------------R---------------------  165 (443)
Q Consensus       165 ----------------------------------------------------------~---------------------  165 (443)
                                                                                .                     
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                      0                     


Q ss_pred             -C----------------------C--------CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHH
Q 013404          166 -D----------------------S--------SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY  214 (443)
Q Consensus       166 -~----------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~  214 (443)
                       +                      .        ..+||-||||+.-+|.++++.+.-..   .....++++.+|++||.|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence             0                      0        23578899999988888887533111   357789999999999999


Q ss_pred             hhhcCCCceEecCCCcccEEecCCCceEEccccccccCC----C------------CCccccccccccCccccccccccc
Q 013404          215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP----E------------GRTNYLSTRVMGTFGYVAPEYAMT  278 (443)
Q Consensus       215 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~  278 (443)
                      +|+.+   ||||||||.||+|+++..+||+|||+|....    .            .......+..+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99999   9999999999999999999999999998621    0            011112456789999999999976


Q ss_pred             C---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccC--CCCCHHHHHHHHHHH
Q 013404          279 G---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG--GKYPKEDFIRVCTIA  353 (443)
Q Consensus       279 ~---~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~li  353 (443)
                      .   .|+.|+|+||||+|++||+.   ||...  .+....             +..+.+..+.  ..+.......=.++|
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~i-------------L~~LR~g~iP~~~~f~~~~~~~e~slI  851 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASI-------------LTNLRKGSIPEPADFFDPEHPEEASLI  851 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHH-------------HHhcccCCCCCCcccccccchHHHHHH
Confidence            4   49999999999999999985   45421  111111             1111111111  112222233346899


Q ss_pred             HHccCcCCCCCCCHHHHHHH
Q 013404          354 AACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       354 ~~cl~~dp~~RPs~~evl~~  373 (443)
                      .++++.||++|||+.|+++.
T Consensus       852 ~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  852 RWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHhcCCCccCCCHHHHhhc
Confidence            99999999999999999863

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=289.10  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=202.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .+.|..-++||+||||.||-++. .+|+.||.|.+.+..   .....-.++|-.+|.+++.+.||.+--.|..  ...++
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--kd~LC  261 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET--KDALC  261 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--CCceE
Confidence            46788889999999999999984 579999999885432   2333456789999999999999998766664  44899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ||+..|+||+|.-+|.+..  +..+++..++-++.+|+.||++||+..   ||.|||||+|||||+.|+++|+|+|||..
T Consensus       262 lVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             EEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEe
Confidence            9999999999999987543  356999999999999999999999999   99999999999999999999999999998


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      +.....   ....+||.+|||||++.++.|+...|-|||||+||||+.|+.||.........  .+.-+....+.     
T Consensus       337 i~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--eEvdrr~~~~~-----  406 (591)
T KOG0986|consen  337 IPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--EEVDRRTLEDP-----  406 (591)
T ss_pred             cCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--HHHHHHHhcch-----
Confidence            876653   23448999999999999999999999999999999999999999643221111  01111111111     


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQS  373 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~  373 (443)
                             .+++..-.+...+|....|+.||++|-     .+++|.+|
T Consensus       407 -------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  407 -------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             -------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence                   133433344577888899999999996     45677665

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=274.88  Aligned_cols=260  Identities=23%  Similarity=0.269  Sum_probs=202.0

Q ss_pred             HhcCCCCC-ceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecC--CCCe
Q 013404           95 ATNNFEPA-SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR--DSSQ  169 (443)
Q Consensus        95 ~~~~~~~~-~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~  169 (443)
                      .+++|.+. ++||-|-.|.|..+. ..+++.+|+|++..     .....+|+++-=.. .|||||.++++|.+.  ....
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            56777764 679999999999988 45789999999863     34456788764333 699999999998642  3446


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceEEccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADF  246 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df  246 (443)
                      +++|||+|+||.|...++...  ...+++.++-.|+.||..|+.|||+.+   |.||||||+|+|.+.   |-.+||+||
T Consensus       134 LLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence            789999999999999998644  456999999999999999999999999   999999999999964   567999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      |+|+.....   ......+-|+.|.|||++....|+..+|+||+||++|-|++|.+||.........   --.+..+.. 
T Consensus       209 GFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~-  281 (400)
T KOG0604|consen  209 GFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRT-  281 (400)
T ss_pred             ccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhc-
Confidence            999876532   2234567899999999999999999999999999999999999999743321110   001111111 


Q ss_pred             ccccccccCccCCCCCHHH----HHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          327 DRLEELADPRLGGKYPKED----FIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~----~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                              ..  -.+|.++    .+...++|+.+|..+|++|.|+.+++++-|..+...
T Consensus       282 --------gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  282 --------GQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             --------cC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence                    00  1233322    345678999999999999999999999877655433

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=325.68  Aligned_cols=255  Identities=27%  Similarity=0.372  Sum_probs=199.0

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           94 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ..+-+++-...||.|.||.||-|. .++|...|+|.++....  ...+.+.+|..++..|+|||+|+++|+-.  +....
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv--HRekv 1309 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV--HREKV 1309 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee--cHHHH
Confidence            345566677899999999999998 67899999998875432  23356788999999999999999999865  44478


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +|.||||++|+|.+.+...    ...++.....+..|++.|++|||++|   ||||||||.||+|+.+|.+|++|||.|.
T Consensus      1310 ~IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence            8999999999999999642    23556666778899999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccc--cccccccCcccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          251 QAPEGRTNY--LSTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       251 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      .........  ......||+-|||||++.+.   ....+.||||+|||++||+||+.||...+.       .|....--.
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~ 1455 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVA 1455 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHh
Confidence            775542111  12346899999999999754   456789999999999999999999964332       121111000


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                           .    .-...+|......-.+++..||+.||++|.++.|++++
T Consensus      1456 -----~----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 -----A----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -----c----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                 0    01123344444556789999999999999999988875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=276.74  Aligned_cols=239  Identities=29%  Similarity=0.378  Sum_probs=191.5

Q ss_pred             eeecCcEEEEEEEEC-CCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       105 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      ||+|+||.||++... +++.+|+|.+......   ....+..|+.++++++||||+++++.+.  +....+++|||++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~~   78 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPGG   78 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCCC
Confidence            699999999999964 5889999998754332   3457889999999999999999998876  455889999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      +|.+++...    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  .
T Consensus        79 ~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (250)
T cd05123          79 ELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--R  149 (250)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--c
Confidence            999999743    35899999999999999999999988   99999999999999999999999999987644321  1


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      .....++..|++||...+...+.++|+||||+++||+++|..||...+.      ......+....        .    .
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~--------~----~  211 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDP--------L----R  211 (250)
T ss_pred             ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCC--------C----C
Confidence            2345688899999999888889999999999999999999999964332      11111111110        1    1


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCH---HHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPTM---GEVVQ  372 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs~---~evl~  372 (443)
                      ++......+.+++.+||..||++||++   +++++
T Consensus       212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         212 FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            111123347899999999999999999   55554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-37  Score=275.36  Aligned_cols=267  Identities=22%  Similarity=0.376  Sum_probs=203.6

Q ss_pred             HHHHHHHhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC
Q 013404           89 YEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD  166 (443)
Q Consensus        89 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  166 (443)
                      ++++...+     .+.||+|+|+.|--+. +.+|..||||++.+..........+|++++.+. .|+||++|+++|+  +
T Consensus        75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE--d  147 (463)
T KOG0607|consen   75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE--D  147 (463)
T ss_pred             HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--c
Confidence            45665555     3679999999999988 789999999999877666678899999999998 5999999999998  4


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC---ceEE
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAKV  243 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl  243 (443)
                      ....|||||-|.||.|..+|++    ...+++.++.++..+|+.||.|||.++   |.||||||+|||..+..   -+||
T Consensus       148 d~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             cceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceee
Confidence            5589999999999999999985    456999999999999999999999999   99999999999996543   4899


Q ss_pred             ccccccccCCCCCc-----cccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 013404          244 ADFGLAKQAPEGRT-----NYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE  313 (443)
Q Consensus       244 ~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~  313 (443)
                      +||.|.........     .......+|+..|||||+..     ...|+.++|.||||||||-|++|.+||...-..+-.
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG  300 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG  300 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence            99998754322111     01112467899999999763     236789999999999999999999999654322111


Q ss_pred             -----hHHHHHHHHhhccccccccccCccCCCCCHHHH----HHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          314 -----NLVTWARPILRDKDRLEELADPRLGGKYPKEDF----IRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       314 -----~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~----~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                           .-...-.      ...+.+.+..  -++|..+.    ....+++...+..|+.+|-++.+++++-+.-
T Consensus       301 WdrGe~Cr~CQ~------~LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~  365 (463)
T KOG0607|consen  301 WDRGEVCRVCQN------KLFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ  365 (463)
T ss_pred             ccCCCccHHHHH------HHHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence                 0000000      1111111111  13444432    3456788889999999999999999876543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.8e-35  Score=308.13  Aligned_cols=145  Identities=28%  Similarity=0.392  Sum_probs=127.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|.+.+.||+|+||.||+|... +++.||||+++.....   ....+..|+.+++.++||||+++++++.  .....++
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~l   81 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ--SANNVYL   81 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE--ECCEEEE
Confidence            57889999999999999999965 6899999999754322   2356888999999999999999998876  3448899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ||||+++++|.+++...    ..+++..++.++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999642    35788999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-36  Score=272.98  Aligned_cols=208  Identities=26%  Similarity=0.352  Sum_probs=170.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-C--C--CcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-S--D--GTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~--~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      ....|+....||+|.||.||++.- +  +  ...+|+|+++.....  ......+|+.+++.++|||++.+..++... .
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d  100 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-D  100 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-C
Confidence            345789999999999999999963 2  2  237999999855322  235678999999999999999999988754 4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCC-CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC----CceE
Q 013404          168 SQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN----FHAK  242 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~k  242 (443)
                      ..++|++||.+. +|+..|+-.+ .....++...+..|++||+.|+.|||++-   |+||||||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence            578999999977 9998885322 12346888899999999999999999998   9999999999999877    9999


Q ss_pred             EccccccccCCCCCccc-cccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          243 VADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      |+|||+++.+...-... ....++-|..|.|||.+.+. .|+.+.|||+.|||+.||+|-++-|...
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            99999999875543222 23446789999999999875 6899999999999999999988877543

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=310.55  Aligned_cols=259  Identities=24%  Similarity=0.326  Sum_probs=209.1

Q ss_pred             HHHHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeec
Q 013404           89 YEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS  164 (443)
Q Consensus        89 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  164 (443)
                      ..+++...++|+++++||+|+||.|.+++. .+++.||+|++++.   ......-|..|-.+|..-+.+=|+.+.-.|. 
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-  145 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ-  145 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-
Confidence            446666789999999999999999999995 57899999999762   2344567888999999888888999865555 


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA  244 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  244 (443)
                       +..++|+|||||+||+|-.++...   . ++++..+.-++..|+-||.-||+.|   +|||||||+|||||..|++||+
T Consensus       146 -D~~~LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLA  217 (1317)
T KOG0612|consen  146 -DERYLYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLA  217 (1317)
T ss_pred             -CccceEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeec
Confidence             667999999999999999999753   2 6899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccc----c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM----T-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      |||.+-.+..+. .......+|||.|++||++.    + +.|+..+|-||+||++|||+.|..||+      .++++.-.
T Consensus       218 DFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY  290 (1317)
T KOG0612|consen  218 DFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETY  290 (1317)
T ss_pred             cchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHH
Confidence            999987765432 33455678999999999985    2 568999999999999999999999997      34455555


Q ss_pred             HHHhhccccccccccCccCCCCC--HHHHHHHHHHHHHccCcCCCCCCC---HHHHHHHH
Q 013404          320 RPILRDKDRLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPT---MGEVVQSL  374 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~L  374 (443)
                      ..++.-+..+          .+|  .+......+||...+. +|+.|-.   ++++..|.
T Consensus       291 ~KIm~hk~~l----------~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  291 GKIMNHKESL----------SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             HHHhchhhhc----------CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            5555443222          122  1123346677777766 5888887   99998774

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=296.89  Aligned_cols=262  Identities=27%  Similarity=0.438  Sum_probs=214.2

Q ss_pred             HHHHHHHhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecC-
Q 013404           89 YEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR-  165 (443)
Q Consensus        89 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  165 (443)
                      ++.+...++.|++.++||.|.+|.||+++ .++++.+|+|++.... ...++...|.++|+.+ .|||++.++|+|... 
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            34444456788999999999999999999 5688999999887543 3456778899999988 699999999988642 


Q ss_pred             --CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEE
Q 013404          166 --DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV  243 (443)
Q Consensus       166 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  243 (443)
                        .+++++||||||.+|+..|++++..  ...+.|..+..|+..++.||.+||.+.   ++|||||-.|||++.++.+||
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence              3468999999999999999998876  567999999999999999999999999   999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~  318 (443)
                      +|||++........  ......||+.|||||++...     .|+.++|+||||++..||.-|.+|+....+...      
T Consensus       165 vDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------  236 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------  236 (953)
T ss_pred             eeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------
Confidence            99999998765443  34557899999999999643     467899999999999999999999864433211      


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         +      +.-..+|.....-+..=..++.++|..||..|-++||++.++++|
T Consensus       237 ---L------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  237 ---L------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---h------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence               1      111122333333455556678999999999999999999999865

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-35  Score=271.80  Aligned_cols=220  Identities=20%  Similarity=0.208  Sum_probs=174.1

Q ss_pred             cCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhh
Q 013404          108 GGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL  186 (443)
Q Consensus       108 G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  186 (443)
                      |.||.||++.. .+++.||+|.+....     .+..|...+....||||+++++++.  +....+++|||+++|+|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV--SEDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee--cCCeEEEEEecCCCCCHHHHH
Confidence            89999999995 578999999997532     3345556666668999999999887  445889999999999999998


Q ss_pred             cCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccccccccc
Q 013404          187 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG  266 (443)
Q Consensus       187 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  266 (443)
                      ...    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++|||++.......     ....+
T Consensus        77 ~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~  144 (237)
T cd05576          77 SKF----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAV  144 (237)
T ss_pred             HHh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCc
Confidence            642    34899999999999999999999998   9999999999999999999999999886654321     22345


Q ss_pred             CcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHH
Q 013404          267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF  346 (443)
Q Consensus       267 t~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  346 (443)
                      +..|+|||.+.+..++.++||||+|+++|||++|+.|+.......            ..      ....    ..+....
T Consensus       145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~------~~~~----~~~~~~~  202 (237)
T cd05576         145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT------HTTL----NIPEWVS  202 (237)
T ss_pred             CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc------cccc----CCcccCC
Confidence            678999999988889999999999999999999998875321100            00      0000    1111222


Q ss_pred             HHHHHHHHHccCcCCCCCCCHH
Q 013404          347 IRVCTIAAACVAPEANQRPTMG  368 (443)
Q Consensus       347 ~~l~~li~~cl~~dp~~RPs~~  368 (443)
                      ..+.+++.+||+.||++||++.
T Consensus       203 ~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         203 EEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHHHccCCHHHhcCCC
Confidence            3578999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=282.11  Aligned_cols=256  Identities=28%  Similarity=0.429  Sum_probs=196.2

Q ss_pred             cCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCC-CC------CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           97 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG-QQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      ++|-++.+||+|||+.||++. +...+.||||+-..+. ..      ..+...+|.++-+.|.||.||++++||.- +..
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-Dtd  541 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-DTD  541 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-ccc
Confidence            456667889999999999999 6678899999865432 11      12356789999999999999999999864 555


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceEEcc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVAD  245 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D  245 (443)
                      ..|-|+|||+|.+|.-||+.    .+-++++++..|+.||+.||.||.+.. |+|+|-||||.||||.+   -|.+||+|
T Consensus       542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence            78999999999999999975    345899999999999999999999885 55999999999999965   47899999


Q ss_pred             ccccccCCCCCcc-----ccccccccCcccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 013404          246 FGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV  316 (443)
Q Consensus       246 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~  316 (443)
                      |||++...+....     ...+...||.+|++||.+.-+    ..+.|.||||.|||+|.++.|+.||......  ..  
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Qd--  692 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QD--  692 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HH--
Confidence            9999988665443     234567899999999988643    4678999999999999999999999754421  11  


Q ss_pred             HHHHHHhhccccccccccCccCCCCC--HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQ  372 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs~~evl~  372 (443)
                           ++.....+    ...- ..+|  +........+|++||+..-++|....++..
T Consensus       693 -----ILqeNTIl----kAtE-VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  693 -----ILQENTIL----KATE-VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             -----HHhhhchh----ccee-ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                 11111111    0000 0111  111223568999999999999988777754

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=277.30  Aligned_cols=263  Identities=23%  Similarity=0.319  Sum_probs=200.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC--CCc----eeeEEEeeecCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH--HRN----LVKLVGYYSSRDS  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~l~~~~~~~~~  167 (443)
                      .+++|.+...+|+|.||.|..+... .+..||||+++.-. ...+..+-|+++|.++.  .|+    +|.+.+||.  -.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd--yr  163 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD--YR  163 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh--cc
Confidence            3789999999999999999998854 47899999997432 22455677999999993  232    677777776  44


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC----------
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN----------  237 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----------  237 (443)
                      ++.|+|+|.+ |-+++++|..+.  -.+++...+..|++|++++++|||+.+   ++|-||||+|||+.+          
T Consensus       164 ghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccC
Confidence            5889999998 669999998643  456888999999999999999999999   999999999999942          


Q ss_pred             ----------CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          238 ----------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       238 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                                +..++|+|||.|......     .+.++.|..|.|||++.+..++.++||||+||||.|+.+|...|...
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                      346899999999865433     25568899999999999999999999999999999999999999766


Q ss_pred             CCCCcchHHHHHHHHhhc--------c--------ccc-----------cccccCc----cCCCCCHHHHHHHHHHHHHc
Q 013404          308 QPSGQENLVTWARPILRD--------K--------DRL-----------EELADPR----LGGKYPKEDFIRVCTIAAAC  356 (443)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~--------~--------~~~-----------~~~~d~~----~~~~~~~~~~~~l~~li~~c  356 (443)
                      +..+.....+   .++..        .        +++           ....++-    ..-.....+...|.+|+..|
T Consensus       313 en~EHLaMMe---rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m  389 (415)
T KOG0671|consen  313 ENLEHLAMME---RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM  389 (415)
T ss_pred             CcHHHHHHHH---HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence            5333221111   11110        0        000           0000000    00012345567799999999


Q ss_pred             cCcCCCCCCCHHHHHHHH
Q 013404          357 VAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       357 l~~dp~~RPs~~evl~~L  374 (443)
                      |..||.+|+|+.|++.|-
T Consensus       390 L~fDP~~RiTl~EAL~Hp  407 (415)
T KOG0671|consen  390 LEFDPARRITLREALSHP  407 (415)
T ss_pred             HccCccccccHHHHhcCH
Confidence            999999999999999763

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=289.34  Aligned_cols=243  Identities=24%  Similarity=0.295  Sum_probs=194.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++.|+....+|.|+|+.|-.+. ..+++..+||++....    .+-.+|+.++... +||||+++.+.+.  +..+.++|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~v  394 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYLV  394 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceec--CCceeeee
Confidence            6778888899999999999988 4578899999997552    2334577666655 7999999999987  66689999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe-cCCCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~  252 (443)
                      ||.+.++-|.+.+....     ....++..|+.+|+.|+.|||+++   ++||||||+|||+ ++.++++|+|||.++..
T Consensus       395 ~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             ehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            99999998888876322     223777889999999999999999   9999999999999 58899999999999877


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ...     ....+-|..|.|||++....|+++||+||||++||+|++|+.||.....+  .++.    .         .+
T Consensus       467 ~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~---------~i  526 (612)
T KOG0603|consen  467 ERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----T---------RI  526 (612)
T ss_pred             chh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----H---------hh
Confidence            654     12346688999999999999999999999999999999999999754332  1111    1         11


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ..+    .+.........+|+.+||+.||.+||+|.++..+-+.
T Consensus       527 ~~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  527 QMP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cCC----ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            111    1122233447789999999999999999999988666

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=267.01  Aligned_cols=256  Identities=24%  Similarity=0.352  Sum_probs=191.0

Q ss_pred             CCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHh-hcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           99 FEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLS-RLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .+-+..||.|+||+|++-.. +.|+..|||+++.... ...++++.|.+... .-+.||||+++|.+.  ..+..+++||
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F--~EGdcWiCME  143 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF--SEGDCWICME  143 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh--cCCceeeeHH
Confidence            34457899999999999884 5799999999986654 44567888887654 457999999999876  3447899999


Q ss_pred             ecCCCChhHhhcCCC-CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          176 LVPNGSLESWLHGPL-GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      .|+- +|..+...-. .....+++...-.|+...+.||.||...-.  |+|||+||+||||+..|.+||||||++-.+..
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            9954 7766543110 113457888888899999999999987643  99999999999999999999999999976644


Q ss_pred             CCccccccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .   ...+.-.|-..|||||.+..  ..|+.+|||||||++|+|+.||+.||...+     +..+.+..+....  ...+
T Consensus       221 S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gd--pp~l  290 (361)
T KOG1006|consen  221 S---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGD--PPIL  290 (361)
T ss_pred             H---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCC--CCee
Confidence            2   23455678889999999864  358999999999999999999999996432     2222233222221  1111


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..+.-    ..+....++.++..||..|-++||.+.++.++
T Consensus       291 ~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 LFDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCccc----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11110    01123458899999999999999999999865

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.8e-34  Score=287.61  Aligned_cols=266  Identities=22%  Similarity=0.333  Sum_probs=183.9

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-----------------CCCcEEEEEEeccCCCCCHHH--------------HHHH
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-----------------SDGTAVAIKRLTCGGQQGDKE--------------FLVE  143 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  143 (443)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467999999999999999999963                 235679999987543322233              3347


Q ss_pred             HHHHhhcCCCce-----eeEEEeeecC------CCCeeEEEEeecCCCChhHhhcCCCCC--------------------
Q 013404          144 VEMLSRLHHRNL-----VKLVGYYSSR------DSSQHLLCYELVPNGSLESWLHGPLGV--------------------  192 (443)
Q Consensus       144 ~~~l~~l~h~ni-----v~l~~~~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------  192 (443)
                      +.++.+++|.++     ++++++|...      .....+|||||+++++|.++++...+.                    
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777876654     6777877532      234679999999999999999743210                    


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCccccc
Q 013404          193 NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA  272 (443)
Q Consensus       193 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a  272 (443)
                      ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            123567888999999999999999998   99999999999999999999999999976543221 11122345889999


Q ss_pred             ccccccCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCCCCC------cchHHHHHHHHh
Q 013404          273 PEYAMTGHL----------------------LVKSDVYSYGVVLLELLTGRK-PVDMSQPSG------QENLVTWARPIL  323 (443)
Q Consensus       273 PE~~~~~~~----------------------~~~sDv~S~G~il~elltg~~-p~~~~~~~~------~~~~~~~~~~~~  323 (443)
                      ||.+.....                      ..+.||||+||+++||++|.. ||.......      ...+..|.. ..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~  457 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YK  457 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hc
Confidence            998754321                      234799999999999999875 664211100      011111211 00


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCC---CCCCCHHHHHHHHH
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA---NQRPTMGEVVQSLK  375 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~evl~~L~  375 (443)
                      .....+          ...........+++.+||..+|   .+|+|++|+++|-+
T Consensus       458 ~~~~~~----------~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        458 GQKYDF----------SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             ccCCCc----------ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence            000000          0011122346789999998766   68999999998754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.5e-34  Score=295.74  Aligned_cols=266  Identities=21%  Similarity=0.279  Sum_probs=171.2

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-C----CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEee----ecC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-D----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY----SSR  165 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~----~~~  165 (443)
                      ..++|++.+.||+|+||.||+|++. +    +..||+|++.....  .+.+..|  .+....+.++..++..+    ...
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999964 4    68999998864321  1112211  12222222332222111    112


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCCC----------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCC
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLGV----------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK  229 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  229 (443)
                      +....++||||+++++|.++++.....                ........+..++.|++.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            455789999999999999998643100                001123446689999999999999998   9999999


Q ss_pred             cccEEecC-CCceEEccccccccCCCCCccccccccccCcccccccccccC----------------------CCCchhh
Q 013404          230 ASNILLEN-NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG----------------------HLLVKSD  286 (443)
Q Consensus       230 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD  286 (443)
                      |+|||+++ ++.+||+|||+++....... +......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986543322 233456789999999965322                      2345679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc---cccCcc----CCCC--CHHHHHHHHHHHHHcc
Q 013404          287 VYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE---LADPRL----GGKY--PKEDFIRVCTIAAACV  357 (443)
Q Consensus       287 v~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~d~~~----~~~~--~~~~~~~l~~li~~cl  357 (443)
                      ||||||+||||+++..+++..       +..+...+.........   ...+..    ...+  .........+|+.+||
T Consensus       362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            999999999999977665321       11111111110000000   000100    0000  0001123458999999


Q ss_pred             CcCCCCCCCHHHHHHHHH
Q 013404          358 APEANQRPTMGEVVQSLK  375 (443)
Q Consensus       358 ~~dp~~RPs~~evl~~L~  375 (443)
                      +.||++|||++|+++|-+
T Consensus       435 ~~dP~kR~ta~e~L~Hpf  452 (566)
T PLN03225        435 RFKGRQRISAKAALAHPY  452 (566)
T ss_pred             cCCcccCCCHHHHhCCcC
Confidence            999999999999998743

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-35  Score=242.18  Aligned_cols=263  Identities=25%  Similarity=0.341  Sum_probs=196.0

Q ss_pred             CCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|.-.++||+|.||+||+|+ .++++.||+|+++.+...  .....++|+-+|+.++|.|||+++++..  ....+-+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh--sdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc--cCceeEEeH
Confidence            45556889999999999999 567899999998765433  3467899999999999999999999865  334788999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      |||.. +|..|....   +..++.+.+..++.|+++||.++|+++   +.||||||+|.|++.+|++|++|||+++.++-
T Consensus        81 e~cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             HHhhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            99955 899888643   445889999999999999999999999   99999999999999999999999999997754


Q ss_pred             CCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcc----cc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK----DR  328 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~  328 (443)
                      .-.  ..+..+-|..|.+|.++.+. -|++..|+||-||++.|+.. |++.|...+-  .+++...++.+-...    ..
T Consensus       154 pvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  154 PVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             ceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCc
Confidence            322  12334678999999999876 47888999999999999987 5555654332  223333333221110    11


Q ss_pred             ccccccCccCCCCCH---------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          329 LEELADPRLGGKYPK---------EDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +..+.|-..-..++.         .....=.+++.+.+.-+|.+|.++++.+++
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            222222222222221         111123467778888899999999998864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-33  Score=260.78  Aligned_cols=239  Identities=31%  Similarity=0.404  Sum_probs=190.7

Q ss_pred             CcEEEEEEEEC-CCcEEEEEEeccCCCCC-HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhh
Q 013404          109 GFGRVFKGVLS-DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL  186 (443)
Q Consensus       109 ~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l  186 (443)
                      +||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++..  ....++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHH
Confidence            58999999975 58999999998665544 6789999999999999999999999874  35789999999999999998


Q ss_pred             cCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccccccccc
Q 013404          187 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG  266 (443)
Q Consensus       187 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  266 (443)
                      ....    .+++..++.++.+++.++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......+
T Consensus        79 ~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~  148 (244)
T smart00220       79 KKRG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG  148 (244)
T ss_pred             Hhcc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence            7432    2889999999999999999999998   9999999999999999999999999998765432   1234568


Q ss_pred             CcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHH
Q 013404          267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF  346 (443)
Q Consensus       267 t~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  346 (443)
                      +..|++||.+....++.++|||+||+++|+|++|..||.....  ......+   ........      .....   ...
T Consensus       149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~---~~~~~~~~------~~~~~---~~~  214 (244)
T smart00220      149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKK---IGKPKPPF------PPPEW---KIS  214 (244)
T ss_pred             CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHH---HhccCCCC------ccccc---cCC
Confidence            8899999999988899999999999999999999999964211  1111111   11110000      00000   022


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          347 IRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       347 ~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..+.+++.+||..+|++||++.+++++
T Consensus       215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      215 PEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHHHHHccCCchhccCHHHHhhC
Confidence            358899999999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-36  Score=262.72  Aligned_cols=272  Identities=22%  Similarity=0.341  Sum_probs=197.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecC------CC
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR------DS  167 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  167 (443)
                      ..|+-..+||+|.||.||+++. ++|+.||+|++-....  .-.....+|+++|..|+|+|++.++..|...      +.
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            3456678899999999999994 5688899987654322  2235678899999999999999999887542      33


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++||.+|+. +|..+|...   ...++..++.+++.++..||.|+|...   |+|||+|+.|+||+.++.+||+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence            458999999987 999988643   346899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCcc--ccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH------
Q 013404          248 LAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW------  318 (443)
Q Consensus       248 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~------  318 (443)
                      +++.+......  ..-+..+-|..|.+||.+.+. .|+++.|||.-||++.||+||.+-+......-+..++..      
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99765433211  112345669999999988765 789999999999999999999988865432222222111      


Q ss_pred             --HHHHhhccccccccccCcc-CCCCC--HHHH------HHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          319 --ARPILRDKDRLEELADPRL-GGKYP--KEDF------IRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       319 --~~~~~~~~~~~~~~~d~~~-~~~~~--~~~~------~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                        +|+.+..-.....+-.+.+ .+.+.  .+..      ...++|+..++..||.+|+.+.+++.+-.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~  317 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF  317 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence              1111100001111100101 01100  0111      14678999999999999999999998754

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=267.35  Aligned_cols=241  Identities=25%  Similarity=0.359  Sum_probs=192.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC---CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  170 (443)
                      ..+|..+.+||+|+||.|.++..+ +.+.+|||+++++-.   .+.+--+.|-++|+-. +-|.++++..+|+.  ...+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRL  425 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRL  425 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhhe
Confidence            457888999999999999999854 567899999986532   1222335577777766 57788888888774  4489


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+.||+|--++++.    ..+.+..+.-++..||-||-+||+++   |+.||||.+||+||.+|.+||+|||+++
T Consensus       426 yFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence            9999999999999998753    34778889999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ..--...  .....+||+.|+|||++..++|+...|-|||||+||||+.|++||+..+..      +.++.+...     
T Consensus       499 Eni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------elF~aI~eh-----  565 (683)
T KOG0696|consen  499 ENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQAIMEH-----  565 (683)
T ss_pred             ccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHc-----
Confidence            6433222  245679999999999999999999999999999999999999999865432      222222222     


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP  365 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  365 (443)
                             ...+|.....+...++...|...|.+|.
T Consensus       566 -------nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 -------NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence                   1245555555677888899999999995

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=274.69  Aligned_cols=247  Identities=22%  Similarity=0.324  Sum_probs=194.6

Q ss_pred             CceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          102 ASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      .++||+|.||+||-|.. ++|+.||||.+.+...  .....+.+|+.+|+++.||.||.+...|+..+  ..+.|||-+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e--rvFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE--RVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc--eEEEEehhhc
Confidence            57899999999999994 5899999999976532  33467899999999999999999998887544  7899999994


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC---CceEEccccccccCCCC
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFGLAKQAPEG  255 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~~  255 (443)
                       |+..+.|-..  ....|++....-++.||+.||.|||.++   |+|+||||+||||.+.   -.+||||||+|+..+..
T Consensus       647 -GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  647 -GDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             -chHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence             5666655321  2345888888889999999999999999   9999999999999653   46999999999998764


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .   .....+||+.|+|||+++++.|...-|+||.|||+|--++|..||..++.     +.+.++   .    ..-+.-+
T Consensus       721 s---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQ---N----AaFMyPp  785 (888)
T KOG4236|consen  721 S---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQ---N----AAFMYPP  785 (888)
T ss_pred             h---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhh---c----cccccCC
Confidence            3   34567999999999999999999999999999999999999999964321     111111   0    0001111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..    -.+......++|...|+..-.+|-+.+.-+.+-|
T Consensus       786 ~P----W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  786 NP----WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             Cc----hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence            11    1222334678999999999999999999887654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=288.00  Aligned_cols=248  Identities=29%  Similarity=0.409  Sum_probs=186.6

Q ss_pred             CCCCceeeecCcEE-EEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEee
Q 013404           99 FEPASILGEGGFGR-VFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        99 ~~~~~~lg~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      |...+.+|.|+.|+ ||+|.+ +|+.||||++-..   ......+|+..|+.- +|||||++++  .+.+....|+..|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEehH
Confidence            44456789998875 799998 4789999998622   234567899999887 6999999965  45577789999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-----CCceEEcccccccc
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQ  251 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~  251 (443)
                      |. .+|.+++...........-...+.++.|+++||++||+.+   ||||||||+||||+.     ...++|+|||+++.
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            94 5999999864111111111456788999999999999999   999999999999965     25799999999998


Q ss_pred             CCCCCcccc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          252 APEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       252 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...+..... .....||.+|+|||++....-+.++|||||||++|+.++| .+||+..-.. +.       .++.....+
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~-------NIl~~~~~L  732 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QA-------NILTGNYTL  732 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hh-------hhhcCccce
Confidence            876655433 3456799999999999998888899999999999999995 8999632111 11       122222222


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..+..       ..++  ...+||.+|++++|..||++.+|+.|
T Consensus       733 ~~L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  733 VHLEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             eeecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            21111       1111  46789999999999999999999864

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=273.14  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=204.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCc-EEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGT-AVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .+++....||-|+||.|-++...... .+|+|.+++..   ....+....|-++|...+.|.||+++--|.  +...+|+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~kyvYm  497 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR--DSKYVYM  497 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cchhhhh
Confidence            45566778999999999999865433 48888887653   233456788999999999999999987766  6668999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +||-|-||.|+..|+.    +..++.....-++..+++|++|||+++   ||.|||||+|.+|+.+|-+||.|||+|+..
T Consensus       498 LmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  498 LMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             hHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999999975    445888888999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ..+..   +-.++||+.|.|||++.+...+..+|.||||+++|||++|++||...++....+++      +..   +..+
T Consensus       571 ~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------LkG---id~i  638 (732)
T KOG0614|consen  571 GSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LKG---IDKI  638 (732)
T ss_pred             ccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hhh---hhhh
Confidence            76543   34579999999999999999999999999999999999999999877665433322      211   1111


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHHHHh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLKMV  377 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L~~~  377 (443)
                             .+|........+++++....+|.+|--     +.+|.+|-|..
T Consensus       639 -------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  639 -------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             -------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence                   123333334567888888999999975     78888886643

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=253.19  Aligned_cols=248  Identities=21%  Similarity=0.339  Sum_probs=199.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|.++++||+|+|..|.++++ .+.+.+|+|++++..   ..+..-.+.|-.+..+. +||.+|.+..+|..  ...+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl  326 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL  326 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence            47899999999999999999994 577899999987653   23344567788888776 79999999988874  4488


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++|.||++||+|--++++    ...++++.+.-+...|..||.|||+.|   |+.||||.+|+|+|..|.+||+|+|+++
T Consensus       327 ffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             EEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence            999999999999888765    346899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ-PSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ..-...  ...+.++||+.|+|||++++..|....|-|+|||+++||+.|+.||+... .....+..++..+++-++.  
T Consensus       400 e~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--  475 (593)
T KOG0695|consen  400 EGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--  475 (593)
T ss_pred             cCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--
Confidence            643322  23567899999999999999999999999999999999999999997422 1223445555544433321  


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP  365 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  365 (443)
                               -.+|.....+...+++.-|+.||.+|.
T Consensus       476 ---------iriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 ---------IRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---------ccccceeehhhHHHHHHhhcCCcHHhc
Confidence                     112333334456788899999999995

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-33  Score=269.00  Aligned_cols=208  Identities=25%  Similarity=0.362  Sum_probs=173.5

Q ss_pred             cCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .-|...+.||-|+||.|.++. .++...||+|.+++.+-   ........|-.||..-..+-||+|+-.|.  +...+|+
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ--DkdnLYF  706 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ--DKDNLYF  706 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec--cCCceEE
Confidence            345667889999999999998 56678899999976532   33445778999999999999999976665  6669999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||+|++||++-.+|-+    ..-+.+..+.-++.++..|+++.|..|   +|||||||+|||||.+|.+||+||||+.-+
T Consensus       707 VMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence            9999999999999864    234777888888999999999999999   999999999999999999999999998532


Q ss_pred             CC---------CC-------------------------------ccccccccccCcccccccccccCCCCchhhHHHHHH
Q 013404          253 PE---------GR-------------------------------TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV  292 (443)
Q Consensus       253 ~~---------~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~  292 (443)
                      ..         ++                               ........+||+.|+|||++....|+.-||-||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            10         00                               001123578999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCcc
Q 013404          293 VLLELLTGRKPVDMSQPSGQE  313 (443)
Q Consensus       293 il~elltg~~p~~~~~~~~~~  313 (443)
                      |||||+.|+.||-...+.+..
T Consensus       860 il~em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcce
Confidence            999999999999877776554

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=238.92  Aligned_cols=205  Identities=29%  Similarity=0.421  Sum_probs=167.9

Q ss_pred             HhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ..++......||+|++|.|-+-+ .++|+..|+|++...-. +..++.++|+.+..+- .+|.+|.++|.+.  +....+
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdvw  121 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDVW  121 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccEE
Confidence            34445556789999999998888 56899999999975532 3346678888876554 7999999999765  445789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +.||.|+. +|..|..+-......+++..+-+|+..+.+||.|||++-+  ++|||+||+|||++.+|++|+||||.+-.
T Consensus       122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEccccccee
Confidence            99999965 8988876554456678999999999999999999998753  99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCccccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      +.+.-   ..+-..|-..|||||.+..    ..|+-|+||||||+.+.||.+++.||+..
T Consensus       199 L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  199 LVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            65432   2233467888999998853    37899999999999999999999999743

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8.7e-33  Score=238.69  Aligned_cols=262  Identities=19%  Similarity=0.312  Sum_probs=199.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+++|+|.++.||.|. ..+++.++||.++.   ...+.+.+|+.+|..|. ||||++++++..+..+....|+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            5789999999999999999999 56789999999973   34577899999999996 9999999999988888888999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~  252 (443)
                      +||+++-+...+..       .++.-.+...+.++++||.|||+.|   |.|||+||.|+++|. ...++|+|+|+|.+.
T Consensus       114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999988776653       3677888999999999999999999   999999999999986 457999999999987


Q ss_pred             CCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-----
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-----  326 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  326 (443)
                      ........   .+.+..|--||.+.. ..|+-.-|+|||||+|..|+..+.||-..... .++++..+..+-.+.     
T Consensus       184 Hp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  184 HPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             CCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHH
Confidence            66554322   256677889998865 45677889999999999999999999543322 233333222110000     


Q ss_pred             ccccccccCccCC---CCC------------H-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          327 DRLEELADPRLGG---KYP------------K-EDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       327 ~~~~~~~d~~~~~---~~~------------~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ....--+||....   ..+            . -...+..+++.+.|..|-.+|||+.|.+.|-
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence            0011112222211   000            0 0013467899999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7.2e-34  Score=251.25  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=195.4

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC---CeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~  171 (443)
                      +.+..+-||.|+||.||.+++ ++|+.||.|++..--  -...+.+.+|+++|..++|.|++..+++..-..-   .+.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345568899999999999985 579999999986432  1234678999999999999999998876542211   1467


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      .++|.|.. +|+..+-.    ..+++...+.-+++||++||+|||+.+   |.||||||.|.|++.|..+||+|||+++.
T Consensus       134 V~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence            78888854 88888753    456888889999999999999999999   99999999999999999999999999997


Q ss_pred             CCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc-----
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-----  325 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  325 (443)
                      ....+.. .++..+-|..|.|||++++. .|+.+.||||.||++.||+..+..|....+..+..++.-   ++.-     
T Consensus       206 ee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd---LLGTPs~Ea  281 (449)
T KOG0664|consen  206 WDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID---LLGTPSQEA  281 (449)
T ss_pred             cchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH---HhCCCcHHH
Confidence            6554432 34555778999999999975 689999999999999999999988876555443332221   1100     


Q ss_pred             -----ccccccccc-----CccCC----CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          326 -----KDRLEELAD-----PRLGG----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       326 -----~~~~~~~~d-----~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                           ++.-..++.     |.+..    ..+.........+...++..||++|.+.++.+.++-
T Consensus       282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence                 000000000     11100    001111223456777889999999999999987753

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.9e-30  Score=232.47  Aligned_cols=210  Identities=36%  Similarity=0.571  Sum_probs=180.3

Q ss_pred             eeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCCh
Q 013404          105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL  182 (443)
Q Consensus       105 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL  182 (443)
                      ||+|++|.||++... +++.+++|.+...... ....+.+|++.++.++|++++++++++..  ....++++||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCcH
Confidence            689999999999975 4899999999755432 34679999999999999999999999874  3578999999999999


Q ss_pred             hHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEccccccccCCCCCccccc
Q 013404          183 ESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEGRTNYLS  261 (443)
Q Consensus       183 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~  261 (443)
                      .+++....   ..+++..+..++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  ..
T Consensus        79 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~  150 (215)
T cd00180          79 KDLLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL  150 (215)
T ss_pred             HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence            99997431   35889999999999999999999998   999999999999999 89999999999986654321  12


Q ss_pred             cccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC
Q 013404          262 TRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK  340 (443)
Q Consensus       262 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  340 (443)
                      ....+...|++||..... .++.+.|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            334578889999998877 788999999999999999                                           


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       341 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                            ..+.+++..|++.+|++||++.+++++
T Consensus       188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                  136789999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=247.93  Aligned_cols=268  Identities=21%  Similarity=0.310  Sum_probs=194.9

Q ss_pred             cCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-----C---CceeeEEEeeec--C
Q 013404           97 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----H---RNLVKLVGYYSS--R  165 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--~  165 (443)
                      .+|.+.++||-|.|++||++. .++.+.||+|+.+.. ..-.+..+.||++|++++     |   .+||+|+++|..  .
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            578888999999999999998 567889999998732 233456788999999983     2   369999999864  4


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-------
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-------  238 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-------  238 (443)
                      ++.++|+|+|++ |.+|..+|....  -+.++...+.+|+.||+.||.|||..+.  |+|-||||+|||+..+       
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhh
Confidence            566899999999 779999986432  3458889999999999999999999864  9999999999999300       


Q ss_pred             --------------------------------------------------------------------------------
Q 013404          239 --------------------------------------------------------------------------------  238 (443)
Q Consensus       239 --------------------------------------------------------------------------------  238 (443)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             -------------------------------------------------------------------------------C
Q 013404          239 -------------------------------------------------------------------------------F  239 (443)
Q Consensus       239 -------------------------------------------------------------------------------~  239 (443)
                                                                                                     .
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                           0


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC---cc-hH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG---QE-NL  315 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~---~~-~~  315 (443)
                      .+||+|||-|......     .+.-..|..|.|||++.+..|++.+|||||+|++|||+||...|+..+...   .+ .+
T Consensus       392 ~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi  466 (590)
T KOG1290|consen  392 RVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI  466 (590)
T ss_pred             eEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence            1233333333322111     122345778999999999999999999999999999999999997443222   11 11


Q ss_pred             ---HH----HHHHHhhccccccccccCc--------c-----------CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 013404          316 ---VT----WARPILRDKDRLEELADPR--------L-----------GGKYPKEDFIRVCTIAAACVAPEANQRPTMGE  369 (443)
Q Consensus       316 ---~~----~~~~~~~~~~~~~~~~d~~--------~-----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  369 (443)
                         ++    .-+.+...+..-.++++.+        +           .-.++.++..++.+++.-||+.+|++|||+.+
T Consensus       467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~  546 (590)
T KOG1290|consen  467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ  546 (590)
T ss_pred             HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence               11    0111111222222222221        0           02356788889999999999999999999999


Q ss_pred             HHHHHH
Q 013404          370 VVQSLK  375 (443)
Q Consensus       370 vl~~L~  375 (443)
                      .+++-|
T Consensus       547 cl~hPw  552 (590)
T KOG1290|consen  547 CLKHPW  552 (590)
T ss_pred             HhcCcc
Confidence            998754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=235.49  Aligned_cols=259  Identities=23%  Similarity=0.340  Sum_probs=193.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC--CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----CC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  168 (443)
                      ..+|.-++.+|.|.- .|.-+.. -.++.||+|++...  .....+...+|..++..++|+||++++.+|.-..    ..
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777788888888 5555553 25789999987643  2344567889999999999999999999986432    23


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      +.++|||+|. .+|...++.      .++-..+..++.|++.|++|||+.+   |+||||||+||++..+..+||.|||+
T Consensus        95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence            5789999995 599998862      2566888999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH-------
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP-------  321 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~-------  321 (443)
                      ++.....   ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+.     ..+.+|.+.       
T Consensus       165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-----d~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-----DHIDQWNKIIEQLGTP  236 (369)
T ss_pred             hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-----hHHHHHHHHHHHhcCC
Confidence            9865443   3456678899999999999999999999999999999999999888632     222222211       


Q ss_pred             --------------Hhhccccc------cccccCccC--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          322 --------------ILRDKDRL------EELADPRLG--GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       322 --------------~~~~~~~~------~~~~d~~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                                    .+......      +.+-|....  .+.+........+++.+||-.||++|-++++++.|
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                          11110000      000111110  01111222346789999999999999999999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.9e-29  Score=227.74  Aligned_cols=199  Identities=35%  Similarity=0.481  Sum_probs=170.1

Q ss_pred             CCCCceeeecCcEEEEEEEECC-CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           99 FEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      |.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++..  ....++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEec
Confidence            5667899999999999999764 889999999866544 56788999999999999999999998873  3478899999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.+++.....   .+++..+..++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||++.......
T Consensus        79 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       79 CEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             cCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            999999999975321   1788999999999999999999998   9999999999999999999999999998765442


Q ss_pred             ccccccccccCccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 013404          257 TNYLSTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRKPVDM  306 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~G~il~elltg~~p~~~  306 (443)
                      .. ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       153 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 AA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            11 12334678889999998 666778899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-31  Score=258.94  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=201.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|+....+|.|.||.||+++ ...++..|+|.++........-.+.|+-+++..+|||||.++|.+...+  ..+++|
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d--klwicM   91 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD--KLWICM   91 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc--CcEEEE
Confidence            4678999999999999999999 5678999999999877777777889999999999999999999887444  789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      |||.+|+|++..+.    ..++++.++..+....++||+|||+.+   =+|||||-.|||+++.|.+|++|||.+..+..
T Consensus        92 EycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh
Confidence            99999999998874    567999999999999999999999999   78999999999999999999999999987654


Q ss_pred             CCccccccccccCccccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .-.  ....+.||+.|||||+.   +.+.|..++|||++|+...|+---..|.....+.  ..     ..++. +...  
T Consensus       165 ti~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~-----l~LmT-kS~~--  232 (829)
T KOG0576|consen  165 TIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RA-----LFLMT-KSGF--  232 (829)
T ss_pred             hhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HH-----HHHhh-ccCC--
Confidence            322  23457899999999976   4678999999999999999998777664321111  00     00111 0000  


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                       .-+.+...  ..-...+-++++.|+..+|++||+++.++.|
T Consensus       233 -qpp~lkDk--~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  233 -QPPTLKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             -CCCcccCC--ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence             01111111  1112347789999999999999999988753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-30  Score=250.27  Aligned_cols=196  Identities=24%  Similarity=0.395  Sum_probs=165.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--------CHHHHHHHHHHHhhcC---CCceeeEEEeeec
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--------GDKEFLVEVEMLSRLH---HRNLVKLVGYYSS  164 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  164 (443)
                      .+|...+.+|+|+||.|+++.++ +...|+||.+.+...-        .....-.|+++|..++   |+||++++++|+ 
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE-  639 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE-  639 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee-
Confidence            45788899999999999999965 4667999988754211        1123446999999997   999999999998 


Q ss_pred             CCCCeeEEEEeec-CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEE
Q 013404          165 RDSSQHLLCYELV-PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV  243 (443)
Q Consensus       165 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  243 (443)
                       ++..++|+||-. ++-+|.++|..    ...+++.++..|+.||+.|+++||+++   |||||||-+|+.++.+|-+||
T Consensus       640 -ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  640 -DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             -cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence             555889999965 45699999964    446899999999999999999999999   999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCC
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVD  305 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~G~il~elltg~~p~~  305 (443)
                      +|||.+.....+.    ...++||..|.|||++.+..|- ..-|||++|++||.++....||.
T Consensus       712 idfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999998765443    2456899999999999998885 55799999999999999999985

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=2.1e-30  Score=247.04  Aligned_cols=270  Identities=23%  Similarity=0.260  Sum_probs=199.5

Q ss_pred             HHHHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC------CCceeeEEEeeec
Q 013404           92 LKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH------HRNLVKLVGYYSS  164 (443)
Q Consensus        92 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~  164 (443)
                      -+....+|.+....|+|-|++|.+|..+ -|..||||++..+.. -.+.=+.|+++|++|+      --|+++|+-.|. 
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~-  504 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK-  504 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh-
Confidence            3445678888999999999999999954 478999999985532 2344567999999995      347788877766 


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-CceEE
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKV  243 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl  243 (443)
                       ...++|||||-+ ..+|.+.|... +.+..|....+..++.|+.-||..|...+   |+|.||||.|||+++. ..+||
T Consensus       505 -hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKL  578 (752)
T KOG0670|consen  505 -HKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKL  578 (752)
T ss_pred             -hcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeee
Confidence             455899999998 56999999764 34566888999999999999999999999   9999999999999875 56899


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH-----
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW-----  318 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~-----  318 (443)
                      ||||.|........    +-..-+..|.|||++.+..|+...|+||.||+||||.||+..|.+........+..-     
T Consensus       579 CDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  579 CDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             ccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            99999987654332    112334569999999999999999999999999999999999875443221111110     


Q ss_pred             HHHHhhccccccccccCc--------------------------------c--CCCCCHHH---HHHHHHHHHHccCcCC
Q 013404          319 ARPILRDKDRLEELADPR--------------------------------L--GGKYPKED---FIRVCTIAAACVAPEA  361 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~--------------------------------~--~~~~~~~~---~~~l~~li~~cl~~dp  361 (443)
                      -..++..+.-..+.+|..                                +  ...++.+.   ...+.+|+..||..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence            001111111111111110                                0  01133333   3468889999999999


Q ss_pred             CCCCCHHHHHHH
Q 013404          362 NQRPTMGEVVQS  373 (443)
Q Consensus       362 ~~RPs~~evl~~  373 (443)
                      ++|.|..+.++|
T Consensus       735 ~KRit~nqAL~H  746 (752)
T KOG0670|consen  735 EKRITVNQALKH  746 (752)
T ss_pred             hhcCCHHHHhcC
Confidence            999999999876

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.3e-29  Score=221.68  Aligned_cols=255  Identities=20%  Similarity=0.334  Sum_probs=186.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ..+.|.+.+.||+|.||.+.++.++ ..+.+++|-+... .....+|.+|...--.| .|.||+.-+++.. +..+.+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF   99 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVF   99 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEE
Confidence            3467889999999999999999964 5778999988643 23457899998876666 5999998776532 23447789


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe-c-CCCceEEccccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-E-NNFHAKVADFGLAK  250 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-~-~~~~~kl~Dfgla~  250 (443)
                      ++||+|.|+|..-+..     ..+.+....+++.|++.|+.|+|+.+   +||||||.+|||+ + +..++||||||+.+
T Consensus       100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999999988753     34778889999999999999999999   9999999999998 3 34589999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      ..+..-     ....-+..|.+||.....     ...+.+|||.||++++.++||+.||... ......+..|..-  ..
T Consensus       172 k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w--~~  243 (378)
T KOG1345|consen  172 KVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQW--LK  243 (378)
T ss_pred             ccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHH--hc
Confidence            654322     122345579999976532     3356789999999999999999999732 2333344444322  11


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      +...   .-|+.-..+..    .+..+.++-|..++++|--..++.++.
T Consensus       244 rk~~---~~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  244 RKNP---ALPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ccCc---cCchhhcccCH----HHHHHHHHhcCCcccccchhHHHHHHH
Confidence            1111   11222223333    367788889999999996655555543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=2.1e-28  Score=229.29  Aligned_cols=201  Identities=28%  Similarity=0.406  Sum_probs=165.2

Q ss_pred             HHHHhcCCCCCceeeecCcEEEEEEEEC----CCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC
Q 013404           92 LKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD  166 (443)
Q Consensus        92 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  166 (443)
                      +....+.|...++||+|.|++||++.+.    .++.||+|.+....  ......+|+++|..+ .+.||+++.+++.  .
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~r--n  106 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFR--N  106 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhc--c
Confidence            4455678899999999999999999843    46789999987543  345688999999999 5999999999887  4


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEcc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVAD  245 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~D  245 (443)
                      ++..++|+||++...-.+++..       ++..++..+++.+..||+++|.+|   ||||||||+|+|.+. .+.-.|.|
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             CCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence            4588999999999999998863       678899999999999999999999   999999999999975 46778999


Q ss_pred             ccccccCCCC---------------------------------Ccccc---------ccccccCcccccccccccC-CCC
Q 013404          246 FGLAKQAPEG---------------------------------RTNYL---------STRVMGTFGYVAPEYAMTG-HLL  282 (443)
Q Consensus       246 fgla~~~~~~---------------------------------~~~~~---------~~~~~gt~~y~aPE~~~~~-~~~  282 (443)
                      ||+|......                                 .....         .....||++|.|||++... ..+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            9999621000                                 00000         1135799999999998754 568


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCC
Q 013404          283 VKSDVYSYGVVLLELLTGRKPVDM  306 (443)
Q Consensus       283 ~~sDv~S~G~il~elltg~~p~~~  306 (443)
                      +++||||-|||++-+++++.||..
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             Cccceeeccceeehhhcccccccc
Confidence            899999999999999999999954

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=8.8e-29  Score=266.64  Aligned_cols=201  Identities=19%  Similarity=0.260  Sum_probs=141.1

Q ss_pred             hcCC-CceeeEEEeeecC-----CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCc
Q 013404          149 RLHH-RNLVKLVGYYSSR-----DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC  222 (443)
Q Consensus       149 ~l~h-~niv~l~~~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  222 (443)
                      .++| +||++++++|...     +...+++++||+ +++|.++|...   ...+++.+++.++.||++||.|||+++   
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g---  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG---  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            3455 5788888876221     123466778887 56999999743   345899999999999999999999999   


Q ss_pred             eEecCCCcccEEecC-------------------CCceEEccccccccCCCCCc--------------cccccccccCcc
Q 013404          223 VIHRDFKASNILLEN-------------------NFHAKVADFGLAKQAPEGRT--------------NYLSTRVMGTFG  269 (443)
Q Consensus       223 ivH~Dlkp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~  269 (443)
                      |+||||||+||||+.                   ++.+|++|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   45566777777654211000              000112458889


Q ss_pred             cccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHH
Q 013404          270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRV  349 (443)
Q Consensus       270 y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l  349 (443)
                      |||||++.+..++.++|||||||+||||++|..|+....        .....+..      ....+..     .......
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~------~~~~~~~-----~~~~~~~  241 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRH------RVLPPQI-----LLNWPKE  241 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHH------hhcChhh-----hhcCHHH
Confidence            999999999999999999999999999999988864211        00110100      0011110     0112235


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          350 CTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       350 ~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..++.+||+.+|.+||++.||+++-+
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhchh
Confidence            67889999999999999999987643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.1e-27  Score=209.28  Aligned_cols=169  Identities=21%  Similarity=0.180  Sum_probs=127.4

Q ss_pred             CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccc
Q 013404          180 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY  259 (443)
Q Consensus       180 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  259 (443)
                      |+|.++++..   ...+++.+++.++.|++.||.|||+.+         ||+|||++.++.+|+  ||+++......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence            6899999743   345999999999999999999999876         999999999999999  99998654321   


Q ss_pred             cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCC
Q 013404          260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG  339 (443)
Q Consensus       260 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  339 (443)
                          ..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+......    .    ++.. .
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~----~----~~~~-~  129 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPA----D----DPRD-R  129 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhcc----C----Cccc-c
Confidence                258899999999999999999999999999999999999996432211 111111111100    0    0000 0


Q ss_pred             CCCHHHHH--HHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          340 KYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       340 ~~~~~~~~--~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      ..+.....  .+.+++.+||+.+|++||++.|+++++..+..
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            01111122  58899999999999999999999999987753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.4e-27  Score=208.99  Aligned_cols=247  Identities=20%  Similarity=0.316  Sum_probs=190.7

Q ss_pred             CCceeeecCcEEEEEEEECCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          101 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       101 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +..+|.+...|..|+|+++.+. +++|++.....  ....+|..|.-.|+-+.||||++++|.|.  ...++.++..||+
T Consensus       194 l~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn--sppnlv~isq~mp  270 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN--SPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc--CCCCceEeeeecc
Confidence            4567889999999999997544 56677654432  23467999999999999999999999997  4458899999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc--cccccccCCCCC
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA--DFGLAKQAPEGR  256 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--Dfgla~~~~~~~  256 (443)
                      .|+|+..|++..  ....+..++.+++.++++|++|||+.. |-|.---|.+..+++|++.+++|+  |--++...    
T Consensus       271 ~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe----  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE----  343 (448)
T ss_pred             chHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec----
Confidence            999999999754  445778899999999999999999985 335556789999999999998875  32222211    


Q ss_pred             ccccccccccCcccccccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                           ....-.+.||+||.+...+-+   ..+|+|||.+++|||.|...||....+.+..-                .+.
T Consensus       344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------------kia  402 (448)
T KOG0195|consen  344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------------KIA  402 (448)
T ss_pred             -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----------------hhh
Confidence                 112346789999999876543   56899999999999999999997655443221                111


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      -..+...+|+.....+++++.-|++.||.+||.+..|+-.|+.++
T Consensus       403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            123334556666667899999999999999999999999998764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=7.3e-25  Score=211.83  Aligned_cols=263  Identities=22%  Similarity=0.253  Sum_probs=194.1

Q ss_pred             CCCCCceeeecCcEEEEEEEECC--CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC----CceeeEEEeeecCCCCeeE
Q 013404           98 NFEPASILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH----RNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~~  171 (443)
                      +|.+.+.||+|+||.||++....  ...+|+|............+..|+.++..+..    +++..+++... ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence            79999999999999999999654  35789998876543333377889999999873    58888887763 2444678


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-----CceEEccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-----FHAKVADF  246 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Df  246 (443)
                      +||+.+ |.+|.++.....  ...++..+++.++.|++.+|+++|+.|   ++||||||.|+++...     ..+.|.||
T Consensus        98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence            999988 889999886443  467999999999999999999999999   9999999999999754     46999999


Q ss_pred             cccc--cCCCCCcc----cc--ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 013404          247 GLAK--QAPEGRTN----YL--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       247 gla~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~  318 (443)
                      |+++  ........    ..  .....||..|+++....+...+.+.|+||++.++.|++.|..||............. 
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~-  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE-  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH-
Confidence            9998  32222111    11  123569999999999999999999999999999999999999996444322211111 


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                        .....     .....  .....+.+   +.++...+-..+..++|....+.+.|+.....
T Consensus       251 --~~~~~-----~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  251 --KDPRK-----LLTDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             --HHhhh-----hcccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence              00000     00000  11223333   44555555568899999999999988776543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=7.3e-26  Score=218.72  Aligned_cols=167  Identities=20%  Similarity=0.171  Sum_probs=129.9

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEEC--CCcEEEEEEeccCC-----CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGG-----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD  166 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  166 (443)
                      ...++|.+.+.||+|+||.||+|...  +++.||||++....     ......|.+|+++|++++|+|+++.+..+    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            45678999999999999999999854  57788999875331     11245689999999999999999533221    


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCC-CcccEEecCCCceEEcc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF-KASNILLENNFHAKVAD  245 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~D  245 (443)
                       ...++||||++|++|... ..       ..   ...++.|++++|.|||+.+   |+|||| ||+|||++.++.+||+|
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence             246999999999999732 10       01   1467889999999999999   999999 99999999999999999


Q ss_pred             ccccccCCCCCcccc------ccccccCcccccccccccC
Q 013404          246 FGLAKQAPEGRTNYL------STRVMGTFGYVAPEYAMTG  279 (443)
Q Consensus       246 fgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  279 (443)
                      ||+++..........      -+...++..|+|||++...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999997655432221      1346788899999988643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=6.7e-23  Score=196.87  Aligned_cols=261  Identities=30%  Similarity=0.408  Sum_probs=196.4

Q ss_pred             CCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCC-ceeeEEEeeecCCCCeeEEEE
Q 013404           99 FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHR-NLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~~lv~  174 (443)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+++.  .....++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEEE
Confidence            667789999999999999976  78999998765443   356799999999999988 7999999985  333578999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-ceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  253 (443)
                      +|+.+++|.+++...... ..+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.++...
T Consensus        78 ~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             ecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            999999999777643211 35888999999999999999999999   99999999999999988 79999999998554


Q ss_pred             CCCccc----cccccccCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-CcchHHHHHHHHhhc
Q 013404          254 EGRTNY----LSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS-GQENLVTWARPILRD  325 (443)
Q Consensus       254 ~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~G~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~  325 (443)
                      ......    ......|+..|+|||.+.+   ..+....|+||+|++++++++|..||...... .........   ...
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~---~~~  230 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII---LEL  230 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH---Hhc
Confidence            433221    2355689999999999987   57889999999999999999999997543321 011111111   111


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...   .................+.+++..|+..+|..|.+..+....
T Consensus       231 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 PTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111   000001011111122357789999999999999999988765

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=7.6e-24  Score=184.82  Aligned_cols=266  Identities=21%  Similarity=0.317  Sum_probs=197.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC-CceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ...|.+.++||.|+||.+|+|. ..+|..||+|.-+....  ..++..|.++++.|++ ..|..+..|..  +...-.+|
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~--e~~ynvlV   89 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGT--EKDYNVLV   89 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhcc--ccccceee
Confidence            4679999999999999999999 77899999999764432  3467789999999975 45555655554  44567899


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC---CceEEccccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFGLAK  250 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~  250 (443)
                      |+.+ |.+|.+++.-.   ...++..+++.++-|++.-++|+|..+   ++||||||+|+|..-+   ..+.++|||+++
T Consensus        90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence            9998 88999988632   345888999999999999999999999   9999999999998643   468899999999


Q ss_pred             cCCCCCccc-----cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          251 QAPEGRTNY-----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       251 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      ...+..+..     ......||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||.........+-.+   .+.+.
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE---kI~Ek  239 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE---KISEK  239 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH---HHHHh
Confidence            775543321     1235789999999888888888999999999999999999999997654433222111   11111


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      +  +...+ ..+...+|.+    +.-.+.-|=..-=++-|...-+.+.+..+.+.+.
T Consensus       240 K--~s~~i-e~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  240 K--MSTPI-EVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             h--cCCCH-HHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence            0  00000 1122334443    5666777777777788998888887777665544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=6.5e-23  Score=186.74  Aligned_cols=264  Identities=20%  Similarity=0.284  Sum_probs=193.3

Q ss_pred             cCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      -+|.+.++||+|+||..+.|+ +-+++.||||.-...+  ...++..|.+.++.| ..++|..++-|  .+++.+-.||+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~NiLVi  103 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF--GQEGKYNILVI  103 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee--ccccchhhhhh
Confidence            479999999999999999999 6689999999875332  345677788888888 46888777533  44666778999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-----CCceEEcccccc
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLA  249 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla  249 (443)
                      |.+ |.+|+|+..-.   ...++.+++..+|.|++.-++|+|++.   +|.|||||+|+||..     ...+.|+|||+|
T Consensus       104 dLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence            998 88999988633   456999999999999999999999999   999999999999953     346899999999


Q ss_pred             ccCCCCCccc-----cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          250 KQAPEGRTNY-----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       250 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      +...+..+..     ......||.+||+-....+...+.+.|+-|||-++++.+-|..||..........-   .. .+.
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k---Ye-KIG  252 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK---YE-KIG  252 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH---HH-Hhc
Confidence            9876554321     23457899999999999999999999999999999999999999975443222111   11 112


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      +.++...+-  .+...+| +++...+..++   ..+=.+-|..+-+...+..+...+
T Consensus       253 e~Kr~T~i~--~Lc~g~P-~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  253 ETKRSTPIE--VLCEGFP-EEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             cccccCCHH--HHHhcCH-HHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHHhc
Confidence            222111110  1111223 33333344443   445567899888877776665443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.3e-24  Score=223.29  Aligned_cols=258  Identities=22%  Similarity=0.258  Sum_probs=183.7

Q ss_pred             CCCceeeecCcEEEEEEEE-CCCcEEEEEEecc---CCCCCH---HHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404          100 EPASILGEGGFGRVFKGVL-SDGTAVAIKRLTC---GGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~---~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ...+.+|.|++|.|+.... ......+.|....   ......   ..+..|..+-..+.|||++..+..+....  ...-
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~--~~~~  398 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID--GILQ  398 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc--cchh
Confidence            3467899999998877763 3334444443321   111111   12555777777889999988777665333  3344


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      .||||++ +|..++...    ..++..++..++.|+..|++|+|+.|   |.|||||++|++++.++.+||+|||.+...
T Consensus       399 ~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf  470 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVF  470 (601)
T ss_pred             hhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceee
Confidence            4999999 999998642    35888999999999999999999999   999999999999999999999999998766


Q ss_pred             CCCCcc--ccccccccCcccccccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          253 PEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVK-SDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       253 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ......  ......+|+-.|+|||.+.+..|.++ .||||.|+++..|++|+.||............      .......
T Consensus       471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~~~~~  544 (601)
T KOG0590|consen  471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNYSDQR  544 (601)
T ss_pred             ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hcccccc
Confidence            544333  44567889999999999999999765 79999999999999999999755443322100      0000000


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ....-+   ...-.........++.++|+.||.+|.|+++|++.-|.
T Consensus       545 ~~~~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~  588 (601)
T KOG0590|consen  545 NIFEGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI  588 (601)
T ss_pred             ccccCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence            000000   00111223346779999999999999999999986553

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=3.3e-24  Score=220.84  Aligned_cols=247  Identities=21%  Similarity=0.250  Sum_probs=179.0

Q ss_pred             CCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCC-CCCHHHHHHHHHH--HhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG-QQGDKEFLVEVEM--LSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +|...+.||++.|=+|.+++.++|. |+||++-+.. .-....|.++++-  ...++|||++++.-+-.  ...-.|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~--t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV--TDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH--hhHHHHHHH
Confidence            6777899999999999999998887 8999886554 3334455554443  44458999999876533  223457778


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC-
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP-  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~-  253 (443)
                      +|+.+ +|+|.|..    +..+...+...|+.|++.||..+|..+   |+|||||.+||||+.-..+.|+||.--+... 
T Consensus       101 qyvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL  172 (1431)
T ss_pred             HHHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence            88865 99999863    445788889999999999999999999   9999999999999999999999998765432 


Q ss_pred             -CCCc---cccccccccCcccccccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHH
Q 013404          254 -EGRT---NYLSTRVMGTFGYVAPEYAMTG----------H-LLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT  317 (443)
Q Consensus       254 -~~~~---~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~  317 (443)
                       .++.   .+....-..-..|+|||.+...          . .+++.||||+||++.||++ |++||+..+      +..
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a  246 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA  246 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence             2111   1112222344579999977431          2 5778999999999999988 788886321      222


Q ss_pred             HHHHH-hhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          318 WARPI-LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       318 ~~~~~-~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +...- ......++.+-|.            .+..++..|++.||++|-++++.++.
T Consensus       247 Yr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  247 YRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence            21110 0001112223222            36789999999999999999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=2.8e-23  Score=187.00  Aligned_cols=173  Identities=12%  Similarity=0.159  Sum_probs=134.9

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHH---------HHHHHHHHhhcCCCceeeEEEeeecC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE---------FLVEVEMLSRLHHRNLVKLVGYYSSR  165 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~  165 (443)
                      ..++|+..++||.|+||.||+... ++..+|+|.+..........         +.+|++.+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            478999999999999999999766 56789999997543333222         67899999999999999998886533


Q ss_pred             C------CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          166 D------SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       166 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                      +      ....+|+|||++|.+|.++..        ++.    ....+++.+|..+|+.+   ++|||++|+||++++++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            2      235789999999999988742        222    34569999999999999   99999999999999988


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL  298 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ell  298 (443)
                       ++|+|||...........              ..+.....+..++|+|+||+++.-+.
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999988765322111              11334455667999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.7e-22  Score=178.34  Aligned_cols=140  Identities=15%  Similarity=0.154  Sum_probs=108.1

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCC--C-------HHH-----------------HHHHHHHHhhcCCCce
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--G-------DKE-----------------FLVEVEMLSRLHHRNL  155 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni  155 (443)
                      .+.||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999878999999999754211  1       012                 2349999999987776


Q ss_pred             eeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHh-hhcCCCceEecCCCcccEE
Q 013404          156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL-HEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       156 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp~NIl  234 (443)
                      .....+..  .  ..+|||||+++++|...+..    ...+++.++..++.|++.+|.|| |+.+   |+||||||+|||
T Consensus        82 ~~p~~~~~--~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl  150 (190)
T cd05147          82 PCPEPILL--K--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL  150 (190)
T ss_pred             CCCcEEEe--c--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence            43322221  1  23899999998877654321    23588899999999999999999 6888   999999999999


Q ss_pred             ecCCCceEEccccccccCC
Q 013404          235 LENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~  253 (443)
                      +++ +.++|+|||++....
T Consensus       151 i~~-~~v~LiDFG~a~~~~  168 (190)
T cd05147         151 YHD-GKLYIIDVSQSVEHD  168 (190)
T ss_pred             EEC-CcEEEEEccccccCC
Confidence            984 689999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=3.1e-21  Score=172.07  Aligned_cols=140  Identities=16%  Similarity=0.166  Sum_probs=110.8

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCC---------------------C-----HHHHHHHHHHHhhcCCCce
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ---------------------G-----DKEFLVEVEMLSRLHHRNL  155 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni  155 (443)
                      .+.||+|+||.||+|...+|+.||||+++.....                     .     ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999999778999999998764211                     0     1123578999999999987


Q ss_pred             eeEEEeeecCCCCeeEEEEeecCCCChhHh-hcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccE
Q 013404          156 VKLVGYYSSRDSSQHLLCYELVPNGSLESW-LHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNI  233 (443)
Q Consensus       156 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NI  233 (443)
                      .....+..  .  ..+|||||++++++... +.     ...++..+...++.|++.++.++|+ .+   |+||||||+||
T Consensus        82 ~~p~~~~~--~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NI  149 (190)
T cd05145          82 PVPEPILL--K--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNI  149 (190)
T ss_pred             CCceEEEe--c--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhE
Confidence            54433332  1  24899999998865433 33     2346788999999999999999999 88   99999999999


Q ss_pred             EecCCCceEEccccccccCCC
Q 013404          234 LLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~  254 (443)
                      +++ ++.++|+|||++.....
T Consensus       150 ll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         150 LYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEE-CCCEEEEEcccceecCC
Confidence            999 78999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=6.1e-21  Score=168.31  Aligned_cols=187  Identities=18%  Similarity=0.090  Sum_probs=140.7

Q ss_pred             CCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC----HHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEE
Q 013404          100 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .+...|++|+||+||++.. .+.+++.+.+.....-.    ...|.+|+++|++|. |+++.+++++    +  ..+++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~--~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D--GRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c--CEEEEE
Confidence            4568899999999997665 67888888776543311    124789999999995 5889999886    2  468999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCC-CcccEEecCCCceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF-KASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||+.|.+|...+..           ....++.|++.+|.++|+++   |+|||| ||.|||++.++.++|+|||++....
T Consensus        78 eyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         78 SYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             eeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            99999999764321           11357789999999999999   999999 7999999999999999999998654


Q ss_pred             CCCcc-----------ccccccccCcccccccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          254 EGRTN-----------YLSTRVMGTFGYVAPEYAMTG-HLL-VKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       254 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      .....           ........++.|++|+...-. ..+ .+.+-++-|+-+|.++|++.+.-.+
T Consensus       144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            33210           001223467788888855432 233 5678889999999999999886433

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=2.3e-21  Score=190.81  Aligned_cols=218  Identities=24%  Similarity=0.387  Sum_probs=160.8

Q ss_pred             HhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEec
Q 013404          147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHR  226 (443)
Q Consensus       147 l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  226 (443)
                      |+.+.|.|+.+++|.+..  +...+.|.+||..|+|.|.+..   ....++|.....+..+++.||+|||+-.  -..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg   73 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHG   73 (484)
T ss_pred             CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeee
Confidence            456899999999999984  4688999999999999999975   2456899999999999999999999754  23999


Q ss_pred             CCCcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccC-------CCCchhhHHHHHHHHHHHHh
Q 013404          227 DFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVLLELLT  299 (443)
Q Consensus       227 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~S~G~il~ellt  299 (443)
                      .+++.|+++|....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            99999999999999999999998776431111112223345679999998763       14667999999999999999


Q ss_pred             CCCCCCCCCCCCc-chHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          300 GRKPVDMSQPSGQ-ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       300 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      .+.||+....... ..++.++..      .-.....|.+...  .+....+..++..||..+|++||++++|-..++.+.
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             ccCccccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9999976433322 222222221      0111111221100  022235888999999999999999999988776664


Q ss_pred             h
Q 013404          379 R  379 (443)
Q Consensus       379 ~  379 (443)
                      .
T Consensus       226 ~  226 (484)
T KOG1023|consen  226 K  226 (484)
T ss_pred             c
Confidence            4

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=4.8e-21  Score=177.72  Aligned_cols=236  Identities=18%  Similarity=0.265  Sum_probs=150.5

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCC----------CceeeEEEee-
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHH----------RNLVKLVGYY-  162 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~l~~~~-  162 (443)
                      ++...+.||.|+|+.||.++.. +|+.+|||.......   ...+++.+|.-....+.+          -.++.-++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455788999999999999965 589999998865442   223556666644444322          1111111111 


Q ss_pred             --------ecC-CCC-----eeEEEEeecCCCChhHhhc---CCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEe
Q 013404          163 --------SSR-DSS-----QHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH  225 (443)
Q Consensus       163 --------~~~-~~~-----~~~lv~e~~~~gsL~~~l~---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  225 (443)
                              ... +..     +.+++|+-+ .+||.+++.   ........+....++.+..|+++.+++||+.+   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                    100 011     336778777 559988764   11111234555667888899999999999999   999


Q ss_pred             cCCCcccEEecCCCceEEccccccccCCCCCccccccccccCccccccccccc--------CCCCchhhHHHHHHHHHHH
Q 013404          226 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLEL  297 (443)
Q Consensus       226 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~S~G~il~el  297 (443)
                      +||+|+|++++.+|.++|+||+.....+....    . ...+..|.+||....        -.++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999998876543211    1 345578999997643        2478899999999999999


Q ss_pred             HhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCC
Q 013404          298 LTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR  364 (443)
Q Consensus       298 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  364 (443)
                      +||+.||+...+......                     .-..|. +..+.+..||..+|+.||++|
T Consensus       244 WC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999986543322211                     112344 555668899999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3.5e-20  Score=166.42  Aligned_cols=138  Identities=19%  Similarity=0.253  Sum_probs=106.4

Q ss_pred             CCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-----CCCceeeEEEeeecCCC-CeeE-E
Q 013404          100 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-----HHRNLVKLVGYYSSRDS-SQHL-L  172 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~-~~~~-l  172 (443)
                      .-.+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+     .||||++++|++....+ +..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996 3233444 79988765444567899999999999     57999999999986542 2323 7


Q ss_pred             EEee--cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHH-HHhhhcCCCceEecCCCcccEEecC----CCceEEcc
Q 013404          173 CYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL-AYLHEDSQPCVIHRDFKASNILLEN----NFHAKVAD  245 (443)
Q Consensus       173 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D  245 (443)
                      |+||  +++|+|.+++.+.     .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +..++|+|
T Consensus        83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            8999  6679999999642     24444  35677888777 9999999   999999999999974    34799999


Q ss_pred             cccc
Q 013404          246 FGLA  249 (443)
Q Consensus       246 fgla  249 (443)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=4.8e-20  Score=193.62  Aligned_cols=200  Identities=22%  Similarity=0.243  Sum_probs=157.8

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC---CCceeeEEEeeecCCC
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDS  167 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  167 (443)
                      ++......|.+.+.||+|+||.||+|...+|+.||+|.-+...   ..+|.--.+++.+|+   -+.|..+...+...+ 
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~-  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQN-  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCC-
Confidence            4455567888899999999999999998789999999987433   234444455666665   223333333333223 


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-------CCc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-------NFH  240 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~  240 (443)
                       ..+||+||.+.|+|.++++.    .+.++|..++.++.|++.-+++||..+   |||+||||+|+||..       ...
T Consensus       768 -~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  768 -ASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             -cceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence             46899999999999999973    556899999999999999999999999   999999999999942       456


Q ss_pred             eEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 013404          241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK  302 (443)
Q Consensus       241 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~  302 (443)
                      ++|+|||.+..+.--.........++|-.+-.+|...+..++...|.|.|..+++-|+.|+.
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999999875432222223455678999999999999999999999999999999999975

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.2e-20  Score=185.83  Aligned_cols=225  Identities=28%  Similarity=0.347  Sum_probs=175.6

Q ss_pred             eeeecCcEEEEEEE----ECCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEEee
Q 013404          104 ILGEGGFGRVFKGV----LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus       104 ~lg~G~fg~V~~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .+|+|.||.|+++.    .+.|..+|+|.+++.....  ......|..++...+ ||.+|++.-.+.  .....+++++|
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq--t~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ--TDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec--cccchhHhhhh
Confidence            37999999999876    2357789999887553221  224556788888886 999999976665  44478899999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      ..+|+|...+..    ...+++.........++-+++++|+.+   |+|||+|++||+++.+|.+++.|||+++..-...
T Consensus        79 ~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   79 LRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            999999988864    334667777778888999999999999   9999999999999999999999999998764432


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCc
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR  336 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  336 (443)
                      .      .+||..|||||++.  ......|-||||++++||+||..||..          +....++..+          
T Consensus       152 ~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~~----------  203 (612)
T KOG0603|consen  152 I------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKAE----------  203 (612)
T ss_pred             h------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhhc----------
Confidence            2      28999999999988  567789999999999999999999963          1122222211          


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 013404          337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTM  367 (443)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  367 (443)
                        -..|.+......+++..++..+|..|--.
T Consensus       204 --~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 --LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             --cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence              13455555567788888999999999654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.5e-20  Score=180.35  Aligned_cols=240  Identities=23%  Similarity=0.311  Sum_probs=157.5

Q ss_pred             CCCceeeecCcEEEEEEEECC----CcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEE------EeeecCC--
Q 013404          100 EPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLV------GYYSSRD--  166 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~------~~~~~~~--  166 (443)
                      .+.+..++.+++.+...+...    ...++.+..+.+.........+++-.+... .|++.+..-      ..+....  
T Consensus       247 ~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~  326 (516)
T KOG1033|consen  247 SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVG  326 (516)
T ss_pred             cccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccc
Confidence            344556666666666655322    234444544433311222223333333333 444433221      0111111  


Q ss_pred             -CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcc
Q 013404          167 -SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD  245 (443)
Q Consensus       167 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  245 (443)
                       ...+++.|++|...+|.+||.+... ....++.....++.|++.|++|   ++   .+|+|+||.||+...+..+||.|
T Consensus       327 ~~~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD  399 (516)
T KOG1033|consen  327 KKVYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD  399 (516)
T ss_pred             cccchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence             2247899999999999999975433 3446788899999999999999   66   89999999999999999999999


Q ss_pred             ccccccCCCCC----ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHH
Q 013404          246 FGLAKQAPEGR----TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       246 fgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~  320 (443)
                      ||+........    .....+...||..||+||.+.+..|+.|+||||||++|+|++. -..+++-              
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------------  465 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------------  465 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------------
Confidence            99987665443    1223456789999999999999999999999999999999997 2222210              


Q ss_pred             HHhhcccccccccc----CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 013404          321 PILRDKDRLEELAD----PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV  370 (443)
Q Consensus       321 ~~~~~~~~~~~~~d----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev  370 (443)
                           ...+.++.|    |.....+|.+     ..++.+++.+.|.+||++.++
T Consensus       466 -----~~t~~d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  466 -----IATLTDIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             -----HHhhhhhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence                 011111222    2222233433     578999999999999954443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=6.1e-19  Score=164.45  Aligned_cols=200  Identities=22%  Similarity=0.292  Sum_probs=140.1

Q ss_pred             CCCceeeEEEeeecC-------------------------CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHH
Q 013404          151 HHRNLVKLVGYYSSR-------------------------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA  205 (443)
Q Consensus       151 ~h~niv~l~~~~~~~-------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  205 (443)
                      +|||||++.++|.+.                         ++..+|+||.-++. +|..++..     ...+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence            599999999876431                         23467899988755 99999863     346667788899


Q ss_pred             HHHHHHHHHhhhcCCCceEecCCCcccEEe--cCCC--ceEEccccccccCCCC--Ccccc--ccccccCcccccccccc
Q 013404          206 LDAARGLAYLHEDSQPCVIHRDFKASNILL--ENNF--HAKVADFGLAKQAPEG--RTNYL--STRVMGTFGYVAPEYAM  277 (443)
Q Consensus       206 ~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~Dfgla~~~~~~--~~~~~--~~~~~gt~~y~aPE~~~  277 (443)
                      .|+++|+.|||.++   |.|||+|++|||+  |+|+  .+.|+|||++-.....  +..+.  .-...|...-||||+..
T Consensus       348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            99999999999999   9999999999998  4443  5789999987533221  11111  11245777899999885


Q ss_pred             cCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHH
Q 013404          278 TGH------LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCT  351 (443)
Q Consensus       278 ~~~------~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~  351 (443)
                      ..+      ...|+|.|+.|.+.||+++...||...... ......           ..+-.-|.+...+|.    .+.+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----------Yqe~qLPalp~~vpp----~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----------YQESQLPALPSRVPP----VARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----------hhhhhCCCCcccCCh----HHHH
Confidence            432      246899999999999999999999752211 111111           111112333333444    4788


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHHH
Q 013404          352 IAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       352 li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ++...|+.||++|++..-....|+
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999998766555443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=1.4e-18  Score=156.17  Aligned_cols=146  Identities=17%  Similarity=0.176  Sum_probs=114.5

Q ss_pred             HHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC----------------------CHHHHHHHHHHH
Q 013404           90 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ----------------------GDKEFLVEVEML  147 (443)
Q Consensus        90 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l  147 (443)
                      .++......|.+.+.||+|+||.||++...+|+.||||++......                      ....+..|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            3455555568889999999999999999888999999987643210                      012356788999


Q ss_pred             hhcCCCc--eeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEe
Q 013404          148 SRLHHRN--LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH  225 (443)
Q Consensus       148 ~~l~h~n--iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  225 (443)
                      .++.|++  +...++.      ...+++|||+++++|.+....          .....++.+++.++.++|+.+   ++|
T Consensus        88 ~~l~~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H  148 (198)
T cd05144          88 KALYEEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIH  148 (198)
T ss_pred             HHHHHcCCCCCceeec------CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCc
Confidence            9998774  4444432      245899999999999765421          345678899999999999988   999


Q ss_pred             cCCCcccEEecCCCceEEccccccccCCC
Q 013404          226 RDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       226 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      +||||+||++++++.++|+|||++.....
T Consensus       149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         149 GDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>smart00090 RIO RIO-like kinase

Probab=99.78  E-value=1.4e-18  Score=159.74  Aligned_cols=145  Identities=16%  Similarity=0.170  Sum_probs=112.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEE--ECCCcEEEEEEeccCCCC------------------------CHHHHHHHHHHHhh
Q 013404           96 TNNFEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQ------------------------GDKEFLVEVEMLSR  149 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  149 (443)
                      ...|.+.+.||+|+||.||+|.  ..+|+.||+|.++.....                        ....+..|++.+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458889999999999999998  568999999998754210                        01235689999999


Q ss_pred             cCCC--ceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecC
Q 013404          150 LHHR--NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRD  227 (443)
Q Consensus       150 l~h~--niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  227 (443)
                      +.+.  .+.+++++    .  ..++||||+++++|..+...    ...+...+...++.|++.++.+||+.+.  ++|||
T Consensus       107 L~~~~i~~p~~~~~----~--~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~D  174 (237)
T smart00090      107 LYEAGVPVPKPIAW----R--RNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGD  174 (237)
T ss_pred             HHhcCCCCCeeeEe----c--CceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCC
Confidence            9753  34444443    1  34799999999888766422    2235566778999999999999998763  99999


Q ss_pred             CCcccEEecCCCceEEccccccccCC
Q 013404          228 FKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       228 lkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+||+++ ++.++|+|||.+....
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999 7899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.8e-18  Score=156.96  Aligned_cols=134  Identities=19%  Similarity=0.316  Sum_probs=110.2

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC--------HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      +.||+|++|.||+|.. +|..+++|.........        ...+.+|++++..+.|+++.....++..  ....+++|
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEE
Confidence            5799999999999987 56789999865432211        1357789999999999988766666543  33678999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ||++|++|.+++...       .+ .+..++.+++.+|.++|+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999998632       12 78899999999999999999   99999999999999 78899999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=4.3e-18  Score=153.07  Aligned_cols=131  Identities=20%  Similarity=0.289  Sum_probs=103.3

Q ss_pred             eeeecCcEEEEEEEECCCcEEEEEEeccCCCCC--------HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404          104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus       104 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .||+|+||.||+|.+ +|..|++|.........        ...+.+|++++..++|+++.....++..  ....+++||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEEE
Confidence            489999999999986 56789999865432111        2457789999999988875443333332  235689999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |++|++|.+++....           ..++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++...
T Consensus        78 ~~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999999875311           078999999999999999   99999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=5.8e-18  Score=174.62  Aligned_cols=138  Identities=20%  Similarity=0.294  Sum_probs=109.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEE-eccCCC-------CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKR-LTCGGQ-------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      ...|...+.||+|+||.||+|.+.+.. +++|+ +.....       ...+.+.+|+++++.++|++++....++..  .
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~  408 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--P  408 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--C
Confidence            445567899999999999999875544 44443 221111       112468899999999999999887766653  3


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++||||+++++|.+++.            ....++.+++++|.|||+.+   ++||||||+|||+ +++.++|+|||
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence            35689999999999999874            35678999999999999999   9999999999999 57799999999


Q ss_pred             ccccC
Q 013404          248 LAKQA  252 (443)
Q Consensus       248 la~~~  252 (443)
                      +++..
T Consensus       473 la~~~  477 (535)
T PRK09605        473 LGKYS  477 (535)
T ss_pred             ccccC
Confidence            99753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.71  E-value=1.3e-17  Score=172.39  Aligned_cols=209  Identities=23%  Similarity=0.373  Sum_probs=141.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ..+|+..++|..|++|.||+.++. ..+.+|+|+-+ ..     .      +++     ||..+-      +  ..+.| 
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----l------ilR-----nilt~a------~--npfvv-  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----L------ILR-----NILTFA------G--NPFVV-  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----h------hhh-----cccccc------C--Cccee-
Confidence            467889999999999999999865 46678884322 11     0      111     122221      1  11222 


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                           |+-...+...    .++..        +++.+++|||+.+   |+|||+||+|.+|+.-|.+|+.|||+++....
T Consensus       136 -----gDc~tllk~~----g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 -----GDCATLLKNI----GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             -----chhhhhcccC----CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                 4444444421    12221        2277899999999   99999999999999999999999999875422


Q ss_pred             CCc-------------cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 013404          255 GRT-------------NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       255 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      ...             ......++||+.|+|||++..+.|...+|-|++|+|+||.+-|..||..+.+++.      +..
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~  269 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQ  269 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhh
Confidence            111             1112346899999999999999999999999999999999999999987655432      222


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP  365 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  365 (443)
                      ++.+....     +.-....+.+    ..+++...|+.+|..|-
T Consensus       270 visd~i~w-----pE~dea~p~E----a~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  270 VISDDIEW-----PEEDEALPPE----AQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             hhhhhccc-----cccCcCCCHH----HHHHHHHHHHhChHhhc
Confidence            22221111     1111223333    67888999999999994

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=3.6e-16  Score=133.28  Aligned_cols=135  Identities=22%  Similarity=0.194  Sum_probs=112.4

Q ss_pred             CCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC--CceeeEEEeeecCCCCeeEEEEeecC
Q 013404          101 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       101 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+..++.++|  .++.++++++..  ....+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecC
Confidence            45789999999999999854 7899999865433  5678999999999976  588898887653  357899999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++.+..+           +......++.+++++|+++|.....+++|+|++|+||++++++.++++|||.++.
T Consensus        77 g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8777643           4466778899999999999986545599999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.8e-16  Score=140.95  Aligned_cols=137  Identities=21%  Similarity=0.241  Sum_probs=98.9

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC--HHH----------------------HHHHHHHHhhcCCCc--e
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKE----------------------FLVEVEMLSRLHHRN--L  155 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i  155 (443)
                      .+.||+|+||.||+|...+|+.||||++.......  ...                      ...|.+.+.++.+.+  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            56899999999999998789999999987532211  111                      134666666664432  4


Q ss_pred             eeEEEeeecCCCCeeEEEEeecCCCChhHh-hcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccE
Q 013404          156 VKLVGYYSSRDSSQHLLCYELVPNGSLESW-LHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNI  233 (443)
Q Consensus       156 v~l~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NI  233 (443)
                      .+.+++.      ..+++|||++++.+... +...     ... .++..++.+++.++.++|. .+   |+|+||||+||
T Consensus        82 ~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni  146 (187)
T cd05119          82 PKPIDLN------RHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI  146 (187)
T ss_pred             CceEecC------CCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence            4444331      35899999999554321 1110     011 6678899999999999999 87   99999999999


Q ss_pred             EecCCCceEEccccccccCCC
Q 013404          234 LLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~  254 (443)
                      +++ ++.++|+|||.+.....
T Consensus       147 li~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEE-CCcEEEEECcccccccC
Confidence            999 88999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=5.2e-16  Score=143.06  Aligned_cols=138  Identities=21%  Similarity=0.256  Sum_probs=105.5

Q ss_pred             Cceee-ecCcEEEEEEEECCCcEEEEEEeccCC-------------CCCHHHHHHHHHHHhhcCCCce--eeEEEeeecC
Q 013404          102 ASILG-EGGFGRVFKGVLSDGTAVAIKRLTCGG-------------QQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSR  165 (443)
Q Consensus       102 ~~~lg-~G~fg~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  165 (443)
                      ...|| .||.|+||++... +..++||++....             ......+.+|++++.+|.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35688 8999999998875 6789999875321             0123467889999999998875  6677664432


Q ss_pred             CCC--eeEEEEeecCC-CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceE
Q 013404          166 DSS--QHLLCYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK  242 (443)
Q Consensus       166 ~~~--~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  242 (443)
                      ...  ..++||||+++ .+|.+++...     .++..    .+.+++.+|.+||+.+   |+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence            221  23599999997 6999988632     24433    3678999999999999   99999999999999988999


Q ss_pred             EccccccccC
Q 013404          243 VADFGLAKQA  252 (443)
Q Consensus       243 l~Dfgla~~~  252 (443)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999988754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.9e-17  Score=170.63  Aligned_cols=256  Identities=24%  Similarity=0.294  Sum_probs=187.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC--CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~  171 (443)
                      ..|.+.+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-..+. |+|++.+++...  +....+
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~--~~~~~~   97 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS--SPRSYL   97 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC--CCcccc
Confidence            45677788999999999887753  34466777665443  112233444777777776 999999999866  445778


Q ss_pred             EEEeecCCCChhHhh-cCCCCCCCCCChHHHHHHHHHHHHHHHHhh-hcCCCceEecCCCcccEEecCCC-ceEEccccc
Q 013404          172 LCYELVPNGSLESWL-HGPLGVNCHLDWETRMKIALDAARGLAYLH-EDSQPCVIHRDFKASNILLENNF-HAKVADFGL  248 (443)
Q Consensus       172 lv~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgl  248 (443)
                      +..+|..++++.+.+ +..   ....+....-..+.|+..++.|+| ..+   +.|+||||+|.+++..+ .++++|||+
T Consensus        98 ~~~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             cccCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchh
Confidence            999999999999988 422   113566777889999999999999 888   99999999999999999 999999999


Q ss_pred             cccCCC-CCcccccccccc-CcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          249 AKQAPE-GRTNYLSTRVMG-TFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       249 a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      |..... ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....... .+..|....   
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---  247 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---  247 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---
Confidence            987766 444444455678 9999999999885 446778999999999999999999975443321 122222110   


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                       ...        .............+++.+++..+|+.|.+.+++...
T Consensus       248 -~~~--------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 -GRF--------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             -ccc--------ccCccccCChhhhhcccccccCCchhcccccccccc
Confidence             000        000111112235678899999999999999998654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.60  E-value=6.8e-16  Score=141.11  Aligned_cols=209  Identities=22%  Similarity=0.288  Sum_probs=144.8

Q ss_pred             HHHhhcCCCceeeEEEeeecC---CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCC
Q 013404          145 EMLSRLHHRNLVKLVGYYSSR---DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP  221 (443)
Q Consensus       145 ~~l~~l~h~niv~l~~~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  221 (443)
                      ..|-++.|.|||++..|+.+.   +.....++.|||..|+|..+|++.+.....+....-.+|+.||..||.|||+.. |
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            345566799999999987642   345678999999999999999876666667888888999999999999999985 5


Q ss_pred             ceEecCCCcccEEecCCCceEEccccccccCCC--CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh
Q 013404          222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT  299 (443)
Q Consensus       222 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt  299 (443)
                      +|+|+++..+.|++..++-+|+.----......  ...........+-++|.+||+=.....+.++|||+||...+||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            599999999999999999888842111100000  000011122356789999998777788889999999999999988


Q ss_pred             CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          300 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       300 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      +..--...... ...-+.....+       ..+-++.            -..++..|++..|+.||+|++++.|.
T Consensus       278 lEiq~tnseS~-~~~ee~ia~~i-------~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  278 LEIQSTNSESK-VEVEENIANVI-------IGLENGL------------QRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             heeccCCCcce-eehhhhhhhhe-------eeccCcc------------ccCcCcccccCCCCCCcchhhhhcCc
Confidence            76532111100 00000000000       0000100            13588899999999999999998653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=2.3e-14  Score=143.41  Aligned_cols=143  Identities=24%  Similarity=0.272  Sum_probs=101.8

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC--------------------------H--------------HHHH
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------------------------D--------------KEFL  141 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~--------------~~~~  141 (443)
                      .+.||.|++|.||+|++.+|+.||||+.+......                          .              -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986432100                          0              0255


Q ss_pred             HHHHHHhhc----CCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHH-HHHHhh
Q 013404          142 VEVEMLSRL----HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR-GLAYLH  216 (443)
Q Consensus       142 ~E~~~l~~l----~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH  216 (443)
                      +|++.+.++    +|.+-+.+-.++... ....+|||||++|++|.++......   ..   ....++..++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHH
Confidence            566666655    233334443444321 2356899999999999987642111   11   23456666665 467889


Q ss_pred             hcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       217 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ..+   ++|+|++|.||++++++.++++|||++.....
T Consensus       275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            888   99999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=9.2e-14  Score=137.47  Aligned_cols=249  Identities=24%  Similarity=0.322  Sum_probs=175.5

Q ss_pred             cCCCCCceeee--cCcEEEEEEEE---CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCC
Q 013404           97 NNFEPASILGE--GGFGRVFKGVL---SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        97 ~~~~~~~~lg~--G~fg~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  168 (443)
                      ..|.+...+|.  |.+|.||.+..   .++..+|+|+-+....  .....=.+|+....++ .|+|.++....+.  +.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e--~~~  191 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE--GSG  191 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc--cCC
Confidence            45667788999  99999999986   3578899998543322  3333344566666666 4999999666655  555


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHH----HHHHhhhcCCCceEecCCCcccEEecCC-CceEE
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR----GLAYLHEDSQPCVIHRDFKASNILLENN-FHAKV  243 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl  243 (443)
                      ..++-+|++ +.+|..+.+...   ..++....+..+.+...    ||.++|+.+   ++|-|+||.||++..+ ..+++
T Consensus       192 ~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  192 ILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence            778888888 579999887543   23666778888888888    999999998   9999999999999999 89999


Q ss_pred             ccccccccCCCCCccc---cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 013404          244 ADFGLAKQAPEGRTNY---LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~  320 (443)
                      +|||+...+....-..   ......|...|++||... +-++..+|+|++|.++.+..++..+....-.      ..|..
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~  337 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ  337 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc
Confidence            9999998876654211   112236788999999655 4568899999999999999988765532210      01110


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ  372 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  372 (443)
                        ++...    +.+     ++...-...+...+..++..+|-.|++.+.+.+
T Consensus       338 --~r~~~----ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 --LRQGY----IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --ccccc----Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence              00000    000     111111123445888899999999999888765

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.41  E-value=8.4e-13  Score=115.29  Aligned_cols=131  Identities=17%  Similarity=0.086  Sum_probs=97.2

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCcee-eEEEeeecCCCCeeEEEEeecCCC
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      .+.|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.+++ +++.+..  +  ..++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~--~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--E--TGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--C--CCeEEEEecCCC
Confidence            356889999999999875 67899998764422 223567899999998765555 4444322  2  347999999998


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcC--CCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--QPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++.+.-            .....++.+++++|+.||..+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        77 ~l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            876430            111345678999999999887  23469999999999999 56899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.41  E-value=7.3e-13  Score=134.22  Aligned_cols=148  Identities=16%  Similarity=0.168  Sum_probs=98.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC-CcEEEEEEeccCCCC--------------------------C--------H---
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ--------------------------G--------D---  137 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~--------------------------~--------~---  137 (443)
                      -..|+. +.||+|++|.||+|++.+ |+.||||+.+.....                          .        .   
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999876 999999999743100                          0        0   


Q ss_pred             ---HHHHHHHHHHhhcC----CCceeeEEEeeecCCCCeeEEEEeecCCCChhHhh--cCCCCCCCCCChHHHHHHHHHH
Q 013404          138 ---KEFLVEVEMLSRLH----HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDA  208 (443)
Q Consensus       138 ---~~~~~E~~~l~~l~----h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i  208 (443)
                         -+|.+|+..+.+++    +.+.+.+-.++.+- ....+|||||++|+.|.++-  .........+....+..++.|+
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence               12455666555552    44445544444321 23578999999999998752  2111011123233333344444


Q ss_pred             HHHHHHhhhcCCCceEecCCCcccEEecCCC----ceEEccccccccCCCC
Q 013404          209 ARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVADFGLAKQAPEG  255 (443)
Q Consensus       209 ~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~~~  255 (443)
                             ...|   ++|+|++|.||+++.++    .++++|||++......
T Consensus       277 -------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   3467   99999999999999888    9999999999877543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.33  E-value=4.5e-11  Score=119.77  Aligned_cols=166  Identities=18%  Similarity=0.221  Sum_probs=123.6

Q ss_pred             ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCC
Q 013404          118 LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD  197 (443)
Q Consensus       118 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~  197 (443)
                      ..++.+|.|...+...........+-++.|+.++||||++++..+.  ..+..|||+|-+.  .|..++.+       +.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e--~~~~~ylvTErV~--Pl~~~lk~-------l~  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE--EEGTLYLVTERVR--PLETVLKE-------LG  102 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc--ccCceEEEeeccc--cHHHHHHH-------hH
Confidence            4467888888877655433445677788999999999999999876  4448899999874  67777753       33


Q ss_pred             hHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccc
Q 013404          198 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM  277 (443)
Q Consensus       198 ~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  277 (443)
                      ......-+.||+.||.|||+.+.  ++|++|.-.-|+++..|..||++|.++........  .......-..|..|+.+.
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcC
Confidence            56777788999999999986654  99999999999999999999999999865433221  011112222466666544


Q ss_pred             cCCCCchhhHHHHHHHHHHHHhC
Q 013404          278 TGHLLVKSDVYSYGVVLLELLTG  300 (443)
Q Consensus       278 ~~~~~~~sDv~S~G~il~elltg  300 (443)
                      ...  -..|.|-|||++||++.|
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCc
Confidence            332  235999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.31  E-value=3.9e-11  Score=106.03  Aligned_cols=138  Identities=17%  Similarity=0.166  Sum_probs=99.2

Q ss_pred             CceeeecCcEEEEEEEECC-------CcEEEEEEeccCC------------C---------CC-HHHH----HHHHHHHh
Q 013404          102 ASILGEGGFGRVFKGVLSD-------GTAVAIKRLTCGG------------Q---------QG-DKEF----LVEVEMLS  148 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~------------~---------~~-~~~~----~~E~~~l~  148 (443)
                      ...||.|--+.||.|...+       +..+|||..+...            .         .. .+.+    .+|.+.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998543       4789999875321            0         01 1222    37999999


Q ss_pred             hcC--CCceeeEEEeeecCCCCeeEEEEeecCCCChhH-hhcCCCCCCCCCChHHHHHHHHHHHHHHHHh-hhcCCCceE
Q 013404          149 RLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLES-WLHGPLGVNCHLDWETRMKIALDAARGLAYL-HEDSQPCVI  224 (443)
Q Consensus       149 ~l~--h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iv  224 (443)
                      ++.  .-++.+.+++    .  ..+|||||+.+..+.. .+.     ...++..+...+..+++.+|..| |..+   ++
T Consensus        82 rl~~~Gv~vP~pi~~----~--~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lV  147 (197)
T cd05146          82 RMQKAGIPCPEVVVL----K--KHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LV  147 (197)
T ss_pred             HHHHcCCCCCeEEEe----c--CCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            985  3456666654    1  4589999997654422 222     12244556778889999999999 8888   99


Q ss_pred             ecCCCcccEEecCCCceEEccccccccCCC
Q 013404          225 HRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       225 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      |+||++.||++++ +.+.|+|||.+.....
T Consensus       148 HGDLs~~NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         148 HADLSEYNMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             cCCCCHHHEEEEC-CcEEEEECCCceeCCC
Confidence            9999999999974 5799999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=2.2e-12  Score=127.83  Aligned_cols=248  Identities=23%  Similarity=0.271  Sum_probs=172.1

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE--CCCcEEEEEEeccCCCCCHHH--HHHHHHHHhhc-CCCceeeEEEeeecCCCCe
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL--SDGTAVAIKRLTCGGQQGDKE--FLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  169 (443)
                      .+.+|..+..||.|.|+.|+....  .++..|++|.+.........+  -..|+.+...+ .|.+++.....+...+  .
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r--~  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR--Q  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc--c
Confidence            345788899999999999999874  467899999887654333222  24566666666 4888887655544323  5


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-CceEEccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGL  248 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl  248 (443)
                      .++--||++++++...+.    ....+++..++.+..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||+
T Consensus       341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccc
Confidence            568889999999887762    2345778889999999999999999888   9999999999999886 8899999999


Q ss_pred             cccCCCCCccccccccccCccc-ccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGY-VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ...+.....    .....+..| .+++......+..+.|+||||..+.|.+++..--...        +.|..       
T Consensus       414 ~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~~-------  474 (524)
T KOG0601|consen  414 WTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSLT-------  474 (524)
T ss_pred             ccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCccc--------cccee-------
Confidence            864322111    111223334 3566666778889999999999999999987532211        11110       


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                       +..-.-+..    +..- ..+..+...+..+++..||.+.++..+...
T Consensus       475 -i~~~~~p~~----~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  475 -IRSGDTPNL----PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             -eecccccCC----CchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence             000000111    1111 345667788899999999999888766543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=3.8e-11  Score=109.44  Aligned_cols=144  Identities=22%  Similarity=0.245  Sum_probs=109.9

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCC--CceeeEEEeeecCC-CCeeEEEEeecC
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRD-SSQHLLCYELVP  178 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~-~~~~~lv~e~~~  178 (443)
                      +.|+.|.++.||++...+|..+++|....... .....+..|+++++.+.+  .++.+++.+..... .+..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987678899999765432 134578899999999975  34566777654321 124689999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS---------------------------------------  219 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  219 (443)
                      |.+|.+.+..     ..++..+...++.+++++|.+||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9988876531     23667778888888888888888521                                       


Q ss_pred             --------------CCceEecCCCcccEEecC--CCceEEcccccccc
Q 013404          220 --------------QPCVIHRDFKASNILLEN--NFHAKVADFGLAKQ  251 (443)
Q Consensus       220 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~  251 (443)
                                    ...++|+|+.+.||++++  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245899999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.26  E-value=3.5e-10  Score=110.15  Aligned_cols=172  Identities=20%  Similarity=0.246  Sum_probs=130.4

Q ss_pred             CcEEEEEEE-ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeec--CCCCeeEEEEeecCC-CChhH
Q 013404          109 GFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS--RDSSQHLLCYELVPN-GSLES  184 (443)
Q Consensus       109 ~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~~~lv~e~~~~-gsL~~  184 (443)
                      .-.+.|++. ..+|..|++|+++............-+++++++.|+|+|++..++..  .....+++||+|+|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            346788888 45899999999954433333344556889999999999999988753  233467899999997 57887


Q ss_pred             hhcCCCC-----------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          185 WLHGPLG-----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       185 ~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      +......           .+...++..+|.++.|+..||.++|+.|   +.-+-|.+.+||++.+.+++|+.+|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            6643221           2234678899999999999999999999   8889999999999999999999988876554


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK  302 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~  302 (443)
                      .+..                |-+..   -.+-|.=.||.+++.|.||..
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            3321                11111   125699999999999999964

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=7.1e-10  Score=94.95  Aligned_cols=130  Identities=18%  Similarity=0.286  Sum_probs=94.5

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEe-ccCCCCC-------HHHHHHHHHHHhhcCCCce--eeEEEeeecCCCCeeEE
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRL-TCGGQQG-------DKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLL  172 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~-~~~~~~~-------~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~~l  172 (443)
                      ..+++|+-+.+|.+.+. |..+++|.- .+.-...       ...-.+|++++.+++--.|  ..++++    +.....|
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv----D~~~~~I   76 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV----DPDNGLI   76 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE----cCCCCEE
Confidence            35789999999999764 344556543 2221111       1346679999998854333  334433    4446789


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||++|-.|.+++...           ...++..+-.-+.-||..+   |+|+||.++||++..+. +.++||||+...
T Consensus        77 ~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          77 VMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            99999999999998642           2456777778888999999   99999999999998774 999999999743

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.12  E-value=7.5e-10  Score=94.35  Aligned_cols=143  Identities=21%  Similarity=0.290  Sum_probs=99.3

Q ss_pred             CCceeeecCcEEEEEEEECCCcEEEEEEe-ccCCC-------CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404          101 PASILGEGGFGRVFKGVLSDGTAVAIKRL-TCGGQ-------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus       101 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ....|-+|+-+.|+++.+. |+...||.- .+.-.       -..+...+|++.|.++.--.|.--.-++.  +...-.|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~--D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI--DTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE--ecCCCeE
Confidence            5678999999999999985 666666643 22111       11346788999999986433332222333  2224478


Q ss_pred             EEeecCC-CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC---ceEEccccc
Q 013404          173 CYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGL  248 (443)
Q Consensus       173 v~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgl  248 (443)
                      +|||+++ .++.+++.....  ..........++..|-+.+.-||.++   |+|+||..+||+|..++   .+.++|||+
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             EEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecc
Confidence            8999976 488888864321  12222333788899999999999999   99999999999996554   358999999


Q ss_pred             ccc
Q 013404          249 AKQ  251 (443)
Q Consensus       249 a~~  251 (443)
                      +..
T Consensus       163 s~~  165 (229)
T KOG3087|consen  163 SSV  165 (229)
T ss_pred             hhc
Confidence            864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.08  E-value=4.5e-11  Score=124.71  Aligned_cols=251  Identities=22%  Similarity=0.240  Sum_probs=164.8

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEE-ECCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           94 EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ...+.|.+.+-+-+|.++.++.+. -..|...+.|......   ....+....+-.++-..++|-++...--+.  ....
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~--~rsP  878 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP--CRSP  878 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC--CCCC
Confidence            455677788889999999999876 2234444444332211   111122222222222234555554432222  3446


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      ..|+++|+.+++|...|+...    ..+..-.......+.+.++|||...   +.|+|++|.|+|...++..+++|||..
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccc
Confidence            789999999999999998533    3455555666777888999999987   899999999999999999999999843


Q ss_pred             ccCCCC-----------------------------CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhC
Q 013404          250 KQAPEG-----------------------------RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTG  300 (443)
Q Consensus       250 ~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg  300 (443)
                      ......                             +.........||+.|.+||.+.+......+|.|++|++++|.++|
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence            221100                             000112346799999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 013404          301 RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG  368 (443)
Q Consensus       301 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  368 (443)
                      ..||....+...      ++.+...       .-+..  ..+.+......+++...+..+|.+|-.+.
T Consensus      1032 ~pp~na~tpq~~------f~ni~~~-------~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQI------FENILNR-------DIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCcchhhh------hhccccC-------CCCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence            999976544321      1111111       01111  11222333456788888899999997766

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.03  E-value=3.7e-09  Score=93.16  Aligned_cols=126  Identities=22%  Similarity=0.309  Sum_probs=84.2

Q ss_pred             EEEEEEECCCcEEEEEEeccCC--------------C--------CC----HHHHHHHHHHHhhcCCC--ceeeEEEeee
Q 013404          112 RVFKGVLSDGTAVAIKRLTCGG--------------Q--------QG----DKEFLVEVEMLSRLHHR--NLVKLVGYYS  163 (443)
Q Consensus       112 ~V~~~~~~~~~~vavK~~~~~~--------------~--------~~----~~~~~~E~~~l~~l~h~--niv~l~~~~~  163 (443)
                      .||.|...+|..+|||..+...              .        ..    .....+|.+.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999876421              0        00    12456799999999755  455666542 


Q ss_pred             cCCCCeeEEEEeecC--CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHH-hhhcCCCceEecCCCcccEEecCCCc
Q 013404          164 SRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY-LHEDSQPCVIHRDFKASNILLENNFH  240 (443)
Q Consensus       164 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~NIll~~~~~  240 (443)
                           ..+|||||++  |..+..+...      .++......++.+++..+.. +|..+   |+|+||.+.||+++++ .
T Consensus        80 -----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   80 -----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             -----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-C
T ss_pred             -----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-e
Confidence                 3479999998  5555544321      12245567778888885555 57888   9999999999999988 9


Q ss_pred             eEEccccccccCC
Q 013404          241 AKVADFGLAKQAP  253 (443)
Q Consensus       241 ~kl~Dfgla~~~~  253 (443)
                      +.|+|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.03  E-value=5.7e-09  Score=97.41  Aligned_cols=143  Identities=18%  Similarity=0.122  Sum_probs=101.3

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCCC-----------CHHHHHHHHHHHhhcCCC--ceeeEEEeeecCC---
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-----------GDKEFLVEVEMLSRLHHR--NLVKLVGYYSSRD---  166 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---  166 (443)
                      +.+-......|++..+ +|+.|.||+.......           ....+.+|...+.++..-  .....+++.....   
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4555555556777766 5678999977533211           112477899988888432  3334455543211   


Q ss_pred             CCeeEEEEeecCCC-ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-------C
Q 013404          167 SSQHLLCYELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-------N  238 (443)
Q Consensus       167 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------~  238 (443)
                      ....+||+|++++- +|.+++....  ....+...+..++.+++..+.-||..|   |+|+|+++.|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence            22468999999886 8999985321  123456677899999999999999999   999999999999975       4


Q ss_pred             CceEEcccccccc
Q 013404          239 FHAKVADFGLAKQ  251 (443)
Q Consensus       239 ~~~kl~Dfgla~~  251 (443)
                      ..+.|+||+.++.
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6899999998864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.96  E-value=7e-08  Score=92.20  Aligned_cols=271  Identities=17%  Similarity=0.176  Sum_probs=158.6

Q ss_pred             CCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEe-----eecCCCCeeEEE
Q 013404          100 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGY-----YSSRDSSQHLLC  173 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-----~~~~~~~~~~lv  173 (443)
                      ...+.||+|+-+.+|-.--- +. .+.|+..........+   -+..|... .||-+..=+.+     +-.+.+...-++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            34678999999999954311 12 3446665443322222   23334443 56644331111     101122225567


Q ss_pred             EeecCCC-ChhHhhcC--CCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          174 YELVPNG-SLESWLHG--PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       174 ~e~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      |..+++. -...++.-  .+..-....|...++.+..++.+.+-||..|   .+-+|++++|+|+.+++.+.|.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            7777654 23333321  1222345789999999999999999999999   8999999999999999999998754333


Q ss_pred             cCCCCCccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCcc--hHH-HHHHH
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTG-RKPVDMSQPSGQE--NLV-TWARP  321 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg-~~p~~~~~~~~~~--~~~-~~~~~  321 (443)
                      ....+.   ..-..+|...|.+||.-.     +..-+...|-|.||+++++++.| ++||..-......  .+. +...-
T Consensus       166 i~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 INANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            322211   123457899999999654     33456778999999999999886 9999753322111  011 00000


Q ss_pred             HhhccccccccccCccCCCCCHHH-HHHHHHHHHHccCc--CCCCCCCHHHHHHHHHHhHhhhh
Q 013404          322 ILRDKDRLEELADPRLGGKYPKED-FIRVCTIAAACVAP--EANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~-~~~l~~li~~cl~~--dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      .+........-..+. ....|-.. ...+..+..+|+..  ++.-|||++-.+..|..+.+.+.
T Consensus       243 ~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         243 RFAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             eeeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            000000000000000 01112111 12355677778765  35689999999999988876654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=2.6e-08  Score=90.42  Aligned_cols=138  Identities=21%  Similarity=0.203  Sum_probs=99.2

Q ss_pred             CCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCC----------------------CCHHHHHHHHHHHhhcCCC--
Q 013404           98 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ----------------------QGDKEFLVEVEMLSRLHHR--  153 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--  153 (443)
                      -..+.+.||-|--+.||.|..+.|.++|||.=+....                      .......+|.++|.+|.-.  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3456789999999999999999999999995432100                      0112456799999998644  


Q ss_pred             ceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       154 niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                      .+.+-+++      +..++||||++|-.|...-         ++....-.++..|++-+..+-..|   +||+|+.+-||
T Consensus       172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIAW------NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNI  233 (304)
T ss_pred             CCCCcccc------ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheE
Confidence            56666543      2568999999986665432         223334445555555555555667   99999999999


Q ss_pred             EecCCCceEEccccccccCC
Q 013404          234 LLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~  253 (443)
                      +++++|.+.++||-.+....
T Consensus       234 lV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         234 LVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             EEecCCCEEEEeCcccccCC
Confidence            99999999999998776543

>PRK09902 hypothetical protein; Provisional

Probab=98.79  E-value=1.4e-07  Score=83.65  Aligned_cols=141  Identities=18%  Similarity=0.173  Sum_probs=103.3

Q ss_pred             eeecCcEEEEEEEECCCcEEEEEEeccCC------CCCHHHHHHHHHHHhhcCC--CceeeEEEeeec---CCCCeeEEE
Q 013404          105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGG------QQGDKEFLVEVEMLSRLHH--RNLVKLVGYYSS---RDSSQHLLC  173 (443)
Q Consensus       105 lg~G~fg~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~---~~~~~~~lv  173 (443)
                      -|+||.+-|+....+ |..+-+|+-....      ......|.+|...|.+|..  -++.+.+ ++..   ...-..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            457899999997775 4578899865221      2345789999999999853  2344444 3321   112245799


Q ss_pred             EeecCC-CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc--eEEccccccc
Q 013404          174 YELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--AKVADFGLAK  250 (443)
Q Consensus       174 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~  250 (443)
                      +|-+++ -+|.+++.+..  ..+.+...+..++.++++.+.-||+.+   +.|+|+.+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997764 58998885422  234677788899999999999999999   999999999999986666  9999998776


Q ss_pred             cC
Q 013404          251 QA  252 (443)
Q Consensus       251 ~~  252 (443)
                      ..
T Consensus       179 ~~  180 (216)
T PRK09902        179 RR  180 (216)
T ss_pred             hh
Confidence            43

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=6.2e-08  Score=87.39  Aligned_cols=110  Identities=25%  Similarity=0.273  Sum_probs=83.8

Q ss_pred             HHHHHHHHHHHhhcC--CCceeeEEEeeecCCC--CeeEEEEeecCCC-ChhHhhcCCCCCCCCCChHHHHHHHHHHHHH
Q 013404          137 DKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS--SQHLLCYELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARG  211 (443)
Q Consensus       137 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~--~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~  211 (443)
                      .....+|...+..|.  .-.+.+.+++......  ...+||+|++++. +|.+++....    .++......++.+++..
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL  130 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence            346778888888774  3334455555543222  2457999999884 8999987422    15557788999999999


Q ss_pred             HHHhhhcCCCceEecCCCcccEEecCCC---ceEEccccccccCC
Q 013404          212 LAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGLAKQAP  253 (443)
Q Consensus       212 l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~  253 (443)
                      +.-||..+   |+|+|+++.|||++.+.   .+.++||+-++...
T Consensus       131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            99999999   99999999999999887   89999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=3.4e-09  Score=106.95  Aligned_cols=152  Identities=20%  Similarity=0.300  Sum_probs=101.5

Q ss_pred             HHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc-------ccccccCcccccccccc
Q 013404          205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL-------STRVMGTFGYVAPEYAM  277 (443)
Q Consensus       205 ~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~  277 (443)
                      +.+++.||.|+|..-  .+||++|.|++|.++.++..||+.|+.+........+..       .........|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345559999999754  399999999999999999999999999876544221111       11123456799999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHc
Q 013404          278 TGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAAC  356 (443)
Q Consensus       278 ~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~c  356 (443)
                      +...+.++|+||+||++|.+.. |+.-+..........   ...    .......   .......|.    ++.+-+.++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~---~~~----~~~~~~~---~~~s~~~p~----el~~~l~k~  248 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS---FSR----NLLNAGA---FGYSNNLPS----ELRESLKKL  248 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhh---hhh----ccccccc---ccccccCcH----HHHHHHHHH
Confidence            9888999999999999999995 444443221111110   000    0000100   111123333    477778888


Q ss_pred             cCcCCCCCCCHHHHHH
Q 013404          357 VAPEANQRPTMGEVVQ  372 (443)
Q Consensus       357 l~~dp~~RPs~~evl~  372 (443)
                      +..++.-||++.++..
T Consensus       249 l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLS  264 (700)
T ss_pred             hcCCcccCcchhhhhc
Confidence            9999999998887753

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.58  E-value=1.1e-06  Score=80.20  Aligned_cols=138  Identities=17%  Similarity=0.234  Sum_probs=81.9

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCce--eeEEEeeecCCCCeeEEEEeecCCC
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-++  .+.+++..  +.....++||+++|.
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~--~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVE--DGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEe--cCCeeeeeeeecCCc
Confidence            57999999999984   24467788876422  34567889999998864333  45666654  333567899999886


Q ss_pred             C-hhHhh---------------------cCCCCCCCCCChHHHHH-HHH----------HHHH-HHHHhhh-cCCCceEe
Q 013404          181 S-LESWL---------------------HGPLGVNCHLDWETRMK-IAL----------DAAR-GLAYLHE-DSQPCVIH  225 (443)
Q Consensus       181 s-L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------~i~~-~l~~LH~-~~~~~ivH  225 (443)
                      + +...+                     |........+  ..... +..          .+.. ...+|.. ...+.++|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l--~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTF--QSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcH--HHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            3 22111                     2110001111  11000 000          0001 1122211 12345899


Q ss_pred             cCCCcccEEecCCCceEEccccccc
Q 013404          226 RDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       226 ~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +|+.|.||++++++ +.|+||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.57  E-value=1.4e-07  Score=95.41  Aligned_cols=144  Identities=19%  Similarity=0.224  Sum_probs=93.6

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCC--------------------------CCH----H----------HHHH
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--------------------------QGD----K----------EFLV  142 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--------------------------~~~----~----------~~~~  142 (443)
                      +-|+.++-|.||+|++.+|+.||||+.+.+-.                          -..    +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999998764210                          000    0          2455


Q ss_pred             HHHHHhhcC----CCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc
Q 013404          143 EVEMLSRLH----HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED  218 (443)
Q Consensus       143 E~~~l~~l~----h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  218 (443)
                      |...+.+++    +..-+.+-.+|.. -....+|+|||++|-.+.+...-..   ..++.+.+.....++.  +..+=..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f--~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWE-YTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAF--LRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehh-ccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHH--HHHHHhc
Confidence            666666552    2222333344432 1235689999999999988742111   1233333322222221  2222234


Q ss_pred             CCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       219 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |   +.|.|..|.||+++.++.+.+.|||+.......
T Consensus       285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             C---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            6   999999999999999999999999999877543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.47  E-value=2.1e-06  Score=76.63  Aligned_cols=140  Identities=16%  Similarity=0.163  Sum_probs=92.9

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHH---------HHHHHHHHhhcCC---CceeeEEEee
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE---------FLVEVEMLSRLHH---RNLVKLVGYY  162 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~l~~~~  162 (443)
                      ...+|...+++-......|.+-.. +|..+.+|..+.......+.         ..+++..+.+++.   .....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            457788888888888888888777 46889999887544322222         2234444444432   2222222221


Q ss_pred             ec---CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          163 SS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       163 ~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                      .-   .-....+|+|||++|..|.++..        ++.    .++..+.+++.-||..|   ++|+|..|.|+++++++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence            11   11224568999999988877542        222    24566778899999999   99999999999999664


Q ss_pred             ceEEcccccccc
Q 013404          240 HAKVADFGLAKQ  251 (443)
Q Consensus       240 ~~kl~Dfgla~~  251 (443)
                       ++++||+..+.
T Consensus       173 -i~iID~~~k~~  183 (229)
T PF06176_consen  173 -IRIIDTQGKRM  183 (229)
T ss_pred             -EEEEECccccc
Confidence             99999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.47  E-value=2.7e-06  Score=76.77  Aligned_cols=153  Identities=18%  Similarity=0.201  Sum_probs=103.7

Q ss_pred             cCHHHHHHHhcCCCCCce---eeecCcEEEEEEEECCCcEEEEEEeccCCCC-------------------CHH-----H
Q 013404           87 LAYEELKEATNNFEPASI---LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-------------------GDK-----E  139 (443)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~---lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~  139 (443)
                      .+.+.+....++..+...   |..|--+.||+|...++..+|||+.+.....                   ...     .
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            345556666666666554   5567778899999888999999998743211                   111     1


Q ss_pred             HHHHHHHHhhcC--CCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh
Q 013404          140 FLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE  217 (443)
Q Consensus       140 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  217 (443)
                      ...|..-|.++.  +-.+.+-+++.      .-.|||||+....    ...+.-...++...+...+..++++.+.-|-.
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~------~nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR------NNVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec------CCeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHH
Confidence            345777888773  44455555543      2379999996531    11111122334444677778888888888776


Q ss_pred             -cCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          218 -DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       218 -~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                       .+   +||+||..-|||+. ++.+.|+|||-|....
T Consensus       185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             hcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence             66   99999999999999 7799999999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=2e-06  Score=78.78  Aligned_cols=146  Identities=19%  Similarity=0.185  Sum_probs=84.8

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCC--ceeeEEEeeecC-CCCeeEEEEeecC
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR--NLVKLVGYYSSR-DSSQHLLCYELVP  178 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~-~~~~~~lv~e~~~  178 (443)
                      .+.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.++... .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3579999999999999877 68999997533  2346788899999888533  345666544322 2234689999999


Q ss_pred             CCChhH----------------hh---cCCCCCCCCCChHH---------HHHH------------HHHHHH-HHHHhhh
Q 013404          179 NGSLES----------------WL---HGPLGVNCHLDWET---------RMKI------------ALDAAR-GLAYLHE  217 (443)
Q Consensus       179 ~gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~  217 (443)
                      +..+..                .+   +........+.+..         ....            ...+.+ .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   11100011111100         0000            111222 2333332


Q ss_pred             ----cCCCceEecCCCcccEEec-CCCceEEccccccc
Q 013404          218 ----DSQPCVIHRDFKASNILLE-NNFHAKVADFGLAK  250 (443)
Q Consensus       218 ----~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~  250 (443)
                          .....++|+|+.+.||+++ +++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                2345699999999999999 56666899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.37  E-value=6e-06  Score=76.54  Aligned_cols=141  Identities=21%  Similarity=0.224  Sum_probs=83.9

Q ss_pred             eeeecCc-EEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEEeecCCCC
Q 013404          104 ILGEGGF-GRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGS  181 (443)
Q Consensus       104 ~lg~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~gs  181 (443)
                      .|-.|.. ..||+.... +..+.||+.....   .....+|+++++.+. +--+.+++++...  ....++|||+++|.+
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G~~   78 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVPGVP   78 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeCCcc
Confidence            3445555 788998764 4678888875432   345678999988884 4345567766543  235789999999987


Q ss_pred             hhHhh-------------------cCCCCCCCCCCh--HHHHHHHH--------------------HHHHHHHHhh----
Q 013404          182 LESWL-------------------HGPLGVNCHLDW--ETRMKIAL--------------------DAARGLAYLH----  216 (443)
Q Consensus       182 L~~~l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------~i~~~l~~LH----  216 (443)
                      |....                   |.......++..  ........                    .+...+..|-    
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            76432                   111100001110  00000000                    0111122221    


Q ss_pred             hcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       217 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ....+.++|+|+.|.|||++++....|+||+.+.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            1234669999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.33  E-value=2.3e-06  Score=75.68  Aligned_cols=105  Identities=25%  Similarity=0.235  Sum_probs=81.7

Q ss_pred             HHHHHHHhhcCC-CceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcC
Q 013404          141 LVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS  219 (443)
Q Consensus       141 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  219 (443)
                      ..|.-+++.+++ +++.+++|+|-      .+++.||...+++..... ....-...+|..+.+||.++++.+.+|++..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            357888888875 69999999983      367899998776643200 0000123689999999999999999999865


Q ss_pred             CCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       220 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ...+.-.|++++|+-+++++++|++|.+.+...
T Consensus        80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            455888999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=1.4e-05  Score=86.87  Aligned_cols=81  Identities=16%  Similarity=0.213  Sum_probs=57.9

Q ss_pred             CceeeecCcEEEEEEEECCC---cEEEEEEeccCCC-CCHHHHHHHHHHHhhcC-CCce--eeEEEeeecCC-CCeeEEE
Q 013404          102 ASILGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLH-HRNL--VKLVGYYSSRD-SSQHLLC  173 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~~-~~~~~lv  173 (443)
                      .+.|+.|.++.+|+....++   ..+++|+...... .....+.+|+++|+.+. |.++  .+++.+|.... .+..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999886654   3677887654322 23457889999999995 6665  67777775321 1357899


Q ss_pred             EeecCCCCh
Q 013404          174 YELVPNGSL  182 (443)
Q Consensus       174 ~e~~~~gsL  182 (443)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.22  E-value=8.6e-06  Score=69.60  Aligned_cols=130  Identities=19%  Similarity=0.185  Sum_probs=91.0

Q ss_pred             CCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceee-EEEeeecCCCCeeEEEEeecC
Q 013404          100 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK-LVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      +..+.|++|.+|.||+|.+. |..+|+|.-+.++  ....+..|+++|..+.-.++-+ ++.|-      .-++.|||+.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg------~~~i~me~i~   95 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG------EDFIRMEYID   95 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec------hhhhhhhhhc
Confidence            34578999999999999986 4578999876433  3567889999999998777664 44432      2245699999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCC-cccEEecCCCceEEccccccccC
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK-ASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |-.|.+.-...       +    .+-...+++.---|...|   |-|+.|. |...+|.++..+.|+||.-|...
T Consensus        96 G~~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIGG-------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhcc-------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            98888765421       1    123344455544456667   9999987 55555555559999999988743

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.21  E-value=5.3e-06  Score=83.86  Aligned_cols=144  Identities=17%  Similarity=0.186  Sum_probs=92.0

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC-------------------------------------HHHHHHHH
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-------------------------------------DKEFLVEV  144 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E~  144 (443)
                      .+.||.-+.|.||+|++.+|+.||||+-+..-...                                     .-+|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999865321100                                     01356666


Q ss_pred             HHHhhc----CCCc---eeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh
Q 013404          145 EMLSRL----HHRN---LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE  217 (443)
Q Consensus       145 ~~l~~l----~h~n---iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  217 (443)
                      +-..+.    .|-+   -|.+-.++.+ -....+|+||||+|..+.|.-.-.   ...++...+..-+.+...-+-+  .
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~-~st~RVLtME~~~G~~i~Dl~~i~---~~gi~~~~i~~~l~~~~~~qIf--~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD-LSTKRVLTMEYVDGIKINDLDAID---KRGISPHDILNKLVEAYLEQIF--K  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh-cCcceEEEEEecCCccCCCHHHHH---HcCCCHHHHHHHHHHHHHHHHH--h
Confidence            554443    4555   1222233322 223678999999998777653211   1224444444433333222222  2


Q ss_pred             cCCCceEecCCCcccEEecC----CCceEEccccccccCCC
Q 013404          218 DSQPCVIHRDFKASNILLEN----NFHAKVADFGLAKQAPE  254 (443)
Q Consensus       218 ~~~~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla~~~~~  254 (443)
                      .|   ++|+|-.|.||++..    ++.+.+.|||+......
T Consensus       320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            35   999999999999983    67899999999987654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.17  E-value=2e-05  Score=72.54  Aligned_cols=75  Identities=13%  Similarity=0.170  Sum_probs=45.8

Q ss_pred             ceeeecCcE-EEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCC---ceeeEEEeeecCCC-CeeEEEEeec
Q 013404          103 SILGEGGFG-RVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR---NLVKLVGYYSSRDS-SQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~-~~~~lv~e~~  177 (443)
                      +.|+.|+.. .||+.    +..+++|..+.  ......+.+|.+++..+...   .+.++++.....+. ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777776 48875    23477776543  22345788999999888532   23344443322111 2347889999


Q ss_pred             CCCChh
Q 013404          178 PNGSLE  183 (443)
Q Consensus       178 ~~gsL~  183 (443)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.12  E-value=6.4e-05  Score=71.75  Aligned_cols=80  Identities=14%  Similarity=0.057  Sum_probs=57.8

Q ss_pred             CCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC---CceeeEEEeeecC-CCCeeEEEEe
Q 013404          100 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH---RNLVKLVGYYSSR-DSSQHLLCYE  175 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~-~~~~~~lv~e  175 (443)
                      ...+.||.|..+.||+....+++ +.+|..+.  ......|..|.+.|+.|.-   -.+.+++++|... ..+..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            34567999999999998766554 66777542  1134578999999999843   3677888877532 2245799999


Q ss_pred             ecCCCCh
Q 013404          176 LVPNGSL  182 (443)
Q Consensus       176 ~~~~gsL  182 (443)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.10  E-value=3.4e-07  Score=91.81  Aligned_cols=187  Identities=19%  Similarity=0.158  Sum_probs=128.8

Q ss_pred             CCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc-eeeEEEeeecCCCCeeEEEEee
Q 013404           98 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN-LVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      -+....-+++|+++.++|.+-.-.+...++.+...     ....-++++|.+++||| .+..++-+.  .....++.+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCC--cccccchhhhh
Confidence            33444557899999999987322233335555422     34456889999999999 555554443  33366788999


Q ss_pred             cCCC-ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          177 VPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       177 ~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      +.++ +-.....   .....+..-+...+...-+++++|||+.-   =+|+|    ||+..+ +..+..||+....+...
T Consensus       316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             hcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence            9776 2222111   11112333344556667788999999875   58998    887776 58899999998877654


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD  305 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~  305 (443)
                      .   ......+++.|+|||+.....+..+.|+|++|+--.++.-|-+|-.
T Consensus       385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            3   2345679999999999999999999999999987777777766643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.09  E-value=5.3e-05  Score=66.94  Aligned_cols=127  Identities=27%  Similarity=0.390  Sum_probs=90.9

Q ss_pred             cCCCCCceeeecCc-EEEEEEEECCCcEEEEEEecc---CCC------------------CCHHHHHHHHHHHhhcC---
Q 013404           97 NNFEPASILGEGGF-GRVFKGVLSDGTAVAIKRLTC---GGQ------------------QGDKEFLVEVEMLSRLH---  151 (443)
Q Consensus        97 ~~~~~~~~lg~G~f-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~---  151 (443)
                      .+++..+.||.|.- |.||++.+. |..+|+|.++.   ...                  .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78899999999999 999999984 67999999432   100                  01135888999988884   


Q ss_pred             CCce--eeEEEeeecC----------------CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHH
Q 013404          152 HRNL--VKLVGYYSSR----------------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA  213 (443)
Q Consensus       152 h~ni--v~l~~~~~~~----------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~  213 (443)
                      +.++  |+.+||..-.                ......||.||.+...             .+.    ..-+.++.+-|.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence            5566  8999986322                1123357777776532             122    234556677788


Q ss_pred             HhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       214 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .+|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            999999   999999999986     4589999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.06  E-value=2.5e-05  Score=72.99  Aligned_cols=139  Identities=18%  Similarity=0.130  Sum_probs=79.7

Q ss_pred             eeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCcee-eEEEeeecCCCCeeEEEEeecCCCChh
Q 013404          105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELVPNGSLE  183 (443)
Q Consensus       105 lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~lv~e~~~~gsL~  183 (443)
                      +..|-.+.+|+... ++..+++|..........-...+|.++++.+....++ +++..+   .   -.+||||++|..+.
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~---~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---E---HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---C---CEEEEEeccCcccc
Confidence            55677889998874 4667888876543222112457799999988644343 344332   1   26899999987654


Q ss_pred             Hh-----------------hcCCCCCCCCCChHHH-HHHHHH---------HHHHHHHhhhc-----CCCceEecCCCcc
Q 013404          184 SW-----------------LHGPLGVNCHLDWETR-MKIALD---------AARGLAYLHED-----SQPCVIHRDFKAS  231 (443)
Q Consensus       184 ~~-----------------l~~~~~~~~~l~~~~~-~~i~~~---------i~~~l~~LH~~-----~~~~ivH~Dlkp~  231 (443)
                      ..                 ||.......+++.... .....+         +...+..+-..     ..+.++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 1222111122222211 111111         11112222111     1345999999999


Q ss_pred             cEEecCCCceEEcccccccc
Q 013404          232 NILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       232 NIll~~~~~~kl~Dfgla~~  251 (443)
                      ||++++++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999876 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.04  E-value=0.00014  Score=64.75  Aligned_cols=133  Identities=17%  Similarity=0.261  Sum_probs=90.4

Q ss_pred             CCceeeecCcEEEEEEEECCCcEEEEEEeccCC----------------CCCHHHHHHHHHHHhhcC------CCceeeE
Q 013404          101 PASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG----------------QQGDKEFLVEVEMLSRLH------HRNLVKL  158 (443)
Q Consensus       101 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l  158 (443)
                      ....||+|+.-.||.  ++++....||+.....                .....++.+|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346799999999995  4455667888887554                122456777887777766      8889999


Q ss_pred             EEeeecCCCCeeEEEEeecCC------CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCccc
Q 013404          159 VGYYSSRDSSQHLLCYELVPN------GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN  232 (443)
Q Consensus       159 ~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  232 (443)
                      +|+..++.  ..-+|+|.+.+      -+|.+++..     ..++. ...+.+.   +-..||-+++   |+.+|++|.|
T Consensus        83 ~G~veT~~--G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~N  148 (199)
T PF10707_consen   83 YGFVETNL--GLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHN  148 (199)
T ss_pred             eEEEecCC--ceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHH---HHHHHHHHcC---CeecCCCccc
Confidence            99987544  45677776543      258888853     22444 3344444   4456677777   9999999999


Q ss_pred             EEecCC---C-ceEEcc-cccc
Q 013404          233 ILLENN---F-HAKVAD-FGLA  249 (443)
Q Consensus       233 Ill~~~---~-~~kl~D-fgla  249 (443)
                      |++...   . .+.|+| ||-.
T Consensus       149 Iv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EEEEecCCCceEEEEEeCCCCc
Confidence            999542   2 577776 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.02  E-value=0.00033  Score=69.08  Aligned_cols=76  Identities=18%  Similarity=0.175  Sum_probs=53.9

Q ss_pred             CceeeecCcEEEEEEEECCC-cEEEEEEeccC------C-CCCHHHHHHHHHHHhhcC---CCceeeEEEeeecCCCCee
Q 013404          102 ASILGEGGFGRVFKGVLSDG-TAVAIKRLTCG------G-QQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~  170 (443)
                      .+.||.|.+..||++...+| +.|+||.-...      . ......+..|.+.|..+.   -.++.+++.+.    ....
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCC
Confidence            35799999999999998776 48999985311      1 123456778888888863   24566777662    2356


Q ss_pred             EEEEeecCCCC
Q 013404          171 LLCYELVPNGS  181 (443)
Q Consensus       171 ~lv~e~~~~gs  181 (443)
                      ++||||+++..
T Consensus       107 ~lVME~L~~~~  117 (401)
T PRK09550        107 VTVMEDLSDHK  117 (401)
T ss_pred             EEEEecCCCcc
Confidence            89999998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.91  E-value=0.00014  Score=66.95  Aligned_cols=142  Identities=21%  Similarity=0.184  Sum_probs=81.7

Q ss_pred             ceeeecCcEEEEEEEECC--CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCcee-eEEEeeecCCCCeeEEEEeecCC
Q 013404          103 SILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELVPN  179 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~lv~e~~~~  179 (443)
                      +.|..|-...+|+....+  +..|++|....... ......+|+.+++.+...+++ ++++.+.  .    .++|||++|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~----~~l~e~i~G   76 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N----GLIYEFIPG   76 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C----cEEEEeeCC
Confidence            567788889999988664  67889997653322 112334788888888544443 4444321  2    379999998


Q ss_pred             CChhHh-----------------hcCCCCCC-------CCCC-hHHHHHHHH----------------------HHH---
Q 013404          180 GSLESW-----------------LHGPLGVN-------CHLD-WETRMKIAL----------------------DAA---  209 (443)
Q Consensus       180 gsL~~~-----------------l~~~~~~~-------~~l~-~~~~~~i~~----------------------~i~---  209 (443)
                      .++...                 +|......       .... +..+..+..                      .+.   
T Consensus        77 ~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  156 (235)
T cd05157          77 RTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEI  156 (235)
T ss_pred             CcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHH
Confidence            776321                 11111000       0111 122111111                      111   


Q ss_pred             HHHH-Hhhhc-CCCceEecCCCcccEEecC-CCceEEcccccccc
Q 013404          210 RGLA-YLHED-SQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQ  251 (443)
Q Consensus       210 ~~l~-~LH~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~  251 (443)
                      ..|. .+... ....++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus       157 ~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         157 SWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            1111 11111 2345999999999999998 57899999998753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.90  E-value=7e-05  Score=80.50  Aligned_cols=198  Identities=22%  Similarity=0.202  Sum_probs=135.8

Q ss_pred             HHHHHHHHhhcCCCceeeEEEeeecCCCC--eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh
Q 013404          140 FLVEVEMLSRLHHRNLVKLVGYYSSRDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE  217 (443)
Q Consensus       140 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~  217 (443)
                      ...|+..+.++.|+|++.++.|-......  ...+..+++..-++...+..    -..++....+.+..++.+||.|+|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            34577788889999999998886532221  22344578888788877753    3357788889999999999999999


Q ss_pred             cCCCceEecCCCcc---cEEecCCCceEEc--cccccccCCCCCccccccccccCcccccccccccCCCCc--hhhHHHH
Q 013404          218 DSQPCVIHRDFKAS---NILLENNFHAKVA--DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV--KSDVYSY  290 (443)
Q Consensus       218 ~~~~~ivH~Dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDv~S~  290 (443)
                      ..   ..|.-+..+   +.-.+.++...++  ||+.++........   ....-+..|.++|......+..  ..|+|.+
T Consensus       305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence            86   666666555   5555666777777  99888776553322   2234456688888877665544  4799999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 013404          291 GVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV  370 (443)
Q Consensus       291 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev  370 (443)
                      |..+..+..|..+-....                   ....+++.    .+..    .+.+....|+..++++|++..++
T Consensus       379 gll~~~~~~~~~i~~~~~-------------------~~~~~l~~----~~~~----~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA-------------------VPVSLLDV----LSTS----ELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHhhhhhcCccccccc-------------------chhhhhcc----ccch----hhhhhhhhhcchhhhhccchhhh
Confidence            999999998876532110                   00011110    1111    24567889999999999999999


Q ss_pred             HHHH
Q 013404          371 VQSL  374 (443)
Q Consensus       371 l~~L  374 (443)
                      +.+.
T Consensus       432 l~~~  435 (1351)
T KOG1035|consen  432 LTHP  435 (1351)
T ss_pred             hhch
Confidence            9764

>PRK05231 homoserine kinase; Provisional

Probab=97.77  E-value=0.00035  Score=67.47  Aligned_cols=161  Identities=16%  Similarity=0.146  Sum_probs=85.3

Q ss_pred             cCHHHHHHHhcCCCC-----CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc--eeeEE
Q 013404           87 LAYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLV  159 (443)
Q Consensus        87 ~~~~~~~~~~~~~~~-----~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  159 (443)
                      ++.+++......|.+     .+.|+.|....+|+....+| .+++|+.. .  ........|+.++..|...+  +.+.+
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcce
Confidence            345556555556654     34566777789999887665 58889875 1  22344445666666653222  22333


Q ss_pred             Ee----eecCCCCeeEEEEeecCCCChhH-----------h---hcCCC-CC------CCCCCh-HHHHH----------
Q 013404          160 GY----YSSRDSSQHLLCYELVPNGSLES-----------W---LHGPL-GV------NCHLDW-ETRMK----------  203 (443)
Q Consensus       160 ~~----~~~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~~-~~------~~~l~~-~~~~~----------  203 (443)
                      ..    ......+..+++++|++|..+..           .   +|... +.      ...+.| .....          
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            21    00011335689999999875421           1   11110 00      001111 11111          


Q ss_pred             --HHHH-HHHHHHHhhhc----CCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          204 --IALD-AARGLAYLHED----SQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       204 --i~~~-i~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                        .+.+ +...++.+...    -+.++||+|+.+.||+++++...-|+||+.+..
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence              1111 11122233211    233599999999999999776568999998753

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.76  E-value=0.00019  Score=68.50  Aligned_cols=145  Identities=18%  Similarity=0.141  Sum_probs=84.3

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc--eeeEEEeee----cCCCCeeEEEEe
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLVGYYS----SRDSSQHLLCYE  175 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~----~~~~~~~~lv~e  175 (443)
                      .+.|..|....+|+....+ ..+++|+...   ........|++++..+.+.+  +.+++....    ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4557778788999987654 4688888763   23456777888888885332  444443210    011234678999


Q ss_pred             ecCCCChhH----hh----------cCC----CCC---CCCCChHHHH----------HHHHHHHHHHHHhhh----cCC
Q 013404          176 LVPNGSLES----WL----------HGP----LGV---NCHLDWETRM----------KIALDAARGLAYLHE----DSQ  220 (443)
Q Consensus       176 ~~~~gsL~~----~l----------~~~----~~~---~~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~  220 (443)
                      |++|..+..    .+          |..    ...   .....|....          .....+..++.++..    .-.
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    00          110    000   0111221111          011112334444443    122


Q ss_pred             CceEecCCCcccEEecCCCceEEccccccc
Q 013404          221 PCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       221 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ..++|+|+.|.||+++++..+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            349999999999999998777899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.66  E-value=0.00034  Score=66.97  Aligned_cols=141  Identities=27%  Similarity=0.283  Sum_probs=83.4

Q ss_pred             ceeeecCcEEEEEEEECC-------CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCcee-eEEEeeecCCCCeeEEEE
Q 013404          103 SILGEGGFGRVFKGVLSD-------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~lv~  174 (443)
                      +.|..|-...+|+....+       ++.+++|...... ....+..+|.+++..+...++. ++++++.  +    .+|+
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~~v~   76 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N----GRIE   76 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C----Cchh
Confidence            456667778999988654       5789999876433 2224557788888888543333 4555542  2    3579


Q ss_pred             eecCCCChhHh-----------------hcCCCCCC-------CCCChHHHHH--------------------------H
Q 013404          175 ELVPNGSLESW-----------------LHGPLGVN-------CHLDWETRMK--------------------------I  204 (443)
Q Consensus       175 e~~~~gsL~~~-----------------l~~~~~~~-------~~l~~~~~~~--------------------------i  204 (443)
                      ||++|..+...                 +|......       .+.-|.....                          +
T Consensus        77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (302)
T cd05156          77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF  156 (302)
T ss_pred             heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence            99998776431                 11111100       0000111111                          1


Q ss_pred             HHHHHHHHHHhhh------cCCCceEecCCCcccEEecCC----CceEEccccccc
Q 013404          205 ALDAARGLAYLHE------DSQPCVIHRDFKASNILLENN----FHAKVADFGLAK  250 (443)
Q Consensus       205 ~~~i~~~l~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~  250 (443)
                      ...+...+.+|-.      .....++|+|+.+.||+++++    +.+.++||..+.
T Consensus       157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            1122223334432      234569999999999999984    789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.64  E-value=0.0015  Score=62.83  Aligned_cols=160  Identities=19%  Similarity=0.201  Sum_probs=89.7

Q ss_pred             CHHHHHHHhcCCCC-----CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc--eeeEEE
Q 013404           88 AYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLVG  160 (443)
Q Consensus        88 ~~~~~~~~~~~~~~-----~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~  160 (443)
                      +.+++....+.|.+     .+.++.|....+|+....+| .+++|......  .......|++++..|...+  +.+++.
T Consensus         8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~   84 (307)
T TIGR00938         8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK   84 (307)
T ss_pred             CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence            44556555555644     34567777789999876555 57788765321  2345566778877774322  334433


Q ss_pred             eee----cCCCCeeEEEEeecCCCChhH--------------hhcCCC-CCCC-------CCChHHHH------------
Q 013404          161 YYS----SRDSSQHLLCYELVPNGSLES--------------WLHGPL-GVNC-------HLDWETRM------------  202 (443)
Q Consensus       161 ~~~----~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~-~~~~-------~l~~~~~~------------  202 (443)
                      ...    ....+..+++++|++|..+..              .+|... +...       .-.|....            
T Consensus        85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~  164 (307)
T TIGR00938        85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA  164 (307)
T ss_pred             CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence            211    112345689999998865421              011100 0000       01111110            


Q ss_pred             HHHHHHHHHHHHhhh----cCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          203 KIALDAARGLAYLHE----DSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       203 ~i~~~i~~~l~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      .....+.+.++++..    ..+..++|+|+.+.||++++++...|+||+.+.
T Consensus       165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            011123334555532    223459999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.40  E-value=0.0023  Score=61.06  Aligned_cols=141  Identities=18%  Similarity=0.182  Sum_probs=81.5

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEecc--CCCCCHHHHHHHHHHHhhcCC--CceeeEEEeeecCCCCeeEEEEeec
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      .+.+..|..-.+|..... ++.+++. ...  ..........+|.++|+.+.-  --+...+++|....-+..+.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            344434444444444433 7778888 321  112234456678888888742  2334556666543324678999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHH-HHHHHHHHHhh----------------------------------------
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIA-LDAARGLAYLH----------------------------------------  216 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~~i~~~l~~LH----------------------------------------  216 (443)
                      +|..+.+.+....     ..    .+++ ..+++.|+-||                                        
T Consensus       108 eGe~~~~~~~~~~-----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         108 EGEVVWSALPPES-----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             cceeccCcCCccc-----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            8854433322100     00    0111 13333333333                                        


Q ss_pred             ----------h-----cCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          217 ----------E-----DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       217 ----------~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                                .     .+.++++|+|+.+.|++++++..+-|.||+++..-.
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence                      2     234679999999999999999889999999987543

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.37  E-value=0.0018  Score=61.31  Aligned_cols=75  Identities=20%  Similarity=0.277  Sum_probs=46.3

Q ss_pred             CCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC---CCceeeEEEeeecCCCCeeEEEEee
Q 013404          100 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      +..+.++.|....+|+.. .+++.+.||.-.   ......|..|.+-|+.|.   --.+.+.+++....+  ..+|++||
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~~fLlle~   93 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--DAFLLLEF   93 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--CCEEEEE-
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--CceEEEEe
Confidence            345678989999999977 567889999876   223456888999888883   334567777765433  45899999


Q ss_pred             cCCC
Q 013404          177 VPNG  180 (443)
Q Consensus       177 ~~~g  180 (443)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.32  E-value=0.0003  Score=66.06  Aligned_cols=139  Identities=19%  Similarity=0.188  Sum_probs=96.1

Q ss_pred             CCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCC-----------------CC-----CHHHHHHHHHHHhhcC-CCc
Q 013404           98 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG-----------------QQ-----GDKEFLVEVEMLSRLH-HRN  154 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-----------------~~-----~~~~~~~E~~~l~~l~-h~n  154 (443)
                      -+.+.++||-|--+.||.+...+|++.++|.-+...                 ..     ..-...+|...|+.|. |-.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            356789999999999999999999999988532110                 00     0113456888888884 433


Q ss_pred             -eeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          155 -LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       155 -iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                       +.+.+++      ...++|||++.+-.|...-+       ..+..++..   .+..-+.-|..+|   +||+|..-=||
T Consensus       173 pVPkpiD~------~RH~Vvmelv~g~Pl~~v~~-------v~d~~~ly~---~lm~~Iv~la~~G---lIHgDFNEFNi  233 (465)
T KOG2268|consen  173 PVPKPIDH------NRHCVVMELVDGYPLRQVRH-------VEDPPTLYD---DLMGLIVRLANHG---LIHGDFNEFNI  233 (465)
T ss_pred             CCCCcccc------cceeeHHHhhcccceeeeee-------cCChHHHHH---HHHHHHHHHHHcC---ceecccchhee
Confidence             3333333      35789999999888865432       122333333   3333455677778   99999999999


Q ss_pred             EecCCCceEEccccccccCCCC
Q 013404          234 LLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      +++++..++++||--.......
T Consensus       234 mv~dd~~i~vIDFPQmvS~sh~  255 (465)
T KOG2268|consen  234 MVKDDDKIVVIDFPQMVSTSHP  255 (465)
T ss_pred             EEecCCCEEEeechHhhccCCC
Confidence            9999999999999876655443

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.31  E-value=4.3e-05  Score=83.95  Aligned_cols=161  Identities=14%  Similarity=0.001  Sum_probs=114.9

Q ss_pred             HHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc--C
Q 013404          142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED--S  219 (443)
Q Consensus       142 ~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--~  219 (443)
                      .|..-++...|+++.....=.......+.+.+++|+.+|++.+.|-+......+++..-+...-.+...+..-+|+.  +
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            34445556689988776554444455677889999999999999865443334444443333333335555555543  2


Q ss_pred             CCceEecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh
Q 013404          220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT  299 (443)
Q Consensus       220 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt  299 (443)
                      ....+|++||+-|.+|..+.++|++++|+.+......  .......+++.|+.|++...-.++.++|+|..|+.+|+..-
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            3347899999999999999999999999998332221  12344567889999999888899999999999999999988


Q ss_pred             CCCCC
Q 013404          300 GRKPV  304 (443)
Q Consensus       300 g~~p~  304 (443)
                      |..+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            87765

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.19  E-value=0.0043  Score=58.53  Aligned_cols=32  Identities=22%  Similarity=0.462  Sum_probs=26.4

Q ss_pred             CCceEecCCCcccEEecCCCc-eEEcccccccc
Q 013404          220 QPCVIHRDFKASNILLENNFH-AKVADFGLAKQ  251 (443)
Q Consensus       220 ~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~  251 (443)
                      .+.++|+|+.+.||++++++. .-|+||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            456999999999999997554 56999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.13  E-value=0.0056  Score=59.74  Aligned_cols=142  Identities=17%  Similarity=0.204  Sum_probs=81.4

Q ss_pred             ceeeecCcEEEEEEEECC-----CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCcee-eEEEeeecCCCCeeEEEEee
Q 013404          103 SILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~lv~e~  176 (443)
                      +.|-.|-...+|+....+     ++.|++|......... -+-.+|..+++.+..-++. ++++.+.  ++    .+++|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~--~g----~v~ef  114 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFP--NG----RVEEF  114 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEEC--Cc----eEEEe
Confidence            345557778899887532     3678899876543222 2236788888888544444 4555542  21    57899


Q ss_pred             cCCCChhHh-----------------hcCCC--CCCCCCChHHHHHHHHHH-----------------HHHHHHh----h
Q 013404          177 VPNGSLESW-----------------LHGPL--GVNCHLDWETRMKIALDA-----------------ARGLAYL----H  216 (443)
Q Consensus       177 ~~~gsL~~~-----------------l~~~~--~~~~~l~~~~~~~i~~~i-----------------~~~l~~L----H  216 (443)
                      +++.+|...                 +|...  .......+.++.++..++                 ...+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            987776421                 12211  001111233333332221                 1111122    2


Q ss_pred             h-cCCCceEecCCCcccEEecC-CCceEEcccccccc
Q 013404          217 E-DSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQ  251 (443)
Q Consensus       217 ~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~  251 (443)
                      . .....++|+|+++.||++++ ++.+.++||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1 22345999999999999986 46899999998753

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.01  E-value=0.0048  Score=59.11  Aligned_cols=143  Identities=17%  Similarity=0.161  Sum_probs=95.3

Q ss_pred             CCCceeeecCcEEEEEEEECCCcEEEEEEeccCC-----C-----------------CCH----HHHHHHHHHHhhcCCC
Q 013404          100 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG-----Q-----------------QGD----KEFLVEVEMLSRLHHR  153 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-----~-----------------~~~----~~~~~E~~~l~~l~h~  153 (443)
                      ++..+|..|--..||.+.-.+|..+|||+.+.+.     .                 ...    -....|++-|++|+.-
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4557889999999999998899999999876421     0                 000    1234588888888654


Q ss_pred             ceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       154 niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                      .|..---+..    ...+|||+|+. ++=+   ..++-....++...+..+-.|++.-|.-|-..+.  +||.||.--|+
T Consensus       227 GIP~PePIlL----k~hVLVM~FlG-rdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~  296 (520)
T KOG2270|consen  227 GIPCPEPILL----KNHVLVMEFLG-RDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL  296 (520)
T ss_pred             CCCCCCceee----ecceEeeeecc-CCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence            4321100111    13479999994 2221   1111123456777777777888888877766653  99999999999


Q ss_pred             EecCCCceEEccccccccCC
Q 013404          234 LLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~  253 (443)
                      |+.+ |.+.|+|-+-+....
T Consensus       297 Lyhd-G~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  297 LYHD-GKLYIIDVSQSVEHD  315 (520)
T ss_pred             eEEC-CEEEEEEccccccCC
Confidence            9875 589999988776443

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.95  E-value=0.013  Score=56.88  Aligned_cols=79  Identities=18%  Similarity=0.220  Sum_probs=50.8

Q ss_pred             eeeecCcEEEEEEEECCC-cEEEEEEec----c-C-C-CCCHHHHHHHHHHHhhcC--CCc-eeeEEEeeecCCCCeeEE
Q 013404          104 ILGEGGFGRVFKGVLSDG-TAVAIKRLT----C-G-G-QQGDKEFLVEVEMLSRLH--HRN-LVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus       104 ~lg~G~fg~V~~~~~~~~-~~vavK~~~----~-~-~-~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~~~l  172 (443)
                      .||.|....||++..++| +.|+||.-.    . . + .....+...|.+.|....  -|. +.+++.|    +.....+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~----D~e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF----DTEMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE----cccccee
Confidence            479999999999997654 589999643    1 1 1 223345566778777663  353 4456554    3446679


Q ss_pred             EEeecCCC-ChhHhh
Q 013404          173 CYELVPNG-SLESWL  186 (443)
Q Consensus       173 v~e~~~~g-sL~~~l  186 (443)
                      +||+++.. .|.+.|
T Consensus        78 vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        78 VMEDLSHHKIARKGL   92 (370)
T ss_pred             hHhhCccchHHHHHH
Confidence            99999653 343444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.94  E-value=0.018  Score=56.76  Aligned_cols=80  Identities=15%  Similarity=0.099  Sum_probs=52.4

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCC----C---CCHHHHHHHHHHHhhcC---CCceeeEEEeeecCCCCeeE
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG----Q---QGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~----~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~  171 (443)
                      .+.||.|....||+.... +..++||.-....    .   .....-..|.+.|+.+.   ..++.+++.++.  +  ..+
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d--~~v  111 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--T--MAL  111 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--C--CCE
Confidence            467899999999998864 4568899765211    1   12333444567776653   246778888865  2  458


Q ss_pred             EEEeecCC--CChhHhh
Q 013404          172 LCYELVPN--GSLESWL  186 (443)
Q Consensus       172 lv~e~~~~--gsL~~~l  186 (443)
                      ++|||+++  ..+.+.+
T Consensus       112 lvME~L~~~~~ilr~~L  128 (418)
T PLN02756        112 IGMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEEeecCCcceehhhhh
Confidence            89999977  3454444

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.90  E-value=0.008  Score=57.76  Aligned_cols=32  Identities=16%  Similarity=0.259  Sum_probs=28.2

Q ss_pred             CCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       220 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ..+++|+|+.+.|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            33599999999999999998999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.80  E-value=0.0054  Score=55.36  Aligned_cols=30  Identities=30%  Similarity=0.468  Sum_probs=21.2

Q ss_pred             ceEecCCCcccEEe-cCCCceEEcccccccc
Q 013404          222 CVIHRDFKASNILL-ENNFHAKVADFGLAKQ  251 (443)
Q Consensus       222 ~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~  251 (443)
                      .++|+|+.+.|||+ +.++.++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.71  E-value=0.026  Score=54.38  Aligned_cols=143  Identities=22%  Similarity=0.258  Sum_probs=82.8

Q ss_pred             eeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc---eee---EEEeeecCCC--CeeEEEEe
Q 013404          104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN---LVK---LVGYYSSRDS--SQHLLCYE  175 (443)
Q Consensus       104 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n---iv~---l~~~~~~~~~--~~~~lv~e  175 (443)
                      .|.+ .-..+|+....+|.. ++|.....  ....+...|+..|..|.-.+   .++   +=|-....-.  ...+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 567799988877776 88887754  34566777888888873211   122   1111111112  36778899


Q ss_pred             ecCCCChhH-hh--------------c----CC----CCCCCCCChHH-------------HHHHHHHHHHHHHHhhhc-
Q 013404          176 LVPNGSLES-WL--------------H----GP----LGVNCHLDWET-------------RMKIALDAARGLAYLHED-  218 (443)
Q Consensus       176 ~~~~gsL~~-~l--------------~----~~----~~~~~~l~~~~-------------~~~i~~~i~~~l~~LH~~-  218 (443)
                      |++|..+.. .-              |    +.    ........|..             ......++...+..+.+. 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988873 11              1    11    11111233331             011233334444444432 


Q ss_pred             ---CC---CceEecCCCcccEEecCCCc-eEEccccccc
Q 013404          219 ---SQ---PCVIHRDFKASNILLENNFH-AKVADFGLAK  250 (443)
Q Consensus       219 ---~~---~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~  250 (443)
                         -.   ..+||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               12   22899999999999999874 8899999875

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.65  E-value=0.023  Score=54.52  Aligned_cols=29  Identities=31%  Similarity=0.462  Sum_probs=25.2

Q ss_pred             CceEecCCCcccEEecCCCceEEccccccc
Q 013404          221 PCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       221 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45999999999999988 568899999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.56  E-value=0.0041  Score=62.01  Aligned_cols=50  Identities=22%  Similarity=0.331  Sum_probs=39.2

Q ss_pred             HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcC
Q 013404          137 DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG  188 (443)
Q Consensus       137 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  188 (443)
                      ..+.+....+++.+.|+|+...+++.... .....+|+|++ +.+|++.+..
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhh-ccchHHHHHh
Confidence            45677788899999999999999886532 33477899999 5699998863

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.55  E-value=0.018  Score=55.91  Aligned_cols=142  Identities=14%  Similarity=0.168  Sum_probs=79.6

Q ss_pred             ceeeecCcEEEEEEEECC----CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCcee-eEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.|..|=...+|+....+    +..|++|....... ..-+-.+|..+++.+..-++- ++++++.  .+    ++.+|+
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G----~i~~fi   92 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG----MIQSFI   92 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc----Eeehhh
Confidence            445557778889887543    23788998764432 222345788888888655554 4555542  21    478999


Q ss_pred             CCCChhH--h---------------hcCCCCC--CCCCChHHHHHHHHHH----------------------HHHHH---
Q 013404          178 PNGSLES--W---------------LHGPLGV--NCHLDWETRMKIALDA----------------------ARGLA---  213 (443)
Q Consensus       178 ~~gsL~~--~---------------l~~~~~~--~~~l~~~~~~~i~~~i----------------------~~~l~---  213 (443)
                      ++..|..  +               +|.....  ..+--|..+.++..++                      .+-+.   
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            7766532  1               1221100  1111222222222111                      11111   


Q ss_pred             -Hhhh-cCCCceEecCCCcccEEecC-CCceEEcccccccc
Q 013404          214 -YLHE-DSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQ  251 (443)
Q Consensus       214 -~LH~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~  251 (443)
                       ++.. ..+..++|+|+.+.|||+++ ++.++++||..|..
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence             1211 12335899999999999974 57899999998854

>PRK06148 hypothetical protein; Provisional

Probab=96.40  E-value=0.045  Score=61.12  Aligned_cols=145  Identities=22%  Similarity=0.238  Sum_probs=79.2

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-------CCceeeEE-E----eeecCCCC-e
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-------HRNLVKLV-G----YYSSRDSS-Q  169 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-~----~~~~~~~~-~  169 (443)
                      +.|+ |..-.+|+....+|..+++|+.+...  .......|.+.|..|.       -|.+++-. |    .....++. .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4453 45688899888888899999987542  2334445556665552       22333221 0    11111221 4


Q ss_pred             eEEEEeecCCCChhHhhc---------------------C--CCCCCCCCChHH-----------------HHHHHHHHH
Q 013404          170 HLLCYELVPNGSLESWLH---------------------G--PLGVNCHLDWET-----------------RMKIALDAA  209 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~---------------------~--~~~~~~~l~~~~-----------------~~~i~~~i~  209 (443)
                      .+-+++|++|..|.+...                     .  .......+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            567899999987765211                     0  011111233321                 112222232


Q ss_pred             HHHH-----HhhhcCCCceEecCCCcccEEecCCC--ceE-Ecccccccc
Q 013404          210 RGLA-----YLHEDSQPCVIHRDFKASNILLENNF--HAK-VADFGLAKQ  251 (443)
Q Consensus       210 ~~l~-----~LH~~~~~~ivH~Dlkp~NIll~~~~--~~k-l~Dfgla~~  251 (443)
                      +...     .+... +..+||+|+.+.|||++.+.  .+. |+|||.+..
T Consensus       188 ~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2221     12111 33499999999999999875  454 999998864

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.22  E-value=0.036  Score=54.45  Aligned_cols=81  Identities=17%  Similarity=0.218  Sum_probs=52.8

Q ss_pred             CceeeecCcEEEEEEEECC-CcEEEEEEec----cC-C-CCCHHHHHHHHHHHhhcC--CCc-eeeEEEeeecCCCCeeE
Q 013404          102 ASILGEGGFGRVFKGVLSD-GTAVAIKRLT----CG-G-QQGDKEFLVEVEMLSRLH--HRN-LVKLVGYYSSRDSSQHL  171 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~----~~-~-~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~~~  171 (443)
                      .+.||.|.-..||++...+ ++.|+||.-.    .. + .-...+...|.+.|+...  -|. +.+++.+    +.....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~----D~e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF----DSVMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE----CcHHhh
Confidence            4678999999999999743 5679998642    11 1 223456677888888763  454 4456554    444667


Q ss_pred             EEEeecCCC-ChhHhh
Q 013404          172 LCYELVPNG-SLESWL  186 (443)
Q Consensus       172 lv~e~~~~g-sL~~~l  186 (443)
                      +|||+++.. .|.+.|
T Consensus       110 ~vMEdL~~~~ilR~~L  125 (409)
T PRK12396        110 CVMEDLSDHTILRTAL  125 (409)
T ss_pred             HHHHhCcccHHHHHHH
Confidence            899999653 344443

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.18  E-value=0.038  Score=49.47  Aligned_cols=137  Identities=15%  Similarity=0.168  Sum_probs=83.5

Q ss_pred             EEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHH
Q 013404          124 VAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM  202 (443)
Q Consensus       124 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~  202 (443)
                      ..+|++....-. ...-|..+.++++++.  .|+++.    ..+...+-++.|+|.....                .. .
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~----NDn~~~yGvIlE~Cy~~~i----------------~~-~  144 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK----NDNNYKYGVILERCYKIKI----------------NF-S  144 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee----cCCCceeEEEEeeccCccc----------------ch-h
Confidence            345555433333 4456788888888875  366665    2234455688898843111                01 1


Q ss_pred             HHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCC
Q 013404          203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL  282 (443)
Q Consensus       203 ~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  282 (443)
                      .++.--++.|.-.|+..+ ..+|+|..|+||+-|..|.+||.|=+..-..              +..|.--   .....+
T Consensus       145 N~i~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~vN~---~Y~~lT  206 (308)
T PF07387_consen  145 NFITAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNMVNI---EYESLT  206 (308)
T ss_pred             HHHHHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeEEee---eccccC
Confidence            122222466778886543 3899999999999999999999997654211              1112221   123456


Q ss_pred             chhhHHHHHHHHHHHHhCC
Q 013404          283 VKSDVYSYGVVLLELLTGR  301 (443)
Q Consensus       283 ~~sDv~S~G~il~elltg~  301 (443)
                      .++.+-+|=.-++++....
T Consensus       207 ~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  207 QEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             hHHHHHHHHHHHHHHHHHH
Confidence            6788888877777777643

The function of this family is unknown.

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=96.17  E-value=0.0047  Score=49.75  Aligned_cols=35  Identities=31%  Similarity=0.344  Sum_probs=21.4

Q ss_pred             cccceeEehhHHHHHHHHHHHHHHHHHHHHhcCCC
Q 013404           22 HSNLILIFGIGTGLLITAIISVLIICSCAFRGRKS   56 (443)
Q Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   56 (443)
                      +.+...+++|++|++++++++++++.+|.+|+||+
T Consensus        60 ~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk   94 (122)
T PF01102_consen   60 RFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKK   94 (122)
T ss_dssp             SSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS--
T ss_pred             CccccceeehhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence            33445678888888887776666666665555544

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.15  E-value=0.23  Score=48.11  Aligned_cols=94  Identities=15%  Similarity=0.077  Sum_probs=54.3

Q ss_pred             ccCHHHHHHHhcCCCCC---c-eeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCC--ceeeEE
Q 013404           86 FLAYEELKEATNNFEPA---S-ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR--NLVKLV  159 (443)
Q Consensus        86 ~~~~~~~~~~~~~~~~~---~-~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~  159 (443)
                      .++.+.+..+...+-+.   + ..-.+.-..||+....+|..+++|..+.. .....+...|++.+..|...  .++..+
T Consensus        10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~   88 (325)
T PRK11768         10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL   88 (325)
T ss_pred             CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence            34555555555444321   1 22234557799998878888999987532 23456677888888777321  122211


Q ss_pred             ---E--eeecCCCCeeEEEEeecCCCCh
Q 013404          160 ---G--YYSSRDSSQHLLCYELVPNGSL  182 (443)
Q Consensus       160 ---~--~~~~~~~~~~~lv~e~~~~gsL  182 (443)
                         |  +..  -++..+.++++++|...
T Consensus        89 ~~~G~~~~~--~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         89 AFNGQTLHE--HQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cCCCCEEEE--ECCEEEEEEeeeCCCCC
Confidence               1  111  12356788999987643

>PTZ00384 choline kinase; Provisional

Probab=95.88  E-value=0.064  Score=52.98  Aligned_cols=74  Identities=19%  Similarity=0.272  Sum_probs=45.0

Q ss_pred             ceeeecCcEEEEEEEECCC--cE-----EEEEEeccCCCCCHHHHHHHHHHHhhcCCCcee-eEEEeeecCCCCeeEEEE
Q 013404          103 SILGEGGFGRVFKGVLSDG--TA-----VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~lv~  174 (443)
                      +.|..|-...+|++...++  ..     |.++.... .....-+-.+|+++++.+...++. ++++.+.      -.+++
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~------~g~l~  128 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG------DFTIQ  128 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC------CEEEE
Confidence            4565688889999875433  22     44443221 111112345689999999766555 4555542      25889


Q ss_pred             eecCCCChh
Q 013404          175 ELVPNGSLE  183 (443)
Q Consensus       175 e~~~~gsL~  183 (443)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999988764

>PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region

Probab=95.86  E-value=0.005  Score=50.96  Aligned_cols=12  Identities=33%  Similarity=0.659  Sum_probs=6.9

Q ss_pred             hcCCCCCceeee
Q 013404           96 TNNFEPASILGE  107 (443)
Q Consensus        96 ~~~~~~~~~lg~  107 (443)
                      .++|+-...||.
T Consensus       111 ~~~y~s~splg~  122 (154)
T PF04478_consen  111 SDKYESNSPLGS  122 (154)
T ss_pred             ccccccCCCCCC
Confidence            455666666664

The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway [].

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.68  E-value=0.1  Score=47.14  Aligned_cols=75  Identities=16%  Similarity=0.216  Sum_probs=48.4

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC---CceeeEEEeeecCCCCeeEEEEeecCC
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH---RNLVKLVGYYSSRDSSQHLLCYELVPN  179 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~~~lv~e~~~~  179 (443)
                      +.+.-|.--..|...+ +...+.||+-.   .....-|..|+.-|..|.-   -++.+++.+-.  +....++|+||++-
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~--~~~~sylVle~L~~   95 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGA--SRDHSYLVLEYLPT   95 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecC--CCCeeEEEEeeccC
Confidence            3454555555555443 34678888743   2334668889988887743   34556655543  56688999999998


Q ss_pred             CChh
Q 013404          180 GSLE  183 (443)
Q Consensus       180 gsL~  183 (443)
                      |.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            7765

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	443
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-58
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-57
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-54
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-54
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-38
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-24
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-24
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-24
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-24
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-24
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-24
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-24
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-24
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-24
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-24
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-24
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-24
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-24
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-23
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-23
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-22
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-20
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-18
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-17
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-16
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-16
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-16
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-16
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-16
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-16
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-16
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-16
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-16
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-16
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-16
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-16
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-16
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-16
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-16
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-16
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-16
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-16
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-16
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-15
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-15
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-15
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-15
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-15
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-15
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-15
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-14
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		8e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-13
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-13
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-13
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-13
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-13
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-13
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-13
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-13
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-13
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-13
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-13
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-06
3soa_A	444	Full-Length Human Camkii Length = 444		4e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  222 bits (566), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 126/299 (42%), Positives = 184/299 (61%), Gaps = 7/299 (2%)
Query: 80  HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK- 138
           H    +  +  EL+ A++NF   +ILG GGFG+V+KG L+DGT VA+KRL     QG + 
Sbjct: 21  HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL 80
Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW 198
           +F  EVEM+S   HRNL++L G+  +   ++ LL Y  + NGS+ S L         LDW
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDW 138
Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
             R +IAL +ARGLAYLH+   P +IHRD KA+NILL+  F A V DFGLAK   + +  
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDX 197
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN--LV 316
           ++   V GT G++APEY  TG    K+DV+ YGV+LLEL+TG++  D+++ +  ++  L+
Sbjct: 198 HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 257
Query: 317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
            W + +L++K +LE L D  L G Y  E+  ++  +A  C      +RP M EVV+ L+
Sbjct: 258 DWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  218 bits (555), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 124/299 (41%), Positives = 182/299 (60%), Gaps = 7/299 (2%)
Query: 80  HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK- 138
           H    +  +  EL+ A++NF   +ILG GGFG+V+KG L+DG  VA+KRL     QG + 
Sbjct: 13  HLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL 72
Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW 198
           +F  EVEM+S   HRNL++L G+  +   ++ LL Y  + NGS+ S L         LDW
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
             R +IAL +ARGLAYLH+   P +IHRD KA+NILL+  F A V DFGLAK   + +  
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDX 189
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN--LV 316
           ++   V G  G++APEY  TG    K+DV+ YGV+LLEL+TG++  D+++ +  ++  L+
Sbjct: 190 HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
            W + +L++K +LE L D  L G Y  E+  ++  +A  C      +RP M EVV+ L+
Sbjct: 250 DWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  209 bits (533), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 121/292 (41%), Positives = 172/292 (58%), Gaps = 6/292 (2%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 150
           +L+EATNNF+   ++G G FG+V+KGVL DG  VA+KR T    QG +EF  E+E LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H +LV L+G+   R+  + +L Y+ + NG+L+  L+G       + WE R++I + AAR
Sbjct: 93  RHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GL YLH  +   +IHRD K+ NILL+ NF  K+ DFG++K+  E    +L   V GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 330
           + PEY + G L  KSDVYS+GVVL E+L  R  +  S P    NL  WA     +  +LE
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLE 266
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 382
           ++ DP L  K   E   +    A  C+A  +  RP+MG+V+  L+   R+ E
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  209 bits (532), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 121/292 (41%), Positives = 172/292 (58%), Gaps = 6/292 (2%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 150
           +L+EATNNF+   ++G G FG+V+KGVL DG  VA+KR T    QG +EF  E+E LS  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H +LV L+G+   R+  + +L Y+ + NG+L+  L+G       + WE R++I + AAR
Sbjct: 93  RHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GL YLH  +   +IHRD K+ NILL+ NF  K+ DFG++K+  E    +L   V GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE 330
           + PEY + G L  KSDVYS+GVVL E+L  R  +  S P    NL  WA     +  +LE
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLE 266
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE 382
           ++ DP L  K   E   +    A  C+A  +  RP+MG+V+  L+   R+ E
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 110/306 (35%), Positives = 177/306 (57%), Gaps = 23/306 (7%)
Query: 82  TSTRF--LAYEELKEATNNFE--PASI----LGEGGFGRVFKGVLSDGTAVAIKRLTC-- 131
           + TRF   ++ ELK  TNNF+  P S+    +GEGGFG V+KG +++ T VA+K+L    
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 66
Query: 132 --GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 189
               ++  ++F  E++++++  H NLV+L+G+  S D     L Y  +PNGSL   L   
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGF--SSDGDDLCLVYVYMPNGSLLDRL-SC 123
Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
           L     L W  R KIA  AA G+ +LHE+     IHRD K++NILL+  F AK++DFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLA 180
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           + + +     + +R++GT  Y+APE A+ G +  KSD+YS+GVVLLE++TG   VD  + 
Sbjct: 181 RASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 369
              + L+     I  ++  +E+  D ++           + ++A+ C+  + N+RP + +
Sbjct: 240 P--QLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 370 VVQSLK 375
           V Q L+
Sbjct: 297 VQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 110/306 (35%), Positives = 176/306 (57%), Gaps = 23/306 (7%)
Query: 82  TSTRF--LAYEELKEATNNFE--PASI----LGEGGFGRVFKGVLSDGTAVAIKRLTC-- 131
           + TRF   ++ ELK  TNNF+  P S+    +GEGGFG V+KG +++ T VA+K+L    
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 66
Query: 132 --GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 189
               ++  ++F  E++++++  H NLV+L+G+  S D     L Y  +PNGSL   L   
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGF--SSDGDDLCLVYVYMPNGSLLDRL-SC 123
Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
           L     L W  R KIA  AA G+ +LHE+     IHRD K++NILL+  F AK++DFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLA 180
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           + + +     +  R++GT  Y+APE A+ G +  KSD+YS+GVVLLE++TG   VD  + 
Sbjct: 181 RASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 369
              + L+     I  ++  +E+  D ++           + ++A+ C+  + N+RP + +
Sbjct: 240 P--QLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 370 VVQSLK 375
           V Q L+
Sbjct: 297 VQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 110/306 (35%), Positives = 176/306 (57%), Gaps = 23/306 (7%)
Query: 82  TSTRF--LAYEELKEATNNFE--PASI----LGEGGFGRVFKGVLSDGTAVAIKRLTC-- 131
           + TRF   ++ ELK  TNNF+  P S+    +GEGGFG V+KG +++ T VA+K+L    
Sbjct: 2   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 60
Query: 132 --GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 189
               ++  ++F  E++++++  H NLV+L+G+  S D     L Y  +PNGSL   L   
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGF--SSDGDDLCLVYVYMPNGSLLDRL-SC 117
Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
           L     L W  R KIA  AA G+ +LHE+     IHRD K++NILL+  F AK++DFGLA
Sbjct: 118 LDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLA 174
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           + + +     +  R++GT  Y+APE A+ G +  KSD+YS+GVVLLE++TG   VD  + 
Sbjct: 175 RASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 233
Query: 310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 369
              + L+     I  ++  +E+  D ++           + ++A+ C+  + N+RP + +
Sbjct: 234 P--QLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRPDIKK 290
Query: 370 VVQSLK 375
           V Q L+
Sbjct: 291 VQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 98/234 (41%), Positives = 140/234 (59%), Gaps = 20/234 (8%)
Query: 84  TRF--LAYEELKEATNNFE--PASI----LGEGGFGRVFKGVLSDGTAVAIKRLTC---- 131
           TRF   ++ ELK  TNNF+  P S+     GEGGFG V+KG +++ T VA+K+L      
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDI 59
Query: 132 GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG 191
             ++  ++F  E+++ ++  H NLV+L+G+  S D     L Y   PNGSL   L   L 
Sbjct: 60  TTEELKQQFDQEIKVXAKCQHENLVELLGF--SSDGDDLCLVYVYXPNGSLLDRL-SCLD 116
Query: 192 VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 251
               L W  R KIA  AA G+ +LHE+     IHRD K++NILL+  F AK++DFGLA+ 
Sbjct: 117 GTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 173
Query: 252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + +       +R++GT  Y APE A+ G +  KSD+YS+GVVLLE++TG   VD
Sbjct: 174 SEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 142/295 (48%), Gaps = 42/295 (14%)
Query: 95  ATNNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGD-------KEFLVEVEM 146
           A N  E    +G+GGFG V KG ++ D + VAIK L  G  +G+       +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           +S L+H N+VKL G   +       +  E VP G L    H  L     + W  ++++ L
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLML 129
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQAPEGRTNYLS 261
           D A G+ Y+ ++  P ++HRD ++ NI L++        AKVADFGL++Q+    +    
Sbjct: 130 DIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG--- 185
Query: 262 TRVMGTFGYVAPEY--AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 319
             ++G F ++APE   A       K+D YS+ ++L  +LTG  P D     G+   +   
Sbjct: 186 --LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINMI 242
Query: 320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           R         EE   P +    P++   R+  +   C + +  +RP    +V+ L
Sbjct: 243 R---------EEGLRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 82
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 83  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 137
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 229

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 81
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 82  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 136
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 194 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 228

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 82
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 83  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 137
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 229

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 85
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 86  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 140
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 232

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 84
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 85  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 139
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 231

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 76
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 131
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 77
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 78  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 132
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 190 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 224

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 76
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 131
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 78
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 79  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 133
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIED---NEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 191 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 225

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 86
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 87  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 141
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 233

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 76
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 131
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 141/295 (47%), Gaps = 42/295 (14%)
Query: 95  ATNNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGD-------KEFLVEVEM 146
           A N  E    +G+GGFG V KG ++ D + VAIK L  G  +G+       +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           +S L+H N+VKL G   +       +  E VP G L    H  L     + W  ++++ L
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLML 129
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQAPEGRTNYLS 261
           D A G+ Y+ ++  P ++HRD ++ NI L++        AKVADFG ++Q+    +    
Sbjct: 130 DIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSG--- 185
Query: 262 TRVMGTFGYVAPEY--AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 319
             ++G F ++APE   A       K+D YS+ ++L  +LTG  P D     G+   +   
Sbjct: 186 --LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINMI 242
Query: 320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           R         EE   P +    P++   R+  +   C + +  +RP    +V+ L
Sbjct: 243 R---------EEGLRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 71
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 72  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 126
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 218

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 141/295 (47%), Gaps = 42/295 (14%)
Query: 95  ATNNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGD-------KEFLVEVEM 146
           A N  E    +G+GGFG V KG ++ D + VAIK L  G  +G+       +EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           +S L+H N+VKL G   +       +  E VP G L    H  L     + W  ++++ L
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR----MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLML 129
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQAPEGRTNYLS 261
           D A G+ Y+ ++  P ++HRD ++ NI L++        AKVADF L++Q+    +    
Sbjct: 130 DIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSG--- 185
Query: 262 TRVMGTFGYVAPEY--AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 319
             ++G F ++APE   A       K+D YS+ ++L  +LTG  P D     G+   +   
Sbjct: 186 --LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINMI 242
Query: 320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           R         EE   P +    P++   R+  +   C + +  +RP    +V+ L
Sbjct: 243 R---------EEGLRPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/215 (33%), Positives = 113/215 (52%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 72
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 73  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 127
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HR+ +A+NIL+ +    K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 219

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/202 (36%), Positives = 110/202 (54%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L  Y   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            +   +++C E +  GSL  +L G +G   +L     + +A   A G+AY+   +    +
Sbjct: 83  SEEPIYIVC-EYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 136
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 126/273 (46%), Gaps = 25/273 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKLVGYY 162
           +G G FG V +     G+ VA+K L       ++  EFL EV ++ RL H N+V  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
           +   +    +  E +  GSL   LH   G    LD   R+ +A D A+G+ YLH +  P 
Sbjct: 104 TQPPNLS--IVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 282
           ++HRD K+ N+L++  +  KV DFGL++   +      S    GT  ++APE        
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 283 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 342
            KSDVYS+GV+L EL T      + QP G  N       +     RLE           P
Sbjct: 218 EKSDVYSFGVILWELAT------LQQPWGNLNPAQVVAAVGFKCKRLE----------IP 261
Query: 343 KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           +    +V  I   C   E  +RP+   ++  L+
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK--EFLVEVEMLSRLHHRNLVKLVGYY 162
           +G G FG V +     G+ VA+K L       ++  EFL EV ++ RL H N+V  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
           +   +    +  E +  GSL   LH   G    LD   R+ +A D A+G+ YLH +  P 
Sbjct: 104 TQPPNLS--IVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR-VMGTFGYVAPEYAMTGHL 281
           ++HR+ K+ N+L++  +  KV DFGL++      + +LS++   GT  ++APE       
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK---ASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             KSDVYS+GV+L EL T      + QP G  N       +     RLE           
Sbjct: 217 NEKSDVYSFGVILWELAT------LQQPWGNLNPAQVVAAVGFKCKRLE----------I 260
Query: 342 PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           P+    +V  I   C   E  +RP+   ++  L+
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 111/215 (51%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G  G V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L   Y+ 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRL---YAV 76
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E + NGSL  +L  P G+   ++    + +A   A G+A++ E +    I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAFIEERN---YI 131
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+ +    K+ADFGLA+   +      + R    F   + APE    G   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEX---TAREGAKFPIKWTAPEAINYGTFT 188
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENL 315
           +KSDV+S+G++L E++T GR P   M+ P   +NL
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 72
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G +G    L     + +A   A G+AY+   +    +
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN---YV 127
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 185 IKSDVWSFGILLTELTTKGRVP 206

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G +G    L     + +A   A G+AY+   +    +
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN---YV 136
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIED---NEXTARQGAKFPIKWTAPEAALYGRFT 193
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 70
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G +G    L     + +A   A G+AY+   +    +
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN---YV 125
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 183 IKSDVWSFGILLTELTTKGRVP 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G +G    L     + +A   A G+AY+   +    +
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN---YV 136
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G +G    L     + +A   A G+AY+   +    +
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN---YV 136
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ ++ H  LV+L   Y+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQL---YAV 81
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G +G    L     + +A   A G+AY+   +    +
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN---YV 136
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 74
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G  G    L     + +A   A G+AY+   +    +
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVERMN---YV 129
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 187 IKSDVWSFGILLTELTTKGRVP 208

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G +G    L     + +A   A G+AY+   +    +
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN---YV 136
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD  A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 71
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G  G    L     + +A   A G+AY+   +    +
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVERMN---YV 126
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIED---NEXTARQGAKFPIKWTAPEAALYGRFT 183
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 184 IKSDVWSFGILLTELTTKGRVP 205

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L  G     + FL E +++ +L H  LV+L   Y+ 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL---YAV 330
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G  G   +L     + +A   A G+AY+   +    +
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 385
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 443 IKSDVWSFGILLTELTTKGRVP 464

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 247
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G  G   +L     + +A   A G+AY+   +    +
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 247
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G  G   +L     + +A   A G+AY+   +    +
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP 381

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L  G    +  FL E +++ +L H  LV+L   Y+ 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQL---YAV 248
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G +G   +L     + +A   A G+AY+   +    +
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 303
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGL +   +   N  + R    F   + APE A+ G   
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 360
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 361 IKSDVWSFGILLTELTTKGRVP 382

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  G L  +L G +G   +L     + +A   A G+AY+   +    +
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 136
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 81
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  G L  +L G +G   +L     + +A   A G+AY+   +    +
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 136
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 194 IKSDVWSFGILLTELTTKGRVP 215

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/202 (36%), Positives = 106/202 (52%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 247
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G  G   +L     + +A   A G+AY+   +    +
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMN---YV 302
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 360 IKSDVWSFGILLTELTTKGRVP 381

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 78
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G  G    L     + ++   A G+AY+   +    +
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQIASGMAYVERMN---YV 133
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIED---NEWTARQGAKFPIKWTAPEAALYGRFT 190
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 191 IKSDVWSFGILLTELTTKGRVP 212

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG+G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL---YAV 78
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L G  G    L     + ++   A G+AY+   +    +
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQIASGMAYVERMN---YV 133
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  N   KVADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL T GR P
Sbjct: 191 IKSDVWSFGILLTELTTKGRVP 212

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 134/295 (45%), Gaps = 37/295 (12%)
Query: 99  FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            E   ++G G FG V K        VAIK++    ++  K F+VE+  LSR++H N+VKL
Sbjct: 10  IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKL 66
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHG----PLGVNCHLDWETRMKIALDAARGLAY 214
            G       +   L  E    GSL + LHG    P     H      M   L  ++G+AY
Sbjct: 67  YG----ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH-----AMSWCLQCSQGVAY 117
Query: 215 LHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           LH      +IHRD K  N+LL       K+ DFG A       TN       G+  ++AP
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAAWMAP 172
Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
           E     +   K DV+S+G++L E++T RKP D  +  G    + WA   + +  R     
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWA---VHNGTR----- 222
Query: 334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTL 388
            P L    PK     + ++   C + + +QRP+M E+V+ +  + R     D  L
Sbjct: 223 -PPLIKNLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 100/300 (33%), Positives = 137/300 (45%), Gaps = 37/300 (12%)
Query: 105 LGEGGFGRV---FKGVLSDGTA--VAIKRLTC-GGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+V        +DGT   VA+K L    G Q    +  E+++L  L+H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL-HGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
            G      ++   L  E VP GSL  +L    +G+         +  A     G+AYLH 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA------QLLLFAQQICEGMAYLHA 152
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPE 274
                 IHRD  A N+LL+N+   K+ DFGLAK  PEG   Y   R  G    F Y APE
Sbjct: 153 QH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXY-RVREDGDSPVFWY-APE 207
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ--PSGQENLVTWAR---PILRDKDRL 329
                     SDV+S+GV L ELLT     D SQ  P+    L+  A+    +LR  + L
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTH---CDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264
Query: 330 EELADPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPT 387
           E       G + P+ D     V  +   C   EA+ RPT   ++  LK V    + Q P+
Sbjct: 265 ER------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/295 (30%), Positives = 134/295 (45%), Gaps = 37/295 (12%)
Query: 99  FEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            E   ++G G FG V K        VAIK++    ++  K F+VE+  LSR++H N+VKL
Sbjct: 11  IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKL 67
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHG----PLGVNCHLDWETRMKIALDAARGLAY 214
            G       +   L  E    GSL + LHG    P     H      M   L  ++G+AY
Sbjct: 68  YG----ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH-----AMSWCLQCSQGVAY 118
Query: 215 LHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           LH      +IHRD K  N+LL       K+ DFG A       TN       G+  ++AP
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-----KGSAAWMAP 173
Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
           E     +   K DV+S+G++L E++T RKP D  +  G    + WA   + +  R     
Sbjct: 174 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWA---VHNGTR----- 223
Query: 334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTL 388
            P L    PK     + ++   C + + +QRP+M E+V+ +  + R     D  L
Sbjct: 224 -PPLIKNLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 273

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  +  T VAIK L   G    + FL E +++ +L H  LV+L   Y+ 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQL---YAV 72
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L    G    L     + +A   A G+AY+   +    I
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAYIERMN---YI 127
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +++NIL+ N    K+ADFGLA+   +   N  + R    F   + APE A+ G   
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIED---NEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L EL+T GR P
Sbjct: 185 IKSDVWSFGILLTELVTKGRVP 206

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 90/323 (27%), Positives = 142/323 (43%), Gaps = 50/323 (15%)
Query: 69  ADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TA 123
            + +T  G+ P+    R L   ELK          +LG G FG V+KG+ + +G      
Sbjct: 17  VEPLTPSGTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIP 69
Query: 124 VAIKRLT-CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL 182
           VAIK L    G + + EF+ E  +++ + H +LV+L+G   S       L  +L+P+G L
Sbjct: 70  VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ---LVTQLMPHGCL 126
Query: 183 ESWLH---GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 239
             ++H     +G    L+W       +  A+G+ YL E     ++HRD  A N+L+++  
Sbjct: 127 LEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPN 177
Query: 240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           H K+ DFGLA+        Y +        ++A E         +SDV+SYGV + EL+T
Sbjct: 178 HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237
Query: 300 -GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTIAAAC 356
            G KP D               P     D LE+      G + P+     I V  +   C
Sbjct: 238 FGGKPYD-------------GIPTREIPDLLEK------GERLPQPPICTIDVYMVMVKC 278
Query: 357 VAPEANQRPTMGEVVQSLKMVQR 379
              +A+ RP   E+      + R
Sbjct: 279 WMIDADSRPKFKELAAEFSRMAR 301

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 100/294 (34%), Positives = 135/294 (45%), Gaps = 43/294 (14%)
Query: 105 LGEGGFGRV---FKGVLSDGTA--VAIKRLT--CGGQQ--GDKEFLVEVEMLSRLHHRNL 155
           LGEG FG+V        +DGT   VA+K L   CG Q   G K+   E+++L  L+H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL-HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +K  G    +      L  E VP GSL  +L    +G+         +  A     G+AY
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLA------QLLLFAQQICEGMAY 132
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYV 271
           LH       IHR+  A N+LL+N+   K+ DFGLAK  PEG   Y   R  G    F Y 
Sbjct: 133 LHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWY- 187
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ--PSGQENLVTWAR---PILRDK 326
           APE          SDV+S+GV L ELLT     D SQ  P+    L+  A+    +LR  
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLTH---CDSSQSPPTKFLELIGIAQGQMTVLRLT 244
Query: 327 DRLEELADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 378
           + LE       G + P+ D     V  +   C   EA+ RPT   ++  LK V 
Sbjct: 245 ELLER------GERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVH 292

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 12/202 (5%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY ++
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH         + +  + IA   ARG+ YLH  S   +I
Sbjct: 92  ---PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHL 281
           HRD K++NI L  +   K+ DFGLA +      ++   ++ G+  ++APE      +   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
             +SDVY++G+VL EL+TG+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 100/294 (34%), Positives = 135/294 (45%), Gaps = 43/294 (14%)
Query: 105 LGEGGFGRV---FKGVLSDGTA--VAIKRLT--CGGQQ--GDKEFLVEVEMLSRLHHRNL 155
           LGEG FG+V        +DGT   VA+K L   CG Q   G K+   E+++L  L+H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL-HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +K  G    +      L  E VP GSL  +L    +G+         +  A     G+AY
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLA------QLLLFAQQICEGMAY 132
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYV 271
           LH       IHR+  A N+LL+N+   K+ DFGLAK  PEG   Y   R  G    F Y 
Sbjct: 133 LHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWY- 187
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ--PSGQENLVTWAR---PILRDK 326
           APE          SDV+S+GV L ELLT     D SQ  P+    L+  A+    +LR  
Sbjct: 188 APECLKEYKFYYASDVWSFGVTLYELLTH---CDSSQSPPTKFLELIGIAQGQMTVLRLT 244
Query: 327 DRLEELADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 378
           + LE       G + P+ D     V  +   C   EA+ RPT   ++  LK V 
Sbjct: 245 ELLER------GERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVH 292

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 95/342 (27%), Positives = 147/342 (42%), Gaps = 56/342 (16%)
Query: 76  GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRLT 130
           G+ P+    R L   ELK          +LG G FG V+KG+ + +G      VAIK L 
Sbjct: 1   GTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN 53
Query: 131 -CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-- 187
              G + + EF+ E  +++ + H +LV+L+G   S       L  +L+P+G L  ++H  
Sbjct: 54  ETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ---LVTQLMPHGCLLEYVHEH 110
Query: 188 -GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 246
              +G    L+W       +  A+G+ YL E     ++HRD  A N+L+++  H K+ DF
Sbjct: 111 KDNIGSQLLLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDF 161
Query: 247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVD 305
           GLA+        Y +        ++A E         +SDV+SYGV + EL+T G KP D
Sbjct: 162 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221
Query: 306 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTIAAACVAPEANQ 363
                          P     D LE+      G + P+     I V  +   C   +A+ 
Sbjct: 222 -------------GIPTREIPDLLEK------GERLPQPPICTIDVYMVMVKCWMIDADS 262
Query: 364 RPTMGEVVQSLKMVQR------VIECQDPTLTSSNNRANLRQ 399
           RP   E+      + R      VI+  D     S N +   Q
Sbjct: 263 RPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQ 304

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH         + +  + IA   ARG+ YLH  S   +I
Sbjct: 92  ---PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---II 142
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHL 281
           HRD K++NI L  +   K+ DFGLA +      ++   ++ G+  ++APE      +   
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
             +SDVY++G+VL EL+TG+ P
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLP 224

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH         + +  + IA   ARG+ YLH  S   +I
Sbjct: 80  ---PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---II 130
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHL 281
           HRD K++NI L  +   K+ DFGLA        ++   ++ G+  ++APE      +   
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
             +SDVY++G+VL EL+TG+ P
Sbjct: 191 SFQSDVYAFGIVLYELMTGQLP 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 96  ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 146
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA +      ++   ++ G+  ++APE          
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 207 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 246
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 247 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 292

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 76  ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA +      ++   ++ G+  ++APE          
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 226
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 104 ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA +      ++   ++ G+  ++APE          
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 254
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 255 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY ++
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 76  ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA        ++   ++ G+  ++APE          
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 226
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 78  ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 128
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA        ++   ++ G+  ++APE          
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 228
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 229 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 274

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 81  ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA        ++   ++ G+  ++APE          
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 231
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 232 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 81  ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 131
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA        ++   ++ G+  ++APE          
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 231
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 232 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 277

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 76  ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 126
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA        ++   ++ G+  ++APE          
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 226
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 103 ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 153
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA        ++   ++ G+  ++APE          
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 253
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 254 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 299

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++  +GY + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
               Q  +  +     SL   LH    +    +    + IA   A+G+ YLH  S   +I
Sbjct: 104 ---PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---II 154
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---L 281
           HRD K++NI L  +   K+ DFGLA        ++   ++ G+  ++APE          
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVY++G+VL EL+TG+ P                   + ++D++  +    +G  Y
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSN----------------INNRDQIIFM----VGRGY 254
Query: 342 PKEDFIRVCT--------IAAACVAPEANQRPTMGEVVQSLKMVQR 379
              D  +V +        + A C+  + ++RP   +++ S++++ R
Sbjct: 255 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 300

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 95/288 (32%), Positives = 129/288 (44%), Gaps = 31/288 (10%)
Query: 105 LGEGGFGRV---FKGVLSDGTA--VAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+V        +DGT   VA+K L  G G Q    +  E+E+L  L+H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G    +      L  E VP GSL  +L      +C +     +  A     G+AYLH  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHC-VGLAQLLLFAQQICEGMAYLHAQ 131
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 275
                IHR   A N+LL+N+   K+ DFGLAK  PEG   Y   R  G    F Y APE 
Sbjct: 132 H---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWY-APEC 186
Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR---PILRDKDRLEEL 332
                    SDV+S+GV L ELLT     + S  +    L+   +    +LR  + LE  
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT-YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLER- 244
Query: 333 ADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 378
                G + P+ D     +  +   C   EA+ RPT   +V  L+  Q
Sbjct: 245 -----GERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQ 287

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 95/288 (32%), Positives = 129/288 (44%), Gaps = 31/288 (10%)
Query: 105 LGEGGFGRV---FKGVLSDGTA--VAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+V        +DGT   VA+K L  G G Q    +  E+E+L  L+H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G    +      L  E VP GSL  +L      +C +     +  A     G+AYLH  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHC-VGLAQLLLFAQQICEGMAYLHAQ 130
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 275
                IHR   A N+LL+N+   K+ DFGLAK  PEG   Y   R  G    F Y APE 
Sbjct: 131 H---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWY-APEC 185
Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR---PILRDKDRLEEL 332
                    SDV+S+GV L ELLT     + S  +    L+   +    +LR  + LE  
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT-YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLER- 243
Query: 333 ADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 378
                G + P+ D     +  +   C   EA+ RPT   +V  L+  Q
Sbjct: 244 -----GERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQ 286

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  ++ T VA+K L   G    + FL E  ++  L H  LV+L     +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAV-VT 78
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           R+   +++  E +  GSL  +L    G    L     +  +   A G+AY+   +    I
Sbjct: 79  REEPIYIIT-EYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKN---YI 132
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+N+L+  +   K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KSDV+S+G++L E++T G+ P
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIP 211

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 122/283 (43%), Gaps = 35/283 (12%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 131
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEYA 276
               IHRD    NIL+EN    K+ DFGL K  P+ +  +   +  G    F Y APE  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EFFKVKEPGESPIFWY-APESL 189
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKD 327
                 V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249
Query: 328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
           RL     PR  G  P E    +  I   C     NQRP+  ++
Sbjct: 250 RL-----PRPDG-CPDE----IYMIMTECWNNNVNQRPSFRDL 282

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+    +  T VA+K +  G    +  FL E  ++  L H  LVKL   ++ 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL---HAV 78
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L    G    L     +  +   A G+A++    Q   I
Sbjct: 79  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNYI 133
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  +   K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQP 309
           +KSDV+S+G++L+E++T GR P   MS P
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIPYPGMSNP 219

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 124/274 (45%), Gaps = 35/274 (12%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+    +  T VA+K +  G    +  FL E  ++  L H  LVKL   ++ 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL---HAV 251
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L    G    L     +  +   A G+A++    Q   I
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNYI 306
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  +   K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
           +KSDV+S+G++L+E++T GR P   MS P            ++R  +R   +  P     
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----------VIRALERGYRMPRPE---N 409
Query: 341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
            P+E    +  I   C      +RPT  E +QS+
Sbjct: 410 CPEE----LYNIMMRCWKNRPEERPTF-EYIQSV 438

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 30/280 (10%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V+KG      AV I ++     +  + F  EV +L +  H N++  +GY + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            + +   +  +     SL   LH              + IA   A+G+ YLH  +   +I
Sbjct: 104 DNLA---IVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---II 154
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHL 281
           HRD K++NI L      K+ DFGLA        +    +  G+  ++APE          
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             +SDVYSYG+VL EL+TG  P   S  + ++ ++                A P L   Y
Sbjct: 215 SFQSDVYSYGIVLYELMTGELP--YSHINNRDQIIFMVG---------RGYASPDLSKLY 263
Query: 342 ---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 378
              PK     +  + A CV     +RP   +++ S++++Q
Sbjct: 264 KNCPKA----MKRLVADCVKKVKEERPLFPQILSSIELLQ 299

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 121/244 (49%), Gaps = 36/244 (14%)
Query: 75  GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKG-VLSDGTAV--AIKRLTC 131
           G + P PT    L + ++K     F+   ++GEG FG+V K  +  DG  +  AIKR+  
Sbjct: 10  GKNNPDPTIYPVLDWNDIK-----FQ--DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 62
Query: 132 GGQQGD-KEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 189
              + D ++F  E+E+L +L HH N++ L+G    R      L  E  P+G+L  +L   
Sbjct: 63  YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKS 120
Query: 190 LGVNCH------------LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN 237
             +               L  +  +  A D ARG+ YL   SQ   IHRD  A NIL+  
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGE 177
Query: 238 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLL 295
           N+ AK+ADFGL++    G+  Y+  + MG     ++A E          SDV+SYGV+L 
Sbjct: 178 NYVAKIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232
Query: 296 ELLT 299
           E+++
Sbjct: 233 EIVS 236

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V  G   +   VAIK +   G   +++F+ E E++ +L H  LV+L G    
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV--C 69
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            + +   L +E + +G L  +L    G+      ET + + LD   G+AYL E    CVI
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 284
           HRD  A N L+  N   KV+DFG+ +   + +    ST       + +PE         K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 182
Query: 285 SDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK 343
           SDV+S+GV++ E+ + G+ P +    S           ++ D      L  PRL   +  
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNS----------EVVEDISTGFRLYKPRLASTH-- 230
Query: 344 EDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                V  I   C       RP    +++ L
Sbjct: 231 -----VYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/271 (28%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V  G   +   VAIK +   G   +++F+ E E++ +L H  LV+L G    
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV--C 71
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            + +   L +E + +G L  +L    G+      ET + + LD   G+AYL E    CVI
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEE---ACVI 125
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 284
           HRD  A N L+  N   KV+DFG+ +   + +    ST       + +PE         K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 184
Query: 285 SDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK 343
           SDV+S+GV++ E+ + G+ P +    S           ++ D      L  PRL   +  
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNS----------EVVEDISTGFRLYKPRLASTH-- 232
Query: 344 EDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                V  I   C       RP    +++ L
Sbjct: 233 -----VYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 132
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEYA 276
               IHR+    NIL+EN    K+ DFGL K  P+ +  Y   +  G    F Y APE  
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK-EYYKVKEPGESPIFWY-APESL 190
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKD 327
                 V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  
Sbjct: 191 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 250
Query: 328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
           RL     PR  G  P E ++    I   C     NQRP+  ++
Sbjct: 251 RL-----PRPDG-CPDEIYM----IMTECWNNNVNQRPSFRDL 283

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 118/271 (43%), Gaps = 28/271 (10%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V  G   +   VAIK +  G    D +F+ E E++ +L H  LV+L G    
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED-DFIEEAEVMMKLSHPKLVQLYGV--C 91
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            + +   L +E + +G L  +L    G+      ET + + LD   G+AYL E    CVI
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEE---ACVI 145
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 284
           HRD  A N L+  N   KV+DFG+ +   + +    ST       + +PE         K
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 204
Query: 285 SDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK 343
           SDV+S+GV++ E+ + G+ P +    S           ++ D      L  PRL   +  
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYENRSNS----------EVVEDISTGFRLYKPRLASTH-- 252
Query: 344 EDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                V  I   C       RP    +++ L
Sbjct: 253 -----VYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V  G   +   VAIK +   G   +++F+ E E++ +L H  LV+L G    
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV--C 74
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            + +   L +E + +G L  +L    G+      ET + + LD   G+AYL E    CVI
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEE---ACVI 128
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 284
           HRD  A N L+  N   KV+DFG+ +   + +    ST       + +PE         K
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 187
Query: 285 SDVYSYGVVLLELLT-GRKPVD 305
           SDV+S+GV++ E+ + G+ P +
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYE 209

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/240 (32%), Positives = 119/240 (49%), Gaps = 36/240 (15%)
Query: 79  PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKG-VLSDGTAV--AIKRLTCGGQQ 135
           P PT    L + ++K     F+   ++GEG FG+V K  +  DG  +  AIKR+     +
Sbjct: 4   PDPTIYPVLDWNDIK-----FQ--DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK 56
Query: 136 GD-KEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
            D ++F  E+E+L +L HH N++ L+G    R      L  E  P+G+L  +L     + 
Sbjct: 57  DDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLE 114
Query: 194 CH------------LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 241
                         L  +  +  A D ARG+ YL   SQ   IHRD  A NIL+  N+ A
Sbjct: 115 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVA 171
Query: 242 KVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           K+ADFGL++    G+  Y+  + MG     ++A E          SDV+SYGV+L E+++
Sbjct: 172 KIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 134
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 254
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E    +  I   C     NQRP+  ++
Sbjct: 255 -----PRPDG-CPDE----IYMIMTECWNNNVNQRPSFRDL 285

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 93/181 (51%), Gaps = 13/181 (7%)
Query: 144 VEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           +  L  LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  E   
Sbjct: 62  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILG 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           K+++   RGLAYL E  Q  ++HRD K SNIL+ +    K+ DFG++ Q      + ++ 
Sbjct: 118 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMAN 171
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 322
             +GT  Y+APE     H  V+SD++S G+ L+EL  GR P+    P  +E    + RP+
Sbjct: 172 SFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI--PPPDAKELEAIFGRPV 229
Query: 323 L 323
           +
Sbjct: 230 V 230

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L        H+     ++      +G+ YL    
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL---LQYTSQICKGMEYL---G 134
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 254
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E    +  I   C     NQRP+  ++
Sbjct: 255 -----PRPDG-CPDE----IYMIMTECWNNNVNQRPSFRDL 285

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/216 (35%), Positives = 102/216 (47%), Gaps = 38/216 (17%)
Query: 103 SILGEGGFGRV---FKGVLSDGTA--VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           S LG+G FG V       L D T   VA+K+L   G    ++F  E+++L  LH   +VK
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 158 L--VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
              V Y   R S +  L  E +P+G L  +L              R +  LDA+R L Y 
Sbjct: 76  YRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQ-------------RHRARLDASRLLLY- 119
Query: 216 HEDSQPC----------VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              SQ C           +HRD  A NIL+E+  H K+ADFGLAK  P  + +Y   R  
Sbjct: 120 --SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREP 176
Query: 266 GT--FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           G     + APE         +SDV+S+GVVL EL T
Sbjct: 177 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/216 (35%), Positives = 102/216 (47%), Gaps = 38/216 (17%)
Query: 103 SILGEGGFGRV---FKGVLSDGTA--VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           S LG+G FG V       L D T   VA+K+L   G    ++F  E+++L  LH   +VK
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 158 L--VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
              V Y   R S +  L  E +P+G L  +L              R +  LDA+R L Y 
Sbjct: 77  YRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQ-------------RHRARLDASRLLLY- 120
Query: 216 HEDSQPC----------VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              SQ C           +HRD  A NIL+E+  H K+ADFGLAK  P  + +Y   R  
Sbjct: 121 --SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREP 177
Query: 266 GT--FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           G     + APE         +SDV+S+GVVL EL T
Sbjct: 178 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/216 (35%), Positives = 102/216 (47%), Gaps = 38/216 (17%)
Query: 103 SILGEGGFGRV---FKGVLSDGTA--VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           S LG+G FG V       L D T   VA+K+L   G    ++F  E+++L  LH   +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 158 L--VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
              V Y   R S +  L  E +P+G L  +L              R +  LDA+R L Y 
Sbjct: 89  YRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQ-------------RHRARLDASRLLLY- 132
Query: 216 HEDSQPC----------VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              SQ C           +HRD  A NIL+E+  H K+ADFGLAK  P  + +Y   R  
Sbjct: 133 --SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DYYVVREP 189
Query: 266 GT--FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           G     + APE         +SDV+S+GVVL EL T
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 134
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 195 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 254
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E ++    I   C     NQRP+  ++
Sbjct: 255 -----PRPDG-CPDEIYM----IMTECWNNNVNQRPSFRDL 285

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 105/226 (46%), Gaps = 23/226 (10%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL 150
           L++    FE   ++G G +G+V+KG  +  G   AIK +   G + ++E   E+ ML + 
Sbjct: 19  LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKY 77
Query: 151 -HHRNLVKLVGYYSSRD----SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
            HHRN+    G +  ++      Q  L  E    GS+   +    G     +W     I 
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--IC 135
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE--GRTNYLSTR 263
            +  RGL++LH   Q  VIHRD K  N+LL  N   K+ DFG++ Q     GR N     
Sbjct: 136 REILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--- 189
Query: 264 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKPV 304
            +GT  ++APE              KSD++S G+  +E+  G  P+
Sbjct: 190 -IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 136
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 197 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 256
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E    +  I   C     NQRP+  ++
Sbjct: 257 -----PRPDG-CPDE----IYMIMTECWNNNVNQRPSFRDL 287

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+ G  ++ T VA+K L   G    + FL E  ++  L H  LV+L    + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            +     +  E +  GSL  +L    G    L     +  +   A G+AY+   +    I
Sbjct: 79  EEPI--YIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERKN---YI 131
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+N+L+  +   K+ADFGLA+   +   N  + R    F   + APE    G   
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
           +KS+V+S+G++L E++T G+ P
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIP 210

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 111/252 (44%), Gaps = 25/252 (9%)
Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF           D   VA+K L        K+F  E E+L+ L H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGV-------NCHLDWETRMKIALDAA 209
            G     D    ++ +E + +G L  +L  HGP  V          L     + IA   A
Sbjct: 81  YGVCVEGDPL--IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+ YL   +    +HRD    N L+  N   K+ DFG+++         +    M    
Sbjct: 139 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENL--VTWARPILRDK 326
           ++ PE  M      +SDV+S GVVL E+ T G++P    Q S  E +  +T  R + R +
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--WYQLSNNEVIECITQGRVLQRPR 253
Query: 327 DRLEELADPRLG 338
              +E+ +  LG
Sbjct: 254 TCPQEVYELMLG 265

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 130
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 191 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 250
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E ++    I   C     NQRP+  ++
Sbjct: 251 -----PRPDG-CPDEIYM----IMTECWNNNVNQRPSFRDL 281

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 131
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E ++    I   C     NQRP+  ++
Sbjct: 252 -----PRPDG-CPDEIYM----IMTECWNNNVNQRPSFRDL 282

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 135
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 196 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 255
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E    +  I   C     NQRP+  ++
Sbjct: 256 -----PRPDG-CPDE----IYMIMTECWNNNVNQRPSFRDL 286

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 105 LGEGGFGRVFKGVL-----SDGTAVAIKRLTC-GGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+V          + G  VA+K L    G     +   E+E+L  L+H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +    +   L  E +P+GSL+ +L  P   N  ++ + ++K A+   +G+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKN-KINLKQQLKYAVQICKGMDYLGSR 145
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTFGYVAPEYA 276
                +HRD  A N+L+E+    K+ DFGL K  +  +        R    F Y APE  
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 201
Query: 277 MTGHLLVKSDVYSYGVVLLELLT 299
           M     + SDV+S+GV L ELLT
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 137
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 198 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 257
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E    +  I   C     NQRP+  ++
Sbjct: 258 -----PRPDG-CPDE----IYMIMTECWNNNVNQRPSFRDL 288

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 131
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E ++    I   C     NQRP+  ++
Sbjct: 252 -----PRPDG-CPDEIYM----IMTECWNNNVNQRPSFRDL 282

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRVFK---GVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 162
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E ++    I   C     NQRP+  ++
Sbjct: 283 -----PRPDG-CPDEIYM----IMTECWNNNVNQRPSFRDL 313

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 129
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 190 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 249
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E ++    I   C     NQRP+  ++
Sbjct: 250 -----PRPDG-CPDEIYM----IMTECWNNNVNQRPSFRDL 280

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 138
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 199 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 258
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E    +  I   C     NQRP+  ++
Sbjct: 259 -----PRPDG-CPDE----IYMIMTECWNNNVNQRPSFRDL 289

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVG 160
           I+G GGFG+V++   + D  AV   R        Q  +    E ++ + L H N++ L G
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGP-LGVNCHLDWETRMKIALDAARGLAYLHEDS 219
                      L  E    G L   L G  +  +  ++W      A+  ARG+ YLH+++
Sbjct: 74  V--CLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEA 125
Query: 220 QPCVIHRDFKASNILL----EN----NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
              +IHRD K+SNIL+    EN    N   K+ DFGLA++    RT  +S    G + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSA--AGAYAWM 181
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE          SDV+SYGV+L ELLTG  P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 18/215 (8%)
Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V +G L       + VAIK L  G  ++  +EFL E  ++ +  H N+++L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +  +S   ++  E + NG+L+S+L    G    +     ++     A G+ YL E 
Sbjct: 83  EGVVT--NSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLAEM 137
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 275
           S    +HRD  A NIL+ +N   KV+DFGL++   E  ++   T  +G      + APE 
Sbjct: 138 S---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 276 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQ 308
                    SD +SYG+V+ E+++ G +P  DMS 
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSN 229

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 149
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 269
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E ++    I   C     NQRP+  ++
Sbjct: 270 -----PRPDG-CPDEIYM----IMTECWNNNVNQRPSFRDL 300

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 105 LGEGGFGRVFKGVL-----SDGTAVAIKRLTC-GGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+V          + G  VA+K L    G     +   E+E+L  L+H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +    +   L  E +P+GSL+ +L  P   N  ++ + ++K A+   +G+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKN-KINLKQQLKYAVQICKGMDYLGSR 133
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAK--QAPEGRTNYLSTRVMGTFGYVAPEYA 276
                +HRD  A N+L+E+    K+ DFGL K  +  +        R    F Y APE  
Sbjct: 134 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 189
Query: 277 MTGHLLVKSDVYSYGVVLLELLT 299
           M     + SDV+S+GV L ELLT
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 121/274 (44%), Gaps = 45/274 (16%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V+    +  T VA+K +  G    +  FL E  ++  L H  LVKL   ++ 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKL---HAV 245
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
                  +  E +  GSL  +L    G    L     +  +   A G+A++    Q   I
Sbjct: 246 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNYI 300
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD +A+NIL+  +   K+ADFGLA             RV   F   + APE    G   
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLA-------------RVGAKFPIKWTAPEAINFGSFT 347
Query: 283 VKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
           +KSDV+S+G++L+E++T GR P   MS P            ++R  +R   +  P     
Sbjct: 348 IKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----------VIRALERGYRMPRPE---N 393
Query: 341 YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
            P+E    +  I   C      +RPT  E +QS+
Sbjct: 394 CPEE----LYNIMMRCWKNRPEERPTF-EYIQSV 422

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 120/281 (42%), Gaps = 31/281 (11%)
Query: 105 LGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG+G FG V       L D  G  VA+K+L    ++  ++F  E+E+L  L H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G   S       L  E +P GSL  +L         +D    ++      +G+ YL    
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---G 149
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMT 278
               IHRD    NIL+EN    K+ DFGL K  P+ +    +         + APE    
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 279 GHLLVKSDVYSYGVVLLELLT-----GRKPVDMSQPSGQEN----LVTWARPILRDKDRL 329
               V SDV+S+GVVL EL T        P +  +  G +     +V     +L++  RL
Sbjct: 210 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 269
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
                PR  G  P E ++    I   C     NQRP+  ++
Sbjct: 270 -----PRPDG-CPDEIYM----IMTECWNNNVNQRPSFRDL 300

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 34/281 (12%)
Query: 105 LGEGGFGRVFKGVL-SDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G FG VF G L +D T VA+K  R T       K FL E  +L +  H N+V+L+G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
            + +      +  ELV  G   ++L         L  +T +++  DAA G+ YL      
Sbjct: 181 CTQKQPI--YIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK--- 232
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           C IHRD  A N L+      K++DFG++++  +G              + APE    G  
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 282 LVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
             +SDV+S+G++L E  + G  P                 P L ++   E +     GG+
Sbjct: 293 SSESDVWSFGILLWETFSLGASPY----------------PNLSNQQTREFVEK---GGR 333
Query: 341 YPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
            P  +     V  +   C A E  QRP+   + Q L+ +++
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 109/214 (50%), Gaps = 18/214 (8%)
Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V +G L       + VAIK L  G  ++  +EFL E  ++ +  H N+++L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +  +S   ++  E + NG+L+S+L    G    +     ++     A G+ YL E 
Sbjct: 81  EGVVT--NSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLR---GIASGMRYLAEM 135
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 275
           S    +HRD  A NIL+ +N   KV+DFGL++   E  ++   T  +G      + APE 
Sbjct: 136 S---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 276 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 307
                    SD +SYG+V+ E+++ G +P  DMS
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS 226

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V  G   +   VAIK +   G   +++F+ E E++ +L H  LV+L G    
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV--C 72
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            + +   L  E + +G L  +L    G+      ET + + LD   G+AYL E    CVI
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEE---ACVI 126
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 284
           HRD  A N L+  N   KV+DFG+ +   + +    ST       + +PE         K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 185
Query: 285 SDVYSYGVVLLELLT-GRKPVD 305
           SDV+S+GV++ E+ + G+ P +
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYE 207

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 34/281 (12%)
Query: 105 LGEGGFGRVFKGVL-SDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G FG VF G L +D T VA+K  R T       K FL E  +L +  H N+V+L+G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
            + +      +  ELV  G   ++L         L  +T +++  DAA G+ YL      
Sbjct: 181 CTQKQPI--YIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK--- 232
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           C IHRD  A N L+      K++DFG++++  +G              + APE    G  
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 282 LVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
             +SDV+S+G++L E  + G  P                 P L ++   E +     GG+
Sbjct: 293 SSESDVWSFGILLWETFSLGASPY----------------PNLSNQQTREFVEK---GGR 333
Query: 341 YPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
            P  +     V  +   C A E  QRP+   + Q L+ +++
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           +F+   ++G GGFG+VFK     DG    IKR+    ++ ++E    V+ L++L H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIV 67
Query: 157 KLVGYY---------SSRDSSQH-----LLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
              G +         SS++SS+       +  E    G+LE W+    G    LD    +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLAL 125
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           ++     +G+ Y+H      +I+RD K SNI L +    K+ DFGL       + +    
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRX 179
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 298
           R  GT  Y++PE   +     + D+Y+ G++L ELL
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 119/240 (49%), Gaps = 36/240 (15%)
Query: 79  PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKG-VLSDGTAV--AIKRLTCGGQQ 135
           P PT    L + ++K     F+   ++GEG FG+V K  +  DG  +  AIKR+     +
Sbjct: 11  PDPTIYPVLDWNDIK-----FQ--DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK 63
Query: 136 GD-KEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
            D ++F  E+E+L +L HH N++ L+G    R      L  E  P+G+L  +L     + 
Sbjct: 64  DDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLE 121
Query: 194 CH------------LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 241
                         L  +  +  A D ARG+ YL   SQ   IHR+  A NIL+  N+ A
Sbjct: 122 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVA 178
Query: 242 KVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           K+ADFGL++    G+  Y+  + MG     ++A E          SDV+SYGV+L E+++
Sbjct: 179 KIADFGLSR----GQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 28/274 (10%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G G FG V  G   +   VAIK +   G   +++F+ E E++ +L H  LV+L G    
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV--C 71
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
            + +   L +E + +G L  +L    G+      ET + + LD   G+AYL E S   VI
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAA---ETLLGMCLDVCEGMAYLEEAS---VI 125
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 284
           HRD  A N L+  N   KV+DFG+ +   + +    ST       + +PE         K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSK 184
Query: 285 SDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK 343
           SDV+S+GV++ E+ + G+ P +    S           ++ D      L  PRL   +  
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNS----------EVVEDISTGFRLYKPRLASTH-- 232
Query: 344 EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
                V  I   C       RP    +++ L  +
Sbjct: 233 -----VYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 103 SILGEGGFGRV---FKGVLSD--GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           S LG+G FG V       L D  G  VA+K+L   G    ++F  E+++L  LH   +VK
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
             G        +  L  E +P+G L  +L              R +  LDA+R L Y   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQ-------------RHRARLDASRLLLY--- 116
Query: 218 DSQPC----------VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV-MG 266
            SQ C           +HRD  A NIL+E+  H K+ADFGLAK  P  +   +       
Sbjct: 117 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              + APE         +SDV+S+GVVL EL T
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 102 ASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
             +LG+G FG+  K    + G  + +K L    ++  + FL EV+++  L H N++K +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
               +D   + +  E +  G+L   +     ++    W  R+  A D A G+AYLH  + 
Sbjct: 75  VLY-KDKRLNFIT-EYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN- 128
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLA------KQAPEG-RTNYLSTR-----VMGTF 268
             +IHRD  + N L+  N +  VADFGLA      K  PEG R+     R     V+G  
Sbjct: 129 --IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELL 298
            ++APE         K DV+S+G+VL E++
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 108/240 (45%), Gaps = 34/240 (14%)
Query: 94  EATNNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--- 149
           E   +F+  ++LG+G F  V++   +  G  VAIK +       DK+ + +  M+ R   
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-------DKKAMYKAGMVQRVQN 60
Query: 150 -------LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG---PLGVNCHLDWE 199
                  L H ++++L  Y+   DS+   L  E+  NG +  +L     P   N     E
Sbjct: 61  EVKIHCQLKHPSILELYNYF--EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN-----E 113
Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
            R         G+ YLH      ++HRD   SN+LL  N + K+ADFGLA Q       +
Sbjct: 114 AR-HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 319
            +  + GT  Y++PE A      ++SDV+S G +   LL GR P D        N V  A
Sbjct: 170 YT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 119/242 (49%), Gaps = 29/242 (11%)
Query: 74  LGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKR 128
           + G+ P+    R L   EL++         +LG G FG V+KG+ + DG      VAIK 
Sbjct: 1   MSGAAPNQALLRILKETELRKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKV 53
Query: 129 L-TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH 187
           L      + +KE L E  +++ +    + +L+G   +   S   L  +L+P G L   + 
Sbjct: 54  LRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLT---STVQLVTQLMPYGCLLDHVR 110
Query: 188 ---GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 244
              G LG    L+W       +  A+G++YL ED +  ++HRD  A N+L+++  H K+ 
Sbjct: 111 ENRGRLGSQDLLNW------CMQIAKGMSYL-EDVR--LVHRDLAARNVLVKSPNHVKIT 161
Query: 245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           DFGLA+      T Y +        ++A E  +      +SDV+SYGV + EL+T G KP
Sbjct: 162 DFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKP 221
Query: 304 VD 305
            D
Sbjct: 222 YD 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 30/211 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT----AVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           LG GG   V+   L++ T     VAIK +    ++ +   K F  EV   S+L H+N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYL 215
           ++      D   + L  E +   +L  ++  HGPL V+  +++  ++   LD   G+ + 
Sbjct: 76  MIDVDEEDDC--YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI---LD---GIKHA 127
Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE---GRTNYLSTRVMGTFGYVA 272
           H+     ++HRD K  NIL+++N   K+ DFG+AK   E    +TN+    V+GT  Y +
Sbjct: 128 HD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH----VLGTVQYFS 180
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           PE A        +D+YS G+VL E+L G  P
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           +F+   ++G GGFG+VFK     DG    I+R+    ++ ++E    V+ L++L H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIV 68
Query: 157 KLVGYY--------------------------SSRDSSQHLLC-YELVPNGSLESWLHGP 189
              G +                          SSR  ++ L    E    G+LE W+   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
            G    LD    +++     +G+ Y+H      +IHRD K SNI L +    K+ DFGL 
Sbjct: 129 RGEK--LDKVLALELFEQITKGVDYIHSKK---LIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 298
                 + +   TR  GT  Y++PE   +     + D+Y+ G++L ELL
Sbjct: 184 TSL---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 119/289 (41%), Gaps = 41/289 (14%)
Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF           D   VA+K L        K+F  E E+L+ L H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGV----------NCHLDWETRMKIAL 206
            G     D    ++ +E + +G L  +L  HGP  +             L     + IA 
Sbjct: 83  YGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
             A G+ YL   +    +HRD    N L+  N   K+ DFG+++         +    M 
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRD 325
              ++ PE  M      +SDV+S+GV+L E+ T G++P      +     +T  R + R 
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLER- 256
Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                    PR+    PKE    V  +   C   E  QR  + E+ + L
Sbjct: 257 ---------PRVC---PKE----VYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ELK+  ++FE  S LG G  G VFK      G  +A K +    +   +  ++    L  
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR--ELQV 57
Query: 150 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  +   K+++  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q  +   N      +GT 
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTR 167
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            Y++PE     H  V+SD++S G+ L+E+  GR P+    P  +E+    +RP +   + 
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI--PPPDAKED----SRPPMAIFEL 221
Query: 329 LEELAD---PRL-GGKYPKE--DFIRVCTI 352
           L+ + +   P+L  G +  E  DF+  C I
Sbjct: 222 LDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 251

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRN 154
           +++E   ++G G    V     +     VAIKR+     Q    E L E++ +S+ HH N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCH----LDWETRMKIALDAA 209
           +V    YY+S      L L  +L+  GS+   +   +    H    LD  T   I  +  
Sbjct: 75  IV---SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG---RTNYLSTRVMG 266
            GL YLH++ Q   IHRD KA NILL  +   ++ADFG++     G     N +    +G
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 267 TFGYVAPEYA--MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 324
           T  ++APE    + G+   K+D++S+G+  +EL TG  P     P     +      +  
Sbjct: 189 TPCWMAPEVMEQVRGYDF-KADIWSFGITAIELATGAAPYHKYPP-----MKVLMLTLQN 242
Query: 325 DKDRLEE-LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
           D   LE  + D  +  KY K  F ++ ++   C+  +  +RPT  E+++
Sbjct: 243 DPPSLETGVQDKEMLKKYGK-SFRKMISL---CLQKDPEKRPTAAELLR 287

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 135/297 (45%), Gaps = 36/297 (12%)
Query: 108 GGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD 166
           G FG V+K  +L++  AV I  +    Q    E+  EV  L  + H N+++ +G    R 
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIFPIQ-DKQSWQNEY--EVYSLPGMKHENILQFIGA-EKRG 90
Query: 167 SSQHL---LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED----- 218
           +S  +   L       GSL  +L   +     + W     IA   ARGLAYLHED     
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 219 --SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
              +P + HRD K+ N+LL+NN  A +ADFGLA +   G++   +   +GT  Y+APE  
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-V 204
Query: 277 MTGHL------LVKSDVYSYGVVLLELLT----GRKPVDMSQPSGQENLVTWARPILRDK 326
           + G +       ++ D+Y+ G+VL EL +       PVD      +E +     P L D 
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ--HPSLEDM 262
Query: 327 DR--LEELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 380
               + +   P L   + K      +C     C   +A  R + G V + +  +QR+
Sbjct: 263 QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRN 154
           +++E   ++G G    V     +     VAIKR+     Q    E L E++ +S+ HH N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCH----LDWETRMKIALDAA 209
           +V    YY+S      L L  +L+  GS+   +   +    H    LD  T   I  +  
Sbjct: 70  IV---SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG---RTNYLSTRVMG 266
            GL YLH++ Q   IHRD KA NILL  +   ++ADFG++     G     N +    +G
Sbjct: 127 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 267 TFGYVAPEYA--MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 324
           T  ++APE    + G+   K+D++S+G+  +EL TG  P     P     L      +  
Sbjct: 184 TPCWMAPEVMEQVRGYDF-KADIWSFGITAIELATGAAPYHKYPPMKVLMLT-----LQN 237
Query: 325 DKDRLEE-LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
           D   LE  + D  +  KY K  F ++ ++   C+  +  +RPT  E+++
Sbjct: 238 DPPSLETGVQDKEMLKKYGK-SFRKMISL---CLQKDPEKRPTAAELLR 282

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 16  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 74  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW---- 126
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 127 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 181
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 234
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 235 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 282

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 141/306 (46%), Gaps = 43/306 (14%)
Query: 104 ILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVG 160
           I   G FG V+K  +++D  AV I  L     Q  + +  E E+ S   + H NL++ + 
Sbjct: 22  IKARGRFGCVWKAQLMNDFVAVKIFPL-----QDKQSWQSEREIFSTPGMKHENLLQFIA 76
Query: 161 --YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
                S    +  L       GSL  +L G +     + W     +A   +RGL+YLHED
Sbjct: 77  AEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLHED 131
Query: 219 --------SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
                    +P + HRDFK+ N+LL+++  A +ADFGLA +   G+    +   +GT  Y
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 271 VAPEYAMTGHL------LVKSDVYSYGVVLLELLTGRK----PVD-----MSQPSGQENL 315
           +APE  + G +       ++ D+Y+ G+VL EL++  K    PVD       +  GQ   
Sbjct: 192 MAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPS 250
Query: 316 VTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           +   + ++  K     + D  L  K+P     ++C     C   +A  R + G V + + 
Sbjct: 251 LEELQEVVVHKKMRPTIKDHWL--KHP--GLAQLCVTIEECWDHDAEARLSAGCVEERVS 306
Query: 376 MVQRVI 381
           +++R +
Sbjct: 307 LIRRSV 312

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 15  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 73  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW---- 125
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 126 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 233
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 234 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 281

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 13  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 71  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW---- 123
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 124 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 231
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 232 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 279

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 12  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 70  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW---- 122
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 123 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 230
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 231 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 99  FEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLV 156
           +E    LG GGFG V + +  D G  VAIK+        ++E + +E++++ +L+H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 157 KLV----GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARG 211
                  G      +   LL  E    G L  +L+     NC    E  ++  L D +  
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ--FENCCGLKEGPIRTLLSDISSA 134
Query: 212 LAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
           L YLHE+    +IHRD K  NI+L+        K+ D G AK+  +G    L T  +GT 
Sbjct: 135 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTL 188
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            Y+APE        V  D +S+G +  E +TG +P
Sbjct: 189 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 14  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 72  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW---- 124
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 125 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 232
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 233 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 280

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 108/216 (50%), Gaps = 16/216 (7%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ELK+  ++FE  S LG G  G VFK      G  +A K +    +   +  ++    L  
Sbjct: 64  ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR--ELQV 119
Query: 150 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  +   K+++  
Sbjct: 120 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 175
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q      + ++   +GT 
Sbjct: 176 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTR 229
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            Y++PE     H  V+SD++S G+ L+E+  GR P+
Sbjct: 230 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 13  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 71  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW---- 123
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 124 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 178
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 231
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 232 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 279

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G +    +  L      D +       + A 
Sbjct: 71  RHPNILRLYGYF--HDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELAN 124
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 177
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 99  FEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNLV 156
           +E    LG GGFG V + +  D G  VAIK+        ++E + +E++++ +L+H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 157 KLV----GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARG 211
                  G      +   LL  E    G L  +L+     NC    E  ++  L D +  
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ--FENCCGLKEGPIRTLLSDISSA 133
Query: 212 LAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
           L YLHE+    +IHRD K  NI+L+        K+ D G AK+  +G    L T  +GT 
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTL 187
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            Y+APE        V  D +S+G +  E +TG +P
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 92  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 145
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 146 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 198
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 6   LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 64  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 116
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 117 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 224
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 225 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 18  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 76  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 128
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 129 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 183
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 184 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 236
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 237 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 284

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 14  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 72  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 124
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 125 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 179
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 232
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 233 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 280

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 15  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 73  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 125
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 126 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 233
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 234 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 281

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 19  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 77  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 129
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 130 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 237
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 238 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 285

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 15  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 73  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 125
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 126 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 233
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 234 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 281

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 12  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 70  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW---- 122
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 123 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 230
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 231 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 12  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 70  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 122
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 123 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 230
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 231 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 37  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 95  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 147
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 148 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 202
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 203 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 255
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 256 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 303

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 66  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTELCGTLDY 172
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 83  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 136
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 137 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 189
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 67  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 120
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R   LS    GT  Y
Sbjct: 121 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDY 173
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 22  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 80  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 132
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 133 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 187
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 188 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 240
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 241 ILEKGERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 288

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 15  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 73  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 125
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 126 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 180
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 233
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 234 ILEKGERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 281

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 69  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 123 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 175
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 92  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 145
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R + L     GT  Y
Sbjct: 146 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDY 198
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G +    +  L      D +       + A 
Sbjct: 71  RHPNILRLYGYF--HDATRVYLILEYAPRGEV----YKELQKLSKFDEQRTATYITELAN 124
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R   L     GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX----GTLDY 177
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 104 ILGEGGFGRVFKGVLSDGTA-----VAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           ++G G FG V+KG+L   +      VAIK L  G  +  + +FL E  ++ +  H N+++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G  S       ++  E + NG+L+ +L    G    L     ++     A G+ YL  
Sbjct: 111 LEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYL-- 163
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPE 274
            +    +HRD  A NIL+ +N   KV+DFGL++     PE    Y ++       + APE
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPIRWTAPE 220
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                     SDV+S+G+V+ E++T G +P
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 66  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 172
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 71  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 124
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 177
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 136/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 12  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 70  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 122
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 123 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 230
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 231 ILEKGERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ELK+  ++FE  S LG G  G VFK      G  +A K +    +   +  ++    L  
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR--ELQV 57
Query: 150 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  +   K+++  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q  +   N      +GT 
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTR 167
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            Y++PE     H  V+SD++S G+ L+E+  GR P+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ELK+  ++FE  S LG G  G VFK      G  +A K +    +   +  ++    L  
Sbjct: 29  ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR--ELQV 84
Query: 150 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  +   K+++  
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAV 140
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q  +   N      +GT 
Sbjct: 141 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTR 194
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            Y++PE     H  V+SD++S G+ L+E+  GR P+
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 9   LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 67  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 119
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 120 --CVQIAEGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 175 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 227
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 228 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 275

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G+G FG V  G    G  VA+K +        + FL E  ++++L H NLV+L+G    
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 165 RDSSQHLLCYELVPNGSLESWLHG----PLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
                +++  E +  GSL  +L       LG +C L      K +LD    + YL  ++ 
Sbjct: 258 EKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLL------KFSLDVCEAMEYLEGNN- 309
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 278
              +HRD  A N+L+  +  AKV+DFGL K+A        ST+  G     + APE    
Sbjct: 310 --FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALRE 360
Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                KSDV+S+G++L E+ + GR P
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 71  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 124
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 177
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 66  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDY 172
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ELK+  ++FE  S LG G  G VFK      G  +A K +    +   +  ++    L  
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR--ELQV 57
Query: 150 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  +   K+++  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q  +   N      +GT 
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTR 167
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            Y++PE     H  V+SD++S G+ L+E+  GR P+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 67  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 120
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 121 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDY 173
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 66  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDY 172
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+     +   +   ++    Q      + +   EVE+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   DS++  L  E  P G++    +  L      D +       + A 
Sbjct: 66  RHPNILRLYGYF--HDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R   L     GT  Y
Sbjct: 120 ALSYCHSKK---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDY 172
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 65  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 118
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 119 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 171
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G+G FG V  G    G  VA+K +        + FL E  ++++L H NLV+L+G    
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 165 RDSSQHLLCYELVPNGSLESWLHG----PLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
                +++  E +  GSL  +L       LG +C L      K +LD    + YL  ++ 
Sbjct: 71  EKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLL------KFSLDVCEAMEYLEGNN- 122
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 278
              +HRD  A N+L+  +  AKV+DFGL K+A        ST+  G     + APE    
Sbjct: 123 --FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALRE 173
Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                KSDV+S+G++L E+ + GR P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 133/286 (46%), Gaps = 37/286 (12%)
Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V  G L         VAIK L  G  ++  ++FL E  ++ +  H N++ L
Sbjct: 40  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 99
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +   S+  ++  E + NGSL+S+L    G    +     ++     A G+ YL + 
Sbjct: 100 EGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLADM 154
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 275
           +    +HRD  A NIL+ +N   KV+DFGL++   +  ++   T  +G      + APE 
Sbjct: 155 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 276 AMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL-A 333
                    SDV+SYG+V+ E+++ G +P              W    + ++D +  +  
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERPY-------------WD---MTNQDVINAIEQ 255
Query: 334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ 378
           D RL    P +    +  +   C   + N RP  G++V +L KM++
Sbjct: 256 DYRLPP--PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 299

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 67  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 120
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R + L     GT  Y
Sbjct: 121 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTLDY 173
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 87  LAYEELKEATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQGDKEFLVEVE 145
           +A  ELK+  ++FE  S LG G  G VFK      G  +A K +    +   +  ++   
Sbjct: 1   MALGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-- 56
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
            L  LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  +   K+
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKV 112
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           ++   +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q      + ++   
Sbjct: 113 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDEMANEF 166
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +GT  Y++PE     H  V+SD++S G+ L+E+  GR P
Sbjct: 167 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ELK+  ++FE  S LG G  G VFK      G  +A K +    +   +  ++    L  
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR--ELQV 57
Query: 150 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  +   K+++  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAV 113
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q  +   N      +GT 
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTR 167
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            Y++PE     H  V+SD++S G+ L+E+  GR P+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ELK+  ++FE  S LG G  G VFK      G  +A K +    +   +  ++    L  
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR--ELQV 57
Query: 150 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  +   K+++  
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAV 113
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q  +   N      +GT 
Sbjct: 114 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTR 167
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            Y++PE     H  V+SD++S G+ L+E+  GR P+
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G+G FG V  G    G  VA+K +        + FL E  ++++L H NLV+L+G    
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 165 RDSSQHLLCYELVPNGSLESWLHG----PLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
                +++  E +  GSL  +L       LG +C L      K +LD    + YL  ++ 
Sbjct: 86  EKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLL------KFSLDVCEAMEYLEGNN- 137
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 278
              +HRD  A N+L+  +  AKV+DFGL K+A        ST+  G     + APE    
Sbjct: 138 --FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALRE 188
Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                KSDV+S+G++L E+ + GR P
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 69  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 123 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 175
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 66  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTXLCGTLDY 172
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 71  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 124
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDY 177
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/321 (27%), Positives = 141/321 (43%), Gaps = 46/321 (14%)
Query: 69  ADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDG----TA 123
            + +T  G  P+    R L   E       F+   +LG G FG V+KG+ + +G      
Sbjct: 28  VEPLTPSGEAPNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP 80
Query: 124 VAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL 182
           VAI  L      + +KE L E  +++ + + ++ +L+G   +   S   L  +L+P G L
Sbjct: 81  VAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCL 137
Query: 183 ESWLH---GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF 239
             ++      +G    L+W       +  A+G+ YL ED +  ++HRD  A N+L++   
Sbjct: 138 LDYVREHKDNIGSQYLLNW------CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQ 188
Query: 240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           H K+ DFGLAK        Y +        ++A E  +      +SDV+SYGV + EL+T
Sbjct: 189 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248
Query: 300 -GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVA 358
            G KP D   P+ +         IL   +RL +          P    I V  I   C  
Sbjct: 249 FGSKPYD-GIPASE------ISSILEKGERLPQ----------PPICTIDVYMIMVKCWM 291
Query: 359 PEANQRPTMGEVVQSLKMVQR 379
            +A+ RP   E++     + R
Sbjct: 292 IDADSRPKFRELIIEFSKMAR 312

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 27/206 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G+G FG V  G    G  VA+K +        + FL E  ++++L H NLV+L+G    
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 165 RDSSQHLLCYELVPNGSLESWLHG----PLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
                +++  E +  GSL  +L       LG +C L      K +LD    + YL  ++ 
Sbjct: 77  EKGGLYIVT-EYMAKGSLVDYLRSRGRSVLGGDCLL------KFSLDVCEAMEYLEGNN- 128
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 278
              +HRD  A N+L+  +  AKV+DFGL K+A        ST+  G     + APE    
Sbjct: 129 --FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALRE 179
Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                KSDV+S+G++L E+ + GR P
Sbjct: 180 AAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 25  PHTFEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKH 140
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 141 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           LA+   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 193 LARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 70  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 123
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 124 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 176
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ELK+  ++FE  S LG G  G VFK      G  +A K +    +   +  ++    L  
Sbjct: 21  ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR--ELQV 76
Query: 150 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           LH  N   +VG+Y +  S   + +C E +  GSL+  L         +  +   K+++  
Sbjct: 77  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAV 132
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +GL YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q  +   N      +GT 
Sbjct: 133 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTR 186
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            Y++PE     H  V+SD++S G+ L+E+  GR P+
Sbjct: 187 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 91/340 (26%), Positives = 143/340 (42%), Gaps = 41/340 (12%)
Query: 55  KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 114
           K K  PK   + +  ++   G S      T+    E+ +   NN +    LG G FG+V 
Sbjct: 5   KYKQKPKYQVRWKIIESYE-GNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVV 63
Query: 115 K------GVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRNLVKLVGYYSSRD 166
           +      G       VA+K L       +KE L+ E++++S L  H N+V L+G  +   
Sbjct: 64  EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG--ACTH 121
Query: 167 SSQHLLCYELVPNGSLESWLHGPLGV----------NCHLDWETRMKIALDAARGLAYLH 216
               L+  E    G L ++L     V          N  L     +  +   A+G+A+L 
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLA 181
Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
             S+ C IHRD  A N+LL N   AK+ DFGLA+         +         ++APE  
Sbjct: 182 --SKNC-IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 335
                 V+SDV+SYG++L E+ + G  P     P    N   +   +++D     ++A P
Sbjct: 239 FDCVYTVQSDVWSYGILLWEIFSLGLNPY----PGILVNSKFYK--LVKDG---YQMAQP 289
Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
               K        + +I  AC A E   RPT  ++   L+
Sbjct: 290 AFAPK-------NIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 68  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 121
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R   L     GT  Y
Sbjct: 122 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDY 174
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 89/336 (26%), Positives = 143/336 (42%), Gaps = 37/336 (11%)
Query: 55  KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 114
           K K  PK   + +  ++   G S      T+    E+ +   NN +    LG G FG+V 
Sbjct: 5   KYKQKPKYQVRWKIIESYE-GNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVV 63
Query: 115 K------GVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRNLVKLVGYYSSRD 166
           +      G       VA+K L       +KE L+ E++++S L  H N+V L+G  +   
Sbjct: 64  EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG--ACTH 121
Query: 167 SSQHLLCYELVPNGSLESWLHGPLGVNCH------LDWETRMKIALDAARGLAYLHEDSQ 220
               L+  E    G L ++L      +        L+    +  +   A+G+A+L   S+
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA--SK 179
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
            C IHRD  A N+LL N   AK+ DFGLA+         +         ++APE      
Sbjct: 180 NC-IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV 238
Query: 281 LLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGG 339
             V+SDV+SYG++L E+ + G  P     P    N   +   +++D     ++A P    
Sbjct: 239 YTVQSDVWSYGILLWEIFSLGLNPY----PGILVNSKFYK--LVKDG---YQMAQPAFAP 289
Query: 340 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           K        + +I  AC A E   RPT  ++   L+
Sbjct: 290 K-------NIYSIMQACWALEPTHRPTFQQICSFLQ 318

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 25  PHTFEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEXMENGSLDSFLRKH 140
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 141 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFG 192
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L++   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 113/230 (49%), Gaps = 23/230 (10%)
Query: 84  TRFLAYEELKE---ATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQ---G 136
            RFL ++ L+      N F    +LG+GGFG V    V + G   A K+L     +   G
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 137 DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNC 194
           +   L E ++L +++ R +V L   Y ++D+    L   L+  G L+  ++  G  G   
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDAL--CLVLTLMNGGDLKFHIYHMGQAGFP- 284
Query: 195 HLDWETRMKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 253
               E R    A +   GL  LH +    +++RD K  NILL+++ H +++D GLA   P
Sbjct: 285 ----EARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           EG+T  +  RV GT GY+APE           D ++ G +L E++ G+ P
Sbjct: 338 EGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+L+H+N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKLNHQNIV 97
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 98  RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 144
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 145 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+L+H+N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKLNHQNIV 111
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 112 RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 158
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 159 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 113/230 (49%), Gaps = 23/230 (10%)
Query: 84  TRFLAYEELKE---ATNNFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQQ---G 136
            RFL ++ L+      N F    +LG+GGFG V    V + G   A K+L     +   G
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG 227
Query: 137 DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNC 194
           +   L E ++L +++ R +V L   Y ++D+    L   L+  G L+  ++  G  G   
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDAL--CLVLTLMNGGDLKFHIYHMGQAGFP- 284
Query: 195 HLDWETRMKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 253
               E R    A +   GL  LH +    +++RD K  NILL+++ H +++D GLA   P
Sbjct: 285 ----EARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           EG+T  +  RV GT GY+APE           D ++ G +L E++ G+ P
Sbjct: 338 EGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 16  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 74  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW---- 126
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFG AK        Y + 
Sbjct: 127 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 181
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 234
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 235 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 282

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +L  G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 19  LKE--TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 77  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW---- 129
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 130 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 237
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 238 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 285

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 14  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 72  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW---- 124
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFG AK        Y + 
Sbjct: 125 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 232
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 233 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 280

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 78  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 133
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E        + +    
Sbjct: 134 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           +++PE    G     SDV+S+GVVL E+ T
Sbjct: 191 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 69  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R + L     GT  Y
Sbjct: 123 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDY 175
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +L  G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 12  LKE--TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 70  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 122
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 123 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 230
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 231 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 25  PHTFEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKH 140
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 141 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFG 192
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L++   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 63  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 116
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R     T + GT  Y
Sbjct: 117 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDY 169
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +L  G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 19  LKE--TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 77  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 129
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFGLAK        Y + 
Sbjct: 130 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 184
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 237
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 238 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 285

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 12  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 70  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 122
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFG AK        Y + 
Sbjct: 123 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 177
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 230
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 231 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG VFKG+ +     VAIK +     + + E +  E+ +LS+     + K  G Y
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQP 221
             +D+   ++   L    +L+    GPL        ET++   L +  +GL YLH + + 
Sbjct: 90  L-KDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHSEKK- 140
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
             IHRD KA+N+LL  +   K+ADFG+A Q  +  T       +GT  ++APE       
Sbjct: 141 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             K+D++S G+  +EL  G  P     P     L+    P             P L G Y
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 243
Query: 342 --PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             P ++F+       AC+  E + RPT  E+++
Sbjct: 244 SKPLKEFVE------ACLNKEPSFRPTAKELLK 270

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG VFKG+ +     VAIK +     + + E +  E+ +LS+     + K  G Y
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQP 221
             +D+   ++   L    +L+    GPL        ET++   L +  +GL YLH + + 
Sbjct: 95  L-KDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHSEKK- 145
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
             IHRD KA+N+LL  +   K+ADFG+A Q  +  T       +GT  ++APE       
Sbjct: 146 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             K+D++S G+  +EL  G  P     P     L+    P             P L G Y
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 248
Query: 342 --PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             P ++F+       AC+  E + RPT  E+++
Sbjct: 249 SKPLKEFVE------ACLNKEPSFRPTAKELLK 275

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG VFKG+ +     VAIK +     + + E +  E+ +LS+     + K  G Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQP 221
             +D+   ++   L    +L+    GPL        ET++   L +  +GL YLH + + 
Sbjct: 75  L-KDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHSEKK- 125
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
             IHRD KA+N+LL  +   K+ADFG+A Q  +  T       +GT  ++APE       
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             K+D++S G+  +EL  G  P     P     L+    P             P L G Y
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 228
Query: 342 --PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             P ++F+       AC+  E + RPT  E+++
Sbjct: 229 SKPLKEFVE------ACLNKEPSFRPTAKELLK 255

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 66  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R   L     GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDY 172
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 25  PHTYEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKH 140
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 141 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L++   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 25  PHTFEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKH 140
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 141 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L++   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 69  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R   L     GT  Y
Sbjct: 123 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDY 175
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 87  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 142
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E        + +    
Sbjct: 143 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           +++PE    G     SDV+S+GVVL E+ T
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 68  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 121
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+A+FG +  AP  R     T + GT  Y
Sbjct: 122 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDY 174
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 19  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 77  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 129
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFG AK        Y + 
Sbjct: 130 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 184
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 237
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 238 ILEKGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 285

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 25  PHTYEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEXMENGSLDSFLRKH 140
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 141 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L++   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHL----DWETRMKIALDAARG 211
           L+G  S    +  L+  EL+  G L+S+L    P   N  +         +++A + A G
Sbjct: 93  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-- 269
           +AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G     
Sbjct: 151 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 205
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           +++PE    G     SDV+S+GVVL E+ T
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 25  PHTYEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKH 140
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 141 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L++   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 69  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R   L     GT  Y
Sbjct: 123 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDY 175
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 25  PHTFEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKH 140
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 141 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L++   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 193 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG VFKG+ +     VAIK +     + + E +  E+ +LS+     + K  G Y
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQP 221
             +D+   ++   L    +L+    GPL        ET++   L +  +GL YLH + + 
Sbjct: 75  L-KDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILREILKGLDYLHSEKK- 125
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
             IHRD KA+N+LL  +   K+ADFG+A Q  +  T       +GT  ++APE       
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             K+D++S G+  +EL  G  P     P     L+    P             P L G Y
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNY 228
Query: 342 --PKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             P ++F+       AC+  E + RPT  E+++
Sbjct: 229 SKPLKEFVE------ACLNKEPSFRPTAKELLK 255

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 52/295 (17%)
Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF           D   VA+K L    +   ++F  E E+L+ L H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLH-----------------GPLGVNCHLDWETR 201
            G  +  +    L+ +E + +G L  +L                  GPLG+         
Sbjct: 86  FGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG------QL 137
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
           + +A   A G+ YL   +    +HRD    N L+      K+ DFG+++         + 
Sbjct: 138 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 194
Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 320
            R M    ++ PE  +      +SDV+S+GVVL E+ T G++P      +   + +T  R
Sbjct: 195 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 254
Query: 321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                     EL  PR     P E    V  I   C   E  QR ++ +V   L+
Sbjct: 255 ----------ELERPR---ACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQ 292

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 52/295 (17%)
Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF           D   VA+K L    +   ++F  E E+L+ L H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLH-----------------GPLGVNCHLDWETR 201
            G  +  +    L+ +E + +G L  +L                  GPLG+         
Sbjct: 80  FGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG------QL 131
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
           + +A   A G+ YL   +    +HRD    N L+      K+ DFG+++         + 
Sbjct: 132 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 188
Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 320
            R M    ++ PE  +      +SDV+S+GVVL E+ T G++P      +   + +T  R
Sbjct: 189 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 248
Query: 321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                     EL  PR     P E    V  I   C   E  QR ++ +V   L+
Sbjct: 249 ----------ELERPR---ACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQ 286

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 23  PHTYEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 80
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 81  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKH 138
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 139 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 190
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L++   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 191 LSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 105 LGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           LG G FG V +GV         VAIK L  G ++ D +E + E +++ +L +  +V+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +      +L  E+   G L  +L   +G    +      ++    + G+ YL E + 
Sbjct: 78  VCQA---EALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEKN- 130
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 278
              +HRD  A N+LL N  +AK++DFGL+K A     +Y + R  G +   + APE    
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                +SDV+SYGV + E L+ G+KP
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 32/226 (14%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNL 155
           +FEP   LG GGFG VF+     D    AIKR+    ++  +E  + EV+ L++L H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 156 VKLVGYYSSRDSSQHL----------LCYELVPNGSLESWLHGPLGVNCHLDWETR---M 202
           V+    +  +++++ L          +  +L    +L+ W++G     C ++   R   +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG----RCTIEERERSVCL 121
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL--AKQAPEGRTNYL 260
            I L  A  + +LH      ++HRD K SNI    +   KV DFGL  A    E     L
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 261 S--------TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 298
           +        T  +GT  Y++PE         K D++S G++L ELL
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 22/210 (10%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHL----DWETRMKIALDAARG 211
           L+G  S    +  L+  EL+  G L+S+L    P   N  +         +++A + A G
Sbjct: 83  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 140
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-- 269
           +AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G     
Sbjct: 141 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 195
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           +++PE    G     SDV+S+GVVL E+ T
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 14  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 72  VMASVDNPHVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW---- 124
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFG AK        Y + 
Sbjct: 125 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 232
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 233 ILEKGERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 280

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 96
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 97  RCIGV--SLQSLPRFILMELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 143
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 144 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 102 ASILGEGGFGRVFKGVLS--DGTA--VAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
             ILGEG FG V +G L   DGT+  VA+K  +L    Q+  +EFL E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 156 VKLVGY---YSSRDSSQHLLCYELVPNGSLESWL------HGPLGVNCHLDWETRMKIAL 206
           ++L+G     SS+   + ++    +  G L ++L       GP     H+  +T +K  +
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP----KHIPLQTLLKFMV 154
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
           D A G+ YL   S    +HRD  A N +L ++    VADFGL+K+   G   Y   R+  
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG-DYYRQGRIAK 210
Query: 267 T-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
               ++A E         KSDV+++GV + E+ T
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 113/237 (47%), Gaps = 20/237 (8%)
Query: 76  GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTC 131
           G +P  ++     + +  +ATN      ++G G FG V  G L        +VAIK L  
Sbjct: 13  GLVPRGSTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV 71
Query: 132 G-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HG 188
           G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H 
Sbjct: 72  GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHD 129
Query: 189 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 248
                  L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFGL
Sbjct: 130 AQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 181
Query: 249 AKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           ++   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 182 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 23/227 (10%)
Query: 90  EELKEAT-----NNFEPASI-LGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGD-KE 139
           EELK+       +N   A I LG G FG V +GV         VAIK L  G ++ D +E
Sbjct: 323 EELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE 382
Query: 140 FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWE 199
            + E +++ +L +  +V+L+G   +      +L  E+   G L  +L   +G    +   
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGGGPLHKFL---VGKREEIPVS 436
Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
              ++    + G+ YL E +    +HR+  A N+LL N  +AK++DFGL+K A     +Y
Sbjct: 437 NVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSY 492
Query: 260 LSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            + R  G +   + APE         +SDV+SYGV + E L+ G+KP
Sbjct: 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 66  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 119
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R   L     GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDY 172
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRL 150
           A  +FE    LG+G FG V+         +   ++    Q      + +   EVE+ S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L GY+   D+++  L  E  P G++    +  L      D +       + A 
Sbjct: 69  RHPNILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELAN 122
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L+Y H      VIHRD K  N+LL +    K+A+FG +  AP  R     T + GT  Y
Sbjct: 123 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR----RTTLCGTLDY 175
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + PE         K D++S GV+  E L G+ P +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 96
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 97  RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 143
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 144 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 113/238 (47%), Gaps = 25/238 (10%)
Query: 79  PH----PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLT 130
           PH    PT T     +EL +ATN      ++G G FG V  G L        +VAIK L 
Sbjct: 25  PHTFEDPTQTVHEFAKEL-DATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--H 187
            G  ++  ++FL E  ++ +  H N+++L G  +   S   ++  E + NGSL+S+L  H
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKH 140
Query: 188 GPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                   L     + +    A G+ YL   S    +HRD  A NIL+ +N   KV+DFG
Sbjct: 141 DAQFTVIQL-----VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 248 LAKQAPEGRTNYLSTRVMGT-FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L +   +      +TR       + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 88
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 89  RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 135
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 136 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 193 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 52/295 (17%)
Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF           D   VA+K L    +   ++F  E E+L+ L H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLH-----------------GPLGVNCHLDWETR 201
            G  +  +    L+ +E + +G L  +L                  GPLG+         
Sbjct: 109 FGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG------QL 160
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
           + +A   A G+ YL   +    +HRD    N L+      K+ DFG+++         + 
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWAR 320
            R M    ++ PE  +      +SDV+S+GVVL E+ T G++P      +   + +T  R
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277
Query: 321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                     EL  PR     P E    V  I   C   E  QR ++ +V   L+
Sbjct: 278 ----------ELERPR---ACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQ 315

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 113
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 114 RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 161 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 217
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 218 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 111
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 112 RCIGV--SLQSLPRFILMELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 158
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 159 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 216 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 93  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 148
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G   
Sbjct: 149 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 203
Query: 270 --YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             +++PE    G     SDV+S+GVVL E+ T
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 41/298 (13%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGV-LSDG----TAVAIKRL-TCGGQQGDKEFLVEVE 145
           LKE    F+   +LG G FG V+KG+ + +G      VAIK L      + +KE L E  
Sbjct: 14  LKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRM 202
           +++ + + ++ +L+G   +   S   L  +L+P G L  ++      +G    L+W    
Sbjct: 72  VMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 124
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
              +  A+G+ YL ED +  ++HRD  A N+L++   H K+ DFG AK        Y + 
Sbjct: 125 --CVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAE 179
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP 321
                  ++A E  +      +SDV+SYGV + EL+T G KP D   P+ +         
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASE------ISS 232
Query: 322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           IL   +RL +          P    I V  I   C   +A+ RP   E++     + R
Sbjct: 233 ILEKGERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 280

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 97
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 98  RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 144
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 145 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 17/214 (7%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH 151
           K+    F+    LGEG +G V+K +  + G  VAIK++    +   +E + E+ ++ +  
Sbjct: 25  KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCD 82
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
             ++VK  G Y    ++   +  E    GS+   +      N  L  +    I     +G
Sbjct: 83  SPHVVKYYGSYFK--NTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKG 137
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFG 269
           L YLH   +   IHRD KA NILL    HAK+ADFG+A Q     T+ ++ R  V+GT  
Sbjct: 138 LEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQL----TDXMAKRNXVIGTPF 190
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           ++APE          +D++S G+  +E+  G+ P
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 91/340 (26%), Positives = 144/340 (42%), Gaps = 41/340 (12%)
Query: 55  KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 114
           K K  PK   + +  ++   G S      T+    E+ +   NN +    LG G FG+V 
Sbjct: 5   KYKQKPKYQVRWKIIESYE-GNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVV 63
Query: 115 K------GVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRNLVKLVGYYSSRD 166
           +      G       VA+K L       +KE L+ E++++S L  H N+V L+G  +   
Sbjct: 64  EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG--ACTH 121
Query: 167 SSQHLLCYELVPNGSLESWLH--------GPLGVNCHLDWETR--MKIALDAARGLAYLH 216
               L+  E    G L ++L          P     +    TR  +  +   A+G+A+L 
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
             S+ C IHRD  A N+LL N   AK+ DFGLA+         +         ++APE  
Sbjct: 182 --SKNC-IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 335
                 V+SDV+SYG++L E+ + G  P     P    N   +   +++D     ++A P
Sbjct: 239 FDCVYTVQSDVWSYGILLWEIFSLGLNPY----PGILVNSKFYK--LVKDG---YQMAQP 289
Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
               K        + +I  AC A E   RPT  ++   L+
Sbjct: 290 AFAPK-------NIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 80  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 135
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G   
Sbjct: 136 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 190
Query: 270 --YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             +++PE    G     SDV+S+GVVL E+ T
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 97  NNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLH 151
            N     ++G G FG V  G L        +VAIK L  G  ++  ++FL E  ++ +  
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAA 209
           H N+++L G  +   S   ++  E + NGSL+S+L  H        L     + +    A
Sbjct: 76  HPNIIRLEGVVTK--SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 128
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-F 268
            G+ YL   S    +HRD  A NIL+ +N   KV+DFGL++   +      +TR      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 123
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 124 RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 170
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 171 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 227
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 228 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 103
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 104 RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 150
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 151 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 208 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 97  NNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLH 151
            N     ++G G FG V  G L        +VAIK L  G  ++  ++FL E  ++ +  
Sbjct: 16  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 75
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAA 209
           H N+++L G  +   S   ++  E + NGSL+S+L  H        L     + +    A
Sbjct: 76  HPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIA 128
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-F 268
            G+ YL   S    +HRD  A NIL+ +N   KV+DFGL++   +      +TR      
Sbjct: 129 SGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPI 185
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            + +PE          SDV+SYG+VL E+++ G +P
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 86  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 141
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G   
Sbjct: 142 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 196
Query: 270 --YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             +++PE    G     SDV+S+GVVL E+ T
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 86  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 141
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G   
Sbjct: 142 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 196
Query: 270 --YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             +++PE    G     SDV+S+GVVL E+ T
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 97
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 98  RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 144
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 145 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 202 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 84  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 139
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G   
Sbjct: 140 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 194
Query: 270 --YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             +++PE    G     SDV+S+GVVL E+ T
Sbjct: 195 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 91/342 (26%), Positives = 144/342 (42%), Gaps = 43/342 (12%)
Query: 55  KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 114
           K K  PK   + +  ++   G S      T+    E+ +   NN +    LG G FG+V 
Sbjct: 5   KYKQKPKYQVRWKIIESYE-GNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVV 63
Query: 115 K------GVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRNLVKLVGYYSSRD 166
           +      G       VA+K L       +KE L+ E++++S L  H N+V L+G  +   
Sbjct: 64  EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG--ACTH 121
Query: 167 SSQHLLCYELVPNGSLESWLHG--PLGVNC----------HLDWETRMKIALDAARGLAY 214
               L+  E    G L ++L    P G+             L     +  +   A+G+A+
Sbjct: 122 GGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAF 181
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
           L   S+ C IHRD  A N+LL N   AK+ DFGLA+         +         ++APE
Sbjct: 182 L--ASKNC-IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 238
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
                   V+SDV+SYG++L E+ + G  P     P    N   +   +++D     ++A
Sbjct: 239 SIFDCVYTVQSDVWSYGILLWEIFSLGLNPY----PGILVNSKFYK--LVKDG---YQMA 289
Query: 334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
            P    K        + +I  AC A E   RPT  ++   L+
Sbjct: 290 QPAFAPK-------NIYSIMQACWALEPTHRPTFQQICSFLQ 324

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 37/228 (16%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVE--VEMLSRLHHRN 154
           +N +   ++G G +G V+KG L D   VA+K  +   +Q    F+ E  +  +  + H N
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 155 LVKLV---GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL-DWETRMKIALDAAR 210
           + + +      ++    ++LL  E  PNGSL  +L      + H  DW +  ++A    R
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCRLAHSVTR 122
Query: 211 GLAYLHED------SQPCVIHRDFKASNILLENNFHAKVADFGLA------KQAPEGRTN 258
           GLAYLH +       +P + HRD  + N+L++N+    ++DFGL+      +    G  +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 259 YLSTRVMGTFGYVAPEYAMTGHL--------LVKSDVYSYGVVLLELL 298
             +   +GT  Y+APE  + G +        L + D+Y+ G++  E+ 
Sbjct: 183 NAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 40/219 (18%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           LG G FG V++G +S          VA+K L     +Q + +FL+E  ++S+ +H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------MK 203
            +G   S  S    +  EL+  G L+S+L            ETR              + 
Sbjct: 113 CIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLLH 159
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNYL 260
           +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+          
Sbjct: 160 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
               M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 217 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRLHHR 153
           +F+    LG+G FG V+         +   ++    Q      + +   EVE+ S L H 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           N+++L GY+   D+++  L  E  P G++    +  L      D +       + A  L+
Sbjct: 73  NILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALS 126
Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           Y H      VIHRD K  N+LL +N   K+ADFG +  AP  R     T + GT  Y+ P
Sbjct: 127 YCHSKR---VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR----RTTLCGTLDYLPP 179
Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           E         K D++S GV+  E L G  P +
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 87  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 142
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G   
Sbjct: 143 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 197
Query: 270 --YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             +++PE    G     SDV+S+GVVL E+ T
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 127/288 (44%), Gaps = 43/288 (14%)
Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTC-------GGQQGDKEFLVEVEMLSRLHHRNL 155
           +LG G FG V KGV + +G ++ I    C        G+Q  +     +  +  L H ++
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIP--VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRMKIALDAARGL 212
           V+L+G       S   L  + +P GSL   +    G LG    L+W  ++      A+G+
Sbjct: 96  VRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGM 146
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            YL E     ++HR+  A N+LL++    +VADFG+A   P      L +       ++A
Sbjct: 147 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
            E    G    +SDV+SYGV + EL+T G +P    + +   +L+          ++ E 
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----------EKGER 253
Query: 332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           LA P++         I V  +   C   + N RPT  E+      + R
Sbjct: 254 LAQPQICT-------IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 294

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 114
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 115 RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 161
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 162 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 218
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 219 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 42/220 (19%)
Query: 105 LGEGGFGRVFKGVLS------DGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG G FG V++G +S          VA+K L   C  +Q + +FL+E  ++S+ +H+N+V
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQNIV 137
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--------------M 202
           + +G   S  S    +  EL+  G L+S+L            ETR              +
Sbjct: 138 RCIGV--SLQSLPRFILLELMAGGDLKSFLR-----------ETRPRPSQPSSLAMLDLL 184
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQAPEGRTNY 259
            +A D A G  YL E+     IHRD  A N LL        AK+ DFG+A+         
Sbjct: 185 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                M    ++ PE  M G    K+D +S+GV+L E+ +
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG----DKEFLVEVEMLSRLHHR 153
           +F+    LG+G FG V+         +   ++    Q      + +   EVE+ S L H 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           N+++L GY+   D+++  L  E  P G++    +  L      D +       + A  L+
Sbjct: 73  NILRLYGYF--HDATRVYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALS 126
Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           Y H      VIHRD K  N+LL +N   K+ADFG +  AP  R + L     GT  Y+ P
Sbjct: 127 YCHSKR---VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLDYLPP 179
Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           E         K D++S GV+  E L G  P +
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/316 (26%), Positives = 135/316 (42%), Gaps = 36/316 (11%)
Query: 75  GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFK------GVLSDGTAVAIKR 128
           G S      T+    E+ +   NN +    LG G FG+V +      G       VA+K 
Sbjct: 16  GNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 75
Query: 129 LTCGGQQGDKEFLV-EVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL 186
           L       +KE L+ E++++S L  H N+V L+G  +       L+  E    G L ++L
Sbjct: 76  LKSTAHADEKEALMSELKIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFL 133
Query: 187 HGPLGVNCH------LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 240
                 +        L+    +  +   A+G+A+L   S+ C IHRD  A N+LL N   
Sbjct: 134 RRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA--SKNC-IHRDVAARNVLLTNGHV 190
Query: 241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT- 299
           AK+ DFGLA+         +         ++APE        V+SDV+SYG++L E+ + 
Sbjct: 191 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 250
Query: 300 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAP 359
           G  P     P    N   +   +++D     ++A P    K        + +I  AC A 
Sbjct: 251 GLNPY----PGILVNSKFYK--LVKDG---YQMAQPAFAPK-------NIYSIMQACWAL 294
Query: 360 EANQRPTMGEVVQSLK 375
           E   RPT  ++   L+
Sbjct: 295 EPTHRPTFQQICSFLQ 310

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 127/288 (44%), Gaps = 43/288 (14%)
Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTC-------GGQQGDKEFLVEVEMLSRLHHRNL 155
           +LG G FG V KGV + +G ++ I    C        G+Q  +     +  +  L H ++
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIP--VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHLDWETRMKIALDAARGL 212
           V+L+G       S   L  + +P GSL   +    G LG    L+W  ++      A+G+
Sbjct: 78  VRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGM 128
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            YL E     ++HR+  A N+LL++    +VADFG+A   P      L +       ++A
Sbjct: 129 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
            E    G    +SDV+SYGV + EL+T G +P    + +   +L+          ++ E 
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----------EKGER 235
Query: 332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           LA P++         I V  +   C   + N RPT  E+      + R
Sbjct: 236 LAQPQICT-------IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 115 LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 170
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N ++  +F  K+ DFG+ +   E  T+Y      G   
Sbjct: 171 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 225
Query: 270 --YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             +++PE    G     SDV+S+GVVL E+ T
Sbjct: 226 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 133/287 (46%), Gaps = 39/287 (13%)
Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V  G L         VAIK L  G  ++  ++FL E  ++ +  H N++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +   S+  ++  E + NGSL+S+L    G    +     ++     A G+ YL + 
Sbjct: 74  EGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLADM 128
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG---TFGYVAPEY 275
           +    +HR   A NIL+ +N   KV+DFGL++   +  ++   T  +G      + APE 
Sbjct: 129 N---YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 276 AMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQENLVTWARPILRDKDRLEEL- 332
                    SDV+SYG+V+ E+++ G +P  DM+                 ++D +  + 
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-----------------NQDVINAIE 228
Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ 378
            D RL    P +    +  +   C   + N RP  G++V +L KM++
Sbjct: 229 QDYRLPP--PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 273

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +LG+G +G V+ G  LS+   +AIK +     +  +    E+ +   L H+N+V+ +G +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 163 SSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH-LDWETRMKIALDAARGLAYLHED 218
           S     +  +  E VP GSL + L    GPL  N   + + T+  +      GL YLH++
Sbjct: 89  SENGFIKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN 141
Query: 219 SQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
               ++HRD K  N+L+ N +    K++DFG +K+      N  +    GT  Y+APE  
Sbjct: 142 Q---IVHRDIKGDNVLI-NTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEII 195
Query: 277 MTG--HLLVKSDVYSYGVVLLELLTGRKPV-DMSQP 309
             G       +D++S G  ++E+ TG+ P  ++ +P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 231

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 105 LGEGGFGRVFKGVLS----DGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           LG+G FG V +G          +VA+K L        +   +F+ EV  +  L HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G   +       +  EL P GSL   L    G   H    T  + A+  A G+ YL  
Sbjct: 80  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES 133
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYVAPEYA 276
                 IHRD  A N+LL      K+ DFGL +  P+   +Y+        F + APE  
Sbjct: 134 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            T      SD + +GV L E+ T G++P
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 105 LGEGGFGRVFKGVLS----DGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           LG+G FG V +G          +VA+K L        +   +F+ EV  +  L HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G   +       +  EL P GSL   L    G   H    T  + A+  A G+ YL  
Sbjct: 76  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES 129
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYVAPEYA 276
                 IHRD  A N+LL      K+ DFGL +  P+   +Y+        F + APE  
Sbjct: 130 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            T      SD + +GV L E+ T G++P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 96  TNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL 150
           ++ +E   ILG GG   V     L D   VA+K L     + D  F +    E +  + L
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAAL 69
Query: 151 HHRNLVKLVGYYSSRDSSQHL--LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL 206
           +H  +V +     +   +  L  +  E V   +L   +H  GP+        +  +++  
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------TPKRAIEVIA 123
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVM 265
           DA + L + H++    +IHRD K +NIL+      KV DFG+A+  A  G +   +  V+
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVI 180
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           GT  Y++PE A    +  +SDVYS G VL E+LTG  P     P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 105 LGEGGFGRVF----KGVLSDG--TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V+    KGV+ D   T VAIK +       ++ EFL E  ++   +  ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--------HGPLGVNCHLDWETRMKIALDAA 209
           L+G  S    +  L+  EL+  G L+S+L        + P+     L     +++A + A
Sbjct: 80  LLGVVSQGQPT--LVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIA 135
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+AYL+ +     +HRD  A N  +  +F  K+ DFG+ +   E  T+Y      G   
Sbjct: 136 DGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 190
Query: 270 --YVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             +++PE    G     SDV+S+GVVL E+ T
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 105 LGEGGFGRVFKGVLS----DGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           LG+G FG V +G          +VA+K L        +   +F+ EV  +  L HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G   +       +  EL P GSL   L    G   H    T  + A+  A G+ YL  
Sbjct: 86  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES 139
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYA 276
                 IHRD  A N+LL      K+ DFGL +  P+   +Y +       F + APE  
Sbjct: 140 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            T      SD + +GV L E+ T G++P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 16/212 (7%)
Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V  G L        AVAIK L  G  ++  ++FL E  ++ +  H N+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +       ++  E + NG+L+++L    G    +     ++     A G+ YL + 
Sbjct: 110 EGVVTR--GKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLR---GIAAGMRYLADM 164
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAM 277
                +HRD  A NIL+ +N   KV+DFGL++   +     Y +T       + APE   
Sbjct: 165 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 307
                  SDV+SYG+V+ E+++ G +P  DMS
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 253

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 105 LGEGGFGRVFKGVLS----DGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           LG+G FG V +G          +VA+K L        +   +F+ EV  +  L HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G   +       +  EL P GSL   L    G   H    T  + A+  A G+ YL  
Sbjct: 80  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES 133
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYVAPEYA 276
                 IHRD  A N+LL      K+ DFGL +  P+   +Y+        F + APE  
Sbjct: 134 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            T      SD + +GV L E+ T G++P
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 96  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 147
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L        +HRD  A N +L+  F  KVADFGLA+   +     +  +        ++A
Sbjct: 148 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 259
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 260 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 105 LGEGGFGRVFKGVLS----DGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           LG+G FG V +G          +VA+K L        +   +F+ EV  +  L HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G   +       +  EL P GSL   L    G   H    T  + A+  A G+ YL  
Sbjct: 76  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES 129
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYVAPEYA 276
                 IHRD  A N+LL      K+ DFGL +  P+   +Y+        F + APE  
Sbjct: 130 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            T      SD + +GV L E+ T G++P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 38/286 (13%)
Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G   D       T VA+K +       ++ EFL E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCH----LDWETRMKIALDAARG 211
           L+G  S    +  L+  EL+ +G L+S+L    P   N         +  +++A + A G
Sbjct: 85  LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           +AYL+       +HRD  A N ++ ++F  K+ DFG+ +   E        + +    ++
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
           APE    G     SD++S+GVVL E+ +  +     QP             L ++  L+ 
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAE-----QPYQG----------LSNEQVLKF 244
Query: 332 LADPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLK 375
           + D   GG   + D    RV  +   C     N RPT  E+V  LK
Sbjct: 245 VMD---GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 97  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 148
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +     +  +        ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 260
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 261 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 95  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 146
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +     +  +        ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 258
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 259 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 116 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 167
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L        +HRD  A N +L+  F  KVADFGLA+   +     +  +        ++A
Sbjct: 168 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 279
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 280 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 97  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 148
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +     +  +        ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 260
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 261 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +LG+G +G V+ G  LS+   +AIK +     +  +    E+ +   L H+N+V+ +G +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 163 SSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCH-LDWETRMKIALDAARGLAYLHED 218
           S     +  +  E VP GSL + L    GPL  N   + + T+  +      GL YLH++
Sbjct: 75  SENGFIKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN 127
Query: 219 SQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
               ++HRD K  N+L+ N +    K++DFG +K+      N  +    GT  Y+APE  
Sbjct: 128 Q---IVHRDIKGDNVLI-NTYSGVLKISDFGTSKRL--AGINPCTETFTGTLQYMAPEII 181
Query: 277 MTG--HLLVKSDVYSYGVVLLELLTGRKPV-DMSQP 309
             G       +D++S G  ++E+ TG+ P  ++ +P
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 217

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 92  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 143
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +     +  +        ++A
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 255
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 256 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 89  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 140
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--PEGRTNYLSTRVMGTFGYVA 272
           L        +HRD  A N +L+  F  KVADFGLA+     E  + +  T       ++A
Sbjct: 141 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 252
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 253 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 94  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 145
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +     +  +        ++A
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 257
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 258 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 115 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 166
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L        +HRD  A N +L+  F  KVADFGLA+   +     +  +        ++A
Sbjct: 167 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 278
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 279 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ +
Sbjct: 98  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKF 149
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +   + +  +        ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 261
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 262 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ Y
Sbjct: 96  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKY 147
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +     +  +        ++A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 259
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 260 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 117/237 (49%), Gaps = 36/237 (15%)
Query: 86  FLAYEELKEATNNFEPASI------LGEGGFGRVFKGVLSDGTAVAI-KRLTCGGQQGDK 138
           F + ++ +  T +  P         LG+G FG+V+K    + + +A  K +    ++  +
Sbjct: 20  FQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE 79
Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESW---LHGPLGVNCH 195
           +++VE+++L+   H N+VKL+  +   ++   L+  E    G++++    L  PL     
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILI--EFCAGGAVDAVMLELERPLT---- 133
Query: 196 LDWETRMKIA----LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 251
              E+++++     LDA   L YLH++    +IHRD KA NIL   +   K+ADFG++  
Sbjct: 134 ---ESQIQVVCKQTLDA---LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS-- 182
Query: 252 APEGRTNYLSTRVMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKP 303
           A   RT       +GT  ++APE  M           K+DV+S G+ L+E+     P
Sbjct: 183 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ +
Sbjct: 98  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKF 149
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +   + +  +        ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 261
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 262 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ +
Sbjct: 97  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKF 148
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +   + +  +        ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 260
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 261 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ +
Sbjct: 95  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKF 146
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +   + +  +        ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 258
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 259 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ +
Sbjct: 97  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKF 148
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +   + +  +        ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 260
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 261 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ +
Sbjct: 102 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKF 153
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L   +    +HRD  A N +L+  F  KVADFGLA+   +   + +  +        ++A
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 265
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 266 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 96  TNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL 150
           ++ +E   ILG GG   V     L D   VA+K L     + D  F +    E +  + L
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAAL 69
Query: 151 HHRNLVKLVGYYSSRDSSQHL--LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL 206
           +H  +V +     +   +  L  +  E V   +L   +H  GP+        +  +++  
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT------PKRAIEVIA 123
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVM 265
           DA + L + H++    +IHRD K +NI++      KV DFG+A+  A  G +   +  V+
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           GT  Y++PE A    +  +SDVYS G VL E+LTG  P     P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 104 ILGEGGFGRVFKGVL--SDGTAV--AIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L  +DG  +  A+K L      G+  +FL E  ++    H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL----HGPLGVNCHLDWETRMKIALDAARGLAY 214
           +G    R     L+    + +G L +++    H P         +  +   L  A+G+ +
Sbjct: 156 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-------TVKDLIGFGLQVAKGMKF 207
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVA 272
           L        +HRD  A N +L+  F  KVADFGLA+   +   + +  +        ++A
Sbjct: 208 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL--E 330
            E   T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L  E
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQPE 319
Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              DP             +  +   C  P+A  RP+  E+V  +  +
Sbjct: 320 YCPDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 96  TNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL 150
           ++ +E   ILG GG   V     L D   VA+K L     + D  F +    E +  + L
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAAL 69
Query: 151 HHRNLVKLVGYYSSRDSSQHL--LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL 206
           +H  +V +     +   +  L  +  E V   +L   +H  GP+        +  +++  
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------TPKRAIEVIA 123
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVM 265
           DA + L + H++    +IHRD K +NI++      KV DFG+A+  A  G +   +  V+
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           GT  Y++PE A    +  +SDVYS G VL E+LTG  P     P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 38/240 (15%)
Query: 97  NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           ++FE  ++LG+G FG+V K   + D    AIK++    ++     L EV +L+ L+H+ +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYV 64
Query: 156 VKLVGYYSSR-----------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
           V+    +  R             S   +  E   NG+L   +H     N +   +   ++
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRL 121
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-------------Q 251
                  L+Y+H      +IHRD K  NI ++ + + K+ DFGLAK             Q
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 252 APEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELL----TGRKPVDM 306
              G ++ L T  +GT  YVA E    TGH   K D+YS G++  E++    TG + V++
Sbjct: 179 NLPGSSDNL-TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 37/285 (12%)
Query: 104 ILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKL 158
           ILGEG FG V++GV ++  G  + +   TC         ++F+ E  ++  L H ++VKL
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G      +    +  EL P G L  +L         L   T +  +L   + +AYL  +
Sbjct: 75  IGIIEEEPT---WIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYL--E 126
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
           S  CV HRD    NIL+ +    K+ DFGL++   E    Y ++       +++PE    
Sbjct: 127 SINCV-HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINF 184
Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 337
                 SDV+ + V + E+L+ G++P              W    L +KD +  L     
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQP------------FFW----LENKDVIGVLEK--- 225
Query: 338 GGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 380
           G + PK D     + T+   C   + + RP   E+V SL  V ++
Sbjct: 226 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 270

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 21/228 (9%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAV-AIKRLT---CGGQQGDKEFLVEVEMLSRLHH 152
           ++FE    +G+G FG+V     +D   + A+K +    C  +   +    E++++  L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             LV L  +YS +D     +  +L+  G L   L      N H   ET      +    L
Sbjct: 75  PFLVNL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMAL 128
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            YL       +IHRD K  NILL+ + H  + DF +A   P  R   ++T + GT  Y+A
Sbjct: 129 DYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITT-MAGTKPYMA 182
Query: 273 PEYAMT----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
           PE   +    G+     D +S GV   ELL GR+P  +   +  + +V
Sbjct: 183 PEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 87/329 (26%), Positives = 138/329 (41%), Gaps = 49/329 (14%)
Query: 75  GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFK------GVLSDGTAVAIKR 128
           G S      T+    E+ +   NN +    LG G FG+V +      G       VA+K 
Sbjct: 9   GNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM 68
Query: 129 LTCGGQQGDKEFLV-EVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL 186
           L       +KE L+ E++++S L  H N+V L+G  +       L+  E    G L ++L
Sbjct: 69  LKSTAHADEKEALMSELKIMSHLGQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFL 126
Query: 187 ---------------HGPLGVNCH----LDWETRMKIALDAARGLAYLHEDSQPCVIHRD 227
                            P G++      L+    +  +   A+G+A+L   S+ C IHRD
Sbjct: 127 RRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLA--SKNC-IHRD 183
Query: 228 FKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDV 287
             A N+LL N   AK+ DFGLA+         +         ++APE        V+SDV
Sbjct: 184 VAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 243
Query: 288 YSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF 346
           +SYG++L E+ + G  P     P    N   +   +++D     ++A P    K      
Sbjct: 244 WSYGILLWEIFSLGLNPY----PGILVNSKFYK--LVKDG---YQMAQPAFAPK------ 288
Query: 347 IRVCTIAAACVAPEANQRPTMGEVVQSLK 375
             + +I  AC A E   RPT  ++   L+
Sbjct: 289 -NIYSIMQACWALEPTHRPTFQQICSFLQ 316

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 37/285 (12%)
Query: 104 ILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKL 158
           ILGEG FG V++GV ++  G  + +   TC         ++F+ E  ++  L H ++VKL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G      +    +  EL P G L  +L         L   T +  +L   + +AYL  +
Sbjct: 79  IGIIEEEPT---WIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYL--E 130
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
           S  CV HRD    NIL+ +    K+ DFGL++   E    Y ++       +++PE    
Sbjct: 131 SINCV-HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINF 188
Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 337
                 SDV+ + V + E+L+ G++P              W    L +KD +  L     
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP------------FFW----LENKDVIGVLEK--- 229
Query: 338 GGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 380
           G + PK D     + T+   C   + + RP   E+V SL  V ++
Sbjct: 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 17/213 (7%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ---QG-DKEFLVEVEMLSRLHH 152
           ++FE    LG+G FG V+         +   ++    Q   +G + +   E+E+ + LHH
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
            N+++L  Y+   D  +  L  E  P G L    +  L  +C  D +    I  + A  L
Sbjct: 83  PNILRLYNYFY--DRRRIYLILEYAPRGEL----YKELQKSCTFDEQRTATIMEELADAL 136
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            Y H      VIHRD K  N+LL      K+ADFG +  AP  R   +     GT  Y+ 
Sbjct: 137 MYCHGKK---VIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GTLDYLP 189
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           PE         K D++  GV+  ELL G  P +
Sbjct: 190 PEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 37/285 (12%)
Query: 104 ILGEGGFGRVFKGVLSD--GTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKL 158
           ILGEG FG V++GV ++  G  + +   TC         ++F+ E  ++  L H ++VKL
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G      +    +  EL P G L  +L         L   T +  +L   + +AYL  +
Sbjct: 91  IGIIEEEPT---WIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYL--E 142
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
           S  CV HRD    NIL+ +    K+ DFGL++   E    Y ++       +++PE    
Sbjct: 143 SINCV-HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINF 200
Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 337
                 SDV+ + V + E+L+ G++P              W    L +KD +  L     
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQP------------FFW----LENKDVIGVLEK--- 241
Query: 338 GGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 380
           G + PK D     + T+   C   + + RP   E+V SL  V ++
Sbjct: 242 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 286

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 95/226 (42%), Gaps = 19/226 (8%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ---QG-DKEFLVEVEMLS 148
           K   ++F+    LG+G FG V+         +   ++    Q   +G + +   E+E+ S
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
            L H N++++  Y+   D  +  L  E  P G L    +  L  +   D +       + 
Sbjct: 70  HLRHPNILRMYNYFH--DRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEEL 123
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
           A  L Y HE     VIHRD K  N+L+      K+ADFG +  AP  R   +     GT 
Sbjct: 124 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTL 176
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 314
            Y+ PE         K D++  GV+  E L G  P D   PS  E 
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTET 220

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 93  KEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVE------ 145
           K +  +F+    LG G FGRV       +G   A+K L        KE +V ++      
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLKQVEHTN 54
Query: 146 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
               MLS + H  ++++ G  + +D+ Q  +  + +  G L S L      +        
Sbjct: 55  DERLMLSIVTHPFIIRMWG--TFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVA 108
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
              A +    L YLH      +I+RD K  NILL+ N H K+ DFG AK  P+     ++
Sbjct: 109 KFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VT 160
Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             + GT  Y+APE   T       D +S+G+++ E+L G  P
Sbjct: 161 YXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 76  LIGVITENPV---WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES 129
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 130 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 185
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 103 IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+          +T
Sbjct: 161 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                  ++APE         +SDV+S+GV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVK 157
           LGE  FG+V+KG L          AVAIK L    +    +EF  E  + +RL H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLG-------VNCHLDWETRMKIA 205
           L+G  +       +  Y    +G L  +L     H  +G       V   L+    + + 
Sbjct: 94  LLGVVTKDQPLSMIFSY--CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              A G+ YL   S   V+H+D    N+L+ +  + K++D GL ++        L    +
Sbjct: 152 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
               ++APE  M G   + SD++SYGVVL E+ + G +P
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 103 IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 161 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKN 215
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 17/217 (7%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ---QG-DKEFLVEVEMLS 148
           K   ++F+    LG+G FG V+         +   ++    Q   +G + +   E+E+ S
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
            L H N++++  Y+   D  +  L  E  P G L    +  L  +   D +       + 
Sbjct: 71  HLRHPNILRMYNYFH--DRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEEL 124
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
           A  L Y HE     VIHRD K  N+L+      K+ADFG +  AP  R   +     GT 
Sbjct: 125 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTL 177
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
            Y+ PE         K D++  GV+  E L G  P D
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V     +  G  +A+K+L+   Q     
Sbjct: 35  PTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHA 94
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 95  KRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 154
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 155 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 206
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H  +  D++S G ++ ELLTGR
Sbjct: 207 EMTGYVATR-----WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G+G FG V+ G   D        AIK L+     Q  + FL E  ++  L+H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G     +   H+L   +  +G L  ++  P       D    +   L  ARG+ YL E 
Sbjct: 88  IGIMLPPEGLPHVLLPYMC-HGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYLAEQ 143
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR----VMGTFGYVAPE 274
                +HRD  A N +L+ +F  KVADFGLA+   +    Y S +          + A E
Sbjct: 144 K---FVHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQQHRHARLPVKWTALE 198
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
              T     KSDV+S+GV+L ELLT   P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 103 IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+          +T
Sbjct: 161 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                  ++APE         +SDV+S+GV++ E+ T
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 78  LIGVITENPV---WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES 131
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 132 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 187
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 188 FRRFTSASDVWMFGVCMWEILMHGVKP 214

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 73  LIGVITENPV---WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES 126
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 127 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 182
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKP 209

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 93  KEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEM 146
           K+   +F+   ILGEG F  V     L+     AIK L    +   KE  V     E ++
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDV 63
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKI 204
           +SRL H   VKL  Y++ +D  +         NG L  ++   G     C     TR   
Sbjct: 64  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYT 116
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A +    L YLH      +IHRD K  NILL  + H ++ DFG AK          +   
Sbjct: 117 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
           +GT  YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 173 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRN 154
           ++ EP   LG G +G V K   +  G  +A+KR+      Q  K  L+++++  R     
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
               V +Y +      + +C EL+ + SL+ +    +     +  +   KIA+   + L 
Sbjct: 111 FT--VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 167
Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL--------AKQAPEGRTNYLSTRVM 265
           +LH  S+  VIHRD K SN+L+      K+ DFG+        AK    G   Y++    
Sbjct: 168 HLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPE-- 223
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
                + PE    G+  VKSD++S G+ ++EL   R P D           +W  P  + 
Sbjct: 224 ----RINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQL 267
Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
           K  +EE   P+L       +F+      + C+   + +RPT  E++Q
Sbjct: 268 KQVVEE-PSPQLPADKFSAEFV---DFTSQCLKKNSKERPTYPELMQ 310

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 100/232 (43%), Gaps = 25/232 (10%)
Query: 93  KEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEM 146
           K+   +F+   ILGEG F  V     L+     AIK L    +   KE  V     E ++
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDV 62
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKI 204
           +SRL H   VKL  Y++ +D  +         NG L  ++   G     C     TR   
Sbjct: 63  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYT 115
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A +    L YLH      +IHRD K  NILL  + H ++ DFG AK          +   
Sbjct: 116 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
           +GT  YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 172 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 219

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G   D       T VA+K +       ++ EFL E  ++      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCH----LDWETRMKIALDAARG 211
           L+G  S    +  L+  EL+ +G L+S+L    P   N         +  +++A + A G
Sbjct: 82  LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           +AYL+       +HRD  A N ++ ++F  K+ DFG+ +   E        + +    ++
Sbjct: 140 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLEL 297
           APE    G     SD++S+GVVL E+
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V  G L         VAIK L  G   +  ++FL E  ++ +  H N++ L
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +       ++  E + NGSL+++L    G    +     ++       G+ YL + 
Sbjct: 96  EGVVTK--CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLSDM 150
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYVAPEYAM 277
           S    +HRD  A NIL+ +N   KV+DFG+++   +      +TR       + APE   
Sbjct: 151 S---AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKPV-DMS 307
                  SDV+SYG+V+ E+++ G +P  DMS
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 239

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 87  LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ-QGDKEFLV-EV 144
           L ++ L E     E    +GEG +G V+K   S G  VA+KR+    + +G     + E+
Sbjct: 14  LYFQGLMEKYQKLEK---VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI 70
Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
            +L  LHH N+V L+    S        C  LV    +E  L   L  N     ++++KI
Sbjct: 71  SLLKELHHPNIVSLIDVIHSER------CLTLVFE-FMEKDLKKVLDENKTGLQDSQIKI 123
Query: 205 AL-DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
            L    RG+A+ H+     ++HRD K  N+L+ ++   K+ADFGLA+       +Y  T 
Sbjct: 124 YLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--TH 178
Query: 264 VMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            + T  Y AP+  M       S D++S G +  E++TG+
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 456 LIGVITENPV---WIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES 509
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 510 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 565
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 76  LIGVITENPV---WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES 129
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 130 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 185
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 87  LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ-QGDKEFLV-EV 144
           L ++ L E     E    +GEG +G V+K   S G  VA+KR+    + +G     + E+
Sbjct: 14  LYFQGLMEKYQKLEK---VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI 70
Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
            +L  LHH N+V L+    S        C  LV    +E  L   L  N     ++++KI
Sbjct: 71  SLLKELHHPNIVSLIDVIHSER------CLTLVFE-FMEKDLKKVLDENKTGLQDSQIKI 123
Query: 205 AL-DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
            L    RG+A+ H+     ++HRD K  N+L+ ++   K+ADFGLA+       +Y  T 
Sbjct: 124 YLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--TH 178
Query: 264 VMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            + T  Y AP+  M       S D++S G +  E++TG+
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 104/236 (44%), Gaps = 33/236 (13%)
Query: 93  KEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEM 146
           K+   +F+   ILGEG F  V     L+     AIK L    +   KE  V     E ++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDV 61
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKI 204
           +SRL H   VKL  Y++ +D  +         NG L  ++   G     C     TR   
Sbjct: 62  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYT 114
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK----QAPEGRTNYL 260
           A +    L YLH      +IHRD K  NILL  + H ++ DFG AK    ++ + R N  
Sbjct: 115 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
               +GT  YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 171 ----VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 218

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 103 IITLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 161 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVK 157
           LGE  FG+V+KG L          AVAIK L    +    +EF  E  + +RL H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLG-------VNCHLDWETRMKIA 205
           L+G  +       +  Y    +G L  +L     H  +G       V   L+    + + 
Sbjct: 77  LLGVVTKDQPLSMIFSY--CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              A G+ YL   S   V+H+D    N+L+ +  + K++D GL ++        L    +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
               ++APE  M G   + SD++SYGVVL E+ + G +P
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 104/236 (44%), Gaps = 33/236 (13%)
Query: 93  KEATNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEM 146
           K+   +F+   ILGEG F  V     L+     AIK L    +   KE  V     E ++
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDV 60
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKI 204
           +SRL H   VKL  Y++ +D  +         NG L  ++   G     C     TR   
Sbjct: 61  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYT 113
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK----QAPEGRTNYL 260
           A +    L YLH      +IHRD K  NILL  + H ++ DFG AK    ++ + R N  
Sbjct: 114 A-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
               +GT  YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 170 ----VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 217

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 103 IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 161 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 104 LIGVITENPV---WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES 157
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 158 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 213
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 214 FRRFTSASDVWMFGVCMWEILMHGVKP 240

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 15/207 (7%)
Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V  G L         VAIK L  G  ++  ++FL E  ++ +  H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +   S   ++  E + NGSL+++L    G    +     ++     + G+ YL   
Sbjct: 89  EGVVTK--SKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR---GISAGMKYL--- 140
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYVAPEYAM 277
           S    +HRD  A NIL+ +N   KV+DFGL++   +      +TR       + APE   
Sbjct: 141 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 200
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+SYG+V+ E+++ G +P
Sbjct: 201 FRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 116/237 (48%), Gaps = 36/237 (15%)
Query: 86  FLAYEELKEATNNFEPASI------LGEGGFGRVFKGVLSDGTAVAI-KRLTCGGQQGDK 138
           F + ++ +  T +  P         LG+G FG+V+K    + + +A  K +    ++  +
Sbjct: 20  FQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE 79
Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESW---LHGPLGVNCH 195
           +++VE+++L+   H N+VKL+  +   ++   L+  E    G++++    L  PL     
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILI--EFCAGGAVDAVMLELERPLT---- 133
Query: 196 LDWETRMKIA----LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 251
              E+++++     LDA   L YLH++    +IHRD KA NIL   +   K+ADFG++  
Sbjct: 134 ---ESQIQVVCKQTLDA---LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS-- 182
Query: 252 APEGRTNYLSTRVMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKP 303
           A   R        +GT  ++APE  M           K+DV+S G+ L+E+     P
Sbjct: 183 AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 81  LIGVITENPV---WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES 134
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 135 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 190
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKP 217

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 104 ILGEGGFGRVFK---GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
           +LG+G FG V K    +     AV +        +     L EVE+L +L H N++KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL-- 86
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR-------GLA 213
           +    DSS   +  EL   G L   +      + H           DAAR       G+ 
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----------DAARIIKQVFSGIT 135
Query: 214 YLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           Y+H+ +   ++HRD K  NILLE+   +   K+ DFGL+    +     +  R+ GT  Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI-GTAYY 189
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +APE  + G    K DV+S GV+L  LL+G  P
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G   D       T VA+K +       ++ EFL E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCH----LDWETRMKIALDAARG 211
           L+G  S    +  L+  EL+ +G L+S+L    P   N         +  +++A + A G
Sbjct: 85  LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           +AYL+       +HRD  A N ++ ++F  K+ DFG+ +   E        + +    ++
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLEL 297
           APE    G     SD++S+GVVL E+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 79  LIGVITENPV---WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES 132
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 133 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 188
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 189 FRRFTSASDVWMFGVCMWEILMHGVKP 215

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 116/237 (48%), Gaps = 36/237 (15%)
Query: 86  FLAYEELKEATNNFEPASI------LGEGGFGRVFKGVLSDGTAVAI-KRLTCGGQQGDK 138
           F + ++ +  T +  P         LG+G FG+V+K    + + +A  K +    ++  +
Sbjct: 20  FQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE 79
Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESW---LHGPLGVNCH 195
           +++VE+++L+   H N+VKL+  +   ++   L+  E    G++++    L  PL     
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILI--EFCAGGAVDAVMLELERPLT---- 133
Query: 196 LDWETRMKIA----LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 251
              E+++++     LDA   L YLH++    +IHRD KA NIL   +   K+ADFG++  
Sbjct: 134 ---ESQIQVVCKQTLDA---LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS-- 182
Query: 252 APEGRTNYLSTRVMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVLLELLTGRKP 303
           A   R        +GT  ++APE  M           K+DV+S G+ L+E+     P
Sbjct: 183 AKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 83
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 84  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 136
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNK 193
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 238
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 239 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 149 IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 207 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 261
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 105 LGEGGFGRVFKGVLS----DGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           LG+G FG V +G          +VA+K L        +   +F+ EV  +  L HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G   +       +  EL P GSL   L    G   H    T  + A+  A G+ YL  
Sbjct: 76  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES 129
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYA 276
                 IHRD  A N+LL      K+ DFGL +  P+   +  +       F + APE  
Sbjct: 130 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            T      SD + +GV L E+ T G++P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 103 IIHLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 161 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 83
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 84  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 136
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 238
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 239 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 105 LGEGGFGRVFKGVLS----DGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           LG+G FG V +G          +VA+K L        +   +F+ EV  +  L HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G   +       +  EL P GSL   L    G   H    T  + A+  A G+ YL  
Sbjct: 86  LYGVVLTPPMK---MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLES 139
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYA 276
                 IHRD  A N+LL      K+ DFGL +  P+   +  +       F + APE  
Sbjct: 140 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196
Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            T      SD + +GV L E+ T G++P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 83
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 84  TREPPFYIII-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 136
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 238
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 239 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 79
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 80  TREPPFYIII-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 132
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 133 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNK 189
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 234
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 235 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 79
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 80  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 132
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 133 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNK 189
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 190 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 234
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 235 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 268

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 82
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 83  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 135
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 136 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 237
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 238 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 32/213 (15%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGY- 161
           +G+G +G V++G L  G +VA+K  +   +Q    +  E E+ +   L H N++  +   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQS---WFRETEIYNTVLLRHDNILGFIASD 71
Query: 162 YSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-- 218
            +SR+SS  L L      +GSL  +L     +  HL     +++A+ AA GLA+LH +  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQ-TLEPHL----ALRLAVSAACGLAHLHVEIF 126
Query: 219 ---SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST----RVMGTFGYV 271
               +P + HRDFK+ N+L+++N    +AD GLA    +G ++YL      RV GT  Y+
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQG-SDYLDIGNNPRV-GTKRYM 184
Query: 272 APEYAMTGHLLVK-------SDVYSYGVVLLEL 297
           APE  +   +          +D++++G+VL E+
Sbjct: 185 APE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V  G L         VAIK L  G   +  ++FL E  ++ +  H N++ L
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +       ++  E + NGSL+++L    G    +     ++       G+ YL + 
Sbjct: 81  EGVVTK--CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLSDM 135
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYVAPEYAM 277
           S    +HRD  A NIL+ +N   KV+DFG+++   +      +TR       + APE   
Sbjct: 136 S---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQ 308
                  SDV+SYG+V+ E+++ G +P  DMS 
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 225

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 78
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 79  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 131
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 233
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 234 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 83
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 84  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 136
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 238
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 239 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 80
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 81  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 133
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIKWTAPESLAYNK 190
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 235
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 236 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRN 154
           ++ EP   LG G +G V K   +  G  +A+KR+      Q  K  L+++++  R     
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
               V +Y +      + +C EL+ + SL+ +    +     +  +   KIA+   + L 
Sbjct: 67  FT--VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL--------AKQAPEGRTNYLSTRVM 265
           +LH  S+  VIHRD K SN+L+      K+ DFG+        AK    G   Y++    
Sbjct: 124 HLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE-- 179
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
                + PE    G+  VKSD++S G+ ++EL   R P D           +W  P  + 
Sbjct: 180 ----RINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQL 223
Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
           K  +EE   P+L       +F+      + C+   + +RPT  E++Q
Sbjct: 224 KQVVEE-PSPQLPADKFSAEFV---DFTSQCLKKNSKERPTYPELMQ 266

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 103/229 (44%), Gaps = 27/229 (11%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 90
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 91  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 142
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGT 267
              L YLH      +IHRD K  NILL  + H ++ DFG AK  +PE +    ++ V GT
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GT 198
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
             YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 243

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 106/244 (43%), Gaps = 26/244 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 89
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 141
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+ +A+ I  + D 
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEGLI-FAKIIKLEYDF 253
Query: 329 LEEL 332
            E+ 
Sbjct: 254 PEKF 257

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 99  FEPASILGEGGFGRVFKG---VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           +    +LG+G FG V K    +     AV +        +     L EVE+L +L H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           +KL  +    DSS   +  EL   G L   +      + H       +I      G+ Y+
Sbjct: 84  MKL--FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARIIKQVFSGITYM 137
Query: 216 HEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
           H+ +   ++HRD K  NILLE+   +   K+ DFGL+    +     +  R+ GT  Y+A
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIA 191
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           PE  + G    K DV+S GV+L  LL+G  P
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 90  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 148 SCTYQLARGMEYLA--SQKC-IHRDLTARNVLVTENNVMKIADFGLARDI--NNIDYYKK 202
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 203 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 104 ILGEGGFGRVFKGVLS----DGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V  G L         VAIK L  G   +  ++FL E  ++ +  H N++ L
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +       ++  E + NGSL+++L    G    +     ++       G+ YL + 
Sbjct: 75  EGVVTK--CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLR---GIGSGMKYLSDM 129
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT-FGYVAPEYAM 277
           S    +HRD  A NIL+ +N   KV+DFG+++   +      +TR       + APE   
Sbjct: 130 S---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQ 308
                  SDV+SYG+V+ E+++ G +P  DMS 
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 20/233 (8%)
Query: 76  GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ 134
           GS   PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q
Sbjct: 1   GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 135 Q--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGP 189
                K    E+ +L  + H N++ L+  ++   S +      LV +     L + +   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ 120
Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
              + H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 172
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
           +   +  T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 173 RHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 42/288 (14%)
Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G   D       T VA+K +       ++ EFL E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCH----LDWETRMKIALDAARG 211
           L+G  S    +  L+  EL+ +G L+S+L    P   N         +  +++A + A G
Sbjct: 85  LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-- 269
           +AYL+       +HR+  A N ++ ++F  K+ DFG+ +   E  T+Y      G     
Sbjct: 143 MAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 197
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           ++APE    G     SD++S+GVVL E+ +  +     QP             L ++  L
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE-----QPYQG----------LSNEQVL 242
Query: 330 EELADPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLK 375
           + + D   GG   + D    RV  +   C     N RPT  E+V  LK
Sbjct: 243 KFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 36/277 (12%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G FG V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 76
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   +     + +A   +  + YL + + 
Sbjct: 77  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQISSAMEYLEKKN- 129
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 130 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNK 186
Query: 281 LLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD-RLEELADPRLG 338
             +KSDV+++GV+L E+ T G  P     PS    L+        +KD R+E        
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL--------EKDYRMER------- 231
Query: 339 GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
              P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 232 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 80
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 81  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 133
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 190
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 235
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 236 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 78
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 79  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 131
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 233
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 234 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 91
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 92  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 144
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 145 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 201
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 202 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 246
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 247 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 280

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 80
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 81  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 133
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 190
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 191 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 235
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 236 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 269

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 99  FEPASILGEGGFGRVFK---GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           +    +LG+G FG V K    +     AV +        +     L EVE+L +L H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           +KL  +    DSS   +  EL   G L   +      + H       +I      G+ Y+
Sbjct: 84  MKL--FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARIIKQVFSGITYM 137
Query: 216 HEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
           H+ +   ++HRD K  NILLE+   +   K+ DFGL+    +     +  R+ GT  Y+A
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIA 191
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           PE  + G    K DV+S GV+L  LL+G  P
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 42/288 (14%)
Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G   D       T VA+K +       ++ EFL E  ++      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCH----LDWETRMKIALDAARG 211
           L+G  S    +  L+  EL+ +G L+S+L    P   N         +  +++A + A G
Sbjct: 86  LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-- 269
           +AYL+       +HR+  A N ++ ++F  K+ DFG+ +   E  T+Y      G     
Sbjct: 144 MAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 198
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           ++APE    G     SD++S+GVVL E+ +  +     QP             L ++  L
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE-----QPYQG----------LSNEQVL 243
Query: 330 EELADPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLK 375
           + + D   GG   + D    RV  +   C     N RPT  E+V  LK
Sbjct: 244 KFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG+G FG+V+K    + G   A K +    ++  ++++VE+E+L+   H  +VKL+G Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                +  +  E  P G++++ +   L ++  L       +       L +LH      +
Sbjct: 87  H--DGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSKR---I 138
Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL- 282
           IHRD KA N+L+      ++ADFG++  A   +T       +GT  ++APE  M   +  
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 283 ----VKSDVYSYGVVLLELLTGRKP 303
                K+D++S G+ L+E+     P
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 106/244 (43%), Gaps = 26/244 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 89
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 141
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+ +A+ I  + D 
Sbjct: 199 QYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFR----AGNEGLI-FAKIIKLEYDF 253
Query: 329 LEEL 332
            E+ 
Sbjct: 254 PEKF 257

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 95  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 153 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 207
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 208 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 25/228 (10%)
Query: 97  NNFEPASILGEGGFGR-VFKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F   V    L+     AIK L    +   KE  V     E +++SRL
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 87
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 88  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 139
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 240

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 92  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 150 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 204
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 205 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+    D          ++  +
Sbjct: 103 IINLLGA-CTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   ++ADFGLA+       +Y   
Sbjct: 161 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMRIADFGLARDI--NNIDYYKK 215
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 25/228 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 90
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 91  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 142
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 143 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 199
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 200 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 243

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LGEGGF  V     L DG   A+KR+ C  QQ  +E   E +M    +H N+++LV Y  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 164 SRDSSQH--LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
               ++H   L       G+L + +         L  +  + + L   RGL  +H     
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-- 154
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQA---PEGRTNYLSTRVMG----TFGYVAPE 274
              HRD K +NILL +     + D G   QA    EG    L+ +       T  Y APE
Sbjct: 155 -YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 275 -YAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDM 306
            +++  H ++  ++DV+S G VL  ++ G  P DM
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 25/228 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 87
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 88  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 139
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 240

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG+G FG+V+K    + G   A K +    ++  ++++VE+E+L+   H  +VKL+G Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                +  +  E  P G++++ +   L ++  L       +       L +LH      +
Sbjct: 79  H--DGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQMLEALNFLHSKR---I 130
Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL- 282
           IHRD KA N+L+      ++ADFG++  A   +T       +GT  ++APE  M   +  
Sbjct: 131 IHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 283 ----VKSDVYSYGVVLLELLTGRKP 303
                K+D++S G+ L+E+     P
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG VFKG+ +     VAIK +     + + E +  E+ +LS+     + K  G Y
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 163 SSRDSSQHLLCYELVPNGS-LESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
                S+  +  E +  GS L+    GP          T +K  L   +GL YLH + + 
Sbjct: 91  LK--GSKLWIIMEYLGGGSALDLLRAGPFD---EFQIATMLKEIL---KGLDYLHSEKK- 141
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
             IHRD KA+N+LL      K+ADFG+A Q  +  T       +GT  ++APE       
Sbjct: 142 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 282 LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKY 341
             K+D++S G+  +EL  G  P     P     L+    P             P L G +
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PTLVGDF 244
Query: 342 PK--EDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
            K  ++FI       AC+  + + RPT  E+++
Sbjct: 245 TKSFKEFID------ACLNKDPSFRPTAKELLK 271

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 25/228 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 87
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 88  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 139
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 240

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 21/208 (10%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VA+K +  G    D EF  E + + +L H  LVK  G   S
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGV-CS 73
Query: 165 RDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
           ++   +++  E + NG L ++L  HG       L+    +++  D   G+A+L E  Q  
Sbjct: 74  KEYPIYIVT-EYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFL-ESHQ-- 124
Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTG 279
            IHRD  A N L++ +   KV+DFG+ +   + +  Y+S+  +GT     + APE     
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSS--VGTKFPVKWSAPEVFHYF 180
Query: 280 HLLVKSDVYSYGVVLLELLT-GRKPVDM 306
               KSDV+++G+++ E+ + G+ P D+
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 20/234 (8%)
Query: 75  GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG 133
           G S   PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 134 QQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHG 188
           Q     K    E+ +L  + H N++ L+  ++   S +      LV +     L + +  
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 130
Query: 189 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 248
               + H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGL
Sbjct: 131 QKLTDDHVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGL 182
Query: 249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
           A+   +  T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 183 ARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 25/228 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 89
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 141
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 242

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 7/205 (3%)
Query: 98  NFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHRN 154
           ++E    +G G +GR  K    SDG  +  K L  G   + +K+ LV EV +L  L H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +V+       R ++   +  E    G L S +        +LD E  +++       L  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 215 LHE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            H   D    V+HRD K +N+ L+   + K+ DFGLA+      T++  T V GT  Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKTFV-GTPYYMS 184
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLEL 297
           PE         KSD++S G +L EL
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 25/228 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 89
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 141
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 242

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G   D       T VA+K +       ++ EFL E  ++      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCH----LDWETRMKIALDAARG 211
           L+G  S    +  L+  EL+ +G L+S+L    P   N         +  +++A + A G
Sbjct: 84  LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-- 269
           +AYL+       +HRD  A N ++ ++F  K+ DFG+ +   E  T+Y      G     
Sbjct: 142 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 196
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           ++APE    G     SD++S+GVVL E+ +               L       L ++  L
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 241
Query: 330 EELADPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLK 375
           + + D   GG   + D    RV  +   C       RPT  E+V  LK
Sbjct: 242 KFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 83
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   +     + +A   +  + YL + + 
Sbjct: 84  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQISSAMEYLEKKN- 136
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 193
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 238
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 239 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 272

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 87
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 88  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 139
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGT 267
              L YLH      +IHRD K  NILL  + H ++ DFG AK  +PE +    +  V GT
Sbjct: 140 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GT 195
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
             YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 240

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 25/228 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 89
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 141
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 242

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 18/220 (8%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEF---LVEVEM 146
           ++K    +FE   +LG+G FG+VF           AIK L       D +    +VE  +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 147 LS-RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKI 204
           LS    H  L  +   + ++++       E +  G L   +      +CH  D       
Sbjct: 72  LSLAWEHPFLTHMFCTFQTKENL--FFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFY 124
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A +   GL +LH      +++RD K  NILL+ + H K+ADFG+ K+   G     +   
Sbjct: 125 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEF 179
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            GT  Y+APE  +        D +S+GV+L E+L G+ P 
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 98  NFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRLH 151
           +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 87
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAA 209
           H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A +  
Sbjct: 88  HPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIV 139
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGTF 268
             L YLH      +IHRD K  NILL  + H ++ DFG AK  +PE +    ++ V GT 
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTA 195
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 196 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 239

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 100/237 (42%), Gaps = 37/237 (15%)
Query: 97  NNFEPASILGEGGFGRVFK----GVL--SDGTAVAIKRL---TCGGQQGDKEFLVEVEML 147
           NN E    +GEG FGRVF+    G+L     T VA+K L        Q D  F  E  ++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREAALM 104
Query: 148 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNC--HLDWETRMK 203
           +   + N+VKL+G  +        L +E +  G L  +L    P  V    H D  TR +
Sbjct: 105 AEFDNPNIVKLLGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 204 ----------------IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
                           IA   A G+AYL E      +HRD    N L+  N   K+ADFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFG 219
Query: 248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           L++                   ++ PE         +SDV++YGVVL E+ + G +P
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 25/228 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 92
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 93  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 144
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 145 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 201
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 202 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 245

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 20/234 (8%)
Query: 75  GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG 133
           G S   PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   
Sbjct: 11  GMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 70
Query: 134 QQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHG 188
           Q     K    E+ +L  + H N++ L+  ++   S +      LV +     L + +  
Sbjct: 71  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 130
Query: 189 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 248
               + H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGL
Sbjct: 131 QKLTDDHVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 182
Query: 249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
           A+   +  T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 183 ARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 129/288 (44%), Gaps = 42/288 (14%)
Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G   D       T VA+K +       ++ EFL E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCH----LDWETRMKIALDAARG 211
           L+G  S    +  L+  EL+ +G L+S+L    P   N         +  +++A + A G
Sbjct: 85  LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG-- 269
           +AYL+       +HRD  A N ++ ++F  K+ DFG+ +   E  T+Y      G     
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 197
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           ++APE    G     SD++S+GVVL E+ +  +     QP             L ++  L
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE-----QPYQG----------LSNEQVL 242
Query: 330 EELADPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLK 375
           + + D   GG   + D    RV  +   C       RPT  E+V  LK
Sbjct: 243 KFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 102/232 (43%), Gaps = 33/232 (14%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 71
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 72  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 123
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK----QAPEGRTNYLSTRV 264
              L YLH      +IHRD K  NILL  + H ++ DFG AK    ++ + R N      
Sbjct: 124 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---- 176
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
           +GT  YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 177 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 224

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 78
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   +     + +A   +  + YL + + 
Sbjct: 79  TREPPFYIII-EFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQISSAMEYLEKKN- 131
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 233
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 234 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 93  KEATNNFEPASILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVE--M 146
           K   ++FE   +LG+G FG+VF   K    D G   A+K L     +       ++E  +
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           L+ ++H  +VKL  +Y+ +   +  L  + +  G L + L   +        E  +K  L
Sbjct: 84  LADVNHPFVVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVKFYL 136
Query: 207 -DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            + A GL +LH      +I+RD K  NILL+   H K+ DFGL+K+A +      S    
Sbjct: 137 AELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FC 191
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           GT  Y+APE          +D +SYGV++ E+LTG  P
Sbjct: 192 GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 78
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   +     + +A   +  + YL + + 
Sbjct: 79  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQISSAMEYLEKKN- 131
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 233
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 234 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 78
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   +     + +A   +  + YL + + 
Sbjct: 79  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQISSAMEYLEKKN- 131
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 233
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 234 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 38/232 (16%)
Query: 98  NFEPASILGEGGFGRVFK----GVLSDGTA--VAIKRLTCGGQQGDKEFLV-EVEMLSRL 150
           N E   +LG G FG+V      G+   G +  VA+K L       ++E L+ E++M+++L
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 151 -HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP-------------------- 189
             H N+V L+G  +   S    L +E    G L ++L                       
Sbjct: 106 GSHENIVNLLG--ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 190 --LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
             L V   L +E  +  A   A+G+ +L  + + CV HRD  A N+L+ +    K+ DFG
Sbjct: 164 EDLNV---LTFEDLLCFAYQVAKGMEFL--EFKSCV-HRDLAARNVLVTHGKVVKICDFG 217
Query: 248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
           LA+         +         ++APE    G   +KSDV+SYG++L E+ +
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/229 (31%), Positives = 103/229 (44%), Gaps = 27/229 (11%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 89
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 90  DHPFFVKL--YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC-----TRFYTA-EI 141
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGT 267
              L YLH      +IHRD K  NILL  + H ++ DFG AK  +PE +    ++ V GT
Sbjct: 142 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GT 197
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
             YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 242

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 38/286 (13%)
Query: 105 LGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LG+G FG V++G   D       T VA+K +       ++ EFL E  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCH----LDWETRMKIALDAARG 211
           L+G  S    +  L+  EL+ +G L+S+L    P   N         +  +++A + A G
Sbjct: 85  LLGVVSKGQPT--LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           +AYL+       +HRD  A N ++ ++F  K+ DFG+ +   E        + +    ++
Sbjct: 143 MAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
           APE    G     SD++S+GVVL E+ +  +     QP             L ++  L+ 
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAE-----QPYQG----------LSNEQVLKF 244
Query: 332 LADPRLGGKYPKEDFI--RVCTIAAACVAPEANQRPTMGEVVQSLK 375
           + D   GG   + D    RV  +   C       RPT  E+V  LK
Sbjct: 245 VMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 36/277 (12%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 76
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   +     + +A   +  + YL + + 
Sbjct: 77  TREPPFYIII-EFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQISSAMEYLEKKN- 129
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 130 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPESLAYNK 186
Query: 281 LLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD-RLEELADPRLG 338
             +KSDV+++GV+L E+ T G  P     PS    L+        +KD R+E        
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL--------EKDYRMER------- 231
Query: 339 GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
              P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 232 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 78
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   +     + +A   +  + YL + + 
Sbjct: 79  TREPPFYIII-EFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQISSAMEYLEKKN- 131
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 188
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 233
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 234 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G  +       ++ Y     G+L  +L    P G+    D          ++  +
Sbjct: 103 IINLLGACTQDGPLYVIVAY--ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 161 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 7/205 (3%)
Query: 98  NFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHRN 154
           ++E    +G G +GR  K    SDG  +  K L  G   + +K+ LV EV +L  L H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +V+       R ++   +  E    G L S +        +LD E  +++       L  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 215 LHE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            H   D    V+HRD K +N+ L+   + K+ DFGLA+          +   +GT  Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMS 184
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLEL 297
           PE         KSD++S G +L EL
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 97/228 (42%), Gaps = 25/228 (10%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRL 150
            +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 94
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDA 208
            H   VKL  Y+  +D  +         NG L  ++   G     C     TR   A + 
Sbjct: 95  DHPFFVKL--YFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EI 146
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 147 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 203
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
            YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 204 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 247

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 102/231 (44%), Gaps = 33/231 (14%)
Query: 98  NFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLSRLH 151
           +F+   ILGEG F  V     L+     AIK L    +   KE  V     E +++SRL 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 87
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAA 209
           H   VKL  Y++ +D  +         NG L  ++   G     C     TR   A +  
Sbjct: 88  HPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTA-EIV 139
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK----QAPEGRTNYLSTRVM 265
             L YLH      +IHRD K  NILL  + H ++ DFG AK    ++ + R N      +
Sbjct: 140 SALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF----V 192
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
           GT  YV+PE          SD+++ G ++ +L+ G  P      +G E L+
Sbjct: 193 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR----AGNEYLI 239

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 20/224 (8%)
Query: 96  TNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL 150
           ++ +E   ILG GG   V     L     VA+K L     + D  F +    E +  + L
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAAL 69
Query: 151 HHRNLVKLVGYYSSRDSSQHL--LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL 206
           +H  +V +     +   +  L  +  E V   +L   +H  GP+        +  +++  
Sbjct: 70  NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------TPKRAIEVIA 123
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVM 265
           DA + L + H++    +IHRD K +NI++      KV DFG+A+  A  G +   +  V+
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           GT  Y++PE A    +  +SDVYS G VL E+LTG  P     P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 95  ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHH 152
           +++ F+    LG G +  V+KG+  + G  VA+K +    ++G     + E+ ++  L H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL------HGPLGVNCHL----DWETRM 202
            N+V+L  Y      ++  L +E + N  L+ ++      + P G+  +L     W+   
Sbjct: 63  ENIVRL--YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ--- 116
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                  +GLA+ HE+    ++HRD K  N+L+      K+ DFGLA+ A     N  S+
Sbjct: 117 -----LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSS 167
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            V+ T  Y AP+  M       S D++S G +L E++TG+
Sbjct: 168 EVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF----KGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRN 154
           LGEG FG+V      G+  D     T VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-CH---------LDWETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+  C+         L  +  +
Sbjct: 81  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y   
Sbjct: 139 SCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 193
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G FG V+KG+ +     VAIK +     + + E +  E+ +LS+     + +  G Y
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 163 SSRDSSQHLLCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL-DAARGLAYLHEDSQ 220
               S++  +  E +  GS    L  GPL        ET +   L +  +GL YLH + +
Sbjct: 87  LK--STKLWIIMEYLGGGSALDLLKPGPLE-------ETYIATILREILKGLDYLHSERK 137
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD KA+N+LL      K+ADFG+A Q  +  T       +GT  ++APE      
Sbjct: 138 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSA 192
Query: 281 LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
              K+D++S G+  +EL  G  P     P     L+    P             P L G+
Sbjct: 193 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQ 239
Query: 341 Y--PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           +  P ++F+       AC+  +   RPT  E+++  K + R
Sbjct: 240 HSKPFKEFVE------ACLNKDPRFRPTAKELLKH-KFITR 273

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 20/233 (8%)
Query: 76  GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ 134
           GS   PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q
Sbjct: 1   GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 60
Query: 135 Q--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGP 189
                K    E+ +L  + H N++ L+  ++   S +      LV +     L + +   
Sbjct: 61  SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ 120
Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
              + H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGL 
Sbjct: 121 KLTDDHVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLC 172
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
           +   +  T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 173 RHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 38/240 (15%)
Query: 97  NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           ++FE  ++LG+G FG+V K   + D    AIK++    ++     L EV +L+ L+H+ +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYV 64
Query: 156 VKLVGYYSSR-----------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
           V+    +  R             S   +  E   N +L   +H     N +   +   ++
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE---NLNQQRDEYWRL 121
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-------------Q 251
                  L+Y+H      +IHRD K  NI ++ + + K+ DFGLAK             Q
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 252 APEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELL----TGRKPVDM 306
              G ++ L T  +GT  YVA E    TGH   K D+YS G++  E++    TG + V++
Sbjct: 179 NLPGSSDNL-TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 7/205 (3%)
Query: 98  NFEPASILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHRN 154
           ++E    +G G +GR  K    SDG  +  K L  G   + +K+ LV EV +L  L H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +V+       R ++   +  E    G L S +        +LD E  +++       L  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 215 LHE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            H   D    V+HRD K +N+ L+   + K+ DFGLA+      +   +   +GT  Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMS 184
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLEL 297
           PE         KSD++S G +L EL
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +    +   +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 76  LIGVITE---NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES 129
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+ +N   K+ DFGL++   E  T   +++      ++APE   
Sbjct: 130 KR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESIN 185
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 23/221 (10%)
Query: 95  ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC-GGQQGDKEFLV-EVEMLSRLH 151
           AT+ +EP + +G G +G V+K      G  VA+K +    G++G     V EV +L RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 152 ---HRNLVKLVGYYSSRDSSQHL---LCYELVPNGSLESWLHG--PLGVNCHLDWETRMK 203
              H N+V+L+   ++  + + +   L +E V +  L ++L    P G    L  ET   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG----LPAETIKD 116
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           +     RGL +LH +   C++HRD K  NIL+ +    K+ADFGLA+             
Sbjct: 117 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAP 170
Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
           V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 23/221 (10%)
Query: 95  ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC-GGQQGDKEFLV-EVEMLSRLH 151
           AT+ +EP + +G G +G V+K      G  VA+K +    G++G     V EV +L RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 152 ---HRNLVKLVGYYSSRDSSQHL---LCYELVPNGSLESWLHG--PLGVNCHLDWETRMK 203
              H N+V+L+   ++  + + +   L +E V +  L ++L    P G    L  ET   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG----LPAETIKD 116
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           +     RGL +LH +   C++HRD K  NIL+ +    K+ADFGLA+        +    
Sbjct: 117 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALF---P 170
Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
           V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 11  PTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 70
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 130
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 131 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDD 182
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 183 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 105 LGEGGFGRVF----KGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRN 154
           LGEG FG+V      G+  D     T VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNC----------HLDWETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+             L  +  +
Sbjct: 96  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+          +T
Sbjct: 154 SCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                  ++APE         +SDV+S+GV+L E+ T
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF----KGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRN 154
           LGEG FG+V      G+  D     T VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVN-CH---------LDWETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+  C+         L  +  +
Sbjct: 96  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y   
Sbjct: 154 SCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 208
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG           AV I +          E L E  ++ +L +  +V+++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 437 GIC---EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN 489
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 490 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 545
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 107/221 (48%), Gaps = 23/221 (10%)
Query: 95  ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC-GGQQGDKEFLV-EVEMLSRLH 151
           AT+ +EP + +G G +G V+K      G  VA+K +    G++G     V EV +L RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 152 ---HRNLVKLVGYYSSRDSSQHL---LCYELVPNGSLESWLHG--PLGVNCHLDWETRMK 203
              H N+V+L+   ++  + + +   L +E V +  L ++L    P G    L  ET   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG----LPAETIKD 116
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           +     RGL +LH +   C++HRD K  NIL+ +    K+ADFGLA+             
Sbjct: 117 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDP 170
Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
           V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 171 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 20/224 (8%)
Query: 96  TNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL 150
           ++ +E   ILG GG   V     L     VA+K L     + D  F +    E +  + L
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAAL 69
Query: 151 HHRNLVKLVGYYSSRDSSQHL--LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL 206
           +H  +V +     +   +  L  +  E V   +L   +H  GP+        +  +++  
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------TPKRAIEVIA 123
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVM 265
           DA + L + H++    +IHRD K +NI++      KV DFG+A+  A  G +   +  V+
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           GT  Y++PE A    +  +SDVYS G VL E+LTG  P     P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF--------KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL-HHRN 154
           LGEG FG+V         K    +   VA+K L     + D   LV E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNCHLD----------WETRM 202
           ++ L+G  +       ++ Y     G+L  +L    P G+    D          ++  +
Sbjct: 103 IINLLGACTQDGPLYVIVGY--ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   SQ C IHRD  A N+L+  N   K+ADFGLA+       +Y   
Sbjct: 161 SCTYQLARGMEYLA--SQKC-IHRDLAARNVLVTENNVMKIADFGLARDI--NNIDYYKK 215
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV++ E+ T
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 11  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 70
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 130
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 131 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDD 182
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 183 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG           AV I +          E L E  ++ +L +  +V+++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 438 GIC---EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEESN 490
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 491 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 546
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 18  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHA 77
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 78  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 137
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 138 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 189
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 190 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 76  LIGVITENPV---WIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES 129
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+      K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 130 KR---FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 185
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 186 FRRFTSASDVWMFGVCMWEILMHGVKP 212

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF----KGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRN 154
           LGEG FG+V      G+  D     T VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNC----------HLDWETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+             L  +  +
Sbjct: 85  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y   
Sbjct: 143 SCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 197
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 36/277 (12%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 76
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   +     + +A   +  + YL + + 
Sbjct: 77  TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQISSAMEYLEKKN- 129
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 130 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPESLAYNK 186
Query: 281 LLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD-RLEELADPRLG 338
             +KSDV+++GV+L E+ T G  P     PS    L+        +KD R+E        
Sbjct: 187 FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELL--------EKDYRMER------- 231
Query: 339 GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
              P+    +V  +  AC     + RP+  E+ Q+ +
Sbjct: 232 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 265

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 13  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 133 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 185 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF----KGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRN 154
           LGEG FG+V      G+  D     T VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNC----------HLDWETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+             L  +  +
Sbjct: 96  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y   
Sbjct: 154 SCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 208
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 13  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 133 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 185 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 324
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   ++    + +A   +  + YL + + 
Sbjct: 325 TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVNAVVLLYMATQISSAMEYLEKKN- 377
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHR+  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 378 --FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNK 434
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 435 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 479
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
                P+    +V  +  AC     + RP+  E+ Q+ + +
Sbjct: 480 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 93  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 149 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF----KGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRN 154
           LGEG FG+V      G+  D     T VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNC----------HLDWETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+             L  +  +
Sbjct: 89  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y   
Sbjct: 147 SCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 201
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF----KGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRN 154
           LGEG FG+V      G+  D     T VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNC----------HLDWETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+             L  +  +
Sbjct: 88  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y   
Sbjct: 146 SCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 200
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 31/219 (14%)
Query: 105 LGEGGFGRVF----KGVLSDG----TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRN 154
           LGEG FG+V      G+  D     T VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNC----------HLDWETRM 202
           ++ L+G   ++D   +++  E    G+L  +L    P G+             L  +  +
Sbjct: 96  IINLLGA-CTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y   
Sbjct: 154 SCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYKK 208
Query: 263 RVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 40/281 (14%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V++GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G   
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV-C 285
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQ 220
           +R+   +++  E +  G+L  +L       C+   +     + +A   +  + YL + + 
Sbjct: 286 TREPPFYIIT-EFMTYGNLLDYLR-----ECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHR+  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
             +KSDV+++GV+L E+ T G  P   +D+SQ             +L    R+E      
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 440
Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
                P+    +V  +  AC     + RP+  E+ Q+ + +
Sbjct: 441 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK-----EFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG       V    +     + +      E L E  ++ +L +  +V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 95  G---ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 89  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 145 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK-----EFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG       V    +     + +      E L E  ++ +L +  +V+++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 95  G---ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 148 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 44/229 (19%)
Query: 96  TNNFEPASILGEGGFGRVF---KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLH 151
           ++ ++   +LG+G FG V      +     AV +       Q+ DKE L+ EV++L +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-LDAAR 210
           H N++KL  ++   D     L  E+   G L   +             +R + + +DAAR
Sbjct: 91  HPNIMKLYEFFE--DKGYFYLVGEVYTGGELFDEII------------SRKRFSEVDAAR 136
Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYL 260
                  G+ Y+H++    ++HRD K  N+LLE+   + + ++ DFGL+       T++ 
Sbjct: 137 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFE 186
Query: 261 STRVM----GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           +++ M    GT  Y+APE  + G    K DV+S GV+L  LL+G  P +
Sbjct: 187 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 8   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 67
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 127
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 128 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 179
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 180 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 8   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 67
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 127
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 128 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 179
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 180 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 18  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 77
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 78  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 137
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 138 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 189
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 190 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 18  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 77
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 78  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 137
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 138 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 189
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 190 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 112/251 (44%), Gaps = 37/251 (14%)
Query: 76  GSLPHPTSTRFLA----YEELKEATNNF---------EPASILGEGGFGRVFKGVL---- 118
           G LP P   +F A    YEE   A  +F             I+G G  G V  G L    
Sbjct: 18  GKLPEP---QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPG 74
Query: 119 SDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 177
                VAIK L  G  ++  ++FL E  ++ +  H N+++L G  +       ++  E +
Sbjct: 75  QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLAMIVTEYM 132
Query: 178 PNGSLESWLHGPLGVNCHLDWETRMKIA---LDAARGLAYLHEDSQPCVIHRDFKASNIL 234
            NGSL+++L        H    T M++         G+ YL   S    +HRD  A N+L
Sbjct: 133 ENGSLDTFL------RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 235 LENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 293
           +++N   KV+DFGL++   +     Y +T       + APE          SDV+S+GVV
Sbjct: 184 VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243
Query: 294 LLELLT-GRKP 303
           + E+L  G +P
Sbjct: 244 MWEVLAYGERP 254

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 13  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 133 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 185 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 122 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 174 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 122
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 123 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 174
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 175 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 26/224 (11%)
Query: 95  ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-----EVEMLS 148
           AT+ +EP + +G G +G V+K      G  VA+K +      G    L      EV +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 149 RLH---HRNLVKLVGYYSSRDSSQHL---LCYELVPNGSLESWLHG--PLGVNCHLDWET 200
           RL    H N+V+L+   ++  + + +   L +E V +  L ++L    P G    L  ET
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG----LPAET 121
Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 260
              +     RGL +LH +   C++HRD K  NIL+ +    K+ADFGLA+          
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMA 175
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 11  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 70
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 130
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 131 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 182
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 183 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 3   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 62
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 63  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 122
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 123 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 174
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 175 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 5   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 64
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 65  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 124
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 125 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 176
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 177 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 4   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 63
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 64  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 123
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 124 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 175
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 176 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 44/229 (19%)
Query: 96  TNNFEPASILGEGGFGRVF---KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLH 151
           ++ ++   +LG+G FG V      +     AV +       Q+ DKE L+ EV++L +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-LDAAR 210
           H N++KL  ++   D     L  E+   G L   +             +R + + +DAAR
Sbjct: 85  HPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEII------------SRKRFSEVDAAR 130
Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYL 260
                  G+ Y+H++    ++HRD K  N+LLE+   + + ++ DFGL+       T++ 
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFE 180
Query: 261 STRVM----GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           +++ M    GT  Y+APE  + G    K DV+S GV+L  LL+G  P +
Sbjct: 181 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 44/229 (19%)
Query: 96  TNNFEPASILGEGGFGRVF---KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLH 151
           ++ ++   +LG+G FG V      +     AV +       Q+ DKE L+ EV++L +L 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-LDAAR 210
           H N++KL  ++   D     L  E+   G L   +             +R + + +DAAR
Sbjct: 108 HPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEII------------SRKRFSEVDAAR 153
Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYL 260
                  G+ Y+H++    ++HRD K  N+LLE+   + + ++ DFGL+       T++ 
Sbjct: 154 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFE 203
Query: 261 STRVM----GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           +++ M    GT  Y+APE  + G    K DV+S GV+L  LL+G  P +
Sbjct: 204 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 11  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 70
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 71  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 130
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 131 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 182
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 183 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEF---LVEVEMLSRLHHRNLVKLVG 160
           +G G FG V F   + +   VAIK+++  G+Q ++++   + EV  L +L H N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDS 219
            Y    ++  ++ Y L     L      PL        E  +  +   A +GLAYLH  +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQ-------EVEIAAVTHGALQGLAYLHSHN 174
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
              +IHRD KA NILL      K+ DFG A   AP       +   +GT  ++APE  + 
Sbjct: 175 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILA 224
Query: 279 ---GHLLVKSDVYSYGVVLLELLTGRKPV 304
              G    K DV+S G+  +EL   + P+
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 26  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 85
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 86  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 145
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 146 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 197
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 198 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 25  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 84
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 85  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 144
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 145 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 196
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 197 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 8   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 67
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 127
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 128 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 179
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 180 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 29  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 88
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 89  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 148
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 149 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 200
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 201 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 105 LGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVK 157
           +GEG FG V +G+     +   AVAIK  TC     D   ++FL E   + +  H ++VK
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIK--TCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G  +        +  EL   G L S+L         LD  + +  A   +  LAYL  
Sbjct: 456 LIGVITENPV---WIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES 509
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                 +HRD  A N+L+      K+ DFGL++   E  T Y +++      ++APE   
Sbjct: 510 KR---FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESIN 565
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                  SDV+ +GV + E+L  G KP
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKP 592

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 13  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 133 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 184
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 185 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 44/229 (19%)
Query: 96  TNNFEPASILGEGGFGRVF---KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLH 151
           ++ ++   +LG+G FG V      +     AV +       Q+ DKE L+ EV++L +L 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-LDAAR 210
           H N++KL  ++   D     L  E+   G L   +             +R + + +DAAR
Sbjct: 109 HPNIMKLYEFF--EDKGYFYLVGEVYTGGELFDEII------------SRKRFSEVDAAR 154
Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYL 260
                  G+ Y+H++    ++HRD K  N+LLE+   + + ++ DFGL+       T++ 
Sbjct: 155 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFE 204
Query: 261 STRVM----GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           +++ M    GT  Y+APE  + G    K DV+S GV+L  LL+G  P +
Sbjct: 205 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 12  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 71
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 131
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 132 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 184 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 20/224 (8%)
Query: 96  TNNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL 150
           ++ +E   ILG GG   V     L     VA+K L     + D  F +    E +  + L
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAAL 86
Query: 151 HHRNLVKLVGYYSSRDSSQHL--LCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL 206
           +H  +V +     +   +  L  +  E V   +L   +H  GP+        +  +++  
Sbjct: 87  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------TPKRAIEVIA 140
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVM 265
           DA + L + H++    +IHRD K +NI++      KV DFG+A+  A  G +   +  V+
Sbjct: 141 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 197
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           GT  Y++PE A    +  +SDVYS G VL E+LTG  P     P
Sbjct: 198 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE-----FLVEV 144
           ++K     +E    LGEG F  V+K    +    VAIK++  G +   K+      L E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK- 203
           ++L  L H N++ L+  +  + +   +  +       +E+ L   +  N  +   + +K 
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDF-------METDLEVIIKDNSLVLTPSHIKA 116
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
             L   +GL YLH   Q  ++HRD K +N+LL+ N   K+ADFGLAK    G  N     
Sbjct: 117 YMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXH 171
Query: 264 VMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELL 298
            + T  Y APE      +  V  D+++ G +L ELL
Sbjct: 172 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 89  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 145 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 8   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 67
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 68  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 127
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 128 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDD 179
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 180 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 89  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 145 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 93  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 149 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V        G  VA+K++    QQ  +    EV ++   HH N+V +   Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  G+L       +  +  ++ E    + L   R L+YLH      V
Sbjct: 113 VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIATVCLSVLRALSYLHNQG---V 162
Query: 224 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           IHRD K+ +ILL ++   K++DFG    ++K+ P+ +       ++GT  ++APE     
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKX------LVGTPYWMAPEVISRL 216
Query: 280 HLLVKSDVYSYGVVLLELLTGRKP 303
               + D++S G++++E++ G  P
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 91  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 146
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 147 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK-----EFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG       V    +     + +      E L E  ++ +L +  +V+++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 93  G---ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 145
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 146 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 201
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 89  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 145 --VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 12  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 71
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 131
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 132 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDD 183
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 184 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEF---LVEVEMLSRLHHRNLVKLVG 160
           +G G FG V F   + +   VAIK+++  G+Q ++++   + EV  L +L H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDS 219
            Y    ++  ++ Y L     L      PL        E  +  +   A +GLAYLH  +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQ-------EVEIAAVTHGALQGLAYLHSHN 135
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAK-QAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
              +IHRD KA NILL      K+ DFG A   AP       +   +GT  ++APE  + 
Sbjct: 136 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILA 185
Query: 279 ---GHLLVKSDVYSYGVVLLELLTGRKPV 304
              G    K DV+S G+  +EL   + P+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 122 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 174 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDD 121
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 122 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 174 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 25  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 84
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 85  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 144
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 145 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 196
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 197 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G +G V+ GV    +  VA+K L     + + EFL E  ++  + H NLV+L+G  +
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR---MKIALDAARGLAYLHEDSQ 220
                   +  E +P G+L  +L       C+ +  T    + +A   +  + YL + + 
Sbjct: 99  LE--PPFYIVTEYMPYGNLLDYLR-----ECNREEVTAVVLLYMATQISSAMEYLEKKN- 150
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
              IHRD  A N L+  N   KVADFGL++    G T            + APE      
Sbjct: 151 --FIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNT 207
Query: 281 LLVKSDVYSYGVVLLELLT-GRKP---VDMSQ 308
             +KSDV+++GV+L E+ T G  P   +D+SQ
Sbjct: 208 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 239

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 37  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 97  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 152
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 153 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 210
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 211 KGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 89  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 145 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 37/222 (16%)
Query: 105 LGEGGFGRVFKGVLSDG-----------TAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-H 151
           LGEG FG+V   VL++            T VA+K L     + D  + + E+EM+  +  
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG--PLGVNC----------HLDWE 199
           H+N++ L+G   ++D   +++  E    G+L  +L    P G+             L  +
Sbjct: 134 HKNIINLLGA-CTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
             +  A   ARG+ YL   S+ C IHRD  A N+L+  +   K+ADFGLA+       +Y
Sbjct: 192 DLVSCAYQVARGMEYLA--SKKC-IHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDY 246
Query: 260 LSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                 G     ++APE         +SDV+S+GV+L E+ T
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 27  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 87  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 142
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 143 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 93  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKCQ-HLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 34  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 94  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 149
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 150 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 35  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 95  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 150
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 151 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 26  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 86  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 141
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 142 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 93  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 12  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 71
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 131
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 132 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 184 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK-----EFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG       V    +     + +      E L E  ++ +L +  +V+++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 85  G---ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 27  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 87  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 142
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 143 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 26  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 85
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 86  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 145
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 146 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 197
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 198 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK-----EFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG       V    +     + +      E L E  ++ +L +  +V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 79  G---ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 132 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 187
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 109 IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 164
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 165 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 12  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 71
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 72  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 131
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 132 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 183
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 184 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK-----EFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG       V    +     + +      E L E  ++ +L +  +V+++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 73  G---ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 125
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 126 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 181
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK-----EFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG       V    +     + +      E L E  ++ +L +  +V+++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 75  G---ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     NY   +  G +   + APE   
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 112/253 (44%), Gaps = 41/253 (16%)
Query: 76  GSLPHPTSTRFLA----YEELKEATNNF---------EPASILGEGGFGRVFKGVL---- 118
           G LP P   +F A    YEE   A  +F             I+G G  G V  G L    
Sbjct: 18  GKLPEP---QFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPG 74
Query: 119 SDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV 177
                VAIK L  G  ++  ++FL E  ++ +  H N+++L G  +       ++  E +
Sbjct: 75  QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLAMIVTEYM 132
Query: 178 PNGSLESWLHGPLGVNCHLDWETRMKIA---LDAARGLAYLHEDSQPCVIHRDFKASNIL 234
            NGSL+++L        H    T M++         G+ YL   S    +HRD  A N+L
Sbjct: 133 ENGSLDTFL------RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVL 183
Query: 235 LENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYG 291
           +++N   KV+DFGL++     P+        ++     + APE          SDV+S+G
Sbjct: 184 VDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFG 241
Query: 292 VVLLELLT-GRKP 303
           VV+ E+L  G +P
Sbjct: 242 VVMWEVLAYGERP 254

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 63  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 109
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQE 216

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 63  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 109
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 61
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 62  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 108
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 109 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 63  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 109
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GDKEFLVEVEML 147
           E+ E   N  P   +G G +G V        G  VA+K+L+   Q     K    E+ +L
Sbjct: 29  EVPERYQNLAP---VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLL 85
Query: 148 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNCHLDWETRMKI 204
             + H N++ L+  ++   S +      LV +     L + +      + H+ +     +
Sbjct: 86  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----L 140
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +  T Y++TR 
Sbjct: 141 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 196
Query: 265 MGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
                Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 197 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 123/296 (41%), Gaps = 38/296 (12%)
Query: 88  AYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG-GQQGDKEFLVEVE 145
           A E  +   ++ EP   LG G +G V K   +  G   A+KR+      Q  K  L +++
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLD 84
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
           +  R         V +Y +      + +C EL  + SL+ +    +     +  +   KI
Sbjct: 85  ISXRTVDCPFT--VTFYGALFREGDVWICXELX-DTSLDKFYKQVIDKGQTIPEDILGKI 141
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL--------AKQAPEGR 256
           A+   + L +LH  S+  VIHRD K SN+L+      K  DFG+        AK    G 
Sbjct: 142 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGC 199
Query: 257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
             Y +         + PE    G+  VKSD++S G+  +EL   R P D           
Sbjct: 200 KPYXAPE------RINPELNQKGY-SVKSDIWSLGITXIELAILRFPYD----------- 241
Query: 317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
           +W  P  + K  +EE   P+L       +F+      + C+   + +RPT  E+ Q
Sbjct: 242 SWGTPFQQLKQVVEE-PSPQLPADKFSAEFV---DFTSQCLKKNSKERPTYPELXQ 293

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G +G V   +    G  VAIK+L+   Q     K    E+ +L  + H N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           ++   S ++   + LV    +++ L   +G+      E    +     +GL Y+H     
Sbjct: 92  FTPASSLRNFYDFYLV-MPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG-- 146
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-H 280
            V+HRD K  N+ +  +   K+ DFGLA+ A    T Y+ TR      Y APE  ++  H
Sbjct: 147 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMH 200
Query: 281 LLVKSDVYSYGVVLLELLTGR 301
                D++S G ++ E+LTG+
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V    V S G  VA+K++    QQ  +    EV ++    H N+V++   Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  G+L       +  +  ++ E    + L   + L+ LH      V
Sbjct: 219 VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 268
Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV 283
           IHRD K+ +ILL ++   K++DFG   Q    +       ++GT  ++APE         
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKXLVGTPYWMAPELISRLPYGP 326
Query: 284 KSDVYSYGVVLLELLTGRKP 303
           + D++S G++++E++ G  P
Sbjct: 327 EVDIWSLGIMVIEMVDGEPP 346

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 96/232 (41%), Gaps = 34/232 (14%)
Query: 96  TNNFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSR 149
             +++    LGEG +G V      V  +  AV I   KR     +   KE  +     + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----AM 61
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L+H N+VK  G+   R+ +   L  E    G L   +   +G+              DA 
Sbjct: 62  LNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQ 108
Query: 210 R-------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           R       G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  
Sbjct: 109 RFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
           ++ GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 14/206 (6%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G G +G V K V    G  +A+KR+ +   ++  K+ L++++++ R    +   +V +Y
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR--SSDCPYIVQFY 87
Query: 163 SSR-DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
            +        +C EL+     + + +    ++  +  E   KI L   + L +L E+ + 
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE----YAM 277
            +IHRD K SNILL+ + + K+ DFG++ Q  +       TR  G   Y+APE     A 
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSAS 202
Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKP 303
                V+SDV+S G+ L EL TGR P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ D+GLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAI++++    Q   +  L E+++L R  H N++ +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 93  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXIN----KMLN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 63  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 109
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G +G V   +    G  VAIK+L+   Q     K    E+ +L  + H N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           ++   S ++   + LV    +++ L   +G+      E    +     +GL Y+H     
Sbjct: 110 FTPASSLRNFYDFYLV-MPFMQTDLQKIMGME--FSEEKIQYLVYQMLKGLKYIHSAG-- 164
Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-H 280
            V+HRD K  N+ +  +   K+ DFGLA+ A    T Y+ TR      Y APE  ++  H
Sbjct: 165 -VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWMH 218
Query: 281 LLVKSDVYSYGVVLLELLTGR 301
                D++S G ++ E+LTG+
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGK 239

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXIN----KMLN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 63  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 109
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 167 XGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 119/268 (44%), Gaps = 36/268 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    D EF+ E +++  L H  LV+L G  + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L     +      +  +++  D    + YL E  Q   +
Sbjct: 76  QRPI--FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FL 127
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGHL 281
           HRD  A N L+ +    KV+DFGL++   +    Y S+R  G+     +  PE  M    
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--EYTSSR--GSKFPVRWSPPEVLMYSKF 183
Query: 282 LVKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGG 339
             KSD++++GV++ E+ + G+ P +  +     E++    R           L  P L  
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----------LYRPHLAS 232
Query: 340 KYPKEDFIRVCTIAAACVAPEANQRPTM 367
           +       +V TI  +C   +A++RPT 
Sbjct: 233 E-------KVYTIMYSCWHEKADERPTF 253

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 96  TNNFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSR 149
             +++    LGEG +G V      V  +  AV I   KR     +   KE  +       
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KM 61
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L+H N+VK  G+   R+ +   L  E    G L   +   +G+              DA 
Sbjct: 62  LNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQ 108
Query: 210 R-------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           R       G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  
Sbjct: 109 RFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
           ++ GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 96  TNNFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSR 149
             +++    LGEG +G V      V  +  AV I   KR     +   KE  +       
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KM 60
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L+H N+VK  G+   R+ +   L  E    G L   +   +G+              DA 
Sbjct: 61  LNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQ 107
Query: 210 R-------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           R       G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  
Sbjct: 108 RFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
           ++ GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 165 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 96  TNNFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSR 149
             +++    LGEG +G V      V  +  AV I   KR     +   KE  +       
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXIN----KM 61
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L+H N+VK  G+   R+ +   L  E    G L   +   +G+              DA 
Sbjct: 62  LNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQ 108
Query: 210 R-------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           R       G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  
Sbjct: 109 RFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
           ++ GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 166 KMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 96  TNNFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSR 149
             +++    LGEG +G V      V  +  AV I   KR     +   KE  +       
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KM 60
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L+H N+VK  G+   R+ +   L  E    G L   +   +G+              DA 
Sbjct: 61  LNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQ 107
Query: 210 R-------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           R       G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  
Sbjct: 108 RFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
           ++ GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 96  TNNFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSR 149
             +++    LGEG +G V      V  +  AV I   KR     +   KE  +       
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KM 60
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L+H N+VK  G+   R+ +   L  E    G L   +   +G+              DA 
Sbjct: 61  LNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQ 107
Query: 210 R-------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           R       G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  
Sbjct: 108 RFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
           ++ GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 96  TNNFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSR 149
             +++    LGEG +G V      V  +  AV I   KR     +   KE  +       
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KM 60
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L+H N+VK  G+   R+ +   L  E    G L   +   +G+              DA 
Sbjct: 61  LNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQ 107
Query: 210 R-------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           R       G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  
Sbjct: 108 RFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
           ++ GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 96  TNNFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSR 149
             +++    LGEG +G V      V  +  AV I   KR     +   KE  +       
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KM 61
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L+H N+VK  G+   R+ +   L  E    G L   +   +G+              DA 
Sbjct: 62  LNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQ 108
Query: 210 R-------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           R       G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  
Sbjct: 109 RFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
           ++ GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 104 ILGEGGFGRVF--KGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +LG G F  VF  K  L+ G   A+K +       D     E+ +L ++ H N+V L   
Sbjct: 16  VLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           Y S  ++ + L  +LV  G L   +    GV    D    ++  L A +   YLHE+   
Sbjct: 75  YES--TTHYYLVMQLVSGGELFDRI-LERGVYTEKDASLVIQQVLSAVK---YLHENG-- 126
Query: 222 CVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
            ++HRD K  N+L    E N    + DFGL+K    G    + +   GT GYVAPE    
Sbjct: 127 -IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQ 181
Query: 279 GHLLVKSDVYSYGVVLLELLTGRKP 303
                  D +S GV+   LL G  P
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    D EF+ E +++  L H  LV+L G  + 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L     +      +  +++  D    + YL E  Q   +
Sbjct: 71  QRPI--FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FL 122
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD  A N L+ +    KV+DFGL++   +      ++ V   F   +  PE  M     
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
            KSD++++GV++ E+ + G+ P +  +     E++    R           L  P L  +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----------LYRPHLASE 228
Query: 341 YPKEDFIRVCTIAAACVAPEANQRPTM 367
                  +V TI  +C   +A++RPT 
Sbjct: 229 -------KVYTIMYSCWHEKADERPTF 248

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 95/232 (40%), Gaps = 34/232 (14%)
Query: 96  TNNFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSR 149
             +++    LGEG +G V      V  +  AV I   KR     +   KE  +       
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KM 60
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L+H N+VK  G+   R+ +   L  E    G L   +   +G+              DA 
Sbjct: 61  LNHENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQ 107
Query: 210 R-------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           R       G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  
Sbjct: 108 RFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 263 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
           ++ GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 165 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    D EF+ E +++  L H  LV+L G  + 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L     +      +  +++  D    + YL E  Q   +
Sbjct: 75  QRPI--FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FL 126
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD  A N L+ +    KV+DFGL++   +      ++ V   F   +  PE  M     
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
            KSD++++GV++ E+ + G+ P +  +     E++    R           L  P L  +
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----------LYRPHLASE 232
Query: 341 YPKEDFIRVCTIAAACVAPEANQRPTM 367
                  +V TI  +C   +A++RPT 
Sbjct: 233 -------KVYTIMYSCWHEKADERPTF 252

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 38/240 (15%)
Query: 97  NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           ++FE  ++LG+G FG+V K   + D    AIK++    ++     L EV +L+ L+H+ +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYV 64
Query: 156 VKLVGYYSSR-----------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
           V+    +  R             S   +  E   N +L   +H     N +   +   ++
Sbjct: 65  VRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE---NLNQQRDEYWRL 121
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK-------------Q 251
                  L+Y+H      +IHR+ K  NI ++ + + K+ DFGLAK             Q
Sbjct: 122 FRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 252 APEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELL----TGRKPVDM 306
              G ++ L T  +GT  YVA E    TGH   K D YS G++  E +    TG + V++
Sbjct: 179 NLPGSSDNL-TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVNI 237

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 18/220 (8%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEF---LVEVEM 146
           ++K    +F    +LG+G FG+VF           AIK L       D +    +VE  +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 147 LS-RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWETRMKI 204
           LS    H  L  +   + ++++       E +  G L   +      +CH  D       
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENL--FFVMEYLNGGDLMYHIQ-----SCHKFDLSRATFY 123
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A +   GL +LH      +++RD K  NILL+ + H K+ADFG+ K+   G     +   
Sbjct: 124 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXF 178
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
            GT  Y+APE  +        D +S+GV+L E+L G+ P 
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 64  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 110
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 64  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 110
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 64  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 110
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 64  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 110
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG +G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 63  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 109
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    D EF+ E +++  L H  LV+L G  + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L     +      +  +++  D    + YL E  Q   +
Sbjct: 91  QRPI--FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FL 142
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD  A N L+ +    KV+DFGL++   +      ++ V   F   +  PE  M     
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE---TSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
            KSD++++GV++ E+ + G+ P +  +     E++    R           L  P L  +
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----------LYRPHLASE 248
Query: 341 YPKEDFIRVCTIAAACVAPEANQRPTM 367
                  +V TI  +C   +A++RPT 
Sbjct: 249 -------KVYTIMYSCWHEKADERPTF 268

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 20/230 (8%)
Query: 85  RFLAYEELKE---ATNNFEPASILGEGGFGRVFKGVL-SDGTAVA------IKRLTCGGQ 134
           RFL ++ L+      + F    +LG GGFG VF   + + G   A       +     G 
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 135 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 194
           QG    +VE ++L+++H R +V L   Y+    +   L   ++  G +   ++     N 
Sbjct: 230 QGA---MVEKKILAKVHSRFIVSLA--YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                  +        GL +LH   Q  +I+RD K  N+LL+++ + +++D GLA +   
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
           G+T   +    GT G++APE  +        D ++ GV L E++  R P 
Sbjct: 342 GQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    D EF+ E +++  L H  LV+L G  + 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L     +      +  +++  D    + YL E  Q   +
Sbjct: 91  QRPI--FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FL 142
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD  A N L+ +    KV+DFGL++   +      ++ V   F   +  PE  M     
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
            KSD++++GV++ E+ + G+ P +  +     E++    R           L  P L  +
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----------LYRPHLASE 248
Query: 341 YPKEDFIRVCTIAAACVAPEANQRPTM 367
                  +V TI  +C   +A++RPT 
Sbjct: 249 -------KVYTIMYSCWHEKADERPTF 268

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV------EVEMLSRLHHRNLVK 157
           LG G FG+V  G     G  VA+K L    +Q  +   V      E++ L    H +++K
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKIL---NRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L    S+   S   +  E V  G L  ++      N  LD +   ++      G+ Y H 
Sbjct: 81  LYQVIST--PSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCH- 133
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
             +  V+HRD K  N+LL+ + +AK+ADFGL+    +G     S    G+  Y APE  +
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPE-VI 187
Query: 278 TGHLLV--KSDVYSYGVVLLELLTGRKPVD 305
           +G L    + D++S GV+L  LL G  P D
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 107/230 (46%), Gaps = 20/230 (8%)
Query: 85  RFLAYEELKE---ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG------GQ 134
           RFL ++ L+      + F    +LG GGFG VF   + + G   A K+L         G 
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 135 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 194
           QG    +VE ++L+++H R +V L   Y+    +   L   ++  G +   ++     N 
Sbjct: 230 QGA---MVEKKILAKVHSRFIVSLA--YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                  +        GL +LH+ +   +I+RD K  N+LL+++ + +++D GLA +   
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
           G+T   +    GT G++APE  +        D ++ GV L E++  R P 
Sbjct: 342 GQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 20/230 (8%)
Query: 85  RFLAYEELKE---ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG------GQ 134
           RFL ++ L+      + F    +LG GGFG VF   + + G   A K+L         G 
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 135 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 194
           QG    +VE ++L+++H R +V L   Y+    +   L   ++  G +   ++     N 
Sbjct: 230 QGA---MVEKKILAKVHSRFIVSLA--YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                  +        GL +LH   Q  +I+RD K  N+LL+++ + +++D GLA +   
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
           G+T   +    GT G++APE  +        D ++ GV L E++  R P 
Sbjct: 342 GQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 20/230 (8%)
Query: 85  RFLAYEELKE---ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG------GQ 134
           RFL ++ L+      + F    +LG GGFG VF   + + G   A K+L         G 
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 135 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 194
           QG    +VE ++L+++H R +V L   Y+    +   L   ++  G +   ++     N 
Sbjct: 230 QGA---MVEKKILAKVHSRFIVSLA--YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                  +        GL +LH   Q  +I+RD K  N+LL+++ + +++D GLA +   
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
           G+T   +    GT G++APE  +        D ++ GV L E++  R P 
Sbjct: 342 GQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 102/234 (43%), Gaps = 20/234 (8%)
Query: 75  GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG 133
             S   PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   
Sbjct: 23  NASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 82
Query: 134 QQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHG 188
           Q     K    E+ +L  + H N++ L+  ++   S +      LV +     L + +  
Sbjct: 83  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 142
Query: 189 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 248
               + H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGL
Sbjct: 143 QKLTDDHVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 194
Query: 249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
           A+   +    Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 195 ARHTDDEMXGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    D EF+ E +++  L H  LV+L G  + 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L     +      +  +++  D    + YL E  Q   +
Sbjct: 76  QRPI--FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FL 127
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD  A N L+ +    KV+DFGL++   +      ++ V   F   +  PE  M     
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
            KSD++++GV++ E+ + G+ P +  +     E++    R           L  P L  +
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----------LYRPHLASE 233
Query: 341 YPKEDFIRVCTIAAACVAPEANQRPTM 367
                  +V TI  +C   +A++RPT 
Sbjct: 234 -------KVYTIMYSCWHEKADERPTF 253

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 93  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 148
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+          + T  Y APE  +  
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 34  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 94  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 149
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+          + T  Y APE  +  
Sbjct: 150 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           LG G FG V  G       VAIK +  G    D EF+ E +++  L H  LV+L G  + 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +      +  E + NG L ++L     +      +  +++  D    + YL E  Q   +
Sbjct: 82  QRPI--FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FL 133
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLL 282
           HRD  A N L+ +    KV+DFGL++   +      ++ V   F   +  PE  M     
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 283 VKSDVYSYGVVLLELLT-GRKPVD-MSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
            KSD++++GV++ E+ + G+ P +  +     E++    R           L  P L  +
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----------LYRPHLASE 239
Query: 341 YPKEDFIRVCTIAAACVAPEANQRPTM 367
                  +V TI  +C   +A++RPT 
Sbjct: 240 -------KVYTIMYSCWHEKADERPTF 259

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V    V S G  VA+K++    QQ  +    EV ++    H N+V++   Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  G+L       +  +  ++ E    + L   + L+ LH      V
Sbjct: 99  VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 148
Query: 224 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           IHRD K+ +ILL ++   K++DFG    ++K+ P  +       ++GT  ++APE     
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX------LVGTPYWMAPELISRL 202
Query: 280 HLLVKSDVYSYGVVLLELLTGRKP 303
               + D++S G++++E++ G  P
Sbjct: 203 PYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V    V S G  VA+K++    QQ  +    EV ++    H N+V++   Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  G+L       +  +  ++ E    + L   + L+ LH      V
Sbjct: 97  VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 146
Query: 224 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           IHRD K+ +ILL ++   K++DFG    ++K+ P  +       ++GT  ++APE     
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX------LVGTPYWMAPELISRL 200
Query: 280 HLLVKSDVYSYGVVLLELLTGRKP 303
               + D++S G++++E++ G  P
Sbjct: 201 PYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V    V S G  VA+K++    QQ  +    EV ++    H N+V++   Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  G+L       +  +  ++ E    + L   + L+ LH      V
Sbjct: 142 VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 191
Query: 224 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           IHRD K+ +ILL ++   K++DFG    ++K+ P  +       ++GT  ++APE     
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX------LVGTPYWMAPELISRL 245
Query: 280 HLLVKSDVYSYGVVLLELLTGRKP 303
               + D++S G++++E++ G  P
Sbjct: 246 PYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 36/225 (16%)
Query: 96  TNNFEPASILGEGGFGRVF---KGVLSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLH 151
           ++ ++   +LG+G FG V      +     AV +       Q+ DKE L+ EV++L +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-LDAAR 210
           H N+ KL  ++   D     L  E+   G L   +             +R + + +DAAR
Sbjct: 85  HPNIXKLYEFF--EDKGYFYLVGEVYTGGELFDEII------------SRKRFSEVDAAR 130
Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYL 260
                  G+ Y H++    ++HRD K  N+LLE+   + + ++ DFGL+      +    
Sbjct: 131 IIRQVLSGITYXHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--- 184
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
               +GT  Y+APE  + G    K DV+S GV+L  LL+G  P +
Sbjct: 185 XKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL--VG 160
           +GEG +G V         T VAIK+++    Q   +  L E+++L R  H N++ +  + 
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
             S+ ++ + +   + +    L   L      N H+ +           RGL Y+H  + 
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-----FLYQILRGLKYIHSAN- 164
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+L+      K+ DFGLA+ A PE       T  + T  Y APE  +  
Sbjct: 165 --VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNS 222
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 133/300 (44%), Gaps = 36/300 (12%)
Query: 94  EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRL--TCGGQQGDKEFLVEVEMLSRL 150
           ++   +E   ++GEG +G V K    D G  VAIK+   +   +   K  + E+++L +L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H NLV L+     +   +  L +E V +  L+     P G    LD++   K       
Sbjct: 82  RHENLVNLLE--VCKKKKRWYLVFEFVDHTILDDLELFPNG----LDYQVVQKYLFQIIN 135
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--AP-EGRTNYLSTRVMGT 267
           G+ + H  +   +IHRD K  NIL+  +   K+ DFG A+   AP E   + ++TR    
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR---- 188
Query: 268 FGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRK--PVDMSQPSGQENLVTWARPILR 324
             Y APE  +      K+ DV++ G ++ E+  G    P D         ++     I R
Sbjct: 189 -WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247
Query: 325 DKD-----------RLEELADPR-LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
            ++           RL E+ +   L  +YPK   + V  +A  C+  + ++RP   E++ 
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEV-VIDLAKKCLHIDPDKRPFCAELLH 306

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 99  FEPASILGEGGFGRVF---KGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           ++    LG G +G V      V     A+ I R T      + + L EV +L  L H N+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           +KL  ++   D   + L  E    G L   +   +  N  +D    +K  L    G+ YL
Sbjct: 99  MKLYDFF--EDKRNYYLVMECYKGGELFDEIIHRMKFN-EVDAAVIIKQVL---SGVTYL 152
Query: 216 HEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
           H+ +   ++HRD K  N+LLE+   +   K+ DFGL+  A       +  R +GT  Y+A
Sbjct: 153 HKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS--AVFENQKKMKER-LGTAYYIA 206
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           PE  +      K DV+S GV+L  LL G  P
Sbjct: 207 PE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L    H N++ +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 91  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 146
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 147 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V    V S G  VA+K++    QQ  +    EV ++    H N+V++   Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  G+L       +  +  ++ E    + L   + L+ LH      V
Sbjct: 88  VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 137
Query: 224 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           IHRD K+ +ILL ++   K++DFG    ++K+ P  +       ++GT  ++APE     
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX------LVGTPYWMAPELISRL 191
Query: 280 HLLVKSDVYSYGVVLLELLTGRKP 303
               + D++S G++++E++ G  P
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T  ++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGXVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+  FGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V    V S G  VA+K++    QQ  +    EV ++    H N+V++   Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D  +  +  E +  G+L       +  +  ++ E    + L   + L+ LH      V
Sbjct: 92  VGD--ELWVVMEFLEGGALTD-----IVTHTRMNEEQIAAVCLAVLQALSVLHAQG---V 141
Query: 224 IHRDFKASNILLENNFHAKVADFG----LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           IHRD K+ +ILL ++   K++DFG    ++K+ P  +       ++GT  ++APE     
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX------LVGTPYWMAPELISRL 195
Query: 280 HLLVKSDVYSYGVVLLELLTGRKP 303
               + D++S G++++E++ G  P
Sbjct: 196 PYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKG--VLSDGTAVAIKRLTC-GGQQG-DKEFLVEVEML 147
           L  A   +E  + +GEG +G+VFK   + + G  VA+KR+    G++G     + EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 148 SRLH---HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHG--PLGVNCHLDWE 199
             L    H N+V+L  V   S  D    L L +E V +  L ++L      GV      E
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT----E 120
Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
           T   +     RGL +LH      V+HRD K  NIL+ ++   K+ADFGLA+         
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQM 174
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
             T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKG--VLSDGTAVAIKRLTC-GGQQG-DKEFLVEVEML 147
           L  A   +E  + +GEG +G+VFK   + + G  VA+KR+    G++G     + EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 148 SRLH---HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHG--PLGVNCHLDWE 199
             L    H N+V+L  V   S  D    L L +E V +  L ++L      GV      E
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT----E 120
Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
           T   +     RGL +LH      V+HRD K  NIL+ ++   K+ADFGLA+         
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQM 174
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
             T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 97  NNFEPASILGEGGFGRVF---KGVLSDGTAV-AIKRLTCGGQQGDKEFLVEVE--MLSRL 150
           + FE   +LG+G FG+VF   K   SD   + A+K L     +       ++E  +L  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAA 209
           +H  +VKL  +Y+ +   +  L  + +  G L + L   +        E  +K  L + A
Sbjct: 84  NHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVKFYLAELA 136
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
             L +LH      +I+RD K  NILL+   H K+ DFGL+K++ +      S    GT  
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           Y+APE          +D +S+GV++ E+LTG  P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DF LA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 98  NFEPASILGEGGFGRV---FKGVLSDGTAVAI---KRLTCGGQQGDKEFLVEVEMLSRLH 151
           +++    LGEG  G V      V  +  AV I   KR     +   KE  +       L+
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN----KMLN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H N+VK  G+   R+ +   L  E    G L   +   +G+              DA R 
Sbjct: 63  HENVVKFYGH--RREGNIQYLFLEYCSGGELFDRIEPDIGMP-----------EPDAQRF 109
Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA          L  ++
Sbjct: 110 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 166
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            GT  YVAPE         +  DV+S G+VL  +L G  P D    S QE
Sbjct: 167 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 216

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 46/301 (15%)
Query: 90  EELKEATNN-------FEPASILGEGGFGRVFKGVLS--DGT--AVAIKRLTCG--GQQG 136
           +ELKE   +       F    +LG+G FG V +  L   DG+   VA+K L         
Sbjct: 9   DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD 68
Query: 137 DKEFLVEVEMLSRLHHRNLVKLVGY-YSSRDSSQHLLCYELVP---NGSLESWLHGP-LG 191
            +EFL E   +    H ++ KLVG    SR   +  +   ++P   +G L ++L    +G
Sbjct: 69  IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG 128
Query: 192 VN-CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 250
            N  +L  +T ++  +D A G+ YL   S    IHRD  A N +L  +    VADFGL++
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP 309
           +   G              ++A E        V SDV+++GV + E++T G+ P      
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY----- 240
Query: 310 SGQENLVTWARPILRDKDRLEELADPRLGG---KYPKEDFIRVCTIAAACVAPEANQRPT 366
           +G EN                E+ +  +GG   K P E    V  +   C + +  QRP+
Sbjct: 241 AGIEN---------------AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPS 285
Query: 367 M 367
Sbjct: 286 F 286

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
               +++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
               +++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 112/239 (46%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + VL+ G  VA+K +  T       ++   EV ++  L+H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG +      + E R K        
Sbjct: 75  NIVKLFEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFR-QIVSA 126
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G  N L T   G+  Y 
Sbjct: 127 VQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG--NKLDT-FCGSPPYA 180
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 233

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDK-----EFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG       V    +     + +      E L E  ++ +L +  +V+++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL E +
Sbjct: 79  G---ICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAM 277
               +HRD  A N+LL    +AK++DFGL+K A     N    +  G +   + APE   
Sbjct: 132 ---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGKWPVKWYAPECIN 187
Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 KSDV+S+GV++ E  + G+KP
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ D GLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L    H N++ +  
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +    Q    Y  +    +E+ L+  L    HL  +          RGL Y+H  + 
Sbjct: 91  IIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN- 146
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEYAMTG 279
             V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE  +  
Sbjct: 147 --VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 280 HLLVKS-DVYSYGVVLLELLTGR 301
               KS D++S G +L E+L+ R
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKG--VLSDGTAVAIKRLTC-GGQQG-DKEFLVEVEML 147
           L  A   +E  + +GEG +G+VFK   + + G  VA+KR+    G++G     + EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 148 SRLH---HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHG--PLGVNCHLDWE 199
             L    H N+V+L  V   S  D    L L +E V +  L ++L      GV      E
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT----E 120
Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
           T   +     RGL +LH      V+HRD K  NIL+ ++   K+ADFGLA+         
Sbjct: 121 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQM 174
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
             T V+ T  Y APE  +        D++S G +  E+   RKP+
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 122 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
               +++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 174 EMAGFVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ D GLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 97  NNFEPASILGEGGFGRVF---KGVLSDGTAV-AIKRLTCGGQQGDKEFLVEVE--MLSRL 150
           + FE   +LG+G FG+VF   K   SD   + A+K L     +       ++E  +L  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAA 209
           +H  +VKL  +Y+ +   +  L  + +  G L + L   +        E  +K  L + A
Sbjct: 84  NHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVKFYLAELA 136
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
             L +LH      +I+RD K  NILL+   H K+ DFGL+K++ +      S    GT  
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           Y+APE          +D +S+GV++ E+LTG  P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 97  NNFEPASILGEGGFGRVF---KGVLSDGTAV-AIKRLTCGGQQGDKEFLVEVE--MLSRL 150
           + FE   +LG+G FG+VF   K   SD   + A+K L     +       ++E  +L  +
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAA 209
           +H  +VKL  +Y+ +   +  L  + +  G L + L   +        E  +K  L + A
Sbjct: 85  NHPFIVKL--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-----EEDVKFYLAELA 137
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
             L +LH      +I+RD K  NILL+   H K+ DFGL+K++ +      S    GT  
Sbjct: 138 LALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 192
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           Y+APE          +D +S+GV++ E+LTG  P
Sbjct: 193 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 6   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 65
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 66  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 125
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ D GLA+   +
Sbjct: 126 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDD 177
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
             T Y++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 178 EMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           ++    ++G G FG V++  L D G  VAIK++  G    ++    E++++ +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIV 76
Query: 157 KL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           +L   +YSS   +D     L  + VP        H             ++ +     R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTFG 269
           AY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R      
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 187
Query: 270 YVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
           Y APE          S DV+S G VL ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 112/239 (46%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + +L+ G  VA+K +  T       ++   EV ++  L+H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG +      + E R K        
Sbjct: 74  NIVKLFEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFR-QIVSA 125
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G  N L T   G+  Y 
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDT-FCGSPPYA 179
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 232

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 112/239 (46%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + +L+ G  VA+K +  T       ++   EV ++  L+H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG +      + E R K        
Sbjct: 74  NIVKLFEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFR-QIVSA 125
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G  N L T   G+  Y 
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDT-FCGSPPYA 179
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 232

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGY- 161
           +G+G +G V++G    G  VA+K  +    + +K +  E E+ +   L H N++  +   
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 162 YSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH---- 216
            +SR SS  L L       GSL  +L         LD  + ++I L  A GLA+LH    
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 217 -EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST----RVMGTFGYV 271
               +P + HRD K+ NIL++ N    +AD GLA    +  TN L      RV GT  Y+
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS-TNQLDVGNNPRV-GTKRYM 213
Query: 272 APEYAMTGHLLV-------KSDVYSYGVVLLEL 297
           APE  +   + V       + D++++G+VL E+
Sbjct: 214 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGY- 161
           +G+G +G V++G    G  VA+K  +    + +K +  E E+ +   L H N++  +   
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 162 YSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH---- 216
            +SR SS  L L       GSL  +L         LD  + ++I L  A GLA+LH    
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 217 -EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST----RVMGTFGYV 271
               +P + HRD K+ NIL++ N    +AD GLA    +  TN L      RV GT  Y+
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS-TNQLDVGNNPRV-GTKRYM 184
Query: 272 APEYAMTGHLLV-------KSDVYSYGVVLLEL 297
           APE  +   + V       + D++++G+VL E+
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           ++    ++G G FG V++  L D G  VAIK++  G    ++    E++++ +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIV 76
Query: 157 KL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           +L   +YSS   +D     L  + VP        H             ++ +     R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTFG 269
           AY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R      
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----- 187
Query: 270 YVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
           Y APE          S DV+S G VL ELL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGY- 161
           +G+G +G V++G    G  VA+K  +    + +K +  E E+ +   L H N++  +   
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 162 YSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH---- 216
            +SR SS  L L       GSL  +L         LD  + ++I L  A GLA+LH    
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 217 -EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST----RVMGTFGYV 271
               +P + HRD K+ NIL++ N    +AD GLA    +  TN L      RV GT  Y+
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS-TNQLDVGNNPRV-GTKRYM 184
Query: 272 APEYAMTGHLLV-------KSDVYSYGVVLLEL 297
           APE  +   + V       + D++++G+VL E+
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRL 150
             +NFE   +LG+G FG+V    +    D  AV + +     Q  D E  + E  +LS  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 151 -HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI-ALDA 208
            +H  L +L   + + D  +     E V  G L   +      +     E R +  A + 
Sbjct: 81  RNHPFLTQLFCCFQTPD--RLFFVMEFVNGGDLMFHIQKSRRFD-----EARARFYAAEI 133
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GT 267
              L +LH+     +I+RD K  N+LL++  H K+ADFG+ K   EG  N ++T    GT
Sbjct: 134 ISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGT 187
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
             Y+APE           D ++ GV+L E+L G  P +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 103
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 162
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTF 268
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R     
Sbjct: 163 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 215
Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            Y APE          S DV+S G VL ELL G+
Sbjct: 216 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 32/229 (13%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH 151
           KE    ++P  ++G G    V + V  + G   A+K +    ++   E L EV   +R  
Sbjct: 90  KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 152 ---------HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR- 201
                    H +++ L+  Y S  SS   L ++L+  G L  +L   + ++   + ETR 
Sbjct: 150 THILRQVAGHPHIITLIDSYES--SSFMFLVFDLMRKGELFDYLTEKVALS---EKETRS 204
Query: 202 -MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 260
            M+  L+A   +++LH ++   ++HRD K  NILL++N   +++DFG +     G     
Sbjct: 205 IMRSLLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--- 255
Query: 261 STRVMGTFGYVAPEYAMTGHLLV------KSDVYSYGVVLLELLTGRKP 303
              + GT GY+APE               + D+++ GV+L  LL G  P
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 27/283 (9%)
Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK---EFLVEVEMLSRLHHR 153
           NF     +G G F  V++   L DG  VA+K++        K   + + E+++L +L+H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 154 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           N++K   YY+S      L +  EL   G L   +         +   T  K  +     L
Sbjct: 93  NVIK---YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            ++H      V+HRD K +N+ +      K+ D GL +      T   +  ++GT  Y++
Sbjct: 150 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMS 204
Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
           PE         KSD++S G +L E+   + P        + NL +  +       ++E+ 
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCK-------KIEQC 253
Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
             P L   +  E+  ++  +   C+ P+  +RP +  V    K
Sbjct: 254 DYPPLPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDVAK 293

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 111
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 170
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTF 268
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R     
Sbjct: 171 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 223
Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            Y APE          S DV+S G VL ELL G+
Sbjct: 224 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 109
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 168
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTF 268
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R     
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 221
Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            Y APE          S DV+S G VL ELL G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 103 SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKLVG 160
           S +GEG +G V     + +   VAIK+++    Q   +  L E+++L R  H N++ +  
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGP----LGVNCHLDWETRMKIALDAARGLAYLH 216
              +    Q    Y       L + L G     L    HL  +          RGL Y+H
Sbjct: 109 IIRAPTIEQMKDVY-------LVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYVAPEY 275
             +   V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T  Y APE 
Sbjct: 162 SAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 276 AMTGHLLVKS-DVYSYGVVLLELLTGR 301
            +      KS D++S G +L E+L+ R
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 113
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 172
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTF 268
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R     
Sbjct: 173 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 225
Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            Y APE          S DV+S G VL ELL G+
Sbjct: 226 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 114/240 (47%), Gaps = 15/240 (6%)
Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK---LVG 160
           LG GG G VF  V +D    VAIK++     Q  K  L E++++ RL H N+VK   ++G
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 161 YYSSRDSSQHLLCYEL----VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
              S+ +       EL    +    +E+ L   L     L+   R+       RGL Y+H
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGLKYIH 137
Query: 217 EDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAK-QAPEGRTNYLSTRVMGTFGYVAPE 274
             +   V+HRD K +N+ +   +   K+ DFGLA+   P        +  + T  Y +P 
Sbjct: 138 SAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194
Query: 275 YAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
             ++ +   K+ D+++ G +  E+LTG+     +    Q  L+  + P++ ++DR E L+
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 154
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 213
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTF 268
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R     
Sbjct: 214 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 266
Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            Y APE          S DV+S G VL ELL G+
Sbjct: 267 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G +G V     +     VA+K+L+   Q     +    E+ +L  L H N++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 162 Y----SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           +    S  D S+  L   L+    L + +      + H+ +     +     RGL Y+H 
Sbjct: 96  FTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHVQF-----LVYQLLRGLKYIH- 148
Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                +IHRD K SN+ +  +   ++ DFGLA+QA E  T Y++TR      Y APE  +
Sbjct: 149 --SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 278 TG-HLLVKSDVYSYGVVLLELLTGR 301
              H     D++S G ++ ELL G+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 105 LGEGGFGRV---FKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           +G G  G V   F  VL  G  VA+K+L+     Q   K    E+ +L  ++H+N++ L+
Sbjct: 32  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 160 GYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
             ++ + + +      L  EL+ + +L   +H        LD E    +      G+ +L
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIH------MELDHERMSYLLYQMLCGIKHL 142
Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H      +IHRD K SNI+++++   K+ DFGLA+ A    TN++ T  + T  Y APE 
Sbjct: 143 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEV 196
Query: 276 AMTGHLLVKSDVYSYGVVLLELLTG 300
            +        D++S G ++ EL+ G
Sbjct: 197 ILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 40/224 (17%)
Query: 98  NFEPASILGEGGFGRV-FKGVLSDGTAVAIK-----RLTCGGQQGDKEFLVEVEMLSRLH 151
           N++    LGEG FG+V      + G  VA+K      L     QG  E   E+  L  L 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H +++KL     S+D  + ++  E   N   +  +              R K++   AR 
Sbjct: 72  HPHIIKLYDVIKSKD--EIIMVIEYAGNELFDYIVQ-------------RDKMSEQEARR 116
Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
                   + Y H      ++HRD K  N+LL+ + + K+ADFGL+    +G  N+L T 
Sbjct: 117 FFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTS 171
Query: 264 VMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 305
             G+  Y APE  ++G L    + DV+S GV+L  +L  R P D
Sbjct: 172 C-GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 88
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 147
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTF 268
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R     
Sbjct: 148 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 200
Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            Y APE          S DV+S G VL ELL G+
Sbjct: 201 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 40/224 (17%)
Query: 98  NFEPASILGEGGFGRV-FKGVLSDGTAVAIK-----RLTCGGQQGDKEFLVEVEMLSRLH 151
           N++    LGEG FG+V      + G  VA+K      L     QG  E   E+  L  L 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H +++KL     S+D  + ++  E   N   +  +              R K++   AR 
Sbjct: 73  HPHIIKLYDVIKSKD--EIIMVIEYAGNELFDYIVQ-------------RDKMSEQEARR 117
Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
                   + Y H      ++HRD K  N+LL+ + + K+ADFGL+    +G  N+L T 
Sbjct: 118 FFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTS 172
Query: 264 VMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 305
             G+  Y APE  ++G L    + DV+S GV+L  +L  R P D
Sbjct: 173 C-GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    +G G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + KVADFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 80
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 139
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTF 268
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R     
Sbjct: 140 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 192
Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            Y APE          S DV+S G VL ELL G+
Sbjct: 193 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 40/224 (17%)
Query: 98  NFEPASILGEGGFGRV-FKGVLSDGTAVAIK-----RLTCGGQQGDKEFLVEVEMLSRLH 151
           N++    LGEG FG+V      + G  VA+K      L     QG  E   E+  L  L 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H +++KL     S+D  + ++  E   N   +  +              R K++   AR 
Sbjct: 63  HPHIIKLYDVIKSKD--EIIMVIEYAGNELFDYIVQ-------------RDKMSEQEARR 107
Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
                   + Y H      ++HRD K  N+LL+ + + K+ADFGL+    +G  N+L T 
Sbjct: 108 FFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTS 162
Query: 264 VMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 305
             G+  Y APE  ++G L    + DV+S GV+L  +L  R P D
Sbjct: 163 C-GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G +G V     +     VA+K+L+   Q     +    E+ +L  L H N++ L+  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLG--VNCH-LDWETRMKIALDAARGLAYLHED 218
           ++   S +      LV      + +   L   V C  L  E    +     RGL Y+H  
Sbjct: 88  FTPATSIEDFSEVYLV-----TTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
               +IHRD K SN+ +  +   ++ DFGLA+QA E  T Y++TR      Y APE  + 
Sbjct: 143 G---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLN 194
Query: 279 G-HLLVKSDVYSYGVVLLELLTGR 301
             H     D++S G ++ ELL G+
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 112/239 (46%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + +L+ G  VA++ +  T       ++   EV ++  L+H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG +      + E R K        
Sbjct: 74  NIVKLFEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFR-QIVSA 125
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G  N L T   G+  Y 
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDT-FCGSPPYA 179
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 232

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 40/224 (17%)
Query: 98  NFEPASILGEGGFGRV-FKGVLSDGTAVAIK-----RLTCGGQQGDKEFLVEVEMLSRLH 151
           N++    LGEG FG+V      + G  VA+K      L     QG  E   E+  L  L 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           H +++KL     S+D  + ++  E   N   +  +              R K++   AR 
Sbjct: 67  HPHIIKLYDVIKSKD--EIIMVIEYAGNELFDYIVQ-------------RDKMSEQEARR 111
Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
                   + Y H      ++HRD K  N+LL+ + + K+ADFGL+    +G  N+L T 
Sbjct: 112 FFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTS 166
Query: 264 VMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 305
             G+  Y APE  ++G L    + DV+S GV+L  +L  R P D
Sbjct: 167 C-GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 112/239 (46%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + +L+ G  VA+K +  T       ++   EV ++  L+H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG +      + E R K        
Sbjct: 67  NIVKLFEVIETEKTL--YLVMEYASGGEVFDYLVAHGWMK-----EKEARAKFR-QIVSA 118
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G  N L T   G+  Y 
Sbjct: 119 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDT-FCGSPPYA 172
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 173 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 225

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 25/234 (10%)
Query: 79  PHPTSTRFLAYEELKEATNNFEPAS---ILGEGGFGRVFK-GVLSDGTAVAIKRLTCGGQ 134
           P P   R +  ++   A N+F   S   ILG G FG+V K    + G  +A K +   G 
Sbjct: 70  PAPFDHRIVTAKQ--GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM 127
Query: 135 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 194
           +  +E   E+ ++++L H NL++L   + S++    +L  E V  G L   +        
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI--VLVMEYVDGGELFDRIIDESYNLT 185
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN--FHAKVADFGLAKQA 252
            LD    MK       G+ ++H   Q  ++H D K  NIL  N      K+ DFGLA++ 
Sbjct: 186 ELDTILFMK---QICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 253 P---EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
               + + N+      GT  ++APE      +   +D++S GV+   LL+G  P
Sbjct: 240 KPREKLKVNF------GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGV------NCHLDWETRMKI 204
            L+G   ++     ++  E    G+L ++L        P  V         L  E  +  
Sbjct: 95  NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 154 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 96  TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEF-----LVEVEMLSR 149
           +++F+  S+LGEG +G V        G  VAIK++    +  DK       L E+++L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI----EPFDKPLFALRTLREIKILKH 65
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
             H N++ +      R  S        +    +++ LH  +      D   +  I     
Sbjct: 66  FKHENIITIFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTL 122
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE-------------GR 256
           R +  LH  +   VIHRD K SN+L+ +N   KV DFGLA+   E             G 
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           T Y++TR      Y APE  +T     ++ DV+S G +L EL   R+P+
Sbjct: 180 TEYVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 75
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMGTF 268
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R     
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY---- 187
Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            Y APE          S DV+S G VL ELL G+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/313 (25%), Positives = 128/313 (40%), Gaps = 52/313 (16%)
Query: 97  NNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSR 149
            N      LGEG FG+V K         +  T VA+K L       + ++ L E  +L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-----GP-------LGVNCHLD 197
           ++H +++KL G  S       LL  E    GSL  +L      GP          +  LD
Sbjct: 83  VNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 198 WETR--------MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
                       +  A   ++G+ YL E S   ++HRD  A NIL+      K++DFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQ 308
           +   E  +    ++      ++A E         +SDV+S+GV+L E++T G  P     
Sbjct: 198 RDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 309 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 368
           P    NL+     + R  +  EE+                   +   C   E ++RP   
Sbjct: 258 PERLFNLLKTGHRMERPDNCSEEM-----------------YRLMLQCWKQEPDKRPVFA 300
Query: 369 EVVQSLK--MVQR 379
           ++ + L+  MV+R
Sbjct: 301 DISKDLEKMMVKR 313

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 20/228 (8%)
Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ--GD 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 26  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 85
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNC 194
           K    E+ +L  + H N++ L+  ++   S +      LV +     L + +      + 
Sbjct: 86  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 145
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           H+ +     +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+   +
Sbjct: 146 HVQF-----LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 197
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGR 301
                ++TR      Y APE  +   H     D++S G ++ ELLTGR
Sbjct: 198 EMXGXVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 105 LGEGGFGRV---FKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           +G G  G V   F  VL  G  VA+K+L+     Q   K    E+ +L  ++H+N++ L+
Sbjct: 30  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 160 GYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
             ++ + + +      L  EL+ + +L   +H        LD E    +      G+ +L
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELM-DANLCQVIH------MELDHERMSYLLYQMLCGIKHL 140
Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H      +IHRD K SNI+++++   K+ DFGLA+ A    TN++ T  + T  Y APE 
Sbjct: 141 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYYRAPEV 194
Query: 276 AMTGHLLVKSDVYSYGVVLLELLTG 300
            +        D++S G ++ EL+ G
Sbjct: 195 ILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 34/230 (14%)
Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLH-HRN 154
           +E    LG+G +G V+K +    G  VA+K++    Q     +    E+ +L+ L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +V L+    + +     L ++      +E+ LH  +  N  L+   +  +     + + Y
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANI-LEPVHKQYVVYQLIKVIKY 124
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK--------------QAPEGRTNY- 259
           LH      ++HRD K SNILL    H KVADFGL++                 E   N+ 
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 260 ----LSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
               + T  + T  Y APE  +      K  D++S G +L E+L G KP+
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 82/168 (48%), Gaps = 21/168 (12%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS-LESWLHGPLGVNCHLDWETR 201
           E+ +L +L H N+VKLV      +     + +ELV  G  +E     PL  +     + R
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-----QAR 140
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
                D  +G+ YLH      +IHRD K SN+L+  + H K+ADFG++ +  +G    LS
Sbjct: 141 FYFQ-DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLS 195
Query: 262 TRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             V GT  ++APE         +G  L   DV++ GV L   + G+ P
Sbjct: 196 NTV-GTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQCP 239

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 99  FEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHR 153
           FE    LG G F  V   VL++    G   A+K +     +G +  +  E+ +L ++ H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 154 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           N+V L   Y   +S  HL L  +LV  G L   +    G     D  T ++  LDA   +
Sbjct: 81  NIVALEDIY---ESPNHLYLVMQLVSGGELFDRIVEK-GFYTEKDASTLIRQVLDA---V 133
Query: 213 AYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            YLH   +  ++HRD K  N+L    +      ++DFGL+K   EG+ + +ST   GT G
Sbjct: 134 YYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMST-ACGTPG 187
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           YVAPE           D +S GV+   LL G  P
Sbjct: 188 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGV------NCHLDWETRMKI 204
            L+G   ++     ++  E    G+L ++L        P  V         L  E  +  
Sbjct: 86  NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 145 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 105 LGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G +G V     +     VA+K+L+   Q     +    E+ +L  L H N++ L+  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLG--VNCH-LDWETRMKIALDAARGLAYLHED 218
           ++   S +      LV      + +   L   V C  L  E    +     RGL Y+H  
Sbjct: 96  FTPATSIEDFSEVYLVT-----TLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSA 150
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
               +IHRD K SN+ +  +   ++ DFGLA+QA E  T Y++TR      Y APE  + 
Sbjct: 151 G---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLN 202
Query: 279 G-HLLVKSDVYSYGVVLLELLTGR 301
             H     D++S G ++ ELL G+
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGV------NCHLDWETRMKI 204
            L+G   ++     ++  E    G+L ++L        P  V         L  E  +  
Sbjct: 86  NLLGA-CTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 145 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGV------NCHLDWETRMKI 204
            L+G   ++     ++  E    G+L ++L        P  V         L  E  +  
Sbjct: 95  NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 154 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 30/222 (13%)
Query: 97  NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHR 153
           + +E    +G G +G V        G  VAIK++          K  L E+++L    H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGS----------LESWLHGPLGVNCHLDWETRMK 203
           N++ +      +D     +    VP G           +ES LH  +  +  L  E    
Sbjct: 115 NIIAI------KD-----ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRY 163
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLS 261
                 RGL Y+H      VIHRD K SN+L+  N   K+ DFG+A+          Y  
Sbjct: 164 FLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 220
Query: 262 TRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRK 302
           T  + T  Y APE  ++ H   ++ D++S G +  E+L  R+
Sbjct: 221 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGV------NCHLDWETRMKI 204
            L+G   ++     ++  E    G+L ++L        P  V         L  E  +  
Sbjct: 95  NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 154 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G  G V+  + ++ G  VAI+++    QQ  KE ++ E+ ++    + N+V  +  Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              D  +  +  E +  GSL   +         +D      +  +  + L +LH +    
Sbjct: 87  LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           VIHRD K+ NILL  +   K+ DFG   Q  PE       + ++GT  ++APE       
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SEMVGTPYWMAPEVVTRKAY 193
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
             K D++S G++ +E++ G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG-----------VNCHLDWETRMKIA 205
            L+G   ++     ++  E    G+L ++L                    L  E  +  +
Sbjct: 96  NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYS 154
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +           
Sbjct: 155 FQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
               ++APE        ++SDV+S+GV+L E+ +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGV------NCHLDWETRMKI 204
            L+G   ++     ++  E    G+L ++L        P  V         L  E  +  
Sbjct: 132 NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 191 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           ++    ++G G FG V++  L D G  VAIK++  G    ++    E++++ +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIV 76
Query: 157 KL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           +L   +YSS   +D     L  + VP        H             ++ +     R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM-YQLFRSL 135
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           AY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y 
Sbjct: 136 AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYR 189
Query: 272 APEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
           APE          S DV+S G VL ELL G+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 109
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 168
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYY 222
Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            APE          S DV+S G VL ELL G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    +G G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E +P G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + KVADFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    +G G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E +P G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + KVADFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 110/239 (46%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + +L+ G  VA+K +  T       ++   EV ++  L+H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG +      + E R K        
Sbjct: 74  NIVKLFEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFR-QIVSA 125
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G  N L     G   Y 
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDA-FCGAPPYA 179
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 232

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFXEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 30/222 (13%)
Query: 97  NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHR 153
           + +E    +G G +G V        G  VAIK++          K  L E+++L    H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGS----------LESWLHGPLGVNCHLDWETRMK 203
           N++ +      +D     +    VP G           +ES LH  +  +  L  E    
Sbjct: 114 NIIAI------KD-----ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRY 162
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLS 261
                 RGL Y+H      VIHRD K SN+L+  N   K+ DFG+A+          Y  
Sbjct: 163 FLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219
Query: 262 TRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRK 302
           T  + T  Y APE  ++ H   ++ D++S G +  E+L  R+
Sbjct: 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G  G V+  + ++ G  VAI+++    QQ  KE ++ E+ ++    + N+V  +  Y
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              D  +  +  E +  GSL   +         +D      +  +  + L +LH +    
Sbjct: 88  LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 137
Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           VIHRD K+ NILL  +   K+ DFG   Q  PE       + ++GT  ++APE       
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRKAY 194
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
             K D++S G++ +E++ G  P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G  G V+  + ++ G  VAI+++    QQ  KE ++ E+ ++    + N+V  +  Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              D  +  +  E +  GSL   +         +D      +  +  + L +LH +    
Sbjct: 87  LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           VIHRD K+ NILL  +   K+ DFG   Q  PE       + ++GT  ++APE       
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SXMVGTPYWMAPEVVTRKAY 193
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
             K D++S G++ +E++ G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFXEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFXEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G  G V+  + ++ G  VAI+++    QQ  KE ++ E+ ++    + N+V  +  Y
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              D  +  +  E +  GSL   +         +D      +  +  + L +LH +    
Sbjct: 87  LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 136
Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           VIHRD K+ NILL  +   K+ DFG   Q  PE       + ++GT  ++APE       
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 193
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
             K D++S G++ +E++ G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGV------NCHLDWETRMKI 204
            L+G   ++     ++  E    G+L ++L        P  V         L  E  +  
Sbjct: 86  NLLGA-CTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 145 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 83
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 142
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y
Sbjct: 143 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYY 196
Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            APE          S DV+S G VL ELL G+
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 35/226 (15%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGT----AVAIKRLTCGGQQGDKEF-------LVEVEM 146
           N+EP  ILG G    V +  +   T    AV I  +T GG    +E        L EV++
Sbjct: 5   NYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 147 LSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MK 203
           L ++  H N+++L   Y +  ++   L ++L+  G L  +L   + ++   + ETR  M+
Sbjct: 64  LRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLS---EKETRKIMR 118
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
             L+    L  L+      ++HRD K  NILL+++ + K+ DFG + Q   G        
Sbjct: 119 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRE 169
Query: 264 VMGTFGYVAPEY---AMTGH---LLVKSDVYSYGVVLLELLTGRKP 303
           V GT  Y+APE    +M  +      + D++S GV++  LL G  P
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 215

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 94
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 153
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y
Sbjct: 154 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYY 207
Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            APE          S DV+S G VL ELL G+
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 35/226 (15%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGT----AVAIKRLTCGGQQGDKEF-------LVEVEM 146
           N+EP  ILG G    V +  +   T    AV I  +T GG    +E        L EV++
Sbjct: 18  NYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 147 LSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MK 203
           L ++  H N+++L   Y +  ++   L ++L+  G L  +L   + ++   + ETR  M+
Sbjct: 77  LRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLS---EKETRKIMR 131
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
             L+    L  L+      ++HRD K  NILL+++ + K+ DFG + Q   G        
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRE 182
Query: 264 VMGTFGYVAPEY---AMTGH---LLVKSDVYSYGVVLLELLTGRKP 303
           V GT  Y+APE    +M  +      + D++S GV++  LL G  P
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 28/225 (12%)
Query: 96  TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEF-----LVEVEMLSR 149
           +++F+  S+LGEG +G V        G  VAIK++    +  DK       L E+++L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI----EPFDKPLFALRTLREIKILKH 65
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
             H N++ +      R  S        +    +++ LH  +      D   +  I     
Sbjct: 66  FKHENIITIFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTL 122
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------QAPEGRTNYL 260
           R +  LH  +   VIHRD K SN+L+ +N   KV DFGLA+           P G+ + +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
            T  + T  Y APE  +T     ++ DV+S G +L EL   R+P+
Sbjct: 180 -TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------PLGV------NCHLDWETRMKI 204
            L+G   ++     ++  E    G+L ++L        P  V         L  E  +  
Sbjct: 86  NLLGA-CTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 145 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       YS +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 87
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 146
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYY 200
Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            APE          S DV+S G VL ELL G+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 127/313 (40%), Gaps = 52/313 (16%)
Query: 97  NNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSR 149
            N      LGEG FG+V K         +  T VA+K L       + ++ L E  +L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-----GP-------LGVNCHLD 197
           ++H +++KL G  S       LL  E    GSL  +L      GP          +  LD
Sbjct: 83  VNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 198 WETR--------MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
                       +  A   ++G+ YL E     ++HRD  A NIL+      K++DFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQ 308
           +   E  +    ++      ++A E         +SDV+S+GV+L E++T G  P     
Sbjct: 198 RDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 309 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 368
           P    NL+     + R  +  EE+                   +   C   E ++RP   
Sbjct: 258 PERLFNLLKTGHRMERPDNCSEEM-----------------YRLMLQCWKQEPDKRPVFA 300
Query: 369 EVVQSLK--MVQR 379
           ++ + L+  MV+R
Sbjct: 301 DISKDLEKMMVKR 313

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       YS +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       YS +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG----------VNCHLDWETRMKIAL 206
            L+G   ++     ++  E    G+L ++L                   L  E  +  + 
Sbjct: 97  NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
             A+G+ +L        IHRD  A NILL      K+ DFGLA+   +            
Sbjct: 156 QVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
              ++APE        ++SDV+S+GV+L E+ +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 75
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYY 188
Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            APE          S DV+S G VL ELL G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 87
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 146
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y
Sbjct: 147 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYY 200
Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            APE          S DV+S G VL ELL G+
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 111/239 (46%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + +L+ G  VA++ +  T       ++   EV ++  L+H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG +      + E R K        
Sbjct: 74  NIVKLFEVIETEKTL--YLVMEYASGGEVFDYLVAHGRMK-----EKEARAKFR-QIVSA 125
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G  N L     G+  Y 
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLD-EFCGSPPYA 179
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 232

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 35/226 (15%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGT----AVAIKRLTCGGQQGDKEF-------LVEVEM 146
           N+EP  ILG G    V +  +   T    AV I  +T GG    +E        L EV++
Sbjct: 18  NYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 147 LSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MK 203
           L ++  H N+++L   Y +  ++   L ++L+  G L  +L   + ++   + ETR  M+
Sbjct: 77  LRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLS---EKETRKIMR 131
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
             L+    L  L+      ++HRD K  NILL+++ + K+ DFG + Q   G        
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRS 182
Query: 264 VMGTFGYVAPEY---AMTGH---LLVKSDVYSYGVVLLELLTGRKP 303
           V GT  Y+APE    +M  +      + D++S GV++  LL G  P
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 99  FEPASILGEGGFGRVFKGVLSDGT--------AVAIKRLTCGGQQGDKEFLVEVEMLSRL 150
           FE   +LG+GG+G+VF+     G          V  K +     +       E  +L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H  +V L+  Y+ +   +  L  E +  G L   L    G+      +T      + + 
Sbjct: 79  KHPFIVDLI--YAFQTGGKLYLILEYLSGGELFMQLERE-GIFME---DTACFYLAEISM 132
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L +LH   Q  +I+RD K  NI+L +  H K+ DFGL K++    T  ++    GT  Y
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEY 187
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +APE  M        D +S G ++ ++LTG  P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 75
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA------ 209
           V+L  ++ S    + ++   LV +   E+       V  H    +R K  L         
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYR----VARHY---SRAKQTLPVIYVKLYM 128
Query: 210 ----RGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRV 264
               R LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      
Sbjct: 129 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSX 182
Query: 265 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
           + +  Y APE          S DV+S G VL ELL G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 75
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 134
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYY 188
Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            APE          S DV+S G VL ELL G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 79
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 138
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y
Sbjct: 139 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYY 192
Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            APE          S DV+S G VL ELL G+
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 127/313 (40%), Gaps = 52/313 (16%)
Query: 97  NNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSR 149
            N      LGEG FG+V K         +  T VA+K L       + ++ L E  +L +
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH-----GP-------LGVNCHLD 197
           ++H +++KL G  S       LL  E    GSL  +L      GP          +  LD
Sbjct: 83  VNHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 198 WETR--------MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
                       +  A   ++G+ YL E     ++HRD  A NIL+      K++DFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQ 308
           +   E  +    ++      ++A E         +SDV+S+GV+L E++T G  P     
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257
Query: 309 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 368
           P    NL+     + R  +  EE+                   +   C   E ++RP   
Sbjct: 258 PERLFNLLKTGHRMERPDNCSEEM-----------------YRLMLQCWKQEPDKRPVFA 300
Query: 369 EVVQSLK--MVQR 379
           ++ + L+  MV+R
Sbjct: 301 DISKDLEKMMVKR 313

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNL 155
           ++    ++G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNI 76
Query: 156 VKL-VGYYSS---RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           V+L   +YSS   +D     L  + VP        H             ++ +     R 
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-YQLFRS 135
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N      + +  Y
Sbjct: 136 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYY 189
Query: 271 VAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
            APE          S DV+S G VL ELL G+
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEV-EMLSRLHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V++ E+   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKEIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + KV DFGLAK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 99  FEPASILGEGGFGRVFKGVLSDGT--------AVAIKRLTCGGQQGDKEFLVEVEMLSRL 150
           FE   +LG+GG+G+VF+     G          V  K +     +       E  +L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H  +V L+  Y+ +   +  L  E +  G L   L    G+      +T      + + 
Sbjct: 79  KHPFIVDLI--YAFQTGGKLYLILEYLSGGELFMQLERE-GIFME---DTACFYLAEISM 132
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L +LH   Q  +I+RD K  NI+L +  H K+ DFGL K++    T  ++    GT  Y
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEY 187
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +APE  M        D +S G ++ ++LTG  P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 111/239 (46%), Gaps = 44/239 (18%)
Query: 90  EELKEATNN--------FEPASILGEGGFGRVFKGVLSD--GT----AVAIKRLTCGGQQ 135
           E+ K+ +NN        F    +LG+G FG+V   +L+D  GT    A+ I +     Q 
Sbjct: 4   EDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQD 60
Query: 136 GDKE-FLVEVEMLSRLHHRN-LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
            D E  +VE  +L+ L     L +L   + + D    ++  E V  G L           
Sbjct: 61  DDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVM--EYVNGGDLMY--------- 109
Query: 194 CHLDWETRMK------IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG 247
            H+    + K       A + + GL +LH+     +I+RD K  N++L++  H K+ADFG
Sbjct: 110 -HIQQVGKFKEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFG 165
Query: 248 LAKQAPEGRTNYLSTR-VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           + K   E   + ++TR   GT  Y+APE           D ++YGV+L E+L G+ P D
Sbjct: 166 MCK---EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + +L+ G  VAIK +  T       ++   EV ++  L+H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG +      + E R K        
Sbjct: 72  NIVKLFEVIETEKTL--YLIMEYASGGEVFDYLVAHGRMK-----EKEARSKFR-QIVSA 123
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G    L T   G+  Y 
Sbjct: 124 VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDT-FCGSPPYA 177
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 230

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/85 (42%), Positives = 52/85 (61%), Gaps = 6/85 (7%)
Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 282
           ++HRD K  N+LL++N + K+ADFGL+    +G  N+L T   G+  Y APE  + G L 
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSC-GSPNYAAPE-VINGKLY 184
Query: 283 V--KSDVYSYGVVLLELLTGRKPVD 305
              + DV+S G+VL  +L GR P D
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---IGRFXEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + KV DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKI 204
            L+G   ++     ++  E    G+L ++L                     L  E  +  
Sbjct: 97  NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 156 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---IGRFXEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + KV DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG--------VNCHLDWETRMKIALDA 208
            L+G   ++     ++  E    G+L ++L                 L  E  +  +   
Sbjct: 95  NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
           A+G+ +L   +    IHRD  A NILL      K+ DFGLA+   +              
Sbjct: 154 AKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPL 210
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
            ++APE        ++SDV+S+GV+L E+ +
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 79
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 80  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 135
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 136 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTLC----GT 187
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 188 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 108/217 (49%), Gaps = 23/217 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHH-R 153
           N+ E    +G G  G+V+K      G  +A+K++   G ++ +K  L++++++ + H   
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGS--LESWLHGPLGVNCHLDWETRMKIALDAARG 211
            +V+  G + +  ++   +  EL+   +  L+  + GP+          +M +A+   + 
Sbjct: 85  YIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERIL----GKMTVAI--VKA 136
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           L YL E  +  VIHRD K SNILL+     K+ DFG++ +  + +      R  G   Y+
Sbjct: 137 LYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYM 191
Query: 272 APEY-----AMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE             +++DV+S G+ L+EL TG+ P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 106/237 (44%), Gaps = 35/237 (14%)
Query: 84  TRFLAYEELKE----ATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQ 135
           TRF  ++ ++       N+F    I+G GGFG V+    +D G   A+K L       +Q
Sbjct: 172 TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ 231
Query: 136 GDKEFLVEVEMLSRLHHRNLVKLVGY-YSSRDSSQHLLCYELVPNGSLESWL--HGPLGV 192
           G+   L E  MLS +   +   +V   Y+     +     +L+  G L   L  HG    
Sbjct: 232 GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS- 290
Query: 193 NCHLDWETRMKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-- 249
                 E  M+  A +   GL ++H      V++RD K +NILL+ + H +++D GLA  
Sbjct: 291 ------EADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341
Query: 250 --KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
             K+ P           +GT GY+APE    G     S D +S G +L +LL G  P
Sbjct: 342 FSKKKPHAS--------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 106/237 (44%), Gaps = 35/237 (14%)
Query: 84  TRFLAYEELKE----ATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQ 135
           TRF  ++ ++       N+F    I+G GGFG V+    +D G   A+K L       +Q
Sbjct: 172 TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ 231
Query: 136 GDKEFLVEVEMLSRLHHRNLVKLVGY-YSSRDSSQHLLCYELVPNGSLESWL--HGPLGV 192
           G+   L E  MLS +   +   +V   Y+     +     +L+  G L   L  HG    
Sbjct: 232 GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS- 290
Query: 193 NCHLDWETRMKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-- 249
                 E  M+  A +   GL ++H      V++RD K +NILL+ + H +++D GLA  
Sbjct: 291 ------EADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341
Query: 250 --KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
             K+ P           +GT GY+APE    G     S D +S G +L +LL G  P
Sbjct: 342 FSKKKPHAS--------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 106/237 (44%), Gaps = 35/237 (14%)
Query: 84  TRFLAYEELKE----ATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQ 135
           TRF  ++ ++       N+F    I+G GGFG V+    +D G   A+K L       +Q
Sbjct: 172 TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ 231
Query: 136 GDKEFLVEVEMLSRLHHRNLVKLVGY-YSSRDSSQHLLCYELVPNGSLESWL--HGPLGV 192
           G+   L E  MLS +   +   +V   Y+     +     +L+  G L   L  HG    
Sbjct: 232 GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS- 290
Query: 193 NCHLDWETRMKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-- 249
                 E  M+  A +   GL ++H      V++RD K +NILL+ + H +++D GLA  
Sbjct: 291 ------EADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341
Query: 250 --KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
             K+ P           +GT GY+APE    G     S D +S G +L +LL G  P
Sbjct: 342 FSKKKPHAS--------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 96  TNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH 151
           ++ ++    LG G +G V     K   ++     IK+ +          L EV +L +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSL--ESWLHGPLGVNCHLDWETRMKIALDAA 209
           H N++KL  ++   D   + L  E+   G L  E  L         +D    MK  L   
Sbjct: 80  HPNIMKLYEFFE--DKRNYYLVMEVYRGGELFDEIILRQKFS---EVDAAVIMKQVLS-- 132
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLSTRVMG 266
            G  YLH+ +   ++HRD K  N+LLE+       K+ DFGL+     G    +  R +G
Sbjct: 133 -GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKER-LG 185
Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           T  Y+APE  +      K DV+S GV+L  LL G  P
Sbjct: 186 TAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYY 162
           +G+G FG V++G    G  VA+K  +    + ++ +  E E+     L H N++  +   
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 104
Query: 163 SSRDS---SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED- 218
            ++D+   +Q  L  +   +GSL  +L+        +  E  +K+AL  A GLA+LH + 
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 219 ----SQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVA 272
                +P + HRD K+ NIL++ N    +AD GLA    +     +      +GT  Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 273 PEY----AMTGHL--LVKSDVYSYGVVLLEL 297
           PE         H     ++D+Y+ G+V  E+
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTA------VAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           +G G F  V+KG+ ++ T       +  ++LT   +Q  KE   E E L  L H N+V+ 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQHPNIVRF 90
Query: 159 VGYYSSRDSSQH--LLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIALDAARGLAY 214
              + S    +   +L  EL  +G+L+++L       +     W  ++       +GL +
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQF 144
Query: 215 LHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYV 271
           LH  + P +IHRD K  NI +       K+ D GLA  K+A        +  V+GT  + 
Sbjct: 145 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------FAKAVIGTPEFX 197
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ 312
           APE     +     DVY++G   LE  T   P    Q + Q
Sbjct: 198 APEXYEEKY-DESVDVYAFGXCXLEXATSEYPYSECQNAAQ 237

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 86
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFXEPHARF-YAAQ 142
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 143 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 194
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 195 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 106/237 (44%), Gaps = 35/237 (14%)
Query: 84  TRFLAYEELKE----ATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLT---CGGQQ 135
           TRF  ++ ++       N+F    I+G GGFG V+    +D G   A+K L       +Q
Sbjct: 171 TRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ 230
Query: 136 GDKEFLVEVEMLSRLHHRNLVKLVGY-YSSRDSSQHLLCYELVPNGSLESWL--HGPLGV 192
           G+   L E  MLS +   +   +V   Y+     +     +L+  G L   L  HG    
Sbjct: 231 GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS- 289
Query: 193 NCHLDWETRMKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-- 249
                 E  M+  A +   GL ++H      V++RD K +NILL+ + H +++D GLA  
Sbjct: 290 ------EADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 340
Query: 250 --KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
             K+ P           +GT GY+APE    G     S D +S G +L +LL G  P
Sbjct: 341 FSKKKPHAS--------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + KV DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           +GEG  G V        G  VA+K +    QQ  +    EV ++    H N+V++  Y S
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM--YKS 110
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                +  +  E +  G+L   +         L+ E    +     + LAYLH      V
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---V 162
Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV 283
           IHRD K+ +ILL  +   K++DFG   Q  +         ++GT  ++APE         
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYAT 220
Query: 284 KSDVYSYGVVLLELLTGRKP 303
           + D++S G++++E++ G  P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP 240

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + KV DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 105/242 (43%), Gaps = 37/242 (15%)
Query: 77  SLPHPTSTRFLAYE------ELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRL 129
           S P P  + F   E      E++    + +P   +G G +G V   V    G  VAIK+L
Sbjct: 2   SSPPPARSGFYRQEVTKTAWEVRAVYRDLQP---VGSGAYGAVCSAVDGRTGAKVAIKKL 58
Query: 130 TCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN------GS 181
               Q     K    E+ +L  + H N++ L+  ++  ++      + LV        G 
Sbjct: 59  YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK 118
Query: 182 LESWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 240
           L    H  LG       E R++ +     +GL Y+H      +IHRD K  N+ +  +  
Sbjct: 119 LMK--HEKLG-------EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCE 166
Query: 241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLT 299
            K+ DFGLA+QA       + TR      Y APE  +      ++ D++S G ++ E++T
Sbjct: 167 LKILDFGLARQADSEMXGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221
Query: 300 GR 301
           G+
Sbjct: 222 GK 223

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 105 LGEGGFGRVFK----GVLSDGT--AVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNLV 156
           LG G FG+V +    G+    T   VA+K L  G    + +  + E+++L  + HH N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG--------VNCHLDWETRMKIALDA 208
            L+G   ++     ++  E    G+L ++L                 L  E  +  +   
Sbjct: 95  NLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
           A+G+ +L        IHRD  A NILL      K+ DFGLA+   +              
Sbjct: 154 AKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
            ++APE        ++SDV+S+GV+L E+ +
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYY 162
           +G+G FG V++G    G  VA+K  +    + ++ +  E E+     L H N++  +   
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 71
Query: 163 SSRDS---SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED- 218
            ++D+   +Q  L  +   +GSL  +L+        +  E  +K+AL  A GLA+LH + 
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 126
Query: 219 ----SQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVA 272
                +P + HRD K+ NIL++ N    +AD GLA    +     +      +GT  Y+A
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 273 PEY----AMTGHL--LVKSDVYSYGVVLLEL 297
           PE         H     ++D+Y+ G+V  E+
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + KV DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYY 162
           +G+G FG V++G    G  VA+K  +    + ++ +  E E+     L H N++  +   
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 66
Query: 163 SSRDS---SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED- 218
            ++D+   +Q  L  +   +GSL  +L+        +  E  +K+AL  A GLA+LH + 
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 121
Query: 219 ----SQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVA 272
                +P + HRD K+ NIL++ N    +AD GLA    +     +      +GT  Y+A
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 273 PEY----AMTGHL--LVKSDVYSYGVVLLEL 297
           PE         H     ++D+Y+ G+V  E+
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 104 ILGEGGFGRVFKGVLSDGTAV-----AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            LG+GGF + F+   +D   V       K L     Q +K   +E+ +   L H+++V  
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 86
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G++   D     +  EL    SL   LH         + E R  +      G  YLH +
Sbjct: 87  HGFFEDNDFV--FVVLELCRRRSLLE-LHK--RRKALTEPEARYYLR-QIVLGCQYLHRN 140
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR---VMGTFGYVAPE- 274
               VIHRD K  N+ L  +   K+ DFGLA      +  Y   R   + GT  Y+APE 
Sbjct: 141 R---VIHRDLKLGNLFLNEDLEVKIGDFGLAT-----KVEYDGERKKTLCGTPNYIAPEV 192
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
            +  GH   + DV+S G ++  LL G+ P + S
Sbjct: 193 LSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYY 162
           +G+G FG V++G    G  VA+K  +    + ++ +  E E+     L H N++  +   
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 65
Query: 163 SSRDS---SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED- 218
            ++D+   +Q  L  +   +GSL  +L+        +  E  +K+AL  A GLA+LH + 
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 219 ----SQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVA 272
                +P + HRD K+ NIL++ N    +AD GLA    +     +      +GT  Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 273 PEY----AMTGHL--LVKSDVYSYGVVLLEL 297
           PE         H     ++D+Y+ G+V  E+
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 104 ILGEGGFGRVFKGVLSDGTAV-----AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            LG+GGF + F+   +D   V       K L     Q +K   +E+ +   L H+++V  
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 104
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G++   D     +  EL    SL   LH         + E R  +      G  YLH +
Sbjct: 105 HGFFEDNDFV--FVVLELCRRRSLLE-LHK--RRKALTEPEARYYLR-QIVLGCQYLHRN 158
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR---VMGTFGYVAPE- 274
               VIHRD K  N+ L  +   K+ DFGLA      +  Y   R   + GT  Y+APE 
Sbjct: 159 R---VIHRDLKLGNLFLNEDLEVKIGDFGLAT-----KVEYDGERKKVLCGTPNYIAPEV 210
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
            +  GH   + DV+S G ++  LL G+ P + S
Sbjct: 211 LSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV------EVEMLSRLHHRNLVK 157
           LG G FG+V  G     G  VA+K L    +Q  +   V      E++ L    H +++K
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYL 215
           L    S+   +   +  E V  G L  ++  HG +      + E R ++       + Y 
Sbjct: 76  LYQVIST--PTDFFMVMEYVSGGELFDYICKHGRVE-----EMEAR-RLFQQILSAVDYC 127
Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H   +  V+HRD K  N+LL+ + +AK+ADFGL+    +G   +L T   G+  Y APE 
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSC-GSPNYAAPE- 180
Query: 276 AMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 305
            ++G L    + D++S GV+L  LL G  P D
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 28/225 (12%)
Query: 96  TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEF-----LVEVEMLSR 149
           +++F+  S+LGEG +G V        G  VAIK++    +  DK       L E+++L  
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI----EPFDKPLFALRTLREIKILKH 65
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
             H N++ +      R  S        +    +++ LH  +      D   +  I     
Sbjct: 66  FKHENIITIFNI--QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI-YQTL 122
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK---------QAPEGRTNYL 260
           R +  LH  +   VIHRD K SN+L+ +N   KV DFGLA+           P G+ + +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
               + T  Y APE  +T     ++ DV+S G +L EL   R+P+
Sbjct: 180 -VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 104 ILGEGGFGRVFKGVLSDGTAV-----AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            LG+GGF + F+   +D   V       K L     Q +K   +E+ +   L H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 106
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G++   D     +  EL    SL   LH         + E R  +      G  YLH +
Sbjct: 107 HGFFEDNDFV--FVVLELCRRRSLLE-LHK--RRKALTEPEARYYLR-QIVLGCQYLHRN 160
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR---VMGTFGYVAPE- 274
               VIHRD K  N+ L  +   K+ DFGLA      +  Y   R   + GT  Y+APE 
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLAT-----KVEYDGERKKVLCGTPNYIAPEV 212
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
            +  GH   + DV+S G ++  LL G+ P + S
Sbjct: 213 LSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYY 162
           +G+G FG V++G    G  VA+K  +    + ++ +  E E+     L H N++  +   
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 91
Query: 163 SSRDS---SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED- 218
            ++D+   +Q  L  +   +GSL  +L+        +  E  +K+AL  A GLA+LH + 
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 146
Query: 219 ----SQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVA 272
                +P + HRD K+ NIL++ N    +AD GLA    +     +      +GT  Y+A
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 273 PEY----AMTGHL--LVKSDVYSYGVVLLEL 297
           PE         H     ++D+Y+ G+V  E+
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 104 ILGEGGFGRVFKGVLSDGTAV-----AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            LG+GGF + F+   +D   V       K L     Q +K   +E+ +   L H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 82
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G++   D     +  EL    SL   LH         + E R  +      G  YLH +
Sbjct: 83  HGFFEDNDFV--FVVLELCRRRSLLE-LHK--RRKALTEPEARYYLR-QIVLGCQYLHRN 136
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR---VMGTFGYVAPE- 274
               VIHRD K  N+ L  +   K+ DFGLA      +  Y   R   + GT  Y+APE 
Sbjct: 137 R---VIHRDLKLGNLFLNEDLEVKIGDFGLAT-----KVEYDGERKKTLCGTPNYIAPEV 188
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
            +  GH   + DV+S G ++  LL G+ P + S
Sbjct: 189 LSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEV-EMLSRLHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V++ E+   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKEIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + +V DFGLAK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 104 ILGEGGFGRVFKGVLSDGTAV-----AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            LG+GGF + F+   +D   V       K L     Q +K   +E+ +   L H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 82
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G++   D     +  EL    SL   LH         + E R  +      G  YLH +
Sbjct: 83  HGFFEDNDFV--FVVLELCRRRSLLE-LHK--RRKALTEPEARYYLR-QIVLGCQYLHRN 136
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR---VMGTFGYVAPE- 274
               VIHRD K  N+ L  +   K+ DFGLA      +  Y   R   + GT  Y+APE 
Sbjct: 137 R---VIHRDLKLGNLFLNEDLEVKIGDFGLAT-----KVEYDGERKKTLCGTPNYIAPEV 188
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
            +  GH   + DV+S G ++  LL G+ P + S
Sbjct: 189 LSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 77/170 (45%), Gaps = 18/170 (10%)
Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-L 196
           +E   E+ +L  L H N++KL   +   D     L  E    G L   +     +N H  
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFE--DKKYFYLVTEFYEGGELFEQI-----INRHKF 143
Query: 197 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFGLAKQAP 253
           D      I      G+ YLH+ +   ++HRD K  NILLEN     + K+ DFGL+    
Sbjct: 144 DECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +   +Y     +GT  Y+APE  +      K DV+S GV++  LL G  P
Sbjct: 201 K---DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYY 162
           +G+G FG V++G    G  VA+K  +    + ++ +  E E+     L H N++  +   
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA- 68
Query: 163 SSRDS---SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED- 218
            ++D+   +Q  L  +   +GSL  +L+        +  E  +K+AL  A GLA+LH + 
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 123
Query: 219 ----SQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVA 272
                +P + HRD K+ NIL++ N    +AD GLA    +     +      +GT  Y+A
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 273 PEY----AMTGHL--LVKSDVYSYGVVLLEL 297
           PE         H     ++D+Y+ G+V  E+
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 114
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 170
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 171 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 222
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 96  TNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH 151
           ++ ++    LG G +G V     K   ++     IK+ +          L EV +L +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSL--ESWLHGPLGVNCHLDWETRMKIALDAA 209
           H N++KL  ++   D   + L  E+   G L  E  L         +D    MK  L   
Sbjct: 63  HPNIMKLYEFFE--DKRNYYLVMEVYRGGELFDEIILRQKFS---EVDAAVIMKQVL--- 114
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLSTRVMG 266
            G  YLH+ +   ++HRD K  N+LLE+       K+ DFGL+     G    +  R +G
Sbjct: 115 SGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKER-LG 168
Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           T  Y+APE  +      K DV+S GV+L  LL G  P
Sbjct: 169 TAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP 204

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYY 162
           +G+G  G V+  + ++ G  VAI+++    QQ  KE ++ E+ ++    + N+V  +  Y
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              D  +  +  E +  GSL   +         +D      +  +  + L +LH +    
Sbjct: 88  LVGD--ELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ--- 137
Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           VIHR+ K+ NILL  +   K+ DFG   Q  PE       + ++GT  ++APE       
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAY 194
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
             K D++S G++ +E++ G  P
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 99  FEPASILGEGGFGRVFKGVLSDG-TAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           +E    +GEG +G VFK    +    VA+KR  L    +      L E+ +L  L H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           V+L     S    +  L +E   +  L+ +       N  LD E          +GL + 
Sbjct: 64  VRLHDVLHS--DKKLTLVFEFC-DQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H  +   V+HRD K  N+L+  N   K+ADFGLA+        Y +  V  T  Y  P+ 
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDV 172
Query: 276 AMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
                L   S D++S G +  EL    +P+
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 86
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E VP G + S L     +    +   R   A  
Sbjct: 87  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR---IGRFSEPHARF-YAAQ 142
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 143 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 194
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 195 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           + + V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 95  IQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + KVADFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 104 ILGEGGFGRVFKGVLSDGTAV-----AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            LG+GGF + F+   +D   V       K L     Q +K   +E+ +   L H+++V  
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF 80
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G++   D     +  EL    SL   LH         + E R  +      G  YLH +
Sbjct: 81  HGFFEDNDFV--FVVLELCRRRSLLE-LHK--RRKALTEPEARYYLR-QIVLGCQYLHRN 134
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR---VMGTFGYVAPE- 274
               VIHRD K  N+ L  +   K+ DFGLA      +  Y   R   + GT  Y+APE 
Sbjct: 135 R---VIHRDLKLGNLFLNEDLEVKIGDFGLAT-----KVEYDGERKKVLCGTPNYIAPEV 186
Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
            +  GH   + DV+S G ++  LL G+ P + S
Sbjct: 187 LSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           L E   G ++KG    G  + +K L       +  ++F  E   L    H N++ ++G  
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
            S  +    L    +P GSL + LH   G N  +D    +K ALD ARG+A+LH   +P 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPL 133
Query: 223 VIHRDFKASNILLENNFHAKV--ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
           +      + +++++ +  A++  AD   + Q+P GR        M    +VAPE      
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSP-GR--------MYAPAWVAPEALQKKP 184
Query: 281 LLVK---SDVYSYGVVLLELLTGRKP 303
                  +D++S+ V+L EL+T   P
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 94  EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRL 150
           E   NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           +H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +
Sbjct: 67  NHPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQ 121
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GLA+ H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y
Sbjct: 122 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 176
Query: 271 VAPEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
            APE  +   +     D++S G +  E++T R
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 94  EATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRL 150
           E   NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           +H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +
Sbjct: 67  NHPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQ 121
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           GLA+ H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y
Sbjct: 122 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWY 176
Query: 271 VAPEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
            APE  +   +     D++S G +  E++T R
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + +L+ G  VAIK +  T       ++   EV ++  L+H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG +      + E R K        
Sbjct: 75  NIVKLFEVIETEKTL--YLIMEYASGGEVFDYLVAHGRMK-----EKEARSKFR-QIVSA 126
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G          G   Y 
Sbjct: 127 VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYA 180
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 233

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E  P G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + KV DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 98  NFEPASILGEGGFGRV--FKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
           N+     +G+G F +V   + +L+ G  VA+K +  T       ++   EV +   L+H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           N+VKL     +  +    L  E    G +  +L  HG        + E R K        
Sbjct: 74  NIVKLFEVIETEKTL--YLVXEYASGGEVFDYLVAHGRXK-----EKEARAKFR-QIVSA 125
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G  N L     G   Y 
Sbjct: 126 VQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFG--NKLDA-FCGAPPYA 179
Query: 272 APE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           APE +    +   + DV+S GV+L  L++G  P D     GQ NL      +LR K R+
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-----GQ-NLKELRERVLRGKYRI 232

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+ + +L         +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQ------VIQMELDHERMSYLLYQMLV 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 93/222 (41%), Gaps = 14/222 (6%)
Query: 105 LGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNLVKLVGYY 162
           LG G FG V      S G    IK +     Q   E +  E+E+L  L H N++K+   +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
              D     +  E    G L   +         L      ++       LAY H      
Sbjct: 90  --EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--- 144
Query: 223 VIHRDFKASNILLENNF-HA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG 279
           V+H+D K  NIL ++   H+  K+ DFGLA+     +++  ST   GT  Y+APE     
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF---KSDEHSTNAAGTALYMAPE-VFKR 200
Query: 280 HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 321
            +  K D++S GVV+  LLTG  P   +     +   T+  P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 97  NNFEPASILGEGGFGRVFK----GVLSDGTA--VAIKRLTCGGQQGDKEFLV-EVEMLSR 149
           N       LG G FG+V +    G++    A  VA+K L       ++E L+ E+++LS 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 150 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRM----- 202
           L +H N+V L+G  +       L+  E    G L ++L        C       M     
Sbjct: 99  LGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 156
Query: 203 --------KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                     +   A+G+A+L   S+ C IHRD  A NILL +    K+ DFGLA+    
Sbjct: 157 ALDLEDLLSFSYQVAKGMAFLA--SKNC-IHRDLAARNILLTHGRITKICDFGLARDIKN 213
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                +         ++APE         +SDV+SYG+ L EL + G  P
Sbjct: 214 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 263

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 105 LGEGGFGR-VFKGVLSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +GEG FG+ +      DG    IK +       +  +E   EV +L+ + H N+V+   Y
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ---Y 88
Query: 162 YSSRDSSQHL-LCYELVPNGSLESWLHGPLGV----NCHLDWETRMKIALDAARGLAYLH 216
             S + +  L +  +    G L   ++   GV    +  LDW  ++ +AL       ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK------HVH 142
Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
           +     ++HRD K+ NI L  +   ++ DFG+A+      T  L+   +GT  Y++PE  
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEIC 197
Query: 277 MTGHLLVKSDVYSYGVVLLELLT 299
                  KSD+++ G VL EL T
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCT 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+ + +L         +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQ------VIQMELDHERMSYLLYQMLV 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 120/300 (40%), Gaps = 46/300 (15%)
Query: 97  NNFEPASILGEGGFGRVFK----GVLSDGTA--VAIKRLTCGGQQGDKEFLV-EVEMLSR 149
           N       LG G FG+V +    G++    A  VA+K L       ++E L+ E+++LS 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 150 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRM----- 202
           L +H N+V L+G  +       L+  E    G L ++L        C       M     
Sbjct: 83  LGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 203 --------KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                     +   A+G+A+L   S+ C IHRD  A NILL +    K+ DFGLA+    
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLA--SKNC-IHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQ 312
                +         ++APE         +SDV+SYG+ L EL + G  P   M   S  
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             ++     +L  +    E+ D                 I   C   +  +RPT  ++VQ
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPTFKQIVQ 300

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 122/303 (40%), Gaps = 46/303 (15%)
Query: 97  NNFEPASILGEGGFGRVFK----GVLSDGTA--VAIKRLTCGGQQGDKEFLV-EVEMLSR 149
           N       LG G FG+V +    G++    A  VA+K L       ++E L+ E+++LS 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 150 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRM----- 202
           L +H N+V L+G  +       L+  E    G L ++L        C       M     
Sbjct: 106 LGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 203 --------KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                     +   A+G+A+L   S+ C IHRD  A NILL +    K+ DFGLA+    
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFL--ASKNC-IHRDLAARNILLTHGRITKICDFGLARHIKN 220
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQ 312
                +         ++APE         +SDV+SYG+ L EL + G  P   M   S  
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             ++     +L  +    E+ D                 I   C   +  +RPT  ++VQ
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPTFKQIVQ 323
Query: 373 SLK 375
            ++
Sbjct: 324 LIE 326

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 98  NFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRN 154
            +E    +GEG +G VFK    D G  VAIK+           K  L E+ ML +L H N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           LV L+  +  R    HL+ +E   +  L        GV  HL       I     + + +
Sbjct: 64  LVNLLEVFR-RKRRLHLV-FEYCDHTVLHELDRYQRGVPEHL----VKSITWQTLQAVNF 117
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H+ +    IHRD K  NIL+  +   K+ DFG A+    G ++Y    V  T  Y +PE
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEV-ATRWYRSPE 172
Query: 275 YAMTGHLLVKS-------DVYSYGVVLLELLTG 300
                 LLV         DV++ G V  ELL+G
Sbjct: 173 ------LLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 97  NNFEPASILGEGGFGRVFK----GVLSDGTA--VAIKRLTCGGQQGDKEFLV-EVEMLSR 149
           N       LG G FG+V +    G++    A  VA+K L       ++E L+ E+++LS 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 150 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRM----- 202
           L +H N+V L+G  +       L+  E    G L ++L        C       M     
Sbjct: 101 LGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 158
Query: 203 --------KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                     +   A+G+A+L   S+ C IHRD  A NILL +    K+ DFGLA+    
Sbjct: 159 ALDLEDLLSFSYQVAKGMAFL--ASKNC-IHRDLAARNILLTHGRITKICDFGLARDIKN 215
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                +         ++APE         +SDV+SYG+ L EL + G  P
Sbjct: 216 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 265

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E V +  L++++         L         L   +GLA+
Sbjct: 63  IVKLLDVIHTEN--KLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQL--LQGLAF 117
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 172
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L ++ H N++ L   Y +R  +  +L  ELV  G L  +L     ++   +  + +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKESLSEE-EATSFI 121
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           K  LD   G+ YLH      + H D K  NI LL+ N    H K+ DFGLA +  +G   
Sbjct: 122 KQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE- 174
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 68  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 122
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 123 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 177
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +GEG +G V+K   + G   A+K  RL    +      + E+ +L  L H N+VKL  Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH--LDWETRMKIALDAARGLAYLHEDSQ 220
                 + +L +E      L+  L   L V C   L+  T     L    G+AY H+   
Sbjct: 68  VIHTKKRLVLVFE-----HLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TG 279
             V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y AP+  M + 
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSK 176
Query: 280 HLLVKSDVYSYGVVLLELLTG 300
                 D++S G +  E++ G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L++++         L         L   +G
Sbjct: 64  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQL--LQG 118
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 119 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L ++ H N++ L   Y +R  +  +L  ELV  G L  +L     ++   +  + +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKESLSEE-EATSFI 121
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           K  LD   G+ YLH      + H D K  NI LL+ N    H K+ DFGLA +  +G   
Sbjct: 122 KQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE- 174
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 122/303 (40%), Gaps = 46/303 (15%)
Query: 97  NNFEPASILGEGGFGRVFK----GVLSDGTA--VAIKRLTCGGQQGDKEFLV-EVEMLSR 149
           N       LG G FG+V +    G++    A  VA+K L       ++E L+ E+++LS 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 150 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPL-GVNCHLDWETRM----- 202
           L +H N+V L+G  +       L+  E    G L ++L        C       M     
Sbjct: 106 LGNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 163
Query: 203 --------KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                     +   A+G+A+L   S+ C IHRD  A NILL +    K+ DFGLA+    
Sbjct: 164 ALDLEDLLSFSYQVAKGMAFLA--SKNC-IHRDLAARNILLTHGRITKICDFGLARDIKN 220
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPV-DMSQPSGQ 312
                +         ++APE         +SDV+SYG+ L EL + G  P   M   S  
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             ++     +L  +    E+ D                 I   C   +  +RPT  ++VQ
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPTFKQIVQ 323
Query: 373 SLK 375
            ++
Sbjct: 324 LIE 326

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 64  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 118
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 173
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 62  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 116
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y 
Sbjct: 117 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 171
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L ++ H N++ L   Y +R  +  +L  ELV  G L  +L     ++   +  + +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKESLSEE-EATSFI 121
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           K  LD   G+ YLH      + H D K  NI LL+ N    H K+ DFGLA +  +G   
Sbjct: 122 KQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE- 174
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 64  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 118
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 173
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 63  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 117
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 172
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 63  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 117
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 172
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +GEG +G V+K   + G   A+K  RL    +      + E+ +L  L H N+VKL  Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH--LDWETRMKIALDAARGLAYLHEDSQ 220
                 + +L +E      L+  L   L V C   L+  T     L    G+AY H+   
Sbjct: 68  VIHTKKRLVLVFE-----HLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TG 279
             V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y AP+  M + 
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSK 176
Query: 280 HLLVKSDVYSYGVVLLELLTG 300
                 D++S G +  E++ G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +GEG +G V+K   + G   A+K  RL    +      + E+ +L  L H N+VKL  Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH--LDWETRMKIALDAARGLAYLHEDSQ 220
                 + +L +E      L+  L   L V C   L+  T     L    G+AY H+   
Sbjct: 68  VIHTKKRLVLVFE-----HLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TG 279
             V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y AP+  M + 
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPDVLMGSK 176
Query: 280 HLLVKSDVYSYGVVLLELLTG 300
                 D++S G +  E++ G
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNG 197

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L ++ H N++ L   Y +R  +  +L  ELV  G L  +L     ++   +  + +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKESLSEE-EATSFI 121
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           K  LD   G+ YLH      + H D K  NI LL+ N    H K+ DFGLA +  +G   
Sbjct: 122 KQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE- 174
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 64  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 118
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 173
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L ++ H N++ L   Y +R  +  +L  ELV  G L  +L     ++   +  + +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENR--TDVVLILELVSGGELFDFLAQKESLSEE-EATSFI 121
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           K  LD   G+ YLH      + H D K  NI LL+ N    H K+ DFGLA +  +G   
Sbjct: 122 KQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE- 174
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLV------EVEMLSRLHHRNLVK 157
           LG G FG+V  G     G  VA+K L    +Q  +   V      E++ L    H +++K
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYL 215
           L    S+   +   +  E V  G L  ++  HG +      + E R ++       + Y 
Sbjct: 76  LYQVIST--PTDFFMVMEYVSGGELFDYICKHGRVE-----EMEAR-RLFQQILSAVDYC 127
Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H   +  V+HRD K  N+LL+ + +AK+ADFGL+    +G   +L     G+  Y APE 
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRDSC-GSPNYAAPE- 180
Query: 276 AMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 305
            ++G L    + D++S GV+L  LL G  P D
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E+E+L +L+H  ++K+  ++ + D   + +  EL+  G L   + G    N  L   T  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVG----NKRLKEATCK 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNY 259
                    + YLHE+    +IHRD K  N+LL   E +   K+ DFG +K    G T+ 
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 172
Query: 260 LSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ-------- 308
           + T + GT  Y+APE  +   T       D +S GV+L   L+G  P    +        
Sbjct: 173 MRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 309 -PSGQENLV--TWARPILRDKDRLEEL--ADPRLGGKYPKEDFIR 348
             SG+ N +   WA    +  D +++L   DP+   ++  E+ +R
Sbjct: 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK--ARFTTEEALR 274

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L ++ H N++ L   Y +R  +  +L  ELV  G L  +L     ++   +  + +
Sbjct: 65  EVSILRQVLHPNIITLHDVYENR--TDVVLILELVSGGELFDFLAQKESLSEE-EATSFI 121
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           K  LD   G+ YLH      + H D K  NI LL+ N    H K+ DFGLA +  +G   
Sbjct: 122 KQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE- 174
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 64  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 118
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 119 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 63  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 117
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 118 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 61  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 115
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E+E+L +L+H  ++K+  ++ + D   + +  EL+  G L   + G    N  L   T  
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVG----NKRLKEATCK 116
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNY 259
                    + YLHE+    +IHRD K  N+LL   E +   K+ DFG +K    G T+ 
Sbjct: 117 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 171
Query: 260 LSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ-------- 308
           + T + GT  Y+APE  +   T       D +S GV+L   L+G  P    +        
Sbjct: 172 MRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 230
Query: 309 -PSGQENLV--TWARPILRDKDRLEEL--ADPRLGGKYPKEDFIR 348
             SG+ N +   WA    +  D +++L   DP+   ++  E+ +R
Sbjct: 231 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK--ARFTTEEALR 273

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 61  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 115
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E V +  L+ ++         L         L   +G
Sbjct: 64  HPNIVKLLDVIHTEN--KLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 118
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 119 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + FE    LG G FGRV     +  G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 61  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 115
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 61  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL--LQG 115
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 116 LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E+E+L +L+H  ++K+  ++ + D   + +  EL+  G L   + G    N  L   T  
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVG----NKRLKEATCK 123
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNY 259
                    + YLHE+    +IHRD K  N+LL   E +   K+ DFG +K    G T+ 
Sbjct: 124 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 178
Query: 260 LSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ-------- 308
           + T + GT  Y+APE  +   T       D +S GV+L   L+G  P    +        
Sbjct: 179 MRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 237
Query: 309 -PSGQENLV--TWARPILRDKDRLEEL--ADPRLGGKYPKEDFIR 348
             SG+ N +   WA    +  D +++L   DP+   ++  E+ +R
Sbjct: 238 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK--ARFTTEEALR 280

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 63  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 117
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 118 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E+E+L +L+H  ++K+  ++ + D   + +  EL+  G L   + G    N  L   T  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVG----NKRLKEATCK 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNY 259
                    + YLHE+    +IHRD K  N+LL   E +   K+ DFG +K    G T+ 
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 172
Query: 260 LSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ-------- 308
           + T + GT  Y+APE  +   T       D +S GV+L   L+G  P    +        
Sbjct: 173 MRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 309 -PSGQENLV--TWARPILRDKDRLEEL--ADPRLGGKYPKEDFIR 348
             SG+ N +   WA    +  D +++L   DP+   ++  E+ +R
Sbjct: 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK--ARFTTEEALR 274

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E+E+L +L+H  ++K+  ++ + D   + +  EL+  G L   + G    N  L   T  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVG----NKRLKEATCK 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNY 259
                    + YLHE+    +IHRD K  N+LL   E +   K+ DFG +K    G T+ 
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 172
Query: 260 LSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ-------- 308
           + T + GT  Y+APE  +   T       D +S GV+L   L+G  P    +        
Sbjct: 173 MRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 309 -PSGQENLV--TWARPILRDKDRLEEL--ADPRLGGKYPKEDFIR 348
             SG+ N +   WA    +  D +++L   DP+   ++  E+ +R
Sbjct: 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK--ARFTTEEALR 274

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 110/268 (41%), Gaps = 42/268 (15%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD-----------KE 139
           EL    + +     +  G +G V  GV S+G  VAIKR+      G            K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 140 FLVEVEMLSRLHHRNLVKLVGYYSS-RDSSQH--LLCYELVPNGSLESWLHGPLGVNCHL 196
            L E+ +L+  HH N++ L   +    + + H   L  EL+    L   +H    V    
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ 134
Query: 197 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APE 254
             +  M   L    GL  LHE     V+HRD    NILL +N    + DF LA++  A  
Sbjct: 135 HIQYFMYHIL---LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVK-SDVYSYGVVLLELLTGR------------ 301
            +T+Y++ R      Y APE  M      K  D++S G V+ E+   +            
Sbjct: 189 NKTHYVTHR-----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 302 -KPVDMSQPSGQENLVTWARPILRDKDR 328
            K V++      E++V ++ P  RD  R
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLR 271

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 110/268 (41%), Gaps = 42/268 (15%)
Query: 91  ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD-----------KE 139
           EL    + +     +  G +G V  GV S+G  VAIKR+      G            K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 140 FLVEVEMLSRLHHRNLVKLVGYYSS-RDSSQH--LLCYELVPNGSLESWLHGPLGVNCHL 196
            L E+ +L+  HH N++ L   +    + + H   L  EL+    L   +H    V    
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ 134
Query: 197 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APE 254
             +  M   L    GL  LHE     V+HRD    NILL +N    + DF LA++  A  
Sbjct: 135 HIQYFMYHIL---LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVK-SDVYSYGVVLLELLTGR------------ 301
            +T+Y++ R      Y APE  M      K  D++S G V+ E+   +            
Sbjct: 189 NKTHYVTHR-----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 302 -KPVDMSQPSGQENLVTWARPILRDKDR 328
            K V++      E++V ++ P  RD  R
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLR 271

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 19/158 (12%)
Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKL--- 158
           +L EGGF  V++   +  G   A+KRL    ++ ++  + EV  + +L  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 159 --VGYYSSRDSSQHLLCYELVPNGSLESWL-----HGPLGVNCHLDWETRMKIALDAARG 211
             +G   S       L    +  G L  +L      GPL  +      T +KI     R 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD------TVLKIFYQTCRA 148
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
           + ++H   +P +IHRD K  N+LL N    K+ DFG A
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 63  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 117
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 118 LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 63  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 117
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y APE
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 172
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 62  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 116
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 117 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 171
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 64  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 118
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 119 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 64  HPNIVKLLDVIHTEN--KLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL--LQG 118
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 119 LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 65  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 119
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 120 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 174
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 64  HPNIVKLLDVIHTEN--KLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQG 118
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 119 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 61  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 115
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 170
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 62  HPNIVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQG 116
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 117 LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 171
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 63  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 117
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y APE
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 172
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 96  TNNFEPASILGEGGFGRVFKGVLSDGTA--VAIKRLTCGGQQGDKEFL-VEVEMLSRLHH 152
           ++ FE  S LG G    V++     GT    A+K L    +  DK+ +  E+ +L RL H
Sbjct: 52  SDFFEVESELGRGATSIVYR-CKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSH 107
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
            N++KL   + +   ++  L  ELV  G L   +    G     D    +K  L+A   +
Sbjct: 108 PNIIKLKEIFET--PTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEA---V 161
Query: 213 AYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
           AYLHE+    ++HRD K  N+L      +   K+ADFGL+K         L   V GT G
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPG 215
Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           Y APE         + D++S G++   LL G +P
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 99  FEPASILGEGGFGRVFKGVLSDG-TAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           +E    +GEG +G VFK    +    VA+KR  L    +      L E+ +L  L H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           V+L     S    +  L +E   +  L+ +       N  LD E          +GL + 
Sbjct: 64  VRLHDVLHS--DKKLTLVFEFC-DQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H  +   V+HRD K  N+L+  N   K+A+FGLA+        Y +  V  T  Y  P+ 
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDV 172
Query: 276 AMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
                L   S D++S G +  EL    +P+
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L YLHE     +I+RD K  N+LL++  H K+ D+G+ K+    R    ++   GT  Y
Sbjct: 165 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNY 219
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 306
           +APE           D ++ GV++ E++ GR P D+
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 62  HPNIVKLLDVIHTEN--KLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL--LQG 116
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 117 LAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 171
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L YLHE     +I+RD K  N+LL++  H K+ D+G+ K+    R    ++   GT  Y
Sbjct: 133 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSXFCGTPNY 187
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 306
           +APE           D ++ GV++ E++ GR P D+
Sbjct: 188 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 223

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVG-- 160
           +G+G +G V+ G    G  VA+K      +     +  E E+     + H N++  +   
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHENILGFIAAD 100
Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-- 218
              +   +Q  L  +   NGSL  +L      +  LD ++ +K+A  +  GL +LH +  
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 219 ---SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL----STRVMGTFGYV 271
               +P + HRD K+ NIL++ N    +AD GLA +     TN +    +TRV GT  Y+
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD-TNEVDIPPNTRV-GTKRYM 213
Query: 272 APEY----AMTGHL--LVKSDVYSYGVVLLEL 297
            PE         H    + +D+YS+G++L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 95  ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLH 151
           +  NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL+    + +  +  L +E + +  L+ ++         L         L   +G
Sbjct: 63  HPNIVKLLDVIHTEN--KLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQG 117
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LA+ H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y 
Sbjct: 118 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE  +   +     D++S G +  E++T R
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 65  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 119
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y    V  T  Y APE
Sbjct: 120 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 77/177 (43%), Gaps = 20/177 (11%)
Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
           E  +  +   ARG+ +L   S+ C IHRD  A NILL  N   K+ DFGLA+   +    
Sbjct: 199 EDLISYSFQVARGMEFLS--SRKC-IHRDLAARNILLSENNVVKICDFGLARDIYKNPDY 255
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVT 317
                      ++APE         KSDV+SYGV+L E+ + G  P     P  Q +   
Sbjct: 256 VRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPY----PGVQMDEDF 311
Query: 318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
            +R  LR+  R+          + P+     +  I   C   +  +RP   E+V+ L
Sbjct: 312 CSR--LREGMRM----------RAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKGVLS-DGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GL++
Sbjct: 64  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLSF 118
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 173
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L YLHE     +I+RD K  N+LL++  H K+ D+G+ K+    R    ++   GT  Y
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSXFCGTPNY 176
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 306
           +APE           D ++ GV++ E++ GR P D+
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 5/96 (5%)
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
            L YLHE     +I+RD K  N+LL++  H K+ D+G+ K+    R    ++   GT  Y
Sbjct: 118 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSXFCGTPNY 172
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDM 306
           +APE           D ++ GV++ E++ GR P D+
Sbjct: 173 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 208

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQV-------IQMELDHERMSYLLYQMLX 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKG---VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K    +  +  A+   RL    +      + E+ +L  L+H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 64  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 118
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 173
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 98  NFEPASILGEGGFGRVFKG---VLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K    +  +  A+   RL    +      + E+ +L  L+H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+    + +  +  L +E + +  L+ ++         L         L   +GLA+
Sbjct: 63  IVKLLDVIHTEN--KLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAF 117
Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y  T  + T  Y APE
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 172
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELLTGR 301
             +   +     D++S G +  E++T R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 89  YEELKEATNNFEPASILGEGGFGRVFKGVLSDGT----AVAIK---RLTCGGQQGDKEFL 141
           +++ ++  + ++   +LG G F  V   +L++       VAIK   +    G++G  E  
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSME-- 64
Query: 142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
            E+ +L ++ H N+V L   Y   +S  HL L  +LV  G L   +    G     D   
Sbjct: 65  NEIAVLHKIKHPNIVALDDIY---ESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASR 120
Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL---LENNFHAKVADFGLAKQAPEGRT 257
            +   LDA +   YLH+     ++HRD K  N+L   L+ +    ++DFGL+K    G  
Sbjct: 121 LIFQVLDAVK---YLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             LST   GT GYVAPE           D +S GV+   LL G  P
Sbjct: 175 --LST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 89  YEELKEATNNFEPASILGEGGFGRVFKGVLSDGT----AVAIK---RLTCGGQQGDKEFL 141
           +++ ++  + ++   +LG G F  V   +L++       VAIK   +    G++G  E  
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSME-- 64
Query: 142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
            E+ +L ++ H N+V L   Y   +S  HL L  +LV  G L   +    G     D   
Sbjct: 65  NEIAVLHKIKHPNIVALDDIY---ESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASR 120
Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL---LENNFHAKVADFGLAKQAPEGRT 257
            +   LDA +   YLH+     ++HRD K  N+L   L+ +    ++DFGL+K    G  
Sbjct: 121 LIFQVLDAVK---YLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             LST   GT GYVAPE           D +S GV+   LL G  P
Sbjct: 175 --LST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 89  YEELKEATNNFEPASILGEGGFGRVFKGVLSDGT----AVAIK---RLTCGGQQGDKEFL 141
           +++ ++  + ++   +LG G F  V   +L++       VAIK   +    G++G  E  
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSME-- 64
Query: 142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
            E+ +L ++ H N+V L   Y   +S  HL L  +LV  G L   +    G     D   
Sbjct: 65  NEIAVLHKIKHPNIVALDDIY---ESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASR 120
Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL---LENNFHAKVADFGLAKQAPEGRT 257
            +   LDA +   YLH+     ++HRD K  N+L   L+ +    ++DFGL+K    G  
Sbjct: 121 LIFQVLDAVK---YLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             LST   GT GYVAPE           D +S GV+   LL G  P
Sbjct: 175 --LST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E+E+L +L+H  ++K+  ++   D+  + +  EL+  G L   + G    N  L   T  
Sbjct: 190 EIEILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVG----NKRLKEATCK 242
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNY 259
                    + YLHE+    +IHRD K  N+LL   E +   K+ DFG +K    G T+ 
Sbjct: 243 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 297
Query: 260 LSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ-------- 308
           + T + GT  Y+APE  +   T       D +S GV+L   L+G  P    +        
Sbjct: 298 MRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 356
Query: 309 -PSGQENLV--TWARPILRDKDRLEEL--ADPRLGGKYPKEDFIR 348
             SG+ N +   WA    +  D +++L   DP+   ++  E+ +R
Sbjct: 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK--ARFTTEEALR 399

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+ + +L         +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQ------VIQMELDHERMSYLLYQMLV 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 89  YEELKEATNNFEPASILGEGGFGRVFKGVLSDGT----AVAIK---RLTCGGQQGDKEFL 141
           +++ ++  + ++   +LG G F  V   +L++       VAIK   +    G++G  E  
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSME-- 64
Query: 142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
            E+ +L ++ H N+V L   Y   +S  HL L  +LV  G L   +    G     D   
Sbjct: 65  NEIAVLHKIKHPNIVALDDIY---ESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASR 120
Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL---LENNFHAKVADFGLAKQAPEGRT 257
            +   LDA +   YLH+     ++HRD K  N+L   L+ +    ++DFGL+K    G  
Sbjct: 121 LIFQVLDAVK---YLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174
Query: 258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             LST   GT GYVAPE           D +S GV+   LL G  P
Sbjct: 175 --LST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 34/225 (15%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E+E+L +L+H  ++K+  ++ + D   + +  EL+  G L   + G    N  L   T  
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAED---YYIVLELMEGGELFDKVVG----NKRLKEATCK 256
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNY 259
                    + YLHE+    +IHRD K  N+LL   E +   K+ DFG +K    G T+ 
Sbjct: 257 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 311
Query: 260 LSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ-------- 308
           + T + GT  Y+APE  +   T       D +S GV+L   L+G  P    +        
Sbjct: 312 MRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 370
Query: 309 -PSGQENLV--TWARPILRDKDRLEEL--ADPRLGGKYPKEDFIR 348
             SG+ N +   WA    +  D +++L   DP+   ++  E+ +R
Sbjct: 371 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK--ARFTTEEALR 413

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 16/212 (7%)
Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH 152
           N FE   +LG+G FG+V     K          +K+     +      L E  +L    H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             L  L   + + D     LC+ +      E + H  L        +       +    L
Sbjct: 208 PFLTALKYSFQTHDR----LCFVMEYANGGELFFH--LSRERVFSEDRARFYGAEIVSAL 261
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFGYV 271
            YLH  S+  V++RD K  N++L+ + H K+ DFGL K   EG  +  + +   GT  Y+
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYL 316
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE           D +  GVV+ E++ GR P
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 16/212 (7%)
Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH 152
           N FE   +LG+G FG+V     K          +K+     +      L E  +L    H
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             L  L   + + D     LC+ +      E + H  L        +       +    L
Sbjct: 211 PFLTALKYSFQTHDR----LCFVMEYANGGELFFH--LSRERVFSEDRARFYGAEIVSAL 264
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-GTFGYV 271
            YLH  S+  V++RD K  N++L+ + H K+ DFGL K   EG  +  + +   GT  Y+
Sbjct: 265 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYL 319
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE           D +  GVV+ E++ GR P
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+     +        +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L+    GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLA----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 114
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFXEPHARF-YAAQ 170
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 171 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 222
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 88
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 89  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFXEPHARF-YAAQ 144
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 145 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 196
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 197 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+     +        +   LD E    +      
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 138
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S G ++ E++ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFXEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFXEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFXEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+ + +L         +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQ------VIQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 104 ILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            LG+GGF + ++    D        V  K +     Q +K    E+ +   L + ++V  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGF 107
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G++   D    +L  E+    SL   LH         +    M+  +   +G+ YLH +
Sbjct: 108 HGFFEDDDFVYVVL--EICRRRSLLE-LHKRRKAVTEPEARYFMRQTI---QGVQYLHNN 161
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP-EGRTNYLSTRVMGTFGYVAPEYAM 277
               VIHRD K  N+ L ++   K+ DFGLA +   +G        + GT  Y+APE   
Sbjct: 162 R---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KXLCGTPNYIAPEVLC 215
Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
                 + D++S G +L  LL G+ P + S
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+     +        +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQV-------IQMELDHERMSYLLYQMLX 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQV-------IQMELDHERMSYLLYQMLX 130
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 28/227 (12%)
Query: 94  EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEML 147
           +  + +E  + +G+G FG VFK      G  VA+K++     + +KE      L E+++L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKIL 71
Query: 148 SRLHHRNLVKLVGYYSSRDSSQH------LLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
             L H N+V L+    ++ S  +       L ++   +  L   L   L      + +  
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 130
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---APEGRTN 258
           M++ L+   GL Y+H +    ++HRD KA+N+L+  +   K+ADFGLA+    A   + N
Sbjct: 131 MQMLLN---GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPV 304
               RV+ T  Y  PE  +         D++  G ++ E+ T R P+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFAEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 104 ILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            LG+GGF + ++    D        V  K +     Q +K    E+ +   L + ++V  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGF 107
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G++   D    +L  E+    SL   LH         +    M+  +   +G+ YLH +
Sbjct: 108 HGFFEDDDFVYVVL--EICRRRSLLE-LHKRRKAVTEPEARYFMRQTI---QGVQYLHNN 161
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP-EGRTNYLSTRVMGTFGYVAPEYAM 277
               VIHRD K  N+ L ++   K+ DFGLA +   +G        + GT  Y+APE   
Sbjct: 162 R---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTPNYIAPEVLC 215
Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
                 + D++S G +L  LL G+ P + S
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+     +        +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 104 ILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
            LG+GGF + ++    D        V  K +     Q +K    E+ +   L + ++V  
Sbjct: 49  FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGF 107
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G++   D    +L  E+    SL   LH         +    M+  +   +G+ YLH +
Sbjct: 108 HGFFEDDDFVYVVL--EICRRRSLLE-LHKRRKAVTEPEARYFMRQTI---QGVQYLHNN 161
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP-EGRTNYLSTRVMGTFGYVAPEYAM 277
               VIHRD K  N+ L ++   K+ DFGLA +   +G        + GT  Y+APE   
Sbjct: 162 R---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KTLCGTPNYIAPEVLC 215
Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
                 + D++S G +L  LL G+ P + S
Sbjct: 216 KKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+ + +L         +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQ------VIQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 77  SLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF--KGVLSDGTAV-----AIKRL 129
           ++ H   T  L     K    NFE   +LG G +G+VF  + +    T        +K+ 
Sbjct: 34  TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93
Query: 130 TCGGQQGDKEFL-VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 188
           T   +    E    E ++L  +     +  + Y    ++  HL+  + +  G L + L  
Sbjct: 94  TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL-DYINGGELFTHLSQ 152
Query: 189 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 248
                 H   E ++ +  +    L +LH   +  +I+RD K  NILL++N H  + DFGL
Sbjct: 153 RERFTEH---EVQIYVG-EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKP 303
           +K+     T   +    GT  Y+AP+      +GH     D +S GV++ ELLTG  P
Sbjct: 206 SKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASP 261

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+ + +L         +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQ------VIQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 107/256 (41%), Gaps = 52/256 (20%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAV----------AIKRLTCGGQQGDKEFLV--EVE 145
           +FE   ++G G FG V    L +   V           +KR      + +++ LV  + +
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 146 MLSRLHH-----RNLVKLVGYYSSRDSSQHLLCYE-LVPNGSLESWLHGPLGVNCHLDWE 199
            ++ LH+      NL  ++ YY   D    L  +E  +P      +L             
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL------------- 181
Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
             M IA+D+   L Y         +HRD K  NIL++ N H ++ADFG   +  E  T  
Sbjct: 182 AEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-V 231
Query: 260 LSTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 314
            S+  +GT  Y++PE   AM    G    + D +S GV + E+L G  P         E+
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF------YAES 285
Query: 315 LVTWARPILRDKDRLE 330
           LV     I+  K+R +
Sbjct: 286 LVETYGKIMNHKERFQ 301

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 86/212 (40%), Gaps = 16/212 (7%)
Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH 152
           N FE   +LG+G FG+V     K          +K+     +      L E  +L    H
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             L  L   + + D     LC+ +      E + H  L        +       +    L
Sbjct: 70  PFLTALKYSFQTHDR----LCFVMEYANGGELFFH--LSRERVFSEDRARFYGAEIVSAL 123
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYV 271
            YLH  S+  V++RD K  N++L+ + H K+ DFGL K+   +G T        GT  Y+
Sbjct: 124 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKXFCGTPEYL 178
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE           D +  GVV+ E++ GR P
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLX----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 86/212 (40%), Gaps = 16/212 (7%)
Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH 152
           N FE   +LG+G FG+V     K          +K+     +      L E  +L    H
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             L  L   + + D     LC+ +      E + H  L        +       +    L
Sbjct: 69  PFLTALKYSFQTHDR----LCFVMEYANGGELFFH--LSRERVFSEDRARFYGAEIVSAL 122
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYV 271
            YLH  S+  V++RD K  N++L+ + H K+ DFGL K+   +G T        GT  Y+
Sbjct: 123 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKXFCGTPEYL 177
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE           D +  GVV+ E++ GR P
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 86/212 (40%), Gaps = 16/212 (7%)
Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH 152
           N FE   +LG+G FG+V     K          +K+     +      L E  +L    H
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             L  L   + + D     LC+ +      E + H  L        +       +    L
Sbjct: 68  PFLTALKYSFQTHDR----LCFVMEYANGGELFFH--LSRERVFSEDRARFYGAEIVSAL 121
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTFGYV 271
            YLH  S+  V++RD K  N++L+ + H K+ DFGL K+   +G T        GT  Y+
Sbjct: 122 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKXFCGTPEYL 176
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE           D +  GVV+ E++ GR P
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 105 LGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGY 161
           LGEG +  V+KG   L+D   VA+K +    ++G     + EV +L  L H N+V L   
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLH--GPLGVNCHLDWETRMKIAL-DAARGLAYLHED 218
             +  S    L +E + +  L+ +L   G + +N H      +K+ L    RGLAY H  
Sbjct: 69  IHTEKSLT--LVFEYL-DKDLKQYLDDCGNI-INMH-----NVKLFLFQLLRGLAYCHRQ 119
Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM- 277
               V+HRD K  N+L+      K+ADFGLA+        Y +  V  T  Y  P+  + 
Sbjct: 120 K---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLG 174
Query: 278 TGHLLVKSDVYSYGVVLLELLTGR 301
           +     + D++  G +  E+ TGR
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 155
           N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N+
Sbjct: 28  NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 156 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           + L+  ++ + + +      L  EL+     +        +   LD E    +      G
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQV-------IQMELDHERMSYLLYQMLCG 138
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
           APE  +        D++S G ++ E      L  GR  +D
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 94
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 150
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 202
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 7/102 (6%)
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A + A GL +L       +I+RD K  N++L++  H K+ADFG+ K   E   + ++T+ 
Sbjct: 448 AAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKX 501
Query: 265 M-GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
             GT  Y+APE           D +++GV+L E+L G+ P +
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP-EGRTNYLSTRVMGTF 268
           +G+ YLH +    VIHRD K  N+ L ++   K+ DFGLA +   +G        + GT 
Sbjct: 137 QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTP 190
Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS 307
            Y+APE         + D++S G +L  LL G+ P + S
Sbjct: 191 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 28/227 (12%)
Query: 94  EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEML 147
           +  + +E  + +G+G FG VFK      G  VA+K++     + +KE      L E+++L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKIL 71
Query: 148 SRLHHRNLVKLVGYYSSRDSSQH------LLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
             L H N+V L+    ++ S  +       L ++   +  L   L   L      + +  
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 130
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---APEGRTN 258
           M++ L+   GL Y+H +    ++HRD KA+N+L+  +   K+ADFGLA+    A   + N
Sbjct: 131 MQMLLN---GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPV 304
               RV+ T  Y  PE  +         D++  G ++ E+ T R P+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 155
           N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N+
Sbjct: 28  NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 156 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           + L+  ++ + + +      L  EL+     +        +   LD E    +      G
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLCG 138
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y 
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG---TSFMMTPYVVTRYYR 192
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
           APE  +        D++S G ++ E      L  GR  +D
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 155
           N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N+
Sbjct: 66  NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 156 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           + L+  ++ + + +      L  EL+     +        +   LD E    +      G
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLCG 176
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y 
Sbjct: 177 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYR 230
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
           APE  +        D++S G ++ E      L  GR  +D
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 28/227 (12%)
Query: 94  EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEML 147
           +  + +E  + +G+G FG VFK      G  VA+K++     + +KE      L E+++L
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKIL 71
Query: 148 SRLHHRNLVKLVGYYSSRDSSQH------LLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
             L H N+V L+    ++ S  +       L ++   +  L   L   L      + +  
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 130
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---APEGRTN 258
           M++ L+   GL Y+H +    ++HRD KA+N+L+  +   K+ADFGLA+    A   + N
Sbjct: 131 MQMLLN---GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPV 304
               RV+ T  Y  PE  +         D++  G ++ E+ T R P+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 107/227 (47%), Gaps = 28/227 (12%)
Query: 94  EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEML 147
           +  + +E  + +G+G FG VFK      G  VA+K++     + +KE      L E+++L
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKIL 70
Query: 148 SRLHHRNLVKLVGYYSSRDSSQH------LLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
             L H N+V L+    ++ S  +       L ++   +  L   L   L      + +  
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---APEGRTN 258
           M++ L+   GL Y+H +    ++HRD KA+N+L+  +   K+ADFGLA+    A   + N
Sbjct: 130 MQMLLN---GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPV 304
               RV+ T  Y  PE  +         D++  G ++ E+ T R P+
Sbjct: 184 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 36/223 (16%)
Query: 102 ASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLV 159
           + +LGEG + +V   V L +G   A+K +             EVE L +   ++N+++L+
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
            ++   D ++  L +E +  GS+ + +        H +     ++  D A  L +LH   
Sbjct: 78  EFF--EDDTRFYLVFEKLQGGSILAHIQK----QKHFNEREASRVVRDVAAALDFLHTKG 131
Query: 220 QPCVIHRDFKASNILLENNFH---AKVADFGLAK----------------QAPEGRTNYL 260
              + HRD K  NIL E+       K+ DF L                    P G   Y+
Sbjct: 132 ---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYM 188
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +  V+  F   A  Y        + D++S GVVL  +L+G  P
Sbjct: 189 APEVVEVFTDQATFYDK------RCDLWSLGVVLYIMLSGYPP 225

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 80
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 81  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 136
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 137 IVLTFEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAKRV-KGRTWXLC----GT 188
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 189 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL-VEVEMLSRLHHRNLVKLVG-Y 161
           ++G G FG VF+  L +   VAIK++       DK F   E++++  + H N+V L   +
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVL-----QDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 162 YSSRDSSQHL---LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL------DAARGL 212
           YS+ D    +   L  E VP     +  H       +   +  M + L         R L
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRH-------YAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           AY+H      + HRD K  N+LL+      K+ DFG AK    G  N      + +  Y 
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSXICSRYYR 208
Query: 272 APEYAM-TGHLLVKSDVYSYGVVLLELLTGR 301
           APE      +     D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 29  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 86
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+     +        +   LD E    +      
Sbjct: 87  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 139
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++    + T  Y
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYY 193
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTG 300
            APE  +        D++S G ++ E++ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 138
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 233

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 105 LGEGGFGRVFKGVLSDGTAV--AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G G +G V K  +  GT +  A K++     +    F  E+E++  L H N+++L  Y 
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL--YE 73
Query: 163 SSRDSSQHLLCYELVPNGSL-ESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           +  D++   L  EL   G L E  +H  +            +I  D    +AY H+ +  
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA-----ARIMKDVLSAVAYCHKLN-- 126
Query: 222 CVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
            V HRD K  N L      +   K+ DFGLA +   G+   + T+V GT  YV+P+  + 
Sbjct: 127 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYVSPQ-VLE 181
Query: 279 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
           G    + D +S GV++  LL G  P   S P+  E ++
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPP--FSAPTDXEVML 217

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 104/239 (43%), Gaps = 26/239 (10%)
Query: 88  AYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEM 146
           A E  ++  + F+   + G+G FG V  G   S G +VAIK++    +  ++E  + ++ 
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQD 72
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR----- 201
           L+ LHH N+V+L  Y+ +         Y  V    +   LH      C  ++  R     
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLH-----RCCRNYYRRQVAPP 127
Query: 202 ---MKIAL-DAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR 256
              +K+ L    R +  LH  S   V HRD K  N+L+ E +   K+ DFG AK+     
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 257 TN--YLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ 312
            N  Y+ +R      Y APE      H     D++S G +  E++ G         +GQ
Sbjct: 187 PNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 131
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 131
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 130
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 232

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNL 155
           N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N+
Sbjct: 66  NLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 156 VKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           + L+  ++ + + +      L  EL+     +        +   LD E    +      G
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLCG 176
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y 
Sbjct: 177 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYR 230
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
           APE  +        D++S G ++ E      L  GR  +D
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 26  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 83
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 84  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 136
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 190
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 231

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  VL     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + + +      L  EL+     +        +   LD E    +      
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 138
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 233

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 105 LGEGGFGRVFKGVLSDGTAV--AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G G +G V K  +  GT +  A K++     +    F  E+E++  L H N+++L  Y 
Sbjct: 34  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL--YE 90
Query: 163 SSRDSSQHLLCYELVPNGSL-ESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           +  D++   L  EL   G L E  +H  +            +I  D    +AY H+ +  
Sbjct: 91  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA-----ARIMKDVLSAVAYCHKLN-- 143
Query: 222 CVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
            V HRD K  N L      +   K+ DFGLA +   G+   + T+V GT  YV+P+  + 
Sbjct: 144 -VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYVSPQ-VLE 198
Query: 279 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV 316
           G    + D +S GV++  LL G  P   S P+  E ++
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPP--FSAPTDXEVML 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 39/273 (14%)
Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---QQGDKEFLVEVE-MLSRLH 151
           ++F    ++G+G FG+V      ++    A+K L       ++ +K  + E   +L  + 
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H  LV L   + + D    +L Y  +  G L   L       C L+   R   A + A  
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDY--INGGELFYHLQRE---RCFLEPRARF-YAAEIASA 151
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           L YLH  +   +++RD K  NILL++  H  + DFGL K+  E   N  ++   GT  Y+
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYL 206
Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD-----------MSQP-SGQENLVTWA 319
           APE           D +  G VL E+L G  P             +++P   + N+   A
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA 266
Query: 320 RPILR---DKDRLEELADPRLGGKYPKEDFIRV 349
           R +L     KDR +     RLG    K+DF+ +
Sbjct: 267 RHLLEGLLQKDRTK-----RLGA---KDDFMEI 291

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 41/282 (14%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G GG  +VF+ +       AIK   L     Q    +  E+  L++L   +  K++  Y
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 122
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MKIALDAARGLAYLHEDSQ 220
               + Q++       N  L SWL     ++    WE +   K  L+A      +H   Q
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSIDP---WERKSYWKNMLEA------VHTIHQ 173
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY----- 275
             ++H D K +N L+ +    K+ DFG+A Q     T+ +    +GT  Y+ PE      
Sbjct: 174 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 276 ------AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
                      +  KSDV+S G +L  +  G+ P                + I+    +L
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKL 277
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
             + DP    ++P      +  +   C+  +  QR ++ E++
Sbjct: 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 7/102 (6%)
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           A + A GL +L       +I+RD K  N++L++  H K+ADFG+ K   E   + ++T+ 
Sbjct: 127 AAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKX 180
Query: 265 M-GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
             GT  Y+APE           D +++GV+L E+L G+ P +
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N++++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLIIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 41/282 (14%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G GG  +VF+ +       AIK   L     Q    +  E+  L++L   +  K++  Y
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 75
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MKIALDAARGLAYLHEDSQ 220
               + Q++       N  L SWL     ++    WE +   K  L+A      +H   Q
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERKSYWKNMLEA------VHTIHQ 126
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY----- 275
             ++H D K +N L+ +    K+ DFG+A Q     T+ +    +GT  Y+ PE      
Sbjct: 127 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 276 ------AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
                      +  KSDV+S G +L  +  G+ P                + I+    +L
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKL 230
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
             + DP    ++P      +  +   C+  +  QR ++ E++
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ ++  G  P    QP
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 41/282 (14%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G GG  +VF+ +       AIK   L     Q    +  E+  L++L   +  K++  Y
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 78
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MKIALDAARGLAYLHEDSQ 220
               + Q++       N  L SWL     ++    WE +   K  L+A      +H   Q
Sbjct: 79  DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERKSYWKNMLEA------VHTIHQ 129
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY----- 275
             ++H D K +N L+ +    K+ DFG+A Q     T+ +    +GT  Y+ PE      
Sbjct: 130 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 276 ------AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
                      +  KSDV+S G +L  +  G+ P                + I+    +L
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKL 233
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
             + DP    ++P      +  +   C+  +  QR ++ E++
Sbjct: 234 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 41/282 (14%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G GG  +VF+ +       AIK   L     Q    +  E+  L++L   +  K++  Y
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 94
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MKIALDAARGLAYLHEDSQ 220
               + Q++       N  L SWL     ++    WE +   K  L+A      +H   Q
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERKSYWKNMLEA------VHTIHQ 145
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY----- 275
             ++H D K +N L+ +    K+ DFG+A Q     T+ +    +GT  Y+ PE      
Sbjct: 146 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 276 ------AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
                      +  KSDV+S G +L  +  G+ P                + I+    +L
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKL 249
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
             + DP    ++P      +  +   C+  +  QR ++ E++
Sbjct: 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 41/282 (14%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G GG  +VF+ +       AIK   L     Q    +  E+  L++L   +  K++  Y
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 122
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MKIALDAARGLAYLHEDSQ 220
               + Q++       N  L SWL     ++    WE +   K  L+A      +H   Q
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERKSYWKNMLEA------VHTIHQ 173
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY----- 275
             ++H D K +N L+ +    K+ DFG+A Q     T+ +    +GT  Y+ PE      
Sbjct: 174 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 276 ------AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
                      +  KSDV+S G +L  +  G+ P                + I+    +L
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKL 277
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
             + DP    ++P      +  +   C+  +  QR ++ E++
Sbjct: 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 112/282 (39%), Gaps = 41/282 (14%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G GG  +VF+ +       AIK   L     Q    +  E+  L++L   +  K++  Y
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 74
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MKIALDAARGLAYLHEDSQ 220
               + Q++       N  L SWL     ++    WE +   K  L+A      +H   Q
Sbjct: 75  DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERKSYWKNMLEA------VHTIHQ 125
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY----- 275
             ++H D K +N L+ +    K+ DFG+A Q     T+ +    +GT  Y+ PE      
Sbjct: 126 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 276 ------AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
                      +  KSDV+S G +L  +  G+ P                + I+    +L
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKL 229
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
             + DP    ++P      +  +   C+  +  QR ++ E++
Sbjct: 230 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 91  ELKEATNNFEPASILGEGGFGRV----FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM 146
           +L+    ++E   ++G G FG V     K          + +     +     F  E ++
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----ETRM 202
           ++  +   +V+L  +Y+ +D     +  E +P G L + +      +    W       +
Sbjct: 123 MAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEV 177
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEGRTNYLS 261
            +ALDA   + +         IHRD K  N+LL+ + H K+ADFG   K   EG      
Sbjct: 178 VLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR--C 226
Query: 262 TRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 303
              +GT  Y++PE   +    G+   + D +S GV L E+L G  P
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    +P
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKEF---LVEVE 145
           K   N+F+   +LG+G FG+V   +L    + G   A+K L         E    + E  
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           +L    H  L  L   + + D     LC+ +      E + H  L        E      
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDR----LCFVMEYANGGELFFH--LSRERVFTEERARFYG 114
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            +    L YLH      V++RD K  N++L+ + H K+ DFGL K   EG ++  + +  
Sbjct: 115 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTF 168
Query: 266 -GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT  Y+APE           D +  GVV+ E++ GR P
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKEF---LVEVE 145
           K   N+F+   +LG+G FG+V   +L    + G   A+K L         E    + E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           +L    H  L  L   + + D     LC+ +      E + H  L        E      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDR----LCFVMEYANGGELFFH--LSRERVFTEERARFYG 111
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            +    L YLH      V++RD K  N++L+ + H K+ DFGL K   EG ++  + +  
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTF 165
Query: 266 -GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT  Y+APE           D +  GVV+ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 91  ELKEATNNFEPASILGEGGFGRV----FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM 146
           +L+    ++E   ++G G FG V     K          + +     +     F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----ETRM 202
           ++  +   +V+L  +Y+ +D     +  E +P G L + +      +    W       +
Sbjct: 128 MAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEV 182
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA-KQAPEGRTNYLS 261
            +ALDA   + +         IHRD K  N+LL+ + H K+ADFG   K   EG      
Sbjct: 183 VLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR--C 231
Query: 262 TRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 303
              +GT  Y++PE   +    G+   + D +S GV L E+L G  P
Sbjct: 232 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKEF---LVEVE 145
           K   N+F+   +LG+G FG+V   +L    + G   A+K L         E    + E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           +L    H  L  L   + + D     LC+ +      E + H  L        E      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDR----LCFVMEYANGGELFFH--LSRERVFTEERARFYG 111
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            +    L YLH      V++RD K  N++L+ + H K+ DFGL K   EG ++  + +  
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTF 165
Query: 266 -GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT  Y+APE           D +  GVV+ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 91  ELKEATNNFEPASILGEGGFGRV----FKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM 146
           +L+    ++E   ++G G FG V     K          + +     +     F  E ++
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----ETRM 202
           ++  +   +V+L  +Y+ +D     +  E +P G L + +      +    W       +
Sbjct: 128 MAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEV 182
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL-AKQAPEGRTNYLS 261
            +ALDA   + +         IHRD K  N+LL+ + H K+ADFG   K   EG      
Sbjct: 183 VLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR--C 231
Query: 262 TRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 303
              +GT  Y++PE   +    G+   + D +S GV L E+L G  P
Sbjct: 232 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           L E   G ++KG    G  + +K L       +  ++F  E   L    H N++ ++G  
Sbjct: 18  LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
            S  +    L     P GSL + LH   G N  +D    +K ALD ARG A+LH   +P 
Sbjct: 77  QSPPAPHPTLITHWXPYGSLYNVLHE--GTNFVVDQSQAVKFALDXARGXAFLHT-LEPL 133
Query: 223 VIHRDFKASNILLENNFHAKV--ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
           +      + ++ ++ +  A++  AD   + Q+P GR  Y          +VAPE      
Sbjct: 134 IPRHALNSRSVXIDEDXTARISXADVKFSFQSP-GRX-YAP-------AWVAPEALQKKP 184
Query: 281 LLVK---SDVYSYGVVLLELLTGRKP-VDMS 307
                  +D +S+ V+L EL+T   P  D+S
Sbjct: 185 EDTNRRSADXWSFAVLLWELVTREVPFADLS 215

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKEF---LVEVE 145
           K   N+F+   +LG+G FG+V   +L    + G   A+K L         E    + E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           +L    H  L  L   + + D     LC+ +      E + H  L        E      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDR----LCFVMEYANGGELFFH--LSRERVFTEERARFYG 111
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            +    L YLH      V++RD K  N++L+ + H K+ DFGL K   EG ++  + +  
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXF 165
Query: 266 -GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT  Y+APE           D +  GVV+ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKEF---LVEVE 145
           K   N+F+   +LG+G FG+V   +L    + G   A+K L         E    + E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           +L    H  L  L   + + D     LC+ +      E + H  L        E      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDR----LCFVMEYANGGELFFH--LSRERVFTEERARFYG 111
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            +    L YLH      V++RD K  N++L+ + H K+ DFGL K   EG ++  + +  
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXF 165
Query: 266 -GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT  Y+APE           D +  GVV+ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 32  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 89
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+     +        +   LD E    +      
Sbjct: 90  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 142
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 196
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYID 237

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKEF---LVEVE 145
           K   N+F+   +LG+G FG+V   +L    + G   A+K L         E    + E  
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 62
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           +L    H  L  L   + + D     LC+ +      E + H  L        E      
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDR----LCFVMEYANGGELFFH--LSRERVFTEERARFYG 116
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            +    L YLH      V++RD K  N++L+ + H K+ DFGL K   EG ++  + +  
Sbjct: 117 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXF 170
Query: 266 -GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT  Y+APE           D +  GVV+ E++ GR P
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+     +        +   LD E    +      
Sbjct: 79  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 131
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++ T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYID 226

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+AP   ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 23/219 (10%)
Query: 93  KEATNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDKEF---LVEVE 145
           K   N+F+   +LG+G FG+V   +L    + G   A+K L         E    + E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           +L    H  L  L   + + D     LC+ +      E + H  L        E      
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDR----LCFVMEYANGGELFFH--LSRERVFTEERARFYG 111
Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            +    L YLH      V++RD K  N++L+ + H K+ DFGL K   EG ++  + +  
Sbjct: 112 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXF 165
Query: 266 -GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT  Y+APE           D +  GVV+ E++ GR P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 49/287 (17%)
Query: 105 LGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG+G F ++FKGV  +         T V +K L    +   + F     M+S+L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC-HLDWETRMKIALDAARGLAYL 215
              G     D  +++L  E V  GSL+++L      NC ++ W  ++++A   A  + +L
Sbjct: 76  LNYGVCVCGD--ENILVQEFVKFGSLDTYLKK--NKNCINILW--KLEVAKQLAAAMHFL 129
Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT------NYLSTRVMGTFG 269
            E++   +IH +  A NILL      K  +    K +  G +      + L  R+     
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI----P 182
Query: 270 YVAPE-YAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 327
           +V PE      +L + +D +S+G  L E+ + G KP  +S    Q  L  +       +D
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQRKLQFY-------ED 233
Query: 328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           R  +L  P+            +  +   C+  E + RP+   +++ L
Sbjct: 234 R-HQLPAPKAA---------ELANLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 49/287 (17%)
Query: 105 LGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           LG+G F ++FKGV  +         T V +K L    +   + F     M+S+L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC-HLDWETRMKIALDAARGLAYL 215
              G     D  +++L  E V  GSL+++L      NC ++ W  ++++A   A  + +L
Sbjct: 76  LNYGVCFCGD--ENILVQEFVKFGSLDTYLKK--NKNCINILW--KLEVAKQLAWAMHFL 129
Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT------NYLSTRVMGTFG 269
            E++   +IH +  A NILL      K  +    K +  G +      + L  R+     
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI----P 182
Query: 270 YVAPE-YAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD 327
           +V PE      +L + +D +S+G  L E+ + G KP  +S    Q  L  +       +D
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQRKLQFY-------ED 233
Query: 328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
           R  +L  P+            +  +   C+  E + RP+   +++ L
Sbjct: 234 R-HQLPAPKAA---------ELANLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 93  KEATNNFEPASILGEGGFGRVFK----GVLSDGTAVAIK-RLTCGGQQG--DKEFLVEVE 145
           ++  +++E    LG G F  V K    G   +  A  IK R     ++G   +E   EV 
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-MKI 204
           +L  + H N++ L   + ++  +  +L  ELV  G L  +L     +    D  T+ +K 
Sbjct: 68  ILREIRHPNIITLHDIFENK--TDVVLILELVSGGELFDFLAEKESLTE--DEATQFLKQ 123
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADFGLAKQAPEGRTNYL 260
            LD   G+ YLH      + H D K  NI+L +    N   K+ DFG+A +   G     
Sbjct: 124 ILD---GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 174
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
              + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 114
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 170
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK     R    +  + GT
Sbjct: 171 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGT 222
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
             Y+APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 116
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 172
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 116
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 172
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 99  FEPASILGEGGFGRVFKGVLSD-GTAVAIK-----RLTCGGQQGDKEFLVEVEMLSRLHH 152
           +E   ++G+G F  V + +  + G   A+K     + T       ++   E  +   L H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 153 RNLVKLVGYYSSRDSSQHL---------LCYELVPNGSLESWLHGPLGVNCHLDWETRMK 203
            ++V+L+  YSS D   ++         LC+E+V     ++       V  H      M+
Sbjct: 86  PHIVELLETYSS-DGMLYMVFEFMDGADLCFEIVKRA--DAGFVYSEAVASHY-----MR 137
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYL 260
             L+A R   Y H+++   +IHRD K  N+LL   EN+   K+ DFG+A Q   G +  +
Sbjct: 138 QILEALR---YCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLV 189
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +   +GT  ++APE           DV+  GV+L  LL+G  P
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 97  NNFEPASILGEGGFGRVFK----GVLSDGTAVAIK-RLTCGGQQG--DKEFLVEVEMLSR 149
           +++E    LG G F  V K    G   +  A  IK R     ++G   +E   EV +L  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-MKIALDA 208
           + H N++ L   + ++  +  +L  ELV  G L  +L     +    D  T+ +K  LD 
Sbjct: 65  IRHPNIITLHDIFENK--TDVVLILELVSGGELFDFLAEKESLTE--DEATQFLKQILD- 119
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADFGLAKQAPEGRTNYLSTRV 264
             G+ YLH      + H D K  NI+L +    N   K+ DFG+A +   G        +
Sbjct: 120 --GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 96  TNNFEPASILGEGGFGRVFK------GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ++N++    LG+G F  V +      G+      +  K+L+    Q   +   E  +  +
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 84
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L H N+V+L  + S ++ S H L ++LV  G L       +    + + +    I     
Sbjct: 85  LQHPNIVRL--HDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQ-QIL 138
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHA---KVADFGLAKQAPEGRTNYLSTRVMG 266
             +AY H +    ++HR+ K  N+LL +       K+ADFGLA +  +    +      G
Sbjct: 139 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAG 192
Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           T GY++PE           D+++ GV+L  LL G  P
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 96  TNNFEPASILGEGGFGRVFK------GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ++N++    LG+G F  V +      G+      +  K+L+    Q   +   E  +  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L H N+V+L  + S ++ S H L ++LV  G L       +    + + +    I     
Sbjct: 62  LQHPNIVRL--HDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQ-QIL 115
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLSTRVMG 266
             +AY H +    ++HR+ K  N+LL +       K+ADFGLA +  +    +      G
Sbjct: 116 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAG 169
Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           T GY++PE           D+++ GV+L  LL G  P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 96  TNNFEPASILGEGGFGRVFK------GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ++N++    LG+G F  V +      G+      +  K+L+    Q   +   E  +  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 61
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L H N+V+L  + S ++ S H L ++LV  G L       +    + + +    I     
Sbjct: 62  LQHPNIVRL--HDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQ-QIL 115
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLSTRVMG 266
             +AY H +    ++HR+ K  N+LL +       K+ADFGLA +  +    +      G
Sbjct: 116 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAG 169
Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           T GY++PE           D+++ GV+L  LL G  P
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILILELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 96  TNNFEPASILGEGGFGRVFK------GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           ++N++    LG+G F  V +      G+      +  K+L+    Q   +   E  +  +
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRK 60
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L H N+V+L  + S ++ S H L ++LV  G L       +    + + +    I     
Sbjct: 61  LQHPNIVRL--HDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQ-QIL 114
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLSTRVMG 266
             +AY H +    ++HR+ K  N+LL +       K+ADFGLA +  +    +      G
Sbjct: 115 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAG 168
Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           T GY++PE           D+++ GV+L  LL G  P
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 41/84 (48%), Gaps = 1/84 (1%)
Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK 284
           HRD K  NIL+  +  A + DFG+A    + +   L   V GT  Y APE     H   +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 285 SDVYSYGVVLLELLTGRKPVDMSQ 308
           +D+Y+   VL E LTG  P    Q
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQ 239

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/282 (21%), Positives = 111/282 (39%), Gaps = 41/282 (14%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G GG  +VF+ +       AIK   L     Q    +  E+  L++L   +  K++  Y
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 122
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MKIALDAARGLAYLHEDSQ 220
               + Q++       N  L SWL     ++    WE +   K  L+A      +H   Q
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERKSYWKNMLEA------VHTIHQ 173
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY----- 275
             ++H D K +N L+ +    K+ DFG+A Q     T+ +    +G   Y+ PE      
Sbjct: 174 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 276 ------AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
                      +  KSDV+S G +L  +  G+ P                + I+    +L
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKL 277
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
             + DP    ++P      +  +   C+  +  QR ++ E++
Sbjct: 278 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRN 154
           + F+    LG G FGRV      + G   A+K L       DK+ +V+++ +   L+ + 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKR 93
Query: 155 LVKLVGY-------YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +++ V +       +S +D+S   +  E V  G + S L     +    +   R   A  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARF-YAAQ 149
Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
                 YLH      +I+RD K  N+L++   + +V DFG AK+  +GRT  L     GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWXLC----GT 201
Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
              +APE  ++       D ++ GV++ E+  G  P    QP
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           EV +L  + H N++ L   Y ++  +  +L  ELV  G L  +L         L  E   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENK--TDVILIGELVAGGELFDFL----AEKESLTEEEAT 117
Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNI-LLENNF---HAKVADFGLAKQAPEGRTN 258
           +       G+ YLH      + H D K  NI LL+ N      K+ DFGLA +   G   
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173
Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                + GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 126/285 (44%), Gaps = 57/285 (20%)
Query: 104 ILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEF------LVEVEMLSRLH----H 152
           +LG+GGFG VF G  L+D   VAIK +      G           +EV +L ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR 210
             +++L+ ++ +++    +L   L P   L  ++   GPLG        +R       A 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPL-PAQDLFDYITEKGPLGEG-----PSRCFFGQVVA- 150
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGL-AKQAPEGRTNYLSTRVMGTF 268
            + + H      V+HRD K  NIL++     AK+ DFG  A    E  T++  TRV    
Sbjct: 151 AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV---- 203
Query: 269 GYVAPEY-AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 327
            Y  PE+ +   +  + + V+S G++L +++ G  P +                  RD++
Sbjct: 204 -YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE------------------RDQE 244
Query: 328 RLE-ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
            LE EL        +P       C +   C+AP+ + RP++ E++
Sbjct: 245 ILEAEL-------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/282 (21%), Positives = 110/282 (39%), Gaps = 41/282 (14%)
Query: 105 LGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G GG  +VF+ +       AIK   L     Q    +  E+  L++L   +  K++  Y
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 94
Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR--MKIALDAARGLAYLHEDSQ 220
               + Q++       N  L SWL     ++    WE +   K  L+A      +H   Q
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERKSYWKNMLEA------VHTIHQ 145
Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY----- 275
             ++H D K +N L+ +    K+ DFG+A Q        +    +GT  Y+ PE      
Sbjct: 146 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMS 204
Query: 276 ------AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
                      +  KSDV+S G +L  +  G+ P                + I+    +L
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIINQISKL 249
Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
             + DP    ++P      +  +   C+  +  QR ++ E++
Sbjct: 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 97  NNFEPASILGEGGFGRVFK----GVLSDGTAVAIK-RLTCGGQQG--DKEFLVEVEMLSR 149
           +++E    LG G F  V K    G   +  A  IK R     ++G   +E   EV +L  
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-MKIALDA 208
           + H N++ L   + ++  +  +L  ELV  G L  +L     +    D  T+ +K  LD 
Sbjct: 86  IRHPNIITLHDIFENK--TDVVLILELVSGGELFDFLAEKESLTE--DEATQFLKQILD- 140
Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADFGLAKQAPEGRTNYLSTRV 264
             G+ YLH      + H D K  NI+L +    N   K+ DFG+A +   G        +
Sbjct: 141 --GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 192
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 193 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G FG V +    + G   A K +    +   +    E++ +S L H  LV L  + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL--HDA 222
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D ++ ++ YE +  G L          +  +  +  ++      +GL ++HE++    
Sbjct: 223 FEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 276
Query: 224 IHRDFKASNILL--ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           +H D K  NI+   + +   K+ DFGL       ++  ++T   GT  + APE A    +
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPV 333
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
              +D++S GV+   LL+G  P
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSP 355

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 14/202 (6%)
Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G FG V +    + G   A K +    +   +    E++ +S L H  LV L   + 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D ++ ++ YE +  G L          +  +  +  ++      +GL ++HE++    
Sbjct: 119 --DDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 170
Query: 224 IHRDFKASNILL--ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           +H D K  NI+   + +   K+ DFGL       ++  ++T   GT  + APE A    +
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPV 227
Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
              +D++S GV+   LL+G  P
Sbjct: 228 GYYTDMWSVGVLSYILLSGLSP 249

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+     +        +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++    + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYID 232

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 14/104 (13%)
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           +ALDA   +          +IHRD K  N+LL+ + H K+ADFG   +  E    +  T 
Sbjct: 185 LALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA 235
Query: 264 VMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVLLELLTGRKP 303
           V GT  Y++PE   +    G+   + D +S GV L E+L G  P
Sbjct: 236 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 102 ASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-------EVEMLSRLHHR 153
           + ILG+G    VF+G     G   AIK         +  FL        E E+L +L+H+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFN------NISFLRPVDVQMREFEVLKKLNHK 67
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGL 212
           N+VKL        +   +L  E  P GSL + L  P   N +   E+   I L D   G+
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125
Query: 213 AYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +L E+    ++HR+ K  NI+     +     K+ DFG A++  E    ++S  + GT 
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS--LYGTE 179
Query: 269 GYVAPEYAMTGHLL--------VKSDVYSYGVVLLELLTGRKP 303
            Y+ P+      L            D++S GV      TG  P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 27/221 (12%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRN 154
            N +P     +G     +  +L     VAIK+L+     Q   K    E+ ++  ++H+N
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 155 LVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           ++ L+  ++ + S +      +  EL+     +        +   LD E    +      
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV-------IQMELDHERMSYLLYQMLC 137
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A    T+++    + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLE------LLTGRKPVD 305
            APE  +        D++S G ++ E      L  GR  +D
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYID 232

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 204 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 206 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGY 161
           +LGEG   RV   + L      A+K +             EVEML +   HRN+++L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           +   D  +  L +E +  GS+ S +H     N   + E  + +  D A  L +LH     
Sbjct: 80  FEEED--RFYLVFEKMRGGSILSHIHKRRHFN---ELEASV-VVQDVASALDFLHNKG-- 131
Query: 222 CVIHRDFKASNILLENNFHA---KVADFGLAKQ----------------APEGRTNYLST 262
            + HRD K  NIL E+       K+ DFGL                    P G   Y++ 
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            V+  F   A  Y        + D++S GV+L  LL+G  P
Sbjct: 191 EVVEAFSEEASIYDK------RCDLWSLGVILYILLSGYPP 225

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 199 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 3/95 (3%)
Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
           +   A+G+ +L   S+ C IHRD  A NILL      K+ DFGLA+   +          
Sbjct: 197 SFQVAKGMEFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
                ++APE        ++SDV+S+GV+L E+ +
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 90  EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAV----------AIKRLTCGGQQGDKE 139
           +E++    +FE   ++G G FG V    + +   +           +KR      + +++
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 140 FLV--EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL---HGPLGVNC 194
            LV  + + ++ LH          Y+ +D +   L  +    G L + L      L  + 
Sbjct: 127 VLVNGDCQWITALH----------YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM 176
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG-LAKQAP 253
              +   M +A+D+   L Y         +HRD K  N+LL+ N H ++ADFG   K   
Sbjct: 177 ARFYIGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMND 227
Query: 254 EGRTNYLSTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLTGRKP 303
           +G     S+  +GT  Y++PE   AM    G    + D +S GV + E+L G  P
Sbjct: 228 DGTVQ--SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 35/223 (15%)
Query: 102 ASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV-------EVEMLSRLHHR 153
           + ILG+G    VF+G     G   AIK         +  FL        E E+L +L+H+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFN------NISFLRPVDVQMREFEVLKKLNHK 67
Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL-DAARGL 212
           N+VKL        +   +L  E  P GSL + L  P   N +   E+   I L D   G+
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125
Query: 213 AYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +L E+    ++HR+ K  NI+     +     K+ DFG A++  +         + GT 
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVXLYGTE 179
Query: 269 GYVAPEYAMTGHLL--------VKSDVYSYGVVLLELLTGRKP 303
            Y+ P+      L            D++S GV      TG  P
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 100/260 (38%), Gaps = 53/260 (20%)
Query: 92  LKEATNNFEPASILGEGGFGRVFKGVLSDGTAV-AIK-----RLTCGGQQGDKEFLVEVE 145
           L E    +     +G+G +G V   + +   A+ AIK     ++     +  +    EV 
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL----------------------- 182
           ++ +LHH N+ +L   Y   D     L  EL   G L                       
Sbjct: 81  LMKKLHHPNIARLYEVYE--DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 183 --------ESWLHGPL-GVNCHLDWETRMKIALDAAR----GLAYLHEDSQPCVIHRDFK 229
                   E  ++G + G    LD+  R K+  +  R     L YLH      + HRD K
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIK 195
Query: 230 ASNILLENN--FHAKVADFGLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLV-- 283
             N L   N  F  K+ DFGL+K+  +      Y  T   GT  +VAPE   T +     
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255
Query: 284 KSDVYSYGVVLLELLTGRKP 303
           K D +S GV+L  LL G  P
Sbjct: 256 KCDAWSAGVLLHLLLMGAVP 275

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 23/221 (10%)
Query: 94  EATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL---------VEV 144
           E +  +   S LG G FG V+  V  +     + +     +  +  ++         +E+
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGS-LESWLHGPLGVNCHLDWETRMK 203
            +LSR+ H N++K++  + ++   Q ++      +GS L+  L   +  +  LD      
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVM----EKHGSGLD--LFAFIDRHPRLDEPLASY 134
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           I       + YL       +IHRD K  NI++  +F  K+ DFG A     G+  Y    
Sbjct: 135 IFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY---T 188
Query: 264 VMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKP 303
             GT  Y APE  M   +   + +++S GV L  L+    P
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 90  EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAV----------AIKRLTCGGQQGDKE 139
           +E++    +FE   ++G G FG V    + +   +           +KR      + +++
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 140 FLV--EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL---HGPLGVNC 194
            LV  + + ++ LH          Y+ +D +   L  +    G L + L      L  + 
Sbjct: 143 VLVNGDCQWITALH----------YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM 192
Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG-LAKQAP 253
              +   M +A+D+   L Y         +HRD K  N+LL+ N H ++ADFG   K   
Sbjct: 193 ARFYIGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMND 243
Query: 254 EGRTNYLSTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVLLELLTGRKP 303
           +G     S+  +GT  Y++PE   AM    G    + D +S GV + E+L G  P
Sbjct: 244 DGTVQ--SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 27/218 (12%)
Query: 102 ASILGEGGFGRVFKGVLSDGT------AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
             +LGEG +G+V K VL   T       +  K+       G+     E+++L RL H+N+
Sbjct: 10  GDLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68
Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA------LDAA 209
           ++LV    + +  +  +  E    G  E     P         E R  +           
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP---------EKRFPVCQAHGYFCQLI 119
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            GL YLH      ++H+D K  N+LL      K++  G+A+       +       G+  
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 270 YVAPEYA--MTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           +  PE A  +      K D++S GV L  + TG  P +
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 25/187 (13%)
Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRL-HHRN 154
           +F P  +LG G  G +    + D   VA+KR+   C     D+    EV++L     H N
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-FADR----EVQLLRESDEHPN 79
Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +++   + + +D     +  EL    +L+ ++      +  L+  T ++       GLA+
Sbjct: 80  VIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAH 133
Query: 215 LHEDSQPCVIHRDFKASNILLEN-NFHAK----VADFGLAKQAPEGRTNYLSTR--VMGT 267
           LH  +   ++HRD K  NIL+   N H K    ++DFGL K+   GR ++ S R  V GT
Sbjct: 134 LHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF-SRRSGVPGT 189
Query: 268 FGYVAPE 274
            G++APE
Sbjct: 190 EGWIAPE 196

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 48/256 (18%)
Query: 76  GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ 134
            S+P P S          +  + +E   ++G G +G V +     +   VAIK++    +
Sbjct: 40  ASMPRPHSDW--------QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 135 Q--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL--VPNGSLESWLHGPL 190
                K  L E+ +L+RL+H ++VK++     +D  +    Y +  + +   +     P+
Sbjct: 92  DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 191 GVNCHLDWETRMKIAL-DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
            +      E  +K  L +   G+ Y+H      ++HRD K +N L+  +   KV DFGLA
Sbjct: 152 YLT-----ELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203
Query: 250 KQA--PEG--------------------RTNYLSTRVMG---TFGYVAPEYAMTGHLLVK 284
           +    PE                      T  L  ++ G   T  Y APE  +      +
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263
Query: 285 S-DVYSYGVVLLELLT 299
           + DV+S G +  ELL 
Sbjct: 264 AIDVWSIGCIFAELLN 279

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHH 152
           T+ ++    +G+G F  V + V L  G   A K +       +  ++   E  +   L H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-LDAARG 211
            N+V+L  + S  +   H L ++LV  G L              D   R   +  DA+  
Sbjct: 63  SNIVRL--HDSISEEGFHYLVFDLVTGGELFE------------DIVAREYYSEADASHC 108
Query: 212 LAYLHEDSQPC----VIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLSTRV 264
           +  + E    C    V+HRD K  N+LL +       K+ADFGLA +    +  +     
Sbjct: 109 IQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--F 166
Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GT GY++PE           D+++ GV+L  LL G  P
Sbjct: 167 AGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 87/213 (40%), Gaps = 33/213 (15%)
Query: 105 LGEGGFG------RVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LG+G F       +V  G       +  K+L+    Q   +   E  +   L H N+V+L
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIVRL 86
Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-LDAARGLAYLHE 217
             + S  +   H L ++LV  G L              D   R   +  DA+  +  + E
Sbjct: 87  --HDSISEEGHHYLIFDLVTGGELFE------------DIVAREYYSEADASHCIQQILE 132
Query: 218 DSQPC----VIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
               C    V+HRD K  N+LL +       K+ADFGLA +    +  +      GT GY
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGY 190
Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           ++PE           D+++ GV+L  LL G  P
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 73/321 (22%), Positives = 121/321 (37%), Gaps = 57/321 (17%)
Query: 77  SLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG 136
           S P   S   +  +E        E   ++G+G FG+V+ G      A+ +  +    +  
Sbjct: 13  SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQ 72
Query: 137 DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCH 195
            K F  EV    +  H N+V  +G   +  S  HL +   L    +L S +     V   
Sbjct: 73  LKAFKREVMAYRQTRHENVVLFMG---ACMSPPHLAIITSLCKGRTLYSVVRDAKIV--- 126
Query: 196 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA--- 252
           LD     +IA +  +G+ YLH      ++H+D K+ N+  +N     + DFGL   +   
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVL 182
Query: 253 PEGRTNYLSTRVMGTFGYVAPEYA-------------MTGHLLVKSDVYSYGVVLLELLT 299
             GR         G   ++APE                + H    SDV++ G +  EL  
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH----SDVFALGTIWYELHA 238
Query: 300 GRKPVDMSQPSGQENLVTW-----ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAA 354
              P   +QP+     + W      +P L      +E++D                 I  
Sbjct: 239 REWPFK-TQPA---EAIIWQMGTGMKPNLSQIGMGKEISD-----------------ILL 277
Query: 355 ACVAPEANQRPTMGEVVQSLK 375
            C A E  +RPT  +++  L+
Sbjct: 278 FCWAFEQEERPTFTKLMDMLE 298

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 94/236 (39%), Gaps = 42/236 (17%)
Query: 82  TSTRFLAYEELKEATNNFEPASILGEGGFG------RVFKGVLSDGTAVAIKRLTCGGQQ 135
           T TRF         T  ++    LG+G F       +V  G       +  K+L+    Q
Sbjct: 5   TCTRF---------TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ 55
Query: 136 GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH 195
             +    E  +   L H N+V+L  + S  +   H L ++LV  G L             
Sbjct: 56  KLER---EARICRLLKHPNIVRL--HDSISEEGHHYLIFDLVTGGELFE----------- 99
Query: 196 LDWETRMKIA-LDAARGLAYLHEDSQPC----VIHRDFKASNILLENNFH---AKVADFG 247
            D   R   +  DA+  +  + E    C    V+HR+ K  N+LL +       K+ADFG
Sbjct: 100 -DIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158
Query: 248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           LA +    +  +      GT GY++PE           D+++ GV+L  LL G  P
Sbjct: 159 LAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGY 161
           +LGEG   RV   + L      A+K +             EVEML +   HRN+++L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
           +   D  +  L +E +  GS+ S +H     N   + E  + +  D A  L +LH     
Sbjct: 80  FEEED--RFYLVFEKMRGGSILSHIHKRRHFN---ELEASV-VVQDVASALDFLHNKG-- 131
Query: 222 CVIHRDFKASNILLENNFHA---KVADFGLAKQ----------------APEGRTNYLST 262
            + HRD K  NIL E+       K+ DF L                    P G   Y++ 
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            V+  F   A  Y        + D++S GV+L  LL+G  P
Sbjct: 191 EVVEAFSEEASIYDK------RCDLWSLGVILYILLSGYPP 225

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 15/100 (15%)
Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGLAKQ---APEGRTNYLSTR 263
            G+ YLH+++   ++H D K  NILL + +     K+ DFG++++   A E R       
Sbjct: 142 EGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR------E 192
Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +MGT  Y+APE      +   +D+++ G++   LLT   P
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 32/231 (13%)
Query: 82  TSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTA------VAIKRLTCGGQQ 135
           T TRF         T++++    LG+G F  V + V    T       +  K+L+    Q
Sbjct: 25  TCTRF---------TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ 75
Query: 136 GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH 195
             +    E  +   L H N+V+L  + S  +   H L ++LV  G L   +         
Sbjct: 76  KLER---EARICRLLKHPNIVRL--HDSISEEGFHYLVFDLVTGGELFEDIVAR------ 124
Query: 196 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAKQA 252
            ++ +    +    + L  ++   Q  ++HRD K  N+LL +       K+ADFGLA + 
Sbjct: 125 -EYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV 183
Query: 253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
              +  +      GT GY++PE           D+++ GV+L  LL G  P
Sbjct: 184 QGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAK-QAPEGRTNYLST-- 262
            A  GL YLH      ++H D KA N+LL ++  HA + DFG A    P+G    L T  
Sbjct: 193 QALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD 249
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            + GT  ++APE  +      K DV+S   ++L +L G  P
Sbjct: 250 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 33/222 (14%)
Query: 96  TNNFEPASILGEGGFGRVFK------GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           T+ ++    LG+G F  V +      G       +  K+L+    Q   +   E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRL 59
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-LDA 208
           L H N+V+L  + S  +   H L ++LV  G L              D   R   +  DA
Sbjct: 60  LKHPNIVRL--HDSISEEGFHYLVFDLVTGGELFE------------DIVAREYYSEADA 105
Query: 209 ARGLAYLHEDSQPC----VIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLS 261
           +  +  + E    C    ++HRD K  N+LL +       K+ADFGLA +    +  +  
Sbjct: 106 SHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
               GT GY++PE           D+++ GV+L  LL G  P
Sbjct: 166 --FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 46/232 (19%)
Query: 104 ILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLH-HRNLVK 157
           ILG G  G V F+G    G  VA+KR+         +F    L+E+++L+    H N+++
Sbjct: 22  ILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIR 73
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR---MKIALDAARGLAY 214
              YY S  + + L     + N +L+  +      + +L  +     + +    A G+A+
Sbjct: 74  ---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 215 LHEDSQPCVIHRDFKASNILLEN-------------NFHAKVADFGLAKQAPEGRTNYLS 261
           LH      +IHRD K  NIL+               N    ++DFGL K+   G++++ +
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 262 --TRVMGTFGYVAPEY------AMTGHLLVKS-DVYSYGVVLLELLT-GRKP 303
                 GT G+ APE         T   L +S D++S G V   +L+ G+ P
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 33/222 (14%)
Query: 96  TNNFEPASILGEGGFGRVFK------GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR 149
           T+ ++    LG+G F  V +      G       +  K+L+    Q   +   E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRL 59
Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-LDA 208
           L H N+V+L  + S  +   H L ++LV  G L              D   R   +  DA
Sbjct: 60  LKHPNIVRL--HDSISEEGFHYLVFDLVTGGELFE------------DIVAREYYSEADA 105
Query: 209 ARGLAYLHEDSQPC----VIHRDFKASNILLENNFH---AKVADFGLAKQAPEGRTNYLS 261
           +  +  + E    C    ++HRD K  N+LL +       K+ADFGLA +    +  +  
Sbjct: 106 SHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
               GT GY++PE           D+++ GV+L  LL G  P
Sbjct: 166 --FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 42/228 (18%)
Query: 104 ILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLH-HRNLVK 157
           ILG G  G V F+G    G  VA+KR+         +F    L+E+++L+    H N+++
Sbjct: 40  ILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIR 91
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR---MKIALDAARGLAY 214
              YY S  + + L     + N +L+  +      + +L  +     + +    A G+A+
Sbjct: 92  ---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 215 LHEDSQPCVIHRDFKASNILLEN-------------NFHAKVADFGLAKQAPEGRTNYLS 261
           LH      +IHRD K  NIL+               N    ++DFGL K+   G+  +  
Sbjct: 149 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 262 --TRVMGTFGYVAPEY--AMTGHLLVKS-DVYSYGVVLLELLT-GRKP 303
                 GT G+ APE     T   L +S D++S G V   +L+ G+ P
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 33/229 (14%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTA-VAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHR 153
           +N+    ++G G +G V+     +    VAIK++    +     K  L E+ +L+RL   
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 154 NLVKLVGYYSSRDSSQHLLCYEL--VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
            +++L       D  +    Y +  + +  L+     P+     L  E    I  +   G
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI----FLTEEHIKTILYNLLLG 141
Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLS--------- 261
             ++HE     +IHRD K +N LL  +   KV DFGLA+    E  TN ++         
Sbjct: 142 ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 262 ----------TRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLT 299
                     T  + T  Y APE  +      KS D++S G +  ELL 
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 42/228 (18%)
Query: 104 ILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLH-HRNLVK 157
           ILG G  G V F+G    G  VA+KR+         +F    L+E+++L+    H N+++
Sbjct: 40  ILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIR 91
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR---MKIALDAARGLAY 214
              YY S  + + L     + N +L+  +      + +L  +     + +    A G+A+
Sbjct: 92  ---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 148
Query: 215 LHEDSQPCVIHRDFKASNILLEN-------------NFHAKVADFGLAKQAPEGRTNYLS 261
           LH      +IHRD K  NIL+               N    ++DFGL K+   G+  +  
Sbjct: 149 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 262 --TRVMGTFGYVAPEY--AMTGHLLVKS-DVYSYGVVLLELLT-GRKP 303
                 GT G+ APE     T   L +S D++S G V   +L+ G+ P
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 105 LGEGGFGRVFKGVLSDGT-AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LGEG F    K V      A A+K ++   +   ++ +  +++     H N+VKL   + 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVF- 75
Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             D     L  EL+  G L   +        H        I       ++++H+     V
Sbjct: 76  -HDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---V 127
Query: 224 IHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
           +HRD K  N+L     +N   K+ DFG A+  P      L T    T  Y APE      
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPCF-TLHYAAPELLNQNG 185
Query: 281 LLVKSDVYSYGVVLLELLTGRKP 303
                D++S GV+L  +L+G+ P
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVP 208

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 7/101 (6%)
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAK-QAPEGRTNYLST-- 262
            A  GL YLH      ++H D KA N+LL ++  HA + DFG A    P+G    L T  
Sbjct: 174 QALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            + GT  ++APE  +      K DV+S   ++L +L G  P
Sbjct: 231 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 105 LGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKL--V 159
           LGEG +G V+K + +     VAIKR+    ++       + EV +L  L HRN+++L  V
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
            +++ R    HL+ +E   N      L   +  N  +              G+ + H  S
Sbjct: 102 IHHNHR---LHLI-FEYAEND-----LKKYMDKNPDVSMRVIKSFLYQLINGVNFCH--S 150
Query: 220 QPCVIHRDFKASNILLENNFHA-----KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
           + C +HRD K  N+LL  +  +     K+ DFGLA+    G      T  + T  Y  PE
Sbjct: 151 RRC-LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPE 207
Query: 275 YAM-TGHLLVKSDVYSYGVVLLELL 298
             + + H     D++S   +  E+L
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 38/236 (16%)
Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTA-VAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHR 153
           +N+E   ++G G +G V+     +    VAIK++    +     K  L E+ +L+RL   
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 154 NLVKLVGYYSSRDSSQHLLCYEL--VPNGSLESWLHGPLGVNCHLDWETRMK-IALDAAR 210
            +++L       D  +    Y +  + +  L+     P+ +      E  +K I  +   
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLT-----EQHVKTILYNLLL 142
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS--------- 261
           G  ++HE     +IHRD K +N LL  +   K+ DFGLA+     +  ++          
Sbjct: 143 GEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 262 --------------TRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRK 302
                         T  + T  Y APE  +       S D++S G +  ELL   K
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMK 255

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 99  FEPASILGEGGFGRVFKGVLSD-GTAVAIK-----RLTCGGQQGDKEFLVEVEMLSRLHH 152
           +E   ++G+G F  V + +  + G   A+K     + T       ++   E  +   L H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 153 RNLVKLVGYYSSRDSSQHL---------LCYELVPNGSLESWLHGPLGVNCHLDWETRMK 203
            ++V+L+  YSS D   ++         LC+E+V     ++       V  H      M+
Sbjct: 88  PHIVELLETYSS-DGMLYMVFEFMDGADLCFEIVKRA--DAGFVYSEAVASHY-----MR 139
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYL 260
             L+A R   Y H+++   +IHRD K   +LL   EN+   K+  FG+A Q   G +  +
Sbjct: 140 QILEALR---YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLV 191
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +   +GT  ++APE           DV+  GV+L  LL+G  P
Sbjct: 192 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 234

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 9   ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 68
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 69  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 114
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 175 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229
Query: 305 DMSQ 308
           +  +
Sbjct: 230 EHDE 233

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 29  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 88
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 89  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 134
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 195 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249
Query: 305 DMSQ 308
           +  +
Sbjct: 250 EHDE 253

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 10  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 69
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 70  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 115
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 176 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230
Query: 305 DMSQ 308
           +  +
Sbjct: 231 EHDE 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 99  FEPASILGEGGFGRVFKGVLSD-GTAVAIK-----RLTCGGQQGDKEFLVEVEMLSRLHH 152
           +E   ++G+G F  V + +  + G   A+K     + T       ++   E  +   L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 153 RNLVKLVGYYSSRDSSQHL---------LCYELVPNGSLESWLHGPLGVNCHLDWETRMK 203
            ++V+L+  YSS D   ++         LC+E+V     ++       V  H      M+
Sbjct: 86  PHIVELLETYSS-DGMLYMVFEFMDGADLCFEIVKRA--DAGFVYSEAVASHY-----MR 137
Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYL 260
             L+A R   Y H+++   +IHRD K   +LL   EN+   K+  FG+A Q   G +  +
Sbjct: 138 QILEALR---YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLV 189
Query: 261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +   +GT  ++APE           DV+  GV+L  LL+G  P
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 10  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 69
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 70  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 115
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 176 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230
Query: 305 DMSQ 308
           +  +
Sbjct: 231 EHDE 234

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 9   ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 68
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 69  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 114
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 175 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229
Query: 305 DMSQ 308
           +  +
Sbjct: 230 EHDE 233

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 10  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 69
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 70  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 115
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 176 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230
Query: 305 DMSQ 308
           +  +
Sbjct: 231 EHDE 234

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 69/175 (39%), Gaps = 34/175 (19%)
Query: 143 EVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
           E+E+L R   H N++ L   Y   D     +  EL+  G L             LD   R
Sbjct: 65  EIEILLRYGQHPNIITLKDVYD--DGKYVYVVTELMKGGEL-------------LDKILR 109
Query: 202 MK---------IALDAARGLAYLHEDSQPCVIHRDFKASNILLE----NNFHAKVADFGL 248
            K         +     + + YLH      V+HRD K SNIL      N    ++ DFG 
Sbjct: 110 QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF 166
Query: 249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           AKQ      N L      T  +VAPE           D++S GV+L  +LTG  P
Sbjct: 167 AKQLRA--ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 22  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 81
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 127
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 188 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242
Query: 305 DMSQ 308
           +  +
Sbjct: 243 EHDE 246

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 23  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 82
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 128
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 189 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243
Query: 305 DMSQ 308
           +  +
Sbjct: 244 EHDE 247

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 113/244 (46%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 23  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 82
Query: 137 DKEFL-VEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +   + +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 128
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 189 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243
Query: 305 DMSQ 308
           +  +
Sbjct: 244 EHDE 247

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 23  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 82
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 128
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 189 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243
Query: 305 DMSQ 308
           +  +
Sbjct: 244 EHDE 247

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 113/244 (46%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 22  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 81
Query: 137 DKEFL-VEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +   + +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 127
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 188 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242
Query: 305 DMSQ 308
           +  +
Sbjct: 243 EHDE 246

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 37  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 96
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 97  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 142
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 203 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257
Query: 305 DMSQ 308
           +  +
Sbjct: 258 EHDE 261

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 42  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 101
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 102 NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 147
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 208 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 262
Query: 305 DMSQ 308
           +  +
Sbjct: 263 EHDE 266

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 22  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 81
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 127
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 188 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242
Query: 305 DMSQ 308
           +  +
Sbjct: 243 EHDE 246

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 23  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 82
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 83  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 128
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 189 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243
Query: 305 DMSQ 308
           +  +
Sbjct: 244 EHDE 247

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 22  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 81
Query: 137 D-KEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +     +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 82  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 127
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 188 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242
Query: 305 DMSQ 308
           +  +
Sbjct: 243 EHDE 246

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 113/244 (46%), Gaps = 37/244 (15%)
Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQG 136
           +T+    +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  
Sbjct: 37  ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP 96
Query: 137 DKEFL-VEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVN 193
           +   + +EV +L ++      +++L+ ++   DS      + L+        L  P  V 
Sbjct: 97  NGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQ 142
Query: 194 CHLDWET-RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADF 246
              D+ T R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 247 GLAKQAPEG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPV 304
           G      +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P 
Sbjct: 203 GSGALLKDTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257
Query: 305 DMSQ 308
           +  +
Sbjct: 258 EHDE 261

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 104 ILGEGGFGRV-FKGVLSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLH-HRNLVK 157
           ILG G  G V F+G    G  VA+KR+         +F    L+E+++L+    H N+++
Sbjct: 22  ILGYGSSGTVVFQGSFQ-GRPVAVKRMLI-------DFCDIALMEIKLLTESDDHPNVIR 73
Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR---MKIALDAARGLAY 214
              YY S  + + L     + N +L+  +      + +L  +     + +    A G+A+
Sbjct: 74  ---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 215 LHEDSQPCVIHRDFKASNILLEN-------------NFHAKVADFGLAKQAPEGRTNYLS 261
           LH      +IHRD K  NIL+               N    ++DFGL K+   G+  +  
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 187
Query: 262 --TRVMGTFGYVAPEY------AMTGHLLVKS-DVYSYGVVLLELLT-GRKP 303
                 GT G+ APE         T   L +S D++S G V   +L+ G+ P
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/239 (19%), Positives = 99/239 (41%), Gaps = 30/239 (12%)
Query: 90  EELKEATNNFEPASILGEGGFGRV--------FKGVLSDGTAVAIKRLTCGGQQGDK--- 138
           +E  +  N++     L +G F ++        F  +     ++  K+        DK   
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 139 -----EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL----ESWLHGP 189
                +F  E+++++ + +   +   G  ++ D  +  + YE + N S+    E +    
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLD 141
Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
               C +  +    I        +Y+H +   C  HRD K SNIL++ N   K++DFG +
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGES 199
Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLTGRKPVDM 306
           +   + +     +R  GT+ ++ PE+    + +   K D++S G+ L  +     P  +
Sbjct: 200 EYMVDKKIK--GSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 37/237 (15%)
Query: 90  EELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGD-KEFLV 142
           +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  +     +
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 143 EVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWET 200
           EV +L ++      +++L+ ++   DS      + L+        L  P  V    D+ T
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQDLFDFIT 107
Query: 201 -RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADFGLAKQAP 253
            R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DFG      
Sbjct: 108 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 167
Query: 254 EG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQ 308
           +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P +  +
Sbjct: 168 DTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 219

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 37/237 (15%)
Query: 90  EELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGD-KEFLV 142
           +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  +     +
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 143 EVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWET 200
           EV +L ++      +++L+ ++   DS      + L+        L  P  V    D+ T
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQDLFDFIT 106
Query: 201 -RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADFGLAKQAP 253
            R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DFG      
Sbjct: 107 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 166
Query: 254 EG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQ 308
           +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P +  +
Sbjct: 167 DTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 13/107 (12%)
Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL--AKQAPEGRTNY 259
           + I +  A  + +LH      ++HRD K SNI    +   KV DFGL  A    E     
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 260 LSTR--------VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL 298
           L+           +GT  Y++PE     +   K D++S G++L ELL
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 37/237 (15%)
Query: 90  EELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGD-KEFLV 142
           +E +   + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  +     +
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 143 EVEMLSRLH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWET 200
           EV +L ++      +++L+ ++   DS      + L+        L  P  V    D+ T
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQDLFDFIT 107
Query: 201 -RMKIALDAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADFGLAKQAP 253
            R  +  + AR   + + E  + C    V+HRD K  NIL++ N    K+ DFG      
Sbjct: 108 ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 167
Query: 254 EG-RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQ 308
           +   T++  TRV     Y  PE+        +S  V+S G++L +++ G  P +  +
Sbjct: 168 DTVYTDFDGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 219

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 21/284 (7%)
Query: 96  TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRL-H 151
           T  F     +G G FG VFK V   DG   AIKR      G   ++  L EV   + L  
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 152 HRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           H ++V+   Y+S+     H+L   E    GSL   +     +  +        + L   R
Sbjct: 68  HSHVVR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFG 269
           GL Y+H  S   ++H D K SNI +        A       + EG   ++ S +VM   G
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA-------SEEGDEDDWASNKVMFKIG 174
Query: 270 YVAPEYAMTGHLLVKSDV-YSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            +     ++   + + D  +    VL E  T     D+   +        A P+ R+ D+
Sbjct: 175 DLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 234
Query: 329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             E+   RL  + P+        +    + P+  +RP+   +V+
Sbjct: 235 WHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 277

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 21/284 (7%)
Query: 96  TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRL-H 151
           T  F     +G G FG VFK V   DG   AIKR      G   ++  L EV   + L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 152 HRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           H ++V+   Y+S+     H+L   E    GSL   +     +  +        + L   R
Sbjct: 70  HSHVVR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFG 269
           GL Y+H  S   ++H D K SNI +        A       + EG   ++ S +VM   G
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA-------SEEGDEDDWASNKVMFKIG 176
Query: 270 YVAPEYAMTGHLLVKSDV-YSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            +     ++   + + D  +    VL E  T     D+   +        A P+ R+ D+
Sbjct: 177 DLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             E+   RL  + P+        +    + P+  +RP+   +V+
Sbjct: 237 WHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 37/230 (16%)
Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGD-KEFLVEVEMLSR 149
           + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  +     +EV +L +
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 150 LH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWET-RMKIAL 206
           +      +++L+ ++   DS      + L+        L  P  V    D+ T R  +  
Sbjct: 69  VSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQDLFDFITERGALQE 114
Query: 207 DAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADFGLAKQAPEG-RTNY 259
           + AR   + + E  + C    V+HRD K  NIL++ N    K+ DFG      +   T++
Sbjct: 115 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 174
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQ 308
             TRV     Y  PE+        +S  V+S G++L +++ G  P +  +
Sbjct: 175 DGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 219

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 21/284 (7%)
Query: 96  TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRL-H 151
           T  F     +G G FG VFK V   DG   AIKR      G   ++  L EV   + L  
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 152 HRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           H ++V+   Y+S+     H+L   E    GSL   +     +  +        + L   R
Sbjct: 66  HSHVVR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFG 269
           GL Y+H  S   ++H D K SNI +        A       + EG   ++ S +VM   G
Sbjct: 123 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA-------SEEGDEDDWASNKVMFKIG 172
Query: 270 YVAPEYAMTGHLLVKSDV-YSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            +     ++   + + D  +    VL E  T     D+   +        A P+ R+ D+
Sbjct: 173 DLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQ 232
Query: 329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             E+   RL  + P+        +    + P+  +RP+   +V+
Sbjct: 233 WHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 275

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 21/284 (7%)
Query: 96  TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRL-H 151
           T  F     +G G FG VFK V   DG   AIKR      G   ++  L EV   + L  
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 152 HRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           H ++V+   Y+S+     H+L   E    GSL   +     +  +        + L   R
Sbjct: 68  HSHVVR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFG 269
           GL Y+H  S   ++H D K SNI +        A       + EG   ++ S +VM   G
Sbjct: 125 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA-------SEEGDEDDWASNKVMFKIG 174
Query: 270 YVAPEYAMTGHLLVKSDV-YSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            +     ++   + + D  +    VL E  T     D+   +        A P+ R+ D+
Sbjct: 175 DLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 234
Query: 329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             E+   RL  + P+        +    + P+  +RP+   +V+
Sbjct: 235 WHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 277

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAK-QAPEGRTNYLST-- 262
            A  GL YLH      ++H D KA N+LL ++   A + DFG A    P+G    L T  
Sbjct: 158 QALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            + GT  ++APE  M      K D++S   ++L +L G  P
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAK-QAPEGRTNYLST-- 262
            A  GL YLH      ++H D KA N+LL ++   A + DFG A    P+G    L T  
Sbjct: 174 QALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 230
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            + GT  ++APE  M      K D++S   ++L +L G  P
Sbjct: 231 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAK-QAPEGRTNYLST-- 262
            A  GL YLH      ++H D KA N+LL ++   A + DFG A    P+G    L T  
Sbjct: 172 QALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 228
Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            + GT  ++APE  M      K D++S   ++L +L G  P
Sbjct: 229 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFL-VEVEMLSR 149
           + ++   +LG GGFG V+ G+ +SD   VAIK     R++  G+  +   + +EV +L +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 150 LH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWET-RMKIAL 206
           +      +++L+ ++   DS      + L+        L  P  V    D+ T R  +  
Sbjct: 64  VSSGFSGVIRLLDWFERPDS------FVLI--------LERPEPVQDLFDFITERGALQE 109
Query: 207 DAARGLAY-LHEDSQPC----VIHRDFKASNILLE-NNFHAKVADFGLAKQAPEG-RTNY 259
           + AR   + + E  + C    V+HRD K  NIL++ N    K+ DFG      +   T++
Sbjct: 110 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF 169
Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQ 308
             TRV     Y  PE+        +S  V+S G++L +++ G  P +  +
Sbjct: 170 DGTRV-----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	443
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-179
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-174
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-102
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-72
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-69
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-69
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-68
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-64
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-63
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-61
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-61
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-60
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-57
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-44
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-44
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-44
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-39
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-38
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-38
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-37
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-37
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-36
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-36
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-33
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-32
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-32
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-32
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-32
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-26
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-23
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-22
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-12
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-07

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  514 bits (1326), Expect = 0.0
 Identities = 126/316 (39%), Positives = 178/316 (56%), Gaps = 6/316 (1%)

Query: 65  KPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAV 124
           K   +    L  S   P  +  +   +L+EATNNF+   ++G G FG+V+KGVL DG  V
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66

Query: 125 AIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLES 184
           A+KR T    QG +EF  E+E LS   H +LV L+G+   R+  + +L Y+ + NG+L+ 
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN--EMILIYKYMENGNLKR 124

Query: 185 WLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 244
            L+G       + WE R++I + AARGL YLH      +IHRD K+ NILL+ NF  K+ 
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT 181

Query: 245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV 304
           DFG++K+  E    +LST V GT GY+ PEY + G L  KSDVYS+GVVL E+L  R  +
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

Query: 305 DMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR 364
             S P    NL  WA        +LE++ DP L  K   E   +    A  C+A  +  R
Sbjct: 242 VQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300

Query: 365 PTMGEVVQSLKMVQRV 380
           P+MG+V+  L+   R+
Sbjct: 301 PSMGDVLWKLEYALRL 316

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  502 bits (1296), Expect = e-179
 Identities = 128/299 (42%), Positives = 183/299 (61%), Gaps = 7/299 (2%)

Query: 80  HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-DK 138
           H    +  +  EL+ A++NF   +ILG GGFG+V+KG L+DGT VA+KRL     QG + 
Sbjct: 13  HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72

Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW 198
           +F  EVEM+S   HRNL++L G+      ++ LL Y  + NGS+ S L         LDW
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCM--TPTERLLVYPYMANGSVASCLRERPESQPPLDW 130

Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN 258
             R +IAL +ARGLAYLH+   P +IHRD KA+NILL+  F A V DFGLAK      T 
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT- 189

Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE--NLV 316
           +++T V GT G++APEY  TG    K+DV+ YGV+LLEL+TG++  D+++ +  +   L+
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249

Query: 317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
            W + +L++K +LE L D  L G Y  E+  ++  +A  C      +RP M EVV+ L+
Sbjct: 250 DWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  488 bits (1260), Expect = e-174
 Identities = 105/309 (33%), Positives = 172/309 (55%), Gaps = 21/309 (6%)

Query: 80  HPTSTRFLAYEELKEATNNFEP------ASILGEGGFGRVFKGVLSDGTAVAIKRLTCG- 132
             T     ++ ELK  TNNF+        + +GEGGFG V+KG + + T VA+K+L    
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMV 66

Query: 133 ---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 189
               ++  ++F  E++++++  H NLV+L+G+  S D     L Y  +PNGSL   L   
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGF--SSDGDDLCLVYVYMPNGSLLDRLSCL 124

Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
            G    L W  R KIA  AA G+ +LHE+     IHRD K++NILL+  F AK++DFGLA
Sbjct: 125 DG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           + + +     +++R++GT  Y+APE  + G +  KSD+YS+GVVLLE++TG   VD  + 
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

Query: 310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 369
              + L+     I  ++  +E+  D ++           + ++A+ C+  + N+RP + +
Sbjct: 240 --PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKK 296

Query: 370 VVQSLKMVQ 378
           V Q L+ + 
Sbjct: 297 VQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  307 bits (789), Expect = e-102
 Identities = 86/325 (26%), Positives = 132/325 (40%), Gaps = 26/325 (8%)

Query: 74  LGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG 133
           +G    H +S   L  E L   +   +   +   G FG V+K  L     VA+K      
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD 59

Query: 134 QQGDKEFLVEVEMLSRLHHRNLVKLVGY--YSSRDSSQHLLCYELVPNGSLESWLHGPLG 191
           +Q   +   EV  L  + H N+++ +G     +       L       GSL  +L   + 
Sbjct: 60  KQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV- 117

Query: 192 VNCHLDWETRMKIALDAARGLAYLHED-------SQPCVIHRDFKASNILLENNFHAKVA 244
               + W     IA   ARGLAYLHED        +P + HRD K+ N+LL+NN  A +A
Sbjct: 118 ----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173

Query: 245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLT 299
           DFGLA +   G++   +   +GT  Y+APE             ++ D+Y+ G+VL EL +
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

Query: 300 GRKPVDMSQPSGQENL--VTWARPILRDKDRL--EELADPRLGGKYPKEDFIR-VCTIAA 354
                D                 P L D   +   +   P L   + K   +  +C    
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE 293

Query: 355 ACVAPEANQRPTMGEVVQSLKMVQR 379
            C   +A  R + G V + +  +QR
Sbjct: 294 ECWDHDAEARLSAGCVGERITQMQR 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  228 bits (584), Expect = 7e-72
 Identities = 70/338 (20%), Positives = 131/338 (38%), Gaps = 41/338 (12%)

Query: 87  LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM 146
            A  E     +N +   ++G G +G V+KG L D   VA+K  +       + F+ E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58

Query: 147 --LSRLHHRNLVKLVGY---YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
             +  + H N+ + +      ++    ++LL  E  PNGSL  +L          DW + 
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSS 113

Query: 202 MKIALDAARGLAYLHED------SQPCVIHRDFKASNILLENNFHAKVADFGLAK----- 250
            ++A    RGLAYLH +       +P + HRD  + N+L++N+    ++DFGL+      
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 251 -QAPEGRTNYLSTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVLLELLTGRK 302
                G  +  +   +GT  Y+APE              L + D+Y+ G++  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 303 PVDMSQPSGQENL----VTWARPILRDKDRL--EELADPRLGGKYPKEDFI--RVCTIAA 354
            +   +   +  +         P   D   L   E   P+    + +       +     
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 355 ACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSN 392
            C   +A  R T     + +  +  + E       +++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  220 bits (563), Expect = 6e-69
 Identities = 85/298 (28%), Positives = 134/298 (44%), Gaps = 38/298 (12%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G G FG V +     G+ VA+K L       +   EFL EV ++ RL H N+V  +G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA- 102

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
                    +  E +  GSL   LH   G    LD   R+ +A D A+G+ YLH    P 
Sbjct: 103 -VTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 282
           ++HR+ K+ N+L++  +  KV DFGL++   +  T   S    GT  ++APE        
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 283 VKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE--ELADPRLGG 339
            KSDVYS+GV+L EL T ++P  +++        V  A  +     RLE     +P++  
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAA--VGFKCKRLEIPRNLNPQVA- 269

Query: 340 KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNRANL 397
                       I   C   E  +RP+   ++  L+ + +       +     NR++L
Sbjct: 270 -----------AIIEGCWTNEPWKRPSFATIMDLLRPLIK-------SAVPPPNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  219 bits (561), Expect = 8e-69
 Identities = 89/317 (28%), Positives = 136/317 (42%), Gaps = 51/317 (16%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           ++G G FG V K        VAIK++    +   K F+VE+  LSR++H N+VKL G   
Sbjct: 15  VVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA-- 69

Query: 164 SRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
                 + +C   E    GSL + LHG      +      M   L  ++G+AYLH     
Sbjct: 70  ----CLNPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 222 CVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH 280
            +IHRD K  N+LL       K+ DFG A            T   G+  ++APE     +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPEVFEGSN 179

Query: 281 LLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWA-----RPILRDKDRLEELAD 334
              K DV+S+G++L E++T RKP  ++  P+ +   + WA     RP L           
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWAVHNGTRPPL----------- 225

Query: 335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNR 394
            +     PK     + ++   C + + +QRP+M E+V+ +  + R     D  L      
Sbjct: 226 IK---NLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC-- 276

Query: 395 ANLRQSSTTFDSDGTSS 411
               Q S     DG   
Sbjct: 277 ----QHSLPPGEDGRVE 289

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  217 bits (556), Expect = 4e-68
 Identities = 82/290 (28%), Positives = 133/290 (45%), Gaps = 48/290 (16%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-------KEFLVEVEMLSRLHHRNL 155
            +G+GGFG V KG  + D + VAIK L  G  +G+       +EF  EV ++S L+H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           VKL G   +       +  E VP G L   L         + W  ++++ LD A G+ Y+
Sbjct: 86  VKLYGLMHN----PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138

Query: 216 HEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
             +  P ++HRD ++ NI L++        AKVADFGL++Q     + +  + ++G F +
Sbjct: 139 Q-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192

Query: 271 VAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKD 327
           +APE           K+D YS+ ++L  +LTG  P  + S        + +   I  +  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGL 247

Query: 328 RLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           R    E   PRL              +   C + +  +RP    +V+ L 
Sbjct: 248 RPTIPEDCPPRLR------------NVIELCWSGDPKKRPHFSYIVKELS 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  207 bits (530), Expect = 2e-64
 Identities = 59/287 (20%), Positives = 110/287 (38%), Gaps = 44/287 (15%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGY 161
            L E   G ++KG    G  + +K L          ++F  E   L    H N++ ++G 
Sbjct: 17  KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
             S  +    L    +P GSL + LH        +D    +K ALD ARG+A+LH   +P
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLH-TLEP 132

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------Y 275
            +      + +++++ +  A+++   +         ++ S   M    +VAPE       
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPE 185

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE--EL 332
                    +D++S+ V+L EL+T   P  D+S        +     +  +  R      
Sbjct: 186 DTNRR---SADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGLRPTIPPG 235

Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
             P +              +   C+  +  +RP    +V  L+ +Q 
Sbjct: 236 ISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  205 bits (525), Expect = 8e-64
 Identities = 72/287 (25%), Positives = 115/287 (40%), Gaps = 46/287 (16%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD----KEFLVEVEMLSRLHHRNLVKLV 159
           I+G GGFG+V++     G  VA+K       +      +    E ++ + L H N++ L 
Sbjct: 14  IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G           L  E    G L   L G       +  +  +  A+  ARG+ YLH+++
Sbjct: 73  G--VCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEA 125

Query: 220 QPCVIHRDFKASNILL--------ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
              +IHRD K+SNIL+         +N   K+ DFGLA++              G + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWM 181

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE 330
           APE          SDV+SYGV+L ELLTG  P   +   +     V +   +  +K  L 
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYG--VAMNKLALP 234

Query: 331 --ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                                  +   C  P+ + RP+   ++  L 
Sbjct: 235 IPSTCPEPFA------------KLMEDCWNPDPHSRPSFTNILDQLT 269

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  205 bits (523), Expect = 3e-63
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 32/282 (11%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G G FG V+KG    G  VA+K L          + F  EV +L +  H N++  +GY 
Sbjct: 32  IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 88

Query: 163 SSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
               S+   L    +     SL   LH         + +  + IA   ARG+ YLH    
Sbjct: 89  ----STAPQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLH---A 138

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---YAM 277
             +IHRD K++NI L  +   K+ DFGLA +      ++   ++ G+  ++APE      
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 337
           +     +SDVY++G+VL EL+TG+ P        Q   +     + R     +       
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM--VGRGSLSPDLSKVRS- 252

Query: 338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
               PK     +  + A C+  + ++RP+   ++  ++ + R
Sbjct: 253 --NCPKR----MKRLMAECLKKKRDERPSFPRILAEIEELAR 288

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  204 bits (521), Expect = 2e-62
 Identities = 68/357 (19%), Positives = 134/357 (37%), Gaps = 51/357 (14%)

Query: 56  SKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFK 115
           +   P E+ +     + + G     P   +    ++++           +G+G +G V+ 
Sbjct: 3   TYIPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMV-------KQIGKGRYGEVWM 55

Query: 116 GVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGY--YSSRDSSQHL 171
           G    G  VA+K         +  +  E E+     + H N++  +      +   +Q  
Sbjct: 56  GKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111

Query: 172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-----SQPCVIHR 226
           L  +   NGSL  +L         LD ++ +K+A  +  GL +LH +      +P + HR
Sbjct: 112 LITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHR 166

Query: 227 DFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV- 283
           D K+ NIL++ N    +AD GLA    +     +      +GT  Y+ PE  +   L   
Sbjct: 167 DLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRN 225

Query: 284 ------KSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLVTWARPILRDKDR 328
                  +D+YS+G++L E+        + +              +       +   K R
Sbjct: 226 HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR 285

Query: 329 LEELADPRLGGKYPKEDFIR-VCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ 384
                 P    ++  ++ +R +  +   C A     R T   V ++L  +    + +
Sbjct: 286 ------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  202 bits (517), Expect = 4e-62
 Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 42/298 (14%)

Query: 105 LGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG+G FG+  K      G  + +K L    ++  + FL EV+++  L H N++K +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG--V 75

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                +     E +  G+L   +      +    W  R+  A D A G+AYLH  +   +
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---I 129

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY------------LSTRVMGTFGYV 271
           IHRD  + N L+  N +  VADFGLA+   + +T                  V+G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP---VDMSQPSGQENLVTWARPILRDKDR 328
           APE         K DV+S+G+VL E++                  N+  +        + 
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-YCPPNC 248

Query: 329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDP 386
                                  I   C   +  +RP+  ++   L+ ++  +    P
Sbjct: 249 PPSFFP-----------------ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  200 bits (510), Expect = 4e-61
 Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 51/295 (17%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVGY 161
           ++G+G FG+V+ G    G  VAI+ +       D  K F  EV    +  H N+V  +G 
Sbjct: 40  LIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
                     +   L    +L S +         LD     +IA +  +G+ YLH  ++ 
Sbjct: 98  --CMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLH--AKG 150

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
            ++H+D K+ N+  +N     + DFGL         GR         G   ++APE    
Sbjct: 151 -ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208

Query: 279 GHLLV---------KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-----RPILR 324
                          SDV++ G +  EL     P   +QP+     + W      +P L 
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEA---IIWQMGTGMKPNLS 264

Query: 325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
                +E++D                 I   C A E  +RPT  +++  L+ + +
Sbjct: 265 QIGMGKEISD-----------------ILLFCWAFEQEERPTFTKLMDMLEKLPK 302

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  199 bits (507), Expect = 8e-61
 Identities = 65/299 (21%), Positives = 121/299 (40%), Gaps = 42/299 (14%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGY 161
            +G+G +G V++G    G  VA+K  +    + +K +  E E+     L H N++  +  
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 162 --YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED- 218
              S   S+Q  L       GSL  +L         LD  + ++I L  A GLA+LH + 
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 219 ----SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT--NYLSTRVMGTFGYVA 272
                +P + HRD K+ NIL++ N    +AD GLA    +     +  +   +GT  Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 273 PE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLVT 317
           PE               + D++++G+VL E+        + +              +   
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245

Query: 318 WARPILRDKDRLEELADPRLGGKYPKEDFIR-VCTIAAACVAPEANQRPTMGEVVQSLK 375
             + +  D+ R      P +  ++  +  +  +  +   C     + R T   + ++L 
Sbjct: 246 MRKVVCVDQQR------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  191 bits (487), Expect = 2e-57
 Identities = 63/303 (20%), Positives = 123/303 (40%), Gaps = 42/303 (13%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEM--LSRLHHRNLVKLVGY 161
            +G+G FG V++G    G  VA+K  +    + ++ +  E E+     L H N++  +  
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 162 YSSRDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
            +  + +  Q  L  +   +GSL  +L+        +  E  +K+AL  A GLA+LH + 
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEI 159

Query: 220 Q-----PCVIHRDFKASNILLENNFHAKVADFGLA--KQAPEGRTNYLSTRVMGTFGYVA 272
                 P + HRD K+ NIL++ N    +AD GLA    +     +      +GT  Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 273 PEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLV 316
           PE  +   + +       ++D+Y+ G+V  E+        + +              ++ 
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM 376
              + +   K R   + +     +  +     +  I   C       R T   + ++L  
Sbjct: 279 EMRKVVCEQKLRP-NIPNRWQSCEALRV----MAKIMRECWYANGAARLTALRIKKTLSQ 333

Query: 377 VQR 379
           + +
Sbjct: 334 LSQ 336

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  157 bits (400), Expect = 6e-45
 Identities = 91/299 (30%), Positives = 127/299 (42%), Gaps = 31/299 (10%)

Query: 103 SILGEGGFGRVFKGVL-----SDGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
             LGEG FG+V            G  VA+K L    G Q    +  E+++L  L+H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           K  G      ++   L  E VP GSL  +L         +     +  A     G+AYLH
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLH 151

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV----- 271
             +Q   IHRD  A N+LL+N+   K+ DFGLAK  PEG   Y     +   G       
Sbjct: 152 --AQHY-IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 330
           APE          SDV+S+GV L ELLT        S P+    L+  A+  +      E
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQGQMTVLRLTE 262

Query: 331 ELADPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPT 387
            L     G + P+ D     V  +   C   EA+ RPT   ++  LK V    + Q P+
Sbjct: 263 LLER---GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  157 bits (398), Expect = 2e-44
 Identities = 85/302 (28%), Positives = 124/302 (41%), Gaps = 28/302 (9%)

Query: 103 SILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           S LG+G FG V          + G  VA+K+L   G    ++F  E+++L  LH   +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
             G           L  E +P+G L  +L         LD    +  +    +G+ YL  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG- 144

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEY 275
            S+ C +HRD  A NIL+E+  H K+ADFGLAK  P    +Y   R  G     + APE 
Sbjct: 145 -SRRC-VHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQSPIFWYAPES 201

Query: 276 AMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 334
                   +SDV+S+GVVL EL T   K    S  +    ++   R +      LE L +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 335 PRLGGKYPKEDFIRVCTIA-----AACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLT 389
              G + P       C          C AP    RP+   +   L M+       +    
Sbjct: 260 ---GQRLPAPP---ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313

Query: 390 SS 391
           ++
Sbjct: 314 TA 315

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  154 bits (391), Expect = 7e-44
 Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 35/271 (12%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLVG 160
            +G G F  V+KG+       VA   L          + F  E EML  L H N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 161 YYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            + S    +  +    EL+ +G+L+++L         +  +          +GL +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 219 SQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
           + P +IHRD K  NI +       K+ D GLA      +    +  V+GT  ++APE   
Sbjct: 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYE 203

Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--DRLEELADP 335
             +     DVY++G+ +LE+ T   P      S  +N     R +         +++A P
Sbjct: 204 EKYDE-SVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDKVAIP 257

Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPT 366
            +      ++ I        C+    ++R +
Sbjct: 258 EV------KEIIE------GCIRQNKDERYS 276

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  156 bits (397), Expect = 9e-44
 Identities = 79/283 (27%), Positives = 128/283 (45%), Gaps = 38/283 (13%)

Query: 105 LGEGGFGRVFKGVL-SDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +G G FG VF G L +D T VA+K            +FL E  +L +  H N+V+L+G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 163 SSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
           + +      +  ELV  G   ++L   G       L  +T +++  DAA G+ YL   S+
Sbjct: 182 TQKQP--IYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLE--SK 232

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMT 278
            C IHRD  A N L+      K++DFG++++  +G   Y ++  +        APE    
Sbjct: 233 CC-IHRDLAARNCLVTEKNVLKISDFGMSREEADG--VYAASGGLRQVPVKWTAPEALNY 289

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
           G    +SDV+S+G++L E  + G  P  ++   S Q+      R  +    RL       
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNL---SNQQ-----TREFVEKGGRLPC----- 336

Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
                P+     V  +   C A E  QRP+   + Q L+ +++
Sbjct: 337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  153 bits (388), Expect = 2e-43
 Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 19/286 (6%)

Query: 103 SILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
             LG+G FG V          + G  VA+K+L    ++  ++F  E+E+L  L H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
             G   S       L  E +P GSL  +L         +D    ++      +G+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG- 131

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEY 275
            ++   IHRD    NIL+EN    K+ DFGL K  P+ +  +   +  G     + APE 
Sbjct: 132 -TKRY-IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF-KVKEPGESPIFWYAPES 188

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 335
                  V SDV+S+GVVL EL T  +            +    +  +     +E L + 
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN- 247

Query: 336 RLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
              G+ P+ D     +  I   C     NQRP+  ++   +  ++ 
Sbjct: 248 --NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  152 bits (387), Expect = 6e-43
 Identities = 81/330 (24%), Positives = 128/330 (38%), Gaps = 28/330 (8%)

Query: 67  RTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGRVFKGVL--- 118
              D  T                 +  +    FE   +     LG+G FG V        
Sbjct: 10  HDYDIPTTENLYFQGAMGSAFEDRDPTQ----FEERHLKFLQQLGKGNFGSVEMCRYDPL 65

Query: 119 --SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL 176
             + G  VA+K+L    ++  ++F  E+E+L  L H N+VK  G   S       L  E 
Sbjct: 66  QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125

Query: 177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE 236
           +P GSL  +L         +D    ++      +G+ YL   ++   IHRD    NIL+E
Sbjct: 126 LPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLG--TKRY-IHRDLATRNILVE 179

Query: 237 NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVL 294
           N    K+ DFGL K  P+ +  Y   +  G     + APE        V SDV+S+GVVL
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238

Query: 295 LELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTI 352
            EL T  +            +    +  +     +E L +    G+ P+ D     +  I
Sbjct: 239 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN---NGRLPRPDGCPDEIYMI 295

Query: 353 AAACVAPEANQRPTMGEVVQSLKMVQRVIE 382
              C     NQRP+  ++   +  ++  + 
Sbjct: 296 MTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  151 bits (383), Expect = 1e-42
 Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 24/288 (8%)

Query: 103 SILGEGGFGRVFKGVL-----SDGTAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
             LGEG FG+V          + G  VA+K L    G     +   E+E+L  L+H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           K  G  +    +   L  E +P+GSL+ +L         ++ + ++K A+   +G+ YL 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLG 143

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPE 274
             S+   +HRD  A N+L+E+    K+ DFGL K     +  Y + +        + APE
Sbjct: 144 --SRQY-VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-TVKDDRDSPVFWYAPE 199

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
             M     + SDV+S+GV L ELLT        S  +    ++      +     +  L 
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTLK 257

Query: 334 DPRLGGKYPKEDF--IRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ 378
           +   G + P        V  +   C   + + R +   +++    +++
Sbjct: 258 E---GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  149 bits (378), Expect = 9e-42
 Identities = 68/308 (22%), Positives = 115/308 (37%), Gaps = 41/308 (13%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           ++     LGEGGF  V     L DG   A+KR+ C  QQ  +E   E +M    +H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 157 KLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +LV Y      ++H           G+L + +         L  +  + + L   RGL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM-------GT 267
           +H        HRD K +NILL +     + D G   QA            +        T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 268 FGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP 321
             Y APE      + +      ++DV+S G VL  ++ G  P DM    G    +     
Sbjct: 207 ISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258

Query: 322 ILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
            ++++             ++       +       + +  + +QRP +  ++  L+ +Q 
Sbjct: 259 AVQNQLS------IPQSPRHSSALWQLLN------SMMTVDPHQRPHIPLLLSQLEALQP 306

Query: 380 VIECQDPT 387
               Q  T
Sbjct: 307 PAPGQHTT 314

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  146 bits (370), Expect = 2e-40
 Identities = 79/307 (25%), Positives = 128/307 (41%), Gaps = 42/307 (13%)

Query: 76  GSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDG-----TAVAIKRLT 130
           G  P+    R L   E K+         +LG G FG V+KG+           VAIK L 
Sbjct: 1   GEAPNQALLRILKETEFKKIK-------VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 53

Query: 131 CG-GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 189
                + +KE L E  +++ + + ++ +L+G   +   S   L  +L+P G L  ++   
Sbjct: 54  EATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREH 110

Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
                ++  +  +   +  A+G+ YL       ++HRD  A N+L++   H K+ DFGLA
Sbjct: 111 KD---NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMS 307
           K        Y +        ++A E  +      +SDV+SYGV + EL+T G KP   + 
Sbjct: 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI- 223

Query: 308 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 367
                E        IL   +RL +          P    I V  I   C   +A+ RP  
Sbjct: 224 --PASE-----ISSILEKGERLPQ----------PPICTIDVYMIMRKCWMIDADSRPKF 266

Query: 368 GEVVQSL 374
            E++   
Sbjct: 267 RELIIEF 273

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  143 bits (364), Expect = 5e-40
 Identities = 73/326 (22%), Positives = 124/326 (38%), Gaps = 74/326 (22%)

Query: 80  HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDK 138
           H    RF           +F+   ++G GGFG+VFK     DG    IKR+    +  ++
Sbjct: 3   HTVDKRFG---------MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNE 49

Query: 139 EFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY--------------ELVPNGSLES 184
           +   EV+ L++L H N+V   G +   D                      E    G+LE 
Sbjct: 50  KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109

Query: 185 WLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA 244
           W+    G    LD    +++     +G+ Y+H      +I+RD K SNI L +    K+ 
Sbjct: 110 WIEKRRGE--KLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIG 164

Query: 245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELL 298
           DFGL            +    GT  Y++PE      Y   G    + D+Y+ G++L ELL
Sbjct: 165 DFGLVTSL--KNDGKRTRSK-GTLRYMSPEQISSQDY---GK---EVDLYALGLILAELL 215

Query: 299 TGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAAC 356
                             T             +L D  +   + K+    ++        
Sbjct: 216 HVCDT-----AFETSKFFT-------------DLRDGIISDIFDKKEKTLLQ------KL 251

Query: 357 VAPEANQRPTMGEVVQSLKMVQRVIE 382
           ++ +   RP   E++++L + ++  E
Sbjct: 252 LSKKPEDRPNTSEILRTLTVWKKSPE 277

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (364), Expect = 5e-40
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 25/231 (10%)

Query: 87  LAYEELKEATNNFEPASI------LGEGGFGRVFKGVL---SDGTAVAIKRLTCG--GQQ 135
           +A EE++      +   +      LG G FG V KG          VA+K L        
Sbjct: 1   MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60

Query: 136 GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH 195
              E L E  ++ +L +  +V+++G   +      +L  E+   G L  +L      N H
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAELGPLNKYLQQ----NRH 113

Query: 196 LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 255
           +  +  +++    + G+ YL    +   +HRD  A N+LL    +AK++DFGL+K     
Sbjct: 114 VKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170

Query: 256 RTNYLSTRVMGTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
              Y   +  G +   + APE         KSDV+S+GV++ E  + G+KP
Sbjct: 171 ENYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (364), Expect = 6e-40
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 105 LGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVG 160
           LG G FG V +GV         VAIK L  G ++ D  E + E +++ +L +  +V+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ 220
              +      +L  E+   G L  +L G       +      ++    + G+ YL    +
Sbjct: 78  VCQA---EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYL---EE 128

Query: 221 PCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--GYVAPEYAMT 278
              +HRD  A N+LL N  +AK++DFGL+K      + Y + R  G +   + APE    
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINF 187

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                +SDV+SYGV + E L+ G+KP
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (362), Expect = 1e-39
 Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 40/283 (14%)

Query: 104 ILGEGGFGRVFKGVL----SDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLV 156
            LG+G FG V +G          +VA+K L        +   +F+ EV  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           +L G   +       +  EL P GSL   L    G   H    T  + A+  A G+ YL 
Sbjct: 85  RLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYL- 137

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAP 273
                  IHRD  A N+LL      K+ DFGL +  P+   +Y+          F + AP
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEE 331
           E   T      SD + +GV L E+ T G++P + +   +G + L      I ++ +RL  
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQIL----HKIDKEGERLPR 246

Query: 332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
                     P++    +  +   C A +   RPT   +   L
Sbjct: 247 ----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  143 bits (363), Expect = 1e-39
 Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 54/306 (17%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 154
            ++FE  ++LG+G FG+V K     D    AIK++    ++     L EV +L+ L+H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 155 LVKLVGYYSSRDSSQHLLCY-----------ELVPNGSLESWLHGPLGVNCHLDWETRMK 203
           +V+    +  R +    +             E   NG+L   +H     N +   +   +
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ------------ 251
           +       L+Y+H      +IHRD K  NI ++ + + K+ DFGLAK             
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 252 -APEGRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
               G ++ L++ + GT  YVA E    TGH   K D+YS G++  E++           
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------F 228

Query: 310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTM 367
           S     V   + +            P       K     IR        +  + N+RP  
Sbjct: 229 STGMERVNILKKLRSVSIEF----PPDFDDNKMKVEKKIIR------LLIDHDPNKRPGA 278

Query: 368 GEVVQS 373
             ++ S
Sbjct: 279 RTLLNS 284

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  141 bits (358), Expect = 8e-39
 Identities = 74/327 (22%), Positives = 126/327 (38%), Gaps = 46/327 (14%)

Query: 75  GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG 133
           G  +P     + L  +       NF     +G G F  V++   L DG  VA+K++    
Sbjct: 10  GPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69

Query: 134 QQGDKE---FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGP 189
               K     + E+++L +L+H N++K   YY+S      L    EL   G L   +   
Sbjct: 70  LMDAKARADCIKEIDLLKQLNHPNVIK---YYASFIEDNELNIVLELADAGDLSRMIKHF 126

Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
                 +   T  K  +     L ++H      V+HRD K +N+ +      K+ D GL 
Sbjct: 127 KKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG 183

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +     +T    + V GT  Y++PE      Y        KSD++S G +L E+   + P
Sbjct: 184 RFF-SSKTTAAHSLV-GTPYYMSPERIHENGYNF------KSDIWSLGCLLYEMAALQSP 235

Query: 304 VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEA 361
                   + NL +  + I +          P     Y +E    +        C+ P+ 
Sbjct: 236 FYGD----KMNLYSLCKKIEQCD------YPPLPSDHYSEELRQLVN------MCINPDP 279

Query: 362 NQRPTMGEVVQSLKMVQRVIECQDPTL 388
            +RP +  V     + +R+  C   +L
Sbjct: 280 EKRPDVTYV---YDVAKRMHACTASSL 303

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  139 bits (352), Expect = 2e-38
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
            +G G FG V  G   +   VAIK +  G    + +F+ E E++ +L H  LV+L G   
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             + +   L  E + +G L  +L    G       ET + + LD   G+AYL E++   V
Sbjct: 74  --EQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYL-EEAC--V 125

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 281
           IHRD  A N L+  N   KV+DFG+ +   +   +  ++     F     +PE       
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQYTSSTGTKFPVKWASPEVFSFSRY 182

Query: 282 LVKSDVYSYGVVLLELLT-GRKP 303
             KSDV+S+GV++ E+ + G+ P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  138 bits (351), Expect = 3e-38
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 19/203 (9%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
            +G+G FG V  G    G  VA+K +        + FL E  ++++L H NLV+L+G   
Sbjct: 28  TIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                 +++  E +  GSL  +L         L  +  +K +LD    + YL        
Sbjct: 85  EEKGGLYIVT-EYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 281
           +HRD  A N+L+  +  AKV+DFGL       +    ST+  G       APE       
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLT------KEAS-STQDTGKLPVKWTAPEALREKKF 191

Query: 282 LVKSDVYSYGVVLLELLT-GRKP 303
             KSDV+S+G++L E+ + GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  142 bits (361), Expect = 4e-38
 Identities = 86/315 (27%), Positives = 133/315 (42%), Gaps = 37/315 (11%)

Query: 68  TADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGRVFKGVLSDGT 122
           +  A  L   L     T     + L +        S+     LG+G FG V+ G  +  T
Sbjct: 150 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT 209

Query: 123 AVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL 182
            VAIK L  G    +  FL E +++ +L H  LV+L    S        +  E +  GSL
Sbjct: 210 RVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSL 265

Query: 183 ESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 242
             +L G  G   +L     + +A   A G+AY+   +    +HRD +A+NIL+  N   K
Sbjct: 266 LDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCK 320

Query: 243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GR 301
           VADFGLA+   +               + APE A+ G   +KSDV+S+G++L EL T GR
Sbjct: 321 VADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

Query: 302 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDF--IRVCTIAAACVAP 359
            P                 P + +++ L+++     G + P        +  +   C   
Sbjct: 380 VPY----------------PGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWRK 420

Query: 360 EANQRPTMGEVVQSL 374
           E  +RPT   +   L
Sbjct: 421 EPEERPTFEYLQAFL 435

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  139 bits (353), Expect = 4e-38
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)

Query: 104 ILGEGGFGRVFKGVLSDG-----TAVAIKRL-TCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           +LG G FG V KGV           V IK +    G+Q  +     +  +  L H ++V+
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G       S   L  + +P GSL   +    G    L  +  +   +  A+G+ YL  
Sbjct: 80  LLGLCPG---SSLQLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYL-- 131

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
             +  ++HR+  A N+LL++    +VADFG+A   P      L +       ++A E   
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP 303
            G    +SDV+SYGV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  138 bits (351), Expect = 6e-38
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 33/221 (14%)

Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVK 157
           ILGEG FG V +G L         VA+K +      Q+  +EFL E   +    H N+++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 158 LVGYYSSRDSSQHLLCY---ELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGL 212
           L+G      S            +  G L ++L          H+  +T +K  +D A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------KQAPEGRTNYLSTR 263
            YL   S    +HRD  A N +L ++    VADFGL+         +Q    +   +  +
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK---MPVK 214

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            +      A E         KSDV+++GV + E+ T G  P
Sbjct: 215 WI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  138 bits (350), Expect = 7e-38
 Identities = 69/304 (22%), Positives = 118/304 (38%), Gaps = 55/304 (18%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRN 154
            +FEP   LG GGFG VF+     D    AIKR+    ++  +E  + EV+ L++L H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 155 LVKLVGYYSS-----------RDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETR 201
           +V+   Y+++             S +  L    +L    +L+ W++G   +    +    
Sbjct: 65  IVR---YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVC 120

Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---------- 251
           + I L  A  + +LH      ++HRD K SNI    +   KV DFGL             
Sbjct: 121 LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 311
                     T  +GT  Y++PE         K D++S G++L ELL          P  
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------PFS 228

Query: 312 QENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGE 369
            +         +R+         P L  +        ++        ++P   +RP    
Sbjct: 229 TQMERVRTLTDVRNLKF------PPLFTQKYPCEYVMVQ------DMLSPSPMERPEAIN 276

Query: 370 VVQS 373
           ++++
Sbjct: 277 IIEN 280

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (350), Expect = 8e-38
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 46/297 (15%)

Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L D        A+K L      G+  +FL E  ++    H N++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           +G    R     L+    + +G L +++          +   +  +   L  A+G+ YL 
Sbjct: 92  LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLA 145

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG------Y 270
             S+  V HRD  A N +L+  F  KVADFGLA+   +    Y    V    G      +
Sbjct: 146 --SKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYD--KEY--YSVHNKTGAKLPVKW 198

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDR 328
           +A E   T     KSDV+S+GV+L EL+T G  P  D+   +  +         L    R
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFD-----ITVYLLQGRR 250

Query: 329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 385
           L +          P+     +  +   C  P+A  RP+  E+V  +  +      + 
Sbjct: 251 LLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  137 bits (348), Expect = 9e-38
 Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
            LG G FG V+ G  +  T VA+K L  G    D  FL E  ++ +L H+ LV+L    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                   +  E + NGSL  +L  P G+   L     + +A   A G+A++    +   
Sbjct: 79  QE---PIYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFI---EERNY 130

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMTGH 280
           IHRD +A+NIL+ +    K+ADFGLA+   +    Y  T   G      + APE    G 
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIED--NEY--TAREGAKFPIKWTAPEAINYGT 186

Query: 281 LLVKSDVYSYGVVLLELLT-GRKP 303
             +KSDV+S+G++L E++T GR P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP 210

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  139 bits (351), Expect = 9e-38
 Identities = 79/327 (24%), Positives = 133/327 (40%), Gaps = 39/327 (11%)

Query: 104 ILGEGGFGRVFKGVLSDG-----TAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRNLVK 157
           +LG G FG V+KG+           VAIK L      + +KE L E  +++ + + ++ +
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+G   +   S   L  +L+P G L  ++        ++  +  +   +  A+G+ YL  
Sbjct: 82  LLGICLT---STVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYL-- 133

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                ++HRD  A N+L++   H K+ DFGLAK        Y +        ++A E  +
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 278 TGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADP 335
                 +SDV+SYGV + EL+T G KP   +      E        IL   +RL +    
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASE-----ISSILEKGERLPQ---- 240

Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ---RVIECQDPTLTSS 391
                 P    I V  I   C   +A+ RP   E++    KM +   R +  Q       
Sbjct: 241 ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 294

Query: 392 NNRANLRQSSTTFDSDGTSSMFSSGPY 418
            +  +        D +    +  +  Y
Sbjct: 295 PSPTDSNFYRALMDEEDMDDVVDADEY 321

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  141 bits (358), Expect = 1e-37
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 17/202 (8%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
            +G+G FG V  G    G  VA+K +        + FL E  ++++L H NLV+L+G   
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV-I 255

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
             +     +  E +  GSL  +L         L  +  +K +LD    + YL        
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYL---EGNNF 310

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLL 282
           +HRD  A N+L+  +  AKV+DFGL K+A   +    L  +        APE        
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------APEALREKKFS 364

Query: 283 VKSDVYSYGVVLLELLT-GRKP 303
            KSDV+S+G++L E+ + GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  136 bits (346), Expect = 1e-37
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
            LG G FG V  G       VA+K +  G    D EF  E + + +L H  LVK  G  S
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 164 SRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
                   +  E + NG L ++L  HG       L+    +++  D   G+A+L      
Sbjct: 74  --KEYPIYIVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFL---ESH 123

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEYAMT 278
             IHRD  A N L++ +   KV+DFG+ +   +    Y     +GT     + APE    
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQY--VSSVGTKFPVKWSAPEVFHY 179

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                KSDV+++G+++ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  143 bits (362), Expect = 1e-37
 Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 19/265 (7%)

Query: 46  ICSCAFRGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASIL 105
           + S  +    ++ +  +  +P   D          P   +       ++     +    L
Sbjct: 287 LNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD--IEL 344

Query: 106 GEGGFGRVFKGVLSDG---TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKLVGY 161
           G G FG V +GV         VAIK L  G ++ D  E + E +++ +L +  +V+L+G 
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
             +      +L  E+   G L  +L G       +      ++    + G+ YL    + 
Sbjct: 405 CQA---EALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYL---EEK 455

Query: 222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTG 279
             +HR+  A N+LL N  +AK++DFGL+K      + Y + R  G +     APE     
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFR 514

Query: 280 HLLVKSDVYSYGVVLLELLT-GRKP 303
               +SDV+SYGV + E L+ G+KP
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP 539

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  137 bits (347), Expect = 1e-37
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 15/203 (7%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
            LG G FG V  G       VAIK +  G    D EF+ E +++  L H  LV+L G  +
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                   +  E + NG L ++L            +  +++  D    + YL        
Sbjct: 90  --KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYL---ESKQF 141

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 281
           +HRD  A N L+ +    KV+DFGL++   +   +  ++ V   F      PE  M    
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLMYSKF 198

Query: 282 LVKSDVYSYGVVLLELLT-GRKP 303
             KSD++++GV++ E+ + G+ P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  137 bits (348), Expect = 2e-37
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 21/211 (9%)

Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 158
           ++G+G FG V+ G   D        AIK L+   +      FL E  ++  L+H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G           +    + +G L  ++  P     +   +  +   L  ARG+ YL   
Sbjct: 88  IGI-MLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYL--A 141

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV-----AP 273
            Q   +HRD  A N +L+ +F  KVADFGLA+   +    Y S +       +     A 
Sbjct: 142 EQKF-VHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQ-QHRHARLPVKWTAL 197

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           E   T     KSDV+S+GV+L ELLT G  P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  137 bits (347), Expect = 2e-37
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 25/217 (11%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +LG+G +G V+ G  LS+   +AIK +     +  +    E+ +   L H+N+V+   Y 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---YL 85

Query: 163 SSRDSSQHLLCY-ELVPNGSLESWL---HGPLGVNCHLDWETRMK-IALDAARGLAYLHE 217
            S   +  +  + E VP GSL + L    GPL  N     E  +         GL YLH+
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIGFYTKQILEGLKYLHD 140

Query: 218 DSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE-- 274
           +    ++HRD K  N+L+   +   K++DFG +K+         +    GT  Y+APE  
Sbjct: 141 N---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195

Query: 275 -YAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQP 309
                G+    +D++S G  ++E+ TG+ P  ++ +P
Sbjct: 196 DKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGEP 231

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  138 bits (349), Expect = 3e-37
 Identities = 64/350 (18%), Positives = 123/350 (35%), Gaps = 55/350 (15%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHR 153
             +     +GEG FG+        DG    IK +        ++E    EV +L+ + H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 154 NLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           N+V+    +    S    L    +    G L   ++   GV      +  +   +     
Sbjct: 84  NIVQYRESFEENGS----LYIVMDYCEGGDLFKRINAQKGV--LFQEDQILDWFVQICLA 137

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           L ++H+     ++HRD K+ NI L  +   ++ DFG+A+             + GT  Y+
Sbjct: 138 LKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYL 192

Query: 272 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
           +PE      Y        KSD+++ G VL EL T +   +        ++      I+  
Sbjct: 193 SPEICENKPYNN------KSDIWALGCVLYELCTLKHAFE------AGSMKNLVLKIISG 240

Query: 326 KDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC 383
                    P +   Y  +    +                RP++  +++   + +R+ + 
Sbjct: 241 S-------FPPVSLHYSYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKF 287

Query: 384 QDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTA 433
             P L +            TF   G+  + +  P SG ++       +  
Sbjct: 288 LSPQLIAEE------FCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKIT 331

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  137 bits (347), Expect = 3e-37
 Identities = 71/326 (21%), Positives = 110/326 (33%), Gaps = 50/326 (15%)

Query: 54  RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 113
             +K     +AK +     T        T        E +E  +       +G G FG V
Sbjct: 15  SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEV 74

Query: 114 FKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH 170
            +      G   A+K  RL     +       E+   + L    +V     Y +      
Sbjct: 75  HRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVP---LYGAVREGPW 124

Query: 171 LLCY-ELVPNGSLESWL--HGPLGVNCHLDWETR-MKIALDAARGLAYLHEDSQPCVIHR 226
           +  + EL+  GSL   +   G L        E R +     A  GL YLH      ++H 
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLP-------EDRALYYLGQALEGLEYLHTR---RILHG 174

Query: 227 DFKASNILLENN-FHAKVADFGLAKQ-APEGRTNYLSTR--VMGTFGYVAPEYAM-TGHL 281
           D KA N+LL ++   A + DFG A    P+G    L T   + GT  ++APE  M     
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234

Query: 282 LVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK 340
             K D++S   ++L +L G  P     +      + +   PI         L        
Sbjct: 235 A-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT------- 286

Query: 341 YPKEDFIRVCTIAAACVAPEANQRPT 366
                 I+        +  E   R +
Sbjct: 287 ---AQAIQ------EGLRKEPVHRAS 303

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  138 bits (350), Expect = 4e-37
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 21/211 (9%)

Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L D        A+K L      G+  +FL E  ++    H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G    R     L+    + +G L +++        +   +  +   L  A+G+ +L   
Sbjct: 156 LGI-CLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFL--A 209

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV-----AP 273
           S+  V HRD  A N +L+  F  KVADFGLA+   +    + S     T   +     A 
Sbjct: 210 SKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVH-NKTGAKLPVKWMAL 265

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           E   T     KSDV+S+GV+L EL+T G  P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  136 bits (344), Expect = 4e-37
 Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 40/289 (13%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQ-QGDKEFLV-EVEMLSRLHHR 153
            ++E    +G G +GR  K    SDG  +  K L  G   + +K+ LV EV +L  L H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           N+V+       R ++   +  E    G L S +        +LD E  +++       L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 214 YLHE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
             H   D    V+HRD K +N+ L+   + K+ DFGLA+      T++  T V GT  Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYM 183

Query: 272 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
           +PE      Y        KSD++S G +L EL     P          +    A  I   
Sbjct: 184 SPEQMNRMSYNE------KSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREG 231

Query: 326 KDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
           K         R+  +Y  E  + I         +  +   RP++ E+++
Sbjct: 232 K-------FRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEILE 267

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  141 bits (357), Expect = 4e-37
 Identities = 75/236 (31%), Positives = 109/236 (46%), Gaps = 16/236 (6%)

Query: 74  LGGSLPHPTSTRFLAYEELKEATNNFEPASI-----LGEGGFGRVFKGVLSDGTAVAIKR 128
           L   L     T     + L +        S+     LG+G FG V+ G  +  T VAIK 
Sbjct: 239 LCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT 298

Query: 129 LTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG 188
           L  G    +  FL E +++ +L H  LV+L    S        +  E +  GSL  +L G
Sbjct: 299 LKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKGSLLDFLKG 354

Query: 189 PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 248
             G   +L     + +A   A G+AY+   +    +HRD +A+NIL+  N   KVADFGL
Sbjct: 355 ETG--KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 409

Query: 249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           A+   +               + APE A+ G   +KSDV+S+G++L EL T GR P
Sbjct: 410 ARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  137 bits (346), Expect = 5e-37
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 20/215 (9%)

Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVK 157
           +LG+G FG V +  L         VA+K L          +EFL E   +    H ++ K
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 158 LVGYYSSRDSSQHLLCY----ELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           LVG      +   L         + +G L ++L          +L  +T ++  +D A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF--G 269
           + YL   S+   IHRD  A N +L  +    VADFGL+++      +Y            
Sbjct: 150 MEYL--SSRNF-IHRDLAARNCMLAEDMTVCVADFGLSRKIYS--GDYYRQGCASKLPVK 204

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           ++A E        V SDV+++GV + E++T G+ P
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  140 bits (354), Expect = 7e-37
 Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 15/204 (7%)

Query: 104 ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
            LG G +G V++GV       VA+K L     + + EFL E  ++  + H NLV+L+G  
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
           +        +  E +  G+L  +L         +     + +A   +  + YL + +   
Sbjct: 286 T--REPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKN--- 338

Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGH 280
            IHR+  A N L+  N   KVADFGL++       +  +      F     APE      
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 281 LLVKSDVYSYGVVLLELLT-GRKP 303
             +KSDV+++GV+L E+ T G  P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP 419

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  138 bits (350), Expect = 1e-36
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 15/203 (7%)

Query: 104 ILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
            LG G FG V+    +  T VA+K +  G    +  FL E  ++  L H  LVKL    +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV 223
                   +  E +  GSL  +L    G          +  +   A G+A++    Q   
Sbjct: 254 K---EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFI---EQRNY 305

Query: 224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGHL 281
           IHRD +A+NIL+  +   K+ADFGLA+   +   N  + R    F     APE    G  
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIED---NEYTAREGAKFPIKWTAPEAINFGSF 362

Query: 282 LVKSDVYSYGVVLLELLT-GRKP 303
            +KSDV+S+G++L+E++T GR P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  134 bits (340), Expect = 1e-36
 Identities = 64/305 (20%), Positives = 107/305 (35%), Gaps = 63/305 (20%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRL-H 151
           T  F     +G G FG VFK V   DG   AIKR      G   ++  L EV   + L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 152 HRNLVKLVGYYSSRDSSQHLLCY-ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           H ++V+   Y+S+     H+L   E    GSL   +     +  +        + L   R
Sbjct: 70  HSHVVR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENN-------------------FHAKVADFGLAKQ 251
           GL Y+H  S   ++H D K SNI +                         K+ D G   +
Sbjct: 127 GLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 252 APEGRTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
               +         G   ++A E       HL  K+D+++  + ++             P
Sbjct: 184 ISSPQV------EEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL-----P 231

Query: 310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTM 367
              +    W    +R          PR+     +E  + ++        + P+  +RP+ 
Sbjct: 232 RNGD---QWHE--IRQGRL------PRIPQVLSQEFTELLK------VMIHPDPERRPSA 274

Query: 368 GEVVQ 372
             +V+
Sbjct: 275 MALVK 279

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  135 bits (341), Expect = 2e-36
 Identities = 65/282 (23%), Positives = 96/282 (34%), Gaps = 42/282 (14%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRL-HHR 153
           +F+  S LG G +G VFK     DG   A+KR      G +     L EV    ++  H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 154 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             V+      + +    L L  EL    SL+            L          D    L
Sbjct: 118 CCVR---LEQAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLAL 170

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
           A+LH      ++H D K +NI L      K+ DFGL  +   G       +  G   Y+A
Sbjct: 171 AHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQE-GDPRYMA 224

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
           PE     +    +DV+S G+ +LE+    +      P G E         LR        
Sbjct: 225 PELLQGSYGT-AADVFSLGLTILEVACNMEL-----PHGGEGW-----QQLRQGY----- 268

Query: 333 ADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             P        E    +         + P+   R T   ++ 
Sbjct: 269 LPPEFTAGLSSELRSVLV------MMLEPDPKLRATAEALLA 304

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (342), Expect = 2e-36
 Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 17/208 (8%)

Query: 104 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 158
           I+G G  G V  G L         VAIK L  G  +  + +FL E  ++ +  H N+++L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +       ++  E + NGSL+++L    G          + +      G+ YL   
Sbjct: 116 EGVVT--RGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYL--- 167

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYA 276
           S    +HRD  A N+L+++N   KV+DFGL++   E   +   T   G       APE  
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTAPEAI 226

Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                   SDV+S+GVV+ E+L  G +P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  134 bits (339), Expect = 2e-36
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 158
            +GEG FG V +G+         AVAIK          + +FL E   + +  H ++VKL
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G  +    +   +  EL   G L S+L         LD  + +  A   +  LAYL   
Sbjct: 82  IGVITE---NPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYL--- 132

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
                +HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE    
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 191

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP 303
                 SDV+ +GV + E+L  G KP
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP 217

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  134 bits (339), Expect = 2e-36
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 15/204 (7%)

Query: 104 ILGEGGFGRVFKGVLSDG-TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
            LG G +G V++GV       VA+K L     + + EFL E  ++  + H NLV+L+G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPC 222
           +        +  E +  G+L  +L         +     + +A   +  + YL    +  
Sbjct: 79  TREPPF--YIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYL---EKKN 131

Query: 223 VIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYAMTGH 280
            IHRD  A N L+  N   KVADFGL++       +  +      F     APE      
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNK 188

Query: 281 LLVKSDVYSYGVVLLELLT-GRKP 303
             +KSDV+++GV+L E+ T G  P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  135 bits (343), Expect = 2e-36
 Identities = 65/356 (18%), Positives = 125/356 (35%), Gaps = 57/356 (16%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRL--HHRNLVKLVG 160
           +G GG  +VF+ +       AIK +            +  E+  L++L  H   +++L  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           Y          +  E   N  L SWL     +      D   R     +    +  +H+ 
Sbjct: 77  YE--ITDQYIYMVMECG-NIDLNSWLKKKKSI------DPWERKSYWKNMLEAVHTIHQH 127

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---- 274
               ++H D K +N L+ +    K+ DFG+A Q     T+ +    +GT  Y+ PE    
Sbjct: 128 G---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 275 --YAMTGHLLV-----KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 327
              +            KSDV+S G +L  +  G+ P          N +           
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQI----------S 228

Query: 328 RLEELADPRLGGKYPK------EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI 381
           +L  + DP    ++P       +D ++       C+  +  QR ++ E++    +  +  
Sbjct: 229 KLHAIIDPNHEIEFPDIPEKDLQDVLK------CCLKRDPKQRISIPELLAHPYVQIQTH 282

Query: 382 ECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSE 437
                   ++     +       +S  +    +   Y   S  ++ N S +  F +
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEK 338

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  133 bits (337), Expect = 4e-36
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 22/209 (10%)

Query: 104 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 158
           ILGEG FG V++GV      +   VA+K         +K +F+ E  ++  L H ++VKL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G           +  EL P G L  +L         L   T +  +L   + +AYL   
Sbjct: 79  IGIIEE---EPTWIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYL--- 129

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT---FGYVAPEY 275
                +HRD    NIL+ +    K+ DFGL++   +   +Y   +   T     +++PE 
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED--EDY--YKASVTRLPIKWMSPES 185

Query: 276 AMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                    SDV+ + V + E+L+ G++P
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP 214

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (342), Expect = 5e-36
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 17/208 (8%)

Query: 104 ILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V  G L        +VAIK L  G  +  + +FL E  ++ +  H N+++L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            G  +   S   ++  E + NGSL+S+L               + +    A G+ YL   
Sbjct: 112 EGVVT--KSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYL--- 163

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY--VAPEYA 276
           S    +HRD  A NIL+ +N   KV+DFGL +   +      +TR  G       +PE  
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR-GGKIPIRWTSPEAI 222

Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                   SDV+SYG+VL E+++ G +P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP 250

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  133 bits (338), Expect = 8e-36
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 28/214 (13%)

Query: 104 ILGEGGFGRVFKGVLSDGTA-----VAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           ++G G FG V+KG+L   +      VAIK L  G  +  + +FL E  ++ +  H N+++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L G  S       ++  E + NG+L+ +L    G          + +    A G+ YL  
Sbjct: 111 LEGVIS--KYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYL-- 163

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV-------MGTFGY 270
            +    +HRD  A NIL+ +N   KV+DFGL++   +      +T               
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----- 217

Query: 271 VAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            APE          SDV+S+G+V+ E++T G +P
Sbjct: 218 -APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  135 bits (342), Expect = 1e-35
 Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 44/289 (15%)

Query: 98  NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL-HH 152
           +F P  +LG G  G +    + D   VA+KR+         E       EV++L     H
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-------LPECFSFADREVQLLRESDEH 77

Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
            N+++        D     +  EL    +L+ ++      +  L+    + +      GL
Sbjct: 78  PNVIRYFCTEK--DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGL 131

Query: 213 AYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLAKQAPEGRTNYLSTR-VMG 266
           A+LH  +   ++HRD K  NIL+          A ++DFGL K+   GR ++     V G
Sbjct: 132 AHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 267 TFGYVAPEY---AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 323
           T G++APE        +     D++S G V   +++         P G+         IL
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH-----PFGKSLQRQAN--IL 241

Query: 324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
                L+ L   +      + + I         +A +  +RP+   V++
Sbjct: 242 LGACSLDCLHPEKHEDVIAR-ELIE------KMIAMDPQKRPSAKHVLK 283

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  132 bits (334), Expect = 2e-35
 Identities = 56/227 (24%), Positives = 89/227 (39%), Gaps = 22/227 (9%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGY 161
           ILG+G    VF+G     G   AIK           +  + E E+L +L+H+N+VKL   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQP 221
                +   +L  E  P GSL + L  P      L     + +  D   G+ +L E+   
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 222 CVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
            ++HR+ K  NI+     +     K+ DFG A++  +       +   GT  Y+ P+   
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLY-GTEEYLHPDMYE 188

Query: 278 TGHLLV--------KSDVYSYGVVLLELLTGRKP-VDMSQPSGQENL 315
              L            D++S GV      TG  P      P   + +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  130 bits (330), Expect = 5e-35
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 32/218 (14%)

Query: 104 ILGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
            LG+G F ++FKGV            T V +K L    +   + F     M+S+L H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           V   G        +++L  E V  GSL+++L         ++   ++++A   A  + +L
Sbjct: 75  VLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFL 129

Query: 216 HEDSQPCVIHRDFKASNILLE--------NNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
               +  +IH +  A NILL         N    K++D G++        + L  R+   
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--KDILQERIPWV 184

Query: 268 FGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLT-GRKP 303
                PE       L + +D +S+G  L E+ + G KP
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  132 bits (334), Expect = 6e-35
 Identities = 73/405 (18%), Positives = 141/405 (34%), Gaps = 51/405 (12%)

Query: 52  RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 111
           RG   K +     + +  D+  LG       S+   A E +      +     +G GG  
Sbjct: 13  RGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS--ANECISVKGRIYSILKQIGSGGSS 70

Query: 112 RVFKGVLSDGTAVAIKR--LTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDS 167
           +VF+ +       AIK   L     Q    +  E+  L++L   +   ++L  Y      
Sbjct: 71  KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--ITD 128

Query: 168 SQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIH 225
               +  E   N  L SWL     +      D   R     +    +  +H+     ++H
Sbjct: 129 QYIYMVMECG-NIDLNSWLKKKKSI------DPWERKSYWKNMLEAVHTIHQHG---IVH 178

Query: 226 RDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTG 279
            D K +N L+ +    K+ DFG+A Q     T+ +    +G   Y+ PE       +   
Sbjct: 179 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237

Query: 280 HLLV-----KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE--EL 332
                    KSDV+S G +L  +  G+ P          N ++    I+     +E  ++
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAIIDPNHEIEFPDI 292

Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSN 392
            +  L      +D ++       C+  +  QR ++ E++    +  +          ++ 
Sbjct: 293 PEKDL------QDVLK------CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 340

Query: 393 NRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTAVFSE 437
               +       +S  +    +   Y   S  ++ N S +  F +
Sbjct: 341 EMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEK 385

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  136 bits (344), Expect = 6e-35
 Identities = 72/279 (25%), Positives = 117/279 (41%), Gaps = 35/279 (12%)

Query: 104 ILGEGGFGRVFKGVLSDG----TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVKL 158
            +GEG FG V +G+         AVAIK          + +FL E   + +  H ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G  +    +   +  EL   G L S+L         LD  + +  A   +  LAYL   
Sbjct: 457 IGVITE---NPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLE-- 508

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
           S+  V HRD  A N+L+ +N   K+ DFGL++   E  T Y +++      ++APE    
Sbjct: 509 SKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINF 566

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
                 SDV+ +GV + E+L  G KP   +      +         + + +RL       
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNND-----VIGRIENGERLPM----- 613

Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P      + ++   C A + ++RP   E+   L 
Sbjct: 614 -----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  130 bits (330), Expect = 8e-35
 Identities = 50/240 (20%), Positives = 88/240 (36%), Gaps = 30/240 (12%)

Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD--K 138
              T  L ++ +      +     +G GG  +VF+ +       AIK +           
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 71

Query: 139 EFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNC 194
            +  E+  L++L   +   ++L  Y          +  E   N  L SWL     +    
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYE--ITDQYIYMVMECG-NIDLNSWLKKKKSI---- 124

Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
             D   R     +    +  +H+     ++H D K +N L+ +    K+ DFG+A Q   
Sbjct: 125 --DPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 178

Query: 255 GRTNYLSTRVMGTFGYVAPE------YAMTGHLLV-----KSDVYSYGVVLLELLTGRKP 303
             T+ +    +GT  Y+ PE       +            KSDV+S G +L  +  G+ P
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  130 bits (330), Expect = 9e-35
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 37/223 (16%)

Query: 104 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 156
            LG+G FG V++GV          T VAIK +       ++ EFL E  ++   +  ++V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMK----IALDAAR 210
           +L+G  S       L+  EL+  G L+S+L    P   N  +     +     +A + A 
Sbjct: 92  RLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------KQAPEGRTNYLS 261
           G+AYL+  +   V HRD  A N ++  +F  K+ DFG+          ++  +G    L 
Sbjct: 150 GMAYLN--ANKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL---LP 203

Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            R M      +PE    G     SDV+S+GVVL E+ T   +P
Sbjct: 204 VRWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  130 bits (329), Expect = 1e-34
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 33/222 (14%)

Query: 105 LGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF     +         VA+K L    +   ++F  E E+L+ L H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR---------MKIALD 207
            G     +    L+ +E + +G L  +L  HGP         +           + +A  
Sbjct: 109 FG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
            A G+ YL   +    +HRD    N L+      K+ DFG+++      T+Y   R +G 
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--TDY--YR-VGG 218

Query: 268 FGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
              +      PE  +      +SDV+S+GVVL E+ T G++P
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (340), Expect = 2e-34
 Identities = 66/316 (20%), Positives = 109/316 (34%), Gaps = 48/316 (15%)

Query: 99  FEPASILGEGGFGRVFKGV--LSDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLHHRNL 155
           +E    +  GG G ++  +    +G  V +K L   G    +   + E + L+ + H ++
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 156 VKLVGYYSSRDSSQHLLCY---ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           V++  +    D     + Y   E V   SL+      L           +   L+    L
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL------PVAEAIAYLLEILPAL 195

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
           +YLH      +++ D K  NI+L      K+ D G   +       Y    + GT G+ A
Sbjct: 196 SYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGY----LYGTPGFQA 245

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
           PE        V +D+Y+ G  L  L       +     G    +    P+L+  D    L
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----LPEDDPVLKTYDSYGRL 300

Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQRVIECQDPTLTSS 391
                              +  A   P+  QR  T  E+   L  V R +  QD  +   
Sbjct: 301 -------------------LRRAI-DPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRP 340

Query: 392 NNRANLRQSSTTFDSD 407
                   S +TF  D
Sbjct: 341 GLSTIFSPSRSTFGVD 356

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (325), Expect = 3e-34
 Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 38/225 (16%)

Query: 105 LGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKL 158
           LGEG FG+VF           D   VA+K L        K+F  E E+L+ L H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMKIAL 206
            G     D    ++ +E + +G L  +L              P      L     + IA 
Sbjct: 83  YG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS--TRV 264
             A G+ YL   +    +HRD    N L+  N   K+ DFG++      R  Y +   RV
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVYSTDYYRV 191

Query: 265 MGTFGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            G    +      PE  M      +SDV+S+GV+L E+ T G++P
Sbjct: 192 GGH-TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  129 bits (327), Expect = 3e-34
 Identities = 90/326 (27%), Positives = 135/326 (41%), Gaps = 60/326 (18%)

Query: 104 ILGEGGFGRVFKGVLSDG---TAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNLVKL 158
           ++GEG FG+V K  +         AIKR+     + D  +F  E+E+L +L HH N++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMKIAL 206
           +G    R      L  E  P+G+L  +L                     L  +  +  A 
Sbjct: 92  LGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST---- 262
           D ARG+ YL   SQ   IHRD  A NIL+  N+ AK+ADFGL++        Y+      
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV----YVKKTMGR 202

Query: 263 ---RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP-VDMSQPSGQENLVT 317
              R M      A E          SDV+SYGV+L E+++ G  P   M   +  E    
Sbjct: 203 LPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAE---- 249

Query: 318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KM 376
                L    RLE+   P        E    V  +   C   +  +RP+  +++ SL +M
Sbjct: 250 -LYEKLPQGYRLEK---PL---NCDDE----VYDLMRQCWREKPYERPSFAQILVSLNRM 298

Query: 377 VQRVIECQDPTLTSSNNRANLRQSST 402
           ++      + TL      A +  S+ 
Sbjct: 299 LEERKTYVNTTLYEKFTYAGIDCSAE 324

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (330), Expect = 3e-34
 Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 22/234 (9%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRN 154
           + +  + ILG+G    VF+G     G   AIK           +  + E E+L +L+H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL        +   +L  E  P GSL + L  P      L     + +  D   G+ +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127

Query: 215 LHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           L E+    ++HR+ K  NI+     +     K+ DFG A++  +       +   GT  Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLY-GTEEY 181

Query: 271 VAPEYAMTGHLLV--------KSDVYSYGVVLLELLTGRKP-VDMSQPSGQENL 315
           + P+      L            D++S GV      TG  P      P   + +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  129 bits (326), Expect = 3e-34
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 29/219 (13%)

Query: 104 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 156
            LG G FG V++G +S          VA+K L     + D+ +FL+E  ++S+ +H+N+V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGP-LGVNCHLDWETRMKIALDAARGLA 213
           + +G   S  S    +  EL+  G L+S+L    P       L     + +A D A G  
Sbjct: 97  RCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 214 YLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           YL  +     IHRD  A N LL        AK+ DFG+A+          S    G    
Sbjct: 155 YL--EENHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGCAM 206

Query: 271 V-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           +      PE  M G    K+D +S+GV+L E+ + G  P
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  132 bits (333), Expect = 1e-33
 Identities = 68/258 (26%), Positives = 103/258 (39%), Gaps = 22/258 (8%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL 150
            +    +E    LG GGFG V + +    G  VAIK+        ++E    E++++ +L
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69

Query: 151 HHRNLVKLVGYYSSR----DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           +H N+V              +   LL  E    G L  +L+      C L       +  
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLS 128

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           D +  L YLHE+    +IHRD K  NI+L         K+ D G AK+  +G     +  
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEF 183

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 323
           V GT  Y+APE        V  D +S+G +  E +TG +P            V W    +
Sbjct: 184 V-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL-----PNWQPVQWHG-KV 236

Query: 324 RDKDRLEELADPRLGGKY 341
           R+K     +    L G  
Sbjct: 237 REKSNEHIVVYDDLTGAV 254

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  126 bits (320), Expect = 2e-33
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 39/228 (17%)

Query: 104 ILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 155
            LG G FG+V +         +    VA+K L  G    +    + E+++L  + HH N+
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMK 203
           V L+G   ++     ++  E    G+L ++L                     L  E  + 
Sbjct: 94  VNLLGA-CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST- 262
            +   A+G+ +L   +    IHRD  A NILL      K+ DFGLA+   +   +Y+   
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-DYVRKG 208

Query: 263 ------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 + M      APE        ++SDV+S+GV+L E+ + G  P
Sbjct: 209 DARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (318), Expect = 2e-33
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 103 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVK 157
             LG GG   V+          VAIK +     +  +E L     EV   S+L H+N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYL 215
           +       +   + L  E +   +L  ++  HGPL        +T +        G+ + 
Sbjct: 76  M--IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL------SVDTAINFTNQILDGIKHA 127

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H+     ++HRD K  NIL+++N   K+ DFG+AK A    +   +  V+GT  Y +PE 
Sbjct: 128 HDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQ 183

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           A        +D+YS G+VL E+L G  P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (321), Expect = 3e-33
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 29/219 (13%)

Query: 104 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 156
            LG G FG V++G +S          VA+K L     + D+ +FL+E  ++S+ +H+N+V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGP-LGVNCHLDWETRMKIALDAARGLA 213
           + +G   S  S    +  EL+  G L+S+L    P       L     + +A D A G  
Sbjct: 138 RCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 214 YLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           YL  +     IHRD  A N LL        AK+ DFG+A+               G    
Sbjct: 196 YL--EENHF-IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----GYYRKGGCAM 247

Query: 271 V-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           +      PE  M G    K+D +S+GV+L E+ + G  P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  124 bits (314), Expect = 8e-33
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 29/221 (13%)

Query: 105 LGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           LGE  FG+V+KG L          AVAIK L    +   + EF  E  + +RL H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETRMKIA 205
           L+G  +        + +    +G L  +L                 V   L+    + + 
Sbjct: 77  LLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              A G+ YL   S   V H+D    N+L+ +  + K++D GL ++      +Y      
Sbjct: 135 AQIAAGMEYL--SSHHVV-HKDLATRNVLVYDKLNVKISDLGLFREVYA--ADYYKLLGN 189

Query: 266 GTF--GYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                 ++APE  M G   + SD++SYGVVL E+ + G +P
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  125 bits (316), Expect = 1e-32
 Identities = 41/348 (11%), Positives = 77/348 (22%), Gaps = 51/348 (14%)

Query: 57  KASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKG 116
               +   +P            P    T   +   L +     +    L  G    VF  
Sbjct: 24  YCREEALKEPAAMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLV 81

Query: 117 V-LSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSRLHHRN------------------ 154
             +      A+K  T G +    E           +RL   +                  
Sbjct: 82  RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141

Query: 155 ------LVKLVGYYSSRDSSQHLLCYELVP--NGSLESWLHGPLGVNCHLDWETRMKIAL 206
                   +L         + +LL           L S L                 +  
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTA 201

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
              R  A L       ++H  F   N+ +  +    + D     +               
Sbjct: 202 QLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SSV 253

Query: 267 TFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR 324
              Y   E+            + +  G+ +  +     P  +  P  +    +W RP LR
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG---SWKRPSLR 310

Query: 325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
                              +  I         +  +  +R    E ++
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRLLPLEAME 352

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  123 bits (311), Expect = 2e-32
 Identities = 67/221 (30%), Positives = 94/221 (42%), Gaps = 37/221 (16%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVE 145
            +FE    LG+G FG V+          +A+K L        K  L           EVE
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-------FKAQLEKAGVEHQLRREVE 61

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMK 203
           + S L H N+++L GY+   D+++  L  E  P G++   L            +  T   
Sbjct: 62  IQSHLRHPNILRLYGYFH--DATRVYLILEYAPLGTVYRELQKLSKFD-----EQRTA-T 113

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
              + A  L+Y H      VIHRD K  N+LL +    K+ADFG +  AP  R   L   
Sbjct: 114 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-- 168

Query: 264 VMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKP 303
             GT  Y+ PE      H   K D++S GV+  E L G+ P
Sbjct: 169 --GTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPP 206

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  124 bits (313), Expect = 2e-32
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 20/211 (9%)

Query: 103 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVK 157
            ILG GG   V     L D   VA+K L       D  F +    E +  + L+H  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 158 L--VGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLA 213
           +   G   +       +  E V   +L   +   GP+        +  +++  DA + L 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------TPKRAIEVIADACQALN 130

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST-RVMGTFGYVA 272
           + H++    +IHRD K +NI++      KV DFG+A+   +   +   T  V+GT  Y++
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           PE A    +  +SDVYS G VL E+LTG  P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  124 bits (314), Expect = 2e-32
 Identities = 62/229 (27%), Positives = 92/229 (40%), Gaps = 42/229 (18%)

Query: 105 LGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRN 154
           LGEG FG+V                  VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----------M 202
           ++ L+G  +        +  E    G+L  +L    P G+    D              +
Sbjct: 103 IINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                 ARG+ YL   +    IHRD  A N+L+  N   K+ADFGLA+        Y  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-DYYKKT 216

Query: 263 RV-------MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                    M      APE         +SDV+S+GV++ E+ T G  P
Sbjct: 217 TNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  124 bits (314), Expect = 2e-32
 Identities = 43/238 (18%), Positives = 90/238 (37%), Gaps = 48/238 (20%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV-------------- 142
           N++     L +G F ++      D    A+K+        +K  L               
Sbjct: 31  NDYRIIRTLNQGKFNKI-ILCEKDNKFYALKKY-------EKSLLEKKRDFTKSNNDKIS 82

Query: 143 ----------EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPL 190
                     E+++++ + +   +   G  +  +  +  + YE + N S+  +      L
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIIT--NYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 191 --GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL 248
                C +  +    I        +Y+H  ++  + HRD K SNIL++ N   K++DFG 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGE 198

Query: 249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLTGRKP 303
           ++   + +   +     GT+ ++ PE   +        K D++S G+ L  +     P
Sbjct: 199 SEYMVDKK---IKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (312), Expect = 2e-32
 Identities = 53/208 (25%), Positives = 80/208 (38%), Gaps = 20/208 (9%)

Query: 103 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRLHHRNLVK 157
            ++G GG G V++         VA+K ++      D  F      E     RL   ++V 
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYL 215
           +  +       Q  +   L+    L + L   GPL           + I       L   
Sbjct: 99  I--HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAP------PRAVAIVRQIGSALDAA 150

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           H        HRD K  NIL+  +  A + DFG+A    + +   L    +GT  Y+APE 
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPER 206

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKP 303
               H   ++D+Y+   VL E LTG  P
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPP 234

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  125 bits (316), Expect = 5e-32
 Identities = 71/308 (23%), Positives = 117/308 (37%), Gaps = 59/308 (19%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL----VEVEMLSRL-H 151
           N      ILG G  G V       G  VA+KR+         +F     +E+++L+    
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM-------LIDFCDIALMEIKLLTESDD 67

Query: 152 HRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL-D 207
           H N+++     ++      L +  EL  N +L+  +        N  L  E      L  
Sbjct: 68  HPNVIRYYCSETTDR---FLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILL-------------ENNFHAKVADFGLAKQAPE 254
            A G+A+LH      +IHRD K  NIL+               N    ++DFGL K+   
Sbjct: 124 IASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 255 GRTNYLSTR--VMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVLLELLTGRKPVD 305
           G++++ +      GT G+ APE     + L          D++S G V   +L+  K   
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-- 238

Query: 306 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPK-EDFIRVCTIAAACVAPEANQR 364
              P G +        I+R    L+E+          +  D I         +  +  +R
Sbjct: 239 ---PFGDKYSRESN--IIRGIFSLDEMKCLHDRSLIAEATDLIS------QMIDHDPLKR 287

Query: 365 PTMGEVVQ 372
           PT  +V++
Sbjct: 288 PTAMKVLR 295

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  123 bits (310), Expect = 6e-32
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 47/235 (20%)

Query: 104 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLV 156
            LGEG FG+V K            T VA+K L       +  + L E  +L +++H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNC------------------HL 196
           KL G   S+D    L+  E    GSL  +L     +G                      L
Sbjct: 90  KLYGA-CSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 197 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 256
                +  A   ++G+ YL   ++  ++HRD  A NIL+      K++DFGL++   E  
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE- 203

Query: 257 TNYLST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            +Y+         + M      A E         +SDV+S+GV+L E++T G  P
Sbjct: 204 DSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  122 bits (309), Expect = 6e-32
 Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 42/230 (18%)

Query: 104 ILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 155
            LG G FG+V +              VA+K L       ++   + E+++LS L +H N+
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR------------ 201
           V L+G  +       L+  E    G L ++L       +                     
Sbjct: 90  VNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
           +  +   A+G+A+L   +    IHRD  A NILL +    K+ DFGLA+      +NY+ 
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND-SNYVV 203

Query: 262 T-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
                   + M      APE         +SDV+SYG+ L EL + G  P
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  123 bits (311), Expect = 6e-32
 Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 38/226 (16%)

Query: 104 ILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 155
            LG G FG+V +              VA+K L       +K   + E++++S L  H N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL----------HGPLGVNCHLDWETRMKIA 205
           V L+G  +       L+  E    G L ++L                N        +  +
Sbjct: 113 VNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST--- 262
              A+G+A+L   +    IHRD  A N+LL N   AK+ DFGLA+      +NY+     
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-SNYIVKGNA 226

Query: 263 ----RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
               + M      APE        V+SDV+SYG++L E+ + G  P
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  123 bits (310), Expect = 1e-31
 Identities = 38/362 (10%), Positives = 97/362 (26%), Gaps = 73/362 (20%)

Query: 54  RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 113
           R  +A+ + T++   + A +L  +    T   F    EL E        ++LG+      
Sbjct: 30  RIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAY 89

Query: 114 FKGV-LSDGTAVAIKRLTCGGQQGDKE----------------------------FLVEV 144
            +      G +  +       +                                 F+   
Sbjct: 90  LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149

Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV--PNGSLESWLHGPLGVNCHLDWETRM 202
           +++     + ++++               Y  +     +    L      +  L    R+
Sbjct: 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 209

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           ++ L   R LA LH      ++H   +  +I+L+      +  F    +           
Sbjct: 210 QLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV----- 261

Query: 263 RVMGTFGYVAPEYAMTGHLLV-----------KSDVYSYGVVLLELLTGRKPVDMSQPSG 311
               + G+  PE       +              D ++ G+V+  +     P+       
Sbjct: 262 -SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT------ 314

Query: 312 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
           ++  +  +  I R    + +               +         +      R    + +
Sbjct: 315 KDAALGGSEWIFRSCKNIPQPV----------RALLE------GFLRYPKEDRLLPLQAM 358

Query: 372 QS 373
           ++
Sbjct: 359 ET 360

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  122 bits (308), Expect = 2e-31
 Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 42/230 (18%)

Query: 104 ILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHR 153
            LGEG FG+V                  VA+K L     + D  + + E+EM+  +  H+
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL------------HGPLGVNCHLDWETR 201
           N++ L+G  +        +  E    G+L  +L                     + ++  
Sbjct: 148 NIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
           +      ARG+ YL   +    IHRD  A N+L+  N   K+ADFGLA+        Y  
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-DYYKK 261

Query: 262 TRV-------MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           T         M      APE         +SDV+S+GV++ E+ T G  P
Sbjct: 262 TTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (308), Expect = 3e-31
 Identities = 77/341 (22%), Positives = 129/341 (37%), Gaps = 72/341 (21%)

Query: 105 LGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRN 154
           LGEG FG+V             +  T VA+K L     + D  + + E+EM+  +  H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR----------M 202
           ++ L+G  +        +  E    G+L  +L    P G+    +              +
Sbjct: 137 IINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
             A   ARG+ YL   +    IHRD  A N+L+  +   K+ADFGLA+        Y  T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-DYYKKT 250

Query: 263 -------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQP----S 310
                  + M      APE         +SDV+S+GV+L E+ T G        P     
Sbjct: 251 TNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGVP 298

Query: 311 GQENLVTWARPILRDKDRLE--ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG 368
            +E        +L++  R++        L   Y          +   C     +QRPT  
Sbjct: 299 VEELF-----KLLKEGHRMDKPSNCTNEL---Y---------MMMRDCWHAVPSQRPTFK 341

Query: 369 EVVQSL-KMVQRVIECQDPTLTSSNNRANLRQSSTTFDSDG 408
           ++V+ L ++V      +       ++      ++     +G
Sbjct: 342 QLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTENLYFNG 382

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  121 bits (305), Expect = 3e-31
 Identities = 62/260 (23%), Positives = 94/260 (36%), Gaps = 35/260 (13%)

Query: 58  ASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV 117
            +P +  K         G     P +           +   +     LG+GGF + F+  
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS 61

Query: 118 -LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHRNLVKLVGYYSSRD 166
                   A K +        K  L+          E+ +   L H+++V   G++   D
Sbjct: 62  DADTKEVFAGKIV-------PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--D 112

Query: 167 SSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI 224
           +    +  EL    SL         L      + E R         G  YLH   +  VI
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALT-----EPEAR-YYLRQIVLGCQYLH---RNRVI 163

Query: 225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-TGHLLV 283
           HRD K  N+ L  +   K+ DFGLA +  E         + GT  Y+APE     GH   
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-LCGTPNYIAPEVLSKKGHSF- 220

Query: 284 KSDVYSYGVVLLELLTGRKP 303
           + DV+S G ++  LL G+ P
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP 240

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  120 bits (302), Expect = 4e-31
 Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 35/220 (15%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVE 145
           ++F+    LG+G FG V+      +   +A+K L        K  L           E+E
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVL-------FKSQLEKEGVEHQLRREIE 66

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMK 203
           + S L H N++++  Y+   D  +  L  E  P G L   L  HG        +  +   
Sbjct: 67  IQSHLRHPNILRMYNYFH--DRKRIYLMLEFAPRGELYKELQKHGRFD-----EQRSATF 119

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           +  + A  L Y HE     VIHRD K  N+L+      K+ADFG +  AP  R   +   
Sbjct: 120 ME-ELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC-- 173

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             GT  Y+ PE         K D++  GV+  E L G  P
Sbjct: 174 --GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (304), Expect = 4e-31
 Identities = 69/326 (21%), Positives = 116/326 (35%), Gaps = 56/326 (17%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYY 162
           L EGGF  V++   +  G   A+KRL    ++ ++  + EV  + +L  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 163 SSRDSSQHLLCYELV-----PNGSL-----ESWLHGPLGVNCHLDWETR-MKIALDAARG 211
           S           E +       G L     +    GPL            +KI     R 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL-------SCDTVLKIFYQTCRA 148

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA---PEGRTNYLSTRVM--- 265
           + ++H   +P +IHRD K  N+LL N    K+ DFG A      P+   +     ++   
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 266 ----GTFGYVAPE-YAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 318
                T  Y  PE   +  +  +  K D+++ G +L  L   + P +             
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--------- 258

Query: 319 ARPILRDKDRLEELADPRLGGKYPK-EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
              I+  K  +     P    +Y      IR      A +     +R ++ EVV  L+ +
Sbjct: 259 -LRIVNGKYSI-----PPHDTQYTVFHSLIR------AMLQVNPEERLSIAEVVHQLQEI 306

Query: 378 QRVIECQDPTLTSSNNRANLRQSSTT 403
                    +  +     N    S T
Sbjct: 307 AAARNVNPKSPITELLEQNGGYGSAT 332

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  121 bits (305), Expect = 4e-31
 Identities = 61/232 (26%), Positives = 90/232 (38%), Gaps = 43/232 (18%)

Query: 105 LGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRLHHRNLVK 157
           +GEG FGRVF+            T VA+K L        + +F  E  +++   + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR-------------- 201
           L+G           L +E +  G L  +L    P  V      +                
Sbjct: 115 LLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 202 ----MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 257
               + IA   A G+AYL    +  V HRD    N L+  N   K+ADFGL++       
Sbjct: 173 CAEQLCIARQVAAGMAYLS--ERKFV-HRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 258 NYLSTRVMGTFGYV-----APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
            Y           +      PE         +SDV++YGVVL E+ + G +P
Sbjct: 230 -Y----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  120 bits (302), Expect = 1e-30
 Identities = 58/235 (24%), Positives = 98/235 (41%), Gaps = 47/235 (20%)

Query: 104 ILGEGGFGRVFKGVLSDG------TAVAIKRLTCGGQQGDK-EFLVEVEMLSRL-HHRNL 155
           +LG G FG+V                VA+K L       ++   + E++M+++L  H N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETR------------ 201
           V L+G  +        L +E    G L ++L           +++E +            
Sbjct: 112 VNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 202 -----MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 256
                +  A   A+G+ +L        +HRD  A N+L+ +    K+ DFGLA+      
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 225

Query: 257 TNYLST-------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKP 303
           +NY+         + M      APE    G   +KSDV+SYG++L E+ + G  P
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  121 bits (304), Expect = 1e-30
 Identities = 42/416 (10%), Positives = 99/416 (23%), Gaps = 78/416 (18%)

Query: 54  RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 113
            ++            AD++            R  +  EL E        ++LG+      
Sbjct: 37  PQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVES--ELGERPRTLVRGTVLGQEDPYAY 94

Query: 114 FKGV-LSDGTAVAIKRLTCGGQQGDKE----------------------------FLVEV 144
            +      G +  +       +                                 F+   
Sbjct: 95  LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154

Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV--PNGSLESWLHGPLGVNCHLDWETRM 202
           +++     + ++++               Y  +     +    L      +  L    R+
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
           ++ L   R LA LH      ++H   +  +I+L+      +  F    +      +    
Sbjct: 215 QLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS-PIG 270

Query: 263 RVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 317
           R        A             +    D ++ G+ +  +     P         +  + 
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD------DAALG 324

Query: 318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
            +  I R    + +               +         +      R    + +      
Sbjct: 325 GSEWIFRSCKNIPQPV----------RALLE------GFLRYPKEDRLLPLQAM------ 362

Query: 378 QRVIECQDPTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAFDNENVSRTA 433
                 + P       R  L  +   + +DG  +     P SG S  D    +   
Sbjct: 363 ------ETPEYE--QLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAV 410

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  119 bits (301), Expect = 2e-30
 Identities = 70/310 (22%), Positives = 122/310 (39%), Gaps = 58/310 (18%)

Query: 97  NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRN 154
           ++FE  S LG G  G VFK      G  +A K +    +     + + E+++L   +   
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           +V    +Y +  S   + +C E +  GSL+  L   G +            K+++   +G
Sbjct: 93  IVG---FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL------GKVSIAVIKG 143

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           L YL E  +  ++HRD K SNIL+ +    K+ DFG++ Q      + ++   +GT  Y+
Sbjct: 144 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYM 197

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKP------------VDMSQPSGQENLVTWA 319
           +PE     H  V+SD++S G+ L+E+  GR P                            
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257

Query: 320 RPILRDKDRLEELADPRLG------------------GKYPKE--DFIRVCTIAAACVAP 359
           R   R  ++    + P +                   G +  E  DF+  C I       
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK------ 311

Query: 360 EANQRPTMGE 369
              +R  + +
Sbjct: 312 NPAERADLKQ 321

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  119 bits (300), Expect = 2e-30
 Identities = 37/235 (15%), Positives = 75/235 (31%), Gaps = 29/235 (12%)

Query: 90  EELKEATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDKEFLVE 143
            E +  +       +LGEG F +V++    D           +K           EF + 
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEFYIG 114

Query: 144 VEMLSRL---HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH-LDWE 199
            +++ RL        +K    +  ++ S  +L  EL   G+L + ++         +   
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-----------ENNFHAKVADFGL 248
             +  A+     +  +H+     +IH D K  N +L           + +    + D G 
Sbjct: 173 LVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +          + T    T G+   E         + D +     +  +L G   
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  117 bits (295), Expect = 3e-30
 Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 40/230 (17%)

Query: 91  ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV------- 142
            + E   +F+  ++LG+G F  V++   +  G  VAIK +       DK+ +        
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMI-------DKKAMYKAGMVQR 57

Query: 143 ---EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH---GPLGVNCHL 196
              EV++  +L H ++++L  Y+   DS+   L  E+  NG +  +L     P       
Sbjct: 58  VQNEVKIHCQLKHPSILELYNYFE--DSNYVYLVLEMCHNGEMNRYLKNRVKPFS----- 110

Query: 197 DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA--KQAPE 254
           + E R  +      G+ YLH      ++HRD   SN+LL  N + K+ADFGLA   + P 
Sbjct: 111 ENEARHFMH-QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166

Query: 255 GRTNYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKP 303
            +     T + GT  Y++PE A  + H L +SDV+S G +   LL GR P
Sbjct: 167 EK---HYT-LCGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPP 211

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  116 bits (293), Expect = 6e-30
 Identities = 68/281 (24%), Positives = 116/281 (41%), Gaps = 38/281 (13%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEM-LSRLHHR 153
           ++ EP   LG G +G V K   +  G  +A+KR+       + K  L+++++ +  +   
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
             V   G           +C EL+ + SL+ +    +     +  +   KIA+   + L 
Sbjct: 67  FTVTFYGALF--REGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS-TRVMGTFGYVA 272
           +LH      VIHRD K SN+L+      K+ DFG++        + ++     G   Y+A
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMA 177

Query: 273 PE----YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
           PE            VKSD++S G+ ++EL   R P             +W  P  +   +
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFP-----------YDSWGTPF-QQLKQ 225

Query: 329 LEELADPRL-GGKYPKE--DFIRVCTIAAACVAPEANQRPT 366
           + E   P+L   K+  E  DF   C          + +RPT
Sbjct: 226 VVEEPSPQLPADKFSAEFVDFTSQCLKK------NSKERPT 260

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (294), Expect = 6e-30
 Identities = 59/222 (26%), Positives = 87/222 (39%), Gaps = 35/222 (15%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEM 146
            +     LG+GGF + F+          A K +        K  L+          E+ +
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV-------PKSLLLKPHQREKMSMEISI 68

Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKI 204
              L H+++V   G++   D    +L  EL    SL         L      + E R   
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVL--ELCRRRSLLELHKRRKALT-----EPEAR-YY 120

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                 G  YLH   +  VIHRD K  N+ L  +   K+ DFGLA +  E         +
Sbjct: 121 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERKKV-L 175

Query: 265 MGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVD 305
            GT  Y+APE     GH   + DV+S G ++  LL G+ P +
Sbjct: 176 CGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFE 216

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (288), Expect = 5e-29
 Identities = 82/279 (29%), Positives = 118/279 (42%), Gaps = 49/279 (17%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLV 156
           F     +G+G FG VFKG+       VAIK +     + + E +  E+ +LS+     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 157 KLVGYYSSRDSSQHL-LCYELVPNGSLESWLH-GPLGVNCHLDWETRMKIAL---DAARG 211
           K   YY S      L +  E +  GS    L  GPL            +IA    +  +G
Sbjct: 84  K---YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL---------DETQIATILREILKG 131

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFG 269
           L YLH +     IHRD KA+N+LL  +   K+ADFG+A Q     T+    R   +GT  
Sbjct: 132 LDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL----TDTQIKRNTFVGTPF 184

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           ++APE         K+D++S G+  +EL  G  P     P     L+    P        
Sbjct: 185 WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------- 236

Query: 330 EELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPT 366
                P L G Y K   +F+       AC+  E + RPT
Sbjct: 237 -----PTLEGNYSKPLKEFV------EACLNKEPSFRPT 264

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  113 bits (286), Expect = 7e-29
 Identities = 67/296 (22%), Positives = 124/296 (41%), Gaps = 44/296 (14%)

Query: 89  YEELKEATNNFEPASI------LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFL 141
            E+L+   +  +P         +G+G  G V+  + ++ G  VAI+++    Q   +  +
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
            E+ ++    + N+V    Y  S      L +  E +  GSL   +         +D   
Sbjct: 66  NEILVMRENKNPNIVN---YLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQ 117

Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 260
              +  +  + L +LH +    VIHRD K+ NILL  +   K+ DFG   Q     T   
Sbjct: 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQ 170

Query: 261 STR--VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVT 317
           S R  ++GT  ++APE         K D++S G++ +E++ G  P ++ +       + T
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230

Query: 318 WARPILRDKDRL-EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
              P L++ ++L                DF+  C      +  E  +R +  E++Q
Sbjct: 231 NGTPELQNPEKLSAIF-----------RDFLNRCL----EMDVE--KRGSAKELLQ 269

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  112 bits (282), Expect = 4e-28
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 25/225 (11%)

Query: 89  YEELKEATNNFEPASI------LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFL 141
              L+   +  +P  +      +GEG  G V        G  VA+K +    QQ  +   
Sbjct: 31  KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF 90

Query: 142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
            EV ++    H N+V+    Y S    + L +  E +  G+L   +         L+ E 
Sbjct: 91  NEVVIMRDYQHFNVVE---MYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQ 142

Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 260
              +     + LAYLH      VIHRD K+ +ILL  +   K++DFG   Q     +  +
Sbjct: 143 IATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI----SKDV 195

Query: 261 STR--VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             R  ++GT  ++APE         + D++S G++++E++ G  P
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (282), Expect = 4e-28
 Identities = 67/250 (26%), Positives = 108/250 (43%), Gaps = 40/250 (16%)

Query: 77  SLPHPTSTRFLAYEEL---KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG 132
           S+   +  R L   +L   ++    FE   ++G G +G+V+KG  +  G   AIK +   
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 133 GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGS----LE 183
           G + ++E   E+ ML +  HHRN+    G +  ++         L  E    GS    ++
Sbjct: 61  GDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119

Query: 184 SWLHGPLGVNCHLDWETRMKIAL---DAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 240
           +     L             IA    +  RGL++LH+     VIHRD K  N+LL  N  
Sbjct: 120 NTKGNTL---------KEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167

Query: 241 AKVADFGLAKQAPEGRTNYLSTR--VMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVV 293
            K+ DFG++ Q        +  R   +GT  ++APE              KSD++S G+ 
Sbjct: 168 VKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223

Query: 294 LLELLTGRKP 303
            +E+  G  P
Sbjct: 224 AIEMAEGAPP 233

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (282), Expect = 4e-28
 Identities = 70/304 (23%), Positives = 129/304 (42%), Gaps = 40/304 (13%)

Query: 77  SLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ 135
           S+      +    +       + +    +G G +G V K V    G  +A+KR+     +
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

Query: 136 GD-KEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGV 192
            + K+ L++++++ R      +V+   +Y +        +C EL+ + S + +      V
Sbjct: 62  KEQKQLLMDLDVVMRSSDCPYIVQ---FYGALFREGDCWICMELM-STSFDKFYKYVYSV 117

Query: 193 NCHLDWETRM-KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ 251
              +  E  + KI L   + L +L E+ +  +IHRD K SNILL+ + + K+ DFG++ Q
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 252 APEGRTNYLS-TRVMGTFGYVAPEYAMTGHLL----VKSDVYSYGVVLLELLTGRKPVDM 306
                 + ++ TR  G   Y+APE            V+SDV+S G+ L EL TGR P   
Sbjct: 176 L----VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231

Query: 307 SQPSGQ--ENLVTWARPILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEAN 362
                     +V    P L + +            ++     +F+ +C         + +
Sbjct: 232 WNSVFDQLTQVVKGDPPQLSNSE----------EREFSPSFINFVNLCLTK------DES 275

Query: 363 QRPT 366
           +RP 
Sbjct: 276 KRPK 279

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  112 bits (283), Expect = 4e-28
 Identities = 68/268 (25%), Positives = 106/268 (39%), Gaps = 42/268 (15%)

Query: 57  KASPKETAKPRTADAVTLGGSLPHPTSTRF--LAYEELKEATNNFEPASI------LGEG 108
                +   P T +    G   P P   R   L   ++ E     +P  +      +G G
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHG 65

Query: 109 GFGRVFKGV-LSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKLVGYYSS 164
            FG V+    + +   VAIK+++  G+Q +   ++ + EV  L +L H N ++   Y   
Sbjct: 66  SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---YRGC 122

Query: 165 RDSSQHL-LCYELVPNGSLE--SWLHGPLGVNCHLDWETRMKIAL---DAARGLAYLHED 218
                   L  E     + +       PL           ++IA     A +GLAYLH  
Sbjct: 123 YLREHTAWLVMEYCLGSASDLLEVHKKPL---------QEVEIAAVTHGALQGLAYLHSH 173

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
           +   +IHRD KA NILL      K+ DFG A       +       +GT  ++APE  + 
Sbjct: 174 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILA 224

Query: 279 GHLL---VKSDVYSYGVVLLELLTGRKP 303
                   K DV+S G+  +EL   + P
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPP 252

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  114 bits (286), Expect = 6e-28
 Identities = 61/253 (24%), Positives = 102/253 (40%), Gaps = 42/253 (16%)

Query: 77  SLPHPTSTRFLAYEELKEATNNFEPASI---------LGEGGFGRVFKGV-LSDGTAVAI 126
           +L    +  F+ + +L     +  P ++         LG G  G V           VAI
Sbjct: 107 ALSLSRNKVFV-FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAI 165

Query: 127 KRL------TCGGQQGDKEFLV--EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVP 178
           + +          ++ D    V  E+E+L +L+H  ++K+  ++   D+  + +  EL+ 
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF---DAEDYYIVLELME 222

Query: 179 NGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL- 235
            G L   +  +  L          +          + YLHE+    +IHRD K  N+LL 
Sbjct: 223 GGELFDKVVGNKRLKEA-----TCK-LYFYQMLLAVQYLHENG---IIHRDLKPENVLLS 273

Query: 236 --ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE---YAMTGHLLVKSDVYSY 290
             E +   K+ DFG +K   E   + + T   GT  Y+APE      T       D +S 
Sbjct: 274 SQEEDCLIKITDFGHSKILGET--SLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSL 330

Query: 291 GVVLLELLTGRKP 303
           GV+L   L+G  P
Sbjct: 331 GVILFICLSGYPP 343

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (287), Expect = 8e-28
 Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 24/209 (11%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHHRNLVKLV 159
           +LG+G FG V        G   A+K +       +   +  L EV++L +L H N++KL 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
            ++   D     L  E+   G L   +                  +I      G+ Y+H+
Sbjct: 93  EFFE--DKGYFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHK 144

Query: 218 DSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
           +    ++HRD K  N+LLE+   + + ++ DFGL+      +   +  ++ GT  Y+APE
Sbjct: 145 NK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKI-GTAYYIAPE 198

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             + G    K DV+S GV+L  LL+G  P
Sbjct: 199 -VLHGTYDEKCDVWSTGVILYILLSGCPP 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  110 bits (277), Expect = 2e-27
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           +E    LG+G FG+V+K      G   A K +    ++  ++++VE+E+L+   H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 158 LVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           L+G Y        L +  E  P G++++ +         L       +       L +LH
Sbjct: 81  LLGAYYHDG---KLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLH 134

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR--VMGTFGYVAPE 274
                 +IHRD KA N+L+      ++ADFG++ +        L  R   +GT  ++APE
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKN----LKTLQKRDSFIGTPYWMAPE 187

Query: 275 YAMTGHLL-----VKSDVYSYGVVLLELLTGRKP 303
             M   +       K+D++S G+ L+E+     P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (278), Expect = 2e-27
 Identities = 66/345 (19%), Positives = 112/345 (32%), Gaps = 92/345 (26%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEML------- 147
            +FEP   +G GGFG VF+     D    AIKR+    ++  +E  + EV+ L       
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 148 ----------------------------------------------SRLHHRNLVKLVGY 161
                                                          R       K    
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 162 YSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
                S +  L    +L    +L+ W++    +    +    + I +  A  + +LH   
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE-DREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQ----------APEGRTNYLSTRVMGTFG 269
              ++HRD K SNI    +   KV DFGL                       T  +GT  
Sbjct: 185 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           Y++PE     +   K D++S G++L ELL              E +       +R+    
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-------QMERVRIITD--VRNLKF- 291

Query: 330 EELADPRLGGKYPKE-DFIRVCTIAAACVAPEANQRPTMGEVVQS 373
                     KYP+E   ++        ++P   +RP   +++++
Sbjct: 292 ----PLLFTQKYPQEHMMVQ------DMLSPSPTERPEATDIIEN 326

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  113 bits (284), Expect = 2e-27
 Identities = 59/208 (28%), Positives = 87/208 (41%), Gaps = 23/208 (11%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHRNLVKLVG 160
            LG G +G V            AIK +  T      + + L EV +L  L H N++KL  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           ++   D   + L  E    G L   +            +      I      G+ YLH+ 
Sbjct: 104 FFE--DKRNYYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 219 SQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
           +   ++HRD K  N+LLE+   +   K+ DFGL+          +  R+ GT  Y+APE 
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERL-GTAYYIAPE- 208

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            +      K DV+S GV+L  LL G  P
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPP 236

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  113 bits (284), Expect = 2e-27
 Identities = 62/231 (26%), Positives = 90/231 (38%), Gaps = 58/231 (25%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRL------------TCGGQQGDKEFLV-EVEMLSR 149
            LG G +G V      +  +  AIK +                 +   E +  E+ +L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---- 205
           L H N++KL   +   D     L  E    G L              +     +I     
Sbjct: 103 LDHPNIIKLFDVFE--DKKYFYLVTEFYEGGEL-------------FE-----QIINRHK 142

Query: 206 ---LDAAR-------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQA 252
               DAA        G+ YLH+ +   ++HRD K  NILLEN     + K+ DFGL+   
Sbjct: 143 FDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            +     L  R+ GT  Y+APE  +      K DV+S GV++  LL G  P
Sbjct: 200 SKDYK--LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  110 bits (276), Expect = 5e-27
 Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 55/278 (19%)

Query: 54  RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRV 113
             ++A     A+P+  + +      P      + A +E  +    ++P  ++G G    V
Sbjct: 54  LLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQ---KYDPKDVIGRGVSSVV 110

Query: 114 FKGV-LSDGTAVAIK-------RLTCGGQQGDKEFLV-EVEMLSRLH-HRNLVKLVGYYS 163
            + V  + G   A+K       RL+    +  +E    E  +L ++  H +++ L+  Y 
Sbjct: 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170

Query: 164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----------ETR--MKIALDAARG 211
              SS   L ++L+  G L              D+          ETR  M+  L+A   
Sbjct: 171 --SSSFMFLVFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEA--- 212

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           +++LH ++   ++HRD K  NILL++N   +++DFG +     G    L     GT GY+
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELC-GTPGYL 266

Query: 272 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           APE               + D+++ GV+L  LL G  P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (275), Expect = 8e-27
 Identities = 42/238 (17%), Positives = 81/238 (34%), Gaps = 23/238 (9%)

Query: 80  HPTSTRFLAYEELKEATNNFEPASILGEG--GFGRVFKGV-LSDGTAVAIKR--LTCGGQ 134
           H  +  F            +E  +++G+G      V        G  V ++R  L     
Sbjct: 8   HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67

Query: 135 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVN 193
           +       E+ +    +H N+V    Y ++  +   L +    +  GS +  +       
Sbjct: 68  EMVTFLQGELHVSKLFNHPNIVP---YRATFIADNELWVVTSFMAYGSAKDLIC--THFM 122

Query: 194 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 253
             ++      I     + L Y+H       +HR  KAS+IL+  +    ++         
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179

Query: 254 EGRT-----NYLSTRVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVLLELLTGRKP 303
                    +      +    +++PE  +  +L     KSD+YS G+   EL  G  P
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  108 bits (271), Expect = 1e-26
 Identities = 68/230 (29%), Positives = 108/230 (46%), Gaps = 37/230 (16%)

Query: 90  EELKEATNNFEPASI------LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV 142
           ++L E +   +P  +      LGEG +G V+K +    G  VAIK++    +   +E + 
Sbjct: 16  KKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIK 73

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLE---SWLHGPLGVNCHLDW 198
           E+ ++ +    ++VK   YY S   +  L +  E    GS+       +  L        
Sbjct: 74  EISIMQQCDSPHVVK---YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL-------- 122

Query: 199 ETRMKIAL---DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 255
            T  +IA       +GL YLH       IHRD KA NILL    HAK+ADFG+A Q    
Sbjct: 123 -TEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQL--- 175

Query: 256 RTNYLSTR--VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            T+ ++ R  V+GT  ++APE          +D++S G+  +E+  G+ P
Sbjct: 176 -TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (276), Expect = 2e-26
 Identities = 73/244 (29%), Positives = 105/244 (43%), Gaps = 48/244 (19%)

Query: 80  HPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL-TCGGQQGD 137
           H +S R   Y +       +    +LG+G FG V K          A+K +     +  D
Sbjct: 6   HHSSGRENLYFQ-GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 138 KE-FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL 196
               L EVE+L +L H N++KL       DSS   +  EL   G L              
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILE--DSSSFYIVGELYTGGEL-------------F 109

Query: 197 DWETRMKIA-------LDAAR-------GLAYLHEDSQPCVIHRDFKASNILLEN---NF 239
           D     +I         DAAR       G+ Y+H+ +   ++HRD K  NILLE+   + 
Sbjct: 110 D-----EIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC 161

Query: 240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT 299
             K+ DFGL+    +     +  R+ GT  Y+APE  + G    K DV+S GV+L  LL+
Sbjct: 162 DIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLS 217

Query: 300 GRKP 303
           G  P
Sbjct: 218 GTPP 221

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  106 bits (267), Expect = 2e-26
 Identities = 66/233 (28%), Positives = 94/233 (40%), Gaps = 21/233 (9%)

Query: 79  PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD 137
            H +S R   Y +     + F     LG G FG V      S G    IK +     Q  
Sbjct: 5   HHHSSGRENLYFQ-GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP 63

Query: 138 KE-FLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL 196
            E    E+E+L  L H N++K+   +   D     +  E    G L   +         L
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFE--DYHNMYIVMETCEGGELLERIVSAQARGKAL 121

Query: 197 ---DWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAK 250
                   MK  ++A   LAY H      V+H+D K  NIL ++   +   K+ DFGLA+
Sbjct: 122 SEGYVAELMKQMMNA---LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                   + +    GT  Y+APE      +  K D++S GVV+  LLTG  P
Sbjct: 176 LFKSD--EHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (268), Expect = 3e-26
 Identities = 61/216 (28%), Positives = 84/216 (38%), Gaps = 41/216 (18%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
           +LG G F  VF       G   A+K +       D     E+ +L ++ H N+V L   Y
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----------ETR--MKIALDAAR 210
            S     + L  +LV  G L              D           +    ++  L A  
Sbjct: 76  ESTTH--YYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSA-- 118

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
            + YLHE+    ++HRD K  N+L      N    + DFGL+K    G    +ST   GT
Sbjct: 119 -VKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTAC-GT 170

Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
            GYVAPE           D +S GV+   LL G  P
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (269), Expect = 3e-26
 Identities = 60/290 (20%), Positives = 120/290 (41%), Gaps = 51/290 (17%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH-HR 153
           N+ E    +G G  G+V+K      G  +A+K++   G + + K  L++++++ + H   
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 154 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLE--SWLHGPLGVNCHLDWETRMKIALDAAR 210
            +V+    + +  ++  + +  EL+   + +    + GP+            K+ +   +
Sbjct: 85  YIVQ---CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL------GKMTVAIVK 135

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ--APEGRTNYLSTRVMGTF 268
            L YL E     VIHRD K SNILL+     K+ DFG++ +    + +         G  
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-----AGCA 188

Query: 269 GYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKPVDMSQPSGQ--ENLVTWARP 321
            Y+APE             +++DV+S G+ L+EL TG+ P    +   +    ++    P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP 248

Query: 322 ILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGE 369
           +L                 +  +   F++ C         +  +RP   +
Sbjct: 249 LLPGHM------------GFSGDFQSFVKDCLTK------DHRKRPKYNK 280

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  108 bits (271), Expect = 3e-26
 Identities = 64/257 (24%), Positives = 99/257 (38%), Gaps = 58/257 (22%)

Query: 75  GGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGG 133
           G       +    A E  ++  + F+   + G+G FG V  G     G +VAIK++    
Sbjct: 1   GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--- 57

Query: 134 QQGDKEF----LVEVEMLSRLHHRNLVKLVGYYSSRDSSQH-----LLCYELVPNGSLES 184
              D  F    L  ++ L+ LHH N+V+L  Y+ +            +  E VP      
Sbjct: 58  --QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----D 110

Query: 185 WLHGPLGVNCHLDWETRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNIL 234
            LH             R ++A              R +  LH  S   V HRD K  N+L
Sbjct: 111 TLHR------CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVL 163

Query: 235 L-ENNFHAKVADFGLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKS------ 285
           + E +   K+ DFG AK+      N  Y+ +R      Y APE      L+  +      
Sbjct: 164 VNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPE------LIFGNQHYTTA 212

Query: 286 -DVYSYGVVLLELLTGR 301
            D++S G +  E++ G 
Sbjct: 213 VDIWSVGCIFAEMMLGE 229

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  106 bits (267), Expect = 3e-26
 Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 61/260 (23%)

Query: 73  TLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK---- 127
           T   +LP   ST             N+EP  ILG G    V + +        A+K    
Sbjct: 1   TRDAALPGSHST--------HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDV 52

Query: 128 ----RLTCGGQQGDKEFLV-EVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGS 181
                 +    Q  +E  + EV++L ++  H N+++L   Y    ++   L ++L+  G 
Sbjct: 53  TGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--TNTFFFLVFDLMKKGE 110

Query: 182 LESWLHGPLGVNCHLDW----------ETR--MKIALDAARGLAYLHEDSQPCVIHRDFK 229
           L              D+          ETR  M+  L+    +  LH+ +   ++HRD K
Sbjct: 111 L-------------FDYLTEKVTLSEKETRKIMRALLEV---ICALHKLN---IVHRDLK 151

Query: 230 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLV 283
             NILL+++ + K+ DFG + Q   G    L     GT  Y+APE               
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPG--EKLREVC-GTPSYLAPEIIECSMNDNHPGYGK 208

Query: 284 KSDVYSYGVVLLELLTGRKP 303
           + D++S GV++  LL G  P
Sbjct: 209 EVDMWSTGVIMYTLLAGSPP 228

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (268), Expect = 4e-26
 Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 54/239 (22%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL------TCGGQQGDKEFLV--E 143
           K   + +  +  LG G  G V           VAIK +          ++ D    V  E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 144 VEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW----- 198
           +E+L +L+H  ++K+  ++   D+  + +  EL+  G L              D      
Sbjct: 66  IEILKKLNHPCIIKIKNFF---DAEDYYIVLELMEGGEL-------------FDKVVGNK 109

Query: 199 -----ETR--MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGL 248
                  +      L A   + YLHE+    +IHRD K  N+LL +   +   K+ DFG 
Sbjct: 110 RLKEATCKLYFYQMLLA---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163

Query: 249 AKQAPEGRTNYLSTRVMGTFGYVAPE----YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +K   E   + + T   GT  Y+APE        G+     D +S GV+L   L+G  P
Sbjct: 164 SKILGET--SLMRTLC-GTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPP 218

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  106 bits (266), Expect = 4e-26
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 17/218 (7%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRN 154
           +++E   ++G G    V           VAIKR+     Q   + L+ E++ +S+ HH N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWE-TRMKIAL---DAA 209
           +V    YY+S      L L  +L+  GS+   +   +    H         IA    +  
Sbjct: 75  IVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTR--VMG 266
            GL YLH++ Q   IHRD KA NILL  +   ++ADFG++   A  G       R   +G
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188

Query: 267 TFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKP 303
           T  ++APE          K+D++S+G+  +EL TG  P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  106 bits (267), Expect = 1e-25
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 55/234 (23%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEF-LVEVEMLSRLH 151
           ++    +    ++G G FG VF+  L +   VAIK++       DK F   E++++  + 
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVK 90

Query: 152 HRNLVKLVGYYSSRDSSQHLLC----YELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           H N+V L  ++ S    +  +      E VP       ++             ++K  + 
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYR------ASRHYAKLKQTMP 139

Query: 208 AA----------RGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR 256
                       R LAY+H      + HRD K  N+LL   +   K+ DFG AK    G 
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196

Query: 257 TN--YLSTRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGR 301
            N  Y+ +R      Y APE      L+  +       D++S G V+ EL+ G+
Sbjct: 197 PNVSYICSRY-----YRAPE------LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  106 bits (267), Expect = 2e-25
 Identities = 72/282 (25%), Positives = 111/282 (39%), Gaps = 63/282 (22%)

Query: 53  GRKSKASPKETAKPRTADAVTLGGSLPHP-------TSTRFLAYEELKEATNNFEPASIL 105
           GR    S  E+ KP    +      +          T          +    ++    ++
Sbjct: 3   GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62

Query: 106 GEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEF-LVEVEMLSRLHHRNLVKLVGYYS 163
           G G FG V++  L D G  VAIK++       DK F   E++++ +L H N+V+L  ++ 
Sbjct: 63  GNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 117

Query: 164 SRDSSQHLLC----YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA---------- 209
           S    +  +      + VP       ++            +R K  L             
Sbjct: 118 SSGEKKDEVYLNLVLDYVP-----ETVYR------VARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHA-KVADFGLAKQAPEGRTN--YLSTRVMG 266
           R LAY+H      + HRD K  N+LL+ +    K+ DFG AKQ   G  N  Y+ +R   
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221

Query: 267 TFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGR 301
              Y APE      L+  +       DV+S G VL ELL G+
Sbjct: 222 ---YRAPE------LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  104 bits (262), Expect = 2e-25
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 45/224 (20%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-----------EVEMLSRLHH 152
           LGEG +G+V + +        A+K L        K+ L            E+++L RL H
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKIL-------KKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 153 RNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR- 210
           +N+++LV    + +  Q + +  E    G  E      +     LD     +  +  A  
Sbjct: 66  KNVIQLVDVLYN-EEKQKMYMVMEYCVCGMQE------M-----LDSVPEKRFPVCQAHG 113

Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
                  GL YLH      ++H+D K  N+LL      K++  G+A+       +     
Sbjct: 114 YFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170

Query: 264 VMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 305
             G+  +  PE A         K D++S GV L  + TG  P +
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (261), Expect = 3e-25
 Identities = 59/277 (21%), Positives = 89/277 (32%), Gaps = 67/277 (24%)

Query: 82  TSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQ 135
               +     L E    +     +G+G +G V   +        AIK     ++     +
Sbjct: 11  RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70

Query: 136 GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSL------------- 182
             +    EV ++ +LHH N+ +L   Y   D     L  EL   G L             
Sbjct: 71  DVERIKTEVRLMKKLHHPNIARLYEVYE--DEQYICLVMELCHGGHLLDKLNVFIDDSTG 128

Query: 183 -------------ESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHEDS 219
                            +          +   +         +         L YLH   
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188

Query: 220 QPCVIHRDFKASNILLEN--NFHAKVADFGLAK---QAPEGRTNYLSTRVMGTFGYVAPE 274
              + HRD K  N L     +F  K+ DFGL+K   +   G    ++T+  GT  +VAPE
Sbjct: 189 ---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE 244

Query: 275 --------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                   Y        K D +S GV+L  LL G  P
Sbjct: 245 VLNTTNESYGP------KCDAWSAGVLLHLLLMGAVP 275

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  104 bits (260), Expect = 9e-25
 Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 42/268 (15%)

Query: 55  KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFE------PASILGEG 108
            S A   E    ++     L   +P P +     +  +                 ILG G
Sbjct: 43  WSNADLTERMPVKSKRTSALAVDIPAPPAPF--DHRIVTAKQGAVNSFYTVSKTEILGGG 100

Query: 109 GFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS 167
            FG+V K    + G  +A K +   G +  +E   E+ ++++L H NL++L   +     
Sbjct: 101 RFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE--SK 158

Query: 168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHE 217
           +  +L  E V  G L              D        L   D          G+ ++H+
Sbjct: 159 NDIVLVMEYVDGGEL-------------FDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 218 DSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEY 275
                ++H D K  NIL  N      K+ DFGLA++        L     GT  ++APE 
Sbjct: 206 MY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNF-GTPEFLAPEV 259

Query: 276 AMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                +   +D++S GV+   LL+G  P
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  102 bits (257), Expect = 1e-24
 Identities = 60/231 (25%), Positives = 89/231 (38%), Gaps = 53/231 (22%)

Query: 97  NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLV----------EVE 145
            +F+   ILGEG F  V      +     AIK L       +K  ++          E +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKIL-------EKRHIIKENKVPYVTRERD 82

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           ++SRL H   VKL  Y++ +D  +         NG L            ++         
Sbjct: 83  VMSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLK----------YIRKIGS--FD 128

Query: 206 LDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 257
               R         L YLH      +IHRD K  NILL  + H ++ DFG AK       
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 185

Query: 258 NYLSTRVMGTFGYVAPEYAMTGHLLVK-----SDVYSYGVVLLELLTGRKP 303
              +   +GT  YV+PE      L  K     SD+++ G ++ +L+ G  P
Sbjct: 186 QARANSFVGTAQYVSPEL-----LTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (255), Expect = 1e-24
 Identities = 67/249 (26%), Positives = 99/249 (39%), Gaps = 56/249 (22%)

Query: 79  PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT---CGGQ 134
            H +S R   Y +       +    +LG+G FG V K          A+K +       +
Sbjct: 5   HHHSSGRENLYFQ-GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63

Query: 135 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 194
                 L EVE+L +L H N++KL       DSS   +  EL   G L            
Sbjct: 64  DTST-ILREVELLKKLDHPNIMKLFEILE--DSSSFYIVGELYTGGEL------------ 108

Query: 195 HLDWETR------------MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NF 239
             D   +            +K        + Y+H+ +   ++HRD K  NILLE+   + 
Sbjct: 109 -FDEIIKRKRFSEHDAARIIKQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDC 161

Query: 240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVL 294
             K+ DFGL+    +     +  R+ GT  Y+APE     Y        K DV+S GV+L
Sbjct: 162 DIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIAPEVLRGTYDE------KCDVWSAGVIL 212

Query: 295 LELLTGRKP 303
             LL+G  P
Sbjct: 213 YILLSGTPP 221

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (257), Expect = 3e-24
 Identities = 51/262 (19%), Positives = 93/262 (35%), Gaps = 35/262 (13%)

Query: 55  KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 114
                  +   P+  D       +      + +  ++     + ++    LG G FG V 
Sbjct: 10  HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILEELGSGAFGVVH 68

Query: 115 KGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC 173
           + V  + G     K +             E+ ++++LHH  L+ L   +   D  + +L 
Sbjct: 69  RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLI 126

Query: 174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHEDSQPCV 223
            E +  G L              D        +   +          GL ++HE S   +
Sbjct: 127 LEFLSGGEL-------------FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170

Query: 224 IHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL 281
           +H D K  NI+ E    +  K+ DFGLA +        +      T  + APE      +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKVTT-ATAEFAAPEIVDREPV 227

Query: 282 LVKSDVYSYGVVLLELLTGRKP 303
              +D+++ GV+   LL+G  P
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSP 249

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  100 bits (252), Expect = 3e-24
 Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 45/218 (20%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYY 162
            +G G +G V   V        A K++     +    F  E+E++  L H N+++L   +
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 163 SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR----- 210
              D++   L  EL   G L              +     ++         DAAR     
Sbjct: 76  E--DNTDIYLVMELCTGGEL-------------FE-----RVVHKRVFRESDAARIMKDV 115

Query: 211 --GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVM 265
              +AY H+ +   V HRD K  N L      +   K+ DFGLA +   G    + T+V 
Sbjct: 116 LSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKV- 169

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           GT  YV+P+  + G    + D +S GV++  LL G  P
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  104 bits (261), Expect = 3e-24
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 37/223 (16%)

Query: 97  NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQGDKEFLV---EVEM------ 146
           N+F    I+G GGFG V+       G   A+K L       DK+ +       +      
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL-------DKKRIKMKQGETLALNERI 241

Query: 147 ----LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
               +S      +V +   Y+     +     +L+  G L   L         +  E  M
Sbjct: 242 MLSLVSTGDCPFIVCM--SYAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADM 294

Query: 203 KI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
           +  A +   GL ++H      V++RD K +NILL+ + H +++D GLA    + + +   
Sbjct: 295 RFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--- 348

Query: 262 TRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
             V GT GY+APE    G     S D +S G +L +LL G  P
Sbjct: 349 ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  101 bits (254), Expect = 4e-24
 Identities = 70/269 (26%), Positives = 101/269 (37%), Gaps = 60/269 (22%)

Query: 55  KSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVF 114
           +S +S   +A P TA  V                +E   E          LG G    V+
Sbjct: 21  QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESE----------LGRGATSIVY 70

Query: 115 KGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRLHHRNLVKLVGYYSSRDSSQHLL 172
           +          A+K L    +  DK+ +  E+ +L RL H N++KL   + +       L
Sbjct: 71  RCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE--ISL 125

Query: 173 CYELVPNGSLESWLHGPLGVNCHLDW--------ETRMKIALDAAR-------GLAYLHE 217
             ELV  G L              D         E       DAA         +AYLHE
Sbjct: 126 VLELVTGGEL-------------FDRIVEKGYYSER------DAADAVKQILEAVAYLHE 166

Query: 218 DSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
           +    ++HRD K  N+L      +   K+ADFGL+K         + T   GT GY APE
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVC-GTPGYCAPE 220

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                    + D++S G++   LL G +P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (250), Expect = 8e-24
 Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 56/239 (23%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIK----------------------RLTCGGQQGDKEFL 141
           +G+G +G V      +D T  A+K                      R   GG    +  +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 142 V----EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 197
                E+ +L +L H N+VKLV      +     + +ELV  G +             ++
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127

Query: 198 WETRMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
             T   ++ D AR        G+ YLH      +IHRD K SN+L+  + H K+ADFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLTGRKPVD 305
            +  +G    LS  V GT  ++APE       +      DV++ GV L   + G+ P  
Sbjct: 185 NE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 99.6 bits (249), Expect = 8e-24
 Identities = 58/235 (24%), Positives = 92/235 (39%), Gaps = 60/235 (25%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLH 151
           ++N++    LG+G F  V + V  + G   A K +       +   K    E  +  +L 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA------ 205
           H N+V+L       + S H L ++LV  G L              +      I       
Sbjct: 64  HPNIVRLHDSIQ--EESFHYLVFDLVTGGEL-------------FE-----DIVAREFYS 103

Query: 206 -LDAAR-------GLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPE 254
             DA+         +AY H +    ++HR+ K  N+LL         K+ADFGLA +  +
Sbjct: 104 EADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160

Query: 255 GRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                      GT GY++PE      Y+         D+++ GV+L  LL G  P
Sbjct: 161 SEA--WHGFA-GTPGYLSPEVLKKDPYSK------PVDIWACGVILYILLVGYPP 206

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 62/228 (27%), Positives = 84/228 (36%), Gaps = 60/228 (26%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--------EVEMLSRLHHRNL 155
           LGEG +G V   V      AVA+K +       D +  V        E+ +   L+H N+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENV 67

Query: 156 VKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR-- 210
           VK    Y  R       L  E    G L   +                 M      A+  
Sbjct: 68  VKF---YGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPE--PDAQRF 110

Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 263
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA           L+  
Sbjct: 111 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167

Query: 264 VMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
             GT  YVAPE      +          DV+S G+VL  +L G  P D
Sbjct: 168 C-GTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  100 bits (250), Expect = 1e-23
 Identities = 60/233 (25%), Positives = 91/233 (39%), Gaps = 51/233 (21%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLS 148
            + ++    LG G F  V K    S G   A K     +     +   +E +  EV +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA--- 205
           ++ H N++ L   Y   + +  +L  ELV  G L              D      +A   
Sbjct: 71  QVLHHNVITLHDVYE--NRTDVVLILELVSGGEL-------------FD-----FLAQKE 110

Query: 206 ----LDAAR-------GLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK 250
                +A         G+ YLH      + H D K  NI+L        H K+ DFGLA 
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

Query: 251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +  +G          GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 168 EIEDGVE--FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 46/220 (20%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV---------EVEMLSRLHHRN 154
           +G+G F +V     +  G  VAIK +       DK  L          EV ++  L+H N
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKII-------DKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 155 LVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
           +VKL   +   ++ + L L  E    G +  +L  HG +        E R          
Sbjct: 76  IVKL---FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EAR-SKFRQIVSA 126

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           + Y H   Q  ++HRD KA N+LL+ + + K+ADFG + +   G    L     G   Y 
Sbjct: 127 VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFC-GAPPYA 180

Query: 272 APE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           APE      Y   G    + DV+S GV+L  L++G  P D
Sbjct: 181 APELFQGKKYD--GP---EVDVWSLGVILYTLVSGSLPFD 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (254), Expect = 2e-23
 Identities = 63/246 (25%), Positives = 107/246 (43%), Gaps = 46/246 (18%)

Query: 81  PTSTRFLAYEELKEAT---NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQG 136
               RFL ++ L+      + F    +LG GGFG VF   +   G   A K+L       
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL------- 218

Query: 137 DKEFLV---EVEM-------LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESW 185
           +K+ L      +        L+++H R +V L     + ++   L L   ++  G +   
Sbjct: 219 NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL---AYAFETKTDLCLVMTIMNGGDIRYH 275

Query: 186 LHGPLGVNCHLDWETRMK-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH 240
           ++     N     E R       I      GL +LH+ +   +I+RD K  N+LL+++ +
Sbjct: 276 IYNVDEDNPGFQ-EPRAIFYTAQIVS----GLEHLHQRN---IIYRDLKPENVLLDDDGN 327

Query: 241 AKVADFGLAKQAPEG--RTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLEL 297
            +++D GLA +   G  +T        GT G++APE  + G     S D ++ GV L E+
Sbjct: 328 VRISDLGLAVELKAGQTKTK---GYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEM 382

Query: 298 LTGRKP 303
           +  R P
Sbjct: 383 IAARGP 388

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 60/233 (25%), Positives = 93/233 (39%), Gaps = 51/233 (21%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLS 148
            +++E    LG G F  V K      G   A K     RL+   +   +E +  EV +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA--- 205
            + H N++ L   +   + +  +L  ELV  G L              D      +A   
Sbjct: 64  EIRHPNIITLHDIFE--NKTDVVLILELVSGGEL-------------FD-----FLAEKE 103

Query: 206 ----LDAAR-------GLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADFGLAK 250
                +A +       G+ YLH      + H D K  NI+L +    N   K+ DFG+A 
Sbjct: 104 SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160

Query: 251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +   G          GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 161 KIEAGNE--FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 76/369 (20%), Positives = 123/369 (33%), Gaps = 100/369 (27%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLVEVEMLSRLHH 152
           +E   ++G+G F  V + +    G   A+K     + T       ++   E  +   L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSL--ESWLHGPLGVN------CHLDWETRMKI 204
            ++V+L+  YS        + +E +    L  E       G         H      M+ 
Sbjct: 86  PHIVELLETYS--SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-----MRQ 138

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLS 261
            L+A   L Y H+++   +IHRD K   +LL   EN+   K+  FG+A Q  E       
Sbjct: 139 ILEA---LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAG 191

Query: 262 TRVMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW 318
            RV GT  ++APE       G      DV+  GV+L  LL+G  P              +
Sbjct: 192 GRV-GTPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSGCLP-------------FY 234

Query: 319 ARPILRDKDRLEELADPRLGGKY--PKE----------DFIRVC---------TIAAA-- 355
                      E L +  + GKY               D +R           T+  A  
Sbjct: 235 GTK--------ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286

Query: 356 ----CVAPEANQRPTMGEVVQSLK----------MVQRVIECQDPTLTSSNNRANLRQSS 401
                       +  + E V+ L+           V   +         ++   +  +  
Sbjct: 287 HPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSH----KFNSFYGDPPEEL 342

Query: 402 TTFDSDGTS 410
             F  D TS
Sbjct: 343 PDFSEDPTS 351

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 60/233 (25%), Positives = 91/233 (39%), Gaps = 51/233 (21%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLS 148
            + ++    LG G F  V K    S G   A K     +     +   +E +  EV +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA--- 205
           ++ H N++ L   Y   + +  +L  ELV  G L              D      +A   
Sbjct: 71  QVLHPNIITLHDVYE--NRTDVVLILELVSGGEL-------------FD-----FLAQKE 110

Query: 206 ----LDAAR-------GLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK 250
                +A         G+ YLH      + H D K  NI+L        H K+ DFGLA 
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

Query: 251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
           +  +G          GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 168 EIEDGVE--FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 65/267 (24%), Positives = 99/267 (37%), Gaps = 69/267 (25%)

Query: 64  AKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGT 122
           A       +  G       ST+F    ++KE          LG+G F  V + V  + G 
Sbjct: 5   ASMTGGQQMGRGSEFMMNASTKFSDNYDVKE---------ELGKGAFSVVRRCVHKTTGL 55

Query: 123 AVAIKRLT---CGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN 179
             A K +       +   K    E  +  +L H N+V+L       + S H L ++LV  
Sbjct: 56  EFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQ--EESFHYLVFDLVTG 112

Query: 180 GSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR-------GLAYLHEDSQPCVIH 225
           G L              +      I         DA+         +AY H +    ++H
Sbjct: 113 GEL-------------FE-----DIVAREFYSEADASHCIQQILESIAYCHSNG---IVH 151

Query: 226 RDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 282
           R+ K  N+LL         K+ADFGLA +  +           GT GY++PE      +L
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFA-GTPGYLSPE------VL 202

Query: 283 VKS------DVYSYGVVLLELLTGRKP 303
            K       D+++ GV+L  LL G  P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  100 bits (250), Expect = 5e-23
 Identities = 61/253 (24%), Positives = 93/253 (36%), Gaps = 68/253 (26%)

Query: 78  LPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTC 131
           +   T TRF    +L E          LG+G F  V + V +  G   A       +L+ 
Sbjct: 1   MATITCTRFTEEYQLFE---------ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA 51

Query: 132 GGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG 191
              Q  +    E  +   L H N+V+L    S      H L ++LV  G L         
Sbjct: 52  RDHQKLER---EARICRLLKHPNIVRLHDSISEEGH--HYLIFDLVTGGEL--------- 97

Query: 192 VNCHLDW----------ETR--MKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---E 236
                +           +    ++  L+A   + + H+     V+HR+ K  N+LL    
Sbjct: 98  ----FEDIVAREYYSEADASHCIQQILEA---VLHCHQMG---VVHRNLKPENLLLASKL 147

Query: 237 NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSY 290
                K+ADFGLA +              GT GY++PE      Y          D+++ 
Sbjct: 148 KGAAVKLADFGLAIEVEGE-QQAWFGFA-GTPGYLSPEVLRKDPYGK------PVDLWAC 199

Query: 291 GVVLLELLTGRKP 303
           GV+L  LL G  P
Sbjct: 200 GVILYILLVGYPP 212

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  100 bits (251), Expect = 6e-23
 Identities = 68/246 (27%), Positives = 108/246 (43%), Gaps = 55/246 (22%)

Query: 84  TRFLAYEELKEAT---NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKE 139
            RFL ++ L+      N F    +LG+GGFG V    +   G   A K+L       +K+
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL-------EKK 220

Query: 140 FLV---EVEM-------LSRLHHRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLH 187
            +       M       L +++ R +V L   Y ++D+    LC    L+  G L+    
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA----LCLVLTLMNGGDLKF--- 273

Query: 188 GPLGVNCHLDWETRMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNF 239
                  H+    +       A         GL  LH +    +++RD K  NILL+++ 
Sbjct: 274 -------HIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHG 323

Query: 240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLEL 297
           H +++D GLA   PEG+T     RV GT GY+APE      +    S D ++ G +L E+
Sbjct: 324 HIRISDLGLAVHVPEGQTI--KGRV-GTVGYMAPEVVKNERY--TFSPDWWALGCLLYEM 378

Query: 298 LTGRKP 303
           + G+ P
Sbjct: 379 IAGQSP 384

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 60/224 (26%), Positives = 86/224 (38%), Gaps = 51/224 (22%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFLV-EVEMLSRLHHRNLVK 157
           LG G F  V K    S G   A K     R     +   +E +  EV +L  + H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR 210
           L   Y   + +  +L  ELV  G L              D      +A        +A  
Sbjct: 79  LHEVYE--NKTDVILILELVAGGEL-------------FD-----FLAEKESLTEEEATE 118

Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLEN----NFHAKVADFGLAKQAPEGRTNY 259
                  G+ YLH      + H D K  NI+L +        K+ DFGLA +   G    
Sbjct: 119 FLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 173

Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                 GT  +VAPE      L +++D++S GV+   LL+G  P
Sbjct: 174 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 97.8 bits (244), Expect = 6e-23
 Identities = 62/228 (27%), Positives = 84/228 (36%), Gaps = 60/228 (26%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--------EVEMLSRLHHRNL 155
           LGEG +G V   V      AVA+K +       D +  V        E+ +   L+H N+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINKMLNHENV 67

Query: 156 VKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR-- 210
           VK    Y  R       L  E    G L   +                 M      A+  
Sbjct: 68  VKF---YGHRREGNIQYLFLEYCSGGELFDRIEPDI------------GMPE--PDAQRF 110

Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN-YLSTR 263
                 G+ YLH      + HRD K  N+LL+   + K++DFGLA           L+  
Sbjct: 111 FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167

Query: 264 VMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
             GT  YVAPE      +          DV+S G+VL  +L G  P D
Sbjct: 168 C-GTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 71/311 (22%), Positives = 107/311 (34%), Gaps = 77/311 (24%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGY 161
           +LGEG   RV   + L      A+K +             EVEML +   HRN+++L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR---- 210
           +   +  +  L +E +  GS+             L       I        L+A+     
Sbjct: 80  FE--EEDRFYLVFEKMRGGSI-------------LS-----HIHKRRHFNELEASVVVQD 119

Query: 211 ---GLAYLHEDSQPCVIHRDFKASNILLENNFHA---KVADFGLAKQAPEGR------TN 258
               L +LH      + HRD K  NIL E+       K+ DF L              T 
Sbjct: 120 VASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVLLELLTGRKPVDMSQPSGQE 313
            L T   G+  Y+APE                D++S GV+L  LL+G  P       G+ 
Sbjct: 177 ELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV-----GRC 230

Query: 314 NLVTWARPILRDKDRLEELADPRLGGKY--PKE----------DFIRVCTIAAACVAPEA 361
                             L +    GKY  P +          D I         +  +A
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLIS------KLLVRDA 284

Query: 362 NQRPTMGEVVQ 372
            QR +  +V+Q
Sbjct: 285 KQRLSAAQVLQ 295

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 99.1 bits (247), Expect = 2e-22
 Identities = 52/267 (19%), Positives = 95/267 (35%), Gaps = 38/267 (14%)

Query: 54  RKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEP----ASILGEGG 109
           R+     ++    R    V+           +    + ++   ++          LG G 
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169

Query: 110 FGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS 168
           FG V +    + G   A K +    +   +    E++ +S L H  LV L   +   +  
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE- 228

Query: 169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---DAAR-------GLAYLHED 218
             ++ YE +  G L              +        +   +A         GL ++HE+
Sbjct: 229 -MVMIYEFMSGGEL-------------FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274

Query: 219 SQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
           +    +H D K  NI+         K+ DFGL       ++  +     GT  + APE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTT-GTAEFAAPEVA 328

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKP 303
               +   +D++S GV+   LL+G  P
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSGLSP 355

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 47/225 (20%), Positives = 83/225 (36%), Gaps = 37/225 (16%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV-EVEMLSRL 150
           KE    +  A  LG G FG V + V  S       K +   G   D+  +  E+ +L+  
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIA 58

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL---D 207
            HRN++ L   + S +    ++ +E +    +              +        L   +
Sbjct: 59  RHRNILHLHESFESMEE--LVMIFEFISGLDI-------------FERINTSAFELNERE 103

Query: 208 AAR-------GLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTN 258
                      L +LH  +   + H D +  NI+ +    +  K+ +FG A+Q   G   
Sbjct: 104 IVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159

Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                      Y APE      +   +D++S G ++  LL+G  P
Sbjct: 160 -FRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 95.9 bits (239), Expect = 3e-22
 Identities = 55/264 (20%), Positives = 88/264 (33%), Gaps = 79/264 (29%)

Query: 72  VTLGGSLPHPTSTRFLA-YEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL 129
           + +    P P        Y+  K+         +LG G  G+V +      G   A+K L
Sbjct: 12  LEVLFQGPEPKKYAVTDDYQLSKQ---------VLGLGVNGKVLECFHRRTGQKCALKLL 62

Query: 130 TCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLVGYY--SSRDSSQHLLCYELVPNGSLES 184
                          EV+   +     ++V ++  Y          L+  E +  G L  
Sbjct: 63  -------YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL-- 113

Query: 185 WLHGPLGVNCHLDWETRMKIA---------LDAAR-------GLAYLHEDSQPCVIHRDF 228
                             +I           +AA         + +LH  +   + HRD 
Sbjct: 114 -----------FS-----RIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDV 154

Query: 229 KASNILLEN---NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS 285
           K  N+L  +   +   K+ DFG AK+  +     L T    T  YVAPE      +L   
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAPE------VLGPE 204

Query: 286 ------DVYSYGVVLLELLTGRKP 303
                 D++S GV++  LL G  P
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPP 228

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 66/310 (21%), Positives = 102/310 (32%), Gaps = 98/310 (31%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----EVEMLSRL-HHRNLVK 157
            LGEG F    K V      A A+K +        K        E+  L     H N+VK
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKII-------SKRMEANTQKEITALKLCEGHPNIVK 70

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA-------LDAAR 210
           L   +   D     L  EL+  G L              +     +I         +A+ 
Sbjct: 71  LHEVFH--DQLHTFLVMELLNGGEL-------------FE-----RIKKKKHFSETEASY 110

Query: 211 -------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYL 260
                   ++++H+     V+HRD K  N+L  +   N   K+ DFG A+  P      L
Sbjct: 111 IMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPL 166

Query: 261 STRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGRKPVDMSQPSGQEN 314
            T    T  Y APE      LL ++      D++S GV+L  +L+G+ P           
Sbjct: 167 KTPC-FTLHYAAPE------LLNQNGYDESCDLWSLGVILYTMLSGQVPF---------- 209

Query: 315 LVTWARPILRDKDRLEELADPRLGGKY--PKE----------DFIRVCTIAAACVAPEAN 362
               +           E+      G +    E          D I+        +  + N
Sbjct: 210 ---QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQ------GLLTVDPN 260

Query: 363 QRPTMGEVVQ 372
           +R  M  +  
Sbjct: 261 KRLKMSGLRY 270

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 62/231 (26%), Positives = 94/231 (40%), Gaps = 53/231 (22%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLV----------EVE 145
           ++FE    +G+G FG+V     +D     A+K +       +K+  V          E++
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQ 67

Query: 146 MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA 205
           ++  L H  LV L  +YS +D     +  +L+  G L            HL      K  
Sbjct: 68  IMQGLEHPFLVNL--WYSFQDEEDMFMVVDLLLGGDLRY----------HLQQNVHFKE- 114

Query: 206 LDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 257
            +  +         L YL       +IHRD K  NILL+ + H  + DF +A   P    
Sbjct: 115 -ETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170

Query: 258 NYLSTRVMGTFGYVAPE----YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
               T + GT  Y+APE        G+    + D +S GV   ELL GR+P
Sbjct: 171 ---ITTMAGTKPYMAPEMFSSRKGAGYS--FAVDWWSLGVTAYELLRGRRP 216

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 50/253 (19%), Positives = 92/253 (36%), Gaps = 66/253 (26%)

Query: 96  TNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEF-LVEVEMLSRLHHR 153
           +  +     LG G FG V +    + G   A+K++       D  +   E++++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKVLDHV 60

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH------------------ 195
           N++KLV Y+ +    +         +  L    +G    +                    
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 196 -------LDWETRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNILLENN 238
                  L    R   ++             R + ++H      + HRD K  N+L+ + 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSK 177

Query: 239 FHA-KVADFGLAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKS-------DVY 288
            +  K+ DFG AK+      +  Y+ +R      Y APE      L++ +       D++
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE------LMLGATEYTPSIDLW 226

Query: 289 SYGVVLLELLTGR 301
           S G V  EL+ G+
Sbjct: 227 SIGCVFGELILGK 239

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.8 bits (234), Expect = 7e-22
 Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 63/229 (27%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHR 153
           LG G FG+V  G     G  VA+K L       +++ +           E++ L    H 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 154 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR 210
           +++KL   Y    +     +  E V  G L  ++  HG            R++     AR
Sbjct: 72  HIIKL---YQVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEE--MEAR 114

Query: 211 --------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                    + Y H   +  V+HRD K  N+LL+ + +AK+ADFGL+    +G   +L T
Sbjct: 115 RLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 169

Query: 263 RVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
              G+  Y APE      YA  G    + D++S GV+L  LL G  P D
Sbjct: 170 SC-GSPNYAAPEVISGRLYA--GP---EVDIWSCGVILYALLCGTLPFD 212

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 59/271 (21%), Positives = 104/271 (38%), Gaps = 42/271 (15%)

Query: 52  RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 111
                 +S         A    L  +   P   +       +   + ++   +LG GGFG
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEK-------EPLESQYQVGPLLGSGGFG 57

Query: 112 RVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFL-VEVEMLSRLHHR--NLVKLVGYY 162
            V+ G+ +SD   VAIK     R++  G+  +   + +EV +L ++      +++L+ ++
Sbjct: 58  SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117

Query: 163 SSRDSSQHLLCYELV-PNGSLESWL--HGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
              DS   +L  E   P   L  ++   G L          R          + + H   
Sbjct: 118 ERPDS--FVLILERPEPVQDLFDFITERGALQEE-----LAR-SFFWQVLEAVRHCH--- 166

Query: 220 QPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM- 277
              V+HRD K  NIL+  N    K+ DFG      +      +    GT  Y  PE+   
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFD-GTRVYSPPEWIRY 222

Query: 278 ---TGHLLVKSDVYSYGVVLLELLTGRKPVD 305
               G     + V+S G++L +++ G  P +
Sbjct: 223 HRYHGR---SAAVWSLGILLYDMVCGDIPFE 250

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 61/245 (24%), Positives = 93/245 (37%), Gaps = 49/245 (20%)

Query: 84  TRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGD------ 137
                  EL    + +     +  G +G V  GV S+G  VAIKR+      G       
Sbjct: 9   AMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILS 68

Query: 138 -----KEFLVEVEMLSRLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGP 189
                K  L E+ +L+  HH N++ L  +  +    +   L L  EL     + + L   
Sbjct: 69  DSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQV 123

Query: 190 LGVNCHLDWETRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNILLENNF 239
           +            +I +              GL  LHE     V+HRD    NILL +N 
Sbjct: 124 IHDQ---------RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNN 171

Query: 240 HAKVADFGLAKQAPEGR--TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLE 296
              + DF LA++       T+Y++ R      Y APE  M      K  D++S G V+ E
Sbjct: 172 DITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAE 226

Query: 297 LLTGR 301
           +   +
Sbjct: 227 MFNRK 231

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 60/242 (24%), Positives = 90/242 (37%), Gaps = 61/242 (25%)

Query: 90  EELKEATNNF----EPASILGEGGFGRVFKGV-LSDGTAVAIKRLT---CGGQQGDKEFL 141
           ++L   +  F    E    +G G +    + +  +     A+K +        +      
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE------ 64

Query: 142 VEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWET 200
            E+E+L R   H N++ L   Y   D     +  EL+  G L             LD   
Sbjct: 65  -EIEILLRYGQHPNIITLKDVYD--DGKYVYVVTELMKGGEL-------------LDKIL 108

Query: 201 RMK---------IALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFG 247
           R K         +     + + YLH      V+HRD K SNIL      N    ++ DFG
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165

Query: 248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGR 301
            AKQ        L T    T  +VAPE      +L +       D++S GV+L  +LTG 
Sbjct: 166 FAKQLRAE-NGLLMTPC-YTANFVAPE------VLERQGYDAACDIWSLGVLLYTMLTGY 217

Query: 302 KP 303
            P
Sbjct: 218 TP 219

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 62/251 (24%), Positives = 97/251 (38%), Gaps = 50/251 (19%)

Query: 79  PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK-----RLTCG 132
           P       LA  E  E +  +   S LG G FG V+  V       V +K     ++   
Sbjct: 7   PKAVELEGLAACE-GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLED 65

Query: 133 GQQGDKEFL---VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGP 189
               D +     +E+ +LSR+ H N++K++  + ++        ++LV    +E   HG 
Sbjct: 66  CWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF------FQLV----ME--KHGS 113

Query: 190 LG-VNCHLDWETRMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFH 240
              +   +D   R+      A          + YL       +IHRD K  NI++  +F 
Sbjct: 114 GLDLFAFIDRHPRLDE--PLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFT 168

Query: 241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVL 294
            K+ DFG A     G      T   GT  Y APE      Y   G    + +++S GV L
Sbjct: 169 IKLIDFGSAAYLERG--KLFYTFC-GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTL 220

Query: 295 LELLTGRKPVD 305
             L+    P  
Sbjct: 221 YTLVFEENPFC 231

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 94.5 bits (235), Expect = 5e-21
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 63/229 (27%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR----------LHHR 153
           LG G FG+V  G     G  VA+K L       +++ +  ++++ +            H 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKIL-------NRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 154 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR 210
           +++KL   Y    +   + +  E V  G L  ++  +G            R+      +R
Sbjct: 77  HIIKL---YQVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDE--KESR 119

Query: 211 --------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
                   G+ Y H   +  V+HRD K  N+LL+ + +AK+ADFGL+    +G   +L T
Sbjct: 120 RLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 174

Query: 263 RVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
              G+  Y APE      YA  G    + D++S GV+L  LL G  P D
Sbjct: 175 SC-GSPNYAAPEVISGRLYA--G---PEVDIWSSGVILYALLCGTLPFD 217

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 60/236 (25%), Positives = 99/236 (41%), Gaps = 25/236 (10%)

Query: 77  SLPHPTSTRFLAYEELK---EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG 132
           S P P  + F   E  K   E    +     +G G +G V   V    G  VAIK+L   
Sbjct: 2   SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP 61

Query: 133 GQQGD--KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWL 186
            Q     K    E+ +L  + H N++ L+  ++  ++        L         + + L
Sbjct: 62  FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDL 116

Query: 187 HGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF 246
              +     L  +    +     +GL Y+H      +IHRD K  N+ +  +   K+ DF
Sbjct: 117 GKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 172

Query: 247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
           GLA+QA    T Y+ TR      Y APE  +      ++ D++S G ++ E++TG+
Sbjct: 173 GLARQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 55/227 (24%), Positives = 82/227 (36%), Gaps = 61/227 (26%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV------EVEMLSRLHHRNLVK 157
           +G G FG             VA+K +       ++   +      E+     L H N+V+
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYI-------ERGAAIDENVQREIINHRSLRHPNIVR 80

Query: 158 LVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAAR---- 210
                    +  HL +  E    G L   +   G            R     D AR    
Sbjct: 81  F---KEVILTPTHLAIIMEYASGGELYERICNAG------------RFSE--DEARFFFQ 123

Query: 211 ----GLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNYLSTRV 264
               G++Y H      + HRD K  N LL+ +     K+ DFG +K +     +   + V
Sbjct: 124 QLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTV 178

Query: 265 MGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
            GT  Y+APE      Y   G     +DV+S GV L  +L G  P +
Sbjct: 179 -GTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 93.3 bits (232), Expect = 6e-21
 Identities = 57/283 (20%), Positives = 90/283 (31%), Gaps = 77/283 (27%)

Query: 52  RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 111
                  +      P+      +   L    +     Y+   +         +LG G  G
Sbjct: 26  PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGING 76

Query: 112 RVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLVGYY--SSR 165
           +V +          A+K L               EVE+  R     ++V++V  Y     
Sbjct: 77  KVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYENLYA 129

Query: 166 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---------LDAAR------ 210
                L+  E +  G L                    +I           +A+       
Sbjct: 130 GRKCLLIVMECLDGGEL-------------FS-----RIQDRGDQAFTEREASEIMKSIG 171

Query: 211 -GLAYLHEDSQPCVIHRDFKASNILLENNFHA---KVADFGLAKQAPEGRTNYLSTRVMG 266
             + YLH  +   + HRD K  N+L  +       K+ DFG AK+      N L+T    
Sbjct: 172 EAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPC-Y 225

Query: 267 TFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGRKP 303
           T  YVAPE      +L         D++S GV++  LL G  P
Sbjct: 226 TPYYVAPE------VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 49/222 (22%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLVG 160
           LG G F  V + +  S G   A K L    +  D    +  E+ +L        ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---------LDAAR- 210
            Y   ++S+ +L  E    G +                                 D  R 
Sbjct: 97  VYE--NTSEIILILEYAAGGEI-------------FS-----LCLPELAEMVSENDVIRL 136

Query: 211 ------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTNYLS 261
                 G+ YLH+++   ++H D K  NILL +       K+ DFG++++        L 
Sbjct: 137 IKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LR 191

Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
             + GT  Y+APE      +   +D+++ G++   LLT   P
Sbjct: 192 EIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)

Query: 94  EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRL 150
           E    +   + +G G +G V   +    G  VAIK+L+   Q     K    E+ +L  +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80

Query: 151 HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
            H N++ L+  ++   S ++     L         +++ L   +G+      E    +  
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLK--FSEEKIQYLVY 133

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
              +GL Y+H      V+HRD K  N+ +  +   K+ DFGLA+ A    T Y+ TR   
Sbjct: 134 QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-- 188

Query: 267 TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
              Y APE  ++     ++ D++S G ++ E+LTG+
Sbjct: 189 ---YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 58/231 (25%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---------- 142
           + F+    LG G FGRV     K     G   A+K L       DK+ +V          
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKIL-------DKQKVVKLKQIEHTLN 90

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E  +L  ++   LVKL   +S +D+S   +  E V  G + S          HL    R 
Sbjct: 91  EKRILQAVNFPFLVKL--EFSFKDNSNLYMVMEYVAGGEMFS----------HLRRIGR- 137

Query: 203 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
             +   AR           YLH      +I+RD K  N+L++   + +V DFG AK+  +
Sbjct: 138 -FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-K 192

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKS-DVYSYGVVLLELLTGRKP 303
           GRT  L     GT   +APE  ++ G+   K+ D ++ GV++ E+  G  P
Sbjct: 193 GRTWTLC----GTPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPP 237

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 90.7 bits (226), Expect = 3e-20
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 34/226 (15%)

Query: 91  ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEV 144
           ++K     +E    LGEG F  V+K    +    VAIK++  G +   K+      L E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMK 203
           ++L  L H N++ L+  +  + +   + L ++ +    LE  +      +  L       
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSN---ISLVFDFMET-DLEVIIKDN---SLVLTPSHIKA 116

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLST 262
             L   +GL YLH+     ++HRD K +N+LL+ N   K+ADFGLAK      R    + 
Sbjct: 117 YMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTH 171

Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
           +V+ T  Y APE      LL  + +Y  GV       +L ELL   
Sbjct: 172 QVV-TRWYRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 31/217 (14%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIK-----RLTCGGQQGDKEFL-VEVEMLSRLH----HR 153
           LG+GGFG VF G  L+D   VAIK     R+       D     +EV +L ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIALDAARG 211
            +++L+ ++ +++    +L    +P   L  ++   GPLG        +R          
Sbjct: 99  GVIRLLDWFETQEGFMLVLERP-LPAQDLFDYITEKGPLGEG-----PSR-CFFGQVVAA 151

Query: 212 LAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY 270
           + + H      V+HRD K  NIL+      AK+ DFG      +      +    GT  Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFD-GTRVY 204

Query: 271 VAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVD 305
             PE+ ++ H      + V+S G++L +++ G  P +
Sbjct: 205 SPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 56/225 (24%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV----------EVEMLSRLHHR 153
           LGEG FG+V           VA+K +        ++ L           E+  L  L H 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFI-------SRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 154 NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMK----IAL 206
           +++KL   Y    +   + +  E    G L  ++     +  +     E R      I  
Sbjct: 70  HIIKL---YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQIIC- 119

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
                + Y H   +  ++HRD K  N+LL++N + K+ADFGL+    +G  N+L T   G
Sbjct: 120 ----AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSC-G 169

Query: 267 TFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGRKPVD 305
           +  Y APE      YA  G    + DV+S G+VL  +L GR P D
Sbjct: 170 SPNYAAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGRLPFD 209

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 90.1 bits (224), Expect = 6e-20
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 26/218 (11%)

Query: 94  EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTC--GGQQGDKEFLVEVEMLSRL 150
                ++    +G G  G V     +     VAIK+L+     Q   K    E+ ++  +
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81

Query: 151 HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           +H+N++ L+  ++ + S +      +  EL+   +L   +   L          RM   L
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMEL-------DHERMSYLL 133

Query: 207 -DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR--TNYLSTR 263
                G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A      T Y+ TR
Sbjct: 134 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
                 Y APE  +        D++S G ++ E++ G 
Sbjct: 191 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 59/224 (26%), Positives = 87/224 (38%), Gaps = 45/224 (20%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF-----LVEVEMLSRL 150
             +E    +GEG +G VFK      G  VAIK+     +  D        L E+ ML +L
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQL 59

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLESWLHGPLGVNCHLDWETRMKIALD 207
            H NLV L+  +  R    HL+ +E   +     L+            +       I   
Sbjct: 60  KHPNLVNLLEVFR-RKRRLHLV-FEYCDHTVLHELDR-------YQRGVPEHLVKSITWQ 110

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGR--TNYLSTRV 264
             + + + H+ +    IHRD K  NIL+  +   K+ DFG A+          + ++TR 
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR- 166

Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
                Y +PE      LLV    Y   V       V  ELL+G 
Sbjct: 167 ----WYRSPE------LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 26/235 (11%)

Query: 79  PHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD 137
               +   +   ++ +    +   S +GEG +G V       +   VAIK+++    Q  
Sbjct: 9   AAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY 68

Query: 138 -KEFLVEVEMLSRLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVN 193
            +  L E+++L R  H N++ +  +    + +  + + +  +L     +E+ L+  L   
Sbjct: 69  CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQ 123

Query: 194 CHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 253
            HL  +          RGL Y+H  +   V+HRD K SN+LL      K+ DFGLA+ A 
Sbjct: 124 -HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179

Query: 254 EGR------TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
                    T Y++TR      Y APE  +      KS D++S G +L E+L+ R
Sbjct: 180 PDHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 38/268 (14%), Positives = 74/268 (27%), Gaps = 61/268 (22%)

Query: 105 LGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRNLVKL 158
            G     + ++ +  D      VA+  +   G   D   +E L     LSR+    + ++
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
                    +  L+  E +  GSL+                  ++     A      H  
Sbjct: 97  --LDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP------VGAIRAMQSLAAAADAAHRA 148

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT 278
               V       S + +                + +G        V+     +       
Sbjct: 149 G---VALSIDHPSRVRV----------------SIDGDV------VLAYPATMPDANP-- 181

Query: 279 GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR-L 337
                + D+   G  L  LL  R P+       +  + +   P  RD     +  +P  +
Sbjct: 182 -----QDDIRGIGASLYALLVNRWPLP------EAGVRSGLAPAERDTA--GQPIEPADI 228

Query: 338 GGKYPKEDFIRVCTIAAACVAPEANQRP 365
               P +    +  +AA  V  +   R 
Sbjct: 229 DRDIPFQ----ISAVAARSVQGDGGIRS 252

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 55/233 (23%), Positives = 91/233 (39%), Gaps = 41/233 (17%)

Query: 90  EELKEATNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKE---FLV 142
            +L+    ++E   ++G G FG V     K         A+K L+        +   F  
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWE 118

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E ++++  +   +V+L  +Y+ +D     +  E +P G L + +                
Sbjct: 119 ERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMS-------------NY 163

Query: 203 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
            +    AR         L  +H       IHRD K  N+LL+ + H K+ADFG   +  +
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVK----SDVYSYGVVLLELLTGRKP 303
                  T V GT  Y++PE   +           D +S GV L E+L G  P
Sbjct: 221 EGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 40/234 (17%)

Query: 90  EELKEATNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKE---FLV 142
           ++++    +FE   ++G G FG V     K         A+K L         E   F  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E ++L     + +  L  +Y+ +D +   L  +    G L + L            +   
Sbjct: 124 ERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLS-----------KFED 170

Query: 203 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           ++  + AR         +  +H+      +HRD K  NIL++ N H ++ADFG   +  E
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVLLELLTGRKP 303
             T   S  V GT  Y++PE                D +S GV + E+L G  P
Sbjct: 228 DGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.8 bits (216), Expect = 3e-19
 Identities = 67/231 (29%), Positives = 101/231 (43%), Gaps = 58/231 (25%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
            +F+    LG G FGRV     +    +G   A+K L        KE +V   +VE    
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVL-------KKEIVVRLKQVEHTND 55

Query: 146 ---MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
              MLS + H  ++++  + + +D+ Q  +  + +  G L S           L    R 
Sbjct: 56  ERLMLSIVTHPFIIRM--WGTFQDAQQIFMIMDYIEGGELFS----------LLRKSQRF 103

Query: 203 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                 A+         L YLH      +I+RD K  NILL+ N H K+ DFG AK  P+
Sbjct: 104 PN--PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158

Query: 255 GRTNYLSTRVMGTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
             T  L     GT  Y+APE  +   +   KS D +S+G+++ E+L G  P
Sbjct: 159 -VTYTLC----GTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 46/248 (18%)

Query: 74  LGGSLPHPTSTRFLAYEEL-KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC 131
           +G    H +S   L  E L  ++   +E   ++GEG +G V K      G  VAIK+   
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL- 59

Query: 132 GGQQGDKEF-----LVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPN---GSLE 183
             +  D +      + E+++L +L H NLV L+     +    +L+ +E V +     LE
Sbjct: 60  --ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-KKKRWYLV-FEFVDHTILDDLE 115

Query: 184 SWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV 243
                       LD++   K       G+ + H  +   +IHRD K  NIL+  +   K+
Sbjct: 116 L-------FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKL 165

Query: 244 ADFGLAKQ-APEGR--TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------V 293
            DFG A+  A  G    + ++TR      Y APE      LLV    Y   V       +
Sbjct: 166 CDFGFARTLAAPGEVYDDEVATR-----WYRAPE------LLVGDVKYGKAVDVWAIGCL 214

Query: 294 LLELLTGR 301
           + E+  G 
Sbjct: 215 VTEMFMGE 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 87.6 bits (217), Expect = 7e-19
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 24/217 (11%)

Query: 94  EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTC--GGQQGDKEFLVEVEMLSRL 150
                ++    +G G  G V           VAIK+L+     Q   K    E+ ++  +
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 118

Query: 151 HHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           +H+N++ L+  ++ + + +      L  EL     +++ L   + +   LD E    +  
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQME--LDHERMSYLLY 171

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR--TNYLSTRV 264
               G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A      T Y+ TR 
Sbjct: 172 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228

Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
                Y APE  +        D++S G ++ E++  +
Sbjct: 229 -----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 85.3 bits (212), Expect = 9e-19
 Identities = 59/221 (26%), Positives = 88/221 (39%), Gaps = 35/221 (15%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRL 150
             +E    +GEG +G VFK         VA+KR+       D E      L E+ +L  L
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKEL 58

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H+N+V+L     S       L +E      L+ +       N  LD E          +
Sbjct: 59  KHKNIVRLHDVLHSDKKL--TLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLK 112

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFG 269
           GL + H      V+HRD K  N+L+  N   K+A+FGLA+      R    S  V+ T  
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVV-TLW 166

Query: 270 YVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGRKP 303
           Y  P+      +L  + +YS  +       +  EL    +P
Sbjct: 167 YRPPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 50/232 (21%), Positives = 94/232 (40%), Gaps = 43/232 (18%)

Query: 89  YEELK---EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEV 144
           YE         ++++    LG G +  VF+ + +++   V +K L        K+   E+
Sbjct: 25  YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREI 81

Query: 145 EMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR-- 201
           ++L  L    N++ L        S    L +E V N   +      L      D++ R  
Sbjct: 82  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-TLT-----DYDIRFY 135

Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR--TN 258
           M   L   + L Y H      ++HRD K  N+++   +   ++ D+GLA+    G+    
Sbjct: 136 MYEIL---KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189

Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGRKP 303
            +++R      +  PE      LLV         D++S G +L  ++  ++P
Sbjct: 190 RVASRY-----FKGPE------LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 22/233 (9%)

Query: 77  SLPHPTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQ 135
           S   PT  R    + + E    ++  S +G G +G V     +  G  VA+K+L+   Q 
Sbjct: 9   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68

Query: 136 GD--KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGP 189
               K    E+ +L  + H N++ L+  ++   S +      L   L     + + L+  
Sbjct: 69  IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNI 123

Query: 190 LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
           +     L  +    +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA
Sbjct: 124 VKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
           +   +  T Y++TR      Y APE  +      ++ D++S G ++ ELLTGR
Sbjct: 180 RHTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 51/307 (16%), Positives = 98/307 (31%), Gaps = 62/307 (20%)

Query: 53  GRKSKASPKETAKPRTADAVTLGGSLPHPTST--------RFLAYEELKEATNNFEPASI 104
           G   +A+  +     T   V+                            +  + +E   +
Sbjct: 1   GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF---------LVEVEMLSRLHHRN 154
           +G G +G V +     +   VAIK++        + F         L E+ +L+RL+H +
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDH 113

Query: 155 LVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           +VK+  +      +    L +  E+      +S          +L       +  +   G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---------KQAPEGRTNYLST 262
           + Y+H      ++HRD K +N L+  +   KV DFGLA                      
Sbjct: 169 VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 263 RVMGTFGYVAPEYAMTGH----------LLVKSDVYSYGV-------VLLELLTGRKPVD 305
            ++        +  +TGH          L++  + Y+  +       +  ELL   K   
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285

Query: 306 MSQPSGQ 312
                  
Sbjct: 286 AYHADRG 292

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 39/227 (17%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-F----LVEVEMLSRL 150
           + +E  + +G+G FG VFK      G  VA+K++     + +KE F    L E+++L  L
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLL 73

Query: 151 HHRNLVKLVGYYSSRDSSQHL------LCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
            H N+V L+    ++ S  +       L ++   +  L   L                ++
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRV 129

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ---APEGRTNYLS 261
                 GL Y+H +    ++HRD KA+N+L+  +   K+ADFGLA+    A   + N  +
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186

Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
            RV+ T  Y  PE      LL+    Y   +       ++ E+ T  
Sbjct: 187 NRVV-TLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 35/223 (15%)

Query: 95  ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSR 149
           +++ F+    LG G +  V+KG+  + G  VA+K +    ++G        + E+ ++  
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKE 59

Query: 150 LHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWETRMKIAL 206
           L H N+V+L     + +    L L +E + N  L+ ++           L+         
Sbjct: 60  LKHENIVRLYDVIHTENK---LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW 115

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVM 265
              +GLA+ HE+    ++HRD K  N+L+      K+ DFGLA+       T   S+ V+
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVV 170

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
            T  Y AP+      +L+ S  YS  +       +L E++TG+
Sbjct: 171 -TLWYRAPD------VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 56/269 (20%), Positives = 95/269 (35%), Gaps = 48/269 (17%)

Query: 90  EELKEATNNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKE---FLV 142
           +E++   ++FE   ++G G F  V     K     G   A+K +         E   F  
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E ++L     R + +L  +++ +D +   L  E    G L + L            +   
Sbjct: 111 ERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLS-----------KFGE 157

Query: 203 KIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
           +I  + AR         +  +H       +HRD K  NILL+   H ++ADFG   +   
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVY-------SYGVVLLELLTGRKPVDMS 307
             T      V GT  Y++PE          +  Y       + GV   E+  G+ P    
Sbjct: 215 DGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-- 271

Query: 308 QPSGQENLVTWARPILRDKDRLEELADPR 336
                ++       I+  K+ L       
Sbjct: 272 ----ADSTAETYGKIVHYKEHLSLPLVDE 296

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 84.2 bits (209), Expect = 3e-18
 Identities = 58/229 (25%), Positives = 96/229 (41%), Gaps = 35/229 (15%)

Query: 94  EATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH 152
           +  + +     LG GG G VF  V +D    VAIK++     Q  K  L E++++ RL H
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH 67

Query: 153 RNLVKLV-----------GYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
            N+VK+                S      + +  E      +E+ L   L     L  E 
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQG-PLLEEH 121

Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGR--- 256
                    RGL Y+H  +   V+HRD K +N+ +   +   K+ DFGLA+         
Sbjct: 122 ARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178

Query: 257 ---TNYLSTRVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
              +  L T+      Y +P   ++ +   K+ D+++ G +  E+LTG+
Sbjct: 179 GHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 151
             ++    +GEG +G V+K   S G  VA+KR+       + E      + E+ +L  LH
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELH 77

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+V L+    S       L +E +    L+  L         L             RG
Sbjct: 78  HPNIVSLIDVIHSERCL--TLVFEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRG 131

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGY 270
           +A+ H+     ++HRD K  N+L+ ++   K+ADFGLA+      R+   +  V+ T  Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVV-TLWY 185

Query: 271 VAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
            AP+      +L+ S  YS  V       +  E++TG+
Sbjct: 186 RAPD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 82.9 bits (206), Expect = 5e-18
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 34/218 (15%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLH 151
             +     +GEG +G V+K   + G   A+K++     + + E      + E+ +L  L 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKELK 58

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H N+VKL     ++     +L +E +    L+  L         L+  T     L    G
Sbjct: 59  HSNIVKLYDVIHTKKRL--VLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNG 112

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGY 270
           +AY H+     V+HRD K  N+L+      K+ADFGLA+      R    +  ++ T  Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIV-TLWY 166

Query: 271 VAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
            AP+      +L+ S  YS  +       +  E++ G 
Sbjct: 167 RAPD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 33/227 (14%)

Query: 94  EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH 151
             +++F+  S+LGEG +G V        G  VAIK++    +       L E+++L    
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67

Query: 152 HRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLESWLH-----GPLGVNCHLDWETRMK 203
           H N++ +  +    S ++   + +  EL     +++ LH       L  + H+ +     
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLS-DDHIQY----- 116

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
                 R +  LH  +   VIHRD K SN+L+ +N   KV DFGLA+   E   +     
Sbjct: 117 FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 264 VMGTF--GYV------APEYAMTGHLLVKS-DVYSYGVVLLELLTGR 301
              +    +V      APE  +T     ++ DV+S G +L EL   R
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.0 bits (206), Expect = 7e-18
 Identities = 63/238 (26%), Positives = 101/238 (42%), Gaps = 59/238 (24%)

Query: 95  ATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ-GDKEF----LVEVEMLS 148
           AT+ +EP + +G G +G V+K      G  VA+K +       G        + EV +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 149 RLH---HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDW------E 199
           RL    H N+V+L+   ++  + + +    LV     E           H+D       +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVT-LV----FE-----------HVDQDLRTYLD 110

Query: 200 TRMKIALDAA----------RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
                 L A           RGL +LH +   C++HRD K  NIL+ +    K+ADFGLA
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGR 301
           +         L+  V+ T  Y APE      +L++S      D++S G +  E+   +
Sbjct: 168 RIY--SYQMALTPVVV-TLWYRAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 27/226 (11%)

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR---MKIALDAARGL 212
           V L     S  SSQ       V   SL          + + D+ T    +  +   A+G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            +L   S+ C IHRD  A NILL      K+ DFGLA+   +               ++A
Sbjct: 207 EFLA--SRKC-IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE- 330
           PE        ++SDV+S+GV+L E+ + G  P     P  + +     R  L++  R+  
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKIDEEFCRR--LKEGTRMRA 317

Query: 331 -ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
            +   P +   Y              C   E +QRPT  E+V+ L 
Sbjct: 318 PDYTTPEM---Y---------QTMLDCWHGEPSQRPTFSELVEHLG 351

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 30/155 (19%), Positives = 58/155 (37%), Gaps = 20/155 (12%)

Query: 104 ILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRL-HHRNL 155
            LG G FG+V +         +    VA+K L  G    + +  + E+++L  + HH N+
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           V L+G   ++     ++  E    G+L ++L              R +      +G  + 
Sbjct: 89  VNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLR-----------SKRNEFVPYKTKGARFR 136

Query: 216 HEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK 250
                   I  D K     + ++  +  + F   K
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 42/225 (18%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
           N FE   +LG+G FG+V     K     G   A+K L        KE +V   EV     
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKIL-------KKEVIVAKDEVAHTLT 197

Query: 146 ---MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETR 201
              +L    H  L  L     S  +   L    E    G L   L         +  E R
Sbjct: 198 ENRVLQNSRHPFLTAL---KYSFQTHDRLCFVMEYANGGELFFHLS-----RERVFSEDR 249

Query: 202 MKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 260
            +    +    L YLH  S+  V++RD K  N++L+ + H K+ DFGL K   EG  +  
Sbjct: 250 ARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGA 304

Query: 261 STRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
           + +   GT  Y+APE  +  +   ++ D +  GVV+ E++ GR P
Sbjct: 305 TMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 28/215 (13%)

Query: 97  NNFEPASILGEGGFGRVFKG-VLSDGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRN 154
             +     LGEG +  V+KG        VA+K +    ++G     + EV +L  L H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +V L     +  S    L +E +    L+ +L         ++            RGLAY
Sbjct: 62  IVTLHDIIHTEKSL--TLVFEYLDK-DLKQYLDDC---GNIINMHNVKLFLFQLLRGLAY 115

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTFGYVAP 273
            H   +  V+HRD K  N+L+      K+ADFGLA+  +   +T      V+ T  Y  P
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVV-TLWYRPP 169

Query: 274 EYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
           +      +L+ S  YS  +       +  E+ TGR
Sbjct: 170 D------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 51/222 (22%), Positives = 84/222 (37%), Gaps = 42/222 (18%)

Query: 105 LGEGGFGRVFKGV---LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGY 161
           +G G +G V+K       D    A+K++   G         E+ +L  L H N++ L   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86

Query: 162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA----------RG 211
           + S    +  L ++   +  L   +              +  + L              G
Sbjct: 87  FLSHADRKVWLLFDYAEH-DLWHIIK-----FHRASKANKKPVQLPRGMVKSLLYQILDG 140

Query: 212 LAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQ-APEGRTNYLSTRVMG 266
           + YLH +    V+HRD K +NIL+          K+AD G A+      +       V+ 
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 267 TFGYVAPEYAMTGHLLVKS-------DVYSYGVVLLELLTGR 301
           TF Y APE      LL+ +       D+++ G +  ELLT  
Sbjct: 198 TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 57/262 (21%), Positives = 95/262 (36%), Gaps = 54/262 (20%)

Query: 80  HPTSTRFLAYEELK---EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ 135
           H +S R   Y +        +N+    ++G G +G V+     +    VAIK++      
Sbjct: 6   HHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN----- 60

Query: 136 GDKEF---------LVEVEMLSRLHHRNLVKL--VGYYSSRDSSQHL-LCYELVPNGSLE 183
             + F         L E+ +L+RL    +++L  +           L +  E+      +
Sbjct: 61  --RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-----AD 113

Query: 184 SWLHGPLGVNCHLDWETRMK-IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK 242
           S L         L  E  +K I  +   G  ++HE     +IHRD K +N LL  +   K
Sbjct: 114 SDLKKLFKTPIFLT-EEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVK 169

Query: 243 VADFGLA----KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH----------LLVKS--- 285
           V DFGLA     +      N L             +  +T H          L++     
Sbjct: 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY 229

Query: 286 ----DVYSYGVVLLELLTGRKP 303
               D++S G +  ELL   + 
Sbjct: 230 TKSIDIWSTGCIFAELLNMLQS 251

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 70/280 (25%), Positives = 105/280 (37%), Gaps = 55/280 (19%)

Query: 52  RGRKSKASPKETAKPRTADAVTLGGSLPHPTSTRFLAYEELKEATNNFEPASILGEGGFG 111
                 +           D      ++ H   T  L     K    NFE   +LG G +G
Sbjct: 9   EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYG 68

Query: 112 RVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLVE----VE--------MLSRLHHRNL 155
           +VF   K    D G   A+K L        K  +V+     E        +        L
Sbjct: 69  KVFLVRKISGHDTGKLYAMKVL-------KKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR----- 210
           V L  +Y+ +  ++  L  + +  G L +          HL    R        +     
Sbjct: 122 VTL--HYAFQTETKLHLILDYINGGELFT----------HLSQRERFT--EHEVQIYVGE 167

Query: 211 ---GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
               L +LH+     +I+RD K  NILL++N H  + DFGL+K+     T        GT
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GT 223

Query: 268 FGYVAPE---YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
             Y+AP+      +GH   K+ D +S GV++ ELLTG  P
Sbjct: 224 IEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 69/229 (30%), Positives = 100/229 (43%), Gaps = 49/229 (21%)

Query: 97  NNFEPASILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLV---EVEM--- 146
           + FE   +LG+G FG+VF   K   SD     A+K L        K  L     V     
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKME 76

Query: 147 ---LSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
              L  ++H  +VKL   + +  +   L L  + +  G L + L         +  E  +
Sbjct: 77  RDILVEVNHPFIVKL---HYAFQTEGKLYLILDFLRGGDLFTRLS-----KEVMFTEEDV 128

Query: 203 K-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 257
           K     +AL     L +LH      +I+RD K  NILL+   H K+ DFGL+K   E   
Sbjct: 129 KFYLAELAL----ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---ESID 178

Query: 258 NYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
           +        GT  Y+APE     GH   +S D +S+GV++ E+LTG  P
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTLP 225

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 63/233 (27%), Positives = 94/233 (40%), Gaps = 59/233 (25%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
           N+F+   +LG+G FG+V     K     G   A+K L        KE ++   EV     
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKIL-------RKEVIIAKDEVAHTVT 54

Query: 146 ---MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWETR 201
              +L    H  L  L     +  +   L    E    G L            HL  E  
Sbjct: 55  ESRVLQNTRHPFLTAL---KYAFQTHDRLCFVMEYANGGELFF----------HLSRERV 101

Query: 202 MKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 253
                + AR         L YLH      V++RD K  N++L+ + H K+ DFGL K   
Sbjct: 102 FT--EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--- 153

Query: 254 EGRTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
           EG ++  + +   GT  Y+APE      +   ++ D +  GVV+ E++ GR P
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLP 204

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 39/225 (17%)

Query: 97  NNFEPASILGEGGFGRVFKG--VLSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSR 149
             +E  + +GEG +G+VFK   + + G  VA+KR+     Q  +E      + EV +L  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVLRH 67

Query: 150 LH---HRNLVKL----VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           L    H N+V+L        + R++   L+ +E V    L ++L         +  ET  
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLV-FEHVDQ-DLTTYLDKVPEP--GVPTETIK 123

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
            +     RGL +LH      V+HRD K  NIL+ ++   K+ADFGLA+         L++
Sbjct: 124 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTS 178

Query: 263 RVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVLLELLTGR 301
            V+ T  Y APE      +L++S      D++S G +  E+   +
Sbjct: 179 VVV-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 41/224 (18%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRL 150
           + +   + LGEG +G V+K +       VAIKR+     + ++E      + EV +L  L
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL 90

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            HRN+++L             L +E       E+ L   +  N  +              
Sbjct: 91  QHRNIIELKSVIHHNHRL--HLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLIN 143

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHA-----KVADFGLAKQ-APEGRTNYLSTRV 264
           G+ + H       +HRD K  N+LL  +  +     K+ DFGLA+      R    +  +
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEI 198

Query: 265 MGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VLLELLTGR 301
           + T  Y  PE      +L+ S  YS  V       +  E+L   
Sbjct: 199 I-TLWYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 77.2 bits (191), Expect = 8e-16
 Identities = 63/234 (26%), Positives = 96/234 (41%), Gaps = 57/234 (24%)

Query: 97  NNFEPASILGEGGFGRVF---KGVLSD-GTAVAIKRLTCGGQQGDKEFLV----EVE--- 145
             FE   +LG+GG+G+VF   K   ++ G   A+K L        K  +V    +     
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-------KKAMIVRNAKDTAHTK 69

Query: 146 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
               +L  + H  +V L     +  +   L L  E +  G L             L+ E 
Sbjct: 70  AERNILEEVKHPFIVDL---IYAFQTGGKLYLILEYLSGGELFM----------QLEREG 116

Query: 201 RMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 252
                 D A          L +LH+     +I+RD K  NI+L +  H K+ DFGL K  
Sbjct: 117 IFM--EDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-- 169

Query: 253 PEGRTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
            E   +   T    GT  Y+APE    +GH   ++ D +S G ++ ++LTG  P
Sbjct: 170 -ESIHDGTVTHTFCGTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAPP 220

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.8 bits (191), Expect = 2e-15
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 42/225 (18%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
            +F    +LG+G FG+V     KG        A+K L        K+ ++   +VE    
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKIL-------KKDVVIQDDDVECTMV 390

Query: 146 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
               +        L +L  +   +   +     E V  G L   +            E  
Sbjct: 391 EKRVLALPGKPPFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQ-----QVGRFKEPH 443

Query: 202 MKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 260
               A + A GL +L       +I+RD K  N++L++  H K+ADFG+ K   E   + +
Sbjct: 444 AVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGV 497

Query: 261 STRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
           +T+   GT  Y+APE  +      KS D +++GV+L E+L G+ P
Sbjct: 498 TTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 49/228 (21%)

Query: 103 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---------- 151
             LG G F  V+    + + T VA+K +    +   +    E+++L R++          
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 152 -HRNLVKLVGYYSSR-DSSQHL-LCYELV-PN--GSLESWLHGPLGVNCHLDWETRMKIA 205
              +++KL+ +++ +  +  H+ + +E++  N    ++ + H  + +        + +I+
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY-----VK-QIS 137

Query: 206 LDAARGLAYLHEDSQPCVIHRDFKASNILL------ENNFHAKVADFGLAKQAPEGRTNY 259
                GL Y+H      +IH D K  N+L+      EN    K+AD G A    E  TN 
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195

Query: 260 LSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGR 301
           + TR      Y +PE      +         +D++S   ++ EL+TG 
Sbjct: 196 IQTRE-----YRSPEVLLGAPWGC------GADIWSTACLIFELITGD 232

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 50/229 (21%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
            +F    +LG+G FG+VF    K         AIK L        K+ ++   +VE    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKAL-------KKDVVLMDDDVECTMV 66

Query: 146 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
               +     H  L  +  + + +         E +  G L   +      +CH    +R
Sbjct: 67  EKRVLSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQ-----SCHKFDLSR 119

Query: 202 MK-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR 256
                  I L    GL +LH      +++RD K  NILL+ + H K+ADFG+ K   E  
Sbjct: 120 ATFYAAEIIL----GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENM 169

Query: 257 TNYLSTRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
                T    GT  Y+APE  + G     S D +S+GV+L E+L G+ P
Sbjct: 170 LGDAKTNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 51/230 (22%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK------RLTCGGQQGDKEFLVEVEMLS 148
            + +E  S++G+G FG+V K     +   VAIK             Q      +EV +L 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---NQA----QIEVRLLE 105

Query: 149 RLHHR------NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWE 199
            ++         +V L  ++  R    HL L +E++ + +L   L      GV+ +L   
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFR---NHLCLVFEML-SYNLYDLLRNTNFRGVSLNL--- 158

Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRT 257
           TR K A      L +L    +  +IH D K  NILL N   +  K+ DFG + Q  +   
Sbjct: 159 TR-KFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY 216

Query: 258 NYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGR 301
            Y+ +R    F Y +PE      Y +        D++S G +L+E+ TG 
Sbjct: 217 QYIQSR----F-YRSPEVLLGMPYDL------AIDMWSLGCILVEMHTGE 255

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 54/231 (23%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
           ++F    ++G+G FG+V     K    +    A+K L        K+ ++   E +    
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVL-------QKKAILKKKEEKHIMS 87

Query: 146 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
               +L  + H  LV L   + S  ++  L    + +  G L   L            E 
Sbjct: 88  ERNVLLKNVKHPFLVGL---HFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEP 139

Query: 201 RMK-----IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG 255
           R +     IA      L YLH  +   +++RD K  NILL++  H  + DFGL K   E 
Sbjct: 140 RARFYAAEIAS----ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK---EN 189

Query: 256 RTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
             +  +T    GT  Y+APE      +   ++ D +  G VL E+L G  P
Sbjct: 190 IEHNSTTSTFCGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPP 238

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 60/234 (25%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
            +F    +LG+G FG+V     KG        A+K L        K+ ++   +VE    
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKIL-------KKDVVIQDDDVECTMV 69

Query: 146 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
               +        L +L   +S   +   L    E V  G L            H+    
Sbjct: 70  EKRVLALPGKPPFLTQL---HSCFQTMDRLYFVMEYVNGGDLMY----------HIQQVG 116

Query: 201 RMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 252
           R K     A         GL +L       +I+RD K  N++L++  H K+ADFG+ K  
Sbjct: 117 RFK--EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-- 169

Query: 253 PEGRTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
            E   + ++T+   GT  Y+APE  A   +   KS D +++GV+L E+L G+ P
Sbjct: 170 -ENIWDGVTTKTFCGTPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAP 220

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 63/228 (27%)

Query: 103 SILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF----LVEVEMLSRLHHR---- 153
            ++G+G FG+V K         VA+K +     + +K F      E+ +L  L  +    
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV-----RNEKRFHRQAAEEIRILEHLRKQDKDN 157

Query: 154 --NLVKLVGYYSSRDSSQHLLC----------YELVPNGSLESWLHGPLGVNCHLDWETR 201
             N++ ++  ++ R    H+ C          YEL+     +       G +  L    R
Sbjct: 158 TMNVIHMLENFTFR---NHI-CMTFELLSMNLYELIKKNKFQ-------GFSLPL---VR 203

Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA--KVADFGLAKQAPEGRTNY 259
            K A    + L  LH++    +IH D K  NILL+    +  KV DFG +    +    Y
Sbjct: 204 -KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTY 259

Query: 260 LSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVLLELLTGR 301
           + +R    F Y APE      Y M        D++S G +L ELLTG 
Sbjct: 260 IQSR----F-YRAPEVILGARYGM------PIDMWSLGCILAELLTGY 296

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 64/234 (27%), Positives = 97/234 (41%), Gaps = 60/234 (25%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
           +NFE   +LG+G FG+V     K     G   A+K L        K+ ++   +VE    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVL-------KKDVILQDDDVECTMT 72

Query: 146 ----MLSRLHHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWLHGPLGVNCHLDWET 200
               +    +H  L +L   +    +   L    E V  G L            H+    
Sbjct: 73  EKRILSLARNHPFLTQL---FCCFQTPDRLFFVMEFVNGGDLMF----------HIQKSR 119

Query: 201 RMKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA 252
           R       AR         L +LH+     +I+RD K  N+LL++  H K+ADFG+ K  
Sbjct: 120 RFD--EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-- 172

Query: 253 PEGRTNYLSTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
            EG  N ++T    GT  Y+APE      +    + D ++ GV+L E+L G  P
Sbjct: 173 -EGICNGVTTATFCGTPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGHAP 223

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.3 bits (171), Expect = 2e-13
 Identities = 43/254 (16%), Positives = 69/254 (27%), Gaps = 66/254 (25%)

Query: 95  ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--------QQGDKEFLVEVEM 146
            T   +    +GEG FG VF+ +  D T VAIK +   G        Q+  +E L E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 147 LSRLH---------HRNLVKLVGYY----------------------------SSRDSSQ 169
              L              + L   +                                  Q
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK 229
             +  E    G     +   L         T   I       LA      +    HRD  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL-----SSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189

Query: 230 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP--EYAMTGHLLVKSDV 287
             N+LL+     K+      K           +  + + G      +Y ++        V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERDGIVV 238

Query: 288 YSYGVVLLELLTGR 301
           +    +  +L TG 
Sbjct: 239 FCDVSMDEDLFTGD 252

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 56/232 (24%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
            +F+   ++G G + +V     K         A+K +        KE +    +++    
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVV-------KKELVNDDEDIDWVQT 58

Query: 146 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
                    +H  LV L  +   +  S+     E V  G L   +        H+  + +
Sbjct: 59  EKHVFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDL---MF-------HMQRQRK 106

Query: 202 MKIALDAAR--------GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP 253
           +    + AR         L YLHE     +I+RD K  N+LL++  H K+ D+G+ K   
Sbjct: 107 LP--EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--- 158

Query: 254 EGRTNYLSTRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
           EG     +T    GT  Y+APE  + G     S D ++ GV++ E++ GR P
Sbjct: 159 EGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 65/248 (26%)

Query: 94  EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEF---------LVE 143
                +E    LG+G +G V+K +    G  VA+K++          F           E
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFRE 58

Query: 144 VEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           + +L+ L  H N+V L+    + +     L ++      +E+ LH  +          R 
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-----METDLHAVI----------RA 103

Query: 203 KIALDA---------ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA---K 250
            I              + + YLH      ++HRD K SNILL    H KVADFGL+    
Sbjct: 104 NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160

Query: 251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGH----------LLVKS-------DVYSYGVV 293
                  N   +    T  +   +  +T +          +L+ S       D++S G +
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220

Query: 294 LLELLTGR 301
           L E+L G+
Sbjct: 221 LGEILCGK 228

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 47/225 (20%), Positives = 72/225 (32%), Gaps = 77/225 (34%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLV--EVEMLSRL-HHRNLVKLV 159
           +LG G  G+V +          A+K L               EVE+  R     ++V++V
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 77

Query: 160 GYY--SSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIA---------LDA 208
             Y          L+  E +  G L                    +I           +A
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGEL-------------FS-----RIQDRGDQAFTEREA 119

Query: 209 AR-------GLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAKQAPEGRTN 258
           +         + YLH  +   + HRD K  N+L  +   N   K+ DFG AK+       
Sbjct: 120 SEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------- 169

Query: 259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP 303
                  G   Y               D++S GV++  LL G  P
Sbjct: 170 -----TTGE-KYDK-----------SCDMWSLGVIMYILLCGYPP 197

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 42/225 (18%)

Query: 97  NNFEPASILGEGGFGRVF----KGVLSDGTAVAIKRLTCGGQQGDKEFLV---EVE---- 145
            +F+   ++G G + +V     K         A++ +        KE +    +++    
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVV-------KKELVNDDEDIDWVQT 101

Query: 146 ----MLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
                    +H  LV L  +   +  S+     E V  G L   +            E  
Sbjct: 102 EKHVFEQASNHPFLVGL--HSCFQTESRLFFVIEYVNGGDLMFHMQ-----RQRKLPEEH 154

Query: 202 MKI-ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL 260
            +  + + +  L YLHE     +I+RD K  N+LL++  H K+ D+G+ K   EG     
Sbjct: 155 ARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGD 208

Query: 261 STRVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKP 303
           +T    GT  Y+APE  + G     S D ++ GV++ E++ GR P
Sbjct: 209 TTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 75/251 (29%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIK------RLTCGGQQGDKEFLVEVEMLS 148
            N F     +G+G FGRV     + +    A+K      + T   +       +E ++L 
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT---RSA----KIEADILK 86

Query: 149 RL-----HHRNLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDWET 200
           ++     ++ N+VK  G +   D   H+ L +E +   SL   +  +   G +       
Sbjct: 87  KIQNDDINNNNIVKYHGKFMYYD---HMCLIFEPL-GPSLYEIITRNNYNGFHIED---I 139

Query: 201 RMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA------------------- 241
           +    ++  + L YL + S   + H D K  NILL++ +                     
Sbjct: 140 K-LYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195

Query: 242 ------KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYS 289
                 K+ DFG A    +   + ++TR      Y APE      + +       SD++S
Sbjct: 196 TKSTGIKLIDFGCATFKSDYHGSIINTR----Q-YRAPEVILNLGWDV------SSDMWS 244

Query: 290 YGVVLLELLTG 300
           +G VL EL TG
Sbjct: 245 FGCVLAELYTG 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 52/247 (21%), Positives = 88/247 (35%), Gaps = 71/247 (28%)

Query: 96  TNNFEPASILGEGGFGRVFKGV--LSDGTAVAIK------RLTCGGQQGDKEFLVEVEML 147
              +E    LGEG FG+V + +      + VA+K      +     +       +E+ +L
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR---EAA----RLEINVL 70

Query: 148 SRLHHR------NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDW 198
            ++  +        V +  +++      H+ + +EL+   +   +L  +           
Sbjct: 71  KKIKEKDKENKFLCVLMSDWFNFH---GHMCIAFELL-GKNTFEFLKENNFQPYPLPH-- 124

Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA----------------- 241
             R  +A      L +LHE+    + H D K  NIL  N+                    
Sbjct: 125 -VR-HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179

Query: 242 --KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVV 293
             +VADFG A    E  T  ++TR      Y  PE      +A         DV+S G +
Sbjct: 180 SIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQ------PCDVWSIGCI 228

Query: 294 LLELLTG 300
           L E   G
Sbjct: 229 LFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 54/247 (21%), Positives = 94/247 (38%), Gaps = 71/247 (28%)

Query: 96  TNNFEPASILGEGGFGRVFKGV--LSDGTAVAIK--RLTCGGQQGDKEF----LVEVEML 147
           +  +E    LGEG FG+V + +   + G  VA+K  +           +      E+++L
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVL 65

Query: 148 SRLHHR------NLVKLVGYYSSRDSSQHL-LCYELVPNGSLESWL--HGPLGVNCHLDW 198
             L+          V+++ ++       H+ + +EL+   S   ++  +G L        
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHH---GHICIVFELL-GLSTYDFIKENGFLPFRLDH-- 119

Query: 199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA----------------- 241
             R K+A    + + +LH +    + H D K  NIL   + +                  
Sbjct: 120 -IR-KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174

Query: 242 --KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVV 293
             KV DFG A    E  +  +STR      Y APE      ++         DV+S G +
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCI 223

Query: 294 LLELLTG 300
           L+E   G
Sbjct: 224 LIEYYLG 230

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 1e-09
 Identities = 52/324 (16%), Positives = 95/324 (29%), Gaps = 85/324 (26%)

Query: 84  TRFLAYEELKEATNNFEPASIL---GEGGFGRVFKGVLSDGTAVAIKR----------LT 130
           +R   Y +L++A     PA  +   G  G G   K  ++    ++ K           L 
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWVALDVCLSYKVQCKMDFKIFWLN 188

Query: 131 CGGQQGDKEFLVEVEMLSRLHHR---NLVKLVGYYSS--------RDSSQHLLCYELVPN 179
                  +  L   EML +L ++   N      + S+        +   + LL  +   N
Sbjct: 189 LKNCNSPETVL---EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245

Query: 180 GSL-------ESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH---EDSQPCVIHRDFK 229
             L        +       ++C +   TR K   D        H   +     +   + K
Sbjct: 246 -CLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304

Query: 230 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYS 289
           +   LL      +  D  L ++         + R +                L   D + 
Sbjct: 305 S---LLLKYLDCRPQD--LPREVLTT-----NPRRLSIIA------ESIRDGLATWDNWK 348

Query: 290 YGVVLLELLTGRKPVDMS----QPSGQENL-------------------VTWARPILRDK 326
           +  V  + LT    ++ S    +P+    +                   + W   I  D 
Sbjct: 349 H--VNCDKLT--TIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404

Query: 327 DR-LEELADPRLGGKYPKEDFIRV 349
              + +L    L  K PKE  I +
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISI 428

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 5e-07
 Identities = 51/304 (16%), Positives = 88/304 (28%), Gaps = 77/304 (25%)

Query: 17  SNKGKHSNLIL----------IFGIG-TGLLITAIISVLIICSCAFRGRKSKA------S 59
           S   ++  L+L           F +    LL T    V    S A     S        +
Sbjct: 240 SKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT 299

Query: 60  PKET----AK---------PRTADAV------TLGGSLPHPTST----RFLAYEELKEAT 96
           P E      K         PR            +  S+    +T    + +  ++L    
Sbjct: 300 PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359

Query: 97  ----NNFEPASILGEGGFGRVFK--GVLSDGTAVAIKRLTCGGQQGDKEFLVEVE-MLSR 149
               N  EPA       + ++F    V      +    L+       K    +V  ++++
Sbjct: 360 ESSLNVLEPAE------YRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS---DVMVVVNK 410

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC-----HLDWETRMKI 204
           LH  +LV+          S   +  EL      E  LH  + V+        D +  +  
Sbjct: 411 LHKYSLVE--KQPKESTISIPSIYLELKVKLENEYALHRSI-VDHYNIPKTFDSDDLIPP 467

Query: 205 ALDAARG-----LAYLH-EDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAPEGRT 257
            LD         + + H ++ +     R      + L+  F   K+     A  A     
Sbjct: 468 YLD---QYFYSHIGH-HLKNIEH--PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL 521

Query: 258 NYLS 261
           N L 
Sbjct: 522 NTLQ 525

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 42/235 (17%), Positives = 80/235 (34%), Gaps = 53/235 (22%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQQGDKEFLVEVEMLSRLHHRNLV------ 156
           +G+GGFG ++   ++   +V              +     E++   R      +      
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 157 ---KLVG----YYSSRDSSQHLLCYELV-----PNGSLESWLHGPLGVNC--HLDWETRM 202
              K +G    + S            ++         L+      +          +T +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQK-----IYEANAKRFSRKTVL 155

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTN 258
           +++L     L Y+HE      +H D KASN+LL     +  +  + D+GLA +      +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY--LVDYGLAYRYCPEGVH 210

Query: 259 ----YLSTRVM-GTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 303
                   R   GT      E+  +  H  V    + D+   G  +++ LTG  P
Sbjct: 211 KAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 54/232 (23%), Positives = 86/232 (37%), Gaps = 49/232 (21%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 153
            +++    +GEG FG +F+G  L +   VAIK         Q   E+           ++
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---------YK 60

Query: 154 NLVKLVG----YYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNC--HLDWETRMKIAL 206
            L    G    YY  ++   ++L  +L+  G SLE      L   C      +T    A 
Sbjct: 61  LLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLED-----LLDLCGRKFSVKTVAMAAK 113

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK-----VADFGLAKQAPEGRTN--- 258
                +  +HE S   +++RD K  N L+            V DFG+ K   +  T    
Sbjct: 114 QMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 170

Query: 259 -YLSTR-VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 303
            Y   + + GT       Y  +  HL      + D+ + G V +  L G  P
Sbjct: 171 PYREKKNLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 55/232 (23%), Positives = 84/232 (36%), Gaps = 49/232 (21%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 153
            NF     +G G FG +  G  L     VAIK   +     Q   E+           ++
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF---------YK 59

Query: 154 NLVKLVG----YYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNCH--LDWETRMKIAL 206
            L    G    YY       + +  EL+  G SLE      L   C      +T + IA+
Sbjct: 60  QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLED-----LFDLCDRTFSLKTVLMIAI 112

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKV--ADFGLAKQAPEGRTN--- 258
                + Y+H  +   +I+RD K  N L+    N     +   DF LAK+  +  T    
Sbjct: 113 QLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169

Query: 259 -YLSTR-VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 303
            Y   + + GT       Y  +  HL      + D+ + G + +  L G  P
Sbjct: 170 PYREHKSLTGT-----ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 39/226 (17%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 153
           N +     +G G FG ++ G  ++ G  VAIK   +     Q      +E ++   +   
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGG 64

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNC--HLDWETRMKIALDAAR 210
             +  +  +   +   +++  EL+  G SLE      L   C      +T + +A     
Sbjct: 65  VGIPTI-RWCGAEGDYNVMVMELL--GPSLED-----LFNFCSRKFSLKTVLLLADQMIS 116

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAK---VADFGLAKQAPEGRTN----YLSTR 263
            + Y+H  +    IHRD K  N L+          + DFGLAK+  + RT+    Y   +
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173

Query: 264 -VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 303
            + GT       YA +  HL +    + D+ S G VL+    G  P
Sbjct: 174 NLTGT-----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 44/232 (18%), Positives = 81/232 (34%), Gaps = 50/232 (21%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV------- 156
           +G GGFG ++     +     A   +     Q +     E++   R+  ++ +       
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 157 --KLVG----YYSSRDSSQHLLCYELV-----PNGSLESWLHGPLGVNCH--LDWETRMK 203
               +G    Y S     +      +V         L+           +      T ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI--DLQKIS------GQNGTFKKSTVLQ 155

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV--ADFGLAKQAPEGRTN--- 258
           + +     L Y+HE+     +H D KA+N+LL      +V  AD+GL+ +      +   
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212

Query: 259 -YLSTRVM-GTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 303
                +   GT      E+  +  H  V    +SDV   G  +L  L G+ P
Sbjct: 213 QENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 50/277 (18%), Positives = 85/277 (30%), Gaps = 67/277 (24%)

Query: 75  GGSLPHPTSTRFLAY---EELKEAT-------NNFEPASILGEGGFGRVFKGV------- 117
           G  L              E L   T         ++  S       G +++         
Sbjct: 10  GVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTC 69

Query: 118 --LSDGTAVAIK------RLTCGG---QQGDKEFLVEVEM-LSRLHHRNLVKLVGYYSSR 165
                    ++K      RL       Q+  K   V     L       +   +G+   +
Sbjct: 70  DSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ 129

Query: 166 DSSQHLLCYELVPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQPC 222
           D  + L+   L    SL+S L            L   + +++A      L +LHE+    
Sbjct: 130 DKYRFLVLPSLGR--SLQSALD-----VSPKHVLSERSVLQVACRLLDALEFLHENE--- 179

Query: 223 VIHRDFKASNILLENNFHAKV--ADFGLAKQ---------APEGRTNYLSTRVMGTFGYV 271
            +H +  A NI ++    ++V  A +G A +           EG  +       G     
Sbjct: 180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHE----GD---- 231

Query: 272 APEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 303
             E+  M  H       +SD+ S G  +L+ L G  P
Sbjct: 232 -LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 39/226 (17%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 153
           N F     +G G FG ++ G  +     VAIK   +     Q     L E ++   L   
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQGG 62

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNG-SLESWLHGPLGVNC--HLDWETRMKIALDAAR 210
             +  V  +   +   ++L  +L+  G SLE      L   C   L  +T + +A     
Sbjct: 63  TGIPNV-RWFGVEGDYNVLVMDLL--GPSLED-----LFNFCSRKLSLKTVLMLADQMIN 114

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAK---VADFGLAKQAPEGRTN----YLSTR 263
            + ++H  S    +HRD K  N L+     A    + DFGLAK+  +  T+    Y   +
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171

Query: 264 -VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVLLELLTGRKP 303
            + GT       YA +  HL +    + D+ S G VL+  L G  P
Sbjct: 172 NLTGT-----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 56/302 (18%), Positives = 91/302 (30%), Gaps = 87/302 (28%)

Query: 105 LGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYS 163
           LG G F  V+    +     VA+K +       +   L E+ +L  + + +         
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSD-PNDPNREM 102

Query: 164 SRDSSQHLL-CYELV-PNGSLESWLHGPLGVN----------CHLDWETRMKIALDAARG 211
                  LL  +++   NG+    +   LG +            L      KI     +G
Sbjct: 103 VV----QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG 158

Query: 212 LAYLHEDSQPCVIHRDFKASNILLE----------------------------------- 236
           L YLH   +  +IH D K  NILL                                    
Sbjct: 159 LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 237 --------------NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL 282
                              K+AD G A    +  T  + TR      Y + E  +     
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271

Query: 283 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYP 342
             +D++S   +  EL TG    +                  RD+D +  + +  L GK P
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEY----------TRDEDHIALIIE--LLGKVP 319

Query: 343 KE 344
           ++
Sbjct: 320 RK 321

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	443
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.84
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.8
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.67
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.6
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.34
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.14
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.08
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.83
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.72
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.67
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.64
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.61
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.55
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.54
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.41
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.19
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.15
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.13
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.91
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.19
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.81
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	95.72
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.26
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	95.2
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	93.97
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.11
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.35
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	84.45
2knc_A	54	Integrin alpha-IIB; transmembrane signaling, prote	83.14
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.24

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.2e-60  Score=450.96  Aligned_cols=263  Identities=26%  Similarity=0.415  Sum_probs=213.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      .++|.+.+.||+|+||.||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.  +...
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~--~~~~   89 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDP   89 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe--eCCE
Confidence            357888999999999999999863      47789999998665555678999999999999999999999997  4457


Q ss_pred             eEEEEeecCCCChhHhhcCCC---------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc
Q 013404          170 HLLCYELVPNGSLESWLHGPL---------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH  240 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  240 (443)
                      .+||||||++|+|.++|+...         .....++|.+++.++.||++||+|||+++   |+||||||+||||++++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCc
Confidence            899999999999999996431         22356999999999999999999999998   999999999999999999


Q ss_pred             eEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHH
Q 013404          241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       241 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~  319 (443)
                      +||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.....      .+..
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~  240 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVI  240 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHH
Confidence            99999999987655443333344679999999999999999999999999999999999 8999974321      1222


Q ss_pred             HHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      ..+.. +...          ..|..+...+.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus       241 ~~i~~-~~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          241 ECITQ-GRVL----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHH-TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHc-CCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            22221 1111          11222334588999999999999999999999999887653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-59  Score=452.29  Aligned_cols=261  Identities=26%  Similarity=0.423  Sum_probs=205.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ++|.+.++||+|+||.||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.  +....
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~--~~~~~  118 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT--EGRPL  118 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEE
Confidence            46777899999999999999864      47889999998665555678999999999999999999999997  44578


Q ss_pred             EEEEeecCCCChhHhhcCCCC-----------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          171 LLCYELVPNGSLESWLHGPLG-----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                      +||||||++|+|.++|+....           ...+++|.+++.++.||++||+|||+.+   |+||||||+||||++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence            999999999999999975422           1346999999999999999999999998   99999999999999999


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~  318 (443)
                      .+||+|||+++...........+...||+.|||||++.+..|+.++|||||||+||||+| |+.||.....      .+.
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~~  269 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEA  269 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HHH
Confidence            999999999997755444434456789999999999999999999999999999999999 8999964321      111


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      ...+. ...++          ..|..+...+.+|+.+||+.||++||||+||+++|+.+.+
T Consensus       270 ~~~i~-~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          270 IDCIT-QGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHH-HTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHH-cCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            22221 11111          1122233458899999999999999999999999998865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3e-59  Score=446.05  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=209.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      .++++.+.||+|+||.||+|.+.      +++.||||+++.... ...++|.+|+.++++++|||||+++|+|..  ...
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~  103 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--DQP  103 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--CCE
Confidence            34566789999999999999863      467899999975533 345789999999999999999999999974  457


Q ss_pred             eEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC
Q 013404          170 HLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN  237 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  237 (443)
                      .+||||||++|+|.++|+....            ....++|.+++.++.||++||+|||+++   |+||||||+||||++
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECC
Confidence            8999999999999999964321            1246899999999999999999999999   999999999999999


Q ss_pred             CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 013404          238 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV  316 (443)
Q Consensus       238 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~  316 (443)
                      ++.+||+|||+++...........+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.....   ..+ 
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~~-  256 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDV-  256 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HHH-
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HHH-
Confidence            99999999999987654443334455689999999999999999999999999999999998 8999964331   112 


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                        ...+ ..+...          ..|..+...+.+|+.+||+.||++||||+||+++|+.+
T Consensus       257 --~~~i-~~~~~~----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          257 --VEMI-RNRQVL----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             --HHHH-HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --HHHH-HcCCCC----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence              2211 221111          12333344588999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-58  Score=439.14  Aligned_cols=263  Identities=28%  Similarity=0.444  Sum_probs=204.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||+||+|++.+  .||||+++....  ...+.|.+|+++|++++|||||+++|+|..   ..++||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEE
Confidence            3578889999999999999999753  599999875432  234679999999999999999999999852   368999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||||++|+|.++|+..   ...++|.+++.|+.||++||+|||+++   |+||||||+||||++++.+||+|||+|+...
T Consensus       110 mEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            9999999999999753   345999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ...........+||+.|||||++.+   ..|+.++|||||||+||||+||+.||......      ......+....   
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~---  254 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGY---  254 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTC---
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCC---
Confidence            4433333455789999999999864   46899999999999999999999999643321      11111122111   


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                        ..|.+ ...+..+...+.+|+.+||+.||++||||.||+++|+.++..+
T Consensus       255 --~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          255 --ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             --CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             --CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence              11111 1122233345889999999999999999999999999886543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.9e-57  Score=441.18  Aligned_cols=272  Identities=25%  Similarity=0.393  Sum_probs=218.3

Q ss_pred             HHHHHHhcCCCCCceeeecCcEEEEEEEECC------CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCC-CceeeEEEe
Q 013404           90 EELKEATNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHH-RNLVKLVGY  161 (443)
Q Consensus        90 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~niv~l~~~  161 (443)
                      .+.+...++|++.+.||+|+||.||+|.+..      ++.||||.++..... ..+.|.+|+++|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3444557889999999999999999998532      357999999765432 24679999999999965 999999999


Q ss_pred             eecCCCCeeEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCC
Q 013404          162 YSSRDSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFK  229 (443)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  229 (443)
                      |.. ++..++||||||++|+|.++|+....            ....+++.+++.++.||++||+|||+++   |+|||||
T Consensus       137 ~~~-~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK  212 (353)
T 4ase_A          137 CTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA  212 (353)
T ss_dssp             ECC-TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EEe-cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence            863 33468999999999999999964321            1345899999999999999999999999   9999999


Q ss_pred             cccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 013404          230 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQ  308 (443)
Q Consensus       230 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~  308 (443)
                      |+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999997765544444456789999999999999999999999999999999998 999997543


Q ss_pred             CCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          309 PSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ..  .    .+...+..+.++          ..|..+...+.+++.+||+.||++|||++||+++|+.+.+..
T Consensus       293 ~~--~----~~~~~i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          293 ID--E----EFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             CS--H----HHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HH--H----HHHHHHHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            21  1    111222222211          112222345889999999999999999999999999887643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-56  Score=432.46  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=209.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      ..|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||+++++|..  ...++||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~ivmE  151 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME  151 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEe
Confidence            5699999999999999999996 4799999999986666666789999999999999999999999984  458999999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      ||++|+|.+++..     ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus       152 y~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          152 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            9999999999973     35899999999999999999999999   999999999999999999999999999877543


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....      ......+....       .+
T Consensus       224 ~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~-------~~  288 (346)
T 4fih_A          224 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNL-------PP  288 (346)
T ss_dssp             SC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSS-------CC
T ss_pred             CC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC-------CC
Confidence            32  23457899999999999999999999999999999999999999964321      12222221110       01


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .+  .........+.+|+.+||+.||++|||++|+++|-+
T Consensus       289 ~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~  326 (346)
T 4fih_A          289 RL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  326 (346)
T ss_dssp             CC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             CC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            11  111122235789999999999999999999998744

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.1e-57  Score=433.51  Aligned_cols=254  Identities=20%  Similarity=0.339  Sum_probs=203.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++......  ..+.|.+|+++|++|+|||||++++++..  ...++||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEE
Confidence            6899999999999999999995 57999999999755332  24679999999999999999999999984  4589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||||+||+|.++|....  ...+++.+++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+...
T Consensus       102 mEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  176 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN  176 (350)
T ss_dssp             EECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred             EeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec
Confidence            99999999999996432  345789999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ...  ...+..+||+.|||||++.+..|+.++|||||||+||||++|+.||....      .......+.....      
T Consensus       177 ~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~------  242 (350)
T 4b9d_A          177 STV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGSF------  242 (350)
T ss_dssp             HHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCC------
T ss_pred             CCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCC------
Confidence            321  12345689999999999999999999999999999999999999997432      2223333332211      


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                       +.....++.    .+.+|+.+||+.||++|||++|++++-+.
T Consensus       243 -~~~~~~~s~----~~~~li~~~L~~dP~~R~s~~e~l~hp~~  280 (350)
T 4b9d_A          243 -PPVSLHYSY----DLRSLVSQLFKRNPRDRPSVNSILEKGFI  280 (350)
T ss_dssp             -CCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             -CCCCccCCH----HHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence             111223333    47899999999999999999999987553

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2e-56  Score=424.27  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=210.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+++|++++|||||++++++.  +....+|
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~yi  109 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYF  109 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence            5799999999999999999995 57899999999643   2344578999999999999999999999998  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||++||+|.+++..    ...+++.++..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+..
T Consensus       110 vmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~  182 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL  182 (311)
T ss_dssp             EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence            9999999999999974    346999999999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ............+||+.|||||++.+..|+.++|||||||++|||++|+.||...+      .......+......    
T Consensus       183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~~~----  252 (311)
T 4aw0_A          183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKIIKLEYD----  252 (311)
T ss_dssp             CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC----
T ss_pred             CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCC----
Confidence            65443334456789999999999999999999999999999999999999996432      22223333322211    


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                          +...++    ..+.+|+.+||+.||++|||++|++.+-+
T Consensus       253 ----~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~~~~~  287 (311)
T 4aw0_A          253 ----FPEKFF----PKARDLVEKLLVLDATKRLGCEEMEGYGP  287 (311)
T ss_dssp             ----CCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGTCHHH
T ss_pred             ----CCcccC----HHHHHHHHHHccCCHhHCcChHHHcCCHH
Confidence                112233    34789999999999999999999765533

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.4e-55  Score=423.39  Aligned_cols=258  Identities=21%  Similarity=0.228  Sum_probs=206.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .+.|++.++||+|+||.||+|+. .+|+.||||+++....     +.+|+.++++++|||||++++++..  ...++|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~--~~~~~ivm  129 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE--GPWVNIFM  129 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence            35678888999999999999996 4789999999975432     2469999999999999999999884  45899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-ceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  253 (443)
                      |||+||+|.++|+.    ...+++.++..++.||+.||+|||+++   |+||||||+||||+.++ .+||+|||+|+...
T Consensus       130 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             CCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            99999999999974    346999999999999999999999999   99999999999999987 69999999998765


Q ss_pred             CCCcc---ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          254 EGRTN---YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       254 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .....   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.........      ..+........
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~~~~~  276 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPPPIR  276 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSCCGGG
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCCCCch
Confidence            43211   1123467999999999999999999999999999999999999999755433221      11222211111


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                           .+...++    ..+.+++.+||+.||++|||+.|++++|....+...
T Consensus       277 -----~~~~~~s----~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          277 -----EIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             -----GSCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             -----hcCccCC----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence                 1112233    347899999999999999999999999987765543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.7e-55  Score=434.16  Aligned_cols=252  Identities=23%  Similarity=0.347  Sum_probs=209.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      +.|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|..  ...+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iVmE  228 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVME  228 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEEEe
Confidence            5699999999999999999996 4799999999987766667789999999999999999999999984  458999999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      ||+||+|.+++..     ..+++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus       229 y~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          229 FLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             CCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            9999999999963     35899999999999999999999999   999999999999999999999999999876543


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....      ......+.....  ..+   
T Consensus       301 ~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~~--~~~---  367 (423)
T 4fie_A          301 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNLP--PRL---  367 (423)
T ss_dssp             CC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC--CCC---
T ss_pred             Cc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCC--CCC---
Confidence            32  23557899999999999999999999999999999999999999964321      122222211110  000   


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .....++    ..+.+|+.+||+.||++|||++|+++|-+
T Consensus       368 ~~~~~~s----~~~~dli~~~L~~dP~~R~ta~ell~Hp~  403 (423)
T 4fie_A          368 KNLHKVS----PSLKGFLDRLLVRDPAQRATAAELLKHPF  403 (423)
T ss_dssp             SCTTSSC----HHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             cccccCC----HHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence            0011223    34789999999999999999999998743

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.1e-56  Score=417.87  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=198.0

Q ss_pred             CCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecC--CCCeeEEEE
Q 013404          100 EPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHLLCY  174 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~lv~  174 (443)
                      ++.++||+|+||.||+|.. .++..||+|.+.....  ...+.|.+|+++|++++|||||+++++|...  ....++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5567899999999999996 4688999999965432  2346799999999999999999999998642  234678999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~  253 (443)
                      |||++|+|.+++..    ...+++..+..++.||+.||+|||+++. +|+||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999974    3468999999999999999999998864 4999999999999984 7999999999998654


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ..    .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.....     .......+... ..     
T Consensus       184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~~~-~~-----  247 (290)
T 3fpq_A          184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSG-VK-----  247 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTT-CC-----
T ss_pred             CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHHcC-CC-----
Confidence            32    2345689999999998865 699999999999999999999999963221     11222222111 10     


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      .+......++    .+.+|+.+||+.||++|||++|+++|-
T Consensus       248 ~~~~~~~~~~----~~~~li~~~L~~dP~~R~s~~e~l~Hp  284 (290)
T 3fpq_A          248 PASFDKVAIP----EVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             CGGGGGCCCH----HHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCCCccCCH----HHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            0111112222    478999999999999999999999863

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-55  Score=420.73  Aligned_cols=268  Identities=23%  Similarity=0.378  Sum_probs=201.5

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHH--HHHHHHhhcCCCceeeEEEeeecCCC--CeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFL--VEVEMLSRLHHRNLVKLVGYYSSRDS--SQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~~~~--~~~~l  172 (443)
                      ++|.+.+.||+|+||.||+|++ +|+.||||+++..   ..+.+.  .|+..+.+++|||||+++++|...+.  ..++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            4577889999999999999998 5899999999643   233444  45556678899999999999975433  35799


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-----CCCceEecCCCcccEEecCCCceEEcccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-----SQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      |||||++|+|.++|+.     ..++|..+++++.|+++||+|||++     ..++|+||||||+||||++++.+||+|||
T Consensus        79 V~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            9999999999999973     3589999999999999999999987     12349999999999999999999999999


Q ss_pred             ccccCCCCCccc--cccccccCcccccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-------
Q 013404          248 LAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-------  312 (443)
Q Consensus       248 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~-------  312 (443)
                      +++.........  .....+||+.|||||++.+.      .++.++|||||||+||||+||..||........       
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            998765433221  22345799999999998764      467899999999999999999887753321110       


Q ss_pred             --chHHHHHHHHhhccccccccccCccCCC-CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          313 --ENLVTWARPILRDKDRLEELADPRLGGK-YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       313 --~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                        .........+...      ..+|.+... .+.+....+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus       234 ~~~~~~~~~~~~~~~------~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             SSCCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhcc------cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence              1111111111111      112222111 123456678999999999999999999999999998864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.3e-55  Score=407.20  Aligned_cols=249  Identities=22%  Similarity=0.337  Sum_probs=192.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+++|++++|||||++++++.  +....++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~i   90 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK--SKDEIIM   90 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEEEE
Confidence            5899999999999999999995 579999999997542   233567999999999999999999999987  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+ +|+|.+++..    ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+..
T Consensus        91 vmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~  162 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM  162 (275)
T ss_dssp             EEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred             EEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence            99999 6899999864    346999999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....   .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||....      .......+......   
T Consensus       163 ~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~~~---  230 (275)
T 3hyh_A          163 TDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGVYT---  230 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC---
T ss_pred             CCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCC---
Confidence            5432   2345689999999999998876 579999999999999999999996432      22223333222111   


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                           +...++    ..+.+++.+||+.||++|||++|+++|-+.
T Consensus       231 -----~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          231 -----LPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             -----CCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             -----CCCCCC----HHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence                 112233    347899999999999999999999998553

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.1e-55  Score=414.49  Aligned_cols=249  Identities=25%  Similarity=0.322  Sum_probs=196.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE----CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ++|++.+.||+|+||.||+|+.    .+++.||||.++....  .....+.+|+++|++++|||||++++++..  ....
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence            5799999999999999999985    2478999999975321  223468899999999999999999999984  4589


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +||||||+||+|.+++..    ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+
T Consensus       102 ~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~  174 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK  174 (304)
T ss_dssp             EEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred             EEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccce
Confidence            999999999999999974    346899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .......  .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+      ..+....+......  
T Consensus       175 ~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~~--  244 (304)
T 3ubd_A          175 ESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD------RKETMTMILKAKLG--  244 (304)
T ss_dssp             C-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC--
T ss_pred             eccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC------HHHHHHHHHcCCCC--
Confidence            6544322  2345689999999999999999999999999999999999999997432      22222333322111  


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL  374 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L  374 (443)
                            ....++    ..+.+|+.+||+.||++|||     ++|+++|-
T Consensus       245 ------~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp  283 (304)
T 3ubd_A          245 ------MPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS  283 (304)
T ss_dssp             ------CCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG
T ss_pred             ------CCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc
Confidence                  111233    34789999999999999998     46887763

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.8e-53  Score=403.67  Aligned_cols=251  Identities=26%  Similarity=0.453  Sum_probs=189.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCC-------
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS-------  167 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  167 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||+++++|...+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4689999999999999999995 47899999999765432 24578999999999999999999999864332       


Q ss_pred             ---CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc
Q 013404          168 ---SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA  244 (443)
Q Consensus       168 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  244 (443)
                         ..+++|||||++|+|.+++..... ....++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence               246899999999999999975432 234566778999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCcc----------ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 013404          245 DFGLAKQAPEGRTN----------YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN  314 (443)
Q Consensus       245 Dfgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~  314 (443)
                      |||+|+........          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||...     ..
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~  232 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----ME  232 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cH
Confidence            99999876543221          11234579999999999999999999999999999999996   77421     11


Q ss_pred             HHHHHHHHhhccccccccccCccCCCCCH---HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          315 LVTWARPILRDKDRLEELADPRLGGKYPK---EDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .......+. .             ..++.   .....+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~-~-------------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          233 RVRTLTDVR-N-------------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHHHH-T-------------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHh-c-------------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111111111 0             11221   222346789999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5e-51  Score=393.73  Aligned_cols=288  Identities=42%  Similarity=0.705  Sum_probs=247.0

Q ss_pred             cCHHHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC
Q 013404           87 LAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD  166 (443)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  166 (443)
                      +...++...+++|++.+.||+|+||.||+|.+.+|+.||||++........+.+.+|+++++.++||||+++++++.  +
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~  106 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD--E  106 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC--C
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--C
Confidence            34445556789999999999999999999998889999999998766666788999999999999999999999987  4


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ....++||||+++|+|.+++.........+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence            45789999999999999999765444456999999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      |+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+........|...... .
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~  262 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-N  262 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-T
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-c
Confidence            999865443333233445689999999999999999999999999999999999999987766666666666554333 3


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      ..+..+.++.+....+.+....+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            456667777777778888899999999999999999999999999999988754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=399.47  Aligned_cols=265  Identities=22%  Similarity=0.304  Sum_probs=202.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecC----CCCe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~  169 (443)
                      ++|++.+.||+|+||.||+|.. .+|+.||||+++.....  ..+.+.+|+++|++++|||||++++++...    +...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999995 57999999999754332  235688999999999999999999987632    3457


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      +|||||||+ |+|.+++..    ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            899999995 689999974    346999999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCc--cccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          250 KQAPEGRT--NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       250 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      +.......  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+..      +....+....
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~------~~l~~I~~~~  279 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV------HQLQLIMMVL  279 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH------HHHHHHHHHH
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH------HHHHHHHHhc
Confidence            87643221  2223457899999999998875 5689999999999999999999999754321      1111111110


Q ss_pred             ccccc-------------cccCc-cCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          327 DRLEE-------------LADPR-LGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       327 ~~~~~-------------~~d~~-~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .....             ..... .....+.     .....+.+|+.+||+.||++|||++|+++|-+
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  347 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPF  347 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHh
Confidence            00000             00000 0000010     01234789999999999999999999998743

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.3e-50  Score=390.15  Aligned_cols=199  Identities=24%  Similarity=0.369  Sum_probs=169.7

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEEC----CCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCC
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  168 (443)
                      ...++|++.+.||+|+||.||+|+.+    +++.||+|.+...  .....+.+|+++|+.+ +|||||++++++..  ..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~   93 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--ND   93 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CC
Confidence            35678999999999999999999842    4678999998643  3456788999999998 69999999999874  45


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-CceEEcccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFG  247 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg  247 (443)
                      ..++||||+++|+|.+++.       .+++.++..++.|++.||+|||+++   |+||||||+|||++.+ +.+||+|||
T Consensus        94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG  163 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG  163 (361)
T ss_dssp             EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence            8999999999999999984       3889999999999999999999999   9999999999999876 799999999


Q ss_pred             ccccCCCCCcc--------------------------ccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhC
Q 013404          248 LAKQAPEGRTN--------------------------YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTG  300 (443)
Q Consensus       248 la~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg  300 (443)
                      +|+........                          ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G  243 (361)
T 4f9c_A          164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG  243 (361)
T ss_dssp             TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence            99865433211                          012335799999999999876 589999999999999999999


Q ss_pred             CCCCCC
Q 013404          301 RKPVDM  306 (443)
Q Consensus       301 ~~p~~~  306 (443)
                      +.||..
T Consensus       244 ~~Pf~~  249 (361)
T 4f9c_A          244 RYPFYK  249 (361)
T ss_dssp             CSSSSC
T ss_pred             CCCCCC
Confidence            999964

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.6e-49  Score=383.88  Aligned_cols=290  Identities=43%  Similarity=0.727  Sum_probs=242.9

Q ss_pred             CccccCHHHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEe
Q 013404           83 STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGY  161 (443)
Q Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~  161 (443)
                      ....++..++....++|++.+.||+|+||.||+|...+|+.||||++...... ....+.+|+++++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            34668889999999999999999999999999999888999999999754322 23478999999999999999999999


Q ss_pred             eecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCce
Q 013404          162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA  241 (443)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  241 (443)
                      |.  +....++||||+++|+|.+++.........+++..+..++.|++.||+|||+...++|+||||||+|||+++++.+
T Consensus        96 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           96 CM--TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EC--CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             Ee--cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            87  4447899999999999999998766556679999999999999999999999922229999999999999999999


Q ss_pred             EEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CCCCcchHHHHH
Q 013404          242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS--QPSGQENLVTWA  319 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~--~~~~~~~~~~~~  319 (443)
                      ||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..  ..........|.
T Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            99999999876543322 234456999999999999999999999999999999999999999621  112233455565


Q ss_pred             HHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ..... ...+..+.+..+...++......+.+++.+||+.||++|||+.||+++|+.
T Consensus       253 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          253 KGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            54433 345667777777788888999999999999999999999999999999975

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.8e-49  Score=408.47  Aligned_cols=254  Identities=21%  Similarity=0.306  Sum_probs=208.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|+++|+.++|||||+++++|.  +...++|||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iv~  233 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNEMVMIY  233 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEEEEEE
Confidence            36899999999999999999995 479999999998655445677899999999999999999999998  455899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC--CceEEccccccccC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN--FHAKVADFGLAKQA  252 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~  252 (443)
                      |||+||+|.++|...   ...+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++..
T Consensus       234 E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          234 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             ECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             eecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999999643   345899999999999999999999999   9999999999999854  89999999999987


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....   ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....      ......+........  
T Consensus       308 ~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~~~~~~~--  376 (573)
T 3uto_A          308 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWNMD--  376 (573)
T ss_dssp             CTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCCCCC--
T ss_pred             cCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHhCCCCCC--
Confidence            55432   2446899999999999999999999999999999999999999964321      222222222211111  


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                        ......++.    .+.+|+.+||+.||++|||+.|+++|-
T Consensus       377 --~~~~~~~s~----~~~dli~~~L~~dp~~R~t~~e~l~Hp  412 (573)
T 3uto_A          377 --DSAFSGISE----DGKDFIRKLLLADPNTRMTIHQALEHP  412 (573)
T ss_dssp             --SGGGTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             --cccccCCCH----HHHHHHHHHccCChhHCcCHHHHhcCc
Confidence              111112233    478999999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.9e-49  Score=405.90  Aligned_cols=252  Identities=25%  Similarity=0.350  Sum_probs=201.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHH---HHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVE---VEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.++||+|+||.||+|+. .+|+.||||++....   ......+.+|   +.+++.++|||||+++++|.  +..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~--~~~  265 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPD  265 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSS
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE--ECC
Confidence            36799999999999999999995 479999999996431   2223334444   56677789999999999998  455


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      .+||||||++||+|.++|..    ...+++..+..++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+
T Consensus       266 ~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccce
Confidence            89999999999999999974    345899999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      |+......    ....+||+.|||||++.. ..|+.++|+|||||+||||++|+.||.........   .....+.....
T Consensus       339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~~~~  411 (689)
T 3v5w_A          339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTMAV  411 (689)
T ss_dssp             CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHHCCC
T ss_pred             eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcCCCC
Confidence            98765433    234689999999999974 57999999999999999999999999754332221   11222222111


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLK  375 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L~  375 (443)
                              .+...++    ..+.+|+.+||+.||++|++     ++||++|-+
T Consensus       412 --------~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf  452 (689)
T 3v5w_A          412 --------ELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  452 (689)
T ss_dssp             --------CCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred             --------CCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence                    1112233    34789999999999999998     789988753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.4e-48  Score=375.29  Aligned_cols=269  Identities=28%  Similarity=0.401  Sum_probs=210.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC--CCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD--SSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++....  ....++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999875 7899999996432 22345667899999999999999999987543  2347899


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc----------CCCceEecCCCcccEEecCCCceEE
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED----------SQPCVIHRDFKASNILLENNFHAKV  243 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~ivH~Dlkp~NIll~~~~~~kl  243 (443)
                      |||+++|+|.++++.     ..+++..++.++.|++.||+|||+.          +   |+||||||+|||++.++.+||
T Consensus       101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred             EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence            999999999999974     3489999999999999999999998          7   999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH--
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV--  316 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~--  316 (443)
                      +|||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||............  
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987655443323344679999999999986     35667899999999999999999999754433222211  


Q ss_pred             --------HHHHHHhhccccccccccCccCCC-CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          317 --------TWARPILRDKDRLEELADPRLGGK-YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       317 --------~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                              .+.......      ...+.+... ........+.+++.+||+.||++|||+.||++.|+.+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHK------KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HCSSCCHHHHHHHHTTS------CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcc------cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                    111111111      011111111 1224456689999999999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-46  Score=359.56  Aligned_cols=283  Identities=36%  Similarity=0.619  Sum_probs=231.2

Q ss_pred             cccCHHHHHHHhcCCCCC------ceeeecCcEEEEEEEECCCcEEEEEEeccCC----CCCHHHHHHHHHHHhhcCCCc
Q 013404           85 RFLAYEELKEATNNFEPA------SILGEGGFGRVFKGVLSDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRN  154 (443)
Q Consensus        85 ~~~~~~~~~~~~~~~~~~------~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~n  154 (443)
                      ..+++.++..++++|...      +.||+|+||.||+|.. +++.||||++....    ....+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            567899999999999877      8999999999999987 57899999987532    223567999999999999999


Q ss_pred             eeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEE
Q 013404          155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       155 iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  234 (443)
                      |+++++++.  +....+++|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus        92 i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil  165 (307)
T 2nru_A           92 LVELLGFSS--DGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL  165 (307)
T ss_dssp             BCCEEEEEC--SSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             eEEEEEEEe--cCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            999999987  44478999999999999999974322 346899999999999999999999999   999999999999


Q ss_pred             ecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 013404          235 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN  314 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~  314 (443)
                      +++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|..||.......  .
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--L  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--B
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--H
Confidence            99999999999999987654433333345679999999998765 57899999999999999999999997544322  2


Q ss_pred             HHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          315 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      +..+..........+....++.+ ...+......+.+++.+||+.||++||++.+|+++|+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            22333333333334444555444 3456677788999999999999999999999999998874

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.4e-47  Score=375.19  Aligned_cols=265  Identities=26%  Similarity=0.416  Sum_probs=212.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE--------CCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEEEeeecC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR  165 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~--------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  165 (443)
                      .++|++.+.||+|+||.||+|..        .++..||||.++..... ..+.+.+|+++++++ +||||++++++|.  
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence            46788999999999999999985        23567999999755322 245789999999999 8999999999987  


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                      +....++||||+++|+|.+++.....            ....+++.+++.++.||+.||+|||+++   |+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence            44578999999999999999975321            1235889999999999999999999999   99999999999


Q ss_pred             EecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 013404          234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ  312 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~  312 (443)
                      |++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....   
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---  311 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  311 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            999999999999999987654433323344567889999999999999999999999999999999 9999975332   


Q ss_pred             chHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      ..+...    +.....      +    ..+......+.+++.+||+.||++||++.|+++.|+.+.+...
T Consensus       312 ~~~~~~----~~~~~~------~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          312 EELFKL----LKEGHR------M----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             GGHHHH----HHTTCC------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHH----HhcCCC------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            111111    111111      1    1122223358899999999999999999999999999876544

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-47  Score=364.14  Aligned_cols=263  Identities=25%  Similarity=0.419  Sum_probs=213.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      ++|.+.+.||+|+||.||++... +++.||+|.+........+.|.+|++++++++||||+++++++..  ....++|||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e   87 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFITE   87 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEEEEE
Confidence            57888999999999999999964 689999999876555556789999999999999999999999884  457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++...   ...+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            99999999999753   345899999999999999999999999   999999999999999999999999999876443


Q ss_pred             Cccc------------cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc---hHHHHHH
Q 013404          256 RTNY------------LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE---NLVTWAR  320 (443)
Q Consensus       256 ~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~---~~~~~~~  320 (443)
                      ....            ......||+.|+|||++.+..++.++||||||+++|||++|..|+.........   .......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            2211            011457999999999999999999999999999999999999998653332211   1111111


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhcCC
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD  385 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~  385 (443)
                                    ......++.    .+.+++.+||+.||++|||+.++++.|+.++.......
T Consensus       242 --------------~~~~~~~~~----~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~  288 (310)
T 3s95_A          242 --------------RYCPPNCPP----SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL  288 (310)
T ss_dssp             --------------HTCCTTCCT----THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred             --------------ccCCCCCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence                          111112222    37899999999999999999999999999987766543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.9e-47  Score=360.12  Aligned_cols=253  Identities=22%  Similarity=0.355  Sum_probs=208.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||.+........+.+.+|+.++++++||||+++++++..  ....++||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~   96 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM   96 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEEEE
Confidence            46899999999999999999994 5789999999987666667889999999999999999999999874  44789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.+++..     ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        97 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           97 EYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             ECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999999999974     34889999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....  ..   
T Consensus       169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~--~~---  235 (297)
T 3fxz_A          169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT--PE---  235 (297)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCS--CC---
T ss_pred             ccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC--CC---
Confidence            332  23446799999999999999999999999999999999999999964321      111111111110  00   


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                          ...+......+.+++.+||+.||++|||++|++++-+
T Consensus       236 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  272 (297)
T 3fxz_A          236 ----LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF  272 (297)
T ss_dssp             ----CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             ----CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence                0112222335789999999999999999999998643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7e-47  Score=362.89  Aligned_cols=263  Identities=29%  Similarity=0.453  Sum_probs=201.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ..++|++.+.||+|+||.||+|+. +|+.||||++.......  .+.+.+|++++++++||||+++++++.  +....++
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l  111 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT--QPPNLSI  111 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--STTCCEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCceEE
Confidence            356889999999999999999987 57899999997654322  357899999999999999999999987  4447899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus       112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~-ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSSC-CCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-EECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999997532 123489999999999999999999998643 999999999999999999999999999865


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   .   ...........     
T Consensus       190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~---~~~~~~~~~~~-----  256 (309)
T 3p86_A          190 ASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---A---QVVAAVGFKCK-----  256 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---H---HHHHHHHHSCC-----
T ss_pred             ccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---HHHHHHHhcCC-----
Confidence            43221  22345799999999999999999999999999999999999999964321   1   11111111110     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                       ...+...++    ..+.+++.+||+.||++|||+++|++.|+.+.+.
T Consensus       257 -~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 -RLEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -CCCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -CCCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence             011112233    3488999999999999999999999999888654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.4e-47  Score=365.30  Aligned_cols=261  Identities=25%  Similarity=0.408  Sum_probs=206.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC----CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|.+.    .+..||||.++.... ...+.|.+|+.++++++||||+++++++.  +....
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~  125 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT--RGRLA  125 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--GGGCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCcc
Confidence            357888999999999999999963    345699999975432 23467999999999999999999999987  44478


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++...   ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       126 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence            9999999999999999643   345899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          251 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....      ......+. ... 
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~-~~~-  271 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVISSVE-EGY-  271 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHH-TTC-
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHH-cCC-
Confidence            76543221 12233456788999999999999999999999999999999 9999964321      11111111 111 


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                           ..    ..+......+.+++.+||+.||++||++.+|++.|+.+.+..
T Consensus       272 -----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          272 -----RL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             -----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             -----CC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                 01    112222335889999999999999999999999999887643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.7e-47  Score=361.40  Aligned_cols=269  Identities=27%  Similarity=0.403  Sum_probs=208.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-----CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++...+....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36788999999999999999984     3688999999986555555789999999999999999999999865444568


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++...   ...+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            9999999999999999743   235899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---------CCcchHHHHHH
Q 013404          251 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP---------SGQENLVTWAR  320 (443)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~---------~~~~~~~~~~~  320 (443)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....         ...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            76543321 122334577889999999999999999999999999999999999853210         00000111111


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      ..+....          ....+......+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       243 ~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          243 ELLKNNG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHTTC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHhccC----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            1111111          1111222334588999999999999999999999999988754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.4e-46  Score=357.32  Aligned_cols=264  Identities=23%  Similarity=0.351  Sum_probs=215.1

Q ss_pred             ccCHHHHHHHhcC----------CCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc
Q 013404           86 FLAYEELKEATNN----------FEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN  154 (443)
Q Consensus        86 ~~~~~~~~~~~~~----------~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  154 (443)
                      .++.++++.+++.          |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4678888887765          666789999999999999965 79999999998776667788999999999999999


Q ss_pred             eeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEE
Q 013404          155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       155 iv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  234 (443)
                      |+++++++..  ....++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+|||
T Consensus       104 iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl  173 (321)
T 2c30_A          104 VVEMYKSYLV--GEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL  173 (321)
T ss_dssp             BCCEEEEEEE--TTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred             cceEEEEEEE--CCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEE
Confidence            9999999884  4478999999999999999863     35899999999999999999999999   999999999999


Q ss_pred             ecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 013404          235 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN  314 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~  314 (443)
                      ++.++.+||+|||+++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....     
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----  246 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----  246 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred             ECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            99999999999999987654322  12446799999999999999999999999999999999999999964321     


Q ss_pred             HHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          315 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                       ......+....       .+.+.  ........+.+++.+||+.||++|||++|++++.+.
T Consensus       247 -~~~~~~~~~~~-------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  298 (321)
T 2c30_A          247 -VQAMKRLRDSP-------PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL  298 (321)
T ss_dssp             -HHHHHHHHHSS-------CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             -HHHHHHHhcCC-------CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence             11111111110       01110  011122347899999999999999999999987554

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.7e-47  Score=371.42  Aligned_cols=273  Identities=25%  Similarity=0.401  Sum_probs=215.8

Q ss_pred             CHHHHHHHhcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEE
Q 013404           88 AYEELKEATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLV  159 (443)
Q Consensus        88 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~  159 (443)
                      ...+.....++|++.+.||+|+||.||+|.+      .+++.||||+++..... ..+.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            3445555678999999999999999999973      24578999999754332 235799999999999 799999999


Q ss_pred             EeeecCCCCeeEEEEeecCCCChhHhhcCCCCC-----------------------------------------------
Q 013404          160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGV-----------------------------------------------  192 (443)
Q Consensus       160 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------------------------------------  192 (443)
                      ++|... ....++||||+++|+|.++++.....                                               
T Consensus        93 ~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           93 GACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            998743 34589999999999999999754321                                               


Q ss_pred             ---------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          193 ---------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       193 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                                     ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           122889999999999999999999999   99999999999999999999999999987654443


Q ss_pred             cccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCc
Q 013404          258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR  336 (443)
Q Consensus       258 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  336 (443)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.......  .+..    .+.....      ..
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~------~~  316 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTR------MR  316 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHH----HHHHTCC------CC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHH----HHHcCCC------CC
Confidence            333445678999999999999999999999999999999998 999996543221  1111    1111111      11


Q ss_pred             cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       337 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      ....++    ..+.+++..||+.||++|||+.||+++|+.+.+.
T Consensus       317 ~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          317 APDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            111223    3488999999999999999999999999988764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.7e-47  Score=374.95  Aligned_cols=260  Identities=28%  Similarity=0.447  Sum_probs=208.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|.+. +++.||||.++..... ....|.+|++++++++||||++++++|.  +....++|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv  190 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQPIYIV  190 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--cCCCcEEE
Confidence            467888999999999999999975 7899999998754322 2346889999999999999999999987  34478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++|+|.+++...   ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            9999999999999742   235899999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||.....   ...    ...+.....+   
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~----~~~~~~~~~~---  334 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQT----REFVEKGGRL---  334 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHH----HHHHHTTCCC---
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHcCCCC---
Confidence            3322111122346778999999999999999999999999999998 9999964321   111    1111111111   


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                             ..+......+.+++.+||+.||++|||+++|++.|+.+.+.
T Consensus       335 -------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          335 -------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                   11222233588999999999999999999999999988653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-46  Score=362.03  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=205.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ..+|++.+.||+|+||.||+|.. .+|+.||||++.....  ...+.+.+|+++++.++||||+++++++.  +....++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~l   91 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE--TEKTLYL   91 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEEE
Confidence            46799999999999999999996 5799999999975432  23456889999999999999999999987  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             EECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             EEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            9999999999999964    235899999999999999999999999   999999999999999999999999999866


Q ss_pred             CCCCccccccccccCcccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....   ......||+.|+|||++.+..+. .++|||||||++|||++|+.||....      .......+......   
T Consensus       165 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~---  232 (328)
T 3fe3_A          165 TVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGKYR---  232 (328)
T ss_dssp             SSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---
T ss_pred             CCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC---
Confidence            5432   23456799999999999988775 79999999999999999999997432      22222222222111   


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                               .+......+.+++.+||+.||++|||++|++++-+
T Consensus       233 ---------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          233 ---------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             ---------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             ---------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence                     11112234789999999999999999999998744

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-46  Score=351.10  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=209.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.  +....++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~   86 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLVFEF   86 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEEEEC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCceEEEEEe
Confidence            5788899999999999999998888999999997543 34578999999999999999999999987  44578999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.+++...   ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        87 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           87 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999753   335899999999999999999999999   9999999999999999999999999998664432


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      . .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+... .      ..
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~~~~~~-~------~~  226 (269)
T 4hcu_A          161 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG-F------RL  226 (269)
T ss_dssp             H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT-C------CC
T ss_pred             c-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhcC-c------cC
Confidence            1 12233457788999999999999999999999999999999 9999964321      1111111111 0      01


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      .....+    ...+.+++.+||+.||++||++.+++++|+.+.+
T Consensus       227 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          227 YKPRLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            111122    2348899999999999999999999999998865

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.5e-46  Score=363.47  Aligned_cols=259  Identities=29%  Similarity=0.466  Sum_probs=202.5

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCc----EEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ++|++.+.||+|+||.||+|.+. +++    +||+|.+.... ....+.|.+|+.++++++||||++++++|...   ..
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TV   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---SE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---Ce
Confidence            57889999999999999999953 444    46888886433 34467899999999999999999999999742   47


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++++||+++|+|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence            8999999999999999753   345899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...............+|..|+|||++.+..++.++|||||||++|||++ |+.||......   .+...    +..... 
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~~~~-  237 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGER-  237 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCC-
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHH----HHcCCC-
Confidence            7655443333344567889999999999999999999999999999999 99999754322   11111    111111 


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                               ...+......+.+++.+||+.||++||++.|++++|+.+.+..
T Consensus       238 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          238 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ---------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ---------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence                     1112223345889999999999999999999999999886543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=353.87  Aligned_cols=272  Identities=21%  Similarity=0.302  Sum_probs=214.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+....++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57889999999999999999965 58999999997543 23457788999999999999999999998866666789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe----cCCCceEEccccccc
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAK  250 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~  250 (443)
                      ||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999975322 233899999999999999999999999   9999999999999    888899999999998


Q ss_pred             cCCCCCccccccccccCcccccccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAM--------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI  322 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  322 (443)
                      .......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||........  .......+
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~  239 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKI  239 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHH
Confidence            7654332   23457999999999886        57889999999999999999999999964332221  12222222


Q ss_pred             hhccc--cccccc-----------cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          323 LRDKD--RLEELA-----------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       323 ~~~~~--~~~~~~-----------d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      .....  ....+.           +.......+......+.+++.+||+.||++|||++|++++..+-
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            22110  000000           00111244567777899999999999999999999999997653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.9e-46  Score=358.68  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=204.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.  +....++|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR--EGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCCeEEEE
Confidence            368999999999999999999965 789999999865432 22456889999999999999999999987  45588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++|+|.+++..    ...+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            999999999999974    345899999999999999999999999   9999999999999999999999999998664


Q ss_pred             CCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ............||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....|.    ......   
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~----~~~~~~---  228 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK----EKKTYL---  228 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHH----TTCTTS---
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHh----cccccC---
Confidence            3333333345689999999999988775 789999999999999999999997543321 1111111    110000   


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                       .+      .......+.+++.+||+.||++|||++|++++-+.
T Consensus       229 -~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~  265 (323)
T 3tki_A          229 -NP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (323)
T ss_dssp             -TT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             -Cc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence             00      01122347789999999999999999999987543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=368.89  Aligned_cols=268  Identities=25%  Similarity=0.387  Sum_probs=214.0

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC--------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEEEeeec
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSS  164 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  164 (443)
                      ..++|.+.+.||+|+||.||+|...        .+..||||+++..... ....+.+|+++++++ +||||++++++|. 
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-  145 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-  145 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec-
Confidence            3468899999999999999999852        2357999999755332 236789999999999 9999999999987 


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCccc
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN  232 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  232 (443)
                       +....++||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||+.+   |+||||||+|
T Consensus       146 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          146 -QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             -cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence             44578999999999999999975331            1245899999999999999999999999   9999999999


Q ss_pred             EEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 013404          233 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSG  311 (443)
Q Consensus       233 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~  311 (443)
                      ||+++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||....   
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---  298 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---  298 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence            9999999999999999987655433333344567899999999999999999999999999999999 999996432   


Q ss_pred             cchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhcC
Q 013404          312 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQ  384 (443)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~  384 (443)
                         .......+ .....      ......++    ..+.+++.+||+.||++||+++||+++|+.+......+
T Consensus       299 ---~~~~~~~~-~~~~~------~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          299 ---VEELFKLL-KEGHR------MDKPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             ---HHHHHHHH-HTTCC------CCCCSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             ---HHHHHHHH-HcCCC------CCCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence               11111111 11111      11112233    34889999999999999999999999999998765543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-46  Score=369.86  Aligned_cols=260  Identities=27%  Similarity=0.450  Sum_probs=197.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC----CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|+..    ++..||||.++.... ...+.|.+|+.++++++||||+++++++.  +....
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~  121 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT--KSKPV  121 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCce
Confidence            357999999999999999999864    567899999975432 23457999999999999999999999987  44578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.++++..   ...+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       122 ~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            9999999999999999753   345899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          251 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       251 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.....      ......+ .....
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~~~~~i-~~~~~  268 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QDVIKAV-DEGYR  268 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HHHHHHH-HTTEE
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-HcCCC
Confidence            765432211 1122346788999999999999999999999999999998 9999964321      1111111 11111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      .          ..+......+.+++.+||+.||++||++.+|++.|+.+.+.
T Consensus       269 ~----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          269 L----------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             C----------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C----------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            0          11122234588999999999999999999999999988654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=372.54  Aligned_cols=266  Identities=27%  Similarity=0.406  Sum_probs=209.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||+|.+.      ++..||||+++.... .....+.+|+.++++++||||+++++++.  +..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~  147 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL--QSL  147 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCC
Confidence            467889999999999999999953      466899999974422 23457889999999999999999999987  444


Q ss_pred             eeEEEEeecCCCChhHhhcCCC---CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC---ceE
Q 013404          169 QHLLCYELVPNGSLESWLHGPL---GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAK  242 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k  242 (443)
                      ..++||||+++|+|.+++....   .....+++.+++.++.|++.||+|||+++   |+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence            7799999999999999996432   12245899999999999999999999999   99999999999999554   599


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....      ......
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~  298 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEF  298 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH
Confidence            999999975432222222334568999999999999999999999999999999998 9999964321      111111


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                      +... ..      ......++    ..+.+++.+||+.||++||++.+|+++|+.+.+....
T Consensus       299 i~~~-~~------~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          299 VTSG-GR------MDPPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             HHTT-CC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             HHcC-CC------CCCCccCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence            1111 11      11112233    3488999999999999999999999999998765543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.7e-46  Score=357.30  Aligned_cols=262  Identities=26%  Similarity=0.408  Sum_probs=210.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|.+.+.||+|+||.||+|..      .++..||||.++.... ...+.+.+|++++++++||||+++++++.  +..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS--QDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe--cCC
Confidence            46788999999999999999985      2457899999975432 22467899999999999999999999987  445


Q ss_pred             eeEEEEeecCCCChhHhhcCCCC--------------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCC
Q 013404          169 QHLLCYELVPNGSLESWLHGPLG--------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF  228 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  228 (443)
                      ..++||||+++|+|.+++.....                    ....+++.+++.++.|++.||.|||+++   |+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence            78999999999999999975332                    1234889999999999999999999999   999999


Q ss_pred             CcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 013404          229 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMS  307 (443)
Q Consensus       229 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~  307 (443)
                      ||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987655443333344567889999999999999999999999999999999 99999754


Q ss_pred             CCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          308 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      ...   .+...    +....      .......++    ..+.+++.+||+.||++||++.+++++|+.+..
T Consensus       257 ~~~---~~~~~----~~~~~------~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          257 PPE---RLFNL----LKTGH------RMERPDNCS----EEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             CGG---GHHHH----HHTTC------CCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHH---HHHHH----hhcCC------cCCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            322   11111    11111      011112233    358899999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.5e-46  Score=361.56  Aligned_cols=259  Identities=28%  Similarity=0.431  Sum_probs=204.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCc----EEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      ++|++.+.||+|+||.||+|.+. +++    +||+|.+.... ......+.+|+.++++++||||+++++++.   ....
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcc
Confidence            57889999999999999999954 444    38888876443 233456788999999999999999999985   3368


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             EEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence            8999999999999999753   346899999999999999999999999   9999999999999999999999999999


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...............+|..|+|||++.+..++.++|||||||++|||++ |+.||.......   ....    +......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~  236 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDL----LEKGERL  236 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHH----HHTTCBC
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHH----HHcCCCC
Confidence            8765544333455678889999999999999999999999999999999 999997543221   1111    1111111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                            .    .+......+.+++.+||+.||++||++.+++++|+.+.+..
T Consensus       237 ------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          237 ------A----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             ------C----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             ------C----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                  0    01111123678999999999999999999999999886543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.8e-46  Score=348.30  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=209.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||+|...++..||+|.++... ...+.+.+|++++.+++||||+++++++.  +....++|||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   83 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS--KEYPIYIVTE   83 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCceEEEEE
Confidence            46788999999999999999999888899999997543 34577999999999999999999999986  4457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++...   ...+++.+++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999642   335899999999999999999999999   999999999999999999999999999876544


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....      .......... .   ..  
T Consensus       158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~-~---~~--  224 (268)
T 3sxs_A          158 QYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------SEVVLKVSQG-H---RL--  224 (268)
T ss_dssp             CEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTT-C---CC--
T ss_pred             hhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh------HHHHHHHHcC-C---CC--
Confidence            322 2233456778999999999899999999999999999999 9999964321      1111111111 1   00  


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                       ......+    ..+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus       225 -~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 -YRPHLAS----DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             -CCCTTSC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             -CCCCcCh----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence             0111122    347899999999999999999999999988754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.6e-45  Score=357.38  Aligned_cols=251  Identities=24%  Similarity=0.306  Sum_probs=206.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||+++.. +|+.||+|.++..   .......+.+|+++++.++||||+++++++.  +....+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~--~~~~~~   81 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLC   81 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE--eCCEEE
Confidence            357899999999999999999964 6899999999643   2344567899999999999999999999987  445899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++..    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        82 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            99999999999999964    335899999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....    
T Consensus       155 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~----  222 (337)
T 1o6l_A          155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILMEEI----  222 (337)
T ss_dssp             SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC----
T ss_pred             cccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHHHHcCCC----
Confidence            433221  2345689999999999999999999999999999999999999996432      1222222222211    


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                          .+...++    ..+.+++.+||+.||++||     +++||++|-+
T Consensus       223 ----~~p~~~s----~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~  263 (337)
T 1o6l_A          223 ----RFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             ----CCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             ----CCCCCCC----HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence                1111223    3478999999999999999     8999998754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-46  Score=361.08  Aligned_cols=266  Identities=26%  Similarity=0.407  Sum_probs=208.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCC-CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD  166 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  166 (443)
                      ..++|++.+.||+|+||.||+|..      .++..||||.+.... ....+.+.+|+.+++++ +||||+++++++..  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence            457889999999999999999995      245689999997543 23346799999999999 89999999999874  


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCC-------------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecC
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGV-------------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRD  227 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  227 (443)
                      ....++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||+.+   |+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence            45789999999999999999754321                   134789999999999999999999999   99999


Q ss_pred             CCcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 013404          228 FKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDM  306 (443)
Q Consensus       228 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~  306 (443)
                      |||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999987654433333344568889999999999999999999999999999998 9999975


Q ss_pred             CCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          307 SQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ....  .....    .+....      ..    ..+......+.+++.+||+.||++||++.+|+++|+.+....
T Consensus       278 ~~~~--~~~~~----~~~~~~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          278 IPVD--ANFYK----LIQNGF------KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCCS--HHHHH----HHHTTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCcH--HHHHH----HHhcCC------CC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            4322  11111    111111      01    111222335889999999999999999999999999876543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.2e-45  Score=349.38  Aligned_cols=263  Identities=24%  Similarity=0.411  Sum_probs=204.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhh--cCCCceeeEEEeeecC--CCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSSR--DSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~--~~~~~~  171 (443)
                      .++|++.+.||+|+||.||+|+. +|+.||||++..   .....+..|.+++..  ++||||+++++++...  .....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999998 689999999864   245567778777776  7999999999986532  234678


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhh--------hcCCCceEecCCCcccEEecCCCceEE
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH--------EDSQPCVIHRDFKASNILLENNFHAKV  243 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl  243 (443)
                      +||||+++|+|.++++.     ..+++..++.++.|++.||+|||        +.+   |+||||||+|||++.++.+||
T Consensus        83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            99999999999999963     35899999999999999999999        777   999999999999999999999


Q ss_pred             ccccccccCCCCCccc--cccccccCcccccccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCC
Q 013404          244 ADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTG----------RKPVD  305 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~G~il~elltg----------~~p~~  305 (443)
                      +|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999997654332211  12334799999999999876      456799999999999999999          78886


Q ss_pred             CCCCCCcchHHHHHHHHhhccccccccccCccC-CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          306 MSQPSGQENLVTWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ........ .... .........     .+.+. ...+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus       235 ~~~~~~~~-~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPS-FEDM-RKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCC-HHHH-HHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcc-hhhh-hHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            44332221 1111 111111111     11111 112334566799999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-46  Score=362.65  Aligned_cols=265  Identities=26%  Similarity=0.371  Sum_probs=209.9

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCC
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD  166 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  166 (443)
                      ...++|++.+.||+|+||.||+|...      +++.||||.++..... ..+.|.+|+.++++++||||+++++++.  +
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA--V  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--S
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--c
Confidence            34688999999999999999999964      3478999999754332 2467899999999999999999999987  4


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCC--------------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEec
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGV--------------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHR  226 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  226 (443)
                      ....++||||+++|+|.+++......                    ...+++.+++.++.|+++||.|||+++   |+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            45789999999999999999753211                    156899999999999999999999999   9999


Q ss_pred             CCCcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 013404          227 DFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVD  305 (443)
Q Consensus       227 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~  305 (443)
                      ||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999986543322222334568899999999999999999999999999999999 999996


Q ss_pred             CCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          306 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      ....      ......+. ....      +.....++    ..+.+++.+||+.||++||++.+|+++|+.+.+.
T Consensus       279 ~~~~------~~~~~~~~-~~~~------~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          279 GMAH------EEVIYYVR-DGNI------LACPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TSCH------HHHHHHHH-TTCC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCCh------HHHHHHHh-CCCc------CCCCCCCC----HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            4321      11111111 1111      11112233    3588999999999999999999999999987643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.7e-45  Score=357.96  Aligned_cols=254  Identities=25%  Similarity=0.324  Sum_probs=205.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC------CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||++... +|+.||+|.++.....      ..+.+.+|+.++++++||||+++++++.  +..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~   88 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE--NRT   88 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSS
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE--eCC
Confidence            467999999999999999999964 6899999999765322      3467999999999999999999999987  455


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC----ceEEc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA  244 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~  244 (443)
                      ..++||||+++|+|.+++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||+++++    .+||+
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEE
Confidence            89999999999999999964    345899999999999999999999999   99999999999998876    79999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      |||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......+..
T Consensus       162 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~  232 (361)
T 2yab_A          162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITA  232 (361)
T ss_dssp             CCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHT
T ss_pred             ecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence            9999987654322   2345799999999999999999999999999999999999999964321      122222221


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ......    +.....++    ..+.+++.+||+.||++|||+.|+++|-+
T Consensus       233 ~~~~~~----~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~e~l~hp~  275 (361)
T 2yab_A          233 VSYDFD----EEFFSQTS----ELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (361)
T ss_dssp             TCCCCC----HHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             cCCCCC----chhccCCC----HHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence            111100    00001122    34789999999999999999999997644

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-45  Score=349.37  Aligned_cols=257  Identities=25%  Similarity=0.372  Sum_probs=207.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||++.+.++..||+|+++... ...+.+.+|++++.+++||||+++++++.  +....++|||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e   99 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIITE   99 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEEEC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEe--cCCCeEEEEe
Confidence            46788999999999999999999888899999997543 34578999999999999999999999987  4457899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++...   ...+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A          100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            99999999999753   345899999999999999999999999   999999999999999999999999999866442


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      .. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....      ......+... .      .
T Consensus       174 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~~-~------~  239 (283)
T 3gen_A          174 EY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQG-L------R  239 (283)
T ss_dssp             HH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTT-C------C
T ss_pred             cc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh------hHHHHHHhcc-c------C
Confidence            21 11223457788999999999999999999999999999998 9999964331      1111111111 0      1


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      .......+    ..+.+++.+||+.||++|||+++++++|+.+..
T Consensus       240 ~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          240 LYRPHLAS----EKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CCCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCcCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            11111222    358899999999999999999999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5e-45  Score=347.96  Aligned_cols=254  Identities=24%  Similarity=0.320  Sum_probs=200.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--------------------------CHHHHHHHHHHHh
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--------------------------GDKEFLVEVEMLS  148 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~  148 (443)
                      .++|++.+.||+|+||.||+|.. .+++.||||.+......                          ..+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46899999999999999999995 46889999998654311                          1356889999999


Q ss_pred             hcCCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCC
Q 013404          149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF  228 (443)
Q Consensus       149 ~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  228 (443)
                      +++||||+++++++........++||||+++++|.+++.     ...+++.++..++.|++.||+|||+++   |+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence            999999999999998655668899999999999988764     346899999999999999999999999   999999


Q ss_pred             CcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCC
Q 013404          229 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLTGRKPVD  305 (443)
Q Consensus       229 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~G~il~elltg~~p~~  305 (443)
                      ||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            99999999999999999999987654322  233457999999999998765   4788999999999999999999996


Q ss_pred             CCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          306 MSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ...      ...+...+.......     + ....++.    .+.+++.+||+.||++||++.|++++-+
T Consensus       242 ~~~------~~~~~~~~~~~~~~~-----~-~~~~~~~----~l~~li~~~l~~dp~~R~s~~e~l~hp~  295 (298)
T 2zv2_A          242 DER------IMCLHSKIKSQALEF-----P-DQPDIAE----DLKDLITRMLDKNPESRIVVPEIKLHPW  295 (298)
T ss_dssp             CSS------HHHHHHHHHHCCCCC-----C-SSSCCCH----HHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred             Ccc------HHHHHHHHhcccCCC-----C-CccccCH----HHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence            422      122222221111100     0 1112333    4789999999999999999999987644

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-45  Score=354.58  Aligned_cols=264  Identities=26%  Similarity=0.412  Sum_probs=211.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+|..      .+++.||||.++.... ...+.+.+|+.+++++ +||||+++++++..  .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--G   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--C
Confidence            46789999999999999999985      3467899999975533 2346789999999999 99999999999874  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCC--------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLG--------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                      ...++||||+++|+|.+++.....              ....+++.+++.++.|++.||.|||+.+   |+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence            578999999999999999975321              1235899999999999999999999999   99999999999


Q ss_pred             EecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 013404          234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ  312 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~  312 (443)
                      |++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--  254 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--  254 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--
Confidence            999999999999999987765543333344567889999999999999999999999999999999 99999654322  


Q ss_pred             chHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      .....    ......      .......++    ..+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       255 ~~~~~----~~~~~~------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          255 SKFYK----MIKEGF------RMLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHH----HHHHTC------CCCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHH----HhccCC------CCCCcccCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11111    111111      011111223    3488999999999999999999999999887653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-46  Score=376.86  Aligned_cols=259  Identities=26%  Similarity=0.428  Sum_probs=210.3

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ...++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.   ....++|
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~lv  260 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYII  260 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEEE
Confidence            3457788999999999999999999888999999998543 45788999999999999999999999985   3368999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++|+|.++++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       261 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             ECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            99999999999997432  235788999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .... .......+|..|+|||++....++.++|||||||++|||++ |+.||.....   ...   ...+ ....++   
T Consensus       336 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~---~~~i-~~~~~~---  404 (454)
T 1qcf_A          336 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEV---IRAL-ERGYRM---  404 (454)
T ss_dssp             CHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH---HHHH-HHTCCC---
T ss_pred             CCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHH---HHHH-HcCCCC---
Confidence            3211 11233456789999999999999999999999999999999 9999964321   111   1111 111111   


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                             ..+......+.+++.+||+.||++|||+++|++.|+.+..
T Consensus       405 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          405 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                   1122223458899999999999999999999999987754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6.7e-46  Score=357.48  Aligned_cols=278  Identities=31%  Similarity=0.420  Sum_probs=211.6

Q ss_pred             CCCCceeeecCcEEEEEEEEC-----CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           99 FEPASILGEGGFGRVFKGVLS-----DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        99 ~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      |++.+.||+|+||.||++.+.     +++.||||+++.... ...+.+.+|++++++++||||+++++++...+....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488999999999999998753     678999999986532 22457899999999999999999999998765668899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..     ..+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence            9999999999999974     34899999999999999999999999   999999999999999999999999999877


Q ss_pred             CCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ...... .......+|..|+|||++.+..++.++||||||+++|||++|+.||....... .....+...... ...+..
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~  262 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMT-VLRLTE  262 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHH-HHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchh-HHHHHH
Confidence            554322 12334568889999999999999999999999999999999999985321000 000000000000 000011


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhcCCC
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDP  386 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~  386 (443)
                      ..........+......+.+++.+||+.||++|||++|+++.|+.+.+....+.|
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p  317 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP  317 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence            1111111122222334588999999999999999999999999999887766544

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.5e-45  Score=370.07  Aligned_cols=253  Identities=27%  Similarity=0.450  Sum_probs=206.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||+|.+. |+.||||.++...  ..+.|.+|+++|++++||||+++++++... ....++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEEEE
Confidence            467888999999999999999985 7899999998543  457899999999999999999999998643 336899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++....  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       268 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             CCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999997432  234789999999999999999999999   999999999999999999999999999854332


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      .     ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......   ....    +....++     
T Consensus       343 ~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~~~-----  405 (450)
T 1k9a_A          343 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKM-----  405 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHTTCCC-----
T ss_pred             c-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCCC-----
Confidence            1     22367889999999999999999999999999999998 999997543322   1111    1111111     


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                           ..+..+...+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       406 -----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          406 -----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                 1122233458899999999999999999999999998864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-45  Score=345.79  Aligned_cols=254  Identities=29%  Similarity=0.471  Sum_probs=194.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCC----CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ----QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||+|... |+.||||.++....    ...+.+.+|+++++.++||||+++++++.  +....+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL--KEPNLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--CC--CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--cCCceE
Confidence            357889999999999999999975 78999999875432    23467899999999999999999999987  445789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC--------CCceEE
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--------NFHAKV  243 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl  243 (443)
                      +||||+++++|.+++..     ..+++..++.++.|++.||.|||+++..+|+||||||+|||++.        ++.+||
T Consensus        83 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             EEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            99999999999999963     35899999999999999999999988555889999999999986        678999


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      +|||+++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      ........
T Consensus       158 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~  227 (271)
T 3dtc_A          158 TDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVA  227 (271)
T ss_dssp             CCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHH
T ss_pred             ccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhh
Confidence            9999998654332    2235789999999999999999999999999999999999999964321      11111111


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ...          .....+......+.+++.+||+.||++|||+.|++++|+.+
T Consensus       228 ~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MNK----------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TSC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cCC----------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            111          01111222233588999999999999999999999998753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.8e-46  Score=361.43  Aligned_cols=270  Identities=28%  Similarity=0.395  Sum_probs=212.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-----CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++...+....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35788999999999999999984     3678999999986655555679999999999999999999999876666678


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++++|.+++...   ...+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence            9999999999999999642   235899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--------CcchHHHHHHH
Q 013404          251 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPS--------GQENLVTWARP  321 (443)
Q Consensus       251 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~--------~~~~~~~~~~~  321 (443)
                      ......... ......||..|+|||++.+..++.++||||||+++|||++|+.||......        ...........
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            765443221 223456888999999999999999999999999999999999998532110        00000001111


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ...          .......+......+.+++.+||+.||++|||++|++++|+.+....
T Consensus       256 ~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          256 LLE----------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             Hhh----------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            111          11111222233345889999999999999999999999999886543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-45  Score=352.46  Aligned_cols=256  Identities=20%  Similarity=0.289  Sum_probs=207.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||++... +++.||+|.+.... .....+.+|+.+++.++||||+++++++..  ....++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEEEE
Confidence            468999999999999999999964 68899999987432 334568899999999999999999999874  45899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC--CCceEEccccccccC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQA  252 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~  252 (443)
                      ||+++|+|.+++...   ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++..
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           81 EFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            999999999999643   235899999999999999999999999   999999999999987  789999999999877


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......+......... 
T Consensus       155 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~~~-  224 (321)
T 1tki_A          155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTFDE-  224 (321)
T ss_dssp             CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCCCH-
T ss_pred             CCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCCCCh-
Confidence            54332   2345799999999999998899999999999999999999999964321      1222222222111100 


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                         .....++    ..+.+++.+||+.||++|||+.|++++-+..
T Consensus       225 ---~~~~~~s----~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  262 (321)
T 1tki_A          225 ---EAFKEIS----IEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             ---HHHTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             ---hhhccCC----HHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence               0001122    3478999999999999999999999987654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.2e-45  Score=344.77  Aligned_cols=255  Identities=22%  Similarity=0.330  Sum_probs=205.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|++. ++.||||.++.....  ..+.|.+|+.++++++||||+++++++...+....++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57889999999999999999985 789999999865322  245799999999999999999999999865556889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.+++....  ...+++.+++.++.|++.||+|||+.+.+ |+||||||+|||++.++.++|+|||+......
T Consensus        89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~~~-i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTSSSC-CTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcCCCc-eecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999998532  33589999999999999999999987643 99999999999999999999999888754322


Q ss_pred             CCccccccccccCcccccccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                             ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||.....      ...........     
T Consensus       166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-----  227 (271)
T 3kmu_A          166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEG-----  227 (271)
T ss_dssp             -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSC-----
T ss_pred             -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcC-----
Confidence                   2346899999999998765544   89999999999999999999964321      11111111111     


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                       ..+.....++    ..+.+++.+||+.||++|||++++++.|+.+.
T Consensus       228 -~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          228 -LRPTIPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             -CCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -CCCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence             1111222233    34889999999999999999999999998875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.1e-45  Score=354.51  Aligned_cols=267  Identities=25%  Similarity=0.399  Sum_probs=194.7

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEECC-Cc---EEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLSD-GT---AVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      ..++|++.+.||+|+||.||+|.... +.   .||||.++...  ....+.+.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34689999999999999999999543 32   79999997542  23356799999999999999999999998743321


Q ss_pred             ----eeEEEEeecCCCChhHhhcCCC--CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceE
Q 013404          169 ----QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK  242 (443)
Q Consensus       169 ----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  242 (443)
                          ..+++|||+++|+|.+++....  .....+++.+++.++.|++.||+|||+.+   |+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                2389999999999999995321  11235899999999999999999999999   99999999999999999999


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      |+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |+.||......   ....   .
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~---~  251 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYN---Y  251 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH---H
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHH---H
Confidence            999999987654433323334567889999999999999999999999999999999 99999754322   1111   1


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      +... ..      .    ..+......+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus       252 ~~~~-~~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          252 LIGG-NR------L----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HHTT-CC------C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HhcC-CC------C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1111 10      1    111222235889999999999999999999999999887543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-45  Score=350.75  Aligned_cols=254  Identities=24%  Similarity=0.318  Sum_probs=204.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC------CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||++... +|+.||+|.+......      ..+.+.+|+.++++++||||+++++++.  +..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~   87 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKT   87 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCC
Confidence            356889999999999999999964 6899999998754322      3577999999999999999999999987  455


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC----ceEEc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA  244 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~  244 (443)
                      ..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++    .+||+
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence            88999999999999999964    345899999999999999999999999   99999999999999887    79999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      |||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+..
T Consensus       161 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~  231 (326)
T 2y0a_A          161 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSA  231 (326)
T ss_dssp             CCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHH
T ss_pred             ECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHHh
Confidence            9999987654322   2345799999999999999999999999999999999999999964321      111111111


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .......    ......+    ..+.+++.+||+.||++|||+.|++++-+
T Consensus       232 ~~~~~~~----~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  274 (326)
T 2y0a_A          232 VNYEFED----EYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQHPW  274 (326)
T ss_dssp             TCCCCCH----HHHTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             cCCCcCc----cccccCC----HHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            1110000    0001122    34789999999999999999999998743

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=360.03  Aligned_cols=256  Identities=22%  Similarity=0.348  Sum_probs=198.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCC--CceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||++...+++.||||++......  ..+.+.+|+.++.+++|  |||+++++++.  +....+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~~~~~   85 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TDQYIY   85 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe--eCCEEE
Confidence            4578999999999999999999888999999999754332  23678999999999976  99999999987  445889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +|||+ .+|+|.+++..    ...+++.++..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.
T Consensus        86 lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence            99995 58899999975    345899999999999999999999999   99999999999997 56899999999987


Q ss_pred             CCCCCccccccccccCccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~  320 (443)
                      ..............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....     ......
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~  231 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH  231 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHH
Confidence            755443333445679999999999865           6789999999999999999999999963221     111111


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ...          ++.....++......+.+++.+||+.||++|||+.|++++.+.-
T Consensus       232 ~~~----------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          232 AII----------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             HHH----------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHh----------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            111          11111122222223578999999999999999999999987654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.9e-45  Score=345.43  Aligned_cols=260  Identities=25%  Similarity=0.385  Sum_probs=202.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC---HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||++.. .+++.||+|.+.......   .+.+.+|+.++++++||||+++++++.  +....+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~   87 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE--EDDCYY   87 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE--CSSEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee--eCCeEE
Confidence            46799999999999999999995 468999999986543333   357889999999999999999999987  455889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++++|.+++..    ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred             EEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence            99999999999999964    235899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      ...........  ...
T Consensus       161 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~--~~~  231 (294)
T 4eqm_A          161 LSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS--VPN  231 (294)
T ss_dssp             C--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC--CCC
T ss_pred             ccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc--CCC
Confidence            6443221 22345799999999999999999999999999999999999999964321      11111111110  000


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHhH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQ  378 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~  378 (443)
                      . .......++    ..+.+++.+||+.||++|| +++++.+.|+.+.
T Consensus       232 ~-~~~~~~~~~----~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 V-TTDVRKDIP----QSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             H-HHHSCTTSC----HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             c-chhcccCCC----HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            0 011112233    3488999999999999998 8888888887654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.1e-45  Score=355.27  Aligned_cols=266  Identities=24%  Similarity=0.391  Sum_probs=211.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC--------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR  165 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  165 (443)
                      .++|++.+.||+|+||.||+|...        ++..||||+++.... .....+.+|+++++++ +||||+++++++.  
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence            468899999999999999999863        467899999975432 2345789999999999 8999999999987  


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCCC------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLGV------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                      +....++||||+++|+|.+++......            ...+++.+++.++.|++.||.|||+.+   |+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence            445789999999999999999754321            234889999999999999999999999   99999999999


Q ss_pred             EecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 013404          234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ  312 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~  312 (443)
                      |++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....   
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---  265 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---  265 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence            999999999999999987655433223344567889999999999999999999999999999999 9999964321   


Q ss_pred             chHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                         ......+ .....      ......++    ..+.+++.+||+.||++||++.|+++.|+.+.+....
T Consensus       266 ---~~~~~~~-~~~~~------~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          266 ---EELFKLL-KEGHR------MDKPANCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             ---HHHHHHH-HHTCC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             ---HHHHHHH-hcCCC------CCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence               1111111 11110      11112233    3488999999999999999999999999999876543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-45  Score=376.00  Aligned_cols=258  Identities=26%  Similarity=0.392  Sum_probs=209.9

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ...+|++.+.||+|+||.||+|.+. ++..||||.++... ...+.|.+|+.+|++++||||++++++|.  +....++|
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~lv  294 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII  294 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe--cCCcEEEE
Confidence            3466888899999999999999976 48899999997543 34678999999999999999999999987  34478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++|+|.+++....  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       295 ~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence            99999999999997432  345899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .... .......++..|+|||++.+..++.++|||||||++|||++ |..||......   .....    +....+    
T Consensus       370 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~----  437 (495)
T 1opk_A          370 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDYR----  437 (495)
T ss_dssp             TCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTCC----
T ss_pred             CCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCC----
Confidence            4322 12233456789999999999999999999999999999999 99999754321   11111    111111    


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                            ...+......+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       438 ------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          438 ------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                  1112223345889999999999999999999999988764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5e-45  Score=348.29  Aligned_cols=265  Identities=26%  Similarity=0.403  Sum_probs=206.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-----CCCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      +.|++.+.||+|+||.||+|++     .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+....
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588899999999999999984     368899999997543 3345789999999999999999999999986555678


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++...   ...+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            9999999999999999542   235899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------CCCcchHHHHHH
Q 013404          251 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ---------PSGQENLVTWAR  320 (443)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~---------~~~~~~~~~~~~  320 (443)
                      ........ .......||..|+|||.+.+..++.++||||||+++|||++|..|+....         ............
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            76554322 22334568889999999999999999999999999999999999864210         001111111111


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                       ......          ....+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       255 -~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 -TLKEGK----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             -HHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHhccC----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence             111111          11122222345889999999999999999999999998775

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-44  Score=349.77  Aligned_cols=265  Identities=18%  Similarity=0.227  Sum_probs=210.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||.+.....  ...+.+|+++++++ +||||+++++++..  ....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv   83 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMV   83 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEE
Confidence            36789999999999999999995 5789999999875432  34688999999999 99999999999874  4478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc-----eEEccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-----AKVADFGL  248 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgl  248 (443)
                      |||+ +++|.+++...   ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+
T Consensus        84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           84 LELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            9999 99999999743   346899999999999999999999999   999999999999999887     99999999


Q ss_pred             cccCCCCCccc-----cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          249 AKQAPEGRTNY-----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       249 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      ++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...................
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            98764432211     1235679999999999999999999999999999999999999997654333222221111100


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      .. ....     .+...++     .+.+++..||+.||.+||++++|++.|+.+.+...
T Consensus       237 ~~-~~~~-----~~~~~~p-----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          237 RA-TPIE-----VLCENFP-----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HH-SCHH-----HHTTTCH-----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cc-CCHH-----HHhccCh-----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            00 0000     0011112     58899999999999999999999999998876553

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-44  Score=347.03  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=200.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|+..+|+.||+|++......  ....+.+|++++++++||||+++++++.  +....++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH--SERCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC--CSSCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc--cCCEEEEE
Confidence            4689999999999999999999988999999999754322  2467889999999999999999999987  44578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++ +|.+++...   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        98 ~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           98 FEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EcCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            999975 888888653   345899999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc--cc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR--LE  330 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~  330 (443)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........  +.. ..........  ..
T Consensus       171 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~  245 (311)
T 3niz_A          171 IPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ--LPK-IFSILGTPNPREWP  245 (311)
T ss_dssp             SCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH--HHH-HHHHHCCCCTTTSG
T ss_pred             CCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHHCCCChHHhh
Confidence            3322  1234578999999999876 5689999999999999999999999975443322  111 1111111000  00


Q ss_pred             c------cccCcc--CCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          331 E------LADPRL--GGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       331 ~------~~d~~~--~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .      ..+...  ....+.     .....+.+++.+||+.||++|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0      000000  000000     112347899999999999999999999976

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=359.21  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=201.0

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCe
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  169 (443)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||+++..   .......+.+|.+++..+ +||||+++++++.  +...
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~   98 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ--TPDR   98 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE--eCCE
Confidence            3578999999999999999999964 6899999999743   223456688999999998 7999999999987  4458


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+++|+|.+++..    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        99 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccce
Confidence            9999999999999999964    245899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      +.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....  
T Consensus       172 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~--  241 (353)
T 3txo_A          172 KEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEV--  241 (353)
T ss_dssp             BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC--
T ss_pred             eecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC--
Confidence            86433221  23456899999999999999999999999999999999999999974321      222222322211  


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQSLK  375 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~L~  375 (443)
                                .++......+.+++.+||+.||++||++      +|+++|-+
T Consensus       242 ----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~  283 (353)
T 3txo_A          242 ----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF  283 (353)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred             ----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence                      1122222347899999999999999998      88887643

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=355.39  Aligned_cols=259  Identities=29%  Similarity=0.466  Sum_probs=200.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCc----EEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      .++|++.+.||+|+||.||+|... +++    +||+|.+.... ....+.+.+|+.++++++||||++++++|...   .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---~   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---S
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---C
Confidence            367999999999999999999953 444    46888876443 34567899999999999999999999998742   4


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .+++++|+++|+|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            78999999999999999753   235899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      +...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   +...    +.....
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~----~~~~~~  237 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI----LEKGER  237 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH----HHTTCC
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCC
Confidence            87654433333344567889999999999999999999999999999999 999997543221   1111    111110


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                                ...+......+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus       238 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 ----------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                      111222233488999999999999999999999999988754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2e-45  Score=353.20  Aligned_cols=273  Identities=25%  Similarity=0.403  Sum_probs=215.7

Q ss_pred             HHHHHHHhcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEEE
Q 013404           89 YEELKEATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVG  160 (443)
Q Consensus        89 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~  160 (443)
                      ..+.....++|++.+.||+|+||.||+|..      .+++.||||.++..... ....+.+|+.++.++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            344445568899999999999999999984      34678999999754332 235789999999999 7999999999


Q ss_pred             eeecCCCCeeEEEEeecCCCChhHhhcCCCCC------------CCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCC
Q 013404          161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGV------------NCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF  228 (443)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  228 (443)
                      ++... ....+++|||+++|+|.+++......            ...+++..++.++.|++.||.|||+.+   |+||||
T Consensus        99 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           99 ACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            98643 34589999999999999999764321            123789999999999999999999999   999999


Q ss_pred             CcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 013404          229 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMS  307 (443)
Q Consensus       229 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~  307 (443)
                      ||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987655433333345678899999999999999999999999999999998 99999654


Q ss_pred             CCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          308 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ...  ..+..    .+.....      ......++    ..+.+++.+||+.||++|||+.||+++|+.+.+..
T Consensus       255 ~~~--~~~~~----~~~~~~~------~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          255 KID--EEFCR----RLKEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCS--HHHHH----HHHHTCC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             chh--HHHHH----HhccCcc------CCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            322  11111    1111111      11111223    34889999999999999999999999999887644

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=359.15  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=203.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++... +++.||+|.+...   .......+.+|+++++.++||||++++++|.  +....++
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~l   92 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ--DEEDMFM   92 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCEEEE
Confidence            57899999999999999999954 6889999998643   2334567899999999999999999999987  4458999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             EECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            9999999999999975    345899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ....   ......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+...   +....   
T Consensus       166 ~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~~~~---  236 (384)
T 4fr4_A          166 PRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---FETTV---  236 (384)
T ss_dssp             CTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---HHHCC---
T ss_pred             cCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hhhcc---
Confidence            5432   2345689999999999874   4589999999999999999999999975544332222221   11111   


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-HHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQS  373 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~  373 (443)
                           .    .++......+.+++.+||+.||++||+ +++|+++
T Consensus       237 -----~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          237 -----V----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             -----C----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             -----c----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                 0    112222335889999999999999998 7777764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.5e-45  Score=355.45  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=205.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC-----CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...     .....+.+.+|+.+++.++||||+++++++..  ...
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~  100 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGM  100 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence            45799999999999999999996 46899999998532     12246789999999999999999999999874  458


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc---eEEccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADF  246 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df  246 (443)
                      .++||||+++|+|.+++.........+++..+..++.||+.||+|||+++   |+||||||+|||++.++.   +||+||
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecC
Confidence            89999999999999888543222345899999999999999999999999   999999999999987654   999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      |+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....    .   .....+....
T Consensus       178 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~---~~~~~i~~~~  248 (351)
T 3c0i_A          178 GVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----E---RLFEGIIKGK  248 (351)
T ss_dssp             TTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----H---HHHHHHHHTC
T ss_pred             cceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----H---HHHHHHHcCC
Confidence            99987654322  2344579999999999999999999999999999999999999996421    1   1111121111


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ...    .+.....++    ..+.+++.+||+.||++|||+.|++++-+.
T Consensus       249 ~~~----~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~hp~~  290 (351)
T 3c0i_A          249 YKM----NPRQWSHIS----ESAKDLVRRMLMLDPAERITVYEALNHPWL  290 (351)
T ss_dssp             CCC----CHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             CCC----CccccccCC----HHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence            100    000001122    347899999999999999999999987553

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.3e-44  Score=343.04  Aligned_cols=255  Identities=33%  Similarity=0.588  Sum_probs=202.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCH-------HHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGD-------KEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++........       +.+.+|++++++++||||+++++++...  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--   95 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--   95 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence            36789999999999999999996 5789999999875443221       6789999999999999999999998532  


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc-----eE
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-----AK  242 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~k  242 (443)
                        .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.+.+ |+||||||+|||++.++.     +|
T Consensus        96 --~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~-ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           96 --PRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             --TEEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSSSC-CBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             --CeEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCCCC-eecCCCCcceEEEeccCCCCceeEE
Confidence              27999999999999998653   34689999999999999999999998643 999999999999988776     99


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR  320 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~  320 (443)
                      |+|||+++.....     .....||+.|+|||++.  ...++.++|||||||++|||++|+.||.......    ..+..
T Consensus       170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~  240 (287)
T 4f0f_A          170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFIN  240 (287)
T ss_dssp             ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHH
T ss_pred             eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHH
Confidence            9999999854332     23457999999999984  5567899999999999999999999997543321    11111


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ......      ..+.....++    ..+.+++.+||+.||++|||++|+++.|+.+
T Consensus       241 ~~~~~~------~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 MIREEG------LRPTIPEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHSC------CCCCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHhccC------CCCCCCcccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111111      1111222233    3588999999999999999999999998753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=347.54  Aligned_cols=273  Identities=24%  Similarity=0.363  Sum_probs=206.3

Q ss_pred             HHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc--CCCceeeEEEeeecCCC
Q 013404           90 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL--HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        90 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~  167 (443)
                      .......++|++.+.||+|+||.||+|+.. |+.||||++...   ....+..|.+++..+  +||||+++++++.....
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            334445678999999999999999999985 899999998632   345566677776665  89999999999875432


Q ss_pred             --CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc--------CCCceEecCCCcccEEecC
Q 013404          168 --SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED--------SQPCVIHRDFKASNILLEN  237 (443)
Q Consensus       168 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~~~~ivH~Dlkp~NIll~~  237 (443)
                        ...++||||+++|+|.++++.     ..+++..++.++.|++.||+|||+.        +   |+||||||+|||++.
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKK  177 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECT
T ss_pred             CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECC
Confidence              578999999999999999963     3589999999999999999999988        6   999999999999999


Q ss_pred             CCceEEccccccccCCCCCccc--cccccccCcccccccccccCCCCch------hhHHHHHHHHHHHHhC---------
Q 013404          238 NFHAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMTGHLLVK------SDVYSYGVVLLELLTG---------  300 (443)
Q Consensus       238 ~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDv~S~G~il~elltg---------  300 (443)
                      ++.+||+|||+++.........  ......||+.|+|||++.+..+..+      +|||||||++|||++|         
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            9999999999997664432211  1224579999999999987766554      9999999999999999         


Q ss_pred             -CCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC-CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          301 -RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK-YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       301 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                       ..||......... .... ........     ..+..... .+......+.+++.+||+.||++|||+.||+++|+.+.
T Consensus       258 ~~~p~~~~~~~~~~-~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          258 YQLPYHDLVPSDPS-YEDM-REIVCIKK-----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CCCTTTTTSCSSCC-HHHH-HHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccHhhhcCCCCc-hhhh-HHHHhhhc-----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence             6666543322211 1111 11111100     01111100 12256677999999999999999999999999999887


Q ss_pred             hhh
Q 013404          379 RVI  381 (443)
Q Consensus       379 ~~~  381 (443)
                      +..
T Consensus       331 ~~~  333 (337)
T 3mdy_A          331 ESQ  333 (337)
T ss_dssp             HTT
T ss_pred             hhc
Confidence            643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.1e-45  Score=370.87  Aligned_cols=258  Identities=30%  Similarity=0.441  Sum_probs=204.2

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ..++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++..   ...++||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~  257 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVT  257 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEe
Confidence            356788899999999999999999888889999998543 346789999999999999999999999863   4689999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.+++....  ...+++.+++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       258 e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             CCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             hhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            9999999999996321  235889999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.....      ......+ ....++    
T Consensus       333 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i-~~~~~~----  400 (452)
T 1fmk_A          333 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQV-ERGYRM----  400 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHH-HTTCCC----
T ss_pred             Cce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-HcCCCC----
Confidence            321 11233457889999999999999999999999999999999 9999964321      1111111 111111    


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                            ..+......+.+++.+||+.||++|||+++|++.|+.+..
T Consensus       401 ------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          401 ------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                  1122233458899999999999999999999999987754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.8e-45  Score=359.19  Aligned_cols=256  Identities=21%  Similarity=0.352  Sum_probs=202.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.++||+|+||.||+++.. +++.||+|+++...   ......+.+|..++.++ +||||+++++++.  +....
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~~  128 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRL  128 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--ECCEE
Confidence            467999999999999999999965 67899999997542   22234688899999887 8999999999987  45589


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++..    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       129 ~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence            999999999999999974    345899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc--chHHH-HHHHHhhccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ--ENLVT-WARPILRDKD  327 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~--~~~~~-~~~~~~~~~~  327 (443)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ..... ....+.....
T Consensus       202 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~  279 (396)
T 4dc2_A          202 EGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI  279 (396)
T ss_dssp             CCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred             ecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence            6432221  23456899999999999999999999999999999999999999964332211  11111 1122222111


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQSL  374 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~L  374 (443)
                                  .++......+.+++.+||+.||++||++      +||++|-
T Consensus       280 ------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp  320 (396)
T 4dc2_A          280 ------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  320 (396)
T ss_dssp             ------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred             ------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence                        1122223347899999999999999985      6787764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-44  Score=362.68  Aligned_cols=265  Identities=22%  Similarity=0.280  Sum_probs=209.2

Q ss_pred             HHHHHHHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeec
Q 013404           89 YEELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS  164 (443)
Q Consensus        89 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  164 (443)
                      +.++....++|++.++||+|+||.||+|+.. +++.||+|+++...   ......+.+|+.++..++||||++++++|. 
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-  144 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-  144 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-
Confidence            3444556789999999999999999999965 57899999986421   122344889999999999999999999987 


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA  244 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  244 (443)
                       +....++||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       145 -~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          145 -DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             -CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             -eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEc
Confidence             455899999999999999999753   345899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      |||+++....... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+.      ....
T Consensus       218 DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------~~~~  290 (437)
T 4aw2_A          218 DFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETY  290 (437)
T ss_dssp             CCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH
T ss_pred             chhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------hHHH
Confidence            9999987654332 2234468999999999987     56789999999999999999999999974321      2222


Q ss_pred             HHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHHH
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK  375 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L~  375 (443)
                      ..++.....   +.-+.....++.    .+.+++.+||+.+|++  ||+++|+++|-+
T Consensus       291 ~~i~~~~~~---~~~p~~~~~~s~----~~~dLi~~lL~~~~~r~~r~~~~eil~Hpf  341 (437)
T 4aw2_A          291 GKIMNHKER---FQFPTQVTDVSE----NAKDLIRRLICSREHRLGQNGIEDFKKHPF  341 (437)
T ss_dssp             HHHHTHHHH---CCCCSSCCCSCH----HHHHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred             Hhhhhcccc---ccCCcccccCCH----HHHHHHHHHhcccccccCCCCHHHHhCCCc
Confidence            222221111   111111122333    4788999999988888  999999998754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=345.22  Aligned_cols=259  Identities=31%  Similarity=0.464  Sum_probs=199.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.+.||+|+||.||++... ++.||||.+...  ...+.|.+|++++++++||||+++++++.  +  ..++||||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~--~~~lv~e~   80 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--N--PVCLVMEY   80 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T--TTEEEEEC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C--CcEEEEEc
Confidence            56888999999999999999985 688999998632  34578999999999999999999999875  2  47899999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc-eEEccccccccCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-AKVADFGLAKQAPEG  255 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~  255 (443)
                      +++|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            999999999975321 234788999999999999999999932122999999999999988876 799999999765432


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                           .....||+.|+|||++.+..++.++||||||+++|||++|+.||......  .  ......... ..      .+
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~--~~~~~~~~~-~~------~~  223 (307)
T 2eva_A          160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--A--FRIMWAVHN-GT------RP  223 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--H--HHHHHHHHT-TC------CC
T ss_pred             -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--H--HHHHHHHhc-CC------CC
Confidence                 12346899999999999999999999999999999999999999643221  1  111111111 10      11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                      .....++.    .+.+++.+||+.||++|||++++++.|+.+.+....
T Consensus       224 ~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          224 PLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             CCBTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             CcccccCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            11122333    478999999999999999999999999998776543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-44  Score=356.28  Aligned_cols=255  Identities=21%  Similarity=0.291  Sum_probs=206.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|... +|+.||+|.+..........+.+|++++++++||||+++++++.  +....++||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~lv~  127 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLIL  127 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE--eCCEEEEEE
Confidence            467999999999999999999964 68999999997654444567899999999999999999999987  455899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC--CCceEEccccccccC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQA  252 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~  252 (443)
                      ||+++|+|.+++...   ...+++.+++.++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++..
T Consensus       128 E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          128 EFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             ECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceec
Confidence            999999999999743   335899999999999999999999999   999999999999974  577999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......+......    
T Consensus       202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~~----  268 (387)
T 1kob_A          202 NPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWE----  268 (387)
T ss_dssp             CTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCC----
T ss_pred             CCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC----
Confidence            54322   2345799999999999999999999999999999999999999964321      1112222111111    


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .++.....++.    .+.+++.+||+.||++|||+.|++++-+
T Consensus       269 ~~~~~~~~~s~----~~~~li~~~L~~dP~~Rpt~~ell~hp~  307 (387)
T 1kob_A          269 FDEDAFSSVSP----EAKDFIKNLLQKEPRKRLTVHDALEHPW  307 (387)
T ss_dssp             CCSSTTTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             CCccccccCCH----HHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence            11111122333    4789999999999999999999998643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-44  Score=353.84  Aligned_cols=256  Identities=22%  Similarity=0.320  Sum_probs=205.1

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+......  ..+.+.+|+.++++++||||+++++++.  +....+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~  104 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHY  104 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEE
Confidence            3567999999999999999999964 6899999999754332  2356889999999999999999999987  455889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC---CceEEccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADFGL  248 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgl  248 (443)
                      +||||+++|+|.+++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|||+
T Consensus       105 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            99999999999999964    345899999999999999999999999   9999999999999865   4599999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+......
T Consensus       178 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~  248 (362)
T 2bdw_A          178 AIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYD  248 (362)
T ss_dssp             CBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC
T ss_pred             ceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCC
Confidence            987654322   2346799999999999999999999999999999999999999964321      1122222211111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ..   .+.. ..++    ..+.+++.+||+.||++||++.|++++-+.
T Consensus       249 ~~---~~~~-~~~~----~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  288 (362)
T 2bdw_A          249 YP---SPEW-DTVT----PEAKSLIDSMLTVNPKKRITADQALKVPWI  288 (362)
T ss_dssp             CC---TTGG-GGSC----HHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred             CC---cccc-cCCC----HHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence            00   0000 1122    347899999999999999999999987543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-44  Score=342.39  Aligned_cols=260  Identities=27%  Similarity=0.496  Sum_probs=194.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|+..  ..||+|.++.....  ..+.|.+|++++++++||||+++++++.   ....++|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~lv   97 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIV   97 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccEEE
Confidence            467999999999999999999864  35999999755432  2367899999999999999999999764   3367999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++++|.+++...   ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence            9999999999999643   345899999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ............||+.|+|||.+.   +..++.++||||||+++|||++|+.||......  ..+..    .........
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~~~~~~~  245 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIE----MVGRGSLSP  245 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHH----HHHHTSCCC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHH----HhcccccCc
Confidence            332222334467999999999986   667889999999999999999999999643321  11111    111111110


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ..  ......++    ..+.+++.+||+.||++||++.++++.|+.+.
T Consensus       246 ~~--~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          246 DL--SKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CT--TSSCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ch--hhccccCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            00  11112333    35889999999999999999999999998875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-45  Score=351.51  Aligned_cols=270  Identities=28%  Similarity=0.426  Sum_probs=211.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-----CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-----SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||++++     .+|+.||||++........+.+.+|++++++++||||+++++++...+....
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45688999999999999999984     3688999999987655556789999999999999999999999875555578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++++|.+++...   ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            9999999999999999753   235899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------CCCcchHHHHHH
Q 013404          251 QAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ---------PSGQENLVTWAR  320 (443)
Q Consensus       251 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~---------~~~~~~~~~~~~  320 (443)
                      ......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+....         ............
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            765443221 1233457788999999999999999999999999999999999885210         000000111111


Q ss_pred             HHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          321 PILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       321 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ..+.....          ...+......+.+++.+||+.||++||++.||++.|+.+.+.+
T Consensus       274 ~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          274 ELLKNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhhcCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11111110          1112222345889999999999999999999999999987654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.4e-45  Score=342.87  Aligned_cols=261  Identities=28%  Similarity=0.435  Sum_probs=210.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++..   ...++|||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e   87 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITE   87 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEEEEe
Confidence            46788999999999999999998888899999997543 346789999999999999999999999752   35789999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++....  ...+++.+++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++......
T Consensus        88 ~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             cCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            999999999996421  225899999999999999999999999   999999999999999999999999999876543


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      .. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+. ...      .
T Consensus       163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~-~~~------~  228 (279)
T 1qpc_A          163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLE-RGY------R  228 (279)
T ss_dssp             CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHH-TTC------C
T ss_pred             cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHHHHHh-ccc------C
Confidence            22 12233457889999999998999999999999999999999 9999964321      11111111 110      0


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                      ......++    ..+.+++.+||+.||++|||++++++.|+.+......
T Consensus       229 ~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          229 MVRPDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             CCCccccc----HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            11112233    3588999999999999999999999999988765443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.9e-45  Score=344.49  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=196.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC----CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|....    +..||+|.+...... ..+.+.+|+.++++++||||+++++++.   ....
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~   90 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc---cCcc
Confidence            4678899999999999999998642    457999998754322 2457899999999999999999999974   2367


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence            8999999999999999743   235899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......   .....   +.. ... 
T Consensus       165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~---i~~-~~~-  235 (281)
T 1mp8_A          165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR---IEN-GER-  235 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH---HHT-TCC-
T ss_pred             ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHH---HHc-CCC-
Confidence            7654322 12233467889999999999999999999999999999997 99999754322   11111   111 110 


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                           ......++    ..+.+++.+||+.||++||++.|+++.|+.+.+..
T Consensus       236 -----~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          236 -----LPMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             -----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                 11112233    35889999999999999999999999999886543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.6e-45  Score=341.13  Aligned_cols=256  Identities=28%  Similarity=0.427  Sum_probs=208.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.+.||+|+||.||++...+++.||+|.+..... ..+.+.+|++++++++||||+++++++..  ....+++|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~   84 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVTEF   84 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEECC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEEEEeC
Confidence            57888999999999999999988888999999985433 45789999999999999999999999874  4578999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++++|.+++...   ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999743   235889999999999999999999999   9999999999999999999999999998664321


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      . .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+... ..      .
T Consensus       159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~-~~------~  224 (267)
T 3t9t_A          159 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG-FR------L  224 (267)
T ss_dssp             H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT-CC------C
T ss_pred             c-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcC-Cc------C
Confidence            1 11233467889999999999999999999999999999999 8999964321      1111111111 00      0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      .    .+......+.+++.+||+.||++||++.+++++|+.+.+
T Consensus       225 ~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          225 Y----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1    111122347899999999999999999999999998864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=348.60  Aligned_cols=248  Identities=27%  Similarity=0.361  Sum_probs=205.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||+++.. +|+.||+|.++..   .....+.+.+|+.+++.++||||+++++++.  +....+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~   82 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIF   82 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE--eCCEEE
Confidence            357899999999999999999964 7899999998643   1234567889999999999999999999987  455899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        83 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCccee
Confidence            99999999999999974    235899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....      .......+......   
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~---  221 (318)
T 1fot_A          156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAELR---  221 (318)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCCC---
T ss_pred             cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC---
Confidence            5432     234579999999999999999999999999999999999999996432      12222223222111   


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                           ....++    ..+.+++.+||+.||++||     +++||++|-+
T Consensus       222 -----~p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~  261 (318)
T 1fot_A          222 -----FPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  261 (318)
T ss_dssp             -----CCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             -----CCCCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence                 111223    3478999999999999999     8999998744

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.2e-45  Score=353.14  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=199.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCC------
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS------  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  167 (443)
                      .++|++.+.||+|+||.||+|+.. +|+.||||+++..... ..+.+.+|++++++++||||++++++|.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357899999999999999999975 7899999999755433 45679999999999999999999998864321      


Q ss_pred             -------------------------------------------------CeeEEEEeecCCCChhHhhcCCCCCCCCCCh
Q 013404          168 -------------------------------------------------SQHLLCYELVPNGSLESWLHGPLGVNCHLDW  198 (443)
Q Consensus       168 -------------------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  198 (443)
                                                                       ...++||||+++|+|.+++..... ....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence                                                             137899999999999999986432 344667


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcc----------ccccccccCc
Q 013404          199 ETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTN----------YLSTRVMGTF  268 (443)
Q Consensus       199 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~  268 (443)
                      ..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            789999999999999999999   999999999999999999999999999876543211          1123457999


Q ss_pred             ccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHH
Q 013404          269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIR  348 (443)
Q Consensus       269 ~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  348 (443)
                      .|+|||++.+..++.++|||||||++|||++|..|+.        ............  ..     +    .........
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~~~--~~-----~----~~~~~~~~~  301 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVRNL--KF-----P----LLFTQKYPQ  301 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHHTT--CC-----C----HHHHHHCHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhhcc--CC-----C----cccccCChh
Confidence            9999999999999999999999999999999877642        111111111000  00     0    011222345


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          349 VCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       349 l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +.+++.+||+.||++|||++|++++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhhc
Confidence            7889999999999999999999975

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4e-45  Score=355.54  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=204.5

Q ss_pred             HHHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           93 KEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        93 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      ....++|++.+.||+|+||.||+|+.. +|+.||+|.++...   ......+..|..++..+ +||||+++++++.  +.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~--~~   90 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TK   90 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE--eC
Confidence            345678999999999999999999964 68999999997531   33456788899999987 8999999999987  45


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeECh
Confidence            589999999999999999964    235899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.... 
T Consensus       164 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~-  234 (345)
T 1xjd_A          164 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDN-  234 (345)
T ss_dssp             TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-
T ss_pred             hhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHhCC-
Confidence            9986533222  23456899999999999999999999999999999999999999964321      12222222211 


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQSL  374 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~~L  374 (443)
                             +.....++    ..+.+++.+||+.||++||++. +|++|-
T Consensus       235 -------~~~p~~~s----~~~~~li~~lL~~dp~~R~~~~~~i~~hp  271 (345)
T 1xjd_A          235 -------PFYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQHP  271 (345)
T ss_dssp             -------CCCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             -------CCCCcccC----HHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence                   11111223    3478999999999999999998 887653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.9e-44  Score=340.64  Aligned_cols=266  Identities=18%  Similarity=0.217  Sum_probs=211.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||.+....  ....+.+|+.+++.+ +|+|++++++++.  +....++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~lv   84 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV   84 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCceeEEE
Confidence            46799999999999999999995 578999999986443  334688999999999 7999999999987  44588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc-----eEEccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-----AKVADFGL  248 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgl  248 (443)
                      |||+ +++|.+++...   ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+
T Consensus        85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999 99999999743   235899999999999999999999999   999999999999987766     99999999


Q ss_pred             cccCCCCCcc-----ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          249 AKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       249 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      ++........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||...................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            9876543221     11244679999999999999999999999999999999999999997654333222222111110


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      .. ...     +.+...++.    .+.+++.+||+.||++||++++|++.|+.+.+...
T Consensus       238 ~~-~~~-----~~~~~~~~~----~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          238 QS-TPL-----RELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HH-SCH-----HHHTTTSCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cC-ccH-----HHHHhhCcH----HHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            00 001     111112333    48899999999999999999999999999876554

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.7e-45  Score=345.45  Aligned_cols=264  Identities=24%  Similarity=0.344  Sum_probs=198.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|...+|+.||+|++.....  .....+.+|++++++++||||+++++++..  ....++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEEE
Confidence            47889999999999999999998899999999975432  224678899999999999999999999874  45789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++ +|.+++...   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        80 e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             ECCSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             EecCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            99975 999998753   245899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc-----c
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-----R  328 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~  328 (443)
                      ...  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......  ..+.... .......     .
T Consensus       153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~-~~~~~~~~~~~~~  227 (288)
T 1ob3_A          153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIF-RILGTPNSKNWPN  227 (288)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH-HHHCCCCTTTSTT
T ss_pred             ccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-HHHCCCChhhchh
Confidence            221  12345789999999998764 5899999999999999999999999643211  1111111 1111000     0


Q ss_pred             ccc--cccCccCC-------CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          329 LEE--LADPRLGG-------KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       329 ~~~--~~d~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ...  ..++....       .........+.+++.+||+.||++|||++|++++-
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  282 (288)
T 1ob3_A          228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (288)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence            000  00111000       00011223478999999999999999999999763

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.6e-45  Score=352.72  Aligned_cols=250  Identities=23%  Similarity=0.319  Sum_probs=203.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|.+.+.||+|+||.||+|.. .+++.||+|.+...   .......+.+|+.+++.++||||+++++++.  +....++
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~l   86 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT--TPTDIVM   86 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence            5789999999999999999995 57899999998642   1223457899999999999999999999988  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+ +|+|.+++..    ...+++.++..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++...
T Consensus        87 v~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             EECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             EEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            99999 7899998864    245899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .....   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........                ..
T Consensus       159 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~  219 (336)
T 3h4j_B          159 TDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KK  219 (336)
T ss_dssp             TTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CC
T ss_pred             cCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HH
Confidence            54322   244579999999999988876 68999999999999999999999643321110                11


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      +....  ...+......+.+++.+||+.||.+|||++|++++-+.-
T Consensus       220 i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  263 (336)
T 3h4j_B          220 VNSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN  263 (336)
T ss_dssp             CCSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHH
T ss_pred             HHcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhc
Confidence            11100  111222233478999999999999999999999987653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=357.09  Aligned_cols=275  Identities=21%  Similarity=0.303  Sum_probs=215.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+....++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357889999999999999999965 58999999997543 2345778899999999999999999999886666678999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe----cCCCceEEcccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLA  249 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla  249 (443)
                      |||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            999999999999975322 223899999999999999999999999   9999999999999    78888999999999


Q ss_pred             ccCCCCCccccccccccCccccccccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      +.......   .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||.........  ......
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~  238 (396)
T 4eut_A          164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYK  238 (396)
T ss_dssp             EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHH
T ss_pred             eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHH
Confidence            87654322   234579999999999865        56788999999999999999999999643322211  122222


Q ss_pred             Hhhccc--cccccc-----------cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          322 ILRDKD--RLEELA-----------DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       322 ~~~~~~--~~~~~~-----------d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      +.....  ....+.           +.......+......+.+++..||+.||++||+++|+++.++.+..
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            222110  000000           0011123456677788999999999999999999999999988765

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.3e-45  Score=360.46  Aligned_cols=255  Identities=21%  Similarity=0.342  Sum_probs=197.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcC--CCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||++...+++.||||++......  ..+.+.+|+.+|++++  ||||+++++++..  ....++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEEEE
Confidence            469999999999999999999878999999999754332  3467899999999996  5999999999874  447899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||| +.+++|.+++...    ..+++.++..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++..
T Consensus       134 v~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             EEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             EEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            999 5688999999753    35888999999999999999999999   99999999999996 578999999999876


Q ss_pred             CCCCccccccccccCccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      .............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....     .......
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~  279 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHA  279 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHH
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHH
Confidence            54433333345679999999999865           4688999999999999999999999964221     1111222


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      +..          +.....++......+.+++.+||+.||++||++.|++++.+.-
T Consensus       280 ~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          280 IID----------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             HHC----------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HhC----------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence            221          1111111211123578999999999999999999999986643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.1e-44  Score=345.69  Aligned_cols=265  Identities=20%  Similarity=0.348  Sum_probs=189.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.++.... .....+.+|++++++++||||+++++++.  +....++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH--TENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC--CTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE--ECCeEEEE
Confidence            46799999999999999999995 4689999999975533 33467899999999999999999999987  44588999


Q ss_pred             EeecCCCChhHhhcCCC--CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          174 YELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      |||++ |+|.+++....  .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99997 59999885321  12245889999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc-cc-
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK-DR-  328 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-  328 (443)
                      ......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......   ............. .. 
T Consensus       158 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          158 FGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             TTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTT
T ss_pred             cCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhH
Confidence            643221  1234578999999999876 46899999999999999999999999743321   1111111111100 00 


Q ss_pred             ---------------------ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          329 ---------------------LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       329 ---------------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                                           +.....+.....++    ..+.+++.+||+.||++|||++|++++-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~L~~dP~~Rpt~~e~l~hp~  296 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLD----GNLMDFLHGLLQLNPDMRLSAKQALHHPW  296 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCC----HHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhhhhhhhhcccccccccchhHHHhhcccccccCC----HHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence                                 00000111111222    34889999999999999999999998743

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=9.7e-45  Score=348.22  Aligned_cols=258  Identities=25%  Similarity=0.358  Sum_probs=196.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC---HHHHHHHHHHHhhcCCCceeeEEEeeecCCCC--e
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS--Q  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--~  169 (443)
                      .++|++.+.||+|+||.||++.. .+++.||||+++......   ...+.+|++++++++||||+++++++......  .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999995 578999999997654333   34688999999999999999999998643322  3


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+++|+|.++++.    ...+++.+++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            5899999999999999964    235899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          250 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       250 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      +........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....      .............
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCC
Confidence            866443221 122345699999999999999999999999999999999999999964321      1111112221111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ...    .....++    ..+.+++.+||+.||++||+..+++.+-
T Consensus       238 ~~~----~~~~~~~----~~l~~li~~~l~~dP~~R~~~~~~l~~~  275 (311)
T 3ork_A          238 PPS----ARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRAD  275 (311)
T ss_dssp             CHH----HHSTTCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             Ccc----cccCCCC----HHHHHHHHHHHhcCHhhChhhHHHHHHH
Confidence            000    0011222    3478999999999999999888877653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.8e-45  Score=363.30  Aligned_cols=260  Identities=23%  Similarity=0.318  Sum_probs=207.4

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD  166 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  166 (443)
                      ++....++|++.+.||+|+||.||+|+.. +++.||+|+++..   .......+.+|+.+++.++||||++++++|.  +
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~  140 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--D  140 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE--C
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--E
Confidence            34445688999999999999999999965 6889999998642   1223345889999999999999999999987  4


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ....++||||+++|+|.++++.     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence            5589999999999999999973     34889999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI  322 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  322 (443)
                      |+++....... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||....      .......+
T Consensus       213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i  285 (410)
T 3v8s_A          213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVGTYSKI  285 (410)
T ss_dssp             TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHH
T ss_pred             ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhhHHHHH
Confidence            99987654332 1234568999999999998765    7899999999999999999999997432      12222222


Q ss_pred             hhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHHH
Q 013404          323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQ--RPTMGEVVQSLK  375 (443)
Q Consensus       323 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L~  375 (443)
                      ......+.   -+. ...++.    .+.+|+.+||+.+|.+  ||+++||++|-+
T Consensus       286 ~~~~~~~~---~p~-~~~~s~----~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~  332 (410)
T 3v8s_A          286 MNHKNSLT---FPD-DNDISK----EAKNLICAFLTDREVRLGRNGVEEIKRHLF  332 (410)
T ss_dssp             HTHHHHCC---CCT-TCCCCH----HHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred             Hhcccccc---CCC-cccccH----HHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence            22211110   010 012233    4789999999999988  999999998854

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1e-44  Score=348.15  Aligned_cols=268  Identities=26%  Similarity=0.391  Sum_probs=199.4

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC----CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      ..++|.+.+.||+|+||.||+|...    ++..||+|.++.....  ..+.+.+|+.++++++||||+++++++...+..
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4567888999999999999999853    3458999999755332  235789999999999999999999998754332


Q ss_pred             ---eeEEEEeecCCCChhHhhcCCC--CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEE
Q 013404          169 ---QHLLCYELVPNGSLESWLHGPL--GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV  243 (443)
Q Consensus       169 ---~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  243 (443)
                         ..+++|||+++|+|.+++....  .....+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence               4589999999999999984221  22456999999999999999999999998   999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHH
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPI  322 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  322 (443)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......   .....   +
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~---~  262 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY---L  262 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH---H
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH---H
Confidence            99999987654332222334567889999999999999999999999999999999 88998644321   11111   1


Q ss_pred             hhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       323 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      ... ..      +.....++    ..+.+++.+||+.||++||++.+++++|+.+.+.++
T Consensus       263 ~~~-~~------~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          263 LHG-HR------LKQPEDCL----DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HTT-CC------CCCBTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             HcC-CC------CCCCcccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            111 10      11112233    358899999999999999999999999999876543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.5e-45  Score=356.07  Aligned_cols=273  Identities=17%  Similarity=0.219  Sum_probs=206.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC------CcEEEEEEeccCCCCC-----------HHHHHHHHHHHhhcCCCceeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQG-----------DKEFLVEVEMLSRLHHRNLVKL  158 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l  158 (443)
                      .++|++.+.||+|+||.||+|.+..      ++.||||.+.......           ...+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999999754      4789999987543111           0123345556677789999999


Q ss_pred             EEeeecCCC--CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec
Q 013404          159 VGYYSSRDS--SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE  236 (443)
Q Consensus       159 ~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~  236 (443)
                      ++++.....  ...++||||+ +++|.+++...   ...+++.+++.++.||+.||+|||+.+   |+||||||+|||++
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            999875322  4578999999 99999999753   346999999999999999999999999   99999999999999


Q ss_pred             --CCCceEEccccccccCCCCCccc-----cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 013404          237 --NNFHAKVADFGLAKQAPEGRTNY-----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP  309 (443)
Q Consensus       237 --~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~  309 (443)
                        .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              88999999999998664322111     11334599999999999999999999999999999999999999974322


Q ss_pred             CCcchHHHHHHHHhhccccccccccCccC-CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          310 SGQENLVTWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                      .  .....+.....  ...+..+.++.+. ..++.    .+.+++..||+.||++||++.+|++.|+.+.+....
T Consensus       267 ~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~----~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~  333 (364)
T 3op5_A          267 D--PKYVRDSKIRY--RENIASLMDKCFPAANAPG----EIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS  333 (364)
T ss_dssp             C--HHHHHHHHHHH--HHCHHHHHHHHSCTTCCCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             C--HHHHHHHHHHh--hhhHHHHHHHhcccccCHH----HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            1  12222221111  1122333333221 22333    478999999999999999999999999988776543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=362.24  Aligned_cols=256  Identities=22%  Similarity=0.261  Sum_probs=204.1

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|.+......  ..+.+.+|+++++.++||||+++++++.  +....+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS--EEGHHY   86 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE--CSSEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE--ECCEEE
Confidence            456799999999999999999985 57899999999754322  2456889999999999999999999987  455889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec---CCCceEEccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGL  248 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl  248 (443)
                      +||||+++|+|.+++..    ...+++..+..++.||+.||.|||+++   |+||||||+|||++   +++.+||+|||+
T Consensus        87 lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            99999999999999864    345899999999999999999999999   99999999999998   467899999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....      .......+......
T Consensus       160 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~  231 (444)
T 3soa_A          160 AIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED------QHRLYQQIKAGAYD  231 (444)
T ss_dssp             CBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCCC
T ss_pred             eEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHhCCCC
Confidence            987654332  2234679999999999999999999999999999999999999996432      11122222221111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .   ..+. ...++    ..+.+++.+||+.||++|||+.|++++-+
T Consensus       232 ~---~~~~-~~~~s----~~~~~li~~~L~~dP~~Rpta~e~L~hp~  270 (444)
T 3soa_A          232 F---PSPE-WDTVT----PEAKDLINKMLTINPSKRITAAEALKHPW  270 (444)
T ss_dssp             C---CTTT-TTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred             C---Cccc-cccCC----HHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence            1   0111 01223    34789999999999999999999998754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3e-45  Score=355.01  Aligned_cols=267  Identities=27%  Similarity=0.420  Sum_probs=210.0

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEECC-C-----cEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecC
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLSD-G-----TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR  165 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  165 (443)
                      ...++|++.+.||+|+||.||+|.... +     ..||+|.+..... ...+.+.+|+.+++++ +||||+++++++.  
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--  120 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--  120 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence            345789999999999999999999642 2     4799999975433 2346789999999999 8999999999987  


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCC----------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLG----------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL  235 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll  235 (443)
                      +....++||||+++|+|.+++.....          ....+++..++.++.|++.||.|||+.+   |+||||||+|||+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            44578999999999999999863210          1235789999999999999999999999   9999999999999


Q ss_pred             cCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcch
Q 013404          236 ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQEN  314 (443)
Q Consensus       236 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~  314 (443)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......  ..
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~  275 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--SK  275 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--HH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--HH
Confidence            9999999999999986644333323344567889999999999999999999999999999998 99999643322  11


Q ss_pred             HHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          315 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ...    .......      .......+    ..+.+++.+||+.||++|||+.||+++|+.+.+..
T Consensus       276 ~~~----~~~~~~~------~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          276 FYK----LVKDGYQ------MAQPAFAP----KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHH----HHHHTCC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHH----HHhcCCC------CCCCCCCC----HHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            111    1111110      01111122    34789999999999999999999999999876543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.4e-44  Score=346.26  Aligned_cols=274  Identities=24%  Similarity=0.385  Sum_probs=212.8

Q ss_pred             CHHHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhh--cCCCceeeEEEeeecC
Q 013404           88 AYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSR--LHHRNLVKLVGYYSSR  165 (443)
Q Consensus        88 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~  165 (443)
                      .........++|++.+.||+|+||.||+|+. +|+.||||.+..   .....+.+|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3444455678899999999999999999998 489999999963   345678889999887  7899999999998754


Q ss_pred             CC--CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhh--------hcCCCceEecCCCcccEEe
Q 013404          166 DS--SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH--------EDSQPCVIHRDFKASNILL  235 (443)
Q Consensus       166 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp~NIll  235 (443)
                      +.  ...++||||+++|+|.+++..     ..+++.+++.++.|++.||.|||        +.+   |+||||||+|||+
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll  180 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV  180 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence            32  268999999999999999973     35899999999999999999999        777   9999999999999


Q ss_pred             cCCCceEEccccccccCCCCCccc--cccccccCcccccccccccC------CCCchhhHHHHHHHHHHHHhC-------
Q 013404          236 ENNFHAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVLLELLTG-------  300 (443)
Q Consensus       236 ~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~G~il~elltg-------  300 (443)
                      +.++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            999999999999998664433211  12345799999999998765      334789999999999999999       


Q ss_pred             ---CCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCC-CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          301 ---RKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGK-YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       301 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                         ..||........ ....+.......      ...+.+... ...+....+.+++.+||+.||++|||+.+|+++|+.
T Consensus       261 ~~~~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDP-SVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCCCCTTTTTSCSSC-CHHHHHHHHTTS------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccccCccccCcCcc-cHHHHHHHHHHH------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence               778864433221 122222222111      111111111 123556679999999999999999999999999998


Q ss_pred             hHhh
Q 013404          377 VQRV  380 (443)
Q Consensus       377 ~~~~  380 (443)
                      +.+.
T Consensus       334 i~~~  337 (342)
T 1b6c_B          334 LSQQ  337 (342)
T ss_dssp             HHHT
T ss_pred             HHHH
Confidence            8753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.2e-44  Score=348.33  Aligned_cols=251  Identities=26%  Similarity=0.342  Sum_probs=195.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE----CCCcEEEEEEeccCC----CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+++.    .+|+.||+|+++...    ......+.+|+.++++++||||+++++++.  +.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~   93 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ--TG   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE--CS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE--cC
Confidence            36799999999999999999996    478999999997542    223456788999999999999999999987  44


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence            578999999999999999964    235889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      +++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....
T Consensus       167 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~  238 (327)
T 3a62_A          167 LCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCKL  238 (327)
T ss_dssp             CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC
T ss_pred             cccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC
Confidence            9976433221  23345799999999999999999999999999999999999999964321      122222222211


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                              .+...++    ..+.+++.+||+.||++||     +++|+++|-+
T Consensus       239 --------~~p~~~~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~  279 (327)
T 3a62_A          239 --------NLPPYLT----QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF  279 (327)
T ss_dssp             --------CCCTTSC----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred             --------CCCCCCC----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence                    1111223    3478999999999999999     7889988754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.9e-44  Score=343.00  Aligned_cols=264  Identities=23%  Similarity=0.315  Sum_probs=199.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+|... +|+.||||++......  ....+.+|+.++++++||||+++++++..  ....++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence            57889999999999999999964 6899999999755432  24678899999999999999999999874  4588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++ +|.+++...   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EECCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence            999976 666665432   345899999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCccccccccccCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc-----
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-----  327 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  327 (443)
                      ....  ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.....  ................     
T Consensus       153 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          153 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             SCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCT
T ss_pred             Cccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhh
Confidence            3322  234457899999999998765 79999999999999999999888643221  1111111111111100     


Q ss_pred             cccccccC---------ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          328 RLEELADP---------RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       328 ~~~~~~d~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ......+.         .............+.+++.+||+.||++|||++|+++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00000000         00001111223457899999999999999999999976

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-44  Score=341.46  Aligned_cols=261  Identities=27%  Similarity=0.429  Sum_probs=209.2

Q ss_pred             cCCCCCc-eeeecCcEEEEEEEEC---CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPAS-ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||||.++.... ...+.+.+|++++++++||||+++++++.   ....+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~   85 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEALM   85 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSSEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCCcE
Confidence            4566666 8999999999999853   577899999986532 23467899999999999999999999984   23589


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        86 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence            999999999999999643   345899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          252 APEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       252 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....   .....   .+. .... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~---~i~-~~~~-  231 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMA---FIE-QGKR-  231 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHH---HHH-TTCC-
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHH---HHh-cCCc-
Confidence            65433221 1223457889999999998899999999999999999998 9999964332   11111   111 1110 


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                           +.....++    ..+.+++.+||+.||++||++.+++++|+.+......
T Consensus       232 -----~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          232 -----MECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             -----CCCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             -----CCCCCCcC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                 11112233    3588999999999999999999999999999876654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-44  Score=343.49  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=212.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ..++|++.+.||+|+||.||+|... ++..||+|.+... ....+.+.+|++++++++||||+++++++.  +....++|
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v   87 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII   87 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCEEEE
Confidence            4567899999999999999999965 5889999999753 334578999999999999999999999987  44578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++++|.+++....  ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999999999997532  345899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......   ......    ...      
T Consensus       163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~----~~~------  228 (288)
T 3kfa_A          163 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKD------  228 (288)
T ss_dssp             SSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTT------
T ss_pred             CCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hcc------
Confidence            4332 22334567889999999999999999999999999999999 99999654321   111111    111      


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ........++    ..+.+++.+||+.||++||+++++++.|+.+.+..
T Consensus       229 ~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          229 YRMERPEGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCC----HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            0111112233    35889999999999999999999999999886543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.9e-45  Score=355.76  Aligned_cols=257  Identities=21%  Similarity=0.294  Sum_probs=196.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.  +....++||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~lv~   95 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAIIM   95 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe--eCCEEEEEE
Confidence            467999999999999999999965 789999999975432 3467889999999999999999999997  445899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc--eEEccccccccC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--AKVADFGLAKQA  252 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~~  252 (443)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.  +||+|||+++..
T Consensus        96 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           96 EYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            99999999999864    235899999999999999999999999   999999999999987765  999999999754


Q ss_pred             CCCCccccccccccCcccccccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVK-SDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....   ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......  ........+.........
T Consensus       169 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~  243 (361)
T 3uc3_A          169 VLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYSIPD  243 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCCCCT
T ss_pred             cccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCCCCC
Confidence            3221   1234579999999999988887655 899999999999999999997543322  222222222222111100


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                            ...++    ..+.+++.+||+.||++|||+.|+++|-+..
T Consensus       244 ------~~~~s----~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  279 (361)
T 3uc3_A          244 ------DIRIS----PECCHLISRIFVADPATRISIPEIKTHSWFL  279 (361)
T ss_dssp             ------TSCCC----HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred             ------cCCCC----HHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence                  01123    3478999999999999999999999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.8e-44  Score=349.93  Aligned_cols=255  Identities=22%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC---HHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++......   ...+.+|+.++.++ +||||+++++++.  +....+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~~~~   86 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESRLF   86 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE--eCCEEE
Confidence            57899999999999999999964 68899999997543222   34578899999988 8999999999987  445899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++..    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        87 lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           87 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence            99999999999999964    235899999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc---chHHHHHHHHhhcccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ---ENLVTWARPILRDKDR  328 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  328 (443)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   .........+..... 
T Consensus       160 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-  236 (345)
T 3a8x_A          160 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-  236 (345)
T ss_dssp             SCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-
T ss_pred             ccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-
Confidence            433221  23456899999999999999999999999999999999999999964322111   111111111211111 


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHHH
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM------GEVVQSL  374 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~L  374 (443)
                                 .++......+.+++.+||+.||++||++      +|+++|-
T Consensus       237 -----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp  277 (345)
T 3a8x_A          237 -----------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  277 (345)
T ss_dssp             -----------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred             -----------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence                       1122223347899999999999999995      6787764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-44  Score=350.87  Aligned_cols=247  Identities=23%  Similarity=0.295  Sum_probs=204.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++...   .....+.+.+|+++++.++||||+++++++.  +....++
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l  118 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--cCCEEEE
Confidence            57889999999999999999964 6899999998643   2234567889999999999999999999987  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       119 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence            9999999999999974    235899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....     
T Consensus       192 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~-----  255 (350)
T 1rdq_E          192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKV-----  255 (350)
T ss_dssp             SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC-----
T ss_pred             cCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHHHHcCCC-----
Confidence            432     234579999999999999999999999999999999999999996432      1222222222211     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSLK  375 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L~  375 (443)
                         .+...++    ..+.+++.+||+.||++||+     ++||++|-+
T Consensus       256 ---~~p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~  296 (350)
T 1rdq_E          256 ---RFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             ---CCCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             ---CCCCCCC----HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence               1112233    34789999999999999998     999988754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.7e-44  Score=342.44  Aligned_cols=252  Identities=23%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CC-------cEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DG-------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+|... ++       ..||+|.+........+.+.+|++++++++||||+++++++..  .
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC--G   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--T
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--C
Confidence            357889999999999999999854 33       4799999976655667789999999999999999999999874  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc-------
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH-------  240 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------  240 (443)
                      ...++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.       
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccc
Confidence            4789999999999999999743   234899999999999999999999999   999999999999998877       


Q ss_pred             -eEEccccccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 013404          241 -AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       241 -~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~  318 (443)
                       +||+|||++......      ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....  .....  
T Consensus       159 ~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~~~~--  228 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQRKL--  228 (289)
T ss_dssp             EEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHH--
T ss_pred             eeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hHHHH--
Confidence             999999998755321      23468899999999987 6789999999999999999996554432211  11111  


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                        ........+.        ...+    ..+.+++.+||+.||++|||++|++++|+.+..
T Consensus       229 --~~~~~~~~~~--------~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          229 --QFYEDRHQLP--------APKA----AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             --HHHHTTCCCC--------CCSS----CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             --HHhhccCCCC--------CCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              1111111111        1111    237789999999999999999999999987754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.5e-45  Score=365.64  Aligned_cols=251  Identities=24%  Similarity=0.311  Sum_probs=195.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||++.. .+|+.||||+++..   .......+.+|+++++.++||||++++++|..  ....+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~  224 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLC  224 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEE
Confidence            46799999999999999999995 47899999998743   23334567889999999999999999999974  44789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++
T Consensus       225 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence            99999999999999964    3458999999999999999999998 88   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....      .......+......  
T Consensus       298 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~~--  367 (446)
T 4ejn_A          298 EGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEEIR--  367 (446)
T ss_dssp             TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC--
T ss_pred             eccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHHHHHHHhCCCC--
Confidence            6433222  2345689999999999999999999999999999999999999996432      12222222222111  


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                            +...++    ..+.+++.+||+.||++||     +++|+++|-+
T Consensus       368 ------~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~  407 (446)
T 4ejn_A          368 ------FPRTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF  407 (446)
T ss_dssp             ------CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             ------CCccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence                  111223    3478999999999999999     9999998743

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-44  Score=373.86  Aligned_cols=260  Identities=27%  Similarity=0.445  Sum_probs=203.9

Q ss_pred             CCCCCc-eeeecCcEEEEEEEEC---CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           98 NFEPAS-ILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        98 ~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++.... ...+.|.+|+++|++++|||||+++++|..   ...++
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~l  412 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALML  412 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEE
Confidence            333444 7999999999999863   456799999986533 356789999999999999999999999863   35899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++...   ...+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus       413 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             EEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            99999999999999753   345899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          253 PEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       253 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   .....    +.....+ 
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~----i~~~~~~-  558 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF----IEQGKRM-  558 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHH----HHTTCCC-
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCC-
Confidence            5432221 1123346789999999999999999999999999999998 99999754321   11111    1111111 


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                               ..+..+...+.+++.+||+.||++||++.+|++.|+.+......
T Consensus       559 ---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          559 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             ---------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             ---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence                     12222334588999999999999999999999999988765543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=349.90  Aligned_cols=265  Identities=25%  Similarity=0.319  Sum_probs=204.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecC--CCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~l  172 (443)
                      .++|++.+.||+|+||.||++.. .+|+.||||++........+.+.+|+++++.++||||+++++++...  .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999996 57899999998765544567799999999999999999999998632  3347789


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++.........+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999999753333456999999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCccc-------cccccccCcccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 013404          253 PEGRTNY-------LSTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI  322 (443)
Q Consensus       253 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  322 (443)
                      .......       ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||........ .....    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~----  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA----  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----
Confidence            3211100       012345799999999987654   68899999999999999999999952111100 11110    


Q ss_pred             hhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       323 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ......      ......++    ..+.+++.+||+.||++||++++++++|+.+.
T Consensus       260 ~~~~~~------~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          260 VQNQLS------IPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHCC--------CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhccCC------CCccccCC----HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            011000      00011223    34889999999999999999999999998775

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=353.84  Aligned_cols=249  Identities=24%  Similarity=0.314  Sum_probs=196.9

Q ss_pred             CceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          102 ASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      .+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.  +....++||||+++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE--SKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEEEECCTTC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEEEEEEeCCCCC
Confidence            56799999999999995 468999999998655445678999999999999999999999987  445889999999999


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe--cCCCceEEccccccccCCCCCcc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL--ENNFHAKVADFGLAKQAPEGRTN  258 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~  258 (443)
                      +|.+++...   ...+++..++.++.|++.||+|||+.+   |+||||||+|||+  ++++.+||+|||+++....... 
T Consensus       172 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-  244 (373)
T 2x4f_A          172 ELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-  244 (373)
T ss_dssp             EEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred             cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence            999988642   345899999999999999999999999   9999999999999  5678999999999987654332 


Q ss_pred             ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccC
Q 013404          259 YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLG  338 (443)
Q Consensus       259 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  338 (443)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+........    ....
T Consensus       245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~~~----~~~~  312 (373)
T 2x4f_A          245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRWDLE----DEEF  312 (373)
T ss_dssp             --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCSC----SGGG
T ss_pred             --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCCCC----hhhh
Confidence              2334699999999999999999999999999999999999999964321      122222222211110    0011


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          339 GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       339 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..++    ..+.+++.+||+.||++||++.|++++-+
T Consensus       313 ~~~~----~~~~~li~~~L~~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          313 QDIS----EEAKEFISKLLIKEKSWRISASEALKHPW  345 (373)
T ss_dssp             TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ccCC----HHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence            1223    34789999999999999999999998755

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.6e-44  Score=341.41  Aligned_cols=259  Identities=26%  Similarity=0.417  Sum_probs=204.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC----CcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|.+.+    +..||+|.+..... ...+.+.+|+.++++++||||+++++++..   ...
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EPT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SSC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCC
Confidence            4678899999999999999998532    34699999875432 234678999999999999999999999753   356


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             EEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence            8999999999999999642   234899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......   ......    ..... 
T Consensus       162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~----~~~~~-  232 (281)
T 3cc6_A          162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVL----EKGDR-  232 (281)
T ss_dssp             CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHH----HHTCC-
T ss_pred             ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHH----hcCCC-
Confidence            7654322 12233467889999999999999999999999999999998 99999643322   111111    11111 


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                           ......++    ..+.+++.+||+.||++||++.|++++|+.+.+..
T Consensus       233 -----~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          233 -----LPKPDLCP----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             -----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCC----HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                 01111223    34889999999999999999999999999887643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=346.84  Aligned_cols=271  Identities=23%  Similarity=0.407  Sum_probs=201.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHH--hhcCCCceeeEEEeeec---CCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEML--SRLHHRNLVKLVGYYSS---RDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~---~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|+. +++.||||++...   ....+..|.+++  ..++||||+++++++..   ......
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            36789999999999999999987 5799999999633   344555565554  45899999999975432   233467


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc---------CCCceEecCCCcccEEecCCCce
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED---------SQPCVIHRDFKASNILLENNFHA  241 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~ivH~Dlkp~NIll~~~~~~  241 (443)
                      ++||||+++|+|.+++..     ...++..++.++.|++.||+|||+.         +   |+||||||+|||++.++.+
T Consensus        88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred             EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence            899999999999999963     2358899999999999999999998         7   9999999999999999999


Q ss_pred             EEccccccccCCCCCc------cccccccccCccccccccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 013404          242 KVADFGLAKQAPEGRT------NYLSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQ  308 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~G~il~elltg~~p~~~~~  308 (443)
                      ||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            9999999987643221      111234579999999999986       456789999999999999999987764322


Q ss_pred             CCCcc--hH---------HHHHHHHhhccccccccccCccCCC--CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          309 PSGQE--NL---------VTWARPILRDKDRLEELADPRLGGK--YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       309 ~~~~~--~~---------~~~~~~~~~~~~~~~~~~d~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .....  .+         .............     .+.+...  ........+.+++.+||+.||++|||++||++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ-----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhccccc-----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            21111  00         0011111111111     1111111  12235557899999999999999999999999999


Q ss_pred             HhHhhhhc
Q 013404          376 MVQRVIEC  383 (443)
Q Consensus       376 ~~~~~~~~  383 (443)
                      .+......
T Consensus       315 ~ll~~~~~  322 (336)
T 3g2f_A          315 ELMMIWER  322 (336)
T ss_dssp             HHHHCCCC
T ss_pred             HHHHHHHh
Confidence            98765543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.4e-45  Score=352.78  Aligned_cols=267  Identities=26%  Similarity=0.411  Sum_probs=210.1

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeee
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYS  163 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  163 (443)
                      +.....++|++.+.||+|+||.||+|...      +++.||+|.+..... .....+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34445678999999999999999999853      367899999975432 22356889999999999999999999987


Q ss_pred             cCCCCeeEEEEeecCCCChhHhhcCCC------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC
Q 013404          164 SRDSSQHLLCYELVPNGSLESWLHGPL------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN  237 (443)
Q Consensus       164 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~  237 (443)
                        +....++||||+++|+|.+++....      .....+++..++.++.|++.||.|||+++   |+||||||+|||++.
T Consensus        99 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~  173 (322)
T 1p4o_A           99 --QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE  173 (322)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred             --cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence              4457899999999999999996321      11235789999999999999999999999   999999999999999


Q ss_pred             CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHH
Q 013404          238 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLV  316 (443)
Q Consensus       238 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~  316 (443)
                      ++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....      .
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~  247 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------E  247 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------H
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------H
Confidence            99999999999986544332222334567889999999999999999999999999999999 8899864321      1


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      .....+... ..      ......++    ..+.+++.+||+.||++|||+.|++++|+.+..
T Consensus       248 ~~~~~~~~~-~~------~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          248 QVLRFVMEG-GL------LDKPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHHTT-CC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHHcC-Cc------CCCCCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111111111 10      11112233    348899999999999999999999999987643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.8e-44  Score=350.69  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=204.1

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCe
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  169 (443)
                      ..++|++.+.||+|+||.||+++.. +|+.||+|+++..   .......+..|..++..+ +||||+++++++.  +...
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR   95 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE--CSSE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE--cCCE
Confidence            3578999999999999999999965 5789999999753   223456788999999988 8999999999987  4458


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+++|+|.+++..    ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            9999999999999999964    235899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      +.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....  
T Consensus       169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~--  238 (353)
T 2i0e_A          169 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHNV--  238 (353)
T ss_dssp             BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC--
T ss_pred             cccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCCC--
Confidence            86432221  2345689999999999999999999999999999999999999996432      1222222322211  


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL  374 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L  374 (443)
                                .++......+.+++.+||+.||++||+     +++|++|-
T Consensus       239 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~  278 (353)
T 2i0e_A          239 ----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  278 (353)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred             ----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence                      112222234789999999999999995     58888764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=348.63  Aligned_cols=253  Identities=26%  Similarity=0.317  Sum_probs=188.7

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||++++++|.  +....++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE--TPTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe--cCCeEEEE
Confidence            4567999999999999999999975 57899999997542  3456889999999999999999999997  44588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceEEccccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLAK  250 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~  250 (443)
                      |||+++|+|.+++..    ...+++.++..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++
T Consensus       127 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          127 LELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             ECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            999999999999974    345899999999999999999999999   999999999999975   8899999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ......+......  
T Consensus       200 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~~~~~--  269 (349)
T 2w4o_A          200 IVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILNCEYY--  269 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHTTCCC--
T ss_pred             ccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHhCCCc--
Confidence            654322   223457999999999999999999999999999999999999999643221     1111112211110  


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                       ... .....++    ..+.+++.+||+.||++|||+.|++++-
T Consensus       270 -~~~-~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~e~l~hp  307 (349)
T 2w4o_A          270 -FIS-PWWDEVS----LNAKDLVRKLIVLDPKKRLTTFQALQHP  307 (349)
T ss_dssp             -CCT-TTTTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             -cCC-chhhhCC----HHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence             000 1111223    3478999999999999999999999863

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.2e-45  Score=375.26  Aligned_cols=257  Identities=30%  Similarity=0.441  Sum_probs=207.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++..   ...++|||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~e  341 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTE  341 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEeee
Confidence            35567788999999999999999888889999998543 346789999999999999999999999863   46899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++....  ...+++.+++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.....
T Consensus       342 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          342 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             hhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            999999999996321  235889999999999999999999999   999999999999999999999999999876432


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      . ........++..|+|||++.+..++.++|||||||+||||++ |+.||.....      .+.... +....++     
T Consensus       417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~-i~~~~~~-----  483 (535)
T 2h8h_A          417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQ-VERGYRM-----  483 (535)
T ss_dssp             H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHH-HHTTCCC-----
T ss_pred             c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HHcCCCC-----
Confidence            1 111223457789999999999999999999999999999999 9999964321      111111 1111111     


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                           ..+..+...+.+|+.+||+.||++|||+++|++.|+.+..
T Consensus       484 -----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          484 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                 1122223458899999999999999999999999987653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-44  Score=356.30  Aligned_cols=205  Identities=28%  Similarity=0.431  Sum_probs=165.3

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCe
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  169 (443)
                      ...++|++.+.||+|+||.||+|.. .+|+.||||++.....  .....+.+|+.++.++. ||||+++++++...+...
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467899999999999999999995 5789999999864422  23456889999999997 999999999998666667


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||++ |+|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999997 599999873     35889999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCC-------------------ccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          250 KQAPEGR-------------------TNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       250 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      +......                   .....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence            8653211                   0112234679999999999986 67899999999999999999999999754

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.1e-44  Score=340.60  Aligned_cols=254  Identities=26%  Similarity=0.462  Sum_probs=205.7

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeec---------
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS---------  164 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  164 (443)
                      ...+|++.+.||+|+||.||+|... +|+.||+|.+....    ..+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467899999999999999999975 78999999997542    467789999999999999999998753         


Q ss_pred             -----CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          165 -----RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       165 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                           ......++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                 12335789999999999999996432  346899999999999999999999999   99999999999999999


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      .+||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..        ...+.
T Consensus       160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--------~~~~~  228 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--------TSKFF  228 (284)
T ss_dssp             EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--------HHHHH
T ss_pred             CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--------HHHHH
Confidence            999999999987654322   2345799999999999999999999999999999999999988731        01111


Q ss_pred             HHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      ...          .+..+...++.    .+.+++.+||+.||++||++.|++++|+.+.+..+
T Consensus       229 ~~~----------~~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          229 TDL----------RDGIISDIFDK----KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHH----------HTTCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHh----------hcccccccCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            111          11112222333    37789999999999999999999999998865443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=346.77  Aligned_cols=247  Identities=25%  Similarity=0.313  Sum_probs=192.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC--HHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.++||+|+||.||+|... +|+.||||++.......  ...+..|+..+.++ +||||++++++|.  +....+
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~--~~~~~~  133 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE--EGGILY  133 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE--eCCEEE
Confidence            357999999999999999999975 78999999987543322  23456666666665 8999999999997  455899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+ +++|.+++...   ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       134 lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             EEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeee
Confidence            999999 67999988643   345999999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......   .....||+.|+|||++.+ .++.++|||||||++|||++|..|+...     .   .| .. +....    
T Consensus       207 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~---~~-~~-~~~~~----  268 (311)
T 3p1a_A          207 LGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----E---GW-QQ-LRQGY----  268 (311)
T ss_dssp             CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----H---HH-HH-HTTTC----
T ss_pred             cccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----c---HH-HH-HhccC----
Confidence            654322   234569999999998876 7899999999999999999997766421     1   11 11 11110    


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                       ..+.....++    ..+.+++.+||+.||++|||++|++++-
T Consensus       269 -~~~~~~~~~~----~~l~~li~~~L~~dP~~Rpt~~ell~hp  306 (311)
T 3p1a_A          269 -LPPEFTAGLS----SELRSVLVMMLEPDPKLRATAEALLALP  306 (311)
T ss_dssp             -CCHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             -CCcccccCCC----HHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence             0011111222    3488999999999999999999999763

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-44  Score=348.06  Aligned_cols=261  Identities=27%  Similarity=0.457  Sum_probs=200.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEECC-----CcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|.+.+.||+|+||.||+|....     +..||||.++..... ....+.+|++++++++||||+++++++.  +....
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~  121 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKPM  121 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe--cCCCc
Confidence            466778999999999999998542     236999999754322 2456899999999999999999999987  44578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++...   ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       122 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999743   345899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          251 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....      ......+ .....
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~-~~~~~  268 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAI-NDGFR  268 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHH-HTTCC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHHH-HCCCc
Confidence            76543221 11223456789999999999999999999999999999999 9999964321      1111111 11111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      .          ..+......+.+++.+||+.||++||++.++++.|+.+.+...
T Consensus       269 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          269 L----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             C----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            1          1111223358899999999999999999999999998876443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-44  Score=349.77  Aligned_cols=252  Identities=24%  Similarity=0.305  Sum_probs=179.9

Q ss_pred             CceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEEeecCC
Q 013404          102 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPN  179 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~  179 (443)
                      .+.||+|+||.||++... +|+.||||++..   .....+.+|+.+++.+. ||||+++++++.  +....++||||+++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~--~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFH--DQLHTFLVMELLNG   90 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEEEEECCCCS
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEE--cCCEEEEEEEccCC
Confidence            478999999999999964 689999999963   24567889999999997 999999999987  45588999999999


Q ss_pred             CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC---ceEEccccccccCCCCC
Q 013404          180 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF---HAKVADFGLAKQAPEGR  256 (443)
Q Consensus       180 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~  256 (443)
                      |+|.+++..    ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++   .+||+|||+++......
T Consensus        91 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           91 GELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             CBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            999999975    345899999999999999999999999   99999999999997665   89999999998665432


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc-chHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-ENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........+......       
T Consensus       164 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-------  234 (325)
T 3kn6_A          164 Q--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-------  234 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-------
T ss_pred             C--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-------
Confidence            2  22345789999999999999999999999999999999999999975433211 1122222222111100       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                       ............+.+++.+||+.||++|||++|++++-+
T Consensus       235 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w  273 (325)
T 3kn6_A          235 -FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW  273 (325)
T ss_dssp             -CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred             -CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence             000000112335889999999999999999999987643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-44  Score=355.00  Aligned_cols=261  Identities=26%  Similarity=0.436  Sum_probs=195.8

Q ss_pred             CCCCCceeeecCcEEEEEEEEC--CC--cEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS--DG--TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .|++.+.||+|+||.||+|.+.  ++  ..||||.++.... ...+.|.+|+.++++++||||++++++|... ....++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCCeEE
Confidence            4566789999999999999853  22  3689999875433 2346799999999999999999999987532 346789


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++...   ...+++..++.++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus       169 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence            99999999999999753   335789999999999999999999999   999999999999999999999999999866


Q ss_pred             CCCCccc--cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          253 PEGRTNY--LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       253 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      .......  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   ....   +. .....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~---~~-~~~~~  315 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LL-QGRRL  315 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH---HH-TTCCC
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH---HH-cCCCC
Confidence            4332111  1233467889999999999999999999999999999999 677776443222   1111   11 11110


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                            .....++    ..+.+++.+||+.||++||++.|+++.|+.+.....
T Consensus       316 ------~~p~~~~----~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          316 ------LQPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             ------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ------CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                  0111233    348899999999999999999999999998876544

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-44  Score=349.07  Aligned_cols=266  Identities=25%  Similarity=0.299  Sum_probs=201.9

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC-----CCCCHHHHHHHHHHHhhcCCCceeeEEEeeec
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG-----GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS  164 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  164 (443)
                      ++....++|++.+.||+|+||.||+|.. .++..||+|++...     .....+.+.+|++++++++||||+++++++. 
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-   98 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-   98 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-
Confidence            3456678899999999999999999996 46889999998643     2344578999999999999999999999997 


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCCC------------------------------------CCCCCChHHHHHHHHHH
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPLG------------------------------------VNCHLDWETRMKIALDA  208 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~i  208 (443)
                       +....++||||+++|+|.+++.....                                    ....+++..+..++.|+
T Consensus        99 -~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           99 -DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             -cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence             45589999999999999999852100                                    01224567788999999


Q ss_pred             HHHHHHhhhcCCCceEecCCCcccEEecCCC--ceEEccccccccCCCCC--ccccccccccCccccccccccc--CCCC
Q 013404          209 ARGLAYLHEDSQPCVIHRDFKASNILLENNF--HAKVADFGLAKQAPEGR--TNYLSTRVMGTFGYVAPEYAMT--GHLL  282 (443)
Q Consensus       209 ~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~  282 (443)
                      +.||+|||+.+   |+||||||+|||++.++  .+||+|||+++......  .........||+.|+|||++.+  ..++
T Consensus       178 ~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  254 (345)
T 3hko_A          178 FSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG  254 (345)
T ss_dssp             HHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC
T ss_pred             HHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC
Confidence            99999999999   99999999999998776  89999999998653221  1112345679999999999875  6789


Q ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCC
Q 013404          283 VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEAN  362 (443)
Q Consensus       283 ~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~  362 (443)
                      .++|||||||++|||++|+.||.....      ......+........   .+.. ..+    ...+.+++.+||+.||+
T Consensus       255 ~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~---~~~~-~~~----~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          255 PKCDAWSAGVLLHLLLMGAVPFPGVND------ADTISQVLNKKLCFE---NPNY-NVL----SPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCTT---SGGG-GGS----CHHHHHHHHHHSCSCTT
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcccccC---Cccc-ccC----CHHHHHHHHHHcCCChh
Confidence            999999999999999999999964321      122222222211111   0000 012    23478999999999999


Q ss_pred             CCCCHHHHHHHHH
Q 013404          363 QRPTMGEVVQSLK  375 (443)
Q Consensus       363 ~RPs~~evl~~L~  375 (443)
                      +||++.|++++-+
T Consensus       321 ~Rps~~~~l~hp~  333 (345)
T 3hko_A          321 ERFDAMRALQHPW  333 (345)
T ss_dssp             TSCCHHHHHHSHH
T ss_pred             HCCCHHHHhcChh
Confidence            9999999998754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.1e-44  Score=347.37  Aligned_cols=266  Identities=23%  Similarity=0.367  Sum_probs=199.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ..+|++.+.||+|+||.||+|.. .+|+.||+|++......   ....+.+|+.++++++||||+++++++..  ....+
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~  108 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELN  108 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEE
Confidence            45799999999999999999995 57899999999754322   24578899999999999999999999874  44889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++.........+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            999999999999998642222445899999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......  ......|++.|+|||++.+..++.++||||||+++|||++|+.||.....    ........+...  ... 
T Consensus       186 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~--~~~-  256 (310)
T 2wqm_A          186 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQC--DYP-  256 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHHTT--CSC-
T ss_pred             ecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhhcc--cCC-
Confidence            543322  12345789999999999999999999999999999999999999964321    112222211111  000 


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                         +.....++.    .+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus       257 ---~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          257 ---PLPSDHYSE----ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             ---CCCTTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ---CCcccccCH----HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence               111122333    47899999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=339.05  Aligned_cols=268  Identities=25%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC-----CCCHHHHHHHHHHHhhcC---CCceeeEEEeeecC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-----QQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSR  165 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  165 (443)
                      ..++|++.+.||+|+||.||+|+. .+|+.||||++....     ......+.+|++++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999995 578999999986432     122356778888887775   99999999998754


Q ss_pred             CCC---eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceE
Q 013404          166 DSS---QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK  242 (443)
Q Consensus       166 ~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  242 (443)
                      ...   ..+++|||+. |+|.+++....  ...+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            322   4789999996 59999997543  234899999999999999999999999   99999999999999999999


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI  322 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  322 (443)
                      |+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   .........
T Consensus       161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~  234 (308)
T 3g33_A          161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDL  234 (308)
T ss_dssp             ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHH
T ss_pred             EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHH
Confidence            999999986643322   24467999999999999999999999999999999999999999643321   111111111


Q ss_pred             hhccc--cccc---cccCccC--CCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          323 LRDKD--RLEE---LADPRLG--GKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       323 ~~~~~--~~~~---~~d~~~~--~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      .....  ....   +......  ...+     .+....+.+++.+||+.||++|||+.|+++|-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~  298 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS  298 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence            11000  0000   0000000  0000     11123578999999999999999999999764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-44  Score=349.58  Aligned_cols=266  Identities=27%  Similarity=0.404  Sum_probs=204.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||+|++      .++..||||.+..... .....+.+|+.++++++||||+++++++..  ..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--CC
Confidence            46899999999999999999984      2467899999974422 234578999999999999999999999874  44


Q ss_pred             eeEEEEeecCCCChhHhhcCCCC---CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceE
Q 013404          169 QHLLCYELVPNGSLESWLHGPLG---VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAK  242 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k  242 (443)
                      ..++||||+++|+|.+++.....   ....+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            78999999999999999975332   1245899999999999999999999999   999999999999984   45699


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      |+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||.....      ......
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~  257 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEF  257 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHHHH
Confidence            999999975543322222334568899999999999999999999999999999998 9999964321      111111


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                      +.. ...      ......++    ..+.+++.+||+.||++||++.+|+++|+.+.+....
T Consensus       258 ~~~-~~~------~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          258 VTS-GGR------MDPPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             HHT-TCC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             Hhc-CCC------CCCCCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence            111 110      11112233    3488999999999999999999999999988765443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.8e-44  Score=339.90  Aligned_cols=262  Identities=26%  Similarity=0.412  Sum_probs=203.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEECC----CcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .+|++.+.||+|+||.||+|...+    ...||+|.+..... ...+.+.+|+.++++++||||++++++|.. +....+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-CCCceE
Confidence            467888999999999999998532    23689999875433 234678999999999999999999998754 334678


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|||+++|+|.+++...   ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus       104 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence            999999999999999753   345889999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCcc--ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          252 APEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       252 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      .......  .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.......   ....   ...... 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~---~~~~~~-  250 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LLQGRR-  250 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHH---HHTTCC-
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHH---HhcCCC-
Confidence            6443221  11233567889999999999999999999999999999999 555665333221   1111   111110 


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                            ......++    ..+.+++.+||+.||++||+++|+++.|+.+.....
T Consensus       251 ------~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          251 ------LLQPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             ------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             ------CCCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                  01111223    348899999999999999999999999998876443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-43  Score=341.74  Aligned_cols=254  Identities=26%  Similarity=0.330  Sum_probs=205.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC------CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||++... +|+.||+|.+......      ..+.+.+|+.++++++||||+++++++.  +..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~   88 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE--NRT   88 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCC
Confidence            457899999999999999999964 6899999999754322      3567999999999999999999999987  445


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC----ceEEc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA  244 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~  244 (443)
                      ..++||||+++++|.+++..    ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||+
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEc
Confidence            88999999999999999974    345899999999999999999999999   99999999999999887    79999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      |||+++.......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+..
T Consensus       162 Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~  232 (321)
T 2a2a_A          162 DFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITS  232 (321)
T ss_dssp             CCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHT
T ss_pred             cCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh
Confidence            9999987654322   2345799999999999999999999999999999999999999964321      111111111


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .....    ++.....++    ..+.+++.+||+.||++|||+.|++++-+
T Consensus       233 ~~~~~----~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          233 VSYDF----DEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             TCCCC----CHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             ccccc----ChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            11100    000001122    34789999999999999999999998643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.4e-44  Score=346.04  Aligned_cols=260  Identities=29%  Similarity=0.435  Sum_probs=204.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcE--EEEEEeccCC-CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTA--VAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|++.+.||+|+||.||+|.. .++..  +|+|.++... ....+.+.+|+++++++ +||||+++++++..  ....+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCceE
Confidence            5789999999999999999995 45664  4999987532 23456789999999999 89999999999874  45889


Q ss_pred             EEEeecCCCChhHhhcCCC------------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          172 LCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                      +||||+++|+|.+++....            .....+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence            9999999999999997543            22346899999999999999999999999   99999999999999999


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~  318 (443)
                      .+||+|||+++......   ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....      ...
T Consensus       180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~  250 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AEL  250 (327)
T ss_dssp             CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHH
T ss_pred             eEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHH
Confidence            99999999997543211   1233467889999999999899999999999999999998 9999964321      111


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ...+ ....      ...    .+......+.+++.+||+.||++||+++|++++|+.+....
T Consensus       251 ~~~~-~~~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          251 YEKL-PQGY------RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HHHG-GGTC------CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHh-hcCC------CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            1111 1110      111    11122235889999999999999999999999999887543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-43  Score=358.64  Aligned_cols=250  Identities=26%  Similarity=0.359  Sum_probs=205.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+++.++||||+++++++.  +....++
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~--~~~~~~l   93 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS--TPSDIFM   93 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEE
Confidence            57899999999999999999965 78999999986431   233567899999999999999999999987  4458999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        94 v~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           94 VMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            9999999999999964    345899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .....   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....      ......+.....    
T Consensus       167 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~----  233 (476)
T 2y94_A          167 SDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDGIF----  233 (476)
T ss_dssp             CTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTTCC----
T ss_pred             ccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCc----
Confidence            54321   234579999999999988766 6899999999999999999999974321      122222221110    


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          .....++    ..+.+++.+||+.||++|||++|++++-+.
T Consensus       234 ----~~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~  270 (476)
T 2y94_A          234 ----YTPQYLN----PSVISLLKHMLQVDPMKRATIKDIREHEWF  270 (476)
T ss_dssp             ----CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred             ----CCCccCC----HHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence                0111222    347899999999999999999999987654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-43  Score=337.67  Aligned_cols=263  Identities=26%  Similarity=0.378  Sum_probs=204.2

Q ss_pred             CCCCCceeeecCcEEEEEEEEC-CC---cEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLS-DG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .|...+.||+|+||.||+|.+. ++   ..||+|.+..... ...+.+.+|+.++++++||||+++++++...+ ...++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcEE
Confidence            4556689999999999999843 33   3799999975433 23467899999999999999999999986433 34589


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +|||+.+|+|.+++...   ...+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus       101 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             EECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            99999999999999753   345889999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCcc--ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          253 PEGRTN--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       253 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ......  .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+.....  .........    ....  
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~----~~~~--  246 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHFLA----QGRR--  246 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHHHH----TTCC--
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHHhh----cCCC--
Confidence            443211  112345688999999999999999999999999999999996655432221  111221111    1110  


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhhc
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIEC  383 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~  383 (443)
                          ......++    ..+.+++.+||+.||++|||++++++.|+.+.+.+..
T Consensus       247 ----~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          247 ----LPQPEYCP----DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             ----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             ----CCCCccch----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                11111223    3588999999999999999999999999998776543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.8e-44  Score=353.68  Aligned_cols=259  Identities=24%  Similarity=0.277  Sum_probs=196.1

Q ss_pred             hcCCCCC-ceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhh-cCCCceeeEEEeeec--CCCCee
Q 013404           96 TNNFEPA-SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSR-LHHRNLVKLVGYYSS--RDSSQH  170 (443)
Q Consensus        96 ~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~--~~~~~~  170 (443)
                      .++|.+. +.||+|+||.||++... +|+.||||++..     ...+.+|+.++.+ .+||||++++++|..  .+....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3466665 68999999999999964 689999999862     3567889988755 489999999998763  234468


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceEEcccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG  247 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  247 (443)
                      ++||||+++|+|.+++....  ...+++.++..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence            99999999999999997532  345899999999999999999999999   999999999999997   7899999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc-hHHHHHHHHhhcc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE-NLVTWARPILRDK  326 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~  326 (443)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......   ....
T Consensus       210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i---~~~~  283 (400)
T 1nxk_A          210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---RMGQ  283 (400)
T ss_dssp             TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH---HHTC
T ss_pred             cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH---HcCc
Confidence            998664322   124467899999999999999999999999999999999999999754432211 111111   1111


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ...   ..+. ...++    ..+.+|+.+||+.||++|||+.|++++-+...
T Consensus       284 ~~~---~~~~-~~~~s----~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          284 YEF---PNPE-WSEVS----EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             CCC---CTTT-TTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ccC---CCcc-cccCC----HHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            000   0000 01223    34789999999999999999999999877653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.8e-44  Score=353.59  Aligned_cols=270  Identities=16%  Similarity=0.224  Sum_probs=202.0

Q ss_pred             hcCCCCCceeeec--CcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEG--GFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G--~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|  +||.||+|+.. +|+.||||++......  ..+.+.+|+.+++.++||||+++++++..  ....
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  101 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNEL  101 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEE
Confidence            3579999999999  99999999965 7899999999754322  23568889999999999999999999884  4589


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++....  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence            99999999999999997532  245899999999999999999999999   9999999999999999999999999986


Q ss_pred             cCCCCCc-----cccccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          251 QAPEGRT-----NYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       251 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      .......     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.........  ........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~  254 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTV  254 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-----
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCC
Confidence            5422111     111223478999999999987  67899999999999999999999999754332211  11000000


Q ss_pred             h----cc----cc-------------ccccc---cCc------cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          324 R----DK----DR-------------LEELA---DPR------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       324 ~----~~----~~-------------~~~~~---d~~------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .    ..    ..             .....   .+.      .....+......+.+|+.+||+.||++|||++|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            0    00    00             00000   000      0001112223458899999999999999999999987


Q ss_pred             H
Q 013404          374 L  374 (443)
Q Consensus       374 L  374 (443)
                      -
T Consensus       335 p  335 (389)
T 3gni_B          335 S  335 (389)
T ss_dssp             G
T ss_pred             H
Confidence            3

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.6e-44  Score=337.02  Aligned_cols=254  Identities=26%  Similarity=0.382  Sum_probs=203.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.+++.++||||+++++++..  ....++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence            467899999999999999999965 789999999875432 335678999999999999999999999874  4578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            999999999999974    345899999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ............|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..+..|.    ......   
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~----~~~~~~---  228 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWK----EKKTYL---  228 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHH----TTCTTS---
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhh----hccccc---
Confidence            3322222345679999999999987765 789999999999999999999997543321 1111111    111000   


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                       .+  ...++    ..+.+++.+||+.||++|||++|++++
T Consensus       229 -~~--~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          229 -NP--WKKID----SAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -TT--GGGSC----HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -Cc--hhhcC----HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             00  01122    347899999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.2e-43  Score=334.70  Aligned_cols=254  Identities=22%  Similarity=0.260  Sum_probs=205.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.  +....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   85 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE--DNTDIYLVM   85 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCeEEEEE
Confidence            467899999999999999999965 57799999998765666788999999999999999999999987  455889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe---cCCCceEEcccccccc
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQ  251 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~  251 (443)
                      ||+++++|.+++..    ...+++..++.++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||++..
T Consensus        86 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           86 ELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            99999999999864    345899999999999999999999999   9999999999999   7889999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......   .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||.....      ......+.........
T Consensus       159 ~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~  228 (277)
T 3f3z_A          159 FKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD------SEVMLKIREGTFTFPE  228 (277)
T ss_dssp             CCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCCCH
T ss_pred             ccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCCCc
Confidence            654332   2345799999999988654 89999999999999999999999964321      1111111111110000


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      .    ....+    ...+.+++.+||+.||++||++.+++++-+.
T Consensus       229 ~----~~~~~----~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~  265 (277)
T 3f3z_A          229 K----DWLNV----SPQAESLIRRLLTKSPKQRITSLQALEHEWF  265 (277)
T ss_dssp             H----HHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             h----hhhcC----CHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence            0    00011    2357899999999999999999999987554

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.7e-45  Score=344.51  Aligned_cols=262  Identities=24%  Similarity=0.361  Sum_probs=205.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .++|++.+.||+|+||.||++... +|+.||+|.+......  ..+.+.+|++++++++||||+++++++........++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367899999999999999999964 7899999999754322  3457899999999999999999999886555568899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcC--CCceEecCCCcccEEecCCCceEEccccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS--QPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ||||+++++|.+++.........+++..++.++.|++.||+|||+.+  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999743333445899999999999999999999876  2349999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .......  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....   .   .....+... . . 
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~i~~~-~-~-  233 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---K---ELAGKIREG-K-F-  233 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHT-C-C-
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---H---HHHHHHhhc-c-c-
Confidence            7654321  12345789999999999999999999999999999999999999974321   1   111111111 1 1 


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          +.+...++    ..+.+++.+||+.||++||++.||+++++.
T Consensus       234 ----~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          234 ----RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ----CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ----ccCCcccC----HHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                11112233    348899999999999999999999987643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.6e-44  Score=340.98  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=197.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.......  .+.+.+|++++++++||||+++++++..  ....++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEE
Confidence            57899999999999999999964 58999999987554322  3568899999999999999999999874  4578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++++|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           81 FEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            999999999998864    345899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh---------
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL---------  323 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  323 (443)
                      ....  ......||..|+|||++.+ ..++.++||||||+++|||++|+.||........   ........         
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~  228 (311)
T 4agu_A          154 GPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQ  228 (311)
T ss_dssp             --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHH
T ss_pred             Cccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhccccccccc
Confidence            3322  1234578999999999876 5789999999999999999999999965432211   11111110         


Q ss_pred             --hccccccccccCccCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          324 --RDKDRLEELADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       324 --~~~~~~~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                        ...........+......+     ......+.+++.+||+.||++|||++|++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  286 (311)
T 4agu_A          229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP  286 (311)
T ss_dssp             HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred             ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence              0000000000000000000     01123478999999999999999999999863

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.6e-44  Score=339.46  Aligned_cols=253  Identities=27%  Similarity=0.449  Sum_probs=198.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||++... |+.||||.++..  ...+.+.+|++++++++||||+++++++.. +....++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC-C--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCCceEEEEe
Confidence            467899999999999999999874 789999999743  345789999999999999999999998753 3346899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++++|.+++....  ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        96 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             cCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999996421  223788999999999999999999999   999999999999999999999999999765432


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      .     ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......   ...   ..+ ....      .
T Consensus       171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~---~~~-~~~~------~  232 (278)
T 1byg_A          171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV---PRV-EKGY------K  232 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH---HHH-TTTC------C
T ss_pred             c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH---HHH-hcCC------C
Confidence            2     22357889999999999999999999999999999998 99999643321   111   111 1110      1


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      ......++    ..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus       233 ~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          233 MDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcccCC----HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            11112233    358899999999999999999999999998865

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.4e-43  Score=333.69  Aligned_cols=266  Identities=20%  Similarity=0.300  Sum_probs=210.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.....  ...+.+|+.+++.++|++++..+.++.. +....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC-CCCceEEEE
Confidence            46899999999999999999995 6789999999875432  3568999999999999888777766643 445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe---cCCCceEEcccccccc
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQ  251 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~  251 (443)
                      ||+ +++|.+++...   ...+++.+++.++.|++.||+|||+++   |+||||||+|||+   ++++.+||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999 89999999632   235899999999999999999999999   9999999999999   4888999999999987


Q ss_pred             CCCCCccc-----cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH-HHHhhc
Q 013404          252 APEGRTNY-----LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-RPILRD  325 (443)
Q Consensus       252 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~  325 (443)
                      ........     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............... ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            65433211     123457999999999999999999999999999999999999999765443333222211 111111


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      .  .     +.+...++.    .+.+++.+||+.||++||++++|++.|+.+.+...
T Consensus       238 ~--~-----~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          238 P--I-----EVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             C--H-----HHHTTTSCH----HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             c--h-----HHHHhhCCH----HHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            0  0     011122333    48899999999999999999999999998876554

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.8e-44  Score=339.42  Aligned_cols=260  Identities=25%  Similarity=0.409  Sum_probs=204.4

Q ss_pred             hcCCCCCc-eeeecCcEEEEEEEE---CCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           96 TNNFEPAS-ILGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        96 ~~~~~~~~-~lg~G~fg~V~~~~~---~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      .++|.+.+ .||+|+||.||+|.+   .+++.||||.++......  .+.+.+|+++++.++||||+++++++.   ...
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SSS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CCC
Confidence            45677777 999999999999964   346789999997553322  467999999999999999999999984   336


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        92 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             cEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            7899999999999999974    235899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          250 KQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       250 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      +......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....   .....    .+....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~----~~~~~~  237 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTA----MLEKGE  237 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHH----HHHTTC
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHcCC
Confidence            8765443221 1223456789999999999899999999999999999999 9999964321   11111    111111


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                            .+.....++    ..+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus       238 ------~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          238 ------RMGCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             ------CCCCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence                  011112233    358899999999999999999999999998876543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=335.98  Aligned_cols=257  Identities=21%  Similarity=0.295  Sum_probs=202.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC----CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||++.. .+++.||+|.++...    ......+.+|++++++++||||+++++++...+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            46899999999999999999996 468899999997432    2345679999999999999999999999865566678


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||++++ |.+++....  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            9999999876 777775432  346899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ...............||+.|+|||++.+..  ++.++||||||+++|||++|+.||....      .......+....  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~--  229 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGKGS--  229 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCC--
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhcCC--
Confidence            765433222334457999999999987654  3789999999999999999999997432      122222221111  


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                            ..+...++    ..+.+++.+||+.||++||+++|++++-+.
T Consensus       230 ------~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          230 ------YAIPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             ------CCCCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             ------CCCCCccC----HHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence                  11112233    347899999999999999999999988554

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.4e-44  Score=337.08  Aligned_cols=254  Identities=25%  Similarity=0.331  Sum_probs=197.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|.+.+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++.  +....++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv   98 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE--DYHNMYIV   98 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee--cCCeEEEE
Confidence            35789999999999999999996 468899999987543 334678999999999999999999999987  45588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe---cCCCceEEccccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAK  250 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~  250 (443)
                      |||+++|+|.+++.........+++..++.++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999999998543222356899999999999999999999999   9999999999999   456789999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .......   .....||+.|+|||++. ..++.++||||||+++|||++|+.||.....      .............. 
T Consensus       176 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~-  244 (285)
T 3is5_A          176 LFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKEPNY-  244 (285)
T ss_dssp             C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC-
T ss_pred             ecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCCccc-
Confidence            6544322   23457999999999875 5689999999999999999999999964321      11111111111100 


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                          ......++.    .+.+++.+||+.||++|||+.||+++
T Consensus       245 ----~~~~~~~~~----~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          245 ----AVECRPLTP----QAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ----CC--CCCCH----HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ----ccccCcCCH----HHHHHHHHHccCChhhCcCHHHHhcC
Confidence                000111233    47799999999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7e-44  Score=365.67  Aligned_cols=256  Identities=25%  Similarity=0.401  Sum_probs=207.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+.+|+++|++++||||+++++++.  +....+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~l~  260 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE--TKDALC  260 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe--eCCEEE
Confidence            467889999999999999999964 7899999998643   2334567889999999999999999999987  445899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++....  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       261 lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence            9999999999999997532  335899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ......+.....    
T Consensus       336 ~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~~~~----  406 (576)
T 2acx_A          336 VPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEVPE----  406 (576)
T ss_dssp             CCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHHCCC----
T ss_pred             cccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhcccc----
Confidence            654332   23458999999999999999999999999999999999999999754432211  111111111111    


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLK  375 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~  375 (443)
                          .+...++    ..+.+++.+||+.||++||     +++||++|-+
T Consensus       407 ----~~p~~~s----~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf  447 (576)
T 2acx_A          407 ----EYSERFS----PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL  447 (576)
T ss_dssp             ----CCCTTSC----HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred             ----cCCccCC----HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence                1112233    3478999999999999999     7899998743

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-44  Score=349.07  Aligned_cols=257  Identities=24%  Similarity=0.311  Sum_probs=203.0

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ..++|++.+.||+|+||.||++... +|+.||||.+.....    .+.+|++++.++ +||||+++++++.  +....++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~l   93 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD--DGKYVYV   93 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE--cCCEEEE
Confidence            3567999999999999999999964 688999999975433    245688888888 7999999999987  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC----CceEEccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN----FHAKVADFGL  248 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgl  248 (443)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||+|||+++   |+||||||+|||+.++    +.+||+|||+
T Consensus        94 v~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           94 VTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999999975    345899999999999999999999999   9999999999998543    3599999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|..||........   ......+......
T Consensus       167 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~~~~  241 (342)
T 2qr7_A          167 AKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EEILARIGSGKFS  241 (342)
T ss_dssp             CEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HHHHHHHHHCCCC
T ss_pred             cccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HHHHHHHccCCcc
Confidence            987644322  22345789999999999988899999999999999999999999975332222   2222222221111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                              +...........+.+++.+||+.||++||++.+++++-+..
T Consensus       242 --------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          242 --------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             --------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             --------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence                    11111112223478999999999999999999999987764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=347.91  Aligned_cols=256  Identities=16%  Similarity=0.167  Sum_probs=203.7

Q ss_pred             HhcCCCCCceeeecCcEEEEEEE------ECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC---CCceeeEEEeeecC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGV------LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSR  165 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  165 (443)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||||+++..   ...++..|+++++.++   |+||+++++++.. 
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-
Confidence            45779999999999999999994      456889999999743   4667888999988886   9999999999874 


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCC-CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-------
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLG-VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-------  237 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------  237 (443)
                       ....++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.       
T Consensus       139 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          139 -QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             -SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred             -CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence             4478999999999999999963211 2346999999999999999999999999   999999999999998       


Q ss_pred             ----CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 013404          238 ----NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE  313 (443)
Q Consensus       238 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~  313 (443)
                          ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......  
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--
Confidence                89999999999976532222233455689999999999999999999999999999999999999995322110  


Q ss_pred             hHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCC-CCHHHHHHHHHHhHhh
Q 013404          314 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR-PTMGEVVQSLKMVQRV  380 (443)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~evl~~L~~~~~~  380 (443)
                                   ..+.    ..+. .++.  ...+.+++..|++.+|.+| |+++++.+.|+.+...
T Consensus       293 -------------~~~~----~~~~-~~~~--~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 -------------CKPE----GLFR-RLPH--LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             -------------EEEC----SCCT-TCSS--HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -------------eeec----hhcc-ccCc--HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                         0011    1111 1111  2346689999999999999 6788888888776543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.8e-44  Score=335.67  Aligned_cols=251  Identities=29%  Similarity=0.421  Sum_probs=201.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||+|... ++..||+|.+....   ......+.+|+.++++++||||+++++++.  +....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   85 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVY   85 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe--cCCEEE
Confidence            467899999999999999999854 57799999985421   223467889999999999999999999987  445889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        86 lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             EEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence            99999999999999864    235899999999999999999999998   99999999999999999999999999865


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .....    .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.....      ......+....     
T Consensus       159 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-----  223 (279)
T 3fdn_A          159 APSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVE-----  223 (279)
T ss_dssp             C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-----
T ss_pred             CCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHhCC-----
Confidence            54322    2345789999999999999999999999999999999999999964321      11111111111     


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                         .    ..+......+.+++.+||+.||++||+++|++++-+.-
T Consensus       224 ---~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          224 ---F----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             ---C----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred             ---C----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence               1    11111223478999999999999999999999986643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=348.61  Aligned_cols=263  Identities=24%  Similarity=0.307  Sum_probs=190.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEeeec------CCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSS------RDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~------~~~  167 (443)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++..........+.+|+.++.++. ||||+++++++..      ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            45789999999999999999996 478999999987655445567899999999996 9999999999842      233


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...+++|||+. |+|.+++..... ...+++.+++.++.|++.||.|||+.+. +|+||||||+|||++.++.+||+|||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEecCc
Confidence            45789999995 799998864211 3458999999999999999999998753 39999999999999999999999999


Q ss_pred             ccccCCCCCccc----------cccccccCccccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 013404          248 LAKQAPEGRTNY----------LSTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN  314 (443)
Q Consensus       248 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~  314 (443)
                      +++.........          ......||+.|+|||++   .+..++.++|||||||++|||++|+.||.......   
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---  260 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---  260 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence            998765432211          01134689999999998   56678999999999999999999999996432110   


Q ss_pred             HHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          315 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                         .    ....      .........+.    .+.+++.+||+.||++||++.|++++|+.+....
T Consensus       261 ---~----~~~~------~~~~~~~~~~~----~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          261 ---I----VNGK------YSIPPHDTQYT----VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ------------------CCCCTTCCSSG----GGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ---h----hcCc------ccCCcccccch----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence               0    0000      00001111222    3678999999999999999999999999887644

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=356.52  Aligned_cols=264  Identities=22%  Similarity=0.270  Sum_probs=206.4

Q ss_pred             HHHHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeec
Q 013404           89 YEELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS  164 (443)
Q Consensus        89 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  164 (443)
                      +.+.....++|++.+.||+|+||.||+++. .+|+.||+|+++...   ......+.+|..++..++||||++++++|. 
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-  131 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-  131 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-
Confidence            344555678999999999999999999996 478999999996421   112345888999999999999999999987 


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA  244 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  244 (443)
                       +....++||||+++|+|.+++...   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+
T Consensus       132 -~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          132 -DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             -eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence             455899999999999999999642   235899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT  317 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~  317 (443)
                      |||+++....... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||.....      ..
T Consensus       205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~  277 (412)
T 2vd5_A          205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AE  277 (412)
T ss_dssp             CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HH
T ss_pred             echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HH
Confidence            9999987654322 1223468999999999987       35789999999999999999999999964321      12


Q ss_pred             HHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCC---CCHHHHHHHHH
Q 013404          318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQR---PTMGEVVQSLK  375 (443)
Q Consensus       318 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~evl~~L~  375 (443)
                      ....+......   ...+.....++.    .+.+++.+||+ +|.+|   |+++||++|-+
T Consensus       278 ~~~~i~~~~~~---~~~p~~~~~~s~----~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf  330 (412)
T 2vd5_A          278 TYGKIVHYKEH---LSLPLVDEGVPE----EARDFIQRLLC-PPETRLGRGGAGDFRTHPF  330 (412)
T ss_dssp             HHHHHHTHHHH---CCCC----CCCH----HHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred             HHHHHHhcccC---cCCCccccCCCH----HHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence            22222221110   111111122333    47899999999 99998   69999988743

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-43  Score=362.28  Aligned_cols=257  Identities=23%  Similarity=0.358  Sum_probs=208.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+++.. +|+.||+|++....   ......+.+|++++++++||||+++++++.  +....++
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~--~~~~l~l  262 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE--TKTDLCL  262 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--eCCEEEE
Confidence            67888899999999999999964 68999999996432   234567889999999999999999999987  4458999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++.........+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999765444556999999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ........+.....     
T Consensus       340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~~-----  410 (543)
T 3c4z_A          340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQAV-----  410 (543)
T ss_dssp             CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCCC-----
T ss_pred             cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhccc-----
Confidence            54332  1234589999999999999999999999999999999999999997543221  12222222222211     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQSL  374 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~L  374 (443)
                             .++......+.+++.+||+.||++||++     ++|++|-
T Consensus       411 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp  450 (543)
T 3c4z_A          411 -------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP  450 (543)
T ss_dssp             -------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred             -------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence                   1122222347899999999999999975     6777653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.6e-43  Score=334.16  Aligned_cols=267  Identities=20%  Similarity=0.299  Sum_probs=207.5

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ..++|++.+.||+|+||.||+|.. .+++.||||.+.....  ...+.+|+++++.++|++++..+.++.. +....+++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC-CCCceEEE
Confidence            457899999999999999999995 5789999998764432  2458889999999999888877776643 44578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe---cCCCceEEccccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAK  250 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~  250 (443)
                      |||+ +++|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+|||+   ++++.+||+|||+++
T Consensus        84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999 99999999732   235899999999999999999999999   9999999999999   788999999999998


Q ss_pred             cCCCCCcc-----ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH-HHHhh
Q 013404          251 QAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA-RPILR  324 (443)
Q Consensus       251 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~  324 (443)
                      ........     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............... .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            76543221     1123467999999999999999999999999999999999999999765444333322221 11111


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      ..  .     +.....++.    .+.+++.+||+.||++||++++|++.|+.+.+...
T Consensus       237 ~~--~-----~~~~~~~~~----~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          237 TP--I-----EVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             SC--H-----HHHTTTSCH----HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ch--h-----hhhhccCCH----HHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            10  0     001112233    48899999999999999999999999999877554

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=333.73  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=183.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||.+....   ....+.+.+|+.++++++||||+++++++.  +....+
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   87 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE--DSNYVY   87 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE--CSSEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc--cCCeEE
Confidence            45789999999999999999996 578999999986431   223467899999999999999999999987  455889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            999999999999999753   346899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .......  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........      ....     .  
T Consensus       162 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-----~--  226 (278)
T 3cok_A          162 LKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVV-----L--  226 (278)
T ss_dssp             CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-----S--
T ss_pred             ccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHh-----h--
Confidence            6433221  22357899999999999989999999999999999999999999754322110      0000     0  


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                       .+......++    ..+.+++.+||+.||++||++++++++-
T Consensus       227 -~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~h~  264 (278)
T 3cok_A          227 -ADYEMPSFLS----IEAKDLIHQLLRRNPADRLSLSSVLDHP  264 (278)
T ss_dssp             -SCCCCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred             -cccCCccccC----HHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence             0111111223    3478999999999999999999998753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.5e-43  Score=340.45  Aligned_cols=258  Identities=25%  Similarity=0.333  Sum_probs=198.0

Q ss_pred             cCCCCC-ceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPA-SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      +.|++. +.||+|+||.||+|.. .+++.||||++..........+.+|++++.++ +||||+++++++..  ....++|
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv   89 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYLV   89 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEEE
Confidence            567774 7899999999999994 57899999999876666678899999999995 79999999999874  4589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc---eEEccccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLAK  250 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~  250 (443)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||+++
T Consensus        90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999964    235899999999999999999999999   999999999999988766   9999999997


Q ss_pred             cCCCCCc-----cccccccccCccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch------
Q 013404          251 QAPEGRT-----NYLSTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN------  314 (443)
Q Consensus       251 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~------  314 (443)
                      .......     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||..........      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            6542211     011123469999999999875     557899999999999999999999997554322110      


Q ss_pred             ---HHHHHHHHhhccccccccccCccCCCCCHH----HHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          315 ---LVTWARPILRDKDRLEELADPRLGGKYPKE----DFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       315 ---~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~----~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                         .......+.....            .++..    ....+.+++.+||+.||++|||+.|++++-+
T Consensus       243 ~~~~~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  298 (316)
T 2ac3_A          243 PACQNMLFESIQEGKY------------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW  298 (316)
T ss_dssp             HHHHHHHHHHHHHCCC------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred             hhHHHHHHHHHhccCc------------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence               0111111111110            11111    1234789999999999999999999998643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.4e-43  Score=358.21  Aligned_cols=265  Identities=21%  Similarity=0.255  Sum_probs=196.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----CC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  168 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....  ....+.+.+|+.+++.++||||+++++++....    ..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            47899999999999999999985 468999999997542  223467889999999999999999999986432    24


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++||||+++ +|.+.+..      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence            67999999976 57777642      3889999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH--------
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR--------  320 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~--------  320 (443)
                      ++......   ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||...+...  .+.....        
T Consensus       211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPE  285 (464)
T ss_dssp             C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHH
T ss_pred             eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence            98765432   2345689999999999999999999999999999999999999997533211  1111000        


Q ss_pred             ----------HHhhcccccc-----ccccCccCCCC---CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          321 ----------PILRDKDRLE-----ELADPRLGGKY---PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       321 ----------~~~~~~~~~~-----~~~d~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                                ..........     ......+....   .......+.+|+.+||+.||++|||++|+++|-+
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  358 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  358 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence                      0000000000     00000000000   0112456889999999999999999999998754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.6e-44  Score=349.66  Aligned_cols=249  Identities=28%  Similarity=0.424  Sum_probs=200.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC---HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      +.|+..+.||+|+||.||+|.. .+|+.||||++.......   .+.+.+|++++++++||||+++++++..  ....++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l  131 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL  131 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEEE
Confidence            4588899999999999999995 578999999997554332   3568899999999999999999999874  448899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||++ |+|.+++...   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus       132 v~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             EEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence            999997 6888888532   345899999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...      ....||+.|+|||++.   ...++.++|||||||++|||++|+.||....      .......+.....  
T Consensus       205 ~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~--  270 (348)
T 1u5q_A          205 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNES--  270 (348)
T ss_dssp             SSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC--
T ss_pred             CCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCC--
Confidence            432      2357999999999984   5678999999999999999999999996432      1112222222110  


Q ss_pred             cccccCcc-CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          330 EELADPRL-GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       330 ~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                           +.. ...++.    .+.+++.+||+.||++|||+++++++.+..
T Consensus       271 -----~~~~~~~~~~----~l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          271 -----PALQSGHWSE----YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             -----CCCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             -----CCCCCCCCCH----HHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence                 111 122333    478999999999999999999999886643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.1e-44  Score=373.59  Aligned_cols=251  Identities=27%  Similarity=0.416  Sum_probs=198.3

Q ss_pred             ceeeecCcEEEEEEEEC---CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      +.||+|+||.||+|.+.   .++.||||+++....  ...++|.+|+++|++++|||||+++++|..   ...++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence            47999999999999753   467899999975432  235789999999999999999999999863   2578999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.+++..    ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       452 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          452 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             CCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            99999999964    345899999999999999999999999   99999999999999999999999999987654332


Q ss_pred             cc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          258 NY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       258 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......      .... .+.....      .
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~-~i~~~~~------~  591 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTA-MLEKGER------M  591 (635)
T ss_dssp             ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHH-HHHTTCC------C
T ss_pred             ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-HHHcCCC------C
Confidence            21 2233457889999999999999999999999999999998 99999643321      1111 1111111      1


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                          ..+......+.+++..||+.||++||++++|++.|+.+...
T Consensus       592 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          592 ----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                11222334588999999999999999999999999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.5e-43  Score=332.49  Aligned_cols=255  Identities=22%  Similarity=0.319  Sum_probs=203.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .++|++.+.||+|+||.||+|... +|+.||+|++......  ..+.+.+|+.++++++||||+++++++.  +....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~   82 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYL   82 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE--cCCEEEE
Confidence            468999999999999999999964 6899999998754322  2356889999999999999999999987  4557899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc---eEEcccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFGLA  249 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla  249 (443)
                      +|||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++
T Consensus        83 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~  155 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA  155 (284)
T ss_dssp             EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence            9999999999998864    345899999999999999999999999   999999999999986655   999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....      ......+.......
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~  226 (284)
T 3kk8_A          156 IEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYDY  226 (284)
T ss_dssp             EECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC
T ss_pred             EEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHHHhccccC
Confidence            87654322   2345799999999999999999999999999999999999999964321      11111111111100


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                         ..+ ....++    ..+.+++.+||+.||++|||+.|++++-+.
T Consensus       227 ---~~~-~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (284)
T 3kk8_A          227 ---PSP-EWDTVT----PEAKSLIDSMLTVNPKKRITADQALKVPWI  265 (284)
T ss_dssp             ---CTT-TTTTSC----HHHHHHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred             ---Cch-hhcccC----HHHHHHHHHHcccChhhCCCHHHHhcCccc
Confidence               000 011223    347899999999999999999999987554

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.6e-44  Score=347.08  Aligned_cols=266  Identities=17%  Similarity=0.212  Sum_probs=197.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC----CCcEEEEEEeccCCCC-----------CHHHHHHHHHHHhhcCCCceeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ-----------GDKEFLVEVEMLSRLHHRNLVKLVG  160 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  160 (443)
                      .++|++.+.||+|+||.||+|...    ++..||+|.+......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999975    5778999998754321           1134667888899999999999999


Q ss_pred             eeec--CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC
Q 013404          161 YYSS--RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN  238 (443)
Q Consensus       161 ~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~  238 (443)
                      ++..  .+....++||||+ +++|.+++...    ..+++.+++.++.|++.||+|||+.+   |+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence            9875  2255789999999 99999999742    36899999999999999999999999   9999999999999987


Q ss_pred             C--ceEEccccccccCCCCCcc-----ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 013404          239 F--HAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG  311 (443)
Q Consensus       239 ~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~  311 (443)
                      +  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... 
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-  266 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-  266 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-
Confidence            7  9999999999866432111     1123457999999999999999999999999999999999999999532211 


Q ss_pred             cchHHHHHHHHhhccccccccccCcc-CCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          312 QENLVTWARPILRDKDRLEELADPRL-GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ..............   +........ ...++.    .+.+++.+||+.||++||++++|++.|+.+
T Consensus       267 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          267 PVAVQTAKTNLLDE---LPQSVLKWAPSGSSCC----EIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHHHT---TTHHHHHHSCTTSCCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             cHHHHHHHHhhccc---ccHHHHhhccccccHH----HHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            11111111111110   100000000 012333    488999999999999999999999988765

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.4e-43  Score=346.99  Aligned_cols=204  Identities=26%  Similarity=0.340  Sum_probs=175.0

Q ss_pred             HHHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-----CCceeeEEEeee
Q 013404           90 EELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----HRNLVKLVGYYS  163 (443)
Q Consensus        90 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~  163 (443)
                      .+.....++|++.+.||+|+||.||+|+. .+++.||||+++.. ......+..|+.+++.+.     ||||+++++++.
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            33344568899999999999999999996 57899999999732 223456788999999986     999999999988


Q ss_pred             cCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC------
Q 013404          164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN------  237 (443)
Q Consensus       164 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~------  237 (443)
                      .  ....++||||+ +++|.+++....  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.      
T Consensus       107 ~--~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          107 Y--YDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             E--TTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred             E--CCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence            4  44889999999 899999997532  235899999999999999999999999   999999999999975      


Q ss_pred             -------------------CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHH
Q 013404          238 -------------------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELL  298 (443)
Q Consensus       238 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ell  298 (443)
                                         ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                               789999999999865432     23457899999999999999999999999999999999


Q ss_pred             hCCCCCCCC
Q 013404          299 TGRKPVDMS  307 (443)
Q Consensus       299 tg~~p~~~~  307 (443)
                      +|+.||...
T Consensus       254 ~g~~pf~~~  262 (360)
T 3llt_A          254 TGSLLFRTH  262 (360)
T ss_dssp             HSSCSCCCS
T ss_pred             HCCCCCCCC
Confidence            999999753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.5e-43  Score=335.16  Aligned_cols=254  Identities=29%  Similarity=0.440  Sum_probs=208.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++..  ....++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEE
Confidence            35688999999999999999985 468999999997554 3345789999999999999999999999874  4478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++++|.+++..     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        99 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             EEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecC
Confidence            999999999999963     35899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+...       .
T Consensus       171 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-------~  235 (303)
T 3a7i_A          171 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLFLIPKN-------N  235 (303)
T ss_dssp             TTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS-------C
T ss_pred             cccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHHHhhcC-------C
Confidence            4321  22345789999999999999999999999999999999999999964321      1111111111       0


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      .+.+...++.    .+.+++.+||+.||++|||+.+++++.+...
T Consensus       236 ~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          236 PPTLEGNYSK----PLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             CCCCCSSCCH----HHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             CCCCccccCH----HHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            1122233343    4789999999999999999999999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=344.33  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=201.7

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--------CHHHHHHHHHHHhhcCCCceeeEEEeeecC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--------GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR  165 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  165 (443)
                      ..++|++.+.||+|+||.||+|.. .+++.||||.++.....        ....+.+|+.++++++||||+++++++.  
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--   99 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE--   99 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence            457899999999999999999995 57889999999765321        2346778999999999999999999987  


Q ss_pred             CCCeeEEEEeecCCC-ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc
Q 013404          166 DSSQHLLCYELVPNG-SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA  244 (443)
Q Consensus       166 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  244 (443)
                      +....++||||+.+| +|.+++...    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~  172 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI  172 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEe
Confidence            455889999999777 999999753    35899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      |||+++.......   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....              
T Consensus       173 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------  235 (335)
T 3dls_A          173 DFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------  235 (335)
T ss_dssp             CCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------
T ss_pred             ecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------
Confidence            9999987654332   234579999999999988877 7899999999999999999999963110              


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                          .......+  ...++    ..+.+++.+||+.||++|||+++++++-+
T Consensus       236 ----~~~~~~~~--~~~~~----~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          236 ----TVEAAIHP--PYLVS----KELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             ----GTTTCCCC--SSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             ----HHhhccCC--CcccC----HHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence                00000000  11123    34789999999999999999999998744

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-43  Score=333.02  Aligned_cols=250  Identities=26%  Similarity=0.376  Sum_probs=204.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|... ++..||+|.+...   .......+.+|++++++++||||+++++++.  +....++
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~l   91 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH--DRKRIYL   91 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE--cCCEEEE
Confidence            57899999999999999999965 6789999998643   1233567899999999999999999999987  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        92 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           92 MLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            9999999999999964    235899999999999999999999999   999999999999999999999999999765


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ....    .....|++.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+....      
T Consensus       165 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~------  228 (284)
T 2vgo_A          165 PSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNVD------  228 (284)
T ss_dssp             SSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC------
T ss_pred             cccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhccc------
Confidence            4322    2345789999999999999999999999999999999999999964321      11112221111      


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                        ......++    ..+.+++.+||+.||++||++++++++-+.-
T Consensus       229 --~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          229 --LKFPPFLS----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             --CCCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             --cCCCCcCC----HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence              11112223    3478999999999999999999999886543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-43  Score=342.78  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=205.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|.+.+.||+|+||.||++... +++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.  +....+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~  117 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--DNDFVF  117 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCCeEE
Confidence            467889999999999999999964 578999999865422   23457889999999999999999999987  445889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++++|.+++..    ...+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       118 lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  190 (335)
T 2owb_A          118 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK  190 (335)
T ss_dssp             EEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence            99999999999999864    245899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....      .......+.....    
T Consensus       191 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~----  258 (335)
T 2owb_A          191 VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEY----  258 (335)
T ss_dssp             CCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCC----
T ss_pred             cccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHhcCCC----
Confidence            643322  1234579999999999999999999999999999999999999996432      1111111111111    


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          .+...++    ..+.+++.+||+.||++||+++|++++-+.
T Consensus       259 ----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~~~~~  295 (335)
T 2owb_A          259 ----SIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFF  295 (335)
T ss_dssp             ----CCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             ----CCCccCC----HHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence                1111223    347889999999999999999999987553

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.2e-44  Score=349.83  Aligned_cols=244  Identities=23%  Similarity=0.308  Sum_probs=190.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC---CCHHHHHHHHHH-HhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEM-LSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+++.. +++.||+|+++....   .....+..|..+ ++.++||||+++++++.  +....
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~--~~~~~  114 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKL  114 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE--CSSEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--eCCEE
Confidence            467999999999999999999964 688999999975432   223456677776 56789999999999987  44589


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++..    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       115 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            999999999999999964    235889999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....      .......+......  
T Consensus       188 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~~--  257 (373)
T 2r5t_A          188 ENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKPLQ--  257 (373)
T ss_dssp             GGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHHHHSCCC--
T ss_pred             ccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcccC--
Confidence            6432221  2345689999999999999999999999999999999999999996432      12222223322111  


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG  368 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  368 (443)
                            +...++    ..+.+++.+||+.||++||++.
T Consensus       258 ------~~~~~~----~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          258 ------LKPNIT----NSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             ------CCSSSC----HHHHHHHHHHTCSSGGGSTTTT
T ss_pred             ------CCCCCC----HHHHHHHHHHcccCHHhCCCCC
Confidence                  111233    3478999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-44  Score=351.92  Aligned_cols=269  Identities=22%  Similarity=0.296  Sum_probs=198.1

Q ss_pred             HHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecC------
Q 013404           93 KEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR------  165 (443)
Q Consensus        93 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  165 (443)
                      ....++|++.+.||+|+||.||+|.. .+|+.||||++.....    ...+|+++++.++||||++++++|...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999995 5789999999875432    234799999999999999999988542      


Q ss_pred             ------------------------------CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHh
Q 013404          166 ------------------------------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL  215 (443)
Q Consensus       166 ------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  215 (443)
                                                    +....++||||++ |+|.+.+.........+++..+..++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                          2334789999998 588877753222245689999999999999999999


Q ss_pred             hhcCCCceEecCCCcccEEec-CCCceEEccccccccCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHH
Q 013404          216 HEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVV  293 (443)
Q Consensus       216 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~i  293 (443)
                      |+.+   |+||||||+|||++ +++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   99999999999997 688999999999987644332   2345789999999998875 48999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc---------cccccccccCccCC-----CCCHHHHHHHHHHHHHccCc
Q 013404          294 LLELLTGRKPVDMSQPSGQENLVTWARPILRD---------KDRLEELADPRLGG-----KYPKEDFIRVCTIAAACVAP  359 (443)
Q Consensus       294 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~d~~~~~-----~~~~~~~~~l~~li~~cl~~  359 (443)
                      +|||++|+.||......  ..+..... ....         ........-+....     .++......+.+++.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~--~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSI--DQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHH--HHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChH--HHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            99999999999743321  11111111 0000         00000110111100     01112233478999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 013404          360 EANQRPTMGEVVQSLK  375 (443)
Q Consensus       360 dp~~RPs~~evl~~L~  375 (443)
                      ||++|||+.|+++|-+
T Consensus       309 dP~~R~t~~e~l~hp~  324 (383)
T 3eb0_A          309 EPDLRINPYEAMAHPF  324 (383)
T ss_dssp             SGGGSCCHHHHHTSGG
T ss_pred             ChhhCCCHHHHhcCHH
Confidence            9999999999998743

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6e-44  Score=337.85  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=198.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+..+..+ +||||+++++++..  ....+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence            467999999999999999999965 789999999976433  2346788999999999 99999999999874  44889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC--------------
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--------------  237 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------------  237 (443)
                      +||||+++|+|.+++.........+++..++.++.|++.||.|||+++   |+||||||+|||++.              
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999999743222245899999999999999999999999   999999999999984              


Q ss_pred             -----CCceEEccccccccCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 013404          238 -----NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG  311 (443)
Q Consensus       238 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~  311 (443)
                           ...+||+|||++.......      ...||+.|+|||.+.+. .++.++|||||||++|||++|..++...    
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----  234 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----  234 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----
Confidence                 4479999999998765432      23589999999999876 6678999999999999999998876421    


Q ss_pred             cchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          312 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                       ...    ..+..  ...     +.+...++.    .+.+++.+||+.||++|||+.|++++-
T Consensus       235 -~~~----~~~~~--~~~-----~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          235 -DQW----HEIRQ--GRL-----PRIPQVLSQ----EFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             -HHH----HHHHT--TCC-----CCCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             -hHH----HHHHc--CCC-----CCCCcccCH----HHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence             111    11111  111     112223333    478999999999999999999999764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.9e-43  Score=337.41  Aligned_cols=261  Identities=18%  Similarity=0.285  Sum_probs=201.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|.. .+++.||||+++.   ...+.+.+|++++++++ ||||+++++++........++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6789999999999999999985 5789999999973   34678999999999997 99999999999865566789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-ceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  253 (443)
                      ||+++++|.+++.       .+++.++..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            9999999999985       2788999999999999999999999   99999999999999766 89999999998765


Q ss_pred             CCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH--------hh
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI--------LR  324 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~  324 (443)
                      ....   .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+.......        +.
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHH
Confidence            4332   234578999999999887 67899999999999999999999999533221 11111111000        00


Q ss_pred             c-c----cccccccc--------CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          325 D-K----DRLEELAD--------PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       325 ~-~----~~~~~~~d--------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      . .    .....+..        .......+......+.+++.+||+.||++|||++|+++|-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp  321 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  321 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence            0 0    00000000        0000111111234588999999999999999999999863

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.2e-43  Score=336.37  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=202.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|.+.+.||+|+||.||+++.. +|+.||+|.++.........+.+|+.++++++||||+++++++.  +....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   85 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE--STTHYYLVM   85 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc--cCCEEEEEE
Confidence            467899999999999999999964 78999999998655445567899999999999999999999987  455889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe---cCCCceEEcccccccc
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAKQ  251 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~  251 (443)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+||++   ++++.+||+|||+++.
T Consensus        86 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           86 QLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            99999999999864    235889999999999999999999999   9999999999999   7889999999999976


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....    ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+.......  
T Consensus       159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~--  226 (304)
T 2jam_A          159 EQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEKIKEGYYEF--  226 (304)
T ss_dssp             CCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHCCCCC--
T ss_pred             cCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCCC--
Confidence            5432    12345689999999999999999999999999999999999999964321      11122222111110  


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                        .......++    ..+.+++.+||+.||++||+++|++++-+
T Consensus       227 --~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (304)
T 2jam_A          227 --ESPFWDDIS----ESAKDFICHLLEKDPNERYTCEKALSHPW  264 (304)
T ss_dssp             --CTTTTTTSC----HHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             --CccccccCC----HHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence              011111223    34889999999999999999999998755

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=341.28  Aligned_cols=266  Identities=22%  Similarity=0.321  Sum_probs=194.5

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC-HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+|++++++++||||+++++++.  +....++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe--eCCEEEEEe
Confidence            57889999999999999999965 78999999997543221 224567999999999999999999987  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||++ |+|.+++...   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        80 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             ECCS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             cccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            9997 5999988643   335899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc--cccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD--RLEE  331 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  331 (443)
                      ...  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....   ...............  ....
T Consensus       153 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~  227 (324)
T 3mtl_A          153 PTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPG  227 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTT
T ss_pred             Ccc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchh
Confidence            322  1234578999999999876 5689999999999999999999999975332   111222211111100  0000


Q ss_pred             cc---------cCccCCC----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          332 LA---------DPRLGGK----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       332 ~~---------d~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ..         .+.....    ........+.+++.+||+.||++|||++|++++-+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  285 (324)
T 3mtl_A          228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF  285 (324)
T ss_dssp             GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence            00         0000000    000112347899999999999999999999987543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.1e-43  Score=330.69  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=200.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC------CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ++|++.+.||+|+||.||++... +|+.||+|.++....      ...+.+.+|+.++++++||||+++++++.  +...
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~   82 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE--NKTD   82 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec--CCCe
Confidence            56889999999999999999965 689999999875432      13578999999999999999999999987  4458


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC----ceEEcc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVAD  245 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~D  245 (443)
                      .++||||+++++|.+++..    ...+++.++..++.|++.||.|||+.+   |+||||||+||+++.++    .+||+|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d  155 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID  155 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence            8999999999999999964    345899999999999999999999999   99999999999998877    899999


Q ss_pred             ccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      ||++........   .....|++.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+...
T Consensus       156 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~  226 (283)
T 3bhy_A          156 FGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QETLTNISAV  226 (283)
T ss_dssp             CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTT
T ss_pred             cccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHHHHHhHhc
Confidence            999987644322   2345689999999999999999999999999999999999999964321      1111111111


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ....    .+......+    ..+.+++.+||+.||++||++.|++++-+
T Consensus       227 ~~~~----~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~h~~  268 (283)
T 3bhy_A          227 NYDF----DEEYFSNTS----ELAKDFIRRLLVKDPKRRMTIAQSLEHSW  268 (283)
T ss_dssp             CCCC----CHHHHTTCC----HHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred             ccCC----cchhcccCC----HHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence            1000    000001122    34789999999999999999999998743

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-43  Score=341.53  Aligned_cols=270  Identities=24%  Similarity=0.314  Sum_probs=197.2

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC-----HHHHHHHHHHHhhcCCCceeeEEEeeecCCC
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-----DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  167 (443)
                      ...++|++.+.||+|+||.||+|.. .+|+.||||.+.......     ...+.+|++++++++||||+++++++.  +.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~   84 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HK   84 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CT
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe--eC
Confidence            3457899999999999999999996 468999999997543211     246889999999999999999999987  44


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++||||+++ +|.+++...   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             CceEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence            578999999976 899988753   345889999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      +++.......  ......||+.|+|||++.+. .++.++|||||||++|||++|..||.....  ...+...........
T Consensus       158 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--~~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          158 LAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPT  233 (346)
T ss_dssp             GGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCC
T ss_pred             cceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHcCCCC
Confidence            9987644322  23445789999999998764 588999999999999999999999864321  111111111100000


Q ss_pred             -ccc---cccccC---ccCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          327 -DRL---EELADP---RLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       327 -~~~---~~~~d~---~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                       ...   ....+.   ......+     ......+.+++.+||+.||++|||++|++++-+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f  295 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  295 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence             000   000000   0000111     1112458899999999999999999999987543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-44  Score=348.98  Aligned_cols=257  Identities=26%  Similarity=0.349  Sum_probs=203.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE----CCCcEEEEEEeccCC----CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD  166 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  166 (443)
                      .++|++.+.||+|+||.||+++.    .+|+.||||+++...    ......+.+|+++++++ +||||+++++++..  
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--  130 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  130 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence            35799999999999999999996    378999999986432    23345677899999999 69999999999874  


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccc
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADF  246 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  246 (443)
                      ....++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred             CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence            4478999999999999999964    235899999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCccccccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      |+++....... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........  ..........
T Consensus       204 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~  280 (355)
T 1vzo_A          204 GLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK  280 (355)
T ss_dssp             SEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH
T ss_pred             CCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhc
Confidence            99986643222 12334579999999999985  3578999999999999999999999975433222  2222222221


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHHHH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSLKM  376 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L~~  376 (443)
                      ..        +.    ++......+.+++.+||+.||++||     +++|++++.+.
T Consensus       281 ~~--------~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          281 SE--------PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             CC--------CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             cC--------CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence            11        11    1222223478999999999999999     99999988654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=344.44  Aligned_cols=267  Identities=15%  Similarity=0.194  Sum_probs=207.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC---------CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceee---------
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD---------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK---------  157 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  157 (443)
                      .++|++.+.||+|+||.||+|....         ++.||+|.+...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999999653         789999998743     46889999999999999988         


Q ss_pred             ------EEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcc
Q 013404          158 ------LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKAS  231 (443)
Q Consensus       158 ------l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~  231 (443)
                            +++++.. +....++||||+ +++|.+++....  ...+++.+++.++.|++.||.|||+++   |+||||||+
T Consensus       116 ~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~  188 (352)
T 2jii_A          116 LLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE  188 (352)
T ss_dssp             TCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred             ccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence                  5666653 345789999999 999999997431  356999999999999999999999999   999999999


Q ss_pred             cEEecCCC--ceEEccccccccCCCCCcc-----ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 013404          232 NILLENNF--HAKVADFGLAKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPV  304 (443)
Q Consensus       232 NIll~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~  304 (443)
                      |||++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999998  9999999999866432211     1123357999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcchHHHHHHHHhhccccccccccCccC-CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhhh
Q 013404          305 DMSQPSGQENLVTWARPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIE  382 (443)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~  382 (443)
                      ...... ...+..........   ...+.+.... ..++    ..+.+++.+||+.||++||++++|++.|+.+.+...
T Consensus       269 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          269 TNCLPN-TEDIMKQKQKFVDK---PGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GGGTTC-HHHHHHHHHHHHHS---CCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccCCcC-HHHHHHHHHhccCC---hhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            754322 12222222222111   1111111110 1223    348899999999999999999999999999876654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2e-43  Score=353.03  Aligned_cols=256  Identities=24%  Similarity=0.331  Sum_probs=193.5

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--------CCCHHHHHHHHHHHhhcCCCceeeEEEeeec
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--------QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS  164 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  164 (443)
                      ...++|.+.+.||+|+||.||+|.. .+++.||||++....        ......+.+|+++|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4568999999999999999999995 468999999986431        1112358899999999999999999999852


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC---Cce
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHA  241 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~  241 (443)
                         ...++||||+++|+|.+++..    ...+++.++..++.|++.||+|||+++   |+||||||+|||++.+   +.+
T Consensus       212 ---~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~  281 (419)
T 3i6u_A          212 ---EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI  281 (419)
T ss_dssp             ---SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCE
T ss_pred             ---CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceE
Confidence               357899999999999999864    345899999999999999999999999   9999999999999754   459


Q ss_pred             EEccccccccCCCCCccccccccccCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 013404          242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~  318 (443)
                      ||+|||+++......   ......||+.|+|||++.+   ..++.++|||||||++|||++|+.||.......  .+...
T Consensus       282 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~  356 (419)
T 3i6u_A          282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ  356 (419)
T ss_dssp             EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH
T ss_pred             EEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH
Confidence            999999998765432   2344679999999999863   678899999999999999999999997433221  11111


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..   ......    .+.....+    ...+.+++.+||+.||++||+++|++++-+
T Consensus       357 i~---~~~~~~----~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  402 (419)
T 3i6u_A          357 IT---SGKYNF----IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALRHPW  402 (419)
T ss_dssp             HH---TTCCCC----CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             Hh---cCCCCC----Cchhhccc----CHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence            11   110000    00000112    234789999999999999999999998744

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9e-44  Score=359.77  Aligned_cols=197  Identities=25%  Similarity=0.385  Sum_probs=154.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecC---CCCe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~  169 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++......  ..+.+.+|+++|++++||||+++++++...   ....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999995 47899999999754322  246788999999999999999999998543   2246


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+ +|+|.+++..    ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence            89999998 5799999974    345899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCcc-------------------------ccccccccCccccccccc-ccCCCCchhhHHHHHHHHHHHHhC
Q 013404          250 KQAPEGRTN-------------------------YLSTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTG  300 (443)
Q Consensus       250 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~G~il~elltg  300 (443)
                      +........                         ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            876432110                         112345789999999976 566799999999999999999993

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.7e-43  Score=340.59  Aligned_cols=261  Identities=21%  Similarity=0.272  Sum_probs=202.6

Q ss_pred             HHHHHhcCCCCC-ceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecC
Q 013404           91 ELKEATNNFEPA-SILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR  165 (443)
Q Consensus        91 ~~~~~~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  165 (443)
                      ......+.|.+. +.||+|+||.||+|... +|+.||+|.+....  ......+.+|+.++..+ .||||+++++++.  
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--   99 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE--   99 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE--
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE--
Confidence            334455667776 88999999999999964 68999999987543  23357899999999999 5799999999987  


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceE
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAK  242 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~k  242 (443)
                      +....++||||+++|+|.+++....  ...+++.+++.++.|++.||+|||+.+   |+||||||+|||++.   ++.+|
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            4558899999999999999986432  346899999999999999999999999   999999999999987   78999


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI  322 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~  322 (443)
                      |+|||+++.......   .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....      ......+
T Consensus       175 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i  245 (327)
T 3lm5_A          175 IVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN------QETYLNI  245 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH
T ss_pred             EeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHH
Confidence            999999987654322   2345799999999999999999999999999999999999999964321      1111111


Q ss_pred             hhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       323 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .......    .......++    ..+.+++.+||+.||++|||+++++++-+
T Consensus       246 ~~~~~~~----~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          246 SQVNVDY----SEETFSSVS----QLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             HHTCCCC----CTTTTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             Hhccccc----CchhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence            1111000    011111222    34789999999999999999999998743

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5e-43  Score=333.35  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC---CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ---QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|.+.+.||+|+||.||++... +++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++.  +....+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~   91 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE--DNDFVF   91 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec--cCCEEE
Confidence            357889999999999999999965 578999999865432   22456889999999999999999999987  445889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++++|.+++..    ...+++.+++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        92 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  164 (294)
T 2rku_A           92 VVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK  164 (294)
T ss_dssp             EEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCcee
Confidence            99999999999999864    235899999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      ......+.....    
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~----  232 (294)
T 2rku_A          165 VEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKKNEY----  232 (294)
T ss_dssp             CCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC----
T ss_pred             cccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhhccC----
Confidence            643222  12345789999999999998999999999999999999999999964321      111111111110    


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          .+...++    ..+.+++.+||+.||++||+++|++++.+.
T Consensus       233 ----~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          233 ----SIPKHIN----PVAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             ----CCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             ----CCccccC----HHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence                1111223    347899999999999999999999987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.1e-43  Score=352.16  Aligned_cols=201  Identities=26%  Similarity=0.384  Sum_probs=166.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCC---Ce
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS---SQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~  169 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++......  ..+.+.+|+++|++++||||+++++++...+.   ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999995 46889999999754322  24678999999999999999999999864322   46


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||++ |+|.+++..    ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999996 599999974    345899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCcc--------------------ccccccccCccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 013404          250 KQAPEGRTN--------------------YLSTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVLLELLTGRKPV  304 (443)
Q Consensus       250 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~G~il~elltg~~p~  304 (443)
                      +........                    ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            876443211                    112456899999999986 5667999999999999999999865554

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.9e-43  Score=335.04  Aligned_cols=259  Identities=21%  Similarity=0.278  Sum_probs=197.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC---HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||++... +++.||+|.+.......   .+.+.+|+.++++++||||+++++++..  ....+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~  110 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY  110 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence            478999999999999999999964 68899999997543322   3678899999999999999999999874  44889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|||+++++|.+++..    ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       111 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             EEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             EEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            99999999999999974    235899999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....      . ..............
T Consensus       184 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~-~~~~~~~~~~~~~~  255 (309)
T 2h34_A          184 TTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------S-VMGAHINQAIPRPS  255 (309)
T ss_dssp             --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------H-HHHHHHHSCCCCGG
T ss_pred             ccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------H-HHHHHhccCCCCcc
Confidence            6443221 12345789999999999999999999999999999999999999964321      1 11111111110000


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHhHh
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQR  379 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~~  379 (443)
                          .....++.    .+.+++.+||+.||++|| +++++++.|+.+..
T Consensus       256 ----~~~~~~~~----~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          256 ----TVRPGIPV----AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             ----GTSTTCCT----HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             ----ccCCCCCH----HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence                11122333    478999999999999999 99999998887643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.8e-44  Score=345.63  Aligned_cols=264  Identities=21%  Similarity=0.297  Sum_probs=191.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ..++|++.+.||+|+||.||+|.. .+++.||||+++.....  ....+.+|++++++++||||+++++++..  ....+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~  109 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLH  109 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEE
Confidence            456899999999999999999995 47899999999755332  24567899999999999999999999874  45889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe-----cCCCceEEccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL-----ENNFHAKVADF  246 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~Df  246 (443)
                      +||||++ |+|.+++...    ..+++..+..++.|++.||+|||+++   |+||||||+|||+     ++++.+||+||
T Consensus       110 lv~e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence            9999997 5999999743    35899999999999999999999999   9999999999999     45566999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      |+++.......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......  ..+...... ...
T Consensus       182 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~-~~~  256 (329)
T 3gbz_A          182 GLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEV-LGL  256 (329)
T ss_dssp             THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHH-HCC
T ss_pred             CCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHH-hCC
Confidence            99987643322  12345789999999999875 5899999999999999999999999643211  111111111 000


Q ss_pred             cc--ccc------ccc--cCccCCCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          326 KD--RLE------ELA--DPRLGGKY-----PKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       326 ~~--~~~------~~~--d~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..  ...      ...  .+......     +......+.+++.+||+.||++|||++|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            00  000      000  00000000     00012357899999999999999999999976

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.7e-43  Score=343.59  Aligned_cols=274  Identities=23%  Similarity=0.296  Sum_probs=200.9

Q ss_pred             CHHHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC-----------HHHHHHHHHHHhhcCCCcee
Q 013404           88 AYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-----------DKEFLVEVEMLSRLHHRNLV  156 (443)
Q Consensus        88 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv  156 (443)
                      ...++....++|++.+.||+|+||.||+|...+|..||||++.......           .+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4567888899999999999999999999998889999999986532221           26789999999999999999


Q ss_pred             eEEEeeecC---CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          157 KLVGYYSSR---DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       157 ~l~~~~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                      ++++++...   .....++||||++ |+|.+++...   ...+++..+..++.|++.||.|||+.+   |+||||||+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            999988542   3346799999997 6898888743   346899999999999999999999999   99999999999


Q ss_pred             EecCCCceEEccccccccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCc
Q 013404          234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ  312 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~  312 (443)
                      |++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--  240 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--  240 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred             EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--
Confidence            99999999999999997544322   1234578999999999877 67899999999999999999999999743311  


Q ss_pred             chHHHHHHHHhhccc----------cccccccCccC---CC----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          313 ENLVTWARPILRDKD----------RLEELADPRLG---GK----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       313 ~~~~~~~~~~~~~~~----------~~~~~~d~~~~---~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                       ..............          ...........   ..    ........+.+++.+||+.||++|||+.|++++-
T Consensus       241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  318 (362)
T 3pg1_A          241 -NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHP  318 (362)
T ss_dssp             -HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             -HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCc
Confidence             11111110000000          00000000000   00    0011123478999999999999999999999863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=334.29  Aligned_cols=253  Identities=24%  Similarity=0.421  Sum_probs=197.4

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      +|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++..  ....++||||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~  100 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFMEQ  100 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEEEe
Confidence            445556999999999999995 5688999999987665566789999999999999999999999874  4478999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEccccccccCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~  255 (443)
                      +++++|.+++..... ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++. ++.+||+|||+++.....
T Consensus       101 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          101 VPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             CCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            999999999975322 235678899999999999999999999   999999999999987 899999999999876442


Q ss_pred             CccccccccccCcccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ..  ......|++.|+|||++.+..  ++.++||||||+++|||++|+.||......   ....+......        .
T Consensus       177 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~--------~  243 (295)
T 2clq_A          177 NP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMFK--------V  243 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHHHHHC--------C
T ss_pred             CC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhhcccc--------c
Confidence            21  123457899999999987653  789999999999999999999999632211   11111100000        1


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .+.+...++    ..+.+++.+||+.||++||++.+++++
T Consensus       244 ~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          244 HPEIPESMS----AEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCCCCTTSC----HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             cccccccCC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            112222233    347899999999999999999999976

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-43  Score=343.88  Aligned_cols=258  Identities=24%  Similarity=0.360  Sum_probs=194.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCC----C
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~  168 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++......  ..+.+.+|+++++.++||||+++++++.....    .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999996 57899999999654322  23578899999999999999999999864321    3


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++||||+ +++|.+++..     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence            569999999 8899999973     35889999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ++.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..      .....+.....
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~l~~i~~~~g  243 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL------DQLKEIMKVTG  243 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHC
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcC
Confidence            9876432     234578999999999887 68999999999999999999999999743321      11111111000


Q ss_pred             c--------------------ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          328 R--------------------LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       328 ~--------------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      .                    +.......+. .........+.+++.+||+.||++|||++|+++|-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp  309 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP  309 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcCh
Confidence            0                    0000000000 00111223478999999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.1e-43  Score=340.76  Aligned_cols=267  Identities=23%  Similarity=0.357  Sum_probs=200.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .++|++.+.||+|+||.||+|... +|+.||||++.......  .+.+.+|+.++++++||||+++++++.  +....++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~l  101 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK--KKKRWYL  101 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--ETTEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee--cCCEEEE
Confidence            357899999999999999999964 58999999987554332  345789999999999999999999987  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       102 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A          102 VFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            9999999999988754    235899999999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHH----------H
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR----------P  321 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~----------~  321 (443)
                      .....  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......  .+.....          .
T Consensus       175 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          175 AAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHH
T ss_pred             cCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhh
Confidence            44322  22345789999999999875 78999999999999999999999997543211  1111110          0


Q ss_pred             HhhccccccccccCccCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          322 ILRDKDRLEELADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .+...........+......+.     .....+.+++.+||+.||++|||++|++++-+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  309 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF  309 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCch
Confidence            1111111111111111111111     12345889999999999999999999998754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-42  Score=339.55  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=204.0

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC--------HHHHHHHHHHHhhc-CCCceeeEEE
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRL-HHRNLVKLVG  160 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l-~h~niv~l~~  160 (443)
                      ......++|++.+.||+|+||.||+|... +|+.||||++.......        .+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999975 79999999987553211        34678899999999 7999999999


Q ss_pred             eeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc
Q 013404          161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH  240 (443)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~  240 (443)
                      ++.  .....++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.
T Consensus       168 ~~~--~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          168 SYE--SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEE--BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEe--eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            987  44588999999999999999964    245899999999999999999999999   999999999999999999


Q ss_pred             eEEccccccccCCCCCccccccccccCccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 013404          241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN  314 (443)
Q Consensus       241 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~  314 (443)
                      +||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....     
T Consensus       239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----  310 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-----  310 (365)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred             EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----
Confidence            99999999987654322   234679999999998863      3588899999999999999999999964321     


Q ss_pred             HHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          315 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                       ......+........   .+.. ...+    ..+.+++.+||+.||++||++.|++++-
T Consensus       311 -~~~~~~i~~~~~~~~---~~~~-~~~~----~~~~~li~~~L~~dP~~Rps~~ell~hp  361 (365)
T 2y7j_A          311 -ILMLRMIMEGQYQFS---SPEW-DDRS----STVKDLISRLLQVDPEARLTAEQALQHP  361 (365)
T ss_dssp             -HHHHHHHHHTCCCCC---HHHH-SSSC----HHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             -HHHHHHHHhCCCCCC---Cccc-ccCC----HHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence             111111111110000   0000 1112    3478999999999999999999999863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.5e-43  Score=333.74  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=198.0

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecC--CCCeeEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQHLL  172 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~~l  172 (443)
                      .|.+.+.||+|+||.||+|.. .++..||+|.+.....  ...+.+.+|+.++++++||||+++++++...  +....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            467788999999999999996 4678999999875432  2345789999999999999999999987642  3456889


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec-CCCceEEcccccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQ  251 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~  251 (443)
                      ||||+++|+|.+++..    ...+++..++.++.|++.||.|||+.+. +|+||||||+|||++ +++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCCC-CEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999964    2458899999999999999999998863 399999999999997 789999999999976


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      .....    .....||+.|+|||++. ..++.++||||||+++|+|++|+.||.....     ........... ...  
T Consensus       182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~-~~~--  248 (290)
T 1t4h_A          182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSG-VKP--  248 (290)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTT-CCC--
T ss_pred             ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHHHhcc-CCc--
Confidence            54332    23457999999999876 4589999999999999999999999964321     11222211111 000  


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                         .......+    ..+.+++.+||+.||++|||++|++++-
T Consensus       249 ---~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~h~  284 (290)
T 1t4h_A          249 ---ASFDKVAI----PEVKEIIEGCIRQNKDERYSIKDLLNHA  284 (290)
T ss_dssp             ---GGGGGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             ---cccCCCCC----HHHHHHHHHHccCChhhCCCHHHHhhCc
Confidence               01111122    2478999999999999999999999763

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-42  Score=326.92  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=195.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|.+.+.||+|+||.||+|... +|+.||||.+...   .....+.+.+|+.+++.++||||+++++++.  +....+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~   87 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS--TPTDFF   87 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe--cCCeEE
Confidence            367899999999999999999975 7899999998643   2234567899999999999999999999987  445889


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++..
T Consensus        88 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             EEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccc
Confidence            99999999999999964    235889999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ......   .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....      .......+.....   
T Consensus       161 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~---  228 (276)
T 2h6d_A          161 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKKIRGGVF---  228 (276)
T ss_dssp             CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC---
T ss_pred             cCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcCcc---
Confidence            654321   234578999999999988765 689999999999999999999996422      1111111111110   


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                           .....++    ..+.+++.+||+.||++|||++|++++-+
T Consensus       229 -----~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          229 -----YIPEYLN----RSVATLLMHMLQVDPLKRATIKDIREHEW  264 (276)
T ss_dssp             -----CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             -----cCchhcC----HHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence                 0111222    34789999999999999999999998754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.4e-44  Score=351.85  Aligned_cols=247  Identities=14%  Similarity=0.198  Sum_probs=190.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHH---HHHhhcCCCceeeEE-------Ee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEV---EMLSRLHHRNLVKLV-------GY  161 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  161 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+   +++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999995 57999999999743   233457789999   555566899999988       55


Q ss_pred             eecCCC----------C-----eeEEEEeecCCCChhHhhcCCC---CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCce
Q 013404          162 YSSRDS----------S-----QHLLCYELVPNGSLESWLHGPL---GVNCHLDWETRMKIALDAARGLAYLHEDSQPCV  223 (443)
Q Consensus       162 ~~~~~~----------~-----~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  223 (443)
                      +...+.          .     ..+++|||+ +|+|.+++....   .....+++..++.++.||+.||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            543211          0     378999999 689999996421   11223446888999999999999999999   9


Q ss_pred             EecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccC-----------CCCchhhHHHHHH
Q 013404          224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGV  292 (443)
Q Consensus       224 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~S~G~  292 (443)
                      +||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     1234567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 013404          293 VLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ  372 (443)
Q Consensus       293 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~  372 (443)
                      ++|||++|+.||........                ...+...  ...++.    .+.+++.+||+.||++||++.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~----------------~~~~~~~--~~~~~~----~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG----------------SEWIFRS--CKNIPQ----PVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CC----------------SGGGGSS--CCCCCH----HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccc----------------hhhhhhh--ccCCCH----HHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999964332211                1111110  123333    4789999999999999999999998


Q ss_pred             HH
Q 013404          373 SL  374 (443)
Q Consensus       373 ~L  374 (443)
                      +-
T Consensus       360 hp  361 (377)
T 3byv_A          360 TP  361 (377)
T ss_dssp             SH
T ss_pred             Ch
Confidence            63

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.7e-43  Score=355.85  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=205.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .++|++.+.||+|+||.||++... +|+.||||++....   ......+.+|+.++++++||||+++++++.  +....+
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~  102 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE--DKGYFY  102 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCEEE
Confidence            457999999999999999999965 78999999986543   334678999999999999999999999987  455899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe---cCCCceEEccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGL  248 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgl  248 (443)
                      +||||+.+|+|.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+
T Consensus       103 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  175 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL  175 (484)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred             EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence            99999999999999974    345899999999999999999999999   9999999999999   5678999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ++.......   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....      ......+......
T Consensus       176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~  245 (484)
T 3nyv_A          176 STHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDILKKVEKGKYT  245 (484)
T ss_dssp             HHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC
T ss_pred             eEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCC
Confidence            987654332   234579999999999876 689999999999999999999999974321      1112222211111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ..   .+.     .......+.+++.+||+.||++|||+.|+++|-+.-
T Consensus       246 ~~---~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~  286 (484)
T 3nyv_A          246 FE---LPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ  286 (484)
T ss_dssp             CC---SGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             CC---Ccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence            00   000     011223478999999999999999999999986643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-43  Score=337.28  Aligned_cols=259  Identities=29%  Similarity=0.446  Sum_probs=196.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC--CCc--EEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS--DGT--AVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||+|.+.  +++  .||||.++...   ....+.+.+|++++++++||||+++++++...   
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence            357899999999999999999853  333  68999987542   22346789999999999999999999998642   


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           94 PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccc
Confidence            478999999999999999642   245899999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          249 AKQAPEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       249 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      ++......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||.....      ......+....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~  241 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEG  241 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSC
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccC
Confidence            98765443221 2234567889999999999899999999999999999999 9999964321      12222222211


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      ...      .....++    ..+.+++.+||+.||++||++.++++.|+.++.
T Consensus       242 ~~~------~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          242 ERL------PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCC------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCC------CCCcCcC----HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            111      1112233    358899999999999999999999999987753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-42  Score=339.63  Aligned_cols=269  Identities=20%  Similarity=0.298  Sum_probs=201.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCC------C
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------S  167 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  167 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++.....  .....+.+|+++++.++||||+++++++....      .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5799999999999999999996 5789999999865432  23457889999999999999999999987533      3


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...++||||+++ +|.+.+...   ...+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            468999999975 888877643   245899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCcc--ccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          248 LAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       248 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      +++........  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......   ...........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~  246 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLCG  246 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Confidence            99876432211  12234578999999999876 46899999999999999999999999753321   11111111111


Q ss_pred             cc-c-cccccccC--------ccCCCCC-HHH------HHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          325 DK-D-RLEELADP--------RLGGKYP-KED------FIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       325 ~~-~-~~~~~~d~--------~~~~~~~-~~~------~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .. . ......+.        ....... .+.      ...+.+|+.+||+.||++|||++|++++-+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  314 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF  314 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence            00 0 00000000        0000000 011      134789999999999999999999998743

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-43  Score=349.34  Aligned_cols=259  Identities=12%  Similarity=0.070  Sum_probs=183.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC---CHHHHHHHHHHHhhc--CCCceeeEE-------Eee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRL--HHRNLVKLV-------GYY  162 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l--~h~niv~l~-------~~~  162 (443)
                      ..+|.+.+.||+|+||.||+|... +|+.||||++......   ..+.+.+|+.+++.|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999964 7899999999865432   234577886555555  699988855       333


Q ss_pred             ecCCC---------------CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHH------HHHHHHHHHHHHHhhhcCCC
Q 013404          163 SSRDS---------------SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR------MKIALDAARGLAYLHEDSQP  221 (443)
Q Consensus       163 ~~~~~---------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~  221 (443)
                      .....               ...++||||++ |+|.+++...   ...+.+..+      +.++.||+.||+|||+++  
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            22111               34799999998 8999999743   223455666      788899999999999999  


Q ss_pred             ceEecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHh
Q 013404          222 CVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLT  299 (443)
Q Consensus       222 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~ellt  299 (443)
                       |+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence             999999999999999999999999999876432     113467799999999987  689999999999999999999


Q ss_pred             CCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          300 GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       300 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      |+.||....+......        . .......................+.+++.+||+.||++|||+.+++++-+
T Consensus       289 g~~Pf~~~~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  355 (371)
T 3q60_A          289 LFLPFGLVTPGIKGSW--------K-RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE  355 (371)
T ss_dssp             SSCSTTBCCTTCTTCC--------C-BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred             CCCCCCCcCcccccch--------h-hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence            9999975543221100        0 00000000111111111122335889999999999999999999998644

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-43  Score=353.58  Aligned_cols=267  Identities=24%  Similarity=0.307  Sum_probs=196.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecC----CCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~~~  171 (443)
                      .+|++.+.||+|+||.||+|+.. +|+.||||++....    ..+.+|+++|++++||||++++++|...    +....+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999974 68999999986432    2234799999999999999999987532    222467


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-CceEEccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAK  250 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~  250 (443)
                      +||||+++ +|.+.+.........+++..+..++.||++||+|||+.+   |+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 676665422122456899999999999999999999999   9999999999999954 678999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh------
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL------  323 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~------  323 (443)
                      .......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....  ...+......+-      
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCHHH
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHHH
Confidence            7644322   2345789999999998765 789999999999999999999999975331  122222221100      


Q ss_pred             --hccccccccccCccCCC-----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          324 --RDKDRLEELADPRLGGK-----YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       324 --~~~~~~~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                        ...........+.+...     ++......+.+|+.+||+.||++||++.|+++|-+.
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence              00001111111111100     111122458899999999999999999999987543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.6e-44  Score=349.44  Aligned_cols=269  Identities=24%  Similarity=0.347  Sum_probs=202.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||++... ++..||+|++..... ...+.+.+|+.++++++||||+++++++..  ....++|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEEE
Confidence            357899999999999999999965 689999999976532 224678999999999999999999999874  4578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++...
T Consensus       110 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             ECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            999999999999964    23588999999999999999999985 8   999999999999999999999999998754


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH---------------
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT---------------  317 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~---------------  317 (443)
                      ...    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............               
T Consensus       183 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          183 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             ccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            221    1234579999999999999999999999999999999999999996432111000000               


Q ss_pred             -------HHHHHhhccc----cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          318 -------WARPILRDKD----RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       318 -------~~~~~~~~~~----~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                             +.........    .+..+................+.+++.+||+.||++|||++|+++|-+.-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  329 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  329 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence                   0000000000    00000000000000111123488999999999999999999999986644

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-42  Score=354.81  Aligned_cols=254  Identities=24%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .+.|++.+.||+|+||.||+|+.. ++..||+|.+....  ......+.+|+.+++.++||||++++++|.  +....++
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l  113 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE--DKRNYYL  113 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence            456999999999999999999964 78899999997543  233567899999999999999999999997  4558899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceEEcccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFGLA  249 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla  249 (443)
                      ||||+++|+|.+++..    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       114 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a  186 (494)
T 3lij_A          114 VMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS  186 (494)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence            9999999999998864    245899999999999999999999999   999999999999976   455999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      +.......   .....||+.|+|||++. ..++.++|||||||++|+|++|+.||.....      ......+.......
T Consensus       187 ~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~  256 (494)
T 3lij_A          187 AVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKVEKGKYTF  256 (494)
T ss_dssp             EECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC
T ss_pred             eECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC
Confidence            87654322   24457999999999876 5689999999999999999999999964321      12222222211111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                         ..+.. ..++    ..+.+++.+||+.||++|||+.|++++-+.
T Consensus       257 ---~~~~~-~~~s----~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  295 (494)
T 3lij_A          257 ---DSPEW-KNVS----EGAKDLIKQMLQFDSQRRISAQQALEHPWI  295 (494)
T ss_dssp             ---CSGGG-TTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred             ---Cchhc-ccCC----HHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence               00111 1223    347899999999999999999999988554

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-43  Score=336.32  Aligned_cols=258  Identities=24%  Similarity=0.352  Sum_probs=187.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC-H-HHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-D-KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .++|++.+.||+|+||.||++.. .+|+.||+|+++...... . ..+.++...++.++||||+++++++.  +....++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~--~~~~~~l   83 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF--REGDVWI   83 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSSEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee--ccCCEEE
Confidence            46789999999999999999996 578999999997543221 2 23444555678889999999999987  4457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ||||++ |+|.+++.........+++..++.++.|++.||+|||++ +   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            999997 588888754222345699999999999999999999998 8   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCccccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYA----MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ......   .....||+.|+|||++    .+..++.++||||||+++|||++|+.||.....    .... .........
T Consensus       160 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~  231 (290)
T 3fme_A          160 LVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----PFQQ-LKQVVEEPS  231 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----HHHH-HHHHHHSCC
T ss_pred             cccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----hHHH-HHHHhccCC
Confidence            644322   2334799999999996    566789999999999999999999999964221    1111 111111110


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                        .    ......++    ..+.+++.+||+.||++|||+.|++++-+.-
T Consensus       232 --~----~~~~~~~~----~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~  271 (290)
T 3fme_A          232 --P----QLPADKFS----AEFVDFTSQCLKKNSKERPTYPELMQHPFFT  271 (290)
T ss_dssp             --C----CCCTTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             --C----CcccccCC----HHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence              0    00111223    3478999999999999999999999876543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.2e-43  Score=345.99  Aligned_cols=267  Identities=20%  Similarity=0.238  Sum_probs=204.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC--------CCceeeEEEeeecC-
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH--------HRNLVKLVGYYSSR-  165 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~~-  165 (443)
                      .++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++        |+||+++++++... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36899999999999999999985 56889999999743 223467889999999985        78899999988632 


Q ss_pred             -CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCC----
Q 013404          166 -DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNF----  239 (443)
Q Consensus       166 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~----  239 (443)
                       +....++||||+ +++|.+++....  ...+++..++.++.||+.||+|||++ +   |+||||||+|||++.++    
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence             344789999999 567766664321  24589999999999999999999998 8   99999999999999775    


Q ss_pred             ---------------------------------------------ceEEccccccccCCCCCccccccccccCccccccc
Q 013404          240 ---------------------------------------------HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE  274 (443)
Q Consensus       240 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE  274 (443)
                                                                   .+||+|||+++.....     .....||+.|+|||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence                                                         7999999999876432     23457899999999


Q ss_pred             ccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc-----------cccccccC--------
Q 013404          275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-----------RLEELADP--------  335 (443)
Q Consensus       275 ~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~d~--------  335 (443)
                      ++.+..++.++|||||||++|||++|+.||.................+.....           ........        
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            99999999999999999999999999999976554332221111111111000           00000000        


Q ss_pred             --c---------cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          336 --R---------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       336 --~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                        .         -....+......+.+|+.+||+.||++|||++|+++|-
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  393 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP  393 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSG
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCc
Confidence              0         00123566677899999999999999999999999763

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5e-43  Score=334.34  Aligned_cols=265  Identities=28%  Similarity=0.425  Sum_probs=185.8

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ..++|++.+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++++++||||+++++++..  ....++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l   90 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWL   90 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES--SSCEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEE
Confidence            357899999999999999999984 478999999987543 2334678899999999999999999999874  447899


Q ss_pred             EEeecCCCChhHhhcCC----CCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          173 CYELVPNGSLESWLHGP----LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ||||+++++|.+++...    ......+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999998521    112345899999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCc---cccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          249 AKQAPEGRT---NYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       249 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      +........   ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......   ..  ......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~--~~~~~~  242 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VL--MLTLQN  242 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH--HHHHTS
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HH--HHHhcc
Confidence            976543221   111234579999999999876 568999999999999999999999997543221   11  111111


Q ss_pred             ccccc-cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 DKDRL-EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 ~~~~~-~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..... ....++.....++.    .+.+++.+||+.||++||++.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGK----SFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             SCCCTTC-----CCCCCCCH----HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCccccccccchhhhhhhH----HHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11111 11111222223333    47899999999999999999999976

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=342.07  Aligned_cols=261  Identities=28%  Similarity=0.462  Sum_probs=200.1

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC--
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD--  166 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--  166 (443)
                      ++....++|++.+.||+|+||.||+|.. .+|+.||||.+.... .....+.+|+.+++++ +||||+++++++....  
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            3444568899999999999999999996 578999999987543 3457889999999999 7999999999987532  


Q ss_pred             --CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc
Q 013404          167 --SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA  244 (443)
Q Consensus       167 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  244 (443)
                        ....++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence              457899999999999999997432  346889999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      |||++........  ......||+.|+|||++.     +..++.++|||||||++|||++|+.||.....      ....
T Consensus       172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~  243 (326)
T 2x7f_A          172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRAL  243 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHH
T ss_pred             eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHH
Confidence            9999986543221  123457899999999987     56788999999999999999999999964321      1111


Q ss_pred             HHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..+....  ....    ....++.    .+.+++.+||+.||++||++++++++-+
T Consensus       244 ~~~~~~~--~~~~----~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~hp~  289 (326)
T 2x7f_A          244 FLIPRNP--APRL----KSKKWSK----KFQSFIESCLVKNHSQRPATEQLMKHPF  289 (326)
T ss_dssp             HHHHHSC--CCCC----SCSCSCH----HHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred             HHhhcCc--cccC----CccccCH----HHHHHHHHHhccChhhCCCHHHHhhChH
Confidence            1111111  0000    1122333    4789999999999999999999998643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.4e-42  Score=353.59  Aligned_cols=255  Identities=25%  Similarity=0.352  Sum_probs=202.3

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC--CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ..++|++.+.||+|+||.||++... +++.||||++...  .......+.+|++++++++||||+++++++.  +....+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~   97 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE--DSSSFY   97 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE--cCCEEE
Confidence            3467999999999999999999964 7899999998643  2334678999999999999999999999987  455899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec---CCCceEEccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGL  248 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgl  248 (443)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++   .++.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            99999999999998864    245899999999999999999999999   99999999999995   456799999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ++.......   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....      ......+......
T Consensus       171 a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~  240 (486)
T 3mwu_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYA  240 (486)
T ss_dssp             TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC
T ss_pred             CeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC
Confidence            986654322   234579999999999876 589999999999999999999999964321      1122222211111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ..   .+.     .......+.+++.+||+.||++|||+.|++++-+.
T Consensus       241 ~~---~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~  280 (486)
T 3mwu_A          241 FD---LPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI  280 (486)
T ss_dssp             SC---SGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred             CC---Ccc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence            00   000     01112347899999999999999999999998654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-42  Score=341.00  Aligned_cols=268  Identities=24%  Similarity=0.314  Sum_probs=201.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCC---CCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD---SSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~  170 (443)
                      .++|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++....   ....
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999954 6889999999754322 2367899999999999999999999986432   2467


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+. |+|.+++..     ..+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            89999997 599999863     35899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccc-cccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          251 QAPEGRTNY-LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       251 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      ......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........   ............
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~  253 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQ  253 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHHHHHCSCCH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHHHHhCCCCH
Confidence            765332211 1234579999999998754 55899999999999999999999999754432211   111111100000


Q ss_pred             --cccc---------ccCccCCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          329 --LEEL---------ADPRLGGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       329 --~~~~---------~d~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                        +..+         .........+     ......+.+++.+||+.||++|||+.|++++-+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  316 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  316 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence              0000         0000000001     111234789999999999999999999998744

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.2e-42  Score=346.77  Aligned_cols=264  Identities=20%  Similarity=0.293  Sum_probs=205.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc-eeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN-LVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.++||+|+||.||+|.. .+++.||||++.....  ...+..|+++++.++|++ +..+..++.  +....+||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~--~~~~~~lv   81 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV--EGDYNVLV   81 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE--ETTEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe--eCCEEEEE
Confidence            46899999999999999999995 5789999998875433  345889999999998754 445544444  44578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe---cCCCceEEccccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL---ENNFHAKVADFGLAK  250 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~  250 (443)
                      |||+ +++|.+++...   ...+++.+++.++.||+.||+|||+++   |+||||||+||||   +.++.+||+|||+++
T Consensus        82 me~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            9999 99999999742   235899999999999999999999999   9999999999999   688999999999998


Q ss_pred             cCCCCCcc-----ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          251 QAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       251 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      ........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||.....................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            76543321     1122567999999999999999999999999999999999999999765443333222221111000


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                       ..+..+     ...++.    .+.+++..||+.||++||++.+|++.|+.+...
T Consensus       235 -~~~~~l-----~~~~p~----~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          235 -TSIEAL-----CRGYPT----EFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             -SCHHHH-----HTTSCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -ccHHHH-----hcCCcH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence             111111     112333    488999999999999999999999999988653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.2e-42  Score=353.66  Aligned_cols=255  Identities=25%  Similarity=0.329  Sum_probs=201.2

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-------------CCHHHHHHHHHHHhhcCCCceeeEEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-------------QGDKEFLVEVEMLSRLHHRNLVKLVG  160 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  160 (443)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999964 688999999875421             23467899999999999999999999


Q ss_pred             eeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-
Q 013404          161 YYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-  239 (443)
Q Consensus       161 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-  239 (443)
                      +|.  +....++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ 
T Consensus       114 ~~~--~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          114 VFE--DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS  184 (504)
T ss_dssp             EEE--CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred             EEE--cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence            997  45589999999999999999864    245899999999999999999999999   99999999999998775 


Q ss_pred             --ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 013404          240 --HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT  317 (443)
Q Consensus       240 --~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~  317 (443)
                        .+||+|||+++.......   .....||+.|+|||++. ..++.++|||||||++|+|++|..||.....      ..
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~  254 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------QD  254 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH
T ss_pred             CccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HH
Confidence              699999999987654322   23457999999999887 4689999999999999999999999974321      12


Q ss_pred             HHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       318 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ....+.........    .....++    ..+.+++.+||+.||.+|||++|++++-+.
T Consensus       255 ~~~~i~~~~~~~~~----~~~~~~s----~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  305 (504)
T 3q5i_A          255 IIKKVEKGKYYFDF----NDWKNIS----DEAKELIKLMLTYDYNKRCTAEEALNSRWI  305 (504)
T ss_dssp             HHHHHHHCCCCCCH----HHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHHHHcCCCCCCc----cccCCCC----HHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence            22222211110000    0001122    347899999999999999999999988654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.6e-43  Score=335.62  Aligned_cols=259  Identities=21%  Similarity=0.343  Sum_probs=197.3

Q ss_pred             HHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcC--CCceeeEEEeeecCCC
Q 013404           92 LKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS  167 (443)
Q Consensus        92 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  167 (443)
                      +....++|++.+.||+|+||.||++...+++.||||.+......  ....+.+|++++++++  ||||+++++++.  +.
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~--~~  100 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI--TD  100 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE--CS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee--cC
Confidence            33445779999999999999999999888999999999754322  3467899999999997  599999999987  44


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...+++|| +.+++|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+|||+++ +.+||+|||
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             CEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence            57899999 568899999974    235889999999999999999999999   999999999999965 799999999


Q ss_pred             ccccCCCCCccccccccccCccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-----------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV  316 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~  316 (443)
                      +++...............||+.|+|||.+.+           ..++.++||||||+++|||++|+.||.....    . .
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~-~  246 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----Q-I  246 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS----H-H
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH----H-H
Confidence            9987654433323344579999999999875           4788899999999999999999999964321    1 1


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ........          +.....++......+.+++.+||+.||++||++.|++++.+.
T Consensus       247 ~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~  296 (313)
T 3cek_A          247 SKLHAIID----------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  296 (313)
T ss_dssp             HHHHHHHC----------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             HHHHHHHh----------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence            11111111          111111121122357899999999999999999999988654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.2e-43  Score=334.98  Aligned_cols=253  Identities=23%  Similarity=0.395  Sum_probs=197.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++..  ....++||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   95 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWIMI   95 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEEEE
Confidence            467999999999999999999975 589999999987666677889999999999999999999999874  45789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++++|.+++...   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999998642   235899999999999999999999999   99999999999999999999999999754321


Q ss_pred             CCccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ..  .......||+.|+|||++.     ...++.++||||||+++|||++|+.||.....      ............  
T Consensus       170 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~--  239 (302)
T 2j7t_A          170 TL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDP--  239 (302)
T ss_dssp             HH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC--
T ss_pred             cc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCC--
Confidence            10  1122346899999999883     66789999999999999999999999964321      111111111110  


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...       ..+......+.+++.+||+.||++|||+.+++++
T Consensus       240 ~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          240 PTL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             CCC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ccc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000       0111222357899999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.5e-42  Score=331.99  Aligned_cols=253  Identities=25%  Similarity=0.344  Sum_probs=196.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--------CCHHHHHHHHHHHhhcCCCceeeEEEeeecC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR  165 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  165 (443)
                      ..++|++.+.||+|+||.||+|... +++.||||.+.....        .....+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999964 688999999865321        1224588999999999999999999998632


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc---eE
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AK  242 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~k  242 (443)
                         ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +|
T Consensus        88 ---~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           88 ---DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ---SEEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred             ---ceEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence               47999999999999999964    345899999999999999999999999   999999999999987654   99


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      |+|||+++......   ......||+.|+|||++.   ...++.++|||||||++|||++|+.||.......  .+....
T Consensus       158 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~  232 (322)
T 2ycf_A          158 ITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI  232 (322)
T ss_dssp             ECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH
T ss_pred             EccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH
Confidence            99999998765422   123457899999999874   5678899999999999999999999997543321  121111


Q ss_pred             HHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .   ......    .+.....++    ..+.+++.+||+.||++||++.+++++
T Consensus       233 ~---~~~~~~----~~~~~~~~~----~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          233 T---SGKYNF----IPEVWAEVS----EKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             H---HTCCCC----CHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             H---hCcccc----CchhhhhcC----HHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            1   110000    000001122    347899999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-42  Score=338.79  Aligned_cols=262  Identities=18%  Similarity=0.249  Sum_probs=203.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC-----------------HHHHHHHHHHHhhcCCCceeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG-----------------DKEFLVEVEMLSRLHHRNLVKL  158 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  158 (443)
                      .++|++.+.||+|+||.||+|.. +|+.||||.+.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999986432111                 1789999999999999999999


Q ss_pred             EEeeecCCCCeeEEEEeecCCCChhHh------hcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcc
Q 013404          159 VGYYSSRDSSQHLLCYELVPNGSLESW------LHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKAS  231 (443)
Q Consensus       159 ~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~  231 (443)
                      ++++..  ....++||||+++|+|.++      +...  ....+++..++.++.|++.||.|||+ .+   |+||||||+
T Consensus       109 ~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~  181 (348)
T 2pml_X          109 EGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS  181 (348)
T ss_dssp             SEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred             EEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence            999874  4588999999999999999      5432  14568999999999999999999999 88   999999999


Q ss_pred             cEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCC
Q 013404          232 NILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLV-KSDVYSYGVVLLELLTGRKPVDMSQP  309 (443)
Q Consensus       232 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~S~G~il~elltg~~p~~~~~~  309 (443)
                      ||+++.++.+||+|||++......    ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            999999999999999999876433    23445799999999999887 6666 99999999999999999999975432


Q ss_pred             CCcchHHHHHHHHhhcccccccc----ccCccC---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          310 SGQENLVTWARPILRDKDRLEEL----ADPRLG---GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~----~d~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      .  .   .....+..........    ..+...   ..........+.+++.+||+.||++||++.|++++-
T Consensus       258 ~--~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp  324 (348)
T 2pml_X          258 L--V---ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE  324 (348)
T ss_dssp             S--H---HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             H--H---HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            1  1   1111121111111000    000000   000011223578999999999999999999999753

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.2e-42  Score=346.41  Aligned_cols=198  Identities=24%  Similarity=0.328  Sum_probs=169.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhc------CCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL------HHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  168 (443)
                      ..+|++.+.||+|+||.||+|... +++.||||+++.. ......+.+|+++++.+      .|+||+++++++..  ..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CC
Confidence            457999999999999999999854 6899999999743 22235678899888887      57799999999874  45


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc--eEEccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH--AKVADF  246 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Df  246 (443)
                      ..++||||+. ++|.+++....  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.  +||+||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeec
Confidence            8899999995 69999987532  235899999999999999999999999   999999999999999887  999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      |+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       247 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          247 GSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            999765432     23357899999999999999999999999999999999999999754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.9e-42  Score=338.32  Aligned_cols=262  Identities=22%  Similarity=0.283  Sum_probs=193.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCC----CC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  168 (443)
                      .++|++.+.||+|+||.||+|.. .+++.||||++......  ..+.+.+|+.+++.++||||+++++++...+    ..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999995 46889999999754322  2356889999999999999999999986433    23


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++||||+++ +|.+++..      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence            67999999974 88888852      3889999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc---
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD---  325 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  325 (443)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..     .. ...+...   
T Consensus       174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~-~~~i~~~~~~  244 (371)
T 2xrw_A          174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-----DQ-WNKVIEQLGT  244 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HH-HHHHHC-CCC
T ss_pred             cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-----HH-HHHHHHHhCC
Confidence            98654322   223457999999999999999999999999999999999999999753311     11 1111110   


Q ss_pred             -------------------ccc-----ccccccCccCCC---CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          326 -------------------KDR-----LEELADPRLGGK---YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       326 -------------------~~~-----~~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                                         ...     ............   ........+.+|+.+||+.||++|||++|++++-+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  322 (371)
T 2xrw_A          245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  322 (371)
T ss_dssp             CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence                               000     000000000000   011224568899999999999999999999998654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-42  Score=366.30  Aligned_cols=251  Identities=23%  Similarity=0.326  Sum_probs=205.1

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCe
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  169 (443)
                      ..++|++.+.||+|+||.||+|... +++.||||+++..   .......+..|..++..+ +||||+++++++.  +...
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~~~  416 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR  416 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CSSE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eCCE
Confidence            4578999999999999999999954 6889999998743   233456788899999988 7999999999987  4558


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .+|||||+++|+|.++++.    ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       417 ~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             EEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence            9999999999999999974    235899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      +.......  ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+      .......+.....  
T Consensus       490 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~------~~~~~~~i~~~~~--  559 (674)
T 3pfq_A          490 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHNV--  559 (674)
T ss_dssp             EECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHSSCC--
T ss_pred             eccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCCC--
Confidence            86433222  2345689999999999999999999999999999999999999997432      1222333332211  


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHHH
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM-----GEVVQSL  374 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~L  374 (443)
                                .++......+.+|+.+||+.||++||++     +||++|-
T Consensus       560 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~  599 (674)
T 3pfq_A          560 ----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA  599 (674)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSG
T ss_pred             ----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCc
Confidence                      1222223357899999999999999998     7887653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.9e-42  Score=327.65  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=201.7

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC---------CHHHHHHHHHHHhhcC-CCceeeEEEeee
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ---------GDKEFLVEVEMLSRLH-HRNLVKLVGYYS  163 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~  163 (443)
                      ..++|++.+.||+|+||.||+|... +|+.||||.+......         ..+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999964 6889999999754311         1346789999999995 999999999987


Q ss_pred             cCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEE
Q 013404          164 SRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV  243 (443)
Q Consensus       164 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  243 (443)
                        +....++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||
T Consensus        95 --~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           95 --TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             --CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             --cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence              45588999999999999999964    245899999999999999999999999   999999999999999999999


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHH
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT  317 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~  317 (443)
                      +|||++........   .....|++.|+|||++.      ...++.++||||||+++|||++|+.||.....      ..
T Consensus       166 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~  236 (298)
T 1phk_A          166 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------ML  236 (298)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH
T ss_pred             ecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HH
Confidence            99999987654322   23457899999999885      45688999999999999999999999964321      11


Q ss_pred             HHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       318 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ....+.......   ..     .........+.+++.+||+.||++||++.|++++
T Consensus       237 ~~~~~~~~~~~~---~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          237 MLRMIMSGNYQF---GS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHHHHHTCCCC---CT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhcCCccc---Cc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            112222111110   00     0011223358899999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=330.62  Aligned_cols=254  Identities=28%  Similarity=0.399  Sum_probs=199.2

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ..++|++.+.||+|+||.||+|... +|+.||+|.+....  ..+.+.+|+.++++++||||+++++++..  ....++|
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv  102 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWIV  102 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEE
Confidence            4578999999999999999999965 58999999997542  35678999999999999999999999874  4478999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus       103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            9999999999998632   345899999999999999999999999   9999999999999999999999999998664


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....      ............      
T Consensus       177 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~------  242 (314)
T 3com_A          177 DTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTNPP------  242 (314)
T ss_dssp             TTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC------
T ss_pred             hhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCC------
Confidence            4322  12345789999999999999999999999999999999999999964321      111111111100      


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                       +..  ..+......+.+++.+||+.||++|||+.+++++-+
T Consensus       243 -~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~  281 (314)
T 3com_A          243 -PTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF  281 (314)
T ss_dssp             -CCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             -ccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence             000  011112235889999999999999999999998754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.3e-43  Score=343.76  Aligned_cols=263  Identities=22%  Similarity=0.333  Sum_probs=183.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecC----CCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~  168 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++......  ..+.+.+|+++++.++||||+++++++...    +..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46899999999999999999995 57899999999754322  245788999999999999999999998643    124


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++++||+ +++|.+++..     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 7899998863     35899999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..   ..............
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~  250 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPG  250 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCC
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCC
Confidence            9865432     234578999999999887 67899999999999999999999999753321   11111111110000


Q ss_pred             --cc--------cccccCcc-CCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          328 --RL--------EELADPRL-GGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       328 --~~--------~~~~d~~~-~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                        .+        ........ ....+.     .....+.+|+.+||+.||++|||+.|++++-+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~  314 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  314 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence              00        00000000 000000     11234789999999999999999999998743

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-42  Score=344.40  Aligned_cols=266  Identities=22%  Similarity=0.266  Sum_probs=194.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC----CCeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SSQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~~  171 (443)
                      ..+|++.+.||+|+||.||+|+...+..||+|++.....    ...+|+++++.++||||++++++|....    ....+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            356899999999999999999987777799998864332    2236999999999999999999986432    22377


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec-CCCceEEccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAK  250 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~  250 (443)
                      +||||++++ |.+.+.........+++..+..++.|++.||+|||+.+   |+||||||+|||++ .++.+||+|||+++
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            999999874 44433211112346899999999999999999999999   99999999999999 79999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh-----
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR-----  324 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  324 (443)
                      .......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......  ..+.......-.     
T Consensus       191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHH
T ss_pred             cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHH
Confidence            7644332   2345789999999998765 5899999999999999999999999753311  111111111000     


Q ss_pred             ---ccccccccccCccCC-----CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          325 ---DKDRLEELADPRLGG-----KYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       325 ---~~~~~~~~~d~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                         .........-+....     .++......+.+|+.+||+.||++|||+.|+++|-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP  323 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence               000000000000000     01111223588999999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.7e-42  Score=337.76  Aligned_cols=276  Identities=21%  Similarity=0.254  Sum_probs=193.3

Q ss_pred             HHHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC--
Q 013404           90 EELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD--  166 (443)
Q Consensus        90 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  166 (443)
                      .......++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|++.++.++||||++++++|....  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            45667788999999999999999999996 468999999986543 23456778888999999999999999986422  


Q ss_pred             ---CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhh--hcCCCceEecCCCcccEEecC-CCc
Q 013404          167 ---SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH--EDSQPCVIHRDFKASNILLEN-NFH  240 (443)
Q Consensus       167 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~  240 (443)
                         ....++||||+++ +|.+.+.........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence               1237899999976 555544321122456889999999999999999999  888   999999999999996 899


Q ss_pred             eEEccccccccCCCCCccccccccccCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          241 AKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       241 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      +||+|||+++.......   .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||......  ..+....
T Consensus       171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~  245 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIV  245 (360)
T ss_dssp             EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHH
T ss_pred             EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHH
Confidence            99999999987654332   23457899999999987654 899999999999999999999999753321  1111111


Q ss_pred             HHHhhcc----------ccccccccC------ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          320 RPILRDK----------DRLEELADP------RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       320 ~~~~~~~----------~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .......          .......+.      .............+.+++.+||+.||++|||+.|+++|-+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  317 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY  317 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence            1100000          000000000      0000111123456889999999999999999999998744

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=342.99  Aligned_cols=273  Identities=21%  Similarity=0.277  Sum_probs=187.0

Q ss_pred             cCCCC-CceeeecCcEEEEEEEEC---CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEP-ASILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~-~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      +.|++ .++||+|+||.||+|...   +++.||||++....  ....+.+|+.+|++++||||+++++++........++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34555 458999999999999965   57899999997432  3457889999999999999999999997656678999


Q ss_pred             EEeecCCCChhHhhcCC-----CCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe----cCCCceEE
Q 013404          173 CYELVPNGSLESWLHGP-----LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKV  243 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl  243 (443)
                      ||||+. |+|.+++...     ......+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 5888887421     111235899999999999999999999999   9999999999999    67889999


Q ss_pred             ccccccccCCCCCcc-ccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC-------cch
Q 013404          244 ADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG-------QEN  314 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~-------~~~  314 (443)
                      +|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......       ...
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            999999876532211 122346799999999999874 58999999999999999999999996543221       011


Q ss_pred             HHHHHHHHhhccc--ccccc-------------ccCccCCCCCH---------HHHHHHHHHHHHccCcCCCCCCCHHHH
Q 013404          315 LVTWARPILRDKD--RLEEL-------------ADPRLGGKYPK---------EDFIRVCTIAAACVAPEANQRPTMGEV  370 (443)
Q Consensus       315 ~~~~~~~~~~~~~--~~~~~-------------~d~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~RPs~~ev  370 (443)
                      +...+. .+....  ....+             ..... .....         .....+.+|+.+||+.||++|||++|+
T Consensus       254 l~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          254 LDRIFN-VMGFPADKDWEDIKKMPEHSTLMKDFRRNTY-TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHH-HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGG-TTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHH-hhCCCChhhcchhhcCcchhhhhhhccccCC-CcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            111111 110000  00000             00000 00000         002247789999999999999999999


Q ss_pred             HHHHHHh
Q 013404          371 VQSLKMV  377 (443)
Q Consensus       371 l~~L~~~  377 (443)
                      ++|-+..
T Consensus       332 L~hp~f~  338 (405)
T 3rgf_A          332 MQDPYFL  338 (405)
T ss_dssp             HTSGGGT
T ss_pred             hcChhhc
Confidence            9986543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=332.71  Aligned_cols=265  Identities=22%  Similarity=0.286  Sum_probs=194.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeec----------
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS----------  164 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  164 (443)
                      .++|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467899999999999999999965 589999999976554455788999999999999999999998742          


Q ss_pred             --CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec-CCCce
Q 013404          165 --RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHA  241 (443)
Q Consensus       165 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~  241 (443)
                        .+....++||||++ |+|.+++..     ..+++..++.++.|++.||+|||+.+   |+||||||+|||++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence              13357899999997 699999963     35889999999999999999999999   99999999999997 57799


Q ss_pred             EEccccccccCCCCCcc-ccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          242 KVADFGLAKQAPEGRTN-YLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      ||+|||+++........ .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......      ...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~  234 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------EQM  234 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence            99999999876432111 11233467999999998865 67899999999999999999999999754321      111


Q ss_pred             HHHhhcccc------------ccccccCccC-CCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          320 RPILRDKDR------------LEELADPRLG-GKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       320 ~~~~~~~~~------------~~~~~d~~~~-~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..+......            +......... ...+     ......+.+++.+||+.||++|||++|++++-+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY  308 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence            111110000            0000000000 0000     011234889999999999999999999998754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.5e-42  Score=337.29  Aligned_cols=258  Identities=22%  Similarity=0.341  Sum_probs=195.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCCC----
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS----  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  168 (443)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++.......  .+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46899999999999999999995 468999999997543322  46788999999999999999999998743321    


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++||||+. ++|.+++.      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence            2489999997 69998884      23899999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......      +....+.....
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~  259 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTG  259 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHC
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhC
Confidence            9865432     234578999999999887 68899999999999999999999999743211      11111111000


Q ss_pred             c-----------------ccccccCccCCC---CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          328 R-----------------LEELADPRLGGK---YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       328 ~-----------------~~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .                 ...+.. .....   ........+.+++.+||+.||++|||++|++++-+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  326 (371)
T 4exu_A          260 VPGTEFVQKLNDKAAKSYIQSLPQ-TPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  326 (371)
T ss_dssp             CCCHHHHTTCSCHHHHHHHHHSCC-CCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             CCcHHHHHHhhhhhhhhhhhccCC-CcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence            0                 000000 00000   00111235889999999999999999999998743

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.3e-42  Score=361.77  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=203.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC----CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS----DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ..++|++.+.||+|+||.||+|.+.    .+..||+|.++..... ..+.|.+|+.++++++||||+++++++..   ..
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~  464 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP  464 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence            3567888999999999999999864    2467999998754322 23679999999999999999999999842   35


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence            79999999999999999743   235899999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      +....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....   .   .....+.. ...
T Consensus       539 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~---~~~~~i~~-~~~  610 (656)
T 2j0j_A          539 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---N---DVIGRIEN-GER  610 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H---HHHHHHHH-TCC
T ss_pred             eecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---H---HHHHHHHc-CCC
Confidence            87654322 22334567889999999999999999999999999999997 9999964321   1   11111111 111


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                            ......++    ..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus       611 ------~~~~~~~~----~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          611 ------LPMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCcccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                  11112233    3588999999999999999999999999988653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.4e-41  Score=326.32  Aligned_cols=268  Identities=24%  Similarity=0.308  Sum_probs=200.6

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEE--CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhc---CCCceeeEEEeeec---
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVL--SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL---HHRNLVKLVGYYSS---  164 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---  164 (443)
                      ..++|++.+.||+|+||.||+|..  .+|+.||+|+++...  ......+.+|+.+++.+   +||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  467899999986432  22234577788887776   89999999998862   


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEc
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVA  244 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~  244 (443)
                      ......++||||++ |+|.+++....  ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence            23447889999997 69999997532  234899999999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      |||+++......   ......||..|+|||++.+..++.++||||||+++|||++|+.||.....   ............
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~  236 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIG  236 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcC
Confidence            999998654321   23345789999999999999999999999999999999999999974331   111111111110


Q ss_pred             ccc--ccc-------ccccC---ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          325 DKD--RLE-------ELADP---RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       325 ~~~--~~~-------~~~d~---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ...  ...       .....   .....+.......+.+++.+||+.||++||++.|++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  298 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  298 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence            000  000       00000   000001111223478999999999999999999999763

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=9.4e-42  Score=332.98  Aligned_cols=268  Identities=24%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecC---CCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|... +|+.||||.+...... ....+.+|++++++++||||+++++++...   .....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999964 6899999999643322 245688999999999999999999987642   13578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +++|||+. |+|.+++..     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999997 699999863     35899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccc--------cccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHH
Q 013404          251 QAPEGRTNY--------LSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       251 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~  321 (443)
                      .........        ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......   ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHH
Confidence            764322110        1123578999999998764 67899999999999999999999999743311   11111111


Q ss_pred             Hhhccc---cc--------cccccCcc-CCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          322 ILRDKD---RL--------EELADPRL-GGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       322 ~~~~~~---~~--------~~~~d~~~-~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ......   ..        ........ ....+     ......+.+++.+||+.||++|||++|++++-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY  308 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence            110000   00        00000000 00000     011234789999999999999999999998643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-41  Score=328.89  Aligned_cols=261  Identities=21%  Similarity=0.246  Sum_probs=176.4

Q ss_pred             HhcCCCCCc-eeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecC--CCCee
Q 013404           95 ATNNFEPAS-ILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR--DSSQH  170 (443)
Q Consensus        95 ~~~~~~~~~-~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~~  170 (443)
                      ..++|.+.+ .||+|+||.||+|... +|+.||||++...    .....+....++.+.||||+++++++...  .....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            356788854 6999999999999965 7899999998632    22223333445667999999999998642  23357


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceEEcccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG  247 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  247 (443)
                      ++||||+++|+|.+++....  ...+++.+++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence            89999999999999997543  346899999999999999999999999   999999999999976   4559999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      +++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........  .....+.....
T Consensus       177 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~  250 (336)
T 3fhr_A          177 FAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRLGQY  250 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhcccc
Confidence            998654322    234578999999999998899999999999999999999999996443221100  00000000000


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                         ....+ ....++    ..+.+++.+||+.||++|||++|++++-+.-.
T Consensus       251 ---~~~~~-~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          251 ---GFPNP-EWSEVS----EDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             ---CCCTT-TSTTCC----HHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ---ccCch-hhccCC----HHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence               00000 001223    34789999999999999999999999876543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.5e-41  Score=328.93  Aligned_cols=261  Identities=21%  Similarity=0.308  Sum_probs=200.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE--CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc------eeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL--SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+|..  .+++.||||+++.. ....+.+.+|+++++.++|+|      ++++++++..  .
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--~   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--H   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--T
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--C
Confidence            35899999999999999999986  36889999999743 223467889999999987654      9999999874  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC----------
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN----------  237 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~----------  237 (443)
                      ...++||||+ +++|.+++....  ...+++..+..++.|++.||+|||+++   |+||||||+|||++.          
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCc
Confidence            4889999999 889999997532  235889999999999999999999999   999999999999987          


Q ss_pred             ---------CCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 013404          238 ---------NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ  308 (443)
Q Consensus       238 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~  308 (443)
                               ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     668999999999865432     234578999999999999999999999999999999999999997543


Q ss_pred             CCCcchHHHHHHHHhhcc--------cccccc--------------------ccCc-cCCCCCHHHHHHHHHHHHHccCc
Q 013404          309 PSGQENLVTWARPILRDK--------DRLEEL--------------------ADPR-LGGKYPKEDFIRVCTIAAACVAP  359 (443)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~--------~~~~~~--------------------~d~~-~~~~~~~~~~~~l~~li~~cl~~  359 (443)
                      ...   ............        ......                    ..+. ............+.+++.+||+.
T Consensus       239 ~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          239 SKE---HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             HHH---HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             hHH---HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence            211   111111111000        000000                    0000 00112334556789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 013404          360 EANQRPTMGEVVQS  373 (443)
Q Consensus       360 dp~~RPs~~evl~~  373 (443)
                      ||++|||+.|++++
T Consensus       316 dP~~Rpt~~ell~h  329 (339)
T 1z57_A          316 DPAKRITLREALKH  329 (339)
T ss_dssp             STTTSCCHHHHTTS
T ss_pred             CcccccCHHHHhcC
Confidence            99999999999976

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8.8e-42  Score=325.38  Aligned_cols=256  Identities=26%  Similarity=0.401  Sum_probs=193.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecC---------
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---------  165 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  165 (443)
                      .++|++.+.||+|+||.||+|+. .+|+.||||.+... ....+.+.+|+.++++++||||+++++++...         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46789999999999999999996 47899999998642 22346788999999999999999999987642         


Q ss_pred             --CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEE
Q 013404          166 --DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKV  243 (443)
Q Consensus       166 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl  243 (443)
                        .....++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence              234678999999999999999742   345788999999999999999999999   999999999999999999999


Q ss_pred             ccccccccCCCCCc------------cccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 013404          244 ADFGLAKQAPEGRT------------NYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPS  310 (443)
Q Consensus       244 ~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~  310 (443)
                      +|||+++.......            ........||+.|+|||++.+. .++.++|||||||++|||++   ||..    
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~----  230 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST----  230 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS----
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC----
Confidence            99999986643210            1112345689999999999865 68999999999999999998   5431    


Q ss_pred             CcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          311 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                       ..........+....        ..+...++......+.+++.+||+.||++|||+.+++++-
T Consensus       231 -~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          231 -GMERVNILKKLRSVS--------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             -HHHHHHHHHHHHSTT--------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             -chhHHHHHHhccccc--------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence             111111111111110        1111222333334578999999999999999999999763

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.4e-42  Score=337.12  Aligned_cols=268  Identities=20%  Similarity=0.280  Sum_probs=201.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-----------CCceeeEEEeee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----------HRNLVKLVGYYS  163 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  163 (443)
                      ..+|++.+.||+|+||.||+|.. .+++.||||.+... ......+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35799999999999999999995 57899999999742 223466889999999886           899999999887


Q ss_pred             cCC--CCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEec----
Q 013404          164 SRD--SSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLE----  236 (443)
Q Consensus       164 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~----  236 (443)
                      ..+  ....+++|||+ +++|.+++....  ...+++..+..++.||+.||+|||++ +   |+||||||+|||++    
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            432  23678999999 889999997532  33589999999999999999999998 8   99999999999994    


Q ss_pred             --CCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch
Q 013404          237 --NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN  314 (443)
Q Consensus       237 --~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~  314 (443)
                        ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence              4458999999999876432     233478999999999999999999999999999999999999997544222111


Q ss_pred             HHHHHHHHhhc---------------------cccccccccCc---------cCCCCCHHHHHHHHHHHHHccCcCCCCC
Q 013404          315 LVTWARPILRD---------------------KDRLEELADPR---------LGGKYPKEDFIRVCTIAAACVAPEANQR  364 (443)
Q Consensus       315 ~~~~~~~~~~~---------------------~~~~~~~~d~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~R  364 (443)
                      .......+...                     ......+....         -...++......+.+|+.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence            11111111110                     00000000000         0113456677789999999999999999


Q ss_pred             CCHHHHHHHHH
Q 013404          365 PTMGEVVQSLK  375 (443)
Q Consensus       365 Ps~~evl~~L~  375 (443)
                      ||++|++++-+
T Consensus       326 pt~~ell~hp~  336 (373)
T 1q8y_A          326 ADAGGLVNHPW  336 (373)
T ss_dssp             BCHHHHHTCGG
T ss_pred             CCHHHHhhChh
Confidence            99999998744

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.5e-43  Score=337.39  Aligned_cols=259  Identities=24%  Similarity=0.335  Sum_probs=197.7

Q ss_pred             HHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           94 EATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        94 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ...++|++.+.||+|+||.||+|...+  .||+|.++...  ....+.+.+|+.++++++||||+++++++..  ....+
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~  105 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLA  105 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceE
Confidence            345789999999999999999999754  49999987543  2234567889999999999999999999874  44789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|||+++++|.+++...   ...+++..++.++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+++.
T Consensus       106 iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             EECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             EEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999999753   335899999999999999999999999   99999999999998 67999999999875


Q ss_pred             CCCCCc---cccccccccCccccccccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          252 APEGRT---NYLSTRVMGTFGYVAPEYAMT---------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       252 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      ......   ........|++.|+|||++..         ..++.++||||||+++|||++|+.||.....      ....
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~  252 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAII  252 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHHH
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH
Confidence            532111   111233468999999999864         4578999999999999999999999964321      1111


Q ss_pred             HHHhhccccccccccCccC-CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          320 RPILRDKDRLEELADPRLG-GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      ..+... .      .+... ..++.    .+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus       253 ~~~~~~-~------~~~~~~~~~~~----~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          253 WQMGTG-M------KPNLSQIGMGK----EISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HHHHTT-C------CCCCCCSSCCT----THHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             HHhccC-C------CCCCCcCCCCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            111111 0      11111 12222    378999999999999999999999999888654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.3e-41  Score=319.73  Aligned_cols=256  Identities=25%  Similarity=0.341  Sum_probs=202.7

Q ss_pred             HHHhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           93 KEATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        93 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ....++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++.  +...
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~   95 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE--DSSS   95 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe--CCCe
Confidence            344678999999999999999999965 78999999986542  344678999999999999999999999987  4558


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC---CceEEccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN---FHAKVADF  246 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df  246 (443)
                      .++||||+++++|.+++..    ...+++.+++.++.|++.||.|||+.+   ++||||||+||+++.+   +.+||+||
T Consensus        96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Df  168 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDF  168 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred             EEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEecc
Confidence            8999999999999998864    235899999999999999999999999   9999999999999754   46999999


Q ss_pred             cccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          247 GLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       247 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      |++........   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....      ......+....
T Consensus       169 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~  238 (287)
T 2wei_A          169 GLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGK  238 (287)
T ss_dssp             TGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC
T ss_pred             CcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC
Confidence            99987654322   233468999999998875 489999999999999999999999964321      11222221111


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ...    +......++    ..+.+++.+||+.||++|||+.|++++-+
T Consensus       239 ~~~----~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~hp~  279 (287)
T 2wei_A          239 YAF----DLPQWRTIS----DDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (287)
T ss_dssp             CCC----CSGGGTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             CCC----CchhhhhcC----HHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence            100    000001223    34789999999999999999999998754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.3e-42  Score=330.40  Aligned_cols=261  Identities=26%  Similarity=0.390  Sum_probs=178.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC-CHHHHHHHHH-HHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ-GDKEFLVEVE-MLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .++|++.+.||+|+||.||+|... +|+.||||++...... ....+..|+. +++.++||||+++++++.  +....++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~--~~~~~~l   98 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF--REGDCWI   98 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE--eCCceEE
Confidence            367889999999999999999964 7899999999754322 2345666666 677789999999999987  4458899


Q ss_pred             EEeecCCCChhHhhcCCC-CCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          173 CYELVPNGSLESWLHGPL-GVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ||||+++ +|.+++.... .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999975 8888775210 1134589999999999999999999998 8   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCccccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYA----MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      .......   .....||+.|+|||++    .+..++.++||||||+++|||++|+.||.......     ...    .. 
T Consensus       175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~----~~-  241 (327)
T 3aln_A          175 QLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQL----TQ-  241 (327)
T ss_dssp             C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CC-
T ss_pred             ecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHH----HH-
Confidence            7644321   2334799999999998    45678999999999999999999999996432110     000    00 


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                        ......+.+...........+.+++.+||+.||++||++.+|+++-+..
T Consensus       242 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          242 --VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             --CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             --HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence              0000001111111111223488999999999999999999999876544

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-42  Score=327.21  Aligned_cols=248  Identities=24%  Similarity=0.421  Sum_probs=192.3

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC------CHHHHHHHHHHHhhc----CCCceeeEE
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRL----HHRNLVKLV  159 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~  159 (443)
                      +.....++|++.+.||+|+||.||+|.. .+++.||||.+......      ....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3444567899999999999999999985 57889999999754322      223466799999998    899999999


Q ss_pred             EeeecCCCCeeEEEEee-cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec-C
Q 013404          160 GYYSSRDSSQHLLCYEL-VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-N  237 (443)
Q Consensus       160 ~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~  237 (443)
                      +++..  ....+++||| +.+++|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+||+++ +
T Consensus       105 ~~~~~--~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          105 DWFET--QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR  175 (312)
T ss_dssp             EEC-------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETT
T ss_pred             EEEec--CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCC
Confidence            99874  4478899999 789999999974    235899999999999999999999999   99999999999999 8


Q ss_pred             CCceEEccccccccCCCCCccccccccccCcccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH
Q 013404          238 NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV  316 (443)
Q Consensus       238 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~  316 (443)
                      ++.+||+|||+++......    .....|+..|+|||++.+..+. .++||||||+++|||++|+.||....        
T Consensus       176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------  243 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------  243 (312)
T ss_dssp             TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred             CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------
Confidence            8999999999998765432    2345689999999999877664 58999999999999999999996311        


Q ss_pred             HHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          317 TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       317 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .    .....        ..+...++    ..+.+++.+||+.||++||+++|++++-+
T Consensus       244 ~----~~~~~--------~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          244 E----ILEAE--------LHFPAHVS----PDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             H----HHHTC--------CCCCTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             H----Hhhhc--------cCCcccCC----HHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            0    11110        01112223    34789999999999999999999998643

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.5e-41  Score=332.05  Aligned_cols=199  Identities=25%  Similarity=0.315  Sum_probs=167.7

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CC-----ceeeEEEeeecCCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HR-----NLVKLVGYYSSRDS  167 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~  167 (443)
                      ..++|++.+.||+|+||.||+|... +++.||||+++.. ......+..|+++++.++ |+     +|+++++++..  .
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~  128 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--R  128 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--T
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--C
Confidence            3578999999999999999999964 6889999999732 122456778999998885 55     49999999874  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh--cCCCceEecCCCcccEEec--CCCceEE
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE--DSQPCVIHRDFKASNILLE--NNFHAKV  243 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~~~~ivH~Dlkp~NIll~--~~~~~kl  243 (443)
                      ...++||||++ |+|.+++....  ...+++..+..++.|++.||.|||.  .+   |+||||||+|||++  .++.+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred             CceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence            48899999996 59999997532  2358999999999999999999995  45   99999999999995  4778999


Q ss_pred             ccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 013404          244 ADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMS  307 (443)
Q Consensus       244 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~  307 (443)
                      +|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999876432     23457899999999999999999999999999999999999999754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=330.50  Aligned_cols=258  Identities=22%  Similarity=0.339  Sum_probs=195.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC--HHHHHHHHHHHhhcCCCceeeEEEeeecCCC----C
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG--DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS----S  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~  168 (443)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||.+.......  ...+.+|+.+++.++||||+++++++...+.    .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36788999999999999999996 468999999997543222  3578899999999999999999999874332    2


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..+++|||++ ++|.+++..      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence            3589999997 699888742      4899999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......      .....+.....
T Consensus       173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~  241 (353)
T 3coi_A          173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTG  241 (353)
T ss_dssp             TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH------HHHHHHHHHHC
T ss_pred             ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhC
Confidence            9865432     234578999999999887 67899999999999999999999999743311      11111111000


Q ss_pred             --------------------cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          328 --------------------RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       328 --------------------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                                          .+.....+.+. .........+.+++.+||+.||++|||++|++++-+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  308 (353)
T 3coi_A          242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  308 (353)
T ss_dssp             BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             CCCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence                                00000000000 111122345889999999999999999999998643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.2e-41  Score=339.66  Aligned_cols=255  Identities=23%  Similarity=0.311  Sum_probs=187.8

Q ss_pred             CCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEEee
Q 013404           98 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .|.+.+.||+|+||+||.+...+|+.||||++...   ..+.+.+|++++.++ +||||+++++++.  +....++||||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~lv~E~   90 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET--TDRFLYIALEL   90 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEEEECC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCeEEEEEec
Confidence            44556889999999998777778999999998642   345678999999987 8999999999987  45588999999


Q ss_pred             cCCCChhHhhcCCCCCCCC---CChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-------------Cc
Q 013404          177 VPNGSLESWLHGPLGVNCH---LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-------------FH  240 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~  240 (443)
                      ++ |+|.+++.........   .++..++.++.||+.||+|||+++   |+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 6999999754322211   234567889999999999999999   9999999999999754             48


Q ss_pred             eEEccccccccCCCCCccc--cccccccCccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 013404          241 AKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPS  310 (443)
Q Consensus       241 ~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~  310 (443)
                      +||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998775433211  1234579999999999875       678999999999999999999 99999643211


Q ss_pred             CcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          311 GQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                          ...    +.......     +.............+.+++.+||+.||++|||+.||+++-
T Consensus       247 ----~~~----i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp  297 (434)
T 2rio_A          247 ----ESN----IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP  297 (434)
T ss_dssp             ----HHH----HHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ----HHH----HhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence                111    11111111     1111122345556789999999999999999999999753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.8e-42  Score=330.87  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=198.7

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC------CHHHHHHHHHHHhhcC--CCceeeEEEe
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLH--HRNLVKLVGY  161 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~  161 (443)
                      +.....++|++.+.||+|+||.||+|.. .+++.||||.+......      ....+.+|+.++++++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3444567899999999999999999985 57899999999754321      2245778999999996  5999999999


Q ss_pred             eecCCCCeeEEEEeecCC-CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec-CCC
Q 013404          162 YSSRDSSQHLLCYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNF  239 (443)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~  239 (443)
                      +.  +....+++|||+.+ ++|.+++..    ...+++..++.++.|++.||+|||+.+   |+||||||+|||++ +++
T Consensus       117 ~~--~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~  187 (320)
T 3a99_A          117 FE--RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG  187 (320)
T ss_dssp             EE--CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred             Ee--cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence            87  44578999999976 899999964    345899999999999999999999999   99999999999999 789


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~  318 (443)
                      .+||+|||+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....        . 
T Consensus       188 ~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~-  254 (320)
T 3a99_A          188 ELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E-  254 (320)
T ss_dssp             EEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H-
T ss_pred             CEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h-
Confidence            99999999998765432    234579999999999987766 688999999999999999999996311        0 


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                         ......        .....++.    .+.+++.+||+.||++||+++||+++-
T Consensus       255 ---~~~~~~--------~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          255 ---IIRGQV--------FFRQRVSS----ECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             ---HHHCCC--------CCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ---hhcccc--------cccccCCH----HHHHHHHHHccCChhhCcCHHHHhcCH
Confidence               111100        11122333    478999999999999999999999764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.2e-41  Score=326.07  Aligned_cols=263  Identities=21%  Similarity=0.294  Sum_probs=198.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CC-cEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc------eeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DG-TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN------LVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  167 (443)
                      .++|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|+.++++++|++      ++.+++++..  .
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--H   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--T
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--C
Confidence            468999999999999999999964 34 68999999743 223467888999999997766      8999998874  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEe------------
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILL------------  235 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll------------  235 (443)
                      ...++||||+ +++|.+++....  ...+++.+++.++.||+.||+|||+.+   |+||||||+|||+            
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccc
Confidence            4889999999 667777775422  245899999999999999999999998   9999999999999            


Q ss_pred             -------cCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 013404          236 -------ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQ  308 (443)
Q Consensus       236 -------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~  308 (443)
                             +.++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                   567899999999998654322     34579999999999999999999999999999999999999997433


Q ss_pred             CCCcchHHHHHHHHhhcc--------ccccccccCcc---------------------CCCCCHHHHHHHHHHHHHccCc
Q 013404          309 PSGQENLVTWARPILRDK--------DRLEELADPRL---------------------GGKYPKEDFIRVCTIAAACVAP  359 (443)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~--------~~~~~~~d~~~---------------------~~~~~~~~~~~l~~li~~cl~~  359 (443)
                      ..   .............        ...........                     ...........+.+++.+||+.
T Consensus       244 ~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          244 NR---EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             HH---HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             HH---HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            21   1111111111000        00000000000                     0011223345788999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 013404          360 EANQRPTMGEVVQSLK  375 (443)
Q Consensus       360 dp~~RPs~~evl~~L~  375 (443)
                      ||++|||+.|++++-+
T Consensus       321 dP~~Rpt~~e~l~hp~  336 (355)
T 2eu9_A          321 DPAQRITLAEALLHPF  336 (355)
T ss_dssp             STTTSCCHHHHTTSGG
T ss_pred             ChhhCcCHHHHhcChh
Confidence            9999999999997643

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.2e-41  Score=334.94  Aligned_cols=251  Identities=25%  Similarity=0.353  Sum_probs=186.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ..+|++.+.||+|+||.||.....+|+.||||++....   ...+.+|+++|+++ +||||+++++++.  +....++||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~~~~~lv~   97 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEK--DRQFQYIAI   97 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEE--ETTEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCEEEEEE
Confidence            35688889999999999766556678999999996432   23466899999999 7999999999987  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-----CCceEEcccccc
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGLA  249 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla  249 (443)
                      ||++ |+|.+++....   ..+.+..++.++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|||++
T Consensus        98 E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             ECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             ECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9996 59999997543   23555677899999999999999999   999999999999953     335889999999


Q ss_pred             ccCCCCCcc-ccccccccCcccccccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          250 KQAPEGRTN-YLSTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       250 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      +........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||......       .......
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~  243 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLG  243 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTT
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhc
Confidence            876543221 1234467999999999997   4567889999999999999999 99998532210       1111111


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                       .....     ..  .........+.+++.+||+.||++|||++||++|
T Consensus       244 -~~~~~-----~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          244 -ACSLD-----CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             -CCCCT-----TS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -cCCcc-----cc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence             10000     00  1122334457899999999999999999999965

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=315.21  Aligned_cols=254  Identities=23%  Similarity=0.383  Sum_probs=179.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC-H-HHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG-D-KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      .++|++.+.||+|+||.||+|... +|+.||||.+....... . +.+.++..+++.++||||+++++++.  +....++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~--~~~~~~l  101 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI--TNTDVFI  101 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe--cCCcEEE
Confidence            467888999999999999999964 78999999997543322 2 23444556778889999999999987  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ||||+ ++.+..++...   ...+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||++..
T Consensus       102 v~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             EECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999 55665555421   24589999999999999999999995 8   99999999999999999999999999976


Q ss_pred             CCCCCccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK  326 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  326 (443)
                      ......   .....||+.|+|||++.     ...++.++||||||+++|||++|+.||.....     ............
T Consensus       175 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~  246 (318)
T 2dyl_A          175 LVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEE  246 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSC
T ss_pred             ccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccC
Confidence            544321   23457999999999984     45788999999999999999999999964221     111222222211


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ..  .+  + ....++.    .+.+++.+||+.||++||++++++++-+
T Consensus       247 ~~--~~--~-~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (318)
T 2dyl_A          247 PP--LL--P-GHMGFSG----DFQSFVKDCLTKDHRKRPKYNKLLEHSF  286 (318)
T ss_dssp             CC--CC--C-SSSCCCH----HHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             CC--CC--C-ccCCCCH----HHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence            10  00  0 0012333    4789999999999999999999998754

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.7e-40  Score=348.07  Aligned_cols=243  Identities=23%  Similarity=0.343  Sum_probs=192.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC--CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC---e
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS--DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS---Q  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---~  169 (443)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||.+..... .....+.+|++++++++||||+++++++...+..   .
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            378999999999999999999974  689999999875432 2245688999999999999999999998754321   2


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .+|||||+++++|.+++..      .+++.+++.++.||+.||.|||+++   |+||||||+|||++.+ .+||+|||++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence            6999999999999988753      5899999999999999999999999   9999999999999986 8999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      +.....      ....||+.|+|||++.+.. +.++|||||||++|||++|..||.........                
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------  285 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------  285 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------------
T ss_pred             hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc----------------
Confidence            876543      3357999999999987654 88999999999999999999887532111000                


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-HHHHHHHHHHhHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-MGEVVQSLKMVQR  379 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~L~~~~~  379 (443)
                              ...........+.+++.+||+.||++||+ ++++...|..+.+
T Consensus       286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                    00001112245789999999999999995 5556666665543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-40  Score=331.86  Aligned_cols=246  Identities=15%  Similarity=0.179  Sum_probs=182.4

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC---CHHHHHHHHHHHhhcCC-Ccee--------------
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ---GDKEFLVEVEMLSRLHH-RNLV--------------  156 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-~niv--------------  156 (443)
                      ..+|...+.||+|+||.||+|.+ .+|+.||||++......   ..+.|.+|+.+++.++| +|..              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34577789999999999999994 57899999998744332   25679999999999977 2211              


Q ss_pred             -------eEEEeeecCC---CCeeEEEEeecCCCChhHhhcCC---CCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCce
Q 013404          157 -------KLVGYYSSRD---SSQHLLCYELVPNGSLESWLHGP---LGVNCHLDWETRMKIALDAARGLAYLHEDSQPCV  223 (443)
Q Consensus       157 -------~l~~~~~~~~---~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  223 (443)
                             .+..++....   ....+++|+++ +++|.+++...   ......+++..++.++.|+++||+|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                   1111111111   22356667665 68999988411   122456888999999999999999999999   9


Q ss_pred             EecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCccccccccc----------ccCCCCchhhHHHHHHH
Q 013404          224 IHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA----------MTGHLLVKSDVYSYGVV  293 (443)
Q Consensus       224 vH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~S~G~i  293 (443)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998865432     234567 999999999          55568899999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          294 LLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       294 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      +|||++|+.||........                ...+....  ..++    ..+.+++.+||+.||++||++.+++++
T Consensus       307 l~elltg~~Pf~~~~~~~~----------------~~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG----------------SEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC----------------SGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHCCCCCCCcchhhh----------------HHHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999999999974432211                11111111  1233    348899999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.3e-40  Score=343.09  Aligned_cols=263  Identities=25%  Similarity=0.361  Sum_probs=198.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeec----CCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSS----RDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~~  170 (443)
                      ++|++.+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|++++++++||||+++++++..    .+....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999995 4689999999875422 234578999999999999999999998754    125577


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCc---eEEcccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFH---AKVADFG  247 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg  247 (443)
                      ++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999975432 335899999999999999999999999   999999999999987664   9999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|||++|..||....     ....|.........
T Consensus       170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-----~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW-----QPVQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC-----HHHHSSTTCC----
T ss_pred             cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc-----chhhhhhhhhcccc
Confidence            9987654322   244679999999999999999999999999999999999999996421     11111110000000


Q ss_pred             ---ccccccc------C--ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 013404          328 ---RLEELAD------P--RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV  371 (443)
Q Consensus       328 ---~~~~~~d------~--~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl  371 (443)
                         .......      .  .............+.+++..||+.||++|||++|++
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence               0000000      0  011123344566789999999999999999999855

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.9e-39  Score=306.34  Aligned_cols=231  Identities=14%  Similarity=0.117  Sum_probs=181.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCC---HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|... +|+.||||.+.......   .+.|.+|+.++.+++||||+++++++..  ....++
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l  108 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLV  108 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEE
Confidence            57999999999999999999965 58999999998654332   3678999999999999999999999874  457899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++++|.+++...      ....++.+++.|++.||+|||+++   |+||||||+|||+++++.+||+++|     
T Consensus       109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-----  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-----  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred             EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence            99999999999999531      355678999999999999999999   9999999999999999999998543     


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc-
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE-  331 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  331 (443)
                                       |++       .++.++|||||||++|||++|+.||...........         ....... 
T Consensus       175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---------~~~~~~~~  221 (286)
T 3uqc_A          175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---------AERDTAGQ  221 (286)
T ss_dssp             -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---------CCBCTTSC
T ss_pred             -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---------HHHHhccC
Confidence                             333       268899999999999999999999975443211100         0000000 


Q ss_pred             ccc-CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          332 LAD-PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       332 ~~d-~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ... ......++    ..+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus       222 ~~~~~~~~~~~~----~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          222 PIEPADIDRDIP----FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             BCCHHHHCTTSC----HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CCChhhcccCCC----HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            000 00112223    348899999999999999 9999999999886543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-38  Score=304.33  Aligned_cols=235  Identities=23%  Similarity=0.290  Sum_probs=181.1

Q ss_pred             hcCCCCC-ceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHH-hhcCCCceeeEEEeeec--CCCCee
Q 013404           96 TNNFEPA-SILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEML-SRLHHRNLVKLVGYYSS--RDSSQH  170 (443)
Q Consensus        96 ~~~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~--~~~~~~  170 (443)
                      .++|.+. +.||+|+||.||++.. .+++.||+|.+..     ...+.+|+.++ +.++||||+++++++..  .+....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567776 7899999999999996 5789999999863     35678899988 55589999999998864  224578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceEEcccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG  247 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  247 (443)
                      ++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            99999999999999997532  346899999999999999999999999   999999999999998   7889999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      ++....                        +..++.++|||||||++|||++|+.||.........            ..
T Consensus       166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~  209 (299)
T 3m2w_A          166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PG  209 (299)
T ss_dssp             TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CC
T ss_pred             cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HH
Confidence            986432                        234678999999999999999999999643221100            00


Q ss_pred             cccccccCccCCCCCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          328 RLEELADPRLGGKYPK----EDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      ....+....  ...+.    .....+.+++.+||+.||++|||+.|++++-+...
T Consensus       210 ~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          210 MKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             SCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence            000000000  01111    11345889999999999999999999999866543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-38  Score=307.16  Aligned_cols=245  Identities=18%  Similarity=0.194  Sum_probs=186.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCC--------CCHHHHHHHHHHHhhcC---------CCceeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--------QGDKEFLVEVEMLSRLH---------HRNLVKL  158 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~l  158 (443)
                      .++|++.+.||+|+||.||+|+. +|+.||||++.....        ...+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688999999999999999998 689999999976532        22378899999999886         8888888


Q ss_pred             EEeeecC----------------------------CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHH
Q 013404          159 VGYYSSR----------------------------DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR  210 (443)
Q Consensus       159 ~~~~~~~----------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~  210 (443)
                      .+++...                            +....++||||+++|++.+.+.+     ..+++..+..++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            7764311                            24578999999999987777642     34899999999999999


Q ss_pred             HHHHhh-hcCCCceEecCCCcccEEecCCC--------------------ceEEccccccccCCCCCccccccccccCcc
Q 013404          211 GLAYLH-EDSQPCVIHRDFKASNILLENNF--------------------HAKVADFGLAKQAPEGRTNYLSTRVMGTFG  269 (443)
Q Consensus       211 ~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  269 (443)
                      ||+||| +.+   |+||||||+|||++.++                    .+||+|||+++.....       ...||+.
T Consensus       173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred             HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence            999999 899   99999999999999887                    8999999999865432       3479999


Q ss_pred             cccccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc-cccCccCCCCCHHHHH
Q 013404          270 YVAPEYAMTGHLLVKSDVYSYGVV-LLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE-LADPRLGGKYPKEDFI  347 (443)
Q Consensus       270 y~aPE~~~~~~~~~~sDv~S~G~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~~~~~~~~~~~~  347 (443)
                      |+|||++.+.. +.++||||||++ .+++++|..||..         ..|.......  .+.. ................
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDK--MLKQMTFKTKCNTPAMKQIKR  310 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHH--HHHTCCCSSCCCSHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHh--hhhhhccCcccchhhhhhcCH
Confidence            99999998776 889999998777 7778889998831         1121111100  0000 0001111112234566


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHH-HH
Q 013404          348 RVCTIAAACVAPEANQRPTMGEVV-QS  373 (443)
Q Consensus       348 ~l~~li~~cl~~dp~~RPs~~evl-~~  373 (443)
                      .+.+|+.+||+.|     |++|++ +|
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHHhccC-----CHHHHHhcC
Confidence            7899999999976     999998 65

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=2.1e-32  Score=282.39  Aligned_cols=185  Identities=18%  Similarity=0.135  Sum_probs=128.7

Q ss_pred             eeeecCcEEEEEEE-ECCCcEEEEEEeccCCCC----------CHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeE
Q 013404          104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQ----------GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus       104 ~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ..+.|++|.+..++ ...|+.||||.+......          ..++|.+|+++|+++ .|+||+++++++.  +....|
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e--d~~~~y  318 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE--NAQSGW  318 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE--CSSEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--ECCEEE
Confidence            35567777666655 446888999999754211          124699999999999 7999999999998  556899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      |||||++|++|.++|...    .+++..   +|+.||+.||+|||++|   ||||||||+||||++++.+||+|||+|+.
T Consensus       319 LVMEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCee
Confidence            999999999999999753    345543   58899999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKP  303 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p  303 (443)
                      ......  .....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       389 ~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            654332  2345689999999999875 456789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=7.4e-29  Score=254.51  Aligned_cols=185  Identities=16%  Similarity=0.181  Sum_probs=143.5

Q ss_pred             CCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCC--------HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404          100 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQG--------DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ...+.||+|+||.||+|.. .+..+++|+........        .+.+.+|++++++++||||+++..++..  ....+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTTE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCccE
Confidence            3467899999999999954 46889999875432221        2348999999999999999954444442  33569


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      |||||+++++|.+++..            +..++.|+++||+|||+++   |+||||||+|||+++  .+||+|||+++.
T Consensus       416 lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             EEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             EEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence            99999999999999964            4589999999999999999   999999999999998  999999999998


Q ss_pred             CCCCCccc-----cccccccCccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 013404          252 APEGRTNY-----LSTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVLLELLTGRKPV  304 (443)
Q Consensus       252 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~G~il~elltg~~p~  304 (443)
                      ........     ......||+.|||||++..  ..|+..+|+|+..+-..+-+.++.+|
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            75432211     1235689999999999987  67888899999999999888887766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=2.4e-25  Score=209.91  Aligned_cols=151  Identities=16%  Similarity=0.115  Sum_probs=120.3

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC------------------CHHHHHHHHHHHhhcCC
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ------------------GDKEFLVEVEMLSRLHH  152 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h  152 (443)
                      .+......|++.+.||+|+||.||+|...+|+.||+|.++.....                  ....+.+|++++++++|
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            344455667777999999999999999977999999999643211                  23568899999999984


Q ss_pred             CceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCccc
Q 013404          153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN  232 (443)
Q Consensus       153 ~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  232 (443)
                         +++.+++..   ...++||||+++|+|.+ +..          .....++.|++.||.|||+.+   |+||||||+|
T Consensus       164 ---~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N  223 (282)
T 1zar_A          164 ---LAVPKVYAW---EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN  223 (282)
T ss_dssp             ---SSSCCEEEE---ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred             ---CCcCeEEec---cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence               555554432   35699999999999998 421          334579999999999999999   9999999999


Q ss_pred             EEecCCCceEEccccccccCCCCCccccccccccCcccccccccc
Q 013404          233 ILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM  277 (443)
Q Consensus       233 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  277 (443)
                      ||++ ++.+||+|||+++..               ..|+|||++.
T Consensus       224 ILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVEV---------------GEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence            9999 999999999998643               3478899774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=5.3e-21  Score=177.89  Aligned_cols=137  Identities=19%  Similarity=0.144  Sum_probs=107.6

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcE--EEEEEeccCCCCC------------------------HHHHHHHHHHHhhc
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTA--VAIKRLTCGGQQG------------------------DKEFLVEVEMLSRL  150 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l  150 (443)
                      -|++.+.||+|+||.||+|.. .+|+.  ||||.++......                        ...+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356789999999999999997 68888  9999876432110                        12578899999999


Q ss_pred             CCCce--eeEEEeeecCCCCeeEEEEeecCC-C----ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhh-hcCCCc
Q 013404          151 HHRNL--VKLVGYYSSRDSSQHLLCYELVPN-G----SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH-EDSQPC  222 (443)
Q Consensus       151 ~h~ni--v~l~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~  222 (443)
                      .|+++  ..++++      ...+|||||+.+ |    +|.++...       .++..+..++.|++.||.||| +.+   
T Consensus       128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---  191 (258)
T 1zth_A          128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---  191 (258)
T ss_dssp             HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---
T ss_pred             HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---
Confidence            88764  344432      146899999942 4    67766431       235678899999999999999 888   


Q ss_pred             eEecCCCcccEEecCCCceEEccccccccC
Q 013404          223 VIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       223 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |+||||||.|||+++  .++|+|||++...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999998  9999999999764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=1.1e-18  Score=169.14  Aligned_cols=138  Identities=15%  Similarity=0.190  Sum_probs=101.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCC--------------CCHHHH--------HHHHHHHhhcCCCc
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--------------QGDKEF--------LVEVEMLSRLHHRN  154 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~h~n  154 (443)
                      .-|++.+.||+|+||.||+|...+|+.||||+++....              .....+        ..|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34899999999999999999988999999998764210              011122        34556666664443


Q ss_pred             ee--eEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCccc
Q 013404          155 LV--KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASN  232 (443)
Q Consensus       155 iv--~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N  232 (443)
                      +.  ..+++    .  ..+|||||++|++|.++..          ......++.|++.+|.|||+.+   ||||||||.|
T Consensus       175 v~vp~p~~~----~--~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~N  235 (397)
T 4gyi_A          175 FPVPEPIAQ----S--RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKHG---LIHGDFNEFN  235 (397)
T ss_dssp             CSCCCEEEE----E--TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred             CCCCeeeec----c--CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence            32  22222    1  2379999999999876543          1234678899999999999999   9999999999


Q ss_pred             EEecCCC----------ceEEccccccccCC
Q 013404          233 ILLENNF----------HAKVADFGLAKQAP  253 (443)
Q Consensus       233 Ill~~~~----------~~kl~Dfgla~~~~  253 (443)
                      ||+++++          .+.|+||+-+....
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9998876          38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=4e-13  Score=124.67  Aligned_cols=148  Identities=16%  Similarity=0.096  Sum_probs=114.7

Q ss_pred             HHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCe
Q 013404           91 ELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        91 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  169 (443)
                      .+......|++...++.|+++.||++... +..+++|............+.+|+++++.+. +.++.++++++..  ...
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~   84 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGW   84 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTE
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCc
Confidence            34455567888888999999999998754 6889999987532223346889999999984 6777889888763  457


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-------------------------------
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-------------------------------  218 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------  218 (443)
                      .++||||++|.+|.+.+.         +......++.+++++|..||+.                               
T Consensus        85 ~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           85 SNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             eEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            899999999999988642         1133457889999999999981                               


Q ss_pred             -------------------------CCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          219 -------------------------SQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       219 -------------------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                                               ..+.++|+|+++.||+++++..+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                     11459999999999999877667799999774

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=2.4e-12  Score=118.86  Aligned_cols=136  Identities=20%  Similarity=0.154  Sum_probs=98.5

Q ss_pred             CCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCce--eeEEEeeecCCCCeeEEEEe
Q 013404           98 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~~~lv~e  175 (443)
                      ++.+....+.|..+.||++...+|..+++|.....   ....+.+|+++++.+.+.++  .+++++..  +....++|||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~--~~~~~~~v~e   95 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLG   95 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc--CCCCCEEEEE
Confidence            44433333455669999998777888999997643   23457889999999965454  45887765  3346799999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS------------------------------------  219 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  219 (443)
                      |++|.+|.  ...       .   ....++.++++.|..||+..                                    
T Consensus        96 ~i~G~~l~--~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           96 EVPGQDLL--SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             CCSSEETT--TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             ecCCcccC--cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            99998884  221       1   12356777888888888643                                    


Q ss_pred             -------------------CCceEecCCCcccEEecCCCceEEccccccc
Q 013404          220 -------------------QPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       220 -------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                                         .+.++|+|++|.||+++++..+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                               2349999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=8.7e-11  Score=114.10  Aligned_cols=144  Identities=15%  Similarity=0.159  Sum_probs=106.3

Q ss_pred             CCceeeecCcEEEEEEEECCCcEEEEEEec--cCCC-CCHHHHHHHHHHHhhcC--CCceeeEEEeeecCCC-CeeEEEE
Q 013404          101 PASILGEGGFGRVFKGVLSDGTAVAIKRLT--CGGQ-QGDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS-SQHLLCY  174 (443)
Q Consensus       101 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~-~~~~lv~  174 (443)
                      ..+.|+.|.++.||+....+ ..+++|+..  .... .....+.+|+++++.+.  +.++.++++++...+. +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            35679999999999988754 678888775  3221 22356888999999996  4567788888764321 3578999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS-----------------------------------  219 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  219 (443)
                      ||++|..+.+..      ...++..++..++.++++.|..||...                                   
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999998875422      123677888999999999999999731                                   


Q ss_pred             --------------------CCceEecCCCcccEEecCCCc--eEEcccccccc
Q 013404          220 --------------------QPCVIHRDFKASNILLENNFH--AKVADFGLAKQ  251 (443)
Q Consensus       220 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~  251 (443)
                                          .+.++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                356999999999999997653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=4.9e-11  Score=113.11  Aligned_cols=185  Identities=21%  Similarity=0.267  Sum_probs=121.4

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCc--eeeEEEeeecCCC-CeeEEEEeec
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRN--LVKLVGYYSSRDS-SQHLLCYELV  177 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~~-~~~~lv~e~~  177 (443)
                      .+.++.|.+..||+..    ..+++|.....  .....+.+|+++|+.+ .+..  +.+++......+. ...++||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4669999999999863    45888886422  2346788999999888 3333  3345544322111 2357899999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED---------------------------------------  218 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------  218 (443)
                      +|.+|.+...      ..++..++..++.++++.|+.||+.                                       
T Consensus        99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9988875332      1366677788888888888888851                                       


Q ss_pred             ----------------CCCceEecCCCcccEEecC--CCceEEccccccccCCCCCccccccccccCccc---ccccccc
Q 013404          219 ----------------SQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGY---VAPEYAM  277 (443)
Q Consensus       219 ----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~  277 (443)
                                      ..+.++|+|+++.||++++  +..+.|+||+.+........-      .....+   ..|+...
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHHH
Confidence                            1256899999999999998  566889999998654221100      000001   1222111


Q ss_pred             c-----CC---------CCchhhHHHHHHHHHHHHhCCCCC
Q 013404          278 T-----GH---------LLVKSDVYSYGVVLLELLTGRKPV  304 (443)
Q Consensus       278 ~-----~~---------~~~~sDv~S~G~il~elltg~~p~  304 (443)
                      .     +.         .....+.|+++.++|.+.+|..+|
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            0     00         112368999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.70  E-value=1.2e-07  Score=87.94  Aligned_cols=135  Identities=16%  Similarity=0.138  Sum_probs=95.3

Q ss_pred             ceeeecCcE-EEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEEeecCC
Q 013404          103 SILGEGGFG-RVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPN  179 (443)
Q Consensus       103 ~~lg~G~fg-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~e~~~~  179 (443)
                      +.+..|..| .||+.... ++..+++|+-..   .....+.+|...|+.+. +-.+.++++++..  ....++|||+++|
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~G  104 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIPG  104 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCCS
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeCC
Confidence            345556655 68987754 566789998652   23456888999999884 3345677887764  3478999999999


Q ss_pred             CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 013404          180 GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS----------------------------------------  219 (443)
Q Consensus       180 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------  219 (443)
                      .++.+....        .......+..+++..|..||...                                        
T Consensus       105 ~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          105 KTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             EEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             ccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            888776531        12333455666666666666421                                        


Q ss_pred             ---------------CCceEecCCCcccEEecCCCceEEccccccc
Q 013404          220 ---------------QPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       220 ---------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                                     .+.++|+|+.+.||++++++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           2348999999999999988777899999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.67  E-value=2.5e-07  Score=87.56  Aligned_cols=137  Identities=22%  Similarity=0.183  Sum_probs=93.6

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCC---ceeeEEEeeecCCCCeeEEEEeecC
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHR---NLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      .+.++.|....||+.    |..+++|.-..  ......+.+|+++|+.+.+.   .+.+.+.++.. ..+..+++|||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccC
Confidence            456889999999987    46688888531  12245788999999999642   34566666542 3345789999999


Q ss_pred             CCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 013404          179 NGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED----------------------------------------  218 (443)
Q Consensus       179 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------  218 (443)
                      |.+|.+....      .++..+...++.++++.|..||+.                                        
T Consensus        97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9888763211      134444555555555555555532                                        


Q ss_pred             -----------------CCCceEecCCCcccEEecC---CCc-eEEcccccccc
Q 013404          219 -----------------SQPCVIHRDFKASNILLEN---NFH-AKVADFGLAKQ  251 (443)
Q Consensus       219 -----------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~Dfgla~~  251 (443)
                                       ..+.++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             3345899999999999987   345 58999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.53  E-value=4.5e-07  Score=87.60  Aligned_cols=83  Identities=6%  Similarity=-0.070  Sum_probs=55.9

Q ss_pred             Ccee-eecCcEEEEEEEEC-------CCcEEEEEEeccCC---CCCHHHHHHHHHHHhhcC-C--CceeeEEEeeecCC-
Q 013404          102 ASIL-GEGGFGRVFKGVLS-------DGTAVAIKRLTCGG---QQGDKEFLVEVEMLSRLH-H--RNLVKLVGYYSSRD-  166 (443)
Q Consensus       102 ~~~l-g~G~fg~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~-  166 (443)
                      .+.| +.|....+|+....       ++..+++|......   ......+.+|+.+++.+. +  -.+.++++++...+ 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998764       26678898865322   111245778999988884 3  34667887765321 


Q ss_pred             CCeeEEEEeecCCCChhH
Q 013404          167 SSQHLLCYELVPNGSLES  184 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~  184 (443)
                      .+..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence            134689999999877654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.34  E-value=3.9e-06  Score=78.40  Aligned_cols=79  Identities=20%  Similarity=0.209  Sum_probs=58.6

Q ss_pred             CCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-C--CceeeEEEeeecCCCCeeEEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-H--RNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .+...+.+|.|..+.||+.++.+|+.|.+|+-..........|..|++.|+.|. .  -.+.+++++.      ..+++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~------~~~lv~   89 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD------DRTLAM   89 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE------TTEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc------CceEEE
Confidence            344567899999999999999999999999876554444456889999999884 2  2344555542      237899


Q ss_pred             eecCCCCh
Q 013404          175 ELVPNGSL  182 (443)
Q Consensus       175 e~~~~gsL  182 (443)
                      ||++++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.27  E-value=4.4e-06  Score=81.88  Aligned_cols=75  Identities=17%  Similarity=0.123  Sum_probs=49.3

Q ss_pred             CceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-------CCHHHHHHHHHHHhhcCC--Ccee-eEEEeeecCCCCee
Q 013404          102 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-------QGDKEFLVEVEMLSRLHH--RNLV-KLVGYYSSRDSSQH  170 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~~  170 (443)
                      .+.||.|.++.||++... +++.++||.......       .....+..|.++|+.+..  +..+ +++.+.    ....
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d----~~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc----CCcc
Confidence            467999999999999753 468899998653211       123457789999988742  4444 555442    2245


Q ss_pred             EEEEeecCCC
Q 013404          171 LLCYELVPNG  180 (443)
Q Consensus       171 ~lv~e~~~~g  180 (443)
                      ++||||+++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            8999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.14  E-value=5.8e-06  Score=78.95  Aligned_cols=143  Identities=22%  Similarity=0.268  Sum_probs=79.3

Q ss_pred             ceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC--CceeeEEEee----ecCCCCeeEEEEee
Q 013404          103 SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYY----SSRDSSQHLLCYEL  176 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~----~~~~~~~~~lv~e~  176 (443)
                      +.|+.|..+.||+....+| .+++|+...    ....+..|+.+++.|..  -.+.+++...    .....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677899999987655 489998864    23445556666666531  1233333210    00123467899999


Q ss_pred             cCCCChh--------------HhhcC----C--C-CC---CCCCChHHH-------------------------------
Q 013404          177 VPNGSLE--------------SWLHG----P--L-GV---NCHLDWETR-------------------------------  201 (443)
Q Consensus       177 ~~~gsL~--------------~~l~~----~--~-~~---~~~l~~~~~-------------------------------  201 (443)
                      ++|..+.              ..+|.    .  . ..   ...-.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              01111    0  0 00   001123211                               


Q ss_pred             HHHHHHHHHHHHHhhh----------cCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          202 MKIALDAARGLAYLHE----------DSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       202 ~~i~~~i~~~l~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ..+...+..++.+|+.          ...+.++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223345666653          124559999999999999888889999999775

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.08  E-value=3.4e-05  Score=72.82  Aligned_cols=139  Identities=17%  Similarity=0.168  Sum_probs=90.2

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC---CCceeeEEEeeecCCCCeeEEEEeecC
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH---HRNLVKLVGYYSSRDSSQHLLCYELVP  178 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~~lv~e~~~  178 (443)
                      .+.|+.|.+..+|+... ++..+++|+....   ....+..|.+.|+.|.   ...+.++++++..  ....++||||++
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l~  114 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEALN  114 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEecc
Confidence            46799999999999876 4677889987532   3567889999999884   3567788887653  357899999999


Q ss_pred             CCChhH-----------hhcCCCC---CC---------------CCCChHHHH---HHHH----------------HHHH
Q 013404          179 NGSLES-----------WLHGPLG---VN---------------CHLDWETRM---KIAL----------------DAAR  210 (443)
Q Consensus       179 ~gsL~~-----------~l~~~~~---~~---------------~~l~~~~~~---~i~~----------------~i~~  210 (443)
                      +..+..           .||....   ..               ..-+|....   ++..                .++.
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            886521           1222111   00               011343221   1111                1111


Q ss_pred             H-HHHhhh-cCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          211 G-LAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       211 ~-l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      . ...|.. ...|.++|+|+.+.|++++.++ +.|.||.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 123432 3367899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.83  E-value=7.7e-05  Score=73.59  Aligned_cols=78  Identities=14%  Similarity=0.154  Sum_probs=48.8

Q ss_pred             CCceEecCCCcccEEecCCCceEEccccccccCCCCCcccccccc-ccCcccccccccccC---CCCchhhHHHHHHHHH
Q 013404          220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV-MGTFGYVAPEYAMTG---HLLVKSDVYSYGVVLL  295 (443)
Q Consensus       220 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~sDv~S~G~il~  295 (443)
                      .+.++|+|+++.|||+++++ ++|+||+.+........  ..... .-...|++|+.....   ......++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            45699999999999999876 99999998875432110  00000 012346666655321   1123456668888888


Q ss_pred             HHHhC
Q 013404          296 ELLTG  300 (443)
Q Consensus       296 elltg  300 (443)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.72  E-value=0.00039  Score=65.60  Aligned_cols=161  Identities=12%  Similarity=0.102  Sum_probs=88.2

Q ss_pred             cCHHHHHHHhcCCCCC-----ceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc--eeeEE
Q 013404           87 LAYEELKEATNNFEPA-----SILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLV  159 (443)
Q Consensus        87 ~~~~~~~~~~~~~~~~-----~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  159 (443)
                      ++.+++......|.+.     +.|+.|....+|+....+| .+++|.....  .....+..|+.+++.|...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4556677666667652     3466788899999987666 5888988642  12345667888887774222  22332


Q ss_pred             Eeeec----CCCCeeEEEEeecCCCChhH--------------hhcC----CCCCC----CCCChHHHHH----------
Q 013404          160 GYYSS----RDSSQHLLCYELVPNGSLES--------------WLHG----PLGVN----CHLDWETRMK----------  203 (443)
Q Consensus       160 ~~~~~----~~~~~~~lv~e~~~~gsL~~--------------~l~~----~~~~~----~~l~~~~~~~----------  203 (443)
                      .....    ...+..+++++|++|..+..              .+|.    .....    ....|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21000    01235688999999865421              0111    00000    0011221110          


Q ss_pred             --HHHHHHHHHHHhhhc----CCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          204 --IALDAARGLAYLHED----SQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       204 --i~~~i~~~l~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                        +...+...+++++..    ..+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              001133445555432    23459999999999999987666899999775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.67  E-value=0.00033  Score=65.59  Aligned_cols=140  Identities=11%  Similarity=0.064  Sum_probs=76.0

Q ss_pred             CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCce-eeEEEeeecCCCCeeEEEEeec-CC
Q 013404          102 ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLLCYELV-PN  179 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~-~~  179 (443)
                      .+.|+.|....+|+.     ..+++|+....... .....+|+.+++.+...++ .++++++.  +  .-++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~--~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--A--TGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--T--TCCEEEECCTTC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--C--CCEEEEeecCCC
Confidence            678999999999998     45888887643211 1123568888877743233 35655432  2  346889999 65


Q ss_pred             CChhH------------------hhcCCCC-CCCCCCh-HHHHHHHH--------------HHHHHH----HHhh-hcCC
Q 013404          180 GSLES------------------WLHGPLG-VNCHLDW-ETRMKIAL--------------DAARGL----AYLH-EDSQ  220 (443)
Q Consensus       180 gsL~~------------------~l~~~~~-~~~~l~~-~~~~~i~~--------------~i~~~l----~~LH-~~~~  220 (443)
                      .+|..                  .+|.... ....... .....+..              .+.+.+    ..|. ....
T Consensus        93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~  172 (301)
T 3dxq_A           93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP  172 (301)
T ss_dssp             EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence            44431                  1122110 0001111 11111100              011111    1111 1234


Q ss_pred             CceEecCCCcccEEecCCCceEEccccccccC
Q 013404          221 PCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       221 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      +.++|+|+.+.||+ ..++.+.|+||..+...
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            56999999999999 55667899999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.64  E-value=0.0003  Score=69.48  Aligned_cols=73  Identities=23%  Similarity=0.279  Sum_probs=50.5

Q ss_pred             CceeeecCcEEEEEEEECC--------CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCce-eeEEEeeecCCCCeeEE
Q 013404          102 ASILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLL  172 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~l  172 (443)
                      .+.|+.|....||+....+        +..+++|+....  .....+..|..+++.|...++ .++++.+.  +    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C----CE
Confidence            4568888899999998753        478999988432  122566689999998853334 46776653  2    38


Q ss_pred             EEeecCCCCh
Q 013404          173 CYELVPNGSL  182 (443)
Q Consensus       173 v~e~~~~gsL  182 (443)
                      |+||++|.+|
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            8999986444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.61  E-value=0.0011  Score=62.53  Aligned_cols=160  Identities=16%  Similarity=0.131  Sum_probs=89.4

Q ss_pred             cCHHHHHHHhcCCCC-----CceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc--eeeEE
Q 013404           87 LAYEELKEATNNFEP-----ASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN--LVKLV  159 (443)
Q Consensus        87 ~~~~~~~~~~~~~~~-----~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  159 (443)
                      ++.+.+......|.+     ...|+ |....||+....+|+.+++|...... .....+..|..+++.+....  +.+++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~   88 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV   88 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence            445555555444432     24566 88889999887777789999986331 23567778888888874222  33443


Q ss_pred             EeeecC----CCCeeEEEEeecCCCChh-----Hh---------hc----CCCC-CCCCCChHHH---------------
Q 013404          160 GYYSSR----DSSQHLLCYELVPNGSLE-----SW---------LH----GPLG-VNCHLDWETR---------------  201 (443)
Q Consensus       160 ~~~~~~----~~~~~~lv~e~~~~gsL~-----~~---------l~----~~~~-~~~~l~~~~~---------------  201 (443)
                      .. ...    ..+..+++|+|++|..+.     .+         +|    .... ....+++...               
T Consensus        89 ~~-~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  167 (328)
T 1zyl_A           89 AF-NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP  167 (328)
T ss_dssp             CB-TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred             ec-CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence            32 100    123557899999875432     10         11    1000 0111222111               


Q ss_pred             -------HHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          202 -------MKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       202 -------~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                             ...+..++..+.-+-. ...+.++|+|+++.||+++ + .+.|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   1111122222222211 1345589999999999999 4 899999998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.55  E-value=0.00099  Score=63.22  Aligned_cols=143  Identities=17%  Similarity=0.112  Sum_probs=72.7

Q ss_pred             ceeeecCcEE-EEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC--CceeeEEEeeecCCCCeeEEEEeecCC
Q 013404          103 SILGEGGFGR-VFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHLLCYELVPN  179 (443)
Q Consensus       103 ~~lg~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~lv~e~~~~  179 (443)
                      +.|+.|.... +|+....+|..+++|.......   ..+..|+.+++.+..  -.+.+++.+..  +.+  +++||++.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g--~ll~e~l~~   96 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARG--LLLIEDLGD   96 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTT--EEEECCCCS
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCC--EEEEeeCCC
Confidence            4465555554 6676654467777776543211   234557777776632  23445666532  222  689999977


Q ss_pred             CChhHhhcCC---------------------CCC-CCCCChHHHH-------HH-------------HHHHHHHHHHhh-
Q 013404          180 GSLESWLHGP---------------------LGV-NCHLDWETRM-------KI-------------ALDAARGLAYLH-  216 (443)
Q Consensus       180 gsL~~~l~~~---------------------~~~-~~~l~~~~~~-------~i-------------~~~i~~~l~~LH-  216 (443)
                      ..+.+++...                     ... ...++.....       .+             ...+...+..+. 
T Consensus        97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~  176 (333)
T 3csv_A           97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS  176 (333)
T ss_dssp             CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred             cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence            6665443211                     000 0111111100       00             001111222221 


Q ss_pred             --hcCCCceEecCCCcccEEecCC----CceEEccccccccC
Q 013404          217 --EDSQPCVIHRDFKASNILLENN----FHAKVADFGLAKQA  252 (443)
Q Consensus       217 --~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~~  252 (443)
                        ....+.++|+|+.+.||+++.+    ..+.|+||+.+...
T Consensus       177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence              1224569999999999999874    67999999988754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.54  E-value=0.00057  Score=67.96  Aligned_cols=74  Identities=14%  Similarity=0.038  Sum_probs=47.9

Q ss_pred             CceeeecCcEEEEEEEECC-CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCce-eeEEEeeecCCCCeeEEEEeecCC
Q 013404          102 ASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLLCYELVPN  179 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~lv~e~~~~  179 (443)
                      .+.|+.|-...+|+....+ +..+++|+....... .-+..+|..+++.|...++ .++++++.  +    .+||||++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~----G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N----GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T----EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C----eEEEEeeCC
Confidence            3568888899999998765 477888887533211 1122578999998865555 46777652  2    258999987


Q ss_pred             CCh
Q 013404          180 GSL  182 (443)
Q Consensus       180 gsL  182 (443)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            554

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.41  E-value=0.00061  Score=65.98  Aligned_cols=142  Identities=19%  Similarity=0.230  Sum_probs=83.5

Q ss_pred             CceeeecCcEEEEEEEEC--------CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCc-eeeEEEeeecCCCCeeEE
Q 013404          102 ASILGEGGFGRVFKGVLS--------DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN-LVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~~l  172 (443)
                      .+.|..|-...+|+....        ++..+++|+... .......+.+|.++++.|.--+ ..++++++.  +    .+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~----g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E----GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T----EE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C----cc
Confidence            356777888889998864        247899998632 2234566778999998884222 346666653  2    28


Q ss_pred             EEeecCCCChhHh-----------------hcCCC-CCCCCCC--hHHHHHHHHHHHH-------------------HHH
Q 013404          173 CYELVPNGSLESW-----------------LHGPL-GVNCHLD--WETRMKIALDAAR-------------------GLA  213 (443)
Q Consensus       173 v~e~~~~gsL~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~~i~~-------------------~l~  213 (443)
                      ||||++|.+|..-                 ||... .......  |.++.++..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            8999998665321                 12111 0111122  3455555544322                   123


Q ss_pred             Hhh----hc-CCCceEecCCCcccEEecCC----CceEEccccccc
Q 013404          214 YLH----ED-SQPCVIHRDFKASNILLENN----FHAKVADFGLAK  250 (443)
Q Consensus       214 ~LH----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~  250 (443)
                      .|.    .. ....++|+|+.+.||+++++    +.+.|+||..+.
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            322    22 23469999999999999876    689999999875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.19  E-value=0.0017  Score=57.04  Aligned_cols=100  Identities=20%  Similarity=0.156  Sum_probs=66.0

Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCcccc
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL  260 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  260 (443)
                      +|.+.|...   +.+++++++|.++.|.+.+|.-+-....+  ..+=+.|..|++..+|.+.+.+ +.+.          
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence            788988643   56799999999999999998776221111  1334457899999999988764 1111          


Q ss_pred             ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 013404          261 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR  301 (443)
Q Consensus       261 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~  301 (443)
                          .....+.+||... ...+.+.=|||||+++|.-+--.
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence                1122366888653 45578899999999999988633

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.15  E-value=0.00083  Score=64.81  Aligned_cols=74  Identities=14%  Similarity=0.088  Sum_probs=44.1

Q ss_pred             CceeeecCcEEEEEEEECC---------CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCce-eeEEEeeecCCCCeeE
Q 013404          102 ASILGEGGFGRVFKGVLSD---------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHL  171 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~  171 (443)
                      .+.|+.|....+|+....+         +..+++|+...... ...+...|.++++.+...++ .++++..   +   -+
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~---~~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF---N---GG  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE---T---TE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec---C---Cc
Confidence            3567788888999988754         26788888653221 11124578888888853333 3566543   1   26


Q ss_pred             EEEeecCCCCh
Q 013404          172 LCYELVPNGSL  182 (443)
Q Consensus       172 lv~e~~~~gsL  182 (443)
                      ++|||++|..+
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            88999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.13  E-value=0.0012  Score=62.86  Aligned_cols=33  Identities=24%  Similarity=0.317  Sum_probs=28.4

Q ss_pred             CCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       220 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ...++|+|+.+.||++++++.+.|+||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            456999999999999998888999999877643

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.19  E-value=0.027  Score=55.13  Aligned_cols=142  Identities=12%  Similarity=0.114  Sum_probs=84.1

Q ss_pred             CceeeecCcEEEEEEEECC--------CcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCce-eeEEEeeecCCCCeeEE
Q 013404          102 ASILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL-VKLVGYYSSRDSSQHLL  172 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~~l  172 (443)
                      .+.|..|-...+|+....+        +..+++|+...... ..-+..+|.++++.+...++ .++++.+.      -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~------~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP------EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET------TEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC------CCE
Confidence            3567778889999998753        57899998654321 12234578888888843233 45655432      268


Q ss_pred             EEeecCCCChhH--h---------------hcCC-------CC--CCCCCChHHHHHHHHHH------------------
Q 013404          173 CYELVPNGSLES--W---------------LHGP-------LG--VNCHLDWETRMKIALDA------------------  208 (443)
Q Consensus       173 v~e~~~~gsL~~--~---------------l~~~-------~~--~~~~l~~~~~~~i~~~i------------------  208 (443)
                      |+||++|..|..  +               ||..       ..  ...+.-|.++.++..++                  
T Consensus       148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  227 (424)
T 3mes_A          148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK  227 (424)
T ss_dssp             EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred             EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence            899999866421  0               0110       00  11111244444443322                  


Q ss_pred             -HHHHHHhh---------------------hcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          209 -ARGLAYLH---------------------EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       209 -~~~l~~LH---------------------~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                       ...+.+|.                     ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence             12223322                     112345899999999999 7788999999998753

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.81  E-value=0.0082  Score=37.88  Aligned_cols=28  Identities=18%  Similarity=0.114  Sum_probs=15.2

Q ss_pred             eEehhHHHHHHHHHHHHHHHHHHHHhcC
Q 013404           27 LIFGIGTGLLITAIISVLIICSCAFRGR   54 (443)
Q Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~   54 (443)
                      ++++++.|+++++++++++++++++|+.
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            4455555666666555555555554443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=95.72  E-value=0.0085  Score=37.71  Aligned_cols=29  Identities=21%  Similarity=0.296  Sum_probs=15.5

Q ss_pred             eEehhHHHHHHHHHHHHHHHHHHHHhcCC
Q 013404           27 LIFGIGTGLLITAIISVLIICSCAFRGRK   55 (443)
Q Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   55 (443)
                      ++.+++.|+++++++++++++++++|+++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            44455555666555555555555544433

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.26  E-value=0.078  Score=51.54  Aligned_cols=29  Identities=28%  Similarity=0.430  Sum_probs=24.5

Q ss_pred             ceEecCCCcccEEe------cCCCceEEccccccc
Q 013404          222 CVIHRDFKASNILL------ENNFHAKVADFGLAK  250 (443)
Q Consensus       222 ~ivH~Dlkp~NIll------~~~~~~kl~Dfgla~  250 (443)
                      .++|+|+.+.|||+      +++..+.++||..|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            36899999999999      446679999999875

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=95.20  E-value=0.016  Score=36.41  Aligned_cols=29  Identities=21%  Similarity=0.263  Sum_probs=14.2

Q ss_pred             ceeEehhHHHHHHHHHHHHHHHHHHHHhc
Q 013404           25 LILIFGIGTGLLITAIISVLIICSCAFRG   53 (443)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   53 (443)
                      ...+++.++|++++++++++++++.++|+
T Consensus        11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR~   39 (44)
T 2jwa_A           11 LTSIISAVVGILLVVVLGVVFGILIKRRQ   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhheehhh
Confidence            33455666665544444444444444443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=93.97  E-value=0.037  Score=33.76  Aligned_cols=22  Identities=27%  Similarity=0.150  Sum_probs=13.2

Q ss_pred             cceeEehhHHHHHHHHHHHHHH
Q 013404           24 NLILIFGIGTGLLITAIISVLI   45 (443)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~   45 (443)
                      +...|++++++.++.+++++++
T Consensus         9 s~GaIAGiVvG~v~gv~li~~l   30 (38)
T 2k1k_A            9 TGGEIVAVIFGLLLGAALLLGI   30 (38)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCceeeeehHHHHHHHHHHHH
Confidence            4556778877776655444433

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.11  E-value=0.053  Score=53.79  Aligned_cols=61  Identities=7%  Similarity=0.025  Sum_probs=17.7

Q ss_pred             CCCceeeecCcEEEEEEEECC-CcEEEE------EEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeee
Q 013404          100 EPASILGEGGFGRVFKGVLSD-GTAVAI------KRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYS  163 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  163 (443)
                      .+.+.||   ||.||+|.+.. ..+|||      |..+...  ......|.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456676   99999999754 367888      7665432  222356888999999999999999877643

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.35  E-value=5.5  Score=34.60  Aligned_cols=116  Identities=7%  Similarity=0.071  Sum_probs=76.0

Q ss_pred             CCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCc
Q 013404          151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKA  230 (443)
Q Consensus       151 ~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp  230 (443)
                      .||++++. .+-.  +...+.+.|+.-  .+...|-.     -..++...+++++.+|+....+++.     -+|--|.|
T Consensus        43 ~~~~Fl~~-~I~e--~eD~v~~~y~~~--~~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P  107 (215)
T 4ann_A           43 HSPYFIDA-ELTE--LRDSFQIHYDIN--DNHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP  107 (215)
T ss_dssp             CCTTBCCE-EEEE--CSSEEEEEECCC--TTSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred             cCCcccce-EEEE--cccEEEEEEEcC--cccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence            68888865 3333  223555555443  33333322     2247789999999999988755543     36889999


Q ss_pred             ccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 013404          231 SNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD  305 (443)
Q Consensus       231 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~  305 (443)
                      +||+++.++.+++.=.|+-....                   |.     ..+...=.-.+=|++..+++++..|+
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~l~-------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNVVD-------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTTBS-------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ceEEEcCCCCEEEEEccCccCCC-------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999998777543222                   21     11222233467789999999998874

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=84.45  E-value=1.4  Score=28.79  Aligned_cols=30  Identities=17%  Similarity=0.356  Sum_probs=13.2

Q ss_pred             eeEehhHHHHHHHHHHHHHHHHHHHHhcCCC
Q 013404           26 ILIFGIGTGLLITAIISVLIICSCAFRGRKS   56 (443)
Q Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   56 (443)
                      ++++++++|+++++++++ +.+-|-+.+|++
T Consensus        11 iIi~svl~GLLLL~Lii~-~LwK~GFFKR~~   40 (54)
T 2l8s_A           11 VILLSAFAGLLLLMLLIL-ALWKIGFFKRPL   40 (54)
T ss_dssp             HHHHHHHHHHHHHHHHHH-HHHHHHHTTSCC
T ss_pred             HHHHHHHHHHHHHHHHHH-HHHHcCcccCCC
Confidence            334444445444444433 333444444444

>2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens}

Probab=83.14  E-value=2.1  Score=28.14  Aligned_cols=29  Identities=24%  Similarity=0.485  Sum_probs=12.6

Q ss_pred             eEehhHHHHHHHHHHHHHHHHHHHHhcCCC
Q 013404           27 LIFGIGTGLLITAIISVLIICSCAFRGRKS   56 (443)
Q Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   56 (443)
                      +++++++|++++++++++ .+-|-+.+|++
T Consensus        15 Ii~svl~GLllL~li~~~-LwK~GFFkR~~   43 (54)
T 2knc_A           15 VLVGVLGGLLLLTILVLA-MWKVGFFKRNR   43 (54)
T ss_dssp             HHHHHHHHHHHHHHHHHH-HHHHHHTTTTC
T ss_pred             HHHHHHHHHHHHHHHHHH-HHHcCcccCCC
Confidence            344444444444444333 33444444443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.24  E-value=7.8  Score=33.75  Aligned_cols=114  Identities=9%  Similarity=0.071  Sum_probs=74.5

Q ss_pred             CCCceeeEEEeeecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHH-HhhhcCCCceEecCCC
Q 013404          151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA-YLHEDSQPCVIHRDFK  229 (443)
Q Consensus       151 ~h~niv~l~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~Dlk  229 (443)
                      .||++-.-+.  .  +.+.+.+.++.-+++.=...++       .++...+++++.+|+.... +++.     -+|--|.
T Consensus        48 ~~~~f~~~I~--~--~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~  111 (219)
T 4ano_A           48 VDPCIVRDID--V--SEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVC  111 (219)
T ss_dssp             SCSSSEEEEE--E--CSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCC
T ss_pred             cCCCCCeEEE--E--eCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEe
Confidence            6888822222  2  3345666666543433333332       3778999999999988776 5543     4688899


Q ss_pred             cccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhH-HHHHHHHHHHHhCCCCCC
Q 013404          230 ASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDV-YSYGVVLLELLTGRKPVD  305 (443)
Q Consensus       230 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv-~S~G~il~elltg~~p~~  305 (443)
                      |+||+++.++.++|.=.|+-...                   +|.-     .+ ..|. -++=|++..++.++..|+
T Consensus       112 P~NL~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          112 PENLMFNRALEPFFLHVGVKESL-------------------PPDE-----WD-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GGGEEECTTCCEEESCCEETTTB-------------------SSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CceEEEeCCCcEEEEEcCCcccC-------------------CCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999999877764322                   2221     11 2233 367788889999888774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	443
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-78
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-71
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-69
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-69
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-67
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-67
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-67
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-66
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-64
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-64
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-63
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-62
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-59
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-58
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-58
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-55
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-52
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-51
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-50
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-49
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-49
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-49
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-48
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-46
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-43
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-36
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-36
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-36
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (620), Expect = 1e-78
 Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 24/286 (8%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
                   +G G FG V+KG      AV +  +T    Q  + F  EV +L +  H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
             +GY     + Q  +  +     SL   LH         +    + IA   A+G+ YLH
Sbjct: 68  LFMGYS---TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
                 +IHRD K++NI L  +   K+ DFGLA        ++   ++ G+  ++APE  
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 277 MT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
                     +SDVY++G+VL EL+TG+ P          N       ++       +L 
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDL- 231

Query: 334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
             ++    PK     +  + A C+  + ++RP   +++ S++++ R
Sbjct: 232 -SKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 7e-71
 Identities = 75/280 (26%), Positives = 116/280 (41%), Gaps = 28/280 (10%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
              +    LG G FG V+ G  +  T VA+K L  G       FL E  ++ +L H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           +L    +        +  E + NGSL  +L  P G+   L     + +A   A G+A++ 
Sbjct: 72  RLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIE 126

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
           E      IHRD +A+NIL+ +    K+ADFGLA+   +               + APE  
Sbjct: 127 E---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAI 182

Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 335
             G   +KSDV+S+G++L E++T GR P            +     ++R  +  EEL   
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ- 241

Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                           +   C       RPT   +   L+
Sbjct: 242 ----------------LMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 2e-69
 Identities = 72/279 (25%), Positives = 118/279 (42%), Gaps = 26/279 (9%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           +       +G G FG V  G   +   VAIK +   G   +++F+ E E++ +L H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           +L G     + +   L +E + +G L  +L            ET + + LD   G+AYL 
Sbjct: 64  QLYGVC--LEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLE 118

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
           E    CVIHRD  A N L+  N   KV+DFG+ +   + +    ST       + +PE  
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVF 174

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
                  KSDV+S+GV++ E+ +  K    ++ + +         ++ D      L  PR
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPR 225

Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           L   +  +       I   C       RP    +++ L 
Sbjct: 226 LASTHVYQ-------IMNHCWKERPEDRPAFSRLLRQLA 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 4e-69
 Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 28/295 (9%)

Query: 105 LGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS 164
           +G+G FG V++G    G  VA+K  +   ++       E+     L H N++  +   + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 165 RDSS--QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED---- 218
            + +  Q  L  +   +GSL  +L+        +  E  +K+AL  A GLA+LH +    
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 219 -SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY--LSTRVMGTFGYVAPEY 275
             +P + HRD K+ NIL++ N    +AD GLA +               +GT  Y+APE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 276 AMTGHLL------VKSDVYSYGVVLLELLTGRKP----VDMSQPSGQENLVTWARPILRD 325
                 +       ++D+Y+ G+V  E+           D   P         +   +R 
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR- 242

Query: 326 KDRLEELADPRLGGKYPKEDFIR-VCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
           K   E+   P +  ++   + +R +  I   C       R T   + ++L  + +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  215 bits (547), Expect = 3e-67
 Identities = 74/308 (24%), Positives = 123/308 (39%), Gaps = 41/308 (13%)

Query: 89  YEELKEATNNF---------EPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCG-GQ 134
           +E+  EA   F         +   ++G G FG V  G L         VAIK L  G  +
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 135 QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNC 194
           +  ++FL E  ++ +  H N++ L        S+  ++  E + NGSL+S+L    G   
Sbjct: 69  KQRRDFLSEASIMGQFDHPNVIHL--EGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123

Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
                  + +    A G+ YL        +HRD  A NIL+ +N   KV+DFGL++   +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 255 GRTNYLSTRV---MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG 311
             ++   T          + APE          SDV+SYG+V+ E+++  +      P  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235

Query: 312 QENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVV 371
                     I +D                P +    +  +   C   + N RP  G++V
Sbjct: 236 DMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 372 QSLKMVQR 379
            +L  + R
Sbjct: 285 NTLDKMIR 292

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 4e-67
 Identities = 62/280 (22%), Positives = 110/280 (39%), Gaps = 28/280 (10%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
            +      LG G FG V  G       VAIK +  G    + EF+ E +++  L H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           +L G  +        +  E + NG L ++L            +  +++  D    + YL 
Sbjct: 63  QLYGVCT--KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE 117

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
                  +HRD  A N L+ +    KV+DFGL++   +      S        +  PE  
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVL 173

Query: 277 MTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP 335
           M      KSD++++GV++ E+ + G+ P +    S     +     + R     E++   
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT- 232

Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                           I  +C   +A++RPT   ++ ++ 
Sbjct: 233 ----------------IMYSCWHEKADERPTFKILLSNIL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 5e-67
 Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 42/310 (13%)

Query: 91  ELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLS 148
           ELK+  ++FE  S LG G  G VFK      G  +A K +    +     + + E+++L 
Sbjct: 2   ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59

Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
             +   +V   G +      +  +C E +  GSL+  L         +  +   K+++  
Sbjct: 60  ECNSPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAV 113

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
            +GL YL    +  ++HRD K SNIL+ +    K+ DFG++ Q  +          +GT 
Sbjct: 114 IKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTR 167

Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVD----------------------M 306
            Y++PE     H  V+SD++S G+ L+E+  GR P+                        
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 307 SQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIA----AACVAPEAN 362
            +P      ++      R    + EL D  +    PK                C+     
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 363 QRPTMGEVVQ 372
           +R  + +++ 
Sbjct: 288 ERADLKQLMV 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 7e-66
 Identities = 67/282 (23%), Positives = 112/282 (39%), Gaps = 28/282 (9%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG--GQQGDKEFLVEVEMLSRLHHRN 154
           ++E    +G G +GR  K    SDG  +  K L  G   +   +  + EV +L  L H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +V+       R ++   +  E    G L S +        +LD E  +++       L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 215 LHE--DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            H   D    V+HRD K +N+ L+   + K+ DFGLA+      +   +   +GT  Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMS 182

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
           PE         KSD++S G +L EL     P          +    A  I   K      
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGK------ 230

Query: 333 ADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
              R+  +Y  E  + I         +  +   RP++ E+++
Sbjct: 231 -FRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEILE 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 1e-64
 Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 33/293 (11%)

Query: 90  EELKEATNNFEPASI-LGEGGFGRVFKGVL---SDGTAVAIKRLTCGGQQGD-KEFLVEV 144
           ++L    +N   A I LG G FG V +GV         VAIK L  G ++ D +E + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
           +++ +L +  +V+L+G      +   +L  E+   G L  +L G       +      ++
Sbjct: 61  QIMHQLDNPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAEL 114

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTR 263
               + G+ YL    +   +HRD  A N+LL N  +AK++DFGL+K      + Y   + 
Sbjct: 115 LHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPI 322
                 + APE         +SDV+SYGV + E L+ G+KP    +       +   + +
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231

Query: 323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
               +   EL                   + + C   +   RP    V Q ++
Sbjct: 232 ECPPECPPELYA-----------------LMSDCWIYKWEDRPDFLTVEQRMR 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 2e-64
 Identities = 66/283 (23%), Positives = 113/283 (39%), Gaps = 30/283 (10%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
              +    +G+G FG V  G    G  VA+K +        + FL E  ++++L H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 157 KLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLH 216
           +L+G     +     +  E +  GSL  +L         L  +  +K +LD    + YL 
Sbjct: 64  QLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 217 EDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
                  +HRD  A N+L+  +  AKV+DFGL K+A   +             + APE  
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEAL 172

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
                  KSDV+S+G++L E+ +  +      P  +  L      + +            
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGY-------KMD 220

Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR 379
                P      V  +   C   +A  RP+  ++ + L+ ++ 
Sbjct: 221 APDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 4e-64
 Identities = 71/279 (25%), Positives = 117/279 (41%), Gaps = 30/279 (10%)

Query: 104 ILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLHHRNLVKL 158
           ++G G FG V+ G L D        A+K L      G+  +FL E  ++    H N++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 159 VGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
           +G    R     L+    + +G L +++        +   +  +   L  A+G+ +L   
Sbjct: 94  LGICL-RSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLA-- 147

Query: 219 SQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP--EGRTNYLSTRVMGTFGYVAPEYA 276
                +HRD  A N +L+  F  KVADFGLA+     E  + +  T       ++A E  
Sbjct: 148 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
            T     KSDV+S+GV+L EL+T   P     P    N       +L+ +  L+      
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQ------ 255

Query: 337 LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                P+     +  +   C  P+A  RP+  E+V  + 
Sbjct: 256 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 4e-64
 Identities = 79/293 (26%), Positives = 120/293 (40%), Gaps = 26/293 (8%)

Query: 83  STRFLAYEELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLV 142
            T+ LA +  +    +      LG+G FG V+ G  +  T VAIK L  G     + FL 
Sbjct: 3   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQ 61

Query: 143 EVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRM 202
           E +++ +L H  LV+L    S        +  E +  GSL  +L G  G          +
Sbjct: 62  EAQVMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLR--LPQLV 116

Query: 203 KIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLST 262
            +A   A G+AY+    +   +HRD +A+NIL+  N   KVADFGLA+   +        
Sbjct: 117 DMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQ 172

Query: 263 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI 322
                  + APE A+ G   +KSDV+S+G++L EL T  +      P            +
Sbjct: 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-----PYPGMVNREVLDQV 227

Query: 323 LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
            R                 P E    +  +   C   E  +RPT   +   L+
Sbjct: 228 ERGYRM-----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  203 bits (518), Expect = 4e-63
 Identities = 68/314 (21%), Positives = 107/314 (34%), Gaps = 48/314 (15%)

Query: 89  YEELKEATNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLT-CGGQQGDKEFL 141
              L+   NN E    +GEG FGRVF+            T VA+K L          +F 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------------- 188
            E  +++   + N+VK              L +E +  G L  +L               
Sbjct: 65  REAALMAEFDNPNIVK--LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 189 -------PLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA 241
                         L    ++ IA   A G+AYL E      +HRD    N L+  N   
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179

Query: 242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR 301
           K+ADFGL++                   ++ PE         +SDV++YGVVL E+ +  
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 302 KPVDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEA 361
                  P            + RD + L            P+   + +  +   C +   
Sbjct: 240 LQ-----PYYGMAHEEVIYYV-RDGNILA----------CPENCPLELYNLMRLCWSKLP 283

Query: 362 NQRPTMGEVVQSLK 375
             RP+   + + L+
Sbjct: 284 ADRPSFCSIHRILQ 297

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 9e-63
 Identities = 71/303 (23%), Positives = 114/303 (37%), Gaps = 46/303 (15%)

Query: 97  NNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQGDKE-FLVEVEMLSR 149
           N       LG G FG+V +              VA+K L       ++E  + E+++LS 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 150 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCH------------- 195
           L +H N+V L+G  +       L+  E    G L ++L                      
Sbjct: 83  LGNHMNIVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 196 -LDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
            LD E  +  +   A+G+A+L        IHRD  A NILL +    K+ DFGLA+    
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE- 313
                +         ++APE         +SDV+SYG+ L EL +         P   + 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 314 -NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             ++     +L  +    E+ D                 I   C   +  +RPT  ++VQ
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYD-----------------IMKTCWDADPLKRPTFKQIVQ 300

Query: 373 SLK 375
            ++
Sbjct: 301 LIE 303

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (515), Expect = 1e-62
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 26/298 (8%)

Query: 89  YEELKEATNNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRLTCGGQQGDKEFLVEVEML 147
           Y++ +    +      LG G +G V++GV       VA+K L     +  +EFL E  ++
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVM 67

Query: 148 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
             + H NLV+L+G  +        +  E +  G+L  +L         +     + +A  
Sbjct: 68  KEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQ 123

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
            +  + YL    +   IHRD  A N L+  N   KVADFGL++    G T          
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 179

Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 327
             + APE        +KSDV+++GV+L E+ T                         D  
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLS 223

Query: 328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 385
           ++ EL +     + P+    +V  +  AC     + RP+  E+ Q+ + + +     D
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 1e-62
 Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 47/306 (15%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSD------GTAVAIKRLTCGGQQGDKE-FLVEVEMLSR 149
            N E   +LG G FG+V                VA+K L       ++E  + E++M+++
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 150 L-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG----------------- 191
           L  H N+V L+G      S    L +E    G L ++L                      
Sbjct: 97  LGSHENIVNLLGAC--TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 192 --VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA 249
                 L +E  +  A   A+G+ +L        +HRD  A N+L+ +    K+ DFGLA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 211

Query: 250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 309
           +         +         ++APE    G   +KSDV+SYG++L E+ +         P
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----P 266

Query: 310 SGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 369
                +      ++++  +++           P      +  I  +C A ++ +RP+   
Sbjct: 267 YPGIPVDANFYKLIQNGFKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPN 316

Query: 370 VVQSLK 375
           +   L 
Sbjct: 317 LTSFLG 322

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-62
 Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 34/278 (12%)

Query: 105 LGEGGFGRVFKGVLSD---GTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHRNLVKLV 159
           LG G FG V KG          VA+K L           E L E  ++ +L +  +V+++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 160 GYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           G     ++   +L  E+   G L  +L      N H+  +  +++    + G+ YL    
Sbjct: 75  GIC---EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE--- 124

Query: 220 QPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYL-STRVMGTFGYVAPEYAMT 278
           +   +HRD  A N+LL    +AK++DFGL+K        Y   T       + APE    
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 279 GHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPRL 337
                KSDV+S+GV++ E  + G+KP    + S    ++     +        E+ D   
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD--- 241

Query: 338 GGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                         +   C   +   RP    V   L+
Sbjct: 242 --------------LMNLCWTYDVENRPGFAAVELRLR 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 6e-62
 Identities = 72/280 (25%), Positives = 111/280 (39%), Gaps = 35/280 (12%)

Query: 97  NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLT---CGGQQGDKEFLVEVEMLSRLHH 152
            +FE    LG+G FG V+          +A+K L          + +   EVE+ S L H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
            N+++L GY+   D+++  L  E  P G++   L          D +       + A  L
Sbjct: 66  PNILRLYGYF--HDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANAL 119

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
           +Y H      VIHRD K  N+LL +    K+ADFG +  AP  R       + GT  Y+ 
Sbjct: 120 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 172

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
           PE         K D++S GV+  E L G+ P +              + I R +    + 
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVEFTFPDF 226

Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
                       D I         +    +QRP + EV++
Sbjct: 227 VTEGA------RDLIS------RLLKHNPSQRPMLREVLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 6e-62
 Identities = 64/277 (23%), Positives = 113/277 (40%), Gaps = 35/277 (12%)

Query: 104 ILGEGGFGRVFKGVLSD-GTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVG 160
            +G G F  V+KG+ ++    VA   L      +   + F  E EML  L H N+V+   
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 161 YYSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED 218
            + S    +  +    EL+ +G+L+++L         +  +          +GL +LH  
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 219 SQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
           + P +IHRD K  NI +       K+ D GLA              V+GT  ++APE   
Sbjct: 132 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM-Y 185

Query: 278 TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ--ENLVTWARPILRDKDRLEELADP 335
                   DVY++G+ +LE+ T   P    Q + Q    + +  +P   DK  + E+ + 
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE- 244

Query: 336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
                           I   C+    ++R ++ +++ 
Sbjct: 245 ----------------IIEGCIRQNKDERYSIKDLLN 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-61
 Identities = 77/290 (26%), Positives = 113/290 (38%), Gaps = 32/290 (11%)

Query: 97  NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSR 149
            +      LG+G FG V +G          +VA+K L        +   +F+ EV  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           L HRNL++L G   +       +  EL P GSL   L    G   H    T  + A+  A
Sbjct: 68  LDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVA 121

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY-LSTRVMGTF 268
            G+ YL        IHRD  A N+LL      K+ DFGL +  P+   +Y +       F
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            + APE   T      SD + +GV L E+ T  +      P    N       I ++ +R
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGER 233

Query: 329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ 378
           L    D       P++    +  +   C A +   RPT   +   L   Q
Sbjct: 234 LPRPED------CPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-61
 Identities = 82/323 (25%), Positives = 131/323 (40%), Gaps = 42/323 (13%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDG---TAVAIKRL-TCGGQQGDKEFLVEVEMLSRL-H 151
           N+ +   ++GEG FG+V K  +         AIKR+     +   ++F  E+E+L +L H
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHG------------PLGVNCHLDWE 199
           H N++ L+G    R      L  E  P+G+L  +L                     L  +
Sbjct: 70  HPNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 200 TRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNY 259
             +  A D ARG+ YL    Q   IHRD  A NIL+  N+ AK+ADFGL++         
Sbjct: 128 QLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-- 182

Query: 260 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA 319
             T       ++A E          SDV+SYGV+L E+++         P          
Sbjct: 183 -KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY 236

Query: 320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KMVQ 378
             + +   RLE           P      V  +   C   +  +RP+  +++ SL +M++
Sbjct: 237 EKLPQGY-RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

Query: 379 RVIECQDPTLTSSNNRANLRQSS 401
                 + TL      A +  S+
Sbjct: 286 ERKTYVNTTLYEKFTYAGIDCSA 308

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 7e-61
 Identities = 64/291 (21%), Positives = 118/291 (40%), Gaps = 31/291 (10%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGT-----AVAIKRLTCGGQQGDK-EFLVEVEMLSRL 150
           +      ++G G FG V+KG+L   +      VAIK L  G  +  + +FL E  ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 151 HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
            H N+++L G          ++  E + NG+L+ +L      +        + +    A 
Sbjct: 67  SHHNIIRLEGVI--SKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAA 121

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG-RTNYLSTRVMGTFG 269
           G+ YL        +HRD  A NIL+ +N   KV+DFGL++   +     Y ++       
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           + APE          SDV+S+G+V+ E++T  +       + +                +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------V 222

Query: 330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV 380
            +  +       P +    +  +   C   E  +RP   ++V  L  + R 
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (503), Expect = 1e-60
 Identities = 68/282 (24%), Positives = 110/282 (39%), Gaps = 40/282 (14%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD---KEFLVEVEMLSRLHHRN 154
           F     +G G FG V+    + +   VAIK+++  G+Q +   ++ + EV  L +L H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
            ++  G Y         L  E     + +            L       +   A +GLAY
Sbjct: 77  TIQYRGCY--LREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAY 130

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
           LH  +   +IHRD KA NILL      K+ DFG A       +       +GT  ++APE
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPE 181

Query: 275 YAMT---GHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLE 330
             +    G    K DV+S G+  +EL   + P  +M+  S   ++     P L+     E
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE 241

Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
              +                    +C+      RPT   +++
Sbjct: 242 YFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 2e-60
 Identities = 65/294 (22%), Positives = 120/294 (40%), Gaps = 36/294 (12%)

Query: 89  YEELKEATN---NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEV 144
           YE +    N    +E    LG+G FG+V+K          A K +    ++  ++++VE+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 145 EMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKI 204
           ++L+   H N+VKL+  +     +   +  E    G++++ +         L       +
Sbjct: 61  DILASCDHPNIVKLLDAF--YYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVV 115

Query: 205 ALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRV 264
                  L YLH++    +IHRD KA NIL   +   K+ADFG++ +             
Sbjct: 116 CKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSF 170

Query: 265 MGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTW 318
           +GT  ++APE  M           K+DV+S G+ L+E+     P  +++       +   
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230

Query: 319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
             P L    R               +DF++       C+    + R T  +++Q
Sbjct: 231 EPPTLAQPSRWSSNF----------KDFLK------KCLEKNVDARWTTSQLLQ 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-59
 Identities = 64/281 (22%), Positives = 104/281 (37%), Gaps = 31/281 (11%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCG-GQQGDKEFLVEVEMLSRLHHRN 154
            +++    LGEG +G V   V      AVA+K +         +    E+ +   L+H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VK  G+   R+ +   L  E    G L   +      +  +      +       G+ Y
Sbjct: 65  VVKFYGHR--REGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVY 118

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
           LH      + HRD K  N+LL+   + K++DFGLA          L  ++ GT  YVAPE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 275 YAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
                       DV+S G+VL  +L G  P D    S QE      +    +  +     
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK----- 230

Query: 334 DPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
                 K        +         +    + R T+ ++ +
Sbjct: 231 ------KIDSAPLALLH------KILVENPSARITIPDIKK 259

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 5e-59
 Identities = 74/333 (22%), Positives = 135/333 (40%), Gaps = 41/333 (12%)

Query: 99  FEPASILGEGGFGRVFKGVLSD-----GTAVAIKRLT-CGGQQGDKEFLVEVEMLSRLHH 152
           F+   +LG G FG V+KG+           VAIK L      + +KE L E  +++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
            ++ +L+G   +       L  +L+P G L  ++        ++  +  +   +  A+G+
Sbjct: 71  PHVCRLLGICLTST---VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 124

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            YL       ++HRD  A N+L++   H K+ DFGLAK        Y +        ++A
Sbjct: 125 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
            E  +      +SDV+SYGV + EL+T G KP D    S   +++     + +      +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID 241

Query: 332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR------VIECQD 385
           +                   I   C   +A+ RP   E++     + R      VI+  +
Sbjct: 242 VYM-----------------IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 284

Query: 386 PTLTSSNNRANLRQSSTTFDSDGTSSMFSSGPY 418
                S   +N  ++    D +    +  +  Y
Sbjct: 285 RMHLPSPTDSNFYRALM--DEEDMDDVVDADEY 315

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 4e-58
 Identities = 69/287 (24%), Positives = 112/287 (39%), Gaps = 33/287 (11%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQGDKE-FLVEVEMLSRLH 151
              E    +GEG FG V +G+         AVAIK          +E FL E   + +  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H ++VKL+G  +        +  EL   G L S+L         LD  + +  A   +  
Sbjct: 67  HPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTA 120

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           LAYL        +HRD  A N+L+ +N   K+ DFGL++   +  T Y +++      ++
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWM 176

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLE 330
           APE          SDV+ +GV + E+L  G KP    + +     +     +    +   
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236

Query: 331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV 377
            L                   +   C A + ++RP   E+   L  +
Sbjct: 237 TLYS-----------------LMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 8e-58
 Identities = 58/279 (20%), Positives = 119/279 (42%), Gaps = 30/279 (10%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRN 154
              +     +G+G  G V+  + ++ G  VAI+++    Q   +  + E+ ++    + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +V  +  Y      +  +  E +  GSL   +         +D      +  +  + L +
Sbjct: 79  IVNYLDSY--LVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEF 131

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
           LH +    VIHRD K+ NILL  +   K+ DFG   Q    ++    + ++GT  ++APE
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPE 186

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKP-VDMSQPSGQENLVTWARPILRDKDRLEELA 333
                    K D++S G++ +E++ G  P ++ +       + T   P L++ ++L  + 
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

Query: 334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
                      DF+        C+  +  +R +  E++Q
Sbjct: 247 ----------RDFLN------RCLDMDVEKRGSAKELLQ 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 7e-57
 Identities = 64/302 (21%), Positives = 112/302 (37%), Gaps = 38/302 (12%)

Query: 97  NNFEPASILGEGGFGRVFKGV------LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSR 149
           +  +    LG G FG+V +         +    VA+K L  G    + +  + E+++L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLD 197
           + H   V  +    ++     ++  E    G+L ++L                     L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 198 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 257
            E  +  +   A+G+ +L        IHRD  A NILL      K+ DFGLA+   +   
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 258 NYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT 317
                       ++APE        ++SDV+S+GV+L E+ +         P     +  
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244

Query: 318 WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL-KM 376
                L++  R+            P      +      C   E +QRPT  E+V+ L  +
Sbjct: 245 EFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

Query: 377 VQ 378
           +Q
Sbjct: 295 LQ 296

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 5e-55
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 34/292 (11%)

Query: 97  NNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLT-CGGQQGDKEFLVEVEMLSR 149
                +  LG+G FG V++GV          T VAIK +      +   EFL E  ++  
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH------GPLGVNCHLDWETRMK 203
            +  ++V+L+G  S       L+  EL+  G L+S+L           V         ++
Sbjct: 80  FNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 204 IALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTR 263
           +A + A G+AYL+       +HRD  A N ++  +F  K+ DFG+ +   E        +
Sbjct: 138 MAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 264 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL 323
            +    +++PE    G     SDV+S+GVVL E+ T  +      P    +     R ++
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-----PYQGLSNEQVLRFVM 249

Query: 324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
                             P      +  +   C       RP+  E++ S+K
Sbjct: 250 EGGLL-----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 3e-54
 Identities = 66/282 (23%), Positives = 104/282 (36%), Gaps = 31/282 (10%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLS 148
           K+   +F+   ILGEG F  V     L+     AIK L       +        E +++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 149 RLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDA 208
           RL H   VKL   +  +D  +         NG L  ++          D         + 
Sbjct: 64  RLDHPFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEI 117

Query: 209 ARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTF 268
              L YLH      +IHRD K  NILL  + H ++ DFG AK          +   +GT 
Sbjct: 118 VSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174

Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            YV+PE          SD+++ G ++ +L+ G  P          N     + I++ +  
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEYD 228

Query: 329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEV 370
             E   P+        D +         +  +A +R    E+
Sbjct: 229 FPEKFFPKA------RDLVE------KLLVLDATKRLGCEEM 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  181 bits (461), Expect = 6e-54
 Identities = 60/281 (21%), Positives = 113/281 (40%), Gaps = 32/281 (11%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           ++++    LG G FG V +    + G   A K +    +   +    E++ +S L H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           V L   +   D ++ ++ YE +  G L   +         +  +  ++      +GL ++
Sbjct: 86  VNLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHM 140

Query: 216 HEDSQPCVIHRDFKASNILL--ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           HE      +H D K  NI+   + +   K+ DFGL       ++        GT  + AP
Sbjct: 141 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAP 194

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
           E A    +   +D++S GV+   LL+G  P         EN     R +      +++ A
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG------GENDDETLRNVKSCDWNMDDSA 248

Query: 334 DPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
              +     ++  DFIR        +  + N R T+ + ++
Sbjct: 249 FSGI----SEDGKDFIR------KLLLADPNTRMTIHQALE 279

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-53
 Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 43/303 (14%)

Query: 97  NNFEPASILGEGGFGRVFKGVL--------SDGTAVAIKRLTCGGQQGD-KEFLVEVEML 147
           +       LGEG FG+V             +  T VA+K L     + D  + + E+EM+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 148 SRL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLH------------GPLGVNC 194
             +  H+N++ L+G  +        +  E    G+L  +L                    
Sbjct: 73  KMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 195 HLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE 254
            L  +  +  A   ARG+ YL        IHRD  A N+L+  +   K+ADFGLA+    
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 314
                 +T       ++APE         +SDV+S+GV+L E+ T         P     
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 242

Query: 315 LVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL 374
            V     +L++  R++           P      +  +   C     +QRPT  ++V+ L
Sbjct: 243 -VEELFKLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

Query: 375 KMV 377
             +
Sbjct: 292 DRI 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  177 bits (451), Expect = 2e-52
 Identities = 65/315 (20%), Positives = 121/315 (38%), Gaps = 34/315 (10%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           + ++    LG G FG V + V  + G     K +             E+ ++++LHH  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           + L   +   D  + +L  E +  G L   +      +  +     +     A  GL ++
Sbjct: 89  INLHDAF--EDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHM 143

Query: 216 HEDSQPCVIHRDFKASNILLE--NNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           HE     ++H D K  NI+ E       K+ DFGLA +               T  + AP
Sbjct: 144 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAP 197

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA 333
           E      +   +D+++ GV+   LL+G  P       G+++L T    + R     +E A
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA-----GEDDLETLQN-VKRCDWEFDEDA 251

Query: 334 DPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQS--LKMVQRVIECQDPTLT 389
              +      E  DFI+        +  E  +R T+ + ++   LK     +  + P+  
Sbjct: 252 FSSV----SPEAKDFIK------NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSR 301

Query: 390 SSNNRANLRQSSTTF 404
            +  R  +++    +
Sbjct: 302 YNKIRQKIKEKYADW 316

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  171 bits (435), Expect = 5e-51
 Identities = 71/294 (24%), Positives = 115/294 (39%), Gaps = 33/294 (11%)

Query: 96  TNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLH 151
           ++ +E   ILG GG   V     L     VA+K L             F  E +  + L+
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 152 HRNLVKLVGYYSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           H  +V +     +   +  L     E V   +L   +H        +  +  +++  DA 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ-APEGRTNYLSTRVMGTF 268
           + L + H+     +IHRD K +NI++      KV DFG+A+  A  G +   +  V+GT 
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 269 GYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
            Y++PE A    +  +SDVYS G VL E+LTG  P         ++ V+ A   +R+   
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVREDPI 232

Query: 329 LEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQR 379
                   L      +    +         +A     R  T  E+   L  V  
Sbjct: 233 PPSARHEGL----SADLDAVVL------KALAKNPENRYQTAAEMRADLVRVHN 276

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  172 bits (438), Expect = 2e-50
 Identities = 65/283 (22%), Positives = 109/283 (38%), Gaps = 40/283 (14%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSD-GTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLH- 151
           N+F    I+G GGFG V+    +D G   A+K L       +QG+   L E  MLS +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 152 --HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
                +V +   +      +     +L+  G L   L      +           A +  
Sbjct: 64  GDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEII 117

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            GL ++H      V++RD K +NILL+ + H +++D GLA    + + +      +GT G
Sbjct: 118 LGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 170

Query: 270 YVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR 328
           Y+APE    G      +D +S G +L +LL G  P    +   +  +           DR
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----------DR 219

Query: 329 LEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGE 369
           +       L   +  E    +         +  + N+R     
Sbjct: 220 MTLTMAVELPDSFSPELRSLLE------GLLQRDVNRRLGCLG 256

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  169 bits (428), Expect = 6e-50
 Identities = 66/294 (22%), Positives = 111/294 (37%), Gaps = 47/294 (15%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGG---------QQGDKEFLVEVEML 147
           N+EP  ILG G    V + +        A+K +   G         Q+  +  L EV++L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 148 SRLH-HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
            ++  H N+++L   Y    ++   L ++L+  G L  +L         L  +   KI  
Sbjct: 64  RKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMR 117

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
                +  LH+     ++HRD K  NILL+++ + K+ DFG + Q   G        V G
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 171

Query: 267 TFGYVAPEYAMTGHLL------VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWAR 320
           T  Y+APE               + D++S GV++  LL G  P            +   R
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLR 225

Query: 321 PILRDKDRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
            I+    +            Y     D +         +  +  +R T  E + 
Sbjct: 226 MIMSGNYQFGSPEWD----DYSDTVKDLVS------RFLVVQPQKRYTAEEALA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-49
 Identities = 65/337 (19%), Positives = 117/337 (34%), Gaps = 37/337 (10%)

Query: 93  KEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH 151
           KE    +  A  LG G FG V + V  S       K +   G         E+ +L+   
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           HRN++ L   + S +  + ++ +E +    +   ++        L+    +         
Sbjct: 60  HRNILHLHESFESME--ELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEA 114

Query: 212 LAYLHEDSQPCVIHRDFKASNILL--ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
           L +LH      + H D +  NI+     +   K+ +FG A+Q   G        +     
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPE 168

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL 329
           Y APE      +   +D++S G ++  LL+G  P         E        I+  +   
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL------AETNQQIIENIMNAEYTF 222

Query: 330 EELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPT 387
           +E A   +      E  DF+         +  E   R T  E +Q    +++ IE     
Sbjct: 223 DEEAFKEI----SIEAMDFVD------RLLVKERKSRMTASEALQH-PWLKQKIERVSTK 271

Query: 388 LTSSNNRANLRQSSTTFDSDGTSSMFSSGPYSGLSAF 424
           +  +      R+   T      + + S+   S   A 
Sbjct: 272 VIRTLKH---RRYYHTLIKKDLNMVVSAARISCGGAI 305

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (424), Expect = 3e-49
 Identities = 52/288 (18%), Positives = 103/288 (35%), Gaps = 29/288 (10%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
           N +     +G G FG ++ G  ++ G  VAIK      +    +  +E ++   +     
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           +  + +  + +   +++  EL+     + +       +     +T + +A      + Y+
Sbjct: 65  IPTIRWCGA-EGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYI 119

Query: 216 HEDSQPCVIHRDFKASNIL---LENNFHAKVADFGLAKQAPEGRTN-----YLSTRVMGT 267
           H       IHRD K  N L    +      + DFGLAK+  + RT+       +  + GT
Sbjct: 120 HS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 327
             Y +    +      + D+ S G VL+    G  P    + + +           R  +
Sbjct: 177 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------YERISE 230

Query: 328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
           +        L   YP E      T    C +   + +P    + Q  +
Sbjct: 231 KKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (424), Expect = 4e-49
 Identities = 59/288 (20%), Positives = 100/288 (34%), Gaps = 29/288 (10%)

Query: 89  YEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-FLVEVEM 146
           +++ ++  + ++   +LG G F  V           VAIK +     +G +     E+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 147 LSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIAL 206
           L ++ H N+V L   Y         L  +LV  G L   +                ++  
Sbjct: 61  LHKIKHPNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIF 114

Query: 207 DAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
                + YLH+        +        L+ +    ++DFGL+K    G      +   G
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACG 171

Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 326
           T GYVAPE           D +S GV+   LL G  P         EN       IL+ +
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQILKAE 225

Query: 327 DRLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQ 372
              +      +         DFIR        +  +  +R T  + +Q
Sbjct: 226 YEFDSPYWDDI----SDSAKDFIR------HLMEKDPEKRFTCEQALQ 263

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 2e-48
 Identities = 63/276 (22%), Positives = 101/276 (36%), Gaps = 34/276 (12%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSR-LH 151
            +F    +LG+G FG+VF           AIK L       D +    +VE  +LS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 152 HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARG 211
           H  L  +   + +++        E +  G L   +          D       A +   G
Sbjct: 62  HPFLTHMFCTFQTKE--NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILG 115

Query: 212 LAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           L +LH      +++RD K  NILL+ + H K+ADFG+ K+   G          GT  Y+
Sbjct: 116 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYI 170

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE 331
           APE  +        D +S+GV+L E+L G+ P         ++       I  D      
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYPR 224

Query: 332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTM 367
             +         +D +            E  +R  +
Sbjct: 225 WLEKEA------KDLLV------KLFVREPEKRLGV 248

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 2e-48
 Identities = 67/298 (22%), Positives = 111/298 (37%), Gaps = 27/298 (9%)

Query: 94  EATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-KEFLVEVEMLSRLH 151
           +    +   S +GEG +G V       +   VAIK+++    Q   +  L E+++L R  
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 152 HRNLVKLVGYYSSRDSSQHLLCY--ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           H N++ +     +    Q    Y    +    L   L        HL  +          
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQIL 119

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA-PEGRTNYLSTRVMGTF 268
           RGL Y+H      V+HRD K SN+LL      K+ DFGLA+ A P+       T  + T 
Sbjct: 120 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 269 GYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA--RPILRD 325
            Y APE  +      KS D++S G +L E+L+ R          Q N +      P   D
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAA-----------ACVAPEANQRPTMGEVVQ 372
            + +  L         P ++ +    +               +    ++R  + + + 
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 2e-47
 Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 22/294 (7%)

Query: 95  ATNNFEPASILGEGGFGRVFKG--VLSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRL 150
           A   +E  + +GEG +G+VFK   + + G  VA+KR+    G +      + EV +L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 151 ---HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
               H N+V+L    +   + +      +  +   +   +        +  ET   +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
             RGL +LH      V+HRD K  NIL+ ++   K+ADFGLA+           T V+ T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178

Query: 268 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD 327
             Y APE  +        D++S G +  E+   +     S    Q   +     +  ++D
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 328 RLEELADPRLG----GKYPKEDFIRVCTIAA-----ACVAPEANQRPTMGEVVQ 372
              ++A PR         P E F+             C+     +R +    + 
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  160 bits (405), Expect = 4e-46
 Identities = 67/274 (24%), Positives = 107/274 (39%), Gaps = 36/274 (13%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHH 152
            +F+    LG G FGRV       +G   A+K L        +  +    E  MLS + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             ++++ G +  +D+ Q  +  + +  G L S L      +           A +    L
Sbjct: 64  PFIIRMWGTF--QDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLAL 117

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            YLH      +I+RD K  NILL+ N H K+ DFG AK  P+           GT  Y+A
Sbjct: 118 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIA 169

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
           PE   T       D +S+G+++ E+L G  P          N +     IL  + R    
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY------DSNTMKTYEKILNAELRFPPF 223

Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT 366
            +  +      +D +         +  + +QR  
Sbjct: 224 FNEDV------KDLLS------RLITRDLSQRLG 245

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-45
 Identities = 68/286 (23%), Positives = 105/286 (36%), Gaps = 28/286 (9%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE-----FLVEVEMLSRLHHRNLVK 157
            LGEG F  V+K    +    VAIK++  G +   K+      L E+++L  L H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE 217
           L+  +     S   L ++ +               +  L         L   +GL YLH+
Sbjct: 65  LLDAF--GHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 218 DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAM 277
                ++HRD K +N+LL+ N   K+ADFGLAK        Y  T  + T  Y APE   
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLF 173

Query: 278 TGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPILRDKDRLEE 331
              +  V  D+++ G +L ELL     +       Q     E L T       D   L +
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 332 LADPRLGGKYPKEDFIRVCTIAA-----ACVAPEANQRPTMGEVVQ 372
               +     P                          R T  + ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 3e-45
 Identities = 66/320 (20%), Positives = 109/320 (34%), Gaps = 35/320 (10%)

Query: 104 ILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGY 161
           +LG G  G+V +          A+K L     Q   +   EVE+  R     ++V++V  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 162 YSSRDSSQHLLC--YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS 219
           Y +  + +  L    E +  G L S +      +         +I       + YLH   
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS-- 129

Query: 220 QPCVIHRDFKASNILL---ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYA 276
              + HRD K  N+L      N   K+ DFG AK+     +         T  YVAPE  
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185

Query: 277 MTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADPR 336
                    D++S GV++  LL G  P       G          I   +          
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243

Query: 337 LGGKYPKE--DFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQDPTLTSSNNR 394
           +     +E    IR        +  E  QR T+ E +     + +  +     L +S   
Sbjct: 244 V----SEEVKMLIR------NLLKTEPTQRMTITEFMNH-PWIMQSTKVPQTPLHTSRVL 292

Query: 395 ANLRQSSTTFDSDGTSSMFS 414
              ++       + TS++ +
Sbjct: 293 KEDKERWEDVKEEMTSALAT 312

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  156 bits (394), Expect = 5e-45
 Identities = 58/289 (20%), Positives = 105/289 (36%), Gaps = 23/289 (7%)

Query: 97  NNFEPASILGEGGFGRVFKGVLSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
             +     +GEG +G V+K   + G   A+K  RL    +      + E+ +L  L H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL          + +L +E +     +            L+  T     L    G+AY
Sbjct: 62  IVKLYDVI--HTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAY 115

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H+     V+HRD K  N+L+      K+ADFGLA+        Y +  ++  +      
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPDV 171

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 334
              +       D++S G +  E++ G         + Q   +         K+       
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 335 PRLGGKY------PKEDFIRVCTIAAA-----CVAPEANQRPTMGEVVQ 372
           P+    +      P E F++    +        +  + NQR T  + ++
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  154 bits (391), Expect = 2e-44
 Identities = 48/290 (16%), Positives = 93/290 (32%), Gaps = 31/290 (10%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL 155
            +++    +GEG FG +F+G  L +   VAIK      +    +   E      L     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62

Query: 156 VKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYL 215
           +  V Y+   +   ++L  +L+     +               +T    A      +  +
Sbjct: 63  IPNVYYFGQ-EGLHNVLVIDLLGPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSI 117

Query: 216 HEDSQPCVIHRDFKASNILL-----ENNFHAKVADFGLAKQAPEGRTN-----YLSTRVM 265
           H   +  +++RD K  N L+     +N     V DFG+ K   +  T           + 
Sbjct: 118 H---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
           GT  Y++    +      + D+ + G V +  L G  P    +        T  +   R 
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA------ATNKQKYERI 228

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK 375
            ++ +      L   +P+E                 +  P    +     
Sbjct: 229 GEKKQSTPLRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 2e-44
 Identities = 60/289 (20%), Positives = 105/289 (36%), Gaps = 23/289 (7%)

Query: 98  NFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHRN 154
           NF+    +GEG +G V+K      G  VA+K  RL    +      + E+ +L  L+H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           +VKL+        ++  L +E +     +      L     +             +GLA+
Sbjct: 63  IVKLLDVI--HTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAF 117

Query: 215 LHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPE 274
            H      V+HRD K  N+L+      K+ADFGLA+        Y +  V+  +      
Sbjct: 118 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEI 173

Query: 275 YAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD 334
                +     D++S G +  E++T R          Q   +        +       + 
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 335 PRLGGKYPK---EDFIRVCTIAAA--------CVAPEANQRPTMGEVVQ 372
           P     +PK   +DF +V               +  + N+R +    + 
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-44
 Identities = 67/292 (22%), Positives = 103/292 (35%), Gaps = 27/292 (9%)

Query: 98  NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV 156
           ++    ++G G FG V++  L   G  VAIK++     Q  +    E++++ +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76

Query: 157 KLVGYYSSRDSSQHL----LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
           +L  ++ S    +      L  + VP        H        L             R L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSL 135

Query: 213 AYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYV 271
           AY+H      + HRD K  N+LL  +    K+ DFG AKQ   G  N   + +   +   
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRA 190

Query: 272 APEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ-----ENLVTWARPILRDK 326
                         DV+S G VL ELL G+          Q     + L T  R  +R+ 
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 327 DRLEELADPRLGGKYPKEDFIRVCTIAAA------CVAPEANQRPTMGEVVQ 372
           +             +P     R  T   A       +      R T  E   
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 4e-43
 Identities = 69/289 (23%), Positives = 108/289 (37%), Gaps = 41/289 (14%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD------KEFLVEVEMLSR 149
           + ++    LG G F  V K    S G   A K +     +        ++   EV +L  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 150 LHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           + H N++ L   Y   + +  +L  ELV  G L  +L         L  E   +      
Sbjct: 70  IQHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQIL 123

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILL----ENNFHAKVADFGLAKQAPEGRTNYLSTRVM 265
            G+ YLH      + H D K  NI+L          K+ DFGLA +   G        + 
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177

Query: 266 GTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
           GT  +VAPE      L +++D++S GV+   LL+G  P            V+       D
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237

Query: 326 K--DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQ 372
           +       LA          +DFIR        +  +  +R T+ + +Q
Sbjct: 238 EYFSNTSALA----------KDFIR------RLLVKDPKKRMTIQDSLQ 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 8e-43
 Identities = 61/277 (22%), Positives = 96/277 (34%), Gaps = 33/277 (11%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL---TCGGQQGDKEFLVEVEMLSRLHH 152
           N+F+   +LG+G FG+V      + G   A+K L       +      + E  +L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             L  L   Y+ +   +     E    G L   L            E       +    L
Sbjct: 65  PFLTAL--KYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSAL 118

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            YLH      V++RD K  N++L+ + H K+ DFGL K+              GT  Y+A
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLA 173

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL 332
           PE           D +  GVV+ E++ GR P         ++       IL ++ R    
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY------NQDHERLFELILMEEIRFPRT 227

Query: 333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 369
             P        +  +         +  +  QR   G 
Sbjct: 228 LSPEA------KSLLA------GLLKKDPKQRLGGGP 252

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-42
 Identities = 65/302 (21%), Positives = 111/302 (36%), Gaps = 48/302 (15%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL------TCGGQQGDKEFLVEVEMLSR 149
           + ++   +LG GGFG V+ G+ +SD   VAIK +        G         +EV +L +
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 150 LH--HRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           +      +++L+ ++   DS   +L  E              +     L  E        
Sbjct: 64  VSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDF---ITERGALQEELARSFFWQ 118

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILL-ENNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
               + + H      V+HRD K  NIL+  N    K+ DFG      +       T   G
Sbjct: 119 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDG 171

Query: 267 TFGYVAPEYAMTGHLLVKS-DVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
           T  Y  PE+        +S  V+S G++L +++ G  P +  +             I+R 
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG 219

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVIECQD 385
           +    +            +  IR       C+A   + RPT  E+      +Q V+  Q+
Sbjct: 220 QVFFRQRVSSEC------QHLIR------WCLALRPSDRPTFEEIQNH-PWMQDVLLPQE 266

Query: 386 PT 387
             
Sbjct: 267 TA 268

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-41
 Identities = 59/302 (19%), Positives = 117/302 (38%), Gaps = 33/302 (10%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD--KEFLVEVEMLSRLHHR 153
           + +E  + +G+G FG VFK      G  VA+K++    ++       L E+++L  L H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 154 NLVKLVGYYSSRDSSQH------LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
           N+V L+    ++ S  +       L ++   +       +    V          ++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQM 125

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS--TRVM 265
              GL Y+H      ++HRD KA+N+L+  +   K+ADFGLA+     + +  +  T  +
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 266 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVT------- 317
            T  Y  PE  +         D++  G ++ E+ T    +  +    Q  L++       
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 318 -WARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAA------CVAPEANQRPTMGEV 370
               P + + +  E+L   +   +  K+          A       +  +  QR    + 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 371 VQ 372
           + 
Sbjct: 303 LN 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 4e-40
 Identities = 62/304 (20%), Positives = 111/304 (36%), Gaps = 29/304 (9%)

Query: 89  YEELKEAT----NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL--TCGGQQGDKEFL 141
            +E+ +        +     +G G +G V   V    G  VAIK+L      +   K   
Sbjct: 6   RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65

Query: 142 VEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETR 201
            E+ +L  + H N++ L+  ++  ++      + LV          G L  +  L  +  
Sbjct: 66  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV--MPFMGTDLGKLMKHEKLGEDRI 123

Query: 202 MKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLS 261
             +     +GL Y+H      +IHRD K  N+ +  +   K+ DFGLA+QA    T    
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---- 176

Query: 262 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV----- 316
             V+  +                 D++S G ++ E++TG+     S    Q   +     
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 317 ----TWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAA----ACVAPEANQRPTMG 368
                + + +  D+ +      P L  K           +A       +  +A QR T G
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

Query: 369 EVVQ 372
           E + 
Sbjct: 297 EALA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 7e-40
 Identities = 63/291 (21%), Positives = 98/291 (33%), Gaps = 25/291 (8%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIK--RLTCGGQQGDKEFLVEVEMLSRLHHR 153
             +E    +GEG +G VFK         VA+K  RL    +      L E+ +L  L H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 154 NLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLA 213
           N+V+L     S           LV     +         N  LD E          +GL 
Sbjct: 62  NIVRLHDVLHSDK------KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 214 YLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
           + H      V+HRD K  N+L+  N   K+A+FGLA+        Y S  V+  +     
Sbjct: 116 FCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPD 171

Query: 274 EYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSG---QENLVTWARPILRDKDRLE 330
                       D++S G +  EL    +P+          +        P       + 
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 331 ELADPRLGGKYPKEDFIRVCT---------IAAACVAPEANQRPTMGEVVQ 372
           +L D +    YP    +             +    +     QR +  E +Q
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (341), Expect = 1e-36
 Identities = 51/234 (21%), Positives = 80/234 (34%), Gaps = 18/234 (7%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKE---FLVEVEMLSRLHH 152
           + F+    LG G FGRV        G   A+K L        K+    L E  +L  ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 153 RNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGL 212
             LVKL   +      +      +V        +   L              A       
Sbjct: 101 PFLVKLEFSF------KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 213 AYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVA 272
            YLH      +I+RD K  N+L++   + +V DFG AK+              GT   +A
Sbjct: 155 EYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALA 206

Query: 273 PEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK 326
           PE  ++       D ++ GV++ E+  G  P    QP      +   +      
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  134 bits (339), Expect = 1e-36
 Identities = 53/306 (17%), Positives = 110/306 (35%), Gaps = 52/306 (16%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRN 154
           ++++    LG G +  VF+ + +++   V +K L        K+   E+++L  L    N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPN 91

Query: 155 LVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAY 214
           ++ L        S    L +E V N   +            L          +  + L Y
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDY 144

Query: 215 LHEDSQPCVIHRDFKASNILLEN-NFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAP 273
            H      ++HRD K  N+++++ +   ++ D+GLA+    G+        + +  +  P
Sbjct: 145 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGP 198

Query: 274 EYAMTGHLL-VKSDVYSYGVVLLELLTGRKP-----------VDMSQPSGQENLVTWARP 321
           E  +   +     D++S G +L  ++  ++P           V +++  G E+L  +   
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258

Query: 322 ILRDKD-------------RLEELADPRLGGKYPKE--DFIRVCTIAAACVAPEANQRPT 366
              + D             R E             E  DF+         +  +   R T
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD------KLLRYDHQSRLT 312

Query: 367 MGEVVQ 372
             E ++
Sbjct: 313 AREAME 318

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 2e-36
 Identities = 70/309 (22%), Positives = 121/309 (39%), Gaps = 27/309 (8%)

Query: 81  PTSTRFLAYEELKEATNNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGD-- 137
           PT  R    + + E    ++  S +G G +G V        G  VA+K+L+   Q     
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 138 KEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLD 197
           K    E+ +L  + H N++ L+  ++   S +      LV +       +  +     L 
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLT 119

Query: 198 WETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT 257
            +    +     RGL Y+H      +IHRD K SN+ +  +   K+ DFGLA+      T
Sbjct: 120 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----T 171

Query: 258 NYLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ---- 312
           +   T  + T  Y APE  +   H     D++S G ++ ELLTGR     +    Q    
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

Query: 313 -ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIA--------AACVAPEANQ 363
              + T    +L+           +   + PK +F  V   A           +  ++++
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291

Query: 364 RPTMGEVVQ 372
           R T  + + 
Sbjct: 292 RITAAQALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 3e-36
 Identities = 65/284 (22%), Positives = 110/284 (38%), Gaps = 35/284 (12%)

Query: 97  NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRL----TCGGQQGDKEFLVEVEMLS 148
            NFE   +LG G +G+VF          G   A+K L         +  +    E ++L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 149 RL-HHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALD 207
            +     LV L  +Y+ +  ++  L  + +  G L + L                    +
Sbjct: 84  HIRQSPFLVTL--HYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGE 137

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGT 267
               L +LH+     +I+RD K  NILL++N H  + DFGL+K+     T   +    GT
Sbjct: 138 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 193

Query: 268 FGYVAPEYAMTGHLLV--KSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD 325
             Y+AP+    G        D +S GV++ ELLTG  P   +    + +    +R IL+ 
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKS 251

Query: 326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGE 369
           +    +            +D I+        +  +  +R   G 
Sbjct: 252 EPPYPQEMSALA------KDLIQ------RLLMKDPKKRLGCGP 283

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 8e-36
 Identities = 58/307 (18%), Positives = 113/307 (36%), Gaps = 44/307 (14%)

Query: 97  NNFEPASILGEGGFGRVFKGV-LSDGTAVAIKRL--TCGGQQGDKEFLVEVEMLSRLHHR 153
             ++    +G G  G V           VAIK+L      Q   K    E+ ++  ++H+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 154 NLVKLVGYYSSRDSSQH----LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAA 209
           N++ L+  ++ + + +      L  EL+     +            LD E    +     
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQML 129

Query: 210 RGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFG 269
            G+ +LH      +IHRD K SNI+++++   K+ DFGLA+ A         T  + T  
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 183

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQ----------------E 313
           Y APE  +        D++S G ++ E++  +          Q                +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243

Query: 314 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAA--------CVAPEANQRP 365
            L    R  + ++ +   L  P+L              + A+         +  +  +R 
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303

Query: 366 TMGEVVQ 372
           ++ + +Q
Sbjct: 304 SVDDALQ 310

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  119 bits (298), Expect = 1e-30
 Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 15/228 (6%)

Query: 99  FEPASILGEGGFGRVFKGV-LSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVK 157
           +     LG G F  V+    + + T VA+K +  G +   +    E+++L R++  +  K
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 158 LVGYYSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHL----------DWETRMKIALD 207
                ++             PNG     +   LG N                   +I+  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 208 AARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAPEGRTNYLSTRVMG 266
              GL Y+H   +  +IH D K  N+L+E  +    +    +A        +   T  + 
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 267 TFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN 314
           T  Y +PE  +       +D++S   ++ EL+TG    +  +      
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 93.7 bits (232), Expect = 5e-23
 Identities = 35/207 (16%), Positives = 60/207 (28%), Gaps = 34/207 (16%)

Query: 103 SILGEGGFGRVFKGVLSDGTAVAIKRL----------TCGGQQGDKEFLVEVEMLSRLHH 152
            ++GEG    VF           +K                  GD  F V     +R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 153 RNLVKLVGYYSSR--DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAAR 210
           R L KL G    +      + +  EL+                  +  E   ++      
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDA-----------KELYRVRVENPDEVLDMILE 114

Query: 211 GLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP-EGRTNYLSTRVMGTFG 269
            +A  +      ++H D    N+L+       + DF  + +   EG    L   V     
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIIT 170

Query: 270 YVAPEYAMTGHLLVKSDVYSYGVVLLE 296
           Y +  Y        + D+ S    +L+
Sbjct: 171 YFSRTYRT------EKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	443
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.81
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.42
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.91
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.31
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.29
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.78

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-56  Score=417.60  Aligned_cols=263  Identities=27%  Similarity=0.466  Sum_probs=205.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|+++  ..||||+++...  ....+.|.+|+++|++++|||||++++++..   ...++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEEE
Confidence            467999999999999999999864  359999997543  3345789999999999999999999998752   367999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+++|+|.++++..   ...+++.+++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus        82 ~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            9999999999999753   345999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ............||+.|||||++.+   ..|+.++|||||||++|||+||+.||.......  .    ............
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~----~~~~~~~~~~~p  229 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIFMVGRGYLSP  229 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H----HHHHHHHTSCCC
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcCCCCC
Confidence            5443334456789999999999864   358999999999999999999999997433211  1    111111111111


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                      ..  +.....++.    .+.+++.+||+.||++|||++||+++|+.+.+.+
T Consensus       230 ~~--~~~~~~~~~----~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         230 DL--SKVRSNCPK----AMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CG--GGSCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             cc--hhccccchH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            10  112223343    4889999999999999999999999999987643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=414.62  Aligned_cols=256  Identities=28%  Similarity=0.428  Sum_probs=199.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.+.||+|+||.||+|.+.+++.||||+++.. ....++|.+|++++++++|||||+++|+|..  ....++||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv~E~   81 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFEF   81 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEEC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceecc--CCceEEEEEe
Confidence            478889999999999999999988889999999754 3456789999999999999999999999974  4478999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++|+|.+++...   ...+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus        82 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             cCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence            9999999998753   345899999999999999999999999   9999999999999999999999999998765433


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......||+.|+|||++.+..++.++|||||||++|||+|+. +||....      .......+.. ...   .   
T Consensus       156 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~i~~-~~~---~---  221 (263)
T d1sm2a_         156 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDIST-GFR---L---  221 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHHHHH-TCC---C---
T ss_pred             ce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHHHHh-cCC---C---
Confidence            22 223457899999999999999999999999999999999954 4443221      1122222111 111   1   


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                          ..|..+...+.+++.+||+.||++||||+||+++|+.+.+
T Consensus       222 ----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         222 ----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                1122223458899999999999999999999999998865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-56  Score=413.90  Aligned_cols=253  Identities=26%  Similarity=0.341  Sum_probs=203.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++..  ....++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEEEE
Confidence            5799999999999999999996 4789999999975432 234568999999999999999999999984  45889999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.+++..    ...+++.++..++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+|+....
T Consensus        83 Ey~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          83 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             eccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999974    346999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      .......+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||......... +..    ........    
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~----~~~~~~~~----  226 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----WKEKKTYL----  226 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHH----HHTTCTTS----
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHH----HhcCCCCC----
Confidence            443334456789999999999988876 57899999999999999999999754322111 111    11111000    


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                            .........+.+|+.+||+.||++|||++|+++|
T Consensus       227 ------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         227 ------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             ------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  0011112347789999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=412.11  Aligned_cols=258  Identities=26%  Similarity=0.419  Sum_probs=209.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|++++++++|||||+++|++..   ...++|||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv~E   87 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITE   87 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEEEEE
Confidence            4578889999999999999999988899999999754 3456789999999999999999999998752   35789999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++....  ...+++.+++.++.||++||+|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus        88 y~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          88 YMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             CCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCC
Confidence            999999999886432  235899999999999999999999998   999999999999999999999999999977544


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. .......||+.|+|||++.+..++.++|||||||++|||+||..|+.....  .   ......+ ....      .+
T Consensus       163 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~---~~~~~~i-~~~~------~~  229 (272)
T d1qpca_         163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--N---PEVIQNL-ERGY------RM  229 (272)
T ss_dssp             CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--H---HHHHHHH-HTTC------CC
T ss_pred             cc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--H---HHHHHHH-HhcC------CC
Confidence            32 233456799999999999999999999999999999999997665532211  1   1111111 1111      11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      .....++    ..+.+|+.+||+.||++||||+||++.|+.+..
T Consensus       230 ~~p~~~~----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         230 VRPDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcccCh----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            1112233    358899999999999999999999999987654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=410.08  Aligned_cols=250  Identities=22%  Similarity=0.372  Sum_probs=207.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      ++|++.+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++..  ....++|||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmE   97 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVME   97 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEEEE
Confidence            4799999999999999999995 5799999999987666667889999999999999999999999984  448999999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++..     ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 y~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            9999999998863     35899999999999999999999999   999999999999999999999999999876543


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.....       +
T Consensus       170 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~-------~  234 (293)
T d1yhwa1         170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT-------P  234 (293)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCS-------C
T ss_pred             cc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCC-------C
Confidence            32  23456799999999999999999999999999999999999999964321      111111211110       0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .  ...+......+.+++.+||+.||++|||++|+++|
T Consensus       235 ~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         235 E--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             C--CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             C--CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  01122223457899999999999999999999876

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-56  Score=414.97  Aligned_cols=258  Identities=26%  Similarity=0.378  Sum_probs=196.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||.+......  ..+.+.+|++++++++|||||++++++........++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6799999999999999999995 57899999999765432  23568999999999999999999999875555678999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCC--CceEecCCCcccEEecCCCceEEcccccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQ--PCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      |||+++|+|.+++.........+++..++.++.|++.||+|||+.+.  ..|+||||||+|||+++++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999986433234569999999999999999999998642  2499999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+....+....  .  
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~i~~~~--~--  231 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKIREGK--F--  231 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTC--C--
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHHHHHcCC--C--
Confidence            654322  23456899999999999999999999999999999999999999964321      12222222111  1  


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         +.+...++.    .+.+|+.+||+.||++|||++|+++|
T Consensus       232 ---~~~~~~~s~----~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         232 ---RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ---CCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCcccCH----HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence               111123333    48899999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=401.86  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=210.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|+|.  +....++||||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~--~~~~~~iv~Ey   80 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC--CSSSEEEEEEC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe--eCCceEEEEEc
Confidence            6899999999999999999999888899999998643 35678999999999999999999999987  44578999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++|+|.+++...   ...+++..+++++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          81 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             cCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            9999999997643   345889999999999999999999998   9999999999999999999999999998765443


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....      .+....+ ....+.      
T Consensus       155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~~~i-~~~~~~------  220 (258)
T d1k2pa_         155 YT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHI-AQGLRL------  220 (258)
T ss_dssp             CC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHH-HTTCCC------
T ss_pred             ce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH------HHHHHHH-HhCCCC------
Confidence            22 2334679999999999999999999999999999999998 8999964331      1112222 121111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                          ..|......+.+++.+||+.||++|||++||+++|.+
T Consensus       221 ----~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         221 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                1122223458899999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-55  Score=415.92  Aligned_cols=258  Identities=25%  Similarity=0.366  Sum_probs=209.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|.+. +|+.||||+++... ...++|.+|+++|++++|||||+++++|.  +....++||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~iv~   92 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYIIT   92 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe--eCCeeEEEe
Confidence            467888999999999999999965 68899999997543 45678999999999999999999999987  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+++|+|.+++....  ...+++..++.++.||++||+|||+++   |+||||||+||||++++.+||+|||+++....
T Consensus        93 E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          93 EFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             ECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             ecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence            9999999999996432  346899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      .... ......|++.|+|||++.+..++.++|||||||++|||++|..||.....  ...+.    ..+....       
T Consensus       168 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~----~~i~~~~-------  233 (287)
T d1opja_         168 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY----ELLEKDY-------  233 (287)
T ss_dssp             SSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH----HHHHTTC-------
T ss_pred             CCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHH----HHHhcCC-------
Confidence            4322 23345689999999999999999999999999999999998777642221  11111    1121111       


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                         ....+......+.+|+.+||+.||++|||++||++.|+.+.
T Consensus       234 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         234 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence               11122222345889999999999999999999999887664

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=403.13  Aligned_cols=248  Identities=29%  Similarity=0.427  Sum_probs=206.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++...   .....+.+.+|++++++++|||||++++++.  +....++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i   83 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH--DATRVYL   83 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE--ECCEEEE
Confidence            47899999999999999999964 6899999998632   2344577899999999999999999999998  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        84 vmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~  156 (263)
T d2j4za1          84 ILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA  156 (263)
T ss_dssp             EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred             EEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence            9999999999999974    345899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....      .......+.....     
T Consensus       157 ~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~-----  221 (263)
T d2j4za1         157 PSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVEF-----  221 (263)
T ss_dssp             CCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCC-----
T ss_pred             CCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCC-----
Confidence            5432    234579999999999999999999999999999999999999996432      1222222222111     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                         .    ++......+.+++.+||+.||++|||++|+++|-+
T Consensus       222 ---~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~  257 (263)
T d2j4za1         222 ---T----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  257 (263)
T ss_dssp             ---C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred             ---C----CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence               1    12222235789999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-54  Score=412.27  Aligned_cols=258  Identities=28%  Similarity=0.463  Sum_probs=195.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CC---cEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DG---TAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      .+|++.++||+|+||.||+|.+. +|   ..||||.+..... ...+.|.+|+++|++++|||||+++|+|.  +....+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~--~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT--KSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSSCE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe--eCCEEE
Confidence            45666789999999999999964 23   3689999865433 23467999999999999999999999987  445789


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++...   ...+++.+++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus       104 iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             EEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceE
Confidence            999999999999998753   335899999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCcccc---ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          252 APEGRTNYL---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       252 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      .........   .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....   .   +....+. ...
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~---~~~~~i~-~~~  250 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---Q---DVINAIE-QDY  250 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H---HHHHHHH-TTC
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---H---HHHHHHH-cCC
Confidence            654332211   122457999999999999999999999999999999998 8999964321   1   1111111 111


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      +.          ..+.+....+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus       251 ~~----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         251 RL----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CC----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            11          1222333458899999999999999999999999987754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=414.60  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=205.9

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC-C-----cEEEEEEeccCC-CCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD-G-----TAVAIKRLTCGG-QQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.++||+|+||.||+|++.. +     ..||||.+.... ......|.+|+.+|.++ +|||||+++++|.  +.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--LS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe--eC
Confidence            4678999999999999999998532 2     369999986543 23346799999999998 8999999999997  44


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCC-------------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCC
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLG-------------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDF  228 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  228 (443)
                      ...++||||+++|+|.++|+....                   ....+++..++.++.||++||+|||+++   |+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence            578999999999999999975432                   1235899999999999999999999999   999999


Q ss_pred             CcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 013404          229 KASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMS  307 (443)
Q Consensus       229 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~  307 (443)
                      ||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||...
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987655444333445678999999999999999999999999999999998 89999744


Q ss_pred             CCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          308 QPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      ...  ..+.    .++....++          ..+......+.+|+.+||+.||++|||++||+++|.
T Consensus       271 ~~~--~~~~----~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVD--ANFY----KLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCS--HHHH----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHH--HHHH----HHHhcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            322  1111    122222111          122222345889999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-54  Score=405.13  Aligned_cols=259  Identities=27%  Similarity=0.459  Sum_probs=208.1

Q ss_pred             cCCCCCce-eeecCcEEEEEEEEC---CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASI-LGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~-lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|.+.+. ||+|+||.||+|.+.   ++..||||+++..... ..+.|.+|+++|++++|||||+++|+|..   ...+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeEE
Confidence            45666674 999999999999853   3557999999755432 34679999999999999999999999863   2578


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++...   ...+++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        85 lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence            999999999999998643   346999999999999999999999999   99999999999999999999999999997


Q ss_pred             CCCCCccc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          252 APEGRTNY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       252 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....   ..+..    .+..+.+.
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~----~i~~~~~~  231 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMA----FIEQGKRM  231 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHH----HHHTTCCC
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCCC
Confidence            76543322 2234578999999999999999999999999999999998 9999974332   11111    11221111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                            .....++    ..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       232 ------~~p~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         232 ------ECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             ------CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCcCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                  1112333    45889999999999999999999999998776543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=408.35  Aligned_cols=252  Identities=24%  Similarity=0.379  Sum_probs=204.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      +.|++.+.||+|+||.||+|+. .+|+.||||+++.......+.|.+|+++|++++|||||++++++..  ....++|||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvmE   89 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIE   89 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEEEe
Confidence            4688999999999999999996 4789999999987666666789999999999999999999999984  448899999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|.+++...   ...+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        90 y~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          90 FCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            99999999998632   245999999999999999999999999   999999999999999999999999999765322


Q ss_pred             CccccccccccCcccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      .  .......||+.|+|||++.     +..|+.++|||||||++|||++|+.||.......   .   ...+.....  .
T Consensus       164 ~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~---~~~i~~~~~--~  233 (288)
T d2jfla1         164 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V---LLKIAKSEP--P  233 (288)
T ss_dssp             H--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHHHSCC--C
T ss_pred             c--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H---HHHHHcCCC--C
Confidence            1  1234568999999999984     4568899999999999999999999997543221   1   111111110  0


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .+       ..+......+.+|+.+||+.||++|||++|+++|
T Consensus       234 ~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         234 TL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             CC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00       1112223458899999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-54  Score=404.16  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=204.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|++++++++|||||++++++.  +....++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~i   85 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYF   85 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE--CSSEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE--ECCEEEE
Confidence            5699999999999999999996 57899999998643   2334567999999999999999999999987  4458899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+..
T Consensus        86 vmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~  158 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL  158 (288)
T ss_dssp             EECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence            9999999999999864    346899999999999999999999999   999999999999999999999999999977


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .............||+.|+|||++.+..++.++|||||||++|||++|+.||...+      .......+.....     
T Consensus       159 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~~~-----  227 (288)
T d1uu3a_         159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLIFQKIIKLEY-----  227 (288)
T ss_dssp             C----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHTTCC-----
T ss_pred             ccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHHHHHHHcCCC-----
Confidence            55443333455689999999999999999999999999999999999999997432      1122222222211     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                         .+...++    ..+.+|+.+||+.||++|||++|++++.+
T Consensus       228 ---~~p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~~~~  263 (288)
T d1uu3a_         228 ---DFPEKFF----PKARDLVEKLLVLDATKRLGCEEMEGYGP  263 (288)
T ss_dssp             ---CCCTTCC----HHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred             ---CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence               1112233    34789999999999999999999876544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=402.04  Aligned_cols=259  Identities=26%  Similarity=0.428  Sum_probs=199.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCC-----cEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDG-----TAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      +.|+..++||+|+||.||+|.+++.     ..||||+++..... ...+|.+|++++++++|||||+++|+|.  +....
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~--~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe--cCCce
Confidence            4577889999999999999996532     37999999754332 2457999999999999999999999987  44578


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      +++|||+.+|+|.+++...   ...+++.+++.++.|++.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        85 ~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          85 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence            9999999999999988643   345999999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+.....  .   .+.... +..+.+ 
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~---~~~~~~-i~~~~~-  231 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--N---HEVMKA-INDGFR-  231 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--H---HHHHHH-HHTTCC-
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--H---HHHHHH-HhccCC-
Confidence            76543322 223345689999999999999999999999999999999997766543221  1   111111 111111 


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                               ...+......+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus       232 ---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         232 ---------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ---------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                     12222333458899999999999999999999999988765

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=399.30  Aligned_cols=249  Identities=27%  Similarity=0.444  Sum_probs=197.6

Q ss_pred             ceeeecCcEEEEEEEEC---CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEeec
Q 013404          103 SILGEGGFGRVFKGVLS---DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELV  177 (443)
Q Consensus       103 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~~  177 (443)
                      ++||+|+||.||+|.++   .++.||||+++.....  ..+.|.+|+++|++++|||||+++|+|..   ...+|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence            57999999999999864   3468999999754332  24679999999999999999999999863   2578999999


Q ss_pred             CCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCCc
Q 013404          178 PNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGRT  257 (443)
Q Consensus       178 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  257 (443)
                      ++|+|.++++.    ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        90 ~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          90 ELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             TTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            99999999974    345899999999999999999999998   99999999999999999999999999987654433


Q ss_pred             cc-cccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          258 NY-LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       258 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....   ..+   .. .+..+.+.      
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~---~~-~i~~~~~~------  229 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV---TA-MLEKGERM------  229 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH---HH-HHHTTCCC------
T ss_pred             ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHH---HH-HHHcCCCC------
Confidence            22 2234579999999999999999999999999999999998 8999964321   111   11 12221111      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      .....++    ..+.+|+.+||+.||++|||+++|++.|+...
T Consensus       230 ~~p~~~~----~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         230 GCPAGCP----REMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCcccC----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            1112233    45889999999999999999999999887654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=398.61  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=196.8

Q ss_pred             CCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeec--CCCCeeEEEE
Q 013404          100 EPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSS--RDSSQHLLCY  174 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~~~lv~  174 (443)
                      ++.++||+|+||+||+|... +++.||+|.+.....  ...+.|.+|+++|++++|||||+++++|..  ......++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999964 688999999875432  234578999999999999999999999864  2344678999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec-CCCceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE-NNFHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~  253 (443)
                      ||+++|+|.+++..    ...+++..+..++.||++||+|||+++. +|+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~~-~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCCC-CEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999964    3458999999999999999999998763 399999999999996 57899999999998654


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ...    .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.....     .......+... ..     
T Consensus       167 ~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~~~i~~~-~~-----  230 (270)
T d1t4ha_         167 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSG-VK-----  230 (270)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTT-CC-----
T ss_pred             CCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHHHHHHcC-CC-----
Confidence            322    245689999999998865 599999999999999999999999963321     11122222211 11     


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .+.+....++    .+.+++.+||+.||++|||++|+++|
T Consensus       231 ~~~~~~~~~~----~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         231 PASFDKVAIP----EVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             CGGGGGCCCH----HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CcccCccCCH----HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            0111112233    47899999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=400.53  Aligned_cols=257  Identities=29%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      .++|++.+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.++++++|||||+++|+|..   ...++|||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv~E   91 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTE   91 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEEEE
Confidence            3579999999999999999999988889999999754 3456789999999999999999999999852   35789999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEG  255 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  255 (443)
                      |+++|+|..++....  ...++|.+++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        92 y~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          92 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             ecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            999999999986422  235899999999999999999999999   999999999999999999999999999876543


Q ss_pred             CccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          256 RTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       256 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                      .. .......||+.|+|||++..+.++.++|||||||++|||++|..|+.....     ..+....+.. ..      .+
T Consensus       167 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~~~i~~-~~------~~  233 (285)
T d1fmka3         167 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVLDQVER-GY------RM  233 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHHHHHHT-TC------CC
T ss_pred             Cc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHHHHHHh-cC------CC
Confidence            32 223446799999999999999999999999999999999997766643221     1111111111 11      11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                          ..+......+.+++.+||+.||++||++++|++.|+...
T Consensus       234 ----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         234 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                122223345889999999999999999999998887654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=413.63  Aligned_cols=264  Identities=25%  Similarity=0.392  Sum_probs=203.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|+++..... ....+.+|+.+|++++|||||+++++|.  +....++|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY--SDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEE
Confidence            46899999999999999999995 57899999999765433 3467899999999999999999999998  44589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      |||+++|+|.+++.+    ...+++..+..++.|++.||.|||+ ++   |+||||||+|||+++++.+||+|||+|+..
T Consensus        83 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999999974    3458999999999999999999997 48   999999999999999999999999999865


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc------
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK------  326 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  326 (443)
                      ...    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+...... . +........      
T Consensus       156 ~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~-~-~~~~~~~~~~~~~~~  229 (322)
T d1s9ja_         156 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL-M-FGCQVEGDAAETPPR  229 (322)
T ss_dssp             HHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH-H-C--------------
T ss_pred             CCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-H-HHHHhcCCcccCCcc
Confidence            322    2345689999999999999999999999999999999999999997543221100 0 000000000      


Q ss_pred             ------------------c----cccccccCccCCCCC-HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          327 ------------------D----RLEELADPRLGGKYP-KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       327 ------------------~----~~~~~~d~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                                        .    ....+..... ...+ ......+.+++.+||+.||++|||++|+++|-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf  300 (322)
T d1s9ja_         230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP-PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  300 (322)
T ss_dssp             ----------------CCCCHHHHHHHHHTSCC-CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             cccccccccccccccccchhHHHHHhhhhccCC-ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence                              0    0000000000 0000 001234788999999999999999999999744

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-52  Score=405.51  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=207.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++..  ....++||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivm  102 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIY  102 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEE
Confidence            35899999999999999999996 5789999999986655556778999999999999999999999884  45899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC--CCceEEccccccccC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN--NFHAKVADFGLAKQA  252 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~  252 (443)
                      ||+++|+|.+++...   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.  ++.+||+|||+++..
T Consensus       103 E~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         103 EFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             CCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            999999999999643   345999999999999999999999999   999999999999954  678999999999877


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....   .....||+.|||||++.+..++.++|||||||++|||++|+.||....      ..+....+......... 
T Consensus       177 ~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~~~~-  246 (350)
T d1koaa2         177 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRNVKSCDWNMDD-  246 (350)
T ss_dssp             CTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCSCC-
T ss_pred             ccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCCCc-
Confidence            54432   244689999999999999999999999999999999999999996432      12222223222211111 


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         .....++    ..+.+|+.+||+.||++|||++|+++|
T Consensus       247 ---~~~~~~s----~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 ---SAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---GGGGGCC----HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---ccccCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               1111122    347899999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=403.00  Aligned_cols=258  Identities=29%  Similarity=0.490  Sum_probs=204.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCc----EEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGT----AVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .+|++.++||+|+||.||+|.+. +|+    +||+|+++... ....+.|.+|++++++++|||||+++|+|...   ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---Ce
Confidence            46999999999999999999854 444    68999986543 34567899999999999999999999999742   56


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++++||+.+|+|.+++...   ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             eEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence            7889999999999988643   446899999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ...............||+.|+|||++.++.++.++|||||||++|||+| |..||......   .+..    .+..+.++
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~----~i~~~~~~  232 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS----ILEKGERL  232 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHH----HHHHTCCC
T ss_pred             ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHH----HHHcCCCC
Confidence            8765544434445679999999999999999999999999999999998 78888654322   1221    11121111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                                ..+......+.+|+.+||+.||++|||+.||+++|+.+.+.
T Consensus       233 ----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         233 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ----------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                      12222334588999999999999999999999999887653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-53  Score=400.72  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=189.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .+.|++.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++|++++|||||++++++.  +....++|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE--SGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEE
Confidence            467999999999999999999964 689999999975432 23456889999999999999999999987  45589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec---CCCceEEccccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAK  250 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~  250 (443)
                      |||+++|+|.+++..    ...+++.++..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++
T Consensus        86 mE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          86 MQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             ECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeE
Confidence            999999999999974    346999999999999999999999999   99999999999994   57899999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||....      .......+....... 
T Consensus       159 ~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~~~~~~~-  228 (307)
T d1a06a_         159 MEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN------DAKLFEQILKAEYEF-  228 (307)
T ss_dssp             -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHTTCCCC-
T ss_pred             EccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHhccCCCC-
Confidence            664432   2244679999999999999999999999999999999999999996432      111222222221111 


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                         .......++    ..+.+++.+||+.||++|||++|+++|
T Consensus       229 ---~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         229 ---DSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ---CTTTTTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---CCccccCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence               111112233    347899999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-53  Score=402.65  Aligned_cols=265  Identities=26%  Similarity=0.375  Sum_probs=209.6

Q ss_pred             HHHHhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCCC-CHHHHHHHHHHHhhcCCCceeeEEEeeec
Q 013404           92 LKEATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRLHHRNLVKLVGYYSS  164 (443)
Q Consensus        92 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~  164 (443)
                      ++..+++|++.+.||+|+||+||+|++.      +++.||||+++..... ..++|.+|+++|++++||||++++++|. 
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-   86 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-   86 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec-
Confidence            3345678999999999999999999863      3578999999754433 2467999999999999999999999987 


Q ss_pred             CCCCeeEEEEeecCCCChhHhhcCCC--------------------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceE
Q 013404          165 RDSSQHLLCYELVPNGSLESWLHGPL--------------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVI  224 (443)
Q Consensus       165 ~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  224 (443)
                       +....+++|||+++|+|.++++...                    .....+++..++.++.|++.||+|||+.+   |+
T Consensus        87 -~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv  162 (301)
T d1lufa_          87 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  162 (301)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             -cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence             4457899999999999999996321                    11235889999999999999999999999   99


Q ss_pred             ecCCCcccEEecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCC-CC
Q 013404          225 HRDFKASNILLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-KP  303 (443)
Q Consensus       225 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~-~p  303 (443)
                      ||||||+|||++.++.+||+|||+++...........+...||+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998765444333344567899999999999999999999999999999999986 56


Q ss_pred             CCCCCCCCcchHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          304 VDMSQPSGQENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      |.....      .+....+ ..+..      +.....++    ..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus       243 ~~~~~~------~e~~~~v-~~~~~------~~~p~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         243 YYGMAH------EEVIYYV-RDGNI------LACPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTSCH------HHHHHHH-HTTCC------CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCH------HHHHHHH-HcCCC------CCCCccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            653321      1111211 12111      11112333    35889999999999999999999999998763

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.4e-52  Score=402.14  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=207.1

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      ++|++.+.||+|+||.||+|.. .+|+.||||+++.........+.+|+++|++++|||||+++++|.  +....++|||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~ivmE  106 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLILE  106 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEEEE
Confidence            5799999999999999999995 579999999998655444567889999999999999999999998  4558999999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec--CCCceEEccccccccCC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE--NNFHAKVADFGLAKQAP  253 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~  253 (443)
                      |+++|+|.+++...   ..++++.+++.++.||+.||+|||+++   |+||||||+||||+  .++.+||+|||+|+...
T Consensus       107 ~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         107 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             cCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecC
Confidence            99999999988643   345999999999999999999999999   99999999999997  57899999999998876


Q ss_pred             CCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELA  333 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (443)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+.......    
T Consensus       181 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~----  247 (352)
T d1koba_         181 PDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWEF----  247 (352)
T ss_dssp             TTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCCC----
T ss_pred             CCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC----
Confidence            5432   3446799999999999999999999999999999999999999964321      12222222211111    


Q ss_pred             cCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          334 DPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       334 d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .......++.    .+.+|+.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~~s~----~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 DEDAFSSVSP----EAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CSSTTTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CcccccCCCH----HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111122333    47899999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-53  Score=401.31  Aligned_cols=247  Identities=27%  Similarity=0.388  Sum_probs=200.3

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC---HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .|+..+.||+|+||.||+|+. .+|+.||||+++......   .+.+.+|+++|++++|||||++++++..  ....++|
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv   93 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLV   93 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEE
Confidence            488899999999999999995 578899999997654332   3468899999999999999999999874  4589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ||||++|+|..++..    ..++++.++..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus        94 ~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          94 MEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             EECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence            999999999877653    346899999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCccccccccccCccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLE  330 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (443)
                      ..      ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.....      ......+.....  .
T Consensus       167 ~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~--~  232 (309)
T d1u5ra_         167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES--P  232 (309)
T ss_dssp             SB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC--C
T ss_pred             CC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC--C
Confidence            32      33579999999999864   4689999999999999999999999964321      111222222110  0


Q ss_pred             ccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 013404          331 ELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLK  375 (443)
Q Consensus       331 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~  375 (443)
                      .+    ....++    ..+.+|+.+||+.||++|||++|+++|-+
T Consensus       233 ~~----~~~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~Hp~  269 (309)
T d1u5ra_         233 AL----QSGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (309)
T ss_dssp             CC----SCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             CC----CCCCCC----HHHHHHHHHHCcCChhHCcCHHHHHhCHH
Confidence            01    111233    34789999999999999999999998643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=400.06  Aligned_cols=266  Identities=26%  Similarity=0.401  Sum_probs=201.8

Q ss_pred             HhcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhc-CCCceeeEEEeeecCC
Q 013404           95 ATNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRD  166 (443)
Q Consensus        95 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  166 (443)
                      ..++|++.+.||+|+||.||+|.+.      +++.||||+++.... ...+.+.+|..++.++ +|+||+.+++++.. +
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~   89 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-P   89 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-T
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-C
Confidence            3468999999999999999999853      346899999975433 2345688888888887 68999999998764 3


Q ss_pred             CCeeEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEE
Q 013404          167 SSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNIL  234 (443)
Q Consensus       167 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIl  234 (443)
                      ....++||||+++|+|.++++....            ....+++.+++.++.||++||+|||+++   |+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence            4468999999999999999964321            1235899999999999999999999999   999999999999


Q ss_pred             ecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcc
Q 013404          235 LENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQE  313 (443)
Q Consensus       235 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~-~p~~~~~~~~~~  313 (443)
                      |++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. .||......  .
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~  244 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E  244 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--H
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--H
Confidence            9999999999999998766554444445678999999999999999999999999999999999975 567533221  1


Q ss_pred             hHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          314 NLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      .    +...+..+...      .....++    ..+.+++.+||+.||++|||++||+++|+.+.+.
T Consensus       245 ~----~~~~~~~~~~~------~~~~~~~----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         245 E----FCRRLKEGTRM------RAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             H----HHHHHHHTCCC------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H----HHHHHhcCCCC------CCCccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1    11122222111      1112233    3488999999999999999999999999988653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-53  Score=390.69  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=198.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      ++|++.+.||+|+||.||+|.++ |+.||||+++..  ...+.|.+|++++++++||||++++|+|... ....++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEEEec
Confidence            46788899999999999999985 788999999753  3457899999999999999999999998632 3457999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++|+|.++|....  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..... 
T Consensus        83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence            99999999996421  235899999999999999999999998   999999999999999999999999999865432 


Q ss_pred             ccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccccccccC
Q 013404          257 TNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRLEELADP  335 (443)
Q Consensus       257 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  335 (443)
                          .....+|..|+|||++.+..++.++|||||||++|||+| |+.||.....   ..+..++    ....      .+
T Consensus       157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i----~~~~------~~  219 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGY------KM  219 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH----TTTC------CC
T ss_pred             ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCC------CC
Confidence                233468899999999999999999999999999999998 6777764322   2222221    1111      11


Q ss_pred             ccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          336 RLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       336 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      .    .+......+.+|+.+||+.||++|||+.+|+++|+.++.
T Consensus       220 ~----~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         220 D----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C----CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            1    222223458899999999999999999999999988754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-52  Score=391.28  Aligned_cols=252  Identities=25%  Similarity=0.320  Sum_probs=204.7

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC------CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ------QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||+|+. .+|+.||||+++....      ...+.|.+|+++|++++|||||+++++|.  +..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~   86 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKT   86 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECC
Confidence            36799999999999999999996 5789999999864321      23578999999999999999999999998  455


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC----ceEEc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF----HAKVA  244 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~  244 (443)
                      ..++||||+++|+|.+++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+
T Consensus        87 ~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          87 DVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEec
Confidence            89999999999999999964    346999999999999999999999999   99999999999998776    49999


Q ss_pred             cccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          245 DFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       245 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      |||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .+....+..
T Consensus       160 DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~  230 (293)
T d1jksa_         160 DFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSA  230 (293)
T ss_dssp             CCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHT
T ss_pred             chhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHHHHh
Confidence            9999987654332   2445799999999999999999999999999999999999999974321      122222222


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .........    ....+    ..+.+|+.+||+.||++|||++|+++|
T Consensus       231 ~~~~~~~~~----~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         231 VNYEFEDEY----FSNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             TCCCCCHHH----HTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCCCCchh----cCCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111111000    01122    347899999999999999999999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-52  Score=391.21  Aligned_cols=258  Identities=27%  Similarity=0.453  Sum_probs=197.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC----CcEEEEEEeccCCCCC-HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCee
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD----GTAVAIKRLTCGGQQG-DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  170 (443)
                      .++|++.+.||+|+||.||+|.+..    +..||||.++...... .+.|.+|++++++++|||||+++++|..   ...
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeE
Confidence            4578999999999999999998642    3578999987543332 4579999999999999999999999852   368


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ++||||+++|+|.+++...   ...+++..++.++.||++||+|||+++   |+||||||+||++++++.+||+|||+++
T Consensus        83 ~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhe
Confidence            9999999999999987643   345899999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccccc
Q 013404          251 QAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKDRL  329 (443)
Q Consensus       251 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (443)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......   .+...   + ......
T Consensus       157 ~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~---i-~~~~~~  228 (273)
T d1mp8a_         157 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR---I-ENGERL  228 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH---H-HTTCCC
T ss_pred             eccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHH---H-HcCCCC
Confidence            7654322 23345678999999999999999999999999999999998 89999754332   12211   1 111111


Q ss_pred             cccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          330 EELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       330 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                            .....++    ..+.+|+.+||+.||++|||++||+++|+.+.+.
T Consensus       229 ------~~~~~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         229 ------PMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                  1112233    4588999999999999999999999999987654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=393.50  Aligned_cols=249  Identities=24%  Similarity=0.315  Sum_probs=206.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++..   .....+.+.+|+.+|++++||||+++++++.  +....++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~i   82 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCF   82 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec--ccccccc
Confidence            5799999999999999999995 57999999999743   2334677899999999999999999999998  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+++|+|.+++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+..
T Consensus        83 v~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          83 VMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             ceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence            9999999999999974    345889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.      ......+.....     
T Consensus       156 ~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~~~-----  222 (337)
T d1o6la_         156 ISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEEI-----  222 (337)
T ss_dssp             CCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC-----
T ss_pred             ccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcCCC-----
Confidence            54322  23456899999999999999999999999999999999999999975331      222222222211     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL  374 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L  374 (443)
                         .+...++    ..+.+|+.+||+.||++||+     ++|+++|-
T Consensus       223 ---~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp  262 (337)
T d1o6la_         223 ---RFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             ---CCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             ---CCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence               1112233    34789999999999999995     88998864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=388.25  Aligned_cols=256  Identities=29%  Similarity=0.446  Sum_probs=196.9

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC--CC--cEEEEEEeccCC---CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS--DG--TAVAIKRLTCGG---QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~--~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||+++...   ....++|.+|+++|++++|||||+++|+|..   ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~   84 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP   84 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cc
Confidence            56899999999999999999853  23  378999987542   2224679999999999999999999999863   25


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+++|+|.+++...   ...+++..++.++.|+++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~  158 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM  158 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             hheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence            78999999999999988642   345999999999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCcccc-ccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          250 KQAPEGRTNYL-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       250 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      +.......... .....||..|+|||++.+..++.++|||||||++|||+| |+.||....      ..+....+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~------~~~~~~~i~~~~~  232 (273)
T d1u46a_         159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGE  232 (273)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCC
T ss_pred             hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC------HHHHHHHHHhCCC
Confidence            98755443322 234568889999999999999999999999999999998 899996332      2222222333222


Q ss_pred             cccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHh
Q 013404          328 RLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMV  377 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~  377 (443)
                      ..      .....++    ..+.+|+.+||+.||++|||++||++.|++.
T Consensus       233 ~~------~~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RL------PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CC------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC------CCccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11      1112233    3488999999999999999999999988765

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=391.75  Aligned_cols=263  Identities=26%  Similarity=0.408  Sum_probs=210.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE------CCCcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEEEeeecCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL------SDGTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDS  167 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  167 (443)
                      .++|++.++||+|+||.||+|++      .+++.||||+++..... ....|.+|+.+++++ +|||||+++++|..  .
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--G   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--C
Confidence            46788999999999999999985      24578999999765432 345789999999999 69999999999974  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCC--------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLG--------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                      ...+++|||+++|+|.++++....              ....+++..+..++.||++||+|||+++   ++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence            478999999999999999964321              2335899999999999999999999999   99999999999


Q ss_pred             EecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCc
Q 013404          234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQ  312 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~-~p~~~~~~~~~  312 (443)
                      |++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+|+. +||......  
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--  254 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--  254 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence            99999999999999999876655444455678999999999999999999999999999999999954 445432221  


Q ss_pred             chHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      ..+..    ++..+.+      +    ..+......+.+|+.+||+.||++|||++||++.|+.+..
T Consensus       255 ~~~~~----~i~~~~~------~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         255 SKFYK----MIKEGFR------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHHHH----HHHHTCC------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH----HHhcCCC------C----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            11111    2222111      1    1122223358899999999999999999999999987654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.8e-51  Score=382.30  Aligned_cols=262  Identities=25%  Similarity=0.344  Sum_probs=203.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC---HHHHHHHHHHHhhcCCCceeeEEEeeecCCC--Ce
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--SQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~  169 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||.++......   ...|.+|+++++.++|||||++++++...+.  ..
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999995 579999999997654333   3468999999999999999999999875432  34


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+++|+|.+++..    ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.++..+|+|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence            7899999999999998864    346899999999999999999999999   999999999999999999999999998


Q ss_pred             ccCCCCCcc-ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          250 KQAPEGRTN-YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       250 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      +........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||....      ..............
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCC
Confidence            765433221 22345679999999999999999999999999999999999999996432      12222223332221


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHhH
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-TMGEVVQSLKMVQ  378 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~~  378 (443)
                      ....    ....++.    .+.+++.+||+.||++|| |++++++.|..++
T Consensus       233 ~~~~----~~~~~s~----~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 PPSA----RHEGLSA----DLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CGGG----TSSSCCH----HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCch----hccCCCH----HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            1111    1122333    478999999999999999 8999988887664

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-51  Score=387.49  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=202.2

Q ss_pred             CceeeecCcEEEEEEEECCC----cEEEEEEeccCC-CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEee
Q 013404          102 ASILGEGGFGRVFKGVLSDG----TAVAIKRLTCGG-QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYEL  176 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e~  176 (443)
                      .++||+|+||+||+|++.++    ..||||+++... ....++|.+|+++|++++||||++++|+|... ....++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEE
Confidence            46899999999999996432    368999997433 23346799999999999999999999998643 3478999999


Q ss_pred             cCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCCCC
Q 013404          177 VPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPEGR  256 (443)
Q Consensus       177 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  256 (443)
                      +++|+|.++++..   ...+++..+++++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999999754   335778899999999999999999999   9999999999999999999999999998765433


Q ss_pred             cc--ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccccc
Q 013404          257 TN--YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEELAD  334 (443)
Q Consensus       257 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  334 (443)
                      ..  .......||..|+|||.+....++.++||||||+++|||+||+.||......  .   ++...+... .+.   ..
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~---~~~~~i~~g-~~~---~~  255 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--F---DITVYLLQG-RRL---LQ  255 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTT-CCC---CC
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--H---HHHHHHHcC-CCC---CC
Confidence            22  1223457899999999999999999999999999999999988887533211  1   111111111 111   11


Q ss_pred             CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          335 PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       335 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                      |   ..++    ..+.+|+.+||+.||++||+|.||+++|+.+.+.
T Consensus       256 p---~~~~----~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         256 P---EYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             C---TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             c---ccCc----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1   1223    3588999999999999999999999999988754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=389.69  Aligned_cols=262  Identities=27%  Similarity=0.412  Sum_probs=206.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEECC--------CcEEEEEEeccCCCC-CHHHHHHHHHHHhhc-CCCceeeEEEeeecC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLSD--------GTAVAIKRLTCGGQQ-GDKEFLVEVEMLSRL-HHRNLVKLVGYYSSR  165 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  165 (443)
                      .++|++.+.||+|+||.||+|+..+        +..||||+++..... ...++.+|+..+.++ +|||||+++++|.  
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~--   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence            4578899999999999999998522        247999999765432 346788999999998 7999999999997  


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCC------------CCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccE
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLG------------VNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNI  233 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NI  233 (443)
                      +....++||||+++|+|.++|.....            ....+++.+++.++.|++.||+|||+.+   |+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence            44578999999999999999975421            2346899999999999999999999999   99999999999


Q ss_pred             EecCCCceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 013404          234 LLENNFHAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLT-GRKPVDMSQPSGQ  312 (443)
Q Consensus       234 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~ellt-g~~p~~~~~~~~~  312 (443)
                      |++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |..||.....   
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---  243 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---  243 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence            999999999999999987755444334455679999999999999999999999999999999998 6888853321   


Q ss_pred             chHHHHHHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          313 ENLVTWARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      ..+    ...+..+...      .....++    ..+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus       244 ~~~----~~~i~~~~~~------~~p~~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 EEL----FKLLKEGHRM------DKPSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHH----HHHHHTTCCC------CCCSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH----HHHHHcCCCC------CCCccch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            111    1122222211      1112233    358899999999999999999999999988864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=388.27  Aligned_cols=255  Identities=21%  Similarity=0.291  Sum_probs=206.5

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .++|++.+.||+|+||.||+|.. .+|+.||||.++... .....+.+|+++|+.++|||||++++++..  ....++||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEE
Confidence            46799999999999999999996 478899999997543 234568899999999999999999999884  45899999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC--CceEEccccccccC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN--FHAKVADFGLAKQA  252 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~  252 (443)
                      |||++|+|.+++...   ...+++.++..++.||+.||+|||+++   |+||||||+|||++.+  ..+||+|||+++..
T Consensus        81 E~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          81 EFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcc
Confidence            999999999999743   235899999999999999999999999   9999999999999854  58999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      .....   .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||....      ..+....+..........
T Consensus       155 ~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~------~~~~~~~i~~~~~~~~~~  225 (321)
T d1tkia_         155 KPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET------NQQIIENIMNAEYTFDEE  225 (321)
T ss_dssp             CTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCCCCCHH
T ss_pred             ccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCCChh
Confidence            54332   234578999999999999999999999999999999999999997432      122223333222111110


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                      ..    ..++    ..+.+|+.+||+.||++|||++|+++|-+.
T Consensus       226 ~~----~~~s----~~~~~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         226 AF----KEIS----IEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             HH----TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             hc----cCCC----HHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            00    1122    347899999999999999999999998553

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.7e-51  Score=388.51  Aligned_cols=246  Identities=28%  Similarity=0.371  Sum_probs=205.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++..   .....+.+.+|+.++++++|||||++++++.  +....++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~i   81 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIFM   81 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe--eCCeeee
Confidence            5799999999999999999996 57899999998643   2344678999999999999999999999988  4558999


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||++||+|..++..    ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus        82 vmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~  154 (316)
T d1fota_          82 IMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV  154 (316)
T ss_dssp             EECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             EeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence            9999999999999874    345788999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ...     .....||+.|+|||++.+..|+.++|||||||++|||++|+.||....      .......+......    
T Consensus       155 ~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~~----  219 (316)
T d1fota_         155 PDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAELR----  219 (316)
T ss_dssp             SSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCCC----
T ss_pred             ccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcCCCC----
Confidence            543     234689999999999999999999999999999999999999997432      12222222222111    


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                          ....++    ..+.+++.+||+.||.+||     |++++++|-
T Consensus       220 ----~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp  258 (316)
T d1fota_         220 ----FPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP  258 (316)
T ss_dssp             ----CCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             ----CCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcCc
Confidence                111223    3478999999999999996     899999873

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=390.43  Aligned_cols=258  Identities=29%  Similarity=0.440  Sum_probs=203.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCc--EEEEEEeccC-CCCCHHHHHHHHHHHhhc-CCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGT--AVAIKRLTCG-GQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|++.++||+|+||.||+|++. +|.  .||||+++.. .....+.|.+|+++|.++ +|||||+++|+|..  ....+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCeeE
Confidence            57888999999999999999964 444  5788888643 333456899999999999 79999999999984  45899


Q ss_pred             EEEeecCCCChhHhhcCCC------------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC
Q 013404          172 LCYELVPNGSLESWLHGPL------------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF  239 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~  239 (443)
                      +||||+++|+|.++|+...            .....+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCC
Confidence            9999999999999997542            22456999999999999999999999998   99999999999999999


Q ss_pred             ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCCcchHHHH
Q 013404          240 HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRK-PVDMSQPSGQENLVTW  318 (443)
Q Consensus       240 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~-p~~~~~~~~~~~~~~~  318 (443)
                      .+||+|||+++.......   .....||..|+|||.+.+..++.++|||||||++|||++|.. ||....      ..+.
T Consensus       165 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~  235 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAEL  235 (309)
T ss_dssp             CEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHH
T ss_pred             ceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHH
Confidence            999999999986543222   234568999999999999999999999999999999999765 564322      1122


Q ss_pred             HHHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          319 ARPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       319 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                      ...+ ....+      +.    .+......+.+|+.+||+.||++||||+||+++|+.+.+
T Consensus       236 ~~~i-~~~~~------~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         236 YEKL-PQGYR------LE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHG-GGTCC------CC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHH-HhcCC------CC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2211 11111      11    122223458899999999999999999999999988865

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.2e-50  Score=376.65  Aligned_cols=251  Identities=26%  Similarity=0.392  Sum_probs=203.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC---------HHHHHHHHHHHhhcC-CCceeeEEEeeecC
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG---------DKEFLVEVEMLSRLH-HRNLVKLVGYYSSR  165 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  165 (443)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++......         .+.+.+|+.++++++ ||||+++++++.  
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--   80 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--   80 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence            5799999999999999999995 578999999997543221         235889999999997 999999999998  


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcc
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD  245 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  245 (443)
                      ++...+|||||+++|+|.++|+.    ..++++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~D  153 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  153 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             cCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEcc
Confidence            55689999999999999999964    346999999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccCccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHH
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWA  319 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~  319 (443)
                      ||+++.......   .....||+.|+|||++.+      ..++.++||||+||++|||++|+.||.....      ....
T Consensus       154 FG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~  224 (277)
T d1phka_         154 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLML  224 (277)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH
T ss_pred             chheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHH
Confidence            999987755332   244679999999998863      3568899999999999999999999974321      1112


Q ss_pred             HHHhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          320 RPILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       320 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ..+.......        ...........+.+++.+||+.||++|||++||++|
T Consensus       225 ~~i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         225 RMIMSGNYQF--------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHHHTCCCC--------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHhCCCCC--------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            2222221111        011111222358899999999999999999999876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=383.49  Aligned_cols=270  Identities=24%  Similarity=0.383  Sum_probs=201.6

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHH--HHhhcCCCceeeEEEeeecCCC--CeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVE--MLSRLHHRNLVKLVGYYSSRDS--SQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~~~~--~~~~l  172 (443)
                      ++|.+.+.||+|+||.||+|++ +|+.||||+++..   ....+..|.+  .+.+++|||||+++++|...+.  ..+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4567788999999999999997 5789999999643   3344444544  4567899999999999975443  35789


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhc-----CCCceEecCCCcccEEecCCCceEEcccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHED-----SQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ||||+++|+|.++|++     ..++|.++++++.|++.||.|||+.     ..++|+||||||+||||++++.+||+|||
T Consensus        79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            9999999999999974     3589999999999999999999974     12339999999999999999999999999


Q ss_pred             ccccCCCCCcc--ccccccccCcccccccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcc------
Q 013404          248 LAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQE------  313 (443)
Q Consensus       248 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~------  313 (443)
                      +++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||.........      
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            99876543322  1233467999999999987643      678999999999999999999887532221110      


Q ss_pred             --hHHHHHHHHhhccccccccccCccCCCC-CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhh
Q 013404          314 --NLVTWARPILRDKDRLEELADPRLGGKY-PKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRV  380 (443)
Q Consensus       314 --~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~  380 (443)
                        ............     ...+|.+.... +.+....+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus       234 ~~~~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         234 SDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SSCCHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence              111111111111     11122221111 234556689999999999999999999999999988753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-50  Score=389.04  Aligned_cols=246  Identities=24%  Similarity=0.304  Sum_probs=204.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLL  172 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~l  172 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+++|+.++|||||++++++.  +....++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~~  118 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLYM  118 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc--ccccccc
Confidence            5799999999999999999996 47999999998642   2334567899999999999999999999987  4558899


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccC
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQA  252 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~  252 (443)
                      ||||+.+|+|.+++..    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus       119 v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            9999999999999964    235899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccccccc
Q 013404          253 PEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEEL  332 (443)
Q Consensus       253 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (443)
                      ...     .....||+.|||||++.+..++.++|||||||++|||++|+.||....      .......+.....     
T Consensus       192 ~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~-----  255 (350)
T d1rdqe_         192 KGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGKV-----  255 (350)
T ss_dssp             SSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCC-----
T ss_pred             ccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcCCC-----
Confidence            532     234579999999999999999999999999999999999999996432      1222222222211     


Q ss_pred             ccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          333 ADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       333 ~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                         .....++.    .+.+++.+||+.||++|+     |++++++|-
T Consensus       256 ---~~p~~~s~----~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp  295 (350)
T d1rdqe_         256 ---RFPSHFSS----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             ---CCCTTCCH----HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             ---CCCccCCH----HHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence               11122333    478999999999999994     899999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-51  Score=387.57  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=208.3

Q ss_pred             hcCCCCCceeeecCcEEEEEEEEC------CCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVLS------DGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  168 (443)
                      .++|++.+.||+|+||.||+|.+.      +++.||||+++.... .....|.+|++++++++|||||+++++|..  ..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~   96 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQ   96 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--SS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec--CC
Confidence            467889999999999999999863      357899999975432 223468999999999999999999999874  44


Q ss_pred             eeEEEEeecCCCChhHhhcCCC------CCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceE
Q 013404          169 QHLLCYELVPNGSLESWLHGPL------GVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAK  242 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k  242 (443)
                      ..++||||+++|+|.+++....      .....+++..+..++.|+++||.|||+++   |+||||||+|||+++++++|
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEE
Confidence            7899999999999999985321      12235789999999999999999999998   99999999999999999999


Q ss_pred             EccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCcchHHHHHHH
Q 013404          243 VADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGR-KPVDMSQPSGQENLVTWARP  321 (443)
Q Consensus       243 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~  321 (443)
                      |+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||...      +.......
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~  247 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRF  247 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHH
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHHH
Confidence            99999998765544444445567999999999999999999999999999999999985 666432      12222222


Q ss_pred             HhhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhH
Q 013404          322 ILRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQ  378 (443)
Q Consensus       322 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~  378 (443)
                      +.. +...      .....++    ..+.+++.+||+.||++|||+++|+++|+...
T Consensus       248 i~~-~~~~------~~p~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         248 VME-GGLL------DKPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             HHT-TCCC------CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHh-CCCC------CCcccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            221 1111      1112233    35899999999999999999999999887653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.3e-50  Score=389.50  Aligned_cols=250  Identities=25%  Similarity=0.362  Sum_probs=198.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC---CCCHHHHHHH---HHHHhhcCCCceeeEEEeeecCCCCe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG---QQGDKEFLVE---VEMLSRLHHRNLVKLVGYYSSRDSSQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~  169 (443)
                      ++|++.++||+|+||.||+|+. .+|+.||||++....   ......+.+|   +++++.++|||||++++++.  +...
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~--~~~~   81 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDK   81 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--CSSE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE--ECCE
Confidence            6799999999999999999996 479999999985321   1223344444   66777778999999999987  4458


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+++|+|.++|..    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        82 ~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             EEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence            9999999999999999964    345889999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR  328 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  328 (443)
                      +......    .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||.........   .........   
T Consensus       155 ~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~~~~~~~~---  224 (364)
T d1omwa3         155 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTM---  224 (364)
T ss_dssp             EECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---HHHHHSSSC---
T ss_pred             eecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcccC---
Confidence            8765432    234579999999999874 56899999999999999999999999754433221   111111111   


Q ss_pred             ccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHHH
Q 013404          329 LEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPT-----MGEVVQSL  374 (443)
Q Consensus       329 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L  374 (443)
                           .......++.    .+.+|+.+||+.||++|||     ++|+++|-
T Consensus       225 -----~~~~~~~~s~----~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp  266 (364)
T d1omwa3         225 -----AVELPDSFSP----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  266 (364)
T ss_dssp             -----CCCCCSSSCH----HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSG
T ss_pred             -----CCCCCCCCCH----HHHHHHHHHcccCHHHhCCCcccCHHHHHcCc
Confidence                 1111122333    4789999999999999999     68998874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=387.03  Aligned_cols=256  Identities=24%  Similarity=0.260  Sum_probs=201.0

Q ss_pred             hcCCCCCc-eeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhc-CCCceeeEEEeeec--CCCCee
Q 013404           96 TNNFEPAS-ILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRL-HHRNLVKLVGYYSS--RDSSQH  170 (443)
Q Consensus        96 ~~~~~~~~-~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--~~~~~~  170 (443)
                      .++|++.+ .||+|+||.||+|+. .+|+.||||+++.     ...+.+|+.++.++ +|||||+++++|..  .....+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35788775 599999999999995 5789999999863     35678899987665 89999999999864  234568


Q ss_pred             EEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC---CCceEEcccc
Q 013404          171 LLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN---NFHAKVADFG  247 (443)
Q Consensus       171 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfg  247 (443)
                      ++|||||+||+|.++|....  ...+++.++..++.||+.||+|||+++   |+||||||+|||+++   ++.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence            99999999999999997532  346999999999999999999999999   999999999999985   5679999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD  327 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  327 (443)
                      +++.......   .....||+.|+|||++.+..|+.++|||||||++|||+||+.||..........   ..        
T Consensus       160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~--------  225 (335)
T d2ozaa1         160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GM--------  225 (335)
T ss_dssp             TCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred             eeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HH--------
Confidence            9987655432   345689999999999999999999999999999999999999996443221110   00        


Q ss_pred             cccccccCccCCCCC--HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 013404          328 RLEELADPRLGGKYP--KEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKM  376 (443)
Q Consensus       328 ~~~~~~d~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~  376 (443)
                       ...+......-..+  ......+.+|+.+||+.||++|||+.|+++|-+.
T Consensus       226 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  275 (335)
T d2ozaa1         226 -KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  275 (335)
T ss_dssp             ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred             -HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence             00011111100011  1223458899999999999999999999987543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=384.87  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=202.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccC---CCCCHHHHHHHHHHHh-hcCCCceeeEEEeeecCCCCeeE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCG---GQQGDKEFLVEVEMLS-RLHHRNLVKLVGYYSSRDSSQHL  171 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~~  171 (443)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..   .....+.+..|..++. .++|||||++++++.  +....+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~--~~~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ--TKENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc--cCCcee
Confidence            5799999999999999999996 47899999999643   2334556777777765 689999999999998  455899


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      +||||+++|+|.+++..    ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.
T Consensus        80 ivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~  152 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  152 (320)
T ss_dssp             EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence            99999999999999974    345889999999999999999999999   99999999999999999999999999987


Q ss_pred             CCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccccccc
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDRLEE  331 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (443)
                      ......  ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+....     
T Consensus       153 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~-----  219 (320)
T d1xjda_         153 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDN-----  219 (320)
T ss_dssp             CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-----
T ss_pred             cccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-----
Confidence            654332  23456899999999999999999999999999999999999999974321      11122222211     


Q ss_pred             cccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHHH
Q 013404          332 LADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMG-EVVQS  373 (443)
Q Consensus       332 ~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~~  373 (443)
                         +.....++    ..+.+|+.+||+.||++||++. |+++|
T Consensus       220 ---~~~p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         220 ---PFYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ---CCCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---CCCCccCC----HHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence               11112233    3478999999999999999995 78765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=376.09  Aligned_cols=259  Identities=25%  Similarity=0.284  Sum_probs=193.3

Q ss_pred             CCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCC-----HHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404          101 PASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQG-----DKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus       101 ~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      .+++||+|+||+||+|+. .+|+.||||+++......     .+.+.+|+.++++++|||||++++++.  +....++||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~--~~~~~~ivm   79 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKSNISLVF   79 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTTCCEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec--cCCceeehh
Confidence            357899999999999995 578999999987543221     246889999999999999999999997  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+.++++..++..    ...+++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        80 E~~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          80 DFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             ECCSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             hhhcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCC
Confidence            99998877766643    345889999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc--c---
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD--R---  328 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~---  328 (443)
                      ...  .....+||+.|+|||++... .++.++|||||||++|||++|..||......   ..............  .   
T Consensus       153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~  227 (299)
T d1ua2a_         153 PNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPD  227 (299)
T ss_dssp             CCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSS
T ss_pred             Ccc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccc
Confidence            332  23345799999999998754 6799999999999999999999999643321   11111111110000  0   


Q ss_pred             ccccccCcc---CCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          329 LEELADPRL---GGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       329 ~~~~~d~~~---~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .........   ....+.     .....+.+|+.+||+.||++|||++|+++|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000000000   001111     112358899999999999999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=376.22  Aligned_cols=265  Identities=22%  Similarity=0.328  Sum_probs=197.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++....  ...+.+.+|+++|++++|||||++++++..  ....++|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence            5899999999999999999995 5789999999975432  235689999999999999999999999984  4589999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      |||+.+ ++.+++...  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~e~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             EECCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             EeecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceecc
Confidence            999976 444444321  1345999999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc-ccc
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR-LEE  331 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  331 (443)
                      ....  ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+..  ..+............. ...
T Consensus       154 ~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~~  229 (298)
T d1gz8a_         154 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPG  229 (298)
T ss_dssp             CCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTT
T ss_pred             CCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhccc
Confidence            4332  234458999999999887665 578999999999999999999999743211  1111111100000000 000


Q ss_pred             c-ccCccCCCC------C-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          332 L-ADPRLGGKY------P-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       332 ~-~d~~~~~~~------~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      . ..+......      .     ......+.+++.+||+.||++|||++|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0 000000000      0     0112357889999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=371.46  Aligned_cols=240  Identities=23%  Similarity=0.388  Sum_probs=195.2

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC------CHHHHHHHHHHHhhcC--CCceeeEEEeeecCCC
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ------GDKEFLVEVEMLSRLH--HRNLVKLVGYYSSRDS  167 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  167 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++......      ....+.+|+.++++++  |||||++++++.  +.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~~   81 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RP   81 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--CS
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--eC
Confidence            5799999999999999999995 57899999998643211      1234678999999996  999999999987  44


Q ss_pred             CeeEEEEeecCC-CChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-CCceEEcc
Q 013404          168 SQHLLCYELVPN-GSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-NFHAKVAD  245 (443)
Q Consensus       168 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~D  245 (443)
                      ...++||||+.+ +++.+++..    ...+++.++..++.|++.||+|||+++   |+||||||+|||++. ++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence            588999999976 688888764    345899999999999999999999999   999999999999985 57999999


Q ss_pred             ccccccCCCCCccccccccccCcccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      ||+++......    .+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+            .+..
T Consensus       155 FG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~  218 (273)
T d1xwsa_         155 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR  218 (273)
T ss_dssp             CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHH
T ss_pred             cccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhh
Confidence            99998754332    345689999999999987765 577899999999999999999996321            1111


Q ss_pred             ccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          325 DKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       325 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...        .....++.    .+.+++.+||+.||++|||++|+++|
T Consensus       219 ~~~--------~~~~~~s~----~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         219 GQV--------FFRQRVSS----ECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CCC--------CCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccc--------CCCCCCCH----HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            111        11123343    47899999999999999999999876

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.8e-49  Score=370.89  Aligned_cols=263  Identities=24%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             cCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.+.||+|+||+||+|+..+|+.||||+++....  ...+.+.+|+.+|++++|||||++++++.  +....++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH--TKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE--CSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc--cCCceeEEE
Confidence            57999999999999999999998999999999975432  23568999999999999999999999998  445789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAPE  254 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  254 (443)
                      ||+.++.+..+...    ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        80 e~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          80 EHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             ECCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             EeehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            99988777666653    346999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcc--c---c
Q 013404          255 GRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDK--D---R  328 (443)
Q Consensus       255 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~---~  328 (443)
                      ...  ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......  ..+...... ....  .   .
T Consensus       153 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~--~~~~~i~~~-~~~~~~~~~~~  227 (286)
T d1ob3a_         153 PVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRI-LGTPNSKNWPN  227 (286)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHH-HCCCCTTTSTT
T ss_pred             Ccc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH--HHHHHHHHh-hCCCChhhccc
Confidence            322  23345689999999998754 5689999999999999999999999643211  111111110 0000  0   0


Q ss_pred             ccccc--cCccC-------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          329 LEELA--DPRLG-------GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       329 ~~~~~--d~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .....  +....       ..........+.+++.+||+.||++|||++|+++|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000  00000       00111112357899999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-48  Score=368.69  Aligned_cols=266  Identities=24%  Similarity=0.314  Sum_probs=198.0

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CC-CcEEEEEEeccCC--CCCHHHHHHHHHHHhhc---CCCceeeEEEeeec---C
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SD-GTAVAIKRLTCGG--QQGDKEFLVEVEMLSRL---HHRNLVKLVGYYSS---R  165 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---~  165 (443)
                      .++|++.+.||+|+||+||+|+. .+ ++.||||+++...  ......+.+|+.+|+.|   +||||++++++|..   .
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999996 34 5679999986432  22234567888887766   79999999998853   2


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcc
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVAD  245 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  245 (443)
                      .....+++|||++++++.......   ...+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence            334678999999887776555432   345899999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          246 FGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       246 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      ||+++......   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||......  ..+.. .......
T Consensus       160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~-i~~~~~~  233 (305)
T d1blxa_         160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGK-ILDVIGL  233 (305)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH-HHHHHCC
T ss_pred             hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHH-HHHhhCC
Confidence            99988654322   234568999999999999999999999999999999999999999744321  11111 1111100


Q ss_pred             ccc--------c-cccccCc---cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          326 KDR--------L-EELADPR---LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       326 ~~~--------~-~~~~d~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ...        . .......   ....+.......+.+|+.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000        0 0000000   0000111122347789999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.1e-46  Score=359.10  Aligned_cols=261  Identities=17%  Similarity=0.260  Sum_probs=199.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCCeeEEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSSQHLLCY  174 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~lv~  174 (443)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++.   ...+.+.+|+++|++++ ||||+++++++........++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999996 5789999999974   34578899999999995 99999999998866666789999


Q ss_pred             eecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCC-CceEEccccccccCC
Q 013404          175 ELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENN-FHAKVADFGLAKQAP  253 (443)
Q Consensus       175 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~  253 (443)
                      ||+.+++|..+.+       .+++..+..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+++...
T Consensus       112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             eecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            9999999987643       4899999999999999999999999   9999999999999865 469999999998765


Q ss_pred             CCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcch--H---------HHHHHH
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQEN--L---------VTWARP  321 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~--~---------~~~~~~  321 (443)
                      ....   .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..........  .         ..|...
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            4432   2445789999999998765 57999999999999999999999996443211100  0         000000


Q ss_pred             Hhhc-cccccccccCc--------cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          322 ILRD-KDRLEELADPR--------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       322 ~~~~-~~~~~~~~d~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      .... ...........        ............+.+|+.+||+.||++|||++|+++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000 00000000000        0000111122347899999999999999999999976

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-47  Score=366.98  Aligned_cols=263  Identities=25%  Similarity=0.325  Sum_probs=192.7

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeec----CCCCeeEE
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSS----RDSSQHLL  172 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~~~l  172 (443)
                      +|+..++||+|+||+||+|+. .+|+.||||+++....    .+.+|+++|++++||||++++++|..    .+....+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            578889999999999999996 4799999999975432    23479999999999999999998853    23345789


Q ss_pred             EEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCC-ceEEcccccccc
Q 013404          173 CYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNF-HAKVADFGLAKQ  251 (443)
Q Consensus       173 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~  251 (443)
                      ||||++++.+..+.+. ......+++.++..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~l~~~-~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHHhh-hhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999987544433321 112446999999999999999999999999   99999999999999765 899999999987


Q ss_pred             CCCCCccccccccccCccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH-------h
Q 013404          252 APEGRTNYLSTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI-------L  323 (443)
Q Consensus       252 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-------~  323 (443)
                      ......   .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......  ..+.......       +
T Consensus       173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHHH
T ss_pred             ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHHhCCChHHhh
Confidence            654332   234579999999998775 57899999999999999999999999644321  1111111100       0


Q ss_pred             -hccccccccccCccC-----CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          324 -RDKDRLEELADPRLG-----GKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       324 -~~~~~~~~~~d~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                       ..........-+...     ..........+.+|+.+||+.||++|||+.|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000000000000000     00111122347899999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=358.08  Aligned_cols=268  Identities=19%  Similarity=0.287  Sum_probs=195.8

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCC--CCCHHHHHHHHHHHhhcCCCceeeEEEeeecCC------C
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGG--QQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD------S  167 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  167 (443)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....  ......+.+|+++|++++||||+++++++....      .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999996 579999999986542  234567899999999999999999999875422      3


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...+++|||+.++.+..+...    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            467899999988776655442    345888999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCcc--ccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhh
Q 013404          248 LAKQAPEGRTN--YLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILR  324 (443)
Q Consensus       248 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  324 (443)
                      +++........  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....   ............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~---~~~~~~i~~~~~  239 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE---QHQLALISQLCG  239 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH---HHHHHHHHHhcC
Confidence            99866543221  112335799999999998765 689999999999999999999999964321   111111111111


Q ss_pred             c-cccc-cccc--------cCccCCCCCH-HH------HHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          325 D-KDRL-EELA--------DPRLGGKYPK-ED------FIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       325 ~-~~~~-~~~~--------d~~~~~~~~~-~~------~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      . .... ....        ........+. +.      ...+.+|+.+||+.||++|||++|+++|-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp  306 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  306 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence            0 0000 0000        0000000111 11      22467899999999999999999999873

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=366.43  Aligned_cols=266  Identities=24%  Similarity=0.316  Sum_probs=195.6

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC-CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCC--CeeE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ-QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDS--SQHL  171 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~~~  171 (443)
                      +.+|++++.||+|+||+||+|+. .+|+.||||++..... ...+.+++|+++|++++||||+++++++.....  ...+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999985 5899999999975432 224578999999999999999999999864321  1334


Q ss_pred             EEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccccc
Q 013404          172 LCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       172 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++++|+.+|+|.+++..     ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.
T Consensus        87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            55667779999999963     35899999999999999999999999   99999999999999999999999999986


Q ss_pred             CCCCCcc-ccccccccCcccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhcccc-
Q 013404          252 APEGRTN-YLSTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKDR-  328 (443)
Q Consensus       252 ~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  328 (443)
                      ....... .......||+.|+|||++. +..++.++||||+||++|||++|+.||...........   .......... 
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~---~~~~~~~~~~~  235 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQE  235 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH---HhhhccCCChh
Confidence            6443221 1234467999999999985 45678999999999999999999999975432111110   0000000000 


Q ss_pred             ---------ccc--cccCccCCCCCH-----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          329 ---------LEE--LADPRLGGKYPK-----EDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       329 ---------~~~--~~d~~~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                               ...  ...+. ....+.     .....+.+|+.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhcccccCCc-cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                     000  00000 000111     011247899999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=364.30  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=193.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecCC----CC
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSRD----SS  168 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  168 (443)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++.....  ..+.+.+|+++|++++|||||+++++|...+    ..
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999995 57999999999754332  2457889999999999999999999987533    23


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccc
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGL  248 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl  248 (443)
                      ..++||||+ +.+|..+++     ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence            579999999 668888775     345999999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHH-----
Q 013404          249 AKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPI-----  322 (443)
Q Consensus       249 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----  322 (443)
                      ++.....     .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+...  .+.......     
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPA  240 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCH
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhccCCCcH
Confidence            9876543     2345799999999998764 56899999999999999999999997543211  111100000     


Q ss_pred             --------------hhccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          323 --------------LRDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       323 --------------~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                                    ...................+    ..+.+|+.+||+.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS----PLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC----HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhhhcchhhhhhhccCCcccccchHHhccCCC----HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                          00000000000000111222    246789999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-46  Score=353.54  Aligned_cols=262  Identities=20%  Similarity=0.311  Sum_probs=198.7

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEEEe
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLCYE  175 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv~e  175 (443)
                      ++|++.+.||+|+||.||+|+. .+|+.||||.+.....  ..++..|+++++.++|+|++..+..+.. +....++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe-cCCEEEEEEE
Confidence            5799999999999999999995 5689999999875433  3457899999999988776665555433 4457889999


Q ss_pred             ecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEec---CCCceEEccccccccC
Q 013404          176 LVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLE---NNFHAKVADFGLAKQA  252 (443)
Q Consensus       176 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~  252 (443)
                      |+ +++|.+.+...   ...+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+..
T Consensus        84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             Ec-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99 55777666432   345899999999999999999999999   99999999999975   3567999999999876


Q ss_pred             CCCCcc-----ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH-HHHHHHhhcc
Q 013404          253 PEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-TWARPILRDK  326 (443)
Q Consensus       253 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~  326 (443)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .+....... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-
Confidence            543321     1223567999999999999999999999999999999999999999754433222211 111111111 


Q ss_pred             ccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHh
Q 013404          327 DRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQR  379 (443)
Q Consensus       327 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~  379 (443)
                       ..     +.+...++.    .+.+++..||+.||++||+++++.+.|+.+..
T Consensus       236 -~~-----~~~~~~~p~----~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         236 -PI-----EVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             -CH-----HHHTTTSCH----HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             -Ch-----hHhccCCCH----HHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence             00     111223343    37899999999999999999999988887654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-46  Score=351.00  Aligned_cols=264  Identities=22%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             cCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCC--CCHHHHHHHHHHHhhcCCCceeeEEEeeecCCCCeeEEE
Q 013404           97 NNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQ--QGDKEFLVEVEMLSRLHHRNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~lv  173 (443)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++....  .....+.+|+.+|+.++||||++++++|.  +....+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc--cccceeEE
Confidence            5799999999999999999995 5789999999975533  23568999999999999999999999998  45588999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEccccccccCC
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLAKQAP  253 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  253 (443)
                      ++++.+++|..++..    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++...
T Consensus        80 ~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          80 FEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhccc
Confidence            999999999888864    345889999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCccccccccccCcccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhccc-----
Q 013404          254 EGRTNYLSTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRDKD-----  327 (443)
Q Consensus       254 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  327 (443)
                      ....  ......++..|+|||.+.... ++.++|||||||++|||++|+.||.....  .......+........     
T Consensus       153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~  228 (292)
T d1unla_         153 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             SCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCT
T ss_pred             CCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhh
Confidence            4432  223446788999999987665 68999999999999999999999753221  1111111111111100     


Q ss_pred             ccccccc---------CccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 013404          328 RLEELAD---------PRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQS  373 (443)
Q Consensus       328 ~~~~~~d---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~  373 (443)
                      ......+         ..............+.+|+.+||+.||++|||++||++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000         000011112223357889999999999999999999876

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-45  Score=349.01  Aligned_cols=265  Identities=18%  Similarity=0.217  Sum_probs=206.8

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC-CceeeEEEeeecCCCCeeEEE
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDSSQHLLC  173 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~~lv  173 (443)
                      .++|++.+.||+|+||.||+|+. .+|+.||||.+....  ....+.+|++.++.++| +|++.+++++.  +....++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee--cCCccEEE
Confidence            36799999999999999999995 478999999986443  23457889999999965 89999999887  44578999


Q ss_pred             EeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecC-----CCceEEccccc
Q 013404          174 YELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLEN-----NFHAKVADFGL  248 (443)
Q Consensus       174 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgl  248 (443)
                      |||+ +++|.++++..   ...+++.++..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+
T Consensus        80 me~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          80 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccce
Confidence            9999 78999998643   335899999999999999999999999   999999999999964     57899999999


Q ss_pred             cccCCCCCcc-----ccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHh
Q 013404          249 AKQAPEGRTN-----YLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPIL  323 (443)
Q Consensus       249 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  323 (443)
                      |+........     .......||+.|||||++.+..++.++|||||||++|||++|+.||...................
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            9876433221     11234679999999999999999999999999999999999999997554433322211111110


Q ss_pred             hccccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHhHhhh
Q 013404          324 RDKDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSLKMVQRVI  381 (443)
Q Consensus       324 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~  381 (443)
                       ......     .+...+|.    .+.+++..|++.+|++||+++.+.+.|+.+.+..
T Consensus       233 -~~~~~~-----~l~~~~p~----~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         233 -QSTPLR-----ELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             -HHSCHH-----HHTTTSCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -CCCChH-----HhcCCCCH----HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence             001111     11223443    4788999999999999999999999888876543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-46  Score=357.94  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=200.4

Q ss_pred             cCCCCCceeeecCcEEEEEEEE----CCCcEEEEEEeccCC----CCCHHHHHHHHHHHhhcCC-CceeeEEEeeecCCC
Q 013404           97 NNFEPASILGEGGFGRVFKGVL----SDGTAVAIKRLTCGG----QQGDKEFLVEVEMLSRLHH-RNLVKLVGYYSSRDS  167 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  167 (443)
                      ++|++.+.||+|+||+||+|..    .+|+.||||.++...    ....+.+.+|++++++++| |||+++++++..  .
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~  101 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E  101 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--C
Confidence            5799999999999999999984    247899999986432    2335678899999999976 899999999874  4


Q ss_pred             CeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccc
Q 013404          168 SQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFG  247 (443)
Q Consensus       168 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  247 (443)
                      ...+++|||+.+|+|.+++..    ...+.+..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG  174 (322)
T d1vzoa_         102 TKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG  174 (322)
T ss_dssp             TEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             CceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence            488999999999999999964    234678899999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCccccccccccCcccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc
Q 013404          248 LAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD  325 (443)
Q Consensus       248 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  325 (443)
                      +++........ ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||..........  .........
T Consensus       175 ~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~~~  251 (322)
T d1vzoa_         175 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS  251 (322)
T ss_dssp             EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC
T ss_pred             chhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcccC
Confidence            99876543322 23446799999999998754  46889999999999999999999997654433221  111111111


Q ss_pred             cccccccccCccCCCCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 013404          326 KDRLEELADPRLGGKYPKEDFIRVCTIAAACVAPEANQRP-----TMGEVVQSL  374 (443)
Q Consensus       326 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L  374 (443)
                      .        +    .++......+.+++.+||+.||++||     |++|+++|-
T Consensus       252 ~--------~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hp  293 (322)
T d1vzoa_         252 E--------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  293 (322)
T ss_dssp             C--------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             C--------C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCH
Confidence            1        1    11222334588999999999999999     488998763

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=356.27  Aligned_cols=265  Identities=22%  Similarity=0.281  Sum_probs=190.5

Q ss_pred             cCCCCCceeeecCcEEEEEEEEC-CCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecC----CCCe
Q 013404           97 NNFEPASILGEGGFGRVFKGVLS-DGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR----DSSQ  169 (443)
Q Consensus        97 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~  169 (443)
                      ++|++.++||+|+||+||+|... +|+.||||++......  ....+.+|+.++++++|||||+++++|...    +...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999964 6999999999755332  235688999999999999999999998643    3357


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .++||||+.++ |.+.+.      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            89999999765 444543      24889999999999999999999999   999999999999999999999999998


Q ss_pred             ccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHH-------------
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLV-------------  316 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~-------------  316 (443)
                      +......   ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+........             
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            8665432   234567999999999999999999999999999999999999999643311100000             


Q ss_pred             ---HHHHHHhhccccc-----cccccCccCCC---CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          317 ---TWARPILRDKDRL-----EELADPRLGGK---YPKEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       317 ---~~~~~~~~~~~~~-----~~~~d~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                         .............     ...........   ........+.+|+.+||+.||++|||++||++|-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp  312 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  312 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence               0000001110000     00000000000   1123345688999999999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=356.35  Aligned_cols=263  Identities=22%  Similarity=0.315  Sum_probs=194.1

Q ss_pred             hcCCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCC--CHHHHHHHHHHHhhcCCCceeeEEEeeecC---CCCe
Q 013404           96 TNNFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQ--GDKEFLVEVEMLSRLHHRNLVKLVGYYSSR---DSSQ  169 (443)
Q Consensus        96 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~  169 (443)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++.....  ..+.+.+|+++|++++|||+|++++++...   +...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999995 57999999999755332  235688999999999999999999988642   2234


Q ss_pred             eEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCceEEcccccc
Q 013404          170 HLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHAKVADFGLA  249 (443)
Q Consensus       170 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla  249 (443)
                      .+++++|+.+|+|.+++..     ..+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence            5667788889999999963     35999999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCccccccccccCcccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHHHHHHhhc-cc
Q 013404          250 KQAPEGRTNYLSTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWARPILRD-KD  327 (443)
Q Consensus       250 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~  327 (443)
                      .....     ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+...   ........... ..
T Consensus       169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGA  240 (348)
T ss_dssp             -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCH
T ss_pred             cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCh
Confidence            76532     22345789999999987765 46889999999999999999999996432111   11100000000 00


Q ss_pred             ccc---------ccccCcc-CCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 013404          328 RLE---------ELADPRL-GGKYP-----KEDFIRVCTIAAACVAPEANQRPTMGEVVQSL  374 (443)
Q Consensus       328 ~~~---------~~~d~~~-~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L  374 (443)
                      ...         ....... .....     ......+.+|+.+||+.||++|||++|+++|-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp  302 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  302 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence            000         0000000 00000     01123477899999999999999999999873

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-41  Score=328.72  Aligned_cols=266  Identities=19%  Similarity=0.221  Sum_probs=191.4

Q ss_pred             CCCCCceeeecCcEEEEEEEE-CCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-----------CCceeeEEEeeecC
Q 013404           98 NFEPASILGEGGFGRVFKGVL-SDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-----------HRNLVKLVGYYSSR  165 (443)
Q Consensus        98 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~  165 (443)
                      +|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            489999999999999999995 579999999997432 12356788999988875           57899999988755


Q ss_pred             CCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-cCCCceEecCCCcccEEecCCC-----
Q 013404          166 DSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-DSQPCVIHRDFKASNILLENNF-----  239 (443)
Q Consensus       166 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~-----  239 (443)
                      .....+++++++..+......... .....+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++     
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            555667777776655433322111 124568889999999999999999997 77   99999999999998654     


Q ss_pred             -ceEEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCcchHHHH
Q 013404          240 -HAKVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTW  318 (443)
Q Consensus       240 -~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il~elltg~~p~~~~~~~~~~~~~~~  318 (443)
                       .++++|||.+......     .....||+.|+|||++.+..++.++||||+||+++||++|+.||..............
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence             4999999999865432     2345799999999999999999999999999999999999999975433221111111


Q ss_pred             HHHHhh---c--------cccccccccC-----c--------------cCCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 013404          319 ARPILR---D--------KDRLEELADP-----R--------------LGGKYPKEDFIRVCTIAAACVAPEANQRPTMG  368 (443)
Q Consensus       319 ~~~~~~---~--------~~~~~~~~d~-----~--------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  368 (443)
                      ....+.   .        ........+.     .              ............+.+|+.+||+.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            111000   0        0000000000     0              01123455667799999999999999999999


Q ss_pred             HHHHH
Q 013404          369 EVVQS  373 (443)
Q Consensus       369 evl~~  373 (443)
                      |+++|
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHhcC
Confidence            99876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.1e-25  Score=197.69  Aligned_cols=169  Identities=15%  Similarity=0.129  Sum_probs=121.9

Q ss_pred             CCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCC-------------C-----HHHHHHHHHHHhhcCCCceeeEEEe
Q 013404          100 EPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQ-------------G-----DKEFLVEVEMLSRLHHRNLVKLVGY  161 (443)
Q Consensus       100 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------------~-----~~~~~~E~~~l~~l~h~niv~l~~~  161 (443)
                      .+.++||+|+||.||+|...+|+.||||.++.....             .     ......|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            457899999999999999888999999987632110             0     1234568889999999999998765


Q ss_pred             eecCCCCeeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcCCCceEecCCCcccEEecCCCce
Q 013404          162 YSSRDSSQHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDSQPCVIHRDFKASNILLENNFHA  241 (443)
Q Consensus       162 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~  241 (443)
                      .      ..+++|||+++..+.+           ++......++.|++++|+|||+++   |+||||||+|||++++ .+
T Consensus        83 ~------~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~  141 (191)
T d1zara2          83 E------GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI  141 (191)
T ss_dssp             E------TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred             c------CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence            3      2379999998765543           344566789999999999999999   9999999999999976 58


Q ss_pred             EEccccccccCCCCCccccccccccCcccccccccccCCCCchhhHHHHHHHH
Q 013404          242 KVADFGLAKQAPEGRTNYLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVL  294 (443)
Q Consensus       242 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G~il  294 (443)
                      +|+|||+|..............   .... -.+ +....|+.++|+||..--+
T Consensus       142 ~liDFG~a~~~~~~~~~~~l~r---d~~~-~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         142 WIIDFPQSVEVGEEGWREILER---DVRN-IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EECCCTTCEETTSTTHHHHHHH---HHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             EEEECCCcccCCCCCcHHHHHH---HHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence            9999999987643322110000   0000 001 1235678889999976444

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.81  E-value=1.3e-08  Score=91.75  Aligned_cols=149  Identities=15%  Similarity=0.091  Sum_probs=101.7

Q ss_pred             HHHHHHhcCCCCCceeeecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcC-CCceeeEEEeeecCCCC
Q 013404           90 EELKEATNNFEPASILGEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLH-HRNLVKLVGYYSSRDSS  168 (443)
Q Consensus        90 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  168 (443)
                      .++...-..|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.++.  +.+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~   83 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDG   83 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETT
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe--cCC
Confidence            46777777887666555555678998865 45667888886554444556788998888774 333556776665  334


Q ss_pred             eeEEEEeecCCCChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhhcC-----------------------------
Q 013404          169 QHLLCYELVPNGSLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHEDS-----------------------------  219 (443)
Q Consensus       169 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------  219 (443)
                      ..++||++++|.++.+....         ......++.++++.+..||+..                             
T Consensus        84 ~~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          84 WSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             EEEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             ceEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            78899999999888665421         1122334455555555555321                             


Q ss_pred             ---------------------------CCceEecCCCcccEEecCCCceEEccccccc
Q 013404          220 ---------------------------QPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       220 ---------------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                                                 .+.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                       2348999999999999988777799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.42  E-value=6.1e-07  Score=79.91  Aligned_cols=130  Identities=22%  Similarity=0.162  Sum_probs=84.0

Q ss_pred             eeeecCc-EEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCC--CceeeEEEeeecCCCCeeEEEEeecCCC
Q 013404          104 ILGEGGF-GRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHH--RNLVKLVGYYSSRDSSQHLLCYELVPNG  180 (443)
Q Consensus       104 ~lg~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~~lv~e~~~~g  180 (443)
                      .+..|.. +.||+....++..+++|......   ...+..|+..++.+..  -.+.++++++.  +....+++|+|++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEEEEEeeecc
Confidence            3445543 67999988888889999876433   2346778888887743  33456777655  344778999999887


Q ss_pred             ChhHhhcCCCCCCCCCChHHHHHHHHHHHHHHHHhhh-------------------------------------------
Q 013404          181 SLESWLHGPLGVNCHLDWETRMKIALDAARGLAYLHE-------------------------------------------  217 (443)
Q Consensus       181 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------------  217 (443)
                      ++.+..         ..   ....+.++++.|.-||.                                           
T Consensus        92 ~~~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (255)
T d1nd4a_          92 DLLSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  159 (255)
T ss_dssp             ETTTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             cccccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence            664321         00   01112222233333332                                           


Q ss_pred             ------------cCCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          218 ------------DSQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       218 ------------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                                  ...+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                        123448999999999999988777899999775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.91  E-value=4e-05  Score=72.57  Aligned_cols=76  Identities=17%  Similarity=0.135  Sum_probs=48.0

Q ss_pred             CceeeecCcEEEEEEEEC-CCcEEEEEEecc----CC---CCCHHHHHHHHHHHhhcC-C--CceeeEEEeeecCCCCee
Q 013404          102 ASILGEGGFGRVFKGVLS-DGTAVAIKRLTC----GG---QQGDKEFLVEVEMLSRLH-H--RNLVKLVGYYSSRDSSQH  170 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~  170 (443)
                      .+.||.|....||+.... +++.|+||.-..    ..   .....+...|.+.|+.+. +  ..+.+++.+..  +  ..
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~--~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--E--MA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--T--TT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--C--CC
Confidence            356899999999999864 467899996432    11   112344567888887763 2  34556665532  2  45


Q ss_pred             EEEEeecCCCC
Q 013404          171 LLCYELVPNGS  181 (443)
Q Consensus       171 ~lv~e~~~~gs  181 (443)
                      +++||++++..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            78999997654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.31  E-value=0.0008  Score=63.31  Aligned_cols=73  Identities=23%  Similarity=0.281  Sum_probs=49.9

Q ss_pred             CceeeecCcEEEEEEEECCC--------cEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCcee-eEEEeeecCCCCeeEE
Q 013404          102 ASILGEGGFGRVFKGVLSDG--------TAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNLV-KLVGYYSSRDSSQHLL  172 (443)
Q Consensus       102 ~~~lg~G~fg~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~~l  172 (443)
                      .+.|+.|-.-.+|+....++        ..|.+++.- . ........+|..+++.+.-.++. ++++++.  +    .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS--G----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C----ce
Confidence            36788899999999986543        456666654 2 23345567899999988533444 6777763  2    57


Q ss_pred             EEeecCCCCh
Q 013404          173 CYELVPNGSL  182 (443)
Q Consensus       173 v~e~~~~gsL  182 (443)
                      |+||++|..|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            8999987554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.29  E-value=0.00069  Score=61.96  Aligned_cols=139  Identities=16%  Similarity=0.114  Sum_probs=77.8

Q ss_pred             cEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCce--eeEEEe---eecCCCCeeEEEEeecCCCChh-
Q 013404          110 FGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLVGY---YSSRDSSQHLLCYELVPNGSLE-  183 (443)
Q Consensus       110 fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~---~~~~~~~~~~lv~e~~~~gsL~-  183 (443)
                      --.||+++.++|..|++|..+.. ....+++..|...+..|...++  +..+..   .........+.++++++|..+. 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            46899999999999999998643 3346778889998888743222  111111   0001233567889998764331 


Q ss_pred             ----Hhh-------------cCCC-CCCCCCCh-------------------HH---HHHHHHHHHHHHHHh-hhcCCCc
Q 013404          184 ----SWL-------------HGPL-GVNCHLDW-------------------ET---RMKIALDAARGLAYL-HEDSQPC  222 (443)
Q Consensus       184 ----~~l-------------~~~~-~~~~~l~~-------------------~~---~~~i~~~i~~~l~~L-H~~~~~~  222 (443)
                          .+-             .... .....+++                   ..   ....+..+...+.-+ .......
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                110             1100 00111111                   11   112223333332222 1223446


Q ss_pred             eEecCCCcccEEecCCCceEEcccccccc
Q 013404          223 VIHRDFKASNILLENNFHAKVADFGLAKQ  251 (443)
Q Consensus       223 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~  251 (443)
                      ++|+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45889998864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.78  E-value=0.018  Score=51.64  Aligned_cols=161  Identities=14%  Similarity=0.065  Sum_probs=84.4

Q ss_pred             cCHHHHHHHhcCCCCCcee-----eecCcEEEEEEEECCCcEEEEEEeccCCCCCHHHHHHHHHHHhhcCCCce--eeEE
Q 013404           87 LAYEELKEATNNFEPASIL-----GEGGFGRVFKGVLSDGTAVAIKRLTCGGQQGDKEFLVEVEMLSRLHHRNL--VKLV  159 (443)
Q Consensus        87 ~~~~~~~~~~~~~~~~~~l-----g~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~  159 (443)
                      ++.+|+.....+|.+.+..     ..|---+.|+.+..+|+ +++|+.....  ...+...|++++..|...++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            4677888888899876554     35666888999887665 8999876432  23445556777777642222  1111


Q ss_pred             Ee----eecCCCCeeEEEEeecCCCChhHhh--------------c---CCCCCCC--CC------------------Ch
Q 013404          160 GY----YSSRDSSQHLLCYELVPNGSLESWL--------------H---GPLGVNC--HL------------------DW  198 (443)
Q Consensus       160 ~~----~~~~~~~~~~lv~e~~~~gsL~~~l--------------~---~~~~~~~--~l------------------~~  198 (443)
                      ..    ....-......++.+..+......-              +   .......  ..                  ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            00    0000112445566666654332100              0   0000000  00                  01


Q ss_pred             HHHHHHHHHHHHHHHHhhhc-CCCceEecCCCcccEEecCCCceEEccccccc
Q 013404          199 ETRMKIALDAARGLAYLHED-SQPCVIHRDFKASNILLENNFHAKVADFGLAK  250 (443)
Q Consensus       199 ~~~~~i~~~i~~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~  250 (443)
                      ......+..+...+...+.. -+.++||+|+.+.||+++++...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11122222333333333321 12349999999999999998777899999875